PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Olsen, JA; Kastrup, JS; Peters, D; Gajhede, M; Balle, T; Ahring, PK				Olsen, Jeppe A.; Kastrup, Jette S.; Peters, Dan; Gajhede, Michael; Balle, Thomas; Ahring, Philip K.			Two Distinct Allosteric Binding Sites at alpha 4 beta 2 Nicotinic Acetylcholine Receptors Revealed by NS206 and NS9283 Give Unique Insights to Binding Activity-associated Linkage at Cys-loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop Receptors; Drug Discovery; Electrophysiology; Nicotinic Acetylcholine Receptors; Xenopus; Allosteric; Modulation	SUBUNIT INTERFACES; ALTERNATE STOICHIOMETRIES; TRANSMEMBRANE SITE; IN-VIVO; MODULATOR; POTENTIATION; SENSITIVITY; SUBTYPES	Background: Positive allosteric modulators (PAMs) of 42 nicotinic acetylcholine receptors have significant therapeutic potential. Results: Two PAMs, NS206 and NS9283, were observed to have differential and additive pharmacological actions due to binding at distinct receptor sites. Conclusion: Modulator binding activity is linked to the specific binding position in Cys-loop receptors. Significance: Diverse PAM profiles increase possibilities for rational drug design and understanding of receptor function. Positive allosteric modulators (PAMs) of 42 nicotinic acetylcholine receptors have the potential to improve cognitive function and alleviate pain. However, only a few selective PAMs of 42 receptors have been described limiting both pharmacological understanding and drug-discovery efforts. Here, we describe a novel selective PAM of 42 receptors, NS206, and compare with a previously reported PAM, NS9283. Using two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes, NS206 was observed to positively modulate acetylcholine (ACh)-evoked currents at both known 42 stoichiometries (2:3 and 3:2). In the presence of NS206, peak current amplitudes surpassed those of maximal efficacious ACh stimulations (E-max(ACh)) with no or limited effects at potencies and current waveforms (as inspected visually). This pharmacological action contrasted with that of NS9283, which only modulated the 3:2 receptor and acted by left shifting the ACh concentration-response relationship. Interestingly, the two modulators can act simultaneously in an additive manner at 3:2 receptors, which results in current levels exceeding E-max(ACh) and a left-shifted ACh concentration-response relationship. Through use of chimeric and point-mutated receptors, the binding site of NS206 was linked to the 4-subunit transmembrane domain, whereas binding of NS9283 was shown to be associated with the -interface in 3:2 receptors. Collectively, these data demonstrate the existence of two distinct modulatory sites in 42 receptors with unique pharmacological attributes that can act additively. Several allosteric sites have been identified within the family of Cys-loop receptors and with the present data, a detailed picture of allosteric modulatory mechanisms of these important receptors is emerging.	[Olsen, Jeppe A.; Peters, Dan] NeuroSearch AS, DK-2750 Ballerup, Denmark; [Olsen, Jeppe A.; Kastrup, Jette S.; Gajhede, Michael] Univ Copenhagen, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Balle, Thomas; Ahring, Philip K.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Aniona ApS, DK-2750 Ballerup, Denmark	University of Copenhagen; University of Sydney	Ahring, PK (corresponding author), Aniona ApS, Baltorpvej 154, DK-2750 Ballerup, Denmark.	pka@aniona.com		Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA research school at the University of Copenhagen, Denmark	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA research school at the University of Copenhagen, Denmark	This work was supported in part by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation and the DRA research school at the University of Copenhagen, Denmark. J. A. O., D. P., and P. K. A. declare that they were employed by NeuroSearch A/S at the time the described work was carried out.	Anderson DJ, 2009, BIOCHEM PHARMACOL, V78, P844, DOI 10.1016/j.bcp.2009.06.024; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Livingstone PD, 2009, BIOCHEM PHARMACOL, V78, P744, DOI 10.1016/j.bcp.2009.06.004; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; MEHTA AK, 1987, J NEUROCHEM, V49, P1491, DOI 10.1111/j.1471-4159.1987.tb01019.x; Mihailescu S, 2000, ARCH MED RES, V31, P131, DOI 10.1016/S0188-4409(99)00087-9; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Pandya A, 2011, BIOCHEM PHARMACOL, V82, P952, DOI 10.1016/j.bcp.2011.04.020; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	32	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35997	36006		10.1074/jbc.M113.498618	http://dx.doi.org/10.1074/jbc.M113.498618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169695	Green Published, hybrid			2022-12-25	WOS:000329814700035
J	Shin, JN; Fattah, EA; Bhattacharya, A; Ko, S; Eissa, NT				Shin, Jin Na; Fattah, Elmoataz Abdel; Bhattacharya, Abhisek; Ko, Soyoung; Eissa, N. Tony			Inflammasome Activation by Altered Proteostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Inflammation; Lysosomes; Macrophages; Protein Misfolding; Inflammasome; Proteostasis	ENDOPLASMIC-RETICULUM STRESS; INDUCED CELL-DEATH; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; PLASMA-MEMBRANE; AUTOPHAGY; DISEASE; RECOGNITION; PROTEINS; CRYSTALS	Background: The mechanisms for association of altered proteostasis and inflammation are not known. Results: The deficiency of either autophagy or p62 led to inflammasome hyperactivation. Conclusion: Accumulation of misfolded proteins caused inflammasome activation by inducing generation of nonmitochondrial ROS and lysosomal damage. Significance: Our results suggest that altered proteostasis results in inflammasome activation and thus provide mechanisms for the association of altered proteostasis with inflammatory disorders. The association between altered proteostasis and inflammatory disorders has been increasingly recognized, but the underlying mechanisms are not well understood. In this study, we show that deficiency of either autophagy or sequestosome 1 (p62 or SQSTM) led to inflammasome hyperactivation in response to LPS and ATP in primary macrophages and in mice in vivo. Importantly, induction of protein misfolding by puromycin, thapsigargin, or geldanamycin resulted in inflammasome activation that was more pronounced in autophagy- or p62-deficient macrophages. Accumulation of misfolded proteins caused inflammasome activation by inducing generation of nonmitochondrial reactive oxygen species and lysosomal damage, leading to release of cathepsin B. Our results suggest that altered proteostasis results in inflammasome activation and thus provide mechanisms for the association of altered proteostasis with inflammatory disorders.	[Shin, Jin Na; Fattah, Elmoataz Abdel; Bhattacharya, Abhisek; Ko, Soyoung; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Eissa, NT (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 285 Ste 535E, Houston, TX 77030 USA.	teissa@bcm.edu	Bhattacharya, Abhisek/AAN-6511-2020	Bhattacharya, Abhisek/0000-0002-1667-7169	National Institutes of Health grant from NHLBI; National Institutes of Health grant from NIAID;  [AI036211];  [CA125123];  [RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health grant from NHLBI; National Institutes of Health grant from NIAID; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants from NHLBI and NIAID and Grants AI036211, CA125123, and RR024574 (to the Cytometry and Cell Sorting Core at Baylor College of Medicine).	Atianand MK, 2013, CELL, V153, P272, DOI 10.1016/j.cell.2013.03.009; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	33	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35886	35895		10.1074/jbc.M113.514919	http://dx.doi.org/10.1074/jbc.M113.514919			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178293	hybrid, Green Published			2022-12-25	WOS:000329814700025
J	Daus, ML; Wagenfuhr, K; Thomzig, A; Boerner, S; Hermann, P; Hermelink, A; Beekes, M; Lasch, P				Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Boerner, Susann; Hermann, Peter; Hermelink, Antje; Beekes, Michael; Lasch, Peter			Infrared Microspectroscopy Detects Protein Misfolding Cyclic Amplification (PMCA)-induced Conformational Alterations in Hamster Scrapie Progeny Seeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Biophysics; Neurodegenerative Diseases; Prions; Protein Misfolding; Infrared Microspectroscopy (IR-MSP); Prion Strains; Prion Structure; Protein Misfolding Cyclic Amplification (PMCA); Seeding Activity	PRION PROTEIN; SECONDARY STRUCTURE; SPECTROSCOPY; STRAINS; DISEASE; MODEL; BETA(2)-MICROGLOBULIN; INFECTIVITY; CONVERSION; INSIGHTS	Background: It is currently under discussion whether protein misfolding cyclic amplification (PMCA) alters strain properties of prions. Results: An improved infrared microspectroscopic approach combined with biochemical and bioassay data revealed altered strain properties of hamster 263K scrapie prions due to PMCA. Conclusion: PMCA can alter strain properties of 263K prions. Significance: Our analytical approach may help to improve the understanding of prion strain conversion. The self-replicative conformation of misfolded prion proteins (PrP) is considered a major determinant for the seeding activity, infectiousness, and strain characteristics of prions in different host species. Prion-associated seeding activity, which converts cellular prion protein (PrPC) into Proteinase K-resistant, infectious PrP particles (PrPTSE), can be monitored in vitro by protein misfolding cyclic amplification (PMCA). Thus, PMCA has been established as a valuable analytical tool in prion research. Currently, however, it is under discussion whether prion strain characteristics are preserved during PMCA when parent seeds are amplified in PrPC substrate from the identical host species. Here, we report on the comparative structural analysis of parent and progeny (PMCA-derived) PrP seeds by an improved approach of sensitive infrared microspectroscopy. Infrared microspectroscopy revealed that PMCA of native hamster 263K scrapie seeds in hamster PrPC substrate caused conformational alterations in progeny seeds that were accompanied by an altered resistance to Proteinase K, higher sedimentation velocities in gradient ultracentrifugations, and a longer incubation time in animal bioassays. When these progeny seeds were propagated in hamsters, misfolded PrP from brain extracts of these animals showed mixed spectroscopic and biochemical properties from both parental and progeny seeds. Thus, strain modifications of 263K prions induced by PMCA seem to have been partially reversed when PMCA products were reinoculated into the original host species.	[Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Boerner, Susann; Beekes, Michael] Robert Koch Inst, FG Unconvent Pathogens & Their Inactivat Appl Inf, D-13353 Berlin, Germany; [Hermann, Peter; Hermelink, Antje; Lasch, Peter] Robert Koch Inst, ZBS Ctr Biol Threats & Special Pathogens Proteom, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Daus, ML (corresponding author), Robert Koch Inst, FG Unconvent Pathogens & Their Inactivat Appl Inf, Nordufer 20, D-13353 Berlin, Germany.	DausM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657; Lasch, Peter/0000-0001-6193-3144	Alberta Prion Research Institute	Alberta Prion Research Institute	This work was supported by the Alberta Prion Research Institute, and the study was carried out within the project "Comprehensive Risk Assessment of CWD Transmission to Humans Using Non-human Primates" aiming at the typing and risk assessment of prion isolates. The technical progress described in this paper for the purification of PrP27-30 and IR-MSP provided a prerequisite for and has been transferred to the above mentioned project for the differentiation of CWD agents in white-tailed deer (manuscript in preparation).	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Barria MA, 2012, METHODS MOL BIOL, V849, P199, DOI 10.1007/978-1-61779-551-0_14; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby D, 2011, COLD SPRING HARB PER, P3; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Daus ML, 2012, PRION, V6, P17, DOI 10.4161/pri.6.1.17776; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Diringer H, 1997, INTERVIROLOGY, V40, P238, DOI 10.1159/000150553; Everest SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019737; FABIAN H, 1994, BIOCHEMISTRY-US, V33, P10725, DOI 10.1021/bi00201a021; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Gonzalez-Montalban N, 2013, FASEB J, V27, P3702, DOI 10.1096/fj.13-230466; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lasch P, 1998, BIOPHYS J, V75, P840, DOI 10.1016/S0006-3495(98)77573-3; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Suzuki SY, 2008, J VET MED SCI, V70, P159, DOI 10.1292/jvms.70.159; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Wang F, 2012, J VIROL, V86, P1874, DOI 10.1128/JVI.06216-11; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35068	35080		10.1074/jbc.M113.497131	http://dx.doi.org/10.1074/jbc.M113.497131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163371	Green Published, hybrid			2022-12-25	WOS:000329867600009
J	Kraut, DA				Kraut, Daniel A.			Slippery Substrates Impair ATP-dependent Protease Function by Slowing Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; Enzyme Kinetics; Pre-steady-state Kinetics; Proteasome; Protein Degradation; Protein Denaturation; Protein Evolution; Protein Translocation; Protein Unfolding	NF-KAPPA-B; DEGRADATION; TRANSLOCATION; INHIBITION; REPEATS; MECHANISM; PROTEINS; PATHWAY; REGION; SIGNAL	Background: ATP-dependent proteases cannot fully degrade so-called slippery substrates. Results: Reanalysis indicates ClpXP has a reduced unfolding rate for slippery substrates, not a faster substrate release rate. Conclusion: The proteasome and ClpXP share a common mechanism of inhibition by slippery substrates. Significance: Comparison of the mechanisms of ATP-dependent proteases across species help explain how these unfolding machines work and evolve. ATP-dependent proteases are responsible for most energy-dependent protein degradation across all species. Proteases initially bind an unstructured region on a substrate and then translocate along the polypeptide chain, unfolding and degrading protein domains as they are encountered. Although this process is normally processive, resulting in the complete degradation of substrate proteins to small peptides, some substrates are released prematurely. Regions of low sequence complexity within the substrate such as the glycine-rich region (GRR) from p105 or glycine-alanine repeats (GAr) from the EBNA1 (Epstein-Barr virus nuclear antigen-1) protein, can trigger partial degradation and fragment release. Loss of processivity could be due to inability to hold on to the substrate (faster release) or inability to unfold and degrade a substrate domain (slower unfolding). I previously showed that the GRR slows domain unfolding by the proteasome (Kraut, D. A., Israeli, E., Schrader, E. K., Patil, A., Nakai, K., Nanavati, D., Inobe, T., and Matouschek, A. (2012) ACS Chem. Biol. 7, 1444-1453). In contrast, a recently published study concluded that GArs increase the rate of substrate release from ClpXP, a bacterial ATP-dependent protease (Too, P. H., Erales, J., Simen, J. D., Marjanovic, A., and Coffino, P. (2013) J. Biol. Chem. 288, 13243-13257). Here, I show that these apparently contradictory results can be reconciled through a reanalysis of the ClpXP GAr data. This reanalysis shows that, as with the proteasome, low complexity sequences in substrates slow their unfolding and degradation by ClpXP, with little effect on release rates. Thus, despite their evolutionary distance and limited sequence identity, both ClpXP and the proteasome share a common mechanism by which substrate sequences regulate the processivity of degradation.	Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University	Kraut, DA (corresponding author), Villanova Univ, Dept Chem, 800 Lancaster Ave, Villanova, PA 19085 USA.	daniel.kraut@villanova.edu		Kraut, Daniel/0000-0002-4428-5832	Villanova University	Villanova University	Supported by a Summer Research Fellowship and Research Support Grant from Villanova University. To whom correspondence should be addressed: Dept. of Chemistry, Villanova University, 800 Lancaster Ave., Villanova, PA 19085. Tel.: 610-519-3910; Fax: 610-519-7167; E-mail: daniel.kraut@villanova.edu.	Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; Fersht A. R., 1999, STRUCTURE MECH PROTE, P149; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gur E, 2012, PROTEIN SCI, V21, P268, DOI 10.1002/pro.2013; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lin L, 1996, MOL CELL BIOL, V16, P2248; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sharipo A, 2001, FEBS LETT, V499, P137, DOI 10.1016/S0014-5793(01)02542-X; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524	25	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34729	34735		10.1074/jbc.M113.512533	http://dx.doi.org/10.1074/jbc.M113.512533			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151080	Green Published, hybrid			2022-12-25	WOS:000329812800039
J	Donskow-Lysoniewska, K; Bien, J; Brodaczewska, K; Krawczak, K; Doligalska, M				Donskow-Lysoniewska, Katarzyna; Bien, Justyna; Brodaczewska, Klaudia; Krawczak, Katarzyna; Doligalska, Maria			Colitis Promotes Adaptation of an Intestinal Nematode: A Heligmosomoides Polygyrus Mouse Model System	PLOS ONE			English	Article							PARASITIC NEMATODE; NEMATOSPIROIDES-DUBIUS; DEXTRAN SULFATE; T-CELLS; EXPRESSION; PROTECTION; COMPONENTS; RESISTANCE	The precise mechanism of the very effective therapeutic effect of gastrointestinal nematodes on some autoimmune diseases is not clearly understood and is currently being intensively investigated. Treatment with living helminths has been initiated to reverse intestinal immune-mediated diseases in humans. However, little attention has been paid to the phenotype of nematodes in the IBD-affected gut and the consequences of nematode adaptation. In the present study, exposure of Heligmosomoides polygyrus larvae to the changed cytokine milieu of the intestine during colitis reduced inflammation in an experimental model of dextran sulphate sodium (DSS)-induced colitis, but increased nematode establishment in the moderate-responder BALB/c mouse strain. We used mass spectrometry in combination with two-dimensional Western blotting to determine changes in protein expression and changes in nematode antigens recognized by IgG1 in mice with colitis. We show that nematode larvae immunogenicity is changed by colitis as soon as 6 days post-infection; IgG1 did not recognize highly conserved proteins Lev-11 (isoform 1 of tropomyosin alpha 1 chain), actin-4 isoform or FTT-2 isoform a (14-3-3 family) protein. These results indicate that changes in the small intestine provoked by colitis directly influence the nematode proteome. The unrecognized proteins seem to be key antigenic epitopes able to induce protective immune responses. The proteome changes were associated with weak immune recognition and increased larval adaptation and worm growth, altered localization in the intestine and increased survival of males but reduced worm fecundity. In this report, the mechanisms influencing nematode survival and the consequences of changed immunogenicity that reflect the immune response at the site colonized by the parasite in mice with colitis are described. The results are relevant to the use of live parasites to ameliorate IBD.	[Donskow-Lysoniewska, Katarzyna; Brodaczewska, Klaudia; Krawczak, Katarzyna; Doligalska, Maria] Univ Warsaw, Dept Parasitol, Warsaw, Poland; [Bien, Justyna] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Donskow-Lysoniewska, K (corresponding author), Univ Warsaw, Dept Parasitol, Warsaw, Poland.	zuzia@biol.uw.edu.pl	Katarzyna, Donskow-Lysoniewska/AAF-8998-2021	Katarzyna, Donskow-Lysoniewska/0000-0003-4924-800X; Doligalska, Maria/0000-0002-3175-4564; Bien-Kalinowska, Justyna/0000-0002-7789-2751; Krawczak - Wojcik, Katarzyna/0000-0001-7557-8059; Brodaczewska, Klaudia K./0000-0003-2374-3600	Polish National Science Centre [N303 819140]	Polish National Science Centre	This work was supported by Polish National Science Centre Grant No. N303 819140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1987, J PARASITOL, V73, P1164, DOI 10.2307/3282298; Andrade MA, 2004, NITRIC OXIDE-BIOL CH, V10, P150, DOI 10.1016/j.niox.2004.03.002; Baermann G., 1917, NEDERLANDS TIJDSCRIF, V57, P131; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; BANSEMIR AD, 1994, J PARASITOL, V80, P24, DOI 10.2307/3283340; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bizimenyera ES, 2006, VET PARASITOL, V142, P336, DOI 10.1016/j.vetpar.2006.06.013; CRIADOFORNELIO A, 1995, PARASITOL RES, V81, P700, DOI 10.1007/BF00931850; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; CYPESS RH, 1977, EXP PARASITOL, V42, P34, DOI 10.1016/0014-4894(77)90059-5; Donskow K, 2011, PARASITE IMMUNOL, V33, P158, DOI 10.1111/j.1365-3024.2010.01262.x; Donskow-Lysoniewska K, 2012, PARASITE IMMUNOL, V34, P536, DOI 10.1111/pim.12003; Donskow-Lysoniewska K, 2013, PRION, V7, P319, DOI 10.4161/pri.25008; Garrelds IM, 2002, DIGEST DIS SCI, V47, P2231, DOI 10.1023/A:1020183110468; Guinnee MA, 2003, PARASITOLOGY, V127, P507, DOI 10.1017/S0031182003003998; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; JENKINS DC, 1984, Z PARASITENKD, V70, P395, DOI 10.1007/BF00927827; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; LIU SK, 1965, EXP PARASITOL, V17, P123, DOI 10.1016/0014-4894(65)90016-0; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561, DOI 10.7326/0003-4819-111-7-561; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; McGonigle S, 2001, FEBS LETT, V490, P65, DOI 10.1016/S0014-5793(01)02133-0; MONROY FG, 1992, PARASITOL TODAY, V8, P49, DOI 10.1016/0169-4758(92)90084-F; Morgan C, 2006, PROTEOMICS, V6, P4633, DOI 10.1002/pmic.200600068; Morimoto M, 2004, J IMMUNOL, V172, P2424, DOI 10.4049/jimmunol.172.4.2424; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Schechtman D, 2001, PARASITOLOGY, V123, P573, DOI 10.1017/S0031182001008769; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Stear MJ, 1997, NATURE, V389, P27, DOI 10.1038/37895; Stear MJ, 1996, PARASITOL TODAY, V12, P438, DOI 10.1016/0169-4758(96)10069-7; Sukhdeo MVK, 1996, INT J PARASITOL, V26, P483, DOI 10.1016/0020-7519(96)89378-7; Viney ME, 2006, PARASITOLOGY, V133, P477, DOI 10.1017/S003118200600062X; WAHID FN, 1992, INT J PARASITOL, V22, P699, DOI 10.1016/0020-7519(92)90118-5; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yan FB, 2010, VET J, V185, P174, DOI 10.1016/j.tvjl.2009.05.021; Yazdanbakhsh M, 2001, TRENDS IMMUNOL, V22, P372, DOI 10.1016/S1471-4906(01)01958-5	36	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78034	10.1371/journal.pone.0078034	http://dx.doi.org/10.1371/journal.pone.0078034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167594	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500054
J	Oreshkova, N; van Keulen, L; Kant, J; Moormann, RJM; Kortekaas, J				Oreshkova, Nadia; van Keulen, Lucien; Kant, Jet; Moormann, Rob J. M.; Kortekaas, Jeroen			A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs	PLOS ONE			English	Article							NSS PROTEIN; SAFETY; EFFICACY; IMMUNOGENICITY; PROTECTION; VECTORS; CATTLE; PATHOGENESIS; PHLEBOVIRUS; PATHOLOGY	Rift Valley fever virus (RVFV) is an important pathogen that affects ruminants and humans. Recently we developed a vaccine based on nonspreading RVFV (NSR) and showed that a single vaccination with this vaccine protects lambs from viremia and clinical signs. However, low levels of viral RNA were detected in the blood of vaccinated lambs shortly after challenge infection. These low levels of virus, when present in a pregnant ewe, could potentially infect the highly susceptible fetus. We therefore aimed to further improve the efficacy of the NSR vaccine. Here we report the expression of Gn, the major immunogenic protein of the virus, from the NSR genome. The resulting NSR-Gn vaccine was shown to elicit superior CD8 and CD4-restricted memory responses and improved virus neutralization titers in mice. A dose titration study in lambs revealed that the highest vaccination dose of 10(6.3) TCID50/ml protected all lambs from clinical signs and viremia. The lambs developed neutralizing antibodies within three weeks after vaccination and no anamnestic responses were observed following challenge. The combined results suggest that sterile immunity was achieved by a single vaccination with the NSR-Gn vaccine.	[Oreshkova, Nadia; van Keulen, Lucien; Kant, Jet; Moormann, Rob J. M.; Kortekaas, Jeroen] Cent Vet Inst, Dept Virol, Lelystad, Netherlands; [Oreshkova, Nadia; Moormann, Rob J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Kortekaas, J (corresponding author), Cent Vet Inst, Dept Virol, Lelystad, Netherlands.	jeroen.kortekaas@wur.nl	amsalu, ribka/G-8780-2019	Oreshkova, Nadia/0000-0001-8830-7055	Dutch Ministry of Economic Affairs [KB-12-004.02-003]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the Dutch Ministry of Economic Affairs, project code KB-12-004.02-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonis AFG, 2013, VECTOR BORNE ZOONOTI; BARNARD BJH, 1979, J S AFR VET ASSOC, V50, P155; BARNARD BJH, 1977, J S AFR VET ASSOC, V48, P45; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2011, J VIROL, V85, P12901, DOI 10.1128/JVI.06046-11; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Botros B, 2006, J MED VIROL, V78, P787, DOI 10.1002/jmv.20624; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1065; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205; COETZER JAW, 1982, ONDERSTEPOORT J VET, V49, P11; Cole Geoffrey A, 2005, Methods Mol Biol, V302, P191; de Boer SM, 2010, VACCINE, V28, P2330, DOI 10.1016/j.vaccine.2009.12.062; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Dufour B, 2008, REV SCI TECH OIE, V27, P529, DOI 10.20506/rst.27.2.1817; Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085; Easterday B C, 1965, Adv Vet Sci, V10, P65; Elliott R.M., 1996, BUNYAVIRIDAE; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gorchakov R, 2007, VIROLOGY, V366, P212, DOI 10.1016/j.virol.2007.04.014; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hunter P, 2002, ONDERSTEPOORT J VET, V69, P95; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Indran SV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00131; KAKACH LT, 1988, J VIROL, V62, P826, DOI 10.1128/JVI.62.3.826-833.1988; Kamal SA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-94; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kasari TR, 2008, JAVMA-J AM VET MED A, V232, P514, DOI 10.2460/javma.232.4.514; KEEGAN K, 1986, J VIROL, V58, P263, DOI 10.1128/JVI.58.2.263-270.1986; Kortekaas J, 2012, VACCINE, V30, P3423, DOI 10.1016/j.vaccine.2012.03.027; Kortekaas J, 2010, VACCINE, V28, P2271, DOI 10.1016/j.vaccine.2010.01.001; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; Morrill JC, 2013, VACCINE, V31, P559, DOI 10.1016/j.vaccine.2012.10.118; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters CJ, 2008, VACCINE; Roger M, 2011, EMERG INFECT DIS, V17, P1319, DOI 10.3201/eid1707.102031; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Villadangos JA, 2001, MOL IMMUNOL, V38, P329, DOI 10.1016/S0161-5890(01)00069-4; von Teichman B, 2011, VACCINE, V29, P5771, DOI 10.1016/j.vaccine.2011.05.055; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07	64	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77461	10.1371/journal.pone.0077461	http://dx.doi.org/10.1371/journal.pone.0077461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167574	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500033
J	Sato, S; Zhao, YS; Imai, M; Simister, PC; Feller, SM; Trackman, PC; Kirsch, KH; Sonenshein, GE				Sato, Seiichi; Zhao, Yingshe; Imai, Misa; Simister, Philip C.; Feller, Stephan M.; Trackman, Philip C.; Kirsch, Kathrin H.; Sonenshein, Gail E.			Inhibition of CIN85-Mediated Invasion by a Novel SH3 Domain Binding Motif in the Lysyl Oxidase Propeptide	PLOS ONE			English	Article							BREAST-CANCER CELLS; GROWTH-FACTOR RECEPTORS; INTRACELLULAR TRAFFICKING; G473A POLYMORPHISM; COMPLEX-FORMATION; STRUCTURAL BASIS; ADAPTER PROTEIN; C-CBL; CIN85; GENE	The lysyl oxidase gene inhibits Ras signaling in transformed fibroblasts and breast cancer cells. Its activity was mapped to the 162 amino acid propeptide domain (LOX-PP) of the lysyl oxidase precursor protein. LOX-PP inhibited the Her-2/Ras signaling axis in breast cancer cells, and reduced the Her-2-driven breast tumor burden in a xenograft model. Since its mechanism of action is largely unknown, co-affinity-purification/mass spectrometry was performed and the "Cbl-interacting protein of 85-kDa" (CIN85) identified as an associating protein. CIN85 is an SH3-containing adapter protein that is overexpressed in invasive breast cancers. The CIN85 SH3 domains interact with c-Cbl, an E3 ubiquitin ligase, via an unconventional PxxxPR ligand sequence, with the highest affinity displayed by the SH3-B domain. Interaction with CIN85 recruits c-Cbl to the AMAP1 complex where its ubiquitination activity is necessary for cancer cells to develop an invasive phenotype and to degrade the matrix. Direct interaction of LOX-PP with CIN85 was confirmed using co-immunoprecipitation analysis of lysates from breast cancer cells and of purified expressed proteins. CIN85 interaction with c-Cbl was reduced by LOX-PP. Domain specific CIN85 regions and deletion mutants of LOX-PP were prepared and used to map the sites of interaction to the SH3-B domain of CIN85 and to an epitope encompassing amino acids 111 to 116 of LOX-PP. Specific LOX-PP point mutant proteins P111A and R116A failed to interact with CIN85 or to compete for CIN85 binding with c-Cbl. Structural modeling identified a new atypical PxpxxRh SH3-binding motif in this region of LOX-PP. The LOX-PP interaction with CIN85 was shown to reduce the invasive phenotype of breast cancer cells, including their ability to degrade the surrounding extracellular matrix and for Matrigel outgrowth. Thus, LOX-PP interacts with CIN85 via a novel SH3-binding motif and this association reduces CIN85-promoted invasion by breast cancer cells.	[Sato, Seiichi; Imai, Misa; Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Zhao, Yingshe; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Simister, Philip C.; Feller, Stephan M.] Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Oxford, England; [Feller, Stephan M.] Univ Halle Wittenberg, Inst Mol Med, Sect Tumor Biol, D-06108 Halle, Saale, Germany; [Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Div Oral Biol, Boston, MA 02215 USA	Tufts University; Boston University; University of Oxford; Martin Luther University Halle Wittenberg; Boston University	Sonenshein, GE (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	gail.sonenshein@tufts.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Kirsch, Kathrin/0000-0003-1532-1715	National Institutes of Health (NIH) [R01 CA143108, PO1 ES011624]; Breast Cancer Campaign (UK); EU FP7 program (Targetbinder consortium); Rosetrees Trust; Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund [C38302/A12278]; NATIONAL CANCER INSTITUTE [R01CA143108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Campaign (UK); EU FP7 program (Targetbinder consortium); Rosetrees Trust(Rosetrees Trust); Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by National Institutes of Health (NIH) grants R01 CA143108 and PO1 ES011624. SF is indebted for funding from the Breast Cancer Campaign (UK) and the EU FP7 program (Targetbinder consortium). SF and PS acknowledge funding from the Rosetrees Trust support by Cancer Research UK (CR-UK) grant number C38302/A12278, through the Oxford Cancer Research Centre Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceregido MA, 2013, FEBS J, V280, P3399, DOI 10.1111/febs.12333; Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Eddy SF, 2007, CANCER RES, V67, P9018, DOI 10.1158/0008-5472.CAN-07-1691; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Feng LF, 2011, CELL BIOCHEM FUNCT, V29, P589, DOI 10.1002/cbf.1792; Finniss S, 2004, BIOCHEM BIOPH RES CO, V325, P174, DOI 10.1016/j.bbrc.2004.10.007; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Jozic D, 2005, NAT STRUCT MOL BIOL, V12, P972, DOI 10.1038/nsmb1000; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Maller O, 2013, J CELL SCI; Mayer BJ, 2001, J CELL SCI, V114, P1253; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Nam JM, 2007, EMBO J, V26, P647, DOI 10.1038/sj.emboj.7601534; Roldan JLO, 2011, J BIOMOL NMR, V50, P103, DOI 10.1007/s10858-011-9505-5; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Ren JH, 2011, DNA CELL BIOL, V30, P111, DOI 10.1089/dna.2010.1098; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; SOMMER P, 1993, LAB INVEST, V69, P460; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Tibaldi EV, 2003, INT IMMUNOL, V15, P313, DOI 10.1093/intimm/dxg032; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wu J, 2012, GENET TEST MOL BIOMA, V16, P915, DOI 10.1089/gtmb.2011.0374; Yoon JH, 2011, APMIS, V119, P762, DOI 10.1111/j.1600-0463.2011.02802.x; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	55	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77288	10.1371/journal.pone.0077288	http://dx.doi.org/10.1371/journal.pone.0077288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167568	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500027
J	Biggs, MB; Papin, JA				Biggs, Matthew B.; Papin, Jason A.			Novel Multiscale Modeling Tool Applied to Pseudomonas aeruginosa Biofilm Formation	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; FLUX BALANCE ANALYSIS; ADAPTATION; GROWTH	Multiscale modeling is used to represent biological systems with increasing frequency and success. Multiscale models are often hybrids of different modeling frameworks and programming languages. We present the MATLAB-NetLogo extension (MatNet) as a novel tool for multiscale modeling. We demonstrate the utility of the tool with a multiscale model of Pseudomonas aeruginosa biofilm formation that incorporates both an agent-based model (ABM) and constraint-based metabolic modeling. The hybrid model correctly recapitulates oxygen-limited biofilm metabolic activity and predicts increased growth rate via anaerobic respiration with the addition of nitrate to the growth media. In addition, a genome-wide survey of metabolic mutants and biofilm formation exemplifies the powerful analyses that are enabled by this computational modeling tool.	[Biggs, Matthew B.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Papin, JA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	papin@virginia.edu		Biggs, Matthew/0000-0001-6492-8180; Papin, Jason/0000-0002-2769-5805	University of Virginia; National Institutes of Health [RO1 GM088244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088244] Funding Source: NIH RePORTER	University of Virginia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding by a Commonwealth Fellowship in Engineering from the University of Virginia [http://bme.virginia.edu/] to MBB, and from the National Institutes of Health (RO1 GM088244)[http://www.nih.gov/] to JAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bengtsson H, 2005, SWEDEN MATH STATICS; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Chave Jerome, 2013, Ecology Letters, V16, P4, DOI 10.1111/ele.12048; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Hayenga HN, 2011, ANN BIOMED ENG, V39, P2669, DOI 10.1007/s10439-011-0363-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Mabrouk N, 2011, UNDERST COMPLEX SYST, P131, DOI 10.1007/978-3-642-20423-4_6; Mabrouk N, 2010, THEOR BIOSCI, V129, P1, DOI 10.1007/s12064-009-0078-8; Magliocca NR, 2013, T GIS, V17, P883, DOI 10.1111/tgis.12012; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Merkey BV, 2011, ENVIRON MICROBIOL, V13, P2435, DOI 10.1111/j.1462-2920.2011.02535.x; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Noguera DR, 2004, MICROBIAL BIOFILMS, P222; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Pizarro G, 2001, J ENVIRON ENG-ASCE, V127, P782, DOI 10.1061/(ASCE)0733-9372(2001)127:9(782); Railsback S., 2012, AGENT BASED INDIVIDU; Robertson SH, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-46; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; The MathWorks Inc, 2012, MATLAB STAT TOOLB; Thiele JC, 2010, ENVIRON MODELL SOFTW, V25, P972, DOI 10.1016/j.envsoft.2010.02.008; Thorne BC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00020; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104; Wilensky U, 1999, NETLOGO; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035	32	43	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78011	10.1371/journal.pone.0078011	http://dx.doi.org/10.1371/journal.pone.0078011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147108	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200093
J	De Jong, HJI; Damoiseaux, JGMC; Vandebriel, RJ; Souverein, PC; Gremmer, ER; Wolfs, M; Klungel, OH; Van Loveren, H; Tervaert, JWC; Verschuren, WMM				De Jong, Hilda J. I.; Damoiseaux, Jan G. M. C.; Vandebriel, Rob J.; Souverein, Patrick C.; Gremmer, Eric R.; Wolfs, Mia; Klungel, Olaf H.; Van Loveren, Henk; Tervaert, Jan Willem Cohen; Verschuren, W. M. Monique			Statin Use and Markers of Immunity in the Doetinchem Cohort Study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REACTIVE PROTEIN; COA REDUCTASE INHIBITOR; ENDOTHELIAL-DEPENDENT VASODILATION; NECROSIS-FACTOR-ALPHA; T-CELLS; ANTINUCLEAR ANTIBODIES; ATORVASTATIN; SIMVASTATIN; THERAPY	It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (> 100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance.	[De Jong, Hilda J. I.; Vandebriel, Rob J.; Gremmer, Eric R.; Van Loveren, Henk] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [De Jong, Hilda J. I.; Van Loveren, Henk] Maastricht Univ, Dept Toxicogen, Med Ctr, Maastricht, Netherlands; [De Jong, Hilda J. I.; Souverein, Patrick C.; Klungel, Olaf H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Dept Pharmaceut Sci, Fac Sci,Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Damoiseaux, Jan G. M. C.; Wolfs, Mia; Tervaert, Jan Willem Cohen] Maastricht Univ, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands; [Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Utrecht University; Maastricht University; Maastricht University; Netherlands National Institute for Public Health & the Environment	Damoiseaux, JGMC (corresponding author), Maastricht Univ, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands.	jan.damoiseaux@mumc.nl	Vandebriel, Rob/P-6769-2019; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	Vandebriel, Rob/0000-0001-9140-952X; Damoiseaux, Jan/0000-0003-4007-6985; de Jong, Hilda/0000-0002-4112-7572; Souverein, Patrick/0000-0002-7452-0477	National Institute for Public Health and the Environment [S/340040]	National Institute for Public Health and the Environment	Funding for this study was obtained from the National Institute for Public Health and the Environment (project S/340040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abud-Mendoza C, 2003, LUPUS, V12, P607, DOI 10.1191/0961203303lu429oa; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; [Anonymous], 2012, LANCET, V379, P93, DOI 10.1016/S0140-6736(12)60041-5; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; BRUMMER E, 1993, CELL IMMUNOL, V149, P258, DOI 10.1006/cimm.1993.1153; Buurma H, 2008, J CLIN PHARM THER, V33, P17, DOI 10.1111/j.1365-2710.2008.00878.x; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Cherfan P, 2007, ATHEROSCLEROSIS, V193, P186, DOI 10.1016/j.atherosclerosis.2006.06.022; Chodick G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000336; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Dalakas MC, 2012, AUTOIMMUN REV, V11, P203, DOI 10.1016/j.autrev.2011.05.013; Damoiseaux JGMC, 2006, AUTOIMMUN REV, V5, P10, DOI 10.1016/j.autrev.2005.05.007; de Jong HJI, 2012, ANN RHEUM DIS, V71, P648, DOI 10.1136/ard.2011.155622; de Jong HJI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041289; de Jong HJI, 2011, SEMIN ARTHRITIS RHEU, V41, P373, DOI 10.1016/j.semarthrit.2011.06.002; Dedeoglu F, 2009, CURR OPIN RHEUMATOL, V21, P547, DOI 10.1097/BOR.0b013e32832f13db; Dieker JWC, 2004, NEPHROL DIAL TRANSPL, V19, P282, DOI 10.1093/ndt/gfg485; FAIRWEATHER D, 2007, ENCY LIFE SCI, P1; Fauchais AL, 2004, REV MED INTERNE, V25, P294, DOI 10.1016/j.revmed.2003.10.013; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; Ferreira GA, 2007, RHEUMATOLOGY, V46, P1560, DOI 10.1093/rheumatology/kem186; FOSSO CK, 1995, J ALLERGY CLIN IMMUN, V95, P1053, DOI 10.1016/S0091-6749(95)70109-5; Funk JL, 2008, J RHEUMATOL, V35, P1083; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Gurevich VS, 2005, AUTOIMMUN REV, V4, P123, DOI 10.1016/j.autrev.2004.08.037; Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083; Henderson CE, 1998, J IMMUNOL METHODS, V213, P99, DOI 10.1016/S0022-1759(98)00014-3; Henneman L, 2010, J INHERIT METAB DIS, V33, P625, DOI 10.1007/s10545-010-9173-8; HERINGS RMC, 1992, J EPIDEMIOL COMMUN H, V46, P136, DOI 10.1136/jech.46.2.136; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hodes RJ, 1997, IMMUNOL REV, V160, P5, DOI 10.1111/j.1600-065X.1997.tb01022.x; Jick SS, 2009, ANN RHEUM DIS, V68, P546, DOI 10.1136/ard.2008.091967; Kagami S, 2008, INT ARCH ALLERGY IMM, V146, P61, DOI 10.1159/000126063; Kagami S, 2009, INT IMMUNOL, V21, P679, DOI 10.1093/intimm/dxp037; Kay Jonathan, 2006, N Engl J Med, V354, P623; Khattri S, 2013, IMMUNOL RES, V56, P348, DOI 10.1007/s12026-013-8409-8; Korpilahde T, 2003, ANN RHEUM DIS, V62, P353, DOI 10.1136/ard.62.4.353; Kotyla PJ, 2008, RHEUMATOLOGY, V47, P381, DOI 10.1093/rheumatology/kem381; Kotyla PJ, 2006, J RHEUMATOL, V33, P2361; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawman S, 2004, J IMMUNOL, V173, P7641, DOI 10.4049/jimmunol.173.12.7641; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lyngdoh T, 2011, ATHEROSCLEROSIS, V219, P253, DOI 10.1016/j.atherosclerosis.2011.07.117; Mammen AL, 2012, ARTHRIT CARE RES, V64, P269, DOI 10.1002/acr.20662; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Matta GME, 2007, CLIN CANCER RES, V13, P5348, DOI 10.1158/1078-0432.CCR-06-2819; Mausner-Fainberg K, 2008, ATHEROSCLEROSIS, V197, P829, DOI 10.1016/j.atherosclerosis.2007.07.031; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Meng X, 2012, MOL MED, V18, P598, DOI 10.2119/molmed.2011.00471; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Mulder DJ, 2007, CARDIOVASC DRUG THER, V21, P91, DOI 10.1007/s10557-007-6010-x; Nilsson TK, 2005, THROMB RES, V116, P249, DOI 10.1016/j.thromres.2004.12.005; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters SAE, 2010, J INTERN MED, V268, P155, DOI 10.1111/j.1365-2796.2010.02230.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Scoble T, 2011, AUTOIMMUN REV, V10, P669, DOI 10.1016/j.autrev.2011.04.030; Sen D, 2010, INT J RHEUM DIS, V13, pe29, DOI 10.1111/j.1756-185X.2010.01481.x; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shimazu H, 2010, CLIN IMMUNOL, V136, P188, DOI 10.1016/j.clim.2010.03.008; Smeenk RJT, 2000, RHEUMATOLOGY, V39, P581, DOI 10.1093/rheumatology/39.6.581; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Steffens S, 2006, NAT CLIN PRACT NEPHR, V2, P378, DOI 10.1038/ncpneph0217; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tervaert JWC, 2007, ANN NY ACAD SCI, V1107, P251, DOI 10.1196/annals.1381.027; Thewissen MM, 2011, OBESITY, V19, P1690, DOI 10.1038/oby.2010.337; van Haelst P L, 2001, Eur J Intern Med, V12, P503, DOI 10.1016/S0953-6205(01)00172-8; Vandebriel RJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3814; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Walter RB, 2003, CLIN CHEM LAB MED, V41, P1314, DOI 10.1515/CCLM.2003.200; Yamagata T, 2007, RHEUMATOL INT, V27, P631, DOI 10.1007/s00296-006-0270-9; Yokota K, 2006, J RHEUMATOL, V33, P463; Yoon SS, 2010, J ATHEROSCLER THROMB, V17, P1176, DOI 10.5551/jat.5652; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	89	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77587	10.1371/journal.pone.0077587	http://dx.doi.org/10.1371/journal.pone.0077587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147031	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400122
J	Klampfl, T; Milosevic, JD; Puda, A; Schonegger, A; Bagienski, K; Berg, T; Harutyunyan, AS; Gisslinger, B; Rumi, E; Malcovati, L; Pietra, D; Elena, C; Della Porta, MG; Pieri, L; Guglielmelli, P; Bock, C; Doubek, M; Dvorakova, D; Suvajdzic, N; Tomin, D; Tosic, N; Racil, Z; Steurer, M; Pavlovic, S; Vannucchi, AM; Cazzola, M; Gisslinger, H; Kralovics, R				Klampfl, Thorsten; Milosevic, Jelena D.; Puda, Ana; Schoenegger, Andreas; Bagienski, Klaudia; Berg, Tiina; Harutyunyan, Ashot S.; Gisslinger, Bettina; Rumi, Elisa; Malcovati, Luca; Pietra, Daniela; Elena, Chiara; Della Porta, Matteo Giovanni; Pieri, Lisa; Guglielmelli, Paola; Bock, Christoph; Doubek, Michael; Dvorakova, Dana; Suvajdzic, Nada; Tomin, Dragica; Tosic, Natasa; Racil, Zdenek; Steurer, Michael; Pavlovic, Sonja; Vannucchi, Alessandro M.; Cazzola, Mario; Gisslinger, Heinz; Kralovics, Robert			Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2	PLOS ONE			English	Article							ACQUIRED UNIPARENTAL DISOMY; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE JAK2; DNA-SEQUENCING DATA; GAIN-OF-FUNCTION; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; GENOMIC ABERRATIONS; TANDEM DUPLICATION	Exome sequencing of primary tumors identifies complex somatic mutation patterns. Assignment of relevance of individual somatic mutations is difficult and poses the next challenge for interpretation of next generation sequencing data. Here we present an approach how exome sequencing in combination with SNP microarray data may identify targets of chromosomal aberrations in myeloid malignancies. The rationale of this approach is that hotspots of chromosomal aberrations might also harbor point mutations in the target genes of deletions, gains or uniparental disomies (UPDs). Chromosome 11 is a frequent target of lesions in myeloid malignancies. Therefore, we studied chromosome 11 in a total of 813 samples from 773 individual patients with different myeloid malignancies by SNP microarrays and complemented the data with exome sequencing in selected cases exhibiting chromosome 11 defects. We found gains, losses and UPDs of chromosome 11 in 52 of the 813 samples (6.4%). Chromosome 11q UPDs frequently associated with mutations of CBL. In one patient the 11qUPD amplified somatic mutations in both CBL and the DNA repair gene DDB1. A duplication within MLL exon 3 was detected in another patient with 11qUPD. We identified several common deleted regions (CDR) on chromosome 11. One of the CDRs associated with de novo acute myeloid leukemia (P=0.013). One patient with a deletion at the LMO2 locus harbored an additional point mutation on the other allele indicating that LMO2 might be a tumor suppressor frequently targeted by 11p deletions. Our chromosome-centered analysis indicates that chromosome 11 contains a number of tumor suppressor genes and that the role of this chromosome in myeloid malignancies is more complex than previously recognized.	[Klampfl, Thorsten; Milosevic, Jelena D.; Puda, Ana; Schoenegger, Andreas; Bagienski, Klaudia; Berg, Tiina; Harutyunyan, Ashot S.; Bock, Christoph; Kralovics, Robert] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Gisslinger, Bettina; Gisslinger, Heinz; Kralovics, Robert] Med Univ Vienna, Div Hematol & Blood Coagulat, Dept Internal Med 1, Vienna, Austria; [Rumi, Elisa; Malcovati, Luca; Pietra, Daniela; Elena, Chiara; Della Porta, Matteo Giovanni; Cazzola, Mario] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy; [Della Porta, Matteo Giovanni; Cazzola, Mario] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Pieri, Lisa; Guglielmelli, Paola; Vannucchi, Alessandro M.] Univ Florence, Sect Hematol, Florence, Italy; [Doubek, Michael; Dvorakova, Dana; Racil, Zdenek] Masaryk Univ, Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Doubek, Michael; Dvorakova, Dana; Racil, Zdenek] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Suvajdzic, Nada; Tomin, Dragica] Univ Belgrade, Sch Med, Clin Hematol, Clin Ctr Serbia, Belgrade, Serbia; [Tosic, Natasa; Pavlovic, Sonja] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Steurer, Michael] Univ Innsbruck Hosp, Div Hematol & Oncol, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; IRCCS Fondazione San Matteo; University of Pavia; University of Florence; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Medical University of Innsbruck	Kralovics, R (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Tosic, Natasa/AAV-1507-2020; Feenstra, Jelena D Milosevic/K-2114-2012; Rumi, Elisa/J-7424-2016; Cazzola, Mario/AAQ-8854-2021; Guglielmelli, Paola/K-7509-2016; Malcovati, Luca/CAJ-1695-2022; Pieri, Lisa/K-1762-2016; Bock, Christoph/AAE-7618-2019; Dvorakova, Dana/E-1105-2012; Vannucchi, Alessandro M./K-7499-2016; Harutyunyan, Ashot S/M-3528-2014; Doubek, Michael/E-1504-2012; Racil, Zdenek/I-2387-2014; Pietra, Daniela/F-3931-2016; Doubek, Michael/J-7011-2018	Feenstra, Jelena D Milosevic/0000-0001-7420-3298; Rumi, Elisa/0000-0002-7572-9504; Cazzola, Mario/0000-0001-6984-8817; Guglielmelli, Paola/0000-0003-1809-284X; Malcovati, Luca/0000-0002-1460-1611; Pieri, Lisa/0000-0003-1812-8072; Bock, Christoph/0000-0001-6091-3088; Vannucchi, Alessandro M./0000-0001-5755-0730; Harutyunyan, Ashot S/0000-0002-9050-9315; Pietra, Daniela/0000-0002-6575-8766; ELENA, CHIARA/0000-0002-0058-7142; Kralovics, Robert/0000-0002-6997-8539; Klampfl, Thorsten/0000-0002-6666-9773; Della Porta, Matteo Giovanni/0000-0002-6915-5970; Tosic, Natasa/0000-0002-1293-6215	Austrian Science Fund (FWF) [P23257-B12]; MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano); Fondazione Berlucchi, Brescia, Italy; Dana Dvorakova's laboratory [MSM0021622430]; Italian Society of Experimental Hematology (SIES); Italian Ministry of Health for young Investigators; Austrian Science Fund (FWF) [P 23257] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro); Fondazione Berlucchi, Brescia, Italy; Dana Dvorakova's laboratory; Italian Society of Experimental Hematology (SIES); Italian Ministry of Health for young Investigators; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF, P23257-B12) (www.fwf.ac.at) and the MPN Research Foundation (www.mpnresearchfoundation.org) (RK). Studies on myeloproliferative neoplasms conducted at the Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and the Hematology Section, University of Florence, were supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative) (www.progettoagimm.it). Studies on myelodysplastic syndromes conducted in Pavia were supported by a grant from Fondazione Cariplo (www.fondazionecariplo.it) to Mario Cazzola, while those on secondary acute myeloid leukemia were supported by a grant from Fondazione Berlucchi, Brescia, Italy (www.fondazioneberlucchi.com) to Matteo Giovanni Della Porta. The work performed at the Masaryk University Brno was supported by MSMT CR CZ.1.05/1.1.00/02.0068 (CEITEC) (www.ceitec.eu), whereas studies in Serbia were supported by III41004 MESTD RSerbia (www.mpn.gov.rs). Studies in Dana Dvorakova's laboratory were supported by MSM0021622430 (www.msmt.cz). Work performed by Elisa Rumi was supported by a grant awarded from the Italian Society of Experimental Hematology (SIES) (www.siesonline.it), and a grant awarded from the Italian Ministry of Health for young Investigators (www.salute.gov.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Buxhofer-Ausch V, 2009, EUR J HAEMATOL, V82, P161, DOI 10.1111/j.1600-0609.2008.01183.x; Caligiuri MA, 1996, CANCER RES, V56, P1418; CHEN CS, 1993, BLOOD, V81, P2386; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Luttikhuis MEMO, 2001, BRIT J CANCER, V85, P531, DOI 10.1054/bjoc.2001.1960; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monni O, 2001, LEUKEMIA LYMPHOMA, V40, P259, DOI 10.3109/10428190109057924; OSHIMURA M, 1977, CANCER, V40, P1161, DOI 10.1002/1097-0142(197709)40:3<1161::AID-CNCR2820400327>3.0.CO;2-2; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; R Development Core Team, 2008, R LANG ENV STAT COMP; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; SCHICHMAN SA, 1994, P NATL ACAD SCI USA, V91, P6236, DOI 10.1073/pnas.91.13.6236; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schnittger S, 2000, LEUKEMIA, V14, P796, DOI 10.1038/sj.leu.2401773; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Stegelmann F, 2010, HAEMATOL-HEMATOL J, V95, P666, DOI 10.3324/haematol.2009.013623; Sverdlow SH, 2008, WHO CLASSIFICATION T; Szpurka H, 2009, LEUKEMIA, V23, P610, DOI 10.1038/leu.2008.249; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77819	10.1371/journal.pone.0077819	http://dx.doi.org/10.1371/journal.pone.0077819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147083	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400137
J	Yang, CX; Jurczyk, A; Diiorio, P; Norowski, E; Brehm, MA; Grant, CW; Guberski, DL; Greiner, DL; Bortell, R				Yang, Chaoxing; Jurczyk, Agata; Diiorio, Philip; Norowski, Elaine; Brehm, Michael A.; Grant, Christian W.; Guberski, Dennis L.; Greiner, Dale L.; Bortell, Rita			Salicylate Prevents Virus-Induced Type 1 Diabetes in the BBDR Rat	PLOS ONE			English	Article							ENTEROVIRUS INFECTION; SERUM; EXPRESSION; IDENTIFICATION; SIGNATURE; SALSALATE; RESISTANT; CHILDREN; TARGET	Epidemiologic and clinical evidence suggests that virus infection plays an important role in human type 1 diabetes pathogenesis. We used the virus-inducible BioBreeding Diabetes Resistant (BBDR) rat to investigate the ability of sodium salicylate, a non-steroidal anti-inflammatory drug (NSAID), to modulate development of type 1 diabetes. BBDR rats treated with Kilham rat virus (KRV) and polyinosinic: polycytidylic acid (pIC, a TLR3 agonist) develop diabetes at nearly 100% incidence by similar to 2 weeks. We found distinct temporal profiles of the proinflammatory serum cytokines, IL-1 beta, IL-6, IFN-gamma, IL-12, and haptoglobin (an acute phase protein) in KRV+pIC treated rats. Significant elevations of IL-1 beta and IL-12, coupled with sustained elevations of haptoglobin, were specific to KRV+ pIC and not found in rats co-treated with pIC and H1, a non-diabetogenic virus. Salicylate administered concurrently with KRV +pIC inhibited the elevations in IL-1 beta, IL-6, IFN-Upsilon and haptoglobin almost completely, and reduced IL-12 levels significantly. Salicylate prevented diabetes in a dose-dependent manner, and diabetes-free animals had no evidence of insulitis. Our data support an important role for innate immunity in virus-induced type 1 diabetes pathogenesis. The ability of salicylate to prevent diabetes in this robust animal model demonstrates its potential use to prevent or attenuate human autoimmune diabetes.	[Yang, Chaoxing; Jurczyk, Agata; Diiorio, Philip; Norowski, Elaine; Brehm, Michael A.; Greiner, Dale L.; Bortell, Rita] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Grant, Christian W.; Guberski, Dennis L.] Biomed Res Models, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Bortell, R (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu		Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI46629, AI073871]; Juvenile Diabetes Research Foundation; NIH Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, U01AI073871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI46629, AI073871, and grants from the Juvenile Diabetes Research Foundation. Core resources supported by the NIH Diabetes Endocrinology Research Center grant (DK32520) were used. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortell Rita, 2012, Methods Mol Biol, V933, P31, DOI 10.1007/978-1-62703-068-7_3; BROWN DW, 1993, J VIROL, V67, P5873, DOI 10.1128/JVI.67.10.5873-5878.1993; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; GUBERSKI DL, 1991, SCIENCE, V254, P1010, DOI 10.1126/science.1658938; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Kaldunski M, 2010, DIABETES, V59, P2375, DOI 10.2337/db10-0372; Kruger AJ, 2010, EXP BIOL MED, V235, P1328, DOI 10.1258/ebm.2010.010150; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Nairn C, 1999, DIABETIC MED, V16, P509, DOI 10.1046/j.1464-5491.1999.00098.x; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Ruan H, 2009, CURR OPIN INVEST DR, V10, P346; Rumore MM, 2010, ANN PHARMACOTHER, V44, P1207, DOI 10.1345/aph.1M483; Schalkwijk CG, 1999, DIABETOLOGIA, V42, P351, DOI 10.1007/s001250051162; Wang XJ, 2008, J IMMUNOL, V180, P1929, DOI 10.4049/jimmunol.180.3.1929; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Zipris D, 2003, J IMMUNOL, V170, P3592, DOI 10.4049/jimmunol.170.7.3592	24	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78050	10.1371/journal.pone.0078050	http://dx.doi.org/10.1371/journal.pone.0078050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147110	Green Published, gold			2022-12-25	WOS:000326019400146
J	Llusia, D; Gomez, M; Penna, M; Marquez, R				Llusia, Diego; Gomez, Miguel; Penna, Mario; Marquez, Rafael			Call Transmission Efficiency in Native and Invasive Anurans: Competing Hypotheses of Divergence in Acoustic Signals	PLOS ONE			English	Article							BULLFROGS RANA-CATESBEIANA; RUFOUS-COLLARED SPARROW; EVOKED VOCAL RESPONSES; RED-LEGGED FROGS; BIOLOGICAL INVASIONS; INTRODUCED BULLFROGS; ADVERTISEMENT CALLS; MIDWIFE TOADS; BATRACHOCHYTRIUM-DENDROBATIDIS; GEOGRAPHICAL VARIATION	Invasive species are a leading cause of the current biodiversity decline, and hence examining the major traits favouring invasion is a key and long-standing goal of invasion biology. Despite the prominent role of the advertisement calls in sexual selection and reproduction, very little attention has been paid to the features of acoustic communication of invasive species in nonindigenous habitats and their potential impacts on native species. Here we compare for the first time the transmission efficiency of the advertisement calls of native and invasive species, searching for competitive advantages for acoustic communication and reproduction of introduced taxa, and providing insights into competing hypotheses in evolutionary divergence of acoustic signals: acoustic adaptation vs. morphological constraints. Using sound propagation experiments, we measured the attenuation rates of pure tones (0.2-5 kHz) and playback calls (Lithobates catesbeianus and Pelophylax perezi) across four distances (1, 2, 4, and 8 m) and over two substrates (water and soil) in seven Iberian localities. All factors considered (signal type, distance, substrate, and locality) affected transmission efficiency of acoustic signals, which was maximized with lower frequency sounds, shorter distances, and over water surface. Despite being broadcast in nonindigenous habitats, the advertisement calls of invasive L. catesbeianus were propagated more efficiently than those of the native species, in both aquatic and terrestrial substrates, and in most of the study sites. This implies absence of optimal relationship between native environments and propagation of acoustic signals in anurans, in contrast to what predicted by the acoustic adaptation hypothesis, and it might render these vertebrates particularly vulnerable to intrusion of invasive species producing low frequency signals, such as L. catesbeianus. Our findings suggest that mechanisms optimizing sound transmission in native habitat can play a less significant role than other selective forces or biological constraints in evolutionary design of anuran acoustic signals.	[Llusia, Diego; Gomez, Miguel; Marquez, Rafael] Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Fonoteca Zool, Madrid, Spain; [Penna, Mario] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Chile	Llusia, D (corresponding author), Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Fonoteca Zool, Madrid, Spain.	diego_llusia@mncn.csic.es	Llusia, Diego/AAB-2576-2020	Llusia, Diego/0000-0001-5432-2716; Gomez, Miguel/0000-0003-2714-2925; Marquez, Rafael/0000-0002-2070-860X	project TEMPURA [CGL2005-00092/BOS]; project ACOURA [CGL2008-04814-C02]; project TATANKA [CGL2011-25062]; Ministerio de Ciencia e Innovacion; FCW, Ministerio de Economia y Competitividad, Spain [CGL2011-16159-E]; Ministerio de Ciencia e Innovacion, Spain [BES-2006-13104]	project TEMPURA; project ACOURA; project TATANKA; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FCW, Ministerio de Economia y Competitividad, Spain; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Research funded by projects TEMPURA (CGL2005-00092/BOS), ACOURA (CGL2008-04814-C02), and TATANKA (CGL2011-25062), Ministerio de Ciencia e Innovacion, and FCW (CGL2011-16159-E), Ministerio de Economia y Competitividad, Spain (PI. R. Marquez). The first author was supported by an FPI predoctoral grant from Ministerio de Ciencia e Innovacion (BES-2006-13104, Spain) (http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; ANDERSON ME, 1985, WILSON BULL, V97, P436; Ayllon E, 2001, SEGUIMIENTO EVOLUCIO; Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Bee MA, 2004, J ACOUST SOC AM, V116, P3770, DOI 10.1121/1.1784445; Bee MA, 2001, ANIM BEHAV, V62, P1129, DOI 10.1006/anbe.2001.1851; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Boatright-Horowitz SL, 2000, ETHOLOGY, V106, P701, DOI 10.1046/j.1439-0310.2000.00580.x; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bosch J, 2001, COPEIA, P169, DOI 10.1643/0045-8511(2001)001[0169:CTIMMA]2.0.CO;2; Both C, 2012, BIOL LETTERS, V8, P714, DOI 10.1098/rsbl.2012.0412; BOWMAN R I, 1979, Journal fuer Ornithologie, V120, P353, DOI 10.1007/BF01642911; Bradbury Jack W., 1998, pi; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; BROWN CH, 1984, Z TIERPSYCHOL, V65, P273; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Cabana Martino, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P101; Capranica R.R., 1965, EVOKED VOCAL RESPONS; Castellano S, 2002, ETHOLOGY, V108, P75, DOI 10.1046/j.1439-0310.2002.00761.x; CHAPUIS C, 1971, Terre et la Vie, V118, P183; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Cook DG, 2007, HERPETOLOGICA, V63, P430, DOI 10.1655/0018-0831(2007)63[430:MUOTCR]2.0.CO;2; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; De la Torre S, 2002, ANIM BEHAV, V63, P847, DOI 10.1006/anbe.2001.1978; Drake JA, 1989, BIOL INVASIONS GLOBA; Elton C., 1958; EMLEN ST, 1976, BEHAV ECOL SOCIOBIOL, V1, P283, DOI 10.1007/BF00300069; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; Farina A, 2013, BIOACOUSTICS, V22, P175, DOI 10.1080/09524622.2012.761571; Fay RR, 1999, COMP HEARING FISH AM; FENG AS, 1975, J COMP PHYSIOL, V100, P221, DOI 10.1007/BF00614532; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Garcia-Paris M., 2004, FAUNA IBERICA, V24; Garcia-Paris M, 1991, REV ESPANOLA HERPETO, V5, P89; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; GERHARDT HC, 1980, BEHAV PROCESS, V5, P143, DOI 10.1016/0376-6357(80)90061-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GISH SL, 1981, Z TIERPSYCHOL, V56, P74; Goicoechea N, 2010, ZOOL SCR, V39, P141, DOI 10.1111/j.1463-6409.2009.00413.x; Gomez M, 2012, THESIS U AUTONOMA MA; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Greenspan SE, 2012, J WILDLIFE DIS, V48, P575, DOI 10.7589/0090-3558-48.3.575; Gridi-Papp M, 2007, SOUNDRULER ACOUSTIC; HANDFORD P, 1991, CONDOR, V93, P644, DOI 10.2307/1368196; HANDFORD P, 1988, CAN J ZOOL, V66, P2658, DOI 10.1139/z88-391; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; HARRIS CM, 1966, J ACOUST SOC AM, V40, P148, DOI 10.1121/1.1910031; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heger Tina, 2003, Biological Invasions, V5, P313; HOWARD RD, 1978, EVOLUTION, V32, P850, DOI 10.1111/j.1558-5646.1978.tb04639.x; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Jehle Robert, 1998, Bioacoustics, V9, P35; JILKA A, 1974, Journal fuer Ornithologie, V115, P192, DOI 10.1007/BF01643290; Kaiser K, 2009, BEHAVIOUR, V146, P1053, DOI 10.1163/156853909X404457; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kiesecker JM, 1998, CONSERV BIOL, V12, P776, DOI 10.1046/j.1523-1739.1998.97125.x; Kiesecker JM, 2001, ECOLOGY, V82, P1964, DOI 10.1890/0012-9658(2001)082[1964:PMUTDO]2.0.CO;2; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kraus Fred, 2009, V4, P1; Lever C, 2003, NATURALIZED REPTILES; LEWIS ER, 1982, J COMP PHYSIOL, V145, P437, DOI 10.1007/BF00612809; Llorente G.A., 2002, ATLAS LIBRO ROJO ANF, P126; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; Lowe S., 2000, ENCY BIOL INVASIONS; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MARQUEZ R, 1995, BEHAVIOUR, V132, P151, DOI 10.1163/156853995X00342; Marquez R, 1995, J ZOOL SYST EVOL RES, V33, P185, DOI 10.1111/j.1439-0469.1995.tb00971.x; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P291, DOI 10.1007/BF00299741; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; MEGELASIMMONS A, 1984, J ACOUST SOC AM, V76, P676, DOI 10.1121/1.391254; MEGELASIMMONS A, 1985, J ACOUST SOC AM, V78, P1236, DOI 10.1121/1.392892; Mockford EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028242; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Narins PM, 2007, HEARING SOUND COMMUN; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; OCONNOR RJ, 1986, PHILOS T R SOC B, V314, P583, DOI 10.1098/rstb.1986.0074; PAILLETT.M, 1969, CR SOC BIOL, V163, P74; Parris KM, 2009, ECOL SOC, V14; Parris KM, 2009, ECOL SOC, V14; Pearl CA, 2004, COPEIA, P11, DOI 10.1643/CE-03-010R2; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Penna M, 2006, J ACOUST SOC AM, V119, P1227, DOI 10.1121/1.2149769; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Penna M, 2012, J ACOUST SOC AM, V132, P4025, DOI 10.1121/1.4763982; Perla BS, 2002, BEHAV ECOL, V13, P844, DOI 10.1093/beheco/13.6.844; Piercy JE, 1991, HDB ACOUSTICAL MEASU, P31; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pleguezuelos J.M., 2002, ATLAS LIBRO ROJO ANF; R Development Core Team, 2012, R LANG ENV STAT COMP; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Ryan M.J., 1988, P637; RYAN MJ, 1980, COPEIA, P108; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1986, BRAIN BEHAV EVOLUT, V28, P70, DOI 10.1159/000118693; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Santos-Barrera G, 2009, IUCN 2013 IUCN RED L; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; SCHNEIDER H, 1982, ZOOL ANZ, V208, P161; SCHNEIDER H, 1990, ZOOL ANZ, V225, P265; Sequeira F, 2008, ATLAS ANFIBIOS REPTE, P92; Shirley SM, 2009, GLOBAL ECOL BIOGEOGR, V18, P450, DOI 10.1111/j.1466-8238.2009.00452.x; SHIROSE LJ, 1993, CAN J ZOOL, V71, P2363, DOI 10.1139/z93-332; SHY E, 1983, BEHAV ECOL SOCIOBIOL, V12, P71, DOI 10.1007/BF00296935; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; SORJONEN J, 1986, BEHAVIOUR, V98, P286, DOI 10.1163/156853986X01017; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; TUBARO PL, 1995, CONDOR, V97, P792, DOI 10.2307/1369187; Veltman CJ, 1996, AM NAT, V147, P542, DOI 10.1086/285865; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vitousek PM, 1996, AM SCI, V84, P468; WAAS JR, 1988, CAN J ZOOL, V66, P2578, DOI 10.1139/z88-379; WALLSCHLAGER D, 1980, EXPERIENTIA, V36, P412, DOI 10.1007/BF01975119; WASER PM, 1977, Z TIERPSYCHOL, V43, P239; WEARY DM, 1991, ANIM BEHAV, V41, P540, DOI 10.1016/S0003-3472(05)80860-7; Werner EE, 1995, J HERPETOL, V29, P600, DOI 10.2307/1564744; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; WILEY RH, 1991, AM NAT, V138, P973, DOI 10.1086/285263; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; WILSON E O, 1992; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	137	13	13	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77312	10.1371/journal.pone.0077312	http://dx.doi.org/10.1371/journal.pone.0077312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155940	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300074
J	Diepstraten, SCE; van de Ven, SMWY; Pijnappel, RM; Peeters, PHM; van den Bosch, MAAJ; Verkooijen, HM; Elias, SG				Diepstraten, Suzanne C. E.; van de Ven, Stephanie M. W. Y.; Pijnappel, Ruud M.; Peeters, Petra H. M.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.; Elias, Sjoerd G.			Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; DIAGNOSIS; DISEASE; RISK; MICROCALCIFICATION; RECOMMENDATIONS; MANAGEMENT; IMPUTATION; SPECIMENS; LESIONS	Background: We aimed to develop a multivariable model for prediction of underestimated invasiveness in women with ductal carcinoma in situ at stereotactic large core needle biopsy, that can be used to select patients for sentinel node biopsy at primary surgery. Methods: From the literature, we selected potential preoperative predictors of underestimated invasive breast cancer. Data of patients with nonpalpable breast lesions who were diagnosed with ductal carcinoma in situ at stereotactic large core needle biopsy, drawn from the prospective COBRA (Core Biopsy after RAdiological localization) and COBRA2000 cohort studies, were used to fit the multivariable model and assess its overall performance, discrimination, and calibration. Results: 348 women with large core needle biopsy-proven ductal carcinoma in situ were available for analysis. In 100 (28.7%) patients invasive carcinoma was found at subsequent surgery. Nine predictors were included in the model. In the multivariable analysis, the predictors with the strongest association were lesion size (OR 1.12 per cm, 95% CI 0.98-1.28), number of cores retrieved at biopsy (OR per core 0.87, 95% CI 0.75-1.01), presence of lobular cancerization (OR 5.29, 95% CI 1.25-26.77), and microinvasion (OR 3.75, 95% CI 1.42-9.87). The overall performance of the multivariable model was poor with an explained variation of 9% (Nagelkerke's R-2), mediocre discrimination with area under the receiver operating characteristic curve of 0.66 (95% confidence interval 0.58-0.73), and fairly good calibration. Conclusion: The evaluation of our multivariable prediction model in a large, clinically representative study population proves that routine clinical and pathological variables are not suitable to select patients with large core needle biopsy-proven ductal carcinoma in situ for sentinel node biopsy during primary surgery.	[Diepstraten, Suzanne C. E.; Pijnappel, Ruud M.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van de Ven, Stephanie M. W. Y.] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA; [Peeters, Petra H. M.; Elias, Sjoerd G.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Stanford University; Utrecht University; Utrecht University Medical Center	Diepstraten, SCE (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	s.c.e.diepstraten@umcutrecht.nl	Elias, Sjoerd G/E-6057-2011	Elias, Sjoerd G/0000-0003-3903-4024; van de Ven, Stephanie/0000-0003-0861-0471; Pijnappel, Ruud/0000-0002-6912-9414	Dutch Cancer Society;  [UU 2010-4893]	Dutch Cancer Society(KWF Kankerbestrijding); 	This research project was supported financially in the form of a grant from the Dutch Cancer Society to Sjoerd G. Elias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number: UU 2010-4893. URL of funder's website: http://dcs.kwfkankerbestrijding.nl/Pages/Home.aspx	Bagnall MJC, 2001, CLIN RADIOL, V56, P828, DOI 10.1053/crad.2001.0779; Bonnett M, 2002, MODERN PATHOL, V15, P95, DOI 10.1038/modpathol.3880497; Brem RF, 2001, RADIOLOGY, V219, P793, DOI 10.1148/radiology.219.3.r01jn34793; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Chan MYP, 2010, ASIAN J SURG, V33, P76, DOI 10.1016/S1015-9584(10)60013-9; Cox D, 2006, BREAST, V15, P210, DOI 10.1016/j.breast.2005.06.001; Dillon MF, 2006, J SURG ONCOL, V93, P559, DOI 10.1002/jso.20445; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Doyle B, 2009, J CLIN PATHOL, V62, P534, DOI 10.1136/jcp.2008.061457; Go EML, 2010, MODERN PATHOL, V23, P737, DOI 10.1038/modpathol.2009.187; Goyal A, 2006, BREAST CANCER RES TR, V98, P311, DOI 10.1007/s10549-006-9167-2; Hoorntje LE, 2003, ANN SURG ONCOL, V10, P748, DOI 10.1245/ASO.2003.11.011; Houssami N, 2007, CANCER, V109, P487, DOI 10.1002/cncr.22435; Houssami N, 2011, ANN SURG ONCOL, V18, P1364, DOI 10.1245/s10434-010-1438-9; Huo L, 2006, CANCER-AM CANCER SOC, V107, P1760, DOI 10.1002/cncr.22216; Jackman RJ, 2001, RADIOLOGY, V218, P497, DOI 10.1148/radiology.218.2.r01fe35497; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Kerlikowske Karla, 2010, Journal of the National Cancer Institute Monographs, P139, DOI 10.1093/jncimonographs/lgq027; King TA, 2001, AM SURGEON, V67, P907; Kurniawan ED, 2010, ARCH SURG-CHICAGO, V145, P1098, DOI 10.1001/archsurg.2010.243; Lee CH, 2000, RADIOLOGY, V217, P466, DOI 10.1148/radiology.217.2.r00nv08466; Lee JW, 2008, J SURG ONCOL, V98, P15, DOI 10.1002/jso.21077; Leikola J, 2007, ACTA ONCOL, V46, P798, DOI 10.1080/02841860601128941; Londero V, 2007, RADIOL MED, V112, P863, DOI 10.1007/s11547-007-0183-z; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Meijnen P, 2007, BRIT J SURG, V94, P952, DOI 10.1002/bjs.5735; Mittendorf Elizabeth A, 2005, Curr Surg, V62, P253; Miyake T, 2011, AM J SURG, V202, P59, DOI 10.1016/j.amjsurg.2010.09.032; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; O'Flynn EAM, 2009, CLIN RADIOL, V64, P178, DOI 10.1016/j.crad.2008.08.007; Pandelidis S, 2003, ANN SURG ONCOL, V10, P43, DOI 10.1245/ASO.2003.05.004; Park HS, 2013, BREAST, V22, P869, DOI 10.1016/j.breast.2013.03.009; Park HS, 2013, J SURG ONCOL, V107, P388, DOI 10.1002/jso.23273; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peters N, 2008, INT J CANCER, V122, P468, DOI 10.1002/ijc.23078; Renshaw AA, 2002, ARCH PATHOL LAB MED, V126, P39; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rutstein LA, 2007, BREAST J, V13, P251, DOI 10.1111/j.1524-4741.2007.00418.x; Schulz S, 2013, BREAST, V22, P537, DOI 10.1016/j.breast.2012.11.002; Sie A, 2006, CANCER, V107, P945, DOI 10.1002/cncr.22090; Son BK, 2011, J BREAST CANCER, V14, P301, DOI 10.4048/jbc.2011.14.4.301; Steyerberg E., 2009, CLIN PREDICTION MODE; Tan JCC, 2007, ANN SURG ONCOL, V14, P638, DOI 10.1245/s10434-006-9211-9; Trentin C, 2012, BREAST, V21, P635, DOI 10.1016/j.breast.2012.06.009; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van Esser S, 2009, ANN SURG ONCOL, V16, P2252, DOI 10.1245/s10434-009-0513-6; Verkooijen HM, 2002, INT J CANCER, V99, P853, DOI 10.1002/ijc.10419; Wahedna Y, 2001, EUR J CANCER, V37, P459, DOI 10.1016/S0959-8049(00)00397-X; WEINBERG CR, 1994, AM J EPIDEMIOL, V140, P565, DOI 10.1093/oxfordjournals.aje.a117283; Wilkie C, 2005, AM J SURG, V190, P563, DOI 10.1016/j.amjsurg.2005.06.011; Won B, 1999, AM J ROENTGENOL, V173, P227, DOI 10.2214/ajr.173.1.10397131; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012; Yi M, 2008, AM J SURG, V196, P81, DOI 10.1016/j.amjsurg.2007.08.057	54	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77826	10.1371/journal.pone.0077826	http://dx.doi.org/10.1371/journal.pone.0077826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147085	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400140
J	Huang, L				Huang, Lin			What Happened if Various Kinds of Postconditioning Working on the Preconditioned Ischemic Skin Flaps	PLOS ONE			English	Article							REPERFUSION INJURY; DELAY; DEFICIENT; SURVIVAL; IMPACT	Objective: Ischemic pre-conditioning and post-conditioning are useful manipulations to reduce the undesirable effects of ischemia-reperfusion skin flap each. But the impact of post-conditioning on the pre-conditioning skin flap is not manifested. Here we investigated the influence of ischemic post-conditioning in a preconditioned axial pattern skin flap model. Method: We used the skin flap in 40 rabbits and divided them into 5 groups randomly. At first we induced the ischemic pre-conditioning of the flap which was applied by 2 periods of 15 minutes of ischemia/15 minutes of reperfusion cycle. Next post-conditioning was performed by 6 cycles of 10 seconds of repeated ischemia/reperfusion periods at different times of just after the reperfusion, 5 minutes after the reperfusion, 10 minutes after the reperfusion. The animals were allocated into 5 groups: group 1 (Ischemia Group); group 2: (Pre-conditioning Group); group 3: (Pre-conditioning+ Post-conditioning Group); group 4 (Pre-conditioning+ Post-conditioning 5 minutes later Group); group5 (Pre-conditioning+ Post-conditioning 10 minutes later). The neutrophil count was assessed with histologic analysis before the dissection of the skin flap. Flap viability was assessed 1 week after the operation, and surviving flap area was recorded as a percentage of the whole flap area. LSD test was used for statistical analysis among different groups to evaluate the effects of ischemic pre-conditioning against ischemia. Result: Among the varying groups, the neutrophil count varied: Group 1 was50.12 +/- 5.91; Group 2, 30.00 +/- 2.00, and Group 3, 18.87 +/- 3; Group 4, 22.50 +/- 1.92; Group 5, 30.12 +/- 1.88. The mean +/- SD surviving areas of the flaps for groups 1, 2, 3, 4 and 5 were 31.76 +/- 4.59, 51.26 +/- 3.24,82.18 +/- 5.28,66.85 +/- 3.87 and 51.13 +/- 2.90 respectively. Spearman correlation analysis shows an increase relation between neutrophil count and flap survival rate in the different groups (P < 0.05). Conclusion: Ischemic post-conditioning has protective effect on ischemic preconditioned skin flaps, but the post-conditioning should be performed within 5 minutes after the end of ischemia.	Capital Univ Med Sci, Anzheng Hosp, Beijing, Peoples R China	Capital Medical University	Huang, L (corresponding author), Capital Univ Med Sci, Anzheng Hosp, Beijing, Peoples R China.	cc.ll.80811@163.com			National Natural Science Foundation of China [81272130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No 81272130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benacquista T, 1996, PLAST RECONSTR SURG, V98, P834, DOI 10.1097/00006534-199610000-00013; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Cederna PS, 1997, PLAST RECONSTR SURG, V99, P183, DOI 10.1097/00006534-199701000-00027; Eppihimer MJ, 1997, SHOCK, V8, P16, DOI 10.1097/00024382-199707000-00004; Fan LK, 2000, ANN PLAS SURG, V44, P65, DOI 10.1097/00000637-200044010-00011; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Hosnuter M, 2003, ANN PLAS SURG, V50, P398, DOI 10.1097/01.SAP.0000037261.84618.7F; Huang L, 2011, TRANSPL P, V43, P2550, DOI 10.1016/j.transproceed.2011.04.018; Huang L, 2011, WOUNDS, V23, P328; ISSEKUTZ TB, 1990, J IMMUNOL, V144, P2140; Jassem W, 1998, TRANSPLANT REV, V12, P14, DOI DOI 10.1016/S0955-470X(98)80037-2; KOENIG WJ, 1992, PLAST RECONSTR SURG, V90, P659, DOI 10.1097/00006534-199210000-00016; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Matsumura H, 2001, BRIT J PLAST SURG, V54, P58, DOI 10.1054/bjps.2000.3470; Meldrum DR, 1997, J MOL CELL CARDIOL, V29, P2849, DOI 10.1006/jmcc.1997.0506; Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506; Moon JG, 2008, MICROSURG, V28, P531, DOI 10.1002/micr.20530; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Salmi AM, 1999, SCAND J PLAST RECONS, V33, P163; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; URKEN ML, 1994, ARCH OTOLARYNGOL, V120, P633	22	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72818	10.1371/journal.pone.0072818	http://dx.doi.org/10.1371/journal.pone.0072818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24147150	Green Submitted, gold, Green Published			2022-12-25	WOS:000326240100019
J	Fujiya, M; Konishi, H; Kamel, MKM; Ueno, N; Inaba, Y; Moriichi, K; Tanabe, H; Ikuta, K; Ohtake, T; Kohgo, Y				Fujiya, M.; Konishi, H.; Kamel, M. K. Mohamed; Ueno, N.; Inaba, Y.; Moriichi, K.; Tanabe, H.; Ikuta, K.; Ohtake, T.; Kohgo, Y.			microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1	ONCOGENE			English	Article						microRNAs; heterogeneous nuclear ribonucleoproteins; colon cancer; apoptosis; autophagy; ubiquitin	POSTTRANSCRIPTIONAL REGULATION; COLORECTAL-CANCER; NONCODING RNAS; C-ELEGANS; GENE; MUTATIONS; RAS; EXPRESSION; PROLIFERATION; TUMORIGENESIS	It is well known that microRNAs (miRs) are abnormally expressed in various cancers and target the messenger RNAs (mRNAs) of cancer-associated genes. While (miRs) are abnormally expressed in various cancers, whether miRs directly target oncogenic proteins is unknown. The present study investigated the inhibitory effects of miR-18a on colon cancer progression, which was considered to be mediated through its direct binding and degradation of heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1). An MTT assay and xenograft model demonstrated that the transfection of miR-18a induced apoptosis in SW620 cells. A binding assay revealed direct binding between miR-18a and hnRNP A1 in the cytoplasm of SW620 cells, which inhibited the oncogenic functions of hnRNP A1. A competitor RNA, which included the complementary sequence of the region of the miR-18a-hnRNP A1 binding site, repressed the effects of miR-18a on the induction of cancer cell apoptosis. In vitro single and in vivo double isotope assays demonstrated that miR-18a induced the degradation of hnRNP A1. An immunocytochemical study of hnRNP A1 and LC3-II and the inhibition of autophagy by 3-methyladenine and ATG7, p62 and BAG3 siRNA showed that miR-18a and hnRNP A1 formed a complex that was degraded through the autophagolysosomal pathway. This is the first report showing a novel function of a miR in the autophagolysosomal degradation of an oncogenic protein resulting from the creation of a complex consisting of the miR and a RNA-binding protein, which suppressed cancer progression.	[Fujiya, M.; Konishi, H.; Kamel, M. K. Mohamed; Ueno, N.; Inaba, Y.; Moriichi, K.; Tanabe, H.; Ikuta, K.; Ohtake, T.; Kohgo, Y.] Asahikawa Med Coll, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Fujiya, M (corresponding author), Asahikawa Med Coll, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	fjym@asahikawa-med.ac.jp	Kohgo, Yutaka/AAN-4863-2020	Tanabe, Hiroki/0000-0001-9029-5081	Grants-in-Aid for Scientific Research [24790671] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Guan RJ, 1999, GASTROENTEROLOGY, V116, P1063, DOI 10.1016/S0016-5085(99)70009-0; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kettern N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016398; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Qased A, 2013, MOL MED REP, V7, P559, DOI 10.3892/mmr.2012.1214; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Ushigome M, 2005, INT J ONCOL, V26, P635; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2	38	48	48	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4847	4856		10.1038/onc.2013.429	http://dx.doi.org/10.1038/onc.2013.429			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24166503				2022-12-25	WOS:000343240100006
J	Turnbull, IC; Karakikes, I; Serrao, GW; Backeris, P; Lee, JJ; Xie, CQ; Senyei, G; Gordon, RE; Li, RA; Akar, FG; Hajjar, RJ; Hulot, JS; Costa, KD				Turnbull, Irene C.; Karakikes, Ioannis; Serrao, Gregory W.; Backeris, Peter; Lee, Jia-Jye; Xie, Chaoqin; Senyei, Grant; Gordon, Ronald E.; Li, Ronald A.; Akar, Fadi G.; Hajjar, Roger J.; Hulot, Jean-Sebastien; Costa, Kevin D.			Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium	FASEB JOURNAL			English	Article						cardiomyocyte development; contractile function; drug discovery; stem cell	CELL-DERIVED CARDIOMYOCYTES; SCAFFOLD-FREE; IN-VITRO; STEM; HEART; MATURATION; MUSCLE; TRANSPLANTATION; GENERATION; CALCIUM	Cardiac experimental biology and translational research would benefit from an in vitro surrogate for human heart muscle. This study investigated structural and functional properties and interventional responses of human engineered cardiac tissues (hECTs) compared to human myocardium. Human embryonic stem cell-derived cardiomyocytes (hESC-CMs, >90% troponin-positive) were mixed with collagen and cultured on force-sensing elastomer devices. hECTs resembled trabecular muscle and beat spontaneously (1.18 +/- 0.48 Hz). Microstructural features and mRNA expression of cardiac-specific genes (-MHC, SERCA2a, and ACTC1) were comparable to human myocardium. Optical mapping revealed cardiac refractoriness with loss of 1:1 capture above 3 Hz, and cycle length dependence of the action potential duration, recapitulating key features of cardiac electrophysiology. hECTs reconstituted the Frank-Starling mechanism, generating an average maximum twitch stress of 660 N/mm(2) at L-max, approaching values in newborn human myocardium. Dose-response curves followed exponential pharmacodynamics models for calcium chloride (EC50 1.8 mM) and verapamil (IC50 0.61 M); isoproterenol elicited a positive chronotropic but negligible inotropic response, suggesting sarcoplasmic reticulum immaturity. hECTs were amenable to gene transfer, demonstrated by successful transduction with Ad.GFP. Such 3-D hECTs recapitulate an early developmental stage of human myocardium and promise to offer an alternative preclinical model for cardiology research.Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J.-J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., Hajjar, R. J., Hulot, J.-S., Costa, K. D. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.	[Turnbull, Irene C.; Karakikes, Ioannis; Serrao, Gregory W.; Backeris, Peter; Lee, Jia-Jye; Xie, Chaoqin; Senyei, Grant; Li, Ronald A.; Akar, Fadi G.; Hajjar, Roger J.; Hulot, Jean-Sebastien; Costa, Kevin D.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Gordon, Ronald E.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Li, Ronald A.] Univ Hong Kong, Li Ka Shing Fac Med, Stem Cell & Regenerat Med Consortium, Pokfulam, Hong Kong, Peoples R China; [Li, Ronald A.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Li, Ronald A.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Pokfulam, Hong Kong, Peoples R China; [Hulot, Jean-Sebastien] Univ Paris 06, Unit Mixte Rech Sante UMRS 956, Paris, France	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Hong Kong; University of Hong Kong; University of Hong Kong; UDICE-French Research Universities; Sorbonne Universite	Costa, KD (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, Cardiovasc Cell & Tissue Engn Lab, 1 Gustave L Levy Pl,POB 1030, New York, NY 10029 USA.	kevin.costa@mssm.edu	Hulot, Jean-Sébastien/A-2278-2016; Senyei, Grant/GQZ-4020-2022	Hulot, Jean-Sébastien/0000-0001-5463-6117; Karakikes, Ioannis/0000-0002-4348-600X	U.S. National Institutes of Health (NIH)/National Center for Research Resources; NIH/National Center for Advancing Translational Sciences [UL1RR029887]; NIH/National Heart Lung and Blood Institute Program of Excellence in Nanotechnology Award [HHSN268201000045C]; Research Grant Council of Hong Kong [TRS T13-706/11]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Center for Advancing Translational Sciences; NIH/National Heart Lung and Blood Institute Program of Excellence in Nanotechnology Award; Research Grant Council of Hong Kong(Hong Kong Research Grants Council); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Timothy Cashman for technical assistance. Confocal laser scanning microscopy was performed at the Mount Sinai Microscopy Shared Resource Facility. This project was supported by the U.S. National Institutes of Health (NIH)/National Center for Research Resources and the NIH/National Center for Advancing Translational Sciences through grant UL1RR029887; an NIH/National Heart Lung and Blood Institute Program of Excellence in Nanotechnology Award, contract HHSN268201000045C; and the Research Grant Council of Hong Kong, grant TRS T13-706/11.	Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; BOHM M, 1991, CIRC RES, V68, P689, DOI 10.1161/01.RES.68.3.689; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Cain BS, 1998, ANN THORAC SURG, V65, P1065, DOI 10.1016/S0003-4975(98)00093-9; Carlsson L, 2006, J INTERN MED, V259, P70, DOI 10.1111/j.1365-2796.2005.01590.x; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; COOPER IC, 1990, J MOL CELL CARDIOL, V22, P439, DOI 10.1016/0022-2828(90)91479-Q; Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Eschenhagen T, 2012, AM J PHYSIOL-HEART C, V303, pH133, DOI 10.1152/ajpheart.00007.2012; Foldes G, 2011, J MOL CELL CARDIOL, V50, P367, DOI 10.1016/j.yjmcc.2010.10.029; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Fulbright JM, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/942090; GODT RE, 1991, CAN J PHYSIOL PHARM, V69, P1692, DOI 10.1139/y91-251; GWATHMEY JK, 1991, J CLIN INVEST, V87, P1023, DOI 10.1172/JCI115061; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hasenfuss G, 1996, CIRCULATION, V94, P3155, DOI 10.1161/01.CIR.94.12.3155; HASENFUSS G, 1994, J MOL CELL CARDIOL, V26, P1461, DOI 10.1006/jmcc.1994.1165; Holubarsch C, 1996, CIRCULATION, V94, P683, DOI 10.1161/01.CIR.94.4.683; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Karakikes I., 2013, STEM CELLS TRANSL ME, DOI 10.5966/sctm.2013-0110; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051; Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Nirmalanandhan VS, 2009, J BIOMOL SCREEN, V14, P755, DOI 10.1177/1087057109336591; Peng S, 2010, J PHARMACOL TOX MET, V61, P277, DOI 10.1016/j.vascn.2010.01.014; PETERS NS, 1994, CIRCULATION, V90, P713, DOI 10.1161/01.CIR.90.2.713; Pillekamp F, 2012, STEM CELLS DEV, V21, P2111, DOI 10.1089/scd.2011.0312; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rossman EI, 2004, J MOL CELL CARDIOL, V36, P33, DOI 10.1016/j.yjmcc.2003.09.001; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; SCHWINGER RHG, 1990, J CARDIOVASC PHARM, V15, P892, DOI 10.1097/00005344-199006000-00006; SCHWINGER RHG, 1992, AM HEART J, V123, P116, DOI 10.1016/0002-8703(92)90755-K; Serrao GW, 2012, TISSUE ENG PT A, V18, P1322, DOI [10.1089/ten.tea.2011.0278, 10.1089/ten.TEA.2011.0278]; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; SONNENBL.EH, 1966, CIRC RES, V19, P980, DOI 10.1161/01.RES.19.5.980; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151; Tiburcy M, 2011, CIRC RES, V109, P1105, DOI 10.1161/CIRCRESAHA.111.251843; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; WHITE M, 1994, CIRCULATION, V90, P1225, DOI 10.1161/01.CIR.90.3.1225; Wiegerinck RF, 2009, PEDIATR RES, V65, P414, DOI 10.1203/PDR.0b013e318199093c; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026	54	115	118	1	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					644	654		10.1096/fj.13-228007	http://dx.doi.org/10.1096/fj.13-228007			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24174427	Green Published			2022-12-25	WOS:000331072200012
J	Congdon, EE; Gu, JP; Sait, HBR; Sigurdsson, EM				Congdon, Erin E.; Gu, Jiaping; Sait, Hameetha B. R.; Sigurdsson, Einar M.			Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fc gamma Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Antibodies; Endocytosis; Immunotherapy; Tau	MOUSE MODEL; A-BETA; ALZHEIMERS-DISEASE; IMMUNOGLOBULIN-G; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; MEDIATED ENDOCYTOSIS; PATHOLOGY; PEPTIDE; IMMUNOTHERAPY	Background: How Tau immunotherapy clears Tau is not well known. Results: Tau antibody uptake correlates with Tau levels, is primarily via clathrin-dependent FcII/III endocytosis, and is required for acute Tau clearance. Conclusion: Following receptor-mediated uptake into neurons, antibodies co-localize with Tau aggregates and promote Tau clearance. Significance: Results support intracellular clearance as a viable route for immunotherapy and have major implications for future development. Tau immunotherapy is effective in transgenic mice, but the mechanisms of Tau clearance are not well known. To this end, Tau antibody uptake was analyzed in brain slice cultures and primary neurons. Internalization was rapid (<1 h), saturable, and substantial compared with control mouse IgG. Furthermore, temperature reduction to 4 degrees C, an excess of unlabeled mouse IgG, or an excess of Tau antibodies reduced uptake in slices by 63, 41, and 62%, respectively (p = 0.002, 0.04, and 0.005). Uptake strongly correlated with total and insoluble Tau levels (r(2) = 0.77 and 0.87 and p = 0.002 and 0.0002), suggesting that Tau aggregates influence antibody internalization and/or retention within neurons. Inhibiting phagocytosis did not reduce uptake in slices or neuronal cultures, indicating limited microglial involvement. In contrast, clathrin-specific inhibitors reduced uptake in neurons (78%, p < 0.0001) and slices (35%, p = 0.03), demonstrating receptor-mediated endocytosis as the primary uptake pathway. Fluid phase endocytosis accounted for the remainder of antibody uptake in primary neurons, based on co-staining with internalized dextran. The receptor-mediated uptake is to a large extent via low affinity FcII/III receptors and can be blocked in slices (43%, p = 0.04) and neurons (53%, p = 0.008) with an antibody against these receptors. Importantly, antibody internalization appears to be necessary for Tau reduction in primary neurons. Overall, these findings clarify that Tau antibody uptake is primarily receptor-mediated, that these antibodies are mainly found in neurons with Tau aggregates, and that their intracellular interaction leads to clearance of Tau pathology, all of which have major implications for therapeutic development of this approach.	[Congdon, Erin E.; Gu, Jiaping; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University	Sigurdsson, EM (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, 550 First Ave MSB 459, New York, NY 10016 USA.	Einar.Sigurdsson@nyumc.org		Congdon, Erin/0000-0001-8322-6176; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [NS077239, AG032611, AG020197]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG020197, R01AG032611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS077239, AG032611, and AG020197. E. M. Sigurdsson is an inventor on NYU patents on Tau immunotherapy licensed to H. Lundbeck A/S.	Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; BOUTAJANGOUT A, 2011, ALZHEIMERS DEMENT, V7, pS480; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Callaway E, 2012, NATURE, V489, P13, DOI 10.1038/489013a; Cao SW, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-42; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2010, M S-MED SCI, V26, P121, DOI 10.1051/medsci/2010262121; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Das P, 2003, J NEUROSCI, V23, P8532; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fernandez-Vizarra P, 2012, BRAIN, V135, P2826, DOI 10.1093/brain/aws195; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goebl NA, 2008, MOL BIOL CELL, V19, P5490, DOI 10.1091/mbc.E07-02-0101; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; Gu JP, 2013, J BIOL CHEM, V288, P33081, DOI 10.1074/jbc.M113.494922; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Krishnamurthy Pavan K, 2011, Front Psychiatry, V2, P59, DOI 10.3389/fpsyt.2011.00059; Lemere CA, 2000, ANN NY ACAD SCI, V920, P328; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; PERESS NS, 1993, J NEUROIMMUNOL, V48, P71, DOI 10.1016/0165-5728(93)90060-C; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Soto C, 2012, NEURON, V73, P621, DOI 10.1016/j.neuron.2012.02.006; Suemitsu S, 2010, NEUROSCIENCE, V166, P819, DOI 10.1016/j.neuroscience.2010.01.004; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; van der Kleij H, 2010, J ALLERGY CLIN IMMUN, V125, P757, DOI 10.1016/j.jaci.2009.10.054; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615	59	142	150	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35452	35465		10.1074/jbc.M113.491001	http://dx.doi.org/10.1074/jbc.M113.491001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163366	Green Published, hybrid			2022-12-25	WOS:000329867600041
J	Adhi, M; Cashman, SM; Kumar-Singh, R				Adhi, Mehreen; Cashman, Siobhan M.; Kumar-Singh, Rajendra			Adeno-Associated Virus Mediated Delivery of a Non-Membrane Targeted Human Soluble CD59 Attenuates Some Aspects of Diabetic Retinopathy in Mice	PLOS ONE			English	Article							COMPLEMENT REGULATORY PROTEIN; RETINAL VASCULAR LEAKAGE; MOUSE MODEL; SYSTEM; CELLS; PATHOGENESIS; IMMUNOLOGY; BREAKDOWN; VECTORS; DRUSEN	Diabetic retinopathy is the leading cause of visual dysfunction in working adults and is attributed to retinal vascular and neural cell damage. Recent studies have described elevated levels of membrane attack complex (MAC) and reduced levels of membrane associated complement regulators including CD55 and CD59 in the retina of diabetic retinopathy patients as well as in animal models of this disease. We have previously described the development of a soluble membrane-independent form of CD59 (sCD59) that when delivered via a gene therapy approach using an adeno-associated virus vector (AAV2/8-sCD59) to the eyes of mice, can block MAC deposition and choroidal neovascularization. Here, we examine AAV2/8-sCD59 mediated attenuation of MAC deposition and ensuing complement mediated damage to the retina of mice following streptozotocin (STZ) induced diabetes. We observed a 60% reduction in leakage of retinal blood vessels in diabetic eyes pre-injected with AAV2/8-sCD59 relative to negative control virus injected diabetic eyes. AAV2/8-sCD59 injected eyes also exhibited protection from non-perfusion of retinal blood vessels. In addition, a 200% reduction in retinal ganglion cell apoptosis and a 40% reduction in MAC deposition were documented in diabetic eyes pre-injected with AAV2/8-sCD59 relative to diabetic eyes pre-injected with the control virus. This is the first study characterizing a viral gene therapy intervention that targets MAC in a model of diabetic retinopathy. Use of AAV2/8-sCD59 warrants further exploration as a potential therapy for advanced stages of diabetic retinopathy.	[Adhi, Mehreen; Cashman, Siobhan M.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Kumar-Singh, R (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	rajendra.kumar-singh@tufts.edu	Adhi, Mehreen/AAS-9733-2021	Kumar-Singh, Rajendra/0000-0002-7754-0713	Ellison Foundation; Virginia B Smith Trust; National Institute of Health/NEI [EY021805, EY013887]; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY021805] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Virginia B Smith Trust; National Institute of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to RKS from The Ellison Foundation, The Virginia B Smith Trust, The National Institute of Health/NEI (EY021805 and EY013887), and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Bossi F, 2011, IMMUNOL LETT, V140, P7, DOI 10.1016/j.imlet.2011.06.006; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Cashman SM, 2011, INVEST OPHTH VIS SCI, V52, P3436, DOI 10.1167/iovs.10-6002; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fletcher EL, 2008, CLIN EXP OPTOM, V91, P67, DOI 10.1111/j.1444-0938.2007.00204.x; Gandhi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021621; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Grant S, 2010, EUR J PHARMACOL, V627, P16, DOI 10.1016/j.ejphar.2009.10.029; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kowluru RA, 2008, CONTEMP DIABETES, P265, DOI 10.1007/978-1-59745-563-3_11; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Maharjan S, 2011, EUR J PHARMACOL, V657, P35, DOI 10.1016/j.ejphar.2011.01.040; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mullins RF, 2011, EXP EYE RES, V93, P565, DOI 10.1016/j.exer.2011.06.015; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Osanai M, 2010, CURR DIABETES REV, V6, P35, DOI 10.2174/157339910790442619; Qin XB, 2004, DIABETES, V53, P2653, DOI 10.2337/diabetes.53.10.2653; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Satofuka S, 2009, DIABETES, V58, P1625, DOI 10.2337/db08-0254; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu KK, 2008, CURR PROTOC PHARM UN, DOI DOI 10.1002/0471141755.PH0547S40.HTTP://; Yanai R, 2012, ADV EXP MED BIOL, V946, P161, DOI 10.1007/978-1-4614-0106-3_10; Zhang A, 2002, DIABETES, V51, P3499; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zolotukhin S, 2005, HUM GENE THER, V16, P551, DOI 10.1089/hum.2005.16.551; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	47	21	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e79661	10.1371/journal.pone.0079661	http://dx.doi.org/10.1371/journal.pone.0079661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167638	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500099
J	Bellone, RR; Holl, H; Setaluri, V; Devi, S; Maddodi, N; Archer, S; Sandmeyer, L; Ludwig, A; Foerster, D; Pruvost, M; Reissmann, M; Bortfeldt, R; Adelson, DL; Lim, SL; Nelson, J; Haase, B; Engensteiner, M; Leeb, T; Forsyth, G; Mienaltowski, MJ; Mahadevan, P; Hofreiter, M; Paijmans, JLA; Gonzalez Fortes, G; Grahn, B; Brooks, SA				Bellone, Rebecca R.; Holl, Heather; Setaluri, Vijayasaradhi; Devi, Sulochana; Maddodi, Nityanand; Archer, Sheila; Sandmeyer, Lynne; Ludwig, Arne; Foerster, Daniel; Pruvost, Melanie; Reissmann, Monika; Bortfeldt, Ralf; Adelson, David L.; Lim, Sim Lin; Nelson, Janelle; Haase, Bianca; Engensteiner, Martina; Leeb, Tosso; Forsyth, George; Mienaltowski, Michael J.; Mahadevan, Padmanabhan; Hofreiter, Michael; Paijmans, Johanna L. A.; Gonzalez Fortes, Gloria; Grahn, Bruce; Brooks, Samantha A.			Evidence for a Retroviral Insertion in TRPM1 as the Cause of Congenital Stationary Night Blindness and Leopard Complex Spotting in the Horse	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MELANIN CONTENT; HUMAN GENES; CHANNEL; PROTEIN; APPALOOSA; ELEMENTS; LP; NYCTALOPIN; MUTATIONS	Leopard complex spotting is a group of white spotting patterns in horses caused by an incompletely dominant gene (LP) where homozygotes (LP/LP) are also affected with congenital stationary night blindness. Previous studies implicated Transient Receptor Potential Cation Channel, Subfamily M, Member 1 (TRPM1) as the best candidate gene for both CSNB and LP. RNA-Seq data pinpointed a 1378 bp insertion in intron 1 of TRPM1 as the potential cause. This insertion, a long terminal repeat (LTR) of an endogenous retrovirus, was completely associated with LP, testing 511 horses (chi(2)=1022.00, p<<0.0005), and CSNB, testing 43 horses (chi(2)=43, p<<0.0005). The LTR was shown to disrupt TRPM1 transcription by premature poly-adenylation. Furthermore, while deleterious transposable element insertions should be quickly selected against the identification of this insertion in three ancient DNA samples suggests it has been maintained in the horse gene pool for at least 17,000 years. This study represents the first description of an LTR insertion being associated with both a pigmentation phenotype and an eye disorder.	[Bellone, Rebecca R.; Nelson, Janelle; Mahadevan, Padmanabhan] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Holl, Heather; Brooks, Samantha A.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Setaluri, Vijayasaradhi; Devi, Sulochana; Maddodi, Nityanand] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI USA; [Sandmeyer, Lynne; Grahn, Bruce] Univ Saskatchewan, Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Ludwig, Arne; Foerster, Daniel; Pruvost, Melanie] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Genet, Berlin, Germany; [Pruvost, Melanie] Inst Jacques Monod, Epigen & Palaeogen Grp, F-75251 Paris, France; [Reissmann, Monika; Bortfeldt, Ralf] Humboldt Univ, Dept Breeding Biol & Mol Genet, D-10099 Berlin, Germany; [Adelson, David L.; Lim, Sim Lin] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Haase, Bianca] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Engensteiner, Martina; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Forsyth, George] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Mienaltowski, Michael J.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Hofreiter, Michael; Paijmans, Johanna L. A.; Gonzalez Fortes, Gloria] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Tampa; Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of Saskatchewan; Leibniz Institut fur Zoo und Wildtierforschung; UDICE-French Research Universities; Universite Paris Cite; Humboldt University of Berlin; University of Adelaide; University of Sydney; University of Bern; University of Saskatchewan; State University System of Florida; University of South Florida; University of York - UK	Bellone, RR (corresponding author), Univ Tampa, Dept Biol, Tampa, FL 33606 USA.	rbellone@ut.edu	Brooks, Samantha/ABD-5279-2020; Leeb, Tosso/G-3187-2014; Adelson, David/E-5506-2011; Gonzalez Fortes, Gloria/L-9213-2014; Hofreiter, Michael/A-3996-2017	Brooks, Samantha/0000-0002-4500-2689; Leeb, Tosso/0000-0003-0553-4880; Bellone, Rebecca/0000-0001-8838-7227; Adelson, David/0000-0003-2404-5636; Forster, Daniel/0000-0002-6934-0404; Gonzalez Fortes, Gloria/0000-0002-3700-7674; Waud, Bianca/0000-0001-6493-9808; Hofreiter, Michael/0000-0003-0441-4705; Paijmans, Johanna L.A./0000-0002-1938-7052	L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan; Dana Faculty Development Grant from the University of Tampa; Swiss National Science Foundation [31003A-133034]; NIH [AR AR056087]; DFG [LU 852/7-4]; NSF [1132229]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056087] Funding Source: NIH RePORTER	L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan; Dana Faculty Development Grant from the University of Tampa; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the L. David Dube and Heather Ryan Veterinary Health Research Fund from the University of Saskatchewan and a Dana Faculty Development Grant from the University of Tampa. This study was also supported by grant no. 31003A-133034 from the Swiss National Science Foundation to TL. Melanocyte culture work was supported by NIH Grant AR AR056087 to VS. Ancient DNA work was supported by the DFG grant LU 852/7-4 and the NSF grant 1132229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; BARSH GS, 1995, AM J HUM GENET, V57, P743; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bellone RR, 2010, ANIM GENET, V41, P207, DOI 10.1111/j.1365-2052.2010.02119.x; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bellone RR, 2010, BRIEF FUNCT GENOMICS, V9, P193, DOI 10.1093/bfgp/elq002; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Chitale M, 2009, BIOINFORMATICS, V25, P1739, DOI 10.1093/bioinformatics/btp309; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Devi S, 2013, PIGM CELL MELANOMA R, V26, P348, DOI 10.1111/pcmr.12083; Devi S, 2009, AM J PHYSIOL-CELL PH, V297, pC679, DOI 10.1152/ajpcell.00092.2009; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; Duncan LM, 1998, CANCER RES, V58, P1515; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; HARRIS R, LASTZ; Hawkins T, 2009, PROTEINS, V74, P566, DOI 10.1002/prot.22172; Horn S, 2012, METHODS MOL BIOL, V840, P177, DOI 10.1007/978-1-61779-516-9_21; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Mager DL, 1999, GENOMICS, V59, P255, DOI 10.1006/geno.1999.5877; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martin M, 2011, CUTADAPT REMOVES ADA; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Meyer M, 2010, COLD SPRING HARB PRO, DOI [DOI 10.1101/PDB.PR0T5448, 10.1101/pdb.prot5448]; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nakamura M, 2010, MOL VIS, V16, P425; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nunnery C, 2005, VET OPHTHALMOL, V8, P415, DOI 10.1111/j.1463-5224.2005.00416.x; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Piriyapongsa J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-291; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruvost M, 2011, P NATL ACAD SCI USA, V108, P18626, DOI 10.1073/pnas.1108982108; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Sandmeyer LS, 2007, VET OPHTHALMOL, V10, P368, DOI 10.1111/j.1463-5224.2007.00572.x; Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Smit A, 1996, REPEATMASKER OPEN 30; SPONENBERG DP, 1990, J HERED, V81, P323, DOI 10.1093/oxfordjournals.jhered.a110997; SPONENBERG DP, 2009, EQUINE COLOR GENETIC, V8; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Terai G, 2010, NUCLEIC ACIDS RES, V38, P1163, DOI 10.1093/nar/gkp1098; Terry RB, 2004, ANIM GENET, V35, P134, DOI 10.1111/j.1365-2052.2004.01113.x; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; WITZEL DA, 1978, INVEST OPHTH VIS SCI, V17, P788; WITZEL DA, 1977, J EQUINE MED SURG, V1, P226	71	73	75	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78280	10.1371/journal.pone.0078280	http://dx.doi.org/10.1371/journal.pone.0078280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167615	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500076
J	Kisiel, M; Klar, AS; Ventura, M; Buijs, J; Mafina, MK; Cool, SM; Hilborn, J				Kisiel, Marta; Klar, Agnieszka S.; Ventura, Manuela; Buijs, Jos; Mafina, Marc-Krystelle; Cool, Simon M.; Hilborn, Joens			Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone Formation	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; IN-VIVO; OSTEOGENIC ACTIVITY; CONTROLLED-RELEASE; HEPARIN; OSTEOINDUCTION; DIFFERENTIATION; PROTEOGLYCANS; ENHANCEMENT; METABOLISM	Bone morphogenetic protein-2 (BMP-2) is considered a promising adjuvant for the treatment of skeletal non-union and spinal fusion. However, BMP-2 delivery in a conventional collagen scaffold necessitates a high dose to achieve an efficacious outcome. To lower its effective dose, we precomplexed BMP-2 with the glycosaminoglycans (GAGs) dermatan sulfate (DS) or heparin (HP), prior to loading it into a hyaluronic acid (HA) hydrogel. In vitro release studies showed that BMP-2 precomplexed with DS or HP had a prolonged delivery compared to without GAG. BMP-2-DS complexes achieved a slightly faster release in the first 24 h than HP; however, both delivered BMP-2 for an equal duration. Analysis of the kinetic interaction between BMP-2 and DS or HP showed that HP had approximately 10 times higher affinity for BMP-2 than DS, yet it equally stabilized the protein, as determined by alkaline phosphatase activity. Ectopic bone formation assays at subcutaneous sites in rats demonstrated that HA hydrogel-delivered BMP-2 precomplexed with GAG induced twice the volume of bone compared with BMP-2 delivered uncomplexed to GAG.	[Kisiel, Marta; Hilborn, Joens] Uppsala Univ, Sci Life Lab, Dept Chem Angstrom, Div Polymers Chem, Uppsala, Sweden; [Klar, Agnieszka S.] Univ Childrens Hosp, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland; [Ventura, Manuela] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Buijs, Jos] GE Healthcare, Sci Life Lab, Stockholm, Sweden; [Mafina, Marc-Krystelle] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Cool, Simon M.] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore, Singapore	Uppsala University; University Children's Hospital Zurich; Radboud University Nijmegen; General Electric; University of London; Queen Mary University London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Hilborn, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Chem Angstrom, Div Polymers Chem, Uppsala, Sweden.	hilborn@kemi.uu.se	Cool, Simon McKenzie/AAG-4346-2021; Kisiel, Marta/AAB-1312-2022; Cool, Simon/W-1257-2018; Mafina, Krystelle/E-5953-2014; Hilborn, Jons/W-2864-2018	Cool, Simon/0000-0001-8543-3056; Klar, Agnes S./0000-0003-3521-8010; Hilborn, Jons/0000-0001-6947-9601; Buijs, Jos/0000-0003-3955-1320	European Community's Seventh Framework Programme (MultiTERM) [238551]; European Community's Seventh Framework Programme (BIODESIGN) [262948]	European Community's Seventh Framework Programme (MultiTERM); European Community's Seventh Framework Programme (BIODESIGN)	This work was supported by the European Community's Seventh Framework Programme (MultiTERM, grant agreement No. 238551 and BIODESIGN, grant agreement No. 262948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; Barger-Lux M Janet, 2002, Top Magn Reson Imaging, V13, P297; Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289; Berner A, 2012, CELL TISSUE RES, V347, P501, DOI 10.1007/s00441-011-1184-8; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; Caetano-Lopes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016947; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chao EYS, 1998, CLIN ORTHOP RELAT R, pS163; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Govender S, 2002, TRANSPORT POROUS MED, V49, P247, DOI 10.1023/A:1016241225343; HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003; Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099; Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023; Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Johnson MR, 2011, CLIN ORTHOP RELAT R, V469, P3111, DOI 10.1007/s11999-011-2012-x; JONES G, 1994, DRUG SAFETY, V10, P480, DOI 10.2165/00002018-199410060-00006; Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071683; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Kozma EM, 2009, BIOCHIMIE, V91, P1394, DOI 10.1016/j.biochi.2009.07.010; Kusumoto K, 1998, BRIT J PLAST SURG, V51, P275, DOI 10.1054/bjps.1998.0008; Laub M, 2001, MATERIALWISS WERKST, V32, P926, DOI 10.1002/1521-4052(200112)32:12<926::AID-MAWE926>3.0.CO;2-1; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Martinez-Sanz E, 2012, J TISSUE ENG REGEN M, V6, ps15, DOI 10.1002/term.1593; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Nageeb M, 2012, MOL CRYST LIQ CRYST, V555, P177, DOI 10.1080/15421406.2012.635530; Neovius E, 2013, J PLAST RECONSTR AES, V66, P37, DOI 10.1016/j.bjps.2012.08.015; Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Osses N, 2006, BIOCHEM BIOPH RES CO, V344, P1207, DOI 10.1016/j.bbrc.2006.04.029; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; PISKOUNOVA S, 2012, J TISSUE ENG REGEN M, P27307; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2; WOLINSKYFRIEDLAND M, 1995, ENDOCRIN METAB CLIN, V24, P395, DOI 10.1016/S0889-8529(18)30046-X; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018; Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	58	43	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78551	10.1371/journal.pone.0078551	http://dx.doi.org/10.1371/journal.pone.0078551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167632	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000326034500093
J	Speier, W; Arnold, C; Pouratian, N				Speier, William; Arnold, Corey; Pouratian, Nader			Evaluating True BCI Communication Rate through Mutual Information and Language Models	PLOS ONE			English	Article							COMPUTER INTERFACE BCI; DATA SET IIB; COMPETITION 2003; BRAIN	Brain-computer interface (BCI) systems are a promising means for restoring communication to patients suffering from "locked-in" syndrome. Research to improve system performance primarily focuses on means to overcome the low signal to noise ratio of electroencephalogric (EEG) recordings. However, the literature and methods are difficult to compare due to the array of evaluation metrics and assumptions underlying them, including that: 1) all characters are equally probable, 2) character selection is memoryless, and 3) errors occur completely at random. The standardization of evaluation metrics that more accurately reflect the amount of information contained in BCI language output is critical to make progress. We present a mutual information-based metric that incorporates prior information and a model of systematic errors. The parameters of a system used in one study were re-optimized, showing that the metric used in optimization significantly affects the parameter values chosen and the resulting system performance. The results of 11 BCI communication studies were then evaluated using different metrics, including those previously used in BCI literature and the newly advocated metric. Six studies' results varied based on the metric used for evaluation and the proposed metric produced results that differed from those originally published in two of the studies. Standardizing metrics to accurately reflect the rate of information transmission is critical to properly evaluate and compare BCI communication systems and advance the field in an unbiased manner.	[Speier, William; Pouratian, Nader] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Pouratian, Nader] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Pouratian, Nader] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Pouratian, Nader] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Speier, William; Arnold, Corey] Univ Calif Los Angeles, Med Imaging Informat Grp, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pouratian, N (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	npouratian@mednet.ucla.edu	Speier, William/H-9974-2019	Speier, William/0000-0002-0890-8684; Pouratian, Nader/0000-0002-0426-3241	NLM Training Grand [T15-LM007356]; National Institute Of Biomedical Imaging and Bioengineering [K23EB014326]; UCLA Scholars in Translational Medicine Program; UCLA Department of Neurosurgery Visionary Ball Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K23EB014326] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007356] Funding Source: NIH RePORTER	NLM Training Grand; National Institute Of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); UCLA Scholars in Translational Medicine Program; UCLA Department of Neurosurgery Visionary Ball Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the NLM Training Grand T15-LM007356 (WS), the National Institute Of Biomedical Imaging and Bioengineering Award Number K23EB014326 (NP), the UCLA Scholars in Translational Medicine Program (NP), and the UCLA Department of Neurosurgery Visionary Ball Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankertz B., 2006, P 3 INT BRAIN COMP I; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Francis W. N., 1979, DEP LINGUISTICS; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Jin J, 2011, MED BIOL ENG COMPUT, V49, P181, DOI 10.1007/s11517-010-0689-8; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kaper M, 2004, C P IEEE ENG MED BIO, V6, P1073; Lu J, 2013, CLIN NEUROPHYSIOL, V124, P306, DOI 10.1016/j.clinph.2012.08.002; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; Pierce J.R., 1980, INTRO INFORM THEORY; Ryan DB, 2011, INT J HUM-COMPUT INT, V27, P69, DOI 10.1080/10447318.2011.535754; Schreuder M., 2011, FRONT NEUROSCI, V5; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Speier W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016004; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Wang P, 2012, ARXIV12120469CSHC CO; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78432	10.1371/journal.pone.0078432	http://dx.doi.org/10.1371/journal.pone.0078432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239OF	24167623	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500084
J	Engineer, CT; Perez, CA; Carraway, RS; Chang, KQ; Roland, JL; Sloan, AM; Kilgard, MP				Engineer, Crystal T.; Perez, Claudia A.; Carraway, Ryan S.; Chang, Kevin Q.; Roland, Jarod L.; Sloan, Andrew M.; Kilgard, Michael P.			Similarity of Cortical Activity Patterns Predicts generalization Behavior	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; SPEECH-PERCEPTION; NEURAL RESPONSES; FACE RECOGNITION; MAP PLASTICITY; ACOUSTIC CUES; TEMPORAL CUES; DISCRIMINATION; REPRESENTATION; FEATURES	Humans and animals readily generalize previously learned knowledge to new situations. Determining similarity is critical for assigning category membership to a novel stimulus. We tested the hypothesis that category membership is initially encoded by the similarity of the activity pattern evoked by a novel stimulus to the patterns from known categories. We provide behavioral and neurophysiological evidence that activity patterns in primary auditory cortex contain sufficient information to explain behavioral categorization of novel speech sounds by rats. Our results suggest that category membership might be encoded by the similarity of the activity pattern evoked by a novel speech sound to the patterns evoked by known sounds. Categorization based on featureless pattern matching may represent a general neural mechanism for ensuring accurate generalization across sensory and cognitive systems.	[Engineer, Crystal T.; Perez, Claudia A.; Carraway, Ryan S.; Chang, Kevin Q.; Roland, Jarod L.; Sloan, Andrew M.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Engineer, CT (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	novitski@utdallas.edu	Roland, Jarod L/J-1433-2019	Roland, Jarod L/0000-0002-1312-8826; Kilgard, Michael/0000-0002-6699-1818; Engineer, Crystal/0000-0002-2188-2335	National Institute on Deafness and other Communicative Disorders [R01DC010433, R15DC006624]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010433, R15DC006624] Funding Source: NIH RePORTER	National Institute on Deafness and other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project described was supported by Grant Numbers R01DC010433 and R15DC006624 from the National Institute on Deafness and other Communicative Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; BERTONCINI J, 1987, J ACOUST SOC AM, V82, P31, DOI 10.1121/1.395570; Bidelman GM, 2013, NEUROIMAGE, V79, P201, DOI 10.1016/j.neuroimage.2013.04.093; Bizley JK, 2013, CURR BIOL, V23, P620, DOI 10.1016/j.cub.2013.03.003; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Boersma P, 2001, GLOT INT, V5, P341; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Cano P, 2005, J VLSI SIG PROC SYST, V41, P271, DOI 10.1007/s11265-005-4151-3; Centanni TM, 2013, J NEUROPHYSIOL, V110, P177, DOI 10.1152/jn.00092.2013; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cohen YE, 2006, BIOL LETTERS, V2, P261, DOI 10.1098/rsbl.2005.0436; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; EGGERMONT JJ, 1995, J ACOUST SOC AM, V98, P911, DOI 10.1121/1.413517; EIMAS PD, 1974, PERCEPT PSYCHOPHYS, V16, P513, DOI 10.3758/BF03198580; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Engineer ND, 2012, NEUROSCIENCE, V205, P81, DOI 10.1016/j.neuroscience.2011.12.056; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Floody OR, 2010, PHYSIOL BEHAV, V101, P260, DOI 10.1016/j.physbeh.2010.05.009; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Francis AL, 2008, J ACOUST SOC AM, V124, P1234, DOI 10.1121/1.2945161; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Haitsma J., 2002, P INT S MUS INF RETR, P1; Hampton James A, 1998, COGNITION, V65, P137, DOI 10.1016/S0010-0277(97)00042-5; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; HOFFMAN HS, 1958, J ACOUST SOC AM, V30, P1035, DOI 10.1121/1.1909448; Kawahara H, 1997, INT CONF ACOUST SPEE, P1303, DOI 10.1109/ICASSP.1997.596185; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LISKER L, 1986, LANG SPEECH, V29, P3, DOI 10.1177/002383098602900102; LOGAN B, 2001, P IEEE INT C MULT EX, P745; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Niwa M, 2013, J NEUROSCI, V33, P8378, DOI 10.1523/JNEUROSCI.2672-12.2013; Niwa M, 2012, J NEUROSCI, V32, P3193, DOI 10.1523/JNEUROSCI.0767-11.2012; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Pavlov I.P., 1927, CONDITIONED REFLEXES; Perez CA, 2013, CEREB CORTEX, V23, P670, DOI 10.1093/cercor/bhs045; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Porter BA, 2011, BEHAV BRAIN RES, V219, P68, DOI 10.1016/j.bbr.2010.12.015; Ranasinghe KG, 2013, NEUROSCIENCE, V252, P80, DOI 10.1016/j.neuroscience.2013.08.005; RANASINGHE KG, 2012, JARO; RAPHAEL LJ, 2005, HDB SPEECH PERCEPTIO; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Reed P, 2003, J EXP ANAL BEHAV, V80, P205, DOI 10.1901/jeab.2003.80-205; Rennaker RL, 2005, J NEUROSCI METH, V142, P169, DOI 10.1016/j.jneumeth.2004.08.009; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Russ BE, 2008, CURR BIOL, V18, P1483, DOI 10.1016/j.cub.2008.08.054; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; SANDELL JH, 1979, J COMP PHYSIOL PSYCH, V93, P626, DOI 10.1037/h0077594; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Schvartz KC, 2012, EAR HEARING, V33, P411, DOI 10.1097/AUD.0b013e31823d78dc; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Selezneva E, 2006, CURR BIOL, V16, P2428, DOI 10.1016/j.cub.2006.10.027; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sharma A, 2000, J ACOUST SOC AM, V108, P3030, DOI 10.1121/1.1320474; Shepard RN, 2004, PSYCHON B REV, V11, P1, DOI 10.3758/BF03206455; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Sinnott JM, 1997, PERCEPT PSYCHOPHYS, V59, P1214, DOI 10.3758/BF03214209; SJOLANDER K, 2000, ICSLP 2000 BEIJ CHIN; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Steinschneider M, 2005, CEREB CORTEX, V15, P170, DOI 10.1093/cercor/bhh120; Steinschneider M, 2003, J ACOUST SOC AM, V114, P307, DOI 10.1121/1.1582449; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Tsunada J, 2011, J NEUROPHYSIOL, V105, P2634, DOI 10.1152/jn.00037.2011; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; Walker KMM, 2009, J ACOUST SOC AM, V126, P1321, DOI 10.1121/1.3179676; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright R, 2004, PHONETICALLY BASED P; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405	96	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78607	10.1371/journal.pone.0078607	http://dx.doi.org/10.1371/journal.pone.0078607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147140	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400159
J	Wu, Y; Liu, YF; Hou, PP; Yan, ZH; Kong, WJ; Liu, BY; Li, X; Yao, J; Zhang, YX; Qin, F; Ding, JP				Wu, Ying; Liu, Yongfeng; Hou, Panpan; Yan, Zonghe; Kong, Wenjuan; Liu, Beiying; Li, Xia; Yao, Jing; Zhang, Yuexuan; Qin, Feng; Ding, Jiuping			TRPV1 Channels Are Functionally Coupled with BK(mSlo1) Channels in Rat Dorsal Root Ganglion (DRG) Neurons	PLOS ONE			English	Article							INFLAMMATORY PAIN; CAPSAICIN RECEPTOR; BK CHANNELS; CALCIUM; CELLS; CONDUCTANCE; ACTIVATION; CURRENTS; COMPLEX	The transient receptor potential vanilloid receptor 1 (TRPV1) channel is a nonselective cation channel activated by a variety of exogenous and endogenous physical and chemical stimuli, such as temperature (>= 42 degrees C), capsaicin, a pungent compound in hot chili peppers, and allyl isothiocyanate. Large-conductance calcium-and voltage-activated potassium (BK) channels regulate the electric activities and neurotransmitter releases in excitable cells, responding to changes in membrane potentials and elevation of cytosolic calcium ions (Ca2+). However, it is unknown whether the TRPV1 channels are coupled with the BK channels. Using patch-clamp recording combined with an infrared laser device, we found that BK channels could be activated at 0 mV by a Ca2+ influx through TRPV1 channels not the intracellular calcium stores in submilliseconds. The local calcium concentration around BK is estimated over 10 mu M. The crosstalk could be affected by 10 mM BAPTA, whereas 5 mM EGTA was ineffectual. Fluorescence and co-immunoprecipitation experiments also showed that BK and TRPV1 were able to form a TRPV1-BK complex. Furthermore, we demonstrated that the TRPV1-BK coupling also occurs in dosal root ganglion (DRG) cells, which plays a critical physiological role in regulating the "pain" signal transduction pathway in the peripheral nervous system.	[Wu, Ying; Liu, Yongfeng; Hou, Panpan; Kong, Wenjuan; Li, Xia; Yao, Jing; Zhang, Yuexuan; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Yan, Zonghe; Liu, Beiying; Qin, Feng] SUNY Buffalo, Dept Physiol & Biophys Sci, Buffalo, NY 14260 USA; [Liu, Yongfeng] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China	Huazhong University of Science & Technology; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Xinxiang Medical University	Qin, F (corresponding author), SUNY Buffalo, Dept Physiol & Biophys Sci, Buffalo, NY 14260 USA.	qin@buffalo.edu; jpding@mail.hust.edu.cn	Hou, Panpan/Q-2941-2019; Liu, Yongfeng/ABG-1361-2020	Liu, Yongfeng/0000-0002-8649-7892; Hou, Panpan/0000-0001-7694-2262	Autonomous innovation funds for international scientific cooperation [2013ZZGH017]; National Basic Research Program of China [2010CB529804]; National Science Foundation of China [30971179, 31170814, 31028006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104521] Funding Source: NIH RePORTER	Autonomous innovation funds for international scientific cooperation; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Autonomous innovation funds for international scientific cooperation (2013ZZGH017), National Basic Research Program of China (2010CB529804), the National Science Foundation of China (30971179, 31170814, 31028006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; GORMAN ALF, 1980, J PHYSIOL-LONDON, V308, P287, DOI 10.1113/jphysiol.1980.sp013472; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; KOSTYUK P, 1993, J PHYSIOL-LONDON, V461, P467, DOI 10.1113/jphysiol.1993.sp019523; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Mergler S, 2012, CELL SIGNAL, V24, P233, DOI 10.1016/j.cellsig.2011.09.005; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Prakriya M, 2000, J NEUROPHYSIOL, V84, P1123, DOI 10.1152/jn.2000.84.3.1123; Schwartz ES, 2011, GASTROENTEROLOGY, V140, P1283, DOI 10.1053/j.gastro.2010.12.033; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Szolcsanyi J., 1993, CAPSAICIN STUDY PAIN, P1; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Wu Y, 2009, J BIOL CHEM, V284, P23353, DOI 10.1074/jbc.M109.027789; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; ZHANG X, 1995, J COMP NEUROL, V352, P481, DOI 10.1002/cne.903520402; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zong XG, 1996, FEBS LETT, V378, P121, DOI 10.1016/0014-5793(95)01434-9	27	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78203	10.1371/journal.pone.0078203	http://dx.doi.org/10.1371/journal.pone.0078203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147119	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400152
J	El Andalousi, J; Li, Y; Anand-Srivastava, MB				El Andalousi, Jasmine; Li, Yuan; Anand-Srivastava, Madhu B.			Natriuretic Peptide Receptor-C Agonist Attenuates the Expression of Cell Cycle Proteins and Proliferation of Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats: Role of Gi Proteins and MAPkinase/PI3kinase Signaling	PLOS ONE			English	Article							ADENYLATE-CYCLASE; ENHANCED EXPRESSION; CLEARANCE RECEPTOR; CYTOPLASMIC DOMAIN; ATRIAL; GROWTH; INHIBITION; MECHANISMS; 3-KINASE; KINASE	Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit hyperproliferation and overexpression of cell cycle proteins. We earlier showed that small peptide fragments of cytoplasmic domain of natriuretic receptor-C (NPR-C) attenuate vasoactive peptide-induced hyperproliferation of VSMC. The present study investigated if C-ANP(4-23), a specific agonist of NPR-C, could attanuate the hyperproliferation of VSMC from SHR by inhibiting the overexpression of cell cycle proteins and examine the underlying signaling pathways contributing to this inhibition. The proliferation of VSMC was determined by [H-3] thymidine incorporation and the expression of proteins was determined by Western blotting. The hyperproliferation of VSMC from SHR and overexpression of cyclin D1, cyclin A, cyclin E, cyclin-dependent kinase 2 (cdk2), phosphorylated retinoblastoma protein (pRb), Gi alpha proteins and enhanced phosphorylation of ERK1/2 and AKT exhibited by VSMC from SHR were attenuated by C-ANP(4-23) to control levels. In addition, in vivo treatment of SHR with C-ANP(4-23) also attenuated the enhanced proliferation of VSMC. Furthemore, PD98059, wortmannin and pertussis toxin, the inhibitors of MAP kinase, PI3kinase and Gi alpha proteins respectively, also attenuated the hyperproliferation of VSMC from SHR and overexpression of cell cycle proteins to control levels. These results indicate that NPR-C activation by C-ANP(4-23) attenuates the enhanced levels of cell cycle proteins through the inhibition of enhanced expression of Gi alpha proteins and enhanced activation of MAPkinase/PI3kinase and results in the attenuation of hyperproliferation of VSMC from SHR. It may be suggested that C-ANP(4-23) could be used as a therapeutic agent in the treatment of vascular complications associated with hypertension, atherosclerosis and restenosis.	[El Andalousi, Jasmine; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Physiol, Quebec City, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Physiol, Quebec City, PQ, Canada.	madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research [MOP 86569]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a grant from Canadian Institutes of Health Research (MOP 86569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1986, AM J PHYSIOL, V251, pF417, DOI 10.1152/ajprenal.1986.251.3.F417; ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ANANDSRIVASTAVA MB, 1986, BIOCHEM BIOPH RES CO, V138, P427, DOI 10.1016/0006-291X(86)90299-8; ANANDSRIVASTAVA MB, 1984, BIOCHEM BIOPH RES CO, V121, P855, DOI 10.1016/0006-291X(84)90756-3; ANANDSRIVASTAVA MB, 1985, LIFE SCI, V36, P1873, DOI 10.1016/0024-3205(85)90161-4; ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931; ANANDSRIVASTAVA MB, 1985, FEBS LETT, V181, P199, DOI 10.1016/0014-5793(85)80259-3; ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; FULLER F, 1988, J BIOL CHEM, V263, P9395; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; Kubo A, 2000, AM J HYPERTENS, V13, P1117, DOI 10.1016/S0895-7061(00)00298-3; Kubo A, 1996, J CARDIOVASC PHARM, V27, P58, DOI 10.1097/00005344-199601000-00010; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; Lee SJ, 2009, INT IMMUNOPHARMACOL, V9, P837, DOI 10.1016/j.intimp.2009.03.010; Levin ER, 1998, NEW ENGL J MED, V339, P321; Li Y, 2005, CAN J CARDIOL, V21, p155C; Li Y, 2013, HYPERTENSION; LIAU G, 1989, J BIOL CHEM, V264, P10315; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; Mouawad R, 2004, MOL PHARMACOL, V65, P917, DOI 10.1124/mol.65.4.917; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; Pedram A, 1998, J BIOL CHEM, V273, P13966, DOI 10.1074/jbc.273.22.13966; Prins BA, 1996, J BIOL CHEM, V271, P14156, DOI 10.1074/jbc.271.24.14156; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Schmidt CM, 1999, EUR J GASTROEN HEPAT, V11, P1393, DOI 10.1097/00042737-199912000-00009; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tanner FC, 2003, HYPERTENSION, V42, P184, DOI 10.1161/01.HYP.0000082360.65547.7C; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661	41	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76183	10.1371/journal.pone.0076183	http://dx.doi.org/10.1371/journal.pone.0076183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155894	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300028
J	Rubin, AN; Kessaris, N				Rubin, Anna Noren; Kessaris, Nicoletta			PROX1: A Lineage Tracer for Cortical Interneurons Originating in the Lateral/Caudal Ganglionic Eminence and Preoptic Area	PLOS ONE			English	Article							CAUDAL MIGRATORY STREAM; FATE MAPPING REVEALS; NEURAL STEM-CELLS; GABAERGIC INTERNEURONS; NEOCORTICAL INTERNEURONS; COUP-TFII; TERMINAL DIFFERENTIATION; CEREBRAL-CORTEX; DIVERSITY; IDENTITY	The homeobox-encoding gene Prox1 and its Drosophila homologue prospero are key regulators of cell fate-specification. In the developing rodent cortex a sparse population of cells thought to correspond to late-generated cortical pyramidal neuron precursors expresses PROX1. Using a series of transgenic mice that mark cell lineages in the subcortical telencephalon and, more specifically, different populations of cortical interneurons, we demonstrate that neurons expressing PROX1 do not represent pyramidal neurons or their precursors but are instead subsets of cortical interneurons. These correspond to interneurons originating in the lateral/caudal ganglionic eminence (LGE/CGE) and a small number of preoptic area (POA)-derived neurons. Expression within the cortex can be detected from late embryonic stages onwards when cortical interneurons are still migrating. There is persistent expression in postmitotic cells in the mature brain mainly in the outer cortical layers. PROX1(+ve) interneurons express neurochemical markers such as calretinin, neuropeptide Y, reelin and vasoactive intestinal peptide, all of which are enriched in LGE/CGE- and some POA-derived cells. Unlike in the cortex, in the striatum PROX1 marks nearly all interneurons regardless of their origin. Weak expression of PROX1 can also be detected in oligodendrocyte lineage cells throughout the forebrain. Our data show that PROX1 can be used as a genetic lineage tracer of nearly all LGE/CGE- and subsets POA-derived cortical interneurons at all developmental and postnatal stages in vivo.	[Kessaris, Nicoletta] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Kessaris, N (corresponding author), UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.	n.tekki-kessaris@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019	Kessaris, Nicoletta/0000-0003-1191-6009; Rubin, Anna/0000-0001-6190-2882	Wellcome Trust; European Research Council (ERC) under the European Community [207807]; MRC [G0501173] Funding Source: UKRI; Medical Research Council [G0501173] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) under the European Community(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.N.R. was supported by a PhD studentship from the Wellcome Trust (http://www.wellcome.ac.uk/). Financial support for the work was provided to N.K. by a European Research Council (ERC) Starting Grant under the European Community's Seventh Framework Programme (Grant agreement no. 207807) (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiades PG, 2011, EUR J NEUROSCI, V34, P1542, DOI 10.1111/j.1460-9568.2011.07904.x; Anderson SA., 2012, JASPERS BASIC MECH E, V4th ed.; Aranguren XL, 2013, J CELL SCI, V126, P1164, DOI 10.1242/jcs.116293; Arber C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00010; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Li L, 2000, GENE DEV, V14, P147; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2009, CEREB CORTEX S1, V19, P196; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Magno L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00065; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Rubin AN, 2010, J NEUROSCI, V30, P12050, DOI 10.1523/JNEUROSCI.6178-09.2010; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Torii MA, 1999, DEVELOPMENT, V126, P443; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Welagen J, 2011, DEV NEUROBIOL, V71, P10, DOI 10.1002/dneu.20857; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005	53	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77339	10.1371/journal.pone.0077339	http://dx.doi.org/10.1371/journal.pone.0077339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155945	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300079
J	Yan, S; Song, H; Pang, DX; Zou, QJ; Li, L; Yan, QM; Fan, NN; Zhao, XJ; Yu, H; Li, ZJ; Wang, HJ; Gao, F; Ouyang, HS; Lai, LX				Yan, Sen; Song, Hong; Pang, Daxin; Zou, Qingjian; Li, Li; Yan, Quanmei; Fan, Nana; Zhao, Xiangjie; Yu, Hao; Li, Zhanjun; Wang, Haijun; Gao, Fei; Ouyang, Hongsheng; Lai, Liangxue			Expression of Plant Sweet Protein Brazzein in the Milk of Transgenic Mice	PLOS ONE			English	Article							RECOMBINANT BRAZZEIN; GENE; SEQUENCES; PROMOTER; EXCISION; GENOME	Sugar, the most popular sweetener, is essential in daily food. However, excessive sugar intake has been associated with several lifestyle-related diseases. Finding healthier and more economical alternatives to sugars and artificial sweeteners has received increasing attention to fulfill the growing demand. Brazzein, which comes from the pulp of the edible fruit of the African plant Pentadiplandra brazzeana Baill, is a protein that is 2,000 times sweeter than sucrose by weight. Here we report the production of transgenic mice that carry the optimized brazzein gene driven by the goat Beta-casein promoter, which specifically directs gene expression in the mammary glands. Using western blot analysis and immunohistochemistry, we confirmed that brazzein could be efficiently expressed in mammalian milk, while retaining its sweetness. This study presents the possibility of producing plant protein-sweetened milk from large animals such as cattle and goats.	[Yan, Sen; Pang, Daxin; Li, Li; Yan, Quanmei; Yu, Hao; Li, Zhanjun; Wang, Haijun; Gao, Fei; Ouyang, Hongsheng; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Song, Hong; Zou, Qingjian; Fan, Nana; Zhao, Xiangjie; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Lai, LX (corresponding author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China.	lai_liangxue@gibh.ac.cn			National Natural Science Foundation of China [31071293]; National Science and Technology Major Project [2009ZX10004-405]; Science and Technology Planning Project of Guangdong Province, China [2011A060901019]; Innovative Research Team in University [IRT1248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Science and Technology Planning Project of Guangdong Province, China; Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Natural Science Foundation of China (Grant no. 31071293), National Science and Technology Major Project (Grant no. 2009ZX10004-405), Science and Technology Planning Project of Guangdong Province, China (Grant no. 2011A060901019), and Innovative Research Team in University (Grant no IRT1248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2000, ARCH BIOCHEM BIOPHYS, V376, P252, DOI 10.1006/abbi.2000.1725; Berlec A, 2006, APPL MICROBIOL BIOT, V73, P158, DOI 10.1007/s00253-006-0438-y; Conner DA, 2001, CURR PROTOC MOL BIOL; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Faus I, 2000, APPL MICROBIOL BIOT, V53, P145, DOI 10.1007/s002530050001; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Guan ZY, 1995, CHEM SENSES, V20, P99; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Haruyama N, 2009, CURR PROTOC CELL BIO; Hellekant G, 2005, CHEM SENSES, V30, pI88, DOI 10.1093/chemse/bjh127; Izawa H, 1996, BIOPOLYMERS, V39, P95, DOI 10.1002/(SICI)1097-0282(199607)39:1<95::AID-BIP10>3.0.CO;2-B; Jin ZY, 2003, FEBS LETT, V544, P33, DOI 10.1016/S0014-5793(03)00383-1; Karatzas CN, 1997, J DAIRY SCI, V80, P2225, DOI 10.3168/jds.S0022-0302(97)76171-X; KEREN DF, 1979, INFECT IMMUN, V24, P441, DOI 10.1128/IAI.24.2.441-448.1979; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lamphear BJ, 2005, PLANT BIOTECHNOL J, V3, P103, DOI 10.1111/j.1467-7652.2004.00105.x; Lee KK, 1999, J BIOCH, V126, P320; Liu S, 2011, TRANSGENIC RES; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; OSTERUD B, 1978, J BIOL CHEM, V253, P5946; PERSUY MA, 1995, GENE, V165, P291, DOI 10.1016/0378-1119(95)00405-U; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rachid A, 2009, CHEM SENSES, V34, pA80; ROBERTS B, 1992, GENE, V121, P255, DOI 10.1016/0378-1119(92)90129-D; RUSSELL SH, 1992, MOL GEN GENET, V234, P49, DOI 10.1007/BF00272344; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697	31	15	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76769	10.1371/journal.pone.0076769	http://dx.doi.org/10.1371/journal.pone.0076769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155905	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300039
J	Gasca-Pineda, J; Cassaigne, I; Alonso, RA; Eguiarte, LE				Gasca-Pineda, Jaime; Cassaigne, Ivonne; Alonso, Rogelio A.; Eguiarte, Luis E.			Effective Population Size, Genetic Variation, and Their Relevance for Conservation: The Bighorn Sheep in Tiburon Island and Comparisons with Managed Artiodactyls	PLOS ONE			English	Article							OVIS-CANADENSIS; NORTH-AMERICA; F-STATISTICS; SOFTWARE; DNA; DIVERSITY; DROUGHT; DECLINE; VARIABILITY; INFERENCE	The amount of genetic diversity in a finite biological population mostly depends on the interactions among evolutionary forces and the effective population size (N-e) as well as the time since population establishment. Because the N-e estimation helps to explore population demographic history, and allows one to predict the behavior of genetic diversity through time, N-e is a key parameter for the genetic management of small and isolated populations. Here, we explored an N-e-based approach using a bighorn sheep population on Tiburon Island, Mexico (TI) as a model. We estimated the current (N-crnt) and ancestral stable (N-stbl) inbreeding effective population sizes as well as summary statistics to assess genetic diversity and the demographic scenarios that could explain such diversity. Then, we evaluated the feasibility of using TI as a source population for reintroduction programs. We also included data from other bighorn sheep and artiodactyl populations in the analysis to compare their inbreeding effective size estimates. The TI population showed high levels of genetic diversity with respect to other managed populations. However, our analysis suggested that TI has been under a genetic bottleneck, indicating that using individuals from this population as the only source for reintroduction could lead to a severe genetic diversity reduction. Analyses of the published data did not show a strict correlation between H-E and N-crnt estimates. Moreover, we detected that ancient anthropogenic and climatic pressures affected all studied populations. We conclude that the estimation of N-crnt and N-stbl are informative genetic diversity estimators and should be used in addition to summary statistics for conservation and population management planning.	[Gasca-Pineda, Jaime; Cassaigne, Ivonne; Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Alonso, Rogelio A.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Eguiarte, LE (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	fruns@servidor.unam.mx			Consejo Nacional de Ciencia y Tecnologia (CONACyT) [199870]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by a scholarship of the Consejo Nacional de Ciencia y Tecnologia (CONACyT) to JGP (number 199870). The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Arif IA, 2010, GENES GENET SYST, V85, P141, DOI 10.1266/ggs.85.141; Ballou Jonathan D., 1996, P263; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2003, GENETICS, V164, P1139; BERGER WH, 1990, GLOBAL PLANET CHANGE, V89, P219, DOI 10.1016/0921-8181(90)90018-8; Booth RK, 2005, HOLOCENE, V15, P321, DOI 10.1191/0959683605hl825ft; Boyce MS, 2002, POPULATION VIABILITY ANALYSIS, P41; Boyce WM, 1999, MOL ECOL, V8, P99, DOI 10.1046/j.1365-294X.1999.00536.x; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; Buechner H. K., 1960, Wildlife Monographs.; Byers DA, 2004, AM ANTIQUITY, V69, P235, DOI 10.2307/4128418; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Cannon Kenneth P., 2001, Great Plains Research, V11, P145; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Coltman DW, 2005, MOL ECOL, V14, P2593, DOI 10.1111/j.1365-294X.2005.02600.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Corti P, 2011, CONSERV GENET, V12, P119, DOI 10.1007/s10592-009-9997-7; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1990, CONVERGENT ISSUES GE, P307; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; EZCURRA E, 1987, VEGETATIO, V71, P49, DOI 10.1007/BF00048511; Falush D, 2003, GENETICS, V164, P1567; Fisher R.A., 1930, GENETICAL THEORY NAT; FLORES D, 1991, J AM HIST, V78, P465, DOI 10.2307/2079530; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frantz AC, 2004, J APPL ECOL, V41, P985, DOI 10.1111/j.0021-8901.2004.00951.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray ST, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016154; Grayson DK, 2001, SCIENCE, V294, P1459; GRAYSON DK, 1991, J WORLD PREHIST, V5, P193, DOI 10.1007/BF00974990; Gutierrez-Espeleta GA, 2001, HEREDITY, V86, P439, DOI 10.1046/j.1365-2540.2001.00853.x; Gutierrez-Espeleta Gustavo A., 2000, Conservation Genetics, V1, P3, DOI 10.1023/A:1010125519304; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; Hedrick P., 2011, GENETICS POPULATIONS; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; Hedrick PW, 2001, MOL ECOL, V10, P851, DOI 10.1046/j.1365-294X.2001.01243.x; Janetski JC, 1997, J ARCHAEOL SCI, V24, P1075, DOI 10.1006/jasc.1996.0187; KACHITVICHYANUKUL V, 1988, COMMUN ACM, V31, P216, DOI 10.1145/42372.42381; Kaeuffer R, 2007, P ROY SOC B-BIOL SCI, V274, P527, DOI 10.1098/rspb.2006.3743; KRAUSMAN PR, 2000, ECOLOGY MANAGEMENT L, P517; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Lyman RL, 2009, HOLOCENE, V19, P143, DOI 10.1177/0959683608098958; McNeely J. A., 1990, CONSERVING WORLDS BI; Montoya B., 1975, DESERT BIGHORN COUNC, V19, P28; Mooring MS, 2003, BEHAVIOUR, V140, P183, DOI 10.1163/156853903321671497; Ni XW, 2009, ANIM BIOL, V59, P273, DOI 10.1163/157075609X454908; Nichols RA, 2001, MOL ECOL, V10, P593, DOI 10.1046/j.1365-294x.2001.01204.x; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Ortego J, 2011, MOL ECOL, V20, P1601, DOI 10.1111/j.1365-294X.2011.05022.x; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz M, 1999, J ADV MATER, V31, P2; Storz JF, 2002, EVOLUTION, V56, P154; Storz JF, 2001, EVOLUTION, V55, P1224; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wand M., 2010, HDRCDE HIGHEST DENSI; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2002, POPULATION VIABILITY ANALYSIS, P147; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whittaker DG, 2004, J WILDLIFE MANAGE, V68, P850, DOI 10.2193/0022-541X(2004)068[0850:GVORCB]2.0.CO;2; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097; ZONTAK K, 1995, GREAT PLAINS QUART, V15, P133; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1007/S10021-010-9402-X	92	20	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78120	10.1371/journal.pone.0078120	http://dx.doi.org/10.1371/journal.pone.0078120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147115	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400144
J	Wagner, LM; DeLuca, NA				Wagner, Lauren M.; DeLuca, Neal A.			Temporal Association of Herpes Simplex Virus ICP4 with Cellular Complexes Functioning at Multiple Steps in PolII Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL-DOMAIN; REGULATORY PROTEIN; MACROMOLECULAR-SYNTHESIS; ALPHA-GENES; TYPE-1; MEDIATOR; BINDING; DNA; IDENTIFICATION	The herpes simplex virus type 1 (HSV-1) immediate early protein, ICP4, participates in the regulation of viral gene expression by both activating and repressing RNA polII transcription. We used affinity purification of ICP4 expressed in infected cells followed by mass spectrometry and western blot analysis to determine the composition of cellular complexes associated with ICP4 throughout infection. ICP4 was associated with TFIID complexes containing a distinct set of TAFs. These complexes were most abundant early, but were detected throughout infection, whereas Mediator was found in ICP4 containing complexes later in infection, indicating a temporal pattern for the utilization of these complexes for the transcription of the viral genome. The form of Mediator copurifying with ICP4 was enriched for the kinase domain and also lacked the activator-specific component, Med26, suggesting that Mediator-ICP4 interactions may be involved in repression of viral transcription. The N-terminal 774 amino acids of ICP4, which retains partial function, were sufficient to form complexes with TFIID and Mediator, although these interactions were not as strong as with full-length ICP4. Additionally, components involved in transcription elongation, chromatin remodeling, and mRNA processing were isolated with ICP4. Together our data indicate that ICP4 plays a more integrated role in mediating HSV transcription, possibly affecting multiple steps in transcription and gene expression.	[Wagner, Lauren M.; DeLuca, Neal A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	DeLuca, NA (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA.	ndeluca@pitt.edu			NIH [R01 AI030612, T32 AI049820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI030612 to NAD. LMW was supported by the NIH training grant T32 AI049820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; ALWINE JC, 1974, VIROLOGY, V60, P302, DOI 10.1016/0042-6822(74)90390-0; BATTERSON W, 1983, J VIROL, V46, P371, DOI 10.1128/JVI.46.2.371-377.1983; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Carrozza MJ, 1996, MOL CELL BIOL, V16, P3085; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1988, J VIROL, V62, P732, DOI 10.1128/JVI.62.3.732-743.1988; DELUCA NA, 1987, NUCLEIC ACIDS RES, V15, P4491, DOI 10.1093/nar/15.11.4491; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FABER SW, 1986, NUCLEIC ACIDS RES, V14, P6067, DOI 10.1093/nar/14.15.6067; FLORES O, 1992, J BIOL CHEM, V267, P2786; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; GERARD M, 1991, J BIOL CHEM, V266, P20940; Grondin B, 2000, J VIROL, V74, P11504, DOI 10.1128/JVI.74.24.11504-11510.2000; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; KRISTIE TM, 1986, P NATL ACAD SCI USA, V83, P3218, DOI 10.1073/pnas.83.10.3218; Kuddus RH, 2007, J VIROL, V81, P9230, DOI 10.1128/JVI.01054-07; Lester JT, 2011, J VIROL, V85, P5733, DOI 10.1128/JVI.00385-11; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; METZLER DW, 1985, J VIROL, V55, P329, DOI 10.1128/JVI.55.2.329-337.1985; MULLER MT, 1987, J VIROL, V61, P858, DOI 10.1128/JVI.61.3.858-865.1987; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; PATERSON T, 1988, NUCLEIC ACIDS RES, V16, P11005, DOI 10.1093/nar/16.23.11005; POST LE, 1981, CELL, V24, P555, DOI 10.1016/0092-8674(81)90346-9; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SHEPARD AA, 1989, J VIROL, V63, P3714, DOI 10.1128/JVI.63.9.3714-3728.1989; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Tsai KL, 2013, NAT STRUCT MOL BIOL; Wagner LM, 2013, J VIROL, V87, P1010, DOI 10.1128/JVI.02844-12; Wagner LM, 2012, J VIROL; WATSON RJ, 1980, NATURE, V285, P329, DOI 10.1038/285329a0; Weller SK, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P1; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	59	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78242	10.1371/journal.pone.0078242	http://dx.doi.org/10.1371/journal.pone.0078242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147125	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400149
J	de la Garza-Rodea, AS; Baldwin, DM; Oskouian, B; Place, RF; Bandhuvula, P; Kumar, A; Saba, JD				de la Garza-Rodea, Anabel S.; Baldwin, Dianna M.; Oskouian, Babak; Place, Robert F.; Bandhuvula, Padmavathi; Kumar, Ashok; Saba, Julie D.			Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression	FASEB JOURNAL			English	Article						myogenesis; sphingolipid; C2C12; Spns2	SKELETAL-MUSCLE REGENERATION; C2C12 MYOBLASTS; SATELLITE CELLS; SPHINGOSINE-1-PHOSPHATE LYASE; CYTOSKELETAL REORGANIZATION; SPHINGOLIPID METABOLISM; TARGET GENES; 1-PHOSPHATE; MIR-206; PROLIFERATION	S1P lyase (SPL) catalyzes the irreversible degradation of sphingosine-1-phosphate (S1P), a bioactive lipid whose signaling activities regulate muscle differentiation, homeostasis, and satellite cell (SC) activation. By regulating S1P levels, SPL also controls SC recruitment and muscle regeneration, representing a potential therapeutic target for muscular dystrophy. We found that SPL is induced during myoblast differentiation. To investigate SPL's role in myogenesis at the cellular level, we generated and characterized a murine myoblast SPL-knockdown (SPL-KD) cell line lacking SPL. SPL-KD cells accumulated intracellular and extracellular S1P and failed to form myotubes under conditions that normally stimulate myogenic differentiation. Under differentiation conditions, SPL-KD cells also demonstrated delayed induction of 3 myogenic microRNAs (miRNAs), miR-1, miR-206, and miR-486. SPL-KD cells successfully differentiated when treated with an S1P(1) agonist, S1P(2) antagonist, and combination treatments, which also increased myogenic miRNA levels. SPL-KD cells transfected with mimics for miR-1 or miR-206 also overcame the differentiation block. Thus, we show for the first time that the S1P/SPL/S1P-receptor axis regulates the expression of a number of miRNAs, thereby contributing to myogenic differentiation.de la Garza-Rodea, A. S., Baldwin, D. M., Oskouian, B., Place, R. F., Bandhuvula, P., Kumar, A., Saba, J. D. Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression.	[de la Garza-Rodea, Anabel S.; Baldwin, Dianna M.; Oskouian, Babak; Place, Robert F.; Bandhuvula, Padmavathi; Kumar, Ashok; Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Baldwin, Dianna M.] San Francisco State Univ, San Francisco, CA 94132 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; California State University System; San Francisco State University	Saba, JD (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	jsaba@chori.org			U.S. National Institutes of Health [GM66954]; Muscular Dystrophy Association [MDA217712]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) [5R25GM59298-12]; California Institute of Regenerative Medicine (CIRM) Bridges grant [TB1-01194]; CIRM clinical fellowship [TG2-01164]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066954, R25GM059298] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE); California Institute of Regenerative Medicine (CIRM) Bridges grant; CIRM clinical fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Abeer Eltanawy, Julia Weisbrod, and Rashed Abu-Alia for technical support and N. Cronen for expert administrative assistance. These studies were supported by U.S. National Institutes of Health grant GM66954, Muscular Dystrophy Association grant MDA217712 and Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) grant 5R25GM59298-12 (to J.D.S.), California Institute of Regenerative Medicine (CIRM) Bridges grant TB1-01194 (to D. B.), and CIRM clinical fellowship TG2-01164 (to A.S.G.R.)	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bandhuvula P, 2009, BIOCHEM BIOPH RES CO, V380, P366, DOI 10.1016/j.bbrc.2009.01.106; Becciolini L, 2006, BBA-MOL CELL BIOL L, V1761, P43, DOI 10.1016/j.bbalip.2006.01.006; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bruni P., 2013, HDB EXP PHARM, V216, P457, DOI [10.1007/978-3-7091-1511-4_23, DOI 10.1007/978-3-7091-1511-4_23]; Calhabeu F, 2013, ONCOGENE, V32, P651, DOI 10.1038/onc.2012.73; Calise S, 2012, BBA-MOL CELL RES, V1823, P439, DOI 10.1016/j.bbamcr.2011.11.016; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Germinario E, 2012, J APPL PHYSIOL, V113, P707, DOI 10.1152/japplphysiol.00300.2012; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Kumar A, 2009, EXPERT OPIN THER TAR, V13, P1013, DOI 10.1517/14728220903039722; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meacci E, 2003, BBA-MOL CELL BIOL L, V1633, P133, DOI 10.1016/S1388-1981(03)00106-9; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Rapizzi E, 2008, MOL CELL BIOCHEM, V314, P193, DOI 10.1007/s11010-008-9780-y; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sassoli C, 2011, J CELL MOL MED, V15, P2498, DOI 10.1111/j.1582-4934.2010.01250.x; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Siehler S, 2001, J BIOL CHEM, V276, P48733, DOI 10.1074/jbc.M011072200; Siow DL, 2010, J LIPID RES, V51, P2546, DOI 10.1194/jlr.M004374; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; SULLARDS MC, 2001, SCI STKE, V67, P1; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Wang F, 1999, CANCER RES, V59, P6185; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zanin M, 2008, AM J PHYSIOL-CELL PH, V294, pC36, DOI 10.1152/ajpcell.00164.2007; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	53	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					506	519		10.1096/fj.13-233155	http://dx.doi.org/10.1096/fj.13-233155			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24158395	Green Published			2022-12-25	WOS:000333526100047
J	Brandis, KA; Gale, S; Jinn, S; Langmade, SJ; Dudley-Rucker, N; Jiang, H; Sidhu, R; Ren, A; Goldberg, A; Schaffer, JE; Ory, DS				Brandis, Katrina A.; Gale, Sarah; Jinn, Sarah; Langmade, Stephen J.; Dudley-Rucker, Nicole; Jiang, Hui; Sidhu, Rohini; Ren, Aileen; Goldberg, Anna; Schaffer, Jean E.; Ory, Daniel S.			Box C/D Small Nucleolar RNA (snoRNA) U60 Regulates Intracellular Cholesterol Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Cholesterol Regulation; Intracellular Trafficking; Lipid Transport; Small Nucleolar RNA (snoRNA); Noncoding RNA	ENDOPLASMIC-RETICULUM CHOLESTEROL; PLASMA-MEMBRANE; STEROL TRANSPORT; ACCESSIBILITY; HOMEOSTASIS; SCREEN; MIR-33; GENES; CELLS; ER	Background: The mechanisms regulating internalization of plasma membrane cholesterol in mammalian cells are not well understood. Results: A cell line haploinsufficient for U60 snoRNA expression exhibits impaired plasma membrane to ER cholesterol trafficking and increased de novo cholesterol synthesis. Conclusion: U60 snoRNA expression regulates cholesterol homeostasis by affecting internalization of plasma membrane cholesterol. Significance: This is the first study to implicate a snoRNA in regulation of cholesterol homeostasis. Mobilization of plasma membrane (PM) cholesterol to the endoplasmic reticulum is essential for cellular cholesterol homeostasis. The mechanisms regulating this retrograde, intermembrane cholesterol transfer are not well understood. Because mutant cells with defects in PM to endoplasmic reticulum cholesterol trafficking can be isolated on the basis of resistance to amphotericin B, we conducted an amphotericin B loss-of-function screen in Chinese hamster ovary (CHO) cells using insertional mutagenesis to identify genes that regulate this trafficking mechanism. Mutant line A1 displayed reduced cholesteryl ester formation from PM-derived cholesterol and increased de novo cholesterol synthesis, indicating a deficiency in retrograde cholesterol transport. Genotypic analysis revealed that the A1 cell line contained one disrupted allele of the U60 small nucleolar RNA (snoRNA) host gene, resulting in haploinsufficiency of the box C/D snoRNA U60. Complementation and mutational studies revealed the U60 snoRNA to be the essential feature from this locus that affects cholesterol trafficking. Lack of alteration in predicted U60-mediated site-directed methylation of 28 S rRNA in the A1 mutant suggests that the U60 snoRNA modulates cholesterol trafficking by a mechanism that is independent of this canonical function. Our study adds to a growing body of evidence for participation of small noncoding RNAs in cholesterol homeostasis and is the first to implicate a snoRNA in this cellular function.	[Brandis, Katrina A.; Gale, Sarah; Jinn, Sarah; Langmade, Stephen J.; Dudley-Rucker, Nicole; Jiang, Hui; Sidhu, Rohini; Ren, Aileen; Goldberg, Anna; Schaffer, Jean E.; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Ory, DS (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	dory@wustl.edu	Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167; Ren, Aileen/0000-0002-1116-900X	National Institutes of Health Grant [P30 DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, R01HL010330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robyn Roth and John Heuser for assistance with electron microscopy experiments. Mass spectrometry analyses were performed in the Metabolomics Facility at Washington University (National Institutes of Health Grant P30 DK020579).	Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DAHL NK, 1994, J LIPID RES, V35, P1839; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; Jacobs NL, 1997, J LIPID RES, V38, P1973; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Norlin M, 2004, BIOCHEM BIOPH RES CO, V316, P158, DOI 10.1016/j.bbrc.2004.02.029; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xia J, 2013, HUM MOL GENET, V22, P737, DOI 10.1093/hmg/dds481; Yamauchi Y, 2007, J BIOL CHEM, V282, P34994, DOI 10.1074/jbc.M703653200	41	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35703	35713		10.1074/jbc.M113.488577	http://dx.doi.org/10.1074/jbc.M113.488577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174535	Green Published, hybrid			2022-12-25	WOS:000329814700009
J	Li, J; Yao, K; Yu, XN; Dong, XR; Gan, LS; Luo, CQ; Wu, YL				Li, Jie; Yao, Ke; Yu, Xiaoning; Dong, Xinran; Gan, Lishe; Luo, Chenqi; Wu, Yalin			Identification of a Novel Lipofuscin Pigment (iisoA2E) in Retina and Its Effects in the Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Phosphatidylethanolamine; Phospholipase D; Retina; Retinal Degeneration; Retinoid; Lipofuscin; Pigment	LIGHT-INDUCED DAMAGE; MACULAR DEGENERATION; STARGARDT-DISEASE; A2E; FLUOROPHORE; ABCR; RPE; OXIDATION; RHODOPSIN; PRODUCTS	Background: Macular degeneration implicates lipofuscin deposition in the retina. Results: Bisretinoid iisoA2E in the retina was characterized; excessive accumulation of iisoA2E was cytotoxic to retinal pigment epithelial cells. Conclusion: Pyridinium iisoA2E is a unique diretinal adduct and serves as a fluorescent biomarker of aberrant all-trans-retinal metabolism. Significance: Characterization of iisoA2E gives a more complete understanding of the biosynthesis of retinal bisretinoid lipofuscin. Lipofuscin accumulation in retinal pigment epithelial (RPE) cells of the eye implicates the etiologies of Stargardt disease and age-related macular degeneration, a leading cause of blindness in the elderly. Here, we have identified a previously unknown RPE lipofuscin component. By one- and two-dimensional NMR techniques and mass spectrometry, we confirmed that this compound is a new type of pyridinium bisretinoid presenting an unusual structure, in which two polyenic side chains are attached to adjacent carbons of a pyridinium ring. This pigment is a light-induced isomer of isoA2E, rather than A2E, referred to as iisoA2E. This pigment is a fluorescent lipofuscin compound with absorbance maxima at approximate to 430 and 352 nm detected in human, pig, mouse, and bovine eyes. Formation of iisoA2E was found in reaction mixtures of all-trans-retinal and ethanolamine. Excess intracellular accumulation of this adduct in RPE cells in vitro leads to a significant loss of cell viability and caused membrane damage. Phospholipase D-mediated phosphodiester cleavage of the A2PE series generated isoA2E and iisoA2E, in addition to A2E, thus corroborating the presence of isoA2PE and iisoA2PE that may serve as biosynthetic precursors of isoA2E and iisoA2E.	[Li, Jie; Gan, Lishe; Wu, Yalin] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Yao, Ke; Yu, Xiaoning; Dong, Xinran; Luo, Chenqi; Wu, Yalin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, YL (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yalinw@zju.edu.cn	Yao, Ke/AAM-6866-2021	Li, Jie/0000-0001-5463-3995; Yao, Ke/0000-0002-6764-7365	National Science Foundation of the People's Republic of China [21202146, 81271018]; Fundamental Research Funds for the Central Universities; Zhejiang Key Innovation Team Project of China Grant [2009R50039]; Zhejiang Key Laboratory Fund of China Grant [2011E10006]	National Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Key Innovation Team Project of China Grant; Zhejiang Key Laboratory Fund of China Grant	This work was supported in part by National Science Foundation of the People's Republic of China Grants 21202146 and 81271018 and by the Fundamental Research Funds for the Central Universities.; Supported by Zhejiang Key Innovation Team Project of China Grant 2009R50039 and Zhejiang Key Laboratory Fund of China Grant 2011E10006.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; ELDRED GE, 1988, EXP EYE RES, V47, P71, DOI 10.1016/0014-4835(88)90025-5; FEENEYBURNS L, 1988, INVEST OPHTH VIS SCI, V29, P708; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Honeyman B., 2005, NANOSCAPE, V2, P89; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; LIU RSH, 1982, METHOD ENZYMOL, V88, P506; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Pang JJ, 2005, MOL VIS, V11, P152; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Paxton JW, 2005, CLIN EXP PHARMACOL P, V32, P633, DOI 10.1111/j.0305-1870.2005.04243.x; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; WADDELL WH, 1976, J AM CHEM SOC, V98, P238, DOI 10.1021/ja00417a041; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xi YM, 2013, ORG BIOMOL CHEM, V11, P2387, DOI 10.1039/c3ob40137e	47	11	11	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35671	35682		10.1074/jbc.M113.511386	http://dx.doi.org/10.1074/jbc.M113.511386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169698	hybrid, Green Published			2022-12-25	WOS:000329814700006
J	Thrasivoulou, C; Millar, M; Ahmed, A				Thrasivoulou, Christopher; Millar, Michael; Ahmed, Aamir			Activation of Intracellular Calcium by Multiple Wnt Ligands and Translocation of beta-Catenin into the Nucleus A CONVERGENT MODEL OF Wnt Ca2+ AND Wnt/beta-CATENIN PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Calcium Signaling; Cell Signaling; Nuclear Membrane; Wnt Signaling; Canonical and Non-canonical Signaling; Intranuclear Calcium; Macromolecular Transport; Nuclear Membrane Potential	PORE COMPLEX; LOCALIZATION SIGNAL; TAIL FORMATION; TRANSPORT; ZEBRAFISH; DEPLETION; CELLS; TRANSFORMATION; DIFFUSION; INTERACTS	Background: Cellular transducers of Wnt signaling, -catenin and Ca2+, are considered to act via independent canonical and non-canonical pathways. Results: Six Wnt ligands activated cytosolic and intranuclear Ca2+ and nuclear translocation of -catenin. Conclusion: Wnt -catenin and Ca2+ signaling are coupled in mammalian cells. Significance: A coupled model of Wnt/Ca2+ and -catenin signaling that challenges the canonical and non-canonical categorization is proposed. Ca2+ and -catenin, a 92-kDa negatively charged transcription factor, transduce Wnt signaling via the non-canonical, Wnt/Ca2+ and canonical, Wnt/-catenin pathways independently. The nuclear envelope is a barrier to large protein entry, and this process is regulated by intracellular calcium [Ca2+](i) and trans-nuclear potential. How -catenin traverses the nuclear envelope is not well known. We hypothesized that Wnt/Ca2+ and Wnt/-catenin pathways act in a coordinated manner and that [Ca2+](i) release facilitates -catenin entry into the nucleus in mammalian cells. In a live assay using calcium dyes in PC3 prostate cancer cells, six Wnt peptides (3A, 4, 5A, 7A, 9B, and 10B) mobilized [Ca2+](i) but Wnt11 did not. Based upon dwell time (range = 15-30 s) of the calcium waveform, these Wnts could be classified into three classes: short, 3A and 5A; long, 7A and 10B; and very long, 4 and 9B. Wnt-activated [Ca2+](i) release was followed by an increase in intranuclear calcium and the depolarization of both the cell and nuclear membranes, determined by using FM4-64. In cells treated with Wnts 5A, 9B, and 10B, paradigm substrates for each Wnt class, increased [Ca2+](i) was followed by -catenin translocation into the nucleus in PC3, MCF7, and 253J, prostate, breast, and bladder cancer cell lines; both the increase in Wnt 5A, 9B, and 10B induced [Ca2+](i) release and -catenin translocation are suppressed by thapsigargin in PC3 cell line. We propose a convergent model of Wnt signaling network where Ca2+ and -catenin pathways may act in a coordinated, interdependent, rather than independent, manner.	[Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, London WC1E 6JJ, England; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Ahmed, Aamir] UCL, Prostate Canc Res Ctr, Div Surg, London W1W 7EJ, England	University of London; University College London; University of Edinburgh; University of London; University College London	Ahmed, A (corresponding author), UCL, Prostate Canc Res Ctr, Div Surg, 3rd Floor Labs,Charles Bell House,67 Riding House, London W1W 7EJ, England.	aamir.ahmed@ucl.ac.uk	Thrasivoulou, Christopher/F-7087-2010	Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre Charity (UK Charity) [802545]	Prostate Cancer Research Centre Charity (UK Charity)	This work was supported by the Prostate Cancer Research Centre Charity (UK Charity 802545).	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; ALLBRITTON NL, 1994, P NATL ACAD SCI USA, V91, P12458, DOI 10.1073/pnas.91.26.12458; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P253; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; GIULIAN D, 1977, J CELL BIOL, V72, P86, DOI 10.1083/jcb.72.1.86; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jan CR, 1999, LIFE SCI, V65, P2513, DOI 10.1016/S0024-3205(99)00518-4; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perez-Terzic C, 1999, CIRC RES, V84, P1292, DOI 10.1161/01.RES.84.11.1292; PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Sarma A, 2011, PROTEIN CELL, V2, P291, DOI 10.1007/s13238-011-1038-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma M, 2012, J BIOL CHEM, V287, P819, DOI 10.1074/jbc.M111.299099; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	57	80	84	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35651	35659		10.1074/jbc.M112.437913	http://dx.doi.org/10.1074/jbc.M112.437913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158438	hybrid, Green Published			2022-12-25	WOS:000329814700004
J	Zhu, TG; Dou, Z; Qin, B; Jin, CJ; Wang, XH; Xu, LL; Wang, ZY; Zhu, LJ; Liu, FS; Gao, XJ; Ke, YW; Wang, ZY; Aikhionbare, F; Fu, CH; Ding, X; Yao, XB				Zhu, Tongge; Dou, Zhen; Qin, Bo; Jin, Changjiang; Wang, Xinghui; Xu, Leilei; Wang, Zhaoyang; Zhu, Lijuan; Liu, Fusheng; Gao, Xinjiao; Ke, Yuwen; Wang, Zhiyong; Aikhionbare, Felix; Fu, Chuanhai; Ding, Xia; Yao, Xuebiao			Phosphorylation of Microtubule-binding Protein Hec1 by Mitotic Kinase Aurora B Specifies Spindle Checkpoint Kinase Mps1 Signaling at the Kinetochore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Kinetochore; Mitosis; Mitotic Spindle; Phosphorylation; Cenp-e; Checkpoint	CENP-E; ASSEMBLY CHECKPOINT; HELA-CELLS; ATTACHMENT; COMPLEX; BUBR1; MAD2; CDC20; LOCALIZATION; ARCHITECTURE	Background: Hec1 is a core component of outer kinetochore essential for chromosome segregation in mitosis. Results: Hec1 interacts with mitotic checkpoint kinase Mps1, and phosphorylation of Hec1 by Aurora B recruits Mps1 to kinetochore. Conclusion: Phosphorylation of Hec1 by Aurora B specifies Mps1 signaling at the kinetochore. Significance: Aurora B-Hec1-Mps1 axis orchestrates chromosome dynamics and stability in mitosis. The spindle assembly checkpoint (SAC) is a quality control device to ensure accurate chromosome attachment to spindle microtubule for equal segregation of sister chromatid. Aurora B is essential for SAC function by sensing chromosome bi-orientation via spatial regulation of kinetochore substrates. However, it has remained elusive as to how Aurora B couples kinetochore-microtubule attachment to SAC signaling. Here, we show that Hec1 interacts with Mps1 and specifies its kinetochore localization via its calponin homology (CH) domain and N-terminal 80 amino acids. Interestingly, phosphorylation of the Hec1 by Aurora B weakens its interaction with microtubules but promotes Hec1 binding to Mps1. Significantly, the temporal regulation of Hec1 phosphorylation orchestrates kinetochore-microtubule attachment and Mps1 loading to the kinetochore. Persistent expression of phosphomimetic Hec1 mutant induces a hyperactivation of SAC, suggesting that phosphorylation-elicited Hec1 conformational change is used as a switch to orchestrate SAC activation to concurrent destabilization of aberrant kinetochore attachment. Taken together, these results define a novel role for Aurora B-Hec1-Mps1 signaling axis in governing accurate chromosome segregation in mitosis.	[Zhu, Tongge; Dou, Zhen; Qin, Bo; Jin, Changjiang; Wang, Xinghui; Xu, Leilei; Wang, Zhaoyang; Zhu, Lijuan; Liu, Fusheng; Gao, Xinjiao; Ke, Yuwen; Wang, Zhiyong; Fu, Chuanhai; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China; [Zhu, Tongge; Dou, Zhen; Aikhionbare, Felix; Fu, Chuanhai] Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Liu, Fusheng; Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Beijing University of Chinese Medicine	Ding, X (corresponding author), Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China.	dingx@bucm.edu.cn; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Fu, Chuanhai/G-8303-2016	Fu, Chuanhai/0000-0003-4354-3796; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, 8G12MD007602, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2014CB964800]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439]; Ministry of Education [20113402130010, WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, 8G12MD007602, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2014CB964800; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, and 31271439; and Ministry of Education Grants 20113402130010, WK2060190018, and WK2340000021.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Caldas GV, 2013, MOL CELL, V51, P3, DOI 10.1016/j.molcel.2013.06.017; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Fischer MS, 2004, J ZOOL SYST EVOL RES, V42, P1; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; He XW, 1998, J CELL SCI, V111, P1635; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takeuchi K, 2012, EXP CELL RES, V318, P1367, DOI 10.1016/j.yexcr.2012.02.016; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	50	45	47	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36149	36159		10.1074/jbc.M113.507970	http://dx.doi.org/10.1074/jbc.M113.507970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187132	Green Published, hybrid			2022-12-25	WOS:000329814700049
J	Chatelain, FC; Bichet, D; Feliciangeli, S; Larroque, MM; Braud, VM; Douguet, D; Lesage, F				Chatelain, Franck C.; Bichet, Delphine; Feliciangeli, Sylvain; Larroque, Marie-Madeleine; Braud, Veronique M.; Douguet, Dominique; Lesage, Florian			Silencing of the Tandem Pore Domain Halothane-inhibited K+ Channel 2 (THIK2) Relies on Combined Intracellular Retention and Low Intrinsic Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Endoplasmic Reticulum (ER); Gating; Plasma Membrane; Potassium Channels; Protein Phosphorylation; Trafficking	POTASSIUM CHANNELS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ER RETENTION; BETA-SUBUNIT; SIGNAL; TRAFFICKING; PHOSPHORYLATION; LEAK; PROTEINS	Background: THIK2 does not generate macroscopic currents in heterologous systems. Results: THIK2 produces K+ currents when mutated in its pore region and/or in its cytoplasmic amino terminus. Conclusion: Silencing of THIK2 is due to low intrinsic activity and intracellular retention. Significance: THIK2 is a functional but silent channel. The tandem pore domain halothane-inhibited K+ channel 1 (THIK1) produces background K+ currents. Despite 62% amino acid identity with THIK1, THIK2 is not active upon heterologous expression. Here, we show that this apparent lack of activity is due to a unique combination of retention in the endoplasmic reticulum and low intrinsic channel activity at the plasma membrane. A THIK2 mutant containing a proline residue (THIK2-A155P) in its second inner helix (M2) produces K+-selective currents with properties similar to THIK1, including inhibition by halothane and insensitivity to extracellular pH variations. Another mutation in the M2 helix (I158D) further increases channel activity and affects current kinetics. We also show that the cytoplasmic amino-terminal region of THIK2 (Nt-THIK2) contains an arginine-rich motif (RRSRRR) that acts as a retention/retrieval signal. Mutation of this motif in THIK2 induces a relocation of the channel to the plasma membrane, resulting in measurable currents, even in the absence of mutations in the M2 helix. Cell surface delivery of a Nt-THIK2-CD161 chimera is increased by mutating the arginines of the retention motif but also by converting the serine embedded in this motif to aspartate, suggesting a phosphorylation-dependent regulation of THIK2 trafficking.	CNRS, Inst Pharmacol Mol & Cellulaire, Lab Excellence Ion Channel Sci & Therapeut, F-06560 Valbonne, France; Univ Nice Sophia Antipolis, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011; douguet, dominique/D-5644-2017; braud, veronique M/I-4597-2013; Feliciangeli, Sylvain/Q-1292-2016	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; braud, veronique M/0000-0001-8213-3947; Feliciangeli, Sylvain/0000-0003-3358-3719; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Medicale Grant Equipe labellisee FRM; Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics" [ANR-11-LABX-0015-01]	Fondation pour la Recherche Medicale Grant Equipe labellisee FRM; Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics"(French National Research Agency (ANR))	The work was supported by Fondation pour la Recherche Medicale Grant Equipe labellisee FRM 2011 and by Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics" Grant ANR-11-LABX-0015-01.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Campanucci VA, 2003, J PHYSIOL-LONDON, V548, P731, DOI 10.1113/jphysiol.2002.035998; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Kang D., 2013, PFLUEGERS ARCH, DOI 10.1007/s00424-013-1358-1; Kim D, 2001, BIOCHEM BIOPH RES CO, V284, P923, DOI 10.1006/bbrc.2001.5064; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2005, J GEN PHYSIOL, V125, P71, DOI 10.1085/jgp.200409194; Lazarenko RM, 2010, J NEUROSCI, V30, P9324, DOI 10.1523/JNEUROSCI.1956-10.2010; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Ren Z, 2003, J NEUROSCI, V23, P6608; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Theilig F, 2008, CELL PHYSIOL BIOCHEM, V21, P63, DOI 10.1159/000113748; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	49	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35081	35092		10.1074/jbc.M113.503318	http://dx.doi.org/10.1074/jbc.M113.503318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163367	Green Published, hybrid			2022-12-25	WOS:000329867600010
J	Kopaskie, KS; Ligtenberg, KG; Schneewind, O				Kopaskie, Karyl S.; Ligtenberg, Katherine Given; Schneewind, Olaf			Translational Regulation of Yersinia enterocolitica mRNA Encoding a Type Ill Secretion Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; mRNA; Ribosomes; Secretion; Translation Regulation	III PROTEIN SECRETION; TARGET-CELL CONTACT; YOP PROTEINS; HELA-CELLS; POSTTRANSCRIPTIONAL MECHANISM; EUKARYOTIC CELLS; TIP COMPLEX; CHAPERONE; PSEUDOTUBERCULOSIS; EXPRESSION	Background:Yersinia enterocolitica yopD, lcrH, and yscM1 control the expression of yopQ encoding a secretion substrate. Results: YopD associates with 30 S ribosomal particles, and YopD, LcrH, and YscM1 block yopQ mRNA translation. Conclusion: In response to environmental signals, Yersinia prevent yopQ expression by blocking the translation of its transcripts. Significance: These results demonstrate translational regulation for the Yersinia type III secretion pathway. Yersinia enterocolitica type III secretion machines transport YopQ and other Yop effectors into host immune cells. YopD and its chaperone LcrH are essential components of the Yersinia type III pathway, enabling effector translocation into host cells. YopD, LcrH, and YscM1 also regulate yop expression post-transcriptionally in response to environmental signals; however, the molecular mechanisms for this regulation and Yop secretion are unknown. We show here that YopD associates with 30 S ribosomal particles in a manner requiring LcrH. When added to ribosomes, YopD, LcrH, and YscM1 block the translation of yopQ mRNA. We propose a model whereby LcrH-dependent association of YopD with 30 S ribosomal particles enables YscM1 to block yopQ translation unless type III machines are induced to secrete the effector.	Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			NICHD, National Institutes of Health; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health) [1-U54-AI-057153]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042797, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Antoni P.A. Hendrickx for training in transmission electron microscopy and members of our laboratory for discussion and critical comments on the manuscript The S3 monoclonal antibody developed by L. Kahan was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD, National Institutes of Health, and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. O. S. acknowledges membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health Award 1-U54-AI-057153).	Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blaylock B, 2008, MOL MICROBIOL, V70, P1210, DOI 10.1111/j.1365-2958.2008.06474.x; Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005; Broms JE, 2007, J BACTERIOL, V189, P8417, DOI 10.1128/JB.00936-07; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2003, MOL MICROBIOL, V50, P1091, DOI 10.1046/j.1365-2958.2003.03812.x; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Jackson MW, 1998, J BACTERIOL, V180, P4912, DOI 10.1128/JB.180.18.4912-4921.1998; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Ligtenberg KG, 2013, J BACTERIOL, V195, P777, DOI 10.1128/JB.02021-12; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Niemann GS, 2013, J BACTERIOL, V195, P2119, DOI 10.1128/JB.00024-13; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Ramamurthi KS, 2005, J BACTERIOL, V187, P707, DOI 10.1128/JB.187.2.707-715.2005; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sorg JA, 2005, J BACTERIOL, V187, P7090, DOI 10.1128/JB.187.20.7090-7102.2005; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08	66	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35478	35488		10.1074/jbc.M113.504811	http://dx.doi.org/10.1074/jbc.M113.504811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158443	hybrid, Green Published			2022-12-25	WOS:000329867600043
J	Cranz-Mileva, S; Pamula, MC; Barua, B; Desai, B; Hong, YH; Russell, J; Trent, R; Wang, JQ; Walworth, NC; Hitchcock-DeGregori, SE				Cranz-Mileva, Susanne; Pamula, Melissa C.; Barua, Bipasha; Desai, Brinda; Hong, Yaejee Hannah; Russell, Jacquelyn; Trent, Richard; Wang, Jianqiu; Walworth, Nancy C.; Hitchcock-DeGregori, Sarah E.			A Molecular Evolution Approach to Study the Roles of Tropomyosin in Fission Yeast	PLOS ONE			English	Article							F-ACTIN CABLES; CONTRACTILE-RING; SCHIZOSACCHAROMYCES-POMBE; MYOSIN-II; SPATIAL REGULATION; BINDING-SITES; DIVISION SITE; CYTOKINESIS; PROTEIN; FORMIN	Tropomyosin, a coiled-coil protein that binds along the length of the actin filament, is a universal regulator of the actin cytoskeleton. We have taken a bioinformatics/proteomic approach to studying structure-function relationships in this protein. The presence of a single, essential tropomyosin gene, cdc8, in fission yeast, Schizosaccharomyces pombe, enables a systems-based approach to define the residues that are important for cellular functions. Using molecular evolution methodologies we identified the most conserved residues and related them to the coiled coil structure. Mutants in which one or more of 21 of the most conserved surface residues was mutated to Ala were tested for the ability to rescue growth of a temperature-sensitive cdc8 mutant when overexpressed at the restrictive temperature. Based on altered morphology of the septum and actin cytoskeleton, we selected three sets of mutations for construction of mutant cdc8 strains using marker reconstitution mutagenesis and analysis of recombinant protein in vitro: D16A.K30A, V114S.E117A.H118A and R121A.D131A.E138A. The mutations have sequence-specific effects on cellular morphology including cell length, organization of cytoskeletal structures (actin patches, actin cables and contractile rings), and in vitro actin affinity, lending credence to the proteomic approach introduced here. We propose that bioinformatics is a valid analysis tool for defining structure-function relationships in conserved proteins in this model organism.	[Cranz-Mileva, Susanne; Pamula, Melissa C.; Barua, Bipasha; Desai, Brinda; Hong, Yaejee Hannah; Russell, Jacquelyn; Trent, Richard; Wang, Jianqiu; Hitchcock-DeGregori, Sarah E.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Walworth, Nancy C.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hitchcock-DeGregori, SE (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	hitchcoc@rwjms.rutgers.edu		Russell, Jacquelyn/0000-0001-9928-2869; Walworth, Nancy/0000-0001-5940-8236; Pamula, Melissa/0000-0002-8010-9975	NIH [RO1 GM093065, GM53194]; Aresty Center for Undergraduate Research at Rutgers University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Center for Undergraduate Research at Rutgers University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH RO1 GM093065 to SEHD and GM53194 to NCW. MCP, YHH, JR and RT received support from the Aresty Center for Undergraduate Research at Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Balasubramanian MK, 1998, GENETICS, V149, P1265; Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161; Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 1996, PROTEINS, V26, P134; Chang F, 1996, J CELL SCI, V109, P131; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; East DA, 2011, BIOCHEM J, V438, P265, DOI 10.1042/BJ20101316; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Forsburg Susan L, 2003, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1317s64; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Hitchcock-De Gregori SE, 1982, J BIOL CHEM, V257, P8; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Huang JQ, 2012, J CELL BIOL, V199, P831, DOI 10.1083/jcb.201209044; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jockusch BM, 2011, REV PHYSIOL BIOCH P, V161, P67, DOI 10.1007/112_2011_1; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kurahashi H, 2002, GENES CELLS, V7, P375, DOI 10.1046/j.1365-2443.2002.00526.x; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Lee IJ, 2012, CYTOSKELETON, V69, P751, DOI 10.1002/cm.21052; Lees JG, 2011, CELL ADHES MIGR, V5, P181, DOI 10.4161/cam.5.2.14438; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; LI XE, BIOPHYS J, V100, P1005; Ma B, 2013, TOP CURR CHEM; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Mishra M, 2013, NAT CELL BIOL, V15, P853, DOI 10.1038/ncb2781; MITCHISON JM, 1985, J CELL SCI, V75, P357; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Motegi F, 2000, J CELL SCI, V113, P1813; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; Nakano K, 2006, GENES CELLS, V11, P893, DOI 10.1111/j.1365-2443.2006.00987.x; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Padmanabhan A, 2011, CURR BIOL, V21, P467, DOI 10.1016/j.cub.2011.01.059; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rasband W., 2006, IMAGEJ; Rincon SA, 2012, CYTOSKELETON, V69, P764, DOI 10.1002/cm.21056; Sambrook J, 2001, MOL CLONING LAB MANU; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; Stark BC, 2010, MOL BIOL CELL, V21, P989, DOI 10.1091/mbc.E09-10-0852; Strand J, 2001, J BIOL CHEM, V276, P34832, DOI 10.1074/jbc.M104750200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Subramanian D, 2013, GENETICS; Sveiczer A, 1996, J CELL SCI, V109, P2947; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; Ujfalusi Z, 2012, J BIOL CHEM, V287, P31894, DOI 10.1074/jbc.M112.341230; Ujfalusi Z, 2009, BIOPHYS J, V96, P162, DOI 10.1529/biophysj.108.138420; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wawro B, 2007, BIOCHEMISTRY-US, V46, P8146, DOI 10.1021/bi700686p; Win TZ, 2001, J CELL SCI, V114, P69; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Yonetani A, 2010, CURR BIOL, V20, P561, DOI 10.1016/j.cub.2010.01.061; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	81	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76726	10.1371/journal.pone.0076726	http://dx.doi.org/10.1371/journal.pone.0076726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167549	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500008
J	Tamburlini, G; Yadgarova, K; Kamilov, A; Bacci, A				Tamburlini, Giorgio; Yadgarova, Klara; Kamilov, Asamidin; Bacci, Alberta		Maternal Neonatal Care Quality	Improving the Quality of Maternal and Neonatal Care: the Role of Standard Based Participatory Assessments	PLOS ONE			English	Article							HOSPITAL-CARE; CHILDREN; MORTALITY; REVIEWS; HEALTH	Background: Gaps in quality of care are seriously affecting maternal and neonatal health globally but reports of successful quality improvement cycles implemented at large scale are scanty. We report the results of a nation-wide program to improve quality of maternal and neonatal hospital care in a lower-middle income country focusing on the role played by standard-based participatory assessments. Methods: Improvements in the quality of maternal and neonatal care following an action-oriented participatory assessment of 19 areas covering the whole continuum from admission to discharge were measured after an average period of 10 months in four busy referral maternity hospitals in Uzbekistan. Information was collected by a multidisciplinary national team with international supervision through visit to hospital services, examination of medical records, direct observation of cases and interviews with staff and mothers. Scores (range 0 to 3) attributed to over 400 items and combined in average scores for each area were compared with the baseline assessment. Results: Between the first and the second assessment, all four hospitals improved their overall score by an average 0.7 points out of 3 (range 0.4 to 1), i.e. by 22%. The improvements occurred in all main areas of care and were greater in the care of normal labor and delivery (+0.9), monitoring, infection control and mother and baby friendly care (+0.8) the role of the participatory action-oriented approach in determining the observed changes was estimated crucial in 6 out of 19 areas and contributory in other 8. Ongoing implementation of referral system and new classification of neonatal deaths impede the improved process of care to be reflected in current statistics. Conclusions: Important improvements in the quality of hospital care provided to mothers and newborn babies can be achieved through a standard-based action-oriented and participatory assessment and reassessment process.	[Tamburlini, Giorgio; Bacci, Alberta] European Sch Maternal Neonatal Child & Adolescent, Trieste, Italy; [Yadgarova, Klara] Tashkent Inst Postgrad Med Educ, Tashkent, Uzbekistan; [Kamilov, Asamidin] Minist Publ Hlth Republ Uzbekistan, Tashkent, Uzbekistan		Tamburlini, G (corresponding author), European Sch Maternal Neonatal Child & Adolescent, Trieste, Italy.	tamburlini@csbonlus.org			World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; European Commission	World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding was provided by: World Health Organization, Regional Office for Europe; UNITED Nations Children's Fund, Regional Office for Central and Eastern Europe; the European Commission. One of the authors ( AB) was regional coordinator for Making Pregnancy Safer at the WHO Regional Office for Europe until June 2011. The funding sources played no role in study design, collection and analysis of data and preparation of the manuscript.	[Anonymous], 2005, WHAT ARE ADV LIMITAT; Bacci A, 2007, REPROD HEALTH MATTER, V15, P145, DOI 10.1016/S0968-8080(07)30334-0; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cattaneo A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-5; Duke T, 2006, LANCET, V367, P919, DOI 10.1016/S0140-6736(06)68382-7; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Lawn J, 2013, HLTH NEWBORN; Legido-Quigley H, 2008, ASSURING QUALITY HLT; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Save the Children, 2012, M REP; Soto EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001282; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Tamburlini G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028763; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO, 2013, EUR STRAT APPR MAK P; WHO, 2010, HLTH ALL DAT BAS; WHO, 2010, TRENDS MAT MORT, P1990; WHO, 2006, IMPAC PREGN CHILDB P; WHO Regional Office for Europe, 2013, MAK PREGN SAF ASS TO; WHO United Nations Population Fund Unicef World Bank, 2003, MAN COMPL PREGN CHIL; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2003, MAN NEWB PROBL GUID; World Health Organization, 2013, LONDON SCH HYGIENE T	27	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78282	10.1371/journal.pone.0078282	http://dx.doi.org/10.1371/journal.pone.0078282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167616	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500077
J	Trevaskis, JL; Mack, CM; Sun, CZ; Soares, CJ; D'Souza, LJ; Levy, OE; Lewis, DY; Jodka, CM; Tatarkiewicz, K; Gedulin, B; Gupta, S; Wittmer, C; Hanley, M; Forood, B; Parkes, DG; Ghosh, SS				Trevaskis, James L.; Mack, Christine M.; Sun, Chengzao; Soares, Christopher J.; D'Souza, Lawrence J.; Levy, Odile E.; Lewis, Diane Y.; Jodka, Carolyn M.; Tatarkiewicz, Krystyna; Gedulin, Bronislava; Gupta, Swati; Wittmer, Carrie; Hanley, Michael; Forood, Bruce; Parkes, David G.; Ghosh, Soumitra S.			Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids	PLOS ONE			English	Article							NATIVE CHEMICAL LIGATION; DIET-INDUCED OBESITY; FOOD-INTAKE; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; LEPTIN RESPONSIVENESS; REPERFUSION INJURY; TREATED PATIENTS; AMYLIN AGONISM; TYPE-2	Combination therapy is being increasingly used as a treatment paradigm for metabolic diseases such as diabetes and obesity. In the peptide therapeutics realm, recent work has highlighted the therapeutic potential of chimeric peptides that act on two distinct receptors, thereby harnessing parallel complementary mechanisms to induce additive or synergistic benefit compared to monotherapy. Here, we extend this hypothesis by linking a known antidiabetic peptide with an anti-obesity peptide into a novel peptide hybrid, which we termed a phybrid. We report on the synthesis and biological activity of two such phybrids (AC164204 and AC164209), comprised of a glucagon-like peptide-1 receptor (GLP1-R) agonist, and exenatide analog, AC3082, covalently linked to a second generation amylin analog, davalintide. Both molecules acted as full agonists at their cognate receptors in vitro, albeit with reduced potency at the calcitonin receptor indicating slightly perturbed amylin agonism. In obese diabetic Lep(ob)/Lep(ob) mice sustained infusion of AC164204 and AC164209 reduced glucose and glycated haemoglobin (Hb(A1c)) equivalently but induced greater weight loss relative to exenatide administration alone. Weight loss was similar to that induced by combined administration of exenatide and davalintide. In diet-induced obese rats, both phybrids dose-dependently reduced food intake and body weight to a greater extent than exenatide or davalintide alone, and equal to co-infusion of exenatide and davalintide. Phybrid-mediated and exenatide + davalintide-mediated weight loss was associated with reduced adiposity and preservation of lean mass. These data are the first to provide in vivo proof-of-concept for multi-pathway targeting in metabolic disease via a peptide hybrid, demonstrating that this approach is as effective as co-administration of individual peptides.	[Trevaskis, James L.; Mack, Christine M.; Sun, Chengzao; Soares, Christopher J.; D'Souza, Lawrence J.; Levy, Odile E.; Lewis, Diane Y.; Jodka, Carolyn M.; Tatarkiewicz, Krystyna; Gedulin, Bronislava; Gupta, Swati; Wittmer, Carrie; Hanley, Michael; Forood, Bruce; Parkes, David G.; Ghosh, Soumitra S.] Amylin Pharmaceut LLC, San Diego, CA USA		Ghosh, SS (corresponding author), Amylin Pharmaceut LLC, San Diego, CA USA.	Soumitra.Ghosh@bms.com	Soares, Carlos José/D-2126-2013	Soares, Carlos José/0000-0002-8830-605X; Trevaskis, James/0000-0002-5356-6118	Amylin Pharmaceuticals, LLC	Amylin Pharmaceuticals, LLC(Bristol-Myers Squibb)	This research was entirely funded by Amylin Pharmaceuticals, LLC. All authors were employed by and were shareholders in Amylin Pharmaceuticals during the study period. Patents filed or issued: United States Patent No 8,076,288, (Hybrid polypeptides having glucose lowering activity). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Astrup A, 2013, INT J OBESITY, V37, P322, DOI 10.1038/ijo.2012.192; Bello NT, 2010, AM J PHYSIOL-REG I, V299, pR945, DOI 10.1152/ajpregu.00275.2010; Bhavsar S, 1998, PHYSIOL BEHAV, V64, P557, DOI 10.1016/S0031-9384(98)00110-3; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Claus TH, 2007, J ENDOCRINOL, V192, P371, DOI 10.1677/JOE-06-0018; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Heal DJ, 2013, INT J OBESITY, V37, P107, DOI 10.1038/ijo.2012.26; Howes LG, 2000, DIABETES OBES METAB, V2, P67, DOI 10.1046/j.1463-1326.2000.00047.x; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Laugero KD, 2009, METAB SYNDR RELAT DI; Mack CM, 2010, INT J OBESITY, V34, P385, DOI 10.1038/ijo.2009.238; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; Roth JD, 2008, INT J OBES LOND; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Roth JD, 2007, ENDOCRINOLOGY, V148, P6054, DOI 10.1210/en.2007-0898; Roth JD, 2012, BRIT J PHARMACOL, V166, P121, DOI 10.1111/j.1476-5381.2011.01537.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith SR, 2008, DIABETES CARE, V31, P1816, DOI 10.2337/dc08-0029; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Trevaskis JL, 2008, ENDOCRINOLOGY, V149, P5679, DOI 10.1210/en.2008-0770; Trevaskis JL, 2010, PHYSIOL BEHAV, V100, P187, DOI 10.1016/j.physbeh.2010.02.023; Turner R, 1999, LANCET, V354, P600, DOI 10.1016/S0140-6736(05)77957-5; Weyer C, 2001, CURR PHARM DESIGN, V7, P1353, DOI 10.2174/1381612013397357; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young A., 2005, AMYLIN PHYSL PHARM	42	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78154	10.1371/journal.pone.0078154	http://dx.doi.org/10.1371/journal.pone.0078154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167604	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500064
J	Unlu, I; Farajollahi, A; Strickman, D; Fonseca, DM				Unlu, Isik; Farajollahi, Ary; Strickman, Daniel; Fonseca, Dina M.			Crouching Tiger, Hidden Trouble: Urban Sources of Aedes albopictus (Diptera: Culicidae) Refractory to Source-Reduction	PLOS ONE			English	Article							TIRE-BREEDING MOSQUITOS; CULEX-PIPIENS DIPTERA; GEOGRAPHIC-DISTRIBUTION; SPATIAL-DISTRIBUTION; MANAGEMENT PROGRAM; PUPAL SURVEY; AEGYPTI; DENGUE; VECTOR; SITES	Our ultimate objective is to design cost-effective control strategies for Aedes albopictus, the Asian tiger mosquito, an important urban nuisance and disease vector that expanded worldwide during the last 40 years. We conducted mosquito larval surveys from May through October 2009 in the City of Trenton, New Jersey, USA, while performing intensive monthly source-reduction campaigns that involved removing, emptying, or treating all accessible containers with larvicides and pupicides. We examined patterns of occurrence of Ae. albopictus and Culex pipiens, another urban mosquito, among different container types by comparing observed and expected number of positive containers of each type. Expected use was based on the relative frequency of each container type in the environment. Aedes albopictus larvae and pupae were found significantly more often than expected in medium volumes of water in buckets and plant saucers but were rarely collected in small volumes of water found in trash items such as discarded cups and cans. They were also absent from large volumes of water such as in abandoned swimming pools and catch basins, although we consistently collected Cx. pipiens from those habitats. The frequency of Ae. albopictus in tires indicated rapid and extensive use of these ubiquitous urban containers. Standard larval-based indices did not correlate with adult catches in BG-Sentinel traps, but when based only on Ae. albopictus key containers (buckets, plant saucers, equipment with pockets of water, and tires) they did. Although we found that only 1.2% of the 20,039 water-holding containers examined contained immature Ae. albopictus (5.3% if only key containers were counted), adult populations were still above nuisance action thresholds six times during the 2009 mosquito season. We conclude that in urban New Jersey, effective source reduction for Ae. albopictus control will require scrupulous and repeated cleaning or treatment of everyday use containers and extensive homeowner collaboration.	[Unlu, Isik; Farajollahi, Ary; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Unlu, Isik; Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Strickman, Daniel] ARS, USDA, Off Natl Programs, Beltsville, MD USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Fonseca, DM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dinafons@rci.rutgers.edu	Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022	Fonseca, Dina Madeira/0000-0003-4726-7100; 	USDA; Rutgers University [USDA-ARS-58-6615-8-105]	USDA(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between USDA and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERASINGHE FP, 1984, INSECT SCI APPL, V5, P493, DOI 10.1017/S1742758400004926; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bartlett-Healy K, 2011, J MED ENTOMOL, V48, P712, DOI 10.1603/ME10168; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Crans WJ, 1996, J AM MOSQUITO CONTR, V12, P307; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Darsie R. F., 2005, IDENTIFICATION GEOGR; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Edillo FE, 2012, SE ASIAN J TROP MED, V43, P1365; ESTRADAFRANCO JG, 1995, BIOL DIS RELATIONSHI, V42, P1; FARAJOLLAHI A, 2013, J AM MOSQ C IN PRESS; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z; Kawada H, 2010, JPN J INFECT DIS, V63, P19; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; MADDER DJ, 1980, CAN ENTOMOL, V112, P173, DOI 10.4039/Ent112173-2; Manrique-Saide P, 2008, J AM MOSQUITO CONTR, V24, P289, DOI 10.2987/5578.1; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; Obenauer PJ, 2009, J MED ENTOMOL, V46, P900, DOI 10.1603/033.046.0424; Preechaporn W., 2006, Dengue Bulletin, V30, P204; Qualls WA, 2006, J AM MOSQUITO CONTR, V22, P601, DOI 10.2987/8756-971X(2006)22[601:LSOTMI]2.0.CO;2; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Rubio A, 2011, MEM I OSWALDO CRUZ, V106, P678, DOI 10.1590/S0074-02762011000600006; Sanchez L, 2010, TROP MED INT HEALTH, V15, P173, DOI 10.1111/j.1365-3156.2009.02437.x; SCHOOLEY DA, 1975, J AGR FOOD CHEM, V23, P293, DOI 10.1021/jf60198a059; Schwarz C. R., 1990, Bulletin Geodesique, V64, P28, DOI 10.1007/BF02530614; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Sokal RR, 1995, BIOMETRY, P578; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Su TY, 2003, J VECTOR ECOL, V28, P79; Sunahara T, 1997, RES POPUL ECOL, V39, P173, DOI 10.1007/BF02765263; Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126; Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu Isik, 2012, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V40, P23; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1; *WHO, 1972, WKLY EPIDEMIOL REC, V25, P73; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; WONGKOON S, 2005, P WORLD ACAD SCI ENG, V32, P216; Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1	57	67	67	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77999	10.1371/journal.pone.0077999	http://dx.doi.org/10.1371/journal.pone.0077999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167593	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500053
J	Banh, A; Chavez, V; Doi, J; Nguyen, A; Hernandez, S; Ha, V; Jimenez, P; Espinoza, F; Johnson, HA				Banh, Andy; Chavez, Valarie; Doi, Julia; Allison Nguyen; Hernandez, Sophia; Vu Ha; Jimenez, Peter; Espinoza, Fernanda; Johnson, Hope A.			Manganese (Mn) Oxidation Increases Intracellular Mn in Pseudomonas putida GB-1	PLOS ONE			English	Article							AFFINITY IRON UPTAKE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; MULTICOPPER OXIDASE; STRESS RESISTANCE; MN(II) OXIDATION; OXIDIZING FACTOR; IDENTIFICATION; MECHANISMS	Bacterial manganese (Mn) oxidation plays an important role in the global biogeochemical cycling of Mn and other compounds, and the diversity and prevalence of Mn oxidizers have been well established. Despite many hypotheses of why these bacteria may oxidize Mn, the physiological reasons remain elusive. Intracellular Mn levels were determined for Pseudomonas putida GB-1 grown in the presence or absence of Mn by inductively coupled plasma mass spectrometry (ICP-MS). Mn oxidizing wild type P. putida GB-1 had higher intracellular Mn than non Mn oxidizing mutants grown under the same conditions. P. putida GB-1 had a 5 fold increase in intracellular Mn compared to the non Mn oxidizing mutant P. putida GB-1-007 and a 59 fold increase in intracellular Mn compared to P. putida GB-1 Delta 2665.2447. The intracellular Mn is primarily associated with the less than 3 kDa fraction, suggesting it is not bound to protein. Protein oxidation levels in Mn oxidizing and non oxidizing cultures were relatively similar, yet Mn oxidation did increase survival of P. putida GB-1 when oxidatively stressed. This study is the first to link Mn oxidation to Mn homeostasis and oxidative stress protection.	[Banh, Andy; Chavez, Valarie; Doi, Julia; Allison Nguyen; Hernandez, Sophia; Vu Ha; Jimenez, Peter; Espinoza, Fernanda; Johnson, Hope A.] Calif State Univ Fullerton, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Johnson, HA (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA.	hajohnson@fullerton.edu		Banh, Andy/0000-0001-7333-8254; Hernandez, Sophia/0000-0001-5763-2672	Research Corporation; National Science Foundation [MCB-1021187]; California State University Fullerton Associated Students, Inc	Research Corporation(Research Corporation for Science Advancement); National Science Foundation(National Science Foundation (NSF)); California State University Fullerton Associated Students, Inc	Funding for this project was provided by Research Corporation (http://www.rescorp.org), the National Science Foundation (MCB-1021187), California State University Fullerton Associated Students, Inc research grants to JD, AB, VC, AN, SH, VH, FE, and PJ; and a State Mini Grant to HAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BOOGERD FC, 1987, J BACTERIOL, V169, P489, DOI 10.1128/jb.169.2.489-494.1987; Brouwers GJ, 1998, AM MINERAL, V83, P1573, DOI 10.2138/am-1998-11-1245; Brouwers GJ, 2000, GEOMICROBIOL J, V17, P1, DOI 10.1080/014904500270459; Brouwers GJ, 1999, APPL ENVIRON MICROB, V65, P1762; Carmichael MJ, 2013, GEOMICROBIOL J, V30, P779, DOI 10.1080/01490451.2013.769651; CARR RJG, 1986, APPL ENVIRON MICROB, V52, P1112, DOI 10.1128/AEM.52.5.1112-1116.1986; Caspi R, 1998, APPL ENVIRON MICROB, V64, P3549; Cellier MFM, 2012, CURR TOP MEMBR, V69, P249, DOI 10.1016/B978-0-12-394390-3.00010-0; Champion OL, 2011, MICROBIOL-SGM, V157, P1115, DOI 10.1099/mic.0.045807-0; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Vrind J, 2003, MOL MICROBIOL, V47, P993, DOI 10.1046/j.1365-2958.2003.03339.x; de Vrind JPM, 1998, APPL ENVIRON MICROB, V64, P3556; Do SH, 2009, CHEMOSPHERE, V75, P8, DOI 10.1016/j.chemosphere.2008.11.075; EHRLICH HL, 1990, ARCH MICROBIOL, V154, P12; Galiazzo F, 1989, Biol Met, V2, P6, DOI 10.1007/BF01116194; Geszvain K, 2013, APPL ENVIRON MICROB, V79, P357, DOI 10.1128/AEM.01850-12; Geszvain K, 2012, BIOCHEM SOC T, V40, P1244, DOI 10.1042/BST20120229; Geszvain K, 2011, ARCH MICROBIOL, V193, P605, DOI 10.1007/s00203-011-0702-0; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515, DOI 10.1146/annurev.mi.38.100184.002503; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Green RT, 2013, ISME J, V7, P581, DOI 10.1038/ismej.2012.140; Hohle TH, 2012, MOL MICROBIOL, V84, P766, DOI 10.1111/j.1365-2958.2012.08057.x; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jakubovics NS, 2009, MOL MICROBIOL, V72, P1, DOI 10.1111/j.1365-2958.2009.06637.x; Johnson HA, 2008, ARCH MICROBIOL, V189, P59, DOI 10.1007/s00203-007-0293-y; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kopytko M, 2002, ELECTRON J BIOTECHNO, V5, P182, DOI 10.2225/vol5-issue2-fulltext-1; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; LAHA S, 1990, ENVIRON SCI TECHNOL, V24, P363, DOI 10.1021/es00073a012; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; MACARA IG, 1973, BIOCHEM J, V135, P785, DOI 10.1042/bj1350785; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Miyata N, 2007, J BIOSCI BIOENG, V104, P1, DOI 10.1263/jbb.104.1; NEALSON KH, 1988, ADV APPL MICROBIOL, V33, P279, DOI 10.1016/S0065-2164(08)70209-0; Okazaki M, 1997, APPL ENVIRON MICROB, V63, P4793, DOI 10.1128/AEM.63.12.4793-4799.1997; Parikh SJ, 2005, GEOMICROBIOL J, V22, P207, DOI 10.1080/01490450590947724; Santelli CM, 2010, APPL ENVIRON MICROB, V76, P4871, DOI 10.1128/AEM.03029-09; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; SUNDA WG, 1994, NATURE, V367, P62, DOI 10.1038/367062a0; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 1997, REV MINERAL, V35, P225; Tebo BM, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P1223; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10; YIM MB, 1990, P NATL ACAD SCI USA, V87, P394, DOI 10.1073/pnas.87.1.394	67	44	46	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77835	10.1371/journal.pone.0077835	http://dx.doi.org/10.1371/journal.pone.0077835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147089	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200081
J	Lin, FM; Chen, Y; Levine, R; Lee, K; Yuan, YJ; Lin, XN				Lin, Fengming; Chen, Yu; Levine, Robert; Lee, Kilho; Yuan, Yingjin; Lin, Xiaoxia Nina			Improving Fatty Acid Availability for Bio-Hydrocarbon Production in Escherichia coli by Metabolic Engineering	PLOS ONE			English	Article							BIODIESEL PRODUCTION; OVERPRODUCTION; BIOSYNTHESIS; CHEMICALS; FUELS; GENE; IDENTIFICATION; STRAINS; BIOMASS; ALKANES	Previous studies have demonstrated the feasibility of producing fatty-acid-derived hydrocarbons in Escherichia coli. However, product titers and yields remain low. In this work, we demonstrate new methods for improving fatty acid production by modifying central carbon metabolism and storing fatty acids in triacylglycerol. Based on suggestions from a computational model, we deleted seven genes involved in aerobic respiration, mixed-acid fermentation, and glyoxylate bypass (in the order of cyoA, nuoA, ndh, adhE, dld, pta, and iclR) to modify the central carbon metabolic/regulatory networks. These gene deletions led to increased total fatty acids, which were the highest in the mutants containing five or six gene knockouts. Additionally, when two key enzymes in the fatty acid biosynthesis pathway were over-expressed, we observed further increase in strain Delta cyoA Delta adhE Delta nuoA Delta ndh Delta pta Delta dld, leading to 202 mg/g dry cell weight of total fatty acids, similar to 250% of that in the wild-type strain. Meanwhile, we successfully introduced a triacylglycerol biosynthesis pathway into E. coli through heterologous expression of wax ester synthase/acylcoenzyme: diacylglycerol acyltransferase (WS/DGAT) enzymes. The added pathway improved both the amount and fuel quality of the fatty acids. These new metabolic engineering strategies are providing promising directions for future investigation.	[Lin, Fengming; Chen, Yu; Levine, Robert; Lee, Kilho; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Lin, Fengming; Yuan, Yingjin] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tianjin University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, XN (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu			NSF [EFRI 0937992]	NSF(National Science Foundation (NSF))	NSF (EFRI 0937992) http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AF, 2008, MICROBIOL-SGM, V154, P2327, DOI 10.1099/mic.0.2008/016568-0; Alvarez HM, 1996, ARCH MICROBIOL, V165, P377, DOI 10.1007/s002030050341; Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cao YJ, 2010, APPL MICROBIOL BIOT, V87, P271, DOI 10.1007/s00253-009-2377-x; Chen Y, 2012, THESIS U MICHIGAN AN; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; Duan YK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020265; GROGAN DW, 1984, J BACTERIOL, V158, P286, DOI 10.1128/JB.158.1.286-295.1984; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Gui LZ, 1996, J BACTERIOL, V178, P321, DOI 10.1128/jb.178.1.321-324.1996; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Lee EG, 2009, BIOTECHNOL BIOENG, V102, P200, DOI 10.1002/bit.22040; Lennen RM, 2012, TRENDS BIOTECHNOL, V30, P659, DOI 10.1016/j.tibtech.2012.09.006; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Liu H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-41; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Park JY, 2008, BIORESOURCE TECHNOL, V99, P1196, DOI 10.1016/j.biortech.2007.02.017; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Ranganathan S, 2012, METAB ENG, V14, P687, DOI 10.1016/j.ymben.2012.08.008; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-36; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Subrahmanyam S, 1998, J BACTERIOL, V180, P4596, DOI 10.1128/JB.180.17.4596-4602.1998; Timmis KN, 2010, GENETICS WAX ESTER T, P527; Xu P, 2011, METAB ENG, V13, P578, DOI 10.1016/j.ymben.2011.06.008; Youngquist JT, 2012, BIOTECHNOL BIOENG, V109, P1518, DOI 10.1002/bit.24420; Yun NR, 2005, J APPL MICROBIOL, V99, P1404, DOI 10.1111/j.1365-2672.2005.02724.x; Zha WJ, 2009, METAB ENG, V11, P192, DOI 10.1016/j.ymben.2009.01.005; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	44	21	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78595	10.1371/journal.pone.0078595	http://dx.doi.org/10.1371/journal.pone.0078595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147139	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200100
J	Sterling, M; Elliott, JM; Cabot, PJ				Sterling, Michele; Elliott, James M.; Cabot, Peter J.			The Course of Serum Inflammatory Biomarkers Following Whiplash Injury and Their Relationship to Sensory and Muscle Measures: a Longitudinal Cohort Study	PLOS ONE			English	Article							LOW-BACK-PAIN; C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; THERAPEUTIC INTERVENTIONS; DISORDER WAD; HYPERSENSITIVITY; HYPERALGESIA; METAANALYSIS; RECOVERY	Tissue damage or pathological alterations are not detectable in the majority of people with whiplash associated disorders (WAD). Widespread hyperalgisa, morphological muscle changes and psychological distress are common features of WAD. However little is known about the presence of inflammation and its association with symptom persistence or the clinical presentation of WAD. This study aimed to prospectively investigate changes in serum inflammatory biomarker levels from the acute (<3 weeks) to chronic (>3 months) stages of whiplash injury. It also aimed to determine relationships between biomarker levels and hyperalgesia, fatty muscle infiltrates of the cervical extensors identified on MRI and psychological factors. 40 volunteers with acute WAD and 18 healthy controls participated. Participants with WAD were classified at 3 months as recovered/mild disability or having moderate/severe disability using the Neck Disability Index. At baseline both WAD groups showed elevated serum levels of CRP but by 3 months levels remained elevated only in the moderate/severe group. The recovered/mild disability WAD group had higher levels of TNF-alpha at both time points than both the moderate/severe WAD group and healthy controls. There were no differences found in serum IL-1 beta. Moderate relationships were found between hyperalgesia and CRP at both time points and between hyperalgesia and IL-1 beta 3 months post injury. There was a moderate negative correlation between TNF-alpha and amount of fatty muscle infiltrate and pain intensity at 3 months. Only a weak relationship was found between CRP and pain catastrophising and no relationship between biomarker levels and posttraumatic stress symptoms. The results of the study indicate that inflammatory biomarkers may play a role in outcomes following whiplash injury as well as being associated with hyperalgesia and fatty muscle infiltrate in the cervical extensors.	[Sterling, Michele] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med CONROD, Brisbane, Qld, Australia; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Cabot, Peter J.] Univ Brisbane, Pharm Australia Ctr Excellence, Sch Pharm, Queensland, Qld, Australia	University of Queensland; Northwestern University; Feinberg School of Medicine	Sterling, M (corresponding author), Univ Queensland, Ctr Natl Res Disabil & Rehabil Med CONROD, Brisbane, Qld, Australia.	m.sterling@uq.edu.au	Cabot, Peter John/B-2424-2013; Sterling, Michele/F-1679-2010	Cabot, Peter John/0000-0003-1778-3753; Sterling, Michele/0000-0003-1772-2248; Sterling, Michele/0000-0001-8242-2685	Physiotherapy Research Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC)	Physiotherapy Research Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding was received from the Physiotherapy Research Foundation of Australia to conduct this study. MS receives a fellowship from the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Afari N, 2011, ANN BEHAV MED, V42, P277, DOI 10.1007/s12160-011-9297-6; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Carp S, 2007, CLIN SCI, V112; Carp S, 2008, BIOMARK MED, V2, P67, DOI 10.2217/17520363.2.1.67; Curatolo M, 2001, CLIN J PAIN, V17, P306, DOI 10.1097/00002508-200112000-00004; Curatolo M, 2011, SPINE, V36, pS309, DOI 10.1097/BRS.0b013e318238842a; Edwards RR, 2008, PAIN, V140, P135, DOI 10.1016/j.pain.2008.07.024; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; Ferroni P, 2003, CIRCULATION, V108, P1673, DOI 10.1161/01.CIR.0000094732.02060.27; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Haheim LL, 2009, SCAND J PUBLIC HEALT, V37, P640, DOI 10.1177/1403494809104358; Haldeman S, 2008, SPINE, V33, pS5; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kivioja J, 2001, CLIN IMMUNOL, V101, P106, DOI 10.1006/clim.2001.5086; Kraychete DC, 2010, SAO PAULO MED J, V128, P259, DOI 10.1590/S1516-31802010000500003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Macintyre PE, 2009, ACUTE PAIN MANAGEMENT, P204, DOI 10.1017/CBO9780511576706.016; Namas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008406; Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Rivest K, 2010, MANUAL THER, V15, P154, DOI 10.1016/j.math.2009.10.001; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Sin DD, 2008, THORAX, V63, P95, DOI 10.1136/thx.2007.088575; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Statistics ABo, 1995, NAT LONG SURV CHILDR, P1; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Sterling M, 2004, SPINE, V29, P182, DOI 10.1097/01.BRS.0000105535.12598.AE; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Sterling M, 2010, PAIN, V150, P501, DOI 10.1016/j.pain.2010.06.003; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Stone A, 2012, MAN THER, V18, P111; Sturmer T, 2005, ANN RHEUM DIS, V64, P921, DOI 10.1136/ard.2004.027045; Taylor J R, 1993, Ann Acad Med Singap, V22, P187; Teasell RW, 2010, PAIN RES MANAG, V15, P313, DOI 10.1155/2010/487279; Teasell RW, 2010, PAIN RES MANAG, V15, P295, DOI 10.1155/2010/640164; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Vernon H., 1996, J MUSCULOSKELET PAIN, V4, P95, DOI [10.1300/J094v04n04_09, DOI 10.1300/J094V04N04_09, DOI 10.1300/J094V04N04_]; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Wang H, 2008, CLIN J PAIN, V24, P273, DOI 10.1097/AJP.0b013e31816111d3; Ware J., 1993, SF 36 HLTH SURVEY MA; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0	50	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77903	10.1371/journal.pone.0077903	http://dx.doi.org/10.1371/journal.pone.0077903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147095	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200084
J	Yu, ZS; Kong, JJ; Pan, B; Sun, HC; Lv, TW; Zhu, J; Huang, GY; Tian, J				Yu, Zhongsu; Kong, Juanjuan; Pan, Bo; Sun, Huichao; Lv, Tiewei; Zhu, Jing; Huang, Guoying; Tian, Jie			Islet-1 May Function as an Assistant Factor for Histone Acetylation and Regulation of Cardiac Development-Related Transcription Factor Mef2c Expression	PLOS ONE			English	Article							2ND HEART FIELD; ARTERIAL POLE; CELLS; ISL1; CONTRIBUTES; LINEAGES; P300	Objective: Islet-1 is an important transcription factor for cardiac development through mediating extensive interactions between DNA and proteins. The present study was to investigate the role of Islet-1 in regulating the expression of cardiac development-related transcription factors and mechanism. Methods and Results: The expression of Islet-1 and histone acetylases (HATs) subtype p300 was determined in newborn mouse hearts and mouse embryonic hearts at different development stages using Western blot. The expression of Islet-1 and cardiac development-related transcription factors Mef2c, GATA4 and Tbx5 as well as histone H3 acetylation level were determined in cardiac progenitor cells with and without transfection of Islet-1 interference RNA (RNAi) in lentivirus using PCR and Western blot. Islet-1 peak expression occurred on day E14.5 in mouse embryonic heart, and was present in the promoter regions of Mef2c, GATA4 and Tbx5 that were precipitated with p300 antibody. When Islet-1 was inhibited with specific RNAi in cardiac progenitor cells, the expression of Mef2c and Tbx5, but not GATA4, was significantly suppressed along with selective reduction in histone H3 acetylation in the promoter region of Mef2c, but not GATA4 and Tbx5. The level of Mef2c DNA, not GATA4 and Tbx5, in the complex associated with p300 was significantly decreased in the cells with Islet-1 knockdown. Conclusions: These data suggested that Islet-1 might function as an assistant factor that was involved in the regulation of histone acetylation and Mef2c expression via assisting p300 on specifically targeting the promoter of Mef2c.	[Yu, Zhongsu; Kong, Juanjuan; Pan, Bo; Sun, Huichao; Lv, Tiewei; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China; [Yu, Zhongsu; Kong, Juanjuan; Zhu, Jing] Chongqing Med Univ, Minist Educ, Key Lab Dev Dis Childhood, Chongqing, Peoples R China; [Huang, Guoying] Fudan Univ, Childrens Hosp, Pediat Heart Ctr, Shanghai 200433, Peoples R China	Chongqing Medical University; Chongqing Medical University; Fudan University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB529505]; Natural Science Foundation of Chongqing, China [2009BA5084]; Research Foundation of Chongqing Medical University, China [XBZD201014]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing); Research Foundation of Chongqing Medical University, China	This study was supported by research grants from the National Basic Research Program of China (973 Program, grant number: 2010CB529505), the Natural Science Foundation of Chongqing, China (grant number: CSTC,2009BA5084), and the Research Foundation of Chongqing Medical University, China (grant number: XBZD201014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cecchetto A, 2010, FUTUR CARDIOL, V6, P373, DOI [10.2217/fca.10.10, 10.2217/FCA.10.10]; Chen GZ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-24; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Fonoudi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055577; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Herrmann F, 2011, DEV DYNAM, V240, P2634, DOI 10.1002/dvdy.22776; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Sun HC, 2010, LIFE SCI, V87, P707, DOI 10.1016/j.lfs.2010.10.009; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Yang XF, 2010, J CHONGQING MED U, V35, P961; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; [智深深 Zhi Shenshen], 2011, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V36, P170; Zhong LL, 2010, CARDIOVASC TOXICOL, V10, P268, DOI 10.1007/s12012-010-9081-z; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	33	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77690	10.1371/journal.pone.0077690	http://dx.doi.org/10.1371/journal.pone.0077690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147056	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200066
J	Carmichael, SN; Bekaert, M; Taggart, JB; Christie, HRL; Bassett, DI; Bron, JE; Skuce, PJ; Gharbi, K; Skern-Mauritzen, R; Sturm, A				Carmichael, Stephen N.; Bekaert, Michael; Taggart, John B.; Christie, Hayden R. L.; Bassett, David I.; Bron, James E.; Skuce, Philip J.; Gharbi, Karim; Skern-Mauritzen, Rasmus; Sturm, Armin			Identification of a Sex-Linked SNP Marker in the Salmon Louse (Lepeophtheirus salmonis) Using RAD Sequencing	PLOS ONE			English	Article							SHRIMP PENAEUS-MONODON; MACROBRACHIUM-ROSENBERGII; DE-NOVO; CRUSTACEA; GENES; LICE; CALIGIDAE; EVOLUTION; COPEPODA; DNA	The salmon louse (Lepeophtheirus salmonis (Kroyer, 1837)) is a parasitic copepod that can, if untreated, cause considerable damage to Atlantic salmon (Salmo salar Linnaeus, 1758) and incurs significant costs to the Atlantic salmon mariculture industry. Salmon lice are gonochoristic and normally show sex ratios close to 1:1. While this observation suggests that sex determination in salmon lice is genetic, with only minor environmental influences, the mechanism of sex determination in the salmon louse is unknown. This paper describes the identification of a sex-linked Single Nucleotide Polymorphism (SNP) marker, providing the first evidence for a genetic mechanism of sex determination in the salmon louse. Restriction site-associated DNA sequencing (RAD-seq) was used to isolate SNP markers in a laboratory-maintained salmon louse strain. A total of 85 million raw Illumina 100 base paired-end reads produced 281,838 unique RAD-tags across 24 unrelated individuals. RAD marker Lsa101901 showed complete association with phenotypic sex for all individuals analysed, being heterozygous in females and homozygous in males. Using an allele-specific PCR assay for genotyping, this SNP association pattern was further confirmed for three unrelated salmon louse strains, displaying complete association with phenotypic sex in a total of 96 genotyped individuals. The marker Lsa101901 was located in the coding region of the prohibitin-2 gene, which showed a sex-dependent differential expression, with mRNA levels determined by RT-qPCR about 1.8-fold higher in adult female than adult male salmon lice. This study's observations of a novel sex-linked SNP marker are consistent with sex determination in the salmon louse being genetic and following a female heterozygous system. Marker Lsa101901 provides a tool to determine the genetic sex of salmon lice, and could be useful in the development of control strategies.	[Carmichael, Stephen N.; Bekaert, Michael; Taggart, John B.; Christie, Hayden R. L.; Bron, James E.; Sturm, Armin] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Skuce, Philip J.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Gharbi, Karim] Univ Edinburgh, Sch Biol Sci, GenePool, Edinburgh, Midlothian, Scotland; [Bassett, David I.] Univ Stirling, Marine Environm Res Lab, Machrihanish, Argyll, Scotland; [Skern-Mauritzen, Rasmus] Inst Marine Res, N-5024 Bergen, Norway	University of Stirling; Moredun Research Institute; University of Edinburgh; University of Stirling; Institute of Marine Research - Norway	Carmichael, SN (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	snc2@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Sturm, Armin/0000-0003-2632-1999; Bekaert, Michael/0000-0002-1206-7654; Taggart, John/0000-0002-3843-9663; Bassett, David/0000-0002-7529-0829	Scottish Salmon Producers Organisation (SSPO); University of Stirling; Moredun Foundation; Medical Research Council [MR/K001744/1] Funding Source: researchfish; MRC [MR/K001744/1] Funding Source: UKRI	Scottish Salmon Producers Organisation (SSPO); University of Stirling; Moredun Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was financed by the Scottish Salmon Producers Organisation (SSPO) (http://www.scottishsalmon.co.uk), the University of Stirling (http://www.stir.ac.uk) and the Moredun Foundation (http://www.moredun.org.uk/charitable-work/the-moredun-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bron J. E., 1993, Pathogens of wild and farmed fish: sea lice., P263; Campos-Ramos R, 2006, AQUAC RES, V37, P1583, DOI 10.1111/j.1365-2109.2006.01604.x; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FAO, 2012, FAO YB FISH AQ STAT; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; Hanfling B, 2011, BIOCONTROL, V56, P573, DOI 10.1007/s10526-011-9380-8; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Horsberg TE, 2012, CURR PHARM BIOTECHNO, V13, P1095; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Hutchinson TH, 1999, ENVIRON TOXICOL CHEM, V18, P2914, DOI [10.1002/etc.5620181237, 10.1897/1551-5028(1999)018&lt;2914:LCSWMC&gt;2.3.CO;2]; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; Juchault P, 1999, CR ACAD SCI III-VIE, V322, P423, DOI 10.1016/S0764-4469(99)80078-X; JUCHAULT P, 1972, CR ACAD SCI D NAT, V274, P1387; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Laufer H, 1998, GEN COMP ENDOCR, V111, P113, DOI 10.1006/gcen.1998.7109; LECHER P, 1995, INVERTEBR REPROD DEV, V27, P85, DOI 10.1080/07924259.1995.9672440; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; LEGRAND JJ, 1987, BIOL REV, V62, P439, DOI 10.1111/j.1469-185X.1987.tb01637.x; Li YT, 2003, AQUACULTURE, V219, P143, DOI 10.1016/S0044-8486(02)00355-1; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Mao H, 2012, MOL BIOL REP, V39, P7031, DOI 10.1007/s11033-012-1534-y; Mazurova E, 2008, BIOLOGIA, V63, P139, DOI 10.2478/s11756-008-0027-x; Michaud M, 2004, MAR ECOL PROG SER, V269, P163, DOI 10.3354/meps269163; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nakamura M, 2010, J EXP ZOOL PART A, V313A, P381, DOI 10.1002/jez.616; Ohbayashi F, 2002, CURR SCI INDIA, V83, P466; Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Peterson JK, 2001, ENVIRON TOXICOL CHEM, V20, P582, DOI [10.1897/1551-5028(2001)020&lt;0582:MAOEAM&gt;2.0.CO;2, 10.1002/etc.5620200318]; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; Ritchie G, 1996, J EXP MAR BIOL ECOL, V201, P285, DOI 10.1016/0022-0981(96)00008-1; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Ventura T, 2011, HEREDITY, V107, P456, DOI 10.1038/hdy.2011.32; Voordouw MJ, 2008, EVOL ECOL RES, V10, P1007; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	55	57	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77832	10.1371/journal.pone.0077832	http://dx.doi.org/10.1371/journal.pone.0077832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147087	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400138
J	Gunnell, AS; Einarsdottir, K; Galvao, DA; Joyce, S; Tomlin, S; Graham, V; McIntyre, C; Newton, RU; Briffa, T				Gunnell, Anthony S.; Einarsdottir, Kristjana; Galvao, Daniel A.; Joyce, Sarah; Tomlin, Stephania; Graham, Vicki; McIntyre, Caroline; Newton, Robert U.; Briffa, Tom			Lifestyle Factors, Medication Use and Risk for Ischaemic Heart Disease Hospitalisation: A Longitudinal Population-Based Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; BRITISH VEGETARIANS; PHYSICAL-ACTIVITY; 52 COUNTRIES; EPIC-OXFORD; ALL-CAUSE; MORTALITY; COHORT	Background: Lifestyle factors have been implicated in ischaemic heart disease (IHD) development however a limited number of longitudinal studies report results stratified by cardio-protective medication use. Purpose: This study investigated the influence of self-reported lifestyle factors on hospitalisation for IHD, stratified by blood pressure and/or lipid-lowering therapy. Methods: A population-based cohort of 14,890 participants aged 45+ years and IHD-free was identified from the Western Australian Health and wellbeing Surveillance System (2004 to 2010 inclusive), and linked with hospital administrative data. Adjusted hazard ratios for future IHD-hospitalisation were estimated using Cox regression. Results: Current smokers remained at higher risk for IHD-hospitalisation (adjusted HR=1.57; 95% CI: 1.22-2.03) after adjustment for medication use, as did those considered overweight (BMI=25-29 kg/m(2); adjusted HR=1.28; 95% CI: 1.04-1.57) or obese (BMI of >= 30kg/m(2); adjusted HR=1.31; 95% CI: 1.03-1.66). Weekly leisure-time physical activity (LTPA) of 150 minutes or more and daily intake of 3 or more fruit/vegetable servings reduced risk by 21% (95% CI: 0.64-0.97) and 26% (95% CI: 0.58-0.96) respectively. Benefits of LTPA appeared greatest in those on blood pressure lowering medication (adjusted HR=0.50; 95% CI: 0.31-0.82 [ for LTPA<150 mins], adjusted HR=0.64; 95% CI: 0.42-0.96 [ for LTPA>=150 mins]). IHD risk in smokers was most pronounced in those taking neither medication (adjusted HR=2.00; 95% CI: 1.41-2.83). Conclusion: This study confirms the contribution of previously reported lifestyle factors towards IHD hospitalisation, even after adjustment for antihypertensive and lipid-lowering medication use. Medication stratified results suggest that IHD risks related to LTPA and smoking may differ according to medication use.	[Gunnell, Anthony S.; Galvao, Daniel A.; McIntyre, Caroline; Newton, Robert U.] Edith Cowan Univ, Hlth & Wellness Inst, Joondalup, WA, Australia; [Gunnell, Anthony S.; Graham, Vicki] Edith Cowan Univ, Survey Res Ctr, Joondalup, WA, Australia; [Einarsdottir, Kristjana] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia; [Joyce, Sarah; Tomlin, Stephania] Western Australian Dept Hlth, Epidemiol Branch, Perth, WA, Australia; [Briffa, Tom] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia	Edith Cowan University; Edith Cowan University; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Gunnell, AS (corresponding author), Edith Cowan Univ, Hlth & Wellness Inst, Joondalup, WA, Australia.	a.gunnell@ecu.edu.au	Newton, Robert Usher/A-3466-2009; Galvao, Daniel A/A-2744-2010; Einarsdóttir, Kristjana/E-8337-2011	Newton, Robert Usher/0000-0003-0302-6129; Galvao, Daniel A/0000-0002-8209-2281; Einarsdóttir, Kristjana/0000-0003-4931-7650; Gunnell, Anthony/0000-0002-5432-6685	Edith Cowan University Health and Wellness Institute	Edith Cowan University Health and Wellness Institute	Financial salary support was received from Edith Cowan University Health and Wellness Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS (Australian Bureau of Statistics), 2012, 303 0 CAUS DEATH ALL; AIHW, 2003, ACT AUSTR SURV GUID, P22; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Australian Institute of Health andWelfare (AIHW), 2011, CARD DIS AUSTR FACTS; Briffa T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b36; Britt H, 2010, GEN PRACTICE SERIES, V27; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; Davis P, 2011, HLTH WELLBEING ADULT; DTF Department of Treasury and Finance Western Australia, 2006, 200602 W AUSTR DTF D; Ge Z, 2012, J HYPERTENS, V30, P2307, DOI 10.1097/HJH.0b013e328359aa1f; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Milionis HJ, 2001, ANGIOLOGY, V52, P575, DOI 10.1177/000331970105200901; Nelson MR, 2006, MED J AUSTRALIA, V185, P487, DOI 10.5694/j.1326-5377.2006.tb00662.x; NHF, 2008, GUID MAN HYPERTENSIO; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Ruff CT, 2011, NAT REV CARDIOL, V8, P140, DOI 10.1038/nrcardio.2010.199; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Turnbull F, 2003, LANCET, V362, P1527; WHO, 2004, GLOB DAT BOD MASS IN; WHO (World Health Organization), 2007, REV CARD DIS GUID AS; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77833	10.1371/journal.pone.0077833	http://dx.doi.org/10.1371/journal.pone.0077833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147088	Green Published, gold			2022-12-25	WOS:000326019400139
J	Jenabian, MA; Patel, M; Kema, I; Kanagaratham, C; Radzioch, D; Thebault, P; Lapointe, R; Tremblay, C; Gilmore, N; Ancuta, P; Routy, JP				Jenabian, Mohammad-Ali; Patel, Mital; Kema, Ido; Kanagaratham, Cynthia; Radzioch, Danuta; Thebault, Pamela; Lapointe, Rejean; Tremblay, Cecile; Gilmore, Norbert; Ancuta, Petronela; Routy, Jean-Pierre			Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers	PLOS ONE			English	Article							REGULATORY T-CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; THERAPY REDUCES DEGRADATION; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; IMMUNE DYSFUNCTION; IDO EXPRESSION; TGF-BETA	Tryptophan (Trp) catabolism into immunosuppressive kynurenine (Kyn) by indoleamine 2,3-dioxygenase (IDO) was previously linked to Th17/Treg differentiation and immune activation. Here we examined Trp catabolism and its impact on Th17/Treg balance in uninfected healthy subjects (HS) and a large cohort of HIV-infected patients with different clinical outcomes: ART-naive, Successfully Treated (ST), and elite controllers (EC). In ART-naive patients, increased IDO activity/expression, together with elevated levels of TNF-alpha and sCD40L, were associated with Treg expansion and an altered Th17/Treg balance. These alterations were normalized under ART. In contrast, Trp 2,3-dioxegenase (TDO) expression was dramatically lower in EC when compared to all other groups. Interestingly, EC displayed a distinctive Trp metabolism characterized by low Trp plasma levels similar to ART-na ve patients without accumulating immunosuppressive Kyn levels which was accompanied by a preserved Th17/Treg balance. These results suggest a distinctive Trp catabolism and Th17/Treg balance in HIV progressors and EC. Thus, IDO-induced immune-metabolism may be considered as a new inflammation-related marker for HIV-1 disease progression.	[Jenabian, Mohammad-Ali; Patel, Mital; Gilmore, Norbert; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada; [Jenabian, Mohammad-Ali; Kanagaratham, Cynthia; Radzioch, Danuta; Gilmore, Norbert; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Kema, Ido] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Thebault, Pamela; Lapointe, Rejean] CHUM Res Ctr CRCHUM, Montreal, PQ, Canada; [Thebault, Pamela; Lapointe, Rejean; Tremblay, Cecile; Ancuta, Petronela] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tremblay, Cecile; Ancuta, Petronela] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Div Hematol, Montreal, PQ, Canada	McGill University; McGill University; University of Groningen; Universite de Montreal; Universite de Montreal; McGill University	Routy, JP (corresponding author), McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada.	jean-pierre.routy@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757	Canadian Institutes of Health Research [103230]; CANFAR; Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada; CIHR Canadian HIV Trials Network [CTN 247]; CANFAR/CTN Postdoctoral Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CANFAR; Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada; CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); CANFAR/CTN Postdoctoral Fellowship Award	This work was supported by Canadian Institutes of Health Research (grant# 103230), CANFAR and Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada. This study was also supported by the CIHR Canadian HIV Trials Network (CTN 247). Dr. M. A. Jenabian is supported by a CANFAR/CTN Postdoctoral Fellowship Award. Dr. J.P. Routy is a holder of Louis Lowenstein Chair in Hematology & Oncology, McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2012, J REPROD IMMUNOL, V94, P131, DOI 10.1016/j.jri.2012.03.488; Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bronte V, 2011, J CLIN INVEST, V121, P1247, DOI 10.1172/JCI57190; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; de Jong WHA, 2009, J CHROMATOGR B, V877, P603, DOI 10.1016/j.jchromb.2009.01.015; Doherty LF, 2011, AM J PHYSIOL-ENDOC M, V300, pE86, DOI 10.1152/ajpendo.00439.2010; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Godin-Ethier J, 2011, MOL IMMUNOL, V49, P253, DOI 10.1016/j.molimm.2011.08.017; Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Huengsberg M, 1998, CLIN CHEM, V44, P858; Hunt P, 2012, CROI 2012; Hunt P, 2011, IMPACT TRYPTOPHAN CA; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Jenabian MA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/908314; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kurtz J, 2009, BLOOD, V113, P3475, DOI 10.1182/blood-2008-01-133736; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042166; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Neurauter G, 2003, ADV EXP MED BIOL, V527, P317; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Presicce P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042802; Puccetti P, 2008, BLOOD CELL MOL DIS, V40, P101, DOI 10.1016/j.bcmd.2007.06.026; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Smith DG, 2001, J NEUROVIROL, V7, P56; Soichot M, 2013, ALCOHOL ALCOHOLISM, V48, P415, DOI 10.1093/alcalc/agt028; Soliman H, 2010, CANCER J, V16, P354, DOI 10.1097/PPO.0b013e3181eb3343; TEFF KL, 1989, PHARMACOL BIOCHEM BE, V34, P829, DOI 10.1016/0091-3057(89)90282-7; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Theze J, 2011, CLIN IMMUNOL, V141, P15, DOI 10.1016/j.clim.2011.07.007; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Grevenynghe J, 2012, CYTOKINE GROWTH F R, V23, P215, DOI 10.1016/j.cytogfr.2012.05.008; Von Bubnoff D, 2011, J IMMUNOL, V186, P6701, DOI 10.4049/jimmunol.1003151; Wu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059749; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231; Zhu XF, 2010, J BIOL CHEM, V285, P21126, DOI 10.1074/jbc.M110.120485; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	56	73	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78146	10.1371/journal.pone.0078146	http://dx.doi.org/10.1371/journal.pone.0078146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147117	Green Published, gold			2022-12-25	WOS:000326019400150
J	Kimura, Y; Jacobs, LL; Flynn, LJ				Kimura, Yuri; Jacobs, Louis L.; Flynn, Lawrence J.			Lineage-Specific Responses of Tooth Shape in Murine Rodents (Murinae, Rodentia) to Late Miocene Dietary Change in the Siwaliks of Pakistan	PLOS ONE			English	Article							NEOGENE MAMMALIAN FAUNAS; CLIMATE-CHANGE; BODY-SIZE; COMPARATIVE PALEOECOLOGY; EVOLUTION; HYPSODONTY; MURIDAE; RECONSTRUCTION; SPECIATION; PALEOGENE	Past ecological responses of mammals to climate change are recognized in the fossil record by adaptive significance of morphological variations. To understand the role of dietary behavior on functional adaptations of dental morphology in rodent evolution, we examine evolutionary change of tooth shape in late Miocene Siwalik murine rodents, which experienced a dietary shift toward C-4 diets during late Miocene ecological change indicated by carbon isotopic evidence. Geometric morphometric analysis in the outline of upper first molars captures dichotomous lineages of Siwalik murines, in agreement with phylogenetic hypotheses of previous studies (two distinct clades: the Karnimata and Progonomys clades), and indicates lineage-specific functional responses to mechanical properties of their diets. Tooth shapes of the two clades are similar at their sympatric origin but deviate from each other with decreasing overlap through time. Shape change in the Karnimata clade is associated with greater efficiency of propalinal chewing for tough diets than in the Progonomys clade. Larger body mass in Karnimata may be related to exploitation of lower-quality food items, such as grasses, than in smaller-bodied Progonomys. The functional and ecophysiological aspects of Karnimata exploiting C-4 grasses are concordant with their isotopic dietary preference relative to Progonomys. Lineage-specific selection was differentially greater in Karnimata, and a faster rate of shape change toward derived Karnimata facilitated inclusion of C-4 grasses in the diet. Sympatric speciation in these clades is most plausibly explained by interspecific competition on resource utilization between the two, based on comparisons of our results with the carbon isotope data. Interspecific competition with Karnimata may have suppressed morphological innovation of the Progonomys clade. Pairwise analyses of morphological and carbon isotope data can uncover ecological causes of sympatric speciation and define functional adaptations of teeth to resources.	[Kimura, Yuri; Jacobs, Louis L.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Kimura, Yuri; Flynn, Lawrence J.] Harvard Univ, Peabody Museum, Cambridge, MA 02138 USA; [Kimura, Yuri; Flynn, Lawrence J.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Southern Methodist University; Harvard University; Harvard University	Kimura, Y (corresponding author), So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA.	ykimura@mail.smu.edu		Kimura, Yuri/0000-0002-7621-9901; Jacobs, Louis/0000-0002-7735-3678	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University	This work was supported by the Society of Vertebrate Paleontology (Mary R. Dawson Grant to Y.K.), the Geological Society of America (Graduate Student Research Grant to Y.K.), and ISEM (travel grants to Y.K.) at Southern Methodist University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; Alroy J, 2000, PALEOBIOLOGY, V26, P259, DOI 10.1666/0094-8373(2000)26[259:GCCANA]2.0.CO;2; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Behrensmeyer AK, 2007, GEOL SOC AM BULL, V119, P1486, DOI 10.1130/B26064.1; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BUTLER PM, 1980, FUNCTIONAL ASPECTS E, P249; Canty A, 2012, BOOT BOOTSTRAP R S P; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Figueirido B, 2012, P NATL ACAD SCI USA, V109, P722, DOI 10.1073/pnas.1110246108; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Goswami A., 2010, PALEONTOL SOC PAP, V16, P213, DOI [10.1017/S1089332600001881, DOI 10.1017/S1089332600001881, 10.1017/s1089332600001881]; GUNNELL GF, 1995, PALAEOGEOGR PALAEOCL, V115, P265, DOI 10.1016/0031-0182(94)00115-O; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JACOBS L L, 1989, Natural History Museum of Los Angeles County Science Series, P157; Jacobs L. L., 1977, PaleoBios, VNo. 25, P1; Jacobs L.L., 1978, MUS NO ARIZONA PRESS, V52, P1; Jacobs LL, 1990, NATO ASI SER, P573; Jacobs Louis L., 2005, P63; Jacobs Louis L., 1994, National Science Museum Monographs, V8, P149; Janis C.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P367; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; JUSTICE KE, 1992, AM NAT, V139, P398, DOI 10.1086/285333; Kimura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069308; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lazzari V, 2011, ARCH ORAL BIOL, V56, P194, DOI 10.1016/j.archoralbio.2010.09.011; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lindsay E.H., 1988, Palaeovertebrata (Montpellier), V18, P95; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Macholan M, 2006, J ZOOL, V270, P672, DOI 10.1111/j.1469-7998.2006.00156.x; Martin Suarez E., 1993, Scripta Geologica, V103, P65; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Misonne X., 1969, Annales du Musee R de l'Afrique Central, VNo. 172, P1; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; MORGAN ME, 1995, PALAEOGEOGR PALAEOCL, V115, P287, DOI 10.1016/0031-0182(94)00116-P; Nowak R. M., 1999, WALKERS MAMMALS WORL, VII, P837; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Patnaik R, 2003, PALAEOGEOGR PALAEOCL, V197, P133, DOI 10.1016/S0031-0182(03)00390-0; R Development Core Team, 2012, LANG ENV STAT COMP; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2002, PALAEOGEOGR PALAEOCL, V184, P163, DOI 10.1016/S0031-0182(02)00255-9; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 1999, LETHAIA, V32, P61; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohlf FJ, 2011, TPSREGR VERSION 1 38; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor PJ, 2009, BIOL J LINN SOC, V96, P913, DOI 10.1111/j.1095-8312.2008.01153.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; vanDam J, 1996, NATO ADV SCI INST SE, V284, P449; VANDERMEULEN AJ, 1992, PALAEOGEOGR PALAEOCL, V93, P227, DOI 10.1016/0031-0182(92)90099-Q; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	75	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76070	10.1371/journal.pone.0076070	http://dx.doi.org/10.1371/journal.pone.0076070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155885	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300019
J	Short, MD; Abell, GCJ; Bodrossy, L; van den Akker, B				Short, Michael D.; Abell, Guy C. J.; Bodrossy, Levente; van den Akker, Ben			Application of a Novel Functional Gene Microarray to Probe the Functional Ecology of Ammonia Oxidation in Nitrifying Activated Sludge	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; 16S RIBOSOMAL-RNA; OXIDIZING ARCHAEA; DIVERSITY; BACTERIA; ABUNDANCE; NICHE; INDUSTRIAL; DYNAMICS; POPULATIONS	We report on the first study trialling a newly-developed, functional gene microarray (FGA) for characterising bacterial and archaeal ammonia oxidisers in activated sludge. Mixed liquor (ML) and media biofilm samples from a full-scale integrated fixed-film activated sludge (IFAS) plant were analysed with the FGA to profile the diversity and relative abundance of ammonia-oxidising archaea and bacteria (AOA and AOB respectively). FGA analyses of AOA and AOB communities revealed ubiquitous distribution of AOA across all samples - an important finding for these newly-discovered and poorly characterised organisms. Results also revealed striking differences in the functional ecology of attached versus suspended communities within the IFAS reactor. Quantitative assessment of AOB and AOA functional gene abundance revealed a dominance of AOB in the ML and approximately equal distribution of AOA and AOB in the media-attached biofilm. Subsequent correlations of functional gene abundance data with key water quality parameters suggested an important functional role for media-attached AOB in particular for IFAS reactor nitrification performance and indicate possible functional redundancy in some IFAS ammonia oxidiser communities. Results from this investigation demonstrate the capacity of the FGA to resolve subtle ecological shifts in key microbial communities in nitrifying activated sludge and indicate its value as a tool for better understanding the linkages between the ecology and performance of these engineered systems.	[Short, Michael D.; van den Akker, Ben] Univ New S Wales, Sch Civil & Environm Engn, UNSW Water Res Ctr, Kensington, NSW 2033, Australia; [Short, Michael D.] Univ S Australia, Sch Nat & Built Environm, SA Water Ctr Water Management & Reuse, Adelaide, SA 5001, Australia; [Abell, Guy C. J.; Bodrossy, Levente] CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia	University of New South Wales Sydney; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Abell, GCJ (corresponding author), CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia.	guy.abell@csiro.au	Abell, Guy C J/A-1767-2010; Bodrossy, Levente/B-8054-2009	Bodrossy, Levente/0000-0001-6940-452X; van den Akker, Ben/0000-0002-1937-6097; Short, Michael/0000-0003-2086-1855	University of New South Wales Faculty of Engineering Early Career Researcher Grant [PS24573]; Australian Research Council Discovery Project [DP1095722]	University of New South Wales Faculty of Engineering Early Career Researcher Grant; Australian Research Council Discovery Project(Australian Research Council)	This work was funded in part by a University of New South Wales Faculty of Engineering Early Career Researcher Grant PS24573 and Australian Research Council Discovery Project DP1095722. The authors thank Bret Robinson from the Australian Water Quality Centre for sampling support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051542; Abell GCJ, 2011, FEMS MICROBIOL ECOL, V75, P111, DOI 10.1111/j.1574-6941.2010.00988.x; Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Adamczyk J, 2003, APPL ENVIRON MICROB, V69, P6875, DOI 10.1128/AEM.69.11.6875-6887.2003; [Anonymous], 2010, R LANG ENV STAT COMP; Bai YH, 2012, FEMS MICROBIOL ECOL, V80, P323, DOI 10.1111/j.1574-6941.2012.01296.x; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Gapes DJ, 2009, PROCESS BIOCHEM, V44, P43, DOI 10.1016/j.procbio.2008.09.004; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Jin T, 2010, APPL MICROBIOL BIOT, V87, P1167, DOI 10.1007/s00253-010-2595-2; Kelly JJ, 2005, WATER RES, V39, P3229, DOI 10.1016/j.watres.2005.05.044; Kim HS, 2011, WATER ENVIRON RES, V83, P627, DOI 10.2175/106143010X12851009156448; Li C, 2012, WATER SCI TECHNOL, V66, P2785, DOI 10.2166/wst.2012.421; Limpiyakorn T, 2013, APPL MICROBIOL BIOT, V97, P1425, DOI 10.1007/s00253-012-4650-7; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Mahendran B, 2012, WATER RES, V46, P5085, DOI 10.1016/j.watres.2012.05.058; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nicol GW, 2011, NITRIFICATION, P157; Oerther Daniel B., 2003, Reviews in Environmental Science and Bio/Technology, V2, P1, DOI 10.1023/B:RESB.0000022932.74077.5e; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Okabe S, 2011, NITRIFICATION, P405; Onnis-Hayden A, 2011, WATER RES, V45, P3845, DOI 10.1016/j.watres.2011.04.039; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Regmi P, 2011, WATER RES, V45, P6699, DOI 10.1016/j.watres.2011.10.009; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Siripong S, 2006, ENVIRON MICROBIOL, V8, P1564, DOI 10.1111/j.1462-2920.2006.01047.x; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; van den Akker B, 2010, WATER RES, V44, P2919, DOI 10.1016/j.watres.2010.02.016; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Winkler MKH, 2013, APPL MICROBIOL BIOT, V97, P7459, DOI 10.1007/s00253-012-4459-4; Xia S, 2008, ECOL ENG, V32, P256, DOI 10.1016/j.ecoleng.2007.11.013; Zhang T, 2009, J APPL MICROBIOL, V107, P970, DOI 10.1111/j.1365-2672.2009.04283.x; [No title captured]; [No title captured]	48	9	9	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77139	10.1371/journal.pone.0077139	http://dx.doi.org/10.1371/journal.pone.0077139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155925	gold, Green Published, Green Accepted			2022-12-25	WOS:000325887300059
J	Trinschek, B; Lussi, F; Haas, J; Wildemann, B; Zipp, F; Wiendl, H; Becker, C; Jonuleit, H				Trinschek, Bettina; Luessi, Felix; Haas, Juergen; Wildemann, Brigitte; Zipp, Frauke; Wiendl, Heinz; Becker, Christian; Jonuleit, Helmut			Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis	PLOS ONE			English	Article							AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-6 IL-6; CYTOKINE MILIEU; TGF-BETA; DISEASE; DIFFERENTIATION; INFLAMMATION; ACTIVATION; GENERATION; T(H)17	In multiple sclerosis (MS) autoaggressive T effector cells (Teff) are not efficiently controlled by regulatory T cells (Treg) but the underlying mechanisms are incompletely understood. Proinflammatory cytokines are key factors facilitating Teff activity in chronic inflammation. Here we investigated the influence of IL-6 on Treg sensitivity of Teff from therapy-naive MS patients with or without active disease. Compared to healthy volunteers and independent of disease course CD4(+) and especially CD8(+) MS-Teff were insensitive against functional active Treg from healthy controls. This unresponsiveness was caused by accelerated production of IL-6, elevated IL-6 receptor expression and phosphorylation of protein kinase B (PKB)/c-Akt in MS-Teff. In a positive feedback loop, IL-6 itself induced its accelerated synthesis and enhanced phosphorylation of PKB/c-Akt that finally mediated Treg resistance. Furthermore, accelerated IL-6 release especially by CD8+ Teff prevented control of surrounding Teff, described here as "bystander resistance". Blockade of IL-6 receptor signaling or direct inhibition of PKB/c-Akt phosphorylation restored Treg responsiveness of Teff and prevented bystander resistance. In Teff of healthy controls (HC) exogenous IL-6 also changed the kinetics of IL-6 production and induced Treg unresponsiveness. This modulation was only transient in Teff from healthy volunteers, whereas accelerated IL-6 production in MS-Teff maintained also in absence of IL-6. Hence, we showed that the kinetics of IL-6 production instead of elevated IL-6 levels defines the Teff responsiveness in early Treg-T cell communication in MS independent of their disease course and propose IL-6 and associated PKB/c-Akt activation as effective therapeutic targets for modulation of Teff activity in MS.	[Trinschek, Bettina; Becker, Christian; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55122 Mainz, Germany; [Luessi, Felix; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Dept Neurol, Univ Med Ctr, D-55122 Mainz, Germany; [Haas, Juergen; Wildemann, Brigitte] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst N, Munster, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Munster	Jonuleit, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55122 Mainz, Germany.	helmut.jonuleit@unimedizin-mainz.de	Becker, Christian/GLS-0862-2022; Zipp, Frauke/C-9968-2015; Wiendl, Heinz/AAX-6041-2021; Jonuleit, Helmut/D-8059-2011	Becker, Christian/0000-0002-1716-7208; Zipp, Frauke/0000-0002-1231-1928; Jonuleit, Helmut/0000-0002-5672-9365; Wiendl, Heinz/0000-0003-4310-3432; Haas, Juergen/0000-0002-2314-7465	Transregio 128; Competence Network for Multiple Sclerosis; Federal Ministry of Education and Research (BMBF) [FKZ 01GI0917]	Transregio 128; Competence Network for Multiple Sclerosis; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support was provided by the Transregio 128 (project A9 and B4) and by the Competence Network for Multiple Sclerosis, funded by the Federal Ministry of Education and Research (BMBF), FKZ 01GI0917 to H.J. and H. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; BARR TA, 2012, J EXP MED, P1465; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Galassetti PR, 2006, AM J PHYSIOL-ENDOC M, V290, pE833, DOI 10.1152/ajpendo.00445.2005; Goodman WA, 2012, CRIT REV IMMUNOL, V32, P65, DOI 10.1615/CritRevImmunol.v32.i1.40; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; KIESEIER BC, 2012, ARCH NEUROL-CHICAGO, P1; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Leech MD, 2013, J IMMUNOL, V190, P881, DOI 10.4049/jimmunol.1202925; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Linker RA, 2008, J NEUROIMMUNOL, V205, P64, DOI 10.1016/j.jneuroim.2008.09.007; Maimone D, 1997, J NEUROL SCI, V146, P59, DOI 10.1016/S0022-510X(96)00283-3; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Pierau M, 2009, J IMMUNOL, V183, P6124, DOI 10.4049/jimmunol.0900246; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SWAAK AJ, 1988, SCAND J RHEUMATOL, V17, P469, DOI 10.3109/03009748809098809; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vladic A, 2002, CYTOKINE, V20, P86, DOI 10.1006/cyto.2002.1984; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	50	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77634	10.1371/journal.pone.0077634	http://dx.doi.org/10.1371/journal.pone.0077634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155968	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300102
J	Wang, Y; Zhang, D; Shen, ZY; Feng, CH; Chen, J				Wang, Ying; Zhang, Di; Shen, Zhenyao; Feng, Chenghong; Chen, Jing			Revealing Sources and Distribution Changes of Dissolved Organic Matter (DOM) in Pore Water of Sediment from the Yangtze Estuary	PLOS ONE			English	Article							PARALLEL FACTOR-ANALYSIS; MOLECULAR CHARACTERIZATION; FLUORESCENCE; MARINE; RIVER; SEA; ENVIRONMENTS; TERRESTRIAL; POREWATER; SHELF	Dissolved organic matter (DOM) in sediment pore waters from Yangtze estuary of China based on abundance, UV absorbance, molecular weight distribution and fluorescence were investigated using a combination of various parameters of DOM as well as 3D fluorescence excitation emission matrix spectra (F-EEMS) with the parallel factor and principal component analysis (PARAFAC-PCA). The results indicated that DOM in pore water of Yangtze estuary was very variable which mainly composed of low aromaticity and molecular weight materials. Three humic-like substances (C1, C2, C4) and one protein-like substance (C3) were identified by PARAFAC model. C1, C2 and C4 exhibited same trends and were very similar. The separation of samples on both axes of the PCA showed the difference in DOM properties. C1, C2 and C4 concurrently showed higher positive factor 1 loadings, while C3 showed highly positive factor 2 loadings. The PCA analysis showed a combination contribution of microbial DOM signal and terrestrial DOM signal in the Yangtze estuary. Higher and more variable DOM abundance, aromaticity and molecular weight of surface sediment pore water DOM can be found in the southern nearshore than the other regions primarily due to the influence of frequent and intensive human activities and tributaries inflow in this area. The DOM abundance, aromaticity, molecular weight and fluorescence intensity in core of different depth were relative constant and increased gradually with depth. DOM in core was mainly composed of humic-like material, which was due to higher release of the sedimentary organic material into the porewater during early diagenesis.	[Wang, Ying; Zhang, Di; Shen, Zhenyao; Feng, Chenghong] Beijing Normal Univ, Sch Environm, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China; [Wang, Ying; Shen, Zhenyao; Chen, Jing] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Sch Environm, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China.	yingwang@bnu.edu.cn	Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Feng, Chenghong/0000-0002-2130-8851; Shen, Zhenyao/0000-0002-6620-1943	National Basic Research Program of China (973 Project) [2010CB429003]; National Natural Science Foundation of China [21177013]	National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Project, Grant No. 2010CB429003) and National Natural Science Foundation of China (Grant No. 21177013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghoth SA, 2011, WATER RES, V45, P797, DOI 10.1016/j.watres.2010.09.005; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Berto D, 2010, MAR ENVIRON RES, V70, P73, DOI 10.1016/j.marenvres.2010.03.005; Burdige DJ, 2004, MAR CHEM, V89, P289, DOI 10.1016/j.marchem.2004.02.015; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Coble PG, 1998, DEEP-SEA RES PT II, V45, P2195, DOI 10.1016/S0967-0645(98)00068-X; Fu PQ, 2007, APPL GEOCHEM, V22, P1668, DOI 10.1016/j.apgeochem.2007.03.041; Gao L, 2011, ENVIRON EARTH SCI, V64, P643, DOI 10.1007/s12665-010-0885-8; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Kawasaki N, 2011, WATER RES, V45, P6240, DOI 10.1016/j.watres.2011.09.021; Lepane V, 2010, PROCEDIA CHEM, V2, P101, DOI 10.1016/j.proche.2009.12.016; Li BH, 2012, MAR POLLUT BULL, V64, P636, DOI 10.1016/j.marpolbul.2011.12.005; Li X, 2013, ENVIRON EARTH SCI, V69, P1537, DOI 10.1007/s12665-012-1988-1; Murphy KR, 2008, MAR CHEM, V108, P40, DOI 10.1016/j.marchem.2007.10.003; O'Loughlin EJ, 2004, BIOGEOCHEMISTRY, V71, P371, DOI 10.1007/s10533-004-0373-x; Para J, 2013, BIOGEOSCIENCES, V10, P2761, DOI 10.5194/bg-10-2761-2013; Qiong L, 2011, PROC SPIE, V8175, DOI 10.1117/12.897865; Rosario-Ortiz FL, 2007, WATER RES, V41, P4115, DOI 10.1016/j.watres.2007.05.045; Sadro S, 2012, ECOSYSTEMS, V15, P363, DOI 10.1007/s10021-011-9515-x; Schmidt F, 2009, GEOCHIM COSMOCHIM AC, V73, P3337, DOI 10.1016/j.gca.2009.03.008; Smith EM, 2005, AQUAT MICROB ECOL, V40, P37, DOI 10.3354/ame040037; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Syvitski JPM, 2011, PHILOS T R SOC A, V369, P957, DOI 10.1098/rsta.2010.0329; Tremblay LB, 2007, MAR CHEM, V105, P15, DOI 10.1016/j.marchem.2006.12.015; Wang K, 2013, INT BIODETER BIODEGR, V85, P617, DOI 10.1016/j.ibiod.2013.03.033; Wang Y, 2012, ENVIRON SCI POLLUT R, V19, P4148, DOI 10.1007/s11356-012-0952-7; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Xue S, 2012, FRONT ENV SCI ENG, V6, P784, DOI 10.1007/s11783-012-0436-5; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Yamashita Y, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000987; Yang F., 2007, J ENV SCI SUSTAINABL, V1, P55; Yang Z, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR003970; Yao X, 2011, CHEMOSPHERE, V82, P145, DOI 10.1016/j.chemosphere.2010.10.049; Zeng H, 2006, SCI TOTAL ENVIRON, V367, P999, DOI 10.1016/j.scitotenv.2006.03.001; Zhang E.F., 2012, HYDROL EARTH SYST SC, V9, P2213, DOI [10.5194/hessd-9-2213-2012, DOI 10.5194/HESSD-9-2213-2012]; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Ziegelgruber KL, 2013, LIMNOL OCEANOGR, V58, P1136, DOI 10.4319/lo.2013.58.3.1136	38	37	37	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76633	10.1371/journal.pone.0076633	http://dx.doi.org/10.1371/journal.pone.0076633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155904	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300038
J	Zheng, YD; Blair, D; Bradley, JE				Zheng, Yadong; Blair, David; Bradley, Janette E.			Phyletic Distribution of Fatty Acid-Binding Protein Genes	PLOS ONE			English	Article							SPLICEOSOMAL INTRONS; ALLERGEN; EVOLUTION; EXPRESSION; GENOME	Fatty acid-binding proteins (FABPs) are a family of fatty acid-binding small proteins essential for lipid trafficking, energy storage and gene regulation. Although they have 20 to 70% amino acid sequence identity, these proteins share a conserved tertiary structure comprised of ten beta sheets and two alpha helixes. Availability of the complete genomes of 34 invertebrates, together with transcriptomes and ESTs, allowed us to systematically investigate the gene structure and alternative splicing of FABP genes over a wide range of phyla. Only in genomes of two cnidarian species could FABP genes not be identified. The genomic loci for FABP genes were diverse and their genomic structure varied. In particular, the intronless FABP genes, in most of which the key residues involved in fatty acid binding varied, were common in five phyla. Interestingly, several species including one trematode, one nematode and four arthropods generated FABP mRNA variants via alternative splicing. These results demonstrate that both gene duplication and post-transcriptional modifications are used to generate diverse FABPs in species studied.	[Zheng, Yadong; Bradley, Janette E.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Zheng, Yadong] CAAS, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Blair, David] James Cook Univ, Townsville, Qld 4811, Australia	University of Nottingham; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; James Cook University	Bradley, JE (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	jan.bradley@nottingham.ac.uk	YD, Zh/HGA-5541-2022; Blair, David/O-2786-2019	YD, Zh/0000-0001-6795-9978; Blair, David/0000-0002-4658-3251; Bradley, Janette/0000-0003-3973-7977	University of Nottingham Scholarship (UK); Lanzhou Veterinary Research Institute, China	University of Nottingham Scholarship (UK); Lanzhou Veterinary Research Institute, China	Y.Z. is an awardee of an Overseas Research Students Awards (ORS), the University of Nottingham Scholarship (UK) and of Stipend from Lanzhou Veterinary Research Institute, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro MJ, 2007, BIOL REPROD, V77, P504, DOI 10.1095/biolreprod.107.061598; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Bonne A, 2003, MOL BIOL REP, V30, P173, DOI 10.1023/A:1024968606162; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Esteves A, 2003, BBA-MOL CELL BIOL L, V1631, P26, DOI 10.1016/S1388-1981(02)00321-9; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Huang LS, 2012, MOL CELL BIOCHEM, V363, P367, DOI 10.1007/s11010-011-1189-3; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jakobsson E, 2003, BBA-PROTEINS PROTEOM, V1649, P40, DOI 10.1016/S1570-9639(03)00151-1; Jeong KY, 2005, CLIN DIAGN LAB IMMUN, V12, P581, DOI 10.1128/CDLI.12.5.581-585.2005; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; Kim SH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001868; Lek M, 2010, MOL BIOL EVOL, V27, P773, DOI 10.1093/molbev/msp268; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Orton SM, 2007, J PARASITOL, V93, P1378, DOI 10.1645/GE-1217.1; Pettitt J, 2010, BIOCHEM SOC T, V38, P1125, DOI 10.1042/BST0381125; Prinsen CFM, 1997, GENE, V193, P245, DOI 10.1016/S0378-1119(97)00129-7; Puerta L, 1999, INT ARCH ALLERGY IMM, V119, P181, DOI 10.1159/000024193; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; ROSS LH, 1995, J BIOL CHEM, V270, P22066, DOI 10.1074/jbc.270.37.22066; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; SPENCE HJ, 1993, MOL BIOCHEM PARASIT, V57, P339, DOI 10.1016/0166-6851(93)90210-O; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TREUNER M, 1994, GENE, V147, P237, DOI 10.1016/0378-1119(94)90073-6; Venkatachalam AB, 2009, FEBS J, V276, P6787, DOI 10.1111/j.1742-4658.2009.07393.x	34	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77636	10.1371/journal.pone.0077636	http://dx.doi.org/10.1371/journal.pone.0077636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155969	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000325887300103
J	Shan, Z; Deng, GY; Li, JP; Li, YY; Zhang, YX; Zhao, QH				Shan, Zhi; Deng, Guoying; Li, Jipeng; Li, Yangyang; Zhang, Yongxing; Zhao, Qinghua			Correlational Analysis of neck/shoulder Pain and Low Back Pain with the Use of Digital Products, Physical Activity and Psychological Status among Adolescents in Shanghai	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COMPUTER OFFICE WORKERS; RISK-FACTORS; SHOULDER PAIN; NECK PAIN; MUSCULOSKELETAL PAIN; CHINESE ADOLESCENTS; YOUNG-ADULTS; PREVALENCE; SYMPTOMS	Purpose: This study investigates the neck/shoulder pain (NSP) and low back pain (LBP) among current high school students in Shanghai and explores the relationship between these pains and their possible influences, including digital products, physical activity, and psychological status. Methods: An anonymous self-assessment was administered to 3,600 students across 30 high schools in Shanghai. This questionnaire examined the prevalence of NSP and LBP and the level of physical activity as well as the use of mobile phones, personal computers (PC) and tablet computers (Tablet). The CES-D (Center for Epidemiological Studies Depression) scale was also included in the survey. The survey data were analyzed using the chi-square test, univariate logistic analyses and a multivariate logistic regression model. Results: Three thousand sixteen valid questionnaires were received including 1,460 (48.41%) from male respondents and 1,556 (51.59%) from female respondents. The high school students in this study showed NSP and LBP rates of 40.8% and 33.1%, respectively, and the prevalence of both influenced by the student's grade, use of digital products, and mental status; these factors affected the rates of NSP and LBP to varying degrees. The multivariate logistic regression analysis revealed that Gender, grade, soreness after exercise, PC using habits, tablet use, sitting time after school and academic stress entered the final model of NSP, while the final model of LBP consisted of gender, grade, soreness after exercise, PC using habits, mobile phone use, sitting time after school, academic stress and CES-D score. Conclusions: High school students in Shanghai showed high prevalence of NSP and LBP that were closely related to multiple factors. Appropriate interventions should be implemented to reduce the occurrences of NSP and LBP.	[Shan, Zhi; Deng, Guoying; Li, Jipeng; Li, Yangyang; Zhang, Yongxing; Zhao, Qinghua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, QH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	sawboneszhao2012@163.com	Deng, Guoying/L-4150-2019	Deng, Guoying/0000-0002-1693-8453	Class Tutor Program of Shanghai Jiao Tong University, School of Medicine [2012006]	Class Tutor Program of Shanghai Jiao Tong University, School of Medicine	This work was financially supported by the Class Tutor Program of Shanghai Jiao Tong University, School of Medicine in contract of 2012006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alricsson M, 2006, THESCIENTIFICWORLDJO, V6, P816, DOI 10.1100/tsw.2006.164; Astfalck RG, 2010, MANUAL THER, V15, P240, DOI 10.1016/j.math.2009.12.007; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Cho CY, 2008, J MANIP PHYSIOL THER, V31, P224, DOI 10.1016/j.jmpt.2008.02.003; Diepenmaat ACM, 2006, PEDIATRICS, V117, P412, DOI 10.1542/peds.2004-2766; Eccleston C, 2003, ARCH DIS CHILD, V88, P881, DOI 10.1136/adc.88.10.881; El-Metwally A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-46; Eltayeb S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-68; Eltayeb SM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-33; Faucett J, 1996, AAOHN J, V44, P33; Fejer R, 2006, RHEUMATOLOGY, V45, P589, DOI 10.1093/rheumatology/kei224; Fritz JM, 2010, J ATHL TRAINING, V45, P61, DOI 10.4085/1062-6050-45.1.61; Hakala P, 2002, BRIT MED J, V325, P743, DOI 10.1136/bmj.325.7367.743; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Harma AM, 2002, SCAND J PRIM HEALTH, V20, P92, DOI 10.1080/713796398; Harreby M, 1999, EUR SPINE J, V8, P444, DOI 10.1007/s005860050203; Jacobs Karen, 2002, Work, V18, P221; Kwon S, 2013, ETHNIC DIS, V23, P129; Mikkelsson M, 1997, PEDIATRICS, V100, P220, DOI 10.1542/peds.100.2.220; Miranda H, 2001, OCCUP ENVIRON MED, V58, P528, DOI 10.1136/oem.58.8.528; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; Palmer KT, 2000, BRIT MED J, V320, P1577, DOI 10.1136/bmj.320.7249.1577; Pollock CM, 2011, MANUAL THER, V16, P246, DOI 10.1016/j.math.2010.10.010; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rempel DM, 2006, OCCUP ENVIRON MED, V63, P300, DOI 10.1136/oem.2005.022285; Roh YH, 2012, CLIN ORTHOP RELAT R, V470, P3470, DOI 10.1007/s11999-012-2503-4; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Siivola SM, 2004, SPINE, V29, P1662, DOI 10.1097/01.BRS.0000133644.29390.43; Smith L, 2009, CEPHALALGIA, V29, P250, DOI 10.1111/j.1468-2982.2008.01714.x; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; Torgen M, 2002, EUR J APPL PHYSIOL, V86, P418, DOI 10.1007/s00421-001-0567-z; Wedderkopp N, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-52; Williams C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052735; Yao WG, 2012, PAIN MED, V13, P658, DOI 10.1111/j.1526-4637.2012.01369.x; Yue PY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-789	38	120	129	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78109	10.1371/journal.pone.0078109	http://dx.doi.org/10.1371/journal.pone.0078109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147114	gold, Green Published			2022-12-25	WOS:000325819400143
J	Ranayhossaini, DJ; Rodriguez, AI; Sahoo, S; Chen, BB; Mallampalli, RK; Kelley, EE; Csanyi, G; Gladwin, MT; Romero, G; Pagano, PJ				Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Sahoo, Sanghamitra; Chen, Beibei B.; Mallampalli, Rama K.; Kelley, Eric E.; Csanyi, Gabor; Gladwin, Mark T.; Romero, Guillermo; Pagano, Patrick J.			Selective Recapitulation of Conserved and Nonconserved Regions of Putative NOXA1 Protein Activation Domain Confers Isoform-specific Inhibition of Nox1 Oxidase and Attenuation of Endothelial Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; NADPH Oxidase; Peptides; Reactive Oxygen Species (ROS); Nox1	NADPH OXIDASE; SUPEROXIDE GENERATION; HYDROGEN-PEROXIDE; NITRIC-OXIDE; OXYGEN; PEROXYNITRITE; HYPERTENSION; PEPTIDE; DIPHENYLENEIODONIUM; EXPRESSION	Background: Nox1, an oxidant source in colon carcinoma and vascular disease, is activated by NOXA1. Results: A NOXA1 peptide blocked NOXA1-Nox1 binding and inhibited colon carcinoma and endothelial oxidants and migration. Conclusion: The findings identify a NOXA1-activating domain and an isoform-specific Nox1 inhibitor. Significance: The data provide insight into Nox1 regulation and present a potential therapy for suppressing oxidative stress-related disease. Excessive vascular and colon epithelial reactive oxygen species production by NADPH oxidase isoform 1 (Nox1) has been implicated in a number of disease states, including hypertension, atherosclerosis, and neoplasia. A peptide that mimics a putative activation domain of the Nox1 activator subunit NOXA1 (NOXA1 docking sequence, also known as NoxA1ds) potently inhibited Nox1-derived superoxide anion (O-radical anion) production in a reconstituted Nox1 cell-free system, with no effect on Nox2-, Nox4-, Nox5-, or xanthine oxidase-derived reactive oxygen species production as measured by cytochrome c reduction, Amplex Red fluorescence, and electron paramagnetic resonance. The ability of NoxA1ds to cross the plasma membrane was tested by confocal microscopy in a human colon cancer cell line exclusively expressing Nox1 (HT-29) using FITC-labeled NoxA1ds. NoxA1ds significantly inhibited whole HT-29 carcinoma cell-derived O-radical anion generation. ELISA and fluorescence recovery after photobleaching experiments indicate that NoxA1ds, but not its scrambled control, binds Nox1. FRET experiments conducted using Nox1-YFP and NOXA1-CFP illustrate that NoxA1ds disrupts the binding interaction between Nox1 and NOXA1, whereas a control peptide did not. Moreover, hypoxia-induced human pulmonary artery endothelial cell O-radical anion production was completely inhibited by NoxA1ds. Human pulmonary artery endothelial cell migration under hypoxic conditions was also reduced by pretreatment with NoxA1ds. Our data indicate that a peptide recapitulating a putative activation subdomain of NOXA1 (NoxA1ds) is a highly efficacious and selective inhibitor of Nox1 activity and establishes a critical interaction site for Nox1-NOXA1 binding required for enzyme activation.	[Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Kelley, Eric E.; Csanyi, Gabor; Gladwin, Mark T.; Pagano, Patrick J.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Sahoo, Sanghamitra; Kelley, Eric E.; Csanyi, Gabor; Romero, Guillermo; Pagano, Patrick J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chen, Beibei B.; Mallampalli, Rama K.; Gladwin, Mark T.] Univ Pittsburgh, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Pagano, PJ (corresponding author), Univ Pittsburgh, BST E1247,200 Lothrop St, Pittsburgh, PA 15261 USA.	pagano@pitt.edu	Pagano, Patrick/GYO-2619-2022		National Institutes of Health [HL079207, HL096376, HL097376, HL098174, HL116472]; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL096376, R01HL079207, R01HL098174, P01HL114453, R01HL112914, P01HL103455, R01HL097376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HL079207; Grants HL096376, HL097376, and HL098174 (to R. K. M.); and Grant HL116472 (to B. B. C.). This work was also supported by a merit review award from the United States Department of Veterans Affairs. This work is the subject of a pending United States patent application No. 61/560,075 titled "Novel Inhibitors of Nox1," on which D. J. R. and P. J. P. are listed as inventors.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Cardey B, 2007, J PHYS CHEM A, V111, P13046, DOI 10.1021/jp0731102; Cascino T, 2011, ANTIOXID REDOX SIGN, V15, P1507, DOI 10.1089/ars.2010.3631; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Csanyi G, 2012, ARTERIOSCL THROM VAS, V32, P2966, DOI 10.1161/ATVBAHA.112.300031; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Dennis KE, 2009, AM J PHYSIOL-LUNG C, V297, pL596, DOI 10.1152/ajplung.90568.2008; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Jacobson GM, 2003, CIRC RES, V92, P637, DOI 10.1161/01.RES.0000063423.94645.8A; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; KELLOGG EW, 1975, J BIOL CHEM, V250, P8812; Kinoshita M, 2005, PHARM RES-DORDR, V22, P716, DOI 10.1007/s11095-005-2586-7; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; LETO TL, 1991, J BIOL CHEM, V266, P19812; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Maehara Y, 2010, J BIOL CHEM, V285, P31435, DOI 10.1074/jbc.M110.161166; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCGUIRE JJ, 1994, J PHARMACOL EXP THER, V271, P708; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Poillot C, 2012, J BIOL CHEM, V287, P17331, DOI 10.1074/jbc.M112.360628; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Roos D, 2010, BLOOD CELL MOL DIS, V44, P291, DOI 10.1016/j.bcmd.2010.01.009; Schroder K, 2009, CIRC RES, V105, P537, DOI 10.1161/CIRCRESAHA.109.205138; Sedeek M, 2009, CURR OPIN NEPHROL HY, V18, P122, DOI 10.1097/MNH.0b013e32832923c3; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	57	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36437	36450		10.1074/jbc.M113.521344	http://dx.doi.org/10.1074/jbc.M113.521344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24187133	Green Published, hybrid			2022-12-25	WOS:000328883400025
J	Thapa, N; Choi, S; Hedman, A; Tan, XJ; Anderson, RA				Thapa, Narendra; Choi, Suyong; Hedman, Andrew; Tan, Xiaojun; Anderson, Richard A.			Phosphatidylinositol Phosphate 5-Kinase I gamma i2 in Association with Src Controls Anchorage-independent Growth of Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; Oncogene; Phosphatidylinositol; Src; Anchorage-independent Growth; Talin	KINASE; ADHESION; LOCALIZATION; TRAFFICKING; METASTASIS; ANOIKIS; PATHWAY; BINDING; TALIN; ACTIVATION	Background: PIPKI isoforms play roles in cell migration, polarization, and membrane trafficking and are overexpressed in triple-negative breast cancers, indicating protumorigenic functions. Results: PIPKIi2 associates with the C terminus of Src, and this interaction interdependently controls their functioning. Conclusion: PIPKIi2 and Src synergistically control anchorage-independent tumor cell growth. Significance: This study shows unexpected mechanisms for a phosphatidylinositol 4,5-biphosphate-generating enzyme that synergizes with the proto-oncogene Src to regulate oncogenic signaling. A fundamental property of tumor cells is to defy anoikis, cell death caused by a lack of cell-matrix interaction, and grow in an anchorage-independent manner. How tumor cells organize signaling molecules at the plasma membrane to sustain oncogenic signals in the absence of cell-matrix interactions remains poorly understood. Here, we describe a role for phosphatidylinositol 4-phosphate 5-kinase (PIPK) Ii2 in controlling anchorage-independent growth of tumor cells in coordination with the proto-oncogene Src. PIPKIi2 regulated Src activation downstream of growth factor receptors and integrins. PIPKIi2 directly interacted with the C-terminal tail of Src and regulated its subcellular localization in concert with talin, a cytoskeletal protein targeted to focal adhesions. Co-expression of PIPKIi2 and Src synergistically induced the anchorage-independent growth of nonmalignant cells. This study uncovers a novel mechanism where a phosphoinositide-synthesizing enzyme, PIPKIi2, functions with the proto-oncogene Src, to regulate oncogenic signaling.	[Thapa, Narendra; Choi, Suyong; Hedman, Andrew; Tan, Xiaojun; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Med Sci Ctr 3750, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health [CA104708, GM057549]; American Heart Association [10POST4290052, 13PRE14690057, PRE2280534]; Howard Hughes Medical Institute International Student Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104708 and GM057549 (to R. A. A.). This work was also supported by American Heart Association Grants 10POST4290052 (to N. T.), 13PRE14690057 (to S. C.), and PRE2280534 (to A. H.) and a Howard Hughes Medical Institute International Student Research Fellowship (to X. T.).	Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Divecha N, 2010, CURR BIOL, V20, pR154, DOI 10.1016/j.cub.2010.01.016; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hemmings L, 1996, J CELL SCI, V109, P2715; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Lai MT, 2011, J PATHOL, V224, P367, DOI 10.1002/path.2867; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIEBL EC, 1992, ONCOGENE, V7, P2417; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nakanishi K, 2002, CANCER RES, V62, P2971; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schramp M, 2011, CANCER RES, V71, P1282, DOI 10.1158/0008-5472.CAN-10-2480; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; SINGHAL RL, 1994, LIFE SCI, V55, P1487, DOI 10.1016/0024-3205(94)00690-3; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Tsatsanis C, 2004, ANN NY ACAD SCI, V1028, P168, DOI 10.1196/annals.1322.019; Tu C, 2010, P NATL ACAD SCI USA, V107, P16107, DOI 10.1073/pnas.1009471107; Wang LH, 2004, MT SINAI J MED, V71, P361; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	49	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34707	34718		10.1074/jbc.M113.512848	http://dx.doi.org/10.1074/jbc.M113.512848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151076	Green Published, hybrid			2022-12-25	WOS:000329812800037
J	Zhao, GY; Krishnamurthy, S; Cai, ZQ; Popov, VL; da Rosa, APT; Guzman, H; Cao, S; Virgin, HW; Tesh, RB; Wang, D				Zhao, Guoyan; Krishnamurthy, Siddharth; Cai, Zhengqiu; Popov, Vsevolod L.; da Rosa, Amelia P. Travassos; Guzman, Hilda; Cao, Song; Virgin, Herbert W.; Tesh, Robert B.; Wang, David			Identification of Novel Viruses Using VirusHunter - an Automated Data Analysis Pipeline	PLOS ONE			English	Article							HUMAN PARVOVIRUS; PROTEIN; ALIGNMENT	Quick and accurate identification of microbial pathogens is essential for both diagnosis and response to emerging infectious diseases. The advent of next-generation sequencing technology offers an unprecedented platform for rapid sequencing-based identification of novel viruses. We have developed a customized bioinformatics data analysis pipeline, VirusHunter, for the analysis of Roche/454 and other long read Next generation sequencing platform data. To illustrate the utility of VirusHunter, we performed Roche/454 GS FLX titanium sequencing on two unclassified virus isolates from the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA). VirusHunter identified sequences derived from a novel bunyavirus and a novel reovirus in the two samples respectively. Further sequence analysis demonstrated that the viruses were novel members of the Phlebovirus and Orbivirus genera. Both Phlebovirus and Orbivirus genera include many economic important viruses or serious human pathogens.	[Zhao, Guoyan; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Zhao, Guoyan; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA; [Zhao, Guoyan; Krishnamurthy, Siddharth; Cai, Zhengqiu; Cao, Song; Virgin, Herbert W.; Wang, David] Midwest Reg Ctr Excellence Biodef & Emerging Dis, St Louis, MO USA; [Krishnamurthy, Siddharth; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Popov, Vsevolod L.; da Rosa, Amelia P. Travassos; Guzman, Hilda; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston	Wang, D (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	davewang@wustl.edu		Virgin, Herbert/0000-0001-8580-7628; Krishnamurthy, Siddharth/0000-0003-1777-8292; Zhao, Guoyan/0000-0001-5615-6774	National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [U54 AI057160]; NIAID [HHSN27220100004OI/HHSN27200004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER	National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [U54 AI057160] and by NIAID contract HHSN27220100004OI/HHSN27200004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Benjamin LA, 2011, EMERG INFECT DIS, V17, P1484, DOI 10.3201/eid1708.110165; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Cheng LL, 1999, AM J TROP MED HYG, V60, P430, DOI 10.4269/ajtmh.1999.60.430; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dilcher M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-166; ELMEKKI AA, 1981, T ROY SOC TROP MED H, V75, P799; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Karabatsos N, 1985, INT CATALOGUE ARBOVI, P885; King A.M.Q., 2011, VIRUS TAXONOMY, P1338; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MIURA T, 1977, ARCH VIROL, V53, P281, DOI 10.1007/BF01315626; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palacios G, 2013, J GEN VIROL, V94, P837, DOI 10.1099/vir.0.048850-0; Palacios G, 2011, J GEN VIROL, V92, P1445, DOI 10.1099/vir.0.029389-0; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06; SHOPE RE, 1981, AM J TROP MED HYG, V30, P509, DOI 10.4269/ajtmh.1981.30.509; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12	36	59	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78470	10.1371/journal.pone.0078470	http://dx.doi.org/10.1371/journal.pone.0078470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167629	gold, Green Published			2022-12-25	WOS:000326034500090
J	Kim, SH; Shim, SH; Sung, SR; Lee, KA; Shim, JY; Cha, DH; Lee, KJ				Kim, Soo Hyun; Shim, Sung Han; Sung, Se Ra; Lee, Kyung A.; Shim, Jung Yun; Cha, Dong Hyun; Lee, Kyoung Jin			Gene Expression Analysis of the Microdissected Trophoblast Layer of Human Placenta after the Spontaneous Onset of Labor	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HUMAN GESTATIONAL TISSUES; FETAL MEMBRANES; MESSENGER-RNA; KAPPA-B; TERM; INFLAMMATION; PROTEIN; SIRT1; DEHYDROGENASE	Background: Despite increasing evidence that human parturition is associated with alteration in gene expression in the uteroplacental unit, the precise mechanisms that elicit spontaneous term labor in humans remain unknown. Our goal in this study was to compare the mRNA expression pattern of the trophoblast layer of normal term placenta between women who had given natural birth (labor group) and those who had undergone an elective cesarean section without labor (non-labor group). Methods: We collected placental tissue samples from six pregnant women after term vaginal deliveries (labor group) and from six pregnant women after scheduled Cesarean sections (non-labor group). Frozen sections were made immediately after placental delivery. Because the placenta is a heterogeneous tissue composed of several cell types, we used laser capture microdissection to separate the trophoblast layer from the rest of the placental tissues. Results: A number of genes were differentially expressed in the trophoblast layer when the labor and non-labor groups were compared. The expression of SIRT1, KAP1, and CRH was significantly lower in the trophoblast layer of the labor group than of the non-labor group. The expression of IL-1b, NF-kB1 and TLR 8 in the labor group was significantly higher than that in the non-labor group. Conclusions: Human term labor may be closely associated with inflammatory response. We suggest that downregulation of SIRT1, KAP1, and CRH gene expression in the trophoblast may play a key role in parturition and initiation of labor in pregnant human females.	[Kim, Soo Hyun; Cha, Dong Hyun; Lee, Kyoung Jin] CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Seoul, South Korea; [Shim, Sung Han; Sung, Se Ra] CHA Gangnam Med Ctr, Genet Lab, Fertil Ctr, Seoul, South Korea; [Lee, Kyung A.] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul, South Korea; [Shim, Jung Yun] CHA Univ, Dept Pathol, CHA Gangnam Med Ctr, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Cha, DH (corresponding author), CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Seoul, South Korea.	chadh001@chamc.co.kr; jlee3575@chamc.co.kr		Cha, Dong Hyun/0000-0003-0722-1714				Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Bollapragada S, 2009, AM J OBSTET GYNECOL, V200, pe101, DOI DOI 10.1016/J.AJ0G.2008.08.032); Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan S, 2004, PLACENTA, V25, P758, DOI 10.1016/j.placenta.2004.02.007; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Cong BH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-43; Curran S, 2000, J CLIN PATHOL-MOL PA, V53, P64, DOI 10.1136/mp.53.2.64; Dudley DJ, 1996, J SOC GYNECOL INVEST, V3, P328, DOI 10.1016/S1071-5576(96)00042-1; Erkhembaatar LO, 2013, PLACENTA, V34, P353, DOI 10.1016/j.placenta.2013.01.014; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; GOLAND RS, 1986, J CLIN ENDOCR METAB, V63, P1199, DOI 10.1210/jcem-63-5-1199; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; HIRST JJ, 1995, REPROD FERT DEVELOP, V7, P633, DOI 10.1071/RD9950633; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; McKeown KJ, 2003, J CLIN ENDOCR METAB, V88, P1737, DOI 10.1210/jc.2002-021369; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; MITCHELL MD, 1984, J DEV PHYSIOL, V6, P107; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; NAKLA S, 1986, AM J OBSTET GYNECOL, V155, P1337, DOI 10.1016/0002-9378(86)90170-5; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; NOVY MJ, 1980, SEMIN PERINATOL, V4, P45; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Sullivan MHF, 1991, ACTA OBSTET GYN SCAN, V70, P425, DOI 10.3109/00016349109007154; Weetman AP, 1999, THYROID, V9, P643, DOI 10.1089/thy.1999.9.643; WOLFE C, 1987, LANCET, V1, P335; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77648	10.1371/journal.pone.0077648	http://dx.doi.org/10.1371/journal.pone.0077648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147045	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200057
J	Jiang, L; Lin, M; Zhang, Y; Li, YP; Xu, X; Li, S; Huang, H				Jiang, Ling; Lin, Ming; Zhang, Yang; Li, Yanping; Xu, Xian; Li, Shuang; Huang, He			Identification and Characterization of a Novel Trehalose Synthase Gene Derived from Saline-Alkali Soil Metagenomes	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORD FACTOR; CLONING; EXPRESSION; YEAST; INSIGHTS; GROWTH; PATHOGENESIS; RESOLUTION; EVOLUTION	A novel trehalose synthase (TreS) gene was identified from a metagenomic library of saline-alkali soil by a simple activity-based screening system. Sequence analysis revealed that TreS encodes a protein of 552 amino acids, with a deduced molecular weight of 63.3 kDa. After being overexpressed in Escherichia coli and purified, the enzymatic properties of TreS were investigated. The recombinant TreS displayed its optimal activity at pH 9.0 and 45 degrees C, and the addition of most common metal ions (1 or 30 mM) had no inhibition effect on the enzymatic activity evidently, except for the divalent metal ions Zn2+ and Hg2+. Kinetic analysis showed that the recombinant TreS had a 4.1-fold higher catalytic efficientcy (Kcat/K-m) for maltose than for trehalose. The maximum conversion rate of maltose into trehalose by the TreS was reached more than 78% at a relatively high maltose concentration (30%), making it a good candidate in the large-scale production of trehalsoe after further study. In addition, five amino acid residues, His172, Asp201, Glu251, His318 and Asp319, were shown to be conserved in the TreS, which were also important for glycosyl hydrolase family 13 enzyme catalysis.	[Jiang, Ling] Nanjing Univ Technol, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Lin, Ming; Xu, Xian; Li, Shuang; Huang, He] Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Yang; Li, Yanping] Nanjing Univ Technol, Coll Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Huang, H (corresponding author), Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China.	biotech@njut.edu.cn			National Science Foundation for Distinguished Young Scholars of China [21225626]; National Basic Research Program of China [2012CB725204]; National Natural Science Foundation of China for Young Scholars [21106064]; Natural Science Foundation of Jiangsu Province [BK20131406, BK20130917]; National High Technology Research and Development Program of China [2012AA022101, 2012AA021700]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The experiments were conceived and designed with the support of the National Science Foundation for Distinguished Young Scholars of China (No. 21225626). The experiment materials were bought mainly with the support of the National Basic Research Program of China (No. 2012CB725204), as well as the National Natural Science Foundation of China for Young Scholars (No. 21106064). The data collection and analysis, together with the preparation of the manuscript were mainly supported by the Natural Science Foundation of Jiangsu Province (No. BK20131406, BK20130917). The isolation of DNA from environmental sample and construction of a metagenomic library in this study were mainly supported by the National High Technology Research and Development Program of China (No. 2012AA022101, 2012AA021700).	Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Benoliel B, 2010, APPL BIOCHEM BIOTECH, V160, P2036, DOI 10.1007/s12010-009-8732-7; BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang SW, 2012, FOOD CHEM, V134, P1745, DOI 10.1016/j.foodchem.2012.03.065; Chen YS, 2006, J AGR FOOD CHEM, V54, P7098, DOI 10.1021/jf060828q; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Filipkowski P, 2012, ACTA BIOCHIM POL, V59, P425; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; GELINAS P, 1989, APPL ENVIRON MICROB, V55, P2453; GRBA S, 1976, EUR J APPL MICROBIOL, V2, P29, DOI 10.1007/BF01385443; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han SE, 2003, PROTEIN EXPRES PURIF, V30, P194, DOI 10.1016/S1046-5928(03)00104-9; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jiang L, 2012, BIOTECHNOL BIOENG, V109, P708, DOI 10.1002/bit.23346; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kim YH, 2000, APPL ENVIRON MICROB, V66, P4620, DOI 10.1128/AEM.66.11.4620-4624.2000; Lee JH, 2005, APPL MICROBIOL BIOT, V68, P213, DOI 10.1007/s00253-004-1862-5; Liang JY, 2013, J MOL CATAL B-ENZYM, V90, P26, DOI 10.1016/j.molcatb.2013.01.014; MARUTA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1829, DOI 10.1271/bbb.59.1829; Mirza O, 2001, BIOCHEMISTRY-US, V40, P9032, DOI 10.1021/bi010706l; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189, DOI 10.1271/bbb.59.2189; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Paiva C L, 1996, Biotechnol Annu Rev, V2, P293, DOI 10.1016/S1387-2656(08)70015-2; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; TEWARI YB, 1991, BIOPHYS CHEM, V40, P59, DOI 10.1016/0301-4622(91)85029-P; Van Vaeck C, 2001, BIOCHEM J, V353, P157; Wang JH, 2007, J AGR FOOD CHEM, V55, P3435, DOI 10.1021/jf070181p; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wei YT, 2004, ACTA BIOCH BIOPH SIN, V36, P477, DOI 10.1093/abbs/36.7.477; Woo EJ, 2010, J MOL BIOL, V404, P247, DOI 10.1016/j.jmb.2010.09.056; Wu XL, 2009, APPL MICROBIOL BIOT, V83, P477, DOI 10.1007/s00253-009-1863-5; Yao J, 2011, J AGR FOOD CHEM, V59, P3812, DOI 10.1021/jf104394m; Yue M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-34; Zhang R, 2011, J BIOL CHEM, V286, P35601, DOI 10.1074/jbc.M111.280362; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	46	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77437	10.1371/journal.pone.0077437	http://dx.doi.org/10.1371/journal.pone.0077437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146994	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400106
J	Jiang, XP; Zhang, DX; Teng, M; Zhang, Q; Zhang, JP; Huang, YS				Jiang, Xu-pin; Zhang, Dong-xia; Teng, Miao; Zhang, Qiong; Zhang, Jia-ping; Huang, Yue-sheng			Downregulation of CD9 in Keratinocyte Contributes to Cell Migration via Upregulation of Matrix Metalloproteinase-9	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE (MMP)-2; HUMAN EPIDERMAL-KERATINOCYTES; TETRASPANIN CD9; WOUND REPAIR; IN-VITRO; MMP-9 EXPRESSION; MELANOMA-CELLS; MOTILITY; PATHWAY; SKIN	Tetraspanin CD9 has been implicated in various cellular and physiological processes, including cell migration. In our previous study, we found that wound repair is delayed in CD9-null mice, suggesting that CD9 is critical for cutaneous wound healing. However, many cell types, including immune cells, endothelial cells, keratinocytes and fibroblasts undergo marked changes in gene expression and phenotype, leading to cell proliferation, migration and differentiation during wound repair, whether CD9 regulates kerationcytes migration directly remains unclear. In this study, we showed that the expression of CD9 was downregulated in migrating keratinocytes during wound repair in vivo and in vitro. Recombinant adenovirus vector for CD9 silencing or overexpressing was constructed and used to infect HaCaT cells. Using cell scratch wound assay and cell migration assay, we have also demonstrated that downregulation of CD9 promoted keratinocyte migration in vitro, whereas CD9 overexpression inhibited cell migration. Moreover, CD9 inversely regulated the activity and expression of MMP-9 in keratinocytes, which was involved in CD9-regulated keratinocyte migration. Importantly, CD9 silencing-activated JNK signaling was accompanied by the upregulation of MMP-9 activity and expression. Coincidentally, we found that SP600125, a JNK pathway inhibitor, decreased the activity and expression of MMP-9 of CD9-silenced HaCaT cells. Thus, our results suggest that CD9 is downregulated in migrating keratinocytes in vivo and in vitro, and a low level of CD9 promotes keratinocyte migration in vitro, in which the regulation of MMP-9 through the JNK pathway plays an important role.	[Jiang, Xu-pin; Zhang, Dong-xia; Zhang, Qiong; Zhang, Jia-ping; Huang, Yue-sheng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Teng, Miao] Chongqing Med Univ, Dept Burn & Plast Surg, Affiliated Hosp 1, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University	Zhang, JP (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	japzhang@yahoo.com.cn; yshuang.tmmu@gmail.com			National Natural Science Foundation of China [30973125]; State Key Development Program for Basic Research of China (973 Program) [2012CB518101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation of China (30973125), and the State Key Development Program for Basic Research of China (973 Program) (No. 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; ANTON ES, 1995, J NEUROSCI, V15, P584; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Baudoux B, 2000, EUR J CELL BIOL, V79, P41, DOI 10.1078/S0171-9335(04)70006-0; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deissler H, 2007, INT J MOL MED, V20, P643; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Ekekezie II, 2004, PEDIATRICS, V113, P1709, DOI 10.1542/peds.113.6.1709; Fan J, 2010, MOL CARCINOGEN, V49, P85, DOI 10.1002/mc.20580; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Karroum A, 2010, CANCER LETT, V295, P242, DOI 10.1016/j.canlet.2010.03.007; Kim S, 2007, FEBS LETT, V581, P3869, DOI 10.1016/j.febslet.2007.06.074; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; Klein-Soyer C, 2000, ARTERIOSCL THROM VAS, V20, P360, DOI 10.1161/01.ATV.20.2.360; Kotha J, 2010, ARTERIOSCL THROM VAS, V30, pE263; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu CY, 2013, ACTA TROP, V125, P320, DOI 10.1016/j.actatropica.2012.11.002; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; Miyake M, 2000, ONCOGENE, V19, P5221, DOI 10.1038/sj.onc.1203919; O'Toole EA, 2008, J CELL PHYSIOL, V214, P47, DOI 10.1002/jcp.21160; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Penas PF, 2005, ACTAS DERMO-SIFILOGR, V96, P30, DOI 10.1016/S0001-7310(05)73029-5; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Ravanti L, 2000, INT J MOL MED, V6, P391; Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x; Reiss MJ, 2010, SURGERY, V147, P295, DOI 10.1016/j.surg.2009.10.016; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Thomas GJ, 2001, J INVEST DERMATOL, V116, P898, DOI 10.1046/j.1523-1747.2001.01352.x; Xue ML, 2008, J INVEST DERMATOL, V128, P2676, DOI 10.1038/jid.2008.136; Zhang JP, 2012, J INVEST DERMATOL, V132, P226, DOI 10.1038/jid.2011.268; Zhang Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038487, DOI 10.1371/J0URNAL.P0NE.0038487.PUBMED:22679510]; Zheng M, 2011, MOL BIOL REP, V38, P2099, DOI [10.1007/ s11033-010-0336-3, DOI 10.1007/S11033-010-0336-3.PUBMED:20857208]	50	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77806	10.1371/journal.pone.0077806	http://dx.doi.org/10.1371/journal.pone.0077806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147081	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400135
J	Liu, W; Zhang, ZJ; Zhao, YJ; Liu, ZF; Li, BC				Liu, Wei; Zhang, Zhi-Jun; Zhao, Ya-Jun; Liu, Zhi-Fang; Li, Bing-Chen			Effects of Awareness on Numerosity Adaptation	PLOS ONE			English	Article							NUMBER; REPRESENTATION; PERCEPTION; SUPPRESSION; ANIMALS; REVEALS; DEPENDS; SCALE; SETS	Numerosity perception is a process involving several stages of visual processing. This study investigated whether distinct mechanisms exist in numerosity adaptation under different awareness conditions to characterize how numerosity perception occurs at each stage. The status of awareness was controlled by masking conditions, in which monoptic and dichoptic masking were proposed to influence different levels of processing. Numerosity adaptation showed significant aftereffects when the participants were aware (monoptic masking) and unaware (dichoptic masking) of adaptors. The interocular transfer for numerosity adaptation was distinct under the different awareness conditions. Adaptation was primarily binocular when participants were aware of stimuli and was purely monocular when participants were unaware of adaptors. Moreover, numerosity adaptation was significantly reduced when the adaptor dots were clustered into chunks with awareness, whereas clustering had no effect on unaware adaptation. These results show that distinct mechanisms exist in numerosity processing under different awareness conditions. It is suggested that awareness is crucial to numerosity cognition. With awareness, grouping (by clustering) influences numerosity coding through altered object representations, which involves higher-level cognitive processing.	[Liu, Wei; Zhang, Zhi-Jun; Li, Bing-Chen] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Ya-Jun] Southwest Univ Nationalities, Coll Sociol & Psychol, Chengdu, Peoples R China; [Liu, Zhi-Fang] Ningbo Univ, Coll Teacher Educ, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Southwest Minzu University; Ningbo University	Zhang, ZJ (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zjzhang@zju.edu.cn			National Natural Science Foundation of China [31271101, 31371039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Funds of the National Natural Science Foundation of China (Grant No. 31271101, 2012; Grant No. 31371039, 2013). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIK J, 1991, PSYCHOL RES-PSYCH FO, V53, P290, DOI 10.1007/BF00920482; ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Burr DC, 2011, SEEING PERCEIVING, V24, P141, DOI 10.1163/187847511X570097; Burr DC, 2011, PHILOS T R SOC B, V366, P504, DOI 10.1098/rstb.2010.0244; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Chen L, 2005, VIS COGN, V12, P553, DOI 10.1080/13506280444000256; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; de Hevia MD, 2011, COGNITION, V121, P253, DOI 10.1016/j.cognition.2011.04.002; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Durgin FH, 2001, VISION RES, V41, P2619, DOI 10.1016/S0042-6989(01)00121-3; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Franconeri SL, 2009, COGNITION, V113, P1, DOI 10.1016/j.cognition.2009.07.002; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gazzaniga M. S., 2008, COGNITIVE NEUROSCIEN; Halberda J, 2006, PSYCHOL SCI, V17, P572, DOI 10.1111/j.1467-9280.2006.01746.x; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; He LX, 2009, PSYCHON B REV, V16, P509, DOI 10.3758/PBR.16.3.509; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kramer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017378; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LIU W, 2012, ACTA PSYCHOL SINICA, V44, P1; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Palmer SE, 2003, ACTA PSYCHOL, V114, P311, DOI 10.1016/j.actpsy.2003.06.003; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Roth HL, 2002, BRAIN, V125, P2023, DOI 10.1093/brain/awf210; SANG CC, 2010, WIRES COGN SCI, V10, P1002; Sophian C, 2008, COGNITION, V107, P460, DOI 10.1016/j.cognition.2007.10.009; Sweeny TD, 2011, PSYCHOL SCI, V22, P943, DOI 10.1177/0956797611413292; Sweeny TD, 2011, J NEUROPHYSIOL, V105, P1236, DOI 10.1152/jn.00061.2010; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; WALK RD, 1966, MONOGR SOC RES CHILD, V31, P82, DOI 10.2307/1165648; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; YANG E, 2010, J VIS, V10, P13, DOI DOI 10.1167/10.12.1.PUBMED:21047733	48	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77556	10.1371/journal.pone.0077556	http://dx.doi.org/10.1371/journal.pone.0077556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24147023	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400120
J	McCarthy, MK; Levine, RE; Procario, MC; McDonnell, PJ; Zhu, LQ; Mancuso, P; Crofford, LJ; Aronoff, DM; Weinberg, JB				McCarthy, Mary K.; Levine, Rachael E.; Procario, Megan C.; McDonnell, Peter J.; Zhu, Lingqiao; Mancuso, Peter; Crofford, Leslie J.; Aronoff, David M.; Weinberg, Jason B.			Prostaglandin E-2 Induction during Mouse Adenovirus Type 1 Respiratory Infection Regulates Inflammatory Mediator Generation but Does Not Affect Viral Pathogenesis	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CYCLOOXYGENASE-1 COX-1; B-LYMPHOCYTES; NITRIC-OXIDE; MICE LACKING; T-CELLS; EXPRESSION; SYNTHASE; IDENTIFICATION; ACTIVATION	Respiratory viruses cause substantial disease and are a significant healthcare burden. Virus-induced inflammation can be detrimental to the host, causing symptoms during acute infection and leading to damage that contributes to long-term residual lung disease. Prostaglandin E-2 (PGE(2)) is a lipid mediator that is increased in response to many viral infections, and inhibition of PGE(2) production during respiratory viral infection often leads to a decreased inflammatory response. We tested the hypothesis that PGE(2) promotes inflammatory responses to mouse adenovirus type 1 (MAV-1) respiratory infection. Acute MAV-1 infection increased COX-2 expression and PGE(2) production in wild type mice. Deficiency of the E prostanoid 2 receptor had no apparent effect on MAV-1 pathogenesis. Virus-induced induction of PGE(2), IFN-gamma, CXCL1, and CCL5 was reduced in mice deficient in microsomal PGE synthase-1 (mPGES-1(-/-) mice). However, there were no differences between mPGES-1(+/+) and mPGES-1(-/-) mice in viral replication, recruitment of leukocytes to airways or lung inflammation. Infection of both mPGES-1(+/+) and mPGES-1(-/-) mice led to protection against reinfection. Thus, while PGE(2) promotes the expression of a variety of cytokines in response to acute MAV-1 infection, PGE(2) synthesis does not appear to be essential for generating pulmonary immunity.	[Levine, Rachael E.; Procario, Megan C.; McDonnell, Peter J.; Weinberg, Jason B.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [McCarthy, Mary K.; Zhu, Lingqiao; Aronoff, David M.; Weinberg, Jason B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Mancuso, Peter] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Crofford, Leslie J.] Vanderbilt Univ, Dept Internal Med, Nashville, TN 37235 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University	Weinberg, JB (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	jbwein@umich.edu	Mancuso, Peter/AGZ-3550-2022	Aronoff, David/0000-0003-4587-6121; Mancuso, Peter/0000-0002-2559-7320; Weinberg, Jason/0000-0002-4768-4361	NIH [R01 AI083334, R01 AR049010]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award; Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award; Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by NIH grants R01 AI083334 (JBW and DMA) and R01 AR049010 (LJC), a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award (DMA), and a Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics (JBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 2009, VIROLOGY, V391, P25, DOI 10.1016/j.virol.2009.06.009; Aronoff DM, 2012, PROSTAG OTH LIPID M, V98, P23, DOI 10.1016/j.prostaglandins.2012.03.002; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bancos S, 2009, CELL IMMUNOL, V258, P18, DOI 10.1016/j.cellimm.2009.03.007; BETZ M, 1991, J IMMUNOL, V146, P108; Bloom D, 1999, CELL IMMUNOL, V194, P21, DOI 10.1006/cimm.1999.1479; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Carey MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011610; Cauthen Angela N, 2007, Methods Mol Med, V130, P41; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Crofford LJ, 2005, J GENE MED, V7, P288, DOI 10.1002/jgm.661; Culver CA, 2007, J IMMUNOL, V179, P4170, DOI 10.4049/jimmunol.179.6.4170; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/ERI.11.56, 10.1586/eri.11.56]; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; KNIPE DM, 2007, FIELDS VIROLOGY, P2355; Lauder SN, 2011, THORAX, V66, P368, DOI 10.1136/thx.2010.150318; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; MCCARTHY MK, 2012, MEDIAT INFLAMM, V2012, P1; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Monrad SU, 2011, PROSTAG LEUKOTR ESS, V84, P113, DOI 10.1016/j.plefa.2010.10.003; Moore ML, 2004, J VIROL, V78, P5584, DOI 10.1128/JVI.78.11.5584-5590.2004; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Natarajan G, 2007, ANN CLIN LAB SCI, V37, P170; Nguyen Y, 2011, VIRUS RES, V160, P351, DOI 10.1016/j.virusres.2011.07.012; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Procario MC, 2012, J VIROL, V86, P4194, DOI 10.1128/JVI.06967-11; Radi ZA, 2010, VIRAL IMMUNOL, V23, P43, DOI 10.1089/vim.2009.0042; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Roper RL, 2002, IMMUNOL LETT, V84, P191, DOI 10.1016/S0165-2478(02)00185-2; ROPER RL, 1995, J IMMUNOL, V154, P162; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Sznajer Y, 2004, J PEDIATR-US, V145, P115, DOI 10.1016/j.jpeds.2004.03.049; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tavakoli S, 2001, AM J PHYSIOL-LUNG C, V280, pL127, DOI 10.1152/ajplung.2001.280.1.L127; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Weinberg JB, 2007, VIROLOGY, V357, P54, DOI 10.1016/j.virol.2006.08.013; Weinberg JB, 2005, VIROLOGY, V340, P245, DOI 10.1016/j.virol.2005.06.021; Weinberg JB, 2002, J VIROL, V76, P10518, DOI 10.1128/JVI.76.20.10518-10523.2002; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	58	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77628	10.1371/journal.pone.0077628	http://dx.doi.org/10.1371/journal.pone.0077628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147040	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400124
J	Bik, HM; Fournier, D; Sung, W; Bergeron, RD; Thomas, WK				Bik, Holly M.; Fournier, David; Sung, Way; Bergeron, R. Daniel; Thomas, W. Kelley			Intra-Genomic Variation in the Ribosomal Repeats of Nematodes	PLOS ONE			English	Article							RDNA COPY NUMBER; RNA GENE; CONCERTED EVOLUTION; SEQUENCE VARIATION; SACCHAROMYCES-CEREVISIAE; INTRAGENOMIC VARIATION; MUTATION-RATE; DNA REPEATS; SIZE; RECOMBINATION	Ribosomal loci represent a major tool for investigating environmental diversity and community structure via high-throughput marker gene studies of eukaryotes (e. g. 18S rRNA). Since the estimation of species' abundance is a major goal of environmental studies (by counting numbers of sequences), understanding the patterns of rRNA copy number across species will be critical for informing such high-throughput approaches. Such knowledge is critical, given that ribosomal RNA genes exist within multi-copy repeated arrays in a genome. Here we measured the repeat copy number for six nematode species by mapping the sequences from whole genome shotgun libraries against reference sequences for their rRNA repeat. This revealed a 6-fold variation in repeat copy number amongst taxa investigated, with levels of intragenomic variation ranging from 56 to 323 copies of the rRNA array. By applying the same approach to four C. elegans mutation accumulation lines propagated by repeated bottlenecking for an average of similar to 400 generations, we find on average a 2-fold increase in repeat copy number (rate of increase in rRNA estimated at 0.0285-0.3414 copies per generation), suggesting that rRNA repeat copy number is subject to selection. Within each Caenorhabditis species, the majority of intragenomic variation found across the rRNA repeat was observed within gene regions (18S, 28S, 5.8S), suggesting that such intragenomic variation is not a product of selection for rRNA coding function. We find that the dramatic variation in repeat copy number among these six nematode genomes would limit the use of rRNA in estimates of organismal abundance. In addition, the unique pattern of variation within a single genome was uncorrelated with patterns of divergence between species, reflecting a strong signature of natural selection for rRNA function. A better understanding of the factors that control or affect copy number in these arrays, as well as their rates and patterns of evolution, will be critical for informing estimates of global biodiversity.	[Bik, Holly M.] Univ Calif Davis, Union Council Davis Genome Ctr, Davis, CA 95616 USA; [Bik, Holly M.; Sung, Way; Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Fournier, David; Bergeron, R. Daniel] Univ New Hampshire, Dept Comp Sci, Durham, NH 03824 USA; [Sung, Way] Indiana Univ, Dept Biol, Bloomington, IN USA	University of California System; University of California Davis; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Indiana University System; Indiana University Bloomington	Bik, HM (corresponding author), Univ Calif Davis, Union Council Davis Genome Ctr, Davis, CA 95616 USA.	holly.bik@gmail.com		Bik, Holly/0000-0002-4356-3837	NSF RAPID award [DEB-1058458]; New Hampshire INBRE [NIH-1P20RR030360-01]; New England Cyberinfrastructure Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR030360] Funding Source: NIH RePORTER	NSF RAPID award; New Hampshire INBRE; New England Cyberinfrastructure Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NSF RAPID award DEB-1058458, New Hampshire INBRE (NIH-1P20RR030360-01), and a Regional Award for Cyber-enabled Research (RACER) awarded by the New England Cyberinfrastructure Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Averbeck KT, 2005, GENETICS, V171, P1837, DOI 10.1534/genetics.105.047670; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Carranza S, 1999, J MOL EVOL, V49, P250, DOI 10.1007/PL00006547; Cavalier-Smith T., 1985, P69; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fenton B, 1998, GENOME, V41, P337, DOI 10.1139/gen-41-3-337; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; GALL JG, 1981, J CELL BIOL, V91, pS3, DOI 10.1083/jcb.91.3.3s; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Glass SK, 2008, GENOME, V51, P988, DOI 10.1139/G08-092; Grishkevich V, 2011, GENOME RES, V21, P707, DOI 10.1101/gr.113381.110; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Houseley J, 2011, NUCLEIC ACIDS RES, V39, P8778, DOI 10.1093/nar/gkr589; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Keller I, 2008, EVOLUTION, V62, P833, DOI 10.1111/j.1558-5646.2008.00320.x; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim KY, 2000, CHROMOSOMA, V109, P161; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LONG EO, 1979, CELL, V18, P1185, DOI 10.1016/0092-8674(79)90231-9; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; MALESZKA R, 1990, MOL GEN GENET, V223, P342, DOI 10.1007/BF00265074; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; RITOSSA FM, 1968, P NATL ACAD SCI USA, V60, P509, DOI 10.1073/pnas.60.2.509; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; TARTOF KD, 1973, GENETICS, V73, P57; TERRACOL R, 1981, BIOCHIMIE, V63, P451, DOI 10.1016/S0300-9084(81)80020-X; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; VanKuren NW, 2013, EVOLUTION, V67, P207, DOI 10.1111/j.1558-5646.2012.01747.x; Veltsos P, 2009, HEREDITY, V103, P54, DOI 10.1038/hdy.2009.32; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	66	67	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78230	10.1371/journal.pone.0078230	http://dx.doi.org/10.1371/journal.pone.0078230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147124	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400148
J	Harris, JBC; Haskell, DG				Harris, J. Berton C.; Haskell, David G.			Simulated Birdwatchers' Playback Affects the Behavior of Two Tropical Birds	PLOS ONE			English	Article							MALE SONG; PLASMA-LEVELS; TESTOSTERONE; GRALLARIA; STRESS; COSTS	Although recreational birdwatchers may benefit conservation by generating interest in birds, they may also have negative effects. One such potentially negative impact is the widespread use of recorded vocalizations, or "playback," to attract birds of interest, including range-restricted and threatened species. Although playback has been widely used to test hypotheses about the evolution of behavior, no peer-reviewed study has examined the impacts of playback in a birdwatching context on avian behavior. We studied the effects of simulated birdwatchers' playback on the vocal behavior of Plain-tailed Wrens Thryothorus euophrys and Rufous Antpittas Grallaria rufula in Ecuador. Study species' vocal behavior was monitored for an hour after playing either a single bout of five minutes of song or a control treatment of background noise. We also studied the effects of daily five minute playback on five groups of wrens over 20 days. In single bout experiments, antpittas made more vocalizations of all types, except for trills, after playback compared to controls. Wrens sang more duets after playback, but did not produce more contact calls. In repeated playback experiments, wren responses were strong at first, but hardly detectable by day 12. During the study, one study group built a nest, apparently unperturbed, near a playback site. The playback-induced habituation and changes in vocal behavior we observed suggest that scientists should consider birdwatching activity when selecting research sites so that results are not biased by birdwatchers' playback. Increased vocalizations after playback could be interpreted as a negative effect of playback if birds expend energy, become stressed, or divert time from other activities. In contrast, the habituation we documented suggests that frequent, regular birdwatchers' playback may have minor effects on wren behavior.	[Harris, J. Berton C.] Fdn Conservac, Jocotoco, Quito, Ecuador; [Harris, J. Berton C.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Haskell, David G.] Univ South, Dept Biol, Sewanee, TN 37375 USA	Princeton University; Sewanee: University of the South	Harris, JBC (corresponding author), Fdn Conservac, Jocotoco, Quito, Ecuador.	johnbh@princeton.edu			Jocotoco Foundation	Jocotoco Foundation	This research was funded by the Jocotoco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Birding Association, 2012, COD ETH; Bates D., 2010, LME4 LINEAR MIXED EF; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bradshaw CJA, 2010, CONSERVATION BIOLOGY FOR ALL, P313; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Crawley MJ., 2007, R BOOK; Deeble B, 1999, ROSE THROATED BECARD, P6; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Emanuel Victor Nature Tours, 2012, VENT BIRD TOURS; Game Arizona and Fish Department, 2001, PACHYRAMPHUS A UNPUB; Greeney Harold F., 2010, Bulletin of the British Ornithologists' Club, V130, P61; Harris J.B.C., 2012, RAFFLES B ZOOL, V25, P189; Jepson P, 2011, B AFRICAN BIRD CLUB; Juina ME, 2009, ORNITOL NEOTROP, V20, P305; Krabbe N, 1999, AUK, V116, P882, DOI 10.2307/4089669; Krabbe N.K., 2003, P682; KROODSMA D. E., 2005, HDB BIRDS WORLD, V10, P356; Langham GM, 2006, ECOSCIENCE, V13, P485, DOI 10.2980/1195-6860(2006)13[485:WPWTPS]2.0.CO;2; Mann NI, 2006, BIOL LETTERS, V2, P1, DOI 10.1098/rsbl.2005.0373; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Michigan Department of Natural Resources, 2003, KIRTL WARBL DENDR KI; Mota PG, 2004, ETHOLOGY, V110, P841, DOI 10.1111/j.1439-0310.2004.01032.x; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; NORRIS K, 1993, J ANIM ECOL, V62, P287, DOI 10.2307/5360; Pinheiro J, 2010, PACKAGE NLME LINEAR; Quantrill B, 1998, B AFRICAN BIRD CLUB, P137; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ralph CJ, 1995, PSWGTR149 US FOR SER; Ridgely RS, 2001, THE BIRDS OF ECUADOR; Royal Society for the Protection of Birds, 2006, BIRDS HAB LAW; Scheipl F, 2010, PACKAGE RLRSIM EXACT; Sekercioglu C.H., 2003, BIRDING, V35, P394; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sen SK, 2009, ETHICS SCI BIRD CALL; Sibley David, 2011, PROPER USE PLAYBACK; Thomas RJ, 2002, ANIM BEHAV, V63, P959, DOI 10.1006/anbe.2001.1969; Thomas RJ, 2003, BEHAVIOUR, V140, P387, DOI 10.1163/156853903321826693; Ward MP, 2004, CONSERV BIOL, V18, P519, DOI 10.1111/j.1523-1739.2004.00494.x; Water Melbourne, 2012, BIRD WATCH PERM; WINGFIELD JC, 1995, ZOOL SCI, V12, P615, DOI 10.2108/zsj.12.615; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; de Lima AMX, 2009, REV BRAS ORNITOL, V17, P37; Zuur Alain F., 2009, P1	46	22	23	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77902	10.1371/journal.pone.0077902	http://dx.doi.org/10.1371/journal.pone.0077902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147094	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400141
J	Soyiri, IN; Reidpath, DD				Soyiri, Ireneous N.; Reidpath, Daniel D.			The Use of Quantile Regression to Forecast Higher Than Expected Respiratory Deaths in a Daily Time Series: A Study of New York City Data 1987-2000	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; AIR-POLLUTION; DAILY MORTALITY; HEALTH; PREDICTION; MODELS; OZONE; CARE	Forecasting higher than expected numbers of health events provides potentially valuable insights in its own right, and may contribute to health services management and syndromic surveillance. This study investigates the use of quantile regression to predict higher than expected respiratory deaths. Data taken from 70,830 deaths occurring in New York were used. Temporal, weather and air quality measures were fitted using quantile regression at the 90th-percentile with half the data (in-sample). Four QR models were fitted: an unconditional model predicting the 90th-percentile of deaths (Model 1), a seasonal / temporal (Model 2), a seasonal, temporal plus lags of weather and air quality (Model 3), and a seasonal, temporal model with 7-day moving averages of weather and air quality. Models were cross-validated with the out of sample data. Performance was measured as proportionate reduction in weighted sum of absolute deviations by a conditional, over unconditional models; i.e., the coefficient of determination (R1). The coefficient of determination showed an improvement over the unconditional model between 0.16 and 0.19. The greatest improvement in predictive and forecasting accuracy of daily mortality was associated with the inclusion of seasonal and temporal predictors (Model 2). No gains were made in the predictive models with the addition of weather and air quality predictors (Models 3 and 4). However, forecasting models that included weather and air quality predictors performed slightly better than the seasonal and temporal model alone (i.e., Model 3 > Model 4 > Model 2) This study provided a new approach to predict higher than expected numbers of respiratory related-deaths. The approach, while promising, has limitations and should be treated at this stage as a proof of concept.	[Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, SEACO, Kuala Lumpur, Malaysia; [Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Kuala Lumpur, Malaysia	Monash University; Monash University Sunway; Monash University; Monash University Sunway	Reidpath, DD (corresponding author), Monash Univ, Sch Med & Hlth Sci, SEACO, Kuala Lumpur, Malaysia.	daniel.reidpath@monash.edu	Soyiri, Ireneous N./H-4594-2011; Soyiri, Ireneous/AAE-7617-2019	Soyiri, Ireneous N./0000-0003-4697-5156; Soyiri, Ireneous/0000-0003-4697-5156; Reidpath, Daniel/0000-0002-8796-0420				BARNETT AG, 2010, ANAL SEASONAL HLTH D, P168; Beyerlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033205; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Burgette LF, 2011, EPIDEMIOLOGY, V22, P859, DOI 10.1097/EDE.0b013e31822908b3; Chatterjee C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004726; Cheng YX, 2012, J EPIDEMIOL, V22, P28, DOI 10.2188/jea.JE20110049; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2005, J TOXICOL ENV HEAL A, V68, P1071, DOI 10.1080/15287390590935932; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; HAO L, 2007, QUANTILE REGRESSION, P139; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Kam HJ, 2010, HEALTHC INFORM RES, V16, P158, DOI 10.4258/hir.2010.16.3.158; Koenker R, 2006, J AM STAT ASSOC, V101, P980, DOI 10.1198/016214506000000672; Machado JAF, 2005, J AM STAT ASSOC, V100, P1226, DOI 10.1198/016214505000000330; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; PENG RD, 2004, R NEWS, V4, P10; Rajarathnam Uma, 2011, Res Rep Health Eff Inst, P47; SOYIRI IN, 2012, INT J BIOMETEOROL, V57, P1; Soyiri IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047823; Soyiri IN, 2012, INT J GEN MED, V5, P693, DOI 10.2147/IJGM.S34647; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Sun Y, 2012, ANN EMERG MED, V60, P299, DOI 10.1016/j.annemergmed.2012.03.011; Tao YB, 2012, ENVIRON HEALTH PERSP, V120, P393, DOI 10.1289/ehp.1103715; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005; Winkelmann R, 2006, J HEALTH ECON, V25, P131, DOI 10.1016/j.jhealeco.2005.03.005; Yang CX, 2012, SCI TOTAL ENVIRON, V426, P83, DOI 10.1016/j.scitotenv.2012.03.036; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517; Zibners LM, 2006, PEDIATR EMERG CARE, V22, P104, DOI 10.1097/01.pec.0000199561.34475.29	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78215	10.1371/journal.pone.0078215	http://dx.doi.org/10.1371/journal.pone.0078215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147122	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400147
J	Quintavalle, C; Mangani, D; Roscigno, G; Romano, G; Diaz-Lagares, A; Iaboni, M; Donnarumma, E; Fiore, D; De Marinis, P; Soini, Y; Esteller, M; Condorelli, G				Quintavalle, Cristina; Mangani, Davide; Roscigno, Giuseppina; Romano, Giulia; Diaz-Lagares, Angel; Iaboni, Margherita; Donnarumma, Elvira; Fiore, Danilo; De Marinis, Pasqualino; Soini, Ylermi; Esteller, Manel; Condorelli, Gerolama			miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells	PLOS ONE			English	Article							PROMOTER METHYLATION; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMAS; GLIOBLASTOMA; CANCER; MICRORNAS; MICE; OVEREXPRESSION; TUMORIGENESIS	Glioblastoma multiforme (GBM) is one of the most deadly types of cancer. To date, the best clinical approach for treatment is based on administration of temozolomide (TMZ) in combination with radiotherapy. Much evidence suggests that the intracellular level of the alkylating enzyme O-6-methylguanine-DNA methyltransferase (MGMT) impacts response to TMZ in GBM patients. MGMT expression is regulated by the methylation of its promoter. However, evidence indicates that this is not the only regulatory mechanism present. Here, we describe a hitherto unknown microRNA-mediated mechanism of MGMT expression regulation. We show that miR-221 and miR-222 are upregulated in GMB patients and that these paralogues target MGMT mRNA, inducing greater TMZ-mediated cell death. However, miR-221/miR-222 also increase DNA damage and, thus, chromosomal rearrangements. Indeed, miR-221 overexpression in glioma cells led to an increase in markers of DNA damage, an effect rescued by reexpression of MGMT. Thus, chronic miR-221/222-mediated MGMT downregulation may render cells unable to repair genetic damage. This, associated also to miR-221/222 oncogenic potential, may poor GBM prognosis.	[Quintavalle, Cristina; Mangani, Davide; Roscigno, Giuseppina; Iaboni, Margherita; Fiore, Danilo; Condorelli, Gerolama] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Quintavalle, Cristina; Roscigno, Giuseppina; Condorelli, Gerolama] CNR, IEOS, I-80125 Naples, Italy; [Romano, Giulia; Donnarumma, Elvira] Fdn IRCCS SDN, Naples, Italy; [Diaz-Lagares, Angel; Esteller, Manel] Hosp Duran & Reynals, Epigenet & Canc Biol Program PEBC IDIBELL, Barcelona, Spain; [De Marinis, Pasqualino] Osped Cardarelli, Naples, Italy; [Soini, Ylermi] Univ Eastern Finland, Canc Ctr Eastern Finland, Inst Clin Med Pathol & Forens Med, Dept Pathol & Forens Med,Sch Med, Kuopio, Finland	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Antonio Cardarelli Hospital; University of Eastern Finland	Condorelli, G (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	gecondor@unina.it	Fiore, Danilo/A-6002-2019; Quintavalle, Cristina/AHH-9379-2022; Esteller, Manel/L-5956-2014; Condorelli, Gerolama/AAC-3472-2022; Mangani, Davide/A-3383-2017	Fiore, Danilo/0000-0003-3004-6862; Esteller, Manel/0000-0003-4490-6093; Condorelli, Gerolama/0000-0003-0177-8829; Mangani, Davide/0000-0001-5297-0234; Roscigno, Giuseppina/0000-0002-5359-6376	Associazione Italiana Ricerca sul Cancro [10620]; MERIT [RBNE08E8CZ_002]; POR Campania; Project CREME; "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship; Xunta de Galicia and European Social Fund; Sara Borrell postdoctoral contract from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness [CD12/00738]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MERIT; POR Campania(Regione Campania); Project CREME; "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship(Fondazione AIRC per la ricerca sul cancro); Xunta de Galicia and European Social Fund; Sara Borrell postdoctoral contract from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness	This work was partially supported by funds from Associazione Italiana Ricerca sul Cancro, to GC (grant n.ro 10620), MERIT (RBNE08E8CZ_002) to GC, POR Campania FSE 2007-2013, Project CREME to GC. CQ and MI was supported by the "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship. GR was supported by a MERIT project Fellowship. ADL was supported by the Angeles Alvarino-2009 postdoctoral fellowship from the Xunta de Galicia and European Social Fund and at present is the recipient of a Sara Borrell postdoctoral contract (CD12/00738) from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allay E, 1999, ONCOGENE, V18, P3783, DOI 10.1038/sj.onc.1202697; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Esteller M, 1999, CANCER RES, V59, P793; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Reese JS, 2001, ONCOGENE, V20, P5258, DOI 10.1038/sj.onc.1204700; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Sakumi K, 1997, CANCER RES, V57, P2415; Sandercock LE, 2008, CARCINOGENESIS, V29, P866, DOI 10.1093/carcin/bgn030; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2013, NAT REV CLIN ONCOL, V10, P69, DOI 10.1038/nrclinonc.2012.240; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; WALTER CA, 1993, CARCINOGENESIS, V14, P1537, DOI 10.1093/carcin/14.8.1537; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089	37	69	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74466	10.1371/journal.pone.0074466	http://dx.doi.org/10.1371/journal.pone.0074466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24147153	Green Submitted, gold, Green Published			2022-12-25	WOS:000324777300035
J	Desquiret-Dumas, V; Gueguen, N; Leman, G; Baron, S; Nivet-Antoine, V; Chupin, S; Chevrollier, A; Vessieres, E; Ayer, A; Ferre, M; Bonneau, D; Henrion, D; Reynier, P; Procaccio, V				Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Baron, Stephanie; Nivet-Antoine, Valerie; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent			Resveratrol Induces a Mitochondrial Complex I-dependent Increase in NADH Oxidation Responsible for Sirtuin Activation in Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Mitochondrial Metabolism; NAD; Resveratrol; Sirtuins; Complex I; NADH Dehydrogenase	NICOTINAMIDE-ADENINE-DINUCLEOTIDE; FATTY-ACID OXIDATION; FLUORESCENCE SPECTROSCOPY; UBIQUINONE OXIDOREDUCTASE; METABOLISM; AMPK; PROTECTS; MICE; DEHYDROGENASE; PGC-1-ALPHA	Background: The mechanism of action of resveratrol on sirtuin and mitochondrial metabolism remains elusive. Results: Resveratrol increases the mitochondrial NAD(+) level by direct stimulation of complex I, leading to a SIRT3-dependent increase in substrate supplies. Conclusion: Our results link the direct stimulation by resveratrol of NADH oxidation to the SIRT3 activation. Significance: Mitochondrial NAD(+)/NADH ratio is a critical parameter mediating resveratrol effect on mitochondrial function. Resveratrol (RSV) has been shown to be involved in the regulation of energetic metabolism, generating increasing interest in therapeutic use. SIRT1 has been described as the main target of RSV. However, recent reports have challenged the hypothesis of its direct activation by RSV, and the signaling pathways remain elusive. Here, the effects of RSV on mitochondrial metabolism are detailed both in vivo and in vitro using murine and cellular models and isolated enzymes. We demonstrate that low RSV doses (1-5 m) directly stimulate NADH dehydrogenases and, more specifically, mitochondrial complex I activity (EC50 approximate to 1 m). In HepG2 cells, this complex I activation increases the mitochondrial NAD(+)/NADH ratio. This higher NAD(+) level initiates a SIRT3-dependent increase in the mitochondrial substrate supply pathways (i.e. the tricarboxylic acid cycle and fatty acid oxidation). This effect is also seen in liver mitochondria of RSV-fed animals (50 mg/kg/day). We conclude that the increase in NADH oxidation by complex I is a crucial event for SIRT3 activation by RSV. Our results open up new perspectives in the understanding of the RSV signaling pathway and highlight the critical importance of RSV doses used for future clinical trials.	[Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent] Univ Angers, F-49000 Angers, France; [Desquiret-Dumas, Valerie; Gueguen, Naig; Chupin, Stephanie; Chevrollier, Arnaud; Ferre, Marc; Bonneau, Dominique; Reynier, Pascal; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, F-49000 Angers, France; [Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent] CNRS, INSERM, UMR 6214, U1083, F-49000 Angers, France; [Baron, Stephanie; Nivet-Antoine, Valerie] Univ Paris 05, Fac Pharm, EA 4466, F-75270 Paris, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UDICE-French Research Universities; Universite Paris Cite	Procaccio, V (corresponding author), CHU Angers, Dept Biochim & Genet, 4 Rue Larrey, F-49933 Angers, France.	ViProcaccio@chu-angers.fr	Nivet-Antoine, Valerie/R-1981-2017; Bonneau, Dominique/K-6110-2015; Baron, Stephanie/AAY-5703-2020; Henrion, Daniel/N-7023-2015; FERRE, Marc/B-4103-2010; CHEVROLLIER, Arnaud/P-6630-2019; Reynier, Pascal/K-3677-2015; Ayer, Audrey/D-5384-2015; Desquiret-Dumas, Valérie/K-2695-2015; LENAERS, Guy/K-2421-2015; Henrion, Daniel/AAK-1995-2021; vessieres, emilie/K-1894-2015; CHEVROLLIER, Arnaud/K-2853-2015; Henrion, Daniel/J-8141-2015; CHEVROLLIER, Arnaud/GSD-3887-2022	Nivet-Antoine, Valerie/0000-0003-2490-0428; Baron, Stephanie/0000-0002-0375-6968; Henrion, Daniel/0000-0003-1094-0285; FERRE, Marc/0000-0001-8265-7249; CHEVROLLIER, Arnaud/0000-0002-5135-6643; LENAERS, Guy/0000-0003-2736-3349; Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Reynier, Pascal/0000-0003-0802-4608; procaccio, Vincent/0000-0002-1537-4684; Desquiret-Dumas, Valerie/0000-0001-9551-9400; Gueguen, Naig/0000-0002-3094-8121; Bonneau, Dominique/0000-0002-6886-0969	Region Pays de la Loire; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Region Pays de la Loire(Region Pays de la Loire); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	This work was supported by grants from "Region Pays de la Loire," "Agence Nationale de la Recherche," "Fondation pour la Recherche Medicale," "Union Nationale des Aveugles et Deficients Visuels," "Retina France," "Ouvrir les Yeux," and "Association contre les Maladies Mitochondriales."	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Flamment M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1162, DOI 10.1152/ajpendo.00169.2009; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goncalves S, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-5; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jiang YG, 2008, CHINESE MED J-PEKING, V121, P1204, DOI 10.1097/00029330-200807010-00010; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kitson TM, 2001, CHEM-BIOL INTERACT, V130, P57, DOI 10.1016/S0009-2797(00)00222-2; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Lopez-Nicolas JM, 2008, J AGR FOOD CHEM, V56, P7600, DOI 10.1021/jf800843e; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; MINEZAKI KK, 1994, J PHYSIOL-LONDON, V476, P459, DOI 10.1113/jphysiol.1994.sp020147; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Richard T., 2001, ANN NY ACAD SCI, V1215, P103; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Stefanatos R, 2011, CELL CYCLE, V10, P1528, DOI 10.4161/cc.10.10.15496; Sun F., 2012, PLOS ONE, V7; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Ungvari Z, 2011, EXERC SPORT SCI REV, V39, P128, DOI 10.1097/JES.0b013e3182141f80; Vinogradov AD, 2008, BBA-BIOENERGETICS, V1777, P729, DOI 10.1016/j.bbabio.2008.04.014; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514	57	97	102	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36662	36675		10.1074/jbc.M113.466490	http://dx.doi.org/10.1074/jbc.M113.466490			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178296	Green Published, hybrid			2022-12-25	WOS:000328883400045
J	Zhou, L; Lovell, KM; Frankowski, KJ; Slauson, SR; Phillips, AM; Streicher, JM; Stahl, E; Schmid, CL; Hodder, P; Madoux, F; Cameron, MD; Prisinzano, TE; Aube, J; Bohn, LM				Zhou, Lei; Lovell, Kimberly M.; Frankowski, Kevin J.; Slauson, Stephen R.; Phillips, Angela M.; Streicher, John M.; Stahl, Edward; Schmid, Cullen L.; Hodder, Peter; Madoux, Franck; Cameron, Michael D.; Prisinzano, Thomas E.; Aube, Jeffrey; Bohn, Laura M.			Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Brain; Drug Discovery; ERK; G Protein-coupled Receptors (GPCR); Opiate Opioid; Pain; Dysphoria; Kappa Opioid Receptor	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN 2; OPIATE RECEPTORS; KINASE-C; ACTIVATION; ANALGESIA; ANTAGONIST; DYNORPHIN; STRESS; MICE	Background: Kappa opioid receptor (KOR) signaling may produce antinociception through G protein or dysphoria through arrestin pathways. Results: Two highly selective, brain penetrant agonist scaffolds bias KOR signaling toward G protein coupling and produce antinociception in mice. Conclusion: Described are first-in-class small molecule agonists that bias KOR signaling through G proteins. Significance: Functionally selective KOR agonists can now be used in vivo. The kappa opioid receptor (KOR) is widely expressed in the CNS and can serve as a means to modulate pain perception, stress responses, and affective reward states. Therefore, the KOR has become a prominent drug discovery target toward treating pain, depression, and drug addiction. Agonists at KOR can promote G protein coupling and arrestin2 recruitment as well as multiple downstream signaling pathways, including ERK1/2 MAPK activation. It has been suggested that the physiological effects of KOR activation result from different signaling cascades, with analgesia being G protein-mediated and dysphoria being mediated through arrestin2 recruitment. Dysphoria associated with KOR activation limits the therapeutic potential in the use of KOR agonists as analgesics; therefore, it may be beneficial to develop KOR agonists that are biased toward G protein coupling and away from arrestin2 recruitment. Here, we describe two classes of biased KOR agonists that potently activate G protein coupling but weakly recruit arrestin2. These potent and functionally selective small molecule compounds may prove to be useful tools for refining the therapeutic potential of KOR-directed signaling in vivo.	[Zhou, Lei; Lovell, Kimberly M.; Phillips, Angela M.; Streicher, John M.; Stahl, Edward; Schmid, Cullen L.; Cameron, Michael D.; Bohn, Laura M.] Scripps Res Inst, Dept Mol Therapeut & Neurosci, Jupiter, FL 33458 USA; [Hodder, Peter; Madoux, Franck] Scripps Res Inst, Dept Lead Identificat, Jupiter, FL 33458 USA; [Frankowski, Kevin J.; Slauson, Stephen R.; Prisinzano, Thomas E.; Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA	Scripps Research Institute; Scripps Research Institute; University of Kansas	Aube, J (corresponding author), Univ Kansas, Dept Med Chem, 2034 Becker Dr, Lawrence, KS 66047 USA.	jaube@ku.edu; lbohn@scripps.edu	Prisinzano, Thomas E/B-7877-2010; Bohn, Laura M/A-7483-2014	Bohn, Laura M/0000-0002-6474-8179; Aube, Jeffrey/0000-0003-1049-5767; Slauson, Stephen/0000-0002-2811-2894; Prisinzano, Thomas/0000-0002-0649-8052; Schmid Mason, Cullen/0000-0002-2882-1842; Streicher, John/0000-0002-4173-7362	National Institutes of Health [R01 DA031927]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA031927 (to L. M. B. and J. A.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ananthan S, 2012, J MED CHEM, V55, P8350, DOI 10.1021/jm300686p; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn Laura M, 2010, Drug Discov Today Technol, V7, pe37, DOI 10.1016/j.ddtec.2010.06.005; Bohn Laura M., 2009, P71, DOI 10.1007/978-1-60327-335-0_5; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; Breivogel CS, 2004, NEUROPHARMACOLOGY, V47, P81, DOI 10.1016/j.neuropharm.2004.02.017; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chavkin C, 2011, NEUROPSYCHOPHARMACOL, V36, P369, DOI 10.1038/npp.2010.137; Cox BM, 2013, MOL PHARMACOL, V83, P723, DOI 10.1124/mol.112.083279; DYKSTRA LA, 1987, J PHARMACOL EXP THER, V242, P413; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Frankowski KJ, 2007, J COMB CHEM, V9, P1188, DOI 10.1021/cc700127f; Frankowski KJ, 2012, ACS CHEM NEUROSCI, V3, P221, DOI 10.1021/cn200128x; Frankowski KJ, 2010, ACS MED CHEM LETT, V1, P189, DOI 10.1021/ml100040t; Goicoechea C, 1999, NEUROSCI LETT, V273, P175, DOI 10.1016/S0304-3940(99)00640-0; Gullapalli S, 2002, BRAIN RES, V946, P191, DOI 10.1016/S0006-8993(02)02880-9; Hedrick M. P., 2010, PROBE REPORTS NIH MO; Jones RM, 2000, EUR J PHARMACOL, V396, P49, DOI 10.1016/S0014-2999(00)00208-9; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; LAHTI RA, 1985, EUR J PHARMACOL, V109, P281, DOI 10.1016/0014-2999(85)90431-5; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; LAWRENCE DMP, 1993, J PHARMACOL EXP THER, V266, P1678; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; MA GH, 1995, MOL PHARMACOL, V47, P1035; MACDONALD RL, 1986, J PHYSIOL-LONDON, V377, P237, DOI 10.1113/jphysiol.1986.sp016184; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; McGuinness R, 2007, CURR OPIN PHARMACOL, V7, P535, DOI 10.1016/j.coph.2007.08.004; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; MILLAN MJ, 1989, J PHARMACOL EXP THER, V251, P342; MINAMI M, 1995, NEUROSCI RES, V23, P121, DOI 10.1016/0168-0102(95)00933-K; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; PASTERNAK GW, 1980, P NATL ACAD SCI-BIOL, V77, P3691, DOI 10.1073/pnas.77.6.3691; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; PRATHER PL, 1995, MOL BRAIN RES, V29, P336, DOI 10.1016/0169-328X(94)00264-F; Raehal KM, 2009, DRUG ALCOHOL DEPEN, V104, P187, DOI 10.1016/j.drugalcdep.2009.04.011; Raehal KM, 2005, AAPS J, V7, pE587, DOI 10.1208/aapsj070360; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rives ML, 2012, J BIOL CHEM, V287, P27050, DOI 10.1074/jbc.C112.387332; Robinson J., 2013, ASSAY DRUG DEV TECHN, DOI 10.1089/adt.2013.526; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Schmid CL, 2013, J BIOL CHEM, V288, P22387, DOI 10.1074/jbc.M113.476234; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Thomas JB, 2001, J MED CHEM, V44, P2687, DOI 10.1021/jm015521r; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valko K, 2001, CURR MED CHEM, V8, P1137, DOI 10.2174/0929867013372643; VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	64	106	115	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36703	36716		10.1074/jbc.M113.504381	http://dx.doi.org/10.1074/jbc.M113.504381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24187130	Green Published, hybrid			2022-12-25	WOS:000328883400048
J	Joseph, J; Wang, S; Lee, J; Ro, JY; Chung, MK				Joseph, John; Wang, Sen; Lee, Jongseok; Ro, Jin Y.; Chung, Man-Kyo			Carboxyl-terminal Domain of Transient Receptor Potential Vanilloid 1 Contains Distinct Segments Differentially Involved in Capsaicin- and Heat-induced Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pain; Patch Clamp Electrophysiology; Receptor Desensitization; Transfection; TRP Channels; Heat	TRP CHANNELS; ION-CHANNEL; BODY-TEMPERATURE; PORE DOMAIN; ACTIVATION; SENSITIVITY; BINDING; THERMOSENSATION; KERATINOCYTES; DETERMINANT	Background: Mechanisms of TRPV1 desensitization by heat are not fully understood. Results: Distinct segments of the TRPV1 carboxyl-terminal domain are differentially involved in capsaicin- and heat-induced desensitization. Conclusion: Capsaicin and heat desensitizes TRPV1 through a distinct structural basis. Significances: Selective enhancement of desensitization could be a novel strategy for suppressing heat hyperalgesia. Multiple Ca2+-dependent processes are involved in capsaicin-induced desensitization of transient receptor potential vanilloid 1 (TRPV1), but desensitization of TRPV1 by heat occurs even in the absence of extracellular Ca2+, although the mechanisms are unknown. In this study, we tested the hypothesis that capsaicin and heat desensitize TRPV1 through distinct mechanisms involving distinct structural segments of TRPV1. In HEK293 cells that heterologously express TRPV1, we found that heat-induced desensitization was not affected by the inclusion of intracellular ATP or alanine mutation of Lys(155), both of which attenuate capsaicin-induced desensitization, suggesting that heat-induced desensitization occurs through mechanisms distinct from capsaicin-induced desensitization. To determine protein domains involved in heat-induced desensitization, we generated chimeric proteins between TRPV1 and TRPV3, a heat-gated channel lacking heat-induced desensitization. We found that TRPV1 with the carboxyl-terminal domain (CTD) of TRPV3 retained heat activation but was impaired in heat-induced desensitization. Further experiments using chimeric or deletion mutants within TRPV1 CTD indicated that the distal half of CTD regulates the activation and desensitization of TRPV1 in modality-specific manners. Within the distal CTD, we identified two segments that distinctly regulated capsaicin- and heat-induced desensitization. The results suggest that the activation and desensitization of TRPV1 by capsaicin and heat can be modulated differentially and disproportionally through different regions of TRPV1 CTD. Identifying the domains involved in thermal regulation of TRPV1 may facilitate the development of novel anti-hyperalgesic approaches aimed at attenuating activation and enhancing desensitization of TRPV1 by thermal stimuli.	[Joseph, John; Wang, Sen; Lee, Jongseok; Ro, Jin Y.; Chung, Man-Kyo] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chung, MK (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA.	mchung@umaryland.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148	NIDCR, National Institutes of Health Grants [DE020866, DE016062]; University of Maryland Dental School start-up fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE020866, R01DE016062] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health Grants; University of Maryland Dental School start-up fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by NIDCR, National Institutes of Health Grants DE020866 (to M.-K. C.) and DE016062 (to J. Y. R.). This work was also supported by the University of Maryland Dental School start-up fund (to M.-K. C.).	Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chaudhury S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-34; Chung MK, 2011, J DENT RES, V90, P1098, DOI 10.1177/0022034511412074; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2011, ADV EXP MED BIOL, V704, P615, DOI 10.1007/978-94-007-0265-3_33; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huang Susan M, 2013, Open Pain J, V6, P119; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Koplas PA, 1997, J NEUROSCI, V17, P3525; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lau SY, 2012, J GEN PHYSIOL, V140, P541, DOI 10.1085/jgp.201210810; Lee J, 2012, BIOCHEM BIOPH RES CO, V424, P358, DOI 10.1016/j.bbrc.2012.07.008; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Reilly RM, 2012, J PHARMACOL EXP THER, V342, P416, DOI 10.1124/jpet.111.190314; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Wang S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-22; Watabiki T, 2011, J PHARMACOL EXP THER, V336, P743, DOI 10.1124/jpet.110.175570; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	48	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35690	35702		10.1074/jbc.M113.513374	http://dx.doi.org/10.1074/jbc.M113.513374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174527	hybrid, Green Published			2022-12-25	WOS:000329814700008
J	Dias, FA; Gandara, ACP; Queiroz-Barros, FG; Oliveira, RLL; Sorgine, MHF; Braz, GRC; Oliveira, PL				Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Oliveira, Raquel L. L.; Sorgine, Marcos H. F.; Braz, Gloria R. C.; Oliveira, Pedro L.			Ovarian Dual Oxidase (Duox) Activity Is Essential for Insect Eggshell Hardening and Waterproofing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Insect; NADPH Oxidase; Protein Cross-linking; Reproduction; Eggshell; Waterproofing	TIME QUANTITATIVE PCR; DROSOPHILA-MELANOGASTER; RHODNIUS-PROLIXUS; AEDES-AEGYPTI; CROSS-LINKING; HUMAN MYELOPEROXIDASE; EXTRACELLULAR-MATRIX; HYDROGEN-PEROXIDE; CHORION PROTEINS; REACTIVE OXYGEN	Background: Hardening of the insect eggshell is due to peroxidases that promote protein cross-linking via H2O2, from an unknown source. Results: In Rhodnius prolixus, this H2O2 is produced by Duox, and it also contributes to waterproofing, preventing desiccation. Conclusion: H2O2 from Duox has a double role in protecting the Rhodnius eggshell. Significance: Duox activity is essential to insect reproduction. In insects, eggshell hardening involves cross-linking of chorion proteins via their tyrosine residues. This process is catalyzed by peroxidases at the expense of H2O2 and confers physical and biological protection to the developing embryo. Here, working with Rhodnius prolixus, the insect vector of Chagas disease, we show that an ovary dual oxidase (Duox), a NADPH oxidase, is the source of the H2O2 that supports dityrosine-mediated protein cross-linking and eggshell hardening. RNAi silencing of Duox activity decreased H2O2 generation followed by a failure in embryo development caused by a reduced resistance to water loss, which, in turn, caused embryos to dry out following oviposition. Phenotypes of Duox-silenced eggs were reversed by incubation in a water-saturated atmosphere, simultaneous silencing of the Duox and catalase genes, or H2O2 injection into the female hemocoel. Taken together, our results show that Duox-generated H2O2 fuels egg chorion hardening and that this process plays an essential role during eggshell waterproofing.	[Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Sorgine, Marcos H. F.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo De Meis, BR-21941590 Rio De Janeiro, Brazil; [Oliveira, Raquel L. L.; Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Dept Bioquim, Inst Quim, BR-21945570 Rio De Janeiro, Brazil; [Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Oliveira, Raquel L. L.; Sorgine, Marcos H. F.; Braz, Gloria R. C.; Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol INCT EM, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Dias, FA (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.	felipe.dias@bioqmed.ufrj.br	Dias, Felipe/L-7390-2013; L. Oliveira, Pedro/A-9438-2010	Dias, Felipe/0000-0003-2074-1052; Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Paiva Gandara, Ana Caroline/0000-0003-3194-4453; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ).	Andersen SA, 2005, INSECT BIOCHEM MOLEC, V35, P1181, DOI 10.1016/j.ibmb.2005.05.009; BEAMENT JWL, 1946, PROC R SOC SER B-BIO, V133, P407, DOI 10.1098/rspb.1946.0021; BEAMENT JWL, 1946, Q J MICROSC SCI, V87, P392; BEAMENT JWL, 1946, NATURE, V157, P370, DOI 10.1038/157370c0; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li JSS, 2006, INSECT BIOCHEM MOLEC, V36, P954, DOI 10.1016/j.ibmb.2006.09.006; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margaritis L.H., 1985, COMPREHENSIVE INSECT, P151; MARGARITIS LH, 1985, TISSUE CELL, V17, P553, DOI 10.1016/0040-8166(85)90031-X; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MINDRINOS MN, 1980, ROUX ARCH DEV BIOL, V189, P187, DOI 10.1007/BF00868677; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; Nguyen TTA, 2011, J BIOL CHEM, V286, P33244, DOI 10.1074/jbc.M111.263178; OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0; PAPASSIDERI IS, 1993, TISSUE CELL, V25, P929, DOI 10.1016/0040-8166(93)90041-I; Papassideri IS, 1996, TISSUE CELL, V28, P401, DOI 10.1016/S0040-8166(96)80026-7; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82; Shaik KS, 2012, EUR J CELL BIOL, V91, P204, DOI 10.1016/j.ejcb.2011.11.005; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wong JL, 2005, DEV BIOL, V288, P317, DOI 10.1016/j.ydbio.2005.07.004; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Wong JL, 2008, DEVELOPMENT, V135, P431, DOI 10.1242/dev.015503; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200	41	26	27	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35058	35067		10.1074/jbc.M113.522201	http://dx.doi.org/10.1074/jbc.M113.522201			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24174530	hybrid, Green Published			2022-12-25	WOS:000329867600008
J	Aravindraja, C; Viszwapriya, D; Pandian, SK				Aravindraja, Chairmandurai; Viszwapriya, Dharmaprakash; Pandian, Shunmugiah Karutha			Ultradeep 16S rRNA Sequencing Analysis of Geographically Similar but Diverse Unexplored Marine Samples Reveal Varied Bacterial Community Composition	PLOS ONE			English	Article							CORAL ACROPORA-DIGITIFERA; PHYLOGENETIC CHARACTERIZATION; MICROBIAL DIVERSITY; BACILLUS-PUMILUS; GENERATION; LIBRARIES; MUCUS; GULF	Background: Bacterial community composition in the marine environment differs from one geographical location to another. Reports that delineate the bacterial diversity of different marine samples from geographically similar location are limited. The present study aims to understand whether the bacterial community compositions from different marine samples harbour similar bacterial diversity since these are geographically related to each other. Methods and Principal Findings: In the present study, 16S rRNA deep sequencing analysis targeting V3 region was performed using Illumina bar coded sequencing. A total of 22.44 million paired end reads were obtained from the metagenomic DNA of Marine sediment, Rhizosphere sediment, Seawater and the epibacterial DNA of Seaweed and Seagrass. Diversity index analysis revealed that Marine sediment has the highest bacterial diversity and the least bacterial diversity was observed in Rhizosphere sediment. Proteobacteria, Actinobacteria and Bacteroidetes were the dominant taxa present in all the marine samples. Nearly 62-71% of rare species were identified in all the samples and most of these rare species were unique to a particular sample. Further taxonomic assignment at the phylum and genus level revealed that the bacterial community compositions differ among the samples. Conclusion: This is the first report that supports the fact that, bacterial community composition is specific for specific samples irrespective of its similar geographical location. Existence of specific bacterial community for each sample may drive overall difference in bacterial structural composition of each sample. Further studies like whole metagenomic sequencing will throw more insights to the key stone players and its interconnecting metabolic pathways. In addition, this is one of the very few reports that depicts the unexplored bacterial diversity of marine samples (Marine sediment, Rhizosphere sediment, Seawater) and the host associated marine samples (Seaweed and Seagrass) at higher depths from uncharacterised coastal region of Palk Bay, India using next generation sequencing technology.	[Aravindraja, Chairmandurai; Viszwapriya, Dharmaprakash; Pandian, Shunmugiah Karutha] Alagappa Univ, Dept Biotechnol, Karaikkudi, Tamil Nadu, India	Alagappa University	Pandian, SK (corresponding author), Alagappa Univ, Dept Biotechnol, Karaikkudi, Tamil Nadu, India.	sk_pandian@rediffmail.com	Pandian, Shunmugiah Karutha/AAV-2803-2020; Shunmugiah, Karutha Pandian/B-6765-2018; Aravindraja, Chairmandurai/GLS-1403-2022	Pandian, Shunmugiah Karutha/0000-0003-2925-0575; Shunmugiah, Karutha Pandian/0000-0003-2925-0575; 	Department of Biotechnology (DBT), the Government of India (GOI) [BT/PR11994/NDB/52/134/2009]; Department of Biotechnology (DBT), the Government of India (GOI); Council of Scientific and Industrial Research (CSIR), India [09/688(0017)/2011-EMR-I]; DBT, GOI [BT/BI/25/001/2006]	Department of Biotechnology (DBT), the Government of India (GOI)(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT), the Government of India (GOI)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT, GOI(Department of Biotechnology (DBT) India)	This study was supported by a Research grant from Department of Biotechnology (DBT), the Government of India (GOI) (Grant number BT/PR11994/NDB/52/134/2009). Financial support provided to CA and DV in the form of Junior Research Fellowship from Department of Biotechnology (DBT), the Government of India (GOI) and Council of Scientific and Industrial Research (CSIR) (09/688(0017)/2011-EMR-I, India, respectively is gratefully acknowledged. The authors sincerely acknowledge the computational and bioinformatics facility provided by the Alagappa University Bioinformatics Infrastructure Facility (funded by DBT, GOI; Grant No, BT/BI/25/001/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen MC, 2002, BIODIVERS CONSERV, V11, P113, DOI 10.1023/A:1014098917535; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Burke C, 2009, APPL ENVIRON MICROB, V75, P252, DOI 10.1128/AEM.01630-08; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jiang YX, 2011, J BIOSCI BIOENG, V111, P153, DOI 10.1016/j.jbiosc.2010.10.006; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nithya C, 2012, APPL BIOCHEM BIOTECH, V167, P1763, DOI 10.1007/s12010-012-9578-y; Nithya C, 2011, BIOFOULING, V27, P519, DOI 10.1080/08927014.2011.586127; Nithya C, 2010, RES MICROBIOL, V161, P293, DOI 10.1016/j.resmic.2010.03.002; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pandey S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-35; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	37	51	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76724	10.1371/journal.pone.0076724	http://dx.doi.org/10.1371/journal.pone.0076724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167548	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500007
J	Hilderink, J; Otto, C; Slump, C; Lenferink, A; Engelse, M; van Blitterswijk, C; de Koning, E; Karperien, M; van Apeldoorn, A				Hilderink, Janneke; Otto, Cees; Slump, Cees; Lenferink, Aufried; Engelse, Marten; van Blitterswijk, Clemens; de Koning, Eelco; Karperien, Marcel; van Apeldoorn, Aart			Label-Free Detection of Insulin and Glucagon within Human Islets of Langerhans Using Raman Spectroscopy	PLOS ONE			English	Article							DIABETES-MELLITUS; CELL FUNCTION; LIVING CELLS; STEM-CELLS; IN-VIVO; TRANSPLANTATION; MICROSCOPY; DISEASE; MICROSPECTROSCOPY; EPIDEMIOLOGY	Intrahepatic transplantation of donor islets of Langerhans is a promising therapy for patients with type 1 diabetes. It is of critical importance to accurately monitor islet quality before transplantation, which is currently done by standard histological methods that are performed off-line and require extensive sample preparation. As an alternative, we propose Raman spectroscopy which is a non-destructive and label-free technique that allows continuous real-time monitoring of the tissue to study biological changes as they occur. By performing Raman spectroscopic measurements on purified insulin and glucagon, we showed that the 520 cm(-1) band assigned to disulfide bridges in insulin, and the 1552 cm(-1) band assigned to tryptophan in glucagon are mutually exclusive and could therefore be used as indirect markers for the label-free distinction between both hormones. High-resolution hyperspectral Raman imaging for these bands showed the distribution of disulfide bridges and tryptophan at sub-micrometer scale, which correlated with the location of insulin and glucagon as revealed by conventional immunohistochemistry. As a measure for this correlation, quantitative analysis was performed comparing the Raman images with the fluorescence images, resulting in Dice coefficients (ranging between 0 and 1) of 0.36 for insulin and 0.19 for glucagon. Although the use of separate microscope systems with different spatial resolution and the use of indirect Raman markers cause some image mismatch, our findings indicate that Raman bands for disulfide bridges and tryptophan can be used as distinctive markers for the label-free detection of insulin and glucagon in human islets of Langerhans.	[Hilderink, Janneke; Karperien, Marcel; van Apeldoorn, Aart] Univ Twente, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands; [Otto, Cees; Lenferink, Aufried] Univ Twente, Dept Med Cell Biophys, NL-7500 AE Enschede, Netherlands; [Slump, Cees] Univ Twente, Dept Syst & Signals, NL-7500 AE Enschede, Netherlands; [Engelse, Marten; de Koning, Eelco] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van Blitterswijk, Clemens] Univ Twente, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Twente	van Apeldoorn, A (corresponding author), Univ Twente, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.	A.A.vanApeldoorn@utwente.nl	Otto, Cees/H-8421-2019; de Koning, Eelco JP/H-6030-2011; van Apeldoorn, Aart/AAP-5433-2021; Karperien, Marcel/R-3270-2018	de Koning, Eelco JP/0000-0002-1232-7022; van Apeldoorn, Aart/0000-0002-2940-5699; Lenferink, Aufried/0000-0002-8210-5898; van Blitterswijk, Clemens/0000-0003-2371-4615; Karperien, Marcel/0000-0003-0751-0604	Dutch Program for Tissue Engineering (DPTE); Dutch Fund for Economic Structure Reinforcement (FES); Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI)	Dutch Program for Tissue Engineering (DPTE); Dutch Fund for Economic Structure Reinforcement (FES); Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI)	The authors gratefully acknowledge the financial support of the Dutch Program for Tissue Engineering (DPTE), the Dutch Fund for Economic Structure Reinforcement (FES) and the Dutch Diabetes Research Foundation as part of the Diabetes Cell Therapy Initiative (DCTI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1992, DIABETES, V41, P508, DOI 10.2337/diabetes.41.4.508; Antkowiak PF, 2009, AM J PHYSIOL-ENDOC M, V296, pE573, DOI 10.1152/ajpendo.90336.2008; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chan JW, 2009, J BIOPHOTONICS, V2, P656, DOI 10.1002/jbio.200910041; Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Ellis DI, 2013, ANALYST, V138, P3871, DOI 10.1039/c3an00698k; Hervada-Sala C, 2004, COMPUT GEOSCI-UK, V30, P881, DOI 10.1016/j.cageo.2004.07.003; Jue T, 2010, BIOMEDICAL APPL BIOP; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Langer RM, 2010, TRANSPL P, V42, P1421, DOI 10.1016/j.transproceed.2010.04.021; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Mariani MM, 2010, INTEGR BIOL-UK, V2, P94, DOI 10.1039/b920572a; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moore A, 2001, DIABETES, V50, P2231, DOI 10.2337/diabetes.50.10.2231; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378; Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215; Ortiz C, 2004, ANAL BIOCHEM, V332, P245, DOI 10.1016/j.ab.2004.06.013; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petrich W, 2000, APPL OPTICS, V39, P3372, DOI 10.1364/AO.39.003372; Pully VV, 2009, J RAMAN SPECTROSC, V40, P473, DOI 10.1002/jrs.2269; Raman CV, 1998, CURR SCI INDIA, V74, P381; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Rong X, 2010, BIOPOLYMERS; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2006, PHYSIOLOGY, V21, P189, DOI 10.1152/physiol.00002.2006; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro A M, 2000, Diabetes Technol Ther, V2, P449, DOI 10.1089/15209150050194314; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yamamoto T, 2009, J HEPATO-BILIARY-PAN, V16, P131, DOI 10.1007/s00534-009-0064-z; YU NT, 1972, J MOL BIOL, V70, P117, DOI 10.1016/0022-2836(72)90167-2; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	18	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78148	10.1371/journal.pone.0078148	http://dx.doi.org/10.1371/journal.pone.0078148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167603	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500063
J	La Monica, S; Caffarra, C; Saccani, F; Galvani, E; Galetti, M; Fumarola, C; Bonelli, M; Cavazzoni, A; Cretella, D; Sirangelo, R; Gatti, R; Tiseo, M; Ardizzoni, A; Giovannetti, E; Petronini, PG; Alfieri, RR				La Monica, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Cretella, Daniele; Sirangelo, Rita; Gatti, Rita; Tiseo, Marcello; Ardizzoni, Andrea; Giovannetti, Elisa; Petronini, Pier Giorgio; Alfieri, Roberta R.			Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; MUTANT LUNG-CANCER; FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; IRREVERSIBLE INHIBITORS; EGFR MUTATION; E-CADHERIN; IN-VITRO; ERLOTINIB	Despite the initial response, all patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). The EGFR-T790M secondary mutation is responsible for half of acquired resistance cases, while MET amplification has been associated with acquired resistance in about 5-15% of NSCLCs. Clinical findings indicate the retained addiction of resistant tumors on EGFR signaling. Therefore, we evaluated the molecular mechanisms supporting the therapeutic potential of gefitinib maintenance in the HCC827 GR5 NSCLC cell line harbouring MET amplification as acquired resistance mechanism. We demonstrated that resistant cells can proliferate and survive regardless of the presence of gefitinib, whereas the absence of the drug significantly enhanced cell migration and invasion. Moreover, the continuous exposure to gefitinib prevented the epithelial-mesenchymal transition (EMT) with increased E-cadherin expression and down-regulation of vimentin and N-cadherin. Importantly, the inhibition of cellular migration was correlated with the suppression of EGFR-dependent Src, STAT5 and p38 signaling as assessed by a specific kinase array, western blot analysis and silencing functional studies. On the contrary, the lack of effect of gefitinib on EGFR phosphorylation in the H1975 cells (EGFR-T790M) correlated with the absence of effects on cell migration and invasion. In conclusion, our findings suggest that certain EGFR-mutated patients may still benefit from a second-line therapy including gefitinib based on the specific mechanism underlying tumor cell resistance.	[La Monica, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Cretella, Daniele; Sirangelo, Rita; Petronini, Pier Giorgio; Alfieri, Roberta R.] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Galvani, Elena; Giovannetti, Elisa] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Galetti, Maricla] Univ Parma, Res Ctr, Italian Workers Compensat Author INAIL, I-43100 Parma, Italy; [Gatti, Rita] Univ Parma, Dept Biotechnol Biomed & Translat Sci, I-43100 Parma, Italy; [Tiseo, Marcello; Ardizzoni, Andrea] Univ Hosp Parma, Div Med Oncol, Parma, Italy	University of Parma; University Hospital of Parma; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Parma; University of Parma; University of Parma; University Hospital of Parma	Giovannetti, E (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	e.giovannetti@vumc.nl; roberta.alfieri@unipr.it	Tiseo, Marcello/K-6119-2016; Galvani, Elena/L-3133-2016; caffarra, cristina/I-2361-2018; Galetti, Maricla/CAG-4178-2022; ardizzoni, andrea/AAC-4337-2021; giovannetti, elisa/F-4261-2011; Galetti, Maricla/AAJ-8927-2020; Cretella, Daniele/AAB-2482-2019; Alfieri, Roberta R/G-6350-2012; Cavazzoni, Andrea/J-8079-2019	Tiseo, Marcello/0000-0002-9553-8465; caffarra, cristina/0000-0003-4582-353X; Galetti, Maricla/0000-0002-8061-8649; ardizzoni, andrea/0000-0003-2678-0714; giovannetti, elisa/0000-0002-7565-7504; Galetti, Maricla/0000-0002-8061-8649; Cavazzoni, Andrea/0000-0002-3752-1868; La Monica, Silvia/0000-0003-3578-3917	AstraZeneca, Milan Italy	AstraZeneca, Milan Italy(AstraZeneca)	This work was supported by AstraZeneca, Milan Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami K, 2013, LUNG CANCER, V79, P276, DOI 10.1016/j.lungcan.2012.11.022; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cavazzoni A, 2008, MOL CANCER THER, V7, P361, DOI 10.1158/1535-7163.MCT-07-0477; Chaft JE, 2011, CLIN CANCER RES, V17, P6298, DOI 10.1158/1078-0432.CCR-11-1468; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faehling M, 2013, LUNG CANCER, V80, P306, DOI 10.1016/j.lungcan.2013.02.010; Fumarola C, 2005, CELL DEATH DIFFER, V12, P1344, DOI 10.1038/sj.cdd.4401660; Galvani E, 2013, CURR PHARM DESIGN, V19, P818, DOI 10.2174/138161213804547222; Galvani E, 2013, NEOPLASIA, V15, P61, DOI 10.1593/neo.121434; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hata A, 2013, J THORAC ONCOL, V8, pE27, DOI 10.1097/JTO.0b013e318282e047; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon CH, 2013, MOL CELLS, V35, P226, DOI 10.1007/s10059-013-2269-x; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Merk BC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-184; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nishie K, 2012, J THORAC ONCOL, V7, P1722, DOI 10.1097/JTO.0b013e31826913f7; Nishino M, 2013, LUNG CANCER, V79, P283, DOI 10.1016/j.lungcan.2012.11.007; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peghini PL, 2002, CLIN CANCER RES, V8, P2273; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suh Y, 2012, ONCOGENE; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wang XF, 2013, ANTI-CANCER AGENT ME, V13, P923, DOI 10.2174/18715206113139990143; Watanabe S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-1; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Yu H., 2013, CLIN CANC RES; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	50	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78656	10.1371/journal.pone.0078656	http://dx.doi.org/10.1371/journal.pone.0078656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167634	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500095
J	Mahmoud, AM; Zhu, T; Parray, A; Siddique, HR; Yang, WC; Saleem, M; Bosland, MC				Mahmoud, Abeer M.; Zhu, Tian; Parray, Aijaz; Siddique, Hifzur R.; Yang, Wancai; Saleem, Mohammad; Bosland, Maarten C.			Differential Effects of Genistein on Prostate Cancer Cells Depend on Mutational Status of the Androgen Receptor	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; KAPPA-B ACTIVATION; LNCAP CELLS; GENE-EXPRESSION; DOWN-REGULATION; WILD-TYPE; IN-VITRO; SOY FOOD; INHIBITION; PROGRESSION	Blocking the androgen receptor (AR) activity is the main goal of therapies for advanced prostate cancer (PCa). However, relapse with a more aggressive, hormone refractory PCa arises, which harbors restored AR activity. One mechanism of such reactivation occurs through acquisition of AR mutations that enable its activation by various steroidal and non-steroidal structures. Thus, natural and chemical compounds that contribute to inappropriate (androgen-independent) activation of the AR become an area of intensive research. Here, we demonstrate that genistein, a soy phytoestrogen binds to both the wild and the Thr877Ala (T877A) mutant types of AR competitively with androgen, nevertheless, it exerts a pleiotropic effect on PCa cell proliferation and AR activity depending on the mutational status of the AR. Genistein inhibited, in a dose-dependent way, cell proliferation and AR nuclear localization and expression in LAPC-4 cells that have wild AR. However, in LNCaP cells that express the T877A mutant AR, genistein induced a biphasic effect where physiological doses (0.5-5 mu mol/L) stimulated cell growth and increased AR expression and transcriptional activity, and higher doses induced inhibitory effects. Similar biphasic results were achieved in PC-3 cells transfected with AR mutants; T877A, W741C and H874Y. These findings suggest that genistein, at physiological concentrations, potentially act as an agonist and activate the mutant AR that can be present in advanced PCa after androgen ablation therapy.	[Mahmoud, Abeer M.; Yang, Wancai; Bosland, Maarten C.] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Zhu, Tian] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL USA; [Parray, Aijaz; Siddique, Hifzur R.; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Sect Mol Chemoprevent & Therapeut, Austin, TX USA; [Yang, Wancai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; Xinxiang Medical University	Mahmoud, AM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	amahmo4@uic.edu; boslandm@uic.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019; Yang, Wancai/O-7655-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487; Yang, Wancai/0000-0001-7437-9197	Egyptian Ministry of Higher Education [GM 842]; NIH [CA 116195]; NATIONAL CANCER INSTITUTE [R01CA116195] Funding Source: NIH RePORTER	Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	1. Grant No. GM 842 from the Egyptian Ministry of Higher Education. 2. NIH Grant No. CA 116195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; [Anonymous], 2011, LIGPREP VERS 2 5; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Basak S, 2008, MOL CANCER THER, V7, P3195, DOI 10.1158/1535-7163.MCT-08-0617; Bektic J, 2004, EUR UROL, V45, P245, DOI 10.1016/j.eururo.2003.09.001; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Case DA., 2010, AMBER 11; Chang KL, 2009, CANCER LETT, V276, P14, DOI 10.1016/j.canlet.2008.10.033; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Davis JN, 2000, INT J ONCOL, V16, P1091; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Davis JN, 2002, MOL CARCINOGEN, V34, P91, DOI 10.1002/mc.10053; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; Ewald P.P, 1921, ANN PHYS-NEW YORK, V64, P253, DOI [10.1002/andp.19213690304, DOI 10.1002/ANDP.19213690304]; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FOTSIS T, 1995, J NUTR, V125, pS790, DOI 10.1093/jn/125.suppl_3.790S; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Gardner CD, 2009, PROSTATE, V69, P719, DOI 10.1002/pros.20922; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Gregory CW, 2001, CANCER RES, V61, P4315; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; IARC, 2008, CANC INCIDENCE 5 CON, VIX, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jian L, 2009, MOL NUTR FOOD RES, V53, P217, DOI 10.1002/mnfr.200800167; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lazarevic B, 2008, ONCOL REP, V19, P1231; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Lee WY, 2007, NUTR CANCER, V58, P239, DOI 10.1080/01635580701328636; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Li YW, 1999, INT J ONCOL, V15, P525; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Li YW, 2002, CLIN CANCER RES, V8, P2369; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Maggiolini M, 2002, MOL PHARMACOL, V62, P1027, DOI 10.1124/mol.62.5.1027; Messina MJ, 2003, NUTR REV, V61, P117, DOI [10.1301/nr.2003.apr.117&ndash;131, 10.1301/nr.2003.apr.117-131]; Nakamura Y, 2000, J AOAC INT, V83, P635; Oh HY, 2010, BIOCHEM BIOPH RES CO, V393, P319, DOI 10.1016/j.bbrc.2010.01.133; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; RuizLarrea MB, 1997, FREE RADICAL RES, V26, P63, DOI 10.3109/10715769709097785; Schiliro T, 2011, J STEROID BIOCHEM, V127, P139, DOI 10.1016/j.jsbmb.2011.03.002; Seo YJ, 2011, J KOREAN MED SCI, V26, P1489, DOI 10.3346/jkms.2011.26.11.1489; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shi XB, 2002, CANCER RES, V62, P1496; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Suzuki H, 1996, PROSTATE, V29, P153, DOI 10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5; Takahashi Y, 2006, MOL CARCINOGEN, V45, P18, DOI 10.1002/mc.20153; Takahashi Y, 2004, MOL CARCINOGEN, V41, P108, DOI 10.1002/mc.20045; Tanner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016027; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Uehara M, 2000, BIOFACTORS, V12, P217, DOI 10.1002/biof.5520120134; Urushibara M, 2007, PROSTATE, V67, P799, DOI 10.1002/pros.20542; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wiren KM, 1997, ENDOCRINOLOGY, V138, P2291, DOI 10.1210/en.138.6.2291; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yan L, 2005, INT J CANCER, V117, P667, DOI 10.1002/ijc.21266; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang LQ, 2003, CANCER RES, V63, P4552; Zhou JM, 2010, PROTEINS, V78, P623, DOI 10.1002/prot.22592; Zhou JR, 2002, PROSTATE, V53, P143, DOI 10.1002/pros.10141	77	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78479	10.1371/journal.pone.0078479	http://dx.doi.org/10.1371/journal.pone.0078479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167630	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500091
J	Spyrakis, F; Singh, R; Cozzini, P; Campanini, B; Salsi, E; Felici, P; Raboni, S; Benedetti, P; Cruciani, G; Kellogg, GE; Cook, PF; Mozzarelli, A				Spyrakis, Francesca; Singh, Ratna; Cozzini, Pietro; Campanini, Barbara; Salsi, Enea; Felici, Paolo; Raboni, Samanta; Benedetti, Paolo; Cruciani, Gabriele; Kellogg, Glen E.; Cook, Paul F.; Mozzarelli, Andrea			Isozyme-Specific Ligands for O-acetylserine sulfhydrylase, a Novel Antibiotic Target	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM LT-2; TIME-RESOLVED FLUORESCENCE; BIENZYME COMPLEX-FORMATION; CYSTEINE SYNTHASE COMPLEX; MYCOBACTERIUM-TUBERCULOSIS; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; ACTIVE-SITE; PHOSPHOSERINE SULFHYDRYLASE; PYRIDOXAL 5'-PHOSPHATE	The last step of cysteine biosynthesis in bacteria and plants is catalyzed by O-acetylserine sulfhydrylase. In bacteria, two isozymes, O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B, have been identified that share similar binding sites, although the respective specific functions are still debated. O-acetylserine sulfhydrylase plays a key role in the adaptation of bacteria to the host environment, in the defense mechanisms to oxidative stress and in antibiotic resistance. Because mammals synthesize cysteine from methionine and lack O-acetylserine sulfhydrylase, the enzyme is a potential target for antimicrobials. With this aim, we first identified potential inhibitors of the two isozymes via a ligand-and structure-based in silico screening of a subset of the ZINC library using FLAP. The binding affinities of the most promising candidates were measured in vitro on purified O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B from Salmonella typhimurium by a direct method that exploits the change in the cofactor fluorescence. Two molecules were identified with dissociation constants of 3.7 and 33 mu M for O-acetylserine sulfhydrylase-A and O-acetylserine sulfhydrylase-B, respectively. Because GRID analysis of the two isoenzymes indicates the presence of a few common pharmacophoric features, cross binding titrations were carried out. It was found that the best binder for O-acetylserine sulfhydrylase-B exhibits a dissociation constant of 29 mu M for O-acetylserine sulfhydrylase-A, thus displaying a limited selectivity, whereas the best binder for O-acetylserine sulfhydrylase-A exhibits a dissociation constant of 50 mu M for O-acetylserine sulfhydrylase-B and is thus 8-fold selective towards the former isozyme. Therefore, isoform-specific and isoform-independent ligands allow to either selectively target the isozyme that predominantly supports bacteria during infection and long-term survival or to completely block bacterial cysteine biosynthesis.	[Spyrakis, Francesca; Cozzini, Pietro] Univ Parma, Dept Food Sci, I-43100 Parma, Italy; [Singh, Ratna; Campanini, Barbara; Salsi, Enea; Felici, Paolo; Raboni, Samanta; Mozzarelli, Andrea] Univ Parma, Dept Pharm, I-43100 Parma, Italy; [Cozzini, Pietro; Mozzarelli, Andrea] Natl Inst Biostruct & Biosyst, Rome, Italy; [Benedetti, Paolo] Mol Discovery Ltd, London, England; [Cruciani, Gabriele] Univ Perugia, Dept Chem, I-06100 Perugia, Italy; [Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA USA; [Cook, Paul F.] Univ Oklahoma, Dept Biochem, Norman, OK 73019 USA	University of Parma; University of Parma; University of Perugia; Virginia Commonwealth University; Virginia Commonwealth University; University of Oklahoma System; University of Oklahoma - Norman	Campanini, B (corresponding author), Univ Parma, Dept Pharm, I-43100 Parma, Italy.	barbara.campanini@unipr.it; andrea.mozzarelli@unipr.it	Benedetti, Paolo/R-2649-2017; Cruciani, Gabriele/E-5927-2014; CRUCIANI, Gabriele/AAH-4627-2019; Campanini, Barbara/L-9723-2017; Mozzarelli, Andrea/C-3615-2014; Singh, Ratna/AAM-7340-2021; RABONI, Samanta/P-7823-2018	Benedetti, Paolo/0000-0001-7985-1753; Cruciani, Gabriele/0000-0002-4162-8692; CRUCIANI, Gabriele/0000-0002-4162-8692; Campanini, Barbara/0000-0003-0359-0627; Mozzarelli, Andrea/0000-0003-3762-0062; Singh, Ratna/0000-0003-0487-2861; RABONI, Samanta/0000-0003-3068-3714; spyrakis, francesca/0000-0002-4016-227X; Kellogg, Glen/0000-0002-6282-6794	University of Parma	University of Parma	University of Parma grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SM, 2008, INT J PARASITOL, V38, P137, DOI 10.1016/j.ijpara.2007.09.009; Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Agren D, 2009, FEBS LETT, V583, P330, DOI 10.1016/j.febslet.2008.12.019; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Amori L, 2012, MEDCHEMCOMM, V3, P1111, DOI 10.1039/c2md20100c; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e; BECKER MA, 1969, J BIOL CHEM, V244, P2418; BECKER MA, 1969, J BIOL CHEM, V244, P6023; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Benci S, 1999, BBA-PROTEIN STRUCT M, V1429, P317, DOI 10.1016/S0167-4838(98)00229-5; Benci S, 1997, BIOCHEMISTRY-US, V36, P15419, DOI 10.1021/bi970464i; Benci S, 1999, J PHOTOCH PHOTOBIO B, V48, P17, DOI 10.1016/S1011-1344(99)00003-2; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bettati S, 2002, BBA-PROTEIN STRUCT M, V1596, P47, DOI 10.1016/S0167-4838(01)00316-8; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bielska Ewa, 2011, Biotechnologia (Poznan), V92, P249; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Brincat JP, 2011, J MED CHEM, V54, P354, DOI 10.1021/jm1011963; Broccatelli F, 2011, J MED CHEM, V54, P1740, DOI 10.1021/jm101421d; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Campanini B, 2003, J BIOL CHEM, V278, P37511, DOI 10.1074/jbc.M305138200; Carosati E, 2008, J MED CHEM, V51, P5552, DOI 10.1021/jm800151n; Carosati E, 2007, J MED CHEM, V50, P2117, DOI 10.1021/jm061440p; Carosati E, 2012, J MED CHEM, V55, P10272, DOI 10.1021/jm300850v; Carosati E, 2010, BIOORGAN MED CHEM, V18, P7773, DOI 10.1016/j.bmc.2010.09.065; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; COOK PF, 1978, J BIOL CHEM, V253, P7874; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; Copland RA, 2005, EVALUATION ENZYME IN; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cross S, 2012, J CHEM INF MODEL, V52, P2587, DOI 10.1021/ci300153d; Cross S, 2012, J CHEM INF MODEL, V52, P2599, DOI [10.1021/ci300154n, 10.1021/ci300154]; Cross S, 2010, J CHEM INF MODEL, V50, P1442, DOI 10.1021/ci100221g; Cross S, 2010, DRUG DISCOV TODAY, V15, P23, DOI 10.1016/j.drudis.2008.12.006; Diner EJ, 2012, GENE DEV, V26, P515, DOI 10.1101/gad.182345.111; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Fornabaio M, 2004, J MED CHEM, V47, P4507, DOI 10.1021/jm030596b; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fyfe PK, 2012, ACTA CRYSTALLOGR F, V68, P738, DOI 10.1107/S1744309112019124; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; HULANICKA MD, 1986, J BACTERIOL, V168, P322, DOI 10.1128/jb.168.1.322-327.1986; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kellogg GE, 2001, J COMPUT AID MOL DES, V15, P381, DOI 10.1023/A:1011136228678; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Koparde VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015920; Kredich N.M., 1996, ESCHERICHIA COLI SAL, P514; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Kumar VUJ, 2013, BIOORG MED CHEM LETT, V23, P1182, DOI 10.1016/j.bmcl.2013.01.031; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; Milletti F, 2007, J CHEM INF MODEL, V47, P2172, DOI 10.1021/ci700018y; Milletti F, 2010, EUR J MED CHEM, V45, P4270, DOI 10.1016/j.ejmech.2010.06.026; Milletti F, 2009, J CHEM INF MODEL, V49, P68, DOI 10.1021/ci800340j; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mozzarelli A, 2011, BBA-PROTEINS PROTEOM, V1814, P1497, DOI 10.1016/j.bbapap.2011.04.011; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagpal I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030305; NAKAMURA T, 1983, J BACTERIOL, V156, P656, DOI 10.1128/JB.156.2.656-662.1983; Nakamura T, 2012, J MOL BIOL, V422, P33, DOI 10.1016/j.jmb.2012.05.009; Nakatani T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-62; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028; Poyraz O, 2013, J MED CHEM, V56, P6457, DOI 10.1021/jm400710k; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Raj I, 2012, ACTA CRYSTALLOGR D, V68, P909, DOI 10.1107/S0907444912016459; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Salsi E, 2010, J BIOL CHEM, V285, P12813, DOI 10.1074/jbc.M109.075762; Salsi E, 2010, J MED CHEM, V53, P345, DOI 10.1021/jm901325e; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Singh R, 2013, J ENZYM INHIB MED CH, V28, P183, DOI 10.3109/14756366.2011.643305; Sirci F, 2012, J CHEM INF MODEL, V52, P3308, DOI 10.1021/ci3004094; Sirci F, 2012, J COMPUT AID MOL DES, V26, P1247, DOI 10.1007/s10822-012-9612-8; Spyrakis F, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-4; Spyrakis F, 2013, CURR PHARM DESIGN, V19, P4291, DOI 10.2174/1381612811319230011; Spyrakis F, 2013, BBA-PROTEINS PROTEOM, V1834, P169, DOI 10.1016/j.bbapap.2012.09.009; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Turnbull AL, 2010, RES MICROBIOL, V161, P643, DOI [10.1016/J.resmic.2010.06.004, 10.1016/j.resmic.2010.06.004]; Turnbull AL, 2008, MICROBIOL-SGM, V154, P3410, DOI 10.1099/mic.0.2008/020347-0; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wade R C, 1989, Prog Clin Biol Res, V289, P433; Wang T, 2012, J BIOL CHEM, V287, P4360, DOI 10.1074/jbc.M111.288423; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	124	42	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77558	10.1371/journal.pone.0077558	http://dx.doi.org/10.1371/journal.pone.0077558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167577	Green Published, gold			2022-12-25	WOS:000326034500036
J	Tola-Arribas, MA; Yugueros, MI; Garea, MJ; Ortega-Valin, F; Ceron-Fernandez, A; Fernandez-Malvido, B; San Jose-Gallegos, A; Gonzalez-Touya, M; Botran-Velicia, A; Iglesias-Rodriguez, V; Diaz-Gomez, B				Angel Tola-Arribas, Miguel; Isabel Yugueros, Maria; Jose Garea, Maria; Ortega-Valin, Fernando; Ceron-Fernandez, Ana; Fernandez-Malvido, Beatriz; San Jose-Gallegos, Antonio; Gonzalez-Touya, Marta; Botran-Velicia, Ana; Iglesias-Rodriguez, Vanessa; Diaz-Gomez, Barbara			Prevalence of Dementia and Subtypes in Valladolid, Northwestern Spain: The DEMINVALL Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; COGNITIVE IMPAIRMENT; MEDITERRANEAN DIET; GLOBAL PREVALENCE; MAJOR SUBTYPES; DIAGNOSIS; RISK; VALIDATION; EDUCATION	Objective: To describe the prevalence of dementia and subtypes in a general elderly population in northwestern Spain and to analyze the influence of socio-demographic factors. Methods: Cross-sectional, two-phase, door-to-door, population-based study. A total of 870 individuals from a rural region and 2,119 individuals from an urban region of Valladolid, Spain, were involved. The seven-minute screen neurocognitive battery was used in the screening phase. A control group was included. Results: A total of 2,170 individuals aged 65 to 104 years (57% women) were assessed. There were 184 subjects diagnosed with dementia. The crude prevalence was 8.5% (95% CI: 7.3-9.7). Age-and sex-adjusted prevalence was 5.5 (95% CI: 4.5-6.5). Main subtypes of dementia were: Alzheimer's disease (AD) 77.7%, Lewy Body disease, 7.6% and vascular dementia (VD) 5.9%. Crude prevalences were 6.6% (AD), 0.6% (Lewy Body disease), and 0.5% (VD). Dementia was associated with age (OR 1.14 for 1-year increase in age), female sex (OR 1.79) and the absence of formal education (OR 2.53 compared to subjects with primary education or more). Conclusion: The prevalence of dementia in the study population was lower than the most recent estimates for Western Europe. There was a high proportion of AD among all dementia cases and very low prevalence of VD. Old age, female sex, and low education level were independent risk factors for dementia and AD.	[Angel Tola-Arribas, Miguel; Isabel Yugueros, Maria; Jose Garea, Maria; Ortega-Valin, Fernando] Hosp Univ Rio Hortega, Dept Neurol, Valladolid, Spain; [Ceron-Fernandez, Ana] Hosp Univ Rio Hortega, Dept Geriatr, Valladolid, Spain; [Fernandez-Malvido, Beatriz] Hosp Univ Rio Hortega, Dept Psychol, Valladolid, Spain; [San Jose-Gallegos, Antonio; Gonzalez-Touya, Marta] Hosp Medina del Campo, Emergency Dept, Valladolid, Spain; [Botran-Velicia, Ana; Iglesias-Rodriguez, Vanessa] Atenc Primaria Area Oeste, Valladolid, Spain; [Diaz-Gomez, Barbara] Ctr Salud Arroyo de la Vega, Madrid, Spain	Hospital del Rio Hortega; Hospital del Rio Hortega; Hospital del Rio Hortega	Tola-Arribas, MA (corresponding author), Hosp Univ Rio Hortega, Dept Neurol, Valladolid, Spain.	mtola.nrl@gmail.com	Arribas, Miguel Angel Tola/D-6936-2016	Arribas, Miguel Angel Tola/0000-0003-4105-0998; Gonzalez-Touya, Marta/0000-0003-4523-1905	Gerencia Regional de Salud de Castilla y Leon [GRS/340/09]; Fundacion General de la Universidad de Valladolid	Gerencia Regional de Salud de Castilla y Leon; Fundacion General de la Universidad de Valladolid	The survey was funded (Grant GRS/340/09) by the Gerencia Regional de Salud de Castilla y Leon (http://www.saludcastillayleon.es) and by the Fundacion General de la Universidad de Valladolid (http://www.funge.uva.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; Tola-Arribas MA, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-86; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Benedetti MD, 2002, NEUROEPIDEMIOLOGY, V21, P74, DOI 10.1159/000048620; Caamano-Isorna F, 2006, NEUROEPIDEMIOLOGY, V26, P226, DOI 10.1159/000093378; CORRADA M, 1995, INT J EPIDEMIOL, V24, P1000, DOI 10.1093/ije/24.5.1000; de Pedro-Cuesta J, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-55; Del Ser T, 2006, DEMENT GERIATR COGN, V22, P454, DOI 10.1159/000095858; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; European Heart Network, 2012, EUROPEAN CARDIOVASCU; Fernandez M, 2008, REV NEUROLOGIA, V46, P89, DOI 10.33588/rn.4602.2007530; Martinez MF, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-39; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Gascon-Bayarri J, 2007, NEUROEPIDEMIOLOGY, V28, P224, DOI 10.1159/000108597; Gavrila D, 2009, ACTA NEUROL SCAND, V120, P300, DOI 10.1111/j.1600-0404.2009.01283.x; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P569, DOI 10.1001/archneur.60.4.569; LINN MW, 1982, J AM GERIATR SOC, V30, P378, DOI 10.1111/j.1532-5415.1982.tb02835.x; Lobo A, 2000, NEUROLOGY, V54, pS4; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meulen EFJ, 2004, J NEUROL NEUROSUR PS, V75, P700, DOI 10.1136/jnnp.2003.021055; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; *OFF OFF PUBL EUR, 2012, 2012 AG REP EC BUDG; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quijano TDS, 2004, NEUROLOGIA, V19, P344; Ravaglia G, 2002, DEMENT GERIATR COGN, V14, P90, DOI 10.1159/000064930; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; REYNISH E, 2006, EUROCODE REPORT WP7; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Spada RS, 2009, J NEUROL SCI, V283, P62, DOI 10.1016/j.jns.2009.02.311; Tognoni G, 2005, ACTA NEUROL SCAND, V112, P65, DOI 10.1111/j.1600-0404.2005.00444.x; Tsivgoulis G, 2013, NEUROLOGY, V80, P1684, DOI 10.1212/WNL.0b013e3182904f69; Virues-Ortega J, 2011, ACTA NEUROL SCAND, V123, P316, DOI 10.1111/j.1600-0404.2010.01398.x; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; World Health Organization, 2013, EUR HLTH REP 2012 CH; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190	47	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77688	10.1371/journal.pone.0077688	http://dx.doi.org/10.1371/journal.pone.0077688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147055	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200065
J	Lai, CH; Chang, LL; Lin, JN; Chen, WF; Kuo, LL; Lin, HH; Chen, YH				Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Chen, Wei-Fang; Kuo, Li-Li; Lin, Hsi-Hsun; Chen, Yen-Hsu			High Seroprevalence of Mycoplasma pneumoniae IgM in Acute Q Fever by Enzyme-Linked Immunosorbent Assay (ELISA)	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SEROLOGICAL CROSS-REACTIONS; COXIELLA-BURNETII; CHLAMYDIA-PNEUMONIAE; COMMERCIAL TESTS; IMMUNOGLOBULIN-G; SOUTHERN TAIWAN; INFECTION; DIAGNOSIS; ANTIBODIES	Q fever is serologically cross-reactive with other intracellular microorganisms. However, studies of the serological status of Mycoplasma pneumoniae and Chlamydophila pneumoniae during Q fever are rare. We conducted a retrospective serological study of M. pneumoniae and C. pneumoniae by enzyme-linked immunosorbent assay (ELISA), a method widely used in clinical practice, in 102 cases of acute Q fever, 39 cases of scrub typhus, and 14 cases of murine typhus. The seropositive (57.8%, 7.7%, and 0%, p<0.001) and seroconversion rates (50.6%, 8.8%, and 0%, p<0.001) of M. pneumoniae IgM, but not M. pneumoniae IgG and C. pneumoniae IgG/IgM, in acute Q fever were significantly higher than in scrub typhus and murine typhus. Another ELISA kit also revealed a high seropositivity (49.5%) and seroconversion rate (33.3%) of M. pneumoniae IgM in acute Q fever. The temporal and age distributions of patients with positive M. pneumoniae IgM were not typical of M. pneumoniae pneumonia. Comparing acute Q fever patients who were positive for M. pneumoniae IgM (59 cases) with those who were negative (43 cases), the demographic characteristics and underlying diseases were not different. In addition, the clinical manifestations associated with atypical pneumonia, including headache (71.2% vs. 81.4%, p=0.255), sore throat (8.5% vs. 16.3%, p=0.351), cough (35.6% vs. 23.3%, p=0.199), and chest x-ray suggesting pneumonia (19.3% vs. 9.5%, p=0.258), were unchanged between the two groups. Clinicians should be aware of the high seroprevalence of M. pneumoniae IgM in acute Q fever, particularly with ELISA kits, which can lead to misdiagnosis, overestimations of the prevalence of M. pneumoniae pneumonia, and underestimations of the true prevalence of Q fever pneumonia.	[Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Kuo, Li-Li; Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Lin, Jiun-Nong; Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Chen, Wei-Fang] I Shou Univ, E Da Hosp, Div Infect Control Lab, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Dept Microbiol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Kuo, Li-Li] Ctr Dis Control, Dept Hlth, Res & Diagnost Ctr, Taipei, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	infchen@gmail.com	Teixeira, JJ/H-6495-2016	Chen, Yen-hsu/0000-0002-8667-4844	National Science Council [NSC 99-2745-B-650-001]; E-Da Hospital [EDAHP100001]	National Science Council(Ministry of Science and Technology, Taiwan); E-Da Hospital	This work was supported by research grants from the National Science Council [NSC 99-2745-B-650-001] and E-Da Hospital [EDAHP100001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RF, 2007, EUR J CLIN MICROBIOL, V26, P495, DOI 10.1007/s10096-007-0323-3; Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Beersma MFC, 2005, J CLIN MICROBIOL, V43, P2277, DOI 10.1128/JCM.43.5.2277-2285.2005; Camacho M T, 2005, J Autoimmune Dis, V2, P10, DOI 10.1186/1740-2557-2-10; Cunha BA, 2006, CLIN MICROBIOL INFEC, V12, P12, DOI 10.1111/j.1469-0691.2006.01393.x; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Graham JV, 2000, CLIN INFECT DIS, V30, P609, DOI 10.1086/313701; Hermann C, 2002, J CLIN MICROBIOL, V40, P1603, DOI 10.1128/JCM.40.5.1603-1609.2002; Hou MY, 2011, JPN J INFECT DIS, V64, P161; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kung CM, 2007, JPN J INFECT DIS, V60, P352; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lai CH, 2007, CLIN INFECT DIS, V45, pE52, DOI 10.1086/520680; Lai CH, 2009, EMERG INFECT DIS, V15, P1659, DOI 10.3201/eid1510.090007; Lai CH, 2009, J FORMOS MED ASSOC, V108, P367, DOI 10.1016/S0929-6646(09)60080-2; LaScola B, 1996, J CLIN MICROBIOL, V34, P2270, DOI 10.1128/JCM.34.9.2270-2274.1996; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Lee CH, 2011, JPN J INFECT DIS, V64, P525; LEVY P, 1989, EUR J EPIDEMIOL, V5, P447, DOI 10.1007/BF00140139; Liu FC, 2008, JPN J INFECT DIS, V61, P397; Lukacova M, 1999, FOLIA MICROBIOL, V44, P579, DOI 10.1007/BF02816263; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Musso D, 1997, CLIN DIAGN LAB IMMUN, V4, P208, DOI 10.1128/CDLI.4.2.208-212.1997; Nir-Paz R, 2006, CLIN MICROBIOL INFEC, V12, P685, DOI 10.1111/j.1469-0691.2006.01469.x; Persson K, 2000, CLIN DIAGN LAB IMMUN, V7, P739, DOI 10.1128/CDLI.7.5.739-744.2000; Petitjean J, 2002, J CLIN MICROBIOL, V40, P165, DOI 10.1128/JCM.40.1.165-171.2002; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rolain JM, 2005, CLIN INFECT DIS, V40, P82, DOI 10.1086/426440; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Talkington DF, 2004, CLIN DIAGN LAB IMMUN, V11, P862, DOI 10.1128/CDLI.11.5.862-867.2004; Vardi M, 2011, EUR J CLIN MICROBIOL, V30, P1527, DOI 10.1007/s10096-011-1255-5; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Yen MY, 2005, J FORMOS MED ASSOC, V104, P724	34	12	13	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77640	10.1371/journal.pone.0077640	http://dx.doi.org/10.1371/journal.pone.0077640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147043	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200056
J	Li, ZW; Huang, JQ; Zeng, GM; Nie, XD; Ma, WM; Yu, W; Guo, W; Zhang, JC				Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang; Zhang, Jiachao			Effect of Erosion on Productivity in Subtropical Red Soil Hilly Region: A Multi-Scale Spatio-Temporal Study by Simulated Rainfall	PLOS ONE			English	Article							ORGANIC-MATTER; CLIMATE-CHANGE; CROP YIELD; CARBON; IMPACTS; WHEAT; REDISTRIBUTION; DEGRADATION; RUNOFF	The effects of water erosion (including long-term historical erosion and single erosion event) on soil properties and productivity in different farming systems were investigated. A typical sloping cropland with homogeneous soil properties was designed in 2009 and then protected from other external disturbances except natural water erosion. In 2012, this cropland was divided in three equally sized blocks. Three treatments were performed on these blocks with different simulated rainfall intensities and farming methods: (1) high rainfall intensity (1.5 - 1.7 mm min(-1)), no-tillage operation; (2) low rainfall intensity (0.5 - 0.7 mm min(-1)), no-tillage operation; and (3) low rainfall intensity, tillage operation. All of the blocks were divided in five equally sized subplots along the slope to characterize the three-year effects of historical erosion quantitatively. Redundancy analysis showed that the effects of long-term historical erosion significantly caused most of the variations in soil productivity in no-tillage and low rainfall erosion intensity systems. The intensities of the simulated rainfall did not exhibit significant effects on soil productivity in no-tillage systems. By contrast, different farming operations induced a statistical difference in soil productivity at the same single erosion intensity. Soil organic carbon (SOC) was the major limiting variable that influenced soil productivity. Most explanations of long-term historical erosion for the variation in soil productivity arose from its sharing with SOC. SOC, total nitrogen, and total phosphorus were found as the regressors of soil productivity because of tillage operation. In general, this study provided strong evidence that single erosion event could also impose significant constraints on soil productivity by integrating with tillage operation, although single erosion is not the dominant effect relative to the long-term historical erosion. Our study demonstrated that an effective management of organic carbon pool should be the preferred option to maintain soil productivity in subtropical red soil hilly region.	[Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha 410082, Hunan, Peoples R China; [Zhang, Jiachao] Hunan Agr Univ, Coll Resources & Environm, Changsha, Hunan, Peoples R China	Hunan University; Hunan University; Hunan Agricultural University	Li, ZW (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.	lizw@hnu.edu.cn	Nie, xiaodong/A-1729-2016; Li, Zhongwu/AAF-9530-2020		National Natural Science Foundation of China [40971179]; Program for New Century Excellent Talents in University [NCET-09-330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was jointly supported by the National Natural Science Foundation of China (40971179) and the Program for New Century Excellent Talents in University (NCET-09-330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MM, 2004, CATENA, V57, P55, DOI 10.1016/j.catena.2003.07.002; Bertol Ildegardis, 2003, Sci. agric. (Piracicaba, Braz.), V60, P581, DOI 10.1590/S0103-90162003000300025; Deluca TH, 1998, ENVIRON MANAGE, V22, P255, DOI 10.1007/s002679900101; Duan XW, 2011, CATENA, V87, P268, DOI 10.1016/j.catena.2011.06.012; EHLERS W, 1975, SOIL SCI, V119, P242, DOI 10.1097/00010694-197503000-00010; Fenton TE, 2005, SOIL TILL RES, V81, P163, DOI 10.1016/j.still.2004.09.005; Fu GB, 2006, SOIL TILL RES, V85, P38, DOI 10.1016/j.still.2004.11.009; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Garcia-Ruiz JM, 2010, CATENA, V81, P1, DOI 10.1016/j.catena.2010.01.001; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Gregg JS, 2010, BIOFUELS-UK, V1, P69, DOI 10.4155/BFS.09.8; Huang JQ, 2013, ECOL ENG, V60, P67, DOI 10.1016/j.ecoleng.2013.07.040; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Kara D, 1997, TALANTA, V44, P2027, DOI 10.1016/S0039-9140(97)00014-3; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kosmas C, 2001, SOIL TILL RES, V58, P31, DOI 10.1016/S0167-1987(00)00175-6; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2001, LAND DEGRAD DEV, V12, P519, DOI 10.1002/ldr.472; Lal R, 2008, SCIENCE, V319, P1040, DOI 10.1126/science.319.5866.1040; Larney F.J., 2012, PRAIRIE SOILS CROPS, V5, P139; Larney FJ, 2009, SOIL TILL RES, V103, P73, DOI 10.1016/j.still.2008.09.008; Li XJ, 2008, GEOMORPHOLOGY, V96, P221, DOI 10.1016/j.geomorph.2007.08.006; Liu YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056443; Liu ZF, 2010, SOIL BIOL BIOCHEM, V42, P445, DOI 10.1016/j.soilbio.2009.11.027; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Morgan, 1996, SOIL EROSION CONSERV, P320; Nearing MA, 2004, J SOIL WATER CONSERV, V59, P43; OLDEMAN LR, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P99; Osunbitan JA, 2005, SOIL TILL RES, V82, P57, DOI 10.1016/j.still.2004.05.007; PHILLIPS RE, 1980, SCIENCE, V208, P1108, DOI 10.1126/science.208.4448.1108; PIERCE FJ, 1983, J SOIL WATER CONSERV, V38, P39; Pimentel D, 2000, ECOSYST HEALTH, V6, P221, DOI 10.1046/j.1526-0992.2000.006004221.x; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Turner B.L., 1990, CUP ARCH; Van Hemelryck H, 2011, EARTH SURF PROC LAND, V36, P427, DOI 10.1002/esp.2055; Van Oost K, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P301; VERITY GE, 1990, CAN J SOIL SCI, V70, P471, DOI 10.4141/cjss90-046; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WEESIES GA, 1994, J SOIL WATER CONSERV, V49, P597; XIAOJUN N, 2013, PLOS ONE, V0008; Yang F, 1989, HUNAN SOILS; Zhang JC, 2011, BIORESOURCE TECHNOL, V102, P2950, DOI 10.1016/j.biortech.2010.11.089; Zhao L, 2012, J MT SCI-ENGL, V9, P96, DOI 10.1007/s11629-012-2241-9	46	14	14	9	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77838	10.1371/journal.pone.0077838	http://dx.doi.org/10.1371/journal.pone.0077838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147090	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200082
J	Livingston, G; Jha, S; Vega, A; Gilbert, L				Livingston, George; Jha, Shalene; Vega, Andres; Gilbert, Lawrence			Conservation Value and Permeability of Neotropical Oil Palm Landscapes for Orchid Bees	PLOS ONE			English	Article							MALE EUGLOSSINE BEES; ELAEIS-GUINEENSIS; BIODIVERSITY; PLANTATIONS; FOREST; HYMENOPTERA; DIVERSITY; PHYLOGENIES; BEHAVIOR; BIOLOGY	The proliferation of oil palm plantations has led to dramatic changes in tropical landscapes across the globe. However, relatively little is known about the effects of oil palm expansion on biodiversity, especially in key ecosystem-service providing organisms like pollinators. Rapid land use change is exacerbated by limited knowledge of the mechanisms causing biodiversity decline in the tropics, particularly those involving landscape features. We examined these mechanisms by undertaking a survey of orchid bees, a well-known group of Neotropical pollinators, across forest and oil palm plantations in Costa Rica. We used chemical baits to survey the community in four regions: continuous forest sites, oil palm sites immediately adjacent to forest, oil palm sites 2km from forest, and oil palm sites greater than 5km from forest. We found that although orchid bees are present in all environments, orchid bee communities diverged across the gradient, and community richness, abundance, and similarity to forest declined as distance from forest increased. In addition, mean phylogenetic distance of the orchid bee community declined and was more clustered in oil palm. Community traits also differed with individuals in oil palm having shorter average tongue length and larger average geographic range size than those in the forest. Our results indicate two key features about Neotropical landscapes that contain oil palm: 1) oil palm is selectively permeable to orchid bees and 2) orchid bee communities in oil palm have distinct phylogenetic and trait structure compared to communities in forest. These results suggest that conservation and management efforts in oil palm-cultivating regions should focus on landscape features.	[Livingston, George; Jha, Shalene; Gilbert, Lawrence] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Vega, Andres] AMBICOR, Tibas, Costa Rica	University of Texas System; University of Texas Austin	Livingston, G (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	glivingston@utexas.edu			Hosteling International-Austin Travel Fellowship; Graduate Program in Ecology, Evolution and Behavior at the University of Texas; US National Science Foundation	Hosteling International-Austin Travel Fellowship; Graduate Program in Ecology, Evolution and Behavior at the University of Texas; US National Science Foundation(National Science Foundation (NSF))	This work was supported by a Hosteling International-Austin Travel Fellowship (http://www.hiusa.org/austin) and a grant from the Graduate Program in Ecology, Evolution and Behavior at the University of Texas (http://www.biosci.utexas.edu/graduate/eeb/default.aspx) to GL. GL was supported by a US National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1982, BIOTROPICA, V14, P241, DOI 10.2307/2388080; ARMBRUSTER WS, 1994, BIOTROPICA, V26, P50, DOI 10.2307/2389110; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Cameron SA, 2004, ANNU REV ENTOMOL, V49, P377, DOI 10.1146/annurev.ento.49.072103.115855; Cao Y, 1997, WATER ENVIRON RES, V69, P95, DOI 10.2175/106143097X125227; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Godfree R, 2004, J VEG SCI, V15, P227, DOI 10.1111/j.1654-1103.2004.tb02257.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; JANZEN DH, 1982, ECOLOGY, V63, P66, DOI 10.2307/1937032; Kehlenbeck K, 2004, AGROFOREST SYST, V63, P53, DOI 10.1023/B:AGFO.0000049433.95038.25; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KIMSEY LS, 1980, ANIM BEHAV, V28, P996, DOI 10.1016/S0003-3472(80)80088-1; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Landolt PJ, 1998, ENVIRON ENTOMOL, V27, P1229, DOI 10.1093/ee/27.5.1229; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; Livingston G, 2013, BIOTROPICA, V45, P10, DOI 10.1111/j.1744-7429.2012.00894.x; Lucey JM, 2012, BIOTROPICA, V44, P368, DOI 10.1111/j.1744-7429.2011.00824.x; Mayfield MM, 2005, ECON BOT, V59, P190, DOI 10.1663/0013-0001(2005)059[0190:TIONFT]2.0.CO;2; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2012, BIOSCI J, V28, P118; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pfeiffer M, 2008, ECOGRAPHY, V31, P21, DOI 10.1111/j.2007.0906-7590.05172.x; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; POWELL AH, 1987, BIOTROPICA, V19, P176, DOI 10.2307/2388742; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Rappole JH, 2003, CONSERV BIOL, V17, P334, DOI 10.1046/j.1523-1739.2003.01548.x; Roubik D.W., 1989, ECOLOGY NATURAL HIST, DOI DOI 10.1126/SCIENCE.248.4958.1026; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Thiele R, 2005, STUD NEOTROP FAUNA E, V40, P39, DOI 10.1080/01650520400025712; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Wang JP, 2010, BIOMETRIKA, V97, P727, DOI 10.1093/biomet/asq026; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	47	17	17	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78523	10.1371/journal.pone.0078523	http://dx.doi.org/10.1371/journal.pone.0078523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147137	gold, Green Published			2022-12-25	WOS:000326022200099
J	Scopinho, AA; Lisboa, SFS; Guimaraes, FS; Correa, FMA; Resstel, LBM; Joca, SRL				Scopinho, America A.; Lisboa, Sabrina F. S.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.; Joca, Samia R. L.			Dorsal and Ventral Hippocampus Modulate Autonomic Responses but Not Behavioral Consequences Associated to Acute Restraint Stress in Rats	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; VENTROLATERAL PERIAQUEDUCTAL GRAY; NITRIC-OXIDE SYNTHASE; LATERAL SEPTAL AREA; ELEVATED PLUS-MAZE; CARDIOVASCULAR-RESPONSES; STRIA TERMINALIS; BED NUCLEUS; NEUROENDOCRINE RESPONSES; ANXIETY-LIKE	Recent evidence has suggested that the dorsal (DH) and the ventral (VH) poles of the hippocampus are structurally, molecularly and functionally different regions. While the DH is preferentially involved in the modulation of spatial learning and memory, the VH modulates defensive behaviors related to anxiety. Acute restraint is an unavoidable stress situation that evokes marked and sustained autonomic changes, which are characterized by elevated blood pressure (BP), intense heart rate (HR) increases, skeletal muscle vasodilatation and cutaneous vasoconstriction, which are accompanied by a rapid skin temperature drop followed by body temperature increases. In addition to those autonomic responses, animals submitted to restraint also present behavioral changes, such as reduced exploration of the open arms of an elevated plus-maze (EPM), an anxiogenic-like effect. In the present work, we report a comparison between the effects of pharmacological inhibition of DH and VH neurotransmission on autonomic and behavioral responses evoked by acute restraint stress in rats. Bilateral microinjection of the unspecific synaptic blocker cobalt chloride (CoCl2, 1mM) into the DH or VH attenuated BP and HR responses, as well as the decrease in the skin temperature, elicited by restraint stress exposure. Moreover, DH or VH inhibition before restraint did not change the delayed increased anxiety behavior observed 24 h later in the EPM. The present results demonstrate for the first time that both DH and VH mediate stress-induced autonomic responses to restraint but they are not involved in the modulation of the delayed emotional consequences elicited by such stress.	[Scopinho, America A.; Lisboa, Sabrina F. S.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Joca, Samia R. L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Pharmacol Lab, Sao Paulo, Brazil; [Guimaraes, Francisco S.; Resstel, Leonardo B. M.; Joca, Samia R. L.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Resstel, LBM (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	leoresstel@yahoo.com.br; samia@usp.br	Lisboa, Sabrina F/G-2672-2012; Joca, Samia/F-8698-2012; Lisboa, Sabrina/N-5710-2019; Correa, Fernando/D-1614-2012; Resstel, Leonardo/C-6100-2012; Guimaraes, Francisco Silveira/C-1059-2012	Lisboa, Sabrina F/0000-0002-2069-3524; Joca, Samia/0000-0003-0255-5889; Lisboa, Sabrina/0000-0002-2069-3524; Correa, Fernando/0000-0003-4067-9524; Guimaraes, Francisco Silveira/0000-0003-4092-7778	FAPESP [2011/06615-1, 2011/17281-7, 2012/09300-4]; FAEPA; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present research was supported by grants from FAPESP (2011/06615-1; 2011/17281-7; 2012/09300-4), FAEPA and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; Antoniadis EA, 2001, EXP BRAIN RES, V138, P200, DOI 10.1007/s002210000645; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BAO JX, 1990, ACTA PHARM SINIC, V11, P130; Benes FM, 1997, J PSYCHIATR RES, V31, P257, DOI 10.1016/S0022-3956(96)00044-1; Bertoglio LJ, 2006, BEHAV BRAIN RES, V175, P183, DOI 10.1016/j.bbr.2006.08.021; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BLANCHAR.RJ, 1970, J COMP PHYSIOL PSYCH, V71, P92, DOI 10.1037/h0028958; BLANCHARD RJ, 1972, J COMP PHYSIOL PSYCH, V78, P77, DOI 10.1037/h0032176; Blessing WW, 2003, NEUROSCIENCE, V117, P939, DOI 10.1016/S0306-4522(02)00810-2; Blessing WW, 2003, CELL MOL NEUROBIOL, V23, P527, DOI 10.1023/A:1025020029037; BORRELL J, 1980, NEUROENDOCRINOLOGY, V31, P53, DOI 10.1159/000123050; Boscan P, 2001, AUTON NEUROSCI-BASIC, V86, P170, DOI 10.1016/S1566-0702(00)00255-1; BRITTON KT, 1992, BRAIN RES, V574, P125, DOI 10.1016/0006-8993(92)90808-M; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; Campos AC, 2010, NEUROSCIENCE, V167, P238, DOI 10.1016/j.neuroscience.2010.01.062; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cavun S, 2001, AM J PHYSIOL-REG I, V281, pR747, DOI 10.1152/ajpregu.2001.281.3.R747; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Chiba T, 2000, NEUROSCI RES, V38, P373, DOI 10.1016/S0168-0102(00)00183-8; Choi DC, 2008, ENDOCRINOLOGY, V149, P818, DOI 10.1210/en.2007-0883; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; Ciriello J, 2008, AM J PHYSIOL-REG I, V294, pR1276, DOI 10.1152/ajpregu.00437.2007; Clark RE, 2000, J NEUROSCI, V20, P8853; Conti LH, 2001, NEUROPEPTIDES, V35, P71, DOI 10.1054/npep.2001.0847; Crestani CC, 2007, J NEUROSCI RES, V85, P1592, DOI 10.1002/jnr.21250; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; CULLINAN WE, 1993, J COMP NEUROL, V332, P1, DOI 10.1002/cne.903320102; Deolindo M, 2008, NEUROSCI LETT, V430, P124, DOI 10.1016/j.neulet.2007.10.028; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Fortaleza EAT, 2009, NEUROSCIENCE, V159, P717, DOI 10.1016/j.neuroscience.2009.01.003; Fouquet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067232; GAMALLO A, 1992, PHYSIOL BEHAV, V51, P1201, DOI 10.1016/0031-9384(92)90309-P; Gold PW, 1996, MOL PSYCHIATR, V1, P257; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; GUIMARAES FS, 1993, BEHAV BRAIN RES, V58, P133, DOI 10.1016/0166-4328(93)90098-B; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; HENKE PG, 1990, BEHAV BRAIN RES, V36, P97, DOI 10.1016/0166-4328(90)90164-A; HENKIN RI, 1963, AM J PHYSIOL, V204, P710, DOI 10.1152/ajplegacy.1963.204.4.710; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; IRWIN MR, 1989, PHARMACOL BIOCHEM BE, V32, P913, DOI 10.1016/0091-3057(89)90058-0; Joca SRL, 2006, PSYCHOPHARMACOLOGY, V185, P298, DOI 10.1007/s00213-006-0326-2; Joca SRL, 2003, BRAIN RES, V978, P177, DOI 10.1016/S0006-8993(03)02943-3; Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063; Kaplan Z, 2001, PSYCHIATR SERV, V52, P824, DOI 10.1176/appi.ps.52.6.824; KENNETT GA, 1985, BRAIN RES, V330, P253, DOI 10.1016/0006-8993(85)90684-5; KENNETT GA, 1987, EUR J PHARMACOL, V134, P265, DOI 10.1016/0014-2999(87)90357-8; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Kubo T, 2002, NEUROSCI LETT, V318, P25, DOI 10.1016/S0304-3940(01)02463-6; Kurumaji A, 2011, NEUROSCI RES, V71, P161, DOI 10.1016/j.neures.2011.06.006; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; Mattson MP, 2001, BIOCHEM SOC SYMP, V67, P151, DOI 10.1042/bss0670151; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Mendonca FH, 1998, BEHAV BRAIN RES, V91, P207, DOI 10.1016/S0166-4328(97)00129-0; Meyer C, 1998, UNFALLCHIRURG, V101, P878, DOI 10.1007/s001130050354; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; OVERTON JM, 1991, PHYSIOL BEHAV, V49, P93, DOI 10.1016/0031-9384(91)90237-I; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; PADOVAN CM, 1993, BRAZ J MED BIOL RES, V26, P1085; Padovan CM, 2000, PHARMACOL BIOCHEM BE, V67, P325, DOI 10.1016/S0091-3057(00)00361-0; Pelosi GG, 2007, AUTON NEUROSCI-BASIC, V131, P70, DOI 10.1016/j.autneu.2006.07.002; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Reis DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023171; Resstel LBM, 2008, NEUROSCIENCE, V154, P869, DOI 10.1016/j.neuroscience.2008.04.007; Resstel LBM, 2004, BRAIN RES, V1015, P136, DOI 10.1016/j.brainres.2004.04.065; Resstel LBM, 2008, BEHAV PHARMACOL, V19, P137, DOI 10.1097/FBP.0b013e3282f62c9e; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Roberts AC, 2007, J COMP NEUROL, V502, P86, DOI 10.1002/cne.21300; RUIT KG, 1988, BRAIN RES, V457, P310, DOI 10.1016/0006-8993(88)90701-9; Saha S., 1996, Indian Journal of Physiology and Pharmacology, V40, P35; Salchner P, 2004, CELL MOL LIFE SCI, V61, P1498, DOI 10.1007/s00018-004-4140-x; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Scopinho AA, 2007, AUTON NEUROSCI-BASIC, V137, P77, DOI 10.1016/j.autneu.2007.08.003; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; Walker DL, 2009, PROG NEURO-PSYCHOPH, V33, P1291, DOI 10.1016/j.pnpbp.2009.06.022; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Yoshino K, 2005, AUTON NEUROSCI-BASIC, V119, P61, DOI 10.1016/j.autneu.2005.02.004	94	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77750	10.1371/journal.pone.0077750	http://dx.doi.org/10.1371/journal.pone.0077750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147071	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200071
J	Varghese, B; Supply, P; Shoukri, M; Allix-Beguec, C; Memish, Z; Abuljadayel, N; Al-Hakeem, R; AlRabiah, F; Al-Hajoj, S				Varghese, Bright; Supply, Philip; Shoukri, Mohammed; Allix-Beguec, Caroline; Memish, Ziad; Abuljadayel, Naila; Al-Hakeem, Raafat; AlRabiah, Fahad; Al-Hajoj, Sahal			Tuberculosis Transmission among Immigrants and Autochthonous Populations of the Eastern Province of Saudi Arabia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PATTERNS; DATABASE; STRAINS; IMPACT; BORN	Background: Eastern province of Saudi Arabia is an industrial zone with large immigrant population and high level of tuberculosis case notification among immigrants. The impact of immigration and current trends of tuberculosis transmission among immigrants and autochthonous population in the region had not been investigated so far using molecular tools. Methodology: During 2009-2011, a total of 524 Mycobacterium tuberculosis isolates were collected from the central tuberculosis reference laboratory, representing an estimated 79.2% of the culture-positive tuberculosis cases over the study period in the province. These isolates were genotyped by using 24 locus-based MIRU-VNTR typing and spoligotyping followed by first line drug susceptibility testing. The molecular clustering profiles and phylogenetic diversity of isolates were determined and compared to the geographical origins of the patients. Principle Findings: Genotyping showed an overall predominance of Delhi/CAS (29.4%), EAI (23.8%) and Ghana (13.3%) lineages, with slightly higher proportions of Delhi/CAS among autochthonous population (33.3 %) and EAI (30.9%) among immigrants. Rate of any drug resistance was 20.2% with 2.5% of multi-drug resistance. Strain cluster analysis indicated 42 clusters comprising 210 isolates, resulting in a calculated recent transmission index of 32.1%. Overall shared cluster ratio was 78.6% while 75.8% were shared between autochthonous population and immigrant population with a predominance of immigrants from South east Asia (40.7%). In contrast, cross national transmission within the immigrant population was limited (24.2%). Younger age (15-30- p value-0.043, 16-45, p value 0.030), Saudi nationality (p value-0.004) and South East Asian origin (p value-0.011) were identified as significant predisposing factors for molecular strain clustering. Conclusions: The high proportion of molecular clusters shared among the autochthonous and immigrant populations suggests a high permeability of tuberculosis transmission between both populations in the province. These results prompt for the need to strengthen the current tuberculosis control strategies and surveillance programs.	[Varghese, Bright; Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Ctr Biotechnol, Riyadh 11211, Saudi Arabia; [Allix-Beguec, Caroline] Genoscreen, Lille, France; [Memish, Ziad; Abuljadayel, Naila; Al-Hakeem, Raafat] Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Allix-Béguec, Caroline/AAI-4645-2021; Memish, Ziad Ahmed/AEJ-9424-2022; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Memish, Ziad Ahmed/0000-0002-5099-0714; Supply, Philip/0000-0003-3690-3853	King Abdul-Aziz City for Science and Technology [AT-26/110]	King Abdul-Aziz City for Science and Technology	This study was financially supported by King Abdul-Aziz City for Science and Technology under the Grant AT-26/110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Al-Jasser FS, 2012, SAUDI MED J, V33, P879; Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Blackwood KS, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-18; Borrell S, 2010, CLIN MICROBIOL INFEC, V16, P568, DOI 10.1111/j.1469-0691.2009.02886.x; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Central Department of Statistics and Information, 2012, STAT YB 2011; Central Department of Statistics and Information, 2002, STAT YB, P1999; Central Department of Statistics and Information, 2011, STAT YB 2010; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; Dale JW, 2005, J MED MICROBIOL, V54, P575, DOI 10.1099/jmm.0.45959-0; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garcia-Garcia JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016272; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Gleason JA, 2012, ANN EPIDEMIOL, V22, P264, DOI 10.1016/j.annepidem.2012.01.007; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ho MJ, 2003, MED ANTHROPOL Q, V17, P442, DOI 10.1525/maq.2003.17.4.442; Inigo J, 2007, J CLIN MICROBIOL, V45, P63, DOI 10.1128/JCM.01644-06; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Martinez-Lirola M, 2008, CLIN INFECT DIS, V47, P8, DOI 10.1086/588785; Ministry of Health, 2009, STAT BOOK YEAR 2009, P52; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rodriguez NA, 2009, CLIN MICROBIOL INFEC, V15, P435, DOI 10.1111/j.1469-0691.2008.02670.x; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Varghese B, 2013, TUBERCULOSIS, V93, P246, DOI 10.1016/j.tube.2012.12.001; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055598; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	41	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77635	10.1371/journal.pone.0077635	http://dx.doi.org/10.1371/journal.pone.0077635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147042	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200055
J	Yamada, T; Shigemura, H; Ishiguro, N; Inoshima, Y				Yamada, Tetsuya; Shigemura, Hiroaki; Ishiguro, Naotaka; Inoshima, Yasuo			Cell Infectivity in Relation to Bovine Leukemia Virus gp51 and p24 in Bovine Milk Exosomes	PLOS ONE			English	Article							STRUCTURES L-PARTICLES; RNA; TRANSMISSION; CATTLE; IDENTIFICATION; ASSOCIATION; MICRORNAS; TEGUMENT; PLASMA; BLOOD	Exosomes are small membranous microvesicles (40-100 nm in diameter) and are extracellularly released from a wide variety of cells. Exosomes contain microRNA, mRNA, and cellular proteins, which are delivered into recipient cells via these exosomes, and play a role in intercellular communication. In bovine leukemia virus (BLV) infection of cattle, although it is thought to be a minor route of infection, BLV can be transmitted to calves via milk. Here, we investigated the association between exosomes and BLV in bovine milk. BLV structural proteins, gp51 (Env) and p24 (Gag), were detected in bovine milk exosomes from BLV-infected cattle by Western blot analysis. In cells inoculated with these milk exosomes, BLV DNA was not detected during three serial passages by nested PCR. Purification of exosomes from persistently BLV-infected cells was achieved by immuno-magnetic separation using an antibody against exosomes coupled to magnetic beads. Consistently, BLV gp51 and p24 proteins were detected in purified exosomes. Moreover, reverse transcriptase activity was observed in purified exosomes, meaning that exosomes also contain viral enzyme. However, BLV DNA was not detected in serially passaged cells after inoculation of purified exosomes, indicating that exosomes carrying BLV proteins appeared to be not infectious. These results suggest that BLV proteins are released with milk exosomes and could be transferred into recipient cells of calves via milk exosomes as an alternative route not requiring virus infection. Moreover it is also possible that bovine milk exosomes play a role in clearance of BLV proteins from infected cells.	[Yamada, Tetsuya; Shigemura, Hiroaki; Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, Dept Vet Med, Gifu, Japan	Gifu University	Inoshima, Y (corresponding author), Gifu Univ, Dept Vet Med, Gifu, Japan.	inoshima@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23380178]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (B) ( No. 23380178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; AOKI N, 1994, BBA-GEN SUBJECTS, V1199, P87, DOI 10.1016/0304-4165(94)90101-5; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; BURNY A, 1988, VET MICROBIOL, V17, P197, DOI 10.1016/0378-1135(88)90066-1; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Campbell TD, 2008, ETHN DIS, V18; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; FERRER JF, 1981, CANCER RES, V41, P4906; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; ITOHARA S, 1984, MICROBIOL IMMUNOL, V28, P251, DOI 10.1111/j.1348-0421.1984.tb00677.x; JOHNSON R, 1991, COMP CONT EDUC PRACT, V13, P315; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; KETTMANN R, 1976, P NATL ACAD SCI USA, V73, P1014, DOI 10.1073/pnas.73.4.1014; Kohara J, 2006, JPN J VET RES, V54, P25; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kuckleburg CJ, 2003, J VET DIAGN INVEST, V15, P72, DOI 10.1177/104063870301500117; LASSAUZET MLG, 1990, CAN J VET RES, V54, P184; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; Meas S, 2002, VET MICROBIOL, V84, P275, DOI 10.1016/S0378-1135(01)00458-8; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Michishita K., 2011, Journal of Veterinary Medicine, Japan, V64, P815; Mohan M, 2001, MOL REPROD DEV, V60, P289, DOI 10.1002/mrd.1090; MURAKAMI K, 1994, VIROLOGY, V202, P458, DOI 10.1006/viro.1994.1362; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; RIXON FJ, 1992, J GEN VIROL, V73, P277, DOI 10.1099/0022-1317-73-2-277; SHIMIZU M, 1987, JPN J VET SCI, V49, P1045; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Der Maaten M J, 1975, Bibl Haematol, P360; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wurdinger T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/767694; Yamada T, 2012, J VET MED SCI, V74, P1523, DOI 10.1292/jvms.12-0032; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	54	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77359	10.1371/journal.pone.0077359	http://dx.doi.org/10.1371/journal.pone.0077359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146982	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200033
J	Zheng, DP; Rodrigues, M; Bile, E; Nguyen, DB; Diallo, K; DeVos, JR; Nkengasong, JN; Yang, CF				Zheng, Du-Ping; Rodrigues, Margarida; Bile, Ebi; Nguyen, Duc B.; Diallo, Karidia; DeVos, Joshua R.; Nkengasong, John N.; Yang, Chunfu			Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance	PLOS ONE			English	Article							BLOOD SPOT SPECIMENS; TRANSMITTED HIV; GENOTYPING ASSAY; TESTING SITES; SURVEILLANCE; DIVERSITY; ACCURACY; HIV/AIDS; PROTEASE; VIETNAM	Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV drug resistance (t-HIVDR) and incidence. However, accurately identifying recent HIV infection is challenging due partially to the limitations of current serological tests. Ambiguous nucleotides are newly emerged mutations in quasispecies, and accumulate by time of viral infection. We utilized ambiguous mutations to establish a measurement for detecting recent HIV infection and monitoring early HIVDR development. Ambiguous nucleotides were extracted from HIV-1 pol-gene sequences in the datasets of recent (HIVDR threshold surveys [HIVDR-TS] in 7 countries; n=416) and established infections (1 HIVDR monitoring survey at baseline; n=271). An ambiguous mutation index of 2.04x10(-3) nts/site was detected in HIV-1 recent infections which is equivalent to the HIV-1 substitution rate (2x10(-3) nts/site/year) reported before. However, significantly higher index (14.41x10(-3) nts/site) was revealed with established infections. Using this substitution rate, 75.2% subjects in HIVDR-TS with the exception of the Vietnam dataset and 3.3% those in HIVDR-baseline were classified as recent infection within one year. We also calculated mutation scores at amino acid level at HIVDR sites based on ambiguous or fitted mutations. The overall mutation scores caused by ambiguous mutations increased (0.54x10(-2)3.48x10(-2)/DR-site) whereas those caused by fitted mutations remained stable (7.50-7.89x10(-2)/DR-site) in both recent and established infections, indicating that t-HIVDR exists in drug-naive populations regardless of infection status in which new HIVDR continues to emerge. Our findings suggest that characterization of ambiguous mutations in HIV may serve as an additional tool to differentiate recent from established infections and to monitor HIVDR emergence.	[Zheng, Du-Ping; Diallo, Karidia; DeVos, Joshua R.; Nkengasong, John N.; Yang, Chunfu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA; [Rodrigues, Margarida] CDC GAP Angola, Luanda, Angola; [Bile, Ebi] CDC GAP Botswana, Gaborone, Botswana; [Nguyen, Duc B.] US CDC, Dept Hlth & Human Serv, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA	Yang, CF (corresponding author), Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA.	CYang1@cdc.gov	Yang, Chunfu/G-6890-2013	Bile, Ebi Celestin/0000-0003-1930-7443	Centers for Disease Control and Prevention; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Bussmann H, 2011, AIDS RES HUM RETROV, V27, P365, DOI [10.1089/aid.2009.0299, 10.1089/aid.2010.0273]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Dean J, 2011, AIDS RES HUM RETROV, V27, P797, DOI 10.1089/aid.2011.0013; Duc NB, 2012, CLIN INFECT DIS, V54, pS343, DOI 10.1093/cid/cir1049; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Gojobori T, 2000, AIDS REV, V2, P39; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kamoto K, 2008, ANTIVIR THER, V13, P83; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Lemey P, 2006, AIDS REV, V8, P125; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Myatt M, 2008, ANTIVIR THER, V13, P37; National AIDS/STDs Control Program FMoH Abuja Nigeria, 2007, NAT GUID HIV AIDS TR; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Oette M, 2012, INTERVIROLOGY, V55, P160, DOI 10.1159/000332018; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Somi GR, 2008, ANTIVIR THER, V13, P77; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; Thanh DC, 2009, AIDS BEHAV, V13, P1151, DOI 10.1007/s10461-008-9451-8; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; WHO, 2012, WHO HIV DRUG RES REP; Who U UNICEF, 2011, GLOB HIV AIDS RESP E; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Zhang J, 2010, AIDS RES HUM RETROV, V26, P99, DOI 10.1089/aid.2009.0184; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77649	10.1371/journal.pone.0077649	http://dx.doi.org/10.1371/journal.pone.0077649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147046	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200058
J	Bin Raies, A; Mansour, H; Incitti, R; Bajic, VB				Bin Raies, Arwa; Mansour, Hicham; Incitti, Roberto; Bajic, Vladimir B.			Combining Position Weight Matrices and Document-Term Matrix for Efficient Extraction of Associations of Methylated Genes and Diseases from Free Text	PLOS ONE			English	Article							DNA METHYLATION; DATABASE; EPIGENETICS; MEINFOTEXT	Background: In a number of diseases, certain genes are reported to be strongly methylated and thus can serve as diagnostic markers in many cases. Scientific literature in digital form is an important source of information about methylated genes implicated in particular diseases. The large volume of the electronic text makes it difficult and impractical to search for this information manually. Methodology: We developed a novel text mining methodology based on a new concept of position weight matrices (PWMs) for text representation and feature generation. We applied PWMs in conjunction with the document-term matrix to extract with high accuracy associations between methylated genes and diseases from free text. The performance results are based on large manually-classified data. Additionally, we developed a web-tool, DEMGD, which automates extraction of these associations from free text. DEMGD presents the extracted associations in summary tables and full reports in addition to evidence tagging of text with respect to genes, diseases and methylation words. The methodology we developed in this study can be applied to similar association extraction problems from free text. Conclusion: The new methodology developed in this study allows for efficient identification of associations between concepts. Our method applied to methylated genes in different diseases is implemented as a Web-tool, DEMGD, which is freely available at http://www.cbrc.kaust.edu.sa/demgd/. The data is available for online browsing and download.	[Bin Raies, Arwa; Bajic, Vladimir B.] KAUST, CBRC, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia; [Mansour, Hicham; Incitti, Roberto] KAUST, Biosci Core Labs, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), KAUST, CBRC, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Incitti, Roberto/AAD-1672-2019; Bajic, Vladimir/D-2810-2009; Raies, Arwa/D-8079-2018	Bajic, Vladimir/0000-0001-5435-4750; Raies, Arwa/0000-0003-3952-7363	KAUST Base Research Funds	KAUST Base Research Funds	This project was funded by the KAUST Base Research Funds to VBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2012, CH CRC DATA MIN KNOW, P3; ALDOUS D, 1991, ANN PROBAB, V19, P1, DOI 10.1214/aop/1176990534; Amoreira C, 2003, NUCLEIC ACIDS RES, V31, P75, DOI 10.1093/nar/gkg093; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brower V, 2011, NATURE, V471, pS12, DOI 10.1038/471S12a; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chun HW, 2006, P PAC S BIOC PSB 11; CLAVERIE JM, 1994, COMPUT CHEM, V18, P287, DOI 10.1016/0097-8485(94)85024-0; Coenen F, 2005, ADV KNOWLEDGE DISCOV; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-471; Fang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-22; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pD75, DOI 10.1093/nar/gkq942; Hakenberg J, 2012, J BIOMED INFORM, V45, P842, DOI 10.1016/j.jbi.2012.04.006; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Han J, 2012, MOR KAUF D, P1; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Li W, 2001, 2001 IEEE INT C DAT; Liu B, 1998, 4 INT C KNOWL DISC D; Luehr S, 2012, NUCLEIC ACIDS RES, V40, pW104, DOI 10.1093/nar/gks602; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Miner G, 2012, PRACTICAL TEXT MINING AND STATISTICAL ANALYSIS FOR NON-STRUCTURED TEXT DATA APPLICATIONS, P1; Nandi S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-416; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Porter MF, 2006, PROGRAM-ELECTRON LIB, V40, P211, DOI 10.1108/eb046814; Quinlan J, 1993, P EUR C MACH LEARN E; Quinlan J.R., 1993, CONSTRUCTING DECISIO, P17; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Scholkopf B., 2005, LEARNING KERNELS SUP, DOI [10.1109/tnn.2005.848998, DOI 10.1109/TNN.2005.848998]; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Summers T, 2013, J CANCER, V4, P210, DOI 10.7150/jca.5839; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Wallach HM, 2006, ICML 06 P 23 INT C M; Wang S, 2008, DNA METHYLATION MICR, P17; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Weiss SM, 2010, TEXTS COMPUT SCI, P1, DOI 10.1007/978-1-84996-226-1; Xin YR, 2012, NUCLEIC ACIDS RES, V40, pD1245, DOI 10.1093/nar/gkr1193; Yang Y, 1997, P 4 INT C MACH LEARN; Yin XX, 2003, SIAM PROC S, P331; Zheng JH, 2013, CLIN CANCER RES, V19, P1400, DOI 10.1158/1078-0432.CCR-12-2888	47	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77848	10.1371/journal.pone.0077848	http://dx.doi.org/10.1371/journal.pone.0077848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147091	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400140
J	Ge, FM; Yuan, SZ; Su, LD; Shen, ZH; He, AB; Huang, T; Gong, WH				Ge, Fangmin; Yuan, Shunzong; Su, Lida; Shen, Zhonghua; He, Aibin; Huang, Tao; Gong, Weihua			Alteration of Innate Immunity by Donor IL-6 Deficiency in a Presensitized Heart Transplant Model	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; KIDNEY-TRANSPLANT; GRAFT-REJECTION; CELLS	Engraftment of IL-6 deficient donor into wild-type recipient could significantly improve allograft survival through T cell lineage particularly regulatory T cells (Tregs) in non-sensitized transplant host. However, its effect on innate immune responses remains uncertain. Our data revealed that donor IL-6 deficiency significantly increased infiltration of two subsets of MDSCs (CD11b+Gr1+myeloid-derived suppressor cells), CD11b+Gr1(-low) and CD11b+Gr1(-int) with strong immunosuppression activity in the transplanted graft. It resulted in a dramatic increase of CD11b+Gr1(-low) frequency and a significant decrease of the frequency of CD11b+Gr1(-high) and CD4-CD8-NK1.1+ cells in the recipient's spleen. Unexpectedly, donor IL-6 deficiency could not significantly reduce macrophage frequency irrespective of in the host's spleen or graft. Taken together, suppression of innate immune effector cells and enhanced activity of regulatory MDSCs contributed to tolerance induction by blockade of IL-6 signaling pathway. The unveiled novel mechanism of targeting IL-6 might shed light on clinical therapeutic application in preventing accelerated allograft rejection for those pre-sensitized transplant recipients.	[Ge, Fangmin; Su, Lida; Shen, Zhonghua; Gong, Weihua] Zhejiang Univ, Sch Med, Dept Surg & Med, TIRC,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Yuan, Shunzong] Acad Mil Med Sci, Dept Lymphoma, Affiliated Hosp, Beijing, Peoples R China; [Yuan, Shunzong; Huang, Tao] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA; [He, Aibin] Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA USA	Zhejiang University; Academy of Military Medical Sciences - China; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Gong, WH (corresponding author), Zhejiang Univ, Sch Med, Dept Surg & Med, TIRC,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	weihua.gong@gmail.com	he, aibin/ABA-2759-2021; Yuan, Shunzong/AAO-3551-2020		Department of Education of Zhejiang Province [Y201226017]; National Natural Science Foundation of China [81270323]; National Foundation of Natural Science of China [31100780]; Qianjiang Talents Project of Zhejiang Province [2012R10022]; Zhejiang Provincial Outstanding Youth Foundation [LR13H020001]	Department of Education of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of Zhejiang Province; Zhejiang Provincial Outstanding Youth Foundation	The work was supported by the Department of Education of Zhejiang Province (Grant No. Y201226017), the National Natural Science Foundation of China (No. 81270323), the National Foundation of Natural Science of China (No. 31100780), the Qianjiang Talents Project of Zhejiang Province (Grant No. 2012R10022), and Zhejiang Provincial Outstanding Youth Foundation (Grant No. LR13H020001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth AJ, 2011, J IMMUNOL, V187, P5764, DOI 10.4049/jimmunol.1100766; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Fairchild RL, 2013, AM J TRANSPLANT, V13, P2235; Fogal B, 2011, J IMMUNOL, V187, P6268, DOI 10.4049/jimmunol.1003774; Ge FM, 2011, EXP CLIN TRANSPLANT, V9, P287; Gelman AE, 2010, AM J TRANSPLANT, V10, P1189, DOI 10.1111/j.1600-6143.2010.03101.x; Gong W, 2009, AM J TRANSPLANT, V9, P1742, DOI 10.1111/j.1600-6143.2009.02725.x; Gong W, 2013, TRANSPLANTATION; Gong W, 2012, EXP CLIN TRANSPLANT, V10, P158, DOI 10.6002/ect.2011.0123; HEIDECKE CD, 1985, TRANSPLANTATION, V40, P441; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Liang Y, 2007, TRANSPLANTATION, V84, P771, DOI 10.1097/01.tp.0000281384.24333.0b; Murphy SP, 2011, IMMUNOL REV, V241, P39, DOI 10.1111/j.1600-065X.2011.01009.x; Oberbarnscheidt MH, 2011, SEMIN IMMUNOL, V23, P264, DOI 10.1016/j.smim.2011.06.006; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Reinhold SW, 2012, CYTOKINE, V57, P379, DOI 10.1016/j.cyto.2011.12.006; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Xu H., 2012, CELL TRANSPLANT; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; Zecher D, 2010, J IMMUNOL, V184, P6649, DOI 10.4049/jimmunol.0903729; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194	25	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77559	10.1371/journal.pone.0077559	http://dx.doi.org/10.1371/journal.pone.0077559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147024	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400121
J	Liew, LC; Singh, MB; Bhalla, PL				Liew, Lim Chee; Singh, Mohan B.; Bhalla, Prem L.			An RNA-Seq Transcriptome Analysis of Histone Modifiers and RNA Silencing Genes in Soybean during Floral Initiation Process	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; FLOWERING-LOCUS-T; DNA METHYLATION; DEACETYLASE FAMILIES; DOMAIN PROTEINS; MOLECULAR-BASIS; NONCODING RNAS; LEAF POLARITY; LYSINE 4; ARABIDOPSIS	Epigenetics has been recognised to play vital roles in many plant developmental processes, including floral initiation through the epigenetic regulation of gene expression. The histone modifying proteins that mediate these modifications involve the SET domain-containing histone methyltransferases, JmjC domain-containing demethylase, acetylases and deacetylases. In addition, RNA interference (RNAi)-associated genes are also involved in epigenetic regulation via RNA-directed DNA methylation and post-transcriptional gene silencing. Soybean, a major crop legume, requires a short day to induce flowering. How histone modifications regulate the plant response to external cues that initiate flowering is still largely unknown. Here, we used RNA-seq to address the dynamics of transcripts that are potentially involved in the epigenetic programming and RNAi mediated gene silencing during the floral initiation of soybean. Soybean is a paleopolyploid that has been subjected to at least two rounds of whole genome duplication events. We report that the expanded genomic repertoire of histone modifiers and RNA silencing genes in soybean includes 14 histone acetyltransferases, 24 histone deacetylases, 47 histone methyltransferases, 15 protein arginine methyltransferases, 24 JmjC domain-containing demethylases and 47 RNAi-associated genes. To investigate the role of these histone modifiers and RNA silencing genes during floral initiation, we compared the transcriptional dynamics of the leaf and shoot apical meristem at different time points after a short-day treatment. Our data reveal that the extensive activation of genes that are usually involved in the epigenetic programming and RNAi gene silencing in the soybean shoot apical meristem are reprogrammed for floral development following an exposure to inductive conditions.	[Liew, Lim Chee; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au	Liew, Lim Chee/Y-6050-2019	Singh, Mohan/0000-0001-9427-8975; Liew, Lim Chee/0000-0001-8243-8521; Bhalla, Prem/0000-0002-2910-0393	Australian Research Council [CE0348212, DP0988972]; McKenzie Postdoctoral Fellowship scheme, University of Melbourne	Australian Research Council(Australian Research Council); McKenzie Postdoctoral Fellowship scheme, University of Melbourne	This work was supported by the Australian Research Council (CE0348212 and DP0988972). L.C. Liew gratefully acknowledges financial support by McKenzie Postdoctoral Fellowship scheme, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 2012, J GENET GENOMICS, P24881; Ahmad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022664; Aquea F, 2010, PLANT PHYSIOL BIOCH, V48, P194, DOI 10.1016/j.plaphy.2009.12.009; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Avramova Z, 2009, INT J DEV BIOL, V53, P371, DOI 10.1387/ijdb.082664za; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Bond DM, 2009, MOL PLANT, V2, P724, DOI 10.1093/mp/ssp021; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen XS, 2011, BBA-GENE REGUL MECH, V1809, P421, DOI 10.1016/j.bbagrm.2011.03.004; Chen XM, 2002, DEVELOPMENT, V129, P1085; Colville A, 2011, PLANT CELL REP, V30, P1969, DOI 10.1007/s00299-011-1105-z; Demetriou K, 2009, PHYSIOL PLANTARUM, V136, P358, DOI 10.1111/j.1399-3054.2009.01236.x; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hemmes H, 2012, PLANT CELL PHYSIOL, V53, P2016, DOI 10.1093/pcp/pcs148; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeong JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008033; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kanno T, 2011, BBA-GENE REGUL MECH, V1809, P444, DOI 10.1016/j.bbagrm.2011.05.002; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Krogan NT, 2012, DEVELOPMENT, V139, P4180, DOI 10.1242/dev.085407; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Lu FL, 2010, CELL RES, V20, P387, DOI 10.1038/cr.2010.27; Lu SX, 2011, PLANT SIGNAL BEHAV, V6, P810, DOI 10.4161/psb.6.6.15171; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Luo M, 2012, J EXP BOT, V63, P3297, DOI 10.1093/jxb/ers059; MA X, 2013, PLANT CELL REP, V32, P1, DOI DOI 10.1007/S00299-012-1342-9.PUBMED:23007688; Malapeira J, 2012, P NATL ACAD SCI USA, V109, P21540, DOI 10.1073/pnas.1217022110; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Thorstensen T, 2011, BBA-GENE REGUL MECH, V1809, P407, DOI 10.1016/j.bbagrm.2011.05.008; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Weller JL, 2012, P NATL ACAD SCI USA, V109, P21158, DOI 10.1073/pnas.1207943110; Weller JL, 2009, J EXP BOT, V60, P2493, DOI 10.1093/jxb/erp120; WESLEY SV, 2004, RNA INTERFERENCE EDI, V265, P117; Wong CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065319; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wong CE, 2009, PLANT SIGNAL BEHAV, V4, P648, DOI [10.1111/j.1365-313X.2008.03730.x, 10.4161/psb.4.7.8978]; Wong CE, 2009, PLANT J, V57, P832, DOI 10.1111/j.1365-313X.2008.03730.x; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	98	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77502	10.1371/journal.pone.0077502	http://dx.doi.org/10.1371/journal.pone.0077502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147010	Green Published, gold			2022-12-25	WOS:000326019400115
J	Fang, IM; Yang, CH; Yang, CM; Chen, MS				Fang, I-Mo; Yang, Chang-Hao; Yang, Chung-May; Chen, Muh-Shy			Chitosan Oligosaccharides Attenuates Oxidative-Stress Related Retinal Degeneration in Rats	PLOS ONE			English	Article							NF-KAPPA-B; WATER-SOLUBLE CHITOSAN; TRANSCRIPTION FACTOR; IN-VITRO; CELLS; BCL-2; GLUTATHIONE; APOPTOSIS; PROTEINS; EFFICACY	This study investigated the therapeutic potential and mechanisms of chitosan oligosaccharides (COS) for oxidative stress-induced retinal diseases. Retinal oxidative damage was induced in Sprague-Dawley rats by intravitreal injection of paraquat (PQ). Low-dose (5 mg/kg) or high-dose (10 mg/kg) COS or PBS was intragastrically given for 14 days after PQ injection. Electroretinograms were performed to determine the functionality of the retinas. The surviving neurons in the retinal ganglion cell layer and retinal apoptosis were determined by counting Neu N-positive cells in whole-mounted retinas and TUNEL staining, respectively. The generation of reactive oxygen species (ROS) was determined by lucigenin- and luminol-enhanced chemiluminescence. Retinal oxidative damages were assessed by staining with nitrotyrosine, acrolein, and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Immunohistochemical studies were used to demonstrate the expression of nuclear factor-kappa B (NF-kappa B) p65 in retinas. An in vitro study using RGC-5 cells was performed to verify the results. We demonstrated COS significantly enhanced the recovery of retinal function, preserved inner retinal thickness, and decreased retinal neurons loss in a dose-dependent manner. COS administration demonstrated anti-oxidative effects by reducing luminol-and lucigenin-dependent chemiluminenscense levels and activating superoxide dismutase and catalase, leading to decreased retinal apoptosis. COS markedly reduced retinal NF-kappa B p65. An in vitro study demonstrated COS increased I kappa B expression, attenuated the increase of p65 and thus decreased NF-kappa B/DNA binding activity in PQ-stimulated RGC-5 cells. In conclusion, COS attenuates oxidative stress-induced retinal damages, probably by decreasing free radicals, maintaining the activities of anti-oxidative enzymes, and inhibiting the activation of NF-kappa B.	[Fang, I-Mo] Taipei City Hosp, Zhongxiao Branch, Dept Ophthalmol, Taipei, Taiwan; [Yang, Chang-Hao; Yang, Chung-May; Chen, Muh-Shy] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Taipei City Hospital; National Taiwan University; National Taiwan University Hospital	Yang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chyangoph@ntu.edu.tw	Yang, Chang-Hao/AAR-3759-2021; Yang, Chung-May/AAV-3737-2020	YANG, CHANG-HAO/0000-0002-4328-8716; YANG, CHUNG-MAY/0000-0003-4082-420X	Department of Health, Taipei City Government [101-43]	Department of Health, Taipei City Government	This study was supported by a research grant from the Department of Health, Taipei City Government (101-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Chen F, 1999, CLIN CHEM, V45, P7; Chen Q, 2006, EUR J PHARMACOL, V541, P1, DOI 10.1016/j.ejphar.2006.03.044; Cho YS, 2011, BIOORG MED CHEM LETT, V21, P3070, DOI 10.1016/j.bmcl.2011.03.033; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Je JY, 2004, FOOD CHEM TOXICOL, V42, P381, DOI 10.1016/j.fct.2003.10.001; Joodi G, 2011, INT J BIOL MACROMOL, V48, P726, DOI 10.1016/j.ijbiomac.2011.02.011; Khodagholi F, 2010, MOL CELL BIOCHEM, V337, P39, DOI 10.1007/s11010-009-0284-1; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001; Luo T, 2006, ANESTH ANALG, V103, P110, DOI 10.1213/01.ane.0000221183.02244.80; Mendis E, 2007, LIFE SCI, V80, P2118, DOI 10.1016/j.lfs.2007.03.016; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ozkan E, 2010, J SURG RES, V159, P588, DOI 10.1016/j.jss.2008.08.006; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pae HO, 2001, LEUKEMIA RES, V25, P339, DOI 10.1016/S0145-2126(00)00138-7; Pangestuti R, 2010, MAR DRUGS, V8, P2117, DOI 10.3390/md8072117; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Ryu B, 2012, CARBOHYD RES, V350, P55, DOI 10.1016/j.carres.2011.12.028; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wei P, 2012, GLYCOCONJUGATE J, V29, P285, DOI 10.1007/s10719-012-9392-3; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Winkler BS, 1999, MOL VIS, V5; Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2; Yoon HJ, 2008, FOOD CHEM TOXICOL, V46, P710, DOI 10.1016/j.fct.2007.09.111; Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013; Yu ZJ, 2004, INT IMMUNOPHARMACOL, V4, P193, DOI 10.1016/j.intimp.2003.12.001	40	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77323	10.1371/journal.pone.0077323	http://dx.doi.org/10.1371/journal.pone.0077323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155943	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300077
J	Gmyrek, GB; Akilesh, HM; Graham, DB; Fuchs, A; Yang, LH; Miller, MJ; Sandoval, GJ; Sheehan, KCF; Schreiber, RD; Diamond, MS; Swat, W				Gmyrek, Grzegorz B.; Akilesh, Holly M.; Graham, Daniel B.; Fuchs, Anja; Yang, Lihua; Miller, Mark J.; Sandoval, Gabriel J.; Sheehan, Kathleen C. F.; Schreiber, Robert D.; Diamond, Michael S.; Swat, Wojciech			Loss of DAP12 and FcR gamma Drives Exaggerated IL-12 Production and CD8(+) T Cell Response by CCR2(+) Mo-DCs	PLOS ONE			English	Article							TRANSCRIPTION FACTOR IRF8; DENDRITIC CELLS; IFN-GAMMA; MONOCYTE MIGRATION; SIGNALING PATHWAYS; GM-CSF; RECEPTOR; INFECTION; MACROPHAGES; ADAPTERS	Dap12 and FcR gamma, the two transmembrane ITAM-containing signaling adaptors expressed in dendritic cells (DC), are implicated in the regulation of DC function. Several activating and adhesion receptors including integrins require these chains for their function in triggering downstream signaling and effector pathways, however the exact role(s) for Dap12 and FcR gamma remains elusive as their loss can lead to both attenuating and enhancing effects. Here, we report that mice congenitally lacking both Dap12 and FcR gamma chains (DF) show a massively enhanced effector CD8(+) T cell response to protein antigen immunization or West Nile Virus (WNV) infection. Thus, immunization of DF mice with MHCI-restricted OVA peptide leads to accumulation of IL-12-producing monocyte-derived dendritic cells (Mo-DC) in draining lymph nodes, followed by vastly enhanced generation of antigen-specific IFN gamma-producing CD8(+) T cells. Moreover, DF mice show increased viral clearance in the WNV infection model. Depletion of CCR2+ monocytes/macrophages in vivo by administration anti-CCR2 antibodies or clodronate liposomes completely prevents the exaggerated CD8+ T cell response in DF mice. Mechanistically, we show that the loss of Dap12 and FcR gamma-mediated signals in Mo-DC leads to a disruption of GM-CSF receptor-induced STAT5 activation resulting in upregulation of expression of IRF8, a transcription factor. Consequently, Dap12- and FcR gamma-deficiency exacerbates GM-CSF-driven monocyte differentiation and production of inflammatory Mo-DC. Our data suggest a novel cross-talk between DC-ITAM and GM-CSF signaling pathways, which controls Mo-DC differentiation, IL-12 production, and CD8(+) T cell responses.	[Gmyrek, Grzegorz B.; Akilesh, Holly M.; Graham, Daniel B.; Fuchs, Anja; Miller, Mark J.; Sandoval, Gabriel J.; Sheehan, Kathleen C. F.; Schreiber, Robert D.; Diamond, Michael S.; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Yang, Lihua; Miller, Mark J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Swat, W (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	swat@wustl.edu	Schreiber, Robert/Q-7550-2019; Diamond, Michael/AAH-1733-2019; Gmyrek, Grzegorz/C-3175-2011	Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert/0000-0003-1590-2341; Miller, Mark/0000-0001-5676-389X	National Institutes of Health [R01AI061077, R01AI073718]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073718, R01AI061077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant nos. R01AI061077 (to W.S.), R01AI073718 (to W.S.), and Leukemia and Lymphoma Society Scholar (W.S.) and Special Fellow (D.B.G.) awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Divangahi M, 2007, J IMMUNOL, V179, P4015, DOI 10.4049/jimmunol.179.6.4015; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Finberg RW, 2009, IMMUNITY, V30, P173, DOI 10.1016/j.immuni.2009.02.001; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Graham DB, 2010, BLOOD, V116, P3208, DOI 10.1182/blood-2009-10-250415; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huynh L, 2012, J IMMUNOL, V188, P3447, DOI 10.4049/jimmunol.1102211; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; McCormick S, 2011, J IMMUNOL, V187, P4280, DOI 10.4049/jimmunol.1101050; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhan YF, 2010, J IMMUNOL, V185, P2125, DOI 10.4049/jimmunol.0903793; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76145	10.1371/journal.pone.0076145	http://dx.doi.org/10.1371/journal.pone.0076145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155889	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300023
J	Ortolan, TG; Menck, CFM				Ortolan, Tatiana Grohmann; Menck, Carlos Frederico M.			UVB-Induced Cell Death Signaling Is Associated with G1-S Progression and Transcription Inhibition in Primary Human Fibroblasts	PLOS ONE			English	Article							LIGHT-INDUCED APOPTOSIS; ULTRAVIOLET-INDUCED APOPTOSIS; DNA-DAMAGE; COUPLED REPAIR; PYRIMIDINE DIMERS; HAMSTER-CELLS; P53 RESPONSE; S-PHASE; GENES; RADIATION	DNA damage induced by ultraviolet (UV) radiation can be removed by nucleotide excision repair through two sub-pathways, one general (GGR) and the other specific for transcribed DNA (TCR), and the processing of unrepaired lesions trigger signals that may lead to cell death. These signals involve the tumor suppressor p53 protein, a central regulator of cell responses to DNA damage, and the E3 ubiquitin ligase Mdm2, that forms a feedback regulatory loop with p53. The involvement of cell cycle and transcription on the signaling to apoptosis was investigated in UVB-irradiated synchronized, DNA repair proficient, CS-B (TCR-deficient) and XP-C (GGR-deficient) primary human fibroblasts. Cells were irradiated in the G1 phase of the cell cycle, with two doses with equivalent levels of apoptosis (low and high), defined for each cell line. In the three cell lines, the low doses of UVB caused only a transient delay in progression to the S phase, whereas the high doses induced permanent cell cycle arrest. However, while accumulation of Mdm2 correlated well with the recovery from transcription inhibition at the low doses for normal and CS-B fibroblasts, for XP-C cells this protein was shown to be accumulated even at UVB doses that induced high levels of apoptosis. Thus, UVB-induced accumulation of Mdm2 is critical for counteracting p53 activation and apoptosis avoidance, but its effect is limited due to transcription inhibition. However, in the case of XP-C cells, an excess of unrepaired DNA damage would be sufficient to block S phase progression, which would signal to apoptosis, independent of Mdm2 accumulation. The data clearly discriminate DNA damage signals that lead to cell death, depending on the presence of UVB-induced DNA damage in replicating or transcribing regions.	[Ortolan, Tatiana Grohmann; Menck, Carlos Frederico M.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Menck, CFM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	cfmmenck@usp.br	Menck, Carlos FM/G-6321-2011	Menck, Carlos FM/0000-0003-1941-0694	FAPESP, Sao Paulo, Brazil; CNPq, Brasilia, Brazil	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESP, Sao Paulo, Brazil, and CNPq, Brasilia, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Batista LFZ, 2006, APOPTOSIS, V11, P1139, DOI 10.1007/s10495-006-7109-4; Cadet J, 2012, PHOTOCHEM PHOTOBIOL, V88, P1048, DOI 10.1111/j.1751-1097.2012.01200.x; Carvalho H, 2008, DNA REPAIR, V7, P922, DOI 10.1016/j.dnarep.2008.03.003; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Conforti G, 2000, ONCOGENE, V19, P2714, DOI 10.1038/sj.onc.1203583; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Courdavault S, 2004, PHOTOCHEM PHOTOBIOL, V79, P145, DOI 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2; D'Errico M, 2005, CANCER RES, V65, P432; De Santis LP, 2002, DNA REPAIR, V1, P209, DOI 10.1016/S1568-7864(01)00017-9; De Santis LP, 2001, MUTAT RES-DNA REPAIR, V485, P121, DOI 10.1016/S0921-8777(00)00065-3; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Dumaz N, 1997, MOL CARCINOGEN, V20, P340, DOI 10.1002/(SICI)1098-2744(199712)20:4<340::AID-MC3>3.0.CO;2-N; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Leite RA, 2009, J INVEST DERMATOL, V129, P502, DOI 10.1038/jid.2008.239; Li G, 1998, BRIT J DERMATOL, V139, P3; Ljungman M, 1996, ONCOGENE, V13, P823; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; ORREN DK, 1995, MOL CELL BIOL, V15, P3722; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Rechkunova NI, 2011, BIOCHEMISTRY-MOSCOW+, V76, P24, DOI 10.1134/S0006297911010056; Sertic S, 2012, CELL CYCLE, V11, P668, DOI 10.4161/cc.11.4.19117; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Moraes MCS, 2012, FRONT BIOSCI-LANDMRK, V17, P1362, DOI 10.2741/3992; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775	41	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76936	10.1371/journal.pone.0076936	http://dx.doi.org/10.1371/journal.pone.0076936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155908	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300042
J	Richardson, A; Gardner, RG; Prelich, G				Richardson, Aaron; Gardner, Richard G.; Prelich, Gregory			Physical and Genetic Associations of the Irc20 Ubiquitin Ligase with Cdc48 and SUMO	PLOS ONE			English	Article							RNA-POLYMERASE-II; AAA ATPASE CDC48/P97; SACCHAROMYCES-CEREVISIAE; HISTONE H2B; PROTEIN UBIQUITINATION; TRANSCRIPTION FACTOR; GENOME STABILITY; DNA-REPAIR; YEAST; DOMAIN	A considerable percentage of the genome is dedicated to the ubiquitin-proteasome system, with the yeast genome predicted to encode approximately 100 ubiquitin ligases (or E3s), and the human genome predicted to encode more than 600 E3s. The most abundant class of E3s consists of RING finger-containing proteins. Although many insights have been obtained regarding the structure and catalytic mechanism of the E3s, much remains to be learned about the function of the individual E3s. Here we characterize IRC20, which encodes a dual RING- and Snf/Swi family ATPase domain-containing protein in yeast that has been implicated in DNA repair. We found that overexpression of IRC20 causes two transcription-associated phenotypes and demonstrate that the Irc20 RING domain possesses ubiquitin E3 activity in vitro. Two mass spectrometry approaches were undertaken to identify Irc20-associated proteins. Wild-type Irc20 associated with Cdc48, a AAA-ATPase that serves as an intermediary in the ubiquitin-proteasome system. A second approach using a RING mutant derivative of Irc20 detected increased association of the Irc20 mutant with SUMO. These findings provide a foundation for understanding the roles of Irc20 in transcription and DNA repair.	[Richardson, Aaron; Prelich, Gregory] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Prelich, G (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	gregory.prelich@EINSTEIN.YU.EDU		Gardner, Richard/0000-0003-2162-6275	Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; National Institutes of Health (NIH) [DA028786]; NIH/NCRR [R21 RR025787]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028786] Funding Source: NIH RePORTER	Training Program in Cellular and Molecular Biology and Genetics; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Training Program in Cellular and Molecular Biology and Genetics, T32 GM007491 and by National Institutes of Health (NIH) grant DA028786 to GP and NIH/NCRR R21 RR025787 to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Bergink S, 2013, NAT CELL BIOL; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Cal-Bakowska M, 2011, NUCLEIC ACIDS RES, V39, P8765, DOI 10.1093/nar/gkr587; Collins GA, 2009, NATURE, V461, pE7, DOI 10.1038/nature08406; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Miura T, 2012, GENETICS, V191, P65, DOI 10.1534/genetics.112.139105; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PRELICH G, 1993, GENETICS, V135, P665; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Ramsey KL, 2004, MOL CELL BIOL, V24, P6362, DOI 10.1128/MCB.24.14.6362-6378.2004; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rose MD., 1990, METHODS YEAST GENETI; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; WINSTON F, 1984, GENETICS, V107, P179; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76424	10.1371/journal.pone.0076424	http://dx.doi.org/10.1371/journal.pone.0076424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155900	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300034
J	Wardill, TJ; Chen, TW; Schreiter, ER; Hasseman, JP; Tsegaye, G; Fosque, BF; Behnam, R; Shields, BC; Ramirez, M; Kimmel, BE; Kerr, RA; Jayaraman, V; Looger, LL; Svoboda, K; Kim, DS				Wardill, Trevor J.; Chen, Tsai-Wen; Schreiter, Eric R.; Hasseman, Jeremy P.; Tsegaye, Getahun; Fosque, Benjamin F.; Behnam, Reza; Shields, Brenda C.; Ramirez, Melissa; Kimmel, Bruce E.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.			A Neuron-Based Screening Platform for Optimizing Genetically-Encoded Calcium Indicators	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; CA2+ INDICATORS; ACTION-POTENTIALS; CELLS; PROBE; ACTIVATION; EXPRESSION; REPORTER; MOUSE	Fluorescent protein-based sensors for detecting neuronal activity have been developed largely based on non-neuronal screening systems. However, the dynamics of neuronal state variables (e. g., voltage, calcium, etc.) are typically very rapid compared to those of non-excitable cells. We developed an electrical stimulation and fluorescence imaging platform based on dissociated rat primary neuronal cultures. We describe its use in testing genetically-encoded calcium indicators (GECIs). Efficient neuronal GECI expression was achieved using lentiviruses containing a neuronal-selective gene promoter. Action potentials (APs) and thus neuronal calcium levels were quantitatively controlled by electrical field stimulation, and fluorescence images were recorded. Images were segmented to extract fluorescence signals corresponding to individual GECI-expressing neurons, which improved sensitivity over full-field measurements. We demonstrate the superiority of screening GECIs in neurons compared with solution measurements. Neuronal screening was useful for efficient identification of variants with both improved response kinetics and high signal amplitudes. This platform can be used to screen many types of sensors with cellular resolution under realistic conditions where neuronal state variables are in relevant ranges with respect to timing and amplitude.	[Wardill, Trevor J.; Chen, Tsai-Wen; Schreiter, Eric R.; Hasseman, Jeremy P.; Tsegaye, Getahun; Fosque, Benjamin F.; Kimmel, Bruce E.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.] Howard Hughes Med Inst, Genetically Encoded Neuronal Indicator & Effector, Ashburn, VA USA; [Behnam, Reza; Shields, Brenda C.; Ramirez, Melissa] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute	Kim, DS (corresponding author), Howard Hughes Med Inst, Genetically Encoded Neuronal Indicator & Effector, Janelia Farm Res Campus, Ashburn, VA USA.	kimd@janelia.hhmi.org	; Fosque, Benjamin/I-1036-2014	Wardill, Trevor/0000-0002-2049-113X; Fosque, Benjamin/0000-0002-8862-2204; Chen, Tsai-Wen/0000-0001-6782-3819; Schreiter, Eric/0000-0002-2864-7469; Kim, Douglas/0000-0001-9029-314X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by funding from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BRENNER JF, 1976, J HISTOCHEM CYTOCHEM, V24, P100, DOI 10.1177/24.1.1254907; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hempel CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025999; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	44	36	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77728	10.1371/journal.pone.0077728	http://dx.doi.org/10.1371/journal.pone.0077728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155972	Green Published, gold			2022-12-25	WOS:000325887300106
J	Formosa, A; Markert, EK; Lena, AM; Italiano, D; Finazzi-Agro, E; Levine, AJ; Bernardini, S; Garabadgiu, AV; Melino, G; Candi, E				Formosa, A.; Markert, E. K.; Lena, A. M.; Italiano, D.; Finazzi-Agro, E.; Levine, A. J.; Bernardini, S.; Garabadgiu, A. V.; Melino, G.; Candi, E.			MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells	ONCOGENE			English	Article						microRNAs; prostate cancer; metastasis	MESENCHYMAL TRANSITION; EXPRESSION; CLUSTER; TUMOR; STEMNESS; TARGETS; MIRNAS; P53	miRNAs act as oncogenes or tumor suppressors in a wide variety of human cancers, including prostate cancer (PCa). We found a severe and consistent downregulation of miRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 region in metastatic cell lines as compared with normal prostatic epithelial cells (PrEC). In specimens of human prostate (28 normals, 99 primary tumors and 13 metastases), lower miRNA levels correlated significantly with a higher incidence of metastatic events and higher prostate specific antigen (PSA) levels, with similar trends observed for lymph node invasion and the Gleason score. We transiently transfected 10 members of the 14q32.31 cluster in normal prostatic epithelial cell lines and characterized their affect on malignant cell behaviors, including proliferation, apoptosis, migration and invasion. Finally, we identified FZD4, a gene important for epithelial-to-mesenchymal transition in (PCa), as a target of miR-377.	[Formosa, A.; Lena, A. M.; Italiano, D.; Finazzi-Agro, E.; Bernardini, S.; Melino, G.; Candi, E.] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Formosa, A.; Melino, G.] IDI IRCCS, Rome, Italy; [Markert, E. K.; Levine, A. J.] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA; [Garabadgiu, A. V.] St Petersburg Technol Inst, Mol Pharmacol Lab, St Petersburg, Russia	University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Institute for Advanced Study - USA; Saint Petersburg State Institute of Technology	Candi, E (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy.	candi@uniroma2.it	Agrò, Enrico Finazzi/N-7969-2018; Lena, Anna Maria/AAI-5042-2020	Agrò, Enrico Finazzi/0000-0002-0308-8824; Garabadjiu, Alexander/0000-0001-9972-8517	AIRC grant [2013IG 13387]; AIRC [2011-IG11955]; Ministry of Education and Science of the Russian Federation [11.G34.31.0069]; Min. Salute [ric. Oncologica26/07]; IstitutoDermopatico-dell'Immacolata [RF06 c.73, RF07 c.57, RF08 c.15]; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	AIRC grant(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Min. Salute(Ministry of Health, Italy); IstitutoDermopatico-dell'Immacolata; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been mainly supported by AIRC grant (2013IG 13387) to EC and partially supported by AIRC (2011-IG11955) and Ministry of Education and Science of the Russian Federation (11.G34.31.0069) to GM. Research described in this article was also supported in part by Min. Salute (ric. Oncologica26/07), 'IstitutoDermopatico-dell'Immacolata' (RF06 c.73, RF07 c.57, RF08 c.15, RF07 c.57) to GM.	Aberdam D, 2008, TRENDS BIOCHEM SCI, V33, P583, DOI 10.1016/j.tibs.2008.09.002; Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Amelio I, 2012, J CELL BIOL, V199, P347, DOI 10.1083/jcb.201203134; Antonov AV, 2013, CELL DEATH DIFFER, V20, P367, DOI 10.1038/cdd.2012.137; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Barlev NA, 2010, CELL DEATH DIFFER, V17, P373, DOI 10.1038/cdd.2009.73; Bartkowiak D, 1999, CYTOMETRY, V37, P191, DOI 10.1002/(SICI)1097-0320(19991101)37:3<191::AID-CYTO5>3.0.CO;2-U; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Devor EJ, 2012, EXP THER MED, V3, P677, DOI 10.3892/etm.2012.458; Ferlay J, 2010, IARC CANCERBASE; Formosa A, 2013, ONCOGENE, V32, P127, DOI 10.1038/onc.2012.14; Gandellini P, 2012, CELL DEATH DIFFER, V19, P1750, DOI 10.1038/cdd.2012.56; Gattolliat CH, 2011, BRIT J CANCER, V105, P1352, DOI 10.1038/bjc.2011.388; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; Hudson RS, 2013, ONCOGENE, V32, P4139, DOI 10.1038/onc.2012.424; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuriyama M, 1996, Int J Urol, V3, P462, DOI 10.1111/j.1442-2042.1996.tb00577.x; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lin J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.134; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Viticchie G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.174; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	50	256	268	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5173	5182		10.1038/onc.2013.451	http://dx.doi.org/10.1038/onc.2013.451			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24166498				2022-12-25	WOS:000343914900004
J	Smith, EC; Smith, SE; Carter, JR; Webb, SR; Gibson, KM; Hellman, LM; Fried, MG; Dutch, RE				Smith, Everett Clinton; Smith, Stacy E.; Carter, James R.; Webb, Stacy R.; Gibson, Kathleen M.; Hellman, Lance M.; Fried, Michael G.; Dutch, Rebecca Ellis			Trimeric Transmembrane Domain Interactions in Paramyxovirus Fusion Proteins ROLES IN PROTEIN FOLDING, STABILITY, AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fusion Protein; Membrane Fusion; Negative-strand RNA Viruses; Virus; Virus Entry; Transmembrane Domain	MEMBRANE-SPANNING DOMAIN; INFLUENZA-VIRUS HEMAGGLUTININ; F-PROTEIN; CYTOPLASMIC DOMAINS; DRIVE ASSOCIATION; CONSERVED REGION; GLYCOPROTEIN; SEQUENCE; POLAR; HEMIFUSION	Background: Mutations in transmembrane domains can affect activity of viral fusion proteins, but little is known about potential interactions between these domains. Results: Isolated paramyxovirus fusion protein transmembrane domains interact as trimers. Conclusion: Viral fusion protein transmembrane domains self-associate. Significance: Transmembrane domain associations may regulate stability of the prefusion conformation. Paramyxovirus fusion (F) proteins promote membrane fusion between the viral envelope and host cell membranes, a critical early step in viral infection. Although mutational analyses have indicated that transmembrane (TM) domain residues can affect folding or function of viral fusion proteins, direct analysis of TM-TM interactions has proved challenging. To directly assess TM interactions, the oligomeric state of purified chimeric proteins containing the Staphylococcal nuclease (SN) protein linked to the TM segments from three paramyxovirus F proteins was analyzed by sedimentation equilibrium analysis in detergent and buffer conditions that allowed density matching. A monomer-trimer equilibrium best fit was found for all three SN-TM constructs tested, and similar fits were obtained with peptides corresponding to just the TM region of two different paramyxovirus F proteins. These findings demonstrate for the first time that class I viral fusion protein TM domains can self-associate as trimeric complexes in the absence of the rest of the protein. Glycine residues have been implicated in TM helix interactions, so the effect of mutations at Hendra F Gly-508 was assessed in the context of the whole F protein. Mutations G508I or G508L resulted in decreased cell surface expression of the fusogenic form, consistent with decreased stability of the prefusion form of the protein. Sedimentation equilibrium analysis of TM domains containing these mutations gave higher relative association constants, suggesting altered TM-TM interactions. Overall, these results suggest that trimeric TM interactions are important driving forces for protein folding, stability and membrane fusion promotion.	[Smith, Everett Clinton; Smith, Stacy E.; Carter, James R.; Webb, Stacy R.; Gibson, Kathleen M.; Hellman, Lance M.; Fried, Michael G.; Dutch, Rebecca Ellis] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Dutch, RE (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	rdutc2@uky.edu		Carter, James/0000-0001-6905-1082; Hellman, Lance/0000-0002-4938-6296; Fried, Michael/0000-0002-5393-2640	National Institutes of Health (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [R01AI051517, U54 AI057157, R01GM070662]; National Institutes of Health from National Center for Research Resources [2P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R01AI051517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	National Institutes of Health (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense; National Institutes of Health from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI051517 and U54 AI057157 (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (to R. E. D.), R01GM070662 (to M. G. F.), and 2P20 RR020171 from the National Center for Research Resources (to R. E. D and M. G. F.).	Adamian L, 2003, J MOL BIOL, V327, P251, DOI 10.1016/S0022-2836(03)00041-X; Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Burgess NK, 2008, METHOD CELL BIOL, V84, P181, DOI 10.1016/S0091-679X(07)84007-6; Carter JR, 2005, J VIROL, V79, P7922, DOI 10.1128/JVI.79.12.7922-7925.2005; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Clancy EK, 2011, J VIROL, V85, P4707, DOI 10.1128/JVI.02223-10; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10; Gardner AE, 2007, J VIROL, V81, P8303, DOI 10.1128/JVI.00366-07; Gardner AE, 2007, BIOCHEMISTRY-US, V46, P5094, DOI 10.1021/bi6025648; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Harrington W F, 1973, Methods Enzymol, V27, P306; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hayes D, 1995, PROGRAM SEDNTERP SED; Joshi SB, 1998, VIROLOGY, V248, P20, DOI 10.1006/viro.1998.9242; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kroch AE, 2006, J MOL BIOL, V357, P184, DOI 10.1016/j.jmb.2005.12.060; Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li Z, 2008, J VIROL, V82, P3329, DOI 10.1128/JVI.02104-07; Lin XX, 2003, J VIROL, V77, P7067, DOI 10.1128/JVI.77.12.7067-7077.2003; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miyauchi K, 2006, JPN J INFECT DIS, V59, P77; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Molina-Garcia AD, 1999, PROG COLL POL SCI S, V113, P57; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Muhlebach MD, 2008, J VIROL, V82, P11437, DOI 10.1128/JVI.00779-08; Odell D, 1997, J VIROL, V71, P7996, DOI 10.1128/JVI.71.10.7996-8000.1997; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; SchrothDiez B, 1998, J VIROL, V72, P133, DOI 10.1128/JVI.72.1.133-141.1998; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Smith EC, 2012, J VIROL, V86, P3003, DOI 10.1128/JVI.05762-11; Stanley AM, 2005, J MOL BIOL, V347, P759, DOI 10.1016/j.jmb.2005.01.059; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tatulian SA, 2000, BIOCHEMISTRY-US, V39, P496, DOI 10.1021/bi991594p; Taylor GM, 1999, MOL BIOL CELL, V10, P2803, DOI 10.1091/mbc.10.9.2803; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vitu E, 2013, J MOL BIOL, V425, P2056, DOI 10.1016/j.jmb.2013.03.001; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; Wilk T, 1996, VIROLOGY, V218, P269, DOI 10.1006/viro.1996.0190; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	69	27	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35726	35735		10.1074/jbc.M113.514554	http://dx.doi.org/10.1074/jbc.M113.514554			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178297	Green Published, hybrid			2022-12-25	WOS:000329814700011
J	Kang'ethe, W; Bernstein, HD				Kang'ethe, Wanyoike; Bernstein, Harris D.			Stepwise Folding of an Autotransporter Passenger Domain Is Not Essential for Its Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Membrane Proteins; Protein Folding; Protein Translocation; Virulence Factors; Autotransporter	OUTER-MEMBRANE TRANSLOCATION; PARALLEL BETA-HELIX; ESCHERICHIA-COLI; BACTERIAL AUTOTRANSPORTER; CRYSTAL-STRUCTURE; RECOMBINANT PROTEINS; VIRULENCE FACTOR; SERINE-PROTEASE; P22 TAILSPIKE; BIOGENESIS	Background: It has been proposed that stepwise folding of the extracellular (passenger) domains of bacterial autotransporter proteins drives their secretion. Results: Mutations in N-terminal or medial segments of a passenger domain that severely impair folding only moderately reduce secretion efficiency. Conclusion: Stepwise folding only partially accounts for the energetics of autotransporter secretion. Significance: Autotransporter secretion may involve the use of a novel energy source. Autotransporters are a superfamily of virulence proteins produced by Gram-negative bacteria. They consist of an N-terminal -helical domain (passenger domain) that is secreted into the extracellular space and a C-terminal -barrel domain (-domain) that anchors the protein to the outer membrane. Because the periplasm lacks ATP, vectorial folding of the passenger domain in a C-to-N-terminal direction has been proposed to drive the secretion reaction. Consistent with this hypothesis, mutations that disrupt the folding of the C terminus of the passenger domain of the Escherichia coli O157:H7 autotransporter EspP have been shown to cause strong secretion defects. Here, we show that point mutations introduced at specific locations near the middle or N terminus of the EspP -helix that perturb folding also impair secretion, but to a lesser degree. Surprisingly, we found that even multiple mutations that potentially abolish the stability of several consecutive rungs of the -helix only moderately reduce secretion efficiency. Although these results provide evidence that the free energy derived from passenger domain folding contributes to secretion efficiency, they also suggest that a significant fraction of the energy required for secretion is derived from another source.	[Kang'ethe, Wanyoike; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			NIDDK Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052037] Funding Source: NIH RePORTER	NIDDK Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the NIDDK Intramural Research Program of the National Institutes of Health.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Betts S, 2004, PROTEIN SCI, V13, P2291, DOI 10.1110/ps.04676704; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Dautin N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jong WSP, 2010, CURR OPIN BIOTECH, V21, P646, DOI 10.1016/j.copbio.2010.07.009; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Khan S, 2011, J MOL BIOL, V413, P985, DOI 10.1016/j.jmb.2011.09.028; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; LATTMAN EE, 1993, P NATL ACAD SCI USA, V90, P439, DOI 10.1073/pnas.90.2.439; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Shi LX, 2013, P NATL ACAD SCI USA, V110, P930, DOI 10.1073/pnas.1115886110; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	44	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35028	35038		10.1074/jbc.M113.515635	http://dx.doi.org/10.1074/jbc.M113.515635			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165126	hybrid, Green Published			2022-12-25	WOS:000329867600005
J	Meier, M; Patel, TR; Booy, EP; Marushchak, O; Okun, N; Deo, S; Howard, R; McEleney, K; Harding, SE; Stetefeld, J; McKenna, SA				Meier, Markus; Patel, Trushar R.; Booy, Evan P.; Marushchak, Oksana; Okun, Natalie; Deo, Soumya; Howard, Ryan; McEleney, Kevin; Harding, Stephen E.; Stetefeld, Joerg; McKenna, Sean A.			Binding of G-quadruplexes to the N-terminal Recognition Domain of the RNA Helicase Associated with AU-rich Element (RHAU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; RNA-binding Protein; RNA Helicase; RNA-Protein Interaction; X-ray Scattering; DHX36; G-quadruplex; G4R1; RHAU	CRYSTAL-STRUCTURE; TETRAMOLECULAR QUADRUPLEX; RESOLUTION STRUCTURE; RESOLVING ACTIVITY; STRUCTURAL BASIS; MAJOR SOURCE; DNA; PROMOTER; REVEALS; GENE	Background: The helicase RHAU requires an N-terminal extension to bind quadruplex structures. Results: This extension adopts an elongated shape and interacts with the guanine tetrad face of quadruplexes. Conclusion: We provide a basis for the understanding of quadruplex binding by the N-terminal domain. Significance: The N-terminal region does not require the 2-OH of the ribose to mediate the protein-quadruplex interaction. Polynucleotides containing consecutive tracts of guanines can adopt an intramolecular G-quadruplex structure where multiple planar tetrads of hydrogen-bound guanines stack on top of each other. Remodeling of G-quadruplexes impacts numerous aspects of nucleotide biology including transcriptional and translational control. RNA helicase associated with AU-rich element (RHAU), a member of the ATP-dependent DEX(H/D) family of RNA helicases, has been established as a major cellular quadruplex resolvase. RHAU contains a core helicase domain responsible for ATP binding/hydrolysis/helicase activity and is flanked on either side by N- and C-terminal extensions. The N-terminal extension is required for quadruplex recognition, and we have previously demonstrated complex formation between this domain and a quadruplex from human telomerase RNA. Here we used an integrated approach that includes small angle x-ray scattering, nuclear magnetic resonance spectroscopy, circular dichroism, and dynamic light scattering methods to demonstrate the recognition of G-quadruplexes by the N-terminal domain of RHAU. Based on our results, we conclude that (i) quadruplex from the human telomerase RNA and its DNA analog both adopt a disc shape in solution, (ii) RHAU(53-105) adopts a defined and extended conformation in solution, and (iii) the N-terminal domain mediates an interaction with a guanine tetrad face of quadruplexes. Together, these data form the foundation for understanding the recognition of quadruplexes by the N-terminal domain of RHAU.	[Meier, Markus; Patel, Trushar R.; Booy, Evan P.; Marushchak, Oksana; Okun, Natalie; Deo, Soumya; Howard, Ryan; Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada; [McEleney, Kevin] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB R3T 2N2, Canada; [Harding, Stephen E.] Univ Nottingham, Natl Ctr Macromol Hydrodynam Lab, Sch Biosci, Loughborough LE12 5RD, Notts, England	University of Manitoba; University of Manitoba; University of Manitoba; University of Nottingham	Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	Jorg.Stetefeld@umanitoba.ca; Sean.McKenna@umanitoba.ca	Krahn, Natalie/HHN-6747-2022; Meier, Markus/F-2798-2011; Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020	Krahn, Natalie/0000-0003-0696-433X; Meier, Markus/0000-0003-1068-746X; Patel, Trushar R/0000-0003-0627-2923; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257; Harding, Stephen E./0000-0002-7798-9692	Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program [RPA-118069]; CIHR postdoctoral fellowship; MHRC postdoctoral fellowship; University of Manitoba Faculty of Science undergraduate student research award; University of Manitoba undergraduate research fellowship; University of Manitoba graduate fellowship; Canada Research Chair program	Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program(Canadian Institutes of Health Research (CIHR)); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); MHRC postdoctoral fellowship; University of Manitoba Faculty of Science undergraduate student research award; University of Manitoba undergraduate research fellowship; University of Manitoba graduate fellowship; Canada Research Chair program(Canada Research Chairs)	This work was supported in part by Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program Grant RPA-118069.; Supported by a CIHR postdoctoral fellowship.; Supported by an MHRC postdoctoral fellowship.; Supported by a University of Manitoba Faculty of Science undergraduate student research award and a University of Manitoba undergraduate research fellowship.; Supported by a University of Manitoba graduate fellowship; Supported by a University of Manitoba undergraduate research fellowship.; Supported by the Canada Research Chair program. .	Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell NH, 2012, METAL IONS LIFE SCI, V10, P119, DOI 10.1007/978-94-007-2172-2_4; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Gros J, 2008, CHEMBIOCHEM, V9, P2075, DOI 10.1002/cbic.200800300; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Kaushik M, 2011, CURR MOL MED, V11, P744, DOI 10.2174/156652411798062421; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patel TR, 2008, MACROMOL BIOSCI, V8, P1108, DOI 10.1002/mabi.200800064; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023	49	42	43	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35014	35027		10.1074/jbc.M113.512970	http://dx.doi.org/10.1074/jbc.M113.512970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151078	Green Published, hybrid			2022-12-25	WOS:000329867600004
J	Tornroos, A; Nordstrom, MC; Bonsdorff, E				Tornroos, Anna; Nordstrom, Marie C.; Bonsdorff, Erik			Coastal Habitats as Surrogates for Taxonomic, Functional and Trophic Structures of Benthic Faunal Communities	PLOS ONE			English	Article							ESTUARINE HABITATS; BIOLOGICAL TRAITS; DIVERSITY; BIODIVERSITY; ECOLOGY; REEF; ASSEMBLAGES; INVERTEBRATES; ASSIMILATION; DISTURBANCE	Due to human impact, there is extensive degradation and loss of marine habitats, which calls for measures that incorporate taxonomic as well as functional and trophic aspects of biodiversity. Since such data is less easily quantifiable in nature, the use of habitats as surrogates or proxies for biodiversity is on the rise in marine conservation and management. However, there is a critical gap in knowledge of whether pre-defined habitat units adequately represent the functional and trophic structure of communities. We also lack comparisons of different measures of community structure in terms of both between-(beta) and within-habitat (alpha) variability when accounting for species densities. Thus, we evaluated a priori defined coastal habitats as surrogates for traditional taxonomic, functional and trophic zoobenthic community structure. We focused on four habitats (bare sand, canopy-forming algae, seagrass above-and belowground), all easily delineated in nature and defined through classification systems. We analyzed uni- and multivariate data on species and trait diversity as well as stable isotope ratios of benthic macrofauna. A good fit between habitat types and taxonomic and functional structure was found, although habitats were more similar functionally. This was attributed to within-habitat heterogeneity so when habitat divisions matched the taxonomic structure, only bare sand was functionally distinct. The pre-defined habitats did not meet the variability of trophic structure, which also proved to differentiate on a smaller spatial scale. The quantification of trophic structure using species density only identified an epi- and an infaunal unit. To summarize the results we present a conceptual model illustrating the match between pre-defined habitat types and the taxonomic, functional and trophic community structure. Our results show the importance of including functional and trophic aspects more comprehensively in marine management and spatial planning.	[Tornroos, Anna; Nordstrom, Marie C.; Bonsdorff, Erik] Abo Akad Univ, Dept Biosci Environm & Marine Biol, Turku, Finland	Abo Akademi University	Tornroos, A (corresponding author), Abo Akad Univ, Dept Biosci Environm & Marine Biol, Turku, Finland.	anna.m.tornroos@abo.fi	Nordström, Marie C./C-8956-2012	Nordström, Marie C./0000-0001-5763-1813; Bonsdorff, Erik/0000-0001-5070-4880; Tornroos, Anna/0000-0002-5790-2449	Maj and Tor Nessling Foundation [2010127, 2011079]; Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change"; Stiftelsen for Abo Akademi	Maj and Tor Nessling Foundation; Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change"; Stiftelsen for Abo Akademi	Financial support was received from Maj and Tor Nessling Foundation (Project no. 2010127 and 2011079) and Stiftelsen for Abo Akademi. Research presented in this paper contributes to the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER), which is funded by the Norden Top-level Research Initiative sub-programme "Effect Studies and Adaptation to Climate Change." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2004, PERMDISP FORTRAN COM; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Bostrom C, 2010, J EXP MAR BIOL ECOL, V390, P106, DOI 10.1016/j.jembe.2010.05.008; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chevenet F, 1994, FRESHWATER BIOL, V43, P277; Clarke KR, 1994, CHANGE MARINE COMMUN; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Davies CE, 2004, J EXP MAR BIOL ECOL, DOI DOI 10.1016/J.JEMBE.2008.07.015; de Juan S, 2007, MAR ECOL PROG SER, V334, P117; Dobson AJ, 2010, INTRO GEN LINEAR MOD, P48; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Frid CLJ, 2008, HYDROBIOLOGIA, V606, P69, DOI 10.1007/s10750-008-9343-y; Fry B., 2006, STABLE ISOTOPE ECOLO; Galparsoro I, 2012, MAR POLLUT BULL, V64, P2630, DOI 10.1016/j.marpolbul.2012.10.010; Guest MA, 2004, MAR ECOL PROG SER, V278, P27, DOI 10.3354/meps278027; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; HELCOM, 2009, HELS COMM BALT SEA B, V116B; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Kosenius AK, 2011, EC VALUATION ECOSYST, V57; Kraufvelin P, 2004, ESTUAR COAST SHELF S, V61, P369, DOI 10.1016/j.ecss.2004.06.006; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Naeem S., 2009, BIODIVERSITY ECOSYST, P281; Nohren E, 2009, ESTUAR COAST SHELF S, V84, P1, DOI 10.1016/j.ecss.2009.05.012; Nordstrom MC, 2010, J EXP MAR BIOL ECOL, V391, P101, DOI 10.1016/j.jembe.2010.06.015; Nordstrom M, 2009, MAR ECOL PROG SER, V378, P13, DOI 10.3354/meps07872; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norusis M, 2010, PASW STAT 18 ADV STA, P418; Olenin S, 2006, MAR POLLUT BULL, V53, P20, DOI 10.1016/j.marpolbul.2006.01.003; Olsen YS, 2013, MAR ENVIRON RES, V86, P12, DOI 10.1016/j.marenvres.2013.02.002; Olsgard F, 1998, MAR ECOL PROG SER, V172, P25, DOI 10.3354/meps172025; Paganelli D, 2012, ESTUAR COAST SHELF S, V96, P245, DOI 10.1016/j.ecss.2011.11.014; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Riera Pascal, 2009, Marine Biodiversity Records, V2, pe47, DOI 10.1017/S1755267209000529; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Schaal G, 2011, MAR BIOL, V158, P623, DOI 10.1007/s00227-010-1586-2; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schmiing M, 2013, MAR ECOL PROG SER, V474, P201, DOI 10.3354/meps10099; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Tornroos A, 2012, ECOL APPL, V22, P2221; Tyler EHM, 2012, GLOBAL ECOL BIOGEOGR, V21, P922, DOI 10.1111/j.1466-8238.2011.00726.x; Van Wynsberge S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040997; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Ward TJ, 1999, ECOL APPL, V9, P691; Wikstrom SA, 2007, ESTUAR COAST SHELF S, V72, P168, DOI 10.1016/j.ecss.2006.10.009	66	24	24	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78910	10.1371/journal.pone.0078910	http://dx.doi.org/10.1371/journal.pone.0078910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167635	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500096
J	Fenner, L; Ballif, M; Graber, C; Nhandu, V; Dusingize, JC; Cortes, CP; Carriquiry, G; Anastos, K; Garone, D; Jong, E; Gnokoro, JC; Sued, O; Ajayi, S; Diero, L; Wools-Kaloustian, K; Kiertiburanakul, S; Castelnuovo, B; Lewden, C; Durier, N; Sterling, TR; Egger, M				Fenner, Lukas; Ballif, Marie; Graber, Claire; Nhandu, Venerandah; Dusingize, Jean Claude; Cortes, Claudia P.; Carriquiry, Gabriela; Anastos, Kathryn; Garone, Daniela; Jong, Eefje; Gnokoro, Joachim Charles; Sued, Omar; Ajayi, Samuel; Diero, Lameck; Wools-Kaloustian, Kara; Kiertiburanakul, Sasisopin; Castelnuovo, Barbara; Lewden, Charlotte; Durier, Nicolas; Sterling, Timothy R.; Egger, Matthias		IeDEA	Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; INTERNATIONAL EPIDEMIOLOGIC DATABASES; HIV-INFECTED ADULTS; EVALUATE AIDS IEDEA; XPERT MTB/RIF TEST; IMMUNE RECONSTITUTION; COHORT PROFILE; SOUTH-AFRICA; THERAPY; MORTALITY	Objectives: In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to TB diagnosis and screening of TB in ART programs in low-and middle-income countries. Methods and findings: We surveyed ART programs treating HIV-infected adults in sub-Saharan Africa, Asia and Latin America in 2012 using online questionnaires to collect program-level and patient-level data. Forty-seven sites from 26 countries participated. Patient-level data were collected on 987 adult TB patients from 40 sites (median age 34.7 years; 54% female). Sputum smear microscopy and chest radiograph were available in 47 (100%) sites, TB culture in 44 (94%), and Xpert MTB/RIF in 23 (49%). Xpert MTB/RIF was rarely available in Central Africa and South America. In sites with access to these diagnostics, microscopy was used in 745 (76%) patients diagnosed with TB, culture in 220 (24%), and chest X-ray in 688 (70%) patients. When free of charge culture was done in 27% of patients, compared to 21% when there was a fee (p = 0.033). Corresponding percentages for Xpert MTB/RIF were 26% and 15% of patients (p = 0.001). Screening practices for active disease before starting ART included symptom screening (46 sites, 98%), chest X-ray (38, 81%), sputum microscopy (37, 79%), culture (16, 34%), and Xpert MTB/RIF (5, 11%). Conclusions: Mycobacterial culture was infrequently used despite its availability at most sites, while Xpert MTB/RIF was not generally available. Use of available diagnostics was higher when offered free of charge.	[Fenner, Lukas; Ballif, Marie; Graber, Claire; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas] Univ Basel, Basel, Switzerland; [Nhandu, Venerandah] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Dusingize, Jean Claude] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Cortes, Claudia P.] Univ Chile Sch Med, Santiago, Chile; [Carriquiry, Gabriela] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Garone, Daniela] Med Sans Frontieres, Khayelitsha ART Programme, Cape Town, South Africa; [Jong, Eefje] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Gnokoro, Joachim Charles] CEPREF ART Program, Abidjan, Cote Ivoire; [Sued, Omar] Fdn Huesped, Buenos Aires, DF, Argentina; [Ajayi, Samuel] Univ Abuja Teaching Hosp, Abuja, Nigeria; [Diero, Lameck; Wools-Kaloustian, Kara] USAID AMPATH, Eldoret, Kenya; [Wools-Kaloustian, Kara] Indiana Univ, Indianapolis, IN 46204 USA; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Castelnuovo, Barbara] Infect Dis Inst, Res Dept, Kampala, Uganda; [Lewden, Charlotte] Univ Bordeaux Segalen, ISPED, Bordeaux, France; [Durier, Nicolas] TREAT Asia, AmfAR Fdn AIDS Res, Bangkok, Thailand; [Sterling, Timothy R.] Vanderbilt Univ Sch Med, Nashville, TN USA	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidad Peruana Cayetano Heredia; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Witwatersrand; United States Agency for International Development (USAID); Indiana University System; Indiana University-Purdue University Indianapolis; Mahidol University; UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	lukas.fenner@unibas.ch	Cortes, Claudia P/AAF-7326-2020; Sued, Omar/H-3325-2019	Cortes, Claudia P/0000-0001-9101-9783; Sued, Omar/0000-0001-5818-770X; Egger, Matthias/0000-0001-7462-5132; Dusingize, Jean Claude/0000-0001-5721-100X; Fenner, Lukas/0000-0003-3309-4835	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U01AI069924, U01AI069907, U01A096299, U01AI069911, U01AI069923, U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907, K24AI065298, U01AI096299, U01AI069924, U01AI069911, U01AI069923, U01AI069919] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number Southern Africa: U01AI069924, Asia: U01AI069907, Central Africa: U01A096299, East Africa: U01AI069911, Caribbean, Central and South America: U01AI069923 and West Africa: U01AI069919. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davies MA, 2009, CLIN INFECT DIS, V49, P973, DOI 10.1086/605501; Edmonds A, 2009, INT J EPIDEMIOL; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Saito S, 2012, JAIDS-J ACQ IMM DEF, V61, P216, DOI 10.1097/QAI.0b013e3182638ec7; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77697	10.1371/journal.pone.0077697	http://dx.doi.org/10.1371/journal.pone.0077697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147059	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000326022200067
J	Okamoto, K; Miyoshi, K; Murawaki, Y				Okamoto, Kinya; Miyoshi, Kenichi; Murawaki, Yoshikazu			miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells	PLOS ONE			English	Article							MICRORNA; CANCER; EXPRESSION; GROWTH; INVASION; GENES; TUMORIGENICITY; BIOGENESIS; RESISTANCE; PTEN	Background and Aims: Cholangiocarcinoma (CCA) is highly resistant to chemotherapy, including gemcitabine (Gem) treatment. MicroRNAs (miRNAs) are endogenous, non-coding, short RNAs that can regulate multiple genes expression. Some miRNAs play important roles in the chemosensitivity of tumors. Here, we examined the relationship between miRNA expression and the sensitivity of CCA cells to Gem. Methods: Microarray analysis was used to determine the miRNA expression profiles of two CCA cell lines, HuH28 and HuCCT1. To determine the effect of candidate miRNAs on Gem sensitivity, expression of each candidate miRNA was modified via either transfection of a miRNA mimic or transfection of an anti-oligonucleotide. Ontology-based programs were used to identify potential target genes of candidate miRNAs that were confirmed to affect the Gem sensitivity of CCA cells. Results: HuCCT1 cells were more sensitive to Gem than were HuH28 cells, and 18 miRNAs were differentially expressed whose ratios over +/- 2log2 between HuH28 and HuCCT1. Among these 18 miRNAs, ectopic overexpression of each of three downregulated miRNAs in HuH28 (miR-29b, miR-205, miR-221) restored Gem sensitivity to HuH28. Suppression of one upregulated miRNA in HuH28, miR-125a-5p, inhibited HuH28 cell proliferation independently to Gem treatment. Selective siRNA-mediated downregulation of either of two software-predicted targets, PIK3R1 (target of miR-29b and miR-221) or MMP-2 (target of miR-29b), also conferred Gem sensitivity to HuH28. Conclusions: miRNA expression profiling was used to identify key miRNAs that regulate Gem sensitivity in CCA cells, and software that predicts miRNA targets was used to identify promising target genes for anti-tumor therapies.	[Okamoto, Kinya; Miyoshi, Kenichi; Murawaki, Yoshikazu] Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan	Tottori University	Okamoto, K (corresponding author), Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan.	okamotka@grape.med.tottori-u.ac.jp		Okamoto, Kinya/0000-0001-9087-8965				Adachi R, 2011, BIOCHEM BIOPH RES CO, V411, P804, DOI 10.1016/j.bbrc.2011.07.033; Amodio N, 2012, ONCOTARGET, V3, P1246; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gesto DS, 2012, CURR MED CHEM, V19, P1076; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; He Q, 2011, MOL CARCINOG; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Kesanakurti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019341; Kim J. K., 2012, HEPATOLOGY; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu K, 2012, J INT MED RES, V40, P467, DOI 10.1177/147323001204000208; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Okano J, 2006, J GASTROENTEROL, V41, P166, DOI 10.1007/s00535-005-1736-3; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papaconstantinou I, 2011, MOL CARCINOG; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Qin AY, 2012, EUR J CELL BIOL; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Skipworth JRA, 2011, ALIMENT PHARM THER, V34, P1063, DOI 10.1111/j.1365-2036.2011.04851.x; Steele Robert, 2010, Genes Cancer, V1, P381; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002	51	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77623	10.1371/journal.pone.0077623	http://dx.doi.org/10.1371/journal.pone.0077623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147037	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200052
J	Walenda, G; Abnaof, K; Joussen, S; Meurer, S; Smeets, H; Rath, B; Hoffmann, K; Frohlich, H; Zenke, M; Weiskirchen, R; Wagner, W				Walenda, Gudrun; Abnaof, Khalid; Joussen, Sylvia; Meurer, Steffen; Smeets, Hubert; Rath, Bjoern; Hoffmann, Kurt; Froehlich, Holger; Zenke, Martin; Weiskirchen, Ralf; Wagner, Wolfgang			TGF-beta1 Does Not Induce Senescence of Multipotent Mesenchymal Stromal Cells and Has Similar Effects in Early and Late Passages	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FALSE DISCOVERY RATE; TGF-BETA; STEM-CELLS; GENE-EXPRESSION; DNA-METHYLATION; CELLULAR SENESCENCE; OSTEOGENIC DIFFERENTIATION; REPLICATIVE SENESCENCE; PROLIFERATION	Transforming growth factor-beta 1 (TGF-beta 1) stimulates a broad range of effects which are cell type dependent, and it has been suggested to induce cellular senescence. On the other hand, long-term culture of multipotent mesenchymal stromal cells (MSCs) has a major impact on their cellular physiology and therefore it is well conceivable that the molecular events triggered by TGF-beta 1 differ considerably in cells of early and late passages. In this study, we analyzed the effect of TGF-beta 1 on and during replicative senescence of MSCs. Stimulation with TGF-beta 1 enhanced proliferation, induced a network like growth pattern and impaired adipogenic and osteogenic differentiation. TGF-beta 1 did not induce premature senescence. However, due to increased proliferation rates the cells reached replicative senescence earlier than untreated controls. This was also evident, when we analyzed senescence-associated DNA-methylation changes. Gene expression profiles of MSCs differed considerably at relatively early (P 3 - 5) and later passages (P 10). Nonetheless, relative gene expression differences provoked by TGF-beta 1 at individual time points or in a time course dependent manner (stimulation for 0, 1, 4 and 12 h) were very similar in MSCs of early and late passage. These results support the notion that TGF-beta 1 has major impact on MSC function, but it does not induce senescence and has similar molecular effects during culture expansion.	[Walenda, Gudrun; Joussen, Sylvia; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany; [Abnaof, Khalid; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr Informat Technol, Bonn, Germany; [Abnaof, Khalid; Hoffmann, Kurt] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Bioanalyt Resource Ctr Aachen, Aachen, Germany; [Meurer, Steffen; Weiskirchen, Ralf] Rhein Westfal TH Aachen, Sch Med, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Smeets, Hubert] Univ Maastricht, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Rath, Bjoern] Rhein Westfal TH Aachen, Sch Med, Dept Orthoped, Aachen, Germany; [Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Dept Cell Biol, Inst Biomed Technol, Aachen, Germany	RWTH Aachen University; University of Bonn; RWTH Aachen University; RWTH Aachen University; Maastricht University; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany.	wwagner@ukaachen.de	Rath, Björn/AAF-3938-2022; Rath, Björn/AFI-8239-2022; Hoffmann, Kurt/P-2539-2014; Weiskirchen, Ralf/O-1734-2018; Fröhlich, Holger/H-1976-2017	Hoffmann, Kurt/0000-0002-7991-423X; Weiskirchen, Ralf/0000-0003-3888-0931; Fröhlich, Holger/0000-0002-5328-1243; Wagner, Wolfgang/0000-0002-1971-3217	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; Interregional Program Alma in Silico	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; Interregional Program Alma in Silico	This work was supported by the Stem Cell Network North Rhine Westphalia (to WW), by the Else-Kroner-Fresenius Stiftung (to WW), and particularly by Interregional Program Alma in Silico (http://www.alma-in-silico.com; to HS, KH, MZ, RW, and WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Chieregato K, 2011, CYTOTHERAPY, V13, P933, DOI 10.3109/14653249.2011.583232; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Iqbal J, 2000, BIOCHEM BIOPH RES CO, V274, P467, DOI 10.1006/bbrc.2000.3167; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Koch CM, 2013, GENOME RES, V23, P248, DOI 10.1101/gr.141945.112; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; KOCH CM, 2013, METHODS MOL IN PRESS; Koli K, 2008, BONE, V43, P679, DOI 10.1016/j.bone.2008.06.016; Kumar A, 2012, ENDOCRINOLOGY, V153, P254, DOI 10.1210/en.2011-1169; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Liang YY, 2009, CELL RES, V19, P140, DOI 10.1038/cr.2008.321; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCCAFFREY TA, 1993, MOL BIOL CELL, V4, P315, DOI 10.1091/mbc.4.3.315; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Muller J, 2010, CELL CYCLE, V9, P4622, DOI 10.4161/cc.9.23.14211; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; VANBEUNINGEN HM, 1994, ANN RHEUM DIS, V53, P593, DOI 10.1136/ard.53.9.593; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	66	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77656	10.1371/journal.pone.0077656	http://dx.doi.org/10.1371/journal.pone.0077656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147049	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200061
J	Fleming, A; Diekmann, H; Goldsmith, P				Fleming, Angeleen; Diekmann, Heike; Goldsmith, Paul			Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish	PLOS ONE			English	Article							P-GLYCOPROTEIN; TRANSGENIC ZEBRAFISH; VASCULAR DEVELOPMENT; IN-VIVO; GENE; DRUGS; PERMEABILITY; PENETRATION; SEIZURES; MODELS	Zebrafish are becoming increasingly popular as an organism in which to model human disease and to study the effects of small molecules on complex physiological and pathological processes. Since larvae are no more than a few millimetres in length, and can live in volumes as small as 100 microliters, they are particularly amenable to high-throughput and high content compound screening in 96 well plate format. There is a growing literature providing evidence that many compounds show similar pharmacological effects in zebrafish as they do in mammals, and in particular humans. However, a major question regarding their utility for small molecule screening for neurological conditions is whether a molecule will reach its target site within the central nervous system. Studies have shown that Claudin-5 and ZO-1, tight-junction proteins which are essential for blood-brain barrier (BBB) integrity in mammals, can be detected in some cerebral vessels in zebrafish from 3 days post-fertilisation (d.p.f.) onwards and this timing coincides with the retention of dyes, immunoreactive tracers and fluorescent markers within some but not all cerebral vessels. Whilst these findings demonstrate that features of a BBB are first present at 3 d.p.f., it is not clear how quickly the zebrafish BBB matures or how closely the barrier resembles that of mammals. Here, we have combined anatomical analysis by transmission electron microscopy, functional investigation using fluorescent markers and compound uptake using liquid chromatography/tandem mass spectrometry to demonstrate that maturation of the zebrafish BBB occurs between 3 d.p.f. and 10 d.p.f. and that this barrier shares both structural and functional similarities with that of mammals.	[Fleming, Angeleen; Diekmann, Heike; Goldsmith, Paul] DanioLabs Ltd, Cambridge, England		Fleming, A (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England.	af425@cam.ac.uk		Fleming, Angeleen/0000-0003-3721-7126	DanioLabs Ltd; MRC Skills Gap Award	DanioLabs Ltd; MRC Skills Gap Award	The authors are all former employees of DanioLabs Ltd (a biotechnology company) and a large part of this work was carried out during this period of employment. Work performed at DanioLabs Ltd was financed by DanioLabs Ltd and not by grant funding. The company no longer exists and there are no restrictions on publishing this data. Dr A Fleming continued working on this project after leaving the company to work at the University of Cambridge and this part of the work was funded by an MRC Skills Gap Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton W, 2010, XENOBIOTICA, V40, P547, DOI 10.3109/00498254.2010.493960; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Chen CP, 2003, DRUG METAB DISPOS, V31, P312, DOI 10.1124/dmd.31.3.312; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hung CC, 2008, PHARMACOGENET GENOM, V18, P390, DOI 10.1097/FPC.0b013e3282f85e36; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; JOHANSSON BB, 1978, ACTA PHYSIOL SCAND, V104, P281, DOI 10.1111/j.1748-1716.1978.tb06280.x; Kalvass JC, 2007, DRUG METAB DISPOS; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Kozler P, 2003, PHYSIOL RES, V52, P607; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEVIN VA, 1980, J MED CHEM, V23, P682, DOI 10.1021/jm00180a022; MacRae CA, DRUG DISCOVERY TODAY; Moitra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016318; Morita S, 2013, J LIPID RES, V54, P1221, DOI 10.1194/jlr.M032425; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; PETITO CK, 1977, BRAIN RES, V127, P251, DOI 10.1016/0006-8993(77)90539-X; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Stewart AM, 2012, BRAIN RES BULL, V87, P135, DOI 10.1016/j.brainresbull.2011.11.020; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Terasaki T, 2003, DRUG DISCOV TODAY, V8, P944, DOI 10.1016/S1359-6446(03)02858-7; Westerfield M, 1997, SEMIN CELL DEV BIOL, V8, P477, DOI 10.1006/scdb.1997.0173; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zheng PP, 2010, ANN NEUROL, V68, P835, DOI 10.1002/ana.22318	36	152	153	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77548	10.1371/journal.pone.0077548	http://dx.doi.org/10.1371/journal.pone.0077548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147021	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400119
J	Hennessy, RC; Doohan, F; Mullins, E				Hennessy, Rosanna C.; Doohan, Fiona; Mullins, Ewen			Generating Phenotypic Diversity in a Fungal Biocatalyst to Investigate Alcohol Stress Tolerance Encountered during Microbial Cellulosic Biofuel Production	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; FUSARIUM-OXYSPORUM; ETHANOL-PRODUCTION; SACCHAROMYCES-CEREVISIAE; INSERTIONAL MUTAGENESIS; GENE-EXPRESSION; IDENTIFICATION; DNA; FERMENTATION; GENOMICS	Consolidated bioprocessing (CBP) of lignocellulosic biomass offers an alternative route to renewable energy. The crop pathogen Fusarium oxysporum is a promising fungal biocatalyst because of its broad host range and innate ability to co-saccharify and ferment lignocellulose to bioethanol. A major challenge for cellulolytic CBP-enabling microbes is alcohol inhibition. This research tested the hypothesis that Agrobacterium tumefaciens - mediated transformation (ATMT) could be exploited as a tool to generate phenotypic diversity in F. oxysporum to investigate alcohol stress tolerance encountered during CBP. A random mutagenesis library of gene disruption transformants (n=1,563) was constructed and screened for alcohol tolerance in order to isolate alcohol sensitive or tolerant phenotypes. Following three rounds of screening, exposure of select transformants to 6% ethanol and 0.75% n-butanol resulted respectively in increased (>= 11.74%) and decreased (<= 43.01%) growth compared to the wild - type (WT). Principal component analysis (PCA) quantified the level of phenotypic diversity across the population of genetically transformed individuals and isolated candidate strains for analysis. Characterisation of one strain, Tr. 259, ascertained a reduced growth phenotype under alcohol stress relative to WT and indicated the disruption of a coding region homologous to a putative sugar transporter (FOXG_09625). Quantitative PCR (RT-PCR) showed FOXG_09625 was differentially expressed in Tr. 259 compared to WT during alcohol-induced stress (P<0.05). Phylogenetic analysis of putative sugar transporters suggests diverse functional roles in F. oxysporum and other filamentous fungi compared to yeast for which sugar transporters form part of a relatively conserved family. This study has confirmed the potential of ATMT coupled with a phenotypic screening program to select for genetic variation induced in response to alcohol stress. This research represents a first step in the investigation of alcohol tolerance in F. oxysporum and has resulted in the identification of several novel strains, which will be of benefit to future biofuel research.	[Hennessy, Rosanna C.; Mullins, Ewen] Teagasc Res Ctr, Dept Crop Sci, Oak Pk, Carlow, Ireland; [Hennessy, Rosanna C.; Doohan, Fiona] Univ Coll Dublin, Mol Plant Microbe Interact Lab, Sch Biol & Environm Sci, Dublin 2, Ireland	Teagasc; University College Dublin	Mullins, E (corresponding author), Teagasc Res Ctr, Dept Crop Sci, Oak Pk, Carlow, Ireland.	ewen.mullins@teagasc.ie	Mullins, Ewen/AAN-2907-2021	Mullins, Ewen/0000-0003-3005-4264; Hennessy, Rosanna C./0000-0002-2359-8565; Doohan, Fiona/0000-0002-1953-6070	Irish Department of Agriculture and Food's Research Stimulus Fund [RSF 07 513]	Irish Department of Agriculture and Food's Research Stimulus Fund	Funding provided through the Irish Department of Agriculture and Food's Research Stimulus Fund (Project Code RSF 07 513; see, http://www.agriculture.gov.ie/research/researchstimulusfundrsf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Ali SAM, 2012, STUD DEV ACCOUNT THO, V14D, P1, DOI 10.1108/S1479-3504(2012)000014D004; Ali SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054701; Ali SS, 2013, BIOENERGY RES; Amore A, 2012, RENEW SUST ENERG REV, V16, P3286, DOI 10.1016/j.rser.2012.02.050; Anderson MJ, 2012, FEMS YEAST RES, V12, P48, DOI 10.1111/j.1567-1364.2011.00762.x; Asiimwe T, 2012, MYCORRHIZA, V22, P471, DOI 10.1007/s00572-011-0424-9; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; Bhatia L, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-65; Bills GF, 2008, J APPL MICROBIOL, V104, P1644, DOI 10.1111/j.1365-2672.2008.03735.x; Brennan JM, 2005, PLANT PATHOL, V54, P156, DOI 10.1111/j.1365-3059.2005.01157.x; Brodeur G., 2011, ENZYME RES, V2011, DOI [https://doi.org/10.4061/2011/787532, DOI 10.4061/2011/787532]; Brown SD, 2011, P NATL ACAD SCI USA, V108, P2011; Chandler M, 2004, ANN MICROBIOL, V54, P427; CHRISTAKOPOULOS P, 1991, ENZYME MICROB TECH, V13, P272, DOI 10.1016/0141-0229(91)90141-V; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Eckardt NA, 2011, PLANT CELL, V23, P3561, DOI 10.1105/tpc.111.231010; Edel V, 2000, MYCOL RES, V104, P518, DOI 10.1017/S0953756299001896; Elkins JG, 2010, CURR OPIN BIOTECH, V21, P657, DOI 10.1016/j.copbio.2010.05.008; Favaro L, 2013, BIOENGINEERED, V4, P97, DOI 10.4161/bioe.22268; Fernandes Sara, 2010, Bioeng Bugs, V1, P424, DOI 10.4161/bbug.1.6.12724; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Hossain SM, 2012, INDIAN J CHEM TECHN, V19, P63; Hu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035542; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Kataoka N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-10; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; la Grange DC, 2010, APPL MICROBIOL BIOT, V87, P1195, DOI 10.1007/s00253-010-2660-x; Lakshman DK, 2012, EUR J PLANT PATHOL, V133, P729, DOI 10.1007/s10658-012-9953-0; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MF, 2008, NEW PHYTOL, V180, P365, DOI 10.1111/j.1469-8137.2008.02539.x; Lubbehusen TL, 2004, APPL MICROBIOL BIOT, V63, P543, DOI 10.1007/s00253-003-1394-4; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; MISHRA C, 1984, APPL ENVIRON MICROB, V48, P224, DOI 10.1128/AEM.48.1.224-228.1984; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Olson DG, 2012, ECENT PROGR CONSOLID, V12, P396; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panagiotou G, 2008, BIORESOURCE TECHNOL, V99, P7397, DOI 10.1016/j.biortech.2008.01.017; Patrascu E, 2009, FOOD BIOTECHNOL, V4; Pfromm PH, 2010, BIOMASS BIOENERG, V34, P515, DOI 10.1016/j.biombioe.2009.12.017; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Ruhl J, 2009, APPL ENVIRON MICROB, V75, P4653, DOI 10.1128/AEM.00225-09; Sakuragi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416931; Sambrook J., 2011, MOL CLONING LAB MANU, V3rd; SINGH A, 1991, CRIT REV BIOTECHNOL, V11, P129, DOI 10.3109/07388559109040619; Snowdon C, 2009, FEMS YEAST RES, V9, P372, DOI 10.1111/j.1567-1364.2009.00497.x; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tako M, 2010, ACTA BIOL HUNG, V61, P101, DOI 10.1556/ABiol.61.2010.1.10; Talbot NJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000308; Vinche HM, 2012, J CHEM TECHNOL BIOT, V87, P1222, DOI [10.1002/jctb.3822, DOI 10.1002/JCTB.3822.PUBMED:23329859]; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wei HJ, 2004, FUNGAL GENET BIOL, V41, P148, DOI 10.1016/j.fgb.2003.10.006; Xiros C, 2011, J CHEM TECHNOL BIOT, V86, P223, DOI 10.1002/jctb.2499; Xiros C, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-4; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; ZEUTHEN ML, 1988, J GEN MICROBIOL, V134, P1375; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	68	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77501	10.1371/journal.pone.0077501	http://dx.doi.org/10.1371/journal.pone.0077501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147009	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400114
J	Kraemer, A; Barjaktarovic, Z; Sarioglu, H; Winkler, K; Eckardt-Schupp, F; Tapio, S; Atkinson, MJ; Moertl, S				Kraemer, Anne; Barjaktarovic, Zarko; Sarioglu, Hakan; Winkler, Klaudia; Eckardt-Schupp, Friederike; Tapio, Soile; Atkinson, Michael J.; Moertl, Simone			Cell Survival Following Radiation Exposure Requires miR-525-3p Mediated Suppression of ARRB1 and TXN1	PLOS ONE			English	Article							IONIZING-RADIATION; INDUCED APOPTOSIS; ENDOTHELIAL-CELLS; LUNG-CANCER; DNA-DAMAGE; MICRORNA EXPRESSION; TARGET RECOGNITION; ANIMAL MICRORNAS; GROWTH-FACTOR; THIOREDOXIN	Background: microRNAs (miRNAs) are non-coding RNAs that alter the stability and translation efficiency of messenger RNAs. Ionizing radiation (IR) induces rapid and selective changes in miRNA expression. Depletion of the miRNA processing enzymes Dicer or Ago2 reduces the capacity of cells to survive radiation exposure. Elucidation of critical radiation-regulated miRNAs and their target proteins offers a promising approach to identify new targets to increase the therapeutic effectiveness of the radiation treatment of cancer. Principal Findings: Expression of miR-525-3p is rapidly up-regulated in response to radiation. Manipulation of miR-525-3p expression in irradiated cells confirmed that this miRNA mediates the radiosensitivity of a variety of non-transformed (RPE, HUVEC) and tumor-derived cell lines (HeLa, U2-Os, EA. hy926) cell lines. Thus, anti-miR-525-3p mediated inhibition of the increase in miR-525-3p elevated radiosensitivity, while overexpression of precursor miR-525-3p conferred radioresistance. Using a proteomic approach we identified 21 radiation-regulated proteins, of which 14 were found to be candidate targets for miR-525-3p-mediated repression. Luciferase reporter assays confirmed that nine of these were indeed direct targets of miR-525-3p repression. Individual analysis of these direct targets by RNAi-mediated knockdown established that ARRB1, TXN1 and HSPA9 are essential miR-525-3p-dependent regulators of radiation sensitivity. Conclusion: The transient up-regulation of miR-525-3p, and the resultant repression of its direct targets ARRB1, TXN1 and HSPA9, is required for cell survival following irradiation. The conserved function of miR-525-3p across several cell types makes this microRNA pathway a promising target for modifying the efficacy of radiotherapy.	[Kraemer, Anne; Barjaktarovic, Zarko; Winkler, Klaudia; Eckardt-Schupp, Friederike; Tapio, Soile; Atkinson, Michael J.; Moertl, Simone] Helmholtz Ctr Munich, Inst Radiat Biol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Sarioglu, Hakan] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Dept Prot Sci, Prote Core Facil, Neuherberg, Germany; [Atkinson, Michael J.] Tech Univ Munich, Chair Radiat Biol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Moertl, S (corresponding author), Helmholtz Ctr Munich, Inst Radiat Biol, German Res Ctr Environm Hlth, Neuherberg, Germany.	moertl@helmholtz-muenchen.de	Tapio, Soile/CAJ-5871-2022; Atkinson, Michael J/E-5537-2011; Atkinson, Michael/AAU-5127-2020; Moertl, Simone/M-7353-2014; Tapio, Soile/M-7358-2014	Atkinson, Michael J/0000-0003-3358-2089; Atkinson, Michael/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Tapio, Soile/0000-0001-9860-3683	Kompetenzerhalt Strahlenforschung (Germany) [03NUK007C/E]	Kompetenzerhalt Strahlenforschung (Germany)	This work was supported by the grant Kompetenzerhalt Strahlenforschung 03NUK007C/E (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P3755; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angermeier M, 2010, CELL SIGNAL, V22, P1388, DOI 10.1016/j.cellsig.2010.05.009; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Byun HS, 2005, FEBS LETT, V579, P4055, DOI 10.1016/j.febslet.2005.06.023; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Du LQ, 2012, EXPERT OPIN BIOL TH, V12, P1221, DOI 10.1517/14712598.2012.697149; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ezekwudo D, 2008, CANCER LETT, V270, P277, DOI 10.1016/j.canlet.2008.05.022; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Guo WW, 2012, MOL MED REP, V6, P1423, DOI 10.3892/mmr.2012.1070; Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449; Haley B, 2009, INT J RADIAT BIOL, V85, P643, DOI 10.1080/09553000903009548; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Huang TC, 2013, PROTEOMICS, V13, P558, DOI 10.1002/pmic.201200339; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P114, DOI 10.1016/j.mrgentox.2010.05.007; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2012, ANAL CHEM, V84, P5097, DOI 10.1021/ac300839d; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; LUNN CA, 1987, INT J RADIAT BIOL, V51, P29, DOI 10.1080/09553008714550461; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mukherjee A, 2008, BRIT J RADIOL, V81, pS57, DOI 10.1259/bjr/34180435; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pena LA, 2000, CANCER RES, V60, P321; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Sagan D, 2009, CARCINOGENESIS, V30, P408, DOI 10.1093/carcin/bgp004; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shonai T, 2002, CELL DEATH DIFFER, V9, P963, DOI 10.1038/sj.cdd.4401050; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Sriharshan A, 2012, J PROTEOMICS, V75, P2319, DOI 10.1016/j.jprot.2012.02.009; Supino R, 2001, EUR J CANCER, V37, P2247, DOI 10.1016/S0959-8049(01)00268-4; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wang XC, 2011, LUNG CANCER, V72, P92, DOI 10.1016/j.lungcan.2010.07.014; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu J, 2012, RNA BIOL, V9, P1031, DOI [10.4161/ma.21729, DOI 10.4161/RNA.21729]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	65	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77484	10.1371/journal.pone.0077484	http://dx.doi.org/10.1371/journal.pone.0077484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147004	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400111
J	Kurapati, KRV; Atluri, VSR; Samikkannu, T; Nair, MPN				Kurapati, Kesava Rao Venkata; Atluri, Venkata Subba Rao; Samikkannu, Thangavel; Nair, Madhavan P. N.			Ashwagandha (Withania somnifera) Reverses beta-Amyloid(1-42) Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; NATURAL-PRODUCTS; IN-VITRO; A-BETA; HYDROGEN-PEROXIDE; MALACHITE GREEN; ROOT EXTRACT; PEPTIDE	Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. At present no curative treatment is available, and research focuses on drugs for slowing disease progression or providing prophylaxis. Withania somnifera (WS) also known as 'ashwagandha' is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is a paucity of data on the potential neuroprotective effects of W. somnifera against beta-Amyloid (1-42)-induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of methanol: Chloroform (3:1) extract of ashwagandha against beta-amyloid induced toxicity and HIV-1(Ba-L) (clade B) infection using a human neuronal SK-N-MC cell line. Our results showed that beta-amyloid induced cytotoxic effects in SK-N-MC cells as shown by decreased cell growth when tested individually. Also, confocal microscopic analysis showed decreased spine density, loss of spines and decreased dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC cells compared to uninfected cells. However, when ashwagandha was added to beta-amyloid treated and HIV-1 infected samples, the toxic effects were neutralized. Further, the MTT cell viability assays and the peroxisome proliferator-activated receptor-gamma (PPAR gamma) levels supported these observations indicating the neuroprotective effect of WS root extract against beta-amyloid and HIV-1(Ba-L) (clade B) induced neuro-pathogenesis.	[Kurapati, Kesava Rao Venkata; Atluri, Venkata Subba Rao; Samikkannu, Thangavel; Nair, Madhavan P. N.] Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Modesto A Maidique Campus, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institutes Health [1R01MH085259, 1R37DA025576, 5RO1DA021537, 1RO1DA027049]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA021537, R01DA027049] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes Health: 1R01MH085259, 1R37DA025576, 5RO1DA021537, and 1RO1DA027049 to Prof. Madhavan Nair. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRANDHI A, 1994, J ETHNOPHARMACOL, V44, P131, DOI 10.1016/0378-8741(94)01119-2; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Houghton PJ, 2005, NEUROSIGNALS, V14, P6, DOI 10.1159/000085382; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Ji HF, 2008, ACTA PHARMACOL SIN, V29, P143, DOI 10.1111/j.1745-7254.2008.00752.x; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Kurapati Kesava Rao V., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P139, DOI 10.1515/jbcpp-2012-0021; London JA, 1996, P NATL ACAD SCI USA, V93, P4147, DOI 10.1073/pnas.93.9.4147; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohamed A, 2011, INT J ALZHEIMERS DIS, V12, P79; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514; Ohyagi Y, 2006, MINI-REV MED CHEM, V6, P1075, DOI 10.2174/138955706778560175; PANANDIKER A, 1992, CANCER LETT, V67, P93, DOI 10.1016/0304-3835(92)90131-E; PANANDIKER A, 1994, CARCINOGENESIS, V15, P2445, DOI 10.1093/carcin/15.11.2445; Rao KVK, 2012, ASIAN PAC J CANCER P, V13, P1031, DOI 10.7314/APJCP.2012.13.3.1031; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang C, 2012, Curr Alzheimer Res; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	74	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77624	10.1371/journal.pone.0077624	http://dx.doi.org/10.1371/journal.pone.0077624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147038	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400123
J	von Wyl, V; Klimkait, T; Yerly, S; Nicca, D; Furrer, H; Cavassini, M; Calmy, A; Bernasconi, E; Boni, J; Aubert, V; Gunthard, HF; Bucher, HC; Glass, TR				von Wyl, Viktor; Klimkait, Thomas; Yerly, Sabine; Nicca, Dunja; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Boeni, Juerg; Aubert, Vincent; Guenthard, Huldrych F.; Bucher, Heiner C.; Glass, Tracy R.		Swiss HIV Cohort Study	Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study	PLOS ONE			English	Article							ANTIRETROVIRAL MEDICATION ADHERENCE; DRUG-RESISTANCE; VIROLOGICAL FAILURE; TREATMENT-NAIVE; THERAPY; TRANSMISSION; PROTEASE; HAART; RISK; NONADHERENCE	Background: Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Virologic failure with subsequent emergence of resistance reduces future treatment options and long-term clinical success. Methods: Prospective observational cohort study including patients starting new class of antiretroviral therapy (ART) between 2003 and 2010. Participants were naive to ART class and completed >= 1 adherence questionnaire prior to resistance testing. Outcomes were development of any IAS-USA, class-specific, or M184V mutations. Associations between adherence and resistance were estimated using logistic regression models stratified by ART class. Results: Of 314 included individuals, 162 started NNRTI and 152 a PI/r regimen. Adherence was similar between groups with 85% reporting adherence >= 95%. Number of new mutations increased with increasing non-adherence. In NNRTI group, multivariable models indicated a significant linear association in odds of developing IAS-USA (odds ratio (OR) 1.66, 95% confidence interval (CI): 1.04-2.67) or class-specific (OR 1.65, 95% CI: 1.00-2.70) mutations. Levels of drug resistance were considerably lower in PI/r group and adherence was only significantly associated with M184V mutations (OR 8.38, 95% CI: 1.26-55.70). Adherence was significantly associated with HIV RNA in PI/r but not NNRTI regimens. Conclusion: Therapies containing PI/r appear more forgiving to incomplete adherence compared with NNRTI regimens, which allow higher levels of resistance, even with adherence above 95%. However, in failing PI/r regimens good adherence may prevent accumulation of further resistance mutations and therefore help to preserve future drug options. In contrast, adherence levels have little impact on NNRTI treatments once the first mutations have emerged.	[von Wyl, Viktor; Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Basel, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Nicca, Dunja] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Boeni, Juerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland; [Aubert, Vincent] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Bucher, Heiner C.; Glass, Tracy R.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Dept Biostat, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel; Swiss Tropical & Public Health Institute	Glass, TR (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	Tracy.Glass@unibas.ch	Boeni, Juerg/B-8386-2015; gunthard, huldrych f/F-1724-2011; Ledergerber, Bruno/B-5656-2009; Pantaleo, Giuseppe/K-6163-2016; Furrer, Hansjakob/G-6768-2013; Glass, Tracy R/D-5046-2017; cavassini, matthias/F-8987-2017	gunthard, huldrych f/0000-0002-1142-6723; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; Glass, Tracy R/0000-0001-7075-9803; Klimkait, Thomas/0000-0003-4945-6511; cavassini, matthias/0000-0003-0933-7833; von Wyl, Viktor/0000-0002-8754-9797	Swiss HIV Cohort Study; Swiss National Science Foundation [33CS30_134277]; SHCS project [654]; Union Bank of Switzerland; Gilead science; Jacob Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [223131]	Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SHCS project; Union Bank of Switzerland; Gilead science(Gilead Sciences); Jacob Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)	This study has been financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant # 33CS30_134277) and by SHCS project 654. Furthermore, the SHCS drug resistance database was supported by a research grant of the Union Bank of Switzerland, in the name of a donor to HFG by an unrestricted research grant from Gilead science and by the Jacob Foundation (to HFG) and the European Community's Seventh Framework Program (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallego O, 2001, AIDS, V15, P1701, DOI 10.1097/00002030-200109070-00014; Gardner EM, 2010, AIDS, V24, P395, DOI 10.1097/QAD.0b013e328335cd8a; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Glass TR, 2008, ANTIVIR THER, V13, P77; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; Harrigan PR, 2005, J INFECT DIS, V191, P1325, DOI 10.1086/428852; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V41, P315, DOI 10.1097/01.qai.0000197071.77482.6e; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Miller RF, 2003, ANTIVIR THER, V8, P253; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Scherrer AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050307; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Walsh JC, 2002, J ACQ IMMUN DEF SYND, V30, P278, DOI [10.1097/01.QAI.0000018000.56638.43, 10.1097/00126334-200207010-00003]; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	41	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77691	10.1371/journal.pone.0077691	http://dx.doi.org/10.1371/journal.pone.0077691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147057	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326019400125
J	Li, JJ; Pan, YQ; Deng, QJ; Cai, H; Ke, Y				Li, Jingjing; Pan, YaQi; Deng, QiuJu; Cai, Hong; Ke, Yang			Identification and Characterization of Eleven Novel Human Gamma-Papillomavirus Isolates from Healthy Skin, Found at Low Frequency in a Normal Population	PLOS ONE			English	Article							EPIDERMODYSPLASIA-VERRUCIFORMIS; DIVERSITY; BETAPAPILLOMAVIRUSES; SPECTRUM	Eleven novel human papillomavirus (HPV) types were isolated and characterized from healthy individuals in China. HPV163 belongs to the gamma-1 species, HPV 164 and HPV 168 fit in the gamma-8 species, HPV 165 and KC5 belongs to the gamma-12 species, HPV 168 is closely allied with the gamma-4 species, HPV 169 is closely related to the gamma-11 species, and HPV 170 is related to the gamma-12 species. In addition, HPV 161, HPV 162, and HPV 166 may form a new HPV species of the gamma-PV genus. The prevalence of these HPV types in the normal population is low.	[Li, Jingjing; Pan, YaQi; Deng, QiuJu; Cai, Hong; Ke, Yang] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China	Peking University	Ke, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	keyang@bjmu.edu.cn			973 project [201202014]; National Natural Sciences Foundation of China [30930102]; Beijing Natural Science Foundation [7100001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110001110037]	973 project(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the grants from the 973 project (201202014), the National Natural Sciences Foundation of China (30930102), the Beijing Natural Science Foundation (7100001), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110001110037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao Y., 2008, ENCY VIROLOGY, P342; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard Hans-Ulrich, 1994, Trends in Microbiology, V2, P140, DOI 10.1016/0966-842X(94)90602-5; Bravo IG, 2007, VIRUS GENES, V34, P249, DOI 10.1007/s11262-006-0017-4; Chouhy D, 2012, J GEN VIROL; CLAUDY AL, 1982, ARCH DERMATOL RES, V274, P213, DOI 10.1007/BF00403724; Crow JM, 2012, NATURE, V486, pS12, DOI 10.1038/486S12a; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; DEAU MC, 1991, VIROLOGY, V184, P492, DOI 10.1016/0042-6822(91)90419-C; Dell'Oste V, 2009, J INVEST DERMATOL, V129, P1026, DOI 10.1038/jid.2008.317; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gottschling M, 2007, MOL BIOL EVOL, V24, P1242, DOI 10.1093/molbev/msm039; Gottschling M, 2007, MOL PHYLOGENET EVOL, V42, P213, DOI 10.1016/j.ympev.2006.07.011; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022529; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Li Jingjing, 2013, J VIROLOGICAL METHOD; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; Page RD, 2002, CURR PROTOC BIOINFOR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77116	10.1371/journal.pone.0077116	http://dx.doi.org/10.1371/journal.pone.0077116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155922	Green Published, gold			2022-12-25	WOS:000325887300056
J	Yu, XH; Liu, J; Zhu, H; Xia, YL; Gao, LJ; Li, Z; Jia, N; Shen, WF; Yang, YZ; Niu, WQ				Yu, Xiaohong; Liu, Jun; Zhu, Hao; Xia, Yunlong; Gao, Lianjun; Li, Zhen; Jia, Nan; Shen, Weifeng; Yang, Yanzong; Niu, Wenquan			An Interactive Association of Advanced Glycation End-Product Receptor Gene Four Common Polymorphisms with Coronary Artery Disease in Northeastern Han Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; RAGE GENE; MYOCARDIAL-INFARCTION; SOLUBLE RECEPTOR; METAANALYSIS; ENDPRODUCTS; EPISTASIS; HAPLOTYPE; PROMOTER; MARKER	Background: Growing evidence indicates that advanced glycation end-product receptor (RAGE) might play a contributory role in the pathogenesis of coronary artery disease (CAD). To shed some light from a genetic perspective, we sought to investigate the interactive association of RAGE gene four common polymorphisms (rs1800625 or T-429C, rs1800624 or T374A, rs2070600 or Gly82Ser, and rs184003 or G1704A) with the risk of developing CAD in a large northeastern Han Chinese population. Methodology/Principal Findings: This was a hospital-based case-control study incorporating 1142 patients diagnosed with CAD and 1106 age-and gender-matched controls. All individuals were angiographically confirmed. Risk estimates were expressed as odds ratio (OR) and 95% confidence interval (CI). Overall there were significant differences in the genotype and allele distributions of rs1800625 and rs184003, even after the Bonferroni correction. Logistic regression analyses indicated that rs1800625 and rs184003 were associated with significant risk of CAD under both additive (OR = 1.20 and 1.23; 95% CI: 1.06-1.37 and 1.06-1.42; P = 0.006 and 0.008) and recessive (OR = 1.75 and 2.39; 95% CI: 1.28-2.40 and 1.47-3.87; P<0.001 and <0.001) models after adjusting for confounders. In haplotype analyses, haplotypes C-T-G-G and T-A-G-T (alleles in order of rs1800625, rs1800624, rs2070600 and rs184003), overrepresented in patients, were associated with 52% (95% CI: 1.19-1.87; P = 0.0052) and 63% (95% CI: 1.14-2.34; P = 0.0075) significant increases in adjusted risk for CAD. Further interactive analyses identified an overall best multifactor dimensionality reduction (MDR) model including rs1800625 and rs184003. This model had a maximal testing accuracy of 0.6856 and a cross-validation consistency of 10 out of 10 (P = 0.0016). The validity of this model was substantiated by classical Logistic regression analysis. Conclusions: Our findings provided strong evidence for the potentially contributory roles of RAGE multiple genetic polymorphisms, especially in the context of locus-to-locus interaction, in the pathogenesis of CAD among northeastern Han Chinese.	[Yu, Xiaohong; Liu, Jun; Zhu, Hao; Xia, Yunlong; Gao, Lianjun; Li, Zhen; Yang, Yanzong] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian, Liaoning, Peoples R China; [Jia, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China; [Shen, Weifeng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China	Dalian Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, YZ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian, Liaoning, Peoples R China.	yyzheart@126.com; niuwenquan_shcn@163.com			Liaoning Provincial Department of Education Scientific Research Project [L2011155, L2012321]	Liaoning Provincial Department of Education Scientific Research Project	Grant support: Liaoning Provincial Department of Education Scientific Research Project (Grant No. L2011155 and L2012321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XY, 2011, ATHEROSCLEROSIS, V217, P536, DOI 10.1016/j.atherosclerosis.2011.05.023; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Gao JX, 2010, J HUM GENET, V55, P668, DOI 10.1038/jhg.2010.85; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Laki J, 2007, MOL IMMUNOL, V44, P648, DOI 10.1016/j.molimm.2006.01.011; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Niu WQ, 2009, J HUM HYPERTENS, V23, P68, DOI 10.1038/jhh.2008.77; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Niu WQ, 2012, INT J CARDIOL, V157, P243, DOI 10.1016/j.ijcard.2011.12.098; Park HJ, 2011, CIRC J, V75, P1685, DOI 10.1253/circj.CJ-10-1248; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; Pollreisz A, 2010, ATHEROSCLEROSIS, V212, P451, DOI 10.1016/j.atherosclerosis.2010.07.011; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; Selejan SR, 2012, CRIT CARE MED, V40, P1513, DOI 10.1097/CCM.0b013e318241e536; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Torres MC, 2012, INT J IMMUNOGENET, V39, P155, DOI 10.1111/j.1744-313X.2011.01073.x; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76966	10.1371/journal.pone.0076966	http://dx.doi.org/10.1371/journal.pone.0076966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155913	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300047
J	Kim, Y; Park, D; Kim, H; Choi, M; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kim, Youngmi; Park, Deokbum; Kim, Hyuna; Choi, Munseon; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			miR-200b and Cancer/Testis Antigen CAGE Form a Feedback Loop to Regulate the Invasion and Tumorigenic and Angiogenic Responses of a Cancer Cell Line to Microtubule-targeting Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Anticancer Drug; Cancer Biology; Invasion; MicroRNA; Angiogenic Potential; CAGE; Feedback Regulatory Loop; Tumorigenic Potential; miR-200b	EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; DOWN-REGULATION; UP-REGULATION; EXPRESSION; RESISTANCE; ASSOCIATION; METASTASIS; MICRORNAS; ZEB1	Background: The microRNA that regulates the expression of CAGE is unknown. Results: miR-200b and CAGE exert opposite regulations on the response to microtubule-targeting drugs, invasion, tumorigenic potential, and angiogenic potential. Conclusion: CAGE and miR-200b form a feedback regulatory loop. Significance: miR-200b may be a target for the treatment of CAGE-driven cancers. Cancer/testis antigen cancer-associated gene (CAGE) is known to be involved in various cellular processes, such as proliferation, cell motility, and anti-cancer drug resistance. However, the mechanism of the expression regulation of CAGE remains unknown. Target scan analysis predicted the binding of microRNA-200b (miR-200b) to CAGE promoter sequences. The expression of CAGE showed an inverse relationship with miR-200b in various cancer cell lines. miR-200b was shown to bind to the 3-UTR of CAGE and to regulate the expression of CAGE at the transcriptional level. miR-200b also enhanced the sensitivities to microtubule-targeting drugs in vitro. miR-200b and CAGE showed opposite regulations on invasion potential and responses to microtubule-targeting drugs. Xenograft experiments showed that miR-200b had negative effects on the tumorigenic and metastatic potential of cancer cells. The effect of miR-200b on metastatic potential involved the expression regulation of CAGE by miR-200b. miR-200b decreased the tumorigenic potential of a cancer cell line resistant to microtubule-targeting drugs in a manner associated with the down-regulation of CAGE. ChIP assays showed the direct regulation of miR-200b by CAGE. CAGE enhanced the invasion potential of a cancer cell line stably expressing miR-200b. miR-200b exerted a negative regulation on tumor-induced angiogenesis. The down-regulation of CAGE led to the decreased expression of plasminogen activator inhibitor-1, a TGF-responsive protein involved in angiogenesis, and VEGF. CAGE mediated tumor-induced angiogenesis and was necessary for VEGF-promoted angiogenesis. Human recombinant CAGE protein displayed angiogenic potential. Thus, miR-200b and CAGE form a feedback regulatory loop and regulate the response to microtubule-targeting drugs, as well as the invasion, tumorigenic potential, and angiogenic potential.	[Kim, Youngmi; Park, Deokbum; Kim, Hyuna; Choi, Munseon; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [2010-0021357, 2011-0010867, 2012H1B8A2025495, C1008749-01-01]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 2010-0021357, 2011-0010867, 2012H1B8A2025495, and C1008749-01-01 and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Bai JX, 2013, ENDOCRINOLOGY, V154, P635, DOI 10.1210/en.2012-1607; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Basu A, 2009, INVEST OPHTH VIS SCI, V50, P4974, DOI 10.1167/iovs.09-3619; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Gho YS, 1999, CANCER RES, V59, P5128; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Iwata T, 2005, CLIN CANCER RES, V11, P3949, DOI 10.1158/1078-0432.CCR-04-1702; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Jung SY, 2011, INT J ONCOL, V38, P571, DOI 10.3892/ijo.2010.859; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051436; Lu L., 2012, PLOS ONE, V7; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Shen WG, 2007, MOL CELL BIOCHEM, V300, P89, DOI 10.1007/s11010-006-9373-6; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Teng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033444; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Wang J, 2013, J BIOL CHEM, V288, P10418, DOI 10.1074/jbc.M112.444463; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Wilson TJ, 2010, CANCER LETT, V288, P162, DOI 10.1016/j.canlet.2009.06.035; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zolova OE, 2011, ASN NEURO, V3, P223, DOI 10.1042/AN20110021	52	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36502	36518		10.1074/jbc.M113.502047	http://dx.doi.org/10.1074/jbc.M113.502047			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24174534	Green Published, hybrid			2022-12-25	WOS:000328883400031
J	Ploier, B; Scharwey, M; Koch, B; Schmidt, C; Schatte, J; Rechberger, G; Kollroser, M; Hermetter, A; Daum, G				Ploier, Birgit; Scharwey, Melanie; Koch, Barbara; Schmidt, Claudia; Schatte, Jessica; Rechberger, Gerald; Kollroser, Manfred; Hermetter, Albin; Daum, Guenther			Screening for Hydrolytic Enzymes Reveals Ayr1p as a Novel Triacylglycerol Lipase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipase; Lipids; Lipid Droplets; Peroxisomes; Triacylglycerol; Yeast	STERYL ESTER SYNTHESIS; LIPID PARTICLES; HYDROLASE LDH1P; NONPOLAR LIPIDS; BETA-OXIDATION; GENES ENCODE; YEAST; PEROXISOMES; ACYLTRANSFERASE; PROTEINS	Background: Triacylglycerols are stored in lipid droplets and can be mobilized by lipases. Results: Ayr1p was identified as a novel triacylglycerol lipase. Conclusion: In addition to the known lipases Tgl3p, Tgl4p, and Tgl5p, further hydrolytic enzymes contribute to the mobilization of non-polar lipids in yeast. Significance: This study opens the view for a broader network of lipolytic enzymes in yeast. Saccharomyces cerevisiae, as well as other eukaryotes, preserves fatty acids and sterols in a biologically inert form, as triacylglycerols and steryl esters. The major triacylglycerol lipases of the yeast S. cerevisiae identified so far are Tgl3p, Tgl4p, and Tgl5p (Athenstaedt, K., and Daum, G. (2003) YMR313c/TGL3 encodes a novel triacylglycerol lipase located in lipid particles of Saccharomyces cerevisiae. J. Biol. Chem. 278, 23317-23323; Athenstaedt, K., and Daum, G. (2005) Tgl4p and Tgl5p, two triacylglycerol lipases of the yeast Saccharomyces cerevisiae, are localized to lipid particles. J. Biol. Chem. 280, 37301-37309). We observed that upon cultivation on oleic acid, triacylglycerol mobilization did not come to a halt in a yeast strain deficient in all currently known triacylglycerol lipases, indicating the presence of additional not yet characterized lipases/esterases. Functional proteome analysis using lipase and esterase inhibitors revealed a subset of candidate genes for yet unknown hydrolytic enzymes on peroxisomes and lipid droplets. Based on the conserved GXSXG lipase motif, putative functions, and subcellular localizations, a selected number of candidates were characterized by enzyme assays in vitro, gene expression analysis, non-polar lipid analysis, and in vivo triacylglycerol mobilization assays. These investigations led to the identification of Ayr1p as a novel triacylglycerol lipase of yeast lipid droplets and confirmed the hydrolytic potential of the peroxisomal Lpx1p in vivo. Based on these results, we discuss a possible link between lipid storage, lipid mobilization, and peroxisomal utilization of fatty acids as a carbon source.	[Ploier, Birgit; Scharwey, Melanie; Koch, Barbara; Schmidt, Claudia; Schatte, Jessica; Hermetter, Albin; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Rechberger, Gerald] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Kollroser, Manfred] Med Univ Graz, Inst Forens Med, A-8010 Graz, Austria	Graz University of Technology; University of Graz; Medical University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at		Rechberger, Gerald N./0000-0002-0071-317X	Austrian Science Fund (FWF) [W901 DK, P23029]; Austrian Federal Ministry of Science and Research (bmwf); Austrian Science Funds, FWF [F3005 SFB LIPOTOX]; Austrian Science Fund (FWF) [P 23029, W 901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (bmwf); Austrian Science Funds, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Projects W901 DK Molecular Enzymology and P23029 (to G. D.), the Austrian Federal Ministry of Science and Research (bmwf) (GOLD project in the framework of GEN-AU/Genome Research in Austria), and the Austrian Science Funds, FWF (Project F3005 SFB LIPOTOX).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Birner-Gruenberger R, 2005, MOL CELL PROTEOMICS, V4, P1710, DOI 10.1074/mcp.M500062-MCP200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Debelyy MO, 2011, EUKARYOT CELL, V10, P776, DOI 10.1128/EC.05040-11; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIGNERY GA, 1988, GENE, V62, P27, DOI 10.1016/0378-1119(88)90577-X; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oskolkova OV, 2003, CHEM PHYS LIPIDS, V125, P103, DOI 10.1016/S0009-3084(03)00085-9; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rosenberger S, 2009, BBA-MOL CELL BIOL L, V1791, P379, DOI 10.1016/j.bbalip.2009.01.015; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Schmidinger H, 2006, CHEMBIOCHEM, V7, P527, DOI 10.1002/cbic.200500276; Schmidinger H, 2005, CHEMBIOCHEM, V6, P1776, DOI 10.1002/cbic.200500013; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Thoms S, 2008, FEBS J, V275, P504, DOI 10.1111/j.1742-4658.2007.06217.x; Thoms S, 2011, EUKARYOT CELL, V10, P770, DOI 10.1128/EC.05038-11; Vico P, 2002, YEAST, V19, P873, DOI 10.1002/yea.882; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	53	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36061	36072		10.1074/jbc.M113.509927	http://dx.doi.org/10.1074/jbc.M113.509927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187129	Green Published, hybrid			2022-12-25	WOS:000329814700041
J	Gao, P; Yoo, SH; Lee, KJ; Rosensweig, C; Takahashi, JS; Chen, BP; Green, CB				Gao, Peng; Yoo, Seung-Hee; Lee, Kyung-Jong; Rosensweig, Clark; Takahashi, Joseph S.; Chen, Benjamin P.; Green, Carla B.			Phosphorylation of the Cryptochrome 1 C-terminal Tail Regulates Circadian Period Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Phosphorylation; Protein Kinases; Protein Stability; Transcription Repressor	DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; DNA-PK; POSTTRANSLATIONAL REGULATION; GENE-EXPRESSION; MAMMALIAN CRY1; CLOCK; IDENTIFICATION; DEGRADATION; DAMAGE	The Cryptochrome (CRY) proteins are critical components of the mammalian circadian clock and act to rhythmically repress the activity of the transcriptional activators CLOCK and BMAL1 at the heart of the clock mechanism. The CRY proteins are part of a large repressive complex, the components of which are not completely known. Using mass spectroscopy, we identified the catalytic subunit of DNA-dependent protein kinase as a CRY-interacting protein and found that loss or inhibition of this kinase results in circadian rhythms with abnormally long periods. We then identified serine 588 in the C-terminal tail of mouse CRY1 as a potential DNA-PK phosphorylation site but surprisingly found that the phosphomimetic mutation S588D also results in long period rhythms, similar to the loss of DNA-PK. Consistent with this, we found that phosphorylation of this site is increased in cells lacking DNA-PK, suggesting that DNA-PK negatively regulates the phosphorylation of this site most likely through indirect means. Furthermore, we found that phosphorylation of this site increases the stability of the CRY1 protein and prevents FBXL3-mediated degradation. The phosphorylation of this site is robustly rhythmic in mouse liver nuclei, peaking in the middle of the circadian day at a time when CRY1 levels are declining. Therefore, these data suggest a new role for the C-terminal tail of CRY1 in which phosphorylation rhythmically regulates CRY1 stability and contributes to the proper circadian period length.	[Gao, Peng; Yoo, Seung-Hee; Rosensweig, Clark; Takahashi, Joseph S.; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Lee, Kyung-Jong; Chen, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Green, CB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, ND4-124A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Carla.Green@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Rosensweig, Clark/0000-0001-6364-2025	National Institutes of Health [R01 GM090247, R01 CA166777]; NATIONAL CANCER INSTITUTE [R01CA166677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM090247 (to C. B. G.) and R01 CA166777 (to B. P. C.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Amatya PN, 2012, BBA-MOL CELL RES, V1823, P2099, DOI 10.1016/j.bbamcr.2012.08.022; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Davis AJ, 2013, J BIOL CHEM, V288, P7037, DOI 10.1074/jbc.M112.434498; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Fan JY, 2009, GENETICS, V181, P139, DOI 10.1534/genetics.108.094805; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Levy C, 2013, NATURE, V495, pE3, DOI 10.1038/nature11995; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Peng YL, 2002, CANCER RES, V62, P6400; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tamanini F, 2007, COLD SPRING HARB SYM, V72, P133, DOI 10.1101/sqb.2007.72.066; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x; Zheng YL, 2010, MOL BIOL CELL, V21, P3601, DOI 10.1091/mbc.E10-01-0054; Zhu HS, 2003, CURR BIOL, V13, P1653, DOI 10.1016/j.cub.2003.08.033; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	69	48	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35277	35286		10.1074/jbc.M113.509604	http://dx.doi.org/10.1074/jbc.M113.509604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158435	hybrid, Green Published			2022-12-25	WOS:000329867600026
J	Kumar, R; Ramaswamy, R; Mallick, BN				Kumar, Rupesh; Ramaswamy, Ram; Mallick, Birendra Nath			Local Properties of Vigilance States: EMD Analysis of EEG Signals during Sleep-Waking States of Freely Moving Rats	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LOCUS-COERULEUS; ELECTROENCEPHALOGRAM; OSCILLATIONS; BEHAVIOR	Understanding the inherent dynamics of the EEG associated to sleep-waking can provide insights into its basic neural regulation. By characterizing the local properties of the EEG using power spectrum, empirical mode decomposition (EMD) and Hilbert-spectral analysis, we can examine the dynamics over a range of time-scales. We analyzed rat EEG during wake, NREMS and REMS using these methods. The average instantaneous phase, power spectral density (PSD) of intrinsic mode functions (IMFs) and the energy content in various frequency bands show characteristic changes in each of the vigilance states. The 2nd and 7th IMFs show changes in PSD for wake and REMS, suggesting that those modes may carry wake-and REMS-associated cognitive, conscious and behavior-specific information of an individual even though the EEG may appear similar. The energy content in theta(2) (6Hz-9Hz) band of the 1st IMF for REMS is larger than that of wake. The decrease in the phase function of IMFs from wake to REMS to NREMS indicates decrease of the mean frequency in these states, respectively. The rate of information processing in waking state is more in the time scale described by the first three IMFs than in REMS state. However, for IMF5-IMF7, the rate is more for REMS than that for wake. We obtained Hilbert-Huang spectral entropy, which is a suitable measure of information processing in each of these state-specific EEG. It is possible to evaluate the complex dynamics of the EEG in each of the vigilance states by applying measures based on EMD and Hilbert-transform. Our results suggest that the EMD based nonlinear measures of the EEG can provide useful estimates of the information possessed by various oscillations associated with the vigilance states. Further, the EMD-based spectral measures may have implications in understanding anatamo-physiological correlates of sleep-waking behavior and clinical diagnosis of sleep-pathology.	[Kumar, Rupesh; Ramaswamy, Ram] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Kumar, Rupesh; Mallick, Birendra Nath] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ramaswamy, Ram] Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; University of Hyderabad	Ramaswamy, R (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	r.ramaswamy@gmail.com; remsbnm@yahoo.com	Chillale, Rupesh/GYU-9179-2022; Nath, Mallick Birendra/AAF-1781-2020; Ramaswamy, Ramakrishna/L-5306-2019	Ramaswamy, Ramakrishna/0000-0002-9085-8224; Kumar, Rupesh/0000-0002-0858-9660	Department of Biotechnology, India; J. C. Bose Fellowship	Department of Biotechnology, India(Department of Biotechnology (DBT) India); J. C. Bose Fellowship(Department of Science & Technology (India))	Department of Biotechnology, India; J. C. Bose Fellowship to BNM and RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2005, COMPUT METH PROG BIO, V80, P37, DOI 10.1016/j.cmpb.2005.06.011; Beersma D G, 1998, Sleep Med Rev, V2, P31, DOI 10.1016/S1087-0792(98)90052-1; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bjorvatn B, 1998, PHYSIOL BEHAV, V63, P413, DOI 10.1016/S0031-9384(97)00460-5; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; Dringenberg HC, 2000, BEHAV BRAIN RES, V115, P235, DOI 10.1016/S0166-4328(00)00261-8; Dringenberg HC, 2000, NEUROBIOL AGING, V21, P135, DOI 10.1016/S0197-4580(00)00108-1; Fang GZ, 2010, PHYSIOL MEAS, V31, P795, DOI 10.1088/0967-3334/31/6/005; Fell J, 1996, ELECTROEN CLIN NEURO, V98, P401, DOI 10.1016/0013-4694(96)95636-9; Ferri R, 1996, ELECTROEN CLIN NEURO, V99, P539; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gottesmann C, 1976, Rev Electroencephalogr Neurophysiol Clin, V6, P37, DOI 10.1016/S0370-4475(76)80058-5; Gupta K, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046220; Hsu D, 2010, J NEUROSCI METH, V194, P179, DOI 10.1016/j.jneumeth.2010.09.019; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Kobayashi T, 1999, PSYCHIAT CLIN NEUROS, V53, P159, DOI 10.1046/j.1440-1819.1999.00540.x; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Lee CK, 2010, HEALTHC INFORM RES, V16, P46, DOI 10.4258/hir.2010.16.1.46; Li XL, 2006, PHYS LETT A, V356, P237, DOI 10.1016/j.physleta.2006.03.045; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Louis RP, 2004, J NEUROSCI METH, V133, P71, DOI 10.1016/j.jneumeth.2003.09.025; Mallick B. N., 2011, RAPID EYE MOVEMENT S, P21; Mallick BN, 2005, BEHAV BRAIN RES, V158, P9, DOI 10.1016/j.bbr.2004.08.004; Mallick BN, 2001, NEUROSCIENCE, V104, P467, DOI 10.1016/S0306-4522(01)00062-8; MARKS GA, 1993, BRAIN RES, V623, P241, DOI 10.1016/0006-8993(93)91434-T; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Ning TK, 2009, IEEE ENG MED BIO, P3437, DOI 10.1109/IEMBS.2009.5334635; NING TK, 1990, IEEE ENG MED BIOL, V9, P47, DOI 10.1109/51.62905; PENTTILA M, 1985, ELECTROEN CLIN NEURO, V60, P1, DOI 10.1016/0013-4694(85)90942-3; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; RIEKKINEN P, 1990, NEUROSCI RES, V8, P12, DOI 10.1016/0168-0102(90)90052-G; RIEKKINEN P, 1990, PHARMACOL BIOCHEM BE, V37, P405, DOI 10.1016/0091-3057(90)90004-2; Rilling G., 2003, IEEE EURASIP WORKSH, V3, P8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sitnikova E, 2009, J NEUROSCI METH, V180, P304, DOI 10.1016/j.jneumeth.2009.04.006; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Suleyman Baykut PG, 2009, P INT C BIOINSP SYST, P14; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008	48	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78174	10.1371/journal.pone.0078174	http://dx.doi.org/10.1371/journal.pone.0078174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167606	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500066
J	Weston, C; Bond, M; Croft, W; Ladds, G				Weston, Cathryn; Bond, Michael; Croft, Wayne; Ladds, Graham			The Coordination of Cell Growth during Fission Yeast Mating Requires Ras1-GTP Hydrolysis (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							NUCLEOTIDE EXCHANGE FACTOR; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; P-FACTOR; RAS; PHEROMONE; GTPASE; CDC42; POLARITY; ACTIVATION	The spatial and temporal control of polarity is fundamental to the survival of all organisms. Cells define their polarity using highly conserved mechanisms that frequently rely upon the action of small GTPases, such as Ras and Cdc42. Schizosaccharomyces pombe is an ideal system with which to study the control of cell polarity since it grows from defined tips using Cdc42-mediated actin remodeling. Here we have investigated the importance of Ras1-GTPase activity for the coordination of polarized cell growth during fission yeast mating. Following pheromone stimulation, Ras1 regulates both a MAPK cascade and the activity of Cdc42 to enable uni-directional cell growth towards a potential mating partner. Like all GTPases, when bound to GTP, Ras1 adopts an active conformation returning to an inactive state upon GTP-hydrolysis, a process accelerated through interaction with negative regulators such as GAPs. Here we show that, at low levels of pheromone stimulation, loss of negative regulation of Ras1 increases signal transduction via the MAPK cascade. However, at the higher concentrations observed during mating, hyperactive Ras1 mutations promote cell death. We demonstrate that these cells die due to their failure to coordinate active Cdc42 into a single growth zone resulting in disorganized actin deposition and unsustainable elongation from multiple tips. These results provide a striking demonstration that the deactivation stage of Ras signaling is fundamentally important in modulating cell polarity.	[Weston, Cathryn; Bond, Michael; Croft, Wayne; Ladds, Graham] Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Weston, C (corresponding author), Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	Cathryn.weston@warwick.ac.uk		Ladds, Graham/0000-0001-7320-9612	Warwick Postgraduate Research Scholarships; University Hospitals of Coventry and Warwickshire NHS Trust; Biotechnology and Biological Sciences Research Council [BB/G01227X/1]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1] Funding Source: UKRI	Warwick Postgraduate Research Scholarships; University Hospitals of Coventry and Warwickshire NHS Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Warwick Postgraduate Research Scholarships, the University Hospitals of Coventry and Warwickshire NHS Trust, the Biotechnology and Biological Sciences Research Council grant number (BB/G01227X/1) and Birmingham Science City Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bendezu FO, 2013, CURR BIOL, V23, P42, DOI 10.1016/j.cub.2012.10.042; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; DAVEY J, 1992, EMBO J, V11, P951, DOI 10.1002/j.1460-2075.1992.tb05134.x; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DAVEY J, 1995, METH MOL G, V6, P247, DOI DOI 10.1016/S1067-2389(06)80016-6; Didmon M, 2002, CURR GENET, V41, P241, DOI 10.1007/s00294-002-0301-3; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; HUGHES DA, 1994, J CELL SCI, V107, P3635; IMAI Y, 1991, MOL CELL BIOL, V11, P3088, DOI 10.1128/MCB.11.6.3088; IMAI Y, 1992, MOL CELL BIOL, V12, P1827, DOI 10.1128/MCB.12.4.1827; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; Kelly FD, 2011, MOL BIOL CELL, V22, P3801, DOI 10.1091/mbc.E11-01-0057; KITAMURA K, 1991, EMBO J, V10, P3743, DOI 10.1002/j.1460-2075.1991.tb04943.x; Ladds G, 2005, MOL MICROBIOL, V55, P482, DOI 10.1111/j.1365-2958.2004.04394.x; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; Ladds G, 2000, MOL MICROBIOL, V36, P377, DOI 10.1046/j.1365-2958.2000.01855.x; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2000, MOL MICROBIOL, V38, P839, DOI 10.1046/j.1365-2958.2000.02180.x; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; MAEDA T, 1990, P NATL ACAD SCI USA, V87, P7814, DOI 10.1073/pnas.87.20.7814; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARKS J, 1986, J CELL SCI, P229; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Merla A, 2000, EUR J CELL BIOL, V79, P469, DOI 10.1078/0171-9335-00073; MITCHISON JM, 1985, J CELL SCI, V75, P357; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nakano K, 2001, GENES CELLS, V6, P1031, DOI 10.1046/j.1365-2443.2001.00485.x; NIELSEN O, 1992, EMBO J, V11, P1391, DOI 10.1002/j.1460-2075.1992.tb05184.x; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Papadaki P, 2002, MOL CELL BIOL, V22, P4598, DOI 10.1128/MCB.22.13.4598-4606.2002; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; SAZER S, 1990, J CELL SCI, V97, P509; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; SNELL V, 1993, DEVELOPMENT, P289; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Toya M, 1999, MOL BIOL CELL, V10, P2745, DOI 10.1091/mbc.10.8.2745; Tratner I, 1997, GENE, V193, P203, DOI 10.1016/S0378-1119(97)00115-7; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	54	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77487	10.1371/journal.pone.0077487	http://dx.doi.org/10.1371/journal.pone.0077487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147005	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400112
J	Liu, YT; Fan, YY; Xu, CH; Lin, XL; Lu, YK; Zhang, XL; Zhang, CX; Chen, YM				Liu, Yuan-ting; Fan, Yu-ying; Xu, Chun-hua; Lin, Xiao-ling; Lu, Yun-kai; Zhang, Xing-lan; Zhang, Cai-xia; Chen, Yu-ming			Habitual Consumption of Soy Products and Risk of Nasopharyngeal Carcinoma in Chinese Adults: A Case-Control Study	PLOS ONE			English	Article							PROSPECTIVE COHORT; FOOD-CONSUMPTION; PRESERVED FOODS; LUNG-CANCER; METAANALYSIS; INHIBITION; FRUIT	Background and Objectives: Many studies have shown a negative association between the consumption of soy products and the risk of some cancers, but little is known about the effect of soy consumption on nasopharyngeal carcinoma. We assessed the association between the consumption of soy products on nasopharyngeal carcinoma risk in Chinese individuals. Methods: This case-control study included 600 (448 males and 152 females) incident cases of nasopharyngeal carcinoma, and an equal number of controls, matched according to gender, age (+/- 3 y) and household type to the nasopharyngeal carcinoma cases. All subjects were recruited from hospitals in Guangzhou, China. A face-to-face interview was conducted with each study individual to collect general information and habitual dietary intake using a 78-item quantitative food-frequency questionnaire. Odds ratios and their 95% confidence intervals were estimated using conditional logistic regression analyses. Results: The median intakes of soy foods (in protein) were 0.5/0.5, 1.4/1.7, 2.7/3.3 and 6.1/7.7 (male/female) g/d in the quartiles 1 to 4. Both univariate and multivariate analyses showed no significant association between the consumption of soy proteins or soy isoflavones and the risk of nasopharyngeal carcinoma. The adjusted odds ratios (95% confidence intervals) between extreme quartiles were 0.97 (0.66-1.45) for soy proteins and 0.97 (0.66-1.42) for total isoflavones. Null associations were also observed between intake of the individual isoflavones daidzein, genistein and glycitein and NPC risk, with adjusted odds ratios for the extreme quartiles ranging between 0.73 and 1.23. Conclusion: Habitual consumption of soy products had no significant effect on the risk of nasopharyngeal carcinoma in Chinese adults with a relatively low intake.	[Liu, Yuan-ting; Xu, Chun-hua; Zhang, Cai-xia; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yuan-ting] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Yu-ying; Lin, Xiao-ling; Zhang, Xing-lan] Sun Yat Sen Univ, Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Yun-kai] Cent Hosp Panyu Dist, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University, Guangzhou, People's Republic of China	Sun Yat-sen University, Guangzhou, People's Republic of China	This study was supported by the 5010 Program for Clinical Researches of Sun Yat-sen University, Guangzhou, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhen Xukurhan, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P783; Chan SG, 2009, J AGR FOOD CHEM, V57, P5386, DOI 10.1021/jf803870k; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883; Han HY, 2010, NUTR CANCER, V62, P641, DOI 10.1080/01635581003605490; Huang C, 2009, J CELL PHYSIOL, V221, P394, DOI 10.1002/jcp.21867; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Johnson J, 2011, MOL NUTR FOOD RES, V55, P58, DOI 10.1002/mnfr.201000420; Keinan-Boker L, 2004, AM J CLIN NUTR, V79, P282; Kim J, 2011, CANCER SCI, V102, P231, DOI 10.1111/j.1349-7006.2010.01770.x; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; Liu YT, 2012, CANCER CAUSE CONTROL, V23, P589, DOI 10.1007/s10552-012-9923-z; Lobo RA, 2011, MENOPAUSE, V18, P237, DOI [10.1097/gme.0b013e3181e9e538, 10.1097/gme.0b013e31821fc8e0]; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; Shimazu T, 2010, AM J CLIN NUTR, V91, P722, DOI 10.3945/ajcn.2009.28161; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xie Y, 2001, CHINESE MED J-PEKING, V114, P530; XU B, 1999, J CLIN ORL, V13, P347; Yang G, 2012, AM J EPIDEMIOL, V176, P846, DOI 10.1093/aje/kws168; Yang G, 2009, AM J CLIN NUTR, V89, P577, DOI 10.3945/ajcn.2008.26742; Yang YX, 2004, CHINA FOOD COMPOSITI; YU MC, 1988, CANCER RES, V48, P1954; Yu WM, 2009, J LARYNGOL OTOL, V123, P1067, DOI 10.1017/S0022215109005623; Zhang C, 2009, CANCER SCI, V101, P501; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zou J, 2000, J Radiat Res, V41 Suppl, P53	30	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77822	10.1371/journal.pone.0077822	http://dx.doi.org/10.1371/journal.pone.0077822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155974	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300108
J	Lo, SC; Hung, GC; Li, BJ; Lei, HY; Li, TW; Nagamine, K; Zhang, J; Tsai, S; Bryant, R				Lo, Shyh-Ching; Hung, Guo-Chiuan; Li, Bingjie; Lei, Haiyan; Li, Tianwei; Nagamine, Kenjiro; Zhang, Jing; Tsai, Shien; Bryant, Richard			Isolation of Novel Afipia septicemium and Identification of Previously Unknown Bacteria Bradyrhizobium sp OHSU_III from Blood of Patients with Poorly Defined Illnesses	PLOS ONE			English	Article							NEWLY DISCOVERED MYCOPLASMA; GENOME SEQUENCE; SP-NOV; STRAIN; SPIROPLASMA; INFECTION; PENETRANS; 16S	Cultures previously set up for isolation of mycoplasmal agents from blood of patients with poorly-defined illnesses, although not yielding positive results, were cryopreserved because of suspicion of having low numbers of unknown microbes living in an inactive state in the broth. We re-initiated a set of 3 cultures for analysis of the "uncultivable" or poorly-grown microbes using NGS technology. Broth of cultures from 3 blood samples, submitted from OHSU between 2000 and 2004, were inoculated into culture flasks containing fresh modified SP4 medium and kept at room temperature (RT), 30 degrees C and 35 degrees C. The cultures showing evidence of microbial growth were expanded and subjected to DNA analysis by genomic sequencing using Illumina MiSeq. Two of the 3 re-initiated blood cultures kept at RT after 7-8 weeks showed evidence of microbial growth that gradually reached into a cell density with detectable turbidity. The microbes in the broth when streaked on SP4 agar plates produced microscopic colonies in similar to 2 weeks. Genomic studies revealed that the microbes isolated from the 2 blood cultures were a novel Afipia species, tentatively named Afipia septicemium. Microbes in the 3 rd culture (OHSU_III) kept at RT had a limited level of growth and could not reach a plateau with high cell density. Genomic sequencing identified the microbe in the culture as a previously unknown species of Bradyrhizobium bacteria. This study reports on the isolation of novel Afipia and Bradyrhizobium species. Isolation of Bradyrhizobium species bacteria has never been reported in humans. The study also reveals a previously unrecognized nature of hematogenous infections by the 2 unique groups of Bradyrhizobiaceae. Our studies show that improvement of culture system plus effective use of NGS technology can facilitate findings of infections by unusual microbes in patients having poorly-defined, sometimes mysterious illnesses.	[Lo, Shyh-Ching; Hung, Guo-Chiuan; Li, Bingjie; Lei, Haiyan; Li, Tianwei; Nagamine, Kenjiro; Zhang, Jing; Tsai, Shien] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA; [Bryant, Richard] Oregon Hlth & Sci Univ, Dept Infect Dis, Portland, OR 97201 USA	US Food & Drug Administration (FDA); Oregon Health & Science University	Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA.	shyhching.lo@fda.hhs.gov			FDA Modernizing Science research grant	FDA Modernizing Science research grant	The study was supported in part by FDA Modernizing Science research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; BEECHAM HJ, 1991, LANCET, V338, P1014, DOI 10.1016/0140-6736(91)91874-T; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; CHEN TA, 1975, SCIENCE, V188, P1015, DOI 10.1126/science.188.4192.1015; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; LO SC, 1991, LANCET, V338, P1415, DOI 10.1016/0140-6736(91)92721-D; LO SC, 1992, INT J SYST BACTERIOL, V42, P357, DOI 10.1099/00207713-42-3-357; de Souza JAM, 2012, J BACTERIOL, V194, P3547, DOI 10.1128/JB.00563-12; McCook A, 2011, NATURE, V476, P270, DOI 10.1038/476270a; Pagnier I, 2012, J BACTERIOL, V194, P7018, DOI 10.1128/JB.01918-12; Pearce SL, 2011, J BACTERIOL, V193, P5057, DOI 10.1128/JB.05647-11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TULLY JG, 1981, LANCET, V1, P1288; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; WANG RYH, 1992, LANCET, V340, P1312, DOI 10.1016/0140-6736(92)92493-Y; Willems A, 2001, INT J SYST EVOL MICR, V51, P111, DOI 10.1099/00207713-51-1-111; WILLIAMSON DL, 1975, SCIENCE, V188, P1018, DOI 10.1126/science.188.4192.1018; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001	28	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76142	10.1371/journal.pone.0076142	http://dx.doi.org/10.1371/journal.pone.0076142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155888	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300022
J	Serafini, A; Pisu, D; Palu, G; Rodriguez, GM; Manganelli, R				Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Rodriguez, G. Marcela; Manganelli, Riccardo			The ESX-3 Secretion System Is Necessary for Iron and Zinc Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							GENE-EXPRESSION; PATHOGENIC MYCOBACTERIA; EXTRACELLULAR SIDEROPHORE; BACILLUS-SUBTILIS; ABC TRANSPORTER; PROTEIN EXPORT; BOVIS BCG; VIRULENCE; SMEGMATIS; IDENTIFICATION	ESX-3 is one of the five type VII secretion systems encoded by the Mycobacterium tuberculosis genome. We recently showed the essentiality of ESX-3 for M. tuberculosis viability and proposed its involvement in iron and zinc metabolism. In this study we confirmed the role of ESX-3 in iron uptake and its involvement in the adaptation to low zinc environment in M. tuberculosis. Moreover, we unveiled functional differences between the ESX-3 roles in M. tuberculosis and M. smegmatis showing that in the latter ESX-3 is only involved in the adaptation to iron and not to zinc restriction. Finally, we also showed that in M. tuberculosis this secretion system is essential for iron and zinc homeostasis not only in conditions in which the concentrations of these metals are limiting but also in metal sufficient conditions.	[Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy; [Rodriguez, G. Marcela] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA	University of Padua; Rutgers State University Newark; Rutgers State University New Brunswick	Manganelli, R (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	riccardo.manganelli@unipd.it	Pisu, Davide/AAK-1095-2021; Manganelli, Riccardo/A-7361-2009; Serafini, Agnese/AAN-6952-2020	Manganelli, Riccardo/0000-0003-0940-7336; Serafini, Agnese/0000-0002-1904-6012; Pisu, Davide/0000-0001-5641-8877	European Community [201762]; National Institutes of Health [AI044856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044856, R01AI044856] Funding Source: NIH RePORTER	European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research received funding from the European Community Seventh Framework Program (FP7/2007-2013) under grant agreement 201762 (RM) and from National Institutes of Health grant AI044856 (GMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Bhat KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052601; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Cascioferro A, 2010, APPL ENVIRON MICROB, V76, P5312, DOI 10.1128/AEM.00382-10; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Di Luca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052059; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Gey van Pittius NC, 2001, GENOME BIOL, V2; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Jones CM, 2010, J BACTERIOL, V192, P6411, DOI 10.1128/JB.00986-10; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Maciag A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-48; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Provvedi R, 2008, J BACTERIOL, V190, P7859, DOI 10.1128/JB.00714-08; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; Reddy PV, 2013, J INFECT DIS; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; SHARMAN GJ, 1995, BIOCHEM J, V305, P187, DOI 10.1042/bj3050187; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; SNOW GA, 1965, BIOCHEM J, V94, P160, DOI 10.1042/bj0940160; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van der Woude AD, 2012, CURR TOP MICROBIOL I; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vaquerizas JM, 2005, NUCLEIC ACIDS RES, V33, pW616, DOI 10.1093/nar/gki500; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0	69	78	83	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78351	10.1371/journal.pone.0078351	http://dx.doi.org/10.1371/journal.pone.0078351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155985	Green Published, gold			2022-12-25	WOS:000325887300120
J	Okoro, DR; Arva, N; Gao, C; Polotskaia, A; Puente, C; Rosso, M; Bargonetti, J				Okoro, Danielle R.; Arva, Nicoleta; Gao, Chong; Polotskaia, Alla; Puente, Cindy; Rosso, Melissa; Bargonetti, Jill			Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator	PLOS ONE			English	Article							ACCELERATES TUMOR-FORMATION; RIBOSOMAL-PROTEIN L26; SOFT-TISSUE TUMORS; MESSENGER-RNA; ONCOPROTEIN MDM2; BREAST-CANCER; DNA-DAMAGE; CELL-CYCLE; GENE AMPLIFICATION; SPLICE VARIANT	Human cancers over-expressing mdm2, through a T to G variation at a single nucleotide polymorphism at position 309 (mdm2 SNP309), have functionally inactivated p53 that is not effectively degraded. They also have high expression of the alternatively spliced transcript, mdm2-C. Alternatively spliced mdm2 transcripts are expressed in many forms of human cancer and when they are exogenously expressed they transform human cells. However no study to date has detected endogenous MDM2 protein isoforms. Studies with exogenous expression of splice variants have been carried out with mdm2-A and mdm2-B, but the mdm2-C isoform has remained virtually unexplored. We addressed the cellular influence of exogenously expressed MDM2-C, and asked if endogenous MDM2-C protein was present in human cancers. To detect endogenous MDM2-C protein, we created a human MDM2-C antibody to the splice junction epitope of exons four and ten (MDM2 C410) and validated the antibody with in vitro translated full length MDM2 compared to MDM2-C. Interestingly, we discovered that MDM2-C co-migrates with MDM2-FL at approximately 98 kDa. Using the validated C410 antibody, we detected high expression of endogenous MDM2-C in human cancer cell lines and human cancer tissues. In the estrogen receptor positive (ER+) mdm2 G/G SNP309 breast cancer cell line, T47D, we observed an increase in endogenous MDM2-C protein with estrogen treatment. MDM2-C localized to the nucleus and the cytoplasm. We examined the biological activity of MDM2-C by exogenously expressing the protein and observed that MDM2-C did not efficiently target p53 for degradation or reduce p53 transcriptional activity. Exogenous expression of MDM2-C in p53-null human cancer cells increased colony formation, indicating p53-independent tumorigenic properties. Our data indicate a role for MDM2-C that does not require the inhibition of p53 for increasing cancer cell proliferation and survival.	[Bargonetti, Jill] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; CUNY, Grad Ctr, Dept Biol, New York, NY USA; CUNY, Grad Ctr, Dept Biochem, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Bargonetti, J (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Bargonetti@genectr.hunter.cuny.edu		Bargonetti, Jill/0000-0003-2692-0991	National Science Foundation [MCB-0744316]; Breast Cancer Research Foundation; Clinical Translational Science Center (CTSC) of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health [TR000457]; National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH) [MD007599]; MBRS-RISE Program [3R25-GM060665]; CUNY Magnet Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060665] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Breast Cancer Research Foundation; Clinical Translational Science Center (CTSC) of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health; National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH); MBRS-RISE Program; CUNY Magnet Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Science Foundation (MCB-0744316), a grant from The Breast Cancer Research Foundation, and a grant from the Clinical Translational Science Center (CTSC) TR000457 of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health to J. Bargonetti. It was also made possible in part by an infrastructure award to Hunter College, grant number MD007599 from the National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH. D.O. was partially supported by a CUNY Magnet Award and M. R. was supported by the MBRS-RISE Program to Hunter College 3R25-GM060665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2001, INT J SURG PATHOL, V9, P99, DOI 10.1177/106689690100900203; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Anderson JJ, 2007, INT J ONCOL, V31, P545; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Arva NC, 2008, ETHNIC DIS, V18; BAKER SJ, 1990, CANCER RES, V50, P7717; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bartel F, 2001, ONCOL RES, V12, P451, DOI 10.3727/096504001108747459; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Bouska A, 2009, CANCER RES, V69, P1697, DOI 10.1158/0008-5472.CAN-08-3732; Brekman A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3130; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Clancy S., 2008, NATURE ED, V1; CORDONCARDO C, 1994, CANCER RES, V54, P794; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Deb SP, 2003, MOL CANCER RES, V1, P1009; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fridman JS, 2003, CANCER RES, V63, P5703; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; HAINES DS, 1994, MOL CELL BIOL, V14, P1171, DOI 10.1128/MCB.14.2.1171; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jeyaraj SC, 2009, FRONT BIOSCI-LANDMRK, V14, P2647, DOI 10.2741/3402; KASTAN MB, 1991, CANCER RES, V51, P6304; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; Liang HL, 2004, GENE, V338, P217, DOI 10.1016/j.gene.2004.05.015; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Lukas J, 2001, CANCER RES, V61, P3212; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Matsumoto R, 1998, CANCER RES, V58, P609; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mozzherin DJ, 1996, BIOCHEMISTRY-US, V35, P3572, DOI 10.1021/bi952142p; NAKAYAMA T, 1995, INT J CANCER, V64, P342, DOI 10.1002/ijc.2910640511; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Okoro DE, 2012, SPLICING MDM2 CANC P; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Schneider-Stock R, 1998, J CANCER RES CLIN, V124, P532; Schuster K, 2007, MOL CANCER RES, V5, P403, DOI 10.1158/1541-7786.MCR-06-0146; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trinh E, 2001, MOL CELL NEUROSCI, V17, P342, DOI 10.1006/mcne.2000.0928; Udayakumar T, 2010, SEMIN RADIAT ONCOL, V20, P258, DOI 10.1016/j.semradonc.2010.05.007; Volk EL, 2009, DIS MODEL MECH, V2, P47, DOI 10.1242/dmm.000992; Volk EL, 2009, MOL CANCER RES, V7, P863, DOI 10.1158/1541-7786.MCR-08-0418; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	73	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77643	10.1371/journal.pone.0077643	http://dx.doi.org/10.1371/journal.pone.0077643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147044	Green Published, gold			2022-12-25	WOS:000325819400131
J	Fardini, Y; Masson, E; Boudah, O; Ben Jouira, R; Cosson, C; Pierre-Eugene, C; Kuo, MS; Issad, T				Fardini, Yann; Masson, Elodie; Boudah, Ouassila; Ben Jouira, Rania; Cosson, Camille; Pierre-Eugene, Cecile; Kuo, Mei-Shiue; Issad, Tarik			O-GlcNAcylation of FoxO1 in pancreatic beta cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism	FASEB JOURNAL			English	Article						insulin-like growth factor-binding protein 1; PI3K signaling; glucotoxicity; Forkhead transcription factor O1; apoptosis	STIMULATED INSULIN-SECRETION; FACTOR-BINDING PROTEIN-1; TRANSCRIPTIONAL ACTIVITY; N-ACETYLGLUCOSAMINE; GLCNAC MODIFICATION; GROWTH; ACTIVATION; GLYCOSYLATION; INCREASES; APOPTOSIS	O-GlcNAcylation on serine/threonine is a post-translational modification that controls the activity of nucleocytoplasmic proteins according to glucose availability. We previously showed that O-GlcNAcylation of FoxO1 in liver cells increases its transcriptional activity. In the present study, we evaluated the potential involvement of FoxO1 O-GlcNAcylation in the context of pancreatic -cell glucotoxicity. FoxO1 was O-GlcNAcylated in INS-1 832/13 cells and isolated rat pancreatic islets. O-GlcNAcylation of FoxO1 resulted in a 2-fold increase in its transcriptional activity toward a FoxO1 reporter gene and a 3-fold increase in the expression of the insulin-like growth factor-binding protein 1 (Igfbp1) gene at the mRNA level, resulting in IGFBP1 protein oversecretion by the cells. Of note, increased IGFBP1 in the culture medium inhibited the activity of the insulin-like growth factor 1 receptor (IGF1R)/phosphatidyl inositol 3 kinase (PI3K)/Akt pathway. We reveal in this report a novel mechanism by which O-GlcNAcylation inhibits Akt activity through an autocrine mechanism. However, although inhibition of IGFBP1 expression using siRNA restored the PI3 kinase/Akt pathway, it did not rescue INS-1 832/13 cells from high-glucose- or O-glcNAcylation-induced cell death. In contrast, FoxO1 down-regulation by siRNA led to 30 to 60% protection of INS-1 832/13 cells from death mediated by glucotoxic conditions. Therefore, whereas FoxO1 O-GlcNAcylation inhibits Akt through an IGFBP1-mediated autocrine pathway, the deleterious effects of FoxO1 O-GlcNAcylation on cell survival appeared to be independent of this pathway.Fardini, Y., Masson, E., Boudah, O., Ben Jouira, R., Cosson, C., Pierre-Eugene, C., Kuo, M.-S., Issad, T. O-GlcNAcylation of FoxO1 in pancreatic cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism.	Univ Paris 05, Inst Cochin, CNRS, Unite Mixte Rech UMR 8104, Paris, France; INSERM, Unite U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Inst Cochin, Dept Diabet Endocrinol & Metab, 22 Rue Mechain, F-75014 Paris, France.	tarik.issad@inserm.fr		MASSON, Elodie/0000-0001-6312-0913; FARDINI, Yann/0000-0002-6800-1777; Issad, Tarik/0000-0002-2638-6330; Ben Jouira, Rania/0000-0001-6999-4566	Agence Nationale de la Recherche (ANR) grant (ANR Geno-path Diab-O-Glyc); Societe Francophone du Diabete (SFD-Alfediam); Cardiovasculaire-Obesite-Rein-Diabete Domaine d'Interet Majeur (CORDDIM) Ile-de-France	Agence Nationale de la Recherche (ANR) grant (ANR Geno-path Diab-O-Glyc)(French National Research Agency (ANR)); Societe Francophone du Diabete (SFD-Alfediam); Cardiovasculaire-Obesite-Rein-Diabete Domaine d'Interet Majeur (CORDDIM) Ile-de-France	The authors thank Dr. C. B. Newgard (Duke University Medical Center, Durham, NC, USA) for providing INS-1 832/13 cells and Dr. Gaelle Filhoulaud for useful technical advice for rat islet isolation. This work was supported by an Agence Nationale de la Recherche (ANR) grant (ANR Geno-path Diab-O-Glyc) and the Societe Francophone du Diabete (SFD-Alfediam). Y.F. was supported by a postdoctoral fellowship from the Cardiovasculaire-Obesite-Rein-Diabete Domaine d'Interet Majeur (CORDDIM) Ile-de-France. The authors declare no conflicts of interest.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Cifarelli V, 2012, MOL ENDOCRINOL, V26, P1213, DOI 10.1210/me.2011-1276; Cooksey RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE334, DOI 10.1152/ajpendo.00265.2005; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Filhoulaud G, 2009, J BIOL CHEM, V284, P24583, DOI 10.1074/jbc.M109.025288; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Kaneto H, 2001, J BIOL CHEM, V276, P31099, DOI 10.1074/jbc.M104115200; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Lefebvre T, 2009, BIOCHIM BIOPHYS ACTA, V1800, P67; Lewitt MS, 2008, DIABETOLOGIA, V51, P1135, DOI 10.1007/s00125-008-1016-x; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Omae N, 2012, MOL CELL ENDOCRINOL, V348, P297, DOI 10.1016/j.mce.2011.09.013; Ruan W., ACTA DIABETOL, V47, P5; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Strobel A, 1999, DIABETOLOGIA, V42, P527, DOI 10.1007/s001250051190; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998	38	27	28	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					1010	1021		10.1096/fj.13-238378	http://dx.doi.org/10.1096/fj.13-238378			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24174424				2022-12-25	WOS:000331072200044
J	Katada, R; Akdemir, G; Asavapanumas, N; Ratelade, J; Zhang, H; Verkman, AS				Katada, Ryuichi; Akdemir, Gokhan; Asavapanumas, Nithi; Ratelade, Julien; Zhang, Hua; Verkman, A. S.			Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia	FASEB JOURNAL			English	Article						water channel; brain swelling; astrocyte; neuroscience	CAROTID-ARTERY OCCLUSION; EXTRACELLULAR-SPACE; WATER TRANSPORT; COGNITIVE IMPAIRMENT; BRAIN EDEMA; LACKING; MODEL; DEATH; VULNERABILITY; OUTCOMES	Aquaporin-4 (AQP4), the principal water channel in astrocytes, is involved in brain water movement, inflammation, and neuroexcitation. In this study, there was strong neuroprotection in mice lacking AQP4 in a model of global cerebral ischemia produced by transient, bilateral carotid artery occlusion (BCAO). Survival and neurological outcome were greatly improved in the AQP4(-/-)vs. AQP4(+/+) mice after occlusion, with large and robust differences in both outbred (CD1) and inbred (C57bl/6) mouse strains without or with mechanical ventilation. Improved survival was also seen in mice lacking the scaffold protein -syntrophin, which manifest reduced astrocyte water permeability secondary to defective AQP4 plasma membrane targeting. Intracranial pressure elevation and brain water accumulation were much reduced in the AQP4(-/-)vs. AQP4(+/+) mice after carotid artery occlusion, as were blood-brain barrier (BBB) disruption and neuronal loss. Brain slices from AQP4(-/-) mice showed significantly reduced cell swelling and cytotoxicity in response to oxygen-glucose deprivation, compared with slices from AQP4(+/+) mice. Our findings suggest that the neuroprotective effect of AQP4 deletion in global cerebral ischemia involves reduced astrocyte swelling and brain water accumulation, resulting in reduced BBB disruption, inflammation, and neuron death. AQP4 water transport inhibition may improve survival and neurological outcome after cardiac arrest and in other conditions associated with global cerebral ischemia.Katada, R., Akdemir, G., Asavapanumas, N., Ratelade, J., Zhang, H., Verkman, A. S. Greatly improved survival and neuroprotection in aquaporin-4 knockout mice following global cerebral ischemia.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci East Tower,Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409; Akdemir, Gokhan/0000-0002-1852-9442; Asavapanumas, Nithi/0000-0002-5362-2124	U.S. National Institutes of Health (Bethesda, MD, USA) [DK35124, EY13574, EB00415, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	U.S. National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK35124, EY13574, EB00415, and DK72517 from the U.S. National Institutes of Health (Bethesda, MD, USA) and grants from the Guthy-Jackson Charitable Foundation.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Cho SG, 2004, NEUROCHEM INT, V45, P117, DOI 10.1016/j.neuint.2003.11.012; Datta SC, 2008, J NEUROSCI METH, V175, P119, DOI 10.1016/j.jneumeth.2008.08.007; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duffy S, 1996, J NEUROSCI, V16, P71; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; FUJIOKA M, 1994, STROKE, V25, P2091, DOI 10.1161/01.STR.25.10.2091; GARCIA JH, 1977, VIRCHOWS ARCH B, V25, P191; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P418, DOI 10.1016/j.bmc.2007.12.038; Jin BJ, 2013, J GEN PHYSIOL, V141, P119, DOI 10.1085/jgp.201210883; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kim DH, 2010, NEUROSCI LETT, V475, P74, DOI 10.1016/j.neulet.2010.03.046; KIRINO T, 1985, PROG BRAIN RES, V63, P39; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Lu DC, 2008, FASEB J, V22, P3216, DOI 10.1096/fj.07-104836; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Magnus T, 2012, CURR OPIN NEUROL, V25, P334, DOI 10.1097/WCO.0b013e328352ede6; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MICKEL HS, 1990, STROKE, V21, P1641, DOI 10.1161/str.21.11.1641c; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murakami K, 1998, BRAIN RES, V780, P304, DOI 10.1016/S0006-8993(97)01217-1; Murakami Y, 2005, J NEUROCHEM, V93, P1616, DOI 10.1111/j.1471-4159.2005.03163.x; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nielsen S, 1997, J NEUROSCI, V17, P171; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Ratelade J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027412; Rossi A, 2012, GLIA, V60, P2027, DOI 10.1002/glia.22417; Soares LM, 2013, BEHAV BRAIN RES, V249, P28, DOI 10.1016/j.bbr.2013.04.010; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Thiagarajah JR, 2005, J NEUROSCI RES, V80, P293, DOI 10.1002/jnr.20439; Walker EJ, 2010, J NEUROSCI RES, V88, P764, DOI 10.1002/jnr.22257; Yamamoto Y, 2009, BRAIN RES, V1295, P218, DOI 10.1016/j.brainres.2009.07.081; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551; Zhang H, 2010, BIOPHYS J, V99, P1284, DOI 10.1016/j.bpj.2010.06.023; Zhen G, 2007, J NEUROSCI METH, V166, P73, DOI 10.1016/j.jneumeth.2007.06.029	49	57	65	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					705	714		10.1096/fj.13-231274	http://dx.doi.org/10.1096/fj.13-231274			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24186965	Green Published			2022-12-25	WOS:000331072200018
J	Islam, KN; Bae, JW; Gao, E; Koch, WJ				Islam, Kazi N.; Bae, Jang-Whan; Gao, Erhe; Koch, Walter J.			Regulation of Nuclear Factor kappa B (NF-kappa B) in the Nucleus of Cardiomyocytes by G Protein-coupled Receptor Kinase 5 (GRK5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Gene Expression; Gene Regulation; NF-Kappa B (NF-KB); Transcription	HYPERTROPHY IN-VIVO; CARDIAC-HYPERTROPHY; TRANSCRIPTIONAL ACTIVITY; MYOCARDIAL HYPERTROPHY; GENE-EXPRESSION; ANGIOTENSIN-II; HEART-FAILURE; ACTIVATION; MICE; REQUIREMENT	Background: NF-B activation and GRK5 up-regulation have been shown to be associated with heart disease. Results: GRK5 induces NF-B signaling pathway both in cardiomyocytes and in mouse hearts. Conclusion: GRK5 triggers the binding of NF-B (p50/p65) to DNA in the nucleus and promotes gene transcription including hypertrophic gene. Significance: GRK5 up-regulation may lead to a significant increase in expression and activation of NF-B seen in heart disease. G protein-coupled receptor kinase 5 GRK5 plays a key role in regulating cardiac signaling and its expression is increased in heart failure. GRK5 activity in the nucleus of myocytes has been shown to be detrimental in the setting of pressure-overload hypertrophy. The ubiquitous nuclear transcription factor B (NF-B) is involved in the regulation of numerous genes in various tissues, and activation of NF-B has been shown to be associated with heart disease. Herein, we investigated whether GRK5 can specifically regulate the NF-B signaling pathway in myocytes. We found that overexpression of GRK5 increased the levels of NF-B -p50 and p65 in vitro and in vivo, whereas loss of GRK5 resulted in lower cardiac NF-B levels. Furthermore, increased GRK5 expression induced the phosphorylation status of p65, increased the activity of a NF-B reporter, and increased NF-B DNA binding activity in cultured neonatal rat ventricular myocytes. Importantly, siRNA against GRK5 presented with the opposite results in neonatal rat ventricular myocytes as p65 and p50 were decreased, and there was a loss of NF-B DNA binding activity. The influence of GRK5 on NF-B expression and activity was dependent on its nuclear localization as overexpression of a mutant GRK5 that cannot enter the nucleus was devoid of NF-B activation or DNA binding. Our study demonstrates that a novel pathological consequence of GRK5 up-regulation in the injured and failing heart is the induction of NF-B expression and activity.	[Islam, Kazi N.; Bae, Jang-Whan; Gao, Erhe; Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Islam, KN (corresponding author), LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 533 Bolivar St,CSRB 401A, New Orleans, LA 70112 USA.	kisla1@lsuhsc.edu; walter.koch@temple.edu			National Institutes of Health Grants [PO1 HL 091799, PO1 HL 075443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091799, P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 091799 (Project 1 to W. J. K. and Core B to E. G.) and PO1 HL 075443 (Project 2 to W. J. K.).	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Patial S, 2011, J CELL PHYSIOL, V226, P1323, DOI 10.1002/jcp.22460; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	36	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35683	35689		10.1074/jbc.M113.529347	http://dx.doi.org/10.1074/jbc.M113.529347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174526	hybrid, Green Published			2022-12-25	WOS:000329814700007
J	Nabilsi, NH; Ryder, DJ; Peraza-Penton, AC; Poudyal, R; Loose, DS; Kladde, MP				Nabilsi, Nancy H.; Ryder, Daniel J.; Peraza-Penton, Ashley C.; Poudyal, Rosha; Loose, David S.; Kladde, Michael P.			Local Depletion of DNA Methylation Identifies a Repressive p53 Regulatory Region in the NEK2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Regulation; Chromatin Structure; DNA Methylation; Epigenetics; Nucleosome; p53; MAPit; NEK2	METHYLTRANSFERASE ACCESSIBILITY PROTOCOL; CELL-CYCLE; INDIVIDUAL TEMPLATES; CPG METHYLATION; PROTEIN-KINASE; SURVIVIN GENE; BREAST-CANCER; EXPRESSION; PATTERNS; TARGET	Background: NEK2 is a mammalian kinase that promotes centrosome separation during the cell cycle. Results: Agents that demethylate the NEK2 promoter or induce DNA damage repress NEK2 expression in a p53-dependent manner. Conclusion: p53 represses NEK2 expression and protects its binding region from accumulating DNA methylation. Significance: Knowledge regarding novel mechanisms of NEK2 regulation may help inform clinical application of NEK2-based anticancer therapeutics. Genome-scale mapping suggests that the function of DNA methylation varies with genomic context beyond transcriptional repression. However, the use of DNA-demethylating agents (e.g. 5-aza-2-deoxycytidine (5aza-dC)) to study epigenetic regulation often focuses on gene activation and ignores repression elicited by 5aza-dC. Here, we show that repression of NEK2, which encodes the never in mitosis A (NIMA)-related kinase, by 5aza-dC is context-specific as NEK2 transcript levels were reduced in HCT116 colon cancer cells but not in isogenic p53(-/-) cells. Bisulfite sequencing showed that DNA methylation was restricted to the distal region of the NEK2 promoter. Demethylation by 5aza-dC was associated with increased accessibility to micrococcal nuclease, i.e. nucleosome depletion. Conversely, methyltransferase accessibility protocol for individual templates (MAPit) methylation footprinting showed that nucleosome occupancy and DNA methylation at the distal promoter were significantly increased in p53(-/-) cells, suggesting dynamic regulation of chromatin structure at this region by p53 in HCT116 cells. Stabilization of endogenous p53 by doxorubicin or ectopic expression of p53, but not a p53 DNA-binding mutant, decreased NEK2 expression. Chromatin immunoprecipitation demonstrated direct and specific association of p53 with the distal NEK2 promoter, which was enhanced by doxorubicin. Luciferase reporters confirmed that this region is required for p53-mediated repression of NEK2 promoter activity. Lastly, modulation of p53 abundance altered nucleosome occupancy and DNA methylation at its binding region. These results identify NEK2 as a novel p53-repressed gene, illustrate that its repression by 5aza-dC is specific and associated with nucleosome reorganization, and provide evidence that identification of partially methylated regions can reveal novel p53 target genes.	[Nabilsi, Nancy H.; Peraza-Penton, Ashley C.; Poudyal, Rosha; Kladde, Michael P.] Univ Florida, Coll Med, Hlth Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ryder, Daniel J.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Phys Therapy, Gainesville, FL 32610 USA; [Loose, David S.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health Science Center Houston	Loose, DS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	David.S.Loose@uth.tmc.edu; kladde@ufl.edu			National Institutes of Health [CA098258, CA155390]; Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship [BD-03]; NATIONAL CANCER INSTITUTE [P50CA098258, P30CA016672, T32CA059365, R01CA155390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098258 (to D. S. L.) and CA155390 (to M. P. K.). This work was also supported by Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship BD-03 (to N. H. N.). We thank Dr. Lei Deng and Dr. Russell Broaddus for providing the p53-luciferase reporter and RNA from doxo-treated breast cancer cells and Dr. Lawrence Donehower for the p53-EGFP construct. We also thank Dr. Carolina Pardo for critical reading of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barbagallo F, 2009, J PATHOL, V217, P431, DOI 10.1002/path.2471; Barletta JM, 1997, CANCER RES, V57, P48; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Brendle A, 2009, EUR J CANCER, V45, P435, DOI 10.1016/j.ejca.2008.10.001; Broude EV, 2007, CELL CYCLE, V6, P1468; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Cui KR, 2012, METHODS MOL BIOL, V833, P413, DOI 10.1007/978-1-61779-477-3_24; Darst RP, 2012, METHOD ENZYMOL, V513, P185, DOI 10.1016/B978-0-12-391938-0.00008-2; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herbert BS, 2010, ONCOTARGET, V1, P405; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kilgore JA, 2007, METHODS, V41, P320, DOI 10.1016/j.ymeth.2006.08.008; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nabilsi NH, 2010, J ENDOCRINOL, V207, P237, DOI 10.1677/JOE-10-0128; Pang LY, 2011, CELL CYCLE, V10, P932, DOI 10.4161/cc.10.6.15012; Pardo Carolina E, 2011, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2122s95; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Petrovich M, 2009, J MOL BIOL, V386, P72, DOI 10.1016/j.jmb.2008.11.054; Qiu XL, 2009, J MED CHEM, V52, P1757, DOI 10.1021/jm8015969; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wu GK, 2008, CANCER RES, V68, P8393, DOI 10.1158/0008-5472.CAN-08-1915; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie R, 2007, MODERN PATHOL, V20, P1045, DOI 10.1038/modpathol.3800940; Xu M, 1998, NUCLEIC ACIDS RES, V26, P3961, DOI 10.1093/nar/26.17.3961; Yang F, 2013, CURR BIOL, V23, P782, DOI 10.1016/j.cub.2013.03.043	58	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35940	35951		10.1074/jbc.M113.523837	http://dx.doi.org/10.1074/jbc.M113.523837			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24163369	Green Published, hybrid			2022-12-25	WOS:000329814700030
J	Richomme, C; Boadella, M; Courcoul, A; Durand, B; Drapeau, A; Corde, Y; Hars, J; Payne, A; Fediaevsky, A; Boschiroli, ML				Richomme, Celine; Boadella, Mariana; Courcoul, Aurelie; Durand, Benoit; Drapeau, Antoine; Corde, Yannick; Hars, Jean; Payne, Ariane; Fediaevsky, Alexandre; Boschiroli, Maria Laura			Exposure of Wild Boar to Mycobacterium tuberculosis Complex in France since 2000 Is Consistent with the Distribution of Bovine Tuberculosis Outbreaks in Cattle	PLOS ONE			English	Article							SUS-SCROFA; DISEASE RISKS; RED DEER; PREVALENCE; ANTIBODIES; LIVESTOCK; SWEDEN; TESTS; SPAIN	The Eurasian wild boar (Sus scrofa) is increasingly considered as a relevant actor in the epidemiology of animal tuberculosis (TB). Therefore, monitoring TB in wild boar becomes a key tool for establishing comprehensive control schemes for this disease. To estimate the exposure of free living wild boar to Mycobacterium tuberculosis complex (MTC) in France, a bovine-purified protein derivative based ELISA was used to test 2,080 archived serum samples of hunter-harvested animals in 58 French "departements". Two cut-off values were used for diagnostic interpretation: 0.2, recommended by the manufacturer (specificity: 96.43%; sensitivity: 72.6%), and 0.5 (specificity: 100%; sensitivity: 64%). During the same period, at the 0.2 cut-off, global true seroprevalence was 5.9% (IC95%: 4.3%-7.7%) and 76% of the sampled "departements" had seropositive wild boar, including seven cattle TB-free "departements. At the 0.5 cut-off, global true seroprevalence was 2.2% (IC95%: 1.5-3.2) and positive wild boar belonged to 21% of the "departements". All but one of these positive "departements" had reported at least one cattle TB outbreak since 2000. A good consistence between seropositive wild boar and TB outbreaks in cattle was found, especially at the 0.5 cut-off value (the mean distance to the nearest cattle TB outbreak was 13km and 27km for seropositive and seronegative wild boar, respectively; P<0.05). The use of an ELISA to detect MTC antibodies in wild boar has permitted the description of the geographic distribution of MTC contact in wild boar in France. Our results suggest that the ELISA could be used as a first screening tool to conduct TB surveillance in wild boar at a population level. High-risk wild boar populations (e. g. overabundant) could be tested and if identified positive by ELISA they should be surveyed in detail by combining pathology and culture.	[Richomme, Celine] Anses, Nancy Lab Rabies & Wildlife, Malzeville, France; [Boadella, Mariana] SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain; [Courcoul, Aurelie; Durand, Benoit] Univ Paris Est, Anses, Hlth Anim Lab, Epidemiol Unit, Maisons Alfort, France; [Drapeau, Antoine; Corde, Yannick; Boschiroli, Maria Laura] Univ Paris Est, Anses, Hlth Anim Lab, Bovine TB Natl Reference Lab, Maisons Alfort, France; [Hars, Jean; Payne, Ariane] Natl Hunting & Wildlife Agcy ONCFS, Res Dept, Gieres, France; [Payne, Ariane] Lyon Univ, UMR CNRS 5558, Villeurbanne, France; [Fediaevsky, Alexandre] Directorate Gen Food DGAI, Minist Food Agr & Fisheries, Paris, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Boschiroli, ML (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bovine TB Natl Reference Lab, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Durand, Benoit/GSE-2511-2022; Boadella, Mariana/I-8029-2012; Boschiroli, Maria Laura/AAR-3319-2021	Boadella, Mariana/0000-0001-6402-9927; Durand, Benoit/0000-0003-0669-1394	Anses	Anses	This study was funded by our own institutional resources (Anses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; ANSES (French agency for food environmental and occupational health and safety), 2011, TUB BOV FAUN SAUV; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; Boadella Mariana, 2011, BMC Res Notes, V4, P498, DOI 10.1186/1756-0500-4-498; Boadella M, 2011, EUR J WILDLIFE RES, V57, P697, DOI 10.1007/s10344-011-0550-x; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Hars J, 2012, B EPIDEMIOLOGIQUE SA, V52, P7; Hartley M, 2010, VET REC, V166, P487, DOI 10.1136/vr.c2051; Lemel J, 2003, WILDLIFE BIOL, V9, P29, DOI 10.2981/wlb.2003.061; Lyashchenko KP, 2007, VET MICROBIOL, V125, P265, DOI 10.1016/j.vetmic.2007.05.026; Marreros N, 2012, TUBERCULOSIS WILD BO; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; Payne A, 2012, EUR J WILDLIFE RES, P1; Payne A., 2011, B PID MIOLOGIQUE ST, V44, P2; Prevot C., 2013, EUR J WILDLIFE RES, V59, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Rhodes SG, 2011, VET IMMUNOL IMMUNOP, V144, P129, DOI 10.1016/j.vetimm.2011.07.020; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Rossi S., 2008, B EPID SANT ANIM ALI, V29, P5; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	33	34	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77842	10.1371/journal.pone.0077842	http://dx.doi.org/10.1371/journal.pone.0077842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167584	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500043
J	Mitchell, DE; Dai, CK; Rahman, MA; Ahn, JH; Della Santina, CC; Cullen, KE				Mitchell, Diana E.; Dai, Chenkai; Rahman, Mehdi A.; Ahn, Joong Ho; Della Santina, Charles C.; Cullen, Kathleen E.			Head Movements Evoked in Alert Rhesus Monkey by Vestibular Prosthesis Stimulation: Implications for Postural and Gaze Stabilization	PLOS ONE			English	Article							HIGH-ACCELERATION ROTATIONS; WHOLE-BODY ROTATION; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULOCOLLIC REFLEX; MULTIMODAL INTEGRATION; QUADRUPEDAL LOCOMOTION; CERVICOCOLLIC REFLEX; SEMICIRCULAR CANALS; NERVE AFFERENTS	The vestibular system detects motion of the head in space and in turn generates reflexes that are vital for our daily activities. The eye movements produced by the vestibulo-ocular reflex (VOR) play an essential role in stabilizing the visual axis (gaze), while vestibulo-spinal reflexes ensure the maintenance of head and body posture. The neuronal pathways from the vestibular periphery to the cervical spinal cord potentially serve a dual role, since they function to stabilize the head relative to inertial space and could thus contribute to gaze (eye-in-head + head-in-space) and posture stabilization. To date, however, the functional significance of vestibular-neck pathways in alert primates remains a matter of debate. Here we used a vestibular prosthesis to 1) quantify vestibularly-driven head movements in primates, and 2) assess whether these evoked head movements make a significant contribution to gaze as well as postural stabilization. We stimulated electrodes implanted in the horizontal semicircular canal of alert rhesus monkeys, and measured the head and eye movements evoked during a 100ms time period for which the contribution of longer latency voluntary inputs to the neck would be minimal. Our results show that prosthetic stimulation evoked significant head movements with latencies consistent with known vestibulo-spinal pathways. Furthermore, while the evoked head movements were substantially smaller than the coincidently evoked eye movements, they made a significant contribution to gaze stabilization, complementing the VOR to ensure that the appropriate gaze response is achieved. We speculate that analogous compensatory head movements will be evoked when implanted prosthetic devices are transitioned to human patients.	[Mitchell, Diana E.; Cullen, Kathleen E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Dai, Chenkai; Rahman, Mehdi A.; Ahn, Joong Ho; Della Santina, Charles C.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	McGill University; Johns Hopkins University	Cullen, KE (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	kathleen.cullen@mcgill.ca			Canadian Institutes of Health Research (CIHR); National Institute on Deafness and Other Communication Disorders (NIDCD) [R01-DC002390, R01-DC009255]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC009255, R01DC002390] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Canadian Institutes of Health Research (CIHR) and the National Institute on Deafness and Other Communication Disorders (NIDCD) grants R01-DC002390 and R01-DC009255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw ST, 2008, NEUROLOGY, V71, P1776, DOI 10.1212/01.wnl.0000335971.43443.d9; Berthoz A, 1985, Rev Oculomot Res, V1, P177; BLANKS RHI, 1985, BRAIN RES, V340, P315, DOI 10.1016/0006-8993(85)90928-X; Brown ET, 2009, IEEE ENG MED BIO, P7261, DOI 10.1109/IEMBS.2009.5334734; Chiang B, 2011, IEEE T NEUR SYS REH, V19, P588, DOI 10.1109/TNSRE.2011.2164937; Cohen B, 2009, ANN NY ACAD SCI, V1164, P89, DOI 10.1111/j.1749-6632.2009.03845.x; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Cremer PD, 2000, NEUROLOGY, V55, P1833, DOI 10.1212/WNL.55.12.1833; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Dai CK, 2011, HEARING RES, V281, P74, DOI 10.1016/j.heares.2011.08.008; Della Santina CC, 2005, P ANN INT IEEE EMBS, P7380, DOI 10.1109/IEMBS.2005.1616217; DIERINGER N, 1987, BRAIN RES, V404, P33, DOI 10.1016/0006-8993(87)91352-7; Ehtemam F, 2012, IEEE T BIO-MED ENG, V59, P1978, DOI 10.1109/TBME.2012.2195178; Elsley JK, 2007, J NEUROPHYSIOL, V98, P1333, DOI 10.1152/jn.00386.2007; Forbes PA, 2013, EXP BRAIN RES, V226, P1, DOI 10.1007/s00221-012-3388-x; Gdowski GT, 1999, J NEUROPHYSIOL, V82, P436, DOI 10.1152/jn.1999.82.1.436; GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311; GOLDBERG J, 1986, J NEUROPHYSIOL, V56, P857, DOI 10.1152/jn.1986.56.3.857; Goldberg JM, 2011, EXP BRAIN RES, V210, P331, DOI 10.1007/s00221-011-2611-5; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Haque A, 2005, J NEUROPHYSIOL, V93, P1165, DOI 10.1152/jn.00966.2004; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; Hedjoudje A, 2012, ASS RES OTOLARYNGOL, P292; Hullar TE, 2006, HEARING RES, V213, P17, DOI 10.1016/j.heares.2005.11.009; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; LISBERGER SG, 1990, J NEUROPHYSIOL, V63, P676, DOI 10.1152/jn.1990.63.4.676; Migliaccio AA, 2004, EXP BRAIN RES, V159, P433, DOI 10.1007/s00221-004-1974-2; Migliaccio AA, 1999, SUPPORTED AUSTRALASI, V22, P73; MONEY KE, 1972, COMP BIOCHEM PHYSIOL, V42, P353, DOI 10.1016/0300-9629(72)90116-8; Nie KB, 2013, IEEE T BIO-MED ENG, V60, P1685, DOI 10.1109/TBME.2013.2241433; Nijhuis LBO, 2007, J PHYSIOL-LONDON, V584, P97, DOI 10.1113/jphysiol.2007.136291; PAIGE GD, 1991, J NEUROPHYSIOL, V65, P1170, DOI 10.1152/jn.1991.65.5.1170; Peng GCY, 1999, IEEE T BIO-MED ENG, V46, P1269, DOI 10.1109/10.797986; Peng GCY, 1996, BIOL CYBERN, V75, P309, DOI 10.1007/s004220050297; PETERSON BW, 1985, J NEUROPHYSIOL, V54, P90, DOI 10.1152/jn.1985.54.1.90; RAMPRASHAD F, 1984, AM J ANAT, V169, P295, DOI 10.1002/aja.1001690306; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P3123, DOI 10.1152/jn.00793.2007; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P2369, DOI 10.1152/jn.00320.2007; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Sadeghi SG, 2012, J NEUROSCI, V32, P14685, DOI 10.1523/JNEUROSCI.2493-12.2012; Sadeghi SG, 2011, J NEUROPHYSIOL, V105, P661, DOI 10.1152/jn.00788.2010; Shanidze N, 2012, J NEUROPHYSIOL, V107, P2260, DOI 10.1152/jn.00314.2011; SUZUKI JI, 1964, EXP NEUROL, V10, P393, DOI 10.1016/0014-4886(64)90031-7; Sylvestre PA, 1999, J NEUROPHYSIOL, V82, P2612, DOI 10.1152/jn.1999.82.5.2612; Thompson LA, 2012, J VESTIBUL RES-EQUIL, V22, P11, DOI 10.3233/VES-2012-0442; Tullio P, 1929, OHR ENTSTEHUNG SPRAC; Wellenius GA, 2000, EXP BRAIN RES, V133, P139, DOI 10.1007/s002210000369; Xiang YQ, 2008, J NEUROPHYSIOL, V100, P763, DOI 10.1152/jn.90256.2008; ZANGEMEISTER WH, 1981, BIOL CYBERN, V41, P19, DOI 10.1007/BF01836124	53	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78767	10.1371/journal.pone.0078767	http://dx.doi.org/10.1371/journal.pone.0078767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147142	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200101
J	Barbour, A; Philip, K; Muniandy, S				Barbour, Abdelahhad; Philip, Koshy; Muniandy, Sekaran			Enhanced Production, Purification, Characterization and Mechanism of Action of Salivaricin 9 Lantibiotic Produced by Streptococcus salivarius NU10	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; NISIN PRODUCTION; SUPPLEMENTED WHEY; PH PROFILES; BIOSYNTHESIS; BACTERIOCIN; INHIBITION; MODE; CELL; AUTOREGULATION	Background: Lantibiotics are small lanthionine-containing bacteriocins produced by lactic acid bacteria. Salivaricin 9 is a newly discovered lantibiotic produced by Streptococcus salivarius. In this study we present the mechanism of action of salivaricin 9 and some of its properties. Also we developed new methods to produce and purify the lantibiotic from strain NU10. Methodology / Principal Findings: Salivaricin 9 was found to be auto-regulated when an induction assay was applied and this finding was used to develop a successful salivaricin 9 production system in liquid medium. A combination of XAD-16 and cation exchange chromatography was used to purify the secondary metabolite which was shown to have a molecular weight of approximately 3000 Da by SDS-PAGE. MALDI-TOF MS analysis indicated the presence of salivaricin 9, a 2560 Da lantibiotic. Salivaricin 9 is a bactericidal molecule targeting the cytoplasmic membrane of sensitive cells. The membrane permeabilization assay showed that salivaricin 9 penetrated the cytoplasmic membrane and induced pore formation which resulted in cell death. The morphological changes of test bacterial strains incubated with salivaricin 9 were visualized using Scanning Electron Microscopy which confirmed a pore forming mechanism of inhibition. Salivaricin 9 retained biological stability when exposed to high temperature (90-100 degrees C) and stayed bioactive at pH ranging 2 to 10. When treated with proteinase K or peptidase, salivaricin 9 lost all antimicrobial activity, while it remained active when treated with lyticase, catalase and certain detergents. Conclusion: The mechanism of antimicrobial action of a newly discovered lantibiotic salivaricin 9 was elucidated in this study. Salivaricin 9 penetrated the cytoplasmic membrane of its targeted cells and induced pore formation. This project has given new insights on lantibiotic peptides produced by S. salivarius isolated from the oral cavities of Malaysian subjects.	[Barbour, Abdelahhad; Philip, Koshy] Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia; [Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Philip, K (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia.	kphil@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; Barbour, Abdelahhad/AAG-1953-2021; PHILIP, Koshy/B-8803-2010; Barbour, Abdelahhad/C-5168-2015	MUNIANDY, SEKARAN/0000-0003-1310-3634; Barbour, Abdelahhad/0000-0003-0184-8890	University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education [UM.C/625/1/HIR/MOHE/SC/08]	University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education	The authors wish to acknowledge the support by way of facilities from University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education grant designated as UM.C/625/1/HIR/MOHE/SC/08 with account F000008-21001 under the Principal Investigator Koshy Philip for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1995, INT J FOOD MICROBIOL, V28, P169, DOI 10.1016/0168-1605(95)00055-0; Al-Mahrous MM, 2011, EXPERT OPIN DRUG DIS, V6, P155, DOI 10.1517/17460441.2011.545387; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Bourbon C, 2008, ANAL BIOCHEM, V381, P279, DOI 10.1016/j.ab.2008.07.005; Chehimi S, 2010, CAN J MICROBIOL, V56, P162, DOI [10.1139/W09-125, 10.1139/w09-125]; Cheigh CI, 2005, BIOTECHNOL LETT, V27, P155, DOI 10.1007/s10529-004-7661-3; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chung W, 2000, INT J FOOD MICROBIOL, V60, P25, DOI 10.1016/S0168-1605(00)00330-5; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Flores SH, 2001, BIOTECHNOL APPL BIOC, V34, P103, DOI 10.1042/BA20010030; Furmanek B, 1999, J APPL MICROBIOL, V87, P856, DOI 10.1046/j.1365-2672.1999.00937.x; GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x; Gonzalez-Toledo SY, 2010, J FOOD SCI, V75, pM347, DOI 10.1111/j.1750-3841.2010.01670.x; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Klocke M, 2005, APPL MICROBIOL BIOT, V67, P532, DOI 10.1007/s00253-004-1838-5; Knerr PJ, 2012, ACS CHEM BIOL, V7, P1791, DOI 10.1021/cb300372b; KORDEL M, 1989, FEBS LETT, V244, P99, DOI 10.1016/0014-5793(89)81171-8; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee JH, 2011, APPL ENVIRON MICROB, V77, P5879, DOI 10.1128/AEM.00571-11; Liu W, 2010, APPL MICROBIOL BIOT, V85, P1401, DOI 10.1007/s00253-009-2217-z; Lv WH, 2005, APPL MICROBIOL BIOT, V68, P322, DOI 10.1007/s00253-005-1892-7; Moll GN, 1996, ANTON LEEUW INT J G, V69, P185, DOI 10.1007/BF00399423; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Ni JQ, 2011, APPL ENVIRON MICROB, V77, P407, DOI 10.1128/AEM.01278-10; Nicolas GG, 2011, BMC MICROBIOL, V11, P1, DOI [10.1186/1471-2180-11-1, DOI 10.1186/1471-2180-11-1]; Papagianni M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-3; Perin LM, 2012, FOLIA MICROBIOL, V57, P183, DOI 10.1007/s12223-012-0113-x; Pongtharangkul T, 2006, APPL MICROBIOL BIOT, V73, P73, DOI 10.1007/s00253-006-0459-6; Qi FX, 2000, APPL ENVIRON MICROB, V66, P3221, DOI 10.1128/AEM.66.8.3221-3229.2000; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; SAHL HG, 1994, APPL ENVIRON MICROB, V60, P752, DOI 10.1128/AEM.60.2.752-755.1994; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SPYR CA, 1995, FEBS LETT, V375, P134, DOI 10.1016/0014-5793(95)01197-M; Swe PM, 2009, J ANTIMICROB CHEMOTH, V63, P679, DOI 10.1093/jac/dkn552; Tiwari SK, 2008, APPL MICROBIOL BIOT, V79, P759, DOI 10.1007/s00253-008-1482-6; Tolonen M, 2004, APPL MICROBIOL BIOT, V63, P659, DOI 10.1007/s00253-003-1413-5; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; Wan X, 2013, APPL MICROBIOL BIOT, V97, P3509, DOI 10.1007/s00253-012-4406-4; Wescombe PA, 2011, MICROBIOL-SGM, V157, P1290, DOI 10.1099/mic.0.044719-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe Philip A, 2012, Int J Microbiol, V2012, P738503, DOI 10.1155/2012/738503; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wilson-Stanford Shawanda, 2011, Recent Pat Antiinfect Drug Discov, V6, P175; Zendo T, 2010, APPL MICROBIOL BIOT, V88, P1, DOI 10.1007/s00253-010-2764-3; Zhao M, 2011, AMINO ACIDS, V41, P1071, DOI 10.1007/s00726-009-0386-9	50	36	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77751	10.1371/journal.pone.0077751	http://dx.doi.org/10.1371/journal.pone.0077751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147072	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400132
J	de Chiara, C; Menon, RP; Kelly, G; Pastore, A				de Chiara, Cesira; Menon, Rajesh P.; Kelly, Geoff; Pastore, Annalisa			Protein-Protein Interactions as a Strategy towards Protein-Specific Drug Design: The Example of Ataxin-1	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; AXH DOMAIN; SPINOCEREBELLAR ATAXIA; NEURODEGENERATIVE DISEASE; FUNCTIONAL INTERACTIONS; REPRESSOR CAPICUA; SCA1; AGGREGATION; NMR; TYPE-1	A main challenge for structural biologists is to understand the mechanisms that discriminate between molecular interactions and determine function. Here, we show how partner recognition of the AXH domain of the transcriptional coregulator ataxin-1 is fine-tuned by a subtle balance between self-and hetero-associations. Ataxin-1 is the protein responsible for the hereditary spinocerebellar ataxia type 1, a disease linked to protein aggregation and transcriptional dysregulation. Expansion of a polyglutamine tract is essential for ataxin-1 aggregation, but the sequence-wise distant AXH domain plays an important aggravating role in the process. The AXH domain is also a key element for non-aberrant function as it intervenes in interactions with multiple protein partners. Previous data have shown that AXH is dimeric in solution and forms a dimer of dimers when crystallized. By solving the structure of a complex of AXH with a peptide from the interacting transcriptional repressor CIC, we show that the dimer interface of AXH is displaced by the new interaction and that, when blocked by the CIC peptide AXH aggregation and misfolding are impaired. This is a unique example in which palindromic self-and hetero-interactions within a sequence with chameleon properties discriminate the partner. We propose a drug design strategy for the treatment of SCA1 that is based on the information gained from the AXH/CIC complex.	[de Chiara, Cesira; Menon, Rajesh P.; Pastore, Annalisa] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Kelly, Geoff] Med Res Council Biomed NMR Ctr, London, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Pastore, A (corresponding author), Natl Inst Med Res, Med Res Council, Mill Hill, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		de Chiara, Cesira/0000-0002-9766-2515	MRC [U117584256]; MRC [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_PC_13054, MC_U117533887] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the MRC (Grant ref. U117584256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2005, STRUCTURE, V13, P743, DOI 10.1016/j.str.2005.02.016; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2013, BIOMOL NMR ASSIGN; de Chiara C, 2013, BIOPHYS J, V104, P1304, DOI 10.1016/j.bpj.2013.01.048; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fryer JD, 2011, SCIENCE, V334, P690, DOI 10.1126/science.1212673; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kim E, 2013, GENE DEV, V27, P590, DOI 10.1101/gad.212068.112; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Masino L, 2004, PROTEIN PEPTIDE LETT, V11, P239, DOI 10.2174/0929866043407147; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RAMACHANDRAN GN, 1971, BIOPOLYMERS, V10, P2113, DOI 10.1002/bip.360101108; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Sardiu ME, 2011, J BIOL CHEM, V286, P23645, DOI 10.1074/jbc.R110.174052; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang ZM, 2013, ANGEW CHEM INT EDIT, V52, P562, DOI 10.1002/anie.201206561; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zen A, 2009, BIOINFORMATICS, V25, P1876, DOI 10.1093/bioinformatics/btp339; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76456	10.1371/journal.pone.0076456	http://dx.doi.org/10.1371/journal.pone.0076456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155902	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300036
J	Kato, T; Zhou, X; Ma, Y				Kato, Toshiaki; Zhou, Xin; Ma, Yan			Possible Involvement of Nitric Oxide and Reactive Oxygen Species in Glucose Deprivation-Induced Activation of Transcription Factor Rst2	PLOS ONE			English	Article							REGULATES CELL INTEGRITY; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; S-NITROSYLATION; HYDROGEN-PEROXIDE; MAP KINASE; THIOREDOXIN; STRESS; GENE	Glucose is one of the most important sources of cellular nutrition and glucose deprivation induces various cellular responses. In Schizosaccharomyces pombe, zinc finger protein Rst2 is activated upon glucose deprivation, and regulates gene expression via the STREP (stress response element of Schizosaccharomyces pombe) motif. However, the activation mechanism of Rst2 is not fully understood. We monitored Rst2 transcriptional activity in living cells using a Renilla luciferase reporter system. Hydrogen peroxide (H2O2) enhanced Rst2 transcriptional activity upon glucose deprivation and free radical scavenger inhibited Rst2 transcriptional activity upon glucose deprivation. In addition, deletion of the trx2(+) gene encoding mitochondrial thioredoxin enhanced Rst2 transcriptional activity. Notably, nitric oxide (NO) generators enhanced Rst2 transcriptional activity upon glucose deprivation as well as under glucose-rich conditions. Furthermore, NO specific scavenger inhibited Rst2 transcriptional activity upon glucose deprivation. Altogether, our data suggest that NO and reactive oxygen species may be involved in the activation of transcription factor Rst2.	[Kato, Toshiaki; Zhou, Xin; Ma, Yan] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Jinzhou, Liaoning Provin, Peoples R China	Kobe University; Jinzhou Medical University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [21790241]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Cao BJ, 2002, EUR J PHARMACOL, V448, P27, DOI 10.1016/S0014-2999(02)01908-8; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ferretti AC, 2012, MOL GENET METAB, V105, P186, DOI 10.1016/j.ymgme.2011.11.007; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; HOFFMAN CS, 1990, GENETICS, V124, P807; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Kig C, 2009, PROTOPLASMA, V238, P59, DOI 10.1007/s00709-009-0074-3; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Koike A, 2012, J BIOL CHEM, V287, P19294, DOI 10.1074/jbc.M111.310615; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; MAEDA T, 1994, J BIOL CHEM, V269, P9632; McConell GK, 2012, AM J PHYSIOL-ENDOC M, V303, pE301, DOI 10.1152/ajpendo.00667.2011; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sengupta R, 2012, BBA-GEN SUBJECTS, V1820, P689, DOI 10.1016/j.bbagen.2011.08.012; Song JY, 2008, J MICROBIOL, V46, P408, DOI 10.1007/s12275-008-0076-4; Song JY, 2008, EUKARYOT CELL, V7, P2160, DOI 10.1128/EC.00106-08; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Toda T, 1996, MOL CELL BIOL, V16, P6752; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78012	10.1371/journal.pone.0078012	http://dx.doi.org/10.1371/journal.pone.0078012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155978	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300112
J	Rozsas, A; Berta, J; Rojko, L; Horvath, LZ; Keszthelyi, M; Kenessey, I; Laszlo, V; Berger, W; Grusch, M; Hoda, MA; Torok, S; Klepetko, W; Renyi-Vamos, F; Hegedus, B; Dome, B; Tovari, J				Rozsas, Anita; Berta, Judit; Rojko, Livia; Horvath, Laszlo Z.; Keszthelyi, Magdolna; Kenessey, Istvan; Laszlo, Viktoria; Berger, Walter; Grusch, Michael; Hoda, Mir Alireza; Torok, Szilvia; Klepetko, Walter; Renyi-Vamos, Ferenc; Hegedus, Balazs; Doeme, Balazs; Tovari, Jozsef			Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; STIMULATING AGENTS; TUMOR-CELLS; IN-VITRO; CANCER; GROWTH; XENOGRAFT; SURVIVAL; HYPOXIA; IMPACT	Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling in human non-small cell lung cancer (NSCLC) also remains controversial, our aim was to study whether EPO treatment modifies tumor growth and if EPOR expression has an impact on the clinical behavior of this malignancy. A total of 43 patients with stage III-IV adenocarcinoma (ADC) and complete clinicopathological data were included. EPOR expression in human ADC samples and cell lines was measured by quantitative real-time polymerase chain reaction. Effects of exogenous rHuEPO alpha were studied on human lung ADC cell lines in vitro. In vivo growth of human ADC xenografts treated with rHuEPO alpha with or without chemotherapy was also assessed. In vivo tumor and endothelial cell (EC) proliferation was determined by 5-bromo-2'-deoxy-uridine (BrdU) incorporation and immunofluorescent labeling. Although EPOR mRNA was expressed in all of the three investigated ADC cell lines, rHuEPO alpha treatment (either alone or in combination with gemcitabine) did not alter ADC cell proliferation in vitro. However, rHuEPO alpha significantly decreased tumor cell proliferation and growth of human H1975 lung ADC xenografts. At the same time, rHuEPO alpha treatment of H1975 tumors resulted in accelerated tumor endothelial cell proliferation. Moreover, in patients with advanced stage lung ADC, high intratumoral EPOR mRNA levels were associated with significantly increased overall survival. This study reveals high EPOR level as a potential novel positive prognostic marker in human lung ADC.	[Rozsas, Anita; Berta, Judit; Keszthelyi, Magdolna; Torok, Szilvia; Doeme, Balazs; Tovari, Jozsef] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Rojko, Livia] Natl Koranyi Inst Pulmonol, Dept Bronchoscopy, Budapest, Hungary; [Rozsas, Anita; Laszlo, Viktoria; Hoda, Mir Alireza; Klepetko, Walter; Renyi-Vamos, Ferenc; Hegedus, Balazs; Doeme, Balazs] Med Univ Vienna, Div Thorac Surg, Vienna, Austria; [Kenessey, Istvan; Hegedus, Balazs; Doeme, Balazs] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Berger, Walter; Grusch, Michael; Hoda, Mir Alireza] Med Univ Vienna, Inst Canc Res, Dept Internal Med 1, Vienna, Austria; [Horvath, Laszlo Z.; Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Renyi-Vamos, Ferenc; Doeme, Balazs] Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Torok, Szilvia] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Medical University of Vienna; Semmelweis University; Medical University of Vienna; National Institute of Oncology Hungary; National Institute of Oncology Hungary; Lund University	Dome, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary.	balazs.dome@meduniwien.ac.at; tozsi@oncol.hu	Hegedus, Balazs/B-6076-2008; Grusch, Michael/C-1183-2008; Keszthelyi, Magdolna/E-6424-2017; laszlo, viktoria/A-4667-2017	Hegedus, Balazs/0000-0002-4341-4153; Grusch, Michael/0000-0001-5486-9340; Keszthelyi, Magdolna/0000-0001-9148-7675; laszlo, viktoria/0000-0002-6567-3965; Dome, Balazs/0000-0001-8799-8624; Berger, Walter/0000-0003-0014-1658	Tarsadalmi Megujulas Operativ Program [424A/1-11-1-2012-0001]; Orszagos Tudomanyos Kutatasi Alap (OTKA) [K109626, OTKA K108465]; Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban [12-1-2013-0041]; Hungarian Oncological Association; Hungarian Pulmonology Foundation	Tarsadalmi Megujulas Operativ Program; Orszagos Tudomanyos Kutatasi Alap (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban; Hungarian Oncological Association; Hungarian Pulmonology Foundation	This work was supported by the Tarsadalmi Megujulas Operativ Program 424A/1-11-1-2012-0001; Orszagos Tudomanyos Kutatasi Alap (OTKA) K109626, OTKA K108465 (BD); Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban 12-1-2013-0041 (BD, JT, FRV). OTKA K76293, K84173 (JT); OTKA MOB (OTKA - Mobilitas Palyazat) 80325 (BH); AR is recipient of an European Association for Cancer Research travel fellowship. JB is recipient of a research fellowship of the Hungarian Oncological Association for PhD students. ST is recipient of an Hungarian Pulmonology Foundation research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2012, BRIT J CANCER, V106, P1249, DOI 10.1038/bjc.2012.42; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; BERDEL WE, 1991, ANN HEMATOL, V63, P5, DOI 10.1007/BF01714953; BERDEL WE, 1992, SEMIN ONCOL, V19, P41; Bertalanffy P, 1999, CLIN CHEM LAB MED, V37, P259, DOI 10.1515/CCLM.1999.045; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Brown WM, 2007, STEM CELLS, V25, P718, DOI 10.1634/stemcells.2006-0687; Bugyik E, 2011, J NEUROPATH EXP NEUR, V70, P979, DOI 10.1097/NEN.0b013e318233afd7; Carvalho G, 2005, ONCOGENE, V24, P737, DOI 10.1038/sj.onc.1208205; Crawford J, 2006, J THORAC ONCOL, V1, P716; Dagnon K, 2005, CLIN CANCER RES, V11, P993; Dezso K, 2009, AM J PATHOL, V175, P835, DOI 10.2353/ajpath.2009.090095; Dome B, 2003, J NEUROPATH EXP NEUR, V62, P655; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Dunlop EA, 2006, NEURODEGENER DIS, V3, P94, DOI 10.1159/000092099; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; Fandrey J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S3-16; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; July LV, 2004, MOL CANCER THER, V3, P223; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kelly K, 2008, J THORAC ONCOL, V3, P664, DOI 10.1097/JTO.0b013e3181758141; Lovey J, 2008, STRAHLENTHER ONKOL, V184, P1, DOI 10.1007/s00066-008-1745-2; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; MUNDT D, 1992, ARZNEIMITTELFORSCH, V42-1, P92; NAKAMURA Y, 1992, SCIENCE, V257, P1138, DOI 10.1126/science.257.5073.1138; Paul I, 2006, LUNG CANCER-J IASLC, V51, P329, DOI 10.1016/j.lungcan.2005.10.020; Rades D, 2011, INT J RADIAT ONCOL, V80, P499, DOI 10.1016/j.ijrobp.2010.02.003; ROSTI V, 1993, HAEMATOLOGICA, V78, P208; Saintigny P, 2007, CLIN CANCER RES, V13, P4825, DOI 10.1158/1078-0432.CCR-06-3061; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; Tovari J, 2008, CURR MOL MED, V8, P481, DOI 10.2174/156652408785747979; Vansteenkiste J, 2012, LUNG CANCER, V76, P478, DOI 10.1016/j.lungcan.2011.12.015; Wu Y, 2005, ANTI-CANCER DRUG, V16, P551, DOI 10.1097/00001813-200506000-00011; Yasuda Y, 2010, ANAT SCI INT, V85, P204, DOI 10.1007/s12565-010-0081-7	37	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77459	10.1371/journal.pone.0077459	http://dx.doi.org/10.1371/journal.pone.0077459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155958	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300092
J	Ren, YY; Overmyer, KA; Qi, NR; Treutelaar, MK; Heckenkamp, L; Kalahar, M; Koch, LG; Britton, SL; Burant, CF; Li, JZ				Ren, Yu-yu; Overmyer, Katherine A.; Qi, Nathan R.; Treutelaar, Mary K.; Heckenkamp, Lori; Kalahar, Molly; Koch, Lauren G.; Britton, Steven L.; Burant, Charles F.; Li, Jun Z.			Genetic Analysis of a Rat Model of Aerobic Capacity and Metabolic Fitness	PLOS ONE			English	Article							ENDURANCE RUNNING CAPACITY; QUANTITATIVE TRAIT LOCI; ALL-CAUSE MORTALITY; EXERCISE CAPACITY; CARDIORESPIRATORY FITNESS; ARTIFICIAL SELECTION; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; INBRED STRAINS; RISK	Aerobic capacity is a strong predictor of all-cause mortality and can influence many complex traits. To explore the biological basis underlying this connection, we developed via artificial selection two rat lines that diverge for intrinsic (i.e. inborn) aerobic capacity and differ in risk for complex disease traits. Here we conduct the first in-depth pedigree and molecular genetic analysis of these lines, the high capacity runners (HCR) and low capacity runners (LCR). Our results show that both HCR and LCR lines maintain considerable narrow-sense heritability (h(2)) for the running capacity phenotype over 28 generations (h(2) = 0.47 +/- 0.02 and 0.43 +/- 0.02, respectively). To minimize inbreeding, the lines were maintained by rotational mating. Pedigree records predict that the inbreeding coefficient increases at a rate of <1% per generation, similar to 37-38% slower than expected for random mating. Genome-wide 10K SNP genotype data for generations 5, 14, and 26 demonstrate substantial genomic evolution: between-line differentiation increased progressively, while within-line diversity deceased. Genome-wide average heterozygosity decreased at a rate of <1% per generation, consistent with pedigree-based predictions and confirming the effectiveness of rotational breeding. Linkage disequilibrium index r(2) decreases to 0.3 at similar to 3 Mb, suggesting that the resolution for mapping quantitative trait loci (QTL) can be as high as 2-3 cM. To establish a test population for QTL mapping, we conducted an HCR-LCR intercross. Running capacity of the F1 population (n=176) was intermediate of the HCR and LCR parentals (28 pairs); and the F2 population (n=645) showed a wider range of phenotypic distribution. Importantly, heritability in the F0-F2 pedigree remained high (h(2)similar to 0.6). These results suggest that the HCR-LCR lines can serve as a valuable system for studying genomic evolution, and a powerful resource for mapping QTL for a host of characters relevant to human health.	[Ren, Yu-yu; Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Overmyer, Katherine A.; Qi, Nathan R.; Treutelaar, Mary K.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Heckenkamp, Lori; Kalahar, Molly; Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, JZ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	junzli@med.umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Li, Jun/0000-0001-6727-0812	Ellison Medical Foundation; Michigan Diabetes Research Center; National Institute of Diabetes & Digestive & Kidney Diseases [NIH5P60 DK20572]; National Institutes of Health [RO1 DK077200]; University of Michigan Animal Phenotyping Core; Michigan Nutrition Obesity Research Center [DK 089503]; Michigan Diabetes Research and Training Center [NIH5P60 DK20572]; National Center for Research Resources [R24 RR017718]; Office of Research Infrastructure Programs/OD grant from the National Institutes of Health [ROD012098A]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200, P60DK020572, P30DK089503, P30DK020572, R01DK099034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Michigan Diabetes Research Center; National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Animal Phenotyping Core; Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a New Scholar in Aging award (J.Z.L) from the Ellison Medical Foundation and a pilot grant (J.Z.L) from the Michigan Diabetes Research Center, funded by NIH5P60 DK20572 from the National Institute of Diabetes & Digestive & Kidney Diseases. This work is also supported by National Institutes of Health grants RO1 DK077200 (C. F. B.) and the University of Michigan Animal Phenotyping Core, supported by Michigan Nutrition Obesity Research Center (DK 089503) and Michigan Diabetes Research and Training Center (NIH5P60 DK20572). The LCR-HCR rat model system was funded by the National Center for Research Resources grant R24 RR017718 and is currently supported by the Office of Research Infrastructure Programs/OD grant ROD012098A (to L. G. K. and S. L. B.) from the National Institutes of Health. Contact L. G. K. (lgkoch@med.umich.edu) or S. L. B. (brittons@umich.edu) for information on the LCR and HCR rats, which are maintained as an international collaborative resource at the University of Michigan, Ann Arbor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2010, R LANG ENV STAT COMP; Barbato JC, 1998, J APPL PHYSIOL, V85, P530, DOI 10.1152/jappl.1998.85.2.530; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bastiaansen JWM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-3; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouchard C, 2000, J APPL PHYSIOL, V88, P551, DOI 10.1152/jappl.2000.88.2.551; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Bray MS, 2000, J APPL PHYSIOL, V88, P788, DOI 10.1152/jappl.2000.88.2.788; Bunger L, 1999, MAMM GENOME, V10, P645, DOI 10.1007/s003359901063; Burghardt PR, 2011, NEUROPSYCHOPHARMACOL, V36, P390, DOI 10.1038/npp.2010.144; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Castle W E, 1921, Science, V54, P223, DOI 10.1126/science.54.1393.223; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; ENGSTROM LM, 1977, ACTA GENET MED GEMEL, V26, P159, DOI 10.1017/S0001566000009958; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARID A, 1987, THEOR APPL GENET, V73, P506, DOI 10.1007/BF00289187; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; HOWALD H, 1976, ANN HUM BIOL, V3, P455, DOI 10.1080/03014467600001721; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Johannesson M, 2009, GENOME RES, V19, P150, DOI 10.1101/gr.081497.108; Kaprio J, 1981, Prog Clin Biol Res, V69 Pt C, P37; KLISSOUR.V, 1971, J APPL PHYSIOL, V31, P338, DOI 10.1152/jappl.1971.31.3.338; Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Leeper NJ, 2013, J VASC SURG, V57, P728, DOI 10.1016/j.jvs.2012.07.051; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Lujan HL, 2006, AM J PHYSIOL-HEART C, V291, pH2933, DOI 10.1152/ajpheart.00514.2006; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Muncey AR, 2010, ANESTHESIOLOGY, V113, P1176, DOI 10.1097/ALN.0b013e3181f56248; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Nomura T, 1996, GENET SEL EVOL, V28, P141, DOI 10.1051/gse:19960202; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; PRUDHOMME D, 1984, MED SCI SPORT EXER, V16, P489, DOI 10.1249/00005768-198410000-00012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SIMONEAU JA, 1986, INT J SPORTS MED, V7, P167, DOI 10.1055/s-2008-1025756; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; Valdar WSJ, 2003, MAMM GENOME, V14, P830, DOI 10.1007/s00335-003-3021-1; Wikgren J, 2012, PHYSIOL BEHAV, V106, P95, DOI 10.1016/j.physbeh.2012.01.011; Windig JJ, 2008, ANIMAL, V2, P1733, DOI 10.1017/S1751731108003029; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wright S., 1968, GENETIC BIOMETRIC FD	58	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77588	10.1371/journal.pone.0077588	http://dx.doi.org/10.1371/journal.pone.0077588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147032	Green Published, gold			2022-12-25	WOS:000325819400128
J	Sun, XJ; Qiu, JJ; Zhu, ST; Cao, BW; Sun, L; Li, S; Li, P; Zhang, ST; Dong, S				Sun, Xiujing; Qiu, Jihui Julia; Zhu, Shengtao; Cao, Bangwei; Sun, Lin; Li, Sen; Li, Peng; Zhang, Shutian; Dong, Shuo			Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INHIBITION; CANCER; GENE; METHYLATION; EXPRESSION; DISEASE	Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. It has been reported that histone demethylases are involved in the carcinogenesis of certain types of tumors. Here, we studied the role of one of the histone lysine demethylases, plant homeodomain finger protein 8 (PHF8), in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). Using short hairpin RNA via lentiviral infection, we established stable ESCC cell lines with constitutive downregulation of PHF8 expression. Knockdown of PHF8 in ESCC cells resulted in inhibition of cell proliferation and an increase of apoptosis. Moreover, there were reductions of both anchorage-dependent and -independent colony formation. In vitro migration and invasion assays showed that knockdown of PHF8 led to a reduction in the number of migratory and invasive cells. Furthermore, downregulation of PHF8 attenuated the tumorigenicity of ESCC cells in vivo. Taken together, our study revealed the oncogenic features of PHF8 in ESCC, suggesting that PHF8 may be a potential diagnostic marker and therapeutic target for ESCC.	[Sun, Xiujing; Qiu, Jihui Julia; Sun, Lin; Li, Sen; Dong, Shuo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Sun, Xiujing; Qiu, Jihui Julia; Sun, Lin; Li, Sen; Dong, Shuo] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Sun, Xiujing; Zhu, Shengtao; Li, Peng; Zhang, Shutian] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Qiu, Jihui Julia] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA; [Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Capital Medical University	Dong, S (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	sdong@bcm.edu			Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine; National Natural Science Foundation of China [81272447]; National Key Basic Research Program of China [2012CB526600]	Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by the Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine, the National Natural Science Foundation of China (81272447), and the National Key Basic Research Program of China (2012CB526600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072335; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lim HJ, 2013, MOL CELL BIOL; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Lynch JT, 2012, EXPERT OPIN THER TAR, V16, P1239, DOI 10.1517/14728222.2012.722206; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Meng XY, 2011, DIS ESOPHAGUS, V24, P444, DOI 10.1111/j.1442-2050.2010.01159.x; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Meng Y, 2011, DIGEST DIS SCI, V56, P3195, DOI 10.1007/s10620-011-1734-7; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shi HY, 2011, CANCER LETT, V309, P19, DOI 10.1016/j.canlet.2011.05.010; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Yang ZQ, 2000, CANCER RES, V60, P4735; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zhao SL, 2011, DIS ESOPHAGUS, V24, P601, DOI 10.1111/j.1442-2050.2011.01199.x; Zhao YQ, 2013, INT J CANCER, V132, P2901, DOI 10.1002/ijc.27954	31	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77353	10.1371/journal.pone.0077353	http://dx.doi.org/10.1371/journal.pone.0077353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146981	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400111
J	Qi, Q; Liu, X; Brat, DJ; Ye, K				Qi, Q.; Liu, X.; Brat, D. J.; Ye, K.			Merlin sumoylation is required for its tumor suppressor activity	ONCOGENE			English	Article						Akt; merlin; NF2; sumoylation; tumor suppressor	PLASMA-MEMBRANE; FERM DOMAIN; RECEPTOR ENDOCYTOSIS; P21-ACTIVATED KINASE; AKT PHOSPHORYLATION; SUMO-1 MODIFICATION; GROWTH SUPPRESSION; CELL MOTILITY; GENE-PRODUCT; NF2	Merlin, encoded by the Neurofibromatosis 2 (NF2) gene, is a multifunctional tumor suppressor that integrates and regulates extracellular cues and intracellular signaling pathways, both at the plasma membrane and in the nucleus, to control cell proliferation, migration and invasion. Molecular mechanisms regulating merlin's tumor-suppressive activity have not been clearly defined. Here we report that merlin can be sumoylated on Lysine residue (K76) in vitro and in vivo. Sumoylation mediates merlin's intramolecular and intermolecular binding activities and regulates its cytoplasm/nucleus trafficking. Interestingly, sumoylation of merlin is regulated by its phosphorylation via Akt and PAK2 kinases. Mutation of K76 into arginine (R) abolishes its sumoylation, disrupts merlin cortical cytoskeleton residency and attenuates its stability. Using a K76R mutant merlin in a subcutaneous U87MG xenograft model, we demonstrate that merlin sumoylation is required for tumor-suppressive activity. Taken together, our findings indicate that merlin is sumoylated and that this post-translational modification is essential for tumor suppression.	[Qi, Q.; Liu, X.; Brat, D. J.; Ye, K.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Ye, K (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Room 141,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			National Cancer Institute, National Institutes of Health R01 [CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health R01; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal Funds from the National Cancer Institute, National Institutes of Health R01 (CA127119 to K Ye). We thank Dr Jolinda Traugh for providing various PAK2 plasmids.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Brault E, 2001, J CELL SCI, V114, P1901; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; de Cristofaro T, 2009, J MOL ENDOCRINOL, V42, P35, DOI 10.1677/JME-08-0100; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Evans DGR, 2011, ADV OTO-RHINO-LARYNG, V70, P91, DOI 10.1159/000322482; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Gutmann DH, 1999, J NEUROSCI RES, V58, P706, DOI 10.1002/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.3.CO;2-Q; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Kressel M, 2002, HUM MOL GENET, V11, P2269, DOI 10.1093/hmg/11.19.2269; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Lu JR, 2008, LARYNGOSCOPE, V118, P169, DOI 10.1097/MLG.0b013e3181566594; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mani T, 2011, MOL CELL BIOL, V31, P1983, DOI 10.1128/MCB.00609-10; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Merrill JC, 2010, J MOL BIOL, V398, P657, DOI 10.1016/j.jmb.2010.03.048; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Okada M, 2009, CANCER RES, V69, P4043, DOI 10.1158/0008-5472.CAN-08-3931; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Trofatter J A, 1993, Cell, V75, P826; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wei BL, 2005, J VIROL, V79, P14976, DOI 10.1128/JVI.79.23.14976-14980.2005; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238	63	12	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4893	4903		10.1038/onc.2013.438	http://dx.doi.org/10.1038/onc.2013.438			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24166499				2022-12-25	WOS:000343767900002
J	Erkan, EP; Strobel, T; Lewandrowski, G; Tannous, B; Madlener, S; Czech, T; Saydam, N; Saydam, O				Erkan, E. P.; Stroebel, T.; Lewandrowski, G.; Tannous, B.; Madlener, S.; Czech, T.; Saydam, N.; Saydam, O.			Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo	ONCOGENE			English	Article						glioblastoma multiforme; minichromosome maintenance; MCM7; the cancer genome atlas; prognostic marker	CELL LUNG-CANCER; MCM PROTEINS; DNA-REPLICATION; PROGNOSTIC-SIGNIFICANCE; PHOSPHORYLATION; IDENTIFICATION; MARKER; FAMILY; PROLIFERATION; INITIATION	Minichromosome maintenance (MCM) proteins are key elements that function as a part of the pre-replication complex to initiate DNA replication in eukaryotes. Consistent with their roles in initiating DNA replication, overexpression of MCM family members has been observed in several malignancies. Through bioinformatic analysis of The Cancer Genome Atlas's data on glioblastoma multiforme (GBM), we found that the genomic region containing MCM7 gene was amplified in more than 80% of the present cases. To validate this finding and to identify the possible contribution of the remaining members of the MCM family to GBM progression, we used quantitative real-time PCR to analyze the gene expression profiles of all MCM family members in Grade IV (GBM) tissue samples and observed a significant upregulation in GBM samples compared with normal white matter tissues. In addition, we compared the observed gene expression profiles with those of Grade II and Grade III astrocytoma samples and determined that the observed upregulation was restricted and specific to Grade IV. MCM7 was the most upregulated gene in the gene set we analyzed, and therefore we wanted to identify the role of MCM7 in GBM progression. We determined that siRNA-mediated knockdown of MCM7 expression reduced GBM cell proliferation and also inhibited tumor growth in both xenograft and orthotopic mouse models of GBM. Taken together, our data suggest that MCM7 can be a potential prognostic marker and a novel therapeutic target in GBM therapy.	[Erkan, E. P.; Madlener, S.; Saydam, N.; Saydam, O.] Med Univ Vienna, Dept Pediat, Mol Neurooncol Res Unit, A-1090 Vienna, Austria; [Stroebel, T.] Med Univ Vienna, Inst Neurol, A-1090 Vienna, Austria; [Lewandrowski, G.; Tannous, B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Expt Therapeut & Mol Imaging Lab, Boston, MA USA; [Czech, T.] Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Harvard University; Harvard Medical School; Massachusetts General Hospital; Medical University of Vienna	Saydam, O (corresponding author), Med Univ Vienna, Dept Pediat, Mol Neurooncol Res Unit, A-1090 Vienna, Austria.	okay.saydam@meduniwien.ac.at	Saydam, Okay/HDM-4999-2022; Madlener, Sibylle/AAP-2541-2020; Erkan, Erdogan Pekcan/GQR-2513-2022; Erkan, Erdogan Pekcan/ABI-6822-2020	Erkan, Erdogan Pekcan/0000-0001-9287-4773; Madlener, Sibylle/0000-0001-7099-9997	Forschungsgesellschaft for Brain Tumors; EU-FP7-PEOPLE-CIG; Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind'	Forschungsgesellschaft for Brain Tumors; EU-FP7-PEOPLE-CIG; Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind'	This work was supported, in part, by Forschungsgesellschaft for Brain Tumors (OS, NS), EU-FP7-PEOPLE-2011-CIG (OS) and Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind' (OS and NS).	BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Facoetti A, 2006, ANTICANCER RES, V26, P3513; Facoetti A, 2006, ANTICANCER RES, V26, P1071; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Giaginis C, 2011, DIGEST DIS SCI, V56, P777, DOI 10.1007/s10620-010-1348-5; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Gruber-Olipitz M, 2006, CANCER LETT, V238, P76, DOI 10.1016/j.canlet.2005.06.024; Guida T, 2005, J CLIN ENDOCR METAB, V90, P4703, DOI 10.1210/jc.2004-2459; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Saydam O, 2005, MOL THER, V12, P803, DOI 10.1016/j.ymthe.2005.07.534; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Saydam O, 2010, J PROTEOME RES, V9, P485, DOI 10.1021/pr900834h; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Tamura T, 2010, J ORAL PATHOL MED, V39, P328, DOI 10.1111/j.1600-0714.2009.00861.x; The WHO, 2020, CLASSIFICATION TUMOU; Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yang J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-203; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222	39	30	32	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4778	4785		10.1038/onc.2013.423	http://dx.doi.org/10.1038/onc.2013.423			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24166506				2022-12-25	WOS:000343239500008
J	Gholami, S; Chen, CH; Lou, E; Belin, LJ; Fujisawa, S; Longo, VA; Chen, NG; Gonen, M; Zanzonico, PB; Szalay, AA; Fong, YM				Gholami, Sepideh; Chen, Chun-Hao; Lou, Emil; Belin, Laurence J.; Fujisawa, Sho; Longo, Valerie A.; Chen, Nanhai G.; Goenen, Mithat; Zanzonico, Pat B.; Szalay, Aladar A.; Fong, Yuman			Vaccinia virus GLV-1h153 in combination with I-131 shows increased efficiency in treating triple-negative breast cancer	FASEB JOURNAL			English	Article						symporter; radiation therapy	SODIUM-IODIDE SYMPORTER; DIFFERENTIATED THYROID-CARCINOMA; RADIOIODINE THERAPY; GENE-EXPRESSION; BONE METASTASES; NUDE-MICE; IN-VITRO; PAPILLARY; AGENT; LUNG	We investigated the therapeutic efficacy of a replication-competent oncolytic vaccinia virus, GLV-1h153, carrying human sodium iodide symporter (hNIS), in combination with radioiodine in an orthotopic triple-negative breast cancer (TNBC) murine model. In vitro viral infection was confirmed by immunoblotting and radioiodine uptake assays. Orthotopic xenografts (MDA-MB-231 cells) received intratumoral injection of GLV-1h153 or PBS. One week after viral injection, xenografts were randomized into 4 treatment groups: GLV-1h153 alone, GLV-1h153 and I-131 (approximate to 5 mCi), I-131 alone, or PBS, and followed for tumor growth. Kruskal-Wallis and Wilcoxon tests were performed for statistical analysis. Radiouptake assay showed a 178-fold increase of radioiodine uptake in hNIS-expressing infected cells compared with PBS control. Systemic I-131-iodide in combination with GLV-1h153 resulted in a 6-fold increase in tumor regression (24 compared to 146 mm(3) for the virus-only treatment group; P<0.05; d 40). We demonstrated that a novel vaccinia virus, GLV-1h153, expresses hNIS, increases the expression of the symporter in TNBC cells, and serves both as a gene marker for noninvasive imaging of virus and as a vehicle for targeted radionuclide therapy with I-131.Gholami, S., Chen, C-H., Lou, E., Belin, L. J., Fujisawa, S., Longo, V. A. Chen, N. G., Gonen, M., Zanzonico, P. B., Szalay, A. A., Fong, Y. Vaccinia virus GLV-1h153 in combination with I-131 shows increased efficiency in treating triple-negative breast cancer.	[Gholami, Sepideh; Chen, Chun-Hao; Belin, Laurence J.; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Fujisawa, Sho] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Longo, Valerie A.] Mem Sloan Kettering Canc Ctr, Small Anim Imaging Core Facil, New York, NY 10065 USA; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Zanzonico, Pat B.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA; [Zanzonico, Pat B.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Lou, Emil] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Dept Radiat Oncol, San Diego, CA 92103 USA; [Chen, Nanhai G.; Szalay, Aladar A.] Genelux Corp, San Diego, CA USA; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg; University of Wurzburg	Fong, YM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	Fongy@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Lou, Emil/0000-0002-1607-1386	William H. and Alice Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Flight Attendant's Medical Research Institute (FAMRI); Cycle for Survival; NATIONAL CANCER INSTITUTE [T32CA009501] Funding Source: NIH RePORTER	William H. and Alice Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Flight Attendant's Medical Research Institute (FAMRI); Cycle for Survival; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Jason Aguilar and Mesruh Turkekul for their excellent technical assistance. Technical services provided by the Research Animal Resource Center (RARC), the Molecular Cytology facilities, and the Small-Animal Imaging Core facilities at Memorial Sloan-Kettering Cancer Center are gratefully acknowledged. This work is supported by the William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center, the Flight Attendant's Medical Research Institute (FAMRI), and Cycle for Survival.	ALLWEISS P, 1984, J NUCL MED, V25, P755; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; BITTON R, 1993, J CLIN ENDOCR METAB, V77, P1423, DOI 10.1210/jc.77.5.1423; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Farina G P, 2000, G Chir, V21, P469; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gholami S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3404; Gholami S, 2012, ANN SURG, V256, P437, DOI 10.1097/SLA.0b013e3182654572; Gholami S, 2011, SURGERY, V150, P1040, DOI 10.1016/j.surg.2011.09.010; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; HALL P, 1991, BRIT J CANCER, V64, P159, DOI 10.1038/bjc.1991.261; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Lee YJ, 2004, THYROID, V14, P889; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; MAXON HR, 1990, ENDOCRIN METAB CLIN, V19, P685, DOI 10.1016/S0889-8529(18)30317-7; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mazzaferri EL, 1997, THYROID, V7, P265, DOI 10.1089/thy.1997.7.265; Rajecki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032871; Renier C, 2009, ANN SURG ONCOL, V16, P962, DOI 10.1245/s10434-008-0280-9; Robbins RJ, 2005, J NUCL MED, V46, p28S; SAMAAN NA, 1985, J CLIN ENDOCR METAB, V60, P376, DOI 10.1210/jcem-60-2-376; SCHLUMBERGER M, 1986, J CLIN ENDOCR METAB, V63, P960; Schlumberger M, 1996, J NUCL MED, V37, P598; SHERMAN SI, 1994, J CLIN ENDOCR METAB, V78, P629, DOI 10.1210/jc.78.3.629; Spitzweg C, 1998, J CLIN ENDOCR METAB, V83, P1746, DOI 10.1210/jc.83.5.1746; Spitzweg C, 2007, HUM GENE THER, V18, P916, DOI 10.1089/hum.2007.081; SWEENEY DC, 1995, ENDOCRIN METAB CLIN, V24, P803, DOI 10.1016/S0889-8529(18)30022-7; U.S. National Institutes of Health, 2008, SAF STUD GL ONC1 ONC; VANNOSTRAND D, 1986, J NUCL MED, V27, P1519; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	35	24	25	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					676	682		10.1096/fj.13-237222	http://dx.doi.org/10.1096/fj.13-237222			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24186964	Green Published			2022-12-25	WOS:000331072200015
J	Paramo, T; Piggot, TJ; Bryant, CE; Bond, PJ				Paramo, Teresa; Piggot, Thomas J.; Bryant, Clare E.; Bond, Peter J.			The Structural Basis for Endotoxin-induced Allosteric Regulation of the Toll-like Receptor 4 (TLR4) Innate Immune Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Endotoxin; Lipopolysaccharide (LPS); Molecular Dynamics; Toll-like receptors (TLRs); Hydrophobic Collapse; Lipid A; Myeloid Differentiation Factor 2 (MD-2)	MOLECULAR-DYNAMICS SIMULATIONS; FORCE-FIELD; LIPID-A; LIPOPOLYSACCHARIDE RECOGNITION; HYDROPHOBIC COLLAPSE; TERTIARY STRUCTURE; TLR4-MD-2 COMPLEX; HUMAN MD-2; PROTEINS; ANTAGONIST	Background: Toll-like receptor 4 (TLR4) in complex with MD-2 stimulates innate immunological pathways in response to bacterial lipopolysaccharide (LPS). Results: Molecular simulations reveal the mechanism of TLR4 complex signaling in response to agonists or antagonists. Conclusion: Conserved clamshell motions in MD-2 allosterically signal ligand-bound state via the conserved phenylalanine 126 residue to TLR4. Significance: The structural basis for molecular switching during endotoxin-induced TLR4 activation is revealed in atomic detail. As part of the innate immune system, Toll-like receptor 4 (TLR4) recognizes bacterial cell surface lipopolysaccharide (LPS) by forming a complex with a lipid-binding co-receptor, MD-2. In the presence of agonist, TLR4MD-2 dimerizes to form an active receptor complex, leading to initiation of intracellular inflammatory signals. TLR4 is of great biomedical interest, but its pharmacological manipulation is complicated because even subtle variations in the structure of LPS can profoundly impact the resultant immunological response. Here, we use atomically detailed molecular simulations to gain insights into the nature of the molecular signaling mechanism. We first demonstrate that MD-2 is extraordinarily flexible. The clamshell-like motions of its -cup fold enable it to sensitively match the volume of its hydrophobic cavity to the size and shape of the bound lipid moiety. We show that MD-2 allosterically transmits this conformational plasticity, in a ligand-dependent manner, to a phenylalanine residue (Phe-126) at the cavity mouth previously implicated in TLR4 activation. Remarkably, within the receptor complex, we observe spontaneous transitions between active and inactive signaling states of Phe-126, and we confirm that Phe-126 is indeed the molecular switch in endotoxic signaling.	[Paramo, Teresa; Bond, Peter J.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Piggot, Thomas J.] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge; University of Southampton; University of Cambridge	Bond, PJ (corresponding author), Bioinformat Inst A STAR, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.	peterjb@bii.a-star.edu.sg	Kleinschmidt, Jörg H/G-3395-2012	Kleinschmidt, Jörg H/0000-0003-0986-334X; Bond, Peter/0000-0003-2900-098X	Unilever; MRC [G1000133] Funding Source: UKRI; Medical Research Council [G1000133] Funding Source: researchfish	Unilever(Unilever); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Unilever (to P. J. B. and T. P.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Casella CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062622; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Figueiredo MD, 2008, AM J VET RES, V69, P796, DOI 10.2460/ajvr.69.6.796; Garate JA, 2013, PROTEINS, V81, P658, DOI 10.1002/prot.24223; Garzon D, 2013, J BIOL CHEM, V288, P19528, DOI 10.1074/jbc.M113.470179; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Godfroy JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048875; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nguyen TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004800; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piggot TJ, 2011, J PHYS CHEM B, V115, P13381, DOI 10.1021/jp207013v; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yu LP, 2012, J BIOL CHEM, V287, P16346, DOI 10.1074/jbc.M112.343467; ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3	41	46	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36215	36225		10.1074/jbc.M113.501957	http://dx.doi.org/10.1074/jbc.M113.501957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178299	Green Published, hybrid			2022-12-25	WOS:000328883400004
J	Bonnet, N; Gineyts, E; Ammann, P; Conway, SJ; Garnero, P; Ferrari, S				Bonnet, Nicolas; Gineyts, Evelyne; Ammann, Patrick; Conway, Simon J.; Garnero, Patrick; Ferrari, Serge			Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice	PLOS ONE			English	Article							MICRODAMAGE ACCUMULATION; MECHANICAL-PROPERTIES; GENE-EXPRESSION; CORTICAL BONE; FEMORAL-NECK; MATRIX; RESORPTION; STRENGTH; REPAIR; MODEL	Bone damage removal and callus formation in response to fatigue loading are essential to prevent fractures. Periostin (Postn) is a matricellular protein that mediates adaptive response of cortical bone to loading. Whether and how periostin influences damage and the injury response to fatigue remains unknown. We investigated the skeletal response of Postn(-/-) and Postn(+/+) mice after fatigue stimulus by axial compression of their tibia. In Postn(+/+) mice, cracks number and surface (CsNb, CsS) increased 1h after fatigue, with a decrease in strength compared to non-fatigued tibia. At 15 days, CsNb had started to decline, while CtTV and CtBV increased in fatigued vs non-fatigued tibia, reflecting a woven bone response that was present in 75% of the fatigued bones. Cortical porosity and remodelling also prominently increased in the fatigued tibia of Postn(+/+) mice. At 30 days, paralleling a continuous removal of cortical damage, strength of the fatigued tibia was similar to the non-fatigue tibia. In Postn(-/-) mice, cracks were detectable even in the absence of fatigue, while the amount of collagen crosslinks and tissue hardness was decreased compared to Postn(+/+). Fatigue significantly increased CsNb and CsS in Postn(-/-), but was not associated with changes in CtTV and CtBV, as only 16% of the fatigued bones formed some woven bone. Cortical porosity and remodelling did not increase either after fatigue in Postn(-/-), and the level of damage remained high even after 30 days. As a result, strength remained compromised in Postn(-/-) mice. Contrary to Postn(+/+), which osteocytic lacunae showed a change in the degree of anisotropy (DA) after fatigue, Postn(-/-) showed no DA change. Hence periostin appears to influence bone materials properties, damage accumulation and repair, including local modeling/remodeling processes in response to fatigue. These observations suggest that the level of periostin expression could influence the propensity to fatigue fractures.	[Bonnet, Nicolas; Ammann, Patrick; Ferrari, Serge] Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland; [Gineyts, Evelyne; Garnero, Patrick] Univ Lyon, Hop Edouard Herriot, INSERM, UMR 1033, Lyon, France; [Conway, Simon J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	University of Geneva; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Indiana University System; Indiana University Bloomington	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland.	nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020	Ferrari, Serge/0000-0002-1372-4417; Bonnet, Nicolas/0000-0001-9832-5767; Gineyts, Evelyne/0000-0003-3868-5810	Swiss National Science Foundation [3100A0-116633/ 1]; EC [201099-TALOS]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	These studies were supported by a Swiss National Science Foundation grant no. 3100A0-116633/ 1 and EC 201099-TALOS (to S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Brennan-Speranza TC, 2011, BONE, V49, P1073, DOI 10.1016/j.bone.2011.07.039; Burr D. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P201; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Conway SJ, 2011, THESCIENTIFICWORLDJO, V11, P1509, DOI 10.1100/tsw.2011.132; Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Gillan L, 2002, CANCER RES, V62, P5358; Gineyts E, 2010, J CHROMATOGR B, V878, P1449, DOI 10.1016/j.jchromb.2010.03.039; Hazenberg JG, 2006, J BIOMECH, V39, P2096, DOI 10.1016/j.jbiomech.2005.06.006; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hsieh YF, 2002, J ORTHOP RES, V20, P764, DOI 10.1016/S0736-0266(01)00161-9; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kidd LJ, 2010, BONE, V46, P369, DOI 10.1016/j.bone.2009.10.009; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kozloff KM, 2004, J BONE MINER RES, V19, P614, DOI 10.1359/JBMR.040111; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Li CY, 2003, CALCIFIED TISSUE INT, V72, P42, DOI 10.1007/s00223-001-1086-y; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Ma DD, 2009, IN VITRO CELL DEV-AN, V45, P467, DOI 10.1007/s11626-009-9214-5; Martin RB, 2001, CRC SER EXERC PHSIOL, P183; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Norman TL, 2008, J BIOMECH, V41, P2868, DOI 10.1016/j.jbiomech.2008.06.032; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Waldorf EI, 2010, J BONE MINER RES, V25, P734, DOI 10.1359/jbmr.091016; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x	52	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78347	10.1371/journal.pone.0078347	http://dx.doi.org/10.1371/journal.pone.0078347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167618	gold, Green Submitted, Green Published			2022-12-25	WOS:000326034500079
J	Kong, PC; Zhu, Y; Wang, MS; Li, HP; Chen, XJ; Jiang, MX				Kong, Peng-Cheng; Zhu, Yan; Wang, Mei-Shan; Li, He-Ping; Chen, Xue-Jin; Jiang, Man-Xi			Reprogramming of Round Spermatids by the Germinal Vesicle Cytoplasm in Mice	PLOS ONE			English	Article							MAMMALIAN SOMATIC-CELLS; XENOPUS-LAEVIS OOCYTE; FULL-TERM DEVELOPMENT; MOUSE OOCYTES; INTRACYTOPLASMIC INJECTION; EMBRYOS; NUCLEUS; BIRTH; MICROINSEMINATION; FERTILIZATION	The birthrate following round spermatid injection (ROSI) remains low in current and evidence suggests that factors in the germinal vesicle (GV) cytoplasm and certain substances in the GV such as the nucleolus might be responsible for genomic reprogramming and embryonic development. However, little is known whether the reprogramming factors in GV oocyte cytoplasm and/or nucleolus in GV are beneficial to the reprogramming of round spermatids and development of ROSI embryos. Here, round spermatids were treated with GV cytolysates and injected this round spermatid alone or co-injected with GV oocyte nucleolus into mature metaphase II oocytes. Subsequent embryonic development was assessed morphologically and by Oct4 expression in blastocysts. There was no significant difference between experimental groups at the zygote to four-cell development stages. Blastocysts derived from oocytes which were injected with cytolysate treated-round spermatid alone or co-injected with nucleoli injection yielded 63.6% and 70.3% high quality embryos, respectively; comparable to blastocysts derived by intracytoplasmic sperm injection (ICSI), but higher than these oocytes which were co-injected with lysis buffer-treated round spermatids and nucleoli or injected with the lysis buffer-treated round spermatids alone. Furthermore, the proportion of live offspring resulting from oocytes which were co-injected with cytolysate treated-round spermatids and nucleoli or injected with cytolysate treated-round spermatids alone was higher than those were injected with lysis buffer treated-round spermaids, but comparable with the ICSI group. Our results demonstrate that factors from the GV cytoplasm improve round spermatid reprogramming, and while injection of the extra nucleolus does not obviously improve reprogramming its potential contribution, although which cannot be definitively excluded. Thus, some reprogramming factors are evidently present in GV oocyte cytoplasm and could significantly facilitate ROSI technology, while the nucleolus in GV seems also having a potential to improve reprogramming of round spermatids.	[Kong, Peng-Cheng; Wang, Mei-Shan; Chen, Xue-Jin; Jiang, Man-Xi] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China; [Zhu, Yan] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices, Natl Populat & Family Planning Comm, Shanghai, Peoples R China; [Li, He-Ping] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Peoples R China	Shanghai Jiao Tong University; Northeast Forestry University - China	Chen, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China.	chenxuejin@shsmu.edu.cn; manxijiang@yahoo.com	Wang, Meishan/O-2023-2019; Jiang, Man-Xi/A-1790-2016	Wang, Meishan/0000-0001-8085-2657; 				Alberio R, 2005, EXP CELL RES, V307, P131, DOI 10.1016/j.yexcr.2005.02.028; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Bian YH, 2009, EPIGENETICS-US, V4, P194, DOI 10.4161/epi.4.3.8787; Bui HT, 2008, DEVELOPMENT, V135, P3935, DOI 10.1242/dev.023747; Bui HT, 2012, DEVELOPMENT, V139, P4330, DOI 10.1242/dev.086116; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Fulka J, 2003, THERIOGENOLOGY, V59, P1879, DOI 10.1016/S0093-691X(02)01226-8; Fulka J, 2011, J ASSIST REPROD GEN, V28, P385, DOI 10.1007/s10815-011-9565-1; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Gasparrini B, 2003, BIOL REPROD, V68, P1259, DOI 10.1095/biolreprod.102.008730; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Haigo K, 2004, BIOL REPROD, V71, P194, DOI 10.1095/biolreprod.104.027706; Halley-Stott RP, 2010, METHODS, V51, P56, DOI 10.1016/j.ymeth.2010.01.035; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Hirabayashi M, 2002, MOL REPROD DEV, V62, P295, DOI 10.1002/mrd.10127; Jiang MX, 2005, ZYGOTE, V13, P249, DOI 10.1017/S0967199405003308; Jiang MX, 2005, MOL REPROD DEV, V72, P129, DOI 10.1002/mrd.20328; Jiang MX, 2005, MOL REPROD DEV, V71, P439, DOI 10.1002/mrd.20299; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Latham KE, 1999, INT REV CYTOL, V193, P71; Miyamoto K, 2007, MOL REPROD DEV, V74, P1268, DOI 10.1002/mrd.20691; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; Ogonuki N, 2003, BIOL REPROD, V68, P1821, DOI 10.1095/biolreprod.102.011726; OGURA A, 1994, P NATL ACAD SCI USA, V91, P7460, DOI 10.1073/pnas.91.16.7460; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Polanski Z, 2005, DEV BIOL, V281, P184, DOI 10.1016/j.ydbio.2005.02.024; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Rathbone AJ, 2010, CELL REPROGRAM, V12, P609, DOI 10.1089/cell.2010.0015; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; SCHULTZ MC, 1990, AM J ANAT, V189, P1, DOI 10.1002/aja.1001890102; Shamanski FL, 1999, HUM REPROD, V14, P1050, DOI 10.1093/humrep/14.4.1050; SOFIKITIS NV, 1994, J ASSIST REPROD GEN, V11, P335, DOI 10.1007/BF02214138; TAKEUCHI IK, 1990, J STRUCT BIOL, V103, P104, DOI 10.1016/1047-8477(90)90014-4; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Van Soom Ann, 2003, Reprod Biomed Online, V7, P664; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	44	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78437	10.1371/journal.pone.0078437	http://dx.doi.org/10.1371/journal.pone.0078437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167624	Green Submitted, gold, Green Published			2022-12-25	WOS:000326034500085
J	Wang, J; Ge, Y; Zhang, CB; Bai, Y; Du, ZK				Wang, Jiang; Ge, Yuan; Zhang, Chong B.; Bai, Yi; Du, Zhao K.			Dominant Functional Group Effects on the Invasion Resistance at Different Resource Levels	PLOS ONE			English	Article							LIMITING SIMILARITY; SPECIES IDENTITY; BIOTIC RESISTANCE; PLANT COMMUNITY; LONG-TERM; DIVERSITY; INVASIBILITY; ESTABLISHMENT; INVASIVENESS; NUTRIENTS	Background: Functional group composition may affect invasion in two ways the effect of abundance, i.e. dominance of functional group; and the effect of traits, i.e. identity of functional groups. However, few studies have focused on the role of abundance of functional group on invasion resistance. Moreover, how resource availability influences the role of the dominant functional group in invasion resistance is even less understood. Methodology/Principal Findings: In this experiment, we established experimental pots using four different functional groups (annual grass, perennial grass, deciduous shrub or arbor and evergreen shrub or arbor), and the dominant functional group was manipulated. These experimental pots were respectively constructed at different soil nitrogen levels (control and fertilized). After one year of growth, we added seeds of 20 different species (five species per functional group) to the experimental pots. Fertilization significantly increased the overall invasion success, while dominant functional group had little effect on overall invasion success. When invaders were grouped into functional groups, invaders generally had lower success in pots dominated by the same functional group in the control pots. However, individual invaders of the same functional group exhibited different invasion patterns. Fertilization generally increased success of invaders in pots dominated by the same than by another functional group. However, fertilization led to great differences for individual invaders. Conclusions/Significance: The results showed that the dominant functional group, independent of functional group identity, had a significant effect on the composition of invaders. We suggest that the limiting similarity hypothesis may be applicable at the functional group level, and limiting similarity may have a limited role for individual invaders as shown by the inconsistent effects of dominant functional group and fertilization.	[Wang, Jiang; Zhang, Chong B.; Bai, Yi; Du, Zhao K.] Taizhou Univ, Sch Life Sci, Linhai, Peoples R China; [Ge, Yuan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA	Taizhou University; University of California System; University of California Santa Barbara	Ge, Y (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Earth Res Inst, Santa Barbara, CA 93106 USA.	gyuan@bren.ucsb.edu	Ge, Yuan/D-2997-2009	Ge, Yuan/0000-0003-0234-5638	National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [LY13C030003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was financially supported by the National Natural Science Foundation of China (Project 31000256) and by the Natural Science Foundation of Zhejiang Province, China (Project LY13C030003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dukes JS, 2002, ECOL APPL, V12, P602, DOI 10.1890/1051-0761(2002)012[0602:SCADAG]2.0.CO;2; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Emery SM, 2007, J ECOL, V95, P1027, DOI 10.1111/j.1365-2745.2007.01274.x; Emery SM, 2007, ECOLOGY, V88, P954, DOI 10.1890/06-0568; Emery SM, 2006, OIKOS, V115, P549, DOI 10.1111/j.2006.0030-1299.15172.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Foster BL, 2002, OIKOS, V99, P300, DOI 10.1034/j.1600-0706.2002.990210.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; Garcia-Serrano H, 2004, CAN J BOT, V82, P1346, DOI [10.1139/B04-097, 10.1139/b04-097]; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Incera M, 2009, MAR ECOL PROG SER, V377, P91, DOI 10.3354/meps07866; Leishman MR, 2005, J ECOL, V93, P38, DOI 10.1111/j.1365-2745.2004.00938.x; Li W, 2012, OIKOS, V121, P435, DOI 10.1111/j.1600-0706.2011.19762.x; Longo G, 2013, J ECOL IN PRESS; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B., 2011, PC ORD MULTIVARIATE; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; Milbau A, 2004, WEED TECHNOL, V18, P1301, DOI 10.1614/0890-037X(2004)018[1301:TROSTI]2.0.CO;2; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Price JN, 2013, OIKOS, V122, P649, DOI 10.1111/j.1600-0706.2012.00121.x; Prieur-Richard AH, 2002, OIKOS, V99, P338, DOI 10.1034/j.1600-0706.2002.990215.x; Prieur-Richard AH, 2002, OECOLOGIA, V130, P96, DOI 10.1007/s004420100774; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Shea K, 1998, ECOL APPL, V8, P824, DOI 10.1890/1051-0761(1998)008[0824:EBAIWM]2.0.CO;2; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Tan WB, 2009, CHINESE SCI BULL, V54, P1759, DOI 10.1007/s11434-009-0046-1; Thompson K, 2010, J ECOL, V98, P480, DOI 10.1111/j.1365-2745.2009.01610.x; Von Holle B, 2005, J ECOL, V93, P16, DOI 10.1111/j.0022-0477.2004.00946.x; Yang R, 2010, SCI TOTAL ENVIRON, V408, P4624, DOI 10.1016/j.scitotenv.2010.06.006	45	8	8	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77220	10.1371/journal.pone.0077220	http://dx.doi.org/10.1371/journal.pone.0077220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167565	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500024
J	Loepfe, L; Cabrales, A; Sanchez, A				Loepfe, Lasse; Cabrales, Antonio; Sanchez, Angel			Towards a Proper Assignment of Systemic Risk: The Combined Roles of Network Topology and Shock Characteristics	PLOS ONE			English	Article							FINANCIAL NETWORKS; INTERBANK MARKET; CONTAGION; MODELS	The 2007-2008 financial crisis solidified the consensus among policymakers that a macro-prudential approach to regulation and supervision should be adopted. The currently preferred policy option is the regulation of capital requirements, with the main focus on combating procyclicality and on identifying the banks that have a high systemic importance, those that are "too big to fail". Here we argue that the concept of systemic risk should include the analysis of the system as a whole and we explore systematically the most important properties for policy purposes of networks topology on resistance to shocks. In a thorough study going from analytical models to empirical data, we show two sharp transitions from safe to risky regimes: 1) diversification becomes harmful with just a small fraction (similar to 2%) of the shocks sampled from a fat tailed shock distributions and 2) when large shocks are present a critical link density exists where an effective giant cluster forms and most firms become vulnerable. This threshold depends on the network topology, especially on modularity. Firm size heterogeneity has important but diverse effects that are heavily dependent on shock characteristics. Similarly, degree heterogeneity increases vulnerability only when shocks are directed at the most connected firms. Furthermore, by studying the structure of the core of the transnational corporation network from real data, we show that its stability could be clearly increased by removing some of the links with highest centrality betweeness. Our results provide a novel insight and arguments for policy makers to focus surveillance on the connections between firms, in addition to capital requirements directed at the nodes.	[Loepfe, Lasse; Sanchez, Angel] Univ Carlos III Madrid, Dept Math, Grp Interdisciplinar Sistemas Complejos, Madrid, Spain; [Cabrales, Antonio] UCL, Dept Econ, London, England	Universidad Carlos III de Madrid; University of London; University College London	Loepfe, L (corresponding author), Univ Carlos III Madrid, Dept Math, Grp Interdisciplinar Sistemas Complejos, Madrid, Spain.	lasse.loepfe@gmail.com	Sánchez, Angel/A-9229-2008; Cabrales, Antonio/AAC-1805-2020	Sánchez, Angel/0000-0003-1874-2881; Cabrales, Antonio/0000-0003-0209-0399	ERA-Net on Complexity through grant RESINEE; MINECO (Spain) through grant PRODIEVO; Comunidad de Madrid through grant MODELICO-CM	ERA-Net on Complexity through grant RESINEE; MINECO (Spain) through grant PRODIEVO; Comunidad de Madrid through grant MODELICO-CM	This project was founded by ERA-Net on Complexity through grant RESINEE (http://www.complexitynet.eu/Pages/default.aspx), by MINECO (Spain, http://www.mineco.gob.es/portal/site/mineco/) through grant PRODIEVO and by Comunidad de Madrid through grant MODELICO-CM (http://modelico.es/index.php/es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Allen F, 2010, FINANCIAL CONNECTION; Amini H, 2012, INT J THEOR APPL FIN, V15, DOI 10.1142/S0219024911006504; [Anonymous], 2011, MAPPING SYSTEMIC RIS; [Anonymous], 2012, RISE NETWORK SOC, DOI DOI 10.1002/9781444319514; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P18338, DOI 10.1073/pnas.1213767109; Battiston S, 2012, J EC DYN CONTR; Battiston S, 2013, NAT PHYS, V9, P123, DOI 10.1038/nphys2575; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Beale N, 2011, P NATL ACAD SCI USA, V108, P12647, DOI 10.1073/pnas.1105882108; Board FS, 2009, REPORT FINANCIAL STA; Borio C.E.V., 2009, OPERATIONAL FRAMEWOR; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Cabrales A, 2013, UC3M WORKING PAPERS, V13; Caccioli F, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500580; Chinazzi M, 2012, POSTMORTEM EXAMINATI; Cont R, 2011, EE BASTOS NETWORK ST; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Drehmann M., 2011, BIS Q REV; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Elliott M, 2012, FINANCIAL NETWORKS C; Estrada E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066102; Farmer JD, 2012, EUR PHYS J-SPEC TOP, V214, P295, DOI 10.1140/epjst/e2012-01696-9; Financial Services Authority (FSA), 2009, TURNER REV REGULATOR; Freixas X, 2000, J MONEY CREDIT BANK, V32, P611, DOI 10.2307/2601198; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Gentleman Robert, 1997, R PROJECT STAT COMPU; Gini C., 1912, J R STAT SOC, V76, P326; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hale G, 2012, J INT EC; Hurd T, 2011, FRAMEWORK ANAL CONTA; Iori G, 2006, J ECON BEHAV ORGAN, V61, P525, DOI 10.1016/j.jebo.2004.07.018; May RM, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0376; Muller J, 2003, 2 APPROACHES ASSESS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Sobol I. M., 1976, COMP MATH MATH PHYS+, V16, P236, DOI DOI 10.1016/0041-5553(76)90154-3; Stiroh KJ, 2006, J BANK FINANC, V30, P2131, DOI 10.1016/j.jbankfin.2005.04.030; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Taleb N, 2010, BLACK SWAN IMPACT HI; Tasca P, 2011, DIVERSIFICATION FINA; Tasca P, 2013, ARXIV13035552; Tedeschi G, 2011, BANKRUPTCY CASCADES; Tessone CJ, 2012, ARXIV12090959; Thurner S, 2003, QUANT FINANC, V3, P306, DOI 10.1088/1469-7688/3/4/307; Upper C, 2011, J FINANC STABIL, V7, P111, DOI 10.1016/j.jfs.2010.12.001; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995	53	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77526	10.1371/journal.pone.0077526	http://dx.doi.org/10.1371/journal.pone.0077526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147017	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200042
J	Muthuswami, M; Ramesh, V; Banerjee, S; Thangaraj, SV; Periasamy, J; Rao, DB; Barnabas, GD; Raghavan, S; Ganesan, K				Muthuswami, Muthulakshmi; Ramesh, Vignesh; Banerjee, Saikat; Thangaraj, Soundara Viveka; Periasamy, Jayaprakash; Rao, Divya Bhaskar; Barnabas, Georgina D.; Raghavan, Swetha; Ganesan, Kumaresan			Breast Tumors with Elevated Expression of 1q Candidate Genes Confer Poor Clinical Outcome and Sensitivity to Ras/PI3K Inhibition	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANCER-CELL-LINES; SINGLE-NUCLEOTIDE POLYMORPHISM; EXO1 GENE; CHROMOSOMAL INSTABILITY; MOLECULAR TARGET; ABERRATIONS; PROFILES; SUSCEPTIBILITY; ASSOCIATION	Genomic aberrations are common in cancers and the long arm of chromosome 1 is known for its frequent amplifications in breast cancer. However, the key candidate genes of 1q, and their contribution in breast cancer pathogenesis remain unexplored. We have analyzed the gene expression profiles of 1635 breast tumor samples using meta-analysis based approach and identified clinically significant candidates from chromosome 1q. Seven candidate genes including exonuclease 1 (EXO1) are consistently over expressed in breast tumors, specifically in high grade and aggressive breast tumors with poor clinical outcome. We derived a EXO1 co-expression module from the mRNA profiles of breast tumors which comprises 1q candidate genes and their co-expressed genes. By integrative functional genomics investigation, we identified the involvement of EGFR, RAS, PI3K / AKT, MYC, E2F signaling in the regulation of these selected 1q genes in breast tumors and breast cancer cell lines. Expression of EXO1 module was found as indicative of elevated cell proliferation, genomic instability, activated RAS/AKT/MYC/E2F1 signaling pathways and loss of p53 activity in breast tumors. mRNA-drug connectivity analysis indicates inhibition of RAS/PI3K as a possible targeted therapeutic approach for the patients with activated EXO1 module in breast tumors. Thus, we identified seven 1q candidate genes strongly associated with the poor survival of breast cancer patients and identified the possibility of targeting them with EGFR/RAS/PI3K inhibitors.	[Muthuswami, Muthulakshmi; Ramesh, Vignesh; Banerjee, Saikat; Thangaraj, Soundara Viveka; Periasamy, Jayaprakash; Rao, Divya Bhaskar; Barnabas, Georgina D.; Ganesan, Kumaresan] Madurai Kamaraj Univ, Sch Biol Sci, Ctr Excellence Genom Sci, Canc Genet Lab,Dept Genet, Madurai 625021, Tamil Nadu, India; [Raghavan, Swetha] Indian Inst Technol Madras, Dept Biotechnol, Chenna, India	Madurai Kamaraj University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Ganesan, K (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Ctr Excellence Genom Sci, Canc Genet Lab,Dept Genet, Madurai 625021, Tamil Nadu, India.	kumar@oncocellomics.org		Raghavan, Swetha/0000-0001-6951-0592; Ganesan, Kumaresan/0000-0003-0533-3181; Thangaraj, Soundara Viveka/0000-0003-4902-468X	Council of Scientific and Industrial Research (CSIR), Govt. of India [27(0223)/10/EMR-II]	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This project was funded by Council of Scientific and Industrial Research (CSIR), Govt. of India through the research grant 27(0223)/10/EMR-II to Kumaresan Ganesan, Madurai Kamaraj University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P279, DOI 10.1016/0165-4608(86)90206-2; Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2012, PROGENETIX ONCOGENOM; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; BIECHE I, 1995, CLIN CANCER RES, V1, P123; Blum R, 2007, CANCER RES, V67, P3320, DOI 10.1158/0008-5472.CAN-06-4287; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang M, 2011, CANCER-AM CANCER SOC, V117, P2024, DOI 10.1002/cncr.25770; Farabegoli F, 2004, MODERN PATHOL, V17, P449, DOI 10.1038/modpathol.3800059; FICHTINGERSCHEPMAN AMJ, 1995, CARCINOGENESIS, V16, P2447, DOI 10.1093/carcin/16.10.2447; Fonseca FLA, 2005, BREAST CANCER RES, V7, pR28, DOI 10.1186/bcr950; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gao YX, 2009, J MOL MED, V87, P145, DOI 10.1007/s00109-008-0408-1; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Hagemann C, 2008, ONCOL REP, V20, P301, DOI 10.3892/or_00000007; Harrouk W, 2000, MUTAT RES-DNA REPAIR, V461, P229, DOI 10.1016/S0921-8777(00)00053-7; Hobday Timothy J, 2005, Cancer Control, V12, P73; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Karlsson E, 2007, CANCER GENET CYTOGEN, V172, P139, DOI 10.1016/j.cancergencyto.2006.09.019; Kim TM, 2005, CLIN CANCER RES, V11, P79; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; Melchor L, 2008, CARCINOGENESIS, V29, P1475, DOI 10.1093/carcin/bgn157; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Park SC, 2007, CLIN EXP MED, V7, P1, DOI 10.1007/s10238-007-0123-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schmutte C, 1998, CANCER RES, V58, P4537; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; T T, 2012, PACK SURV AN S; Therneau M, 2000, MODELING SURVIVAL DA; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang SL, 2011, HISTOPATHOLOGY, V59, P631, DOI 10.1111/j.1365-2559.2011.03941.x; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber-Mangal S, 2003, INT J CANCER, V107, P583, DOI 10.1002/ijc.11460; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	68	38	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77553	10.1371/journal.pone.0077553	http://dx.doi.org/10.1371/journal.pone.0077553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147022	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200045
J	Silva-Sanchez, J; Cruz-Trujillo, E; Barrios, H; Reyna-Flores, F; Sanchez-Perez, A; Garza-Ramos, U				Silva-Sanchez, Jesus; Cruz-Trujillo, Enrique; Barrios, Humberto; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Garza-Ramos, Ulises		Bacterial Resistance Consortium	Characterization of Plasmid-Mediated Quinolone Resistance (PMQR) Genes in Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae Pediatric Clinical Isolates in Mexico	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA; FLUOROQUINOLONES; PREVALENCE; ESBL; PCR	This work describes the characterization of plasmid-mediated quinolone-resistance (PMQR) genes from a multicenter study of ESBL-producing Enterobacteriaceae pediatric clinical isolates in Mexico. The PMQR gene-positive isolates were characterized with respect to ESBLs, and mutations in the GyrA and ParC proteins were determined. The phylogenetic relationship was established by PFGE and the transfer of PMQR genes was determined by mating assays. The prevalence of the PMQR genes was 32.1%, and the rate of qnr-positive isolates was 15.1%; 93.3% of the latter were qnrB and 6.4% were qnrA1. The distribution of isolates in terms of bacterial species was as follows: 23.5% (4/17) corresponded to E. cloacae, 13.7% (7/51) to K. pneumoniae, and 13.6% (6/44) to E. coli. In addition, the prevalence of aac(6')-Ib-cr and qepA was 15.1% and 1.7%, respectively. The molecular characteristics of qnr- and qepA-positive isolates pointed to extended-spectrum beta-lactamase (ESBL) CTX-M-15 as the most prevalent one (70.5%), and to SHV-12 in the case of aac(6')-Ib-cr-positive isolates. GyrA mutations at codons Ser-83 and Asp-87, and ParC mutations at codons Ser-80 were observed in 41.1% and 35.2% of the qnr-positive isolates, respectively. The analysis of the transconjugants revealed a co-transmission of blaCTX-M-15 with the qnrB alleles. In general, the prevalence of PMQR genes (qnr and aac(6')-Ib-cr) presented in this work was much lower in the pediatric isolates, in comparison to the adult isolates in Mexico. Also, ESBL CTX-M-15 was the main ESBL identified in the pediatric isolates, whereas in the adult ones, ESBLs corresponded to the CTX-M and the SHV families. In comparison with other studies, among the PMQR-genes identified in this study, the qnrB-alleles and the aac(6')-Ib-cr gene were the most prevalent, whereas the qnrS1, qnrA1 and qnrB-like alleles were the most prevalent in China and Uruguay.	[Silva-Sanchez, Jesus; Cruz-Trujillo, Enrique; Barrios, Humberto; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Garza-Ramos, Ulises] Inst Nacl Salud Publ, CISEI, Dept Diagnost Epidemiol, Cuernavaca, Morelos, Mexico; [Bacterial Resistance Consortium] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol, Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara 44430, Jalisco, Mexico	Instituto Nacional de Salud Publica; Universidad de Guadalajara	Garza-Ramos, U (corresponding author), Inst Nacl Salud Publ, CISEI, Dept Diagnost Epidemiol, Cuernavaca, Morelos, Mexico.	ulises.garza@insp.mx	Barrios, Humberto/A-6907-2015	Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Silva-Sanchez, Jesus/0000-0002-6580-2990; Garza Ramos, Ulises/0000-0002-5013-3050	CONACyT (Mexican Council for Science and Technology) [SALUD-2008-01-87334, 136339]	CONACyT (Mexican Council for Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants SALUD-2008-01-87334, and 136339 from CONACyT (Mexican Council for Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; Barrios H, 2012, ANTIMICROB AGENTS CH, V56, P4032, DOI 10.1128/AAC.05980-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; *CLIN LAB STAND I, 2012, M07MA9 CLIN LAB STAN; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fulgueiras V, 2011, J ANTIMICROB CHEMOTH, V66, P1725, DOI 10.1093/jac/dkr222; Han C, 2010, MICROBIOL IMMUNOL, V54, P123, DOI 10.1111/j.1348-0421.2010.00200.x; Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Langley J, 2001, Paediatr Child Health, V6, P322; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; Martinez-Martinez L, 2008, EXPERT REV ANTI-INFE, V6, P685, DOI 10.1586/14787210.6.5.685; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Silva-Sanchez J, 2011, MICROB DRUG RESIST, V17, P497, DOI 10.1089/mdr.2011.0086; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; Zhanel GG, 2002, DRUGS, V62, P13, DOI 10.2165/00003495-200262010-00002; Zhao XL, 1997, P NATL ACAD SCI USA, V94, P13991, DOI 10.1073/pnas.94.25.13991	28	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77968	10.1371/journal.pone.0077968	http://dx.doi.org/10.1371/journal.pone.0077968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147104	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200089
J	Bettcher, BM; Walsh, CM; Watson, C; Miller, JW; Green, R; Patel, N; Miller, BL; Neuhaus, J; Yaffe, K; Kramer, JH				Bettcher, Brianne Magouirk; Walsh, Christine M.; Watson, Christa; Miller, Joshua W.; Green, Ralph; Patel, Nihar; Miller, Bruce L.; Neuhaus, John; Yaffe, Kristine; Kramer, Joel H.			Body Mass and White Matter Integrity: The Influence of Vascular and Inflammatory Markers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CEREBRAL HYPOPERFUSION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; FOLLOW-UP; INDEX; RISK; DYSFUNCTION; OBESITY; ATLAS	High adiposity is deleteriously associated with brain health, and may disproportionately affect white matter integrity; however, limited information exists regarding the mechanisms underlying the association between body mass (BMI) and white matter integrity. The present study evaluated whether vascular and inflammatory markers influence the relationship between BMI and white matter in healthy aging. We conducted a cross-sectional evaluation of white matter integrity, BMI, and vascular/inflammatory factors in a cohort of 138 healthy older adults (mean age: 71.3 years). Participants underwent diffusion tensor imaging, provided blood samples, and participated in a health evaluation. Vascular risk factors and vascular/inflammatory blood markers were assessed. The primary outcome measure was fractional anisotropy (FA) of the genu, body, and splenium (corpus callosum); exploratory measures included additional white matter regions, based on significant associations with BMI. Regression analyses indicated that higher BMI was associated with lower FA in the corpus callosum, cingulate, and fornix (p<.001). Vascular and inflammatory factors influenced the association between BMI and FA. Specifically, BMI was independently associated with the genu [beta=-.21; B=-.0024; 95% CI, -.0048 to -.0000; p=.05] and cingulate fibers [beta=-.39; B=-.0035; 95% CI,-.0056 to -.0015; p<.001], even after controlling for vascular/inflammatory risk factors and blood markers. In contrast, BMI was no longer significantly associated with the fornix and middle/posterior regions of the corpus callosum after controlling for these markers. Results partially support a vascular/inflammatory hypothesis, but also suggest a more complex relationship between BMI and white matter characterized by potentially different neuroanatomic vulnerability.	[Bettcher, Brianne Magouirk; Walsh, Christine M.; Watson, Christa; Patel, Nihar; Miller, Bruce L.; Neuhaus, John; Yaffe, Kristine; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Watson, Christa] Stanford Univ, Dept Psychiat, Neuropsychol & Neuroimaging Lab, Palo Alto, CA 94304 USA; [Miller, Joshua W.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Miller, Joshua W.; Green, Ralph] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Stanford University; Rutgers State University New Brunswick; University of California System; University of California Davis; University of California System; University of California San Francisco	Bettcher, BM (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA.	bbettcher@memory.ucsf.edu			NIH-NINDS [HHSN271200623661C]; NIH-NIA [K23 AG042492-01, R01 AG032289]; Larry L. Hillblom Foundation; Alzheimer's Association New Investigator Research Grant [NIRP-12-259223]; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING [K23AG042492, R01AG032289] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; Alzheimer's Association New Investigator Research Grant; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study described was supported by grant number HHSN271200623661C from the NIH-NINDS, and numbers K23 AG042492-01 and R01 AG032289 from the NIH-NIA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Neurological Disorders and Strokes, National Institute on Aging or NIH. This work was also supported by the Larry L. Hillblom Foundation, an Alzheimer's Association New Investigator Research Grant (NIRP-12-259223), and the UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Bobb JF, 2012, HUM BRAIN MAPP; Bonora E, 2006, ANN MED, V38, P64, DOI 10.1080/07853890500401234; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Espinola-Klein C, 2011, FRONT BIOSCI-LANDMRK, V16, P1663, DOI 10.2741/3812; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Gilfix BM, 1997, CLIN CHEM, V43, P687; Gons RAR, 2012, J ALZHEIMERS DIS, V32, P623, DOI 10.3233/JAD-2012-121006; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2012, J ALZHEIMERS DIS, V28, P162, DOI 10.3233/JAD-2011-110917; Huang YH, 2010, J NEUROL SCI, V299, P72, DOI 10.1016/j.jns.2010.08.035; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Knowlton RC, 2002, ARCH NEUROL-CHICAGO, V59, P1882, DOI 10.1001/archneur.59.12.1882; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee EB, 2011, ANN NY ACAD SCI, V1243, P15, DOI 10.1111/j.1749-6632.2011.06274.x; Mazer SP, 2004, J THROMB THROMBOLYS, V17, P95, DOI 10.1023/B:THRO.0000037664.77460.d8; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Segura B, 2009, NEUROLOGY, V73, P438, DOI 10.1212/WNL.0b013e3181b163cd; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Wilson AM, 2006, INT J CARDIOL, V106, P291, DOI 10.1016/j.ijcard.2005.01.068; XU J, 2011, HUM BRAIN MAPP; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8	40	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77741	10.1371/journal.pone.0077741	http://dx.doi.org/10.1371/journal.pone.0077741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147070	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400131
J	Meriki, HD; Tufon, KA; Atanga, PN; Ane-Anyangwe, IN; Anong, DN; Cho-Ngwa, F; Nkuo-Akenji, T				Meriki, Henry D.; Tufon, Kukwah A.; Atanga, Pascal N.; Ane-Anyangwe, Irene N.; Anong, Damian N.; Cho-Ngwa, Fidelis; Nkuo-Akenji, Theresa			Drug Resistance Profiles of Mycobacterium tuberculosis Complex and Factors Associated with Drug Resistance in the Northwest and Southwest Regions of Cameroon	PLOS ONE			English	Article							RISK-FACTORS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; PREVALENCE; WEST; EPIDEMIOLOGY; DETERMINANTS; BURDEN; IMPACT	Background: Anti-tuberculosis drug resistance continues to be a major obstacle to tuberculosis (TB) control programmes with HIV being a major risk factor in developing TB. We investigated anti-TB drug resistance profiles and the impact of socioeconomic as well as behavioural factors on the prevalence of TB and drug resistance in two regions of Cameroon with such data paucity. Methods: This was a hospital-based study in which 1706 participants, comprising 1133 females and 573 males consecutively enrolled from selected TB and HIV treatment centres of the Northwest and Southwest regions. Demographic, clinical and self-reported risk behaviours and socioeconomic data were obtained with the consent of participants using questionnaires. Culture and drug resistance testing were performed according to standard procedures. Results: The prevalence of resistance to at least one anti-TB drug was 27.7% and multi-drug resistance was 5.9%. Smoking, concurrent alcohol consumption and smoking, being on antiretroviral therapy for <= 12 months and previous household contact with TB patient were independently associated with tuberculosis prevalence, while only previous tuberculosis infection was associated with drug resistance in a univariate analysis. Conclusion: The study showed a high prevalence of drug resistance TB in the study population with only previous TB infection associated with drug resistance in a univariate analysis. It also provides evidence in our context, of the role of alcohol and smoking in increasing the risk of developing TB, which is more likely in people living with HIV/AIDS. Therefore, it is important for public health authorities to integrate and intensify alcohol/smoking abstention interventions in TB and HIV control programs in Cameroon.	[Meriki, Henry D.; Tufon, Kukwah A.; Atanga, Pascal N.; Ane-Anyangwe, Irene N.; Anong, Damian N.; Nkuo-Akenji, Theresa] Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Southwest Regio, Cameroon; [Cho-Ngwa, Fidelis] Univ Buea, Dept Biochem & Mol Biol, Fac Sci, Buea, Southwest Regio, Cameroon; [Atanga, Pascal N.] Reg Delegat Publ Hlth, Reg Tech Grp Fight HIV & AIDS, Buea, Southwest Regio, Cameroon; [Meriki, Henry D.; Nkuo-Akenji, Theresa] Univ Buea, Clin Diagnost Lab, Fac Sci, Buea, Southwest Regio, Cameroon		Nkuo-Akenji, T (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Southwest Regio, Cameroon.	wifon@yahoo.com	Meriki, Henry Dilonga/V-4634-2019; Atanga, Pascal Nji/AAB-8620-2020	Meriki, Henry Dilonga/0000-0002-9148-0171; 	University of Buea	University of Buea	Financial assistance was received from the University of Buea 2009-2010 research grant awarded to Prof. Theresa Nkuo-Akenji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Bercion R, 1998, B SOC PATHOL EXOT, V91, P199; Bureau Central des Recensements et des Etudes de la Population (BUCREP), 2010, EM REC GEN POP HAB 3; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Fatkenheuer G, 1999, DIAGN MICR INFEC DIS, V34, P139, DOI 10.1016/S0732-8893(99)00006-1; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; Golub JE, 2001, ARCH INTERN MED, V161, P2254, DOI 10.1001/archinte.161.18.2254; Haar CH, 2007, EMERG INFECT DIS, V13, P776, DOI 10.3201/eid1305.060334; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harper M, 2003, T ROY SOC TROP MED H, V97, P506, DOI 10.1016/S0035-9203(03)80007-X; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Institut National de la Statistique Ministere de l'Economie de la Planification et de l'Amenagement du Territoire Ministere de la Sante Publique Yaounde Cameroun, 2011, NQUET DEM SANT IND M; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Noeske Jurgen, 2012, BMC Res Notes, V5, P160, DOI 10.1186/1756-0500-5-160; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sethi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-137; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Skolnik NS, 2005, HELPING PATIENTS WHO; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; The National Tuberculosis Control Programme Northwest Regional Delegation of Public Health Bamenda Cameroon, 2012, REG TUB CONTR UN ANN; The National Tuberculosis Control Programme Southwest Regional Delegation of Public Health Buea Cameroon, 2012, EG TUB CONTR UN ANN; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2004, WHOHTMTB2004329TB	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77410	10.1371/journal.pone.0077410	http://dx.doi.org/10.1371/journal.pone.0077410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146991	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400104
J	Tian, T; Qin, W; Liu, B; Wang, DW; Wang, JP; Jiang, TZ; Yu, CS				Tian, Tian; Qin, Wen; Liu, Bing; Wang, Dawei; Wang, Junping; Jiang, Tianzi; Yu, Chunshui			Catechol-O-Methyltransferase Val158Met Polymorphism Modulates Gray Matter Volume and Functional Connectivity of the Default Mode Network	PLOS ONE			English	Article							COMT VAL(158)MET GENOTYPE; VAL(108/158) MET GENOTYPE; WORKING-MEMORY; GENE POLYMORPHISM; COGNITIVE PERFORMANCE; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; DOWN-REGULATION; FRONTAL-CORTEX; BRAIN	The effect of catechol-O-methyltransferase (COMT) Val158Met polymorphism on brain structure and function has been previously investigated separately and regionally; this prevents us from obtaining a full picture of the effect of this gene variant. Additionally, gender difference must not be overlooked because estrogen exerts an interfering effect on COMT activity. We examined 323 young healthy Chinese Han subjects and analyzed the gray matter volume (GMV) differences between Val/Val individuals and Met carriers in a voxel-wise manner throughout the whole brain. We were interested in genotype effects and genotype x gender interactions. We then extracted these brain regions with GMV differences as seeds to compute resting-state functional connectivity (rsFC) with the rest of the brain; we also tested the genotypic differences and gender interactions in the rsFCs. Val/Val individuals showed decreased GMV in the posterior cingulate cortex (PCC) compared with Met carriers; decreased GMV in the medial superior frontal gyrus (mSFG) was found only in male Val/Val subjects. The rsFC analysis revealed that both the PCC and mSFG were functionally correlated with brain regions of the default mode network (DMN). Both of these regions showed decreased rsFCs with different parts of the frontopolar cortex of the DMN in Val/Val individuals than Met carriers. Our findings suggest that the COMT Val158Met polymorphism modulates both the structure and functional connectivity within the DMN and that gender interactions should be considered in studies of the effect of this genetic variant, especially those involving prefrontal morphology.	[Tian, Tian; Qin, Wen; Wang, Dawei; Wang, Junping; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Tian, Tian; Qin, Wen; Wang, Dawei; Wang, Junping; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Liu, Bing; Jiang, Tianzi] Chinese Acad Sci, Brainnetome Ctr, Inst Automat, Beijing, Peoples R China; [Liu, Bing; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland	Yu, CS (corresponding author), Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	chunshuiyu@tijmu.edu.cn	Jiang, Tianzi/I-4256-2012; QIN, WEN/F-3783-2015	Jiang, Tianzi/0000-0001-9531-291X; QIN, WEN/0000-0002-9121-8296; liu, bing/0000-0003-2029-5187; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81271551, 81061120533]; Natural Science Foundation of Tianjin [11JCZDJC19300]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Basic Research Program of China (973 program, No. 2011CB707801), the Natural Science Foundation of China (Grant Nos. 81271551 and 81061120533), and the Natural Science Foundation of Tianjin (No. 11JCZDJC19300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033964; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Beck A, 1993, MANUAL BECK DEPRESSI; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bishop SJ, 2008, CEREB CORTEX, V18, P2132, DOI 10.1093/cercor/bhm240; Bishop SJ, 2006, COGN AFFECT BEHAV NE, V6, P62, DOI 10.3758/CABN.6.1.62; Bixo M, 1995, J STEROID BIOCHEM, V55, P297, DOI 10.1016/0960-0760(95)00179-4; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Cerasa A, 2010, NEUROSCIENCE, V167, P809, DOI 10.1016/j.neuroscience.2010.02.040; Cerasa A, 2008, NEUROREPORT, V19, P405, DOI 10.1097/WNR.0b013e3282f5f784; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Dumontheil I, 2011, BIOL PSYCHIAT, V70, P222, DOI 10.1016/j.biopsych.2011.02.027; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Ettinger U, 2008, NEUROPSYCHOPHARMACOL, V33, P3046, DOI 10.1038/sj.npp.1301658; Fallon SJ, 2013, CEREB CORTEX, V23, P361, DOI 10.1093/cercor/bhs025; Favaro A, 2013, J PSYCHIATR NEUROSCI, V38, P241, DOI 10.1503/jpn.120068; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fumagalli F, 2003, MOL PSYCHIATR, V8, P898, DOI 10.1038/sj.mp.4001370; Gennatas ED, 2012, NEUROLOGY, V78, P1663, DOI 10.1212/WNL.0b013e3182574fa1; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Gianotti LRR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00054; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Gong Y. X., 1982, MANUAL MODIFIED WECH; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Green AE, 2013, CEREB CORTEX, V23, P552, DOI 10.1093/cercor/bhs035; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Holtzer R, 2010, NEUROBIOL AGING, V31, P523, DOI 10.1016/j.neurobiolaging.2008.05.011; Honea R, 2009, NEUROIMAGE, V45, P44, DOI 10.1016/j.neuroimage.2008.10.064; Hoth Karin F, 2006, Neuropsychiatr Dis Treat, V2, P219, DOI 10.2147/nedt.2006.2.2.219; Jiang H, 2003, NEUROPHARMACOLOGY, V45, P1011, DOI 10.1016/S0028-3908(03)00286-7; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Kempton MJ, 2009, INT J NEUROPSYCHOPH, V12, P371, DOI 10.1017/S1461145708009395; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kuppers E, 2001, NEUROREPORT, V12, P1175; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; Lee TW, 2011, BRAIN RES, V1377, P21, DOI 10.1016/j.brainres.2010.12.073; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; McIntosh AM, 2007, BIOL PSYCHIAT, V61, P1127, DOI 10.1016/j.biopsych.2006.05.020; Mechelli A, 2009, BIOL PSYCHIAT, V66, P231, DOI 10.1016/j.biopsych.2009.01.033; Mehta MA, 2000, J NEUROSCI, V20; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Montag C, 2008, BEHAV NEUROSCI, V122, P901, DOI 10.1037/0735-7044.122.4.901; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054; Raz N, 2009, NEUROPSYCHOLOGY, V23, P105, DOI 10.1037/a0013487; Raznahan A, 2011, NEUROIMAGE, V57, P1517, DOI 10.1016/j.neuroimage.2011.05.032; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Rowe JB, 2010, NEUROBIOL AGING, V31, P1064, DOI 10.1016/j.neurobiolaging.2008.07.009; Sambataro F, 2012, CNS NEUROL DISORD-DR, V11, P195, DOI 10.2174/187152712800672463; Sambataro F, 2009, BIOL PSYCHIAT, V66, P540, DOI 10.1016/j.biopsych.2009.04.014; Santiago M, 2000, BRAIN RES, V858, P26, DOI 10.1016/S0006-8993(99)02485-3; Schmahl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023658; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shaw P, 2009, MOL PSYCHIATR, V14, P348, DOI 10.1038/mp.2008.121; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swart M, 2011, NEUROIMAGE, V55, P338, DOI 10.1016/j.neuroimage.2010.12.017; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Taylor WD, 2007, PSYCHIAT RES-NEUROIM, V155, P173, DOI 10.1016/j.pscychresns.2007.01.005; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Thomason ME, 2010, NEUROIMAGE, V53, P926, DOI 10.1016/j.neuroimage.2010.01.033; Tunbridge EM, 2013, NEUROIMAGE, V68, P49, DOI 10.1016/j.neuroimage.2012.11.059; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Wacker J, 2012, J PERS SOC PSYCHOL, V102, P427, DOI 10.1037/a0026544; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zhang KJ, 2007, NEUROPSYCHOBIOLOGY, V56, P98, DOI 10.1159/000112950; Zinkstok J, 2006, NEUROSCI LETT, V405, P34, DOI 10.1016/j.neulet.2006.06.034; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	109	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78697	10.1371/journal.pone.0078697	http://dx.doi.org/10.1371/journal.pone.0078697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147141	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400160
J	Yasugi, M; Kubota-Koketsu, R; Yamashita, A; Kawashita, N; Du, A; Misaki, R; Kuhara, M; Boonsathorn, N; Fujiyama, K; Okuno, Y; Nakaya, T; Ikuta, K				Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Yamashita, Akifumi; Kawashita, Norihito; Du, Anariwa; Misaki, Ryo; Kuhara, Motoki; Boonsathorn, Naphatsawan; Fujiyama, Kazuhito; Okuno, Yoshinobu; Nakaya, Takaaki; Ikuta, Kazuyoshi			Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody	PLOS ONE			English	Article							STRUCTURAL BASIS; ESCAPE MUTANTS; HEMAGGLUTININ; SPECIFICITY; EVOLUTION; SEQUENCES; EPITOPE	The swine-origin pandemic A(H1N1) 2009 virus, A(H1N1)pdm09, is still circulating in parts of the human population. To monitor variants that may escape from vaccination specificity, antigenic characterization of circulating viruses is important. In this study, a hybridoma clone producing human monoclonal antibody against A(H1N1) pdm09, designated 5E4, was prepared using peripheral lymphocytes from a vaccinated volunteer. The 5E4 showed viral neutralization activity and inhibited hemagglutination. 5E4 escape mutants harbored amino acid substitutions (A189T and D190E) in the hemagglutinin (HA) protein, suggesting that 5E4 recognized the antigenic site Sb in the HA protein. To study the diversity of Sb in A(H1N1) pdm09, 58 viral isolates were obtained during the 2009/10 and 2010/11 winter seasons in Osaka, Japan. Hemagglutination-inhibition titers were significantly reduced against 5E4 in the 2010/11 compared with the 2009/10 samples. Viral neutralizing titers were also significantly decreased in the 2010/11 samples. By contrast, isolated samples reacted well to ferret anti-A(H1N1) pdm09 serum from both seasons. Nonsynonymous substitution rates revealed that the variant Sb and Ca2 sequences were being positively selected between 2009/10 and 2010/11. In 7,415 HA protein sequences derived from GenBank, variants in the antigenic sites Sa and Sb increased significantly worldwide from 2009 to 2013. These results indicate that the antigenic variants in Sb are likely to be in global circulation currently.	[Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Du, Anariwa; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan; [Yasugi, Mayo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Kubota-Koketsu, Ritsuko; Okuno, Yoshinobu] Osaka Univ, Kanonji Inst, Res Fdn Microbial Dis, Kanonji, Kagawa, Japan; [Yamashita, Akifumi] Osaka Univ, Dept Genome Informat, RIMD, Suita, Osaka, Japan; [Kawashita, Norihito] Osaka Univ, Dept Environm Pharmacometr, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Misaki, Ryo; Fujiyama, Kazuhito] Osaka Univ, Appl Microbiol Lab, Int Ctr Biotechnol, Suita, Osaka, Japan; [Kuhara, Motoki] Med & Biol Labs Corp Ltd, Ina Lab, Ina, Nagano, Japan; [Boonsathorn, Naphatsawan] Minist Publ Hlth, Dept Med Sci, Muang, Nonthaburi, Thailand; [Nakaya, Takaaki] Osaka Univ, Int Res Ctr Infect Dis, RIMD, Suita, Osaka, Japan; [Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Du, Anariwa; Misaki, Ryo; Kuhara, Motoki; Boonsathorn, Naphatsawan; Fujiyama, Kazuhito; Nakaya, Takaaki; Ikuta, Kazuyoshi] Japan Int Cooperat Agcy Sci & Res Partnership Sus, Japan Sci & Technol Agcy, SATREPS, Tokyo, Japan	Osaka University; Osaka Metropolitan University; Osaka University; Osaka University; Osaka University; Osaka University; Ministry of Public Health - Thailand; Osaka University; Japan Science & Technology Agency (JST)	Ikuta, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan.	ikuta@biken.osaka-u.ac.jp			Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS); Japan Society for the Promotion of Science [23790660]; Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS) (http://www.jst.go.jp/global/kadai/h2011_thailand.html); and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to MY. (#23790660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arora DJS, 1997, ARCH VIROL, V142, P401, DOI 10.1007/s007050050086; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barr IG, 2010, EURO SURVEILL, V15; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Di Lonardo A, 2002, J VIROL METHODS, V101, P189, DOI 10.1016/S0166-0934(01)00437-2; Ding XF, 2010, VIRUS GENES, V41, P329, DOI 10.1007/s11262-010-0526-z; El-Shesheny R, 2012, J GEN VIROL, V93, P2564, DOI 10.1099/vir.0.043299-0; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GIRC, 2011, RETR ONP WHILST DEC; GISRS, 2013, INFL LAB SURV INF; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Ilyushina NA, 2004, VIRUS RES, V100, P237, DOI 10.1016/j.virusres.2003.12.032; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Mak G, 2011, EURO SURVEILL, V16; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Moreno A, 2013, J VIROL METHODS, V187, P424, DOI 10.1016/j.jviromet.2012.11.006; Nakagawa N, 2002, J CLIN MICROBIOL, V40, P3068, DOI 10.1128/JCM.40.8.3068-3070.2002; NIID, 2013, INFECT AGENTS SURVEI; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; RAYMOND FL, 1986, VIROLOGY, V148, P275, DOI 10.1016/0042-6822(86)90325-9; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Setthapramote C, 2013, BIOCHEM BIOPH RES CO, V432, P200, DOI 10.1016/j.bbrc.2013.01.107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shirahata S, 1998, METHOD CELL BIOL, V57, P111; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; WHO, 2012, REC COMP INFL VIR VA; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu Z, 2010, ACTA VIROL, V54, P113, DOI 10.4149/av_2010_02_113; Yasugi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003150; Yasugi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030946	50	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77892	10.1371/journal.pone.0077892	http://dx.doi.org/10.1371/journal.pone.0077892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147093	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400141
J	Pereira-Fernandes, A; Demaegdt, H; Vandermeiren, K; Hectors, TLM; Jorens, PG; Blust, R; Vanparys, C				Pereira-Fernandes, Anna; Demaegdt, Heidi; Vandermeiren, Karine; Hectors, Tine L. M.; Jorens, Philippe G.; Blust, Ronny; Vanparys, Caroline			Evaluation of a Screening System for Obesogenic Compounds: Screening of Endocrine Disrupting Compounds and Evaluation of the PPAR Dependency of the Effect	PLOS ONE			English	Article							BISPHENOL-A; ADIPOCYTE DIFFERENTIATION; IN-VITRO; ORGANOTIN COMPOUNDS; MUSK COMPOUNDS; STROMAL CELLS; ADIPOGENESIS; CHEMICALS; PHTHALATE; GAMMA	Recently the environmental obesogen hypothesis has been formulated, proposing a role for endocrine disrupting compounds (EDCs) in the development of obesity. To evaluate this hypothesis, a screening system for obesogenic compounds is urgently needed. In this study, we suggest a standardised protocol for obesogen screening based on the 3T3-L1 cell line, a well-characterised adipogenesis model, and direct fluorescent measurement using Nile red lipid staining technique. In a first phase, we characterised the assay using the acknowledged obesogens rosiglitazone and tributyltin. Based on the obtained dose-response curves for these model compounds, a lipid accumulation threshold value was calculated to ensure the biological relevance and reliability of statistically significant effects. This threshold based method was combined with the well described strictly standardized mean difference (SSMD) method for classification of non-, weak-or strong obesogenic compounds. In the next step, a range of EDCs, used in personal and household care products (parabens, musks, phthalates and alkylphenol compounds), were tested to further evaluate the obesogenicity screening assay for its discriminative power and sensitivity. Additionally, the peroxisome proliferator activated receptor gamma (PPAR gamma) dependency of the positive compounds was evaluated using PPAR. activation and antagonist experiments. Our results showed the adipogenic potential of all tested parabens, several musks and phthalate compounds and bisphenol A (BPA). PPAR gamma activation was associated with adipogenesis for parabens, phthalates and BPA, however not required for obesogenic effects induced by Tonalide, indicating the role of other obesogenic mechanisms for this compound.	[Pereira-Fernandes, Anna; Hectors, Tine L. M.; Blust, Ronny; Vanparys, Caroline] Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Dept Biol, B-2020 Antwerp, Belgium; [Demaegdt, Heidi; Vandermeiren, Karine] Chem Safety Food Chain Vet & Agrochem Res Ctr COD, Brussels, Belgium; [Jorens, Philippe G.] Univ Antwerp, Dept Clin Pharmacol Clin Toxicol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Pereira-Fernandes, A (corresponding author), Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Dept Biol, B-2020 Antwerp, Belgium.	Anna.Pereira-Fernandes@ua.ac.be		Demaegdt, Heidi/0000-0001-6384-8824; Vandermeiren, Karine/0000-0002-3770-3450	University of Antwerp [FA020000/2/3565]; 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium)	University of Antwerp; 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a GOA project (Endocrine disrupting environmental chemicals: From accumulation to their role in the global "neuro-endocrine" epidemic of obesity and its metabolic consequences; FA020000/2/3565) of the University of Antwerp. APF acknowledges the 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233; Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Delgado-Saborit JM, 2011, ENVIRON INT, V37, P383, DOI 10.1016/j.envint.2010.10.011; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Hao Chanjuan, 2013, Front Biosci (Elite Ed), V5, P725; Harvey PW, 2006, BEST PRACT RES CL EN, V20, P145, DOI 10.1016/j.beem.2005.09.008; Harvey PW, 2004, J APPL TOXICOL, V24, P167, DOI 10.1002/jat.978; Hassan M, 2007, BIOCHEM BIOPH RES CO, V361, P208, DOI 10.1016/j.bbrc.2007.07.021; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Hu P, 2013, TOXICOL SCI, V131, P56, DOI 10.1093/toxsci/kfs262; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Janesick A, 2011, J STEROID BIOCHEM, V127, P4, DOI 10.1016/j.jsbmb.2011.01.005; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kannan K, 2005, CHEMOSPHERE, V61, P693, DOI 10.1016/j.chemosphere.2005.03.041; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Li X, 2012, ENVIRON HEALTH PERSP, V120, P1720, DOI 10.1289/ehp.1205383; Li X, 2011, J STEROID BIOCHEM, V127, P9, DOI 10.1016/j.jsbmb.2011.03.012; Masuno H, 2002, J LIPID RES, V43, P676; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Masuno H, 2003, TOXICOL SCI, V75, P314, DOI 10.1093/toxsci/kfg203; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; Moon HB, 2012, CHEMOSPHERE, V86, P485, DOI 10.1016/j.chemosphere.2011.10.008; Muller S, 1996, CHEMOSPHERE, V33, P17, DOI 10.1016/0045-6535(96)00160-9; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; OECD, 2012, OECD ENV HLTH SAF PU; *OSPAR, 2004, FRONT BIOSCI ELITE E, P1465; Pereira-Fernandes A, 2013, MOL CELL ENDOCRINOL, V370, P52, DOI 10.1016/j.mce.2013.02.011; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Rimkus GG, 1996, CHEMOSPHERE, V33, P2033, DOI 10.1016/0045-6535(96)00321-9; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Schiavone A, 2010, ENVIRON POLLUT, V158, P599, DOI 10.1016/j.envpol.2009.08.011; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Taxvig C, 2012, MOL CELL ENDOCRINOL, V361, P106, DOI 10.1016/j.mce.2012.03.021; van Meeuwen JA, 2008, TOXICOL APPL PHARM, V230, P372, DOI 10.1016/j.taap.2008.03.002; Vanparys C, 2006, TOXICOL IN VITRO, V20, P1238, DOI 10.1016/j.tiv.2006.05.002; Vanparys C, 2010, SCI TOTAL ENVIRON, V408, P4451, DOI 10.1016/j.scitotenv.2010.06.049; Wang YF, 2010, BIOTECHNOL LETT, V32, P1789, DOI 10.1007/s10529-010-0359-9; Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	54	111	114	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77481	10.1371/journal.pone.0077481	http://dx.doi.org/10.1371/journal.pone.0077481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155963	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300097
J	Lalle, M; Leptourgidou, F; Camerini, S; Pozio, E; Skoulakis, EMC				Lalle, Marco; Leptourgidou, Flora; Camerini, Serena; Pozio, Edoardo; Skoulakis, Efthimios M. C.			Interkingdom Complementation Reveals Structural Conservation and Functional Divergence of 14-3-3 Proteins	PLOS ONE			English	Article							GIARDIA; BINDING; POLYGLYCYLATION; PHOSPHORYLATION; MUTANTS; NEURONS	The 14-3-3s are small acidic cytosolic proteins that interact with multiple clients and participate in essential cellular functions in all eukaryotes. Available structural and functional information about 14-3-3s is largely derived from higher eukaryotes, which contain multiple members of this protein family suggesting functional specialization. The exceptional sequence conservation among 14-3-3 family members from diverse species suggests a common ancestor for 14-3-3s, proposed to have been similar to modern 14-3-3 epsilon isoforms. Structural features of the sole family member from the protozoan Giardia duodenalis (g14-3-3), are consistent with this hypothesis, but whether g14-3-3 is functionally homologous to the epsilon isoforms is unknown. We use inter-kingdom reciprocal functional complementation and biochemical methods to determine whether g14-3-3 is structurally and functionally homologous with members of the two 14-3-3 conservation groups of the metazoan Drosophila melanogaster. Our results indicate that although g14-3-3 is structurally homologous to D14-3-3 epsilon, functionally it diverges presenting characteristics of other 14-3-3s. Given the basal position of Giardia in eukaryotic evolution, this finding is consistent with the hypothesis that 14-3-3 epsilon isoforms are ancestral to other family members.	[Lalle, Marco; Pozio, Edoardo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Leptourgidou, Flora; Skoulakis, Efthimios M. C.] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Camerini, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Alexander Fleming Biomedical Sciences Research Center; Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Camerini, Serena/A-4637-2017; Lalle, Marco/O-2287-2015	Camerini, Serena/0000-0001-6131-4335; Lalle, Marco/0000-0001-5168-2150	Hellenic general Secretariat for Research and Technology	Hellenic general Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	Initial stages of the work were funded by the Hellenic general Secretariat for Research and Technology. Later phases and presently there are no funds supporting this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bre MH, 1996, J CELL SCI, V109, P727; Elmendorf HG, 2000, MOL BIOCHEM PARASIT, V106, P315, DOI 10.1016/S0166-6851(99)00219-4; Ferl RJ, 2002, GENOME BIOL, V3; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lalle M, 2011, J BIOL CHEM, V286, P4471, DOI 10.1074/jbc.M110.181511; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lane S, 2002, CRIT REV MICROBIOL, V28, P123, DOI 10.1080/10408410490435133; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Messaritou G, 2010, J BIOL CHEM, V285, P1692, DOI 10.1074/jbc.M109.045989; Messaritou G, 2009, FEBS LETT, V583, P2934, DOI 10.1016/j.febslet.2009.08.003; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nino CA, 2003, PARASITOL INT, V52, P291, DOI 10.1016/S1383-5769(03)00032-1; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Tsigkari KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036702; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang WF, 1996, J MOL EVOL, V43, P384; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	36	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78090	10.1371/journal.pone.0078090	http://dx.doi.org/10.1371/journal.pone.0078090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147113	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400142
J	Matsuda, H; Parsons, MJ; Leach, SD				Matsuda, Hiroki; Parsons, Michael J.; Leach, Steven D.			Aldh1-Expressing Endocrine Progenitor Cells Regulate Secondary Islet Formation in Larval Zebrafish Pancreas	PLOS ONE			English	Article							HORMONE-EXPRESSING CELLS; EXOCRINE PANCREAS; CONSERVED ROLE; STEM-CELLS; BETA-CELLS; DIFFERENTIATION; SYSTEM; MOUSE; PTF1A; PDX1	Aldh1 expression is known to mark candidate progenitor populations in adult and embryonic mouse pancreas, and Aldh1 enzymatic activity has been identified as a potent regulator of pancreatic endocrine differentiation in zebrafish. However, the location and identity of Aldh1-expressing cells in zebrafish pancreas remain unknown. In this study we demonstrate that Aldh1-expressing cells are located immediately adjacent to 2F11-positive pancreatic ductal epithelial cells, and that their abundance dramatically increases during zebrafish secondary islet formation. These cells also express neurod, a marker of endocrine progenitor cells, but do not express markers of more mature endocrine cells such as pax6b or insulin. Using formal cre/lox-based lineage tracing, we further show that Aldh1-expressing pancreatic epithelial cells are the direct progeny of pancreatic notch-responsive progenitor cells, identifying them as a critical intermediate between multi-lineage progenitors and mature endocrine cells. Pharmacologic manipulation of Aldh1 enzymatic activity accelerates cell entry into the Aldh1-expressing endocrine progenitor pool, and also leads to the premature maturation of these cells, as evidenced by accelerated pax6b expression. Together, these findings suggest that Aldh1-expressing cells act as both participants and regulators of endocrine differentiation during zebrafish secondary islet formation.	[Leach, Steven D.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Leach, SD (corresponding author), Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA.	stleach@jhmi.edu	Matsuda, Hiroki/K-5055-2019		NIH [DK56211, RR027443, HD058530, DK080730, DK090816]; JDRF [17-2012-408]; Paul K. Neumann Professorship at Johns Hopkins University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080730, R01DK056211, P30DK079637, RC4DK090816] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Paul K. Neumann Professorship at Johns Hopkins University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK56211 and RR027443 (to SDL), NIH HD058530 (to SDL and MJP), NIH grants DK080730 and DK090816 (to MJP), and JDRF 17-2012-408 (to MJP). SDL is also supported by the Paul K. Neumann Professorship at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Ioannou M, 2013, DEV BIOL, V374, P153, DOI 10.1016/j.ydbio.2012.10.030; Kimmel RA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-75; Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; Mastracci TL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003278; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Rieck S, 2012, SEMIN CELL DEV BIOL, V23, P673, DOI 10.1016/j.semcdb.2012.06.005; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Wang A, 2012, J MOL MED, V90, P763, DOI 10.1007/s00109-012-0923-y; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; Yee NS, 2001, GENESIS, V30, P137, DOI 10.1002/gene.1049; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74350	10.1371/journal.pone.0074350	http://dx.doi.org/10.1371/journal.pone.0074350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24147152	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300035
J	Luis-Ravelo, D; Anton, I; Zandueta, C; Valencia, K; Ormazabal, C; Martinez-Canarias, S; Guruceaga, E; Perurena, N; Vicent, S; De Las Rivas, J; Lecanda, F				Luis-Ravelo, D.; Anton, I.; Zandueta, C.; Valencia, K.; Ormazabal, C.; Martinez-Canarias, S.; Guruceaga, E.; Perurena, N.; Vicent, S.; De Las Rivas, J.; Lecanda, F.			A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer	ONCOGENE			English	Article						HDAC4; PITX1; ROBO1; microenvironment; osteoclastogenesis; MMP; outcome	HORMONE-RELATED PROTEIN; GROWTH-FACTOR-BETA; HISTONE DEACETYLASE-4; EXPRESSION; PITX1; RECEPTOR; ADENOCARCINOMA; ACTIVATION; KINASE; CELLS	Bone metastasis of lung adenocarcinoma (AC) is a frequent complication of advanced disease. The purpose of this study was to identify key mediators conferring robust prometastatic activity with clinical significance. We isolated highly metastatic subpopulations (HMS) using a previously described in vivo model of lung AC bone metastasis. We performed transcriptomic profiling of HMS and stringent bioinformatics filtering. Functional validation was assessed by overexpression and lentiviral silencing of single, double and triple combination in vivo and in vitro. We identified HDAC4, PITX1 and ROBO1 that decreased bone metastatic ability after their simultaneous abrogation. These effects were solely linked to defects in osseous colonization. The molecular mechanisms related to bone colonization were mediated by non-cell autonomous effects that include the following: (1) a marked decrease in osteoclastogenic activity in vitro and in vivo, an effect associated with reduced pro-osteoclastogenic cytokines IL-11 and PTHrP expression levels, as well as decreased in vitro expression of stromal rankl in conditions mimicking tumor-stromal interactions; (2) an abrogated response to TGF-beta signaling by decreased phosphorylation and levels of Smad2/3 in tumor cells and (3) an impaired metalloproteolytic activity in vitro. Interestingly, coexpression of HDAC4 and PITX1 conferred high prometastatic activity in vivo. Further, levels of both genes correlated with patients at higher risk of metastasis in a clinical lung AC data set and with a poorer clinical outcome. These findings provide functional and clinical evidence that this metastatic subset is an important determinant of osseous colonization. These data suggest novel therapeutic targets to effectively block lung AC bone metastasis.	[Luis-Ravelo, D.; Anton, I.; Zandueta, C.; Valencia, K.; Ormazabal, C.; Martinez-Canarias, S.; Perurena, N.; Vicent, S.; Lecanda, F.] Univ Navarra, Div Oncol, Adhes & Metastasis Lab, E-31080 Pamplona, Spain; [Guruceaga, E.] Univ Navarra, Ctr Appl Med Res CIMA, Bioinformat & Prote Unit, E-31080 Pamplona, Spain; [Vicent, S.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [De Las Rivas, J.] Univ Salamanca CSIC USAL, Canc Res Ctr, Bioinformat & Funct Genom Res Grp, Salamanca, Spain	University of Navarra; University of Navarra; University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Lecanda, F (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	flecanda@unav.es	Valencia, Karmele/I-8729-2017; De Las Rivas, Javier/G-5936-2014; Vicent, Silvestre/K-4261-2017; Guruceaga, Elizabeth/B-1796-2008	Valencia, Karmele/0000-0002-2882-7427; De Las Rivas, Javier/0000-0002-0984-9946; Vicent, Silvestre/0000-0002-9457-6881; Perurena, Naiara/0000-0003-0874-3389; Zandueta Pascual, Carolina/0000-0002-7931-8649; Luis-Ravelo, Diego/0000-0003-2876-9762; Guruceaga, Elizabeth/0000-0003-0547-681X	'UTE project FIMA' agreement, The Cancer Research Thematic Network of the Health Institute Carlos III [RTICC RD06/0020/0066, PI042282, SAF-2009-11280, SAF2012-40056]; Government of Navarra [67/2005, 09/2009]; La Caixa Foundation; FIMA; FPU; Basque Government; FIS-ISCIII grant [PI12/00624]; Ramon y Cajal Program (MICINN) [RYC-2011-09042]	'UTE project FIMA' agreement, The Cancer Research Thematic Network of the Health Institute Carlos III; Government of Navarra; La Caixa Foundation(La Caixa Foundation); FIMA; FPU(Spanish Government); Basque Government(Basque Government); FIS-ISCIII grant; Ramon y Cajal Program (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We are grateful to the Core Histology Unit and Imaging Group facilities for their outstanding technical assistance. We also thank the Proteomics, Genomics and Bioinformatics Unit at the CIMA. This work was supported by 'UTE project FIMA' agreement, The Cancer Research Thematic Network of the Health Institute Carlos III (RTICC RD06/0020/0066), PI042282, SAF-2009-11280, SAF2012-40056, grants 67/2005 and 09/2009 from the Government of Navarra, and 'La Caixa Foundation' to FL. DL-R was supported by the FIMA and FPU. IA was funded by the Basque Government. JDLR was supported by FIS-ISCIII grant PI12/00624. SV is an investigator of the Ramon y Cajal Program (MICINN, RYC-2011-09042).	Anton I, 2012, AM J RESP CRIT CARE, V186, P96, DOI 10.1164/rccm.201110-1826OC; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Catena R, 2011, CANCER RES, V71, P164, DOI 10.1158/0008-5472.CAN-10-1708; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Fry WA, 1996, CANCER, V77, P1947, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hernandez I, 2010, ONCOGENE, V29, P3758, DOI 10.1038/onc.2010.130; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; LECANDA F, 2011, DRUG DISCOV TODAY DI, V8, P87; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luis-Ravelo D, 2011, CLIN EXP METASTAS, V28, P779, DOI 10.1007/s10585-011-9409-5; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Reddy SDN, 2012, J BIOL CHEM, V287, P27843, DOI 10.1074/jbc.M112.348474; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yang XM, 2010, BIOCHEM BIOPH RES CO, V396, P571, DOI 10.1016/j.bbrc.2010.04.152; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	38	32	32	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5090	5099		10.1038/onc.2013.440	http://dx.doi.org/10.1038/onc.2013.440			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24166494				2022-12-25	WOS:000343768400004
J	Zheng, XQ; Guo, JP; Yang, H; Kanai, M; He, LL; Li, YY; Koomen, JM; Minton, S; Gao, M; Ren, XB; Coppola, D; Cheng, JQ				Zheng, X. Q.; Guo, J. P.; Yang, H.; Kanai, M.; He, L. L.; Li, Y. Y.; Koomen, J. M.; Minton, S.; Gao, M.; Ren, X. B.; Coppola, D.; Cheng, J. Q.			Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ER alpha in breast cancer	ONCOGENE			English	Article						Aurora-A; tamoxifen resistance; ER alpha; phosphorylation; transcriptional activation	ESTROGEN-RECEPTOR-ALPHA; ANTIESTROGEN RESISTANCE; ENDOCRINE RESISTANCE; MAMMARY EPITHELIUM; SERINE 305; KINASE; AMPLIFICATION; EXPRESSION; CELLS; OVEREXPRESSION	Despite the clinical success of tamoxifen, its resistance remains a major challenge in breast cancer. Here we show that Aurora-A determines tamoxifen sensitivity by regulation of oestrogen receptor (ER)alpha. Ectopic expression of Aurora-A decreases and depletion of Aurora-A enhances tamoxifen sensitivity in ER alpha-positive breast cancer. Elevated Aurora-A was significantly associated with the recurrence of ER alpha-positive tumours. Notably, Aurora-A inhibitor MLN8237, which is currently in clinical trial, synergizes with tamoxifen and overcomes tamoxifen resistance. Furthermore, Aurora-A interacts with and phosphorylates ER alpha on serine-167 and -305, leading to increase in ER alpha DNA-binding and transcriptional activity. Elevated levels of Aurora-A are significantly associated with disease-free survival in ER alpha-positive but not ER alpha-negative breast cancers. These data suggest that Aurora-A has a pivotal role in tamoxifen resistance and ER alpha is a bona fide substrate of Aurora-A. Thus, Aurora-A represents a prognostic marker in ER alpha-positive tumour and a critical therapeutic target in tamoxifen-resistant breast cancer, and Aurora-A inhibitor could be used as either an independent or concurrent agent in tamoxifen-resistant tumour.	[Zheng, X. Q.; Guo, J. P.; Yang, H.; Kanai, M.; He, L. L.; Li, Y. Y.; Koomen, J. M.; Cheng, J. Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Zheng, X. Q.; Gao, M.] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Thyroid,Oncol Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zheng, X. Q.; Gao, M.] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Neck Tumour,Oncol Key Lab Canc Prevent & The, Tianjin, Peoples R China; [Zheng, X. Q.; Ren, X. B.] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Immunol,Oncol Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Minton, S.] H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Minton, S.; Coppola, D.] Res Inst, Tampa, FL USA; [Coppola, D.] H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Pathol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Zheng, XQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	Kanai, Motomu/J-6807-2016	Kanai, Motomu/0000-0003-1977-7648	NIH [CA160455]; Florida James and Esther King Biomedical Research Program [1KG02]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA160455, R01CA137041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate Dr Kenji Fukasawa for his scientific input. We are grateful for Tissue Procurement, DNA Sequence, Proteomics and Image Core Facilities at H. Lee Moffitt Cancer Center for providing cancer specimens, sequencing and cell apoptosis analysis. This work was partially supported by grants from NIH grant CA160455 (JQC) and Florida James and Esther King Biomedical Research Program 1KG02 (JQC).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; Bodvarsdottir SK, 2007, CANCER LETT, V248, P96, DOI 10.1016/j.canlet.2006.06.003; Bostner J, 2007, ONCOGENE, V26, P6997, DOI 10.1038/sj.onc.1210506; Bostner J, 2010, CLIN CANCER RES, V16, P1624, DOI 10.1158/1078-0432.CCR-09-1733; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cutrupi S, 2012, ONCOGENE, V31, P4353, DOI 10.1038/onc.2011.627; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Holm C, 2009, J PATHOL, V217, P372, DOI 10.1002/path.2455; Holz MK, 2012, CELL CYCLE, V11, P3159, DOI 10.4161/cc.21194; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kok M, 2011, BREAST CANCER RES TR, V125, P1, DOI 10.1007/s10549-010-0798-y; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Li QY, 2004, J BIOL CHEM, V279, P52175, DOI 10.1074/jbc.M406802200; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Lundgren K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3161; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Ohishi T, 2010, CANCER RES, V70, P2041, DOI 10.1158/0008-5472.CAN-09-2008; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qi WQ, 2011, BIOCHEM PHARMACOL, V81, P881, DOI 10.1016/j.bcp.2011.01.017; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Sehdev V, 2012, MOL CANCER THER, V11, P763, DOI 10.1158/1535-7163.MCT-11-0623; TONETTI DA, 1995, ANTI-CANCER DRUG, V6, P498, DOI 10.1097/00001813-199508000-00002; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Warner SL, 2003, MOL CANCER THER, V2, P589; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907	44	25	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					4985	4996		10.1038/onc.2013.444	http://dx.doi.org/10.1038/onc.2013.444			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24166501	Green Accepted			2022-12-25	WOS:000343768000003
J	Long, JY; Badal, SS; Wang, Y; Chang, BHJ; Rodriguez, A; Danesh, FR				Long, Jianyin; Badal, Shawn S.; Wang, Yin; Chang, Benny H. J.; Rodriguez, Antony; Danesh, Farhad R.			MicroRNA-22 Is a Master Regulator of Bone Morphogenetic Protein-7/6 Homeostasis in the Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Fibrosis; Gene Regulation; Kidney; MicroRNA	RENAL INTERSTITIAL FIBROSIS; UP-REGULATION; MESENCHYMAL TRANSITION; GENE-EXPRESSION; IDENTIFICATION; MECHANISMS; ID1; TESTOSTERONE; ACTIVATION; INHIBITION	Background: BMPs have emerged as key regulators of kidney fibrosis. Results: Deletion of miR-22 attenuated renal fibrosis via direct targeting of BMP-7/6. BMP-7/6 in turn transcriptionally regulates miR-22 expression. Conclusion: miR-22 and BMP-7/6 form a negative feedback circuit. Significance: The present study is the first to report the effect of miR-22 on BMP signaling and kidney fibrosis. Accumulating evidence suggests that microRNAs (miRNAs) contribute to a myriad of kidney diseases. However, the regulatory role of miRNAs on the key molecules implicated in kidney fibrosis remains poorly understood. Bone morphogenetic protein-7 (BMP-7) and its related BMP-6 have recently emerged as key regulators of kidney fibrosis. Using the established unilateral ureteral obstruction (UUO) model of kidney fibrosis as our experimental model, we examined the regulatory role of miRNAs on BMP-7/6 signaling. By analyzing the potential miRNAs that target BMP-7/6 in silica, we identified miR-22 as a potent miRNA targeting BMP-7/6. We found that expression levels of BMP-7/6 were significantly elevated in the kidneys of the miR-22 null mouse. Importantly, mice with targeted deletion of miR-22 exhibited attenuated renal fibrosis in the UUO model. Consistent with these in vivo observations, primary renal fibroblast isolated from miR-22-deficient UUO mice demonstrated a significant increase in BMP-7/6 expression and their downstream targets. This phenotype could be rescued when cells were transfected with miR-22 mimics. Interestingly, we found that miR-22 and BMP-7/6 are in a regulatory feedback circuit, whereby not only miR-22 inhibits BMP-7/6, but miR-22 by itself is induced by BMP-7/6. Finally, we identified two BMP-responsive elements in the proximal region of miR-22 promoter. These findings identify miR-22 as a critical miRNA that contributes to renal fibrosis on the basis of its pivotal role on BMP signaling cascade.	[Long, Jianyin; Badal, Shawn S.; Wang, Yin; Danesh, Farhad R.] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Houston, TX 77030 USA; [Badal, Shawn S.; Danesh, Farhad R.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rodriguez, Antony] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Univ Texas MD Anderson Canc Ctr, Nephrol Sect, 1515 Holcombe Blvd, Houston, TX 77030 USA.	fdanesh@mdanderson.org		Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health [RO1DK091310, RO1DK078900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091310, R01DK078900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK091310 and RO1DK078900 (to F.R.D.).	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bar N., 2010, PLOS ONE, V5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd; Blitz IL, 2009, DEV DYNAM, V238, P1321, DOI 10.1002/dvdy.21984; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Grimwood Lauren, 2009, V466, P25, DOI 10.1007/978-1-59745-352-3_3; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jenkins RH, 2011, AM J PATHOL, V178, P964, DOI 10.1016/j.ajpath.2010.12.010; Jian P, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-20; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Weiskirchen R, 2009, FRONT BIOSCI, V14, P4992, DOI 10.2741/3583; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	63	41	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36202	36214		10.1074/jbc.M113.498634	http://dx.doi.org/10.1074/jbc.M113.498634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24163368	hybrid, Green Published			2022-12-25	WOS:000328883400003
J	Valtcheva, N; Primorac, A; Jurisic, G; Hollmen, M; Detmar, M				Valtcheva, Nadejda; Primorac, Adriana; Jurisic, Giorgia; Hollmen, Maija; Detmar, Michael			The Orphan Adhesion G Protein-coupled Receptor GPR97 Regulates Migration of Lymphatic Endothelial Cells via the Small GTPases RhoA and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Adhesion; Cytoskeleton; Endothelial Cell; Integrin; Lymphangiogenesis; Pb99; Wound Healing Assay	GPCRS; LYMPHANGIOGENESIS; ACTIVATION; GPR56; ROLES; ANGIOGENESIS; PROGRESSION; MECHANISMS; VESSELS; PATHWAY	Background: The identification of G protein-coupled receptors (GPCRs) specific for the lymphatic endothelial cells (LECs) is essential for establishing drugs targeting the lymphatic system. Results: GPR97 is an orphan adhesion GPCR that regulates LEC migration. Conclusion: GPR97 is the first known adhesion GPCR involved in lymphatic remodeling. Significance: This first evidence that adhesion GPCRs govern LEC motility opens new possibilities for modulating lymphangiogenesis. The important role of the lymphatic vascular system in pathological conditions such as inflammation and cancer has been increasingly recognized, but its potential as a pharmacological target is poorly exploited. Our study aimed at the identification and molecular characterization of lymphatic-specific G protein-coupled receptors (GPCRs) to assess new targets for pharmacological manipulation of the lymphatic vascular system. We used a TaqMan quantitative RT-PCR-based low density array to determine the GPCR expression profiles of ex vivo isolated intestinal mouse lymphatic (LECs) and blood vascular endothelial cells (BECs). GPR97, an orphan adhesion GPCR of unknown function, was the most highly and specifically expressed GPCR in mouse lymphatic endothelium. Using siRNA silencing, we found that GPR97-deficient primary human LECs displayed increased adhesion and collective cell migration, whereas single cell migration was decreased as compared with nontargeting siRNA-transfected control LECs. Loss of GPR97 shifted the ratio of active Cdc42 and RhoA and initiated cytoskeletal rearrangements, including F-actin redistribution, paxillin and PAK4 phosphorylation, and 1-integrin activation. Our data suggest a possible role of GPR97 in lymphatic remodeling and furthermore provide the first insights into the biological functions of GPR97.	[Valtcheva, Nadejda; Primorac, Adriana; Jurisic, Giorgia; Hollmen, Maija; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Detmar, M (corresponding author), ETH, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Wolfgang Pauli Str 10,HCI H303, CH-8093 Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Hollmén, Maija/B-5831-2017	Hollmén, Maija/0000-0002-3250-7653; Jurisic Snijder, Giorgia/0000-0002-2102-8593	Swiss National Science Foundation Grant [31003A-130627]; European Research Council Grant LYVICAM; Oncosuisse, Krebsliga Zurich; Leducq Foundation	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); European Research Council Grant LYVICAM; Oncosuisse, Krebsliga Zurich; Leducq Foundation(Leducq Foundation)	This work was supported by Swiss National Science Foundation Grant 31003A-130627, European Research Council Grant LYVICAM, Oncosuisse, Krebsliga Zurich, and the Leducq Foundation.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Fredriksson R, 2002, FEBS LETT, V531, P407, DOI 10.1016/S0014-5793(02)03574-3; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Kong TQ, 2009, MOL BIOL CELL, V20, P4596, DOI 10.1091/mbc.E09-03-0220; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Mizuno N, 2010, ADV EXP MED BIOL, V706, P157; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Sleckman BP, 2000, MOL CELL BIOL, V20, P4405, DOI 10.1128/MCB.20.12.4405-4410.2000; Takashima S, 2008, CARDIOVASC RES, V79, P689, DOI 10.1093/cvr/cvn118; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2010, ADV EXP MED BIOL, V706, P121	45	42	45	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35736	35748		10.1074/jbc.M113.512954	http://dx.doi.org/10.1074/jbc.M113.512954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178298	Green Published, hybrid			2022-12-25	WOS:000329814700012
J	Jung, DY; Chalasani, U; Pan, N; Friedline, RH; Prosdocimo, DA; Nam, M; Azuma, Y; Maganti, R; Yu, K; Velagapudi, A; O'Sullivan-Murphy, B; Sartoretto, JL; Jain, MK; Cooper, MP; Urano, F; Kim, JK; Gray, S				Jung, Dae Young; Chalasani, UmaDevi; Pan, Ning; Friedline, Randall H.; Prosdocimo, Domenick A.; Nam, Minwoo; Azuma, Yoshihiro; Maganti, Rajanikanth; Yu, Kristine; Velagapudi, Ashish; O'Sullivan-Murphy, Bryan; Sartoretto, Juliano L.; Jain, Mukesh K.; Cooper, Marcus P.; Urano, Fumihiko; Kim, Jason K.; Gray, Susan			KLF15 Is a Molecular Link between Endoplasmic Reticulum Stress and Insulin Resistance	PLOS ONE			English	Article							ER STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; AUTOPHAGY; ACTIVATION; OBESITY; MTOR; KINASE; ATF6; CELL	Obesity places major demands on the protein folding capacity of the endoplasmic reticulum (ER), resulting in ER stress, a condition that promotes hepatic insulin resistance and steatosis. Here we identify the transcription factor, Kruppel-like factor 15 (KLF15), as an essential mediator of ER stress-induced insulin resistance in the liver. Mice with a targeted deletion of KLF15 exhibit increased hepatic ER stress, inflammation, and JNK activation compared to WT mice; however, KLF15(-/-) mice are protected against hepatic insulin resistance and fatty liver under high-fat feeding conditions and in response to pharmacological induction of ER stress. The mammalian target of rapamycin complex 1 (mTORC1), a key regulator of cellular energy homeostasis, has been shown to cooperate with ER stress signaling pathways to promote hepatic insulin resistance and lipid accumulation. We find that the uncoupling of ER stress and insulin resistance in KLF15(-/-) liver is associated with the maintenance of a low energy state characterized by decreased mTORC1 activity, increased AMPK phosphorylation and PGC-1 alpha expression and activation of autophagy, an intracellular degradation process that enhances hepatic insulin sensitivity. Furthermore, in primary hepatocytes, KLF15 deficiency markedly inhibits activation of mTORC1 by amino acids and insulin, suggesting a mechanism by which KLF15 controls mTORC1-mediated insulin resistance. This study establishes KLF15 as an important molecular link between ER stress and insulin action.	[Jung, Dae Young; Chalasani, UmaDevi; Friedline, Randall H.; Azuma, Yoshihiro; Maganti, Rajanikanth; Yu, Kristine; Velagapudi, Ashish; Sartoretto, Juliano L.; Kim, Jason K.; Gray, Susan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Div Endocrinol Metab & Diabet, Worcester, MA USA; [Nam, Minwoo; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA USA; [Pan, Ning; O'Sullivan-Murphy, Bryan; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Urano, Fumihiko] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sartoretto, Juliano L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gray, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Susan.Gray@umassmed.edu	Urano, Fumihiko/AAF-4492-2020	O'Sullivan-Murphy, Bryan/0000-0002-1426-5013; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [DK080742, DK080756, DK090963, DK067493, DK016746, P60 DK020579, RR024992, UL1 TR000448, DK089185, HL072952, HL084154, T32HL105338, F32HL110538]; JDRF [11-2011-40]; National Center for Research Resources [S10RR027897]; UMass Mouse Metabolic Phenotyping Center (NIH) [U24-DK093000]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110538, R01HL072952, T32HL105338, R01HL084154, R01HL112486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK093000, R24DK090963, R01DK080742, R01DK016746, R37DK016746, R01DK089185, R01DK080756, P30DK020579, P60DK020579, R01DK067493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UMass Mouse Metabolic Phenotyping Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK080742 to S. G., DK080756 and DK090963 to J.K.K., DK067493, DK016746, P60 DK020579, RR024992, and UL1 TR000448 to F. U., DK089185 to M. P. C., HL072952 and HL084154 to M.K.J., T32HL105338 and F32HL110538 to D. A. P. and by JDRF grant (11-2011-40) to F. U. Electron microscopy was performed at the Core Electron Microscopy Facility at UMass Medical School with support from the National Center for Research Resources (Award #S10RR027897). Part of this study was conducted by the UMass Mouse Metabolic Phenotyping Center (NIH Award #U24-DK093000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brey CW, 2009, INT J BIOL SCI, V5, P622; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	59	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77851	10.1371/journal.pone.0077851	http://dx.doi.org/10.1371/journal.pone.0077851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167585	Green Published, gold			2022-12-25	WOS:000326034500044
J	Rellstab, C; Karvonen, A; Louhi, KR; Jokela, J				Rellstab, Christian; Karvonen, Anssi; Louhi, Katja-Riikka; Jokela, Jukka			Genotype-Specific vs. Cross-Reactive Host Immunity against a Macroparasite	PLOS ONE			English	Article							COMPLEX LIFE-CYCLE; DIPLOSTOMUM-SPATHACEUM; PROTECTIVE IMMUNITY; EYE FLUKES; ONCORHYNCHUS-MYKISS; GENETIC DIVERSITY; SPATIAL VARIATION; RAINBOW-TROUT; TRADE-OFFS; RED QUEEN	Vertebrate hosts often defend themselves against several co-infecting parasite genotypes simultaneously. This has important implications for the ecological dynamics and the evolution of host defence systems and parasite strategies. For example, it can drive the specificity of the adaptive immune system towards high genotype-specificity or cross-reactivity against several parasite genotypes depending on the sequence and probability of re-infections. However, to date, there is very little evidence on these interactions outside mammalian disease literature. In this study we asked whether genotype-specific or cross-reactive responses dominate in the adaptive immune system of a fish host towards a common macroparasite. In other words, we investigated if the infection success of a parasite genotype is influenced by the immunization genotype. We reciprocally immunized and re-exposed rainbow trout (Oncorhynchus mykiss) to a range of genotypes of the trematode eye fluke Diplostomum pseudospathaceum, and measured infection success of the parasite. We found that the infection success of the parasite genotypes in the re-exposure did not depend on the immunization genotype. While immunization reduced average infection success by 31%, the reduction was not larger against the initial immunization genotype. Our results suggest significant cross-reactivity, which may be advantageous for the host in genetically diverse re-exposures and have significant evolutionary implications for parasite strategies. Overall, our study is among the first to demonstrate cross-reactivity of adaptive immunity against genetically diverse macroparasites with complex life cycles.	[Rellstab, Christian; Karvonen, Anssi; Louhi, Katja-Riikka] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Rellstab, Christian] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Jokela, Jukka] Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Jokela, Jukka] ETH, Inst Integrat Biol, Zurich, Switzerland	University of Jyvaskyla; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Jokela, J (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	jukka.jokela@eawag.ch	Rellstab, Christian/D-6460-2012	Rellstab, Christian/0000-0002-0221-5975; Jokela, Jukka/0000-0002-1731-727X; Karvonen, Anssi/0000-0002-2731-3344	Academy of Finland's Centre of Excellence in Evolutionary Research	Academy of Finland's Centre of Excellence in Evolutionary Research(Academy of Finland)	The study was funded by the Academy of Finland's Centre of Excellence in Evolutionary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran S, 2011, J EVOLUTION BIOL, V24, P554, DOI 10.1111/j.1420-9101.2010.02190.x; Byers JE, 2008, ECOLOGY, V89, P439, DOI 10.1890/06-1036.1; Chappell L.H., 1994, P59; Criscione CD, 2004, EVOLUTION, V58, P198, DOI 10.1111/j.0014-3820.2004.tb01587.x; DUPASQUIER L, 1982, NATURE, V296, P311, DOI 10.1038/296311a0; Eisen DP, 2002, AM J TROP MED HYG, V67, P8, DOI 10.4269/ajtmh.2002.67.8; Faltynkova A, 2008, PARASITOLOGY, V135, P1691, DOI 10.1017/S0031182008005027; Faltynkova A, 2009, PARASITOLOGY, V136, P1375, DOI 10.1017/S0031182009990862; GOYAL PK, 1993, PARASITOLOGY, V107, P311, DOI 10.1017/S0031182000079282; Hamilton W.D., 1982, Life Sciences Research Report, P269; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; JOKELA J, 1995, OECOLOGIA, V103, P509, DOI 10.1007/BF00328690; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Karvonen A, 2005, PARASITOL RES, V95, P55, DOI 10.1007/s00436-004-1246-x; Karvonen A, 2004, PARASITOLOGY, V129, P159, DOI 10.1017/S0031182004005505; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Karvonen A, 2003, PARASITOLOGY, V127, P217, DOI 10.1017/S0031182003003561; Karvonen A, 2010, J FISH BIOL, V76, P1508, DOI 10.1111/j.1095-8649.2010.02597.x; Karvonen A, 2008, AQUACULTURE, V279, P6, DOI 10.1016/j.aquaculture.2008.04.013; Karvonen A, 2012, P ROY SOC B-BIOL SCI, V279, P171, DOI 10.1098/rspb.2011.0879; Karvonen Anssi, 2009, Journal of Animal Ecology, V78, P945, DOI 10.1111/j.1365-2656.2009.01562.x; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Louhi KR, 2013, J ANIM ECOL, V82, P191, DOI 10.1111/j.1365-2656.2012.02028.x; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; Wegner KM, 2007, EVOL ECOL, V21, P473, DOI 10.1007/s10682-006-9129-5; Paterson S, 2005, INT J PARASITOL, V35, P1539, DOI 10.1016/j.ijpara.2005.08.007; Paterson S, 2003, P ROY SOC B-BIOL SCI, V270, P1023, DOI 10.1098/rspb.2003.2346; Porrozzi R, 2004, AM J TROP MED HYG, V71, P297, DOI 10.4269/ajtmh.2004.71.297; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Rauch G, 2005, J EVOLUTION BIOL, V18, P1069, DOI 10.1111/j.1420-9101.2005.00895.x; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; Reusch TBH, 2004, MOL ECOL NOTES, V4, P577, DOI 10.1111/j.1471-8286.2004.00740.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Seppala O, 2005, ANIM BEHAV, V70, P889, DOI 10.1016/j.anbehav.2005.01.020; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SWEETING RA, 1974, PARASITOLOGY, V69, P291, DOI 10.1017/S0031182000062995; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Valtonen ET, 1997, ANN ZOOL FENN, V34, P47; WHYTE SK, 1990, J FISH DIS, V13, P281, DOI 10.1111/j.1365-2761.1990.tb00784.x; Wijayalath WAWK, 2008, PARASITE IMMUNOL, V30, P630, DOI 10.1111/j.1365-3024.2008.01065.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; WOOTTEN R, 1974, J HELMINTHOL, V48, P73, DOI 10.1017/S0022149X00022628	55	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78427	10.1371/journal.pone.0078427	http://dx.doi.org/10.1371/journal.pone.0078427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167622	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500083
J	Liao, YJ; Lin, MW; Yen, CH; Lin, YT; Wang, CK; Huang, SF; Chen, KH; Yang, CP; Chen, TL; Hou, MF; Chen, YMA				Liao, Yi-Jen; Lin, Meng-Wei; Yen, Chia-Hung; Lin, Yu-Ting; Wang, Chung-Kwe; Huang, Shiu-Feng; Chen, Kuan-Hsuan; Yang, Ching-Ping; Chen, Tzu-Lang; Hou, Ming-Feng; Chen, Yi-Ming Arthur			Characterization of Niemann-Pick Type C2 Protein Expression in Multiple Cancers Using a Novel NPC2 Monoclonal Antibody	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; CHOLESTEROL TRAFFICKING; BREAST-CANCER; DISEASE; LUNG; IDENTIFICATION; HOMEOSTASIS; CARCINOMA; PLASMA; LIVER	Niemann-Pick Type C2 (NPC2) plays an important role in the regulation of intracellular cholesterol homeostasis via direct binding with free cholesterol. However, little is known about the significance of NPC2 in cancer. In this study, we have pinpointed the impact of various different cancers on NPC2 expression. A series of anti-NPC2 monoclonal antibodies (mAbs) with the IgG2a isotype were generated and peptide screening demonstrated that the reactive epitope were amino acid residues 31-40 of the human NPC2 protein. The specificity of these mAbs was confirmed by Western blotting using shRNA mediated knock-down of NPC2 in human SK-Hep1 cells. By immunohistochemical staining, NPC2 is expressed in normal kidney, liver, breast, colon, lung, esophageal, uterine cervical, pancreatic and stomach tissue. Strong expression of NPC2 was found in the distal and proximal convoluted tubule of kidney and the hepatocytes of liver. Normal esophageal, uterine cervical, pancreatic, stomach, breast, colon and lung tissue stained moderately to weakly. When compared to their normal tissue equivalents, NPC2 overexpression was observed in cancers of the breast, colon and lung. Regarding to breast cancer, NPC2 up-regulation is associated with estrogen receptor (-), progesterone receptor (-) and human epidermal growth factor receptor (+). On the other hand, NPC2 was found to be down-regulated in renal cell carcinoma, liver cirrhosis and hepatoma tissues. By antigen-capture enzyme immunoassay ELISA, the serum NPC2 is increased in patients with cirrhosis and liver cancer. According to western blot data, the change of glycosylated pattern of NPC2 in serum is associated with cirrhosis and liver cancer. To the best of our knowledge, this is the first comprehensive immunohistochemical and serological study investigating the expression of NPC2 in a variety of different human cancers. These novel monoclonal antibodies should help with elucidating the roles of NPC2 in tumor development, especially in liver and breast cancers.	[Liao, Yi-Jen] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Lin, Meng-Wei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yen, Chia-Hung] Kaohsiung Med Univ, Coll Pharm, Grad Inst Natl Prod, Kaohsiung, Taiwan; [Lin, Yu-Ting; Chen, Kuan-Hsuan; Yang, Ching-Ping; Chen, Tzu-Lang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Dept Microbiol, Kaohsiung, Taiwan; [Wang, Chung-Kwe] Taipei City Hosp, Ranai Branch, Dept Int Med, Taipei, Taiwan; [Huang, Shiu-Feng] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Taipei City Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, YMA (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Microbiol, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Huang, Shiu-Feng Kathy/E-3977-2010	Yen, Chia-Hung/0000-0002-6939-5528; Hou, Ming-Feng/0000-0001-6030-9702	National Science Council of the Republic of China [NSC100-2325-B-010-008, NSC102-2320-B-038-003]; Taipei Medical University [TMU101-AE1-B29]; National Science Council [NSC 100-2325-B-182-006]; National Health Research Institutes, Taiwan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Medical University; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by a grant from the National Science Council of the Republic of China (grant NSC100-2325-B-010-008 and NSC102-2320-B-038-003) and Taipei Medical University (grant TMU101-AE1-B29). TLCN has been supported by grants from the National Science Council since 2005 (NSC 100-2325-B-182-006) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Araki N, 2009, BIOCHEM BIOPH RES CO, V388, P290, DOI 10.1016/j.bbrc.2009.07.158; Asakawa JI, 2002, ENDOCRINOLOGY, V143, P4422, DOI 10.1210/en.2002-220550; Caldarella A, 2011, PATHOL ONCOL RES, V17, P753, DOI 10.1007/s12253-011-9381-z; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; CHU TM, 1993, HYBRIDOMA, V12, P417, DOI 10.1089/hyb.1993.12.417; Csepeggi C, 2011, J BIOL CHEM, V286, P2078, DOI 10.1074/jbc.M110.135897; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Griese M, 2010, CLIN GENET, V77, P119, DOI 10.1111/j.1399-0004.2009.01325.x; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liu HH, 2003, J BIOMED SCI, V10, P87, DOI 10.1159/000068083; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nielsen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027287; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Pernemalm M, 2009, PROTEOMICS, V9, P3414, DOI 10.1002/pmic.200800814; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Sugawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015777; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007	26	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77586	10.1371/journal.pone.0077586	http://dx.doi.org/10.1371/journal.pone.0077586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147030	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200049
J	Maus, B; Jung, C; John, JMM; Hugot, JP; Genin, E; Van Steen, K				Maus, Baerbel; Jung, Camille; John, Jestinah M. Mahachie; Hugot, Jean-Pierre; Genin, Emmanuelle; Van Steen, Kristel			Molecular Reclassification of Crohn's Disease: A Cautionary Note on Population Stratification	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CLASSIFICATION; GENE; DIFFERENTIATION; CARD15; SNP	Complex human diseases commonly differ in their phenotypic characteristics, e. g., Crohn's disease (CD) patients are heterogeneous with regard to disease location and disease extent. The genetic susceptibility to Crohn's disease is widely acknowledged and has been demonstrated by identification of over 100 CD associated genetic loci. However, relating CD subphenotypes to disease susceptible loci has proven to be a difficult task. In this paper we discuss the use of cluster analysis on genetic markers to identify genetic-based subgroups while taking into account possible confounding by population stratification. We show that it is highly relevant to consider the confounding nature of population stratification in order to avoid that detected clusters are strongly related to population groups instead of disease-specific groups. Therefore, we explain the use of principal components to correct for population stratification while clustering affected individuals into genetic-based subgroups. The principal components are obtained using 30 ancestry informative markers (AIM), and the first two PCs are determined to discriminate between continental origins of the affected individuals. Genotypes on 51 CD associated single nucleotide polymorphisms (SNPs) are used to perform latent class analysis, hierarchical and Partitioning Around Medoids (PAM) cluster analysis within a sample of affected individuals with and without the use of principal components to adjust for population stratification. It is seen that without correction for population stratification clusters seem to be influenced by population stratification while with correction clusters are unrelated to continental origin of individuals.	[Maus, Baerbel; Jung, Camille; John, Jestinah M. Mahachie; Hugot, Jean-Pierre; Van Steen, Kristel] INSERM, UMR843, Paris, France; [Maus, Baerbel; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium; [Jung, Camille; Hugot, Jean-Pierre] Hop Robert Debre, APHP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Jung, Camille] CHI Creteil, CRC CRB, Creteil, France; [Hugot, Jean-Pierre] Univ Paris Diderot, Labex Inflamex, Paris, France; [Genin, Emmanuelle] INSERM, Genet Genom Fonct & Biotechnol UMR1078, Brest, France; [Genin, Emmanuelle] Ctr Hosp Reg Univ Brest, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest	Maus, B (corresponding author), INSERM, UMR843, Paris, France.	baerbel.maus@outlook.com	Genin, Emmanuelle/C-4974-2013	Genin, Emmanuelle/0000-0003-4117-2813; JUNG, Camille/0000-0001-8486-8939; Van Steen, Kristel/0000-0001-9868-5033; Hugot, Jean-Pierre/0000-0002-8446-6056	Interuniversity Attraction Poles Programme; IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning) [IST-2007-216886]; FNRS PDR Convention [2.4609.11 (1906648)]; European Commission; Walloon Region through the Interreg IV Program.; ANR GENOPATH 2009 - CROHN MODEL; Ministere de la Sante (PHRC)	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning); FNRS PDR Convention(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Walloon Region through the Interreg IV Program.; ANR GENOPATH 2009 - CROHN MODEL(French National Research Agency (ANR)); Ministere de la Sante (PHRC)	Barbel Maus, Jestinah M. Mahachie John and Kristel Van Steen acknowledge research opportunities offered by the Belgian Network DYSCO (Dynamical Systems, Control, and Optimization), funded by the Interuniversity Attraction Poles Programme and initiated by the Belgian State, Science Policy Office. Their work was also in part supported by the IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning), IST-2007-216886, and by the FNRS PDR Convention no 2.4609.11 (1906648). Kristel Van Steen also acknowledges support by Alma in Silico, funded by the European Commission and Walloon Region through the Interreg IV Program. Emmanuelle Genin acknowledges funding by the grant ANR GENOPATH 2009 - CROHN MODEL. This work was financially supported by the Ministere de la Sante (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; [Anonymous], 2012, SNPSTATS SNPMATRIX X; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cleynen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012952; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Hennig C, 2013, FPC FLEXIBLE PROCEDU; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Joy GJ, 2009, PRACT GASTROENTEROL, V33, P23; Jung C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052223; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu Y, 2010, J BIOMED INFORM, V43, P233, DOI 10.1016/j.jbi.2009.11.004; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marsh S, 2003, GUT, V52, P770, DOI 10.1136/gut.52.5.770; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; Neuman RJ, 2000, GENET EPIDEMIOL, V19, pS57; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Thornton-Wells TA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-204; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Vermeire S, 2012, DIGEST DIS, V30, P425, DOI 10.1159/000338147; Vermunt J.K., 2016, TECHNICAL GUIDE LATE; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zhao Y, 2012, INT J EPIDEMIOL, V41, P1798, DOI 10.1093/ije/dys183	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77720	10.1371/journal.pone.0077720	http://dx.doi.org/10.1371/journal.pone.0077720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147066	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200069
J	Olin, JA; Hussey, NE; Grgicak-Mannion, A; Fritts, MW; Wintner, SP; Fisk, AT				Olin, Jill A.; Hussey, Nigel E.; Grgicak-Mannion, Alice; Fritts, Mark W.; Wintner, Sabine P.; Fisk, Aaron T.			Variable delta N-15 Diet-Tissue Discrimination Factors among Sharks: Implications for Trophic Position, Diet and Food Web Models	PLOS ONE			English	Article							PROTECTIVE GILL NETS; INTERPRETING STABLE-ISOTOPES; SOUTH-AFRICA; CARCHARODON-CARCHARIAS; LABORATORY EXPERIMENTS; MOVEMENT PATTERNS; LIPID EXTRACTION; MARINE PREDATORS; SPHYRNA-TIBURO; AMINO-ACIDS	The application of stable isotopes to characterize the complexities of a species foraging behavior and trophic relationships is dependent on assumptions of delta N-15 diet-tissue discrimination factors (Delta N-15). As Delta N-15 values have been experimentally shown to vary amongst consumers, tissues and diet composition, resolving appropriate speciesspecific Delta N-15 values can be complex. Given the logistical and ethical challenges of controlled feeding experiments for determining Delta N-15 values for large and/or endangered species, our objective was to conduct an assessment of a range of reported Delta N-15 values that can hypothetically serve as surrogates for describing the predator-prey relationships of four shark species that feed on prey from different trophic levels (i.e., different mean delta N-15 dietary values). Overall, the most suitable species-specific Delta N-15 values decreased with increasing dietary-delta N-15 values based on stable isotope Bayesian ellipse overlap estimates of shark and the principal prey functional groups contributing to the diet determined from stomach content analyses. Thus, a single Delta N-15 value was not supported for this speciose group of marine predatory fishes. For example, the Delta N-15 value of 3.7% provided the highest percent overlap between prey and predator isotope ellipses for the bonnethead shark (mean diet delta N-15 = 9%) whereas a Delta N-15 value < 2.3% provided the highest percent overlap between prey and predator isotope ellipses for the white shark (mean diet delta N-15 = 15%). These data corroborate the previously reported inverse Delta N-15-dietary delta N-15 relationship when both isotope ellipses of principal prey functional groups and the broader identified diet of each species were considered supporting the adoption of different Delta N-15 values that reflect the predators' delta N-15-dietary value. These findings are critical for refining the application of stable isotope modeling approaches as inferences regarding a species' ecological role in their community will be influenced with consequences for conservation and management actions.	[Olin, Jill A.; Hussey, Nigel E.; Grgicak-Mannion, Alice; Fisk, Aaron T.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Fritts, Mark W.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa; [Wintner, Sabine P.] Univ KwaZulu Natal, Biomed Resource Unit, Durban, South Africa	University of Windsor; University System of Georgia; University of Georgia; University of Kwazulu Natal	Hussey, NE (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	nehussey@uwindsor.ca	Hussey, Nigel E/F-9699-2015	Fritts, Mark/0000-0003-0438-7671; Olin, Jill/0000-0002-2748-1970	Canada Research Chair funds	Canada Research Chair funds	Funding for this research was provided by Canada Research Chair funds to ATF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2014, FISH FISH, V15, P170, DOI 10.1111/faf.12026; Bethea DM, 2007, MAR BIOL, V152, P1009, DOI 10.1007/s00227-007-0728-7; Blanchet-Aurigny A, 2012, J EXP MAR BIOL ECOL, V426, P68, DOI 10.1016/j.jembe.2012.05.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dennis CA, 2010, RAPID COMMUN MASS SP, V24, P3515, DOI 10.1002/rcm.4807; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dudley SFJ, 2005, AFR J MAR SCI, V27, P107, DOI 10.2989/18142320509504072; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Fry B., 2006, STABLE ISOTOPE ECOLO; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2013, MAR ECOL PROG SER, V481, P225, DOI 10.3354/meps10235; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Hussey Nigel E., 2012, P27; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hussey NE, 2010, HYDROBIOLOGIA, V654, P1, DOI 10.1007/s10750-010-0361-1; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Kim SL, 2012, ENVIRON BIOL FISH, V95, P37, DOI 10.1007/s10641-011-9919-7; Layman CA, 2012, MAR ECOL PROG SER, V448, P131, DOI 10.3354/meps09511; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Madigan DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049220; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; Milessi AC, 2010, ECOL MODEL, V221, P2859, DOI 10.1016/j.ecolmodel.2010.08.037; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Olin JA, 2011, RAPID COMMUN MASS SP, V25, P1008, DOI 10.1002/rcm.4946; Overmyer JP, 2008, RAPID COMMUN MASS SP, V22, P694, DOI 10.1002/rcm.3413; Parnell A, 2011, STABLE ISOTOPE ANAL; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perga ME, 2010, J APPL ECOL, V47, P942, DOI 10.1111/j.1365-2664.2009.01730.x; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Prado P, 2012, MAR ECOL PROG SER, V462, P175, DOI 10.3354/meps09786; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	67	35	35	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77567	10.1371/journal.pone.0077567	http://dx.doi.org/10.1371/journal.pone.0077567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147026	Green Published, gold			2022-12-25	WOS:000326022200046
J	Engelberth, J; Contreras, CF; Dalvi, C; Li, T; Engelberth, M				Engelberth, Jurgen; Contreras, Claudia Fabiola; Dalvi, Chinmay; Li, Ting; Engelberth, Marie			Early Transcriptome Analyses of Z-3-Hexenol-Treated Zea mays Revealed Distinct Transcriptional Networks and Anti-Herbivore Defense Potential of Green Leaf Volatiles	PLOS ONE			English	Article							FEEDING SPODOPTERA-LITTORALIS; LIMA-BEAN LEAVES; JASMONIC ACID; HYDROPEROXIDE LYASE; PLANT VOLATILES; LIPOXYGENASE PATHWAY; INDUCED RESISTANCE; MAIZE; RESPONSES; EMISSION	Green leaf volatiles (GLV), which are rapidly emitted by plants in response to insect herbivore damage, are now established as volatile defense signals. Receiving plants utilize these molecules to prime their defenses and respond faster and stronger when actually attacked. To further characterize the biological activity of these compounds we performed a microarray analysis of global gene expression. The focus of this project was to identify early transcriptional events elicited by Z-3-hexenol (Z-3-HOL) as our model GLV in maize (Zea mays) seedlings. The microarray results confirmed previous studies on Z-3-HOL -induced gene expression but also provided novel information about the complexity of Z-3-HOL -induced transcriptional networks. Besides identifying a distinct set of genes involved in direct and indirect defenses we also found significant expression of genes involved in transcriptional regulation, Ca2+-and lipid-related signaling, and cell wall reinforcement. By comparing these results with those obtained by treatment of maize seedlings with insect elicitors we found a high degree of correlation between the two expression profiles at this early time point, in particular for those genes related to defense. We further analyzed defense gene expression induced by other volatile defense signals and found Z-3-HOL to be significantly more active than methyl jasmonate, methyl salicylate, and ethylene. The data presented herein provides important information on early genetic networks that are activated by Z-3-HOL and demonstrates the effectiveness of this compound in the regulation of typical plant defenses against insect herbivores in maize.	[Engelberth, Jurgen; Contreras, Claudia Fabiola; Dalvi, Chinmay; Li, Ting; Engelberth, Marie] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Engelberth, J (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	jurgen.engelberth@utsa.edu	Engelberth, Jurgen/D-3131-2011	Engelberth, Jurgen/0000-0002-6853-1954	National Science Foundation [IOS-0925613]; USDA, NIFA [03836]; College of Science at The University of Texas at San Antonio	National Science Foundation(National Science Foundation (NSF)); USDA, NIFA(United States Department of Agriculture (USDA)); College of Science at The University of Texas at San Antonio	This work was supported by National Science Foundation Award IOS-0925613, USDA, NIFA award 03836 to JE. Furthermore, support by the The College of Science at The University of Texas at San Antonio was greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankala A, 2009, MOL PLANT MICROBE IN, V22, P1555, DOI 10.1094/MPMI-22-12-1555; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Curtius T., 1911, CHEM ZBL, V2, P1142; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Deepak S, 2010, J PHYTOPATHOL, V158, P585, DOI 10.1111/j.1439-0434.2010.01669.x; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; ENGELBERTH J, 2011, BIOCOMMUNICATION PLA, P1465; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Engelberth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034855; Engelberth Jurgen, 2011, BMC Res Notes, V4, P377, DOI 10.1186/1756-0500-4-377; Engelberth J, 2011, J CHEM ECOL, V37, P263, DOI 10.1007/s10886-011-9926-3; FRY SC, 1987, J EXP BOT, V38, P853, DOI 10.1093/jxb/38.5.853; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Hirao T, 2012, J BIOSCI BIOENG, V114, P540, DOI 10.1016/j.jbiosc.2012.06.010; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kollner TG, 2010, PLANT PHYSIOL, V153, P1795, DOI 10.1104/pp.110.158360; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Matthes MC, 2010, PLANTA, V232, P1163, DOI 10.1007/s00425-010-1244-4; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; MCCALL PJ, 1993, J INSECT BEHAV, V6, P625, DOI 10.1007/BF01048128; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; RHOADES DF, 1983, ACS SYM SER, V208, P55; Ruther J, 2005, Z NATURFORSCH C, V60, P743; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Schmelz EA, 2003, PHYSIOL PLANTARUM, V117, P403, DOI 10.1034/j.1399-3054.2003.00054.x; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Szczegielniak J, 2005, PLANT PHYSIOL, V139, P1970, DOI 10.1104/pp.105.066472; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tumlinson James H., 2008, P389, DOI 10.1007/978-1-4020-8182-8_19; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; YE ZH, 1991, PLANT J, V1, P175, DOI 10.1111/j.1365-313X.1991.00175.x; Zebelo SA, 2012, PLANT SCI, V196, P93, DOI 10.1016/j.plantsci.2012.08.006	63	54	57	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77465	10.1371/journal.pone.0077465	http://dx.doi.org/10.1371/journal.pone.0077465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155960	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300094
J	Rahman, CV; Smith, SJ; Morgan, PS; Langmack, KA; Clarke, PA; Ritchie, AA; Macarthur, DC; Rose, FR; Shakesheff, KM; Grundy, RG; Rahman, R				Rahman, Cheryl V.; Smith, Stuart J.; Morgan, Paul S.; Langmack, Keith A.; Clarke, Phil A.; Ritchie, Alison A.; Macarthur, Donald C.; Rose, Felicity R.; Shakesheff, Kevin M.; Grundy, Richard G.; Rahman, Ruman			Adjuvant Chemotherapy for Brain Tumors Delivered via a Novel Intra-Cavity Moldable Polymer Matrix	PLOS ONE			English	Article							DRUG-DELIVERY; LOCAL-DELIVERY; RADIATION-THERAPY; NANOPARTICLES; BIOCOMPATIBILITY; RELEASE; MICROSPHERES; PACLITAXEL; CANCER; GLIOMA	Introduction: Polymer-based delivery systems offer innovative intra-cavity administration of drugs, with the potential to better target micro-deposits of cancer cells in brain parenchyma beyond the resected cavity. Here we evaluate clinical utility, toxicity and sustained drug release capability of a novel formulation of poly(lactic-co-glycolic acid) (PLGA)/poly(ethylene glycol) (PEG) microparticles. Methods: PLGA/PEG microparticle-based matrices were molded around an ex vivo brain pseudo-resection cavity and analyzed using magnetic resonance imaging and computerized tomography. In vitro toxicity of the polymer was assessed using tumor and endothelial cells and drug release from trichostatin A-, etoposide-and methotrexate-loaded matrices was determined. To verify activity of released agents, tumor cells were seeded onto drug-loaded matrices and viability assessed. Results: PLGA/PEG matrices can be molded around a pseudo-resection cavity wall with no polymer-related artifact on clinical scans. The polymer withstands fractionated radiotherapy, with no disruption of microparticle structure. No toxicity was evident when tumor or endothelial cells were grown on control matrices in vitro. Trichostatin A, etoposide and methotrexate were released from the matrices over a 3-4 week period in vitro and etoposide released over 3 days in vivo, with released agents retaining cytotoxic capabilities. PLGA/PEG microparticle-based matrices molded around a resection cavity wall are distinguishable in clinical scanning modalities. Matrices are non-toxic in vitro suggesting good biocompatibility in vivo. Active trichostatin A, etoposide and methotrexate can be incorporated and released gradually from matrices, with radiotherapy unlikely to interfere with release. Conclusion: The PLGA/PEG delivery system offers an innovative intra-cavity approach to administer chemotherapeutics for improved local control of malignant brain tumors.	[Rahman, Cheryl V.; Rose, Felicity R.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Nottingham NG7 2RD, England; [Smith, Stuart J.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Childrens Brain Tumor Res Ctr, Sch Clin Sci, Nottingham NG7 2RD, England; [Smith, Stuart J.; Clarke, Phil A.; Ritchie, Alison A.] Univ Nottingham, Div Preclin Oncol, Nottingham NG7 2RD, England; [Morgan, Paul S.; Langmack, Keith A.] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Macarthur, Donald C.] Univ Nottingham Hosp, Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Rahman, R (corresponding author), Univ Nottingham, Childrens Brain Tumor Res Ctr, Sch Clin Sci, Nottingham NG7 2RD, England.	ruman.rahman@nottingham.ac.uk	Shakesheff, Kevin/AAR-6603-2021; Rahman, Ruman/FFR-5799-2022; Shakesheff, Kevin/O-6371-2018	Rahman, Ruman/0000-0002-6541-9983; Rose, Felicity/0000-0001-6640-8840; Clarke, Philip/0000-0002-9042-4856; Shakesheff, Kevin/0000-0003-3236-2439; Smith, Stuart/0000-0002-4556-2707; Morgan, Paul/0000-0002-5870-1446	Joseph Foote Foundation; Nottingham Advanced Research Fellowship; Medical Research Council [MC_G0900866] Funding Source: researchfish; MRC [MC_G0900866] Funding Source: UKRI	Joseph Foote Foundation; Nottingham Advanced Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Joseph Foote Foundation and a Nottingham Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Bagley CA, 2007, J NEUROSURG-SPINE, V7, P194, DOI 10.3171/SPI-07/08/194; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Brem H, 1995, J NEURO-ONCOL, V26, P111, DOI 10.1007/BF01060217; Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X; Brem S, 2007, CANCER CHEMOTH PHARM, V60, P643, DOI 10.1007/s00280-006-0407-2; Dhillon A, 2011, J MATER SCI-MATER M, V22, P2599, DOI 10.1007/s10856-011-4443-z; DOMB AJ, 1995, BIOMATERIALS, V16, P1069, DOI 10.1016/0142-9612(95)98902-Q; Duffner PK, 2004, NEUROLOGIST, V10, P293, DOI 10.1097/01.nrl.0000144287.35993.96; DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12; Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Fleming AB, 2002, CLIN PHARMACOKINET, V41, P403, DOI 10.2165/00003088-200241060-00002; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; Gould TW, 2013, LARYNGOSCOPE; Grundy RG, 2007, LANCET ONCOL, V8, P696, DOI 10.1016/S1470-2045(07)70208-5; Hadjipanayis CG, 2010, CANCER RES, V70, P6303, DOI 10.1158/0008-5472.CAN-10-1022; Higaki M, 2005, ANN RHEUM DIS, V64, P1132, DOI 10.1136/ard.2004.030759; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Kasperczyk J, 2009, INT J PHARMACEUT, V382, P124, DOI 10.1016/j.ijpharm.2009.08.022; Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139; Langer R, 1998, NATURE, V392, P5; Menei P, 2010, ANN SURG ONCOL, V17, P1740, DOI 10.1245/s10434-010-1081-5; Missirlis D, 2006, EUR J PHARM SCI, V29, P120, DOI 10.1016/j.ejps.2006.06.003; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Rahman C.V., 2012, J TISSUE ENG REGEN M; Rahman CV, 2013, J BIOMED MATER RES B, V101B, P648, DOI 10.1002/jbm.b.32867; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Ranganath SH, 2010, BIOMATERIALS, V31, P5199, DOI 10.1016/j.biomaterials.2010.03.002; Ranganath SH, 2009, PHARM RES-DORDR, V26, P2101, DOI 10.1007/s11095-009-9922-2; Stummer W, 2008, NEURO-ONCOLOGY, V10, P1092; Tang BC, 2010, BIOMATERIALS, V31, P339, DOI 10.1016/j.biomaterials.2009.09.033; Trapani A, 2011, AAPS PHARMSCITECH, V12, P1302, DOI 10.1208/s12249-011-9695-x; Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162; Urbinati G, 2010, INT J PHARMACEUT, V397, P184, DOI 10.1016/j.ijpharm.2010.06.046; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3; Wolff JE, 2010, NEURO-ONCOLOGY, V12, pII89; Wright KD, 2009, CHILD NERV SYST, V25, P1275, DOI 10.1007/s00381-009-0809-7; Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0; Zhang YH, 2011, MED ONCOL, V28, P901, DOI 10.1007/s12032-010-9531-2	45	25	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77435	10.1371/journal.pone.0077435	http://dx.doi.org/10.1371/journal.pone.0077435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155955	Green Accepted, Green Published, gold			2022-12-25	WOS:000325887300089
J	Rishi, G; Crampton, EM; Wallace, DF; Subramaniam, VN				Rishi, Gautam; Crampton, Emily M.; Wallace, Daniel F.; Subramaniam, V. Nathan			In Situ Proximity Ligation Assays Indicate That Hemochromatosis Proteins Hfe and Transferrin Receptor 2 (Tfr2) Do Not Interact	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; HEPCIDIN; GENE; CELLS; LOCALIZATION; COMPLEXES; MICE	The hemochromatosis associated proteins HFE and Transferrin Receptor 2 (TFR2) have been shown to be important for the proper regulation of hepcidin. A number of in vitro studies using transient overexpression systems have suggested that an interaction between HFE and TFR2 is required for the regulation of hepcidin. This model of iron sensing which centers upon the requirement for an interaction between HFE and TFR2 has recently been questioned with in vivo studies in mice from our laboratory and others which suggest that Hfe and Tfr2 can regulate hepcidin independently of each other. To re-examine the postulated interaction between Hfe and Tfr2 we developed a novel expression system in which both proteins are stably co-expressed and used the proximity ligation assay to examine the interactions between Hfe, Tfr1 and Tfr2 at a cellular level. We were able to detect the previously described interaction between Hfe and Tfr1, and heterodimers between Tfr1 and Tfr2; however no interaction between Hfe and Tfr2 was observed in our system. The results from this study indicate that Hfe and Tfr2 do not interact with each other when they are stably expressed at similar levels. Furthermore, these results support in vivo studies which suggest that Hfe and Tfr2 can independently regulate hepcidin.	[Rishi, Gautam; Crampton, Emily M.; Wallace, Daniel F.; Subramaniam, V. Nathan] Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia; [Rishi, Gautam; Subramaniam, V. Nathan] Univ Queensland, Sch Med, Liver Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Subramaniam, VN (corresponding author), Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia.	Nathan.Subramaniam@qimr.edu.au	Wallace, Daniel F/D-2638-2009; Rishi, Gautam/M-5443-2014; Subramaniam, V. Nathan/A-1901-2010	Wallace, Daniel F/0000-0002-6019-9424; Rishi, Gautam/0000-0003-1022-2347; Subramaniam, V. Nathan/0000-0002-4583-7790	National Health and Medical Research Council (NHMRC) of Australia [APP1031325]; Gastroenterological Society of Australia Senior Research Fellowship; NHMRC Senior Research Fellowship [1024672]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia Senior Research Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was Supported in part by a Project Grant (APP1031325) from the National Health and Medical Research Council (NHMRC) of Australia to VNS. DFW is the recipient of the Gastroenterological Society of Australia Senior Research Fellowship. VNS is the recipient of an NHMRC Senior Research Fellowship (1024672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Girelli D, 2011, HAEMATOL-HEMATOL J, V96, P500, DOI 10.3324/haematol.2010.033449; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Griffiths WJH, 2003, J HISTOCHEM CYTOCHEM, V51, P613, DOI 10.1177/002215540305100507; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Kawabata H, 2000, J BIOL CHEM, V275, P16618, DOI 10.1074/jbc.M908846199; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Nantel A, 1999, J BIOL CHEM, V274, P35719, DOI 10.1074/jbc.274.50.35719; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Pietrangelo A, 2005, GASTROENTEROLOGY, V128, P470, DOI 10.1053/j.gastro.2004.11.057; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wallace DF, 2008, AM J PHYSIOL-CELL PH, V294, pC383, DOI 10.1152/ajpcell.00492.2007; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200	26	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77267	10.1371/journal.pone.0077267	http://dx.doi.org/10.1371/journal.pone.0077267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155934	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300068
J	Smith, LD; Lucas, CM; Eperon, IC				Smith, Lindsay D.; Lucas, Christian M.; Eperon, Ian C.			Intron Retention in the Alternatively Spliced Region of RON Results from Weak 3 ' Splice Site Recognition	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PRE-MESSENGER-RNA; COMPLEX E; SCATTER-FACTOR; PROTEIN; EXPRESSION; BINDING; CARCINOMA; SF2/ASF; MET	The RON gene encodes a tyrosine kinase receptor for macrophage-stimulating protein. A constitutively active isoform that arises by skipping of exon 11 is expressed in carcinomas and contributes to an invasive phenotype. However, a high proportion of the mRNA expressed from the endogenous gene, or from transfected minigenes, appears to retain introns 10 and 11. It is not known whether this represents specific repression or the presence of weak splicing signals. We have used chimeric pre-mRNAs spliced in vitro to investigate the reason for intron retention. A systematic test showed that, surprisingly, the exon sequences known to modulate exon 11 skipping were not limiting, but the 3' splice site regions adjacent to exons 11 and 12 were too weak to support splicing when inserted into a globin intron. UV-crosslinking experiments showed binding of hnRNP F/H just 5' of these regions, but the hnRNP F/H target sequences did not mediate inhibition. Instead, the failure of splicing is linked to weak binding of U2AF65, and spliceosome assembly stalls prior to formation of any of the ATP-dependent complexes. We discuss mechanisms by which U2AF65 binding is facilitated in vivo.	[Smith, Lindsay D.; Lucas, Christian M.; Eperon, Ian C.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester	Eperon, IC (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	eci@leicester.ac.uk	Eperon, Ian C./E-8799-2011	Eperon, Ian C./0000-0002-4903-1911	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council postgraduate studentship to L. D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BEZERRA JA, 1994, BIOCHEM BIOPH RES CO, V203, P666, DOI 10.1006/bbrc.1994.2234; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chen QY, 1997, HEPATOLOGY, V26, P59; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; Cherny D, 2010, EMBO J, V29, P2161, DOI 10.1038/emboj.2010.103; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Corrionero A, 2011, RNA, V17, P401, DOI 10.1261/rna.2444811; CUNNINGHAM SA, 1991, J MOL BIOL, V217, P265, DOI 10.1016/0022-2836(91)90541-D; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; de Araujo MM, 2009, RNA, V15, P515, DOI 10.1261/rna.1273209; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Ghigna C, 2010, RNA BIOL, V7, P495, DOI 10.4161/rna.7.4.12744; Ghigna C, 2008, CURR GENOMICS, V9, P556, DOI 10.2174/138920208786847971; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hodson MJ, 2012, NUCLEIC ACIDS RES, V40, P6850, DOI 10.1093/nar/gks322; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; JAMISON SF, 1992, P NATL ACAD SCI USA, V89, P5482, DOI 10.1073/pnas.89.12.5482; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kent OA, 2005, MOL CELL BIOL, V25, P233, DOI 10.1128/MCB.25.1.233-240.2005; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Lefevre S H, 2002, J Med Genet, V39, pE21, DOI 10.1136/jmg.39.5.e21; Leonis NA, 2002, HEPATOLOGY, V36, P1053, DOI 10.1053/jhep.2002.36822; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lu Y, 2007, CANCER LETT, V257, P157, DOI 10.1016/j.canlet.2007.08.007; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; Makarov EM, 2012, NUCLEIC ACIDS RES, V40, P2639, DOI 10.1093/nar/gkr1056; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Ortuno-Pineda C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040315; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Rampino T, 2003, AM J SURG PATHOL, V27, P779, DOI 10.1097/00000478-200306000-00008; Samatanga B, 2013, NUCLEIC ACIDS RES, V41, P2505, DOI 10.1093/nar/gks1289; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Wagh PK, 2011, ONCOGENE, V30, P3694, DOI 10.1038/onc.2011.86; Waltz SE, 1998, ONCOGENE, V16, P27, DOI 10.1038/sj.onc.1201508; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017945; Wang J, 2010, BIOCHEMISTRY-US, V49, P7972, DOI 10.1021/bi100409w; Wang MH, 2003, CARCINOGENESIS, V24, P1291, DOI 10.1093/carcin/bgg089; Wang MH, 1996, EXP CELL RES, V226, P39, DOI 10.1006/excr.1996.0200; WANG MH, 1994, J BIOL CHEM, V269, P14027; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Yue BG, 1999, FEBS LETT, V451, P10, DOI 10.1016/S0014-5793(99)00521-9; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhou DH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-353	72	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77208	10.1371/journal.pone.0077208	http://dx.doi.org/10.1371/journal.pone.0077208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155930	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325887300064
J	Barranco-Medina, S; Pozzi, N; Vogt, AD; Di Cera, E				Barranco-Medina, Sergio; Pozzi, Nicola; Vogt, Austin D.; Di Cera, Enrico			Histone H4 Promotes Prothrombin Autoactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Enzyme Mechanisms; Protein Conformation; Prothrombin; Thrombin	CONFORMATIONAL SELECTION; EXTRACELLULAR HISTONES; CRYSTAL-STRUCTURE; SERINE-PROTEASE; THROMBIN GENERATION; ENERGY-TRANSFER; ACTIVATION; BINDING; MECHANISM; COFACTOR	Background: The molecular origin of the prothrombotic properties of histones is unknown. Results: Histone H4 interacts with prothrombin and promotes autoactivation. Conclusion: The prothrombotic properties of histone H4 are due to direct interaction with prothrombin. Significance: Prothrombin autoactivation has pathophysiological relevance. Recent studies have documented the ability of prothrombin to spontaneously convert to the mature protease thrombin when Arg-320 becomes exposed to solvent for proteolytic attack upon mutation of residues in the activation domain. Whether prothrombin autoactivation occurs in the wild-type under conditions relevant to physiology remains unknown. Here, we report that binding of histone H4 to prothrombin under physiological conditions generates thrombin by autoactivation. The effect is abrogated by mutation of the catalytic Ser-525 and requires the presence of the Gla domain. Fluorescence titrations document direct binding of histone H4 to prothrombin with an affinity in the low nm range. Stopped flow data and luminescence resonance energy transfer measurements indicate that the binding mechanism obeys conformational selection. Among the two conformations of prothrombin, collapsed and fully extended, histone H4 binds selectively to the collapsed form and induces a transition toward a new conformation where the distance between Ser-101 in kringle-1 and Ser-210 in kringle-2 increases by 13 . These findings confirm the molecular plasticity of prothrombin emerged from recent structural studies and suggest that different conformations of the inter-kringle linker domain determine the functional behavior of prothrombin. The results also broaden our mechanistic understanding of the prothrombotic phenotype observed during cellular damage due to the release of histones in the blood stream. Prothrombin autoactivation induced by histone H4 emerges as a mechanism of pathophysiological relevance through which thrombin is generated independently of activation of the coagulation cascade.	[Barranco-Medina, Sergio; Pozzi, Nicola; Vogt, Austin D.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100	National Institutes of Health Research Grants [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R29HL049413, R01HL073813, R01HL049413] Funding Source: NIH RePORTER	National Institutes of Health Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Research Grants HL49413, HL73813, and HL112303.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P221, DOI 10.1248/bpb.24.221; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Etscheid M, 2000, BIOL CHEM, V381, P1223, DOI 10.1515/BC.2000.150; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gansler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050399; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; GONIAS SL, 1985, THROMB RES, V39, P97, DOI 10.1016/0049-3848(85)90125-2; GUINTO ER, 1995, P NATL ACAD SCI USA, V92, P11185, DOI 10.1073/pnas.92.24.11185; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Heyduk E, 1997, ANAL BIOCHEM, V248, P216, DOI 10.1006/abio.1997.2148; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Pemberton AD, 2010, PROTEOMICS, V10, P1484, DOI 10.1002/pmic.200900818; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamamichi S, 2010, J THROMB HAEMOST, V8, P559, DOI 10.1111/j.1538-7836.2009.03641.x; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515	43	37	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35749	35757		10.1074/jbc.M113.509786	http://dx.doi.org/10.1074/jbc.M113.509786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178300	Green Published, hybrid			2022-12-25	WOS:000329814700013
J	Francis, K; Stojkovic, V; Kohen, A				Francis, Kevin; Stojkovic, Vanja; Kohen, Amnon			Preservation of Protein Dynamics in Dihydrofolate Reductase Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Kinetics; Enzyme Mutation; Enzymes; Isotope Effects; Protein Dynamics; Protein Evolution; Marcus-like; Dihydofolate Reductase; Enzyme Dynamics	HYDRIDE TRANSFER; TEMPERATURE-DEPENDENCE; COUPLED MOTION; CHEMICAL STEP; ENZYME; MECHANISM; CATALYSIS; FLUCTUATIONS; KNOCKOUT	Background: Humanized mutants of bacterial dihydrofolate reductase were examined to relate protein dynamics with enzyme evolution. Results: Effects on enzyme dynamics alter the catalyzed C-HC step, but the nature of that step was retained along evolution. Conclusion: Protein dynamics evolved to optimize the catalyzed reaction. Significance: Evolutionary conservation of functional dynamics implicates their role in the catalyzed hydride transfer reaction. The hydride transfer reaction catalyzed by dihydrofolate reductase (DHFR) is a model for examining how protein dynamics contribute to enzymatic function. The relationship between functional motions and enzyme evolution has attracted significant attention. Recent studies on N23PP Escherichia coli DHFR (ecDHFR) mutant, designed to resemble parts of the human enzyme, indicated a reduced single turnover rate. NMR relaxation dispersion experiments with that enzyme showed rigidification of millisecond Met-20 loop motions (Bhabha, G., Lee, J., Ekiert, D. C., Gam, J., Wilson, I. A., Dyson, H. J., Benkovic, S. J., and Wright, P. E. (2011) Science 332, 234-238). A more recent study of this mutant, however, indicated that fast motions along the reaction coordinate are actually more dispersed than for wild-type ecDHFR (WT). Furthermore, a double mutant (N23PP/G51PEKN) that better mimics the human enzyme seems to restore both the single turnover rates and narrow distribution of fast dynamics (Liu, C. T., Hanoian, P., French, T. H., Hammes-Schiffer, S., and Benkovic, S. J. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, 10159-11064). Here, we measured intrinsic kinetic isotope effects for both N23PP and N23PP/G51PEKN double mutant DHFRs over a temperature range. The findings indicate that although the C-HC transfer and dynamics along the reaction coordinate are impaired in the altered N23PP mutant, both seem to be restored in the N23PP/G51PEKN double mutant. This indicates that the evolution of G51PEKN, although remote from the Met-20 loop, alleviated the loop rigidification that would have been caused by N23PP, enabling WT-like H-tunneling. The correlation between the calculated dynamics, the nature of C-HC transfer, and a phylogenetic analysis of DHFR sequences are consistent with evolutionary preservation of the protein dynamics to enable H-tunneling from well reorganized active sites.	[Francis, Kevin; Stojkovic, Vanja; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605	National Science Foundation [CHE 1149023]; National Institutes of Health [R01 GM65368]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065368] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (CHE 1149023) and National Institutes of Health (R01 GM65368).	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Antoniou D, 2002, EUR J BIOCHEM, V269, P3103, DOI 10.1046/j.1432-1033.2002.03021.x; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BLAKLEY RL, 1960, NATURE, V188, P231, DOI 10.1038/188231a0; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108; Cheatum CM, 2013, TOP CURR CHEM, V337, P1, DOI 10.1007/128_2012_407; Chen SX, 2012, J AM CHEM SOC, V134, P18883, DOI 10.1021/ja307179q; Cook P. F., 2007, ENZYME KINETICS MECH; Dametto M, 2012, MOL PHYS, V110, P531, DOI 10.1080/00268976.2012.655337; Fan Y, 2013, BIOCHEMISTRY-US, V52, P2036, DOI 10.1021/bi301559q; Ferrer S, 2003, J PHYS CHEM B, V107, P14036, DOI 10.1021/jp0354898; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Hammes-Schiffer S, 2006, ACCOUNTS CHEM RES, V39, P93, DOI 10.1021/ar040199a; Hay S, 2012, NAT CHEM, V4, P161, DOI [10.1038/NCHEM.1223, 10.1038/nchem.1223]; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kanaan N, 2011, J AM CHEM SOC, V133, P6692, DOI 10.1021/ja1114369; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Kohen A, 2003, PROG REACT KINET MEC, V28, P119, DOI 10.3184/007967403103165486; Kohen A., 2006, ISOTOPE EFFECTS CHEM, V28, P743; Kohen A., 2006, ISOTOPE EFFECTS CHEM; Liu CT, 2013, P NATL ACAD SCI USA, V110, P10159, DOI 10.1073/pnas.1307130110; Liu HB, 2007, J PHYS CHEM B, V111, P7852, DOI 10.1021/jp070938f; Loveridge EJ, 2012, NAT CHEM, V4, P292, DOI 10.1038/nchem.1296; Loveridge EJ, 2009, J AM CHEM SOC, V131, P6926, DOI 10.1021/ja901441k; Maglia G, 2003, J AM CHEM SOC, V125, P13372, DOI 10.1021/ja035692g; Markham KA, 2004, ANAL BIOCHEM, V325, P62, DOI 10.1016/j.ab.2003.10.027; Markham KA, 2003, ANAL BIOCHEM, V322, P26, DOI 10.1016/j.ab.2003.07.010; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; Melander L., 1987, REACTION RATES ISOTO; Miller GP, 1998, BIOCHEMISTRY-US, V37, P6336, DOI 10.1021/bi973065w; Nagel ZD, 2010, CHEM REV, V110, pPR41, DOI 10.1021/cr1001035; NORTHROP DB, 1981, BIOCHEMISTRY-US, V20, P4056, DOI 10.1021/bi00517a017; Pu JZ, 2005, J AM CHEM SOC, V127, P14879, DOI 10.1021/ja054170t; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Roston D, 2012, BIOCHEMISTRY-US, V51, P6860, DOI 10.1021/bi300613e; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Sen A, 2011, BIOCHEMISTRY-US, V50, P6462, DOI 10.1021/bi2003873; Sikorski RS, 2004, J AM CHEM SOC, V126, P4778, DOI 10.1021/ja031683w; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Sutcliffe MJ, 2006, PHILOS T R SOC B, V361, P1375, DOI 10.1098/rstb.2006.1878; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010; Wang Z, 2012, J AM CHEM SOC, V134, P17722, DOI 10.1021/ja307859m; Wang Z, 2012, ADV PROTEIN CHEM STR, V87, P155, DOI 10.1016/B978-0-12-398312-1.00006-8; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102	49	31	32	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35961	35968		10.1074/jbc.M113.507632	http://dx.doi.org/10.1074/jbc.M113.507632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158440	Green Published, hybrid			2022-12-25	WOS:000329814700032
J	James, AD; Chan, A; Erice, O; Siriwardena, AK; Bruce, JIE				James, Andrew D.; Chan, Anthony; Erice, Oihane; Siriwardena, Ajith K.; Bruce, Jason I. E.			Glycolytic ATP Fuels the Plasma Membrane Calcium Pump Critical for Pancreatic Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Calcium ATPase; Calcium Signaling; Cell Death; Glycolysis; Metabolism; Pancreatic Cancer; PMCA; Warburg; Calcium Overload	ACINAR-CELLS; INTRACELLULAR CA2+; DEATH; 3-BROMOPYRUVATE; CA2+-ATPASE; METABOLISM; ACTIVATION; APOPTOSIS; SWITCH; PHOSPHATIDYLSERINE	Background: Pancreatic cancer cells exhibit up-regulated glycolysis. Results: Inhibition of glycolysis, but not mitochondrial metabolism, induced ATP depletion, plasma membrane calcium pump (PMCA) inhibition, Ca2+ overload, and cell death. Conclusion: Glycolytic ATP fuels the PMCA in pancreatic cancer. Significance: Glycolytic regulation of the PMCA may represent a novel chemotherapeutic target for pancreatic cancer. Pancreatic cancer is an aggressive cancer with poor prognosis and limited treatment options. Cancer cells rapidly proliferate and are resistant to cell death due, in part, to a shift from mitochondrial metabolism to glycolysis. We hypothesized that this shift is important in regulating cytosolic Ca2+ ([Ca2+](i)), as the ATP-dependent plasma membrane Ca2+ ATPase (PMCA) is critical for maintaining low [Ca2+](i) and thus cell survival. The present study aimed to determine the relative contribution of mitochondrial versus glycolytic ATP in fuelling the PMCA in human pancreatic cancer cells. We report that glycolytic inhibition induced profound ATP depletion, PMCA inhibition, [Ca2+](i) overload, and cell death in PANC1 and MIA PaCa-2 cells. Conversely, inhibition of mitochondrial metabolism had no effect, suggesting that glycolytic ATP is critical for [Ca2+](i) homeostasis and thus survival. Targeting the glycolytic regulation of the PMCA may, therefore, be an effective strategy for selectively killing pancreatic cancer while sparing healthy cells.	[James, Andrew D.; Erice, Oihane; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chan, Anthony; Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	jason.bruce@manchester.ac.uk	Chan, Anthony K. C./AAR-8892-2021; Chan, Anthony/AAE-1234-2019; Erice, Oihane/C-7694-2018	Chan, Anthony K. C./0000-0003-1551-3995; Chan, Anthony/0000-0001-6380-3124; Erice, Oihane/0000-0002-9894-1356; James, Andrew/0000-0002-2432-5948; James, Andrew/0000-0002-6915-3975	Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant; Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund; BBSRC; AstraZeneca plc CASE Ph.D. studentship; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca plc CASE Ph.D. studentship(AstraZeneca); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant (to J. B.) and a Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund (to A. S. and J. B.).; Supported by a BBSRC and AstraZeneca plc CASE Ph.D. studentship.	Amin Z, 2006, CLIN RADIOL, V61, P996, DOI 10.1016/j.crad.2006.07.005; Ankorina-Stark I, 2002, J MEMBRANE BIOL, V186, P43, DOI 10.1007/s00232-001-0134-x; Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Bouron A, 2000, FEBS LETT, V470, P269, DOI 10.1016/S0014-5793(00)01340-5; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dong H, 2010, AM J PHYSIOL-CELL PH, V299, pC1493, DOI 10.1152/ajpcell.00242.2010; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudjonsson B, 2009, EUR J GASTROEN HEPAT, V21, P1379, DOI 10.1097/MEG.0b013e328323aab7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen MR, 2009, CELL PHYSIOL BIOCHEM, V23, P387, DOI 10.1159/000218185; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hug M, 1996, FEBS LETT, V397, P298, DOI 10.1016/S0014-5793(96)01185-4; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Kim JS, 2008, J BIOENERG BIOMEMBR, V40, P607, DOI 10.1007/s10863-008-9188-0; Kim JS, 2003, GASTROENTEROLOGY, V124, P494, DOI 10.1053/gast.2003.50059; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Krejs GJ, 2010, DIGEST DIS, V28, P355, DOI 10.1159/000319414; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; MILLIGAN LP, 1985, J NUTR, V115, P1374, DOI 10.1093/jn/115.10.1374; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; Nicotera P, 1998, TOXICOL LETT, V103, P139; Putney J. W., 2006, CALCIUM SIGNALING, P73; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; ROSSI JPFC, 1989, BIOCHIM BIOPHYS ACTA, V996, P153, DOI 10.1016/0167-4838(89)90241-0; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; TSAI IH, 1982, J BIOL CHEM, V257, P1438; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; WAKASUGI H, 1981, AM J PHYSIOL, V240, pG281, DOI 10.1152/ajpgi.1981.240.4.G281; WOLFF T, 1993, PFLUG ARCH EUR J PHY, V424, P423, DOI 10.1007/BF00374904; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274	56	20	20	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36007	36019		10.1074/jbc.M113.502948	http://dx.doi.org/10.1074/jbc.M113.502948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158437	hybrid, Green Published			2022-12-25	WOS:000329814700036
J	Symeonidou, IE; Kotsantis, P; Roukos, V; Rapsomaniki, MA; Grecco, HE; Bastiaens, P; Taraviras, S; Lygerou, Z				Symeonidou, Ioanna-Eleni; Kotsantis, Panagiotis; Roukos, Vassilis; Rapsomaniki, Maria-Anna; Grecco, Hernan E.; Bastiaens, Philippe; Taraviras, Stavros; Lygerou, Zoi			Multi-step Loading of Human Minichromosome Maintenance Proteins in Live Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Cycle; Chromatin; DNA Replication; Imaging; Fluorescence Recovery after Photobleaching; Licensing; Live-cell Imaging; Minichromosome Maintenance Complex; Genome Stability	EUKARYOTIC DNA-REPLICATION; ORIGIN RECOGNITION COMPLEX; MCM PROTEINS; S-PHASE; LICENSING FACTOR; BIND CHROMATIN; ATP-HYDROLYSIS; GEMININ; CDT1; HELICASE	Background: MCM2-7 loading onto chromatin licenses origins for replication. Results: MCMs exhibit transient interactions with chromatin in late mitosis, stable binding in G(1) phase and increased loading in late G(1) phase. Conclusion: Multilevel regulation of MCM2-7 loading to chromatin occurs during mitosis and preceding the G(1)/S phase transition. Significance: The dynamics of the DNA licensing system within live human cells reveal multiple control points. Once-per-cell cycle replication is regulated through the assembly onto chromatin of multisubunit protein complexes that license DNA for a further round of replication. Licensing consists of the loading of the hexameric MCM2-7 complex onto chromatin during G(1) phase and is dependent on the licensing factor Cdt1. In vitro experiments have suggested a two-step binding mode for minichromosome maintenance (MCM) proteins, with transient initial interactions converted to stable chromatin loading. Here, we assess MCM loading in live human cells using an in vivo licensing assay on the basis of fluorescence recovery after photobleaching of GFP-tagged MCM protein subunits through the cell cycle. We show that, in telophase, MCM2 and MCM4 maintain transient interactions with chromatin, exhibiting kinetics similar to Cdt1. These are converted to stable interactions from early G(1) phase. The immobile fraction of MCM2 and MCM4 increases during G(1) phase, suggestive of reiterative licensing. In late G(1) phase, a large fraction of MCM proteins are loaded onto chromatin, with maximal licensing observed just prior to S phase onset. Fluorescence loss in photobleaching experiments show subnuclear concentrations of MCM-chromatin interactions that differ as G(1) phase progresses and do not colocalize with sites of DNA synthesis in S phase.	[Symeonidou, Ioanna-Eleni; Kotsantis, Panagiotis; Roukos, Vassilis; Rapsomaniki, Maria-Anna; Lygerou, Zoi] Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece; [Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26500, Greece; [Grecco, Hernan E.; Bastiaens, Philippe] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	University of Patras; University of Patras; Max Planck Society	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece.	lygerou@upatras.gr	Taraviras, Stavros/AAJ-4690-2020; Roukos, Vassilis/AAC-4827-2020; Kotsantis, Panagiotis/AGU-7131-2022; Kotsantis, Panagiotis/AGZ-3258-2022; Roukos, Vassilis/K-6248-2012	Taraviras, Stavros/0000-0002-7455-647X; Kotsantis, Panagiotis/0000-0002-6131-4009; Kotsantis, Panagiotis/0000-0002-6131-4009; Roukos, Vassilis/0000-0002-5065-3937; Rapsomaniki, Maria Anna/0000-0003-3883-4871	Association for International Cancer Research grant; European Research Council Grant [ERC281851_DYNACOM]	Association for International Cancer Research grant; European Research Council Grant(European Research Council (ERC))	This work was supported by an Association for International Cancer Research grant and by European Research Council Grant ERC281851_DYNACOM.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Bancaud Aurelien, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top90; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Chagin VO, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000737; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Dimitrova DS, 1996, P NATL ACAD SCI USA, V93, P1498, DOI 10.1073/pnas.93.4.1498; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Krude T, 1996, J CELL SCI, V109, P309; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lygerou Z, 2000, SCIENCE, V290, P2271; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; McIntosh D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012955; McNairn AJ, 2005, EXP CELL RES, V308, P345, DOI 10.1016/j.yexcr.2005.05.009; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Xouri G, 2007, CELL CYCLE, V6, P1549, DOI 10.4161/cc.6.13.4455	68	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35852	35867		10.1074/jbc.M113.474825	http://dx.doi.org/10.1074/jbc.M113.474825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158436	Green Published, hybrid			2022-12-25	WOS:000329814700022
J	Migheli, R; Del Giudice, MG; Spissu, Y; Sanna, G; Xiong, YL; Dawson, TM; Dawson, VL; Galioto, M; Rocchitta, G; Biosa, A; Serra, PA; Carri, MT; Crosio, C; Iaccarino, C				Migheli, Rossana; Del Giudice, Maria Grazia; Spissu, Ylenia; Sanna, Giovanna; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.; Galioto, Manuela; Rocchitta, Gaia; Biosa, Alice; Serra, Pier Andrea; Carri, Maria Teresa; Crosio, Claudia; Iaccarino, Ciro			LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization	PLOS ONE			English	Article							OXIDE/CYCLIC GMP PATHWAY; MICRODIALYSIS IN-VITRO; PARKINSONS-DISEASE; PC12 CELLS; KINASE-ACTIVITY; PLEOMORPHIC PATHOLOGY; DOPAMINE SECRETION; MUTANT LRRK2; PHOSPHORYLATION; ENDOCYTOSIS	The leucine-rich repeat kinase 2 (LRRK2) gene was found to play a role in the pathogenesis of both familial and sporadic Parkinson's disease (PD). LRRK2 encodes a large multi-domain protein that is expressed in different tissues. To date, the physiological and pathological functions of LRRK2 are not clearly defined. In this study we have explored the role of LRRK2 in controlling vesicle trafficking in different cellular or animal models and using various readouts. In neuronal cells, the presence of LRRK2(G2019S) pathological mutant determines increased extracellular dopamine levels either under basal conditions or upon nicotine stimulation. Moreover, mutant LRRK2 affects the levels of dopamine receptor D1 on the membrane surface in neuronal cells or animal models. Ultrastructural analysis of PC12-derived cells expressing mutant LRRK2(G2019S) shows an altered intracellular vesicle distribution. Taken together, our results point to the key role of LRRK2 to control vesicle trafficking in neuronal cells.	[Migheli, Rossana; Spissu, Ylenia; Rocchitta, Gaia; Biosa, Alice; Serra, Pier Andrea] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Del Giudice, Maria Grazia; Sanna, Giovanna; Galioto, Manuela; Crosio, Claudia; Iaccarino, Ciro] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD USA; [Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Carri, Maria Teresa; Crosio, Claudia; Iaccarino, Ciro] IRCCS, Fdn Santa Lucia, Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Sassari; University of Sassari; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; IRCCS Santa Lucia; University of Rome Tor Vergata	Iaccarino, C (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	ciaccarino@uniss.it	Spissu, Ylenia/AAY-3011-2020; Spissu, Ylenia/AGQ-3624-2022; Dawson, Valina/Y-9757-2019; Rocchitta, Gaia/HHM-8002-2022; Carri, Maria Teresa/K-5480-2016	Spissu, Ylenia/0000-0003-1551-8817; SERRA, Pier Andrea/0000-0003-2401-5146; Carri, Maria Teresa/0000-0002-1789-1546; MIGHELI, Rossana/0000-0001-5520-5511; CROSIO, Claudia/0000-0003-2452-1145; Dawson, Valina/0000-0002-2915-3970; ROCCHITTA, Gaia Giovanna Maria/0000-0002-4319-4197; IACCARINO, Ciro/0000-0003-1619-7146	Fondazione Banco di Sardegna, PRIN [20083R593R_002, 20083R593R_001]; Regione Sardegna [CRP-17171]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [P50NS038377]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	Fondazione Banco di Sardegna, PRIN; Regione Sardegna(Regione Sardegna); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Fondazione Banco di Sardegna, PRIN 2008 (grant no 20083R593R_002 and 20083R593R_001) and Regione Sardegna (grant noCRP-17171). Maria Grazia Dal Giudice is supported by a fellowship of Regione Sardegna. This work was supported in part by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) P50NS038377. Ted M. Dawson is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bonifati V, 2006, CURR NEUROL NEUROSCI, V6, P355, DOI 10.1007/s11910-996-0013-z; BRADBERRY CW, 1991, J NEUROSCI METH, V36, P85, DOI 10.1016/0165-0270(91)90141-L; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Esposito G, 2012, DEV NEUROBIOL, V72, P134, DOI 10.1002/dneu.20916; FINBERG JPM, 1983, NEUROPHARMACOLOGY, V22, P441, DOI 10.1016/0028-3908(83)90194-6; FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Ghijsen WEJM, 2005, CELL MOL LIFE SCI, V62, P937, DOI 10.1007/s00018-004-4525-0; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Heo Hye Young, 2010, Exp Neurobiol, V19, P97, DOI 10.5607/en.2010.19.2.97; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Iaccarino C, 2011, NEUROBIOL DIS, V43, P642, DOI 10.1016/j.nbd.2011.05.013; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jiang Y, 2008, SYNAPSE, V62, P797, DOI 10.1002/syn.20554; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; MARKEY KA, 1980, MOL PHARMACOL, V17, P79; Martin TFJ, 2003, METHOD CELL BIOL, V71, P267, DOI 10.1016/S0091-679X(03)01012-4; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Migheli R, 1999, J NEUROCHEM, V73, P1155, DOI 10.1046/j.1471-4159.1999.0731155.x; Migheli R, 2008, ANAL BIOCHEM, V380, P323, DOI 10.1016/j.ab.2008.05.050; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RODA LG, 1980, EXP CELL RES, V128, P103, DOI 10.1016/0014-4827(80)90392-4; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Serra PA, 2003, J NEUROCHEM, V86, P1403, DOI 10.1046/j.1471-4159.2003.01947.x; Serra PA, 2003, NEUROSCI LETT, V353, P5, DOI 10.1016/j.neulet.2003.07.022; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Stokes AH, 2000, BRAIN RES, V858, P1, DOI 10.1016/S0006-8993(99)02329-X; Tong YR, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-2; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; WICK PF, 1993, J BIOL CHEM, V268, P10983; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012; Zhou HX, 2011, INT J BIOL SCI, V7, P753, DOI 10.7150/ijbs.7.753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	55	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77198	10.1371/journal.pone.0077198	http://dx.doi.org/10.1371/journal.pone.0077198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167564	gold, Green Submitted, Green Published			2022-12-25	WOS:000326034500023
J	Reddy, RM; Srivastava, A; Kumar, A				Reddy, Rachamalla Maheedhar; Srivastava, Akshay; Kumar, Ashok			Monosaccharide-Responsive Phenylboronate-Polyol Cell Scaffolds for Cell Sheet and Tissue Engineering Applications	PLOS ONE			English	Article							POLY(VINYL ALCOHOL); POLYMER; COPOLYMERS; COMPLEXES; CRYOGEL; GRAFTS; BORATE; GEL	Analyte-responsive smart polymeric materials are of great interest and have been actively investigated in the field of regenerative medicine. Phenylboronate containing copolymers form gels with polyols under alkaline conditions. Monosaccharides, by virtue of their higher affinity towards boronate, can displace polyols and solubilize such gels. In the present study, we investigate the possibility of utilizing phenylboronate-polyol interactions at physiological pH in order to develop monosaccharide-responsive degradable scaffold materials for systems dealing with cells and tissues. Amine assisted phenylboronate-polyol interactions were employed to develop novel hydrogel and cryogel scaffolds at neutral pH. The scaffolds displayed monosaccharide inducible gel-sol phase transformability. In vitro cell culture studies demonstrated the ability of scaffolds to support cell adhesion, viability and proliferation. Fructose induced gel degradation is used to recover cells cultured on the hydrogels. The cryogels displayed open macroporous structure and superior mechanical properties. These novel phase transformable phenylboronate-polyol based scaffolds displayed a great potential for various cell sheet and tissue engineering applications. Their monosaccharide responsiveness at physiological pH is very useful and can be utilized in the fields of cell immobilization, spheroid culture, saccharide recognition and analyte-responsive drug delivery.	[Reddy, Rachamalla Maheedhar; Srivastava, Akshay; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Kumar, A (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	ashokkum@iitk.ac.in	Kumar, Ashok/G-8515-2015; KUMAR, ASHOK/AAF-4055-2021	KUMAR, ASHOK/0000-0002-9244-0622; Kumar, Ashok/0000-0002-4910-9440; Srivastava, Akshay/0000-0001-5048-9420				Aoki T, 1996, POLYM J, V28, P371, DOI 10.1295/polymj.28.371; Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C; Dainiak MB, 2006, P NATL ACAD SCI USA, V103, P849, DOI 10.1073/pnas.0508432103; Hisamitsu I, 1997, PHARMACEUT RES, V14, P289, DOI 10.1023/A:1012033718302; Ivanov AE, 2004, POLYMER, V45, P2495, DOI 10.1016/j.polymer.2004.02.022; Ivanov AE, 2008, INT J PHARM, V358, P36, DOI 10.1016/j.ijpharm.2008.02.017; Ivanov AE, 2006, J MOL RECOGNIT, V19, P322, DOI 10.1002/jmr.792; Ivanov AE, 2009, J BIOMED MATER RES A, V88A, P213, DOI 10.1002/jbm.a.31880; Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009; KITANO S, 1991, MAKROMOL CHEM-RAPID, V12, P227; KITANO S, 1992, J CONTROL RELEASE, V19, P162; Kitano S, 1991, POLYM ADVAN TECHNOL, V2, P261, DOI 10.1002/pat.1991.220020508; Kuzimenkova MV, 2008, POLYMER, V49, P1444, DOI 10.1016/j.polymer.2008.02.009; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Mikos Antonios G., 2000, EJB Electronic Journal of Biotechnology, V3, P1; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Plieva FM, 2008, TRENDS MICROBIOL, V16, P543, DOI 10.1016/j.tim.2008.08.005; Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646; Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057; VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2; WISE ET, 1995, MACROMOLECULES, V28, P8321, DOI 10.1021/ma00128a048; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645	28	12	13	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77861	10.1371/journal.pone.0077861	http://dx.doi.org/10.1371/journal.pone.0077861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167587	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500046
J	Curtis, KA; Longosz, AF; Kennedy, MS; Keating, S; Heitman, J; Laeyendecker, O; Owen, SM				Curtis, Kelly A.; Longosz, Andrew F.; Kennedy, M. Susan; Keating, Sheila; Heitman, John; Laeyendecker, Oliver; Owen, S. Michele			Inter-Laboratory Assessment of a Prototype Multiplex Kit for Determination of Recent HIV-1 Infection	PLOS ONE			English	Article							BED-ENZYME-IMMUNOASSAY; PERFORMANCE-CHARACTERISTICS; TYPE-1 SEROCONVERSION; VACCINE PREPAREDNESS; UNITED-STATES; ASSAY; IDENTIFICATION; SEROINCIDENCE; TRIALS	Background: Accurate and reliable laboratory-based assays are needed for estimating HIV-1 incidence from cross-sectional samples. We recently described the development of a customized, HIV-1-specific Bio-Plex assay that allows for the measurement of HIV-specific antibody levels and avidity to multiple analytes for improved HIV-1 incidence estimates. Methods: To assess intra-and inter-laboratory assay performance, prototype multiplex kits were developed and evaluated by three distinct laboratories. Longitudinal seroconversion specimens were tested in parallel by each laboratory and kit performance was compared to that of an in-house assay. Additionally, the ability of the kit to distinguish recent from long-term HIV-1 infection, as compared to the in-house assay, was determined by comparing the reactivity of known recent (infected <6 months) and long-term (infected >12 months) drug naive specimens. Results: Although the range of reactivity for each analyte varied between the prototype kit and in-house assay, a measurable distinction in reactivity between recent and long-term specimens was observed with both assays in all three laboratories. Additionally, kit performance was consistent between all three laboratories. The intra-assay coefficient of variation (CV), between sample replicates for all laboratories, ranged from 0.5% to 6.1%. The inter-laboratory CVs ranged from 8.5% to 21.3% for gp160-avidity index (a) and gp120-normalized mean fluorescent intensity (MFI) value (n), respectively. Conclusion: We demonstrate the feasibility of producing a multiplex kit for measuring HIV antibody levels and avidity, with the potential for improved incidence estimates based on multi-analyte algorithms. The availability of a commercial kit will facilitate the transfer of technology among diverse laboratories for widespread assay use.	[Curtis, Kelly A.; Kennedy, M. Susan; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA; [Longosz, Andrew F.; Laeyendecker, Oliver] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA; [Keating, Sheila; Heitman, John] Blood Syst Res Inst, San Francisco, CA USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Vitalant; Vitalant Research Institute; Johns Hopkins University	Curtis, KA (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA.	czv2@cdc.gov		Laeyendecker, Oliver/0000-0002-6429-4760; Keating, Sheila/0000-0002-8324-3694	Centers for Disease Control; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); HIV Prevention Trials Network; NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS) [U01-AI46745, U01-AI48054, UM1-AI068613, R01-AI095068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046745, R01AI095068, U01AI048054, UM1AI068613, ZIAAI000361] Funding Source: NIH RePORTER	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Prevention Trials Network; NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was provided in part through intramural funding from the Centers for Disease Control. Additional funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funders included: The Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); the HIV Prevention Trials Network sponsored by NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS, U01-AI46745, U01-AI48054, and UM1-AI068613), R01-AI095068.	[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P40; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dobbs T, 2011, J CLIN MICROBIOL, V49, P3470, DOI 10.1128/JCM.01122-11; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2012, AIDS RES HUM RETROVI; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Saphonn V, 2005, JAIDS-J ACQ IMM DEF, V39, P587; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Smolen-Dzirba J, 2011, MED SCI MONITOR, V17, pRA124, DOI 10.12659/MSM.881757; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Westreich Daniel, 2007, S Afr Med J, V97, P480	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77765	10.1371/journal.pone.0077765	http://dx.doi.org/10.1371/journal.pone.0077765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147075	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200073
J	Guo, XY; Yang, GL; Yuan, J; Ruan, P; Zhang, MX; Chen, XC; Zhou, BP				Guo, Xiaoyan; Yang, Guilin; Yuan, Jin; Ruan, Peng; Zhang, Mingxia; Chen, Xincun; Zhou, Boping			Genetic Variation in Interleukin 28B and Response to Antiviral Therapy in Patients with Dual Chronic Infection with Hepatitis B and C Viruses	PLOS ONE			English	Article							PEGYLATED-INTERFERON-ALPHA; HBEAG-POSITIVE PATIENTS; RIBAVIRIN THERAPY; IFN-LAMBDA; IL28B; PEGINTERFERON; PREVALENCE; CLEARANCE; DIAGNOSIS	Concurrent infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) was not uncommon in China. To date, information on predictors of response to treatment of dually-infected HCV/HBV is limited. The aim of this study was to evaluated whether determination of the interleukin 28B (IL-28B) polymorphism statuses sufficient to predict treatment response of interferon (IFN)-based therapy in patients chronically infected with both hepatitis B and C viruses. We investigated the role of IL28B variations (rs8099917 and rs12979860) in response to IFN-based treatment and evaluated its association with the risk of the null virological response (NVR) in HCV /HBV dually-infected patients. We found that the overall distributions of the genotypes among the sustained virological response (SVR), NVR groups were significantly different (P<0.001): patients with the rs8099917 TG genotype had an increased risk of NVR (odds ratio [OR] =2.37 95% confidence interval [CI] = 1.16-4.83, P = 0.017), and those with the GG genotype had a further increased risk of NVR (OR=4.23, 95% CI = 1.17-15.3, P=0.027). The rs12979860 allele was also highly associated with treatment failure (CT/TT vs. CC; OR =2.04, 95% CI = 1.05-3.97, P =0.037). Moreover, we found that IL28B rs8099917 G variants (TG+GG) interact with HCV genotype 1(G1) to result in higher risk of NVR (P=0.009), and that they are also associated with HBV DNA reactivation (TG+GG vs. TT, P=0.005). Furthermore, multivariate regression analysis show that the rs8099917 G allele was the most important factor significantly associated with a NVR in HCV G1 patients. This study suggest that IL28B genotyping may be a valid pretreatment predictor of which patients are likely to respond to treatment in this group of difficult-to-treat HCV/HBV dually-infected patients.	[Guo, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Guilin; Yuan, Jin; Ruan, Peng; Zhang, Mingxia; Chen, Xincun; Zhou, Boping] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Xiaoyan] Shenzhen Third Peoples Hosp, Inst Hepatol, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, XC (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China.	chenxinchun@hotmail.com; zhoubp@hotmail.com			Ministry of Education [820003191004]; National Science and Technology Major Project [2012ZX10002004, 2012ZX10002003]; Sun Yat-Sen University Clinical Research 5010 Program [2007029, 2010011]	Ministry of Education; National Science and Technology Major Project; Sun Yat-Sen University Clinical Research 5010 Program	This study was supported by Scholarship Award for Excellent Doctoral Student granted by Ministry of Education (No. 820003191004). National Science and Technology Major Project (2012ZX10002004, 2012ZX10002003), Sun Yat-Sen University Clinical Research 5010 Program (2007029, 2010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; CRESPO J, 1994, AM J GASTROENTEROL, V89, P1147; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Guo XY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-123; Hung CH, 2005, J GASTROEN HEPATOL, V20, P727, DOI 10.1111/j.1440-1746.2005.03791.x; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Hung CH, 2010, HEPATOLOGY, V52, P1521, DOI 10.1002/hep.23740; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liu CJ, 2009, GASTROENTEROLOGY, V136, P496, DOI 10.1053/j.gastro.2008.10.049; Liu CJ, 2003, HEPATOLOGY, V37, P568, DOI 10.1053/jhep.2003.50096; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; PONTISSO P, 1993, GASTROENTEROLOGY, V105, P1529, DOI 10.1016/0016-5085(93)90161-5; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; ter Borg MJ, 2006, HEPATOLOGY, V44, P721, DOI 10.1002/hep.21302; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; YU ML, 2013, HEPATOLOGY	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77911	10.1371/journal.pone.0077911	http://dx.doi.org/10.1371/journal.pone.0077911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147097	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200086
J	Chen, H; Zhang, Y; Zheng, DH; Praseedom, RK; Dong, JH				Chen, Hao; Zhang, Ying; Zheng, Donghang; Praseedom, Raaj Kumar; Dong, Jiahong			Orthotopic Kidney Transplantation in Mice: Technique Using Cuff for Renal Vein Anastomosis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HEART; MODEL	Mouse renal transplantation is a technically challenging procedure. Although the first kidney transplants in mice were performed over 34 years ago and refined some years later, the classical techniques of mouse renal transplantation required clamping both vena cava and aorta simultaneously and carry out suture anastomoses of the renal artery and vein in a heterotopic position. In our laboratory, we have successfully developed mouse orthotopic kidney transplantation for the first time, using a rapid "cuffed" renal vein technique for vessel anastomosis, wherein the donor's renal vein was inserted through an intravenous catheter, folded back and tied. During grafting, the cuffed renal vein was directly inserted into the recipient's renal vein without the need for the clamping vena cava and suturing of renal vein. This technique allowed for the exact transplantation of the kidney into the original position, compared to the classical technique, and has significantly shortened the clamping time due to a quicker and precise anastomosis of renal vein as described. This also allowed for a quicker recovery of the lower extremity activity, reduction in myoglobinuria with resultant kidney graft survival of 88.9%. Thus we believe that the cuffed renal vein technique simplifies microvascular anastomoses and affords important additional benefits.	[Chen, Hao; Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China; [Chen, Hao; Zheng, Donghang] Univ Florida, Coll Med, Dept Cardiol, Gainesville, FL USA; [Chen, Hao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Ying] Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China; [Praseedom, Raaj Kumar] Addenbrookes Hosp, Dept HPB Transplant Surg, Cambridge, England	Chinese People's Liberation Army General Hospital; State University System of Florida; University of Florida; Zhejiang University; Chinese People's Liberation Army General Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chen, H (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China.	chenhao.dr@gmail.com			973 project [2003CB5500]; National Nature Science Foundation of China	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by grants from the 973 project 2003CB5500, the National Nature Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COFFMAN T, 1993, J IMMUNOL, V151, P425; Gok MA, 2006, J UROLOGY, V175, P641, DOI 10.1016/S0022-5347(05)00170-9; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; Huang LJ, 2012, INT BRAZ J UROL, V38, P395, DOI 10.1590/S1677-55382012000300013; Loverre A, 2007, KIDNEY INT, V72, P994, DOI 10.1038/sj.ki.5002468; Mannon RB, 1999, KIDNEY INT, V55, P1935, DOI 10.1046/j.1523-1755.1999.00423.x; Martins Paulo N., 2006, Int. braz j urol., V32, P713, DOI 10.1590/S1677-55382006000600013; Miller CC, 2008, EUR J CARDIO-THORAC, V33, P691, DOI 10.1016/j.ejcts.2008.01.006; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; SKOSKIEWICZ M, 1973, TRANSPL P, V5, P721; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Wang Hao, 2012, Methods Mol Biol, V885, P125, DOI 10.1007/978-1-61779-845-0_9; Wang JJ, 2009, J VIS EXP, V10, P29; Wang MH, 2003, MICROSURG, V23, P164, DOI 10.1002/micr.10111; Zarjou A, 2012, KIDNEY INT, V82, P1231, DOI 10.1038/ki.2012.277; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212	16	5	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77278	10.1371/journal.pone.0077278	http://dx.doi.org/10.1371/journal.pone.0077278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155935	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300069
J	Lin, JZ; Wu, HF; Shi, H; Pan, W; Yu, HB; Zhu, JG				Lin, Jianzhong; Wu, Hongfei; Shi, Hui; Pan, Wei; Yu, Hongbo; Zhu, Jiageng			Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer	PLOS ONE			English	Article							PHASE-II TRIAL; FACTOR-KAPPA-B; TUMOR-GROWTH; ANDROGEN RECEPTOR; BREAST-CANCER; CELL-LINES; EXPRESSION; GEFITINIB; EFFICACY; DRUGS	The epidermal growth factor receptor (EGFR) and cyclooxygenase-2(COX-2) play a critical role in disease progression, relapse and therapeutic resistance of advanced prostate cancer (PCa). In this paper, we evaluated, for the first time, the therapeutic benefit of blocking EGRF and/or COX-2 (using gefitinib and NS-398, respectively) in terms of improving the efficacy of the conventional clinical chemotherapeutic drug docetaxel in vitro and vivo. We showed that EGFR and COX-2 expression was higher in metastatic than non-metastatic PCa tissues and cells. Docetaxel, alone or in combination with gefitinib or NS-398, resulted in a small decrease in cell viability. The three drug combination decreased cell viability to a greater extent than docetaxel alone or in combination with gefitinib or NS-398. Docetaxel resulted in a modest increase in apoptotic cell in metastatic and non-metastatic cell lines. NS-398 markedly enhanced docetaxel-induced cell apoptosis. The combination of the three drugs caused even more marked apoptosis and resulted in greater suppression of invasive potential than docetaxel alone or in association with gefitinib or NS-398. The combination of all three drugs also resulted in a more marked decrease in NF-kappa B, MMP-9 and VEGF levels in PC-3M cells. These in vitro findings were supported by in vivo studies showing that docetaxel in combination with gefitinib and NS-398 was significantly more effective than any individual agent. Based on previous preclinical research, we conclude that simultaneously blocking EGFR and COX-2 by gefitinib and NS-398 sensitizes advanced PCa cells to docetaxel-induced cytotoxicity.	[Lin, Jianzhong; Wu, Hongfei; Yu, Hongbo] Nanjing Med Univ, BenQ Med Ctr, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Shi, Hui] Jiangsu Inst Planned Parenthood Res, Lab Reprod Hlth, Nanjing, Jiangsu, Peoples R China; [Pan, Wei] Second Hosp Nanjing Jiangning, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jiageng] Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhu, JG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	zhujiageng1972@hotmail.com			Science and Technology planning project of Nanjing, China [201201088]	Science and Technology planning project of Nanjing, China	The work has supported by Science and Technology planning project of Nanjing, China (201201088). The URL of funder's website is http://202.127.12.44/XMSB/Show_JBXXB.jsp?XMBH=2012sc315043&DJXH=20121069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinpour P, 2011, PROSTATE, V71, P813, DOI 10.1002/pros.21297; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Borghese C, 2013, J CELL BIOCHEM, V114, P1135, DOI 10.1002/jcb.24456; Cathomas R, 2012, CLIN CANCER RES, V18, P6049, DOI 10.1158/1078-0432.CCR-12-2219; Chan Emily, 2011, Am J Clin Oncol, V34, P581, DOI 10.1097/COC.0b013e3181fe46a1; Cho KS, 2008, PROSTATE, V68, P803, DOI 10.1002/pros.20743; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clarke NW, 2006, EUR UROL, V50, P428, DOI 10.1016/j.eururo.2006.05.017; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; Cohen BL, 2006, INT J CANCER, V119, P1082, DOI 10.1002/ijc.21749; Dandekar DS, 2005, INT J CANCER, V115, P484, DOI 10.1002/ijc.20878; Dandekar DS, 2004, CLIN CANCER RES, V10, P8037, DOI 10.1158/1078-0432.CCR-04-1208; Farnebo L, 2011, J ORAL PATHOL MED, V40, P739, DOI 10.1111/j.1600-0714.2011.01036.x; Feng Ni, 2012, PLOS ONE, V7; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Halabi S, 2011, CANCER, V117, P526; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kang JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-334; Kim SM, 2010, EUR J PHARMACOL, V10, P631; Lanza-Jacoby S, 2006, CLIN CANCER RES, V12, P6161, DOI 10.1158/1078-0432.CCR-06-0042; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Mathew P, 2011, J INTERF CYTOK RES, V31, P539, DOI 10.1089/jir.2010.0142; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Ortholan C, 2010, EUR J CANCER, V46, P3022, DOI 10.1016/j.ejca.2010.07.021; Pan YQ, 2003, CANCER EPIDEM BIOMAR, V12, P769; Park SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-222; Reuter CWM, 2010, WORLD J UROL, V28, P391, DOI 10.1007/s00345-010-0527-5; Salzberg M, 2007, ONKOLOGIE, V30, P355, DOI 10.1159/000102452; Stavridi F, 2010, CANCER TREAT REV, V36, P122, DOI 10.1016/j.ctrv.2009.06.001; Stock D, 2008, UROL CLIN N AM, V35, P117, DOI 10.1016/j.ucl.2007.09.006; Stoppoloni D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-27; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Walter B, 2010, WORLD J UROL, V28, P745, DOI 10.1007/s00345-010-0567-x; Zhang X, 2005, CLIN CANCER RES, V11, P6261, DOI 10.1158/1078-0432.CCR-04-2102	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76169	10.1371/journal.pone.0076169	http://dx.doi.org/10.1371/journal.pone.0076169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155892	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300026
J	Matito, A; Morgado, JM; Alvarez-Twose, I; Sanchez-Munoz, L; Pedreira, CE; Jara-Acevedo, M; Teodosio, C; Sanchez-Lopez, P; Fernandez-Nunez, E; Moreno-Borque, R; Garcia-Montero, A; Orfao, A; Escribano, L				Matito, Almudena; Mario Morgado, Jose; Alvarez-Twose, Ivan; Sanchez-Munoz, Laura; Eduardo Pedreira, Carlos; Jara-Acevedo, Maria; Teodosio, Cristina; Sanchez-Lopez, Paula; Fernandez-Nunez, Elisa; Moreno-Borque, Ricardo; Garcia-Montero, Andres; Orfao, Alberto; Escribano, Luis			Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome	PLOS ONE			English	Article							MARROW MAST-CELLS; IMMUNOPHENOTYPIC CHARACTERIZATION; SPANISH NETWORK; KIT MUTATION; ANAPHYLAXIS; DIAGNOSIS; SEVERITY; CRITERIA; ALPHA; BLOOD	Background: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. Methods: In total 74 adult ISM patients who were followed for >= 48 months and received no cytoreductive therapy were retrospectively studied. Patients were classified according to the pattern of evolution of sBT observed. Results: Overall 16/74 (22%) cases had decreasing sBT levels, 48 (65%) patients showed increasing sBT levels and 10 (13%) patients showed a fluctuating pattern. Patients with significantly increasing sBT (sBT slope >= 0.15) after 48 months of follow-up showed a slightly greater rate of development of diffuse bone sclerosis (13% vs. 2%) and hepatomegaly plus splenomegaly (16% vs. 5%), as well as a significantly greater frequency of multilineage vs. mast cells (MC)-restricted KIT mutation (p = 0.01) together with a greater frequency of cases with progression of ISM to smouldering and aggressive SM (p = 0.03), and a shorter progression-free survival (p = 0.03). Conclusions: Monitoring of sBT in ISM patients is closely associated with poor prognosis disease features as well as with disease progression, pointing out the need for a closer follow-up in ISM patients with progressively increasing sBT values.	[Matito, Almudena; Mario Morgado, Jose; Alvarez-Twose, Ivan; Sanchez-Munoz, Laura; Sanchez-Lopez, Paula; Fernandez-Nunez, Elisa; Escribano, Luis] Hosp Virgen del Valle, Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain; [Eduardo Pedreira, Carlos] COPPE Inst Alberto Luiz Coimbra Posgrad & Pesquis, Rio De Janeiro, Brazil; [Eduardo Pedreira, Carlos] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Jara-Acevedo, Maria; Teodosio, Cristina; Garcia-Montero, Andres; Orfao, Alberto] Ctr Invest Canc IBMCC CSIC USAL, Serv Gen Citometria, Salamanca, Spain; [Jara-Acevedo, Maria; Teodosio, Cristina; Garcia-Montero, Andres; Orfao, Alberto] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Sanchez-Lopez, Paula; Moreno-Borque, Ricardo] Hosp Rey Juan Carlos, Dept Allergy, Mostoles, Spain	Complejo Hospitalario de Toledo; Universidade Federal do Rio de Janeiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Escribano, L (corresponding author), Hosp Virgen del Valle, Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain.	escribanomoraluis@gmail.com	Nuñez, Elisa Fernandez/Z-1796-2019; Montero, Andres/HGA-9093-2022; Orfao, Alberto/B-5801-2017; Garcia-Montero, Andres C/B-6558-2017; Pedreira, Carlos Eduardo/I-5629-2013	Nuñez, Elisa Fernandez/0000-0001-6651-2576; Garcia-Montero, Andres C/0000-0003-4360-1386; Jara-Acevedo, Maria/0000-0001-7965-7512; Alvarez-Twose, Ivan/0000-0002-1190-4473; Pedreira, Carlos Eduardo/0000-0002-9312-4023; Teodosio, Cristina/0000-0002-2097-7199; Matito, Almudena/0000-0002-9547-4844; Sanchez-Munoz, Laura/0000-0003-1757-7255	Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain [RETICS RD06/0020/0035-FEDER, PS09/00032]; Fundacion Sociosanitaria de Castilla-La Mancha [FISCAM 2007/36, FISCAM 2010/008, G-2010/C-002]; Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain [PI11/02399]; Junta de Castilla y Leon [SAN/103/2011]; Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM);  [RETICS RD09/0076/00074]	Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain(Instituto de Salud Carlos III); Fundacion Sociosanitaria de Castilla-La Mancha; Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM); 	This work was supported by grants from the Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain (RETICS RD06/0020/0035-FEDER and PS09/00032); Fundacion Sociosanitaria de Castilla-La Mancha (FISCAM 2007/36, FISCAM 2010/008 and G-2010/C-002); Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain (PI11/02399); Junta de Castilla y Leon (SAN/103/2011); Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM 2010); Hospital Virgen de la Salud Biobank (BioB-HVS) supported by grant of RETICS RD09/0076/00074, (Toledo, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; CASTELLS MC, 1987, J IMMUNOL, V138, P2184; Caughey GH, 2006, J ALLERGY CLIN IMMUN, V117, P1411, DOI 10.1016/j.jaci.2006.02.026; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Escribano L, 1998, BLOOD, V91, P2731, DOI 10.1182/blood.V91.8.2731.2731_2731_2736; Escribano L, 2004, CYTOM PART B-CLIN CY, V58B, P1, DOI 10.1002/cyto.b.10072; Escribano L, 2002, INT ARCH ALLERGY IMM, V127, P127, DOI 10.1159/000048183; Escribano Luis, 2006, Inflammation & Allergy Drug Targets, V5, P61, DOI 10.2174/187152806775269303; Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003; Sirvent AE, 2010, J NEPHROL, V23, P282; Ferrer M, 2010, CLIN EXP ALLERGY, V40, P1760, DOI 10.1111/j.1365-2222.2010.03582.x; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Haeberli G, 2003, CLIN EXP ALLERGY, V33, P1216, DOI 10.1046/j.1365-2222.2003.01755.x; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kushnir-Sukhov NM, 2006, INT ARCH ALLERGY IMM, V139, P265, DOI 10.1159/000091172; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Miller PD, 2006, REV ENDOCR METAB DIS, V7, P75, DOI 10.1007/s11154-006-9006-0; Orfao A, 1996, AM J PATHOL, V149, P1493; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Sanchez-Munoz L, 2011, MODERN PATHOL, V24, P1157, DOI 10.1038/modpathol.2011.84; Sanchez-Munoz L, 2011, METHOD CELL BIOL, V103, P333, DOI 10.1016/B978-0-12-385493-3.00014-0; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; Schwartz LB, 2001, LEUKEMIA RES, V25, P553, DOI 10.1016/S0145-2126(01)00020-0; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; Simon MR, 2010, INT ARCH ALLERGY IMM, V152, P28, DOI 10.1159/000260080; Sperr WR, 2009, EUR J CLIN INVEST, V39, P914, DOI 10.1111/j.1365-2362.2009.02184.x; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Sperr WR, 2001, LEUKEMIA RES, V25, P529, DOI 10.1016/S0145-2126(01)00041-8; Teodosio C, 2012, LEUKEMIA, V26, P951, DOI 10.1038/leu.2011.293; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Valent P, 2001, WHO CLASSIFICATION T, P291; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5	38	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76116	10.1371/journal.pone.0076116	http://dx.doi.org/10.1371/journal.pone.0076116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155887	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300021
J	Narendra, A; Alkaladi, A; Raderschall, CA; Robson, SKA; Ribi, WA				Narendra, Ajay; Alkaladi, Ali; Raderschall, Chloe A.; Robson, Simon K. A.; Ribi, Willi A.			Compound Eye Adaptations for Diurnal and Nocturnal Lifestyle in the Intertidal Ant, Polyrhachis sokolova	PLOS ONE			English	Article							INSECT PUPIL MECHANISMS; BEE MEGALOPTA-GENALIS; POLARIZED SKYLIGHT; RETINULA CELLS; SPECTRAL SENSITIVITY; FLY PHOTORECEPTORS; VISUAL ADAPTATIONS; MELOPHORUS-BAGOTI; PIGMENT MIGRATION; DESERT ANTS	The Australian intertidal ant, Polyrhachis sokolova lives in mudflat habitats and nests at the base of mangroves. They are solitary foraging ants that rely on visual cues. The ants are active during low tides at both day and night and thus experience a wide range of light intensities. We here ask the extent to which the compound eyes of P. sokolova reflect the fact that they operate during both day and night. The ants have typical apposition compound eyes with 596 ommatidia per eye and an interommatidial angle of 6.0 degrees. We find the ants have developed large lenses (33 mu m in diameter) and wide rhabdoms (5 mu m in diameter) to make their eyes highly sensitive to low light conditions. To be active at bright light conditions, the ants have developed an extreme pupillary mechanism during which the primary pigment cells constrict the crystalline cone to form a narrow tract of 0.5 mu m wide and 16 mu m long. This pupillary mechanism protects the photoreceptors from bright light, making the eyes less sensitive during the day. The dorsal rim area of their compound eye has specialised photoreceptors that could aid in detecting the orientation of the pattern of polarised skylight, which would assist the animals to determine compass directions required while navigating between nest and food sources.	[Narendra, Ajay; Raderschall, Chloe A.; Ribi, Willi A.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Alkaladi, Ali] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Robson, Simon K. A.] James Cook Univ, Fac Sci & Engn, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Ribi, Willi A.] Private Univ Liechtenstein, Triesen, Liechtenstein	Australian National University; King Abdulaziz University; James Cook University	Narendra, A (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	ajay.narendra@anu.edu.au	Robson, Simon KA/D-1168-2011; Raderschall, Chloe/AAF-3516-2022; Raderschall, Chloe/AFH-9100-2022; Narendra, Ajay/A-4960-2008	Robson, Simon KA/0000-0001-8870-1933; Narendra, Ajay/0000-0002-1286-5373; Raderschall, Chloe/0000-0003-2005-1705	Australian Research Council's (ARC) Centres of Excellence Scheme [CEO561903]; ARC Discovery Early Career Award [DE120100019]; ARC Discovery grant [DP1093553]; King Abdulaziz University	Australian Research Council's (ARC) Centres of Excellence Scheme(Australian Research Council); ARC Discovery Early Career Award(Australian Research Council); ARC Discovery grant(Australian Research Council); King Abdulaziz University	This work was funded by Australian Research Council's (ARC) Centres of Excellence Scheme (CEO561903); ARC Discovery Early Career Award (DE120100019); ARC Discovery grant (DP1093553); King Abdulaziz University travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEPLI F, 1985, CELL TISSUE RES, V239, P19, DOI 10.1007/BF00214897; Andersen Alan N., 2013, Diversity-Basel, V5, P139; BRUNNERT A, 1973, J MORPHOL, V140, P15, DOI 10.1002/jmor.1051400103; Collett TS, 2007, J EXP BIOL, V210, P2025, DOI 10.1242/jeb.000315; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Esch HE, 1996, J EXP BIOL, V199, P155; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; KOHOUT R J, 1988, Memoirs of the Queensland Museum, V25, P429; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; MENZEL R, 1975, CYTOBIOLOGIE, V11, P279; MENZI U, 1987, J COMP PHYSIOL A, V160, P11, DOI 10.1007/BF00613437; Narendra A, 2007, J EXP BIOL, V210, P1804, DOI 10.1242/jeb.02769; Narendra A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0683; Narendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058801; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Reid SF, 2010, THESIS AUSTR NATL U; RIBI WA, 1989, ENTOMOL GEN, V14, P233; Robson Simon K.A., 2007, Asian Myrmecology, V1, P81; Robson SKA, 2009, ANT ECOLOGY, P185; Schwarz S, 2011, ARTHROPOD STRUCT DEV, V40, P128, DOI 10.1016/j.asd.2010.10.003; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; STAVENGA DG, 1977, J COMP PHYSIOL, V113, P73, DOI 10.1007/BF00610454; STAVENGA DG, 1977, J COMP PHYSIOL, V113, P55, DOI 10.1007/BF00610453; Stavenga DG, 2006, INVERTEBRATE VISION, P1; Streinzer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057702; Theobald JC, 2006, VISION RES, V46, P2298, DOI 10.1016/j.visres.2006.01.002; VANHATEREN JH, 1993, J COMP PHYSIOL A, V172, P583, DOI 10.1007/BF00213681; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Walcott B., 1975, P20; WALCOTT B, 1969, NATURE, V223, P971, DOI 10.1038/223971a0; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant EJ, 1996, J COMP PHYSIOL A, V39, P223; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; Wehner R, 1996, J EXP BIOL, V199, P129; WEHNER R, 1989, TRENDS NEUROSCI, V12, P353, DOI 10.1016/0166-2236(89)90043-X; Wehner R., 1972, INFORMATION PROCESSI, P37; Wehner R, 1982, NEUROPHYSIOLOGIE VER, P1; Wehner R, 2006, P NATL ACAD SCI USA, V103, P12575, DOI 10.1073/pnas.0604430103; Wehner R, 2006, INVERTEBRATE VISION, P291; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; ZOLLIKOFER CPE, 1995, J EXP BIOL, V198, P1637	53	25	26	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76015	10.1371/journal.pone.0076015	http://dx.doi.org/10.1371/journal.pone.0076015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155883	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325887300017
J	Zhang, ZC; Jian, XD; Zhang, W; Wang, JR; Zhou, Q				Zhang, Zhongchen; Jian, Xiangdong; Zhang, Wei; Wang, Jieru; Zhou, Qian			Using Bosentan to Treat Paraquat Poisoning-Induced Acute Lung Injury in Rats	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; RECEPTOR ANTAGONIST BOSENTAN; ENDOTHELIN-1; HYPERTENSION	Background: Paraquat poisoning is well known for causing multiple organ function failure (MODS) and high mortality. Acute lung injury and advanced pulmonary fibrosis are the most serious complications. Bosentan is a dual endothelin receptor antagonist. It plays an important role in treating PF. There is no related literature on the use of bosentan therapy for paraquat poisoning. Objective: To study the use of bosentan to treat acute lung injury and pulmonary fibrosis as induced by paraquat. Method: A total of 120 adult Wister male rats were randomly assigned to three groups: the paraquat poisoning group (rats were intragastrically administered with paraquat at 50 mg/kg body weight once at the beginning); the bosentan therapy group (rats were administered bosentan at 100 mg/kg body weight by intragastric administration half an hour after paraquat was administered, then the same dose was administered once a day); and a control group (rats were administered intragastric physiological saline). On the 3rd, 7th, 14th, and 21st days following paraquat exposure, rats were sacrificed, and samples of lung tissue and venous blood were collected. The levels of transforming growth factor-beta 1 (TGF-beta 1), endothelin-1 (ET-1), and hydroxyproline (HYP) in the plasma and lung homogenate were determined. Optical and electronic microscopes were used to examine pathological changes. Result: The TGF-beta 1, ET-1, and HYP of the paraquat poisoning group were significantly higher than in the control group, and they were significantly lower in the 21st day therapy group than in the paraquat poisoning group on the same day. Under the optical and electronic microscopes, lung tissue damage was observed to be more severe but was then reduced after bosentan was administered. Conclusion: Bosentan can reduce inflammation factor release. It has a therapeutic effect on acute lung injury as induced by paraquat.	[Zhang, Zhongchen; Jian, Xiangdong; Zhang, Wei; Wang, Jieru; Zhou, Qian] Shandong Univ, Qilu Hosp, Dept Poisoning & Occupat Dis, Jinan 250100, Shandong, Peoples R China	Shandong University	Jian, XD (corresponding author), Shandong Univ, Qilu Hosp, Dept Poisoning & Occupat Dis, Jinan 250100, Shandong, Peoples R China.	j6anxian@public.jn.sd.cn			Natural Science Foundation of Shandong Provience [Y2008C123]	Natural Science Foundation of Shandong Provience	This work was supported by the Natural Science Foundation of Shandong Provience, the project number Y2008C123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadalla EA, 2012, EXP TOXICOL PATHOL, V64, P431, DOI 10.1016/j.etp.2010.10.009; BULLIVANT CM, 1966, BMJ-BRIT MED J, V1, P1272, DOI 10.1136/bmj.1.5498.1272; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chen HW, 2009, J CHIN MED ASSOC, V72, P547, DOI 10.1016/S1726-4901(09)70426-5; CHOI Y, 2008, AM J EMERG MED, V26; Comellas AP, 2009, TRANSL RES, V153, P263, DOI 10.1016/j.trsl.2009.02.007; Ghaffari AR, 2011, SAUDI MED J, V32, P249; Gunther A, 2007, EUR RESPIR J, V29, P713, DOI 10.1183/09031936.00149205; Hong Joong-Rock, 2010, Korean Journal of Internal Medicine, V25, P422, DOI 10.3904/kjim.2010.25.4.422; Kim HR, 2006, LUNG, V184, P287, DOI 10.1007/s00408-005-2592-x; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; Knobloch J, 2009, THORAX, V64, P1044, DOI 10.1136/thx.2008.111047; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Le Saux O, 2008, AM J PHYSIOL-LUNG C, V295, pL1007, DOI 10.1152/ajplung.90207.2008; Li XX, 2011, CHINESE MED J-PEKING, V124, P1923, DOI 10.3760/cma.j.issn.0366-6999.2011.13.001; Liu Shi-ping, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P242; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; Meoli DF, 2010, CAN J PHYSIOL PHARM, V88, P830, DOI 10.1139/Y10-059; Mohammadi-Karakani A, 2006, CLIN CHIM ACTA, V367, P170, DOI 10.1016/j.cca.2005.12.012; Ning Qiong, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P667; Ross B, 2010, AM J RESP CELL MOL, V42, P16, DOI 10.1165/rcmb.2009-0175TR; Schroll S, 2010, RESP PHYSIOL NEUROBI, V170, P32, DOI 10.1016/j.resp.2009.11.005; Trabold B, 2009, INJURY, V40, P946, DOI 10.1016/j.injury.2008.11.016; Wang Wei-hua, 2005, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V17, P293; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhao Bo, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P220	26	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75943	10.1371/journal.pone.0075943	http://dx.doi.org/10.1371/journal.pone.0075943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155875	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300009
J	Wang, YM; O'Connor, JK; Li, DQ; You, HL				Wang, Ya-Ming; O'Connor, Jingmai K.; Li, Da-Qing; You, Hai-Lu			Previously Unrecognized Ornithuromorph Bird Diversity in the Early Cretaceous Changma Basin, Gansu Province, Northwestern China	PLOS ONE			English	Article							ENANTIORNITHINE BIRD; AVES ORNITHOTHORACES; ORNITHURINE BIRD; FOSSIL BIRDS; EVOLUTION; MORPHOLOGY; CLADE	Here we report on three new species of ornithuromorph birds from the Lower Cretaceous Xiagou Formation in the Changma Basin of Gansu Province, northwestern China: Yumenornis huangi gen. et sp. nov., Changmaornis houi gen. et sp. nov., and Jiuquanornis niui gen. et sp. nov.. The last of these is based on a previously published but unnamed specimen: GSGM-05-CM-021. Although incomplete, the specimens can be clearly distinguished from each other and from Gansus yumenensis Hou and Liu, 1984. Phylogenetic analysis resolves the three new taxa as basal ornithuromorphs. This study reveals previously unrecognized ornithuromorph diversity in the Changma avifauna, which is largely dominated by Gansus but with at least three other ornithuromorphs. Body mass estimates demonstrate that enantiornithines were much smaller than ornithuromorphs in the Changma avifauna. In addition, Changma enantiornithines preserve long and recurved pedal unguals, suggesting an arboreal lifestyle; in contrast, Changma ornithuromorphs tend to show terrestrial or even aquatic adaptions. Similar differences in body mass and ecology are also observed in the Jehol avifauna in northeastern China, suggesting niche partitioning between these two clades developed early in their evolutionary history.	[Wang, Ya-Ming] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Wang, Ya-Ming; O'Connor, Jingmai K.; You, Hai-Lu] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [O'Connor, Jingmai K.; You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Li, Da-Qing] Gansu Geol Museum, Lanzhou, Gansu, Peoples R China	Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, YM (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.	yaming21@hotmail.com		You, Hai-Lu/0000-0003-2203-6461	Hundred Talents Project of the Chinese Academy of Sciences; National Natural Science Foundation of China [40672007, 41072019]; Department of Land and Resources of Gansu Province	Hundred Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Land and Resources of Gansu Province	This research was supported by the Hundred Talents Project of the Chinese Academy of Sciences, the National Natural Science Foundation of China (40672007,41072019), and the Department of Land and Resources of Gansu Province to LDQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin FL, 2009, J S AM EARTH SCI, V27, P42, DOI 10.1016/j.jsames.2008.09.003; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; Connor JKO, 2009, J VERTEBR PALEONTOL, V29, P188; Dyke GJ, 2010, GEOL J, V45, P434, DOI 10.1002/gj.1209; Novas FE, 2010, CR PALEVOL, V9, P499, DOI 10.1016/j.crpv.2010.09.005; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Harris JD, 2006, CAN J EARTH SCI, V43, P547, DOI 10.1139/E06-007; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hou L., 1997, MESOZOIC BIRDS CHINA; HOU LH, 1984, SCI SIN B-CHEM B A M, V27, P1296; Ji S.-A, 2006, GEOLOGICAL B CHINA, V25, P1296; Ji SA, 2011, ZOOL J LINN SOC-LOND, V162, P201, DOI 10.1111/j.1096-3642.2010.00671.x; Kurochkin EN., 1982, PALAEONTOL J, V1982, P215; Lamanna MC, 2006, ACTA PALAEONTOL POL, V51, P423; [李岩 Li Yan], 2011, [古脊椎动物学报, Vertebrata Palasiatica], V49, P435; Linnaeus C, 1758, SYSTEMS NATURAE; Liu Di, 2012, Vertebrata Palasiatica, V50, P39; Martin LD, 1983, CURRENT ORNITHOLOGY, V4; Morschhauser EM, 2009, J VERTEBR PALEONTOL, V29, P545, DOI 10.1671/039.029.0210; Nudds RL, 2013, J EVOLUTION BIOL, V26, P150, DOI 10.1111/jeb.12036; O'Connor, 2009, SYSTEMATIC REV ENANT; O'Connor J.J.M., 2012, J EVOLUTIONARY PSYCH, V10, P1, DOI [10.1556/JEP.10.2012.1.1, DOI 10.1556/JEP.10.2012.1.1]; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; O'Connor JK, 2011, LIVING DINOSAURS EVO; Suarez MB, 2013, GEOL SOC SPEC PUBL, V382, P143, DOI 10.1144/SP382.1; You H., 2005, HIST BIOL, V17, P7, DOI DOI 10.1080/08912960500284851; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; You HL, 2010, ACTA PALAEONTOL POL, V55, P617, DOI 10.4202/app.2009.0095; Zhang Yu-Guang, 2008, Vertebrata Palasiatica, V46, P317; Zhou S, 2013, J VERTEBR PALEONTOL, V33, P141, DOI 10.1080/02724634.2012.714431; Zhou Shuang, 2012, Vertebrata Palasiatica, V50, P9; Zhou Z.-H., 2001, CHINESE SCI BULL, V46, P1, DOI DOI 10.1007/BF02900665; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P571, DOI 10.1007/s00114-004-0567-z; Zhou ZH, 2002, NATURE, V420, P285, DOI 10.1038/420285a; Zhou Zhong-He, 2009, Vertebrata Palasiatica, V47, P299; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x	43	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77693	10.1371/journal.pone.0077693	http://dx.doi.org/10.1371/journal.pone.0077693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147058	gold, Green Published			2022-12-25	WOS:000325819400135
J	dela Sena, C; Narayanasamy, S; Riedl, KM; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Narayanasamy, Sureshbabu; Riedl, Kenneth M.; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			Substrate Specificity of Purified Recombinant Human beta-Carotene 15,15 '-Oxygenase (BCO1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Enzymes; Lipid Metabolism; Metabolism; Retinoid; Vitamin A; Acycloretinal; Apocarotenal; Lycopene; Retinal	ACYCLO-RETINOIC ACID; 9-CIS-RETINOIC ACID; IN-VITRO; GEOMETRICAL-ISOMERS; EXCENTRIC CLEAVAGE; INTESTINAL-MUCOSA; RABBIT INTESTINE; CANCER CELLS; HUMAN PLASMA; HUMAN SERUM	Humans cannot synthesize vitamin A and thus must obtain it from their diet. -Carotene 15,15-oxygenase (BCO1) catalyzes the oxidative cleavage of provitamin A carotenoids at the central 15-15 double bond to yield retinal (vitamin A). In this work, we quantitatively describe the substrate specificity of purified recombinant human BCO1 in terms of catalytic efficiency values (k(cat)/K-m). The full-length open reading frame of human BCO1 was cloned into the pET-28b expression vector with a C-terminal polyhistidine tag, and the protein was expressed in the Escherichia coli strain BL21-Gold(DE3). The enzyme was purified using cobalt ion affinity chromatography. The purified enzyme preparation catalyzed the oxidative cleavage of -carotene with a V-max = 197.2 nmol retinal/mg BCO1 x h, K-m = 17.2 m and catalytic efficiency k(cat)/K-m = 6098 m(-1) min(-1). The enzyme also catalyzed the oxidative cleavage of -carotene, -cryptoxanthin, and -apo-8-carotenal to yield retinal. The catalytic efficiency values of these substrates are lower than that of -carotene. Surprisingly, BCO1 catalyzed the oxidative cleavage of lycopene to yield acycloretinal with a catalytic efficiency similar to that of -carotene. The shorter -apocarotenals (-apo-10-carotenal, -apo-12-carotenal, -apo-14-carotenal) do not show Michaelis-Menten behavior under the conditions tested. We did not detect any activity with lutein, zeaxanthin, and 9-cis--carotene. Our results show that BCO1 favors full-length provitamin A carotenoids as substrates, with the notable exception of lycopene. Lycopene has previously been reported to be unreactive with BCO1, and our findings warrant a fresh look at acycloretinal and its alcohol and acid forms as metabolites of lycopene in future studies.	[dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	riedl, ken/G-8621-2014; Harrison, Earl H/AAN-5378-2021; Riedl, Ken/K-1881-2019; NARAYANASAMY, SURESHBABU/AAN-6604-2021	riedl, ken/0000-0002-9020-3471; Schwartz, Steven/0000-0002-1427-5780; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01-HL49879, R01-DK44498]; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-HL49879 and R01-DK44498 and a grant from the Ohio Agricultural Research Development Center.	Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; BenAmotz A, 1996, AM J CLIN NUTR, V63, P729, DOI 10.1093/ajcn/63.5.729; CHANDLER LA, 1987, J FOOD SCI, V52, P669, DOI 10.1111/j.1365-2621.1987.tb06700.x; dePee S, 1996, EUR J CLIN NUTR, V50, pS38; DEVERY J, 1994, BRIT J NUTR, V72, P397, DOI 10.1079/BJN19940042; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; FIDGE NH, 1969, BIOCHEM J, V114, P689, DOI 10.1042/bj1140689; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Gajic M, 2006, J NUTR, V136, P1552, DOI 10.1093/jn/136.6.1552; GAZIANO JM, 1995, AM J CLIN NUTR, V61, P1248, DOI 10.1093/ajcn/61.6.1248; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; HANSEN S, 1988, BIOCHEMISTRY-US, V27, P200, DOI 10.1021/bi00401a030; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i; KHACHIK F, 1995, J CELL BIOCHEM, P236; Kim YS, 2009, BIOTECHNOL LETT, V31, P403, DOI 10.1007/s10529-008-9873-4; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kopec RE, 2010, J AGR FOOD CHEM, V58, P3290, DOI 10.1021/jf100415z; Kotake-Nara E, 2002, ANTICANCER RES, V22, P689; KRINSKY NI, 1990, J NUTR, V120, P1654, DOI 10.1093/jn/120.12.1654; LAKSHMAN.MR, 1972, J LIPID RES, V13, P477; LAKSHMANAN MR, 1968, BIOCHEM BIOPH RES CO, V33, P347, DOI 10.1016/0006-291X(68)90791-2; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Liden M, 2005, EXP CELL RES, V310, P401, DOI 10.1016/j.yexcr.2005.08.002; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Maeda T, 2011, MOL PHARMACOL, V80, P943, DOI 10.1124/mol.111.074732; MINGUEZMOSQUERA MI, 1995, J AOAC INT, V78, P491; NAGAO A, 1994, FASEB J, V8, P968, DOI 10.1096/fasebj.8.12.8088462; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Park CS, 2008, BIOTECHNOL LETT, V30, P735, DOI 10.1007/s10529-007-9598-9; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; STAHL W, 1993, J NUTR, V123, P847, DOI 10.1093/jn/123.5.847; Stahl W, 2000, ARCH BIOCHEM BIOPHYS, V373, P271, DOI 10.1006/abbi.1999.1510; Suzuki T, 1995, J NUTR SCI VITAMINOL, V41, P575, DOI 10.3177/jnsv.41.575; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; Tibaduiza EC, 2002, J NUTR, V132, P1368, DOI 10.1093/jn/132.6.1368; URBACH J, 1994, BIOCHEM J, V299, P459, DOI 10.1042/bj2990459; URBACH J, 1994, FEBS LETT, V351, P429, DOI 10.1016/0014-5793(94)00090-5; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; WANG XD, 1994, ARCH BIOCHEM BIOPHYS, V313, P150, DOI 10.1006/abbi.1994.1371; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; West CE, 1998, INT J VITAM NUTR RES, V68, P371; Wirtz GM, 2001, HELV CHIM ACTA, V84, P2301, DOI 10.1002/1522-2675(20010815)84:8<2301::AID-HLCA2301>3.0.CO;2-U; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yeum KJ, 2000, FREE RADICAL BIO MED, V29, P105, DOI 10.1016/S0891-5849(00)00296-3; You CS, 1996, AM J CLIN NUTR, V64, P177, DOI 10.1093/ajcn/64.2.177; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	56	75	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37094	37103		10.1074/jbc.M113.507160	http://dx.doi.org/10.1074/jbc.M113.507160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24187135	Green Published, hybrid			2022-12-25	WOS:000329189700029
J	Acheson, SK; Bearison, C; Risher, ML; Abdelwahab, SH; Wilson, WA; Swartzwelder, HS				Acheson, Shawn K.; Bearison, Craig; Risher, M. Louise; Abdelwahab, Sabri H.; Wilson, Wilkie A.; Swartzwelder, H. Scott			Effects of Acute or Chronic Ethanol Exposure during Adolescence on Behavioral Inhibition and Efficiency in a Modified Water Maze Task	PLOS ONE			English	Article							COGNITIVE EFFICIENCY; RESPONSE-INHIBITION; SPATIAL MEMORY; BINGE DRINKING; ALCOHOL-USE; AGE; RATS; SENSITIVITY; WITHDRAWAL; DEFICITS	Ethanol is well known to adversely affect frontal executive functioning, which continues to develop throughout adolescence and into young adulthood. This is also a developmental window in which ethanol is misused by a significant number of adolescents. We examined the effects of acute and chronic ethanol exposure during adolescence on behavioral inhibition and efficiency using a modified water maze task. During acquisition, rats were trained to find a stable visible platform onto which they could escape. During the test phase, the stable platform was converted to a visible floating platform (providing no escape) and a new hidden platform was added in the opposite quadrant. The hidden platform was the only means of escape during the test phase. In experiment 1, adolescent animals received ethanol (1.0g/kg) 30min before each session during the test phase. In experiment 2, adolescent animals received chronic intermittent ethanol (5.0g/kg) for 16 days (PND30 To PND46) prior to any training in the maze. At PND72, training was initiated in the same modified water maze task. Results from experiment 1 indicated that acute ethanol promoted behavioral disinhibition and inefficiency. Experiment 2 showed that chronic intermittent ethanol during adolescence appeared to have no lasting effect on behavioral disinhibition or new spatial learning during adulthood. However, chronic ethanol did promote behavioral inefficiency. In summary, results indicate that ethanol-induced promotion of perseverative behavior may contribute to the many adverse behavioral sequelae of alcohol intoxication in adolescents and young adults. Moreover, the long-term effect of adolescent chronic ethanol exposure on behavioral efficiency is similar to that observed after chronic exposure in humans.	[Acheson, Shawn K.; Risher, M. Louise; Abdelwahab, Sabri H.; Wilson, Wilkie A.; Swartzwelder, H. Scott] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA; [Acheson, Shawn K.; Risher, M. Louise; Abdelwahab, Sabri H.; Swartzwelder, H. Scott] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Bearison, Craig; Swartzwelder, H. Scott] Duke Univ, Dept Psychol, Durham, NC 27706 USA; [Bearison, Craig; Swartzwelder, H. Scott] Duke Univ, Dept Neurosci, Durham, NC USA; [Wilson, Wilkie A.] Duke Univ, Social Sci Res Inst, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; Duke University	Acheson, SK (corresponding author), Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA.	shawn.acheson@duke.edu	Risher, Louise/AAP-2646-2020; Acheson, Shawn/A-3299-2016	Risher, Louise/0000-0002-3139-4378; Abdelwahab, Sabri/0000-0001-8745-570X; Bearison, Craig/0000-0003-4451-9560	National Institute of Alcoholism and Alcohol Abuse [U01-AA019925-01-NADIA]; Veteran Affairs Senior Research Career Scientist award; VA Career Development Award [I01BX007080]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001267] Funding Source: NIH RePORTER	National Institute of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veteran Affairs Senior Research Career Scientist award; VA Career Development Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute of Alcoholism and Alcohol Abuse grant U01-AA019925-01-NADIA to HSS; Veteran Affairs Senior Research Career Scientist award to HSS; VA Career Development Award I01BX007080 to SKA; The NIH and VA had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.	Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Acheson SK, 2001, ALCOHOL, V23, P167, DOI 10.1016/S0741-8329(01)00127-6; Cain DP, 1996, BEHAV NEUROSCI, V110, P86, DOI 10.1037/0735-7044.110.1.86; Casbon TS, 2003, J ABNORM PSYCHOL, V112, P476, DOI 10.1037/0021-843X.112.3.476; Cha YM, 2006, ALCOHOL CLIN EXP RES, V30, P113, DOI 10.1111/j.1530-0277.2006.00005.x; Chin VS, 2011, ALCOHOL, V45, P473, DOI 10.1016/j.alcohol.2011.03.001; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Dawson DA, 2004, J STUD ALCOHOL, V65, P477, DOI 10.15288/jsa.2004.65.477; DEVENPORT LD, 1983, PHARMACOL BIOCHEM BE, V18, P55, DOI 10.1016/0091-3057(83)90251-4; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; Doremus-Fitzwater TL, 2012, BEHAV NEUROSCI, V126, P735, DOI 10.1037/a0029697; Fillmore MT, 2000, J STUD ALCOHOL, V61, P239, DOI 10.15288/jsa.2000.61.239; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hefner K, 2007, PSYCHOPHARMACOLOGY, V191, P311, DOI 10.1007/s00213-006-0646-2; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; LOH EA, 1989, ALCOHOL, V6, P311, DOI 10.1016/0741-8329(89)90088-8; LYVERS MF, 1991, BRIT J ADDICT, V86, P399; Lyvers M, 2010, ADDICT BEHAV, V35, P1021, DOI 10.1016/j.addbeh.2010.06.022; Malkki HAI, 2011, NEUROBIOL LEARN MEM, V96, P280, DOI 10.1016/j.nlm.2011.05.005; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Middlemore-Risher ML, 2010, NEUROTOXICOL TERATOL, V32, P415, DOI 10.1016/j.ntt.2010.03.008; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Newsletter N, 2004, NIAAA COUNCIL APPROV; Nixon SJ, 1998, ALCOHOL CLIN EXP RES, V22, P1414, DOI 10.1111/j.1530-0277.1998.tb03929.x; Nixon SJ, 1996, ALCOHOL CLIN EXP RES, V20, P21, DOI 10.1111/j.1530-0277.1996.tb01037.x; NIXON SJ, 1995, ALCOHOL CLIN EXP RES, V19, P577, DOI 10.1111/j.1530-0277.1995.tb01551.x; NIXON SJ, 1991, ALCOHOL CLIN EXP RES, V15, P601, DOI 10.1111/j.1530-0277.1991.tb00567.x; Novier A, 2012, NEUROSCI LETT, V512, P38, DOI 10.1016/j.neulet.2012.01.059; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Odell W. D., 1990, CONTROL ONSET PUBERT, P183; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Rajendran P, 2004, ANN NY ACAD SCI, V1021, P441, DOI 10.1196/annals.1308.060; Rhoads DE, 2012, PHARMACOL BIOCHEM BE, V102, P58, DOI 10.1016/j.pbb.2012.03.024; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; TARTER RE, 1995, DRUG ALCOHOL DEPEN, V39, P15, DOI 10.1016/0376-8716(95)01129-M; Taylor SJ, 2013, DEV PSYCHOL, V49, P1253, DOI 10.1037/a0029871; Tivis LJ, 1999, PSYCHOL ADDICT BEHAV, V13, P284; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Vidal J, 2012, BRAIN COGNITION, V79, P49, DOI 10.1016/j.bandc.2011.12.011; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2	58	22	22	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77768	10.1371/journal.pone.0077768	http://dx.doi.org/10.1371/journal.pone.0077768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147077	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200074
J	Sampath, S; Bhat, S; Gupta, S; O'Connor, A; West, AB; Arking, DE; Chakravarti, A				Sampath, Srirangan; Bhat, Shambu; Gupta, Simone; O'Connor, Ashley; West, Andrew B.; Arking, Dan E.; Chakravarti, Aravinda			Defining the Contribution of CNTNAP2 to Autism Susceptibility	PLOS ONE			English	Article							CARRIER SLC25A12 GENE; GENOMIC SCREEN; GENOTYPE-IMPUTATION; SPECTRUM DISORDERS; UNIFIED APPROACH; ASSOCIATION; LINKAGE; CHILDREN; LOCI; SCAN	Multiple lines of genetic evidence suggest a role for CNTNAP2 in autism. To assess its population impact we studied 2148 common single nucleotide polymorphisms (SNPs) using transmission disequilibrium test (TDT) across the entire similar to 3.3 Mb CNTNAP2 locus in 186 (408 trios) multiplex and 323 simplex families with autistic spectrum disorder (ASD). This analysis yielded two SNPs with nominal statistical significance (rs17170073, p = 2.0 x 10(-4); rs2215798, p = 1.6 x 10(-4)) that did not survive multiple testing. In a combined analysis of all families, two highly correlated (r(2) = 0.99) SNPs in intron 14 showed significant association with autism (rs2710093, p = 9.0 x 10(-6); rs2253031, p = 2.5 x 10(-5)). To validate these findings and associations at SNPs from previous autism studies (rs7794745, rs2710102 and rs17236239) we genotyped 2051 additional families (572 multiplex and 1479 simplex). None of these variants were significantly associated with ASD after corrections for multiple testing. The analysis of Mendelian errors within each family did not indicate any segregating deletions. Nevertheless, a study of CNTNAP2 gene expression in brains of autistic patients and of normal controls, demonstrated altered expression in a subset of patients (p = 1.9 x 10(-5)). Consequently, this study suggests that although CNTNAP2 dysregulation plays a role in some cases, its population contribution to autism susceptibility is limited.	[Sampath, Srirangan; Bhat, Shambu; Gupta, Simone; O'Connor, Ashley; Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA; [West, Andrew B.] Univ Alabama Birmingham, Dept Neurol & Neurobiol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Sampath, S (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA.	aravinda@jhmi.edu		West, Andrew/0000-0002-3034-4061	Simons Foundation [SFARI 102882]; National Institutes of Health (ACE Genetics Consortium) [MH081754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R24MH068855, R01MH081754, R01MH064547, R01MH100027, P01MH039437] Funding Source: NIH RePORTER	Simons Foundation; National Institutes of Health (ACE Genetics Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Simons Foundation (SFARI 102882 to AC) and the National Institutes of Health (ACE Genetics Consortium, MH081754) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barrett S, 1999, AM J MED GENET, V88, P609; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Brun CC, 2009, HUM BRAIN MAPP, V30, P3887, DOI 10.1002/hbm.20814; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Leveille C, 2010, AUTISM RES, V3, P280, DOI 10.1002/aur.155; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Molloy CA, 2005, MOL PSYCHIATR, V10, P741, DOI 10.1038/sj.mp.4001691; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petrin AL, 2010, AM J MED GENET A, V152A, P3164, DOI 10.1002/ajmg.a.33749; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poot M, 2010, NEUROGENETICS, V11, P81, DOI 10.1007/s10048-009-0205-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Rossi E, 2008, EUR J MED GENET, V51, P631, DOI 10.1016/j.ejmg.2008.06.010; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stroganova TA, 2012, CORTEX, V48, P701, DOI 10.1016/j.cortex.2011.02.016; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Viding E, 2007, BEHAV GENET, V37, P51, DOI 10.1007/s10519-006-9105-4; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	70	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77906	10.1371/journal.pone.0077906	http://dx.doi.org/10.1371/journal.pone.0077906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147096	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200085
J	DeAnda, F; Hightower, KE; Nolte, RT; Hattori, K; Yoshinaga, T; Kawasuji, T; Underwood, MR				DeAnda, Felix; Hightower, Kendra E.; Nolte, Robert T.; Hattori, Kazunari; Yoshinaga, Tomokazu; Kawasuji, Takashi; Underwood, Mark R.			Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics	PLOS ONE			English	Article							VIRUS TYPE-1 INTEGRASE; PHOTO-CROSS-LINKING; VIRAL-DNA; NON-INFERIORITY; STRAND TRANSFER; DOUBLE-BLIND; NAIVE ADULTS; RALTEGRAVIR; INHIBITOR; BINDING	Signature HIV-1 integrase mutations associated with clinical raltegravir resistance involve 1 of 3 primary genetic pathways, Y143C/R, Q148H/K/R and N155H, the latter 2 of which confer cross-resistance to elvitegravir. In accord with clinical findings, in vitro drug resistance profiling studies with wild-type and site-directed integrase mutant viruses have shown significant fold increases in raltegravir and elvitegravir resistance for the specified viral mutants relative to wild-type HIV-1. Dolutegravir, in contrast, has demonstrated clinical efficacy in subjects failing raltegravir therapy due to integrase mutations at Y143, Q148 or N155, which is consistent with its distinct in vitro resistance profile as dolutegravir's antiviral activity against these viral mutants is equivalent to its activity against wild-type HIV-1. Kinetic studies of inhibitor dissociation from wild-type and mutant integrase-viral DNA complexes have shown that dolutegravir also has a distinct off-rate profile with dissociative half-lives substantially longer than those of raltegravir and elvitegravir, suggesting that dolutegravir's prolonged binding may be an important contributing factor to its distinct resistance profile. To provide a structural rationale for these observations, we constructed several molecular models of wild-type and clinically relevant mutant HIV-1 integrase enzymes in complex with viral DNA and dolutegravir, raltegravir or elvitegravir. Here, we discuss our structural models and the posited effects that the integrase mutations and the structural and electronic properties of the integrase inhibitors may have on the catalytic pocket and inhibitor binding and, consequently, on antiviral potency in vitro and in the clinic.	[DeAnda, Felix; Nolte, Robert T.] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA; [Hightower, Kendra E.] GlaxoSmithKline, Biol Sci, Res Triangle Pk, NC USA; [Hattori, Kazunari] Shionogi & Co Ltd, Discovery Chem, Osaka, Japan; [Yoshinaga, Tomokazu] Shionogi & Co Ltd, Infect Dis, Osaka, Japan; [Kawasuji, Takashi] Shionogi & Co Ltd, Chem Infect Dis, Osaka, Japan; [Underwood, Mark R.] GlaxoSmithKline, Med Dev Infect Dis, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; GlaxoSmithKline	Underwood, MR (corresponding author), GlaxoSmithKline, Med Dev Infect Dis, Res Triangle Pk, NC USA.	mark.r.underwood@gsk.com		Underwood, Mark/0000-0002-6803-2346	ViiV Healthcare	ViiV Healthcare	Funding for this work was provided by ViiV Healthcare. The sponsor participated in the study design, data collection, data analysis, data interpretation and drafting of the report in collaboration with the authors.	Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Dicker IB, 2008, J BIOL CHEM, V283, P23599, DOI 10.1074/jbc.M804213200; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Goethals O, 2011, ANTIVIR RES, V91, P167, DOI 10.1016/j.antiviral.2011.05.011; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson BC, 2012, ANTIMICROB AGENTS CH, V56, P411, DOI 10.1128/AAC.05292-11; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Kawasuji T, 2006, BIOORGAN MED CHEM, V14, P8430, DOI 10.1016/j.bmc.2006.08.044; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Metifiot M, 2010, BIOCHEMISTRY-US, V49, P3715, DOI 10.1021/bi100130f; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200	34	23	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77448	10.1371/journal.pone.0077448	http://dx.doi.org/10.1371/journal.pone.0077448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146996	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400107
J	Dowdy, DW; Lotia, I; Azman, AS; Creswell, J; Sahu, S; Khan, AJ				Dowdy, David W.; Lotia, Ismat; Azman, Andrew S.; Creswell, Jacob; Sahu, Suvanand; Khan, Aamir J.			Population-Level Impact of Active Tuberculosis Case Finding in an Asian Megacity	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; ANNUAL RISK; TB; REINFECTION; MICROSCOPY; STRATEGIES; INFECTION; RELAPSE; HIV	Background: The potential population-level impact of private-sector initiatives for tuberculosis (TB) case finding in Southeast Asia remains uncertain. In 2011, the Indus Hospital TB Control Program in Karachi, Pakistan, undertook an aggressive case-finding campaign that doubled notification rates, providing an opportunity to investigate potential population-level effects. Methods: We constructed an age-structured compartmental model of TB in the intervention area. We fit the model using field and literature data, assuming that TB incidence equaled the estimated nationwide incidence in Pakistan (primary analysis), or 1.5 times greater (high-incidence scenario). We modeled the intervention as an increase in the rate of formal-sector TB diagnosis and evaluated the potential impact of sustaining this rate for five years. Results: In the primary analysis, the five-year intervention averted 24% (95% uncertainty range, UR: 18-30%) of five-year cumulative TB cases and 52% (95% UR: 45-57%) of cumulative TB deaths. Corresponding reductions in the high-incidence scenario were 12% (95% UR: 8-17%) and 27% (95% UR: 21-34%), although the absolute number of lives saved was higher. At the end of five years, TB notification rates in the primary analysis were below their 2010 baseline, incidence had dropped by 45%, and annual mortality had fallen by 72%. About half of the cumulative impact on incidence and mortality could be achieved with a one-year intervention. Conclusions: Sustained, multifaceted, and innovative approaches to TB case-finding in Asian megacities can have substantial community-wide epidemiological impact.	[Dowdy, David W.; Azman, Andrew S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Lotia, Ismat; Khan, Aamir J.] Interact Res & Dev, Karachi, Sindh, Pakistan; [Creswell, Jacob; Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [Khan, Aamir J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	ddowdy@jhsph.edu		Azman, Andrew/0000-0001-8662-9077; Creswell, Jacob/0000-0002-4885-940X	TB REACH; Stop TB Partnership	TB REACH; Stop TB Partnership	This work was supported by TB REACH and the Stop TB Partnership. The primary modelers (DWD and ASA) received no dedicated funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Ayles H, 2012, SEATTL WASH 19 C RET; Ayles H, 2011, SYMPOSIUM; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Dodd PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029130; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lonnroth K, 2003, INT J TUBERC LUNG D, V7, P165; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wells WA, 2011, INT J TUBERC LUNG D, V15, P746, DOI 10.5588/ijtld.10.0094; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2010, GLOB TUB CONTR 2010; World Health Organization, 2011, GLOB TUB CONTR WHO; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77517	10.1371/journal.pone.0077517	http://dx.doi.org/10.1371/journal.pone.0077517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147015	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400118
J	Aldaz, B; Sagardoy, A; Nogueira, L; Guruceaga, E; Grande, L; Huse, JT; Aznar, MA; Diez-Valle, R; Tejada-Solis, S; Alonso, MM; Fernandez-Luna, JL; Martinez-Climent, JA; Malumbres, R				Aldaz, Beatriz; Sagardoy, Ainara; Nogueira, Lorena; Guruceaga, Elizabeth; Grande, Lara; Huse, Jason T.; Aznar, Maria A.; Diez-Valle, Ricardo; Tejada-Solis, Sonia; Alonso, Marta M.; Fernandez-Luna, Jose L.; Martinez-Climent, Jose A.; Malumbres, Raquel			Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; TARGET RECOGNITION; SELF-RENEWAL; BRAIN-TUMORS; IN-VITRO; EXPRESSION; GLIOMA; MICRORNAS; INHIBIT; GROWTH	Glioblastoma multiforme (GBM)-initiating cells (GICs) represent a tumor subpopulation with neural stem cell-like properties that is responsible for the development, progression and therapeutic resistance of human GBM. We have recently shown that blockade of NF kappa B pathway promotes terminal differentiation and senescence of GICs both in vitro and in vivo, indicating that induction of differentiation may be a potential therapeutic strategy for GBM. MicroRNAs have been implicated in the pathogenesis of GBM, but a high-throughput analysis of their role in GIC differentiation has not been reported. We have established human GIC cell lines that can be efficiently differentiated into cells expressing astrocytic and neuronal lineage markers. Using this in vitro system, a microarray-based high-throughput analysis to determine global expression changes of microRNAs during differentiation of GICs was performed. A number of changes in the levels of microRNAs were detected in differentiating GICs, including overexpression of hsa-miR-21, hsa-miR-29a, hsa-miR-29b, hsa-miR-221 and hsa-miR-222, and down-regulation of hsa-miR-93 and hsa-miR-106a. Functional studies showed that miR-21 over-expression in GICs induced comparable cell differentiation features and targeted SPRY1 mRNA, which encodes for a negative regulator of neural stem-cell differentiation. In addition, miR-221 and miR-222 inhibition in differentiated cells restored the expression of stem cell markers while reducing differentiation markers. Finally, miR-29a and miR-29b targeted MCL1 mRNA in GICs and increased apoptosis. Our study uncovers the microRNA dynamic expression changes occurring during differentiation of GICs, and identifies miR-21 and miR-221/222 as key regulators of this process.	[Aldaz, Beatriz; Sagardoy, Ainara; Aznar, Maria A.; Alonso, Marta M.; Martinez-Climent, Jose A.; Malumbres, Raquel] Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Nogueira, Lorena; Grande, Lara; Fernandez-Luna, Jose L.] Hosp Univ Marques de Valdecilla, Mol Genet Unit, Santander, Spain; [Nogueira, Lorena; Grande, Lara; Fernandez-Luna, Jose L.] Inst Formac & Invest Marques de Valdecilla IFIMA, Santander, Spain; [Guruceaga, Elizabeth] Univ Navarra, Unit Prote Genom & Bioinformat, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Aldaz, Beatriz; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Diez-Valle, Ricardo; Tejada-Solis, Sonia] Univ Navarra Clin, Dept Neurosurg, Pamplona, Spain	University of Navarra; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); University of Navarra; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Navarra	Martinez-Climent, JA (corresponding author), Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	jamcliment@unav.es; rmalumbres@unav.es	Martinez-Climent, Jose A/I-9199-2012; Alonso, Marta M/AAI-9457-2020; Malumbres, Raquel/N-3745-2014; Aznar Gomez, M Angela/K-1925-2014; Aznar, M Angela/K-1688-2014; Guruceaga, Elizabeth/B-1796-2008	Martinez-Climent, Jose A/0000-0002-7938-3950; Alonso, Marta M/0000-0002-7520-7351; Malumbres, Raquel/0000-0003-0767-9442; Aznar Gomez, M Angela/0000-0002-7970-1672; Aznar, M Angela/0000-0002-7970-1672; Guruceaga, Elizabeth/0000-0003-0547-681X	Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health [PI11/00684, PI10/02002, PI12/0202]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD12/0036/0063, RD06/0020/0074, RD12/0036/0022]; Fundacion Mutua Madrilena [FMM 8553/2011]; Spanish Association Against Cancer (AECC) Scientific Foundation; Instituto de Formacion e Investigacion Marques de Valdecilla [API2011-04]; Instituto de Salud Carlos III-FIS	Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC) Scientific Foundation; Instituto de Formacion e Investigacion Marques de Valdecilla; Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Grants from the Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health (PI11/00684 to R. M., PI10/02002 to J.L.F.-L. and PI12/0202 to J.A.M.-C.); from Red Tematica de Investigacion Cooperativa en Cancer (RTICC, RD12/0036/0063 to J.A.M.-C. and RD06/0020/0074 and RD12/0036/0022 to J.L.F.-L.); from Fundacion Mutua Madrilena (FMM 8553/2011 to R. M.); from the Spanish Association Against Cancer (AECC) Scientific Foundation (to R. M.); and from Instituto de Formacion e Investigacion Marques de Valdecilla (API2011-04). B. A. work was supported by a predoctoral fellowship from Instituto de Salud Carlos III-FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Cormack B, 2001, CURR PROTOC NEUROSCI, V4; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Day BW, 2011, NEUROONCOLOGY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faedo A, 2010, J NEUROSCI, V30, P4015, DOI 10.1523/JNEUROSCI.0307-10.2010; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Gomes AL, 2007, CELL ONCOL, V29, P399; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JJ, 2012, PATHOL ONCOL RES, V18, P1047, DOI 10.1007/s12253-012-9543-7; Hamada N, 2012, NEUROCHEM INT, V60, P743, DOI 10.1016/j.neuint.2012.03.010; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Jung JE, 2012, STEM CELLS DEV, V21, P554, DOI 10.1089/scd.2011.0110; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Mathupala SP, 2006, TECHNOL CANCER RES T, V5, P261, DOI 10.1177/153303460600500313; Miller CR, 2007, ARCH PATHOL LAB MED, V131, P397; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Ruiz-Ontanon P, 2013, STEM CELLS, V31, P1075, DOI 10.1002/stem.1349; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zhou XA, 2010, ONCOL REP, V24, P195, DOI 10.3892/or_00000846	48	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77098	10.1371/journal.pone.0077098	http://dx.doi.org/10.1371/journal.pone.0077098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155920	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300054
J	Bucur, O; Stancu, AL; Goganau, I; Petrescu, SM; Pennarun, B; Bertomeu, T; Dewar, R; Khosravi-Far, R				Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Petrescu, Stefana Maria; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya			Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; BONE-MARROW MICROENVIRONMENT; ADAPTER PROTEIN CRKL; TUMOR MICROENVIRONMENT; INDUCED APOPTOSIS; INDUCE APOPTOSIS; IMATINIB; ACTIVATION; CANCER	Emergence of resistance to Tyrosine-Kinase Inhibitors (TKIs), such as imatinib, dasatinib and nilotinib, in Chronic Myelogenous Leukemia (CML) demands new therapeutic strategies. We and others have previously established bortezomib, a selective proteasome inhibitor, as an important potential treatment in CML. Here we show that the combined regimens of bortezomib with mitotic inhibitors, such as the microtubule-stabilizing agent Paclitaxel and the PLK1 inhibitor BI2536, efficiently kill TKIs-resistant and -sensitive Bcr-Abl-positive leukemic cells. Combined treatment activates caspases 8, 9 and 3, which correlate with caspase-induced PARP cleavage. These effects are associated with a marked increase in activation of the stress-related MAP kinases p38MAPK and JNK. Interestingly, combined treatment induces a marked decrease in the total and phosphorylated Bcr-Abl protein levels, and inhibits signaling pathways downstream of Bcr-Abl: downregulation of STAT3 and STAT5 phosphorylation and/or total levels and a decrease in phosphorylation of the Bcr-Abl-associated proteins CrkL and Lyn. Moreover, we found that other mitotic inhibitors (Vincristine and Docetaxel), in combination with bortezomib, also suppress the Bcr-Abl-induced pro-survival signals and result in caspase 3 activation. These results open novel possibilities for the treatment of Bcr-Abl-positive leukemias, especially in the imatinib, dasatinib and nilotinib-resistant CML cases.	[Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bucur, Octavian; Petrescu, Stefana Maria] Romanian Acad, Inst Biochem, Bucharest, Romania; [Stancu, Andreea Lucia; Goganau, Ioana] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Khosravi-Far, Roya] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Carol Davila University of Medicine & Pharmacy; Harvard University; Harvard Medical School	Khosravi-Far, R (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	rkhosrav@bidmc.harvard.edu	Dewar, Rajan/L-2883-2019; Petrescu, Stefana/AAJ-9505-2021; Bucur, Octavian/G-2823-2010; Dewar, Rajan/AAW-2571-2021; Petrescu, Stefana M/I-9240-2012	Petrescu, Stefana/0000-0002-4047-0811; Bucur, Octavian/0000-0002-8501-588X; Petrescu, Stefana M/0000-0002-4047-0811; Bertomeu, Thierry/0000-0002-5313-7057	Lady TATA Memorial Trust, London, UK; Romanian Ministry of Education and Research; National Institutes of Health [CA105306, CA131664, HL080192]; NATIONAL CANCER INSTITUTE [R01CA131664, R01CA105306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080192] Funding Source: NIH RePORTER	Lady TATA Memorial Trust, London, UK; Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Octavian Bucur received a fellowship from the Lady TATA Memorial Trust, London, UK. Ioana Goganau received a fellowship from Romanian Ministry of Education and Research. This work was also supported by the National Institutes of Health grants CA105306, CA131664, and HL080192 (to Roya Khosravi-Far). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bucur O, 2006, FRONT BIOSCI-LANDMRK, V11, P1549, DOI 10.2741/1903; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Cortes J, 2012, BLOOD, V120, P2573, DOI 10.1182/blood-2012-03-415307; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Dai Y, 2001, CANCER RES, V61, P5106; Dewar R, 2011, CANCER BIOL THER, V11, P552, DOI 10.4161/cbt.11.6.14675; Etet PFS, 2012, CELL SIGNAL, V24, P1883, DOI 10.1016/j.cellsig.2012.05.015; Gangemi RMR, 2000, INT J CANCER, V85, P527, DOI 10.1002/(SICI)1097-0215(20000215)85:4<527::AID-IJC14>3.0.CO;2-#; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Habermann TM, 2012, HEMATOLOGY, V17, pS93, DOI 10.1179/102453312X13336169156014; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kim SY, 2011, ANN DERMATOL, V23, P504, DOI 10.5021/ad.2011.23.4.504; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Mehnert JM, 2011, MOL CANCER THER, V10, P1509, DOI 10.1158/1535-7163.MCT-10-0944; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mizuno H, 2012, LEUKEMIA, V26, P2269, DOI 10.1038/leu.2012.81; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; Myssina S, 2009, EXP HEMATOL, V37, P206, DOI 10.1016/j.exphem.2008.10.013; Nardi V, 2009, BLOOD, V113, P3813, DOI 10.1182/blood-2008-07-167189; Nimmanapalli R, 2002, CANCER RES, V62, P5761; Nimmanapalli R, 2003, BLOOD, V101, P3236, DOI 10.1182/blood-2002-08-2675; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Ray S, 2005, APOPTOSIS, V10, P1411, DOI 10.1007/s10495-005-2490-y; Razzak Mina, 2013, Nat Rev Clin Oncol, V10, P65, DOI 10.1038/nrclinonc.2012.226; Santos FPS, 2011, CL LYMPH MYELOM LEUK, V11, P355, DOI 10.1016/j.clml.2011.06.004; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Stein SJ, 2011, ONCOGENE, V30, P4557, DOI 10.1038/onc.2011.156; Uemura N, 1999, J BIOL CHEM, V274, P37525, DOI 10.1074/jbc.274.53.37525; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wohrle FU, 2013, LEUKEMIA, V27, P118, DOI 10.1038/leu.2012.222; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu CR, 2003, CANCER RES, V63, P2118; Yusuf RZ, 2012, NAT MED, V18, P865, DOI 10.1038/nm.2831	55	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77390	10.1371/journal.pone.0077390	http://dx.doi.org/10.1371/journal.pone.0077390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155950	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300084
J	Yuan, XW; Zhang, SZ; Sun, MH; Liu, SY; Qi, BX; Li, XZ				Yuan, Xiaowei; Zhang, Shizhong; Sun, Meihong; Liu, Shiyang; Qi, Baoxiu; Li, Xinzheng			Putative DHHC-Cysteine-Rich Domain S-Acyltransferase in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN PALMITOYLATION; TIP GROWTH; ACYLATION; GENE; LOCALIZATION; MEMBRANE; ACID; RAS; CALCIUM	Protein S-acyltransferases (PATs) containing Asp-His-His-Cys within a Cys-rich domain (DHHC-CRD) are polytopic transmembrane proteins that are found in eukaryotic cells and mediate the S-acylation of target proteins. S-acylation is an important secondary and reversible modification that regulates the membrane association, trafficking and function of target proteins. However, little is known about the characteristics of PATs in plants. Here, we identified 804 PATs from 31 species with complete genomes. The analysis of the phylogenetic relationships suggested that all of the PATs fell into 8 groups. In addition, we analysed the phylogeny, genomic organization, chromosome localisation and expression pattern of PATs in Arabidopsis, Oryza sative, Zea mays and Glycine max. The microarray data revealed that PATs genes were expressed in different tissues and during different life stages. The preferential expression of the ZmPATs in specific tissues and the response of Zea mays to treatments with phytohormones and abiotic stress demonstrated that the PATs play roles in plant growth and development as well as in stress responses. Our data provide a useful reference for the identification and functional analysis of the members of this protein family.	[Yuan, Xiaowei; Zhang, Shizhong; Sun, Meihong; Liu, Shiyang; Qi, Baoxiu; Li, Xinzheng] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Zhang, Shizhong] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An 271018, Shandong, Peoples R China; [Yuan, Xiaowei] Huasheng Agr Ltd Liabil Co, Qingzhou 262500, Shandong, Peoples R China; [Yuan, Xiaowei] Qingzhou City Bur Agr, Qingzhou 262500, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, XZ (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	lxz@sdau.edu.cn		Qi, Baoxiu/0000-0002-9425-935X	Natural Science Foundation of China [31170233, 31110103917]; National Basic Research Program of China [2011CB100706]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (31170233), Natural Science Foundation of China (31110103917) and National Basic Research Program of China (2011CB100706). The funders had roles in study design, data collection and analysis and decision to publish.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], LECT NOTES; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2012, PLANT PHYSIOL, V160, P1597, DOI 10.1104/pp.112.203968; Batistic O, 2012, CELL RES, V22, P1155, DOI 10.1038/cr.2012.71; CHAO S, 1984, NUCLEIC ACIDS RES, V12, P6629, DOI 10.1093/nar/12.16.6629; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hemsley PA, 2005, PLANT CELL, V17, P2554, DOI 10.1105/tpc.105.031237; Hemsley PA, 2008, TRENDS PLANT SCI, V13, P295, DOI 10.1016/j.tplants.2008.04.006; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; Hemsley PA, 2009, MOL MEMBR BIOL, V26, P114, DOI 10.1080/09687680802680090; Jacob Arpith, 2008, ACM Trans Reconfigurable Technol Syst, V1, P9; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kordyukova LV, 2008, J VIROL, V82, P9288, DOI 10.1128/JVI.00704-08; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu Ren-Hu, 2003, Yichuan, V25, P317; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mistry Jaina, 2007, V396, P43; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; SCHIEFELBEIN J, 1993, PLANT PHYSIOL, V103, P979, DOI 10.1104/pp.103.3.979; SCHLESINGER MJ, 1980, J BIOL CHEM, V255, P21; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Schroeder H, 1997, BIOCHEMISTRY-US, V36, P13102, DOI 10.1021/bi9709497; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200; Zhou LZ, 2013, PLANT CELL, V25, P1093, DOI 10.1105/tpc.112.108829	53	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75985	10.1371/journal.pone.0075985	http://dx.doi.org/10.1371/journal.pone.0075985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155879	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325887300013
J	Lippman, SA; Maman, S; MacPhail, C; Twine, R; Peacock, D; Kahn, K; Pettifor, A				Lippman, Sheri A.; Maman, Suzanne; MacPhail, Catherine; Twine, Rhian; Peacock, Dean; Kahn, Kathleen; Pettifor, Audrey			Conceptualizing Community Mobilization for HIV Prevention: Implications for HIV Prevention Programming in the African Context	PLOS ONE			English	Article							FEMALE SEX WORKERS; SOCIAL-MOVEMENTS; PROJECT ACCEPT; INTERVENTION; EMPOWERMENT; PREVALENCE; INFECTION; CAPACITY; IDENTITY; HEALTH	Introduction: Community mobilizing strategies are essential to health promotion and uptake of HIV prevention. However, there has been little conceptual work conducted to establish the core components of community mobilization, which are needed to guide HIV prevention programming and evaluation. Objectives: We aimed to identify the key domains of community mobilization (CM) essential to change health outcomes or behaviors, and to determine whether these hypothesized CM domains were relevant to a rural South African setting. Method: We studied social movements and community capacity, empowerment and development literatures, assessing common elements needed to operationalize HIV programs at a community level. After synthesizing these elements into six essential CM domains, we explored the salience of these CM domains qualitatively, through analysis of 10 key informant in-depth-interviews and seven focus groups in three villages in Bushbuckridge. Results: CM domains include: 1) shared concerns, 2) critical consciousness, 3) organizational structures/networks, 4) leadership (individual and/or institutional), 5) collective activities/actions, and 6) social cohesion. Qualitative data indicated that the proposed domains tapped into theoretically consistent constructs comprising aspects of CM processes. Some domains, extracted from largely Western theory, required little adaptation for the South African context; others translated less effortlessly. For example, critical consciousness to collectively question and resolve community challenges functioned as expected. However, organizations/networks, while essential, operated differently than originally hypothesized - not through formal organizations, but through diffuse family networks. Conclusions: To date, few community mobilizing efforts in HIV prevention have clearly defined the meaning and domains of CM prior to intervention design. We distilled six CM domains from the literature; all were pertinent to mobilization in rural South Africa. While some adaptation of specific domains is required, they provide an extremely valuable organizational tool to guide CM programming and evaluation of critically needed mobilizing initiatives in Southern Africa.	[Lippman, Sheri A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Maman, Suzanne; Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [MacPhail, Catherine; Pettifor, Audrey] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [MacPhail, Catherine] Univ New England, Collaborat Res Network, Armidale, NSW, Australia; [Twine, Rhian; Kahn, Kathleen; Pettifor, Audrey] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Med Res Council,Wits Rural Publ Hlth & Hlth Trans, Johannesburg, South Africa; [Peacock, Dean] Sonke Gender Justice Network, Cape Town, South Africa	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of New England; South African Medical Research Council; University of Witwatersrand	Lippman, SA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA.	sheri.lippman@ucsf.edu	Pettifor, Audrey/H-6793-2019; MacPhail, Catherine/N-4234-2014; Maman, Suzanne/A-3802-2016	Pettifor, Audrey/0000-0002-3387-0817; MacPhail, Catherine/0000-0002-0614-0157; Lippman, Sheri/0000-0003-3152-9372; Kahn, Kathleen/0000-0003-3339-3931; Twine, Rhian/0000-0002-0766-6556	United States National Institute of Mental Health [1R21MH090887-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090887] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the United States National Institute of Mental Health (1R21MH090887-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG EA, 2002, FORGING GAY IDENTITI, P1950; Ballard R, 2005, AFR AFFAIRS, V104, P615, DOI 10.1093/afraf/adi069; BANDYOPADHYAY N, 2003, ROLE COMMUNITY DEV A; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beeker C, 1998, SOC SCI MED, V46, P831, DOI 10.1016/S0277-9536(97)00208-6; BUECHLER SM, 1995, SOCIOL QUART, V36, P441, DOI 10.1111/j.1533-8525.1995.tb00447.x; Campbell C., 2003, LETTING THEM DIE; *CDCP, CTR DIS CONTR PREVEN; COATES T, 2013, ATL PROJ ACC 20 C RE; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Diani M, 2004, THEOR SOC, V33, P281, DOI 10.1023/B:RYSO.0000038610.00045.07; Edelman M, 2001, ANNU REV ANTHROPOL, V30, P285, DOI 10.1146/annurev.anthro.30.1.285; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Evans C, 2008, SOC SCI MED, V66, P467, DOI 10.1016/j.socscimed.2007.08.030; Fawcett SB, 1995, AM J COMMUN PSYCHOL, V23, P677, DOI 10.1007/BF02506987; Foster-Fishman PG, 2007, AM J COMMUN PSYCHOL, V39, P91, DOI 10.1007/s10464-007-9097-0; Freire P., 1999, PEDAGOGY OPPRESSED; FRIEDMAN S, 2006, 164 INT I LAB; GAMSON WA, 1991, SOCIOL FORUM, V6, P27, DOI 10.1007/BF01112726; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Goodman RM, 1998, HEALTH EDUC BEHAV, V25, P258, DOI 10.1177/109019819802500303; Goodwin J, 1999, SOCIOL FORUM, V14, P27, DOI 10.1023/A:1021684610881; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; *HIV PREV TRIALS N, 2011, HPTN 068 EFF CASH TR; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jana S, 1995, Indian J Public Health, V39, P125; LAMBERT H, 2012, J EPIDEMIOL COMMU S2, V66, P3, DOI DOI 10.1136/JECH-2012-201566.PUBMED:22826295; Laverack G, 2001, HEALTH PROMOT INT, V16, P179, DOI 10.1093/heapro/16.2.179; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; McAdam Doug, 1999, POLITICAL PROCESS DE; Melucci A., 1995, SOCIAL MOVEMENTS CUL, V4, P41; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Minkler M, 2002, HLTH BEHAV HLTH ED T; Murray LR, 2010, CULT HEALTH SEX, V12, P293, DOI 10.1080/13691050903450122; Norton BL, 2002, EMERGING THEORIES HL, P194; Parker RG, 1996, AIDS, V10, pS27; Paul J. P., 1995, LESBIAN GAY BISEXUAL, P347; Polletta F, 2001, ANNU REV SOCIOL, V27, P283, DOI 10.1146/annurev.soc.27.1.283; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Putnam RD., 2000, BOWLING ALONE COLLAP; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Tedrow VA, 2012, AIDS BEHAV, V16, P1217, DOI 10.1007/s10461-011-0009-9; Thomas T, 2012, J EPIDEMIOL COMMUN H, V66, pII26, DOI 10.1136/jech-2011-200590; TILLY C, 2004, SOCIAL MOVEMENTS, V262, P1768; Ulin PR, 2005, QUALITATIVE METHODS; *UNAIDS, 1997, COMM MOB AIDS UNAIDS; UNAIDS, 2005, HIV REL STIGM DISCR; Wallerstein N, 2002, SCAND J PUBLIC HEALT, V30, P72, DOI 10.1177/14034948020300031201; *WHO, 2011, EY FACTS HIV EP PROG; WHO, 2003, SOC MOB HLTH PROM	57	43	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78208	10.1371/journal.pone.0078208	http://dx.doi.org/10.1371/journal.pone.0078208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147121	Green Published, gold			2022-12-25	WOS:000325819400146
J	Wiencek, JR; Na, M; Hirbawi, J; Kalafatis, M				Wiencek, Joesph R.; Na, Mahesheema; Hirbawi, Jamila; Kalafatis, Michael			Amino Acid Region 1000-1008 of Factor V Is a Dynamic Regulator for the Emergence of Procoagulant Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Phospholipid Vesicle; Protein Chemistry; Prothrombin; Thrombin; Factor V; Factor Va; Factor Xa; Prothrombinase; Prothrombin	ACTIVATED PROTEIN-C; XA-BINDING-SITE; THROMBIN-CATALYZED ACTIVATION; PEPTIDE-BOND CLEAVAGES; COAGULATION FACTOR XA; HEAVY-CHAIN; DIRECTED MUTAGENESIS; FACTOR VA(R506Q); PROTHROMBIN; INACTIVATION	Single chain factor V (fV) circulates as an M-r 330,000 quiescent pro-cofactor. Removal of the B domain and generation of factor Va (fVa) are vital for procoagulant activity. We investigated the role of the basic amino acid region 1000-1008 within the B domain of fV by constructing a recombinant mutant fV molecule with all activation cleavage sites (Arg(709)/Arg(1018)/Arg(1545)) mutated to glutamine (fV(Q3)), a mutant fV molecule with region 1000-1008 deleted (fV(B9)), and a mutant fV molecule containing the same deletion with activation cleavage sites changed to glutamine (fV(B9/Q3)). The recombinant molecules along with wild type fV (fV(WT)) were transiently expressed in COS-7L cells, purified, and assessed for their ability to bind factor Xa (fXa) prior to and following incubation with thrombin. The data showed that fV(Q3) was severely impaired in its interaction with fXa before and after incubation with thrombin. In contrast, K-D(app) values for fV(B9) (0.9 nm), fVa(B9) (0.4 nm), and fV(B9/Q3) (0.7 nm) were similar to the affinity of fVa(WT) for fXa (0.3 nm). Two-stage clotting assays revealed that although fV(Q3) was deficient in its clotting activity, fV(B9/Q3) had clotting activity comparable with fVa(WT). The k(cat) value of prothrombinase assembled with fV(B9/Q3) was minimally affected, whereas the K-m value of the reaction was increased 57-fold compared with the K-m value obtained with prothrombinase assembled with fVa(WT). These findings strongly suggest that amino acid region 1000-1008 of fV is a regulatory sequence protecting the organisms from spontaneous binding to fXa and unnecessary prothrombinase complex formation, which in turn results in catastrophic physiological consequences.	[Wiencek, Joesph R.; Na, Mahesheema; Kalafatis, Michael] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Hirbawi, Jamila; Kalafatis, Michael] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kalafatis, Michael] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Kalafatis, Michael] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA	Cleveland State University; Cleveland Clinic Foundation; Cleveland State University; Cleveland Clinic Foundation	Kalafatis, M (corresponding author), Cleveland State Univ, Dept Chem, 2351 Euclid Ave,Sci & Res Ctr SR370, Cleveland, OH 44115 USA.	m.kalafatis@csuohio.edu			National Institutes of Health from the NHLBI [R01 HL-73343]; Ohio Department of Development; Center for Gene Regulation in Health and Disease; Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University;  [T32 HL 007914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073343, T32HL007914] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ohio Department of Development; Center for Gene Regulation in Health and Disease; Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-73343 from the NHLBI (to M. K.) by a Third frontier grant from the Ohio Department of Development, and T32 HL 007914. This work was also supported by Funds from the Center for Gene Regulation in Health and Disease. A preliminary report of this work was presented at the 52nd Annual Meeting of the American Society of Hematology, December 4-7, 2010, Orlando, FL. (2010) Blood 116, 2221a.; Supported in part by Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University (to JRW).	ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P6840, DOI 10.1021/bi800057r; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P12835, DOI 10.1021/bi801241r; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Copeland R, 2000, ENZYMES PRACTICAL IN, P120; COTE HCF, 1994, J BIOL CHEM, V269, P11374; Erdogan E, 2008, J THROMB HAEMOST, V6, P118; Erdogan E, 2007, THROMB HAEMOSTASIS, V98, P998, DOI 10.1160/TH07-06-0431; ESMON CT, 1979, J BIOL CHEM, V254, P964; FERSHT A, 1985, ENZYME STRUCTURE MEC, P324; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; Hirbawi J, 2008, BIOCHEMISTRY-US, V47, P7963, DOI 10.1021/bi800593k; Hirbawi J, 2010, BIOCHEMISTRY-US, V49, P8520, DOI 10.1021/bi101097t; Hockin MF, 1999, BIOCHEMISTRY-US, V38, P6918, DOI 10.1021/bi981966e; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1999, P NATL ACAD SCI USA, V96, P10968, DOI 10.1073/pnas.96.20.10968; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P9684; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mann K, 2003, CHEST, V124, P4; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; MANN KG, 1981, BIOCHEMISTRY-US, V20, P28, DOI 10.1021/bi00504a005; Mann KG, 2000, THROMB HAEMOSTASIS, V83, P3; Mathur A, 1997, J BIOL CHEM, V272, P23418, DOI 10.1074/jbc.272.37.23418; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	57	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37026	37038		10.1074/jbc.M113.462374	http://dx.doi.org/10.1074/jbc.M113.462374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24178294	Green Published, hybrid			2022-12-25	WOS:000329189700023
J	Guskiewicz, KM; Goldman, SB				Guskiewicz, Kevin M.; Goldman, Sarah B.			A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics	FASEB JOURNAL			English	Editorial Material							CONCUSSION; STATEMENT		[Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Goldman, Sarah B.] US Army, Off Surgeon Gen, Rehabil & Reintegrat Div, Falls Church, VA 22042 USA	University of North Carolina; University of North Carolina Chapel Hill	Goldman, SB (corresponding author), US Army, Off Surgeon Gen, Rehabil & Reintegrat Div, 7700 Arlington Blvd,3SW128C, Falls Church, VA 22042 USA.	sarah.b.goldman.mil@mail.mil		Guskiewicz, Kevin/0000-0002-8682-2130				*ASS SECR DEF HLTH, 2007, TRAUM BRAIN INJ DEF; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Broglio S., 2013, J ATHLETIC IN PRESS; CLARK EC, 1951, ELECTROEN CLIN NEURO, V3, P9, DOI 10.1016/0013-4694(51)90049-1; Defense and Veterans Brain Injury Center, DOD WORLDW NUMB TBI; Deputy Secretary of Defense, 2010, 09033 DTM US DEP DEF; French L., 2008, J SPEC OPER MED, V8, P67; Gardner A., 2013, BRIT J SPORT MED; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; O'Neil ME., 2013, VA DOD CLIN PRACT GU; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008	14	0	0	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4327	4329		10.1096/fj.13-1101ufm	http://dx.doi.org/10.1096/fj.13-1101ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	24179113				2022-12-25	WOS:000329937500001
J	Mao, X; Li, Y; Zhao, SS; Zhang, J; Lei, Q; Meng, DD; Ma, FY; Hu, W; Chen, MJ; Chang, JL; Wang, YS; Yang, GX; He, GY				Mao, Xiang; Li, Yin; Zhao, Shasha; Zhang, Jian; Lei, Qian; Meng, Dandan; Ma, Fengyun; Hu, Wei; Chen, Mingjie; Chang, Junli; Wang, Yuesheng; Yang, Guangxiao; He, Guangyuan			The Interactive Effects of Transgenically Overexpressed 1Ax1 with Various HMW-GS Combinations on Dough Quality by Introgression of Exogenous Subunits into an Elite Chinese Wheat Variety	PLOS ONE			English	Article							BREAD-MAKING QUALITY; WEIGHT GLUTENIN SUBUNITS; FUNCTIONAL-PROPERTIES; ALLELIC VARIATION; MIXING PROPERTIES; TECHNOLOGICAL QUALITY; AGRONOMIC PERFORMANCE; BAKING PROPERTIES; LINES; FIELD	Seed storage proteins in wheat endosperm, particularly high-molecular-weight glutenin subunits (HMW-GS), are primary determinants of dough properties, and affect both end-use quality and grain utilization of wheat (Triticum aestivum L). In order to investigate the interactive effects between the transgenically overexpressed 1Ax1 subunit with different HMW-GS on dough quality traits, we developed a set of 8 introgression lines (ILs) overexpressing the transgenic HMW-glutenin subunit 1Ax1 by introgression of this transgene from transgenic line B102-1-2/1 into an elite Chinese wheat variety Chuanmai107 (C107), using conventional crossing and backcrossing breeding technique. The donor C107 strain lacks 1Ax1 but contains the HMW-GS pairs 1Dx2+1Dy12 and 1Bx7+1By9. The resultant ILs showed robust and stable expression of 1Ax1 even after five generations of self-pollination, and crossing/backcrossing three times. In addition, overexpression of 1Ax1 was compensated by the endogenous gluten proteins. All ILs exhibited superior agronomic performance when compared to the transgenic parent line, B102-1-2/1. Mixograph results demonstrated that overexpressed 1Ax1 significantly improved dough strength, resistance to extension and over-mixing tolerance, in the targeted wheat cultivar C107. Further, comparisons among the ILs showed the interactive effects of endogenous subunits on dough properties when 1Ax1 was overexpressed: subunit pair 17+18 contributed to increased over-mixing tolerance of the dough; expression of the Glu-D1 allele maintained an appropriate balance between x-type and y-type subunits and thereby improved dough quality. It is consistent with ILs C4 (HMW-GS are 1, 17+18, 2+12) had the highest gluten index and Zeleny sedimentation value. This study demonstrates that wheat quality could be improved by using transgenic wheat overexpressing HMW-GS and the feasibility of using such transgenic lines in wheat quality breeding programs.	[Wang, Yuesheng] HUST, Genet Engn Int Cooperat Base, Chinese Minist Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Wuhan, Peoples R China; HUST, Coll Life Sci & Technol, Key Lab Mol Biophys, Chinese Minist Educ, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, YS (corresponding author), HUST, Genet Engn Int Cooperat Base, Chinese Minist Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Wuhan, Peoples R China.	wysh@hust.edu.cn; ygx@hust.edu.cn; hegy@hust.edu.cn	Ma, Fengyun/I-8408-2019		National Science and Technology Major Project of China [2013ZX08002-004, 2013ZX08010-004]; National Natural Science Foundation of China [30871524, 31071403]; National Natural Science Foundation of Hubei, China [2011CDB370]; Fundamental Research Funds for the Central Universities, HUST [2011TS150]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by 1. the National Science and Technology Major Project of China (2013ZX08002-004; 2013ZX08010-004) (http://www.nmp.gov.cn/), 2. the National Natural Science Foundation of China (No. 30871524 and No. 31071403) (http://www.nsfc.gov.cn/Portal0/default152.htm), 3. the National Natural Science Foundation of Hubei, China (2011CDB370) (http://www.hbstd.gov.cn/), 4. the Fundamental Research Funds for the Central Universities, HUST (2011TS150), (http://kfy.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; Alvarez ML, 2000, THEOR APPL GENET, V100, P319, DOI 10.1007/s001220050042; Alvarez ML, 2001, MOL BREEDING, V8, P103, DOI 10.1023/A:1011995625202; American Association of Cereal Chemists, 2000, APPR METH AACC; Barro F, 2003, MOL BREEDING, V12, P223, DOI 10.1023/A:1026367214120; Barro F, 2003, J CEREAL SCI, V37, P65, DOI 10.1006/jcrs.2002.0479; Barro F, 2002, THEOR APPL GENET, V105, P980, DOI 10.1007/s00122-002-0996-z; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Blechl AE, 1996, NAT BIOTECHNOL, V14, P875, DOI 10.1038/nbt0796-875; Blechl A, 2007, J CEREAL SCI, V45, P172, DOI 10.1016/j.jcs.2006.07.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bregitzer P, 1998, THEOR APPL GENET, V96, P421, DOI 10.1007/s001220050758; CARRILLO JM, 1990, THEOR APPL GENET, V79, P321, DOI 10.1007/BF01186074; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; Darlington H, 2003, J CEREAL SCI, V38, P301, DOI 10.1016/S0733-5210(03)00034-1; Deng ZY, 2005, PLANT BREEDING, V124, P428, DOI 10.1111/j.1439-0523.2005.01158.x; Eagles HA, 2002, AUST J AGR RES, V53, P367, DOI 10.1071/AR01074; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Field JM, 2008, J CEREAL SCI, V48, P457, DOI 10.1016/j.jcs.2007.10.010; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; Hernandez P, 2000, J PLANT PHYSIOL, V156, P223, DOI 10.1016/S0176-1617(00)80310-7; Jin H, 2013, J CEREAL SCI, V57, P146, DOI [10.1016/j.jcs.2012.10.011, 10.1016/j.jcs.2012.10.01]; Juhasz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029501; LAWRENCE GJ, 1987, J CEREAL SCI, V6, P99, DOI 10.1016/S0733-5210(87)80045-0; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; Leon E, 2010, J CEREAL SCI, V51, P13, DOI 10.1016/j.jcs.2009.09.001; Li SH, 2007, ACTA BIOCH BIOPH SIN, V39, P377, DOI 10.1111/j.1745-7270.2007.00284.x; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Li YL, 2010, J CEREAL SCI, V51, P127, DOI 10.1016/j.jcs.2009.10.008; Liu Y, 2007, GENET RESOUR CROP EV, V54, P865, DOI 10.1007/s10722-006-9154-9; Martinant JP, 1998, J CEREAL SCI, V27, P179, DOI 10.1006/jcrs.1997.0156; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; Popineau Y, 2001, J AGR FOOD CHEM, V49, P395, DOI 10.1021/jf001015j; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Rakszegi M, 2005, J CEREAL SCI, V42, P15, DOI 10.1016/j.jcs.2005.02.006; Rooke L, 1999, THEOR APPL GENET, V99, P851, DOI 10.1007/s001220051305; Rooke L, 1999, J CEREAL SCI, V30, P115, DOI 10.1006/jcrs.1999.0265; She MY, 2011, FUNCT INTEGR GENOMIC, V11, P23, DOI 10.1007/s10142-010-0196-x; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry P R, 1995, Methods Mol Biol, V49, P399; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; Shewry PR, 2005, ANN APPL BIOL, V147, P1, DOI 10.1111/j.1744-7348.2005.00009.x; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; Uthayakumaran S, 2001, CEREAL CHEM, V78, P138, DOI 10.1094/CCHEM.2001.78.2.138; Vasil IK, 2001, J PLANT PHYSIOL, V158, P521, DOI 10.1078/0176-1617-00365; Wang YS, 2010, J SCI FOOD AGR, V90, P106, DOI 10.1002/jsfa.3790; Wu YR, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-77; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Yao Q, 2006, J EXP BOT, V57, P3737, DOI 10.1093/jxb/erl145; Zhang YanBin, 2003, Acta Agronomica Sinica, V29, P93	56	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78451	10.1371/journal.pone.0078451	http://dx.doi.org/10.1371/journal.pone.0078451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167625	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500086
J	Rajamoorthi, A; Shrivastava, S; Steele, R; Nerurkar, P; Gonzalez, JG; Crawford, S; Varvares, M; Ray, RB				Rajamoorthi, Ananthi; Shrivastava, Shubham; Steele, Robert; Nerurkar, Pratibha; Gonzalez, Juan G.; Crawford, Susan; Varvares, Mark; Ray, Ratna B.			Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling	PLOS ONE			English	Article							MOMORDICA-CHARANTIA; CANCER; CYCLE; APOPTOSIS; PATHWAYS; KINASE; DEATH; GAMMA; MCL-1	Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, and despite of advances in treatment, the overall survival rate has only modestly improved over the past several years. Thus, there is an urgent need for additional therapeutic modalities. We hypothesized that treatment of HNSCC cells with a dietary product such as bitter melon extract (BME) modulates multiple signaling pathways and regresses HNSCC tumor growth in a preclinical model. We observed a reduced cell proliferation in HNSCC cell lines. The mechanistic studies reveal that treatment of BME in HNSCC cells inhibited c-Met signaling pathway. We also observed that BME treatment in HNSCC reduced phosphoStat3, c-myc and Mcl-1 expression, downstream signaling molecules of c-Met. Furthermore, BME treatment in HNSCC cells modulated the expression of key cell cycle progression molecules leading to halted cell growth. Finally, BME feeding in mice bearing HNSCC xenograft tumor resulted in an inhibition of tumor growth and c-Met expression. Together, our results suggested that BME treatment in HNSCC cells modulates multiple signaling pathways and may have therapeutic potential for treating HNSCC.	[Rajamoorthi, Ananthi; Shrivastava, Shubham; Steele, Robert; Gonzalez, Juan G.; Crawford, Susan; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Crawford, Susan; Varvares, Mark; Ray, Ratna B.] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA; [Nerurkar, Pratibha] Univ Hawaii, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA	Saint Louis University; Saint Louis University; University of Hawaii System	Ray, RB (corresponding author), St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.	rayrb@slu.edu	Nerurkar, Pratibha/AAP-5734-2021	Shrivastava, Shubham/0000-0002-5980-8536	NIH [R21CA137424]; Lottie Caroline Hardy Charitable Trust Fund; Saint Louis University Cancer Center seed grant; NATIONAL CANCER INSTITUTE [R21CA137424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lottie Caroline Hardy Charitable Trust Fund; Saint Louis University Cancer Center seed grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grant R21CA137424 from the NIH, The Lottie Caroline Hardy Charitable Trust Fund, and Saint Louis University Cancer Center seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; Kanda T, 2009, CANCER RES, V69, P9354, DOI 10.1158/0008-5472.CAN-09-2974; Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09; Kaur M, 2013, CARCINOGENESIS, V34, P1585, DOI 10.1093/carcin/bgt081; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kwatra D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/702869; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nerurkar PV, 2006, BRIT J PHARMACOL, V148, P1156, DOI 10.1038/sj.bjp.0706821; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Raj SK, 2005, INT J FOOD SCI NUTR, V56, P185, DOI 10.1080/09637480500103946; Ray RB, 2010, CANCER RES, V70, P1925, DOI 10.1158/0008-5472.CAN-09-3438; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Ru P, 2011, CANCER PREV RES, V4, P2122, DOI 10.1158/1940-6207.CAPR-11-0376; Sahu N, 2011, ANTI-CANCER DRUG, V22, P656, DOI 10.1097/CAD.0b013e32834249ba; SCHER RL, 1993, ARCH OTOLARYNGOL, V119, P432; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Steele Robert, 2010, Genes Cancer, V1, P381; Tabata K, 2012, CANCER SCI, V103, P2153, DOI 10.1111/cas.12021; Tran HM, 2004, OTOLARYNG HEAD NECK, V131, P477, DOI 10.1016/j.otohns.2004.04.019; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022	26	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78006	10.1371/journal.pone.0078006	http://dx.doi.org/10.1371/journal.pone.0078006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147107	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200092
J	Mori, T; Wakabayashi, T; Ogawa, H; Hirahara, Y; Koike, T; Yamada, H				Mori, Tetsuji; Wakabayashi, Taketoshi; Ogawa, Haruyuki; Hirahara, Yukie; Koike, Taro; Yamada, Hisao			Increased Histone H3 Phosphorylation in Neurons in Specific Brain Structures after Induction of Status Epilepticus in Mice	PLOS ONE			English	Article							GYRUS GRANULE NEURONS; EARLY GENE-EXPRESSION; C-FOS; PILOCARPINE MODEL; STRIATAL NEURONS; DOPAMINE NEUROTRANSMISSION; GLUCOCORTICOID-RECEPTOR; EPIGENETIC MECHANISMS; PHOSPHATASE CASCADE; CHRONIC EPILEPSY	Status epilepticus (SE) induces pathological and morphological changes in the brain. Recently, it has become clear that excessive neuronal excitation, stress and drug abuse induce chromatin remodeling in neurons, thereby altering gene expression. Chromatin remodeling is a key mechanism of epigenetic gene regulation. Histone H3 phosphorylation is frequently used as a marker of chromatin remodeling and is closely related to the upregulation of mRNA transcription. In the present study, we analyzed H3 phosphorylation levels in vivo using immunohistochemistry in the brains of mice with pilocarpine-induced SE. A substantial increase in H3 phosphorylation was detected in neurons in specific brain structures. Increased H3 phosphorylation was dependent on neuronal excitation. In particular, a robust upregulation of H3 phosphorylation was detected in the caudate putamen, and there was a gradient of phosphorylated H3(+) (PH3(+)) neurons along the medio-lateral axis. After unilateral ablation of dopaminergic neurons in the substantia nigra by injection of 6-hydroxydopamine, the distribution of PH3(+) neurons changed in the caudate putamen. Moreover, our histological analysis suggested that, in addition to the well-known MSK1 (mitogen and stress-activated kinase)/H3 phosphorylation/c-fos pathway, other signaling pathways were also activated. Together, our findings suggest that a number of genes involved in the pathology of epileptogenesis are upregulated in PH3(+) brain regions, and that H3 phosphorylation is a suitable indicator of strong neuronal excitation.	[Mori, Tetsuji; Wakabayashi, Taketoshi; Ogawa, Haruyuki; Hirahara, Yukie; Koike, Taro; Yamada, Hisao] Kansai Med Univ, Dept Anat & Cell Sci, Hirakata, Osaka, Japan	Kansai Medical University	Mori, T (corresponding author), Kansai Med Univ, Dept Anat & Cell Sci, Hirakata, Osaka, Japan.	morite@hirakata.kmu.ac.jp	Koike, Taro/AAZ-3465-2021; Yamada, Hisao/L-8108-2018	Yamada, Hisao/0000-0003-0403-2061	Japan Society for the Promotion of Science [25430044]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research (C) #25430044 from the Japan Society for the Promotion of Science (T.Mori). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; ALTAJIR G, 1993, J NEURAL TRANSM-PARK, V5, P89, DOI 10.1007/BF02251199; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; BERNARD V, 1993, EUR J NEUROSCI, V5, P1218, DOI 10.1111/j.1460-9568.1993.tb00976.x; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Brami-Cherrier K, 2007, J NEUROCHEM, V101, P697, DOI 10.1111/j.1471-4159.2006.04352.x; Cardoso A, 2009, EPILEPSY BEHAV, V14, P293, DOI 10.1016/j.yebeh.2008.11.004; CENDES F, 1994, BRAIN, V117, P739, DOI 10.1093/brain/117.4.739; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; de Oliveira GNM, 2010, SEIZURE-EUR J EPILEP, V19, P479, DOI 10.1016/j.seizure.2010.07.004; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Haut SR, 2008, NEUROLOGY, V71, P784, DOI 10.1212/01.wnl.0000325637.38931.27; Healy S, 2012, BIOCHEM CELL BIOL, V90, P39, DOI [10.1139/o11-092, 10.1139/O11-092]; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Mori T, 2012, EUR J NEUROSCI, V36, P3184, DOI 10.1111/j.1460-9568.2012.08244.x; Mori T, 2009, ACTA HISTOCHEM CYTOC, V42, P1, DOI 10.1267/ahc.08037; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Parent JM, 2002, PROG BRAIN RES, V135, P121; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reul JMHM, 2009, EPIGENETICS-US, V4, P434, DOI 10.4161/epi.4.7.9806; Rice AC, 1998, BRAIN RES, V782, P240, DOI 10.1016/S0006-8993(97)01285-7; Rotllant D, 2012, NEUROPHARMACOLOGY, V62, P1073, DOI 10.1016/j.neuropharm.2011.10.019; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SHEHAB S, 1992, EXP NEUROL, V118, P261, DOI 10.1016/0014-4886(92)90183-Q; Sng JCG, 2006, EUR J NEUROSCI, V23, P1269, DOI 10.1111/j.1460-9568.2006.04641.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tamura Y, 2004, NEUROSCI RES, V50, P129, DOI 10.1016/j.neures.2004.06.011; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; WALTON NY, 1991, BRAIN RES, V553, P97, DOI 10.1016/0006-8993(91)90235-N; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	56	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77710	10.1371/journal.pone.0077710	http://dx.doi.org/10.1371/journal.pone.0077710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147063	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400127
J	Arum, O; Rasche, ZA; Rickman, DJ; Bartke, A				Arum, Oge; Rasche, Zachary Andrew; Rickman, Dustin John; Bartke, Andrzej			Prevention of Neuromusculoskeletal Frailty in Slow-Aging Ames Dwarf Mice: Longitudinal Investigation of Interaction of Longevity Genes and Caloric Restriction	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; GROWTH-HORMONE; LIFE-SPAN; DIETARY RESTRICTION; OLDER-ADULTS; HEALTH; ASSOCIATION; EXTENSION; INSULIN; GLUCOSE	Ames dwarf (Prop1(df/df)) mice are remarkably long-lived and exhibit many characteristics of delayed aging and extended healthspan. Caloric restriction (CR) has similar effects on healthspan and lifespan, and causes an extension of longevity in Ames dwarf mice. Our study objective was to determine whether Ames dwarfism or CR influence neuromusculoskeletal function in middle-aged (82 +/- 12 weeks old) or old (128 +/- 14 w.o.) mice. At the examined ages, strength was improved by dwarfism, CR, and dwarfism plus CR in male mice; balance/motor coordination was improved by CR in old animals and in middle-aged females; and agility/motor coordination was improved by a combination of dwarfism and CR in both genders of middle-aged mice and in old females. Therefore, extension of longevity by congenital hypopituitarism is associated with improved maintenance of the examined measures of strength, agility, and motor coordination, key elements of frailty during human aging, into advanced age. This study serves as a particularly important example of knowledge related to addressing aging-associated diseases and disorders that results from studies in long-lived mammals.	[Arum, Oge; Rasche, Zachary Andrew; Rickman, Dustin John; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Arum, O (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62702 USA.	oge.arum@gmail.com	Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X	National Institute on Aging [AG19899, U19 AG023122, 3R01AG019899-07S1]; Ellison Medical Foundation; Glenn Foundation for Medical Research; Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG019899] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging Grants AG19899, U19 AG023122, and 3R01AG019899-07S1, as well as a Senior Scholar Award in Aging from The Ellison Medical Foundation, and The Glenn Foundation for Medical Research; this work was vitally supported by a grant from the Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University, and the authors would especially like to thank Drs. Thomas A. Ala, M.D. & Robert G. Struble, Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Anisimov VN, 2009, BIOGERONTOLOGY, V10, P323, DOI 10.1007/s10522-008-9209-8; ARCE VM, 1991, NEUROENDOCRINOLOGY, V53, P467, DOI 10.1159/000125759; Aronow WS, 2006, MED CLIN N AM, V90, P849, DOI 10.1016/j.mcna.2006.05.009; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2004, HORM METAB RES, V36, P550, DOI 10.1055/s-2004-825796; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bartke A, 2001, HDB BIOL AGING; Bartke A, 2008, CLIN INTERV AGING, V3, P659, DOI 10.2147/CIA.S3697; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Bonkowski MS, 2006, J GERONTOL A-BIOL, V61, P562, DOI 10.1093/gerona/61.6.562; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Crawley J. N., 2007, WHATS WRONG MY MOUSE; CREW MD, 1987, ENDOCRINOLOGY, V121, P1251, DOI 10.1210/endo-121-4-1251; De Laet CEDH, 2000, BEST PRACT RES CL EN, V14, P171, DOI 10.1053/beem.2000.0067; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gage PJ, 1996, DEVELOPMENT, V122, P151; Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013; Giannoulis MG, 2012, ENDOCR REV, V33, P314, DOI 10.1210/er.2012-1002; Glantz SA, 2002, PRIMER BIOSTATISTICS; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141; Kandel ER, 1991, PRINCIPLES NEURAL SC; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kinsella K, 2008, INT POPULATION REPOR; Ko FCY, 2011, CLIN GERIATR MED, V27, P89, DOI 10.1016/j.cger.2010.08.007; Landi F, 2010, BIOGERONTOLOGY, V11, P537, DOI 10.1007/s10522-010-9296-1; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082; Lee DM, 2013, J GERONTOL A-BIOL, V68, P837, DOI 10.1093/gerona/gls217; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Liu CK, 2011, CLIN GERIATR MED, V27, P101, DOI 10.1016/j.cger.2010.08.001; Marin RV, 2010, J CLIN DENSITOM, V13, P96, DOI 10.1016/j.jocd.2009.12.001; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Mattson MP, 2010, AGING CELL, V9, P448, DOI 10.1111/j.1474-9726.2010.00561.x; MCCAY CM, 1989, NUTRITION, V5, P155; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB358, DOI 10.1093/gerona/54.8.B358; Miller RA, 2009, J GERONTOL A-BIOL, V64, P157, DOI 10.1093/gerona/gln062; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Moreschi C, 1909, EXPER THERAP, V2, P651; Norrelund H, 2002, GROWTH HORM IGF RES, V12, P198, DOI 10.1016/S1096-6374(02)00043-6; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Panici JA, 2009, J GERONTOL A-BIOL, V64, P1126, DOI 10.1093/gerona/glp111; Parks RJ, 2012, J GERONTOL A-BIOL, V67, P217, DOI 10.1093/gerona/glr193; Rajan KB, 2013, J GERONTOL A-BIOL, V68, P624, DOI 10.1093/gerona/gls208; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433; Schaible R., 1961, Genetics, V46, P896; Shamsi KS, 2012, J GERONTOL A-BIOL, V67, P853, DOI 10.1093/gerona/glr224; Shardell M, 2009, J GERONTOL A-BIOL, V64, P69, DOI 10.1093/gerona/gln007; SONNTAG WE, 1995, NEUROENDOCRINOLOGY, V61, P601, DOI 10.1159/000126885; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Sourial N, 2012, J GERONTOL A-BIOL, V67, P1197, DOI 10.1093/gerona/gls084; Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727, DOI 10.1093/geront/42.6.727; Syed Farhan A, 2011, Curr Osteoporos Rep, V9, P219, DOI 10.1007/s11914-011-0074-z; Syed Farhan A, 2010, Curr Osteoporos Rep, V8, P235, DOI 10.1007/s11914-010-0035-y; Thorner MO, 2009, J GERONTOL A-BIOL, V64, P1039, DOI 10.1093/gerona/glp091; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wan H., 2005, CURRENT POPULATION R; Warner HR, 2009, CAN J AGING, V28, P391, DOI 10.1017/S0714980809990286; Weiss CO, 2011, CLIN GERIATR MED, V27, P39, DOI 10.1016/j.cger.2010.08.003; White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197	74	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e72255	10.1371/journal.pone.0072255	http://dx.doi.org/10.1371/journal.pone.0072255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155868	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300002
J	Hsu, JL; Khan, MA; Sobel, RA; Jiang, XG; Clemons, KV; Nguyen, TT; Stevens, DA; Martinez, M; Nicolls, MR				Hsu, Joe L.; Khan, Mohammad A.; Sobel, Raymond A.; Jiang, Xinguo; Clemons, Karl V.; Nguyen, Tom T.; Stevens, David A.; Martinez, Marife; Nicolls, Mark R.			Aspergillus fumigatus Invasion Increases with Progressive Airway Ischemia	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; LUNG-TRANSPLANTATION; FUNGAL-INFECTIONS; RECIPIENTS; FIBROSIS; REJECTION; HYPOXIA; CELLS; PCR	Despite the prevalence of Aspergillus-related disease in immune suppressed lung transplant patients, little is known of the host-pathogen interaction. Because of the mould's angiotropic nature and because of its capacity to thrive in hypoxic conditions, we hypothesized that the degree of Aspergillus invasion would increase with progressive rejection-mediated ischemia of the allograft. To study this relationship, we utilized a novel orthotopic tracheal transplant model of Aspergillus infection, in which it was possible to assess the effects of tissue hypoxia and ischemia on airway infectivity. Laser Doppler flowmetry and FITC-lectin were used to determine blood perfusion, and a fiber optic microsensor was used to measure airway tissue oxygen tension. Fungal burden and depth of invasion were graded using histopathology. We demonstrated a high efficacy (80%) for producing a localized fungal tracheal infection with the majority of infection occurring at the donor-recipient anastomosis; Aspergillus was more invasive in allogeneic compared to syngeneic groups. During the study period, the overall kinetics of both non-infected and infected allografts was similar, demonstrating a progressive loss of perfusion and oxygenation, which reached a nadir by days 10-12 post-transplantation. The extent of Aspergillus invasion directly correlated with the degree of graft hypoxia and ischemia. Compared to the midtrachea, the donor-recipient anastomotic site exhibited lower perfusion and more invasive disease; a finding consistent with clinical experience. For the first time, we identify ischemia as a putative risk factor for Aspergillus invasion. Therapeutic approaches focused on preserving vascular health may play an important role in limiting Aspergillus infections.	[Hsu, Joe L.; Nicolls, Mark R.] Stanford Univ, Dept Med, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Hsu, Joe L.; Khan, Mohammad A.; Jiang, Xinguo; Nguyen, Tom T.; Nicolls, Mark R.] Vet Affairs Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA USA; [Sobel, Raymond A.] Vet Affairs Palo Alto Hlth Care Syst, Pathol & Lab Serv, Palo Alto, CA USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Clemons, Karl V.; Stevens, David A.; Martinez, Marife] Calif Inst Med Res, Infect Dis Res Lab, San Jose, CA 95128 USA; [Clemons, Karl V.; Stevens, David A.] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Hsu, JL (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA.	joehsu@stanford.edu	Khan, Mohammad Afzal/AAG-3800-2021; Nicolls, Mark/K-6085-2019	Khan, Mohammad Afzal/0000-0002-4738-7893; Sobel, Raymond/0000-0002-0477-9002	National Institutes of Health [HL095686]; Veterans Affairs Merit Award [BX000509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108797, R01HL095686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grant HL095686 and by a Veterans Affairs Merit Award BX000509 to M. R. Nicolls. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu AN, 2007, J CLIN INVEST, V117, P3774, DOI 10.1172/JCI32311; Ben-Ami R, 2009, BLOOD, V114, P5393, DOI 10.1182/blood-2009-07-231209; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Challier S, 2004, J CLIN MICROBIOL, V42, P844, DOI 10.1128/JCM.42.2.844-846.2004; Chow L, 2002, CLIN INFECT DIS, V35, pE106, DOI 10.1086/343743; Dhillon GS, 2010, AM J RESP CRIT CARE, V182, P230, DOI 10.1164/rccm.200910-1573OC; Fleiss J., 1981, STATISTICAL METHODS, P8; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; HALL LA, 1994, J MED MICROBIOL, V41, P311, DOI 10.1099/00222615-41-5-311; Hsu JL, 2011, CRIT REV MICROBIOL, V37, P277, DOI 10.3109/1040841X.2011.581223; Jiang X, 2011, J CLIN INVEST, V121, P2336, DOI 10.1172/JCI46192; Kamai Y, 2006, MED MYCOL, V44, pS115, DOI 10.1080/13693780600897989; Khan MA, 2012, AM J PHYSIOL-LUNG C, V303, pL861, DOI 10.1152/ajplung.00162.2012; Khan MA, 2011, CIRC RES, V109, P1290, DOI 10.1161/CIRCRESAHA.111.250167; Kontoyiannis DP, 2010, VIRULENCE, V1, P192, DOI 10.4161/viru.1.3.11380; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nunley DR, 2002, CHEST, V122, P1185, DOI 10.1378/chest.122.4.1185; Rodland EK, 2010, INFECT IMMUN, V78, P1269, DOI 10.1128/IAI.01091-09; Silveira FP, 2007, MED MYCOL, V45, P305, DOI 10.1080/13693780701200372; Singh G, 2005, ANTIMICROB AGENTS CH, V49, P1369, DOI 10.1128/AAC.49.4.1369-1376.2005; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Singh N, 2003, INFECT DIS CLIN N AM, V17, P113, DOI 10.1016/S0891-5520(02)00067-3; Sole A, 2005, CLIN MICROBIOL INFEC, V11, P359, DOI 10.1111/j.1469-0691.2005.01128.x; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Verleden GM, 2010, CURR OPIN ORGAN TRAN, V15, P568, DOI 10.1097/MOT.0b013e32833debd0; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Weigt SS, 2013, AM J TRANSPLANT, V13, P919, DOI 10.1111/ajt.12131	29	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77136	10.1371/journal.pone.0077136	http://dx.doi.org/10.1371/journal.pone.0077136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155924	Green Submitted, gold, Green Published			2022-12-25	WOS:000325887300058
J	Kudumala, S; Freund, J; Hortsch, M; Godenschwege, TA				Kudumala, Sirisha; Freund, Julie; Hortsch, Michael; Godenschwege, Tanja A.			Differential Effects of Human L1CAM Mutations on Complementing Guidance and Synaptic Defects in Drosophila melanogaster	PLOS ONE			English	Article							ADHESION MOLECULE L1; NEURAL-CELL-ADHESION; PATHOLOGICAL MISSENSE MUTATIONS; NEURITE OUTGROWTH; NERVOUS-SYSTEM; EXTRACELLULAR DOMAIN; LOCOMOTOR BEHAVIOR; AXON OUTGROWTH; HUMAN L1-CAM; FAMILY	A large number of different pathological L1CAM mutations have been identified that result in a broad spectrum of neurological and non-neurological phenotypes. While many of these mutations have been characterized for their effects on homophilic and heterophilic interactions, as well as expression levels in vitro, there are only few studies on their biological consequences in vivo. The single L1-type CAM gene in Drosophila, neuroglian (nrg), has distinct functions during axon guidance and synapse formation and the phenotypes of nrg mutants can be rescued by the expression of human L1CAM. We previously showed that the highly conserved intracellular FIGQY Ankyrin-binding motif is required for L1CAM-mediated synapse formation, but not for neurite outgrowth or axon guidance of the Drosophila giant fiber (GF) neuron. Here, we use the GF as a model neuron to characterize the pathogenic L120V, Y1070C, C264Y, H210Q, E309K and R184Q extracellular L1CAM missense mutations and a L1CAM protein with a disrupted ezrin-moesin-radixin (ERM) binding site to investigate the signaling requirements for neuronal development. We report that different L1CAM mutations have distinct effects on axon guidance and synapse formation. Furthermore, L1CAM homophilic binding and signaling via the ERM motif is essential for axon guidance in Drosophila. In addition, the human pathological H210Q, R184Q and Y1070C, but not the E309K and L120V L1CAM mutations affect outside-in signaling via the FIGQY Ankyrin binding domain which is required for synapse formation. Thus, the pathological phenotypes observed in humans are likely to be caused by the disruption of signaling required for both, guidance and synaptogenesis.	[Kudumala, Sirisha; Freund, Julie; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL USA; [Hortsch, Michael] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	State University System of Florida; Florida Atlantic University; University of Michigan System; University of Michigan	Godenschwege, TA (corresponding author), Florida Atlantic Univ, Dept Biol Sci, John D MacArthur Campus, Jupiter, FL USA.	godensch@fau.edu	Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD050725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050725] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD050725 to T. A. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. J., 2010, COLD SPRING HARB PRO; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cheng L, 2004, MOL CELL NEUROSCI, V27, P522, DOI 10.1016/j.mcn.2004.08.005; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Itoh K, 2011, J NEUROSCI RES, V89, P1637, DOI 10.1002/jnr.22695; Jenkins SM, 2001, J CELL SCI, V114, P3823; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Michelson P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9096; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Mualla R, 2013, NEUROCHEM RES, V38, P1196, DOI 10.1007/s11064-012-0892-0; Nagaraj K, 2009, HUM MOL GENET, V18, P3822, DOI 10.1093/hmg/ddp325; Nakamura Y, 2006, J CELL SCI, V119, P1341, DOI 10.1242/jcs.02862; Nayeem N, 1999, J CELL SCI, V112, P4739; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Runker AE, 2003, J NEUROSCI, V23, P277; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6	43	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76974	10.1371/journal.pone.0076974	http://dx.doi.org/10.1371/journal.pone.0076974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155914	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300048
J	Schaum, CE; Batty, R; Last, KS				Schaum, C. Elisa; Batty, Robert; Last, Kim S.			Smelling Danger - Alarm Cue Responses in the Polychaete Nereis (Hediste) diversicolor (Muller, 1776) to Potential Fish Predation	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; CHEMICAL CUES; PREY INTERACTIONS; RISK-ASSESSMENT; SENSE-ORGANS; BEHAVIOR; ECOLOGY; VIRENS; HABITUATION; KAIROMONES	The harbour ragworm, Nereis (Hediste) diversicolor is a common intertidal marine polychaete that lives in burrows from which it has to partially emerge in order to forage. In doing so, it is exposed to a variety of predators. One way in which predation risk can be minimised is through chemical detection from within the relative safety of the burrows. Using CCTV and motion capture software, we show that H. diversicolor is able to detect chemical cues associated with the presence of juvenile flounder (Platichthys flesus). Number of emergences, emergence duration and distance from burrow entrance are all significantly reduced during exposure to flounder conditioned seawater and flounder mucous spiked seawater above a threshold with no evidence of behavioural habituation. Mucous from bottom-dwelling juvenile plaice (Pleuronectes platessa) and pelagic adult herring (Clupea harengus) elicit similar responses, suggesting that the behavioural reactions are species independent. The data implies that H. diversicolor must have well developed chemosensory mechanisms for predator detection and is consequently able to effectively minimize risk.	[Schaum, C. Elisa; Batty, Robert; Last, Kim S.] Scottish Marine Inst, Scottish Assoc Marine Sci, Dunstaffnage, Scotland		Last, KS (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Dunstaffnage, Scotland.	kim.last@sams.ac.uk			ARC fellowship (SAMS)	ARC fellowship (SAMS)	Funding was provided to KSL through an ARC fellowship (SAMS). ES was self-funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Batty RS, 1995, J FISH BIOL, V47, P931, DOI 10.1111/j.1095-8649.1995.tb06019.x; Beklioglu M, 2006, FRESHWATER BIOL, V51, P2200, DOI 10.1111/j.1365-2427.2006.01642.x; Boeing WJ, 2006, ARCH HYDROBIOL, V166, P241, DOI 10.1127/0003-9136/2006/0166-0241; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; CLARK R. B., 1960, ANIMAL BEHAVIOUR, V8, P82, DOI 10.1016/0003-3472(60)90013-0; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; DAVEY JT, 1986, OPHELIA, V26, P151, DOI 10.1080/00785326.1986.10421985; DORSETT DA, 1964, PROC R SOC SER B-BIO, V159, P652, DOI 10.1098/rspb.1964.0024; DORSETT DA, 1969, Z ZELLFORSCH MIK ANA, V97, P512, DOI 10.1007/BF00332800; ESSELINK P, 1989, MAR ECOL PROG SER, V56, P243, DOI 10.3354/meps056243; EVANS SM, 1969, BIOL BULL, V137, P95, DOI 10.2307/1539933; EVANS SM, 1966, ANIM BEHAV, V14, P107, DOI 10.1016/S0003-3472(66)80018-0; Ferland-Raymond B, 2008, CAN J ZOOL, V86, P1329, DOI 10.1139/Z08-117; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; GAMBI MC, 1996, ATTI, V11, P779; HOLOMUZKI JR, 1994, FRESHWATER BIOL, V32, P585, DOI 10.1111/j.1365-2427.1994.tb01149.x; HOVERMAN JT, 2001, PREDATOR INDUCED PLA, P1465, DOI DOI 10.1002/9780470015902.A0003305.PUB2; Intergovernmental Panel on Climate Change (IPCC) Working Group II., 2007, SUMM POL MAK; Karlson AML, 2007, ICES J MAR SCI, V64, P479, DOI 10.1093/icesjms/fsl049; Kicklighter CE, 2007, ANIM BEHAV, V74, P1481, DOI 10.1016/j.anbehav.2007.02.015; KRISTENSEN E, 1984, HOLARCTIC ECOL, V7, P249; Lass S, 2003, HYDROBIOLOGIA, V491, P221, DOI 10.1023/A:1024487804497; Last KS, 2009, CHRONOBIOL INT, V26, P167, DOI 10.1080/07420520902774524; Last KS, 2003, J EXP MAR BIOL ECOL, V287, P237, DOI 10.1016/S0022-0981(02)00576-2; Lincoln RJ, 1982, DICT ECOLOGY EVOLUTI, P298; Lindsay SM, 2009, ZOOSYMPOSIA, V2, P339, DOI 10.11646/zoosymposia.2.1.24; Mach ME, 2011, J EXP MAR BIOL ECOL, V409, P166, DOI 10.1016/j.jembe.2011.08.018; MARER YB, 1980, J EXP ZOOL, V213, P33, DOI DOI 10.1002/JEZ.1402130106; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; Mccoy MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047495; McKelvey LM, 1995, J PLANKTON RES, V17, P2191, DOI 10.1093/plankt/17.12.2191; Meager JJ, 2007, PHILOS T R SOC B, V362, P2123, DOI 10.1098/rstb.2007.2104; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; MIRON G, 1993, MAR ECOL PROG SER, V101, P147, DOI 10.3354/meps101147; Mueller F., 1776, ZDP, P1; Nunes AL, 2013, OECOLOGIA, V171, P115, DOI 10.1007/s00442-012-2389-6; OLIVE PJW, 1981, B SOC ZOOL FR, V106, P263; PESTANA J, 2013, MAR FRESHW RES, P1465; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; RIISGARD HU, 1991, MAR ECOL PROG SER, V70, P29, DOI 10.3354/meps070029; Ringelberg J, 1998, J PLANKTON RES, V20, P1847, DOI 10.1093/plankt/20.9.1847; Riordan TJ, 2002, J EXP MAR BIOL ECOL, V277, P79, DOI 10.1016/S0022-0981(02)00292-7; Rosenberg R, 2000, MAR BIOL, V136, P43, DOI 10.1007/s002270050006; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; SMITH JE, 1957, PHILOS T ROY SOC B, V240, P135, DOI 10.1098/rstb.1957.0001; SMITH RI, 1955, BIOL BULL, V108, P326, DOI 10.2307/1538519; SMITH RJF, 1986, AM NAT, V128, P604, DOI 10.1086/284591; Tsie MS, 2008, CELL TISSUE RES, V333, P469, DOI 10.1007/s00441-008-0660-2; Tvete T, 2008, J FISH DIS, V31, P343, DOI 10.1111/j.1365-2761.2008.00906.x; Watson GJ, 2005, ANIM BEHAV, V70, P1125, DOI 10.1016/j.anbehav.2005.03.011; Weber A, 2003, HYDROBIOLOGIA, V498, P143, DOI 10.1023/A:1026297106626; Wisenden BD, 2001, ANIM BEHAV, V62, P761, DOI 10.1006/anbe.2001.1797	60	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77431	10.1371/journal.pone.0077431	http://dx.doi.org/10.1371/journal.pone.0077431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155953	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300087
J	Lin, SY; Hsieh, CJ; Chen, YL; Shaw, SWS; Lin, MW; Chen, PC; Lee, CN				Lin, Shin-Yu; Hsieh, Chia-Jung; Chen, Yi-Li; Shaw, Sheng-Wen Steven; Lin, Ming-Wei; Chen, Pau-Chung; Lee, Chien-Nan			The Impact of Down Syndrome Screening on Taiwanese Down Syndrome Births: A Nationwide Retrospective Study and a Screening Result from a Single Medical Centre	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ALPHA-FETOPROTEIN; COST-EFFECTIVENESS; ASIAN POPULATION; MATERNAL AGE; TRENDS; PREVALENCE; TRISOMIES; RISK	A retrospective analysis of the Taiwanese National Birth Defect Registration and Notification System was conducted in order to determine the live birth- and stillbirth rates in infants with Down syndrome, trisomy 18, trisomy 13 and Turner syndrome between 2001 and 2010. The objective was to investigate the impact of Down syndrome screening on the Taiwanese Down syndrome live birth rate. In addition, the results of first-trimester Down syndrome screening between 2006 and 2011, and of second-trimester quadruple testing between 2008 and 2011, were obtained from the National Taiwan University Hospital. All Taiwanese infants born between 2001 and 2010 were included in the first part of the analysis, and women receiving first-trimester Down syndrome screening or second-trimester quadruple testing from the National Taiwan University Hospital were included in the second part. The live birth rate of infants with Down syndrome, per 100 000 live births, decreased from 22.28 in 2001 to 7.79 in 2010. The ratio of liveborn DS to total DS was 48.74% in 2001, and then decreased to 25.88% in 2006, when first-trimester screening was widely introduced in Taiwan. This ratio dropped to 20.64% in 2008, when the second-trimester quadruple test was implemented. The overall positive rate in first-trimester screening in the National Taiwan University Hospital was 3.1%, with a Down syndrome detection rate of 100%; the quadruple test had values of 9.0% and 75%, respectively. The use of first-trimester screening and the second-trimester quadruple test may be responsible for the marked decrease in the Taiwanese Down syndrome live birth rate observed between 2001 and 2010.	[Lin, Shin-Yu] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Shin-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hsieh, Chia-Jung] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan; [Chen, Yi-Li] Natl Taiwan Univ, Grad Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Shaw, Sheng-Wen Steven] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Shaw, Sheng-Wen Steven] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Ming-Wei; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Tzu Chi University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	leecn@ntu.edu.tw	Hsieh, Chia-Jung/AAX-3086-2020; Chen, Pau-Chung/H-5686-2011	Hsieh, Chia-Jung/0000-0002-0381-7783; Chen, Pau-Chung/0000-0002-6242-5974; LIN, SHIN-YU/0000-0002-0753-2793; Lee, Chien-Nan/0000-0002-1725-0407				American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Benn PA, 2003, OBSTET GYNECOL, V101, P451, DOI 10.1016/S0029-7844(02)03159-9; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Egan JFX, 2004, AM J OBSTET GYNECOL, V191, P1044, DOI 10.1016/j.ajog.2004.06.050; EIBEN B, 1990, AM J HUM GENET, V47, P656; Gilbert RE, 2001, BRIT MED J, V323, P423, DOI 10.1136/bmj.323.7310.423; HADDOW JE, 1994, NEW ENGL J MED, V330, P1114, DOI 10.1056/NEJM199404213301603; Hoshi N, 1999, AM J MED GENET, V84, P340, DOI 10.1002/(SICI)1096-8628(19990604)84:4<340::AID-AJMG6>3.0.CO;2-N; Hsu JJ, 1996, OBSTET GYNECOL, V87, P943, DOI 10.1016/0029-7844(96)00042-7; Hwa HL, 2008, J EVAL CLIN PRACT, V14, P191, DOI 10.1111/j.1365-2753.2007.00831.x; International Clearinghouse for Birth Defects Montoring Systems International Centre for Birth Defects WHGP European Registration of Congenital Anomalies, 2003, WORLD ATL BIRTH DEF; Jon HJ, 2005, PRENATAL DIAG, V25, P665, DOI 10.1002/pd.1220; Jou HJ, 2000, FETAL DIAGN THER, V15, P108, DOI 10.1159/000020986; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; KELLNER LH, 1995, AM J OBSTET GYNECOL, V173, P1306, DOI 10.1016/0002-9378(95)91376-9; Khoshnood B, 2004, BJOG-INT J OBSTET GY, V111, P485, DOI 10.1111/j.1471-0528.2004.00117.x; LAI FM, 2002, SINGAP MED J, V43, P93893; LIN S, 1991, INCIDENCE GROWTH SYN; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; MacRae AR, 2010, PRENATAL DIAG, V30, P459, DOI 10.1002/pd.2502; Maiz N, 2009, ULTRASOUND OBST GYN, V33, P512, DOI 10.1002/uog.6330; NICOLAIDES KH, 2001, PRENAT DIAGN, V31, P7; Olsen CL, 1997, PRENATAL DIAG, V17, P1113, DOI 10.1002/(SICI)1097-0223(199712)17:12<1113::AID-PD200>3.0.CO;2-7; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Shaw SWS, 2010, TAIWAN J OBSTET GYNE, V49, P30, DOI 10.1016/S1028-4559(10)60005-8; SNIJDERS RJM, 1995, FETAL DIAGN THER, V10, P356, DOI 10.1159/000264259; Spencer K, 2003, BJOG-INT J OBSTET GY, V110, P281, DOI 10.1016/S1470-0328(03)02946-X; Wald NJ, 2003, LANCET, V361, P835, DOI 10.1016/S0140-6736(03)12680-3; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883	29	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75428	10.1371/journal.pone.0075428	http://dx.doi.org/10.1371/journal.pone.0075428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24147155	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000075
J	Cheruiyot, A; Lee, JA; Gao, FB; Ahmad, ST				Cheruiyot, Abigael; Lee, Jin-A; Gao, Fen-Biao; Ahmad, S. Tariq			Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila	FASEB JOURNAL			English	Article						endosomal-lysosomal pathway; tumorigenesis	ENDOSOMAL ENTRY; MUTATIONS; PROTEIN; PATHWAY; VPS25; DEGENERATION; RECEPTOR; SCREEN; ABSENT	Endosomal sorting complexes required for transport (ESCRTs) mediate sorting of ubiquitinated membrane proteins into multivesicular bodies en route to lysosomes for degradation. A mutation in CHMP2B (CHMP2B(Intron5), an ESCRT-III component) that is associated with a hereditary form of frontotemporal dementia (FTD3) disrupts the endosomal-lysosomal pathway and causes accumulation of autophagosomes and multilamellar structures. We previously demonstrated that expression of CHMP2B(Intron5) in the Drosophila eye using GMR-Gal4 causes misregulation of the Toll receptor pathway. Here, we show that ectopic expression of CHMP2B(Intron5) using eyeless-Gal4 (ey>CHMP2B(Intron5)), a driver with different spatiotemporal expression attributes than GMR-Gal4 in the Drosophila eye, causes eye deformities when compared to expression of wild-type CHMP2B (CHMP2B(WT)) and the Drosophila homologue of CHMP2B (CG4618). In addition, ey>CHMP2B(Intron5) flies showed defects in photoreceptor cell patterning and phototactic behavior. Furthermore, ey>CHMP2B(Intron5) flies showed accumulation of Notch in enlarged endosomes and up-regulation of Notch activity. Partial loss of Notch activity in ey>CHMP2B(Intron5) flies significantly rescued eye deformities, photoreceptor patterning defect, and phototactic behavior defect, indicating that these defects are primarily due to Notch misregulation. These results demonstrate that CHMP2B(Intron5) preferentially affects different receptor signaling pathways in a cellular and developmental context-dependent manner.Cheruiyot, A., Lee, J-A., Gao, F-B., Ahmad, S. T. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.	[Cheruiyot, Abigael; Ahmad, S. Tariq] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Lee, Jin-A] Hannam Univ, Coll Life Sci & Nanotechnol, Dept Biotechnol, Dajeon, South Korea; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	Colby College; Hannam University; University of Massachusetts System; University of Massachusetts Worcester	Ahmad, ST (corresponding author), Colby Coll, Dept Biol, 5720 Mayflower Hill Dr, Waterville, ME 04901 USA.	stahmad@colby.edu		Cheruiyot, Abigael/0000-0003-0612-6280	U.S. National Institutes of Health (NIH) [OD010949-10]; NIH [RO1 NS057553, 8 P20 GM103423-12]; National Center for Research Resources, INBRE [5 P20 RR016463-12]; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057553] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank H. Householder, E. Hergenreder, L. Duff, and G. Lerner (Colby College) for technical assistance. The authors also thank the Bloomington Stock Center (Bloomington, IN, USA), the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA) and the Drosophila Genomics Resource Center [Indiana University, Bloomington, IN, USA; supported by U.S. National Institutes of Health (NIH) grant OD010949-10] for providing the fly stocks, Notch antibody, and cDNA clones, respectively. This project was initiated at the Gladstone Institute of Neurological Disease with a support from the NIH (RO1 NS057553, F.-B.G.) and supported by grants from the National Center for Research Resources, INBRE (5 P20 RR016463-12), and the National Institute of General Medical Sciences (8 P20 GM103423-12) from the NIH to Colby College and Science Division Grant, Colby College (S.T.A.). The authors declare no conflicts of interest.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Aoyama N, 2013, GENES GENET SYST, V88, P45, DOI 10.1266/ggs.88.45; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Ghazi-Noori S, 2012, BRAIN, V135, P819, DOI 10.1093/brain/aws006; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Isaacs AM, 2011, CURR ALZHEIMER RES, V8, P246; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lindquist SG, 2008, EUR J NEUROL, V15, P667, DOI 10.1111/j.1468-1331.2008.02144.x; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stuffers S, 2009, EXP CELL RES, V315, P1619, DOI 10.1016/j.yexcr.2008.10.013; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wolff T., 2007, CSH PROTOCOLS; Woodfield SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056021	46	10	10	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					667	675		10.1096/fj.13-234138	http://dx.doi.org/10.1096/fj.13-234138			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24158394	Green Published			2022-12-25	WOS:000331072200014
J	Seo, HS; Minasov, G; Seepersaud, R; Doran, KS; Dubrovska, I; Shuvalova, L; Anderson, WF; Iverson, TM; Sullam, PM				Seo, Ho Seong; Minasov, George; Seepersaud, Ravin; Doran, Kelly S.; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.; Iverson, Tina M.; Sullam, Paul M.			Characterization of Fibrinogen Binding by Glycoproteins Srr1 and Srr2 of Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Fibrinogen; Protein Crystallization; Streptococcus; Streptococcus agalactiae; Prot	GROUP-B-STREPTOCOCCUS; MICROVASCULAR ENDOTHELIAL-CELLS; RICH REPEAT PROTEINS; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; LIGAND-BINDING; PROMOTES ADHERENCE; EXPRESSION; MSCRAMM; GSPB	Background: The serine-rich repeat glycoproteins Srr1 and Srr2 are surface adhesins of Streptococcus agalactiae important for pathogenicity. Results: Both Srrs bind tandem repeats of the fibrinogen A chain, but Srr2 has greater affinity explained by structure-function analysis of the Srrs. Conclusion: A dock, lock, and latch mechanism describes the Srr-fibrinogen interaction. Significance: The higher affinity of Srr2 may contribute to the hypervirulence of Srr2-expressing strains. The serine-rich repeat glycoproteins of Gram-positive bacteria comprise a large family of cell wall proteins. Streptococcus agalactiae (group B streptococcus, GBS) expresses either Srr1 or Srr2 on its surface, depending on the strain. Srr1 has recently been shown to bind fibrinogen, and this interaction contributes to the pathogenesis of GBS meningitis. Although strains expressing Srr2 appear to be hypervirulent, no ligand for this adhesin has been described. We now demonstrate that Srr2 also binds human fibrinogen and that this interaction promotes GBS attachment to endothelial cells. Recombinant Srr1 and Srr2 bound fibrinogen in vitro, with affinities of K-D = 2.1 x 10(-5) and 3.7 x 10(-6) m, respectively, as measured by surface plasmon resonance spectroscopy. The binding site for Srr1 and Srr2 was localized to tandem repeats 6-8 of the fibrinogen A chain. The structures of both the Srr1 and Srr2 binding regions were determined and, in combination with mutagenesis studies, suggest that both Srr1 and Srr2 interact with a segment of these repeats via a dock, lock, and latch mechanism. Moreover, properties of the latch region may account for the increased affinity between Srr2 and fibrinogen. Together, these studies identify how greater affinity of Srr2 for fibrinogen may contribute to the increased virulence associated with Srr2-expressing strains.	[Seo, Ho Seong; Seepersaud, Ravin; Sullam, Paul M.] Univ Calif San Francisco, Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Seo, Ho Seong; Seepersaud, Ravin; Sullam, Paul M.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Seo, Ho Seong] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup Si 580185, South Korea; [Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; Korea Atomic Energy Research Institute (KAERI); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University	Sullam, PM (corresponding author), Vet Affairs Med Ctr 111W, Div Infect Dis, 4150 Clement St, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu	Seo, Ho Seong/V-1806-2019	Seo, Ho Seong/0000-0002-7103-1344	United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057433, R01AI041513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001653] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Peter Hwang (University of California at San Francisco) for assistance with the SPR studies, Wendy Thomas (University of Washington) for valuable suggestions, and Jeannine Brady (University of Florida) and Craig Rubens (Seattle Children's Hospital) for providing GBS isolates. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817.	Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; BOLYARD MG, 1988, GENE, V66, P183, DOI 10.1016/0378-1119(88)90355-1; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Davies HD, 2004, J INFECT DIS, V189, P1097, DOI 10.1086/382087; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Devi AS, 2010, PROTEIN EXPRES PURIF, V74, P148, DOI 10.1016/j.pep.2010.07.004; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Dramsi S, 2012, MICROBES INFECT, V14, P1044, DOI 10.1016/j.micinf.2012.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Jonsson IM, 2005, J INFECT DIS, V192, P1456, DOI 10.1086/491478; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; LANCEFIELD RC, 1975, J EXP MED, V142, P165, DOI 10.1084/jem.142.1.165; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; LORD ST, 1985, DNA-J MOLEC CELL BIO, V4, P33, DOI 10.1089/dna.1985.4.33; Lord ST, 1996, BIOCHEMISTRY-US, V35, P2342, DOI 10.1021/bi952353u; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Matsuoka E, 2011, PROTEIN SCI, V20, P406, DOI 10.1002/pro.573; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierno M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028108; Pietrocola G, 2006, BIOCHEMISTRY-US, V45, P12840, DOI 10.1021/bi060696u; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Samen U, 2011, MICROBIOL-SGM, V157, P2319, DOI 10.1099/mic.0.044933-0; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Seo HS, 2011, INFECT IMMUN, V79, P3518, DOI 10.1128/IAI.05088-11; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Sunkara B, 2012, INT J INFECT DIS, V16, pE182, DOI 10.1016/j.ijid.2011.11.008; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tazi A, 2012, CURR OPIN MICROBIOL, V15, P44, DOI 10.1016/j.mib.2011.12.002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; WESSELS MR, 1992, INFECT IMMUN, V60, P392, DOI 10.1128/IAI.60.2.392-400.1992; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Xiang H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002751; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004	72	59	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35982	35996		10.1074/jbc.M113.513358	http://dx.doi.org/10.1074/jbc.M113.513358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165132	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000329814700034
J	Gallo-Ebert, C; Donigan, M; Liu, HY; Pascual, F; Manners, M; Pandya, D; Swanson, R; Gallagher, D; Chen, WW; Carman, GM; Nickels, JT				Gallo-Ebert, Christina; Donigan, Melissa; Liu, Hsing-Yin; Pascual, Florencia; Manners, Melissa; Pandya, Devanshi; Swanson, Robert; Gallagher, Denise; Chen, WeiWei; Carman, George M.; Nickels, Joseph T., Jr.			The Yeast Anaerobic Response Element AR1(b) Regulates Aerobic Antifungal Drug-dependent Sterol Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Lipids; Sterol; Transcription; Yeast; Aerobic; Anaerobic; Azole; Lipid; Promoter	PHOSPHATIDATE PHOSPHATASE ENZYME; SQUALENE SYNTHASE GENE; COENZYME-A REDUCTASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; CANDIDA-ALBICANS; FLUCONAZOLE RESISTANCE; SENSING DOMAIN; MANNOPROTEIN GENES; LIPIN HOMOLOG	Background:Saccharomyces cerevisiae sterol gene expression is regulated by a consensus sterol-response promoter element (SRE/AR1(c)). Results: The anaerobic AR1(b) promoter element regulates global antifungal-dependent sterol gene expression. Conclusion: Yeast sterol gene expression is regulated by multiple SRE-like elements. Significance: Understanding sterol gene expression will yield valuable information concerning antifungal drug resistance. Saccharomyces cerevisiae ergosterol biosynthesis, like cholesterol biosynthesis in mammals, is regulated at the transcriptional level by a sterol feedback mechanism. Yeast studies defined a 7-bp consensus sterol-response element (SRE) common to genes involved in sterol biosynthesis and two transcription factors, Upc2 and Ecm22, which direct transcription of sterol biosynthetic genes. The 7-bp consensus SRE is identical to the anaerobic response element, AR1(c). Data indicate that Upc2 and Ecm22 function through binding to this SRE site. We now show that it is two novel anaerobic AR1(b) elements in the UPC2 promoter that direct global ERG gene expression in response to a block in de novo ergosterol biosynthesis, brought about by antifungal drug treatment. The AR1(b) elements are absolutely required for auto-induction of UPC2 gene expression and protein and require Upc2 and Ecm22 for function. We further demonstrate the direct binding of recombinant expressed S. cerevisiae ScUpc2 and pathogenic Candida albicans CaUpc2 and Candida glabrata CgUpc2 to AR1(b) and SRE/AR1(c) elements. Recombinant endogenous promoter studies show that the UPC2 anaerobic AR1(b) elements act in trans to regulate ergosterol gene expression. Our results indicate that Upc2 must occupy UPC2 AR1(b) elements in order for ERG gene expression induction to take place. Thus, the two UPC2-AR1(b) elements drive expression of all ERG genes necessary for maintaining normal antifungal susceptibility, as wild type cells lacking these elements have increased susceptibility to azole antifungal drugs. Therefore, targeting these specific sites for antifungal therapy represents a novel approach to treat systemic fungal infections.	[Gallo-Ebert, Christina; Donigan, Melissa; Liu, Hsing-Yin; Pandya, Devanshi; Chen, WeiWei; Nickels, Joseph T., Jr.] Inst Metab Disorders, Genesis Biotechnol Grp, Hamilton, NJ 08691 USA; [Pascual, Florencia; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Pascual, Florencia; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Manners, Melissa; Swanson, Robert; Gallagher, Denise] Venenum Biodesign, Genesis Biotechnol Grp, Hamilton, NJ 08690 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Nickels, JT (corresponding author), Inst Metab Disorders LLC, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Gallo-Ebert, Christina/0000-0003-0985-3547	National Institutes of Health from USPHS [HL67401, GM28140]; American Heart Association [0615426U]; Genesis Biotechnology Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; American Heart Association(American Heart Association); Genesis Biotechnology Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67401 (to J. T. N.) and GM28140 (to G. M. C.) from USPHS. This work was also supported by American Heart Association Predoctoral Grant 0615426U (to C. G.-E.) and the Genesis Biotechnology Group.	Abramova NE, 2001, GENETICS, V157, P1169; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carman GM, 2007, METHOD ENZYMOL, V434, P305, DOI 10.1016/S0076-6879(07)34017-2; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; Costa M, 2001, THROMB HAEMOSTASIS, V86, P672, DOI 10.1055/s-0037-1616103; Crowley JH, 1998, J BACTERIOL, V180, P4177, DOI 10.1128/JB.180.16.4177-4183.1998; Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Dimster-Denk D, 1999, J LIPID RES, V40, P850; DimsterDenk D, 1996, MOL CELL BIOL, V16, P3981; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Fu LY, 2009, J HYPERTENS, V27, P991, DOI 10.1097/HJH.0b013e3283294bec; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Germann M, 2005, J BIOL CHEM, V280, P35904, DOI 10.1074/jbc.M504978200; Guan GM, 1997, J BIOL CHEM, V272, P10295; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hach A, 1999, MOL CELL BIOL, V19, P4324; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Harendza S, 2009, CELL MOL BIOL LETT, V14, P679, DOI 10.2478/s11658-009-0026-0; Heilmann CJ, 2010, ANTIMICROB AGENTS CH, V54, P353, DOI 10.1128/AAC.01102-09; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Hoot SJ, 2010, EUKARYOT CELL, V9, P1354, DOI 10.1128/EC.00130-10; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; Kennedy MA, 1999, BBA-GENE STRUCT EXPR, V1445, P110, DOI 10.1016/S0167-4781(99)00035-4; Leber R, 2001, EUR J BIOCHEM, V268, P914, DOI 10.1046/j.1432-1327.2001.01940.x; Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Marie C, 2008, FUNGAL GENET BIOL, V45, P1430, DOI 10.1016/j.fgb.2008.07.004; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Nagi M, 2011, GENES CELLS, V16, P80, DOI 10.1111/j.1365-2443.2010.01470.x; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OSBORNE TF, 1991, J BIOL CHEM, V266, P13947; Pam VK, 2012, INT J MOL EPIDEMIOL, V3, P84; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Samaranayake YH, 2013, J MED MICROBIOL, V62, P303, DOI 10.1099/jmm.0.044123-0; Sasse C, 2012, MOL MICROBIOL, V86, P539, DOI 10.1111/j.1365-2958.2012.08210.x; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Shen Yin-zhong, 2010, Zhonghua Nei Ke Za Zhi, V49, P245; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Smith SJ, 1996, MOL CELL BIOL, V16, P5427; STARR PR, 1962, J BACTERIOL, V83, P1042, DOI 10.1128/JB.83.5.1042-1046.1962; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399	69	8	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35466	35477		10.1074/jbc.M113.526087	http://dx.doi.org/10.1074/jbc.M113.526087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163365	hybrid, Green Published			2022-12-25	WOS:000329867600042
J	Rohman, A; van Oosterwijk, N; Thunnissen, AMWH; Dijkstra, BW				Rohman, Ali; van Oosterwijk, Niels; Thunnissen, Andy-Mark W. H.; Dijkstra, Bauke W.			Crystal Structure and Site-directed Mutagenesis of 3-Ketosteroid Delta(1)-Dehydrogenase from Rhodococcus erythropolis SQ1 Explain Its Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Metabolism; Crystal Structure; Dehydrogenase; Enzyme Mechanisms; Flavoproteins; Mycobacterium tuberculosis; 3-Ketosteroid; Rhodococcus erythropolis; Rossmann Fold	GENE; 3-KETOSTEROID-DELTA-1-DEHYDROGENASE; STEROIDS; RING	Background: 3-Ketosteroid (1)-dehydrogenases catalyze the 1,2-desaturation of 3-ketosteroids. Results: First structures of the enzyme from Rhodococcus erythropolis SQ1, combined with site-directed mutagenesis, clarify its catalytic mechanism. Conclusion: Tyr(487) and Gly(491) promote keto-enol tautomerization, whereas Tyr(318)/Tyr(119) and FAD abstract a proton and hydride ion, respectively. Significance: This study is an important step toward tailoring the enzyme for steroid biotransformation applications. 3-Ketosteroid (1)-dehydrogenases are FAD-dependent enzymes that catalyze the 1,2-desaturation of 3-ketosteroid substrates to initiate degradation of the steroid nucleus. Here we report the 2.0 resolution crystal structure of the 56-kDa enzyme from Rhodococcus erythropolis SQ1 ((1)-KSTD1). The enzyme contains two domains: an FAD-binding domain and a catalytic domain, between which the active site is situated as evidenced by the 2.3 resolution structure of (1)-KSTD1 in complex with the reaction product 1,4-androstadiene-3,17-dione. The active site contains four key residues: Tyr(119), Tyr(318), Tyr(487), and Gly(491). Modeling of the substrate 4-androstene-3,17-dione at the position of the product revealed its interactions with these residues and the FAD. The C1 and C2 atoms of the substrate are at reaction distance to the N5 atom of the isoalloxazine ring of FAD and the hydroxyl group of Tyr(318), respectively, whereas the C3 carbonyl group is at hydrogen bonding distance from the hydroxyl group of Tyr(487) and the backbone amide of Gly(491). Site-directed mutagenesis of the tyrosines to phenylalanines confirmed their importance for catalysis. The structural features and the kinetic properties of the mutants suggest a catalytic mechanism in which Tyr(487) and Gly(491) work in tandem to promote keto-enol tautomerization and increase the acidity of the C2 hydrogen atoms of the substrate. With assistance of Tyr(119), the general base Tyr(318) abstracts the axial -hydrogen from C2 as a proton, whereas the FAD accepts the axial -hydrogen from the C1 atom of the substrate as a hydride ion.	[Rohman, Ali] Airlangga Univ, Dept Chem, Fac Sci & Technol, Surabaya 60115, Indonesia; [Rohman, Ali] Airlangga Univ, Inst Trop Dis, Surabaya 60115, Indonesia; [Rohman, Ali; van Oosterwijk, Niels; Thunnissen, Andy-Mark W. H.; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands	Airlangga University; Airlangga University; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Rohman, Ali/GWV-1736-2022; Dijkstra, Bauke W./H-4308-2019; Thunnissen, Andy-Mark/A-1777-2010	Dijkstra, Bauke W./0000-0001-9731-6586; Thunnissen, Andy-Mark/0000-0002-1915-9850; Rohman, Ali/0000-0002-8177-5881	Directorate General of Higher Education; Ministry of Education and Culture, Republic of Indonesia; Ministry of Research and Technology, Republic of Indonesia	Directorate General of Higher Education; Ministry of Education and Culture, Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Research and Technology, Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Recipient of a scholarship from the Directorate General of Higher Education, the Ministry of Education and Culture, Republic of Indonesia, and a research assistance grant from the Ministry of Research and Technology, Republic of Indonesia.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brzezinska M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-43; Donova MV, 2007, APPL BIOCHEM MICRO+, V43, P1, DOI 10.1134/S0003683807010012; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujii C, 1999, J BIOCHEM-TOKYO, V126, P662, DOI 10.1093/oxfordjournals.jbchem.a022500; GALE PH, 1962, BIOCHEMISTRY-US, V1, P788, DOI 10.1021/bi00911a010; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; HAYANO M, 1961, BIOCHEM BIOPH RES CO, V4, P454, DOI 10.1016/0006-291X(61)90307-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P2139, DOI 10.1128/AEM.69.4.2139-2152.2003; ITAGAKI E, 1990, J BIOCHEM-TOKYO, V108, P122, DOI 10.1093/oxfordjournals.jbchem.a123150; ITAGAKI E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P60, DOI 10.1016/0167-4838(90)90010-D; JERUSSI ROBERT, 1965, BIOCHEMISTRY, V4, P2113, DOI 10.1021/bi00886a028; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; LEVY HR, 1959, J BIOL CHEM, V234, P2014; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; MATSUSHITA H, 1992, J BIOCHEM-TOKYO, V111, P594, DOI 10.1093/oxfordjournals.jbchem.a123803; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RINGOLD HJ, 1963, J BIOL CHEM, V238, P1960; Rohman A, 2012, ACTA CRYSTALLOGR F, V68, P551, DOI 10.1107/S1744309112011025; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Oosterwijk N, 2012, J BIOL CHEM, V287, P30975, DOI 10.1074/jbc.M112.374306; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOVCHA MG, 1979, BIOCHIM BIOPHYS ACTA, V574, P471, DOI 10.1016/0005-2760(79)90243-1	38	39	42	0	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35559	35568		10.1074/jbc.M113.522771	http://dx.doi.org/10.1074/jbc.M113.522771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165124	hybrid, Green Published			2022-12-25	WOS:000329867600050
J	Halbert, KMK; Goetze, E; Carlon, DB				Halbert, Kristin M. K.; Goetze, Erica; Carlon, David B.			High Cryptic Diversity across the Global Range of the Migratory Planktonic Copepods Pleuromamma piseki and P. gracilis	PLOS ONE			English	Article							INTEGUMENTAL PORE SIGNATURES; GENUS PLEUROMAMMA; ESTUARINE COPEPOD; SPECIES COMPLEX; PHYLOGEOGRAPHY; MITOCHONDRIAL; ZOOPLANKTON; SPECIATION; ATLANTIC; BIODIVERSITY	Although holoplankton are ocean drifters and exhibit high dispersal potential, a number of studies on single species are finding highly divergent genetic clades. These cryptic species complexes are important to discover and describe, as identification of common marine species is fundamental to understanding ecosystem dynamics. Here we investigate the global diversity within Pleuromamma piseki and P. gracilis, two dominant members of the migratory zooplankton assemblage in subtropical and tropical waters worldwide. Using DNA sequence data from the mitochondrial gene cytochrome c oxidase subunit II (mtCOII) from 522 specimens collected across the Pacific, Atlantic and Indian Oceans, we discover twelve well-resolved genetically distinct clades in this species complex (Bayesian posterior probabilities >0.7; 6.3-17% genetic divergence between clades). The morphologically described species P. piseki and P. gracilis did not form monophyletic groups, rather they were distributed throughout the phylogeny and sometimes co-occurred within well-resolved clades: this result suggests that morphological characters currently used for taxonomic identification of P. gracilis and P. piseki may be inaccurate as indicators of species' boundaries. Cryptic clades within the species complex ranged from being common to rare, and from cosmopolitan to highly restricted in distribution across the global ocean. These novel lineages appear to be ecologically divergent, with distinct biogeographic distributions across varied pelagic habitats. We hypothesize that these mtDNA lineages are distinct species and suggest that resolving their systematic status is important, given the ecological significance of the genus Pleuromamma in subtropical-tropical waters worldwide.	[Halbert, Kristin M. K.; Goetze, Erica] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Halbert, Kristin M. K.; Carlon, David B.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Goetze, E (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA.	egoetze@hawaii.edu			National Science Foundation [OCE-1029478]; Waitt Foundation - National Geographic grant [W119-10]; Division Of Ocean Sciences [1029478] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Waitt Foundation - National Geographic grant; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation grant OCE-1029478 and a Waitt Foundation - National Geographic grant (W119-10) to E. Goetze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairi H, 2001, DEEP-SEA RES PT II, V48, P2083, DOI 10.1016/S0967-0645(00)00174-0; AMBLER JW, 1987, MAR BIOL, V94, P561, DOI 10.1007/BF00431403; Andrews KR, MOL ECOLOGY; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BENNETT JL, 1989, CONTRIB MAR SCI, V31, P119; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Bradford-Grieve JM, 1999, NIWA BIODIVERS MEM, P39; Brinton E., 1962, Bulletin Scripps Institution of Oceanography, V8, P51; Bucklin A, 2000, ICES J MAR SCI, V57, P1592, DOI 10.1006/jmsc.2000.0957; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; BUSKEY EJ, 1989, MAR ECOL PROG SER, V55, P207, DOI 10.3354/meps055207; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Chen G, 2008, MOL ECOL, V17, P1451, DOI 10.1111/j.1365-294X.2007.03657.x; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Claus C, 1863, FREILEBENDEN COPEPOD, DOI [10.5962/bhl.title.58676, DOI 10.5962/BHL.TITLE.58676]; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; DiBattista JD, 2012, J HERED, V103, P617, DOI 10.1093/jhered/ess056; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farran GP, 1929, 1910 NATURAL HIST RE, P203; Farran GP., 1936, SCI REPORTS GREAT BA, V5, P73; Ferrari FD, 1984, CRUSTACEANA S, V7, P166; Ferrari Frank D., 1998, Plankton Biology and Ecology, V45, P203; Frost B., 1968, Bulletin Scripps Institution of Oceanography Technical Series, V12, P1; Goetze E, 2005, PROG OCEANOGR, V65, P55, DOI 10.1016/j.pocean.2005.02.015; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Goetze E, 2010, DEEP-SEA RES PT II, V57, P2110, DOI 10.1016/j.dsr2.2010.09.014; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Halbert KMK, 2013, GENETIC ISOLATION OP; HAURY LR, 1988, HYDROBIOLOGIA, V167, P335, DOI 10.1007/BF00026322; Hays GC, 2001, DEEP-SEA RES PT II, V48, P1063, DOI 10.1016/S0967-0645(00)00109-0; Hays GC, 1997, MAR ECOL PROG SER, V160, P57, DOI 10.3354/meps160057; HAYWARD TL, 1981, LIMNOL OCEANOGR, V26, P374, DOI 10.4319/lo.1981.26.2.0374; HAYWARD TL, 1980, MAR BIOL, V58, P295, DOI 10.1007/BF00390778; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarman SN, 2002, HEREDITY, V88, P280, DOI 10.1038/sj.hdy.6800041; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Landry MR, 2001, DEEP-SEA RES PT II, V48, P2037, DOI 10.1016/S0967-0645(00)00172-7; Lang BT, 1965, TAXONOMIC REV GEOGRA, Vxvi; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Maas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053889; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Marletaz F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r94; Marrone F, 2013, MOL PHYLOGENET EVOL, V66, P190, DOI 10.1016/j.ympev.2012.09.016; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Milligan PJ, 2011, HYDROBIOLOGIA, V666, P155, DOI 10.1007/s10750-010-0097-y; Miyamoto H, 2012, PROG OCEANOGR, V104, P99, DOI 10.1016/j.pocean.2012.06.003; Miyamoto H, 2010, DEEP-SEA RES PT II, V57, P2211, DOI 10.1016/j.dsr2.2010.09.023; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Park JS, 1996, J NAT HIST, V30, P1007, DOI 10.1080/00222939600770541; PARK JS, 1995, J MAR BIOL ASSOC UK, V75, P211, DOI 10.1017/S0025315400015319; PARK JS, 1994, MAR BIOL, V120, P107; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2005, MAR BIOL, V147, P1279, DOI 10.1007/s00227-005-0041-2; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Pritchard VL, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-54; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; ROE HSJ, 1972, J MAR BIOL ASSOC UK, V52, P525, DOI 10.1017/S0025315400021573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Schmaus PH, 1927, WISSENSCHAFTLICHE ER, V1898-1899, P355; SchneiderBroussard R, 1997, MOL BIOL EVOL, V14, P156, DOI 10.1093/oxfordjournals.molbev.a025748; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinberg DK, 2000, DEEP-SEA RES PT I, V47, P137, DOI 10.1016/S0967-0637(99)00052-7; Steuer A., 1932, Wissenschaftliche Ergebnisse der Deutschen Tiefsee Expedition Jena, V24, P1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vervoort W., 1949, Temminckia Leiden, V8, P1; Weiner A, 2012, MOL ECOL, V21, P4063, DOI 10.1111/j.1365-294X.2012.05686.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648; Yebra L, 2011, MAR ECOL PROG SER, V428, P135, DOI 10.3354/meps09056	91	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77011	10.1371/journal.pone.0077011	http://dx.doi.org/10.1371/journal.pone.0077011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167556	gold, Green Submitted, Green Published			2022-12-25	WOS:000326034500015
J	Alcaraz, ML; Hormaza, JI; Rodrigo, J				Librada Alcaraz, Maria; Ignacio Hormaza, Jose; Rodrigo, Javier			Pistil Starch Reserves at Anthesis Correlate with Final Flower Fate in Avocado (Persea americana)	PLOS ONE			English	Article							APRICOT PRUNUS-ARMENIACA; POLLEN-TUBE GROWTH; VITIS-VINIFERA L.; FRUIT-SET; CARBOHYDRATE AVAILABILITY; OUTCROSSING RATE; HASS AVOCADO; HERMAPHRODITIC PLANTS; ABSCISSION; CITRUS	A common observation in different plant species is a massive abscission of flowers and fruitlets even after adequate pollination, but little is known as to the reason for this drop. Previous research has shown the importance of nutritive reserves accumulated in the flower on fertilization success and initial fruit development but direct evidence has been elusive. Avocado (Persea americana) is an extreme case of a species with a very low fruit to flower ratio. In this work, the implications of starch content in the avocado flower on the subsequent fruit set are explored. Firstly, starch content in individual ovaries was analysed from two populations of flowers with a different fruit set capacity showing that the flowers from the population that resulted in a higher percentage of fruit set contained significantly more starch. Secondly, in a different set of flowers, the style of each flower was excised one day after pollination, once the pollen tubes had reached the base of the style, and individually fixed for starch content analysis under the microscope once the fate of its corresponding ovary (that remained in the tree) was known. A high variability in starch content in the style was found among flowers, with some flowers having starch content up to 1,000 times higher than others, and the flowers that successfully developed into fruits presented significantly higher starch content in the style at anthesis than those that abscised. The relationship between starch content in the ovary and the capacity of set of the flower together with the correlation found between the starch content in the style and the fate of the ovary support the hypothesis that the carbohydrate reserves accumulated in the flower at anthesis are related to subsequent abscission or retention of the developing fruit.	[Librada Alcaraz, Maria; Ignacio Hormaza, Jose] Univ Malaga, Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Estac Expt La Mayora, E-29071 Malaga, Spain; [Rodrigo, Javier] Ctr Invest & Tecnol Agroalimentaria Aragon CITA, Unidad Fruticultura, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Hormaza, JI (corresponding author), Univ Malaga, Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Estac Expt La Mayora, E-29071 Malaga, Spain.	ihormaza@eelm.csic.es	Rodrigo, Javier/H-6383-2011; Hormaza, Jose/D-8066-2011	Rodrigo, Javier/0000-0002-8321-1764; Hormaza, Jose/0000-0001-5449-7444	Ministerio de Economia y Competitividad - European Regional Development Fund; European Union [AGL2010-15140]; Junta de Andalucia [FEDER P08-AGR-3694]; Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43)	Ministerio de Economia y Competitividad - European Regional Development Fund; European Union(European Commission); Junta de Andalucia(Junta de Andalucia); Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43)	This work was supported by Ministerio de Economia y Competitividad - European Regional Development Fund, European Union (AGL2010-15140), Junta de Andalucia (FEDER P08-AGR-3694) and Gobierno de Aragon - European Social Fund, European Union (Grupo de Investigacion de Aragon A-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO S, 1981, J JPN SOC HORTIC SCI, V50, P1, DOI 10.2503/jjshs.50.1; Alcaraz ML, 2011, ANN APPL BIOL, V158, P354, DOI 10.1111/j.1744-7348.2011.00469.x; Alcaraz ML, 2009, SCI HORTIC-AMSTERDAM, V121, P267, DOI 10.1016/j.scienta.2009.02.001; Alcaraz ML, 2010, PHYSIOL PLANTARUM, V140, P395, DOI 10.1111/j.1399-3054.2010.01410.x; Aloni B, 1996, ANN BOT-LONDON, V78, P163, DOI 10.1006/anbo.1996.0109; ALONI B, 1991, ANN BOT-LONDON, V67, P371, DOI 10.1093/oxfordjournals.aob.a088170; ARBELOA A, 1991, NEW PHYTOL, V118, P527, DOI 10.1111/j.1469-8137.1991.tb00992.x; AYRE DJ, 1989, TRENDS ECOL EVOL, V4, P267, DOI 10.1016/0169-5347(89)90197-3; Bennett J., 2002, AUSTR NZ GRAPEGROWER, V456, P70; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHARLESWORTH D, 1989, NATURE, V338, P21, DOI 10.1038/338021a0; Clement C, 1996, AM J BOT, V83, P459, DOI 10.2307/2446215; Davenport T. L., 1986, Horticultural Reviews, V8, P257, DOI 10.1002/9781118060810.ch7; Davie S. J., 1995, Yearbook - South African Avocado Growers' Association, V18, P51; Degani C, 1997, J AM SOC HORTIC SCI, V122, P813, DOI 10.21273/JASHS.122.6.813; DEGANI C, 1989, J AM SOC HORTIC SCI, V114, P106; Duchene E, 2003, J INT SCI VIGNE VIN, V37, P39; FALQUE M, 1995, SEX PLANT REPROD, V8, P354, DOI 10.1007/BF00243203; FINAZZO SF, 1994, TREE PHYSIOL, V14, P153, DOI 10.1093/treephys/14.2.153; GARCIALUIS A, 1988, ISRAEL J BOT, V37, P189; Garner LC, 2008, J AM SOC HORTIC SCI, V133, P648, DOI 10.21273/JASHS.133.5.648; Garner LC, 2008, J AM SOC HORTIC SCI, V133, P3, DOI 10.21273/JASHS.133.1.3; GRIGGS W. H., 1941, PROC AMER SOC HORT SCI, V38, P89; HERRERO M, 1979, J CELL SCI, V36, P1; HO LC, 1988, ANNU REV PLANT PHYS, V39, P355, DOI 10.1146/annurev.arplant.39.1.355; Iglesias DJ, 2003, TREE PHYSIOL, V23, P199, DOI 10.1093/treephys/23.3.199; Jean D, 2001, PHYSIOL PLANTARUM, V112, P379, DOI 10.1034/j.1399-3054.2001.1120311.x; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Julian C, 2011, ANN BOT-LONDON, V108, P617, DOI 10.1093/aob/mcr056; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lahav E, 1971, J AM SOC HORTIC SCI, V96, P393; Lebon G, 2008, J EXP BOT, V59, P2565, DOI 10.1093/jxb/ern135; Lebon G, 2004, SEX PLANT REPROD, V17, P71, DOI 10.1007/s00497-004-0217-9; LINSKENS HF, 1957, NATURWISSENSCHAFTEN, V44, P16, DOI 10.1007/BF00629340; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; Nirody BS, 1922, CALIFORNIA AVOCADO A, V7, P65; NOEL ARA, 1970, BOT REV, V36, P162, DOI 10.1007/BF02858959; Oliveira C. M., 1988, Horticultural Reviews, V10, P403, DOI 10.1002/9781118060834.ch10; RACKHAM R. L., 1966, California Citrograph, V51, P408; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rodrigo J, 1998, SEX PLANT REPROD, V11, P86, DOI 10.1007/s004970050124; Rodrigo J, 1997, PHYSIOL PLANTARUM, V99, P105, DOI 10.1034/j.1399-3054.1997.990115.x; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Rodrigo J, 2002, J APPL BOT-ANGEW BOT, V76, P13; Rodrigo J, 2009, ANN APPL BIOL, V154, P365, DOI 10.1111/j.1744-7348.2008.00305.x; Ruiz R, 2001, ANN BOT-LONDON, V87, P805, DOI 10.1006/anbo.2001.1415; SCHOLEFIELD PB, 1985, SCI HORTIC-AMSTERDAM, V25, P99, DOI 10.1016/0304-4238(85)90081-0; SEDGLEY M, 1979, ANN BOT-LONDON, V44, P353, DOI 10.1093/oxfordjournals.aob.a085739; SEDGLEY M, 1980, ANN BOT-LONDON, V46, P771, DOI 10.1093/oxfordjournals.aob.a085974; SEDGLEY M, 1977, J HORTIC SCI, V52, P135, DOI 10.1080/00221589.1977.11514739; SEDGLEY M, 1981, SCI HORTIC-AMSTERDAM, V14, P27, DOI 10.1016/0304-4238(81)90075-3; SHIMIZU T, 1978, J JPN SOC HORTIC SCI, V46, P465, DOI 10.2503/jjshs.46.465; Silber A, 2012, AGR WATER MANAGE, V104, P95, DOI 10.1016/j.agwat.2011.12.003; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stout AB, 1923, CALIF AVOC ASS ANN R, V8, P29; SUTHERLAND S, 1987, EVOLUTION, V41, P750, DOI 10.1111/j.1558-5646.1987.tb05850.x; SUTHERLAND S, 1984, ECOLOGY, V65, P1093, DOI 10.2307/1938317; Syvertsen J.P., 1994, HDB ENV PHYSL FRUIT, P65; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; WILLIAMS RR, 1965, J HORTIC SCI BIOTECH, V40, P31, DOI 10.1080/00221589.1965.11514118; WOLSTENHOLME BN, 1990, SCI HORTIC-AMSTERDAM, V41, P315, DOI 10.1016/0304-4238(90)90112-R	62	25	25	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78467	10.1371/journal.pone.0078467	http://dx.doi.org/10.1371/journal.pone.0078467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167627	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500088
J	Word, DP; Young, JK; Cummings, DAT; Iamsirithaworn, S; Laird, CD				Word, Daniel P.; Young, James K.; Cummings, Derek A. T.; Iamsirithaworn, Sopon; Laird, Carl D.			Interior-Point Methods for Estimating Seasonal Parameters in Discrete-Time Infectious Disease Models	PLOS ONE			English	Article							MEASLES EPIDEMICS; LINE-SEARCH; TRANSMISSION; DYNAMICS; INFERENCE; ALGORITHM; RATES; NOISE	Infectious diseases remain a significant health concern around the world. Mathematical modeling of these diseases can help us understand their dynamics and develop more effective control strategies. In this work, we show the capabilities of interior-point methods and nonlinear programming (NLP) formulations to efficiently estimate parameters in multiple discrete-time disease models using measles case count data from three cities. These models include multiplicative measurement noise and incorporate seasonality into multiple model parameters. Our results show that nearly identical patterns are estimated even when assuming seasonality in different model parameters, and that these patterns show strong correlation to school term holidays across very different social settings and holiday schedules. We show that interior-point methods provide a fast and flexible approach to parameterizing models that can be an alternative to more computationally intensive methods.	[Word, Daniel P.; Young, James K.; Laird, Carl D.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Iamsirithaworn, Sopon] Minist Publ Hlth, Bur Epidemiol, Bangkok, Thailand	Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ministry of Public Health - Thailand	Laird, CD (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	carl.laird@tamu.edu			U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; Scientic Interface from the Burroughs Wellcome Fund; NIH MIDAS Center of Excellence grant; National Science Foundation [5 R01 GM 090204]	U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); Scientic Interface from the Burroughs Wellcome Fund; NIH MIDAS Center of Excellence grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge nancial support provided by Sandia National Laboratories and the Oce of Advanced Scientic Computing Research within the DOE Oce of Science as part of the Applied Mathematics program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. Derek Cummings holds a Career Award at the Scientic Interface from the Burroughs Wellcome Fund. DATC and DSB were funded by a NIH MIDAS Center of Excellence grant. DATC also received funding from the National Science Foundation (5 R01 GM 090204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1999, EPIDEMIC MODELLING I; [Anonymous], BUR EP ANN EP SURV R; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Byrd RH, 2006, NONCONVEX OPTIM, V83, P35; Byrd RH, 1999, SIAM J OPTIMIZ, V9, P877, DOI 10.1137/S1052623497325107; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2002, BIOSTATISTICS, V3, P493, DOI 10.1093/biostatistics/3.4.493; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Fourer R., 1993, AMPL MODELING LANGUA; Gomes MC, 1999, EUR J EPIDEMIOL, V15, P791, DOI 10.1023/A:1007615513441; Gould NIM, 2004, RALTR2004032; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Hart W.E., 2012, PYOMO OPTIMIZATION M, V67, DOI [10.1007/978-1-4614-3226-5, DOI 10.1007/978-1-4614-3226-5]; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hethcote H, 1994, FRONTIERS MATH BIOL, V1; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hooker G, 2010, J ROYAL SOC INTERFAC; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1997, TRENDS MICROBIOL, V5, P513, DOI 10.1016/S0966-842X(97)01147-5; Laird C, 2006, P INT C HIGH PERF CO; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; MOLLISON D, 1993, MATH BIOSCI, V117, P155, DOI 10.1016/0025-5564(93)90021-2; Rooney WC, 2001, AICHE J, V47, P1794, DOI 10.1002/aic.690470811; Rosenthal RE, 2012, GAMS USERS GUIDE; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wachter A, 2002, THESIS CARNEGIE MELL; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Word DP, 2012, J R SOC INTERFACE, V9, P1983, DOI 10.1098/rsif.2011.0829; Word DP, 2010, P AMER CONTR CONF, P5137; YORKE JA, 1973, AM J EPIDEMIOL, V98, P469, DOI 10.1093/oxfordjournals.aje.a121576	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e74208	10.1371/journal.pone.0074208	http://dx.doi.org/10.1371/journal.pone.0074208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167542	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500001
J	Hu, SX; Sheng, WS; Rock, RB				Hu, Shuxian; Sheng, Wen S.; Rock, R. Bryan			CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; NEUROTROPHIC FACTOR PREVENTS; NECROSIS-FACTOR-ALPHA; 2ND CONSTANT DOMAIN; BLOOD-BRAIN-BARRIER; VIRUS TYPE-1 GP120; NIGRA IN-VIVO; OXIDATIVE STRESS; NADPH OXIDASE	Despite the therapeutic impact of anti-retroviral therapy, HIV-1-associated neurocognitive disorder (HAND) remains a serious threat to AIDS patients, and there currently remains no specific therapy for the neurological manifestations of HIV-1. Recent work suggests that the nigrostriatal dopaminergic area is a critical brain region for the neuronal dysfunction and death seen in HAND and that human dopaminergic neurons have a particular sensitivity to gp120-induced damage, manifested as reduced function (decreased dopamine uptake), morphological changes, and reduced viability. Synthetic cannabinoids inhibit HIV-1 expression in human microglia, suppress production of inflammatory mediators in human astrocytes, and there is substantial literature demonstrating the neuroprotective properties of cannabinoids in other neuropathogenic processes. Based on these data, experiments were designed to test the hypothesis that synthetic cannabinoids will protect dopaminergic neurons against the toxic effects of the HIV-1 protein gp120. Using a human mesencephalic neuronal/glial culture model, which contains dopaminergic neurons, microglia, and astrocytes, we were able to show that the CB1/CB2 agonist WIN55,212-2 blunts gp120-induced neuronal damage as measured by dopamine transporter function, apoptosis and lipid peroxidation; these actions were mediated principally by the CB2 receptor. Adding supplementary human microglia to our cultures enhances gp120-induced damage; WIN55,212-2 is able to alleviate this enhanced damage. Additionally, WIN55,212-2 inhibits gp120-induced superoxide production by purified human microglial cells, inhibits migration of human microglia towards supernatants generated from gp120-stimulated human mesencephalic neuronal/glial cultures and reduces chemokine and cytokine production from the human mesencephalic neuronal/glial cultures. These data suggest that synthetic cannabinoids are capable of protecting human dopaminergic neurons from gp120 in a variety of ways, acting principally through the CB2 receptors and microglia.	[Hu, Shuxian; Sheng, Wen S.; Rock, R. Bryan] Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res,Div Infec, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Rock, RB (corresponding author), Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res,Div Infec, Minneapolis, MN 55455 USA.	rockx012@umn.edu			U.S. Public Health Service [DA025525]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025525] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. Public Health Service grant DA025525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Aksenov MY, 2003, BRAIN RES, V987, P1, DOI 10.1016/S0006-8993(03)03194-9; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; AURIAULT C, 1983, FEBS LETT, V153, P11, DOI 10.1016/0014-5793(83)80109-4; AURIAULT C, 1985, INT J IMMUNOPHARMACO, V7, P73, DOI 10.1016/0192-0561(85)90011-6; AYLWARD EH, 1993, NEUROLOGY, V43, P2099, DOI 10.1212/WNL.43.10.2099; Bachis A, 2006, J NEUROSCI, V26, P6771, DOI 10.1523/JNEUROSCI.1054-06.2006; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Becker Y., 2006, VIRUS GENES; Bennett BA, 1995, BRAIN RES, V705, P168, DOI 10.1016/0006-8993(95)01166-8; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; CHAO CC, 1994, J PHARMACOL EXP THER, V269, P198; Chao CC, 1996, P NATL ACAD SCI USA, V93, P8051, DOI 10.1073/pnas.93.15.8051; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; CHAO CC, 1992, J CLIN INVEST, V90, P1786, DOI 10.1172/JCI116053; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Combadiere B, 2003, AIDS, V17, P1279, DOI 10.1097/00002030-200306130-00002; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Corasaniti MT, 2000, BIOCHEM BIOPH RES CO, V274, P664, DOI 10.1006/bbrc.2000.3160; Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x; Cotter R, 2002, J NEUROVIROL, V8, P585, DOI 10.1080/13550280290100950; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Czub S, 2004, ACTA NEUROPATHOL, V107, P216, DOI 10.1007/s00401-003-0801-3; D'Aversa TG, 2005, J NEUROSCI RES, V81, P436, DOI 10.1002/jnr.20486; DONG JF, 1993, NEUROSCIENCE, V56, P53, DOI 10.1016/0306-4522(93)90561-S; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Erichsen D, 2003, J NEUROIMMUNOL, V138, P144, DOI 10.1016/S0165-5728(03)00117-6; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Ferris MJ, 2009, SYNAPSE, V63, P181, DOI 10.1002/syn.20594; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; GENDELMAN HE, 2005, NEUROLOGY AIDS; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hu SX, 2006, J PHARMACOL EXP THER, V318, P1280, DOI 10.1124/jpet.106.103853; Hu SX, 2009, J NEUROVIROL, V15, P401, DOI 10.3109/13550280903296346; Hu SX, 2005, J INFECT DIS, V191, P886, DOI 10.1086/427830; Itoh K, 2000, ACTA NEUROPATHOL, V99, P376, DOI 10.1007/s004010051139; Jones MV, 2000, AIDS, V14, P2709, DOI 10.1097/00002030-200012010-00010; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim HJ, 2011, MOL PHARMACOL, V80, P357, DOI 10.1124/mol.111.071647; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Klein TW, 2006, J NEUROIMMUNE PHARM, V1, P50, DOI 10.1007/s11481-005-9007-x; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P767, DOI 10.1007/s007020200063; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P399, DOI 10.1007/s007020200032; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Mehla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-239; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Minghetti L, 2004, NEUROCHEM RES, V29, P965, DOI 10.1023/B:NERE.0000021241.90133.89; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010; Moldzio R, 2012, PHYTOMEDICINE, V19, P819, DOI 10.1016/j.phymed.2012.04.002; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Nosheny RL, 2007, EUR J NEUROSCI, V25, P2275, DOI 10.1111/j.1460-9568.2007.05506.x; Nosheny RL, 2006, J NEUROBIOL, V66, P1311, DOI 10.1002/neu.20288; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Paul RH, 2005, J NEUROPSYCH CLIN N, V17, P167, DOI 10.1176/appi.neuropsych.17.2.167; Peterson PK, 2004, J NEUROIMMUNOL, V147, P123, DOI 10.1016/j.jneuroim.2003.10.026; Pocernich CB, 2005, BRAIN RES REV, V50, P14, DOI 10.1016/j.brainresrev.2005.04.002; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Raborn ES, 2010, J PHARMACOL EXP THER, V333, P319, DOI 10.1124/jpet.109.163055; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rock RB, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-32; Rock RB, 2007, J NEUROIMMUNE PHARM, V2, P178, DOI 10.1007/s11481-006-9040-4; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Sardar AM, 1996, NEUROREPORT, V7, P910, DOI 10.1097/00001756-199603220-00015; Scheller C, 2005, J NEUROCHEM, V95, P377, DOI 10.1111/j.1471-4159.2005.03373.x; Sevigny JJ, 2007, ARCH NEUROL-CHICAGO, V64, P97, DOI 10.1001/archneur.64.1.97; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sheng WS, 2000, CLIN IMMUNOL, V96, P243, DOI 10.1006/clim.2000.4905; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; SILANI V, 1994, EXP NEUROL, V128, P59, DOI 10.1006/exnr.1994.1113; Silvers JM, 2006, J NEUROVIROL, V12, P140, DOI 10.1080/13550280600724319; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; THANOS S, 1993, J NEUROSCI, V13, P455; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; United Nations Program on HIV/AIDS (UNAIDS), 2011, WHO REP GLOB AIDS EP, P2011; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Weiss JM, 1998, J IMMUNOL, V161, P6896; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Williams R, 2010, GLIA, V58, P611, DOI 10.1002/glia.20949; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; Yang ZQ, 2007, TOXICOL SCI, V98, P488, DOI 10.1093/toxsci/kfm106; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yi YJ, 2004, J NEUROVIROL, V10, P91, DOI 10.1080/13550280490268313; Yoshida H, 2001, NEUROSCI LETT, V303, P132, DOI 10.1016/S0304-3940(01)01699-8; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	130	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77577	10.1371/journal.pone.0077577	http://dx.doi.org/10.1371/journal.pone.0077577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147028	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200048
J	Li, YH; Ding, WY; Wang, H; Song, NP; Lin, LY; Wang, ZH; Zhong, M; Zhang, Y; Zhang, W				Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei			Relationship of CHA(2)DS(2)-VASc and CHADS(2) Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; RISK STRATIFICATION; PREDICTING STROKE; RECOMMENDATIONS; DYSFUNCTION; ANTAGONIST; STRAIN; IMPACT; SIZE	Background: The CHADS(2)/CHA(2)DS(2)-VASc scores are used to predict thrombo-embolic/stroke in patients with nonvalvular atrial fibrillation (AF). Nevertheless, limited data are available regarding the association between these risk stratification for stroke and left atrial (LA) remodeling status of AF patients. The purpose of this study was to explore the association between these scores and LA remodeling status assessed quantificationally by echocardiography in AF patients. Methods: One hundred AF patients were divided into 3 groups based on the CHA(2)DS(2)-VASc/CHADS(2) score: the score of 0 (low stroke risk), the score of 1 (moderate stroke risk) and the score of >= 2 (high stroke risk). All patients were performed through conventional and velocity vector imaging echocardiography. Echocardiographic parameters: maximum LA volume index (LAVImax), LA total emptying fraction (LAEFt) and LA mean strain were obtained to assess quantificationally LA remodeling status. Results: On categorizing with CHA(2)DS(2)-VASc, the score of 1 group showed augment in LAVImax and attenuation in LA mean strain derived from VVI, compared with the score of 0 group (LAVImax: 40.27 +/- 21.91 vs. 26.79 +/- 7.87, p=0.002; LA mean strain: 15.18 +/- 6.36 vs. 22 +/- 8.54, p=0.001). On categorizing with the CHADS(2) score, similar trends were seen between the score of >= 2 and 1 groups (LAVImax: 43.72 +/- 13.77 vs. 31.41 +/- 9.50, p<0.001; LA mean strain: 11.01 +/- 5.31 vs. 18.63 +/- 7.00, p<0.001). With multivariate logistic regression, LAVImax (odds ratio: 0.92, 95% C=I: 0.85 to 0.98, p=0.01) and LA mean strain reflecting LA remodeling (odds ratio: 1.10, 95% CI: 1.02 to 1.19, p=0.01) were strongly predictive of the CHA(2)DS(2)-VASc score of 0. Conclusions: The superiority of the CHADS(2) score may lay in identifying LA remodeling of AF patients with high stroke risk. Whereas, the CHA(2)DS(2)-VASc score was better than the CHADS(2) score at identifying LA remodeling of AF patients presenting low stroke risk.	[Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Chinese Minist Hlth, Jinan, Peoples R China; [Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University	Zhang, W (corresponding author), Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China.	zhangweisduqilu@gmail.com			Key Technologies R & D Program of Shandong Province [2010G0020262]; Independent Innovation Foundation of Shandong University [2012JC034]; Natural Science Foundation of Shandong Province [ZR2009CM022, ZR2009CM025, Y2008C47]; National Natural Science Foundation of China [30971215, 81070192, 81070141, 81100605, 81270352, 81270287]; National Basic Research Program of China (973 Program) [2009CB521904]	Key Technologies R & D Program of Shandong Province; Independent Innovation Foundation of Shandong University; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the research grants from Key Technologies R & D Program of Shandong Province (2010G0020262), the Independent Innovation Foundation of Shandong University (2012JC034), the Natural Science Foundation of Shandong Province (ZR2009CM022, ZR2009CM025, Y2008C47), the National Natural Science Foundation of China (30971215, 81070192, 81070141, 81100605, 81270352 and 81270287), the National Basic Research Program of China (973 Program, grant number 2009CB521904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Dokainish H, 2010, J AM SOC ECHOCARDIOG, V23, P156, DOI 10.1016/j.echo.2009.11.015; Eshoo S, 2009, CIRC-CARDIOVASC IMAG, V2, P93, DOI 10.1161/CIRCIMAGING.108.793190; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; GUTMAN J, 1983, AM J CARDIOL, V51, P336, DOI 10.1016/S0002-9149(83)80061-7; Guyatt GH, 2012, CHEST, V141, p48S, DOI 10.1378/chest.11-2286; Harrell F, 2001, J AM STAT ASSOC, V98, P257; Jarnert C, 2008, EUR J HEART FAIL, V10, P1080, DOI 10.1016/j.ejheart.2008.08.012; Jurcut R, 2008, J AM SOC ECHOCARDIOG, V21, P879, DOI 10.1016/j.echo.2008.02.002; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Lang RM, J AM SOC ECHOCARDIOG, P1440; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; McManus DD, 2010, CIRCULATION, V121, P667, DOI 10.1161/CIRCULATIONAHA.109.885806; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Saha SK, 2011, J AM SOC ECHOCARDIOG, V24, P506, DOI 10.1016/j.echo.2011.02.012; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Stroke Prevention in Atrial Fibrillation Investigators, 1995, J Stroke Cerebrovasc Dis, V5, P147, DOI 10.1016/S1052-3057(10)80166-1; Tayyareci Y, 2010, CIRC J, V74, P2109, DOI 10.1253/circj.CJ-10-0197; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051204	32	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77653	10.1371/journal.pone.0077653	http://dx.doi.org/10.1371/journal.pone.0077653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147047	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200059
J	Lv, ZB; Zou, HC; Peng, KW; Wang, JM; Ding, Y; Li, YL; Ren, XL; Wang, FF; Chang, R; Liang, L; Ding, YQ				Lv, Zhenbing; Zou, Huichun; Peng, Kaiwen; Wang, Jianmei; Ding, Yi; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Chang, Rui; Liang, Li; Ding, Yanqing			The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; BREAST-CANCER CELLS; DOWN-REGULATION; COLORECTAL-CANCER; POOR-PROGNOSIS; GENE; FAMILY; CYCLE; HYPERMETHYLATION; DEMETHYLATION	Background: BTG3 (B-cell translocation gene 3) has been identified as a tumor suppressor and hypermethylation contributes to its down-regulation in some tumors, but its role in hepatocellular carcinoma (HCC) remain unknown. This study aimed to detect the expression and methylation status of BTG3 in HCC cell lines or tissues, and determine its function in HCC progression. Methodology: The expression of BTG3 was detected in HCC cell lines and HCC tissue by real-time RT-PCR, Western blot or immunohistochemistry. The promoter methylation status of BTG3 was measured by using methylation-specific PCR in HCC cell lines. A series of assays were performed to evaluate the effect of BTG3 on proliferation, invasion and cell cycle transition in vitro. Results: BTG3 expression was lower in HCC cell lines than in hepatocyte cell line LO2 (P<0.05). BTG3 was also down-regulated in HCC tissues. Its expression was positively correlated with differentiation and distant metastasis (P<0.05). Patients with lower BTG3 expression had shorter overall survival time (P=0.029). DNA methylation directed repression of BTG3 mRNA expression in HCC cell lines. BTG3 suppressed proliferation, invasion and induces G1/S cycle arrest of HCC cells in vitro. Conclusion: Down-regulation of BTG3 due to the promoter hypermethylation is closely associated with proliferation, invasion and cell cycle arrest of HCC cells. It may be a novel prognostic biomarker for HCC patients.	[Lv, Zhenbing; Wang, Jianmei; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Liang, Li; Ding, Yanqing] Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Jianmei; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Liang, Li; Ding, Yanqing] Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Lv, Zhenbing] Nanchong Cent Hosp, Dept Gen Surg, Nanchong City, Sichuan Provinc, Peoples R China; [Zou, Huichun; Peng, Kaiwen] Southern Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Ding, Yi] Southern Med Univ, Nanfang Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Chang, Rui] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liang, L (corresponding author), Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	redsnow007@hotmail.com; dyq@fimmu.com	Chang, Rui/ABC-2118-2021; liang, li/AAB-9126-2022; Wang, Jianmei/HHZ-0585-2022	Chang, Rui/0000-0001-5763-5371; 	National Natural Science Foundation of China [81272759, 81172382, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; Natural Science Foundation of Guangdong Province [S2012010009669]; Research Fund for Subject and Profession development of Higher Education of Guangdong Province [2012KJCX0026]; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province [2011J2200074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for Subject and Profession development of Higher Education of Guangdong Province; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province	This work was supported by the National Natural Science Foundation of China (81272759, 81172382, 81071735, http://www.nsfc.gov.cn); Major projects of National Natural Science Foundation of China (81090422, http://www.nsfc.gov.cn); Natural Science Foundation of Guangdong Province (S2012010009669, http://gdsf.gdstc.gov.cn/); Research Fund for Subject and Profession development of Higher Education of Guangdong Province (2012KJCX0026, http://202.116.224.16/website/index.jsp); Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province (2011J2200074, http://www.gzsi.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura E, 2005, WORLD J GASTROENTERO, V11, P5601, DOI 10.3748/wjg.v11.i36.5601; Bender CM, 1998, CANCER RES, V58, P95; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Cheng YC, 2013, P NATL ACAD SCI USA, V110, P5993, DOI 10.1073/pnas.1220635110; Deng B, 2013, TUMOUR BIOL; Dong WJ, 2009, BIOCHEM BIOPH RES CO, V387, P132, DOI 10.1016/j.bbrc.2009.06.140; Du J, 2013, ONCOL LETT, V5, P381, DOI 10.3892/ol.2012.974; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Jiang YF, 2000, WORLD J GASTROENTERO, V6, P61, DOI 10.3748/wjg.v6.i1.61; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Li KW, 2012, HEPATO-GASTROENTEROL, V59, P1944, DOI 10.5754/hge11845; Liang L, 2011, HUM PATHOL, V42, P1603, DOI 10.1016/j.humpath.2010.08.025; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lin SY, 2012, ONCOL LETT, V4, P981, DOI 10.3892/ol.2012.864; Lin TY, 2012, ONCOGENE, V31, P3287, DOI 10.1038/onc.2011.491; Macheiner D, 2006, J HEPATOL, V45, P81, DOI 10.1016/j.jhep.2005.12.017; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Majid S, 2009, CARCINOGENESIS, V30, P662, DOI 10.1093/carcin/bgp042; Matsubara N, 2012, DIS COLON RECTUM, V55, P96, DOI 10.1097/DCR.0b013e318233a1ef; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yamamoto N, 2001, BRIT J CANCER, V84, P754, DOI 10.1054/bjoc.2000.1656; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yu JW, 2008, GENE EXPRESSION, V14, P173; Zhang XJ, 2012, J GASTROEN HEPATOL, V27, P1117, DOI 10.1111/j.1440-1746.2011.07049.x; Zhang ZM, 2009, HEPATOB PANCREAT DIS, V8, P288	33	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77473	10.1371/journal.pone.0077473	http://dx.doi.org/10.1371/journal.pone.0077473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147003	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200038
J	Archibald, LMD; Cardy, JO; Joanisse, MF; Ansari, D				Archibald, Lisa M. D.; Cardy, Janis Oram; Joanisse, Marc F.; Ansari, Daniel			Language, Reading, and Math Learning Profiles in an Epidemiological Sample of School Age Children	PLOS ONE			English	Article							SHORT-TERM-MEMORY; DEVELOPMENTAL DYSLEXIA; SENTENCE COMPREHENSION; NONWORD REPETITION; GENETIC INFLUENCES; YOUNG-CHILDREN; IMPAIRMENT; SPEECH; DEFICIT; DIFFICULTIES	Dyscalculia, dyslexia, and specific language impairment (SLI) are relatively specific developmental learning disabilities in math, reading, and oral language, respectively, that occur in the context of average intellectual capacity and adequate environmental opportunities. Past research has been dominated by studies focused on single impairments despite the widespread recognition that overlapping and comorbid deficits are common. The present study took an epidemiological approach to study the learning profiles of a large school age sample in language, reading, and math. Both general learning profiles reflecting good or poor performance across measures and specific learning profiles involving either weak language, weak reading, weak math, or weak math and reading were observed. These latter four profiles characterized 70% of children with some evidence of a learning disability. Low scores in phonological short-term memory characterized clusters with a language-based weakness whereas low or variable phonological awareness was associated with the reading (but not language-based) weaknesses. The low math only group did not show these phonological deficits. These findings may suggest different etiologies for language-based deficits in language, reading, and math, reading-related impairments in reading and math, and isolated math disabilities.	[Archibald, Lisa M. D.; Cardy, Janis Oram] Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada; [Archibald, Lisa M. D.; Joanisse, Marc F.; Ansari, Daniel] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Archibald, LMD (corresponding author), Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada.	larchiba@uwo.ca	Joanisse, Marc/B-5772-2015; Cardy, Janis Oram/AAF-4147-2019; Ansari, Daniel/B-2832-2009	Joanisse, Marc/0000-0002-6352-291X; Cardy, Janis Oram/0000-0002-7170-6145; Ansari, Daniel/0000-0002-7625-618X	Natural Science and Engineering Research Council of Canada [371201-2009]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant to the first author by the Natural Science and Engineering Research Council of Canada (371201-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway T.P., 2007, AUTOMATED WORKING ME; Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Arvedson PJ, 2002, J SPEECH LANG HEAR R, V45, P970, DOI 10.1044/1092-4388(2002/079); Badian NA, 1999, ANN DYSLEXIA, V49, P45; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; BISHOP DVM, 1990, J CHILD PSYCHOL PSYC, V31, P1027, DOI 10.1111/j.1469-7610.1990.tb00844.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P189, DOI 10.1111/1469-7610.00710; Broomfield J, 2004, INT J LANG COMM DIS, V39, P303, DOI 10.1080/13682820310001625589; BUTTERWORTH B, 2002, MATH DIFF PSYCH NEUR, P1465; Conti-Ramsden G, 2003, J SPEECH LANG HEAR R, V46, P1029, DOI 10.1044/1092-4388(2003/082); Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; Dehaene S., 2011, NUMBER SENSE MIND CR; DeThorne LS, 2006, J SPEECH LANG HEAR R, V49, P1280, DOI 10.1044/1092-4388(2006/092); Donlan C, 1998, INT J LANG COMM DIS, V33, P149, DOI 10.1080/136828298247802; Everett J, 1999, PERCEPTION, V28, P243, DOI 10.1068/p2743; FAZIO BB, 1994, J SPEECH HEAR RES, V37, P358, DOI 10.1044/jshr.3702.358; Fazio BB, 1996, J SPEECH HEAR RES, V39, P839, DOI 10.1044/jshr.3904.839; Flax JF, 2003, J SPEECH LANG HEAR R, V46, P530, DOI 10.1044/1092-4388(2003/043); Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Fuchs LS, 2002, J LEARN DISABIL-US, V35, P563, DOI 10.1177/00222194020350060701; FUNHAM A, 2009, LEARN INDIVID DIFFER, V19, P28, DOI DOI 10.1016/J.LINDIF.2008.02.001; Furnham, 2005, PERSONALITY INTELLEC; Gathercole SE, 1999, APPL COGNITIVE PSYCH, V13, P65, DOI 10.1002/(SICI)1099-0720(199902)13:1<65::AID-ACP548>3.0.CO;2-O; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Germano E, 2010, DEV NEUROPSYCHOL, V35, P475, DOI 10.1080/87565641.2010.494748; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Jordan NC, 2000, J LEARN DISABIL-US, V33, P567, DOI 10.1177/002221940003300605; Jordan NC, 1997, J LEARN DISABIL-US, V30, P624, DOI 10.1177/002221949703000606; Jordan NC, 2003, CHILD DEV, V74, P834, DOI 10.1111/1467-8624.00571; Kleemans T, 2011, LEARN INDIVID DIFFER, V21, P555, DOI 10.1016/j.lindif.2011.07.008; Lahey M, 1999, J SPEECH LANG HEAR R, V42, P195, DOI 10.1044/jslhr.4201.195; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Leinonen S, 2001, READ WRIT, V14, P265, DOI 10.1023/A:1011117620895; Leonard L. B., 2004, MIT ENCY COMMUNICATI, P402; LEWIS C, 1994, J CHILD PSYCHOL PSYC, V35, P283, DOI 10.1111/j.1469-7610.1994.tb01162.x; Lonigan CJ, 2000, DEV PSYCHOL, V36, P596, DOI 10.1037//0012-1649.36.5.596; Mayes Susan Dickerson, 2006, J Atten Disord, V9, P486, DOI 10.1177/1087054705283616; McArthur GM, 2000, J CHILD PSYCHOL PSYC, V41, P869, DOI 10.1111/1469-7610.00674; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Montgomery J, 2004, INT J LANG COMM DIS, V39, P115, DOI 10.1080/13682820310001616985; MURPHY L, 1994, ANN DYSLEXIA, V44, P120, DOI 10.1007/BF02648158; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Pennington BF, 2005, ADV CHILD DEV BEHAV, V33, P263, DOI 10.1016/S0065-2407(05)80010-2; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; POLLATSEK A, 1992, J EXP PSYCHOL HUMAN, V18, P148, DOI 10.1037/0096-1523.18.1.148; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; RECORDS NL, 1994, J SPEECH HEAR RES, V37, P144, DOI 10.1044/jshr.3701.144; Redmond SM, 2005, CLIN LINGUIST PHONET, V19, P109, DOI 10.1080/02699200410001669870; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; Rice ML, 2003, LANGUAGE COMPETENCE ACROSS POPULATIONS, P63; RICE ML, 1995, J SPEECH HEAR RES, V38, P850, DOI 10.1044/jshr.3804.850; Robertson EK, 2010, APPL PSYCHOLINGUIST, V31, P141, DOI 10.1017/S0142716409990208; Robertson EK, 2009, DEVELOPMENTAL SCI, V12, P753, DOI 10.1111/j.1467-7687.2009.00806.x; ROURKE BP, 1993, J LEARN DISABIL, V26, P214, DOI 10.1177/002221949302600402; Rourke BP, 1997, J LEARN DISABIL, V30, P34, DOI 10.1177/002221949703000103; ROURKE BP, 1978, J ABNORM CHILD PSYCH, V6, P121, DOI 10.1007/BF00915788; Rubinsten O, 2006, J EDUC PSYCHOL, V98, P854, DOI 10.1037/0022-0663.98.4.854; Rubinsten O, 2009, TRENDS COGN SCI, V13, P92, DOI 10.1016/j.tics.2008.11.002; Schleifer P, 2011, DEVELOPMENTAL SCI, V14, P280, DOI 10.1111/j.1467-7687.2010.00976.x; Semel E.M., 2003, CLIN EVALUATION LANG, V4th ed; Shalev R. S., 1997, MATH COGN, V33, P105, DOI DOI 10.1080/135467997387434; Snowling M J, 2001, Dyslexia, V7, P37; Tirosh E, 1998, J CHILD NEUROL, V13, P493, DOI 10.1177/088307389801301005; Torgensen J., 1999, TEST WORD READING EF; TORGENSEN JK, 2004, LANGUAGE BASIS READI, P1465; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Trauner D, 2000, DEV MED CHILD NEUROL, V42, P470, DOI 10.1017/S0012162200000876; van Weerdenburg M, 2006, J CHILD PSYCHOL PSYC, V47, P176, DOI 10.1111/j.1469-7610.2005.01454.x; vanderLely HKJ, 1996, LINGUA, V98, P243, DOI 10.1016/0024-3841(95)00044-5; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D., 1999, WECHSLER ABBREVIATED; Willburger E, 2008, LEARN INDIVID DIFFER, V18, P224, DOI 10.1016/j.lindif.2008.01.003; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; Woodcock R, 2001, WOODCOCK JOHNSON TES	83	39	39	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77463	10.1371/journal.pone.0077463	http://dx.doi.org/10.1371/journal.pone.0077463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155959	Green Published, gold			2022-12-25	WOS:000325887300093
J	Plainis, S; Petratou, D; Giannakopoulou, T; Radhakrishnan, H; Pallikaris, IG; Charman, WN				Plainis, Sotiris; Petratou, Dionysia; Giannakopoulou, Trisevgeni; Radhakrishnan, Hema; Pallikaris, Ioannis G.; Charman, W. Neil			Small-Aperture Monovision and the Pulfrich Experience: Absence of Neural Adaptation Effects	PLOS ONE			English	Article							CORNEAL INLAY; SURGICAL-CORRECTION; VISUAL-FIELD; FOLLOW-UP; INTRACORNEAL INLAY; INCREASE DEPTH; PRESBYOPIA; LUMINANCE; LATENCY; FOCUS	Purpose: To explore whether adaptation reduces the interocular visual latency differences and the induced Pulfrich effect caused by the anisocoria implicit in small-aperture monovision. Methods: Anisocoric vision was simulated in two adults by wearing in the non-dominant eye for 7 successive days, while awake, an opaque soft contact lens (CL) with a small, central, circular aperture. This was repeated with aperture diameters of 1.5 and 2.5 mm. Each day, monocular and binocular pattern-reversal Visual Evoked Potentials (VEP) were recorded. Additionally, the Pulfrich effect was measured: the task of the subject was to state whether a a 2-deg spot appeared in front or behind the plane of a central cross when moved left-to-right or right-to-left on a display screen. The retinal illuminance of the dominant eye was varied using neutral density (ND) filters to establish the ND value which eliminated the Pulfrich effect for each lens. All experiments were performed at luminance levels of 5 and 30 cd/m(2). Results: Interocular differences in monocular VEP latency (at 30 cd/m(2)) rose to about 12-15 ms and 20-25 ms when the CL aperture was 2.5 and 1.5 mm, respectively. The effect was more pronounced at 5 cd/m(2) (i.e. with larger natural pupils). A strong Pulfrich effect was observed under all conditions, with the effect being less striking for the 2.5 mm aperture. No neural adaptation appeared to occur: neither the interocular differences in VEP latency nor the ND value required to null the Pulfrich effect reduced over each 7-day period of anisocoric vision. Conclusions: Small-aperture monovision produced marked interocular differences in visual latency and a Pulfrich experience. These were not reduced by adaptation, perhaps because the natural pupil diameter of the dominant eye was continually changing throughout the day due to varying illumination and other factors, making adaptation difficult.	[Plainis, Sotiris; Petratou, Dionysia; Giannakopoulou, Trisevgeni; Pallikaris, Ioannis G.] Univ Crete, IVO, Iraklion, Greece; [Plainis, Sotiris; Radhakrishnan, Hema; Charman, W. Neil] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Crete; University of Manchester	Plainis, S (corresponding author), Univ Crete, IVO, Iraklion, Greece.	plainis@med.uoc.gr		Petratou, Dionysia/0000-0002-5521-7747; Plainis, Sotiris/0000-0002-8304-5073				ALPERN M, 1961, Am J Ophthalmol, V52, P762; ANZAI A, 1995, VISUAL NEUROSCI, V12, P77, DOI 10.1017/S0952523800007331; Bach M, 1986, Fortschr Ophthalmol, V83, P532; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Breyer A, 2006, GRAEF ARCH CLIN EXP, V244, P1555, DOI 10.1007/s00417-006-0272-z; Carkeet A, 2012, OPTOMETRY VISION SCI, V89, P38, DOI 10.1097/OPX.0b013e31823874bb; Dexl AK, 2012, AM J OPHTHALMOL, V153, P994, DOI 10.1016/j.ajo.2011.08.044; Dexl AK, 2011, J REFRACT SURG, V27, P876, DOI 10.3928/1081597X-20110802-02; Dexl AK, 2011, J CATARACT REFR SURG, V37, P525, DOI 10.1016/j.jcrs.2010.10.044; Diaper CJM, 1997, SURV OPHTHALMOL, V41, P493, DOI 10.1016/S0039-6257(97)00014-3; Heron G, 2002, GRAEF ARCH CLIN EXP, V240, P644, DOI 10.1007/s00417-002-0501-z; INSLER MS, 1988, ARCH OPHTHALMOL-CHIC, V106, P1680, DOI 10.1001/archopht.1988.01060140852025; JOSEPHSON JE, 1987, AM J OPTOM PHYS OPT, V64, P38; LANDRIGAN DT, 1984, J PSYCHOL, V117, P125, DOI 10.1080/00223980.1984.9923668; Mojon DS, 1998, OPHTHALMOLOGY, V105, P1337, DOI 10.1016/S0161-6420(98)97044-0; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; OSAKA N, 1978, ELECTROEN CLIN NEURO, V44, P785, DOI 10.1016/0013-4694(78)90214-6; Plainis S., 2012, J OPTOM, V5, P156; Plainis S, 2013, OPHTHAL PHYSL OPT, V33, P123, DOI 10.1111/opo.12018; Seyeddain O, 2012, J CATARACT REFR SURG, V38, P35, DOI 10.1016/j.jcrs.2011.07.027; Seyeddain O, 2010, J REFRACT SURG, V26, P707, DOI 10.3928/1081597X-20100408-01; Tabernero J, 2012, J CATARACT REFR SURG, V38, P270, DOI 10.1016/j.jcrs.2011.07.040; Tabernero J, 2011, INVEST OPHTH VIS SCI, V52, P5273, DOI 10.1167/iovs.10-6436; TRICK GL, 1982, INVEST OPHTH VIS SCI, V22, P394; TUCKER J, 1975, AM J OPTOM PHYS OPT, V52, P3; Waring GO, 2011, J REFRACT SURG, V27, P842, DOI 10.3928/1081597X-20111005-04; WERTENBAKER C, 1985, SURV OPHTHALMOL, V29, P297, DOI 10.1016/0039-6257(85)90153-5; WOLPERT DM, 1993, VISION RES, V33, P1421, DOI 10.1016/0042-6989(93)90048-2; Yilmaz OF, 2008, J CATARACT REFR SURG, V34, P1921, DOI 10.1016/j.jcrs.2008.07.015; Yilmaz OF, 2011, J CATARACT REFR SURG, V37, P1275, DOI 10.1016/j.jcrs.2011.01.027; Zhang P, 2011, OPTOMETRY VISION SCI, V88, P1072, DOI 10.1097/OPX.0b013e3182217295	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75987	10.1371/journal.pone.0075987	http://dx.doi.org/10.1371/journal.pone.0075987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155881	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300015
J	Polce, C; Termansen, M; Aguirre-Gutierrez, J; Boatman, ND; Budge, GE; Crowe, A; Garratt, MP; Pietravalle, S; Potts, SG; Ramirez, JA; Somerwill, KE; Biesmeijer, JC				Polce, Chiara; Termansen, Mette; Aguirre-Gutierrez, Jesus; Boatman, Nigel D.; Budge, Giles E.; Crowe, Andrew; Garratt, Michael P.; Pietravalle, Stephane; Potts, Simon G.; Ramirez, Jorge A.; Somerwill, Kate E.; Biesmeijer, Jacobus C.			Species Distribution Models for Crop Pollination: A Modelling Framework Applied to Great Britain	PLOS ONE			English	Article							CLIMATE-CHANGE; LONG-TERM; SERVICES; RISK; COLONIES; DECLINES; HONEYBEE; BIAS; BEES	Insect pollination benefits over three quarters of the world's major crops. There is growing concern that observed declines in pollinators may impact on production and revenues from animal pollinated crops. Knowing the distribution of pollinators is therefore crucial for estimating their availability to pollinate crops; however, in general, we have an incomplete knowledge of where these pollinators occur. We propose a method to predict geographical patterns of pollination service to crops, novel in two elements: the use of pollinator records rather than expert knowledge to predict pollinator occurrence, and the inclusion of the managed pollinator supply. We integrated a maximum entropy species distribution model (SDM) with an existing pollination service model (PSM) to derive the availability of pollinators for crop pollination. We used nationwide records of wild and managed pollinators (honey bees) as well as agricultural data from Great Britain. We first calibrated the SDM on a representative sample of bee and hoverfly crop pollinator species, evaluating the effects of different settings on model performance and on its capacity to identify the most important predictors. The importance of the different predictors was better resolved by SDM derived from simpler functions, with consistent results for bees and hoverflies. We then used the species distributions from the calibrated model to predict pollination service of wild and managed pollinators, using field beans as a test case. The PSM allowed us to spatially characterize the contribution of wild and managed pollinators and also identify areas potentially vulnerable to low pollination service provision, which can help direct local scale interventions. This approach can be extended to investigate geographical mismatches between crop pollination demand and the availability of pollinators, resulting from environmental change or policy scenarios.	[Polce, Chiara; Biesmeijer, Jacobus C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Termansen, Mette] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Aguirre-Gutierrez, Jesus; Biesmeijer, Jacobus C.] Nat Biodivers Ctr, Leiden, Netherlands; [Aguirre-Gutierrez, Jesus; Biesmeijer, Jacobus C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Boatman, Nigel D.; Budge, Giles E.; Crowe, Andrew; Pietravalle, Stephane; Somerwill, Kate E.] Food & Environm Res Agcy, York, N Yorkshire, England; [Garratt, Michael P.; Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Ramirez, Jorge A.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; Aarhus University; Naturalis Biodiversity Center; University of Amsterdam; Food & Environment Research Agency; University of Reading; University of Leeds	Polce, C (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	chiara.polce@gmail.com	Garratt, Michael/AAT-2259-2020; Crowe, Andrew/AAF-9669-2020; Potts, Simon G/C-7250-2008; Potts, Simon/ABF-9221-2020	Garratt, Michael/0000-0002-0196-6013; Crowe, Andrew/0000-0003-3521-7501; Potts, Simon G/0000-0002-2045-980X; Potts, Simon/0000-0002-2045-980X; Biesmeijer, Koos/0000-0003-0328-0573; Ramirez, Jorge/0000-0002-6816-308X; Aguirre Gutierrez, Jesus/0000-0001-9190-3229; Termansen, Mette/0000-0003-4875-2810	BBSRC; Defra; NERC; Scottish Government; Wellcome Trust; LWEC, under the Insect Pollinators Initiative; Mexican National Council for Science and Technology (CONACyT) [214731/310005]; BBSRC [BB/I000348/1, BB/I000275/1, BB/I000429/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000348/1, BB/I000429/1, BB/I000275/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); LWEC, under the Insect Pollinators Initiative; Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was carried out within the project "Sustainable pollination services for UK crops" (http://www.reading.ac.uk/caer/Project_IPI_Crops/project_ipi_crops_index.html), funded jointly by BBSRC, Defra, NERC, the Scottish Government, the Wellcome Trust and the LWEC, under the Insect Pollinators Initiative (https://wiki.ceh.ac.uk/display/ukipi/Home). JA-G received funding from the Mexican National Council for Science and Technology (CONACyT), reference 214731/310005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anonymous, 2010, Bulletin OEPP, V40, P323, DOI 10.1111/j.1365-2338.2010.02419.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blach-Overgaard A, 2010, ECOGRAPHY, V33, P380, DOI 10.1111/j.1600-0587.2010.06273.x; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carvalheiro LG, 2012, J APPL ECOL, V49, P1373, DOI 10.1111/j.1365-2664.2012.02217.x; Carvalheiro LG, 2010, J APPL ECOL, V47, P810, DOI 10.1111/j.1365-2664.2010.01829.x; Crawley MJ., 2007, R BOOK; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2009, ARCGIS DESKT 10; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giannini TC, 2012, ECOL MODEL, V244, P127, DOI 10.1016/j.ecolmodel.2012.06.035; Gordo O, 2005, OECOLOGIA, V146, P484, DOI 10.1007/s00442-005-0240-z; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JOLLIFFE IT, 1973, ROY STAT SOC C-APP, V22, P21; Keil P, 2011, ECOGRAPHY, V34, P392, DOI 10.1111/j.1600-0587.2010.06554.x; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2012, J APPL ECOL, V49, P723, DOI 10.1111/j.1365-2664.2012.02144.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lautenbach S, 2011, ECOL INDIC, V11, P676, DOI 10.1016/j.ecolind.2010.09.007; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; Morton D., 2011, FINAL REPORT LCM2007; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Safriel U., 2005, ECOSYSTEMS HUMAN WEL; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Termansen M, 2006, ECOL MODEL, V192, P410, DOI 10.1016/j.ecolmodel.2005.07.009; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; UK National Ecosystem Assessment, 2011, UK NAT EC ASS TECHN; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Wilensky U, 1999, NETLOGO; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009	59	39	39	6	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76308	10.1371/journal.pone.0076308	http://dx.doi.org/10.1371/journal.pone.0076308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155899	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325887300033
J	Yuan, SQ; Zheng, HL; Zheng, ZH; Yan, W				Yuan, Shuiqiao; Zheng, Huili; Zheng, Zhihong; Yan, Wei			Proteomic Analyses Reveal a Role of Cytoplasmic Droplets as an Energy Source during Epididymal Sperm Maturation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; IN-VITRO; ARTIFICIAL CRYPTORCHIDISM; ALKALINE-PHOSPHATASE; ACROSOME REACTION; LIFE-HISTORY; SPERMATOZOA; MOTILITY; HYPERACTIVATION; CAPACITATION	A small portion of cytoplasm is generally retained as the cytoplasmic droplet (CD) on the flagellum of spermatozoa after spermiation in mice. CDs are believed to play a role in osmoadaptation by allowing water entrance or exit. However, many lines of evidence suggest that CDs may have roles beyond osmoregulation. To gain more insights, we purified CDs from murine epididymal spermatozoa and conducted proteomic analyses on proteins highly enriched in CDs. Among 105 proteins identified, 71 (68%) were enzymes involved in energy metabolism. We also found that sperm mitochondria underwent a reactivation process and glycolytic enzymes were further distributed and incorporated into different regions of the flagellum during epididymal sperm maturation. Both processes appeared to require CDs. Our data suggest that the CD represents a transient organelle that serves as an energy source essential for epididymal sperm maturation.	[Yuan, Shuiqiao; Zheng, Zhihong; Yan, Wei] China Med Univ, Dept Lab Anim Med, Shenyang, Peoples R China; [Yuan, Shuiqiao; Zheng, Huili; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	China Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yan, W (corresponding author), China Med Univ, Dept Lab Anim Med, Shenyang, Peoples R China.	wyan@unr.edu	Yan, Wei/AAH-7943-2019; Yuan, Shuiqiao/AAX-1467-2021	Yuan, Shuiqiao/0000-0003-1460-7682	University of Nevada, Reno; National Institutes of Health [HD0068006]; National Center for Research Resources [5P20RR016464-11]; National Institute of General Medical Sciences from the National Institutes of Health [P20 GM103440-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751, P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440, P20GM103513] Funding Source: NIH RePORTER	University of Nevada, Reno; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by a startup fund from the University of Nevada, Reno and a grant (HD0068006 to W.Y.) from the National Institutes of Health. The proteomic analyses were conducted in the Nevada Proteomic Center, which is supported by grants from the National Center for Research Resources (5P20RR016464-11) and the National Institute of General Medical Sciences (P20 GM103440-11) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; Aitken RJ, 2004, FREE RADICAL BIO MED, V36, P994, DOI 10.1016/j.freeradbiomed.2004.01.017; Amann RP, 2000, THERIOGENOLOGY, V54, P1499, DOI 10.1016/S0093-691X(00)00470-2; Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Bao JQ, 2010, MOL CELL ENDOCRINOL, V327, P89, DOI 10.1016/j.mce.2010.06.006; BAVDEK S, 1970, J REPROD FERTIL, V22, P371, DOI 10.1530/jrf.0.0220371; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Cooper TG, 2009, J ANDROL, V30, P214, DOI 10.2164/jandrol.108.005819; CUMMINS JM, 1970, J REPROD FERTIL, V23, P423; CUMMINS JM, 1973, J REPROD FERTIL, V33, P469, DOI 10.1530/jrf.0.0330469; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; DOTT HM, 1968, EXP CELL RES, V52, P523, DOI 10.1016/0014-4827(68)90493-X; Fetic S, 2006, J ANDROL, V27, P294, DOI 10.2164/jandrol.05122; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Gabers D. L, 1970, Biology Reprod., V3, P327; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; HARRISON RA, 1972, J REPROD FERTIL, V30, P105, DOI 10.1530/jrf.0.0300105; HERMO L, 1988, AM J ANAT, V183, P107, DOI 10.1002/aja.1001830202; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Jha KN, 2002, MOL REPROD DEV, V63, P119, DOI 10.1002/mrd.10152; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Kulanand J, 2001, ANDROLOGIA, V33, P95, DOI 10.1046/j.1439-0272.2001.00410.x; Kuster CE, 2004, J ANDROL, V25, P340; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MONIEM KA, 1972, J REPROD FERTIL, V29, P65, DOI 10.1530/jrf.0.0290065; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; NOLAND TD, 1983, BIOL REPROD, V29, P987, DOI 10.1095/biolreprod29.4.987; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; OKO R, 1993, J CELL BIOL, V123, P809, DOI 10.1083/jcb.123.4.809; Pena AI, 2007, REPROD DOMEST ANIM, V42, P471, DOI 10.1111/j.1439-0531.2006.00809.x; Perl A, 2006, P NATL ACAD SCI USA, V103, P14813, DOI 10.1073/pnas.0602678103; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rengan AK, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-92; RETZIUS G, 1909, BIOL UNTERSUCH, V14, P163; ROBERTS ML, 1976, BIOL REPROD, V14, P421, DOI 10.1095/biolreprod14.4.421; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; Thundathil J, 2001, ANIM REPROD SCI, V65, P181, DOI 10.1016/S0378-4320(00)00231-1; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Wang SH, 2006, BIOL REPROD, V74, P102, DOI 10.1095/biolreprod.105.045484; Williams AC, 2001, J ANDROL, V22, P680; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Xu H, 2013, ASIAN J ANDROL, V15, P799, DOI 10.1038/aja.2013.69; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104; Zini A, 2000, FERTIL STERIL, V74, P461, DOI 10.1016/S0015-0282(00)00703-2	58	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77466	10.1371/journal.pone.0077466	http://dx.doi.org/10.1371/journal.pone.0077466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155961	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300095
J	Zhang, CX; Knudsen, DE; Liu, M; Robertson, DC; Zhang, WP				Zhang, Chengxian; Knudsen, David E.; Liu, Mei; Robertson, Donald C.; Zhang, Weiping		STa Toxoid Vaccine Consortium Grp	Toxicity and Immunogenicity of Enterotoxigenic Escherichia coli Heat-Labile and Heat-Stable Toxoid Fusion 3xSTa(A14Q)-LTS63K/R192G/L211A in a Murine Model	PLOS ONE			English	Article							MUCOSAL IMMUNE-RESPONSES; SUBLINGUAL IMMUNIZATION; CHOLERA-TOXIN; COLONIZATION FACTORS; ENTERO-TOXIN; VACCINE; DIARRHEA; ANTIBODIES; INFECTION; ADJUVANT	Diarrhea is the second leading cause of death to young children. Enterotoxigenic Escherichia coli (ETEC) are the most common bacteria causing diarrhea. Adhesins and enterotoxins are the virulence determinants in ETEC diarrhea. Adhesins mediate bacterial attachment and colonization, and enterotoxins including heat-labile (LT) and heat-stable type Ib toxin (STa) disrupt fluid homeostasis in host cells that leads to fluid hyper-secretion and diarrhea. Thus, adhesins and enterotoxins have been primarily targeted in ETEC vaccine development. A recent study reported toxoid fusions with STa toxoid (STaP13F) fused at the N- or C-terminus, or inside the A subunit of LTR192G elicited neutralizing antitoxin antibodies, and suggested application of toxoid fusions in ETEC vaccine development (Liu et al., Infect. Immun. 79:4002-4009, 2011). In this study, we generated a different STa toxoid (STaA14Q) and a triple-mutant LT toxoid (LTS63K/R192G/L211A, tmLT), constructed a toxoid fusion (3xSTa(A14Q)-tmLT) that carried 3 copies of STaA14Q for further facilitation of anti-STa immunogenicity, and assessed antigen safety and immunogenicity in a murine model to explore its potential for ETEC vaccine development. Mice immunized with this fusion antigen showed no adverse effects, and developed antitoxin antibodies particularly through the IP route. Anti-LT antibodies were detected and were shown neutralizing against CT in vitro. Anti-STa antibodies were also detected in the immunized mice, and serum from the IP immunized mice neutralized STa toxin in vitro. Data from this study indicated that toxoid fusion 3xSTa(A14Q)-tmLT is safe and can induce neutralizing antitoxin antibodies, and provided helpful information for vaccine development against ETEC diarrhea.	[Zhang, Chengxian; Knudsen, David E.; Liu, Mei; Zhang, Weiping] S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Vet & Biomed Sci Dept, Brookings, SD 57007 USA; [Robertson, Donald C.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	South Dakota State University; Kansas State University	Zhang, WP (corresponding author), S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Vet & Biomed Sci Dept, Brookings, SD 57007 USA.	weiping.zhang@sdstate.edu			NIH [AI083897]; EVI/PATH STa Toxoid Vaccine Consortium; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EVI/PATH STa Toxoid Vaccine Consortium; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by NIH AI083897 (W. Zhang), EVI/PATH STa Toxoid Vaccine Consortium (JP Nataro, subaward to W. Zhang), and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuguni JH, 2011, VACCINE, V29, P4778, DOI 10.1016/j.vaccine.2011.04.083; Andrew DW, 2011, J REPROD IMMUNOL, V91, P9, DOI 10.1016/j.jri.2011.06.100; [Anonymous], 1999, WORLD HLTH REPORT 19; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boedeker EC, 2005, CURR OPIN GASTROEN, V21, P15; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; CLEMENTS JD, 1990, INFECT IMMUN, V58, P1159, DOI 10.1128/IAI.58.5.1159-1166.1990; Council NR, 1996, GUIDE CARE USE LAB A; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Czerkinsky C, 2011, HUM VACCINES, V7, P110, DOI 10.4161/hv.7.1.13739; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Delisle B, 2012, J PHARM PHARM SCI, V15, P642, DOI 10.18433/J30W32; Dupont HL, 2008, ALIMENT PHARM THER, V27, P741, DOI 10.1111/j.1365-2036.2008.03647.x; FRANTZ JC, 1981, INFECT IMMUN, V33, P193, DOI 10.1128/IAI.33.1.193-198.1981; Frantz JC, 1983, P 4 INT S NEON DIARR; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Jackson EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041529; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; KLIPSTEIN FA, 1982, INFECT IMMUN, V37, P550, DOI 10.1128/IAI.37.2.550-557.1982; Kurono Y, 2011, ADV OTO-RHINO-LARYNG, V72, P146, DOI 10.1159/000324773; Laurelle L, 1889, CELLULE, V5, P60; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Liu M, 2011, TOXINS, V3, P1146, DOI 10.3390/toxins3091146; Liu M, 2011, INFECT IMMUN, V79, P4002, DOI 10.1128/IAI.00165-11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Negri DRM, 2010, VACCINE, V28, P4175, DOI 10.1016/j.vaccine.2010.04.013; Olvera-Gomez I, 2012, P NATL ACAD SCI USA, V109, P2072, DOI 10.1073/pnas.1105771109; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Ruan XS, 2011, CLIN VACCINE IMMUNOL, V18, P1593, DOI 10.1128/CVI.05120-11; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; SANCHEZ J, 1988, GENE, V64, P265, DOI 10.1016/0378-1119(88)90341-1; Sanders JW, 2005, CURR OPIN GASTROEN, V21, P9; Svennerholm AM, 1992, IMMUNOLOGY GASTROINT, P227; Svennerholm AM, 2011, INDIAN J MED RES, V133, P188; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; Walker RI, 2005, EXPERT REV VACCINES, V4, P807, DOI 10.1586/14760584.4.6.807; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yamamoto M, 2001, SCAND J IMMUNOL, V53, P211, DOI 10.1046/j.1365-3083.2001.00883.x; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2012, EXPERT REV VACCINES, V11, P677, DOI [10.1586/erv.12.37, 10.1586/ERV.12.37]; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09	44	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77386	10.1371/journal.pone.0077386	http://dx.doi.org/10.1371/journal.pone.0077386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146989	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400115
J	Guha, M; Srinivasan, S; Ruthel, G; KKashina, A; Carstens, RP; Mendoza, A; Khanna, C; Van Winkle, T; Avadhani, NG				Guha, M.; Srinivasan, S.; Ruthel, G.; Kashina, A. K.; Carstens, R. P.; Mendoza, A.; Khanna, C.; Van Winkle, T.; Avadhani, N. G.			Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells	ONCOGENE			English	Article						mitochondrial DNA; mitochondrial retrograde signaling; epithelial-mesenchymal transition; breast cancer; ESRP1; cancer stem cells	DNA DEPLETION; RESPIRATORY STRESS; GENOME INSTABILITY; MTDNA DEPLETION; COPY NUMBER; IN-VIVO; MUTATIONS; ACTIVATION; RESISTANCE; APOPTOSIS	Metastatic breast tumors undergo epithelial-to-mesenchymal transition (EMT), which renders them resistant to therapies targeted to the primary cancers. The mechanistic link between mtDNA (mitochondrial DNA) reduction, often seen in breast cancer patients, and EMT is unknown. We demonstrate that reducing mtDNA content in human mammary epithelial cells (hMECs) activates Calcineurin (Cn)-dependent mitochondrial retrograde signaling pathway, which induces EMT-like reprogramming to fibroblastic morphology, loss of cell polarity, contact inhibition and acquired migratory and invasive phenotype. Notably, mtDNA reduction generates breast cancer stem cells. In addition to retrograde signaling markers, there is an induction of mesenchymal genes but loss of epithelial markers in these cells. The changes are reversed by either restoring the mtDNA content or knockdown of CnA alpha mRNA, indicating the causal role of retrograde signaling in EMT. Our results point to a new therapeutic strategy for metastatic breast cancers targeted to the mitochondrial retrograde signaling pathway for abrogating EMT and attenuating cancer stem cells, which evade conventional therapies. We report a novel regulatory mechanism by which low mtDNA content generates EMT and cancer stem cells in hMECs.	[Guha, M.; Srinivasan, S.; Kashina, A. K.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Guha, M.; Srinivasan, S.; Kashina, A. K.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Marie Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Ruthel, G.] Univ Penn, Sch Vet Med, Penn Vet Imaging Core, Philadelphia, PA 19104 USA; [Carstens, R. P.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Mendoza, A.; Khanna, C.] NCI, Tumor & Metastasis Biol Sect, Ctr Canc Res, Bethesda, MD 20892 USA; [Van Winkle, T.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589	NIH grant [CA-22762]; Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE [R37CA022762, R01CA022762] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant CA-22762 and an Endowment from the Harriet Ellison Woodward Trust to NGA. We thank Benjamin Cieply (Carstens laboratory) for providing reagents for the ESRP1 experiments; Drs Brett Kaufman and Jill Kolesar (Kaufman lab) for providing TFAM shRNA constructs; Dr Joseph Baur for the GFP shRNA plasmid; Dr Mauricio Reginato and members of his laboratory for sharing protocols and reagents for immunostaining of the MCF10A 3D spheres; and Drs Christopher Lengner and Qihong Huang for valuable comments on the manuscript. We thank Dr Leslie King for critical comments and editorial help.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Correia RL, 2011, MITOCHONDRION, V11, P48, DOI 10.1016/j.mito.2010.07.001; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fan WW, 2012, GENE DEV, V26, P384, DOI 10.1101/gad.175802.111; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482; Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z; HORWITZ HB, 1971, J CELL BIOL, V49, P546, DOI 10.1083/jcb.49.2.546; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Tang WG, 2012, CARCINOGENESIS, V33, P1762, DOI 10.1093/carcin/bgs190; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6	54	88	90	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5238	5250		10.1038/onc.2013.467	http://dx.doi.org/10.1038/onc.2013.467			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24186204	Green Accepted			2022-12-25	WOS:000345120400002
J	De Saedeleer, CJ; Porporato, PE; Copetti, T; Perez-Escuredo, J; Payen, VL; Brisson, L; Feron, O; Sonveaux, P				De Saedeleer, C. J.; Porporato, P. E.; Copetti, T.; Perez-Escuredo, J.; Payen, V. L.; Brisson, L.; Feron, O.; Sonveaux, P.			Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration	ONCOGENE			English	Article						monocarboxylate transporter 1 (MCT1); basigin; glucose metabolism; mitochondrial dysfunction; reactive oxygen species (ROS); tumor cell migration	MITOCHONDRIAL SUPEROXIDE; GLYCOLYTIC TUMORS; LACTIC-ACID; HYPOXIA; LACTATE; CD147; CANCER; METASTASIS; METABOLISM; PROGRESSION	The glycolytic end-product lactate is a pleiotropic tumor growth-promoting factor. Its activities primarily depend on its uptake, a process facilitated by the lactate-proton symporter monocarboxylate transporter 1 (MCT1). Therefore, targeting the transporter or its chaperon protein CD147/basigin, itself involved in the aggressive malignant phenotype, is an attractive therapeutic option for cancer, but basic information is still lacking regarding the regulation of the expression, interaction and activities of both proteins. In this study, we found that glucose deprivation dose-dependently upregulates MCT1 and CD147 protein expression and their interaction in oxidative tumor cells. While this posttranslational induction could be recapitulated using glycolysis inhibition, hypoxia, oxidative phosphorylation (OXPHOS) inhibitor rotenone or hydrogen peroxide, it was blocked with alternative oxidative substrates and specific antioxidants, pointing out at a mitochondrial control. Indeed, we found that the stabilization of MCT1 and CD147 proteins upon glucose removal depends on mitochondrial impairment and the associated generation of reactive oxygen species. When glucose was a limited resource (a situation occurring naturally or during the treatment of many tumors), MCT1-CD147 heterocomplexes accumulated, including in cell protrusions of the plasma membrane. It endowed oxidative tumor cells with increased migratory capacities towards glucose. Migration increased in cells overexpressing MCT1 and CD147, but it was inhibited in glucose-starved cells provided with an alternative oxidative fuel, treated with an antioxidant, lacking MCT1 expression, or submitted to pharmacological MCT1 inhibition. While our study identifies the mitochondrion as a glucose sensor promoting tumor cell migration, MCT1 is also revealed as a transducer of this response, providing a new rationale for the use of MCT1 inhibitors in cancer.	[De Saedeleer, C. J.; Porporato, P. E.; Copetti, T.; Perez-Escuredo, J.; Payen, V. L.; Brisson, L.; Feron, O.; Sonveaux, P.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pharmacol, B-1200 Brussels, Belgium	Universite Catholique Louvain	Sonveaux, P (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pharmacol, Ave Emmanuel Mounier 53 Box B1-53-09, B-1200 Brussels, Belgium.	pierre.sonveaux@uclouvain.be	Brisson, Lucie/R-1179-2016; FERON, Olivier/AAM-6395-2020; Porporato, Paolo E./A-9932-2018	Brisson, Lucie/0000-0001-7811-1382; FERON, Olivier/0000-0001-5360-0286; Porporato, Paolo E./0000-0001-8519-1552; Sonveaux, Pierre/0000-0001-6484-8834	European Research Council (FP7); European Research Council Independent Researcher Starting Grant [243188]; Belgian Science Policy Office (Belspo) [UP7-03]; Communaute Francaise de Belgique [ARC 09/14-020]; Fondation Belge contre le Cancer; Fonds National de la Recherche Scientifique (FRS-FNRS); Fonds National de la Recherche Scientifique Medicale; Televie	European Research Council (FP7); European Research Council Independent Researcher Starting Grant; Belgian Science Policy Office (Belspo)(Belgian Federal Science Policy Office); Communaute Francaise de Belgique(Australian Research Council); Fondation Belge contre le Cancer; Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Televie	This work was supported by the European Research Council (FP7/2007-2013 European Research Council Independent Researcher Starting Grant No. 243188 TUMETABO to PS), Interuniversity Attraction Pole grant #UP7-03 from the Belgian Science Policy Office (Belspo), an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC 09/14-020 to PS and OF), the Fondation Belge contre le Cancer, the Fonds National de la Recherche Scientifique (FRS-FNRS), the Fonds National de la Recherche Scientifique Medicale, and the Televie. OF is a Honorary Research Director and PS is a Research Associate of the FRS-FNRS. CJD is a Televie Research Fellow. Funding bodies had no role in the design of the study, collection and analysis of data and decision to publish. The authors thank Prof Jacques Pouyssegur (University of Nice Sophia Antipolis, France) for the kind gift of the CD147 vector, and Elise Beneteau, Morgane Tardy, Fabien Rodriguez, Thibaut Vazeille and Floriane Ribeiro for excellent technical assistance. This paper is dedicated to the loving memory of Mrs Anne-Sophie Brouckaert, PharmD.	Asada K, 2003, ONCOLOGY-BASEL, V64, P380, DOI 10.1159/000070297; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Cardaci S, 2012, CANCER RES, V72, P4526, DOI 10.1158/0008-5472.CAN-12-1741; Cheng C, 2012, CELL ONCOL, V35, P217, DOI 10.1007/s13402-012-0081-9; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ferretti AC, 2012, MOL GENET METAB, V105, P186, DOI 10.1016/j.ymgme.2011.11.007; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher SM, 2009, AM J PHYSIOL-CELL PH, V296, pC414, DOI 10.1152/ajpcell.00430.2008; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Jia L, 2008, CANCER INVEST, V26, P977, DOI 10.1080/07357900802072723; Ke X, 2012, CARCINOGENESIS, V33, P1598, DOI 10.1093/carcin/bgs196; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lee GH, 2011, ONCOL LETT, V2, P831, DOI 10.3892/ol.2011.353; Li J, 2010, J DERMATOL SCI, V58, P204, DOI 10.1016/j.jdermsci.2010.03.022; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; WU R, 1959, J BIOL CHEM, V234, P1036; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	49	65	66	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4060	4068		10.1038/onc.2013.454	http://dx.doi.org/10.1038/onc.2013.454			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24166504	hybrid			2022-12-25	WOS:000340595300005
J	Gosein, V; Miller, GJ				Gosein, Varin; Miller, Gregory J.			Conformational Stability of Inositol 1,3,4,5,6-Pentakisphosphate 2-Kinase (IPK1) Dictates Its Substrate Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Inositol Phosphates; Protein Crystallization; Protein Structure; IPK1; Differential Scanning Fluorometry; Kinase Activation; Substrate Recognition	CRYSTAL-STRUCTURE; BINDING; SPECIFICITY	Inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IPK1) converts inositol 1,3,4,5,6-pentakisphosphate(IP5) to inositol hexakisphosphate (IP6). IPK1 shares structural similarity with protein kinases and is suspected to employ a similar mechanism of activation. Previous studies revealed roles for the 1- and 3-phosphates of IP5 in IPK1 activation and revealed that the N-lobe of IPK1 is unstable in the absence of inositol phosphate (IP). Here, we demonstrate the link between IPK1 substrate specificity and the stability of its N-lobe. Limited proteolysis of IPK1 revealed that N-lobe stability is dependent on the presence of the 1-phosphate of the substrate, whereas overall stability of IPK1 was increased in ternary complexes with nucleotide and IPs possessing 1- and 3-phosphates that engage the N-lobe of IPK1. Thus, the 1- and 3-phosphates possess dual roles in both IPK1 activation and IPK1 stability. To test whether kinase stability directly contributed to substrate selectivity of the kinase, we engineered IPK1 mutants with disulfide bonds that artificially stabilized the N-lobe in an IP-independent manner thereby mimicking its substrate-bound state in the absence of IP. IPK1 E82C/S142C exhibited a DTT-sensitive 5-fold increase in k(cat) for 3,4,5,6-inositol tetrakisphosphate (3,4,5,6-IP4) as compared with wild-type IPK1. The crystal structure of the IPK1 E82C/S142C mutant confirmed the presence of the disulfide bond and revealed a small shift in the N-lobe. Finally, we determined that IPK1 E82C/S142C is substantially more stable than wild-type IPK1 under nonreducing conditions, revealing that increased stability of IPK1 E82C/S142C correlates with changes in substrate specificity by allowing IPs lacking the stabilizing 1-phosphate to be used. Taken together, our results show that IPK1 substrate selection is linked to the ability of each potential substrate to stabilize IPK1.	[Gosein, Varin; Miller, Gregory J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Miller, Gregory J.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Miller, Gregory J.] Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA	McGill University; McGill University; Catholic University of America	Miller, GJ (corresponding author), Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA.	millergj@cua.edu			Canadian Institutes of Health (CIHR) [MOP-93687]; CIHR Strategic Training Initiative in Chemical Biology	Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health (CIHR) Research Operating Grant MOP-93687 (to G. J. M.) and a CIHR Strategic Training Initiative in Chemical Biology (to V. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2009, MOL CELL BIOCHEM, V328, P155, DOI 10.1007/s11010-009-0085-6; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2013, J BIOL CHEM, V288, P26908, DOI 10.1074/jbc.M113.487777; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Banos-Sanz JI, 2012, J BIOL CHEM, V287, P29237, DOI 10.1074/jbc.M112.363671; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Verbsky J, 2005, J BIOL CHEM, V280, P29263, DOI 10.1074/jbc.M503366200; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733	27	4	4	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36788	36795		10.1074/jbc.M113.512731	http://dx.doi.org/10.1074/jbc.M113.512731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24165122	Green Published, hybrid			2022-12-25	WOS:000329189700003
J	Gault, VA; Bhat, VK; Irwin, N; Flatt, PR				Gault, Victor A.; Bhat, Vikas K.; Irwin, Nigel; Flatt, Peter R.			A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1 and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Glucose; Insulin; Insulin Secretion; Obesity	ZUCKER RATS; IN-VITRO; DB/DB MICE; GIP; HOMEOSTASIS; EXENDIN-4; HORMONES; WEIGHT; ACTIVATION; THERAPIES	Glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon bind to related members of the same receptor superfamily and exert important effects on glucose homeostasis, insulin secretion, and energy regulation. The present study assessed the biological actions and therapeutic utility of novel GIP/glucagon/GLP-1 hybrid peptides. Nine novel peptides were synthesized and exhibited complete DPP-IV resistance and enhanced in vitro insulin secretion. The most promising peptide, [dA(2)]GLP-1/GcG, stimulated cAMP production in GIP, GLP-1, and glucagon receptor-transfected cells. Acute administration of [dA(2)]GLP-1/GcG in combination with glucose significantly lowered plasma glucose and increased plasma insulin in normal and obese diabetic (ob/ob) mice. Furthermore, [dA(2)]GLP-1/GcG elicited a protracted glucose-lowering and insulinotropic effect in high fat-fed mice. Twice daily administration of [dA(2)]GLP-1/GcG for 21 days decreased body weight and nonfasting plasma glucose and increased circulating plasma insulin concentrations in high fat-fed mice. Furthermore, [dA(2)]GLP-1/GcG significantly improved glucose tolerance and insulin sensitivity by day 21. Interestingly, locomotor activity was increased in [dA(2)]GLP-1/GcG mice, without appreciable changes in aspects of metabolic rate. Studies in knock-out mice confirmed the biological action of [dA(2)]GLP-1/GcG via multiple targets including GIP, GLP-1, and glucagon receptors. The data suggest significant promise for novel triple-acting hybrid peptides as therapeutic options for obesity and diabetes.	[Gault, Victor A.; Bhat, Vikas K.; Irwin, Nigel; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Irwin, N (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	n.irwin@ulster.ac.uk	Irwin, Nigel/H-9696-2019	Irwin, Nigel/0000-0003-4855-964X; Flatt, Peter/0000-0001-8548-7943; Gault, Victor/0000-0001-8501-1013	University of Ulster; Diabetes Research and Wellness Foundation	University of Ulster; Diabetes Research and Wellness Foundation	This work was supported by University of Ulster Strategy Research Funding, a Vice-Chancellors Research Scholarship (to V. B.), and a research grant from Diabetes Research and Wellness Foundation.	Al-Barazanji KA, 2000, OBES RES, V8, P317, DOI 10.1038/oby.2000.38; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; BAILEY CJ, 1982, INT J OBESITY, V6, P11; Bhat VK, 2013, DIABETOLOGIA, V56, P1417, DOI 10.1007/s00125-013-2892-2; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Delmeire D, 2004, BIOCHEM PHARMACOL, V68, P33, DOI 10.1016/j.bcp.2004.02.035; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Gault VA, 2011, CLIN SCI, V121, P107, DOI 10.1042/CS20110006; Gelling RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE695, DOI 10.1152/ajpendo.00082.2009; Greig NH, 1999, DIABETOLOGIA, V42, P45, DOI 10.1007/s001250051111; Gribble FM, 2012, P NUTR SOC, V71, P456, DOI 10.1017/S0029665112000705; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Ionut V, 2013, OBESITY, V21, P1093, DOI 10.1002/oby.20364; Irwin N, 2013, DIABETES OBES METAB, V15, P650, DOI 10.1111/dom.12079; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Parker JA, 2013, INT J OBESITY, V37, P1391, DOI 10.1038/ijo.2012.227; Parlevliet ET, 2010, AM J PHYSIOL-ENDOC M, V299, pE318, DOI 10.1152/ajpendo.00191.2010; Pospisilik JA, 2001, REGUL PEPTIDES, V96, P133, DOI 10.1016/S0167-0115(00)00170-1; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Xiao Q, 2001, BIOCHEMISTRY-US, V40, P2860, DOI 10.1021/bi0014498; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026	33	95	104	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35581	35591		10.1074/jbc.M113.512046	http://dx.doi.org/10.1074/jbc.M113.512046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165127	Green Published, hybrid			2022-12-25	WOS:000329867600052
J	Woskowicz, AM; Weaver, SA; Shitomi, Y; Ito, N; Itoh, Y				Woskowicz, Anna M.; Weaver, Sarah A.; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi			MT-LOOP-dependent Localization of Membrane Type I Matrix Metalloproteinase (MT1-MMP) to the Cell Adhesion Complexes Promotes Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Surface Enzymes; Integrin; Invasion; Matrix Metalloproteinase (MMP); MT-LOOP; MT1-MMP; Focal Adhesion	3-DIMENSIONAL EXTRACELLULAR-MATRIX; HEMOPEXIN-LIKE DOMAIN; TUMOR-GROWTH; RHEUMATOID-ARTHRITIS; PROMMP-2 ACTIVATION; TISSUE INHIBITOR; CYTOPLASMIC TAIL; FOCAL ADHESIONS; SURFACE; MIGRATION	Background: MT1-MMP promotes cancer cell invasion. Results: Deletion of the MT-LOOP region of MT1-MMP or an antibody to the MT-LOOP inhibits cellular invasion. Conclusion: MT-LOOP-dependent MT1-MMP localization to the cell adhesion complex promotes cellular invasion. Significance: Our work reveals a novel mechanism of MT1-MMP regulation during cellular invasion and identifies the MT-LOOP as a novel target region to develop specific inhibitors. Localization of membrane type I matrix metalloproteinase (MT1-MMP) to the leading edge is thought to be a crucial step during cancer cell invasion. However, its mechanisms and functional impact on cellular invasion have not been clearly defined. In this report, we have identified the MT-LOOP, a loop region in the catalytic domain of MT1-MMP ((163)PYAYIREG(170)), as an essential region for MT1-MMP to promote cellular invasion. Deletion of the MT-LOOP effectively inhibited functions of MT1-MMP on the cell surface, including proMMP-2 activation, degradation of gelatin and collagen films, and cellular invasion into a collagen matrix. This is not due to loss of the catalytic function of MT1-MMP but due to inefficient localization of the enzyme to 1-integrin-rich cell adhesion complexes at the plasma membrane. We also found that an antibody that specifically recognizes the MT-LOOP region of MT1-MMP (LOOPAb) inhibited MT1-MMP functions, fully mimicking the phenotype of the MT-LOOP deletion mutant. We therefore propose that the MT-LOOP region is an interface for molecular interactions that mediate enzyme localization to cell adhesion complexes and regulate MT1-MMP functions. Our findings have revealed a novel mechanism regulating MT1-MMP during cellular invasion and have identified the MT-LOOP as a potential exosite target region to develop selective MT1-MMP inhibitors.	[Woskowicz, Anna M.; Weaver, Sarah A.; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Oxford OX3 7FY, England	University of Oxford	Itoh, Y (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Roosevelt Dr, Oxford OX3 7FY, England.	yoshi.itoh@kennedy.ox.ac.uk		Itoh, Yoshifumi/0000-0002-2128-2823	Cancer Research UK Project [C1507/A5541]; Medical Research Council Research [G0802007]; Arthritis Research UK core grant; Kennedy Trust Ph.D. studentship; Medical Research Council [G0802007] Funding Source: researchfish; Versus Arthritis [19797] Funding Source: researchfish; MRC [G0802007] Funding Source: UKRI	Cancer Research UK Project(Cancer Research UK); Medical Research Council Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK core grant(Versus Arthritis); Kennedy Trust Ph.D. studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK Project Grant C1507/A5541, by Medical Research Council Research Grant G0802007, by an Arthritis Research UK core grant (to the Kennedy Institute of Rheumatology), and by a Kennedy Trust Ph.D. studentship.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ingvarsen S, 2013, J BIOL CHEM, V288, P10195, DOI 10.1074/jbc.M112.447169; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2011, BIOCHEM J, V440, P319, DOI 10.1042/BJ20110424; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nakada M, 2001, CANCER RES, V61, P8896; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Palmisano R, 2010, METHODS MOL BIOL, V622, P379, DOI 10.1007/978-1-60327-299-5_23; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Sabeh F, 2010, J IMMUNOL, V184, P6396, DOI 10.4049/jimmunol.0904068; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato T, 1997, J CELL SCI, V110, P589; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52	57	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35126	35137		10.1074/jbc.M113.496067	http://dx.doi.org/10.1074/jbc.M113.496067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165131	Green Published, hybrid			2022-12-25	WOS:000329867600014
J	Chu, BW; Kovary, KM; Guillaume, J; Chen, LC; Teruel, MN; Wandless, TJ				Chu, Bernard W.; Kovary, Kyle M.; Guillaume, Johan; Chen, Ling-chun; Teruel, Mary N.; Wandless, Thomas J.			The E3 Ubiquitin Ligase UBE3C Enhances Proteasome Processivity by Ubiquitinating Partially Proteolyzed Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Proteasome; Protein Degradation; Protein Processing; Protein Stability	DNA-REPAIR; PLASMODIUM-FALCIPARUM; MOLECULAR CHAPERONES; PROTEIN; DEGRADATION; CHAINS; RECOGNITION; CHIP; HUL5; PROMOTES	Background: An RNAi screen identified UBE3C as a key player in degradation of a model unfolded protein. Results: UBE3C knockdown results in incomplete degradation of relatively stable substrates. Conclusion: UBE3C enhances proteasome processivity to prevent the accumulation of potentially harmful protein fragments. Significance: This advances our understanding of proteasome processivity and the consequences of defects therein. To maintain protein homeostasis, cells must balance protein synthesis with protein degradation. Accumulation of misfolded or partially degraded proteins can lead to the formation of pathological protein aggregates. Here we report the use of destabilizing domains, proteins whose folding state can be reversibly tuned using a high affinity ligand, as model substrates to interrogate cellular protein quality control mechanisms in mammalian cells using a forward genetic screen. Upon knockdown of UBE3C, an E3 ubiquitin ligase, a reporter protein consisting of a destabilizing domain fused to GFP is degraded more slowly and incompletely by the proteasome. Partial proteolysis is also observed when UBE3C is present but cannot ubiquitinate substrates because its active site has been mutated, it is unable to bind to the proteasome, or the substrate lacks lysine residues. UBE3C knockdown also results in less substrate polyubiquitination. Finally, knockdown renders cells more susceptible to the Hsp90 inhibitor 17-AAG, suggesting that UBE3C protects against the harmful accumulation of protein fragments arising from incompletely degraded proteasome substrates.	[Chu, Bernard W.; Kovary, Kyle M.; Guillaume, Johan; Chen, Ling-chun; Teruel, Mary N.; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Kovary, Kyle/0000-0002-7616-2968; Teruel, Mary/0000-0002-2854-3598	National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM073046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073046.	Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Berko D, 2012, MOL CELL, V48, P601, DOI 10.1016/j.molcel.2012.08.029; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolan BP, 2012, P NATL ACAD SCI USA, V109, P7025, DOI 10.1073/pnas.1112387109; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Hagai T, 2010, P NATL ACAD SCI USA, V107, P2001, DOI 10.1073/pnas.0912335107; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SLAVIK J, 1981, FOLIA MICROBIOL, V26, P176, DOI 10.1007/BF02927419; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; You JX, 2003, J BIOL CHEM, V278, P23369, DOI 10.1074/jbc.M212887200; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027	67	48	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34575	34587		10.1074/jbc.M113.499350	http://dx.doi.org/10.1074/jbc.M113.499350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24158444	hybrid, Green Published			2022-12-25	WOS:000329812800026
J	Amro, A; Hamdi, S; Lemrani, M; Mouna, I; Mohammed, H; Mostafa, S; Rhajaoui, M; Hamarsheh, O; Schonian, G				Amro, Ahmad; Hamdi, Salsabil; Lemrani, Meryem; Mouna, Idrissi; Mohammed, Hida; Mostafa, Sabri; Rhajaoui, Mohamed; Hamarsheh, Omar; Schoenian, Gabriele			Moroccan Leishmania infantum: Genetic Diversity and Population Structure as Revealed by Multi-Locus Microsatellite Typing	PLOS ONE			English	Article							PHLEBOTOMUS-PERNICIOSUS; VISCERAL LEISHMANIASIS; PALESTINIAN AUTHORITY; MEDITERRANEAN COAST; CLINICAL-SAMPLES; STRAINS; DIFFERENTIATION; EPIDEMIOLOGY; POLYMORPHISM; LONGICUSPIS	Leishmania infantum causes Visceral and cutaneous leishmaniasis in northern Morocco. It predominantly affects children under 5 years with incidence of 150 cases/year. Genetic variability and population structure have been investigated for 33 strains isolated from infected dogs and humans in Morocco. A multilocus microsatellite typing (MLMT) approach was used in which a MLMtype based on size variation in 14 independent microsatellite markers was compiled for each strain. MLMT profiles of 10 Tunisian, 10 Algerian and 21 European strains which belonged to zymodeme MON-1 and non-MON-1 according to multilocus enzyme electrophoresis (MLEE) were included for comparison. A Bayesian model-based approach and phylogenetic analysis inferred two L. infantum sub-populations; Sub-population A consists of 13 Moroccan strains grouped with all European strains of MON-1 type; and sub-population B consists of 15 Moroccan strains grouped with the Tunisian and Algerian MON-1 strains. Theses sub-populations were significantly different from each other and from the Tunisian, Algerian and European non MON-1 strains which constructed one separate population. The presence of these two sub-populations co-existing in Moroccan endemics suggests multiple introduction of L. infantum from/to Morocco; (1) Introduction from/to the neighboring North African countries, (2) Introduction from/to the Europe. These scenarios are supported by the presence of sub-population B and sub-population A respectively. Gene flow was noticed between sub-populations A and B. Five strains showed mixed A/B genotypes indicating possible recombination between the two populations. MLMT has proven to be a powerful tool for eco-epidemiological and population genetic investigations of Leishmania.	[Amro, Ahmad] Alquds Univ, Fac Pharm, Jerusalem, Israel; [Hamdi, Salsabil; Lemrani, Meryem] Inst Pasteur Maroc, Lab Leishmanioses, Casablanca, Morocco; [Mostafa, Sabri] Ibn Sina Hosp, Parasitol Lab, Rabat, Morocco; [Rhajaoui, Mohamed] Natl Inst Hyg, Dept Parasitol, Rabat, Morocco; [Hamarsheh, Omar] Al Quds Univ, Dept Biol Sci, Jerusalem, Israel; [Amro, Ahmad; Schoenian, Gabriele] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Amro, A (corresponding author), Alquds Univ, Fac Pharm, Jerusalem, Israel.	ahmadymm@hotmail.com	Hamarsheh, Omar/AAA-4256-2019; Amro, Ahmad/AAB-1778-2019	Hamarsheh, Omar/0000-0002-3258-9759; Amro, Ahmad/0000-0003-4123-2679; Schoenian, Gabriele/0000-0002-1565-4942	Pastur Institute in Morocco	Pastur Institute in Morocco	The fieldwork and data collection was granted by Pastur Institute in Morocco for Dr. Meryem Lemrani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amro A, 2009, MICROBES INFECT, V11, P484, DOI 10.1016/j.micinf.2009.02.001; Amro A, 2009, T ROY SOC TROP MED H, V103, P731, DOI 10.1016/j.trstmh.2008.10.008; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Azmi K, 2012, T ROY SOC TROP MED H, V106, P554, DOI 10.1016/j.trstmh.2012.06.005; Belkaid P M, 1996, Bull Soc Pathol Exot, V89, P276; Benabdennbi I, 1999, J MED ENTOMOL, V36, P116, DOI 10.1093/jmedent/36.1.116; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GuessousIdrissi N, 1997, PARASITE, V4, P181, DOI 10.1051/parasite/1997042181; Haralambous C, 2007, ACTA TROP, V103, P69, DOI 10.1016/j.actatropica.2007.05.008; Jaffe CL, 2004, TRENDS PARASITOL, V20, P328, DOI 10.1016/j.pt.2004.05.001; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Pesson B, 2004, MED VET ENTOMOL, V18, P25, DOI 10.1111/j.0269-283x.2004.0471.x; Pratlong F, 2004, J CLIN MICROBIOL, V42, P4077, DOI 10.1128/JCM.42.9.4077-4082.2004; Pritchard JK, 2000, GENETICS, V155, P945; Rami M, 2003, PARASITE, V10, P79, DOI 10.1051/parasite/2003101p77; Rhajaoui M, 2007, EMERG INFECT DIS, V13, P1358, DOI 10.3201/eid1309.060946; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; Wright S., 1978, EVOLUTION GENETICS P, P4	28	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77778	10.1371/journal.pone.0077778	http://dx.doi.org/10.1371/journal.pone.0077778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147078	gold, Green Published			2022-12-25	WOS:000326022200075
J	Gharanei, M; Hussain, A; Janneh, O; Maddock, H				Gharanei, Mayel; Hussain, Afthab; Janneh, Omar; Maddock, Helen			Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CONGESTIVE-HEART-FAILURE; INDUCED CARDIOMYOPATHY; CHILDHOOD-CANCER; OXIDATIVE STRESS; BREAST-CANCER; CYTOCHROME-C; CELL-DEATH; FISSION; FRAGMENTATION	Doxorubicin is one of the most effective anti-cancer agents. However, its use is associated with adverse cardiac effects, including cardiomyopathy and progressive heart failure. Given the multiple beneficial effects of the mitochondrial division inhibitor (mdivi-1) in a variety of pathological conditions including heart failure and ischaemia and reperfusion injury, we investigated the effects of mdivi-1 on doxorubicin-induced cardiac dysfunction in naive and stressed conditions using Langendorff perfused heart models and a model of oxidative stress was used to assess the effects of drug treatments on the mitochondrial depolarisation and hypercontracture of cardiac myocytes. Western blot analysis was used to measure the levels of p-Akt and p-Erk 1/2 and flow cytometry analysis was used to measure the levels p-Drp1 and p-p53 upon drug treatment. The HL60 leukaemia cell line was used to evaluate the effects of pharmacological inhibition of mitochondrial division on the cytotoxicity of doxorubicin in a cancer cell line. Doxorubicin caused a significant impairment of cardiac function and increased the infarct size to risk ratio in both naive conditions and during ischaemia/reperfusion injury. Interestingly, co-treatment of doxorubicin with mdivi-1 attenuated these detrimental effects of doxorubicin. Doxorubicin also caused a reduction in the time taken to depolarisation and hypercontracture of cardiac myocytes, which were reversed with mdivi-1. Finally, doxorubicin caused a significant elevation in the levels of signalling proteins p-Akt, p-Erk 1/2, p-Drp1 and p-p53. Co-incubation of mdivi-1 with doxorubicin did not reduce the cytotoxicity of doxorubicin against HL-60 cells. These data suggest that the inhibition of mitochondrial fission protects the heart against doxorubicin-induced cardiac injury and identify mitochondrial fission as a new therapeutic target in ameliorating doxorubicin-induced cardiotoxicity without affecting its anti-cancer properties.	[Gharanei, Mayel; Hussain, Afthab; Janneh, Omar; Maddock, Helen] Coventry Univ, Dept Biomol & Sport Sci, Coventry, W Midlands, England; [Janneh, Omar] Univ London, Div Biomed Sci, London, England	Coventry University; University of London	Maddock, H (corresponding author), Coventry Univ, Dept Biomol & Sport Sci, Coventry, W Midlands, England.	h.maddock@coventry.ac.uk		Hussain, Dr Afthab/0000-0001-8127-4991; Maddock, Helen/0000-0002-6052-1217; Gharanei, Mayel/0000-0002-2411-952X	Coventry University	Coventry University	Funding came from Coventry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Cai C, 2010, J PHARMACOL EXP THER, V335, P223, DOI 10.1124/jpet.110.167965; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen L, 2010, MINERVA CARDIOANGIOL, V58, P213; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Crivellari D, 2000, J CLIN ONCOL, V18, P1412, DOI 10.1200/JCO.2000.18.7.1412; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; Davidson SM, 2006, INT J BIOCHEM CELL B, V38, P414, DOI 10.1016/j.biocel.2005.09.017; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Deres P, 2005, J CARDIOVASC PHARM, V45, P36, DOI 10.1097/00005344-200501000-00007; Doyle JJ, 2005, J CLIN ONCOL, V23, P8597, DOI 10.1200/JCO.2005.02.5841; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; GANEY PE, 1991, CIRC RES, V68, P1610, DOI 10.1161/01.RES.68.6.1610; Geiger S, 2010, ANTI-CANCER DRUG, V21, P578, DOI 10.1097/CAD.0b013e3283394624; Gharanei M, 2013, TOXICOL APPL PHARM, V268, P149, DOI 10.1016/j.taap.2012.12.003; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Granger CB, 2006, CIRCULATION, V114, P2432, DOI 10.1161/CIRCULATIONAHA.106.666248; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Ichihara S, 2007, BIOCHEM BIOPH RES CO, V359, P27, DOI 10.1016/j.bbrc.2007.05.027; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jirkovsky E, 2012, J PHARMACOL EXP THER, V343, P468, DOI 10.1124/jpet.112.198358; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Maddock HL, 2002, AM J PHYSIOL-HEART C, V283, pH1307, DOI 10.1152/ajpheart.00851.2001; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mertens AC, 2008, PEDIATR BLOOD CANCER, V50, P90, DOI 10.1002/pbc.21177; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Montaigne D, 2011, MITOCHONDRION, V11, P22, DOI 10.1016/j.mito.2010.06.001; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Plotnikov EY, 2008, FEBS LETT, V582, P3117, DOI 10.1016/j.febslet.2008.08.002; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; So EC, 2012, EUR J PHARMACOL, V683, P1, DOI 10.1016/j.ejphar.2012.02.012; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zucchi Riccardo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P151, DOI 10.2174/1568011033353434	57	88	94	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77713	10.1371/journal.pone.0077713	http://dx.doi.org/10.1371/journal.pone.0077713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147064	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200068
J	Podoll, AS; Kozar, R; Holcomb, JB; Finkel, KW				Podoll, Amber S.; Kozar, Rosemary; Holcomb, John B.; Finkel, Kevin W.			Incidence and Outcome of Early Acute Kidney Injury in Critically-Ill Trauma Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTENSIVE-CARE-UNIT; HOSPITAL MORTALITY; COHORT ANALYSIS; MULTICENTER; RIFLE; SCORE	Objective: To determine the incidence and effect on mortality of early acute kidney injury in severely injured trauma patients using the Acute Kidney Injury Network creatinine criteria. Design: A retrospective cohort study of severely injured trauma patients admitted to the shock trauma intensive care unit. Setting: Texas Trauma Institute, a state designated level I trauma unit certified by the American College of Surgeons Committee on Trauma. Patients: 901 severely injured trauma patients admitted over a 15 month period to the shock trauma intensive care unit. Interventions: Retrospective analysis of prospectively collected data abstracted from an electronic trauma database. Measurements and Main Results: Of 901 eligible patients admitted to the shock trauma intensive care unit after traumatic injury, 54 patients (6%) developed acute kidney injury, of whom 10 (19%) required renal replacement therapy. The 30-day mortality rate for the entire cohort was 83/901 (9.2%). Patients with early acute kidney injury had a mortality rate of 16/54 (29.6%). When corrected for multiple covariates including injury severity scores, the development of early acute kidney injury was associated with a significantly higher risk of death at 30 days with an OR of 3.4 (95% CI 1.6-7.4). Conclusions: Applying the Acute Kidney Injury Network creatinine criteria in severely injured trauma patients, the incidence of early acute kidney injury was 6%. After correction for injury severity, development of early acute kidney injury was independently associated with significantly higher 30-day mortality.	[Podoll, Amber S.; Finkel, Kevin W.] Univ Texas UT Hlth Sci Ctr Houston, Sch Med, Sect Crit Care Nephrol, Dept Internal Med,Div Renal Dis & Hypertens, Houston, TX USA; [Kozar, Rosemary; Holcomb, John B.] UTHlth Sci Ctr Houston, Sch Med, Trauma & Crit Care Sect, Dept Surg,Div Acute Care Surg,Ctr Translat Injury, Houston, TX USA; [Podoll, Amber S.; Kozar, Rosemary; Holcomb, John B.; Finkel, Kevin W.] UTHlth Sci Ctr Houston, Sch Med, Mem Hermann Hosp, Texas Trauma Inst,Texas Med Ctr, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Finkel, KW (corresponding author), Univ Texas UT Hlth Sci Ctr Houston, Sch Med, Sect Crit Care Nephrol, Dept Internal Med,Div Renal Dis & Hypertens, Houston, TX USA.	kevin.w.finkel@uth.tmc.edu		holcomb, john/0000-0001-8312-9157				Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Ala-Kokko T, 2006, ACTA ANAESTH SCAND, V50, P828, DOI 10.1111/j.1399-6576.2006.01082.x; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Brandt MM, 2007, J TRAUMA, V62, P1362, DOI 10.1097/TA.0b013e318047983d; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kuitunen A, 2006, ANN THORAC SURG, V81, P542, DOI 10.1016/j.athoracsur.2005.07.047; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MORRIS JA, 1991, J TRAUMA, V31, P1584, DOI 10.1097/00005373-199112000-00003; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wohlauer MV, 2012, J TRAUMA ACUTE CARE, V72, P373, DOI 10.1097/TA.0b013e318244869b	15	46	48	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77376	10.1371/journal.pone.0077376	http://dx.doi.org/10.1371/journal.pone.0077376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146987	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200035
J	Mirza, M; Shen, WK; Sofi, A; Tran, C; Jahangir, A; Sultan, S; Khan, U; Viqar, M; Cho, C; Jahangir, A				Mirza, Mahek; Shen, Win-Kuang; Sofi, Aamir; Canh Tran; Jahangir, Ahad; Sultan, Sulaiman; Khan, Uzma; Viqar, Maria; Cho, Chi; Jahangir, Arshad			Frequent Periodic Leg Movement During Sleep Is an Unrecognized Risk Factor for Progression of Atrial Fibrillation	PLOS ONE			English	Article							HEART-RATE RESPONSE; CARDIOVASCULAR-DISEASE; CARDIAC ACTIVATION; AUTONOMIC ACTIVITY; LIMB MOVEMENTS; BLOOD-PRESSURE; TASK-FORCE; ASSOCIATION; APNEA; PATHOPHYSIOLOGY	Sleep apnea has been recognized as a factor predisposing to atrial fibrillation recurrence and progression. The effect of other sleep-disturbing conditions on atrial fibrillation progression is not known. We sought to determine whether frequent periodic leg movement during sleep is a risk factor for progression of atrial fibrillation. In this retrospective study, patients with atrial fibrillation and a clinical suspicion of restless legs syndrome who were referred for polysomnography were divided into two groups based on severity of periodic leg movement during sleep: frequent (periodic movement index >35/h) and infrequent (<= 35/h). Progression of atrial fibrillation to persistent or permanent forms between the two groups was compared using Wilcoxon rank-sum test, chi-square tests and logistic regression analysis. Of 373 patients with atrial fibrillation (77% paroxysmal, 23% persistent), 108 (29%) progressed to persistent or permanent atrial fibrillation during follow-up (median, 33 months; interquartile range, 16-50). Compared to patients with infrequent periodic leg movement during sleep (n=168), patients with frequent periodic leg movement during sleep (n=205) had a higher rate of atrial fibrillation progression (23% vs. 34%; p=0.01). Patients with frequent periodic leg movement during sleep were older and predominantly male; however, there were no significant differences at baseline in clinical factors that promote atrial fibrillation progression between both groups. On multivariate analysis, independent predictors of atrial fibrillation progression were persistent atrial fibrillation at baseline, female gender, hypertension and frequent periodic leg movement during sleep. In patients with frequent periodic leg movement during sleep, dopaminergic therapy for control of leg movements in patients with restless legs syndrome reduced risk of atrial fibrillation progression. Frequent leg movement during sleep in patients with restless legs syndrome is associated with progression of atrial fibrillation to persistent and permanent forms.	[Mirza, Mahek; Cho, Chi; Jahangir, Arshad] Aurora Univ, Wisconsin Med Grp, CIRCA, Milwaukee, WI USA; [Mirza, Mahek; Shen, Win-Kuang; Jahangir, Ahad; Khan, Uzma; Jahangir, Arshad] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA; [Shen, Win-Kuang; Sofi, Aamir; Canh Tran; Sultan, Sulaiman; Viqar, Maria] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Jahangir, A (corresponding author), Aurora Univ, Wisconsin Med Grp, CIRCA, Milwaukee, WI USA.	publishing44@aurora.org	Sofi, Aamir/J-7962-2019; Jahangir, Arshad/M-7916-2016	Cho, Chi/0000-0002-3109-9707	National Heart, Lung, and Blood Institute [RO1 HL101240, R01 HL089542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089542, R01HL101240] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Drs. Jahangir and Mirza's research effort was supported in part by National Heart, Lung, and Blood Institute grants (RO1 HL101240 and R01 HL089542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALI NJ, 1991, SLEEP, V14, P163; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ANCOLIISRAEL S, 1991, SLEEP, V14, P496, DOI 10.1093/sleep/14.6.496; BONNET M, 1993, SLEEP, V16, P748; Braga B, 2009, SLEEP MED, V10, P212, DOI 10.1016/j.sleep.2007.12.007; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; COLEMAN RM, 1980, ANN NEUROL, V8, P416, DOI 10.1002/ana.410080413; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Deguchi Y, 2009, ANN NONINVAS ELECTRO, V14, P280, DOI 10.1111/j.1542-474X.2009.00311.x; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Ferrillo F, 2004, SLEEP MED, V5, P407, DOI 10.1016/j.sleep.2004.01.008; Fuster V, 2006, PUBMED, V116, pe138, DOI [10.1161/ CIRCULATIONAHA. 106.177292, DOI 10.1161/CIRCULATI0NAHA.106.177292.PUBMED:16908781]; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Guggisberg AG, 2007, SLEEP, V30, P755, DOI 10.1093/sleep/30.6.755; Horner RL, 2000, LUNG BIOL HEALTH DIS, V146, P113; Hornyak M, 2007, SLEEP, V30, P861, DOI 10.1093/sleep/30.7.861; Jahangir A, 2007, J APPL PHYSIOL, V103, P2120, DOI 10.1152/japplphysiol.00647.2007; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jahangir A, 2010, J AM COLL CARDIOL, V55, P732, DOI 10.1016/j.jacc.2009.12.010; Javaheri S, 2012, CURR HYPERTENS REP, V14, P442, DOI 10.1007/s11906-012-0289-0; Jongnarangsin K, 2008, J CARDIOVASC ELECTR, V19, P668, DOI 10.1111/j.1540-8167.2008.01118.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lubitz SA, 2010, NAT REV CARDIOL, V7, P451, DOI 10.1038/nrcardio.2010.86; Manconi M, 2011, SLEEP MED, V12, P47, DOI 10.1016/j.sleep.2010.03.019; Mirza M, 2013, J AM SOC ECHOCARDIOG, V26, P783, DOI 10.1016/j.echo.2013.03.018; Mirza M, 2012, CLIN GERIATR MED, V28, P555, DOI 10.1016/j.cger.2012.08.005; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Narkiewicz K, 1998, CIRCULATION, V97, P943; National Institute of Neurological Disorders and Stroke, 2010, OSTL LEGS SYNDR FACT, P10; Nicolas A, 1998, EUR NEUROL, V40, P22, DOI 10.1159/000007951; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Sforza E, 2002, CLIN NEUROPHYSIOL, V113, P883, DOI 10.1016/S1388-2457(02)00066-4; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2005, CLIN NEUROPHYSIOL, V116, P1096, DOI 10.1016/j.clinph.2004.12.018; Sforza E, 1999, NEUROLOGY, V52, P786, DOI 10.1212/WNL.52.4.786; Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]; Spiegelhalder K, 2008, CLIN GERIATR MED, V24, P167, DOI 10.1016/j.cger.2007.08.004; Trenkwalder C, 2010, NAT REV NEUROL, V6, P337, DOI 10.1038/nrneurol.2010.55; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; Varagic J, 2001, CURR OPIN CARDIOL, V16, P336, DOI 10.1097/00001573-200111000-00004; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelman JW, 1999, SLEEP, V22, P575, DOI 10.1093/sleep/22.5.575; Yang CK, 2006, SLEEP, V29, P553, DOI 10.1093/sleep/29.4.553; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001	51	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78359	10.1371/journal.pone.0078359	http://dx.doi.org/10.1371/journal.pone.0078359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147132	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400156
J	Schroder, J; Noack, S; Marhofer, RJ; Mottram, JC; Coombs, GH; Selzer, PM				Schroeder, Joerg; Noack, Sandra; Marhoefer, Richard J.; Mottram, Jeremy C.; Coombs, Graham H.; Selzer, Paul M.			Identification of Semicarbazones, Thiosemicarbazones and Triazine Nitriles as Inhibitors of Leishmania mexicana Cysteine Protease CPB	PLOS ONE			English	Article							CATHEPSIN-B; TRYPANOSOMA-BRUCEI; CRYSTAL-STRUCTURE; SPECIFICITY; DESIGN; CHEMOTHERAPY; PROTEINASES; EXPRESSION; DIFFERENTIATION; VALIDATION	Cysteine proteases of the papain superfamily are present in nearly all eukaryotes. They play pivotal roles in the biology of parasites and inhibition of cysteine proteases is emerging as an important strategy to combat parasitic diseases such as sleeping sickness, Chagas' disease and leishmaniasis. Homology modeling of the mature Leishmania mexicana cysteine protease CPB2.8 suggested that it differs significantly from bovine cathepsin B and thus could be a good drug target. High throughput screening of a compound library against this enzyme and bovine cathepsin B in a counter assay identified four novel inhibitors, containing the warhead-types semicarbazone, thiosemicarbazone and triazine nitrile, that can be used as leads for antiparasite drug design. Covalent docking experiments confirmed the SARs of these lead compounds in an effort to understand the structural elements required for specific inhibition of CPB2.8. This study has provided starting points for the design of selective and highly potent inhibitors of L. mexicana cysteine protease CPB that may also have useful efficacy against other important cysteine proteases.	[Schroeder, Joerg; Noack, Sandra; Marhoefer, Richard J.; Selzer, Paul M.] MSD Anim Hlth Innovat GmbH, Mol Discovery Sci, Schwabenheim, Germany; [Mottram, Jeremy C.; Selzer, Paul M.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Selzer, Paul M.] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	Merck & Company; Intervet International B.V.; University of Glasgow; University of Strathclyde; Eberhard Karls University of Tubingen	Coombs, GH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	graham.coombs@strath.ac.uk; paul.selzer@msd.de		Mottram, Jeremy/0000-0001-5574-3766	MSD Animal Health; MRC [G0700127] Funding Source: UKRI; Medical Research Council [G0700127] Funding Source: researchfish	MSD Animal Health(Merck & CompanyIntervet International B.V.); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JS, SN, RM and PS are or have been paid employees of MSD Animal Health. In that sense MSD Animal Health was the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SC, 2005, ANTIMICROB AGENTS CH, V49, P5160, DOI 10.1128/AAC.49.12.5160-5161.2005; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Brickmann J, 2000, J MOL MODEL, V6, P328, DOI 10.1007/s0089400060328; Brooks DR, 2001, J BIOL CHEM, V276, P47061, DOI 10.1074/jbc.M108498200; BURDEN FR, 1989, J CHEM INF COMP SCI, V29, P225, DOI 10.1021/ci00063a011; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2011, ADV EXP MED BIOL, V712, P84, DOI 10.1007/978-1-4419-8414-2_6; Castanys-Munoz E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.113; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Du XH, 2002, J MED CHEM, V45, P2695, DOI 10.1021/jm010459j; EAKIN AE, 1993, J BIOL CHEM, V268, P6115; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Frame MJ, 2000, PARASITOLOGY, V121, P367, DOI 10.1017/S0031182099006435; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; HASNAIN S, 1993, J BIOL CHEM, V268, P235; Hernandez AA, 2002, CURR OPIN CHEM BIOL, V6, P459, DOI 10.1016/S1367-5931(02)00345-9; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Ihlenfeldt WD, 2002, J CHEM INF COMP SCI, V42, P46, DOI 10.1021/ci010056s; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; KARGEL HJ, 1980, FEBS LETT, V114, P257, DOI 10.1016/0014-5793(80)81128-8; Katunuma N, 2011, P JPN ACAD B-PHYS, V87, P29, DOI 10.2183/pjab.87.29; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Li RS, 1996, BIOORGAN MED CHEM, V4, P1421, DOI 10.1016/0968-0896(96)00136-8; Macarron R, 2006, DRUG DISCOV TODAY, V11, P277, DOI 10.1016/j.drudis.2006.02.001; MCGRATH ME, 1995, J MOL BIOL, V247, P251, DOI 10.1006/jmbi.1994.0137; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Oprea TI, 2000, MOL DIVERS, V5, P199, DOI 10.1023/A:1021368007777; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pearlman RS, 1999, J CHEM INF COMP SCI, V39, P28, DOI 10.1021/ci980137x; Pearlman RS, 1998, PERSPECT DRUG DISCOV, V9-11, P339, DOI 10.1023/A:1027232610247; Proto WR, 2011, J BIOL CHEM, V286, P39914, DOI 10.1074/jbc.M111.292334; Rankovic Z, 2010, BIOORG MED CHEM LETT, V20, P1524, DOI 10.1016/j.bmcl.2010.01.100; Robertson CD, 1996, PERSPECT DRUG DISCOV, V6, P99, DOI 10.1007/BF02174048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanderson SJ, 2000, BIOCHEM J, V347, P383, DOI 10.1042/0264-6021:3470383; Schaeffer M, 2012, ANTIMICROB AGENTS CH, V56, P1190, DOI 10.1128/AAC.05528-11; Schroder J, 2013, J MED CHEM, V56, P1478, DOI 10.1021/jm3013932; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; Selzer PM, 1997, EXP PARASITOL, V87, P212, DOI 10.1006/expr.1997.4220; Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; Spencer RW, 1998, BIOTECHNOL BIOENG, V61, P61, DOI 10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO;2-C; St Hilaire PM, 2000, CHEMBIOCHEM, V1, P115, DOI 10.1002/1439-7633(20000818)1:2<115::AID-CBIC115>3.3.CO;2-#; Steert K, 2010, CHEMMEDCHEM, V5, P1734, DOI 10.1002/cmdc.201000265; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yamamoto A, 2000, J BIOCHEM-TOKYO, V127, P635, DOI 10.1093/oxfordjournals.jbchem.a022651; Yamashita DS, 1997, J AM CHEM SOC, V119, P11351, DOI 10.1021/ja972204u; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	58	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77460	10.1371/journal.pone.0077460	http://dx.doi.org/10.1371/journal.pone.0077460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146999	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000326019400110
J	Giakoumi, S; Sini, M; Gerovasileiou, V; Mazor, T; Beher, J; Possingham, HP; Abdulla, A; Cinar, ME; Dendrinos, P; Gucu, AC; Karamanlidis, AA; Rodic, P; Panayotidis, P; Taskin, E; Jaklin, A; Voultsiadou, E; Webster, C; Zenetos, A; Katsanevakis, S				Giakoumi, Sylvaine; Sini, Maria; Gerovasileiou, Vasilis; Mazor, Tessa; Beher, Jutta; Possingham, Hugh P.; Abdulla, Ameer; Cinar, Melih Ertan; Dendrinos, Panagiotis; Gucu, Ali Cemal; Karamanlidis, Alexandros A.; Rodic, Petra; Panayotidis, Panayotis; Taskin, Ergun; Jaklin, Andrej; Voultsiadou, Eleni; Webster, Chloe; Zenetos, Argyro; Katsanevakis, Stelios			Ecoregion-Based Conservation Planning in the Mediterranean: Dealing with Large-Scale Heterogeneity	PLOS ONE			English	Article							MARINE PROTECTED AREAS; POSIDONIA-OCEANICA MEADOWS; FISH ASSEMBLAGES; CORALLIGENOUS ASSEMBLAGES; PARAMURICEA-CLAVATA; TRADE-OFFS; SEA; SEAGRASS; COASTAL; BIODIVERSITY	Spatial priorities for the conservation of three key Mediterranean habitats, i.e. seagrass Posidonia oceanica meadows, coralligenous formations, and marine caves, were determined through a systematic planning approach. Available information on the distribution of these habitats across the entire Mediterranean Sea was compiled to produce basin-scale distribution maps. Conservation targets for each habitat type were set according to European Union guidelines. Surrogates were used to estimate the spatial variation of opportunity cost for commercial, non-commercial fishing, and aquaculture. Marxan conservation planning software was used to evaluate the comparative utility of two planning scenarios: (a) a whole-basin scenario, referring to selection of priority areas across the whole Mediterranean Sea, and (b) an ecoregional scenario, in which priority areas were selected within eight predefined ecoregions. Although both scenarios required approximately the same total area to be protected in order to achieve conservation targets, the opportunity cost differed between them. The whole-basin scenario yielded a lower opportunity cost, but the Alboran Sea ecoregion was not represented and priority areas were predominantly located in the Ionian, Aegean, and Adriatic Seas. In comparison, the ecoregional scenario resulted in a higher representation of ecoregions and a more even distribution of priority areas, albeit with a higher opportunity cost. We suggest that planning at the ecoregional level ensures better representativeness of the selected conservation features and adequate protection of species, functional, and genetic diversity across the basin. While there are several initiatives that identify priority areas in the Mediterranean Sea, our approach is novel as it combines three issues: (a) it is based on the distribution of habitats and not species, which was rarely the case in previous efforts, (b) it considers spatial variability of cost throughout this socioeconomically heterogeneous basin, and (c) it adopts ecoregions as the most appropriate level for large-scale planning.	[Giakoumi, Sylvaine; Zenetos, Argyro] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Ag Kosmas, Greece; [Giakoumi, Sylvaine; Mazor, Tessa; Beher, Jutta; Possingham, Hugh P.; Abdulla, Ameer] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Sini, Maria] Univ Aegean, Dept Marine Sci, Mitilini, Lesvos Island, Greece; [Gerovasileiou, Vasilis; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece; [Abdulla, Ameer] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Cinar, Melih Ertan] Ege Univ, Fac Fisheries, Dept Hydrobiol, Izmir, Turkey; [Dendrinos, Panagiotis; Karamanlidis, Alexandros A.] MOm Hellen Soc Study & Protect Monk Seal, Athens, Greece; [Gucu, Ali Cemal] Middle E Tech Univ, Inst Marine Sci, Erdemli, Mersin, Turkey; [Rodic, Petra] State Inst Nat Protect, Zagreb, Croatia; [Panayotidis, Panayotis] Hellen Ctr Marine Res, Inst Oceanog, Anavyssos, Greece; [Taskin, Ergun] Celal Bayar Univ, Fac Arts & Sci, Dept Biol, Manisa, Turkey; [Jaklin, Andrej] Rudjer Boskovic Inst Zagreb, Ctr Marine Res Rovinj, Zagreb, Croatia; [Webster, Chloe] Network Managers Marine Protected Areas Mediterra, MedPAN, Marseille, France; [Katsanevakis, Stelios] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, I-21020 Ispra, Italy	Hellenic Centre for Marine Research; University of Queensland; University of Aegean; Aristotle University of Thessaloniki; Ege University; Middle East Technical University; Hellenic Centre for Marine Research; Celal Bayar University; University of Zagreb; European Commission Joint Research Centre; EC JRC ISPRA Site	Giakoumi, S (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Ag Kosmas, Greece.	sylvaine@aegean.gr	Gücü, Ali/ABA-3135-2020; Karamanlidis, Alexandros/S-8239-2017; Giakoumi, Sylvaine/I-2702-2014; TASKIN, ERGUN/C-3828-2014; POSSINGHAM, HUGH/R-8310-2019; Zenetos, Argyro/AAS-3208-2020; Possingham, Hugh/B-1337-2008; TASKIN, ERGUN/AAE-3163-2020; Mazor, Tessa/G-2017-2012; Voultsiadou, Eleni/P-9890-2017; Katsanevakis, Stelios/AGR-7012-2022; Katsanevakis, Stelios/AAD-8289-2020; Gerovasileiou, Vasilis/H-6376-2019; GUCU, Ali Cemal/ABI-4301-2020; beher, jutta/AAQ-5350-2020; CINAR, Melih Ertan/H-3737-2013	Karamanlidis, Alexandros/0000-0003-0943-1619; POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; TASKIN, ERGUN/0000-0003-0531-4546; Mazor, Tessa/0000-0001-7307-5693; Voultsiadou, Eleni/0000-0003-3429-6754; Katsanevakis, Stelios/0000-0002-5137-7540; Gerovasileiou, Vasilis/0000-0002-9143-7480; GUCU, Ali Cemal/0000-0001-9727-5358; beher, jutta/0000-0003-2119-0440; SINI, MARIA/0000-0002-9608-3503; CINAR, Melih Ertan/0000-0002-1802-2801; Giakoumi, Sylvaine/0000-0002-3301-5538	European Social Fund (ESF); Greek State	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	This work is a contribution of the project "NETMED" implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and is co-financed by the European Social Fund (ESF) and the Greek State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiati M, 2009, P 1 S CONS COR BIOC, P269; Abdulahi A., 2008, Safflower: unexploited potential and world adaptability. 7th International Safflower Conference, Wagga Wagga, New South Wales, Australia, 3-6 November, 2008., P1; Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Annoni A, 2001, 20120 EUR EUR COMM; [Anonymous], 2009, BUILDINGS CLIMATE CH, P1; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ballesteros E., 2003, CORALLIGENOUS MEDITE, P1; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Bianchi Carlo Nike, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P39; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bonacorsi M, 2013, MEDITERR MAR SCI, V14, P193, DOI 10.12681/mms.334; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Boudouresque C.F., 2012, RAMOGE PUBLICATION, P1, DOI DOI 10.1007/S10750-015-2333-Y; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Bussoletti E, 2010, P INT WORKSH RED COR, P1; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Celebi B., 2006, BIOL MARINA MEDITERR, V13, P34; Cerrano C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P235; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Cicogna F., 2003, GROTTE MARINE CINQUA, P1; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Conides A., 2007, STATE HELLENIC FISHE, P172; CREOCEAN-DREAL, 2010, REC GROTT SUBM SEM L, P1; Dendrinos P, 2007, MAR MAMMAL SCI, V23, P615, DOI 10.1111/j.1748-7692.2007.00121.x; Doerries MB, 2003, DEEP-SEA RES PT I, V50, P749, DOI 10.1016/S0967-0637(03)00052-9; European Commission, 2008, EUR STAT FOC AGR FIS; FAO, 2011, GFCM TASK 1 STAT B 2, V2008; FAO, 2010, GLOB EUR PRIC REP; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Francour P, 2006, MANAGEMENT GUIDE MAR; Fraschetti S, 2009, MAR ECOL PROG SER, V375, P13, DOI 10.3354/meps07781; Fraschetti S, 2008, J EXP MAR BIOL ECOL, V366, P109, DOI 10.1016/j.jembe.2008.07.015; Gabrie C, 2012, STATUT AIRES MARINES, P1; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Gaudin C, 2007, STUDIES REV, P1; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Giakoumi S, 2012, AQUAT CONSERV, V22, P762, DOI 10.1002/aqc.2273; Giakoumi S, 2012, REV FISH BIOL FISHER, V22, P943, DOI 10.1007/s11160-012-9272-8; Giakoumi S, 2011, BIOL CONSERV, V144, P753, DOI 10.1016/j.biocon.2010.11.006; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Harmelin J.-G., 1985, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V29, P149; Harmelin JG, 1997, VIE MILIEU, V47, P351; HARMELIN JG, 1985, TETHYS, V11, P214; ICES CM, 2008, 1 RES PIL SURV RECR, P15; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/nclimate1533, 10.1038/NCLIMATE1533]; Kalogirou S, 2010, J FISH BIOL, V77, P2338, DOI 10.1111/j.1095-8649.2010.02817.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Maldonado M, 2013, MAR ECOL PROG SER, V479, P127, DOI 10.3354/meps10172; MAPAMED, 2013, DAT MED MAR PROT AR; Marba N, 2002, ENVIRON CONSERV, V29, P509, DOI 10.1017/S037689290200036X; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059038; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; MOm, 2009, ANN TECHN REP 2008 S, P1; Montefalcone M, 2007, MAR POLLUT BULL, V54, P206, DOI 10.1016/j.marpolbul.2006.10.005; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Moranta J, 2006, ESTUAR COAST SHELF S, V68, P579, DOI 10.1016/j.ecss.2006.03.008; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Notarbartolo diSciara G, 2010, OVERVIEW SCI FINDING; OCEANA, 2008, EST BION CABR EST BI, P1; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pergent G., 2012, MEDITERRANEAN SEAGRA; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2012, MAR POLLUT BULL, V64, P2623, DOI 10.1016/j.marpolbul.2012.07.027; Portman ME, 2013, MAR POLICY, V42, P270, DOI 10.1016/j.marpol.2013.03.004; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Riedl R., 1966, BIOL MEERESHOHLEN, P1; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Rovere A, 2011, AQUAT CONSERV, V21, P541, DOI 10.1002/aqc.1214; Salomidi M, 2012, MEDITERR MAR SCI, V13, P49, DOI 10.12681/mms.23; Sartoretto S, 1997, J MAR BIOL ASSOC UK, V77, P565, DOI 10.1017/S0025315400071885; SPA/BD, 1995, BARC CONV BARC 9 10; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spalding MD, 2012, OCEAN COAST MANAGE, V60, P19, DOI 10.1016/j.ocecoaman.2011.12.016; Stewart IS, 2009, COASTAL GEOMORPHOLOG, P385; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Suric M, 2010, ENVIRON EARTH SCI, V61, P1473, DOI 10.1007/s12665-010-0463-0; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Tulloch VJ, BIOL CONSER IN PRESS, V162, P41; Unal V, 2010, MEDITERR MAR SCI, V11, P315, DOI 10.12681/mms.79; UNEP-MAP-RAC/SPA, 2008, ACTION PLAN CONSERVA, P1; UNEP-MAP-RAC/SPA, PROP MIS PL IN PRESS, P1; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Ward TJ, 1999, ECOL APPL, V9, P691; Watling L, 2013, PROG OCEANOGR, V111, P91, DOI 10.1016/j.pocean.2012.11.003; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327	119	130	132	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76449	10.1371/journal.pone.0076449	http://dx.doi.org/10.1371/journal.pone.0076449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155901	Green Published, gold			2022-12-25	WOS:000325887300035
J	Hughes, CM; Damon, IK; Reynolds, MG				Hughes, Christine M.; Damon, Inger K.; Reynolds, Mary G.			Understanding US Healthcare Providers' Practices and Experiences with Molluscum Contagiosum	PLOS ONE			English	Article							PULSED DYE-LASER; EPIDEMIOLOGY; INFECTION; CHILDREN	Introduction: Molluscum contagiosum is a common superficial skin infection caused by the poxvirus, Molluscum Contagiosum virus. The study objective is to obtain a better understanding of physician practices and experiences with molluscum contagiosum in order to focus informational and guidance material. Methods: A cross-sectional survey to assess medical practitioners' knowledge and practices with molluscum contagiosum was conducted using the 2009 DocStyles survey. Questions regarding category and number of molluscum contagiosum patients seen, treatments used and advice given to patients were included in the survey. Results: Dermatologists saw the most cases, with the majority seeing 51-100 molluscum contagiosum cases/year. The most common cases seen were children with multiple lesions and adults with genital lesions. Respondents were most likely to recommend treatment to immunocompromised individuals, HIV patients, adults with genital lesions and children with multiple lesions. Cryotherapy was the top choice for all specialties with the exception of OB/GYNs, whose top choice was curettage. "Avoid intimate contact until lesions resolve'', "Avoid touching lesions to reduce further spread'', and "Don't be concerned, this will go away'' were the top advice choices. Discussion: Most survey respondents have dealt with molluscum contagiosum in their practice during the previous year. Overall, respondents picked appropriate choices for treatment and advice given; however some ineffective or unnecessary treatments were chosen and recommendations to prevent spread were chosen infrequently. Knowledge gaps for appropriate transmission precaution advice might cause unnecessary spread or autoinoculation. This survey has demonstrated that molluscum contagiosum is a common infection seen by many types of practitioners and therefore guidance on treatment considerations and infection control is valuable.	[Hughes, Christine M.; Damon, Inger K.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Hughes, CM (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Atlanta, GA 30329 USA.	christine.hughes@cdc.hhs.gov		Reynolds, Mary/0000-0001-7882-4614	U.S. federal government - Centers for Disease Control and Prevention (CDC)	U.S. federal government - Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. federal government - Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER MW, 1984, BRIT MED J, V288, P213, DOI 10.1136/bmj.288.6412.213; BECKER TM, 1986, SEX TRANSM DIS, V13, P88, DOI 10.1097/00007435-198604000-00007; Berger EM, 2012, ARCH DERMATOL, V20, P1; Binder B, 2008, J DTSCH DERMATOL GES, V6, P121, DOI 10.1111/j.1610-0387.2007.06556.x; Braue A, 2005, PEDIATR DERMATOL, V22, P287, DOI 10.1111/j.1525-1470.2005.22401.x; Brown T, 2005, J AM ACAD DERMATOL, V52, P715, DOI 10.1016/j.jaad.2004.10.861; Campanelli Alexandre, 2005, J Am Acad Dermatol, V52, pE1, DOI 10.1016/j.jaad.2004.10.858; CASTILLA MT, 1995, DERMATOLOGY, V191, P165, DOI 10.1159/000246540; Choong K Y, 1999, Australas J Dermatol, V40, P89, DOI 10.1046/j.1440-0960.1999.00327.x; Cohen JI, 2012, J INFECT DIS, V205, P794, DOI 10.1093/infdis/jir853; Coloe J, 2009, PEDIATR ANN, V38, P321, DOI 10.3928/00904481-20090513-01; Coloe J, 2009, PEDIATR DERMATOL, V26, P405, DOI 10.1111/j.1525-1470.2008.00860.x; COTTON DWK, 1987, BRIT J DERMATOL, V116, P871, DOI 10.1111/j.1365-2133.1987.tb04908.x; Dohil MA, 2006, J AM ACAD DERMATOL, V54, P47, DOI 10.1016/j.jaad.2005.08.035; Hancox JG, 2003, CUTIS, V71, P414; Hanna D, 2006, PEDIATR DERMATOL, V23, P574, DOI 10.1111/j.1525-1470.2006.00313.x; Hayashida S, 2010, J DERMATOL SCI, V60, P173, DOI 10.1016/j.jdermsci.2010.09.003; HUGHES WT, 1991, PEDIATR INFECT DIS J, V10, P152, DOI 10.1097/00006454-199102000-00015; Lee B, 2004, J AM ACAD DERMATOL, V51, P478, DOI 10.1016/j.jaad.2003.12.047; Medicis Pharmaceutical Corporation, PACK INS ZYCL IM CRE; Mosher JS, 2012, PEDIATRICS, V129, pE519, DOI 10.1542/peds.2011-0936; NIIZEKI K, 1984, DERMATOLOGICA, V169, P197, DOI 10.1159/000249604; Pannell RS, 2005, EPIDEMIOL INFECT, V133, P985, DOI 10.1017/S0950268805004425; Pickering LK, 2012, RED BOOK 2012 REPORT, P511; Reynolds MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005255; Rich JD, 1999, CLIN INFECT DIS, V28, P1171, DOI 10.1086/517770; SCHWARTZ JJ, 1992, J AM ACAD DERMATOL, V27, P583, DOI 10.1016/0190-9622(92)70226-6; Villa L, 2010, SEX TRANSM DIS, V37, P423, DOI 10.1097/OLQ.0b013e3181cfca1c	28	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76948	10.1371/journal.pone.0076948	http://dx.doi.org/10.1371/journal.pone.0076948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155912	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300046
J	Nandakumar, KV; Duraisamy, K; Balakrishnan, S; Sunilkumar, M; Sankar, SJ; Sagili, KD; Satyanarayana, S; Kumar, MVA; Enarson, DA				Nandakumar, K., V; Duraisamy, Karthickeyan; Balakrishnan, Shibu; Sunilkumar, M.; Sankar, Jaya S.; Sagili, Karuna D.; Satyanarayana, Srinath; Kumar, Ajay M., V; Enarson, Donald A.			Outcome of Tuberculosis Treatment in Patients with Diabetes Mellitus Treated in the Revised National Tuberculosis Control Programme in Malappuram District, Kerala, India	PLOS ONE			English	Article							IMPACT	Settings: Kerala State, India has reported the greatest dual burden of Tuberculosis (TB) and Diabetes Mellitus (DM). Malappuram district in Kerala has monitored and recorded DM status and its control from 2010 under Revised National Tuberculosis Control Program (RNTCP). Objectives: To assess, under programme conditions, comprehensiveness of recording DM status among TB cases and the TB treatment outcomes among DM patients (disaggregated by glycemic control) and compare with-non DM patients. Design: This retrospective record review included 3,116TB patients from April 2010 to September 2011. DM was defined as per international guidelines and TB treatment outcomes were categorized as favourable(cured and treatment completed) and unfavourable(death, default, failure and transfer out). Relative Risk (RR) and 95% confidence intervals(CI) were calculated to assess the risk of unfavourable outcomes. Results: DM status was recorded in 90% of TB cases and 667 (24%) had DM. 17% of DM patients and 23% of patients with unknown DM status had unfavourable outcomes but this difference was not statistically significant. Unadjusted RR for poor glycemic control or unknown control status for unfavourable outcome were (2.00; 95% CI 0.97-4.13) and (2.14; 95% CI 1.11-4.13). Conclusion: This study could not confirm an adverse association between DM or its control during treatment and the course of response to TB treatment. DM screening in TB cases and recording of DM care needs to be improved to enable more conclusive evidence.	[Nandakumar, K., V] Dist TB Ctr, Manjeri, Kerala, India; [Duraisamy, Karthickeyan; Balakrishnan, Shibu] WHO Country Off India, Dept TB, New Delhi, India; [Sunilkumar, M.] State TB Training & Demonstrat Ctr, Trivandrum, Kerala, India; [Sankar, Jaya S.] State TB Cell, Trivandrum, Kerala, India; [Sagili, Karuna D.; Satyanarayana, Srinath; Kumar, Ajay M., V] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Enarson, Donald A.] Int Union TB & Lung Dis, Montreal, PQ, Canada		Nandakumar, KV (corresponding author), Dist TB Ctr, Manjeri, Kerala, India.	dr.nandakumar.k.v.66@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). Funders had no role in study design, data collection, analysis or interpretation of data. The contents of this paper do not necessarily reflect the views of USAID or the United States Government.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balakrishnan S, 2012, PLOS ONE, V7; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; HemalathaSuryakant, 2012, GJP ASC TECH, V02; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumar A, 2013, TROP MED INT HEALTH, V18, P646, DOI 10.1111/tmi.12083; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Morrato EH, 2006, DIABETES CARE, V29, P543, DOI 10.2337/diacare.29.03.06.dc05-2165; Niaz AK, 2012, J DIABETES METABOLIC; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Restrepo BI, 2008, AM J TROP MED HYG, V79, P541, DOI 10.4269/ajtmh.2008.79.541; Sen Tiyas, 2009, J Assoc Physicians India, V57, P660; Suleiman SAS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/645362; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WHO, 2011, COLLABORATIVE FRAMEW; World Health Organization, 2006, DEF DIAGN DIAB MELL	26	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76275	10.1371/journal.pone.0076275	http://dx.doi.org/10.1371/journal.pone.0076275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155897	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300031
J	Wu, XY; Li, YR; Wang, JH; Wen, X; Marcus, MT; Daniels, G; Zhang, DY; Ye, F; Wang, LH; Du, XX; Adams, S; Singh, B; Zavadil, J; Lee, P; Monaco, ME				Wu, Xinyu; Li, Yirong; Wang, Jinhua; Wen, Xin; Marcus, Max T.; Daniels, Garrett; Zhang, David Y.; Ye, Fei; Wang, Ling Hang; Du, Xinxin; Adams, Sylvia; Singh, Baljit; Zavadil, Jiri; Lee, Peng; Monaco, Marie E.			Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; BASAL-LIKE; IDENTIFICATION; PATHWAY; PROGNOSIS; MECHANISMS; SELECTION; EFFICACY	The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor a (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.	[Wu, Xinyu; Marcus, Max T.; Monaco, Marie E.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [Li, Yirong; Daniels, Garrett; Wang, Ling Hang; Du, Xinxin; Singh, Baljit; Zavadil, Jiri; Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wang, Jinhua; Wen, Xin] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Adams, Sylvia] NYU, Dept Med, Sch Med, New York, NY 10016 USA; [Wang, Jinhua; Wen, Xin; Adams, Sylvia; Singh, Baljit; Zavadil, Jiri; Lee, Peng; Monaco, Marie E.] NYU, NYU Canc Inst, Sch Med, New York, NY 10016 USA; [Wang, Jinhua; Wen, Xin] NYU, NYU Ctr Hlth Informat & Bioinformat, Sch Med, New York, NY 10016 USA; [Zhang, David Y.; Ye, Fei] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Lee, Peng; Monaco, Marie E.] VA New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai	Lee, P (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY USA.	peng.lee@nyumc.org; mem6@nyu.edu	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Adams, Sylvia/0000-0003-4737-1952	Department of Defense [W81XWH-09-1-0572]; NYU School of Medicine's Clinical and Translational Science Institute [1UL1RR029893]; New York University Molecular Oncology and Immunology Training grant [T32CA009161]; NATIONAL CANCER INSTITUTE [T32CA009161, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NYU School of Medicine's Clinical and Translational Science Institute; New York University Molecular Oncology and Immunology Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Department of Defense, W81XWH-09-1-0572, to Marie Monaco (https://cdmrp.org/); by a grant from NYU School of Medicine's Clinical and Translational Science Institute (1UL1RR029893) to Peng Lee (www.nyumc.org); and by the New York University Molecular Oncology and Immunology Training grant (T32CA009161) to Garrett Daniels (www.nyumc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Black PN, 2000, J NUTR, V130, p305S, DOI 10.1093/jn/130.2.305S; Cai CQ, 2008, ONCOGENE, V27, P3201, DOI 10.1038/sj.onc.1210983; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Curigliano Giuseppe, 2011, Journal of the National Cancer Institute Monographs, P108, DOI 10.1093/jncimonographs/lgr038; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; EMAD A, 2007, CANCER, V109, P25, DOI DOI 10.1002/CNCR.22381.PUBMED:17146782; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Gucalp A, 2010, CANCER J, V16, P62, DOI 10.1097/PPO.0b013e3181ce4ae1; He J, 2011, MED ONCOL, V28, P1218, DOI 10.1007/s12032-010-9651-8; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Kantojarvi K, 2011, AUTISM RES, V4, P228, DOI 10.1002/aur.187; Klopocki E, 2004, INT J ONCOL, V25, P641; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liang YC, 2005, WORLD J GASTROENTERO, V11, P2557, DOI 10.3748/wjg.v11.i17.2557; Luo Xiang, 2010, Chin J Cancer, V29, P585; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Maloberti PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015540; Mashima T, 2009, ONCOGENE, V28, P9, DOI 10.1038/onc.2008.355; Mashima T, 2009, CANCER SCI, V100, P1556, DOI 10.1111/j.1349-7006.2009.01203.x; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Meloni I, 2002, NAT GENET, V30, P436, DOI 10.1038/ng857; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Ogawa Y, 2008, INT J CLIN ONCOL, V13, P431, DOI 10.1007/s10147-008-0770-6; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Orlando UD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040794; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sirchia SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005559; Stepanova M, 2010, OBES SURG, V20, P640, DOI 10.1007/s11695-010-0078-2; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Taneja S, 2001, P NATL ACAD SCI USA, V98, P8804, DOI 10.1073/pnas.161011798; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Wang DG, 2011, AM J PATHOL, V179, P1657, DOI 10.1016/j.ajpath.2011.06.010; Wang HX, 2011, MUTAT RES-GEN TOX EN, V723, P171, DOI 10.1016/j.mrgentox.2011.04.008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Ye F, 2009, NUTR CANCER, V61, P530, DOI 10.1080/01635580902803719; Yu Q, 2011, ANN ONCOL, V22, P1288, DOI 10.1093/annonc/mdq586; Zhang Dakang, 2009, Cement Engineering, P4	52	47	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77060	10.1371/journal.pone.0077060	http://dx.doi.org/10.1371/journal.pone.0077060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155918	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300052
J	Zhong, W; Zhao, YT; Sun, XG; Song, ZY; McClain, CJ; Zhou, ZX				Zhong, Wei; Zhao, Yantao; Sun, Xinguo; Song, Zhenyuan; McClain, Craig J.; Zhou, Zhanxiang			Dietary Zinc Deficiency Exaggerates Ethanol-Induced Liver Injury in Mice: Involvement of Intrahepatic and Extrahepatic Factors	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; OXIDATIVE-STRESS; ADIPOSE-TISSUE; DISEASE; ACID; HOMEOSTASIS; EXPRESSION; BARRIER; GUT; ADIPONECTIN	Clinical studies have demonstrated that alcoholics have a lower dietary zinc intake compared to health controls. The present study was undertaken to determine the interaction between dietary zinc deficiency and ethanol consumption in the pathogenesis of alcoholic liver disease. C57BL/6N mice were subjected to 8-week feeding of 4 experimental liquid diets: (1) zinc adequate diet, (2) zinc adequate diet plus ethanol, (3) zinc deficient diet, and (4) zinc deficient diet plus ethanol. Ethanol exposure with adequate dietary zinc resulted in liver damage as indicated by elevated plasma alanine aminotransferase level and increased hepatic lipid accumulation and inflammatory cell infiltration. Dietary zinc deficiency alone increased hepatic lipid contents, but did not induce hepatic inflammation. Dietary zinc deficiency showed synergistic effects on ethanol-induced liver damage. Dietary zinc deficiency exaggerated ethanol effects on hepatic genes related to lipid metabolism and inflammatory response. Dietary zinc deficiency worsened ethanol-induced imbalance between hepatic pro-oxidant and antioxidant enzymes and hepatic expression of cell death receptors. Dietary zinc deficiency exaggerated ethanol-induced reduction of plasma leptin, although it did not affect ethanol-induced reduction of white adipose tissue mass. Dietary zinc deficiency also deteriorated ethanol-induced gut permeability increase and plasma endotoxin elevation. These results demonstrate, for the first time, that dietary zinc deficiency is a risk factor in alcoholic liver disease, and multiple intrahepatic and extrahepatic factors may mediate the detrimental effects of zinc deficiency.	[Zhong, Wei; Sun, Xinguo; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Zhou, Zhanxiang] Univ North Carolina Greensboro, Dept Nutr, Kannapolis, NC USA; [Zhao, Yantao; McClain, Craig J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McClain, Craig J.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig J.] Robley Rex Louisville VAMC, Louisville, KY USA; [Song, Zhenyuan] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Louisville; University of Louisville; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, ZX (corresponding author), Univ North Carolina Greensboro, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC USA.	z_zhou@uncg.edu			National Institutes of Health [R01AA018844, R01AA020212, P01AA 017103, R37AA 010742]; Veterans Administration; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018844, U01AA021901, P01AA017103, R01AA020212, R01AA016013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by the National Institutes of Health grants R01AA018844 (Z.Z.), R01AA020212 (Z.Z.), P01AA 017103 (CJM), R37AA 010742 (C.J.M.); and the Veterans Administration (CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Bergheim I, 2003, EUR J CLIN NUTR, V57, P431, DOI 10.1038/sj.ejcn.1601557; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Cabre M, 2001, INT J VITAM NUTR RES, V71, P229, DOI 10.1024/0300-9831.71.4.229; Chen XC, 2007, AM J PHYSIOL-ENDOC M, V292, pE621, DOI 10.1152/ajpendo.00387.2006; Crabb David W, 2007, Novartis Found Symp, V285, P4; De Minicis S, 2008, J GASTROEN HEPATOL, V23, pS98, DOI 10.1111/j.1440-1746.2007.05277.x; Dieck HT, 2005, J NUTR, V135, P199, DOI 10.1093/jn/135.2.199; Farrell CP, 2011, GASTROENTEROL RES, V4, P243, DOI 10.4021/gr379w; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jing L, 2012, MOL CELL BIOCHEM, V359, P283, DOI 10.1007/s11010-011-1022-z; Kang M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-91; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Kim JY, 2007, J AM COLL NUTR, V26, P1; Li Q, 2013, ALCOHOL CLIN EXP RES, V37, P587, DOI 10.1111/acer.12013; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; Lu ZH, 2003, BIOCHEM BIOPH RES CO, V303, P1002, DOI 10.1016/S0006-291X(03)00449-2; Maher Jacquelyn J, 2002, Semin Gastrointest Dis, V13, P31; Manari AP, 2003, ADDICT BIOL, V8, P201, DOI 10.1080/1355621031000117437; MCCLAIN CJ, 1983, ALCOHOL CLIN EXP RES, V7, P5, DOI 10.1111/j.1530-0277.1983.tb05402.x; McClain CJ, 2002, ALCOHOL, V27, P185, DOI 10.1016/S0741-8329(02)00224-0; MILMAN N, 1983, SCAND J GASTROENTERO, V18, P871, DOI 10.3109/00365528309182108; PERSSON J, 1990, SCAND J GASTROENTERO, V25, P173, DOI 10.3109/00365529009107940; Pravdova E, 2009, Endocr Regul, V43, P117; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Schmitz H, 1999, J CELL SCI, V112, P137; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Shen H, 2007, J NUTR, V137, P2339, DOI 10.1093/jn/137.11.2339; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Tan XB, 2012, AM J PATHOL, V181, P1279, DOI 10.1016/j.ajpath.2012.06.013; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055382; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Yousef MI, 2002, TOXICOLOGY, V175, P223, DOI 10.1016/S0300-483X(02)00049-5; Zhao YT, 2011, AM J PATHOL, V179, P693, DOI 10.1016/j.ajpath.2011.04.006; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009; Zhou SL, 1998, HEPATOLOGY, V27, P1064, DOI 10.1002/hep.510270423; Zhou ZX, 2010, DIGEST DIS, V28, P745, DOI 10.1159/000324282; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	52	47	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76522	10.1371/journal.pone.0076522	http://dx.doi.org/10.1371/journal.pone.0076522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155903	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300037
J	Wang, J; Li, MX; Ma, XR; Bai, KH; Wang, L; Yan, Z; Lv, TT; Zhao, ZQ; Zhao, RR; Liu, HR				Wang, Jin; Li, Meixia; Ma, Xiurui; Bai, Kehua; Wang, Li; Yan, Zi; Lv, Tingting; Zhao, Zhiqing; Zhao, Rongrui; Liu, Huirong			Autoantibodies against the beta(3)-Adrenoceptor Protect from Cardiac Dysfunction in a Rat Model of Pressure Overload	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; FUNCTIONAL AUTOIMMUNE EPITOPE; LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; BETA-1-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTORS; INTERNATIONAL-SOCIETY; SERUM AUTOANTIBODIES; UP-REGULATION; BETA(1)-ADRENOCEPTORS	beta(3)-adrenoceptors (beta(3)-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, which is opposite to that of beta(1)- and beta(2)-ARs. It has been previously demonstrated that autoantibodies against the beta(1/)beta(2)-AR exist in the sera of some patients with heart failure (HF) and these autoantibodies display agonist-like effects. Our aim in this study was to observe whether autoantibodies against the beta(3)-AR (beta(3)-AR Abs) exist in the sera of patients with HF and to assess the effects of beta(3)-AR Abs on rat model of pressure overload cardiomyopthy. In the present study, the level of beta(3)-AR Abs in the sera of HF patients was screened by ELISA. beta(3)-AR Abs from HF patients were administrated to male adult rats with abdominal aortic banding (AAB), and the cardiac function was measured by echocardiographic examination and hemodynamic studies. The biological effects of this autoantibody on cardiomyocytes were evaluated using a motion-edge detection system, intracellular calcium transient assay, and patch clamp techniques. Compared to healthy subjects, the frequency of occurrence and titer of beta(3)-AR Abs in the sera of HF patients were greatly increased, and beta(3)-AR Abs could prevent LV dilation and improve the cardiac function of rats with AAB. beta(3)-AR Abs exhibited negative chronotropic and inotropic effects and were accompanied by a decreased intracellular Ca2+ transient and membrane L-type Ca2+ current in cardiomyocytes. Our results demonstrated the existence of beta(3)-AR Abs in the sera of patients with HF and found that this autoantibody could alleviate the cardiac dysfunction induced by pressure-overload in AAB rats.	[Wang, Jin; Bai, Kehua; Wang, Li; Yan, Zi; Zhao, Zhiqing; Zhao, Rongrui; Liu, Huirong] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Li, Meixia] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ma, Xiurui] Shanxi Cardiovasc Dis Hosp, Taiyuan, Shanxi, Peoples R China; [Lv, Tingting; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Cardiovasc Res Inst, Beijing, Peoples R China; [Zhao, Zhiqing] Mercer Univ, Dept Basic Biomed Sci, Sch Med, Savannah, GA USA	Shanxi Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Capital Medical University; Mercer University	Liu, HR (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China.	liuhr2000@126.com			Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University [2010-06]; Youth Fund of Shanxi Medical University; NSFC (National Nature Science Foundation of People's Republic of China) [30973163]	Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University; Youth Fund of Shanxi Medical University; NSFC (National Nature Science Foundation of People's Republic of China)(National Natural Science Foundation of China (NSFC))	This research is supported in part by grants from Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University (2010-06) to Jin Wang, Youth Fund of Shanxi Medical University to Jin Wang, and NSFC (National Nature Science Foundation of People's Republic of China, 30973163) to Huirong Liu. And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornholz B, 2013, CARDIOVASC RES, V97, P472, DOI 10.1093/cvr/cvs350; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; BRISTOW MR, 1990, CIRCULATION, V82, P12; CHIALE PA, 1995, J AM COLL CARDIOL, V26, P864, DOI 10.1016/0735-1097(95)00262-2; DELCAYRE C, 1991, J HYPERTENS, V9, pS23, DOI 10.1097/00004872-199112002-00004; Du YH, 2012, J CELL BIOCHEM, V113, P3218, DOI 10.1002/jcb.24198; Elies R, 1996, J IMMUNOL, V157, P4203; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holthoff HP, 2012, CIRC RES, V111, P675, DOI 10.1161/CIRCRESAHA.112.272682; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; James MA, 2000, J CARDIOVASC RISK, V7, P187; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Krause E G, 1996, Blood Press Suppl, V3, P37; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; MAGNUSSON Y, 1989, CLIN EXP IMMUNOL, V78, P42; Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307; Matsui S, 2000, HERZ, V25, P267, DOI 10.1007/s000590050018; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Morimoto A, 2004, AM J PHYSIOL-HEART C, V286, pH2425, DOI 10.1152/ajpheart.01045.2003; Nagatomo Y, 2009, J CARD FAIL, V15, P224, DOI 10.1016/j.cardfail.2008.10.027; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Pei JH, 2012, EUR J HEART FAIL, V14, P887, DOI 10.1093/eurjhf/hfs082; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Rasmussen HH, 2009, CURR OPIN INVEST DR, V10, P955; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Ren Jun, 2001, Biological Procedures Online, V3, P43, DOI 10.1251/bpo22; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; ROSENBAUM MB, 1994, J CARDIOVASC ELECTR, V5, P367, DOI 10.1111/j.1540-8167.1994.tb01174.x; SIPIDO KR, 1995, CARDIOVASC RES, V29, P717, DOI 10.1016/S0008-6363(96)88645-7; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Suzuki M, 1998, CARDIOVASC RES, V39, P589, DOI 10.1016/S0008-6363(98)00166-7; Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004; XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559; Yang XL, 2008, J HYPERTENS, V26, P1629, DOI 10.1097/HJH.0b013e328304dbff; Zhang WG, 1999, CIRC RES, V84, P722, DOI 10.1161/01.RES.84.6.722; Zhang ZS, 2005, J PHARMACOL EXP THER, V315, P1203, DOI 10.1124/jpet.105.089672; Zhao Q, 2007, CARDIOVASC DRUG THER, V21, P85, DOI 10.1007/s10557-007-6016-4; Zhao Q, 2013, J CARDIOVASC PHARM T, V18, P133, DOI 10.1177/1074248412460123; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	53	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78207	10.1371/journal.pone.0078207	http://dx.doi.org/10.1371/journal.pone.0078207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147120	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400145
J	Kim, J; Wu, L; Zhao, JC; Jin, HJ; Yu, J				Kim, J.; Wu, L.; Zhao, J. C.; Jin, H-J; Yu, J.			TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c	ONCOGENE			English	Article						TMPRSS2-ERG; miR-200c; EMT; prostate cancer	TO-MESENCHYMAL TRANSITION; CANCER-CELLS; ANDROGEN RECEPTOR; DNA METHYLATION; EXPRESSION; POLYCOMB; ERG; FAMILY; TRANSFORMATION; SIGNATURE	Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients. Although numerous studies have investigated ERG-downstream genes, such studies have not attempted to examine miRNAs, which however are emerging to be important regulators of cancer. Through bioinformatics analysis of ChIP-Seq ERG data and miRNA expression profiling data we nominated miR-200c as a direct target of ERG. Experimentation of PCa cells with ERG overexpression or knockdown demonstrated that ERG directly repressed miR-200c expression by physically binding to the erythroblast transformation-specific (ETS) motif within its promoter. Consequently, miR-200c was downregulated in ERG-positive PCa, and miR-200c target gene expression was restored. In addition, the expression pattern of miR-200c target genes predicted ERG status in clinical PCa specimens. Furthermore, miR-200c was found to be important in modulating ZEB1 upregulation by ERG. Most importantly, miR-200c reconstitution fully reversed ERG-induced epithelial-to-mesenchymal transition (EMT), cell migration and invasion. Therefore, our study report miR-200c as the first miRNA target of ERG and a critical inhibitor of PCa cell motility. Therapeutic delivery of miR-200c may provide personalized treatment for patients with the molecular subtype of PCa that harbors TMPRSS2-ERG gene fusions.	[Kim, J.; Wu, L.; Zhao, J. C.; Jin, H-J; Yu, J.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Yu, J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Yu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med, Lurie 5-117,303 E Super St, Chicago, IL 60611 USA.	jindan-yu@northwestern.edu	Kim, Jung/Q-7801-2016	Kim, Jung/0000-0001-6274-2841; Jin, Hongjian/0000-0003-3833-7170	NIH [R01CA172384, R00CA129565]; Research Scholar Award [RSG-12-085-01]; American Cancer Society; NRSA pre-doctoral fellowship [T32 CA080621]; NATIONAL CANCER INSTITUTE [R00CA129565, T32CA080621, R01CA172384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Scholar Award; American Cancer Society(American Cancer Society); NRSA pre-doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jianjun Yu for helpful discussions. This work was supported by funding from the NIH R01CA172384 (to JY), NIH R00CA129565 (to JY) the Research Scholar Award RSG-12-085-01 (to JY) from the American Cancer Society and the NRSA pre-doctoral fellowship T32 CA080621 (to JK).	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Becker-Santos DD, 2012, CARCINOGENESIS, V33, P2558, DOI 10.1093/carcin/bgs285; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Gordanpour A, 2011, ANTICANCER RES, V31, P403; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hart M, 2013, FEBS J, V280, P2105, DOI 10.1111/febs.12236; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Huang S, 2012, ONCOL REP, V28, P1831, DOI 10.3892/or.2012.2015; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	55	30	30	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5183	5192		10.1038/onc.2013.461	http://dx.doi.org/10.1038/onc.2013.461			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24186205	Green Accepted			2022-12-25	WOS:000343914900005
J	Banerjee, S; Cui, HC; Xie, N; Tan, Z; Yang, SZ; Icyuz, M; Thannickal, VJ; Abraham, E; Liu, G				Banerjee, Sami; Cui, Huachun; Xie, Na; Tan, Zheng; Yang, Shanzhong; Icyuz, Mert; Thannickal, Victor John; Abraham, Edward; Liu, Gang			miR-125a-5p Regulates Differential Activation of Macrophages and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Kruppel-like Factor (KLF); Macrophages; MicroRNA; Toll-like Receptors (TLR); KLF13; Macrophage Polarization; Phagocytosis	TRANSCRIPTION FACTOR; RANTES EXPRESSION; GENE-EXPRESSION; POLARIZATION; MICRORNAS; LIPOPOLYSACCHARIDE; RECEPTOR; SUPPRESSOR; CLEARANCE; MONOCYTES	Macrophage activation is a central event in immune responses. Macrophages undergoing classical activation (M1 macrophages) are proinflammatory, whereas alternatively activated macrophages (M2 macrophages) are generally anti-inflammatory. miRNAs play important regulatory roles in inflammatory response. However, the manner in which miRNAs regulate macrophage activation in response to different environmental cues has not been well defined. In this study, we found that M-BMM macrophages (M2) express greater levels of miR-125a-5p than do GM-BMM macrophages (M1). Stimulation of macrophages through TLR2 and TLR4 but not through TLR3 enhanced miR-125a-5p expression. Up-regulation of miR-125a-5p after TLR2/4 activation requires the adaptor MYD88 but not TRIF. Overexpression of miR-125a-5p diminished M1 phenotype expression induced by LPS but promoted M2 marker expression induced by IL-4. In contrast, knockdown of miR-125a-5p promoted M1 polarization and diminished IL-4-induced M2 marker expression. We found that miR-125a-5p targets KLF13, a transcriptional factor that has an important role in T lymphocyte activation and inflammation. KLF13 knockdown had similar effects on M1 activation as did miR-125a-5p overexpression. In addition, miR-125a-5p regulates phagocytic and bactericidal activities of macrophages. Our data suggest that miR-125a-5p has an important role in suppressing classical activation of macrophages while promoting alternative activation.	[Banerjee, Sami; Cui, Huachun; Xie, Na; Tan, Zheng; Yang, Shanzhong; Icyuz, Mert; Thannickal, Victor John; Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Abraham, Edward] Wake Forest Sch Med, Winston Salem, NC 27157 USA	University of Alabama System; University of Alabama Birmingham; Wake Forest University	Liu, G (corresponding author), Univ Alabama Birmingham, Dept Med, 901 19th St So,BMR 233 2, Birmingham, AL 35294 USA.	gliu@uab.edu	Icyuz, Mert/J-6598-2013	Icyuz, Mert/0000-0003-1681-0115; , Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL114470, amd HL105473, HL076206]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, R01HL076206, R01HL105473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants HL114470 (to V. J. T.) amd HL105473 and HL076206 (to G. L)	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; de Freitas A, 2012, J IMMUNOL, V188, P6381, DOI 10.4049/jimmunol.1200020; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Huang HC, 2012, J LEUKOCYTE BIOL, V92, P171, DOI 10.1189/jlb.1211593; Kim DS, 2012, BLOOD, V120, P1658, DOI 10.1182/blood-2012-03-415968; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063659; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	51	168	184	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35428	35436		10.1074/jbc.M112.426866	http://dx.doi.org/10.1074/jbc.M112.426866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151079	hybrid, Green Published			2022-12-25	WOS:000329867600039
J	Zhang, Y; Evans, GB; Clinch, K; Crump, DR; Harris, LD; Frohlich, RFG; Tyler, PC; Hazleton, KZ; Cassera, MB; Schramm, VL				Zhang, Yong; Evans, Gary B.; Clinch, Keith; Crump, Douglas R.; Harris, Lawrence D.; Froehlich, Richard F. G.; Tyler, Peter C.; Hazleton, Keith Z.; Cassera, Maria B.; Schramm, Vern L.			Transition State Analogues of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Enzyme Catalysis; Malaria; Plasmodium; Pyrimidine; Inhibitor Design; N-Ribosyltransferases; Orotidine 5-Monophosphate	PURINE NUCLEOSIDE PHOSPHORYLASE; NOVO NUCLEOTIDE BIOSYNTHESIS; HUMAN UMP SYNTHASE; DIHYDROOROTATE DEHYDROGENASE; SELECTIVE ACTIVITY; IMMUCILLIN-H; EADOCK DSS; INHIBITORS; HYDROLASES; MALARIA	Background: Human and malaria orotate phosphoribosyltransferases (OPRTs) in the de novo pyrimidine biosynthesis pathway are characterized by ribocation transition states with fully dissociated leaving orotate groups. Results: Transition state analogues with varied ribocation substitutions, different linkers, and distinct leaving groups exhibited nanomolar binding affinities for the OPRT enzymes. Conclusion: Components crucial for inhibitor binding to the OPRT active sites have been identified, and powerful inhibitors were characterized. Significance: Transition state analogues of OPRTs provide new insights into the nature of potential antimalarials and anticancer agents. The survival and proliferation of Plasmodium falciparum parasites and human cancer cells require de novo pyrimidine synthesis to supply RNA and DNA precursors. Orotate phosphoribosyltransferase (OPRT) is an indispensible component in this metabolic pathway and is a target for antimalarials and antitumor drugs. P. falciparum (Pf) and Homo sapiens (Hs) OPRTs are characterized by highly dissociative transition states with ribocation character. On the basis of the geometrical and electrostatic features of the PfOPRT and HsOPRT transition states, analogues were designed, synthesized, and tested as inhibitors. Iminoribitol mimics of the ribocation transition state in linkage to pyrimidine mimics using methylene or ethylene linkers gave dissociation constants (K-d) as low as 80 nm. Inhibitors with pyrrolidine groups as ribocation mimics displayed slightly weaker binding affinities for OPRTs. Interestingly, p-nitrophenyl riboside 5-phosphate bound to OPRTs with K-d values near 40 nm. Analogues designed with a C5-pyrimidine carbon-carbon bond to ribocation mimics gave K-d values in the range of 80-500 nm. Acyclic inhibitors with achiral serinol groups as the ribocation mimics also displayed nanomolar inhibition against OPRTs. In comparison with the nucleoside derivatives, inhibition constants of their corresponding 5-phosphorylated transition state analogues are largely unchanged, an unusual property for a nucleotide-binding site. In silico docking of the best inhibitor into the HsOPRT active site supported an extensive hydrogen bond network associated with the tight binding affinity. These OPRT transition state analogues identify crucial components of potent inhibitors targeting OPRT enzymes. Despite their tight binding to the targets, the inhibitors did not kill cultured P. falciparum.	[Zhang, Yong; Hazleton, Keith Z.; Cassera, Maria B.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Evans, Gary B.; Clinch, Keith; Crump, Douglas R.; Harris, Lawrence D.; Froehlich, Richard F. G.; Tyler, Peter C.] Callaghan Innovat, Carbohydrate Chem Team, Lower Hutt 5040, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Callaghan Innovation	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu	Evans, Gary/B-8343-2011; Evans, Gary/I-4123-2019; Hazleton, Keith Z./AAD-3979-2019	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Hazleton, Keith Z./0000-0003-4098-3411; Harris, Lawrence/0000-0002-4214-1018; Clinch, Keith/0000-0002-3300-4396	National Institutes of Health [AI049512, GM041916, GM007288]; New Zealand Foundation for Research Science and Technology [C08X0701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041916, R01GM041916, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grants AI049512 and GM041916 and Training Grant GM007288. This work was also supported by New Zealand Foundation for Research Science and Technology Contract C08X0701.	Abdo M, 2010, ORG LETT, V12, P2982, DOI 10.1021/ol1010032; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Breda A, 2012, EUR J MED CHEM, V54, P113, DOI 10.1016/j.ejmech.2012.04.031; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Clinch K, 2006, ORG BIOMOL CHEM, V4, P1131, DOI 10.1039/b517883e; Clinch K, 2007, ORG BIOMOL CHEM, V5, P2800, DOI 10.1039/b708796a; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Evans GB, 2004, J ORG CHEM, V69, P2217, DOI 10.1021/jo035744k; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Furneaux RH, 1997, TETRAHEDRON, V53, P2915, DOI 10.1016/S0040-4020(96)01172-6; Furneaux RH, 1999, BIOORGAN MED CHEM, V7, P2599, DOI 10.1016/S0968-0896(99)00210-2; GERO AM, 1990, BLOOD CELLS, V16, P467; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; Gonzalez-Segura L, 2007, BIOCHEMISTRY-US, V46, P14075, DOI 10.1021/bi701023z; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; Huang M, 2008, LEUKEMIA RES, V32, P1268, DOI 10.1016/j.leukres.2007.12.015; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; KRUNGKRAI J, 1992, BIOCHEM PHARMACOL, V43, P1295, DOI 10.1016/0006-2952(92)90506-E; Krungkrai SR, 2004, MOL BIOCHEM PARASIT, V134, P245, DOI 10.1016/j.molbiopara.2003.12.006; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lewandowicz A, 2003, BIOCHEMISTRY-US, V42, P6057, DOI 10.1021/bi0343830; Longshaw AI, 2010, J MED CHEM, V53, P6730, DOI 10.1021/jm100898v; Mazzella LJ, 1996, J AM CHEM SOC, V118, P2111, DOI 10.1021/ja953537z; Parkin DW, 1997, BIOCHEMISTRY-US, V36, P3528, DOI 10.1021/bi962319v; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; QUEEN SA, 1990, ANTIMICROB AGENTS CH, V34, P1393, DOI 10.1128/AAC.34.7.1393; Quemeneur L, 2004, J IMMUNOL, V173, P4945, DOI 10.4049/jimmunol.173.8.4945; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; Schramm V. L., 2003, NUCL ACIDS RES S, V3, P107; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; Schramm VL, 2005, ARCH BIOCHEM BIOPHYS, V433, P13, DOI 10.1016/j.abb.2004.08.035; Schramm VL, 2003, ACCOUNTS CHEM RES, V36, P588, DOI 10.1021/ar0200495; SEYMOUR KK, 1994, BIOCHEMISTRY-US, V33, P5268, DOI 10.1021/bi00183a033; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Suchi M, 1997, AM J HUM GENET, V60, P525; Weber G, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1164, DOI 10.1023/A:1012493232344; Witte JF, 2006, BIOORG MED CHEM LETT, V16, P6112, DOI 10.1016/j.bmcl.2006.08.109; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704; Zhang Y, 2010, J AM CHEM SOC, V132, P17023, DOI 10.1021/ja107806j; Zhang Y, 2010, J AM CHEM SOC, V132, P8787, DOI 10.1021/ja102849w; Zhang Y, 2009, J AM CHEM SOC, V131, P4685, DOI 10.1021/ja808346y	52	18	19	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34746	34754		10.1074/jbc.M113.521955	http://dx.doi.org/10.1074/jbc.M113.521955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24158442	Green Published, hybrid			2022-12-25	WOS:000329812800041
J	Schwer, CI; Lehane, C; Guelzow, T; Zenker, S; Strosing, KM; Spassov, S; Erxleben, A; Heimrich, B; Buerkle, H; Humar, M				Schwer, Christian I.; Lehane, Cornelius; Guelzow, Timo; Zenker, Simone; Strosing, Karl M.; Spassov, Sashko; Erxleben, Anika; Heimrich, Bernd; Buerkle, Hartmut; Humar, Matjaz			Thiopental Inhibits Global Protein Synthesis by Repression of Eukaryotic Elongation Factor 2 and Protects from Hypoxic Neuronal Cell Death	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; FACTOR-II; RAT HIPPOCAMPAL; NMDA RECEPTORS; KINASE PATHWAY; NUCLEAR-FACTOR; EEF2 KINASE; IN-VITRO	Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.	[Schwer, Christian I.; Lehane, Cornelius; Strosing, Karl M.; Spassov, Sashko; Buerkle, Hartmut; Humar, Matjaz] Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Guelzow, Timo] Univ Med Ctr Freiburg, Dept Gen Neurosurg Cellular Neurophysiol, Freiburg, Germany; [Erxleben, Anika] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Zenker, Simone; Heimrich, Bernd] Univ Freiburg, Dept Anat & Cell Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Humar, M (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	matjaz.humar@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013; Buerkle, Hartmut/I-5785-2014	Spassov, Sashko/0000-0002-3585-3682; Erxleben, Anika/0000-0002-7427-6478; Lehane, Cornelius/0000-0001-5173-5216	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	This work was funded by the Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Anderson CM, 2002, J NEUROSCI, V22, P9203; BECKER KE, 1976, ANESTHESIOLOGY, V45, P656, DOI 10.1097/00000542-197612000-00013; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DESSI F, 1992, BRAIN RES, V581, P323, DOI 10.1016/0006-8993(92)90726-P; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; DOENICKE A, 1965, ACTA ANAESTH SCAND, P11; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Humar M, 2009, MOL PHARMACOL, V75, P667, DOI 10.1124/mol.108.052183; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lin CC, 2013, CELL MOL LIFE SCI; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Park WS, 2006, J KOREAN MED SCI, V21, P337, DOI 10.3346/jkms.2006.21.2.337; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Roberts I, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000033; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SMITH DS, 1980, ACTA PHYSIOL SCAND, P129; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568; Zhan RZ, 1998, BRIT J ANAESTH, V81, P932, DOI 10.1093/bja/81.6.932; Zhan RZ, 1998, ANESTHESIOLOGY, V89, P456, DOI 10.1097/00000542-199808000-00023; Zhang XL, 2010, NEUROCHEM RES, V35, P1281, DOI 10.1007/s11064-010-0186-3	69	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77258	10.1371/journal.pone.0077258	http://dx.doi.org/10.1371/journal.pone.0077258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167567	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500026
J	Shimanuki, M; Uehara, L; Pluskal, T; Yoshida, T; Kokubu, A; Kawasaki, Y; Yanagida, M				Shimanuki, Mizuki; Uehara, Lisa; Pluskal, Tomas; Yoshida, Tomoko; Kokubu, Aya; Kawasaki, Yosuke; Yanagida, Mitsuhiro			Klf1, a C2H2 Zinc Finger-Transcription Factor, Is Required for Cell Wall Maintenance during Long-Term Quiescence in Differentiated G0 Phase	PLOS ONE			English	Article							KRUPPEL-LIKE FACTORS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; GENETIC-CONTROL; SEXUAL-DIFFERENTIATION; DIVISION CYCLE; STEM-CELLS; PROTEIN; IDENTIFICATION; PHEROMONE	Fission yeast, Schizoaccharomyces pombe, is a model for studying cellular quiescence. Shifting to a medium that lacks a nitrogen-source induces proliferative cells to enter long-term G0 quiescence. Klf1 is a Kruppel-like transcription factor with a 7-amino acid Cys2His2-type zinc finger motif. The deletion mutant, Delta klf1, normally divides in vegetative medium, but proliferation is not restored after long-term G0 quiescence. Cell biologic, transcriptomic, and metabolomic analyses revealed a unique phenotype of the Delta klf1 mutant in quiescence. Mutant cells had diminished transcripts related to signaling molecules for switching to differentiation; however, proliferative metabolites for cell-wall assembly and antioxidants had significantly increased. Further, the size of Delta klf1 cells increased markedly during quiescence due to the aberrant accumulation of Calcofluor-positive, chitin-like materials beneath the cell wall. After 4 weeks of quiescence, reversible proliferation ability was lost, but metabolism was maintained. Klf1 thus plays a role in G0 phase longevity by enhancing the differentiation signal and suppressing metabolism for growth. If Klf1 is lost, S. pombe fails to maintain a constant cell size and normal cell morphology during quiescence.	[Shimanuki, Mizuki; Uehara, Lisa; Pluskal, Tomas; Yoshida, Tomoko; Kokubu, Aya; Kawasaki, Yosuke; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ OIST, Cell Unit G0, Onna, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Shimanuki, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ OIST, Biol Resources Sect, Onna, Okinawa, Japan.	mizuki.shimanuki@oist.jp; myanagid@gmail.com	Pluskal, Tomáš/C-6247-2012	Pluskal, Tomáš/0000-0002-6940-3006	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was funded by the Okinawa Institute of Science and Technology Promotion Corporation and the Okinawa Institute of Science and Technology Graduate University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC, 2006, YEAST VITAL STAINS C; AONO T, 1994, YEAST, V10, P757, DOI 10.1002/yea.320100607; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Goddard A, 2006, FUNGAL GENET BIOL, V43, P840, DOI 10.1016/j.fgb.2006.06.005; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; HARTWELL LH, 1973, GENETICS, V74, P267; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KITAMURA K, 1991, EMBO J, V10, P3743, DOI 10.1002/j.1460-2075.1991.tb04943.x; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Nakamura T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120117; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okazaki K, 2000, DNA RES, V7, P27, DOI 10.1093/dnares/7.1.27; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Piper PW, 2006, YEAST, V23, P215, DOI 10.1002/yea.1354; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Raponi M, 2002, NUCLEIC ACIDS RES, V30, P2546, DOI 10.1093/nar/30.11.2546; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; SAUER F, 1995, EMBO J, V14, P4773, DOI 10.1002/j.1460-2075.1995.tb00159.x; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Su SSY, 1996, J CELL SCI, V109, P1347; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Sukegawa Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002387; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; UZAWA S, 1992, J CELL SCI, V101, P267; Vilo J, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P384; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006	51	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78545	10.1371/journal.pone.0078545	http://dx.doi.org/10.1371/journal.pone.0078545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167631	gold, Green Submitted, Green Published			2022-12-25	WOS:000326034500092
J	Wu, J; Zhang, YY; Guo, L; Li, H; Chen, DF				Wu, Jian; Zhang, Yun-Yi; Guo, Li; Li, Hong; Chen, Dao-Feng			Bupleurum Polysaccharides Attenuates Lipopolysaccharide-Induced Inflammation via Modulating Toll-Like Receptor 4 Signaling	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; MOLECULAR-MECHANISMS; EXPRESSION; MACROPHAGES; INHIBITION; ACTIVATION; CYTOKINE; ALPHA; INTERLEUKIN-6	Background: Bupleurum polysaccharides (BPs), isolated from Bupleurum smithii var. parvifolium, possesses immunomodulatory activity, particularly on inflammation. Bacterial endotoxin lipopolysaccharide (LPS) triggers innate immune responses through Toll-like receptor 4 (TLR4) on host cell membrane. The present study was performed to evaluate whether the therapeutic efficacy of BPs on suppression of LPS's pathogenecity could be associated with the modulating of TLR4 signaling pathway. Methodology/Principal Findings: LPS stimulated expression and activation of factors in the TLR4 signaling system, including TLR4, CD14, IRAK4, TRAF6, NF-kappa B, and JNK, determined using immunocytochemical and/or Western blot assays. BPs significantly inhibited these effects of LPS. LPS increased pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1 beta, IL-12p40, and IFN-beta) and NO production, evaluated using ELISA and Griess reaction assays, respectively. BPs antagonized these effects of LPS. Interestingly, BPs alone augmented secretion of some pro-inflammatory cytokines of non-LPS stimulated macrophages and enhanced phagocytic activity towards fluorescent E. coli bioparticles. In a rat model of acute lung injury (ALI) with pulmonary hemorrhage and inflammation, BPs ameliorated lung injuries and suppressed TLR4 expression. Significance: The therapeutic properties of BPs in alleviating inflammatory diseases could be attributed to its inhibitory effect on LPS-mediated TLR4 signaling.	[Wu, Jian; Zhang, Yun-Yi; Guo, Li; Li, Hong] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Chen, Dao-Feng] Fudan Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, YY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhcheng@shmu.edu.cn; dfchen@shmu.edu.cn		Wu, Jian/0000-0002-2333-1000	National Natural Science Foundation of China [30925042, 30572315, 81274165]; State Key Program for New Drugs from the Ministry of Science and Technology, China [2009ZX09502-013, 2012ZX09301001-003]; Science and Technology Commission of Shanghai Municipality [10XD1405900, 12JC1400800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program for New Drugs from the Ministry of Science and Technology, China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grant No. 30925042, 30572315, 81274165), the State Key Program for New Drugs from the Ministry of Science and Technology, China (Grant No. 2009ZX09502-013, 2012ZX09301001-003), and the Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1405900, 12JC1400800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bakker AD, 2009, ARTHRITIS RHEUM-US, V60, P3336, DOI 10.1002/art.24920; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Bendjeddou D, 2003, J ETHNOPHARMACOL, V88, P155, DOI 10.1016/S0378-8741(03)00226-5; Chang HS, 2001, CLIN CHIM ACTA, V312, P49, DOI 10.1016/S0009-8981(01)00588-5; Cheng XQ, 2012, INFLAMMATION, V35, P1715, DOI 10.1007/s10753-012-9489-7; Cheng XQ, 2010, J ETHNOPHARMACOL, V130, P363, DOI 10.1016/j.jep.2010.05.019; de las Heras B, 2007, BRIT J PHARMACOL, V152, P249, DOI 10.1038/sj.bjp.0707382; de Santana AP, 2012, CARBOHYD POLYM, V87, P2730, DOI 10.1016/j.carbpol.2011.11.073; Fan J, 2002, J IMMUNOL, V168, P5252, DOI 10.4049/jimmunol.168.10.5252; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Graff JC, 2009, INT IMMUNOPHARMACOL, V9, P1313, DOI 10.1016/j.intimp.2009.07.015; Guo TJ, 2000, IMMUNOPHARMACOLOGY, V49, P307, DOI 10.1016/S0162-3109(00)00245-9; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Heumann D, 1998, CURR OPIN MICROBIOL, V1, P49, DOI 10.1016/S1369-5274(98)80142-2; Heumann D, 2001, INFECT IMMUN, V69, P378, DOI 10.1128/IAI.69.1.378-385.2001; Holderness J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017301; Jenkins SJ, 2005, INT IMMUNOL, V17, P1409, DOI 10.1093/intimm/dxh319; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Komatsu H, 2012, LIFE SCI, V91, P143, DOI 10.1016/j.lfs.2012.06.030; Lee JS, 2011, INT IMMUNOPHARMACOL, V11, P1226, DOI 10.1016/j.intimp.2011.04.001; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Navarro P, 2001, LIFE SCI, V68, P1199, DOI 10.1016/S0024-3205(00)01019-5; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pruett SB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-49; Sato TA, 2003, J IMMUNOL, V170, P158, DOI 10.4049/jimmunol.170.1.158; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sullivan AM, 2008, IMMUNOPHARM IMMUNOT, V30, P553, DOI 10.1080/08923970802135534; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099; USHIO Y, 1991, INT J IMMUNOPHARMACO, V13, P501, DOI 10.1016/0192-0561(91)90069-J; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Wang Z, 2009, J ETHNOPHARMACOL, V124, P481, DOI 10.1016/j.jep.2009.05.013; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhou R, 2006, J PHARMACOL EXP THER, V316, P121, DOI 10.1124/jpet.105.093179	40	30	31	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78051	10.1371/journal.pone.0078051	http://dx.doi.org/10.1371/journal.pone.0078051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167596	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500056
J	Chiba, Y; Mizoguchi, I; Mitobe, K; Higuchi, K; Nagai, H; Nishigori, C; Mizuguchi, J; Yoshimoto, T				Chiba, Yukino; Mizoguchi, Izuru; Mitobe, Kana; Higuchi, Kaname; Nagai, Hiroshi; Nishigori, Chikako; Mizuguchi, Junichiro; Yoshimoto, Takayuki			IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; NATURAL-KILLER-CELLS; ANTITUMOR ACTIVITIES; COMPLETE REGRESSION; INDUCED APOPTOSIS; I INTERFERONS; RIG-I; T-BET; INTERLEUKIN-27; CYTOKINE	Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antitumor activity, which is mediated by multiple mechanisms. Toll-like receptor (TLR) 3 is the critical sensor of the innate immune system that serves to identify viral double-stranded RNA. TLR3 is frequently expressed by various types of malignant cells, and recent studies reported that a synthetic TLR3 agonist, polyinosinic-polycytidylic acid [poly(I:C)], induces antitumor effects on malignant cells. In the present study, we have explored the effect of IL-27 on human melanomas and uncovered a previously unknown mechanism. We found that IL-27 inhibits in vitro tumor growth of human melanomas and greatly enhances the expression of TNF-related apoptosis inducing ligand (TRAIL) in a dose-dependent manner. Neutralizing antibody against TRAIL partly but significantly blocked the IL-27-mediated inhibition of tumor growth. In addition, IL-27 and poly(I: C) cooperatively augmented TRAIL expression and inhibited tumor growth. The cooperative effect could be ascribed to the augmented expression of TLR3, but not retinoic acid-inducible gene-I or anti-melanoma differentiation-associated gene 5, by IL-27. The inhibition of tumor growth by the combination was also significantly abrogated by anti-TRAIL neutralizing antibody. Moreover, IL-27 and poly(I:C) cooperatively suppressed in vivo tumor growth of human melanoma in immunodeficient mice. Taken together, these results suggest that IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with poly(I:C), partly in a TRAIL-dependent manner. Thus, IL-27 and the combination of IL-27 and poly(I:C) may be attractive candidates for cancer immunotherapy.	[Chiba, Yukino; Mizoguchi, Izuru; Mitobe, Kana; Higuchi, Kaname; Yoshimoto, Takayuki] Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan; [Higuchi, Kaname; Mizuguchi, Junichiro] Tokyo Med Univ, Dept Immunol, Tokyo 1608402, Japan; [Nagai, Hiroshi; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Dermatol, Kobe, Hyogo 657, Japan	Tokyo Medical University; Tokyo Medical University; Kobe University	Yoshimoto, T (corresponding author), Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan.	yoshimot@tokyo-med.ac.jp	Yoshimoto, Takayuki/AAN-7995-2020	Yoshimoto, Takayuki/0000-0002-2847-0341	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659595, 25118727, 23590475] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Scientific Research and "University-Industry Joint Research'' Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Airoldi I, 2011, J LEUKOCYTE BIOL, V90, P875, DOI 10.1189/jlb.0511237; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cocco C, 2012, LEUKEMIA, V26, P1365, DOI 10.1038/leu.2011.363; Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kitahara Y, 2010, EUR J IMMUNOL, V40, P2590, DOI 10.1002/eji.201040604; KROWN SE, 1985, J BIOL RESP MODIF, V4, P640; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Liu L, 2008, SCAND J IMMUNOL, V68, P22, DOI 10.1111/j.1365-3083.2008.02111.x; Matsui M, 2009, CANCER RES, V69, P2523, DOI 10.1158/0008-5472.CAN-08-2793; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; Moschos S, 2007, CYTOKINE GROWTH F R, V18, P451, DOI 10.1016/j.cytogfr.2007.06.020; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Ryffel B, 1997, CLIN IMMUNOL IMMUNOP, V83, P18, DOI 10.1006/clin.1996.4306; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshimoto T, 2003, J IMMUNOL, V171, P1352, DOI 10.4049/jimmunol.171.3.1352; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zorzoli A, 2012, CLIN CANCER RES, V18, P1630, DOI 10.1158/1078-0432.CCR-11-2432	55	25	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76159	10.1371/journal.pone.0076159	http://dx.doi.org/10.1371/journal.pone.0076159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155891	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300025
J	Dietrich, D; Uhl, B; Sailer, V; Holmes, EE; Jung, M; Meller, S; Kristiansen, G				Dietrich, Dimo; Uhl, Barbara; Sailer, Verena; Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Kristiansen, Glen			Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition	PLOS ONE			English	Article							METHYLATION BIOMARKERS; GENOMIC DNA; CANCER; PITX2; AMPLIFICATION; POLYMERASE; EXTRACTION; RETRIEVAL; DIAGNOSIS; RECOVERY	Formalin-fixed and paraffin-embedded (FFPE) tissues represent a valuable source for biomarker studies and clinical routine diagnostics. However, they suffer from degradation of nucleic acids due to the fixation process. Since genetic and epigenetic studies usually require PCR amplification, this degradation hampers its use significantly, impairing PCR robustness or necessitating short amplicons. In routine laboratory medicine a highly robust PCR performance is mandatory for the clinical utility of genetic and epigenetic biomarkers. Therefore, methods to improve PCR performance using DNA from FFPE tissue are highly desired and of wider interest. The effect of template DNA derived from FFPE tissues on PCR performance was investigated by means of qPCR and conventional PCR using PCR fragments of different sizes. DNA fragmentation was analyzed via agarose gel electrophoresis. This study showed that poor PCR amplification was partly caused by inhibition of the DNA polymerase by fragmented DNA from FFPE tissue and not only due to the absence of intact template molecules of sufficient integrity. This PCR inhibition was successfully minimized by increasing the polymerase concentration, dNTP concentration and PCR elongation time thereby allowing for the robust amplification of larger amplicons. This was shown for genomic template DNA as well as for bisulfite-converted template DNA required for DNA methylation analyses. In conclusion, PCR using DNA from FFPE tissue suffers from inhibition which can be alleviated by adaptation of the PCR conditions, therefore allowing for a significant improvement of PCR performance with regard to variability and the generation of larger amplicons. The presented solutions to overcome this PCR inhibition are of tremendous value for clinical chemistry and laboratory medicine.	[Dietrich, Dimo; Uhl, Barbara; Sailer, Verena; Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Kristiansen, Glen] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany	University of Bonn	Dietrich, D (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany.	dimo.dietrich@gmail.com						Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Benson LM, 2003, J AM SOC MASS SPECTR, V14, P601, DOI 10.1016/S1044-0305(03)00148-X; Bereczki L, 2007, PATHOL ONCOL RES, V13, P209, DOI 10.1007/BF02893501; Bielawski K, 2001, INT J MOL MED, V8, P573; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gnanapragasam VJ, 2010, BJU INT, V105, P274, DOI 10.1111/j.1464-410X.2009.08665.x; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Huang WY, 2010, CANCER EPIDEM BIOMAR, V19, P973, DOI 10.1158/1055-9965.EPI-10-0091; Huijsmans Cornelis Jj, 2010, BMC Res Notes, V3, P239, DOI 10.1186/1756-0500-3-239; Inadome Y, 2003, DIAGN MOL PATHOL, V12, P231, DOI 10.1097/00019606-200312000-00007; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kneip C, 2009, BIOTECHNIQUES, V47, P737, DOI 10.2144/000113208; Kristensen LS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-453; KUYKENDALL JR, 1992, MUTAT RES, V283, P131, DOI 10.1016/0165-7992(92)90145-8; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/ERM.12.45, 10.1586/erm.12.45]; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Sam SS, 2012, PATHOL RES PRACT, V208, P705, DOI 10.1016/j.prp.2012.08.008; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Vinarskaja A, 2011, UROL ONCOL, DOI [10.1016/j.urolonc.2011.04.01, DOI 10.1016/J.UROLONC.2011.04.01]; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Zsikla V, 2004, J CLIN PATHOL, V57, P654, DOI 10.1136/jcp.2003.013961	35	86	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77771	10.1371/journal.pone.0077771	http://dx.doi.org/10.1371/journal.pone.0077771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155973	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300107
J	Qiu, XW; Wu, XQ; Huang, L; Tian, MQ; Ye, JR				Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren			Specifically Expressed Genes of the Nematode Bursaphelenchus Xylophilus Involved with Early Interactions with Pine Trees	PLOS ONE			English	Article							WOOD NEMATODE; WILT DISEASE; MONOCHAMUS-ALTERNATUS; CELL WALLS; APHELENCHOIDIDAE; COLEOPTERA; VECTOR; SPREAD; CERAMBYCIDAE; SUPERFAMILY	As the causal agent of pine wilt disease (PWD), the pine wood nematode (PWN), Bursaphelenchus xylophilus, causes huge economic losses by devastating pine forests worldwide. However, the pathogenesis-related genes of B. xylophilus are not well characterized. Thus, DNA microarrays were used to investigate differential gene expression in PWN where Pinus thunbergii was inoculated with nematodes, compared with those cultured on Botrytis cinerea. The microarrays comprised 31121 probes, 1310 (4.2%) of which were differentially regulated (changes of >2-fold, P < 0.01) in the two growth conditions. Of these 1310 genes, 633 genes were upregulated, whereas 677 genes were downregulated. Gene Ontology (GO) categories were assigned to the classes Cellular Component, Molecular Function, and Biological Process. The comparative gene expression analysis showed that a large number of the pathogenesis-related genes of B. xylophilus, such as pectate lyase genes, cytochrome P450s, UGTs, and ABC transporter genes, were highly expressed when B. xylophilus infected P. thunbergii. Annotation analysis indicated that these genes contributed to cell wall degradation, detoxification, and the reproduction process. The microarray results were validated using quantitative RT-PCR (qRT-PCR). The microarray data confirmed the specific expression of B. xylophilus genes during infection of P. thunbergii, which provides basic information that facilitates a better understanding of the molecular mechanism of PWD.	[Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren] Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Qiu, Xiuwen; Wu, Xiaoqin; Huang, Lin; Tian, Minqi; Ye, Jianren] Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Ye, JR (corresponding author), Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	jrye784@gmail.com			State Forest Administration of China [201204501]; National Science Research of Jiangsu University in China [11KJA220002]; National Nature Science Foundation of China [31000303]; Natural Science Foundation of Jiangsu Province [BK2010566]	State Forest Administration of China; National Science Research of Jiangsu University in China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the State Forest Administration of China (number 201204501), the project of National Science Research of Jiangsu University in China (number 11KJA220002), National Nature Science Foundation of China (number 31000303), the Natural Science Foundation of Jiangsu Province (number BK2010566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2006, FOREST PATHOL, V36, P1, DOI 10.1111/j.1439-0329.2006.00428.x; Aikawa T, 2003, ENVIRON ENTOMOL, V32, P96, DOI 10.1603/0046-225X-32.1.96; Aikawa T, 2007, NEMATOLOGY, V9, P371, DOI 10.1163/156854107781352007; Braasch H, 2001, FOREST PATHOL, V31, P129, DOI 10.1046/j.1439-0329.2001.00233.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Filho BPD, 2002, INSECT BIOCHEM MOLEC, V32, P1723, DOI 10.1016/S0965-1748(02)00112-1; Fukuda K., 1997, J RES, V2, P171, DOI [10.1007/BF02348216, DOI 10.1007/BF02348216]; Fukuda K, 2007, TREE PHYSIOL, V27, P969, DOI 10.1093/treephys/27.7.969; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JONES TM, 1972, PHYSIOL PLANT PATHOL, V2, P153, DOI 10.1016/0048-4059(72)90023-9; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Li HM, 2007, NEMATOLOGY, V9, P807, DOI 10.1163/156854107782331234; LINIT MJ, 1988, J NEMATOL, V20, P227; Mallez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059165; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Naves P, 2005, J PEST SCI, V78, P57, DOI 10.1007/s10340-004-0068-z; Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Ono N, 2000, MICROBIOL-UK, V146, P385, DOI 10.1099/00221287-146-2-385; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; Santos CS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-599; Schuetz EG, 2001, CURR DRUG METAB, V2, P139, DOI 10.2174/1389200013338595; Shinya R, 2012, APPL ENTOMOL ZOOL, V47, P341, DOI 10.1007/s13355-012-0124-8; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Steiner G, 1934, J AGRIC RES, V48, P0949; Taga Y, 2011, NEMATOLOGY, V13, P701, DOI 10.1163/138855410X543166; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; Takeuchi Y, 2006, NEMATOLOGY, V8, P869, DOI 10.1163/156854106779799295; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tomassini A, 2009, PLANT PATHOL, V58, P556, DOI 10.1111/j.1365-3059.2008.02019.x; Tomminen J., 1989, Silva Fennica, V23, P271; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; Vanholme B, 2007, MOL PLANT PATHOL, V8, P267, DOI 10.1111/J.1364-3703.2007.00392.X; Wang Y, 2005, NEMATOLOGY, V7, P459, DOI 10.1163/156854105774355545; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988; YANG BJ, 1989, CAN J FOREST RES, V19, P1527, DOI 10.1139/x89-232; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhang FuJia, 2013, American Journal of Plant Sciences, V4, P512; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	67	19	25	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78063	10.1371/journal.pone.0078063	http://dx.doi.org/10.1371/journal.pone.0078063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155981	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300115
J	Schmitt, LHM; Brugere, C				Schmitt, Laetitia Helene Marie; Brugere, Cecile			Capturing Ecosystem Services, Stakeholders' Preferences and Trade-Offs in Coastal Aquaculture Decisions: A Bayesian Belief Network Application	PLOS ONE			English	Article							SHRIMP AQUACULTURE; FARMING SYSTEMS; MANAGEMENT; INTEGRATION; VALUATION; CONFLICTS; THAILAND; DELTA	Aquaculture activities are embedded in complex social-ecological systems. However, aquaculture development decisions have tended to be driven by revenue generation, failing to account for interactions with the environment and the full value of the benefits derived from services provided by local ecosystems. Trade-offs resulting from changes in ecosystem services provision and associated impacts on livelihoods are also often overlooked. This paper proposes an innovative application of Bayesian belief networks - influence diagrams - as a decision support system for mediating trade-offs arising from the development of shrimp aquaculture in Thailand. Senior experts were consulted (n = 12) and primary farm data on the economics of shrimp farming (n = 20) were collected alongside secondary information on ecosystem services, in order to construct and populate the network. Trade-offs were quantitatively assessed through the generation of a probabilistic impact matrix. This matrix captures nonlinearity and uncertainty and describes the relative performance and impacts of shrimp farming management scenarios on local livelihoods. It also incorporates export revenues and provision and value of ecosystem services such as coastal protection and biodiversity. This research shows that Bayesian belief modeling can support complex decision-making on pathways for sustainable coastal aquaculture development and thus contributes to the debate on the role of aquaculture in social-ecological resilience and economic development.	[Schmitt, Laetitia Helene Marie] Univ York, Dept Econ & Related Studies, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Brugere, Cecile] Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Brugere, C (corresponding author), Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England.	cecile.brugere@sei-international.org			Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development" [PIEF-GA-2009-235835]; European Community	Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development"; European Community(European Commission)	This research was supported by the Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development" (Project No: PIEF-GA-2009-235835, 2010-11) funded under the European Community 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(ADB) Asian Development Bank (NACA) Network of Aquaculture Centres in Asia-Pacific, 1997, SHRIMP CARP AQ SUST; Ashley Caroline, 1999, SUSTAINABLE LIVELIHO; Bailey C., 2008, FAO Fisheries and Aquaculture Proceedings, P37; Baran E, 2006, COMPR ASSESS WAT MAN, V2, P206, DOI 10.1079/9781845931070.0206; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Binh CT, 1997, AQUAC RES, V28, P599, DOI 10.1046/j.1365-2109.1997.00901.x; Borsuk ME, 2004, ECOL MODEL, V173, P219, DOI 10.1016/j.ecolmodel.2003.08.020; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Brugere C, 2006, COMP ASSESS WAT MAN, V2, P258, DOI 10.1079/9781845931070.0258; Bunting SW, 2013, AQUACULT ECON MANAG, V17, P51, DOI 10.1080/13657305.2013.747226; Bush SR, 2010, ECOL SOC, V15; Cain J, 2001, PLANNING IMPROVEMENT; Castelletti A, 2007, ENVIRON MODELL SOFTW, V22, P1073, DOI 10.1016/j.envsoft.2006.06.001; Davy FB, 2011, SUCCESS STORIES ASIA; FAO, 2011, AQ PROD QUANT VAL 19; FAO NACA UNEP WB, 2006, INT PRINC RESP SHRIM; Farmani R, 2009, ENVIRON MODELL SOFTW, V24, P303, DOI 10.1016/j.envsoft.2008.08.005; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisheries Department, 2008, THAIL EXP OPP AQ CER; Funge-Smith SJ, 1995, EC FACTORS RISKS INF; Hishamunda N, 2009, FOOD POLICY, V34, P102, DOI 10.1016/j.foodpol.2008.06.006; Huitric M, 2002, ECOL ECON, V40, P441, DOI 10.1016/S0921-8009(02)00011-3; Kasai C, 2005, FISHERIES SCI, V71, P791, DOI 10.1111/j.1444-2906.2005.01029.x; Kongkeo H, 1997, AQUAC RES, V28, P789; Kragt M, 2009, INTEGRATED HYDROECON; Levontin P, 2011, ICES J MAR SCI, V68, P632, DOI 10.1093/icesjms/fsr004; Lewis III R.R., 2001, MANGROVE RESTORATION; Loawapong A, 2010, BACKGROUND REPORT FI; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martinez-Alier J, 2001, ENVIRON PLANN C, V19, P713, DOI 10.1068/c15s; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McNay RS, 2006, CAN J FOREST RES, V36, P3117, DOI 10.1139/X06-258; NACA WWF, 2010, SUPP DEM SMALL SCAL; Neiland AE, 2001, MAR POLICY, V25, P265, DOI 10.1016/S0308-597X(01)00017-3; Primavera J.H, 2000, INTEGRATED MANGROVE, P121; Raux P, 2001, LIT REV WORLD SHRIMP, P5; Sadoddin A, 2012, INT J ENV RESOURCES, V1, P1; Sathirathai S., 1998, EC VALUATION MANGROV; Senanan W, 2007, J SHELLFISH RES, V26, P1187, DOI 10.2983/0730-8000(2007)26[1187:TPOTPW]2.0.CO;2; Slater MJ, 2013, OCEAN COAST MANAGE, V73, P22, DOI 10.1016/j.ocecoaman.2012.12.002; Soto D., 2008, FAO Fisheries and Aquaculture Proceedings, P15; Stevenson NJ, 1997, COAST MANAGE, V25, P425, DOI 10.1080/08920759709362334; Szuster B, 2006, COMPR ASSESS WAT MAN, V2, P86, DOI 10.1079/9781845931070.0086; Thailand Customs Department, 2007, STAT SHRIMP IMP EXP; Ticehurst JL, 2007, ENVIRON MODELL SOFTW, V22, P1129, DOI 10.1016/j.envsoft.2006.03.003; Troell M., 2009, FAO Fisheries and Aquaculture Technical Paper, P47; Umesh NR, 2010, SUCCESS STORIES IN ASIAN AQUACULTURE, P41, DOI 10.1007/978-90-481-3087-0_3; Umesh N. R., 2007, Aquaculture Asia Magazine, V12, P8; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Varis O, 1999, ECOL MODEL, V119, P177, DOI 10.1016/S0304-3800(99)00061-7; Wyban J., 2007, Aqua Culture Asia Pacific, V3, P16	54	46	47	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75956	10.1371/journal.pone.0075956	http://dx.doi.org/10.1371/journal.pone.0075956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155876	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300010
J	Zweitzig, DR; Riccardello, NM; Morrison, J; Rubino, J; Axelband, J; Jeanmonod, R; Sodowich, BI; Kopnitsky, MJ; O'Hara, SM				Zweitzig, Daniel R.; Riccardello, Nichol M.; Morrison, John; Rubino, Jason; Axelband, Jennifer; Jeanmonod, Rebecca; Sodowich, Bruce I.; Kopnitsky, Mark J.; O'Hara, S. Mark			Measurement of Microbial DNA Polymerase Activity Enables Detection and Growth Monitoring of Microbes from Clinical Blood Cultures	PLOS ONE			English	Article							UNITED-STATES; DIAGNOSIS; SEPSIS; EPIDEMIOLOGY; TECHNOLOGY; INFECTION; THERAPY	Surveillance of bloodstream infections (BSI) is a high priority within the hospital setting. Broth-based blood cultures are the current gold standard for detecting BSI, however they can require lengthy incubation periods prior to detection of positive samples. We set out to demonstrate the feasibility of using enzymatic template generation and amplification (ETGA)-mediated measurement of DNA polymerase activity to detect microbes from clinical blood cultures. In addition to routine-collected hospital blood cultures, one parallel aerobic blood culture was collected and immediately refrigerated until being transported for ETGA analysis. After refrigeration holding and transport, parallel-collected cultures were placed into a BACTEC incubator and ETGA time-course analysis was performed. Of the 308 clinical blood cultures received, 22 were BACTEC positive, and thus were initially selected for ETGA time course analysis. The ETGA assay detected microbial growth in all 22 parallel-positive blood cultures in less time than a BACTEC incubator and also yielded genomic DNA for qPCR-based organism identification. In summary, feasibility of detecting microbes from clinical blood culture samples using the ETGA blood culture assay was demonstrated. Additional studies are being considered towards development of clinically beneficial versions of this methodology.	[Zweitzig, Daniel R.; Riccardello, Nichol M.; Sodowich, Bruce I.; Kopnitsky, Mark J.; O'Hara, S. Mark] ZEUS Sci, Res & Dev, Raritan, NJ USA; [Morrison, John; Rubino, Jason; Axelband, Jennifer; Jeanmonod, Rebecca] St Lukes Univ Hlth Network, Bethlehem, PA USA		Zweitzig, DR (corresponding author), ZEUS Sci, Res & Dev, Raritan, NJ USA.	dzweitzig@zeusscientific.com			Zeus Scientific Inc.	Zeus Scientific Inc.	This study was funded by Zeus Scientific Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ARONSON MD, 1987, ANN INTERN MED, V106, P246, DOI 10.7326/0003-4819-106-2-246; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barie PS, 2012, SURG CLIN N AM, V92, P345, DOI 10.1016/j.suc.2012.01.015; Clinical and Laboratory Standards Institute, M47A CLIN LAB STAND, V27; Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Munson EL, 2003, J CLIN MICROBIOL, V41, P495, DOI 10.1128/JCM.41.1.495-497.2003; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reimer LG, 1997, CLIN MICROBIOL REV, V10, P444, DOI 10.1128/CMR.10.3.444; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sautter RL, 2006, J CLIN MICROBIOL, V44, P1245, DOI 10.1128/JCM.44.4.1245-1249.2006; Seifert H, 2009, CLIN INFECT DIS, V48, pS238, DOI 10.1086/598188; Textoris J, 2011, EUR J ANAESTH, V28, P318, DOI 10.1097/EJA.0b013e328346c0de; Weinstein MP, 1996, CLIN INFECT DIS, V23, P40, DOI 10.1093/clinids/23.1.40; Wolk D. M., 2011, Journal of Clinical Microbiology, V49, pS62, DOI 10.1128/JCM.00834-11; Zweitzig DR, 2013, J MOL DIAGN, V15, P319, DOI 10.1016/j.jmoldx.2012.12.004; Zweitzig DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks316	24	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78488	10.1371/journal.pone.0078488	http://dx.doi.org/10.1371/journal.pone.0078488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155986	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300121
J	Sommer, E; Koler, M; Frank, V; Sourjik, V; Vaknin, A				Sommer, Erik; Koler, Moriah; Frank, Vered; Sourjik, Victor; Vaknin, Ady			The Sensory Histidine Kinases TorS and EvgS Tend to Form Clusters in Escherichia coli Cells	PLOS ONE			English	Article							RESPONSE REGULATOR; 2-COMPONENT; RECEPTOR; CHEMORECEPTORS; LOCALIZATION; ORGANIZATION; COMPONENTS; PROTEINS; SYSTEMS	Microorganisms use multiple two-component sensory systems to detect changes in their environment and elicit physiological responses. Despite their wide spread and importance, the intracellular organization of two-component sensory proteins in bacteria remains little investigated. A notable exception is the well-studied clustering of the chemoreceptor-kinase complexes that mediate chemotaxis behaviour. However, these chemosensory complexes differ fundamentally from other systems, both structurally and functionally. Therefore, studying the organization of typical sensory kinases in bacteria is essential for understanding the general role of receptor clustering in bacterial sensory signalling. Here, by studying mYFP-tagged sensory kinases in Escherichia coli, we show that the tagged TorS and EvgS sensors have a clear tendency for self-association and clustering. These sensors clustered even when expressed at a level of a few hundred copies per cell. Moreover, the mYFP-tagged response regulator TorR showed clear TorS-dependent clustering, indicating that untagged TorS sensors also tend to form clusters. We also provide evidence for the functionality of these tagged sensors. Experiments with truncated TorS or EvgS proteins suggested that clustering of EvgS sensors depends on the cytoplasmic part of the protein, whereas clustering of TorS sensors can be potentially mediated by the periplasmic/transmembrane domain. Overall, these findings support the notion that sensor clustering plays a role in bacterial sensory signalling beyond chemotaxis.	[Sommer, Erik; Sourjik, Victor] Heidelberg Univ, Dept Mol Biol, Heidelberg, Germany; [Koler, Moriah; Frank, Vered; Vaknin, Ady] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Hebrew University of Jerusalem	Sourjik, V (corresponding author), Heidelberg Univ, Dept Mol Biol, Heidelberg, Germany.	v.sourjik@zmbh.uni-heidelberg.de; avaknin@phys.huji.ac.il			GIF grant [I-909-54.13/2006]; ERC advanced grant [294761]; Minerva center for bio-hybrid complex systems	GIF grant; ERC advanced grant; Minerva center for bio-hybrid complex systems	This work was supported by the GIF grant I-909-54.13/2006, the ERC advanced grant 294761, and the Minerva center for bio-hybrid complex systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baraquet C, 2006, J BIOL CHEM, V281, P38189, DOI 10.1074/jbc.M604321200; Batchelor E, 2006, MOL MICROBIOL, V59, P1767, DOI 10.1111/j.1365-2958.2006.05048.x; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Eguchi Y, 2011, J BACTERIOL, V193, P1222, DOI 10.1128/JB.01124-10; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Kenney LJ, 2010, CURR OPIN MICROBIOL, V13, P168, DOI 10.1016/j.mib.2010.01.013; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Scheu P, 2008, MICROBIOL-SGM, V154, P2463, DOI 10.1099/mic.0.2008/018614-0; Sciara MI, 2008, MOL MICROBIOL, V70, P479, DOI 10.1111/j.1365-2958.2008.06427.x; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thanbichler M, 2009, CURR OPIN MICROBIOL, V12, P715, DOI 10.1016/j.mib.2009.09.013; Vaknin A, 2006, P NATL ACAD SCI USA, V103, P592, DOI 10.1073/pnas.0510047103; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	44	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77708	10.1371/journal.pone.0077708	http://dx.doi.org/10.1371/journal.pone.0077708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147062	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400137
J	Buck, MJ; Raaijmakers, LM; Ramakrishnan, S; Wang, D; Valiyaparambil, S; Liu, S; Nowak, NJ; Pili, R				Buck, M. J.; Raaijmakers, L. M.; Ramakrishnan, S.; Wang, D.; Valiyaparambil, S.; Liu, S.; Nowak, N. J.; Pili, R.			Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma	ONCOGENE			English	Article						Epigenetics; epigenome; FAIRE; FAIRE-seq; renal cell carcinoma	REGULATORY ELEMENTS; FAIRE	Recent studies have demonstrated that in clear cell renal cell carcinoma (ccRCC) several chromatin remodeling enzymes are genetically inactivated. Although, growing evidence in cancer models has demonstrated the importance of epigenetic changes, currently only changes in DNA methylation can be accurately determined from clinical samples. To address this limitation, we have applied formaldehyde-assisted isolation of regulatory elements (FAIREs) combined with next-generation sequencing (FAIRE-seq) to identify specific changes in chromatin accessibility in clinical samples of ccRCC. We modified the FAIRE procedure to allow us to examine chromatin accessibility for small samples of solid tumors. Our FAIRE results were compared with DNA-methylation analysis and show how chromatin accessibility decreases at many sites where DNA-methylation remains unchanged. In addition, our FAIRE-seq analysis allowed us to identify regulatory elements associated with both normal and tumor tissue. We have identified decreases in chromatin accessibility at key ccRCC-linked genes, including PBRM1, SETD2 and MLL2. Overall, our results demonstrate the power of examining multiple aspects of the epigenome.	[Buck, M. J.; Valiyaparambil, S.; Nowak, N. J.] SUNY Buffalo, State Ctr Excellence Bioinformat & Life Sci, Dept Biochem, Buffalo, NY 14214 USA; [Buck, M. J.; Wang, D.; Liu, S.; Nowak, N. J.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Raaijmakers, L. M.] Roswell Pk Canc Inst, CanSys Program, Buffalo, NY 14263 USA; [Ramakrishnan, S.; Pili, R.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Buck, MJ (corresponding author), SUNY Buffalo, State Ctr Excellence Bioinformat & Life Sci, Dept Biochem, Buffalo, NY 14214 USA.	mjbuck@buffalo.edu; njnowak@buffalo.edu; Roberto.Pili@RoswellPark.org			National Cancer Institute at the National Institutes of Health [P30CA016056]; RPCI -Alliance Foundation; Bruce Cuvelier Family Trust; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RPCI -Alliance Foundation; Bruce Cuvelier Family Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Cancer Institute at the National Institutes of Health (P30CA016056; to RP), a grant from the RPCI -Alliance Foundation (to RP) and a donation from the, The Bruce Cuvelier Family Trust (to RP).	[Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Henrique Rui, 2012, Frontiers in Genetics, V3, P94, DOI 10.3389/fgene.2012.00094; Lai WKM, 2012, BIOINFORMATICS, V28, P1021, DOI 10.1093/bioinformatics/bts063; O'Rourke CJ, 2013, PHARMACOL THERAPEUT, V138, P185, DOI 10.1016/j.pharmthera.2013.01.007; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sonpavde G, 2012, CURR ONCOL REP, V14, P295, DOI 10.1007/s11912-012-0237-9; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	21	16	16	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4961	4965		10.1038/onc.2013.455	http://dx.doi.org/10.1038/onc.2013.455			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24186201				2022-12-25	WOS:000343767900009
J	Kamekura, R; Kolegraff, KN; Nava, P; Hilgarth, RS; Feng, M; Parkos, CA; Nusrat, A				Kamekura, R.; Kolegraff, K. N.; Nava, P.; Hilgarth, R. S.; Feng, M.; Parkos, C. A.; Nusrat, A.			Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling	ONCOGENE			English	Article						Desmosome; intestinal epithelium; EGFR; desmoglein; desmocollin; cancer	ADHESION; EXPRESSION; INHIBITION; CARCINOMAS; APOPTOSIS; RECEPTOR; DSG2	Desmosomal cadherins mediate cell-cell adhesion in epithelial tissues and have been known to be altered in cancer. We have previously shown that one of the two intestinal epithelial desmosomal cadherins, desmocollin-2 (Dsc2) loss promotes colonic epithelial carcinoma cell proliferation and tumor formation. In this study we show that loss of the other intestinal desmosomal cadherin, desmoglein-2 (Dsg2) that pairs with Dsc2, results in decreased epithelial cell proliferation and suppressed xenograft tumor growth in mice. Dsg2-deficient cells demonstrated a compensatory increase in Dsc2 expression, and small interfering RNA-mediated loss of Dsc2 restored proliferation in Dsg2-deficient cells. Dsg2 downregulation inhibited epidermal growth factor receptor (EGFR) signaling and cell proliferation through altered phosphorylation of EGFR and downstream extracellular signal-regulated kinase activation in parallel with inhibited EGFR receptor internalization. Additionally, we demonstrated a central role of Dsc2 in controlling EGFR signaling and cell proliferation in intestinal epithelial cells. Consistent with these findings, analyses of human colon cancers demonstrated increased Dsg2 protein expression. Taken together, these data demonstrate that partner desmosomal cadherins Dsg2 and Dsc2 play opposing roles in controlling colonic carcinoma cell proliferation through differential effects on EGFR signaling.	[Kamekura, R.; Kolegraff, K. N.; Hilgarth, R. S.; Feng, M.; Parkos, C. A.; Nusrat, A.] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA; [Nava, P.] Ctr Res & Adv Studies CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico	Emory University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Nusrat, A (corresponding author), Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Whitehead Biomed Res Bldg,Room 105M, Atlanta, GA 30322 USA.	anusrat@emory.edu	Nava, Porfirio/D-8306-2012	Nava, Porfirio/0000-0002-0506-1510	Japan Society of Immunology and Allergology in Otolaryngology; American Gastroenterological Association Research Scholar Award; Crohn's and Colitis Foundation of America Career Development Award; CONACyT [175854]; National Institutes of Health [DK061379, DK072564, DK055679, DK059888]; DDRDC [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007771, R01DK055679, R01DK072564, R24DK064399, R01DK061379, R01DK079392, R01DK059888, R29DK055679] Funding Source: NIH RePORTER	Japan Society of Immunology and Allergology in Otolaryngology; American Gastroenterological Association Research Scholar Award; Crohn's and Colitis Foundation of America Career Development Award; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DDRDC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the 12th Glaxo-SmithKline International Award from Japan Society of Immunology and Allergology in Otolaryngology (RK), an American Gastroenterological Association Research Scholar Award (PN), a Crohn's and Colitis Foundation of America Career Development Award (PN), a CONACyT grant 175854 (PN) and National Institutes of Health grants DK061379, DK072564 (CAP), DK055679, DK059888 (AN) and DDRDC DK064399.	Baron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050024; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Getsios S, 2004, DIFFERENTIATION, V72, P419, DOI 10.1111/j.1432-0436.2004.07208008.x; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ishii K, 2001, J INVEST DERMATOL, V117, P26, DOI 10.1046/j.0022-202x.2001.01400.x; Kolegraff K, 2011, CELL ADHES MIGR, V5, P306, DOI 10.4161/cam.5.4.16911; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Mannan T, 2011, CELL PROLIFERAT, V44, P301, DOI 10.1111/j.1365-2184.2011.00765.x; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Wex T, 2012, HUM PATHOL, V43, P1745, DOI 10.1016/j.humpath.2011.12.024	22	73	75	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4531	4536		10.1038/onc.2013.442	http://dx.doi.org/10.1038/onc.2013.442			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24166502	Green Accepted			2022-12-25	WOS:000341158800008
J	Reinhardt, S; Schuck, F; Grosgen, S; Riemenschneider, M; Hartmann, T; Postina, R; Grimm, M; Endres, K				Reinhardt, Sven; Schuck, Florian; Groesgen, Sven; Riemenschneider, Matthias; Hartmann, Tobias; Postina, Rolf; Grimm, Marcus; Endres, Kristina			Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease	FASEB JOURNAL			English	Article						APP processing; insulin signaling; ER stress; stress response; -secretase	ENDOPLASMIC-RETICULUM STRESS; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; BRAIN INSULIN-RESISTANCE; BOX-BINDING PROTEIN-1; ER STRESS; MESSENGER-RNA; BETA-SECRETASE; TRANSGENIC MICE; CELL-DEATH	In Alzheimer's disease (AD), disturbed homeostasis of the proteases competing for amyloid precursor protein processing has been reported: a disintegrin and metalloproteinase 10 (ADAM10), the physiological -secretase, is decreased in favor of the amyloid--generating enzyme BACE-1. To identify transcription factors that modulate the expression of either protease, we performed a screening approach: 48 transcription factors significantly interfered with ADAM10/BACE-1-promoter activity. One selective inducer of ADAM10 gene expression is the X-box binding protein-1 (XBP-1). This protein regulates the unfolded protein-response pathway. We demonstrate that particularly the spliced XBP-1 variant dose dependently regulates ADAM10 expression, which can be synergistically enhanced by 100 nM insulin. Analysis of 2 different transgenic mouse models (APP/PS1 and 5xFAD) revealed that at early time points in pathology XBP-1 metabolism is induced. This is accompanied by a 2-fold augmented ADAM10 amount as compared with nontransgenic littermates (P=0.011). Along with aging of the mice, the system is counterregulated, and XBP-1 together with ADAM10 expression level decreased to approximate to 50% as compared with control animals. Analyses of expression levels in human AD brains showed that ADAM10 mRNA correlated with active XBP-1 (r=0.3120), but expression did not reach levels of healthy age-matched controls, suggesting deregulation of XBP-1 signaling. Our results demonstrate that XBP-1 is a driver of ADAM10 gene expression and that disturbance of this pathway might contribute to development or progression of AD.Reinhardt, S., Schuck, F., Grosgen, S., Riemenschneider, M., Hartmann, T., Postina, R., Grimm, M., Endres, K. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.	[Reinhardt, Sven; Schuck, Florian; Endres, Kristina] Johannes Gutenberg Univ Mainz, Clin Res Grp, Dept Psychiat & Psychotherapy, D-55131 Mainz, Germany; [Postina, Rolf] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55131 Mainz, Germany; [Groesgen, Sven; Hartmann, Tobias; Grimm, Marcus] Univ Saarland, Dept Neurodegenerat & Neurobiol, Deutsch Inst DemenzPravent DIDP, Homburg, Germany; [Riemenschneider, Matthias] Univ Saarland, Clin Psychiat & Psychotherapy, Homburg, Germany; [Hartmann, Tobias; Grimm, Marcus] Univ Saarland, Dept Expt Neurol, Homburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Saarland University; Saarland University; Saarland University	Endres, K (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, Untere Zahlbacher Str 8, D-55131 Mainz, Germany.	kristina.endres@unimedizin-mainz.de	Hartmann, Tobias/AAB-8297-2022; Grimm, Marcus O. W./F-8134-2011; Endres, Kristina/K-4960-2015	Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430	German Federal Ministry of Education and Research (BMBF);  [FKZ01GS08130];  [01GS08125];  [01GS08129-5]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); ; ; 	This work was supported by the German Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) and FKZ01GS08130, 01GS08125, and 01GS08129-5. The authors kindly thank C. Haass (Ludwig Maximilian University, Munich, Germany) for providing APP antibody 6687 and C. Pietrzik (Johannes Gutenberg University Mainz, Mainz, Germany) for putting 5xFAD brain samples at their disposal. Author contributions: K. E. conceived the project and wrote the manuscript; S. R. performed cell culture experiments and analysis of mouse tissue and in vitro studies, analyzed the data, wrote the manuscript, and prepared the figures; M. G., T. H., and M. R. coordinated and designed the experiments with human samples; S. G. performed experiments with human samples and the fluorescent enzyme assay; S. G. and M. G. analyzed the respective data; F. S. and R. P. provided a critical evaluation of the experimental design and of the manuscript. The authors declare no conflicts of interest.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Augustin R, 2011, INT J ALZHEIMERS DIS, V2011; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Castillo-Carranza DL, 2012, NEUROCHEM RES, V37, P1707, DOI 10.1007/s11064-012-0780-7; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Grimm M. O., 2011, INT J ALZHEIMERS DIS, V2011; Grimm MOW, 2013, INT J MOL SCI, V14, P5879, DOI 10.3390/ijms14035879; Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kim HJ, 2008, J NUTR BIOCHEM, V19, P754, DOI 10.1016/j.jnutbio.2007.09.009; Kogel D, 2012, NEUROBIOL AGING, V33, P2200, DOI 10.1016/j.neurobiolaging.2011.06.012; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lahiri DK, 2004, ANN NY ACAD SCI, V1030, P310, DOI 10.1196/annals.1329.039; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu SY, 2013, CNS NEUROSCI THER, V19, P229, DOI 10.1111/cns.12064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Misiewicz M, 2013, J BIOL CHEM, V288, P20378, DOI 10.1074/jbc.M113.457242; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Ozmen L, 2005, NEURODEGENER DIS, V2, P284, DOI 10.1159/000092314; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rzymski T, 2012, ONCOGENE, V31, P3621, DOI 10.1038/onc.2011.522; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takahashi K, 2009, J NEUROCHEM, V109, P1324, DOI 10.1111/j.1471-4159.2009.06067.x; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Ueki K, 2011, NAT MED, V17, P246, DOI 10.1038/nm0311-246; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Wang Y, 2000, J BIOL CHEM, V275, P27013; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052	85	70	71	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					978	997		10.1096/fj.13-234864	http://dx.doi.org/10.1096/fj.13-234864			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24165480				2022-12-25	WOS:000331072200042
J	Mascle, XH; Lussier-Price, M; Cappadocia, L; Estephan, P; Raiola, L; Omichinski, JG; Aubry, M				Mascle, Xavier H.; Lussier-Price, Mathieu; Cappadocia, Laurent; Estephan, Patricia; Raiola, Luca; Omichinski, James G.; Aubry, Muriel			Identification of a Non-covalent Ternary Complex Formed by PIAS1, SUMO1, and UBC9 Proteins Involved in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); Calorimetry; Gene Regulation; Nuclear Magnetic Resonance; Phosphorylation; Protein Complexes; Sumoylation; E2 SUMO Conjugating Enzyme; E3 SUMO Ligase; SUMO Interacting Motif	UBIQUITIN-LIKE PROTEIN; RESONANCE ENERGY-TRANSFER; NUCLEAR-PORE COMPLEX; E3 LIGASE ACTIVITY; NF-KAPPA-B; CONJUGATING ENZYME; RING DOMAIN; SUBNUCLEAR LOCALIZATION; TUMOR-SUPPRESSOR; YEAST SEPTINS/	Background: Covalent coupling of SUMO by the E2 and E3 enzymes confers repression activity to transcriptional regulators. Results: Identification of a non-covalent E2SUMOE3 complex that can also function in transcriptional repression. Conclusion: SUMO participates in repression as both a covalent modification and through non-covalent interactions with E2 and E3 enzymes. Significance: Similar interaction interfaces in other ubiquitin-like proteins and their cognate enzymes suggest they form analogous ternary complexes. Post-translational modifications with ubiquitin-like proteins require three sequentially acting enzymes (E1, E2, and E3) that must unambiguously recognize each other in a coordinated fashion to achieve their functions. Although a single E2 (UBC9) and few RING-type E3s (PIAS) operate in the SUMOylation system, the molecular determinants regulating the interactions between UBC9 and the RING-type E3 enzymes are still not well defined. In this study we use biochemical and functional experiments to characterize the interactions between PIAS1 and UBC9. Our results reveal that UBC9 and PIAS1 are engaged both in a canonical E2E3 interaction as well as assembled into a previously unidentified non-covalent ternary complex with SUMO as evidenced by bioluminescence resonance energy transfer, nuclear magnetic resonance spectroscopy, and isothermal titration calorimetry studies. In this ternary complex, SUMO functions as a bridge by forming non-overlapping interfaces with UBC9 and PIAS1. Moreover, our data suggest that phosphorylation of serine residues adjacent to the PIAS1 SUMO-interacting motif favors formation of the non covalent PIAS1SUMOUBC9 ternary complex. Finally, our results also indicate that the non-covalent ternary complex is required for the known transcriptional repression activities mediated by UBC9 and SUMO1. Taken together, the data enhance our knowledge concerning the mode of interaction of enzymes of the SUMOylation machinery as well as their role in transcriptional regulation and establishes a framework for investigations of other ubiquitin-like protein systems.	[Mascle, Xavier H.; Lussier-Price, Mathieu; Cappadocia, Laurent; Estephan, Patricia; Raiola, Luca; Omichinski, James G.; Aubry, Muriel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Omichinski, JG (corresponding author), Univ Montreal, Dept Biochim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jg.omichinski@umontreal.ca; muriel.aubry@umontreal.ca		Cappadocia, Laurent/0000-0001-7348-1982	Canadian Cancer Society; Canadian Institutes for Health Research [MOP-74739]; Natural Sciences and Engineering Research Council of Canada	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Cancer Society (to J. G. O.), the Canadian Institutes for Health Research (to J. G. O.; MOP-74739), and the Natural Sciences and Engineering Research Council of Canada (to M. A.).	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Boddy MN, 1996, ONCOGENE, V13, P971; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen A, 1998, BIOCHEM MOL BIOL INT, V46, P1161; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Garner TP, 2011, BIOCHEMISTRY-US, V50, P9076, DOI 10.1021/bi201137e; Germain-Desprez D, 2003, J BIOL CHEM, V278, P22367, DOI 10.1074/jbc.M302234200; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Okura T, 1996, J IMMUNOL, V157, P4277; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schulman BA, 2011, PROTEIN SCI, V20, P1941, DOI 10.1002/pro.750; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	94	16	18	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36312	36327		10.1074/jbc.M113.486845	http://dx.doi.org/10.1074/jbc.M113.486845			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24174529	hybrid, Green Published			2022-12-25	WOS:000328883400014
J	Du, JH; Cleghorn, WM; Contreras, L; Lindsay, K; Rountree, AM; Chertov, AO; Turner, SJ; Sahaboglu, A; Linton, J; Sadilek, M; Satrustegui, J; Sweet, IR; Paquet-Durand, F; Hurley, JB				Du, Jianhai; Cleghorn, Whitney M.; Contreras, Laura; Lindsay, Ken; Rountree, Austin M.; Chertov, Andrei O.; Turner, Sally J.; Sahaboglu, Ayse; Linton, Jonathan; Sadilek, Martin; Satrustegui, Jorgina; Sweet, Ian R.; Paquet-Durand, Franois; Hurley, James B.			Inhibition of Mitochondrial Pyruvate Transport by Zaprinast Causes Massive Accumulation of Aspartate at the Expense of Glutamate in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspartate; Glutamate; Metabolism; Phosphodiesterases; Pyruvate; Retina	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; MICE LACKING; BETA-SUBUNIT; AMINO-ACIDS; DEGENERATION; IDENTIFICATION; CHANNELS; GLUCOSE; SPECIFICITY; ACTIVATION	Background: Pyruvate transport into mitochondria is a key step in energy metabolism. Zaprinast is a well known phosphodiesterase inhibitor. Results: Zaprinast has a strong influence on pyruvate transport into mitochondria. Conclusion: Inhibition of the mitochondrial pyruvate carrier by Zaprinast causes accumulation of aspartate at the expense of glutamate. Significance: Maintenance of normal amino acid levels in the retina relies on pyruvate transport into mitochondria. Transport of pyruvate into mitochondria by the mitochondrial pyruvate carrier is crucial for complete oxidation of glucose and for biosynthesis of amino acids and lipids. Zaprinast is a well known phosphodiesterase inhibitor and lead compound for sildenafil. We found Zaprinast alters the metabolomic profile of mitochondrial intermediates and amino acids in retina and brain. This metabolic effect of Zaprinast does not depend on inhibition of phosphodiesterase activity. By providing C-13-labeled glucose and glutamine as fuels, we found that the metabolic profile of the Zaprinast effect is nearly identical to that of inhibitors of the mitochondrial pyruvate carrier. Both stimulate oxidation of glutamate and massive accumulation of aspartate. Moreover, Zaprinast inhibits pyruvate-driven O-2 consumption in brain mitochondria and blocks mitochondrial pyruvate carrier in liver mitochondria. Inactivation of the aspartate glutamate carrier in retina does not attenuate the metabolic effect of Zaprinast. Our results show that Zaprinast is a potent inhibitor of mitochondrial pyruvate carrier activity, and this action causes aspartate to accumulate at the expense of glutamate. Our findings show that Zaprinast is a specific mitochondrial pyruvate carrier (MPC) inhibitor and may help to elucidate the roles of MPC in amino acid metabolism and hypoglycemia.	[Du, Jianhai; Cleghorn, Whitney M.; Lindsay, Ken; Chertov, Andrei O.; Turner, Sally J.; Linton, Jonathan; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rountree, Austin M.; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Contreras, Laura; Satrustegui, Jorgina] Univ Autonoma Madrid, Consejo Super Invest Cient, CIBER Rare Dis CIBERER, Ctr Mol Biol Severo Ochoa,Dept Mol Biol, E-28049 Madrid, Spain; [Contreras, Laura; Satrustegui, Jorgina] Autonomous Univ Madrid, Fdn Jimenez Diaz, Hlth Res Inst, E-28049 Madrid, Spain; [Sahaboglu, Ayse; Paquet-Durand, Franois] Ctr Ophthalmol, Inst Ophthalm Res, Div Expt Ophthalmol, D-72076 Tubingen, Germany	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jbhhh@u.washington.edu	Du, Jianhai/J-6197-2014; Contreras, Laura/A-2296-2015; Paquet-Durand, Francois/G-6709-2015; Satrustegui, Jorgina/R-6732-2019; Contreras, Laura/ABG-7620-2021	Du, Jianhai/0000-0002-5612-4091; Paquet-Durand, Francois/0000-0001-7355-5742; Contreras, Laura/0000-0003-1157-4942; Sahaboglu, Ayse/0000-0003-3241-0672; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	National Institutes of Health [P30DK017047]; NATIONAL EYE INSTITUTE [F32EY006641, R01EY017863, R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Cngb1<SUP>-/-</SUP> mice were kindly provided by Stylianos Michalakis and Martin Biel, Center for Integrated Protein Science CIPS-M and Department of Pharmacy, Ludwig-Maximilians Universitat Munchen. Oxygen consumption and pyruvate uptake experiments were carried out by Diabetes Research Center Cell Function Analysis Core (National Institutes of Health Grant P30DK017047).	Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brivet M, 2003, MOL GENET METAB, V78, P186, DOI 10.1016/S1096-7192(03)00016-7; BUTTERWORTH RF, 1982, J NEUROCHEM, V38, P1483, DOI 10.1111/j.1471-4159.1982.tb07929.x; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gibson A, 2001, EUR J PHARMACOL, V411, P1, DOI 10.1016/S0014-2999(00)00824-4; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Guo JA, 2008, J PHARMACOL EXP THER, V324, P342, DOI 10.1124/jpet.107.127266; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Janke R, 2010, BIOTECHNOL BIOENG, V107, P566, DOI 10.1002/bit.22817; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Mackenzie A E, 2011, Front Endocrinol (Lausanne), V2, P68, DOI 10.3389/fendo.2011.00068; de la Camara CMF, 2013, EXP EYE RES, V111, P122, DOI 10.1016/j.exer.2013.03.015; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Pardo B, 2011, J CEREBR BLOOD F MET, V31, P90, DOI 10.1038/jcbfm.2010.146; Peng L, 2007, J NEUROSCI RES, V85, P3480, DOI 10.1002/jnr.21262; PROUDLOVE MO, 1987, BIOCHEM J, V247, P441, DOI 10.1042/bj2470441; ROMIJN HJ, 1988, BIOL CELL, V63, P263, DOI 10.1016/0248-4900(88)90116-5; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; SANDBERG M, 1985, J NEUROSCI RES, V13, P489, DOI 10.1002/jnr.490130403; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; SZERB JC, 1987, SYNAPSE, V1, P265, DOI 10.1002/syn.890010308; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; Vallazza-Deschamps G, 2005, EUR J NEUROSCI, V22, P1013, DOI 10.1111/j.1460-9568.2005.04306.x; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	49	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36129	36140		10.1074/jbc.M113.507285	http://dx.doi.org/10.1074/jbc.M113.507285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187136	Green Published, hybrid			2022-12-25	WOS:000329814700047
J	Seldin, MM; Lei, X; Tan, SY; Stanson, KP; Wei, ZK; Wong, GW				Seldin, Marcus M.; Lei, Xia; Tan, Stefanie Y.; Stanson, Kevin P.; Wei, Zhikui; Wong, G. William			Skeletal Muscle-derived Myonectin Activates the Mammalian Target of Rapamycin (mTOR) Pathway to Suppress Autophagy in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Liver; Liver Metabolism; mTOR; Skeletal Muscle	IN-VIVO; ADIPOSE-TISSUE; AMINO-ACIDS; CELL-DEATH; GLUCOSE; MICE; PROTEOLYSIS; METABOLISM; DEPRIVATION; HOMEOSTASIS	Background: Liver autophagy is dynamically regulated in fed and fasted states. Results: Myonectin is secreted by skeletal muscle in response to nutrient availability, and it activates the mTOR signaling pathway to suppress autophagy in liver. Conclusion: Myonectin is a novel regulator of liver autophagy. Significance: Myonectin mediates muscle-liver cross-talk to control energy balance. Cells turn on autophagy, an intracellular recycling pathway, when deprived of nutrients. How autophagy is regulated by hormonal signals in response to major changes in metabolic state is not well understood. Here, we provide evidence that myonectin (CTRP15), a skeletal muscle-derived myokine, is a novel regulator of cellular autophagy. Starvation activated liver autophagy, whereas nutrient supplementation following food deprivation suppressed it; the former and latter correlated with reduced and increased expression and circulating levels of myonectin, respectively, suggestive of a causal link. Indeed, recombinant myonectin administration suppressed starvation-induced autophagy in mouse liver and cultured hepatocytes, as indicated by the inhibition of LC3-dependent autophagosome formation, p62 degradation, and expression of critical autophagy-related genes. Reduction in protein degradation is mediated by the PI3K/Akt/mTOR signaling pathway; inhibition of this pathway abrogated the ability of myonectin to suppress autophagy in cultured hepatocytes. Together, our results reveal a novel skeletal muscle-liver axis controlling cellular autophagy, underscoring the importance of hormone-mediated tissue cross-talk in maintaining energy homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.).; Supported by a postdoctoral grant from the American Heart Association.; Supported by a predoctoral grant from the American Heart Association.	Addis T, 1936, J BIOL CHEM, V115, P111; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byerly M. S., 2013, PLOS ONE, V8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; TOKUYAMA K, 1982, PHYSIOL BEHAV, V28, P899, DOI 10.1016/0031-9384(82)90211-6; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	49	73	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36073	36082		10.1074/jbc.M113.500736	http://dx.doi.org/10.1074/jbc.M113.500736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187137	Green Published, hybrid			2022-12-25	WOS:000329814700042
J	Karabeg, MM; Grauthoff, S; Kollert, SY; Weidner, M; Heiming, RS; Jansen, F; Popp, S; Kaiser, S; Lesch, KP; Sachser, N; Schmitt, AG; Lewejohann, L				Karabeg, Margherita M.; Grauthoff, Sandra; Kollert, Sina Y.; Weidner, Magdalena; Heiming, Rebecca S.; Jansen, Friederike; Popp, Sandy; Kaiser, Sylvia; Lesch, Klaus-Peter; Sachser, Norbert; Schmitt, Angelika G.; Lewejohann, Lars			5-HTT Deficiency Affects Neuroplasticity and Increases Stress Sensitivity Resulting in Altered Spatial Learning Performance in the Morris Water Maze but Not in the Barnes Maze	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; SEROTONIN TRANSPORTER GENE; LONG-TERM POTENTIATION; C-FOS EXPRESSION; HIPPOCAMPAL CA3C NEURONS; PITUITARY-ADRENAL AXIS; RAT DENTATE GYRUS; EARLY-LIFE STRESS; MESSENGER-RNA; PROTEIN EXPRESSION	The purpose of this study was to evaluate whether spatial hippocampus-dependent learning is affected by the serotonergic system and stress. Therefore, 5-HTT knockout (-/-), heterozygous (+/-) and wildtype (+/+) mice were subjected to the Barnes maze (BM) and the Morris water maze (WM), the latter being discussed as more aversive. Additionally, immediate early gene (IEG) expression, hippocampal adult neurogenesis (aN), and blood plasma corticosterone were analyzed. While the performance of 5-HTT-/- mice in the BM was undistinguishable from both other genotypes, they performed worse in the WM. However, in the course of the repeated WM trials 5-HTT-/- mice advanced to wildtype level. The experience of a single trial of either the WM or the BM resulted in increased plasma corticosterone levels in all genotypes. After several trials 5-HTT-/- mice exhibited higher corticosterone concentrations compared with both other genotypes in both tests. Corticosterone levels were highest in 5-HTT-/- mice tested in the WM indicating greater aversiveness of the WM and a greater stress sensitivity of 5-HTT deficient mice. Quantitative immunohistochemistry in the hippocampus revealed increased cell counts positive for the IEG products cFos and Arc as well as for proliferation marker Ki67 and immature neuron marker NeuroD in 5-HTT-/- mice compared to 5-HTT+/+ mice, irrespective of the test. Most differences were found in the suprapyramidal blade of the dentate gyrus of the septal hippocampus. Ki67-immunohistochemistry revealed a genotype x environment interaction with 5-HTT genotype differences in naive controls and WM experience exclusively yielding more Ki67-positive cells in 5-HTT+/+ mice. Moreover, in 5-HTT-/- mice we demonstrate that learning performance correlates with the extent of aN. Overall, higher baseline IEG expression and increased an in the hippocampus of 5-HTT-/- mice together with increased stress sensitivity may constitute the neurobiological correlate of raised alertness, possibly impeding optimal learning performance in the more stressful WM.	[Karabeg, Margherita M.; Kollert, Sina Y.; Weidner, Magdalena; Schmitt, Angelika G.] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Karabeg, Margherita M.; Popp, Sandy; Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Grauthoff, Sandra; Heiming, Rebecca S.; Jansen, Friederike; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Grauthoff, Sandra; Heiming, Rebecca S.; Jansen, Friederike; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Lewejohann, Lars] Univ Osnabruck, Osnabruck, Germany	University of Wurzburg; University of Wurzburg; University of Munster; University of Munster; University Osnabruck	Schmitt, AG (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.	Schmitt_A3@klinik.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Lewejohann, Lars/H-3717-2013; Kollert, Sina/Q-8737-2017	Lesch, Klaus-Peter/0000-0001-8348-153X; Lewejohann, Lars/0000-0002-0202-4351; Weidner, Magdalena/0000-0002-6195-8912; Kaiser, Sylvia/0000-0003-2770-7367	German Research Foundation (DFG) [SFB TRR 58]; Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg) [N-162-N]	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg)	This study was supplied by the German Research Foundation (DFG, http://www.dfg.de/), SFB TRR 58/Project A1 and A5 to NS, AS, KPL and the Interdisciplinary Center for Clinical Research of the University of Wurzburg, (IZKF Wurzburg, http://www.izkf.uk-wuerzburg.de/), Project N-162-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL A, 1988, J NEUROCHEM, V50, P1678, DOI 10.1111/j.1471-4159.1988.tb02462.x; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Armando I, 2003, NEUROENDOCRINOLOGY, V78, P217, DOI 10.1159/000073705; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Benninghoff J, 2010, NEUROPSYCHOPHARMACOL, V35, P893, DOI 10.1038/npp.2009.181; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calais JB, 2013, J NEURAL TRANSM, V120, P259, DOI 10.1007/s00702-012-0861-4; Callaghan CK, 2012, HIPPOCAMPUS, V22, P2127, DOI 10.1002/hipo.22033; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Choi YS, 2003, MOL CELLS, V16, P232; Choi YS, 2007, ARCH PHARM RES, V30, P646, DOI 10.1007/BF02977661; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Eriksson TM, 2012, MOL PSYCHIATR, V17, P173, DOI 10.1038/mp.2010.131; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gardner KL, 2009, BRAIN RES, V1305, P47, DOI 10.1016/j.brainres.2009.09.065; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Harvey JA, 2003, LEARN MEMORY, V10, P355, DOI 10.1101/lm.60803; Heiming RS, 2013, BEHAV BRAIN RES, V242, P135, DOI 10.1016/j.bbr.2012.12.045; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HENKE PG, 1990, BRAIN RES BULL, V25, P691, DOI 10.1016/0361-9230(90)90044-Z; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herman JP, 1998, NEUROSCIENCE, V86, P449, DOI 10.1016/S0306-4522(98)00055-4; Hohoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058880; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Homberg JR, 2007, EUR J NEUROSCI, V26, P2066, DOI 10.1111/j.1460-9568.2007.05839.x; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; IMAKI T, 1995, MOL BRAIN RES, V32, P261, DOI 10.1016/0169-328X(95)00086-8; JANSEN F, 2009, BEHAV BRAIN RES, V207, P1, DOI DOI 10.1016/J.BBR.2009.09.033.PUBMED:19782704; Jedema HP, 2010, MOL PSYCHIATR, V15, P512, DOI 10.1038/mp.2009.90; Jiang X, 2009, PSYCHONEUROENDOCRINO, V34, P317, DOI 10.1016/j.psyneuen.2008.09.011; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kalueff AV, 2006, NEUROREPORT, V17, P1347, DOI 10.1097/01.wnr.0000230514.08962.76; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lanfumey L, 2008, NEUROSCI BIOBEHAV R, V32, P1174, DOI 10.1016/j.neubiorev.2008.04.006; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Lee Margherita M, 2013, Curr Top Behav Neurosci, V14, P153, DOI 10.1007/7854_2012_226; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, NEUROSCIENTIST, V4, P25, DOI 10.1177/107385849800400110; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; LEWEJOHANN L, 2004, DIGITAL IMAGE PROCES; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Li Q, 1999, J PHARMACOL EXP THER, V291, P999; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Meneses A, 2002, NEUROSCI BIOBEHAV R, V26, P309, DOI 10.1016/S0149-7634(02)00005-2; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Molteni R, 2009, EUR NEUROPSYCHOPHARM, V19, P898, DOI 10.1016/j.euroneuro.2009.06.008; MORINOBU S, 1995, NEUROPSYCHOPHARMACOL, V12, P221, DOI 10.1038/sj.npp.1380254; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 1995, BEHAV BRAIN RES, V71, P11, DOI 10.1016/0166-4328(95)00051-8; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Namestkova K, 2005, BEHAV BRAIN RES, V163, P26, DOI 10.1016/j.bbr.2005.04.013; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Ogren SO, 2008, BEHAV BRAIN RES, V195, P54, DOI 10.1016/j.bbr.2008.02.023; Pei Q, 2003, NEUROSCIENCE, V121, P975, DOI 10.1016/S0306-4522(03)00504-9; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Ravinder S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.137; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Schipper P, 2011, BEHAV PHARMACOL, V22, P324, DOI 10.1097/FBP.0b013e328347881b; Schmitt A, 2007, J NEURAL TRANSM, V114, P1107, DOI 10.1007/s00702-007-0724-6; Schmitt A, 2003, J NEUROSCI RES, V71, P701, DOI 10.1002/jnr.10521; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; SENBA E, 1994, MOL BRAIN RES, V24, P283, DOI 10.1016/0169-328X(94)90141-4; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1993, TRENDS NEUROSCI, V16, P56, DOI 10.1016/0166-2236(93)90016-F; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; SUNANDA, 1995, BRAIN RES, V694, P312, DOI 10.1016/0006-8993(95)00822-8; Teather LA, 2005, NEUROBIOL LEARN MEM, V84, P75, DOI 10.1016/j.nlm.2005.03.006; Tjurmina OA, 2004, ANN NY ACAD SCI, V1018, P99, DOI 10.1196/annals.1296.011; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; Uceyler N, 2010, INT J OBESITY, V34, P701, DOI 10.1038/ijo.2009.289; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vertes RP, 1999, J COMP NEUROL, V407, P555; Wallace CS, 1998, J NEUROSCI, V18, P26; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004; Xie L, 2013, J NEUROCHEM, V125, P457, DOI 10.1111/jnc.12210; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	143	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78238	10.1371/journal.pone.0078238	http://dx.doi.org/10.1371/journal.pone.0078238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167611	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500072
J	Kyle, CH; Plantz, AL; Shelton, T; Burks, RL				Kyle, Colin H.; Plantz, Allyson L.; Shelton, Therese; Burks, Romi L.			Count Your Eggs Before They Invade: Identifying and Quantifying Egg Clutches of Two Invasive Apple Snail Species (Pomacea)	PLOS ONE			English	Article							ENVIRONMENTAL DNA; UNITED-STATES; RISK-ASSESSMENT; AQUATIC PLANTS; INSULARUM; BIOLOGY; AMPULLARIIDAE; FECUNDITY; GROWTH; FIELD	Winning the war against invasive species requires early detection of invasions. Compared to terrestrial invaders, aquatic species often thrive undetected under water and do not garner notice until too late for early action. However, fortunately for managers, apple snails (Family Ampullariidae, Genus Pomacea) provide their own conspicuous sign of invasion in the form of vibrantly colored egg clutches. Managers can potentially use egg clutches laid in the riparian zone as a means of early detection and species identification. To facilitate such efforts, we quantified differences in characteristics (length, width, depth, mass, egg number) of field-laid clutches for the two most common invasive species of apple snail, P. canaliculata and P. maculata, in native and non-native populations. Pomacea canaliculata native and non-native populations differed noticeably only in width. Native P. maculata clutches possessed significantly greater width, mass and eggs numbers compared with native P. canaliculata. Non-native P. maculata clutches significantly exceeded all other populations in all measured characteristics. Consequently, these traits may successfully distinguish between species. Fecundity data also allowed us to develop models that accurately estimated the number of eggs per clutch for each species based on clutch dimensions. We tested one, two and three dimensional models of clutches, including rendering a clutch as either a complete ellipsoid or an ellipsoid intersected by a cylinder to represent the oviposition site. Model comparisons found the product of length and depth, with a different function for each population, best predicted egg number for both species. Comparisons of egg number to clutch volume and mass implied non-native P. canaliculata may be food limited, while non-native P. maculata appeared to produce such enormous clutches by having access to greater nutrients than the native population. With these new tools, researchers and managers can quickly identify, quantify and begin eradication of new non-native apple snail populations.	[Kyle, Colin H.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Plantz, Allyson L.; Burks, Romi L.] Southwestern Univ, Dept Biol, Georgetown, TX USA; [Shelton, Therese] Southwestern Univ, Dept Math & Comp Sci, Georgetown, TX USA	University of Chicago	Kyle, CH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	ckyle@uchicago.edu		Shelton, Therese/0000-0003-4909-0767	NSF-IRES [1130297, 1130694]; NSF-ROA [DEB-1214171]; Southwestern University Faculty-Student Collaborative Funds; University of Chicago's Department of Ecology and Evolution Student Research Fund	NSF-IRES(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-ROA(National Science Foundation (NSF)); Southwestern University Faculty-Student Collaborative Funds; University of Chicago's Department of Ecology and Evolution Student Research Fund	Collaborative NSF-IRES Grant (1130297 & 1130694), NSF-ROA Grant (DEB-1214171), Southwestern University Faculty-Student Collaborative Funds (www.southwestern.edu), The University of Chicago's Department of Ecology and Evolution Student Research Fund ($675 for publication fees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2010, J MOLLUS STUD, V76, P138, DOI 10.1093/mollus/eyp050; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; Burks RL, 2010, HYDROBIOLOGIA, V646, P243, DOI 10.1007/s10750-010-0167-1; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; Burnham K. P., 1998, MODEL SELECTION INFE; Byers JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056812; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cazzaniga NJ, 1998, COMP PHYS ECOL, V133, P89; Conner SL, 2008, J MOLLUS STUD, V74, P355, DOI 10.1093/mollus/eyn024; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; Crawley MJ, 2009, R BOOK, P489; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Hanshew BA, 2012, FRESHWATER BIOL, V57, P2285, DOI 10.1111/fwb.12002; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Joshi R. C., 2006, GLOBAL ADV; Kaefer IL, 2007, ANN ZOOL FENN, V44, P435; Keller RP, 2007, CONSERV BIOL, V21, P191, DOI 10.1111/j.1523-1739.2006.00563.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kyle CH, 2011, CURR ZOOL, V57, P630, DOI 10.1093/czoolo/57.5.630; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Martin Charles W., 2012, Gulf of Mexico Science, V30, P30; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Siegel S., 1988, NONPARAMETRIC STAT B, P399; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Tamburi NE, 2011, BIOL INVASIONS, V13, P2351, DOI 10.1007/s10530-011-0047-2; Tanaka K, 1999, RES POPUL ECOL, V41, P253, DOI 10.1007/s101440050029; Van Dyke J, 2012, SNAILBUSTERS BLOG IS; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Zar, 2011, BIOSTAT ANAL	35	19	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77736	10.1371/journal.pone.0077736	http://dx.doi.org/10.1371/journal.pone.0077736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147069	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400130
J	Zhang, GZ; Ducatelle, R; Pasmans, F; D'Herde, K; Huang, LP; Smet, A; Haesebrouck, F; Flahou, B				Zhang, Guangzhi; Ducatelle, Richard; Pasmans, Frank; D'Herde, Katharina; Huang, Liping; Smet, Annemieke; Haesebrouck, Freddy; Flahou, Bram			Effects of Helicobacter suis gamma-Glutamyl Transpeptidase on Lymphocytes: Modulation by Glutamine and Glutathione Supplementation and Outer Membrane Vesicles as a Putative Delivery Route of the Enzyme	PLOS ONE			English	Article							TISSUE EXPRESSION PATTERN; PYLORI SPIRAL ORGANISMS; T-CELL PROLIFERATION; PERSISTENCE STRATEGIES; GASTRIC-MUCOSA; HOST-CELLS; METABOLISM; TRANSPORT; INFECTION; VIRULENCE	Helicobacter (H.) suis colonizes the stomach of the majority of pigs as well as a minority of humans worldwide. Infection causes chronic inflammation in the stomach of the host, however without an effective clearance of the bacteria. Currently, no information is available about possible mechanisms H. suis utilizes to interfere with the host immune response. This study describes the effect on various lymphocytes of the.-glutamyl transpeptidase (GGT) from H. suis. Compared to whole cell lysate from wild-type H. suis, lysate from a H. suis ggt mutant strain showed a decrease of the capacity to inhibit Jurkat T cell proliferation. Incubation of Jurkat T cells with recombinantly expressed H. suis GGT resulted in an impaired proliferation, and cell death was shown to be involved. A similar but more pronounced inhibitory effect was also seen on primary murine CD4(+) T cells, CD8(+) T cells, and CD19(+) B cells. Supplementation with known GGT substrates was able to modulate the observed effects. Glutamine restored normal proliferation of the cells, whereas supplementation with reduced glutathione strengthened the H. suis GGT-mediated inhibition of proliferation. H. suis GGT treatment abolished secretion of IL-4 and IL-17 by CD4(+) T cells, without affecting secretion of IFN-Upsilon. Finally, H. suis outer membrane vesicles (OMV) were identified as a possible delivery route of H. suis GGT to lymphocytes residing in the deeper mucosal layers. Thus far, this study is the first to report that the effects on lymphocytes of this enzyme, not only important for H. suis metabolism but also for that of other Helicobacter species, depend on the degradation of two specific substrates: glutamine and reduced glutatione. This will provide new insights into the pathogenic mechanisms of H. suis infection in particular and infection with gastric helicobacters in general.	[Zhang, Guangzhi; Ducatelle, Richard; Pasmans, Frank; Smet, Annemieke; Haesebrouck, Freddy; Flahou, Bram] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Huang, Liping] Chinese Acad Agr Sci, Div Swine Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China	Ghent University; Ghent University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Zhang, GZ (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	guangzhi.zhang@ugent.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014; D'Herde, Katharina/AAM-4570-2020; Smet, Annemieke/M-9295-2017	Haesebrouck, Freddy/0000-0002-1709-933X; D'Herde, Katharina/0000-0001-6591-0476; Smet, Annemieke/0000-0002-1271-6191	Research Fund of Ghent University, Ghent, Belgium [GOA01G00408, 01SC2411]; China Scholarship Council (CSC) [2010676001]	Research Fund of Ghent University, Ghent, Belgium(Ghent University); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by grants from the Research Fund of Ghent University, Ghent, Belgium (Grant No. GOA01G00408 and 01SC2411), and a grant from China Scholarship Council (CSC) (Grant no. 2010676001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2000, J BIOTECHNOL, V83, P77, DOI 10.1016/S0168-1656(00)00301-1; Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; Axon ATR, 1999, GUT, V45, pI1, DOI 10.1136/gut.45.2008.i1; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Beigier-Bompadre M, 2011, J INFECT DIS, V204, P1339, DOI 10.1093/infdis/jir547; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; CALDER PC, 1994, CLIN NUTR, V13, P2, DOI 10.1016/0261-5614(94)90003-5; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; EECKHAUT V, 2013, GUT; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Flahou B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-75; Flahou B, 2011, CELL MICROBIOL, V13, P1933, DOI 10.1111/j.1462-5822.2011.01682.x; Flahou B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014083; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Grimble RF, 2001, P NUTR SOC, V60, P389, DOI 10.1079/PNS2001102; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hagen SJ, 2009, J NUTR, V139, P912, DOI 10.3945/jn.108.097790; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Johnson IR, 2006, DEV COMP IMMUNOL, V30, P1191, DOI 10.1016/j.dci.2006.03.003; Joosten M, 2013, HELICOBACTER, V18, P392, DOI 10.1111/hel.12054; Josenhans C, 1999, MOL MICROBIOL, V33, P350, DOI 10.1046/j.1365-2958.1999.01478.x; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kirchhoff P, 2006, PFLUG ARCH EUR J PHY, V451, P738, DOI 10.1007/s00424-005-1507-2; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; LEE A, 1989, AUST NZ J MED, V19, P156, DOI 10.1111/j.1445-5994.1989.tb00232.x; Maellaro E, 2000, J CELL SCI, V113, P2671; Nakamura E, 2002, AM J PHYSIOL-GASTR L, V283, pG1264, DOI 10.1152/ajpgi.00235.2002; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; O'Rourke JL, 2004, J PATHOL, V203, P896, DOI 10.1002/path.1593; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; ORIORDAIN MG, 1994, ANN SURG, V220, P212, DOI 10.1097/00000658-199408000-00014; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Perego P, 1997, INT J CANCER, V71, P246; Reeds PJ, 2001, J NUTR, V131, p2505S, DOI 10.1093/jn/131.9.2505S; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; Rhoads JM, 1997, AM J PHYSIOL-GASTR L, V272, pG943, DOI 10.1152/ajpgi.1997.272.5.G943; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Rossi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030543; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; SOLNICK JV, 1993, J INFECT DIS, V168, P379, DOI 10.1093/infdis/168.2.379; Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101; Suzuki A, 2010, HELICOBACTER, V15, P538, DOI 10.1111/j.1523-5378.2010.00801.x; Trebesius K, 2001, J CLIN MICROBIOL, V39, P1510, DOI 10.1128/JCM.39.4.1510-1516.2001; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Verbrugghe Elin, 2012, Vet Res, V43, P22, DOI 10.1186/1297-9716-43-22; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; WILDE SW, 1991, BIOCHEM J, V277, P687, DOI 10.1042/bj2770687; WINDMUELLER HG, 1980, J BIOL CHEM, V255, P107; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yaqoob P, 1997, NUTRITION, V13, P646, DOI 10.1016/S0899-9007(97)83008-0; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	74	22	23	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77966	10.1371/journal.pone.0077966	http://dx.doi.org/10.1371/journal.pone.0077966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147103	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400145
J	Davis, TR; Zucchi, PC; Kumamoto, CA				Davis, Talya R.; Zucchi, Paola C.; Kumamoto, Carol A.			Calmodulin Binding to Dfi1p Promotes Invasiveness of Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; GROWTH; CALCINEURIN; PHOSPHATASE; STRESS; SEARCH; GENE	Candida albicans, a dimorphic fungus, undergoes hyphal development in response to many different environmental cues, including growth in contact with a semi-solid matrix. C. albicans forms hyphae that invade agar when cells are embedded in or grown on the surface of agar, and the integral membrane protein Dfi1p is required for this activity. In addition, Dfi1p is required for full activation of mitogen activated protein kinase Cek1p during growth on agar. In this study, we identified a putative calmodulin binding motif in the C-terminal tail of Dfi1p. This region of Dfi1p bound to calmodulin in vitro, and mutations that affected this region affected both calmodulin binding in vitro and invasive filamentation when incorporated into the full length Dfi1p protein. Moreover, increasing intracellular calcium levels led to calcium-dependent, Dfi1p-dependent Cek1p activation. We propose that conformational changes in Dfi1p in response to environmental conditions encountered during growth allow the protein to bind calmodulin and initiate a signaling cascade that activates Cek1p.	[Davis, Talya R.; Zucchi, Paola C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA; [Kumamoto, Carol A.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University; Tufts University	Kumamoto, CA (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	carol.kumamoto@tufts.edu			National Institutes of Health [AI081794]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081794, R56AI081794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant AI081794 from the National Institutes of Health (to CAK). TRD was supported in part by a predoctoral fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; De Haro L, 2003, BIOL CELL, V95, P459, DOI 10.1016/S0248-4900(03)00076-5; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; SABIE FT, 1989, MYCOPATHOLOGIA, V108, P47, DOI 10.1007/BF00436783; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; Sato T, 2004, BIOL PHARM BULL, V27, P1281, DOI 10.1248/bpb.27.1281; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; TRECO DA, 1993, CURRENT PROTOCOLS MO, pCH13; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x	32	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76239	10.1371/journal.pone.0076239	http://dx.doi.org/10.1371/journal.pone.0076239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155896	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300030
J	Hayashizaki, S; Hirai, S; Ito, Y; Honda, Y; Arime, Y; Sora, I; Okado, H; Kodama, T; Takada, M				Hayashizaki, Seiji; Hirai, Shinobu; Ito, Yumi; Honda, Yoshiko; Arime, Yosefu; Sora, Ichiro; Okado, Haruo; Kodama, Tohru; Takada, Masahiko			Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice	PLOS ONE			English	Article							EXTRACELLULAR DOPAMINE; PREFRONTAL CORTEX; SELF-STIMULATION; KNOCKOUT MICE; DRD5 GENE; AMPHETAMINE; COCAINE; REWARD; PIMOZIDE; RATS	Dopamine regulates the psychomotor stimulant activities of amphetamine-like substances in the brain. The effects of dopamine are mediated through five known dopamine receptor subtypes in mammals. The functional relevance of D5 dopamine receptors in the central nervous system is not well understood. To determine the functional relevance of D5 dopamine receptors, we created D5 dopamine receptor-deficient mice and then used these mice to assess the roles of D5 dopamine receptors in the behavioral response to methamphetamine. Interestingly, D5 dopamine receptor-deficient mice displayed increased ambulation in response to methamphetamine. Furthermore, dopamine transporter threonine phosphorylation levels, which regulate amphetamine-induced dopamine release, were elevated in D5 dopamine receptor-deficient mice. The increase in methamphetamine-induced locomotor activity was eliminated by pretreatment with the dopamine transporter blocker GBR12909. Taken together, these results suggest that dopamine transporter activity and threonine phosphorylation levels are regulated by D5 dopamine receptors.	[Hayashizaki, Seiji; Hirai, Shinobu; Ito, Yumi; Honda, Yoshiko; Okado, Haruo; Kodama, Tohru; Takada, Masahiko] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Hayashizaki, Seiji; Arime, Yosefu; Sora, Ichiro; Takada, Masahiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Arime, Yosefu; Sora, Ichiro] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tohoku University; Kyoto University	Hayashizaki, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan.	hayashizaki-sj@igakuken.or.jp		KODAMA, TOHRU/0000-0001-6915-4428	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency; Grants-in-Aid for Scientific Research [24650192] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Darracq L, 1998, J NEUROSCI, V18, P2729; DELFS JM, 1990, J NEUROSCI, V10, P303; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; Elliot EE, 2003, PSYCHOPHARMACOLOGY, V169, P161, DOI 10.1007/s00213-003-1494-y; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Housley DJE, 2009, ANN HUM GENET, V73, P274, DOI 10.1111/j.1469-1809.2009.00513.x; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P110, DOI 10.1111/j.1601-183X.2004.00101.x; Karlsson RM, 2008, PSYCHOPHARMACOLOGY, V200, P117, DOI 10.1007/s00213-008-1165-0; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; LIEBMAN JM, 1974, N-S ARCH PHARMACOL, V284, P167, DOI 10.1007/BF00501121; Matsuda K, I REC FREE SOFTWARE; MILLER R, 1990, PROG NEUROBIOL, V34, P143, DOI 10.1016/0301-0082(90)90005-2; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ouyang M, 2012, J NEUROSCI, V32, P1932, DOI 10.1523/JNEUROSCI.5231-11.2012; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Riday TT, 2012, NEUROPHARMACOLOGY, V62, P1858, DOI 10.1016/j.neuropharm.2011.12.011; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Scibelli AC, 2011, PSYCHOPHARMACOLOGY, V214, P791, DOI 10.1007/s00213-010-2086-2; Sellings LHL, 2006, SYNAPSE, V59, P374, DOI 10.1002/syn.20247; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Torkamanzehi A, 2006, BEHAV GENET, V36, P903, DOI 10.1007/s10519-006-9078-3; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; Vanyukov MM, 1998, BEHAV GENET, V28, P75, DOI 10.1023/A:1021463722326; Vanyukov MM, 2000, AM J MED GENET, V96, P654, DOI 10.1002/1096-8628(20001009)96:5<654::AID-AJMG11>3.0.CO;2-Y; Ventura R, 2003, J NEUROSCI, V23, P1879; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313	36	11	11	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75975	10.1371/journal.pone.0075975	http://dx.doi.org/10.1371/journal.pone.0075975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155877	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300011
J	Jamison, J; Lauffenburger, D; Wang, JCH; Wells, A				Jamison, Joshua; Lauffenburger, Douglas; Wang, James C-H; Wells, Alan			PKC delta Localization at the Membrane Increases Matrix Traction Force Dependent on PLC gamma 1/EGFR Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; FIBROBLAST CONTRACTILITY; PLASMA-MEMBRANE; M-CALPAIN; CELL; RECEPTOR; ACTIVATION; BINDING; MICROSCOPY	Introduction: During wound healing, fibroblasts initially migrate into the wound bed and later contract the matrix. Relevant mediators of transcellular contractility revealed by systems analyses are protein kinase c delta/myosin light chain-2 (PKC delta/MLC-2). PKC delta is activated by growth factor-driven PLC gamma 1 hydrolysis of phosphoinositide bisphosphate (PIP2) hydrolysis when it becomes tranlocated to the membrane. This leads to MLC-2 phosphorylation that regulates myosin for contractility. Furthermore, PKC delta n-terminus mediates PKC delta localization to the membrane in relative proximity to PLC gamma 1 activity. However, the role this localization and the relationship to its activation and signaling of force is not well understood. Therefore, we investigated whether the membrane localization of PKC delta mediates the transcellular contractility of fibroblasts. Methods: To determine PKC delta activation in targeted membrane locations in mouse fibroblast cells (NR6-WT), two PKC delta constructs were generated; PKC delta-CaaX with farnesylation moiety targeting PKC delta to the membrane and PKC delta-SaaX a non-targeting control. Results: Increased mean cell force was observed before and during EGF stimulation in fibroblasts expressing membrane-targeted PKC delta (PKC delta-CaaX) when analyzed with 2D cell traction force and 3D compaction of collagen matrix. This effect was reduced in cells deficient in EGFR/PLCy1 signaling. In cells expressing non-membrane targeted PKC delta (PKC delta-SaaX), the cell force exerted outside the ECM (extracellular matrix) was less, but cell motility/speed/persistence was increased after EGF stimulation. Change in cell motility and increased force exertion was also preceded by change in cell morphology. Organization of actin stress fibers was also decreased as a result of increasing membrane targeting of PKC delta. Conclusion: From these results membrane tethering of PKC delta leads to increased force exertion on ECM. Furthermore, our data show PLC gamma 1 regulation of PKC delta, at least in part, drives transcellular contractility in fibroblasts.	[Jamison, Joshua; Wells, Alan] Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Wang, James C-H] Univ Pittsburgh, Dept Orthoped Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Lauffenburger, Douglas] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT)	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institute of Health [T32 HL094295, R01 GM069668, AR061395, AR060920]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668, R01GM063569] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All from National Institute of Health: T32 HL094295; R01 GM069668, AR061395, AR060920 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kharait S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-9; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Seki T, 2005, GENES CELLS, V10, P225, DOI 10.1111/j.1365-2443.2005.00830.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; SHERRATT JA, 1992, IMA J MATH APPL MED, V9, P177; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Wang JHC, 2010, OPER TECH ORTHOP, V20, P106, DOI 10.1053/j.oto.2009.10.007; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Wells A, 1999, CELL MOTIL CYTOSKEL, V44, P227, DOI 10.1002/(SICI)1097-0169(199912)44:4<227::AID-CM1>3.0.CO;2-B; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77434	10.1371/journal.pone.0077434	http://dx.doi.org/10.1371/journal.pone.0077434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155954	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300088
J	Shapiro, LR; Salvaudon, L; Mauck, KE; Pulido, H; De Moraes, CM; Stephenson, AG; Mescher, MC				Shapiro, Lori R.; Salvaudon, Lucie; Mauck, Kerry E.; Pulido, Hannier; De Moraes, Consuelo M.; Stephenson, Andrew G.; Mescher, Mark C.			Disease Interactions in a Shared Host Plant: Effects of Pre-Existing Viral Infection on Cucurbit Plant Defense Responses and Resistance to Bacterial Wilt Disease	PLOS ONE			English	Article							ACALYMMA-VITTATUM COLEOPTERA; SALICYLIC-ACID; ERWINIA-TRACHEIPHILA; FEEDING-BEHAVIOR; VIRUS; PATHOGEN; PHYTOHORMONES; BIOSYNTHESIS; TRANSMISSION; MECHANISMS	Both biotic and abiotic stressors can elicit broad-spectrum plant resistance against subsequent pathogen challenges. However, we currently have little understanding of how such effects influence broader aspects of disease ecology and epidemiology in natural environments where plants interact with multiple antagonists simultaneously. In previous work, we have shown that healthy wild gourd plants (Cucurbita pepo ssp. texana) contract a fatal bacterial wilt infection (caused by Erwinia tracheiphila) at significantly higher rates than plants infected with Zucchini yellow mosaic virus (ZYMV). We recently reported evidence that this pattern is explained, at least in part, by reduced visitation of ZYMV-infected plants by the cucumber beetle vectors of E. tracheiphila. Here we examine whether ZYMV-infection may also directly elicit plant resistance to subsequent E. tracheiphila infection. In laboratory studies, we assayed the induction of key phytohormones (SA and JA) in single and mixed infections of these pathogens, as well as in response to the feeding of A. vittatum cucumber beetles on healthy and infected plants. We also tracked the incidence and progression of wilt disease symptoms in plants with prior ZYMV infections. Our results indicate that ZYMV-infection slightly delays the progression of wilt symptoms, but does not significantly reduce E. tracheiphila infection success. This observation supports the hypothesis that reduced rates of wilt disease in ZYMV-infected plants reflect reduced visitation by beetle vectors. We also documented consistently strong SA responses to ZYMV infection, but limited responses to E. tracheiphila in the absence of ZYMV, suggesting that the latter pathogen may effectively evade or suppress plant defenses, although we observed no evidence of antagonistic cross-talk between SA and JA signaling pathways. We did, however, document effects of E. tracheiphila on induced responses to herbivory that may influence host-plant quality for (and hence pathogen acquisition by) cucumber beetles.	[Shapiro, Lori R.; Mauck, Kerry E.; Pulido, Hannier; De Moraes, Consuelo M.; Mescher, Mark C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Salvaudon, Lucie] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France; [Stephenson, Andrew G.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shapiro, Lori R.; Salvaudon, Lucie; Mauck, Kerry E.; Stephenson, Andrew G.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [De Moraes, Consuelo M.; Mescher, Mark C.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mescher, MC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	mescher@usys.ethz.ch		Mauck, Kerry/0000-0001-9678-0619	U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative [2008-35302-04577]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program; US National Science Foundation; USDA AFRI NIFA Pre-doctoral Fellowship	U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program; US National Science Foundation(National Science Foundation (NSF)); USDA AFRI NIFA Pre-doctoral Fellowship	Funding for this research was provided by Grant 2008-35302-04577 from the U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative. L. Salvaudon was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program. L. Shapiro was supported by a Graduate Research Fellowship from the US National Science Foundation. K. Mauck was supported by a USDA AFRI NIFA Pre-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; [Anonymous], R LANG ENV STAT COMP; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Belliure B, 2010, BASIC APPL ECOL, V11, P162, DOI 10.1016/j.baae.2009.09.004; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DEAN RA, 1987, PHYSIOL MOL PLANT P, V31, P69, DOI 10.1016/0885-5765(87)90007-5; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; DECKER DS, 1988, ECON BOT, V42, P4, DOI 10.1007/BF02859022; Desbiez C, 1997, PLANT PATHOL, V46, P809, DOI 10.1046/j.1365-3059.1997.d01-87.x; Eben A, 2007, COLEOPTS BULL, V61, P57, DOI 10.1649/923.1; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; ESAU K, 1967, ANNU REV PHYTOPATHOL, V5, P45, DOI 10.1146/annurev.py.05.090167.000401; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Ferrari MJ, 2007, INT J PLANT SCI, V168, P603, DOI 10.1086/513487; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; Garcia-Salazar C, 2000, ENVIRON ENTOMOL, V29, P542, DOI 10.1603/0046-225X-29.3.542; GESSLER C, 1982, J EXP BOT, V33, P58, DOI 10.1093/jxb/33.1.58; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; LEWIS PA, 1990, ENVIRON ENTOMOL, V19, P8, DOI 10.1093/ee/19.1.8; LISA V, 1981, PHYTOPATHOLOGY, V71, P667, DOI 10.1094/Phyto-71-667; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Mouttet R, 2013, OECOLOGIA, V173, P1379, DOI 10.1007/s00442-013-2716-6; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; MUCHARROMAH E, 1991, CROP PROT, V10, P265, DOI 10.1016/0261-2194(91)90004-B; Musser RO, 2003, J INSECT BEHAV, V16, P247, DOI 10.1023/A:1023919902976; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; SAS, 2011, BAS SAS 9 3 PROC GUI; Sasu MA, 2010, ENVIRON ENTOMOL, V39, P140, DOI 10.1603/EN09190; Sasu MA, 2010, INT J PLANT SCI, V171, P1048, DOI 10.1086/656531; Sasu MA, 2010, AM J BOT, V97, P1025, DOI 10.3732/ajb.0900381; Sasu MA, 2009, P NATL ACAD SCI USA, V106, P19067, DOI 10.1073/pnas.0905106106; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Shapiro L, 2012, ECOL LETT, V15, P1430, DOI 10.1111/ele.12001; TALLAMY DW, 1985, ECOLOGY, V66, P1574, DOI 10.2307/1938019; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079	46	31	31	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77393	10.1371/journal.pone.0077393	http://dx.doi.org/10.1371/journal.pone.0077393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155951	Green Submitted, gold, Green Published			2022-12-25	WOS:000325887300085
J	Shah, MMR; Liu, TX				Shah, M. Mostafizur Rahman; Liu, Tong-Xian			Feeding Experience of Bemisia tabaci (Hemiptera: Aleyrodidae) Affects Their Performance on Different Host Plants	PLOS ONE			English	Article							PHYTOPHAGOUS INSECTS; SPECIES COMPLEX; NATURAL ENEMIES; SWEET-POTATO; B-BIOTYPE; OVIPOSITION; CHINA; ARGENTIFOLII; WHITEFLIES; PREFERENCE	The sweetpotato whitefly, Bemisia tabaci biotype B is extremely polyphagous with >600 species of host plants. We hypothesized that previous experience of the whitefly on a given host plant affects their host selection and performance on the plants without previous experience. We investigated the host selection for feeding and oviposition of adults and development and survival of immatures of three host-plant-experienced populations of B. tabaci, namely Bemisia-eggplant, Bemisia-tomato and Bemisia-cucumber, on their experienced host plant and each of the three other plant species (eggplant, tomato, cucumber and pepper) without previous experience. We found that the influence of previous experience of the whiteflies varied among the populations. All populations refused pepper for feeding and oviposition, whereas the Bemisia-cucumber and the Bemisia-eggplant strongly preferred cucumber. Bemisia-tomato did not show strong preference to any of the three host palnts. Development time from egg to adult eclosion varied among the populations, being shortest on eggplant, longest on pepper, and intermediate on tomato and cucumber except for the Bemisia-cucumber developed similarly on tomato and pepper. The survivorship from egg to adult eclosion of all populations was highest on eggplant (80-98%), lowest on pepper (0-20%), and intermediate on tomato and cucumber. In conclusion, the effects of previous experience of whiteflies on host selection for feeding and oviposition, development, and survivorship varied depending on host plants, and host plants play a stronger role than previous experience. Preference of feeding and oviposition by adults may not accurately reflect host suitability of immatures. These results provided important information for understanding whitefly population dynamics and dispersal among different crop systems.	[Shah, M. Mostafizur Rahman; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Shah, M. Mostafizur Rahman; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Integrated Pest Management Loess Plateau, Minist Agr, Yangling, Shaanxi, Peoples R China; [Shah, M. Mostafizur Rahman] Bangladesh Agr Res Inst, Wheat Res Ctr, Dinajpur, Bangladesh	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Bangladesh Agricultural Research Institute (BARI)	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program) [2012CB114105, 2012CB017359]; Special Fund for Agro-Scientific Research in the Public Interest [201303019]; China Agriculture Research System [CARS-25-B-06]	National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program); Special Fund for Agro-Scientific Research in the Public Interest; China Agriculture Research System	This work was partially supported by the National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program, 2012CB114105 and 2012CB017359), Special Fund for Agro-Scientific Research in the Public Interest (201303019), and China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabeni P, 2001, OIKOS, V92, P225, DOI 10.1034/j.1600-0706.2001.920204.x; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carabali A, 2005, CROP PROT, V24, P643, DOI 10.1016/j.cropro.2004.11.008; Chou I, 1949, J CHIN ENTOMOL, V3, P1; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2012, INSECT SCI, V19, P595, DOI 10.1111/j.1744-7917.2011.01500.x; De Barro P, 2010, BIOL INVASIONS, V12, P3013, DOI 10.1007/s10530-010-9691-1; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2006, BIOL INVASIONS, V8, P287, DOI 10.1007/s10530-005-1261-6; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; ENKEGAARD A, 1993, B ENTOMOL RES, V83, P535, DOI 10.1017/S0007485300039961; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Gruenhagen NM, 2001, ENTOMOL EXP APPL, V99, P387, DOI 10.1023/A:1019296603574; Institute SAS, 2011, SAS STAT 9 2 US GUID; Islam M. Touhidul, 2007, Journal of Entomology, V4, P231; Jiao XG, 2012, J PEST SCI, V85, P423, DOI 10.1007/s10340-012-0441-2; Khan MR, 2011, AFR J BIOTECHNOL, V10, P1467; Lee DH, 2011, BIOL CONTROL, V58, P302, DOI 10.1016/j.biocontrol.2011.06.005; Lee DH, 2009, ENTOMOL EXP APPL, V133, P105, DOI 10.1111/j.1570-7458.2009.00920.x; Lei H, 1998, ENTOMOL EXP APPL, V88, P73, DOI 10.1023/A:1003215227403; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; LIU TX, 1995, J ECON ENTOMOL, V88, P992, DOI 10.1093/jee/88.4.992; Baldin ELL, 2010, J PEST SCI, V83, P221, DOI 10.1007/s10340-010-0289-2; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mansaray A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0101; Martin JH, 2000, B ENTOMOL RES, V90, P407, DOI 10.1017/S0007485300000547; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Naranjo SE, 2009, BIOL CONTROL, V51, P458, DOI 10.1016/j.biocontrol.2009.08.006; Noldus LPJJ, 2009, J APPL ENTOMOL, V101, P492; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Omondi AB, 2005, ENTOMOL EXP APPL, V115, P393, DOI 10.1111/j.1570-7458.2005.00296.x; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Thomas DC, 1993, THESIS WAGENINGEN AG; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Tsueda H, 2011, ENTOMOL EXP APPL, V141, P197, DOI 10.1111/j.1570-7458.2011.01189.x; VANLENTEREN JC, 1991, SYMP BIOL HUNG, V39, P365; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Xu J, 2011, J APPL ENTOMOL, V135, P771, DOI 10.1111/j.1439-0418.2010.01581.x; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhao L, 2000, J AGR SCI, V1, P27	50	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77368	10.1371/journal.pone.0077368	http://dx.doi.org/10.1371/journal.pone.0077368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146985	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400112
J	Lu, L; Hu, SH; Wei, RF; Qiu, X; Lu, KF; Fu, YS; Li, HC; Xing, GC; Li, D; Peng, RY; He, FC; Zhang, LQ				Lu, Li; Hu, Shaohua; Wei, Rongfei; Qiu, Xiao; Lu, Kefeng; Fu, Yesheng; Li, Hongchang; Xing, Guichun; Li, Dong; Peng, Ruiyun; He, Fuchu; Zhang, Lingqiang			The HECT Type Ubiquitin Ligase NEDL2 Is Degraded by Anaphase-promoting Complex/Cyclosome (APC/C)-Cdh1, and Its Tight Regulation Maintains the Metaphase to Anaphase Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Mitosis; Protein Degradation; Tumor; Ubiquitin Ligase; APC; C	SPINDLE CHECKPOINT; CHROMOSOMAL INSTABILITY; FAMILY-MEMBERS; COMPLEX; CELL; CDC20; IDENTIFICATION; BOX; PROTEOLYSIS; ACTIVATION	Background: NEDL2 is a member of the HECT type ubiquitin ligase NEDD4 family, but its function remains largely unknown. Results: NEDL2 is degraded by APC/C-Cdh1 during mitotic exit and regulates metaphase to anaphase transition. Conclusion: NEDL2 appears to dynamically modulate regulation of mitosis. Significance: Our data provide a novel substrate of APC/C-Cdh1 and reveal an additional protein by which HECT type ubiquitin ligase can regulate mitosis. NEDD4-like ubiquitin ligase 2 (NEDL2) is a HECT type ubiquitin ligase. NEDL2 enhances p73 transcriptional activity and degrades ATR kinase in lamin misexpressed cells. Compared with the important functions of other HECT type ubiquitin ligase, there is less study concerning the function and regulation of NEDL2. Using primary antibody immunoprecipitation and mass spectrometry, we identify a list of potential proteins that are putative NEDL2-interacting proteins. The candidate list contains many of mitotic proteins, especially including several subunits of anaphase-promoting complex/cyclosome (APC/C) and Cdh1, an activator of APC/C. Cdh1 can interact with NEDL2 in vivo and in vitro. Cdh1 recognizes one of the NEDL2 destruction boxes (R(740)GSL(743)) and targets it for degradation in an APC/C-dependent manner during mitotic exit. Overexpression of Cdh1 reduces the protein level of NEDL2, whereas knockdown of Cdh1 increases the protein level of NEDL2 but has no effect on the NEDL2 mRNA level. NEDL2 associates with mitotic spindles, and its protein level reaches a maximum in mitosis. The function of NEDL2 during mitosis is essential because NEDL2 depletion prolongs metaphase, and overexpression of NEDL2 induces chromosomal lagging. Elevated expression of NEDL2 protein and mRNA are both found in colon cancer and cervix cancer. We conclude that NEDL2 is a novel substrate of APC/C-Cdh1 as cells exit mitosis and functions as a regulator of the metaphase to anaphase transition. Its overexpression may contribute to tumorigenesis.	[Lu, Li; Wei, Rongfei; Qiu, Xiao; Lu, Kefeng; Fu, Yesheng; Li, Hongchang; Xing, Guichun; Li, Dong; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Zhang, Lingqiang] Dalian Med Univ, Inst Canc Stem Cells, Dalian 116023, Liaoning Provin, Peoples R China; [Lu, Li; He, Fuchu] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China; [Hu, Shaohua; Peng, Ruiyun] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing 100850, Peoples R China; [Wei, Rongfei; Qiu, Xiao; He, Fuchu] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	Academy of Military Medical Sciences - China; Dalian Medical University; Beijing University of Technology; Academy of Military Medical Sciences - China; Tsinghua University	He, FC (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn		Lu, Kefeng/0000-0001-8200-9380	National Basic Research Programs [2012CB910304, 2011CB910602, 2011CB910802]; National Natural Science Foundation Projects [31125010, 81221004]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation Projects(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Programs 2012CB910304, 2011CB910602, and 2011CB910802 and National Natural Science Foundation Projects 31125010 and 81221004.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Kannan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050735; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Kim AH, 2007, MOL CELL NEUROSCI, V34, P281, DOI 10.1016/j.mcn.2006.11.019; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Michor F, 2005, PHILOS T R SOC B, V360, P631, DOI 10.1098/rstb.2004.1617; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Miyazaki K, 2003, BIOCHEM BIOPH RES CO, V308, P106, DOI 10.1016/S0006-291X(03)01347-0; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092	38	37	39	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35637	35650		10.1074/jbc.M113.472076	http://dx.doi.org/10.1074/jbc.M113.472076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24163370	Green Published, hybrid			2022-12-25	WOS:000329814700003
J	Jha, BA; Archer, SK; Clayton, CE				Jha, Bhaskar Anand; Archer, Stuart K.; Clayton, Christine E.			The Trypanosome Pumilio Domain Protein PUF5	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; ELEGANS GERMLINE; BRUCEI; YEAST; FAMILY; LOCALIZATION; SPECIFICITY	PUF proteins are a conserved family of RNA binding proteins found in all eukaryotes examined so far. This study focussed on PUF5, one of 11 PUF family members encoded in the Trypanosoma brucei genome. Native PUF5 is present at less than 50000 molecules per cell in both bloodstream and procyclic form trypanosomes. C-terminally myc-tagged PUF5 was mainly found in the cytoplasm and could be cross-linked to RNA. PUF5 knockdown by RNA interference had no effect on the growth of bloodstream forms. Procyclic forms lacking PUF5 grew normally, but expression of PUF5 bearing a 21 kDa tandem affinity purification tag inhibited growth. Knockdown of PUF5 did not have any effect on the ability of trypanosomes to differentiate from the mammalian to the insect form of the parasite.	[Jha, Bhaskar Anand; Archer, Stuart K.; Clayton, Christine E.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, CE (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019	Clayton, Christine/0000-0002-6384-0731; Archer, Stuart/0000-0003-0450-1243	Deutsche Forschungsgemeinshaft (DFG) [Cl112/14-1]	Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinshaft (DFG), mainly by Cl112/14-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Benz C, 2011, MOL BIOCHEM PARASIT, V177, P148, DOI 10.1016/j.molbiopara.2011.02.007; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Campbell ZT, 2012, J BIOL CHEM, V287, P18854, DOI 10.1074/jbc.M112.352815; Caro F, 2006, EXP PARASITOL, V113, P112, DOI 10.1016/j.exppara.2005.12.015; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Clayton C., 2012, NUCL ACIDS MOL BIOL, V28, P79; Clayton CE, 2005, METH MOL B, V309, P39; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; Dallagiovanna B, 2008, J BIOL CHEM, V283, P8266, DOI 10.1074/jbc.M703097200; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Hafner M, 2010, J VIS EXP; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartmann C, 2008, MOL BIOCHEM PARASIT, V157, P112, DOI 10.1016/j.molbiopara.2007.09.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Miller MA, 2011, WIRES RNA, V2, P471, DOI 10.1002/wrna.69; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Qiu C, 2012, J BIOL CHEM, V287, P6949, DOI 10.1074/jbc.M111.326264; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sambrook J., 2002, MOL CLONING LAB MANU; Schumann Burkard G, 2013, MOL MICROBIOL; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Thomson E, 2007, RNA, V13, P2165, DOI 10.1261/rna.747607; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; Zamore PD, 1997, RNA, V3, P1421; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77371	10.1371/journal.pone.0077371	http://dx.doi.org/10.1371/journal.pone.0077371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167571	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500030
J	Rabineau, M; Kocgozlu, L; Dujardin, D; Senger, B; Haikel, Y; Voegel, JC; Freund, JN; Schaaf, P; Lavalle, P; Vautier, D				Rabineau, Morgane; Kocgozlu, Leyla; Dujardin, Denis; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Freund, Jean-Noel; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique			Contribution of Soft Substrates to Malignancy and Tumor Suppression during Colon Cancer Cell Division	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; ELASTICITY; GROWTH	In colon cancer, a highly aggressive disease, progression through the malignant sequence is accompanied by increasingly numerous chromosomal rearrangements. To colonize target organs, invasive cells cross several tissues of various elastic moduli. Whether soft tissue increases malignancy or in contrast limits invasive colon cell spreading remains an open question. Using polyelectrolyte multilayer films mimicking microenvironments of various elastic moduli, we revealed that human SW480 colon cancer cells displayed increasing frequency in chromosomal segregation abnormalities when cultured on substrates with decreasing stiffness. Our results show that, although decreasing stiffness correlates with increased cell lethality, a significant proportion of SW480 cancer cells did escape from the very soft substrates, even when bearing abnormal chromosome segregation, achieve mitosis and undergo a new cycle of replication in contrast to human colonic HCoEpiC cells which died on soft substrates. This observation opens the possibility that the ability of cancer cells to overcome defects in chromosome segregation on very soft substrates could contribute to increasing chromosomal rearrangements and tumor cell aggressiveness.	[Rabineau, Morgane; Kocgozlu, Leyla; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] INSERM, UMR 1121, Strasbourg, France; [Rabineau, Morgane; Kocgozlu, Leyla; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] Univ Strasbourg, Fac Chirurg Dentaire, Strasbourg, France; [Dujardin, Denis] CNRS, UMR 7213, Illkirch Graffenstaden, France; [Schaaf, Pierre] Inst Charles Sadron, CNRS, UPR 22, F-67083 Strasbourg, France; [Freund, Jean-Noel] Univ Strasbourg, INSERM, UMR S1113, Strasbourg, France; [Freund, Jean-Noel] Univ Strasbourg, Fac Med, Strasbourg, France; [Rabineau, Morgane; Senger, Bernard; Haikel, Youssef; Voegel, Jean-Claude; Freund, Jean-Noel; Schaaf, Pierre; Lavalle, Philippe; Vautier, Dominique] Federat Med Translat, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vautier, D (corresponding author), INSERM, UMR 1121, Strasbourg, France.	vautier@unistra.fr	Lavalle, Philippe/E-6328-2016; Dujardin, Denis/GYA-0463-2022; Freund, Jean-Noel/R-4383-2016; SCHAAF, Pierre/J-2751-2016	Lavalle, Philippe/0000-0001-8798-912X; Freund, Jean-Noel/0000-0002-0971-3774; SCHAAF, Pierre/0000-0001-7423-5492; Dujardin, Denis/0000-0001-6372-5293; Rabineau, Morgane/0000-0001-7325-7518	Alsace Contre le Cancer; Faculte de Chirurgie Dentaire of Strasbourg	Alsace Contre le Cancer; Faculte de Chirurgie Dentaire of Strasbourg	The study was supported by a grant from Alsace Contre le Cancer. M. R. is indebted to the Faculte de Chirurgie Dentaire of Strasbourg for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellis J, 2012, J CELL BIOL, V198, P331, DOI 10.1083/jcb.201204086; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Francius G, 2007, J PHYS CHEM C, V111, P8299, DOI 10.1021/jp070435+; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Indra I, 2011, J CELL BIOCHEM, V112, P3151, DOI 10.1002/jcb.23241; Kocgozlu L, 2012, BIOMATERIALS, V33, P798, DOI 10.1016/j.biomaterials.2011.10.024; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Lavalle P, 2011, ADV MATER, V23, P1191, DOI 10.1002/adma.201003309; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Malanchi I, 2011, NATURE, V7, P85; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050443; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r; Zhai L, 2008, ULTRASONIC IMAGING, V30, P95, DOI 10.1177/016173460803000203; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	29	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78468	10.1371/journal.pone.0078468	http://dx.doi.org/10.1371/journal.pone.0078468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167628	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500089
J	Refos, JM; Vonk, AG; Eadie, K; Lo-Ten-Foe, JR; Verbrugh, HA; van Diepeningen, AD; van de Sande, WWJ				Refos, Jeannine M.; Vonk, Alieke G.; Eadie, Kimberly; Lo-Ten-Foe, Jerome R.; Verbrugh, Henri A.; van Diepeningen, Anne D.; van de Sande, Wendy W. J.			Double-Stranded RNA Mycovirus Infection of Aspergillus fumigatus Is Not Dependent on the Genetic Make-Up of the Host	PLOS ONE			English	Article							DSRNA MYCOVIRUSES; RAPID ISOLATION; VIRUS; VIRULENCE	Aspergillus fumigatus is a fungus that causes opportunistic infections in immunocompromised patients, with high morbidity and mortality. In its turn, A. fumigatus can become infected with mycoviruses. Most mycoviruses have a dsRNA genome and can cause fungal hypovirulence. For that reason, mycoviruses could theoretically be used as therapeutic tools to combat fungal infections. We determined if a certain genetic make-up of A. fumigatus was associated with the presence of mycoviruses in 86 clinical A. fumigatus isolates. Mycovirus screening was performed by isolating dsRNA from mycelial cultures using a Trizol/Chloroform method. The genetic relatedness of dsRNA infected A. fumigatus was determined by cell surface protein (CSP) typing and determination of the mating type. Sixteen (18.6%) of the 86 clinical A. fumigatus isolates contained dsRNA. The A. fumigatus collection could be divided into 11 different CSP types. DsRNA infected A. fumigatus isolates had similar CSP types as non-infected isolates. In both cases, the CSP types t01, t02, t03 and t04 were the most prevalent and the distribution comparable to the CSP types observed in other Dutch collections. Mating types MAT1-1 and MAT1-2 were evenly distributed among all A. fumigatus strains, regardless of CSP type. No difference was observed in mycovirus infections between MAT1-1 and MAT1-2 isolates. DsRNA mycovirus infections in A. fumigatus are not related to either CSP or mating type and therefore represent an interesting future therapeutic tool to combat fungal infections.	[Refos, Jeannine M.; Vonk, Alieke G.; Eadie, Kimberly; Verbrugh, Henri A.; van de Sande, Wendy W. J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Lo-Ten-Foe, Jerome R.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [van Diepeningen, Anne D.] Fungal Biodivers Ctr, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Refos, JM (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	j.refos@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021	van de Sande, Wendy/0000-0002-8652-8783				Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Bhatti MF, 2012, MYCOPATHOLOGIA, V174, P323, DOI 10.1007/s11046-012-9556-5; Bhatti MF, 2011, FUNGAL GENET BIOL, V48, P1071, DOI 10.1016/j.fgb.2011.07.008; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Castillo A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-38; Coenen A, 1997, GENETICAL RES CAMBRI, V67; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; Delhaes L, 2010, MED MYCOL, V48, pS77, DOI 10.3109/13693786.2010.514301; Delye C, 1998, J VIROL METHODS, V74, P149, DOI 10.1016/S0166-0934(98)00079-2; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; Hurst SF, 2009, J CLIN MICROBIOL, V47, P1562, DOI 10.1128/JCM.00124-09; Jamal A, 2010, VIRUS RES, V153, P64, DOI 10.1016/j.virusres.2010.07.008; Kim JW, 2006, VIRUS RES, V120, P212, DOI 10.1016/j.virusres.2006.04.004; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liu WX, 2008, VIRUS GENES, V37, P322, DOI 10.1007/s11262-008-0265-6; Mahdavinia M, 2012, THER ADV RESPIR DIS, V6, P173, DOI 10.1177/1753465812443094; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Peever TL, 2000, APPL ENVIRON MICROB, V66, P4863, DOI 10.1128/AEM.66.11.4863-4869.2000; Pfeiffer I, 1996, CURR GENET, V30, P294, DOI 10.1007/s002940050135; PONTECORVO G, 1953, J GEN MICROBIOL, V8, P198, DOI 10.1099/00221287-8-1-198; Ren YP, 2010, PHARM RES-DORDR, V27, P2509, DOI 10.1007/s11095-010-0251-2; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; van Diepeningen AD, 2000, FUNGAL GENETICS NEWS, V47; vanDiepeningen AD, 1997, CURR GENET, V32, P209, DOI 10.1007/s002940050268; Varga J, 1998, CAN J MICROBIOL, V44, P569, DOI 10.1139/cjm-44-6-569; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Yusibov V, 1997, P NATL ACAD SCI USA, V94, P5784, DOI 10.1073/pnas.94.11.5784	35	16	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77381	10.1371/journal.pone.0077381	http://dx.doi.org/10.1371/journal.pone.0077381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167572	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500031
J	Ghafoory, S; Breitkopf-Heinlein, K; Li, Q; Scholl, C; Dooley, S; Wolfl, S				Ghafoory, Shahrouz; Breitkopf-Heinlein, Katja; Li, Qi; Scholl, Catharina; Dooley, Steven; Woelfl, Stefan			Zonation of Nitrogen and Glucose Metabolism Gene Expression upon Acute Liver Damage in Mouse	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CARBON-TETRACHLORIDE; HEPATOCYTE HETEROGENEITY; AMMONIA METABOLISM; RAT-LIVER; GLUTAMINE; HEPATOTOXICITY; GLUCOSE-6-PHOSPHATASE; NECROSIS; INJURY	Zonation of metabolic activities within specific structures and cell types is a phenomenon of liver organization and ensures complementarity of variant liver functions like protein production, glucose homeostasis and detoxification. To analyze damage and regeneration of liver tissue in response to a toxic agent, expression of liver specific enzymes was analyzed by in situ hybridization in mouse over a 6 days time course following carbon tetrachloride (CCl4) injection. CCl4 mixed with mineral oil was administered to BALB/c mice by intraperitoneal injection, and mice were sacrificed at different time points post injection. Changes in the expression of albumin (Alb), arginase (Arg1), glutaminase 2 (Gls2), Glutamine synthetase (Gs), glucose-6-phosphatase (G6pc), glycogen synthase 2 (Gys2), Glycerinaldehyd-3-phosphat-Dehydrogenase (Gapdh), Cytochrom p450 2E1 (Cyp2e1) and glucagon receptor (Gcgr) genes in the liver were studied by in situ hybridization and qPCR. We observed significant changes in gene expression of enzymes involved in nitrogen and glucose metabolism and their local distribution following CCl4 injury. We also found that Cyp2e1, the primary metabolizing enzyme for CCl4, was strongly expressed in the pericentral zone during recovery. Furthermore, cells in the damaged area displayed distinct gene expression profiles during the analyzed time course and showed complete recovery with strong albumin production 6 days after CCl4 injection. Our results indicate that despite severe damage, liver cells in the damaged area do not simply die but instead display locally adjusted gene expression supporting damage response and recovery.	[Ghafoory, Shahrouz; Scholl, Catharina; Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Breitkopf-Heinlein, Katja; Li, Qi; Dooley, Steven] Heidelberg Univ, Med Fac Mannheim, Sect Mol Hepatol Alcohol Associated Dis, Dept Med 2, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wolfl, S (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wolfl@uni-hd.de	Dooley, Steven/T-6491-2018	Dooley, Steven/0000-0002-4840-6240	German Federal Ministry of Education and Research (BMBF) "Virtual Liver"; German Research Foundation (DFG) [FOR630]	German Federal Ministry of Education and Research (BMBF) "Virtual Liver"(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by grants of the German Federal Ministry of Education and Research (BMBF) "Virtual Liver" and German Research Foundation (DFG) FOR630 to SD, KBH and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS H, 1988, HISTOCHEMISTRY, V89, P253, DOI 10.1007/BF00493149; Diehl AM, 2002, FRONT BIOSCI-LANDMRK, V7, pE301, DOI 10.2741/diehl; EVARTS RP, 1987, CANCER RES, V47, P5469; Ferreira EA, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4891; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Ghafoory S, 2012, HISTOPATHOLOGY, V61, P306, DOI 10.1111/j.1365-2559.2012.04237.x; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Haussinger D, 2007, FRONT BIOSCI-LANDMRK, V12, P371, DOI 10.2741/2070; HAUSSINGER D, 1983, EUR J BIOCHEM, V133, P269, DOI 10.1111/j.1432-1033.1983.tb07458.x; HAUSSINGER D, 1990, JPEN-PARENTER ENTER, V14, pS56, DOI 10.1177/014860719001400405; HAUSSINGER D, 1984, CHEM-BIOL INTERACT, V48, P191, DOI 10.1016/0009-2797(84)90120-0; Ichi I, 2007, J NUTR SCI VITAMINOL, V53, P53, DOI 10.3177/jnsv.53.53; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; JONGES GN, 1992, J BIOL CHEM, V267, P4878; Jungermann K, 1997, KIDNEY INT, V51, P402, DOI 10.1038/ki.1997.53; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; LINDROS KO, 1990, HEPATOLOGY, V12, P1092, DOI 10.1002/hep.1840120503; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; MASUDA Y, 1980, J PHARMACOBIO-DYNAM, V3, P53, DOI 10.1248/bpb1978.3.53; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; MOKUDA O, 1995, BIOCHEM MOL MED, V54, P38, DOI 10.1006/bmme.1995.1006; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; MOORMAN AFM, 1994, FEBS LETT, V356, P76, DOI 10.1016/0014-5793(94)01230-X; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; REYNOLDS ES, 1963, J CELL BIOL, V19, P139, DOI 10.1083/jcb.19.1.139; SCHOLS L, 1990, HISTOCHEMISTRY, V94, P49; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; STEUP DR, 1993, TOXICOL PATHOL, V21, P327, DOI 10.1177/019262339302100309; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Yu H, 2003, J HISTOCHEM CYTOCHEM, V51, P1151, DOI 10.1177/002215540305100905	35	36	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78262	10.1371/journal.pone.0078262	http://dx.doi.org/10.1371/journal.pone.0078262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147127	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200096
J	Gong, JH; Zhang, DX; Tseng, Y; Li, BL; Wirtz, D; Schafer, BW				Gong, Jinghai; Zhang, Daxu; Tseng, Yiider; Li, Baolong; Wirtz, Denis; Schafer, Benjamin William			Form-Finding Model Shows How Cytoskeleton Network Stiffness Is Realized	PLOS ONE			English	Article							A ABP-280 MOLECULES; MECHANICAL-PROPERTIES; ACTIN NETWORKS; CELLULAR TENSEGRITY; VISCOELASTICITY; ELASTICITY	In eukaryotic cells the actin-cytoskeletal network provides stiffness and the driving force that contributes to changes in cell shape and cell motility, but the elastic behavior of this network is not well understood. In this paper a two dimensional form-finding model is proposed to investigate the elasticity of the actin filament network. Utilizing an initially random array of actin filaments and actin-cross-linking proteins the form-finding model iterates until the random array is brought into a stable equilibrium configuration. With some care given to actin filament density and length, distance between host sites for cross-linkers, and overall domain size the resulting configurations from the form-finding model are found to be topologically similar to cytoskeletal networks in real cells. The resulting network may then be mechanically exercised to explore how the actin filaments deform and align under load and the sensitivity of the network's stiffness to actin filament density, length, etc. Results of the model are consistent with the experimental literature, e. g. actin filaments tend to re-orient in the direction of stretching; and the filament relative density, filament length, and actin-cross-linking protein's relative density, control the actin-network stiffness. The model provides a ready means of extension to more complicated domains and a three-dimensional form-finding model is under development as well as models studying the formation of actin bundles.	[Gong, Jinghai; Schafer, Benjamin William] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA; [Gong, Jinghai; Zhang, Daxu; Li, Baolong] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200030, Peoples R China; [Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Wirtz, Denis] Johns Hopkins Univ, Dept Oncol, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Shanghai Jiao Tong University; State University System of Florida; University of Florida; Johns Hopkins University	Schafer, BW (corresponding author), Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA.	schafer@jhu.edu	Zhang, Daxu/H-9674-2012	Zhang, Daxu/0000-0002-6586-5238	Institute for NanoBio Technology at the Johns Hopkins University	Institute for NanoBio Technology at the Johns Hopkins University(Johns Hopkins University)	The authors would like to recognize the Institute for NanoBio Technology at the Johns Hopkins University for partial funding in the development of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baudriller H, 2006, CR MECANIQUE, V334, P662, DOI 10.1016/j.crme.2006.08.004; Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Broedersz CP, 2011, NAT PHYS, V7, P983, DOI [10.1038/nphys2127, 10.1038/NPHYS2127]; Canadas P, 2002, J THEOR BIOL, V218, P155, DOI 10.1006/jtbi.2002.3064; Chu JW, 2006, BIOPHYS J, V90, P1572, DOI 10.1529/biophysj.105.073924; Coughlin MF, 2003, BIOPHYS J, V84, P1328, DOI 10.1016/S0006-3495(03)74948-0; Ethier CR, 2007, CAMB TEXT BIOMED ENG, P1, DOI 10.2277/ 0521841127; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; INGBER DE, 1993, J CELL SCI, V104, P613; INGBER DE, 1981, P NATL ACAD SCI-BIOL, V78, P3901, DOI 10.1073/pnas.78.6.3901; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kang J, 2011, J THEOR BIOL, V274, P109, DOI 10.1016/j.jtbi.2011.01.011; Kasza KE, 2010, BIOPHYS J, V99, P1091, DOI 10.1016/j.bpj.2010.06.025; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Lam RHW, 2012, INTEGR BIOL-UK, V4, P1289, DOI 10.1039/c2ib20134h; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Niediek V, 2012, EUR J CELL BIOL, V91, P118, DOI 10.1016/j.ejcb.2011.10.003; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; RUDDIES R, 1993, EUR BIOPHYS J BIOPHY, V22, P309, DOI 10.1007/BF00213554; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Stamenovic D, 2000, J BIOMECH ENG-T ASME, V122, P39, DOI 10.1115/1.429631; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WOLOSEWICK JJ, 1979, J CELL BIOL, V82, P114, DOI 10.1083/jcb.82.1.114; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Yamazaki M, 2002, J MUSCLE RES CELL M, V23, P525, DOI 10.1023/A:1023418725001	36	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77417	10.1371/journal.pone.0077417	http://dx.doi.org/10.1371/journal.pone.0077417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146992	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200036
J	Kumar, S; Maiti, S				Kumar, Santosh; Maiti, Souvik			The Effect of N-acetylation and N-methylation of Lysine Residue of Tat Peptide on its Interaction with HIV-1 TAR RNA	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ARGININE METHYLATION; HISTONE ACETYLATION; TRANSACTIVATOR TAT; PROTEIN; BINDING; RECOGNITION; TRANSITIONS; DOMAIN	Post-translational modification (PTM) of RNA binding proteins (RBPs) play a very important role in determining their binding to cognate RNAs and therefore regulate the downstream effects. Lysine can undergo various PTMs and thereby contribute to the regulation of different cellular processes. It can be reversibly acetylated and methylated using a pool of respective enzymes, to act as a switch for controlling the binding efficiency of RBPs. Here we have delineated the thermodynamic and kinetic effects of N-acetylation and N-monomethylation of lysine on interaction between HIV-1 TAR RNA and its cognate binder Tat peptide (a model system). Our results indicate that acetylation of lysine 50 (K50), leads to eight-fold reduction in binding affinity, originating exclusively from entropy changes whereas, lysine 51 (K51) acetylation resulted only in three fold decrease with large enthalpy-entropy compensation. The measurement of kinetic parameters indicated major change (4.5 fold) in dissociation rate in case of K50 acetylation however, K51 acetylation showed similar effect on both association and dissociation rates. In contrast, lysine methylation did not affect the binding affinity of Tat peptide to TAR RNA at K50, nonetheless three fold enhancement in binding affinity was observed at K51 position. In spite of large enthalpy-entropy compensation, lysine methylation seems to have more pronounced position specific effect on the kinetic parameters. In case of K50 methylation, simultaneous increase was observed in the rate of association and dissociation leaving binding affinity unaffected. The increased binding affinity for methylated Tat at K51 stems from faster association rate with slightly slower dissociation rate.	[Kumar, Santosh; Maiti, Souvik] CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India; [Maiti, Souvik] CSIR, Natl Chem Lab, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Maiti, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India.	souvik@igib.res.in	Kumar, Santosh/ABF-3590-2021	Kumar, Santosh/0000-0002-3594-4795; Maiti, Souvik/0000-0001-9897-1419	Council of Scientific and Industrial Research (CSIR), Government of India [BSC0123]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This project was financially supported by Council of Scientific and Industrial Research (CSIR), Government of India, (BSC0123 project)."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Black JC, 2013, BIOPOLYMERS, V99, P127, DOI 10.1002/bip.22136; Bres V, 2002, J BIOL CHEM, V277, P22215, DOI 10.1074/jbc.M201895200; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Hyun S, 2007, J AM CHEM SOC, V129, P4514, DOI 10.1021/ja068265m; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee EK, 2012, CURR PROTEIN PEPT SC, V13, P331; Long KS, 1999, BIOCHEMISTRY-US, V38, P10059, DOI 10.1021/bi990590h; MARKY LA, 1983, BIOPOLYMERS, V22, P1247, DOI 10.1002/bip.360220416; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Michael LA, 2009, J MOL BIOL, V392, P774, DOI 10.1016/j.jmb.2009.07.047; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; RUBEN S, 1989, J VIROL, V63, P1; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Suryawanshi H, 2010, J PHYS CHEM B, V114, P11155, DOI 10.1021/jp1000545; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	43	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77595	10.1371/journal.pone.0077595	http://dx.doi.org/10.1371/journal.pone.0077595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147034	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200050
J	Auclair, S; Rossetti, R; Meslin, C; Monestier, O; Di Pasquale, E; Pascal, G; Persani, L; Fabre, S				Auclair, Sylvain; Rossetti, Raffaella; Meslin, Camille; Monestier, Olivier; Di Pasquale, Elisa; Pascal, Geraldine; Persani, Luca; Fabre, Stephane			Positive Selection in Bone Morphogenetic Protein 15 Targets a Natural Mutation Associated with Primary Ovarian Insufficiency in Human	PLOS ONE			English	Article							INCREASED OVULATION RATE; BIASED GENE CONVERSION; TGF-BETA; MAMMALIAN GENOMES; EVOLUTION; OOCYTE; BMP15; STERILITY; PROGESTERONE; PHYLOGENIES	Bone Morphogenetic Protein 15 (BMP15) is a TGF beta-like oocyte-derived growth factor involved in ovarian folliculogenesis as a critical regulator of many granulosa cell processes. Alterations of the BMP15 gene have been found associated with different ovarian phenotypic effects depending on the species, from sterility to increased prolificacy in sheep, slight subfertility in mouse or associated with primary ovarian insufficiency (POI) in women. To investigate the evolving role of BMP15, a phylogenetic analysis of this particular TGF beta family member was performed. A maximum likelihood phylogenetic tree of several TGF beta/BMP family members expressed by the ovary showed that BMP15 has a very strong divergence and a rapid evolution compared to others. Moreover, among 24 mammalian species, we detected signals of positive selection in the hominidae clade corresponding to F146, L189 and Y235 residues in human BMP15. The biological importance of these residues was tested functionally after site directed-mutagenesis in a COV434 cells luciferase assay. By replacing the positively selected amino acid either by alanine or the most represented residue in other studied species, only L189A, Y235A and Y235C mutants showed a significant increase of BMP15 signaling when compared to wild type. Additionally, the Y235C mutant was more potent than wild type in inhibiting progesterone secretion of ovine granulosa cells in primary culture. Interestingly, the Y235C mutation was previously identified in association with POI in women. In conclusion, this study evidences that the BMP15 gene has evolved faster than other members of the TGF beta family and was submitted to a positive selection pressure in the hominidae clade. Some residues under positive selection are of great importance for the normal function of the protein and thus for female fertility. Y235 represents a critical residue in the determination of BMP15 biological activity, thus indirectly confirming its role in the onset of POI in women.	[Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] CNRS, Physiol Reprod & Comportements UMR7247, Nouzilly, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] Univ Tours, Tours, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] IFCE, Nouzilly, France; [Rossetti, Raffaella; Persani, Luca] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Monestier, Olivier; Fabre, Stephane] INRA ENVT, UMR 444, Lab Genet Cellulaire, Castanet Tolosan, France; [Di Pasquale, Elisa] Ist Clin Humanitas, Natl Res Council Italy, Inst Genet & Biomed Res UOS Milan, Milan, Italy; [Persani, Luca] Ist Auxol Italiano, Lab Ric Endocrinometabol, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; University of Milan; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; IRCCS Istituto Auxologico Italiano	Fabre, S (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	stephane.fabre@tours.inra.fr	Rossetti, Raffaella/B-4972-2013; Di Pasquale, Elisa/A-4751-2014; Di Pasquale, Elisa/ABI-6252-2020; Monestier, Olivier/AAB-2220-2020; Persani, Luca/B-6543-2008; Di Pasquale, Elisa/ABI-6210-2020; Pascal, Geraldine/P-8125-2019; Monestier, Olivier/E-2926-2013; PASCAL, Géraldine/L-4519-2013; FABRE, Stéphane/AAQ-8400-2020; Fabre, Stéphane/ABC-1483-2020	Rossetti, Raffaella/0000-0001-9112-6175; Di Pasquale, Elisa/0000-0003-2373-5635; Di Pasquale, Elisa/0000-0003-2373-5635; Monestier, Olivier/0000-0002-3236-0807; Persani, Luca/0000-0003-2068-9581; Pascal, Geraldine/0000-0002-5250-6594; Monestier, Olivier/0000-0002-3236-0807; PASCAL, Géraldine/0000-0002-5250-6594; FABRE, Stéphane/0000-0001-7350-9500; 	French "Agence Nationale de la Recherche" [ANR 2010 BLAN 1608 01]; French "Centre National de la Recherche Scientifique" (CNRS PICS program); Italian Telethon [GGP09126]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); French "Centre National de la Recherche Scientifique" (CNRS PICS program); Italian Telethon(Fondazione Telethon)	This work was sponsored by grants from the French "Agence Nationale de la Recherche" (ANR 2010 BLAN 1608 01, MONOPOLY), the French "Centre National de la Recherche Scientifique" (CNRS PICS program), and was also partially supported by the Italian Telethon (grant GGP09126). The computations were hosted by the Toulouse Midi-Pyrenees bioinformatics platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Busset J, 2011, NUCLEIC ACIDS RES, V39, pW479, DOI 10.1093/nar/gkr243; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Derynck Rik, 2008, P29; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Dudoit S, 2002, STAT SINICA, V12, P111; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ely JJ, 2006, AM J PHYS ANTHROPOL, V130, P96, DOI 10.1002/ajpa.20310; Fabre S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-20; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Galtier N, 2001, GENETICS, V159, P907; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hashimoto O, 2005, P NATL ACAD SCI USA, V102, P5426, DOI 10.1073/pnas.0409533102; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Katoh Y, 2006, INT J MOL MED, V17, P951; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCMAHON HE, 2008, ENDOCRINOLOGY; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; Meslin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044548; Moore RK, 2005, MOL CELL ENDOCRINOL, V234, P67, DOI 10.1016/j.mce.2004.10.012; Persani L, 2011, J ENDOCRINOL INVEST, V34, P244, DOI [10.1007/BF03347073, 10.3275/7502]; Pierre A, 2004, J MOL ENDOCRINOL, V33, P805, DOI 10.1677/jme.1.01545; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961; SAUMANDE J, 1985, THERIOGENOLOGY, V23, P719, DOI 10.1016/0093-691X(85)90147-5; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	48	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78199	10.1371/journal.pone.0078199	http://dx.doi.org/10.1371/journal.pone.0078199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147118	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400151
J	Shackleton, R; Shackleton, C; Shackleton, S; Gambiza, J				Shackleton, Ross; Shackleton, Charlie; Shackleton, Sheona; Gambiza, James			Deagrarianisation and Forest Revegetation in a Biodiversity Hotspot on the Wild Coast, South Africa	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; LAND ABANDONMENT; AGRICULTURE; CONSERVATION; DIVERSITY; REGION	Deagraianisation is a worldwide phenomenon with widespread social, ecological and economic effects yet with little consensus on the local or higher level causes. There have been contested views on the causes and consequences of deagrarianisation on South Africa's Wild Coast, which is an international biodiversity hotspot. Using GIS, household interviews and ecological sampling, we compared the perspectives of current and former cultivators as to why some have abandoned farming, whilst also tracking the uses and woody plant cover and composition of fields abandoned at different periods. The GIS analysis showed that field abandonment had been ongoing over several decades, with a decline from 12.5 % field cover in 1961 to 2.7 % in 2009. The area of forests and woodlands almost doubled in the corresponding period. There was a distinct peak in field abandonment during the time of political transition at the national level in the early 1990s. This political change led to a decrease in government support for livestock farming, which in turn resulted in reduced animal draught power at the household and community level, and hence reduced cropping. The study showed it is largely the wealthier households that have remained in arable agriculture and that the poorer households have abandoned farming. The abandoned fields show a distinct trend of increasing woody biomass and species richness with length of time since abandonment, with approximately three woody plant species added per decade. Most local respondents dislike the increases in forest and woodland extent and density because of anxiety about wild animals causing harm to crops and even humans, and the loss of an agricultural identity to livelihoods and the landscape.	[Shackleton, Ross; Shackleton, Charlie; Shackleton, Sheona; Gambiza, James] Rhodes Univ, Dept Environm Sci, ZA-6140 Grahamstown, South Africa	Rhodes University	Shackleton, C (corresponding author), Rhodes Univ, Dept Environm Sci, ZA-6140 Grahamstown, South Africa.	c.shackleton@ru.ac.za	Shackleton, Ross/AAA-8469-2020; Shackleton, Ross/AAE-7865-2020; Shackleton, Charlie M/F-4177-2014; Gambiza, James/GPX-8046-2022; Shackleton, Charlie/GLV-1260-2022	Shackleton, Ross/0000-0001-5628-4506; Shackleton, Charlie/0000-0002-8489-6136; Shackleton, Sheona/0000-0002-6133-9070	Rhodes University	Rhodes University	This work was funded by Rhodes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliber M, 2009, AGREKON, V48, P384, DOI 10.1080/03031853.2009.9523833; Andrew M., 2004, Development Southern Africa, V21, P687, DOI 10.1080/0376835042000288851; Andrew M., 1992, GEOGRAPHICAL STUDY A; [Anonymous], 1997, FAREWELL FARMS DEAGR; [Anonymous], 2004, INDIGENOUS FORESTS W; Berliner D., 2011, 5 NAT FOR WOODL S RI; Bjarnason T, 2006, J RURAL STUD, V22, P290, DOI 10.1016/j.jrurstud.2005.09.004; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Bonet A, 2004, J ARID ENVIRON, V56, P213, DOI 10.1016/S0140-1963(03)00048-X; Boyes LJ, 2011, PLANT ECOL, V212, P21, DOI 10.1007/s11258-010-9798-6; Castley GH, 1996, PARADOX FOREST CONSE, V85, P35, DOI [10.1016/S0378-1127(96)03748-6, DOI 10.1016/S0378-1127(96)03748-6]; Chalmers N, 2007, ECOL SOC, V12; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Critical Ecosystem Partnership Fund (CEPF), 2010, EC PROF MUP POND ALB; De Klerk H, 2007, THESIS RHODES U GRAH; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Elands BHM, 2004, FOREST POLICY ECON, V6, P469, DOI 10.1016/j.forpol.2004.01.003; Everatt D, 2001, DEV UPDATE, V3, P32; Fay D, 2003, TRUST IS WE WANT PLO; Feely JM., 1987, BAR INT SERIES, V378, P131; Geldenhuys CJ, 2004, WEED TECHNOL, V18, P1386, DOI 10.1614/0890-037X(2004)018[1386:CAPTCI]2.0.CO;2; Hayward MW, 2009, S AFR J WILDL RES, V39, P70, DOI 10.3957/056.039.0108; Hayward MW, 2005, S AFR J WILDL RES, V35, P117; Hebinck P., 2007, LIVELIHOODS LANDSCAP, P335; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Diaz GI, 2011, LANDSCAPE URBAN PLAN, V99, P207, DOI 10.1016/j.landurbplan.2010.11.005; Izquierdo AE, 2009, J ENVIRON MANAGE, V90, P858, DOI 10.1016/j.jenvman.2008.02.013; Khanal N. R., 2006, Mountain Research and Development, V26, P32, DOI 10.1659/0276-4741(2006)026[0032:AOALAI]2.0.CO;2; Local Municipality Mbashe, 2010, INT DEV PLAN 2010 20, P178; Lubke RA, 1996, LANDSCAPE URBAN PLAN, V34, P335, DOI 10.1016/0169-2046(95)00227-8; Mangwale K, 2010, THESIS RHODES U GRAH; McAllister P., 2001, BUILDING HOMESTEAD A; McCusker B, 2006, GEOFORUM, V37, P790, DOI 10.1016/j.geoforum.2005.09.007; Mucina L., 2006, STRELITZIA, V19, P616; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Nzunda EF, 2011, J TROP ECOL, V27, P195, DOI 10.1017/S0266467410000659; Otto R, 2006, J ARID ENVIRON, V65, P156, DOI 10.1016/j.jaridenv.2005.07.005; Pandolfi JM, 2008, ENCY ECOLOGY; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Schneider L., 2006, Agricultural and Resource Economics Review, V35, P167; Shackleton C. M., 2007, Agrekon, V46, P135; Shackleton C. M., 2005, African Journal of Range & Forage Science, V22, P127, DOI 10.2989/10220110509485870; Shackleton CM, 2006, ECOL ECON, V57, P306, DOI 10.1016/j.ecolecon.2005.04.011; Timmermans H., 2004, THESIS RHODES U GRAH; Tognetti PM, 2010, BIOL CONSERV, V143, P2494, DOI 10.1016/j.biocon.2010.06.016; van Averbeke W, 2007, WATER SA, V33, P413; vanAarde RJ, 1996, LANDSCAPE URBAN PLAN, V34, P277, DOI 10.1016/0169-2046(95)00237-5; vonMaltitz GP, 1996, S AFR J BOT, V62, P188, DOI 10.1016/S0254-6299(15)30633-5; Wassenaar TD, 2005, ECOLOGY, V86, P655, DOI 10.1890/03-0836; Weissteiner CJ, 2011, GLOBAL PLANET CHANGE, V79, P20, DOI 10.1016/j.gloplacha.2011.07.009; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x	53	48	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76939	10.1371/journal.pone.0076939	http://dx.doi.org/10.1371/journal.pone.0076939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155911	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300045
J	Theodorou, M; Speletas, M; Mamara, A; Papachristopoulou, G; Lazou, V; Scorilas, A; Katsantoni, E				Theodorou, Marina; Speletas, Matthaios; Mamara, Antigoni; Papachristopoulou, Georgia; Lazou, Vassiliki; Scorilas, Andreas; Katsantoni, Eleni			Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							B-CELLS; TRANSCRIPTION FACTORS; TRANSGENIC MICE; HISTONE ACETYLATION; SIGNAL TRANSDUCERS; PROSTATE-CANCER; BREAST-CANCER; IN-VIVO; EXPRESSION; ACTIVATION	STAT5 controls essential cellular functions and is encoded by two genes, Stat5a and Stat5b. To provide insight to the mechanisms linking hematologic malignancy to STAT5 activation/regulation of target genes, we identified STAT5 target genes and focused on Dpf3 gene, which encodes for an epigenetic factor. Dpf3 expression was induced upon IL-3 stimulation in Ba/F3 cells, while strong binding of both STAT5a and STAT5b was detected in its promoter. Reduced expression of Dpf3 was detected in Ba/F3 cells with Stat5a and Stat5b knock-down, suggesting that this gene is positively regulated by STAT5, upon IL-3 stimulation. Furthermore, this gene was significantly up-regulated in CLL patients, where DPF3 gene/protein up-regulation and strong STAT5 binding to the DPF3 promoter, correlated with increased STAT5 activation, mainly in non-malignant myeloid cells (granulocytes). Our findings provide insights in the STAT5 dependent transcriptional regulation of Dpf3, and demonstrate for the first time increased STAT5 activation in granulocytes of CLL patients. Novel routes of investigation are opened to facilitate the understanding of the role of STAT5 activation in the communication between non-malignant myeloid and malignant B-cells, and the functions of STAT5 target genes networks in CLL biology.	[Theodorou, Marina; Lazou, Vassiliki; Katsantoni, Eleni] Acad Athens, Biomed Res Fdn, Div Hematol Oncol, Athens, Greece; [Speletas, Matthaios; Mamara, Antigoni] Univ Thessaly, Sch Med, Dept Immunol & Histocompatibil, Larisa, Greece; [Papachristopoulou, Georgia; Scorilas, Andreas] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens, Greece	Academy of Athens; University of Thessaly; National & Kapodistrian University of Athens	Katsantoni, E (corresponding author), Acad Athens, Biomed Res Fdn, Div Hematol Oncol, Athens, Greece.	ekatsantoni@bioacademy.gr		Scorilas, Andreas/0000-0003-2427-4949; Katsantoni, Eleni/0000-0001-8249-6035	EU; BRFAA	EU(European Commission); BRFAA	This work was supported by research funding from the EU (European Reintegration Grant) and BRFAA to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bojarska-Junak A, 2009, LEUKEMIA RES, V33, P1319, DOI 10.1016/j.leukres.2009.03.030; Buettner R, 2002, CLIN CANCER RES, V8, P945; BUSCHLE M, 1993, J EXP MED, V177, P213, DOI 10.1084/jem.177.1.213; CHAOUCHI N, 1994, CLIN IMMUNOL IMMUNOP, V73, P197, DOI 10.1006/clin.1994.1188; Choi YP, 2005, PROTEOMICS, V5, P1481, DOI 10.1002/pmic.200401021; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Dawson M, 2012, EDITH WHARTON IN CONTEXT, P41; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; diCelle PF, 1996, BLOOD, V87, P4382, DOI 10.1182/blood.V87.10.4382.bloodjournal87104382; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Gamberale R, 2001, LEUKEMIA, V15, P1860, DOI 10.1038/sj.leu.2402288; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Katsantoni E, 2012, SCI SIGNAL, V5, ppt13; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Katsantoni EZ, 2004, EXP HEMATOL, V32, P224, DOI 10.1016/j.exphem.2003.11.001; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lanvin O, 2004, ONCOGENE, V23, P3040, DOI 10.1038/sj.onc.1207450; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lo KC, 2007, GENE CHROMOSOME CANC, V46, P875, DOI 10.1002/gcc.20474; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MELO JV, 1986, INT J CANCER, V38, P531, DOI 10.1002/ijc.2910380413; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pestina TI, 2003, EXP HEMATOL, V31, P1198, DOI 10.1016/j.exphem.2003.09.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PISTOIA V, 1987, BLOOD, V69, P1340; Planelles L, 2007, HAEMATOLOGICA, V92, P1284, DOI 10.3324/haematol.10317; SALTMAN D, 1990, LEUKEMIA RES, V14, P381, DOI 10.1016/0145-2126(90)90167-8; Schwaller J, 2007, BLOOD, V109, P331, DOI 10.1182/blood-2006-02-001800; Siapati EK, 2005, MOL THER, V12, P537, DOI 10.1016/j.ymthe.2005.01.022; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Speletas M, 2007, LEUKEMIA RES, V31, P1053, DOI 10.1016/j.leukres.2006.09.005; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Yamaji D., 2012, NUCL ACIDS RES; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	54	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76155	10.1371/journal.pone.0076155	http://dx.doi.org/10.1371/journal.pone.0076155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155890	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300024
J	Valenti, L; Motta, BM; Soardo, G; Iavarone, M; Donati, B; Sangiovanni, A; Carnelutti, A; Dongiovanni, P; Rametta, R; Bertelli, C; Facchetti, F; Colombo, M; Fargion, S; Fracanzani, AL				Valenti, Luca; Motta, Benedetta Maria; Soardo, Giorgio; Iavarone, Massimo; Donati, Benedetta; Sangiovanni, Angelo; Carnelutti, Alessia; Dongiovanni, Paola; Rametta, Raffaela; Bertelli, Cristina; Facchetti, Floriana; Colombo, Massimo; Fargion, Silvia; Fracanzani, Anna Ludovica			PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GREATER-THAN-G; VARIANT; SUSCEPTIBILITY; ASSOCIATION; PROGRESSION; MANAGEMENT; STEATOSIS; FIBROSIS; RISK	Background & Aims: Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival. Methods: we considered 460 consecutive HCC patients referred to tertiary care centers in Northern Italy, 353 with follow-up data. Results: Homozygosity for PNPLA3 148M at risk allele was enriched in HCC patients with alcoholic liver disease or nonalcoholic fatty liver disease (ALD&NAFLD: relative risk 5.9, 95% c.i. 3.5-9.9; other liver diseases: relative risk 1.9, 95% c.i. 1.1-3.4). In ALD&NAFLD patients, the PNPLA3 148M allele was associated with younger age, shorter history of cirrhosis, less advanced (Child A) cirrhosis at HCC diagnosis, and lower HCC differentiation grade (p<0.05). Homozygosity for PNPLA3 148M was associated with reduced survival in the overall series (p = 0.009), and with a higher number of HCC lesions at presentation (p = 0.007) and reduced survival in ALD&NAFLD patients (p = 0.003; median survival 30, 95% c.i. 20-39 vs. 45, 95% c.i. 38-52 months), but not in those with HCC related to other etiologies (p = 0.86; 48, 95% c.i. 32-64 vs. 55, 95% c.i. 4367 months). At multivariate Cox regression analysis, homozygosity for PNPLA3 148M was the only negative predictor of survival in ALD&NAFLD patients (HR of death 1.57, 95% c.i. 1.12-2.78). Conclusions: PNPLA3 148M is over-represented in ALD&NAFLD HCC patients, and is associated with occurrence at a less advanced stage of liver disease in ALD&NAFLD. In ALD&NAFLD, PNPLA3 148M is associated with more diffuse HCC at presentation, and with reduced survival.	[Valenti, Luca; Motta, Benedetta Maria; Donati, Benedetta; Dongiovanni, Paola; Rametta, Raffaela; Colombo, Massimo; Fargion, Silvia; Fracanzani, Anna Ludovica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Valenti, Luca; Bertelli, Cristina; Fargion, Silvia; Fracanzani, Anna Ludovica] Osped Maggiore Policlin Milano, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Milan, Italy; [Soardo, Giorgio; Carnelutti, Alessia] Univ Udine, I-33100 Udine, Italy; [Iavarone, Massimo; Sangiovanni, Angelo; Facchetti, Floriana; Colombo, Massimo] Osped Maggiore Policlin Milano, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Div Gastroenterol 1, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Udine; IRCCS Ca Granda Ospedale Maggiore Policlinico	Valenti, L (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	luca.valenti@unimi.it	Dongiovanni, Paola/AAC-9965-2019; Iavarone, Massimo/AAC-1699-2019; Valenti, Luca/B-3695-2009; Donati, Benedetta/AAA-7779-2022; Motta, Benedetta Maria/AAA-8559-2020; Fracanzani, Anna Ludovica/J-8986-2018; Donati, Benedetta/H-7741-2018	Dongiovanni, Paola/0000-0003-4343-7213; Iavarone, Massimo/0000-0003-3493-6504; Valenti, Luca/0000-0001-8909-0345; Donati, Benedetta/0000-0002-9163-8194; Motta, Benedetta Maria/0000-0002-6681-2170; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Donati, Benedetta/0000-0002-9163-8194; sangiovanni, angelo/0000-0002-9996-9385; rametta, raffaela/0000-0003-0091-9394	Associazione Malattie Metaboliche del Fegato ONLUS; Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan)	Associazione Malattie Metaboliche del Fegato ONLUS; Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan)	This work was supported by Associazione Malattie Metaboliche del Fegato ONLUS (nonprofit organization for the study of metabolic liver diseases) and Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burza MA, 2012, DIGEST LIVER DIS, V44, P1037, DOI 10.1016/j.dld.2012.05.006; Corradini SG, 2011, HEPATOLOGY, V53, P1776, DOI 10.1002/hep.24244; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Guyot E, 2012, J HEPATOL IN PRESS; Hassan MM, 2013, MOL CARCINOG; Muller T, 2011, J HEPATOL, V55, P732, DOI 10.1016/j.jhep.2011.01.025; Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035; Nischalke HD, 2012, PLOS ONE, V6; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Takeuchi Y, 2012, J GASTROENTEROL; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2012, ALIMENT PHARM THER, V35, P1434, DOI 10.1111/j.1365-2036.2012.05109.x; Valenti L, 2012, J HEPATOL, V56, pS129, DOI 10.1016/S0168-8278(12)60328-6; Valenti L, 2013, DIG LIVER DIS; Valenti L, 2012, DIGEST LIVER DIS, V44, P974, DOI 10.1016/j.dld.2012.08.023; Valenti L, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-111; Valenti L, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25634; Valenti L, 2012, WORLD J GASTROENTERO, V18, P2813, DOI 10.3748/wjg.v18.i22.2813; Valenti L, 2011, HEPATOLOGY, V53, P1777, DOI 10.1002/hep.24265; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Vigano M, 2013, HEPATOLOGY; Wagenknecht LE, 2011, LIVER INT, V31, P412, DOI 10.1111/j.1478-3231.2010.02444.x; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	35	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75982	10.1371/journal.pone.0075982	http://dx.doi.org/10.1371/journal.pone.0075982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155878	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300012
J	Poon, K; Mandava, S; Chen, K; Barson, JR; Buschlen, S; Leibowitz, SF				Poon, Kinning; Mandava, Sushma; Chen, Karen; Barson, Jessica R.; Buschlen, Sylvie; Leibowitz, Sarah F.			Prenatal Exposure to Dietary Fat Induces Changes in the Transcriptional Factors, TEF and YAP, Which May Stimulate Differentiation of Peptide Neurons in Rat Hypothalamus	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CIRCULATING TRIGLYCERIDES; OREXIGENIC PEPTIDES; CELL-PROLIFERATION; METABOLIC SYNDROME; DNA-BINDING; ENKEPHALIN; OBESITY; DOMAIN	Gestational exposure to a high-fat diet (HFD) stimulates the differentiation of orexigenic peptide-expressing neurons in the hypothalamus of offspring. To examine possible mechanisms that mediate this phenomenon, this study investigated the transcriptional factor, transcription enhancer factor-1 (TEF), and co-activator, Yes-associated protein (YAP), which when inactivated stimulate neuronal differentiation. In rat embryos and postnatal offspring prenatally exposed to a HFD compared to chow, changes in hypothalamic TEF and YAP and their relationship to the orexigenic peptide, enkephalin (ENK), were measured. The HFD offspring at postnatal day 15 (P15) exhibited in the hypothalamic paraventricular nucleus a significant reduction in YAP mRNA and protein, and increased levels of inactive and total TEF protein, with no change in mRNA. Similarly, HFD-exposed embryos at embryonic day 19 (E19) showed in whole hypothalamus significantly decreased levels of YAP mRNA and protein and TEF mRNA, and increased levels of inactive TEF protein, suggesting that HFD inactivates TEF and YAP. This was accompanied by increased density and fluorescence intensity of ENK neurons. A close relationship between TEF and ENK was suggested by the finding that TEF co-localizes with this peptide in hypothalamic neurons and HFD reduced the density of TEF/ENK co-labeled neurons, even while the number and fluorescence intensity of single-labeled TEF neurons were increased. Increased YAP inactivity by HFD was further evidenced by a decrease in number and fluorescence intensity of YAP-containing neurons, although the density of YAP/ENK co-labeled neurons was unaltered. Genetic knockdown of TEF or YAP stimulated ENK expression in hypothalamic neurons, supporting a close relationship between these transcription factors and neuropeptide. These findings suggest that prenatal HFD exposure inactivates both hypothalamic TEF and YAP, by either decreasing their levels or increasing their inactive form, and that this contributes to the stimulatory effect of HFD on ENK expression and possibly the differentiation of ENK-expressing neurons.	[Poon, Kinning; Mandava, Sushma; Chen, Karen; Barson, Jessica R.; Buschlen, Sylvie; Leibowitz, Sarah F.] Rockefeller Univ, Lab Behav Neurobiol, New York, NY 10021 USA	Rockefeller University	Leibowitz, SF (corresponding author), Rockefeller Univ, Lab Behav Neurobiol, 1230 York Ave, New York, NY 10021 USA.	leibow@rockefeller.edu		Barson, Jessica/0000-0001-7227-5730; Poon, Kinning/0000-0001-5671-9194	NIH [5R01DA021518]; NARSAD [CEN5401363]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH Grant 5R01DA021518, and by NARSAD grant CEN5401363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Barson JR, 2013, ALCOHOL CLIN EXP RES, V37, pE141, DOI 10.1111/j.1530-0277.2012.01858.x; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beck B, 2006, BIOCHEM BIOPH RES CO, V342, P452, DOI 10.1016/j.bbrc.2006.01.158; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cerf ME, 2010, INT J DEV NEUROSCI, V28, P625, DOI 10.1016/j.ijdevneu.2010.07.226; Chang GQ, 2007, AM J PHYSIOL-ENDOC M, V292, pE561, DOI 10.1152/ajpendo.00087.2006; Chang GQ, 2010, PHYSIOL BEHAV, V101, P360, DOI 10.1016/j.physbeh.2010.06.005; Chang GQ, 2004, ENDOCRINOLOGY, V145, P3904, DOI 10.1210/en.2003-1582; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Dourmashkin JT, 2006, PHYSIOL BEHAV, V87, P666, DOI 10.1016/j.physbeh.2006.01.008; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Gregorio BM, 2013, EUR J NUTR, V52, P759, DOI 10.1007/s00394-012-0382-9; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; Gupta MP, 2000, NUCLEIC ACIDS RES, V28, P3168, DOI 10.1093/nar/28.16.3168; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Jiang SW, 2001, J BIOL CHEM, V276, P23464, DOI 10.1074/jbc.M010934200; Karatayev O, 2009, BRAIN RES, V1298, P111, DOI 10.1016/j.brainres.2009.08.001; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liang C, 2009, BIRTH DEFECTS RES B, V86, P362, DOI 10.1002/bdrb.20204; Lin S, 1999, BRAIN RES BULL, V49, P215, DOI 10.1016/S0361-9230(99)00049-0; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Poon K, 2012, AM J PHYSIOL-ENDOC M, V303, pE432, DOI 10.1152/ajpendo.00238.2012; PRETEL S, 1991, PEPTIDES, V12, P1243, DOI 10.1016/0196-9781(91)90202-Z; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Salvi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004392; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019745; SPIRO C, 1993, P NATL ACAD SCI USA, V90, P4606, DOI 10.1073/pnas.90.10.4606; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Yu FX, 2012, CELL CYCLE, V11, P4097, DOI 10.4161/cc.22322; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025	58	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77668	10.1371/journal.pone.0077668	http://dx.doi.org/10.1371/journal.pone.0077668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147051	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400132
J	Wang, Y; Tjandra, N				Wang, Yu; Tjandra, Nico			Structural Insights of tBid, the Caspase-8-activated Bid, and Its BH3 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2; NMR; Protein Dynamics; Protein Structure; LPPG Micelles; tBid	BCL-2 FAMILY-MEMBER; CYTOCHROME-C; MEMBRANE-BINDING; MITOCHONDRIAL-MEMBRANE; CONFORMATIONAL-CHANGES; BACKBONE DYNAMICS; PROTEIN FAMILY; ACTIVATE BAX; DEATH; CARDIOLIPIN	Background: The membrane-associated tBid promotes Bax membrane insertion and activation. Results: tBid adopts an extended structure in 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG) micelles with its six helices including the BH3 domain interacting with the micelles. Conclusion: An on the membrane binding mode was suggested for tBid interaction with Bax. Significance: Revealing tBid structure on the membrane is key to the understanding of tBid-mediated Bax activation. The Bcl-2 family proteins regulate mitochondria-mediated apoptosis through intricate molecular mechanisms. One of the pro-apoptotic proteins, tBid, can induce apoptosis by promoting Bax activation, Bax homo-oligomerization, and mitochondrial outer membrane permeabilization. Association of tBid on the mitochondrial outer membrane is key to its biological function. Therefore knowing the conformation of tBid on the membrane will be the first step toward understanding its crucial role in triggering apoptosis. Here, we present NMR characterization of the structure and dynamics of human tBid in 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] micelles. Our data showed that tBid is monomeric with six well defined -helices in the micelles. Compared with the full-length Bid structure, a longer flexible loop between tBid helix (4) and (5) was observed. Helices in tBid do not pack into a compact-fold but form an extended structure with a C-shape configuration in the micelles. All six tBid helices were shown to interact with LPPG micelles, with helix (6) and (7) being more embedded. Of note, the BH3-containing helix (3), which was previously believed to be exposed above the membrane surface, is also membrane associated, suggesting an on the membrane binding mode for tBid interaction with Bax. Our data provided structural details on the membrane-associated state of tBid and the functional implications of its membrane-associated BH3 domain.	[Wang, Yu; Tjandra, Nico] NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov			National Institutes of Health grant from the Intramural Research Program of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program of the NHLBI (to N. T.).	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cho EY, 2012, MOL CELL BIOCHEM, V363, P395, DOI 10.1007/s11010-011-1192-8; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Krueger-Koplin RD, 2004, J BIOMOL NMR, V28, P43, DOI 10.1023/B:JNMR.0000012875.80898.8f; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Manara A, 2009, BBA-MOL CELL BIOL L, V1791, P997, DOI 10.1016/j.bbalip.2009.05.003; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Petit PX, 2009, FEBS J, V276, P6338, DOI 10.1111/j.1742-4658.2009.07345.x; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Ryabov Y, 2011, J AM CHEM SOC, V133, P6154, DOI 10.1021/ja201020c; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shamas-Din A, 2013, J BIOL CHEM, V288, P22111, DOI 10.1074/jbc.M113.482109; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yao Y, 2009, BIOCHEMISTRY-US, V48, P8704, DOI 10.1021/bi901171n; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	79	53	53	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35840	35851		10.1074/jbc.M113.503680	http://dx.doi.org/10.1074/jbc.M113.503680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158446	Green Published, hybrid			2022-12-25	WOS:000329814700021
J	Blazevic, T; Schwaiberger, AV; Schreiner, CE; Schachner, D; Schaible, AM; Grojer, CS; Atanasov, AG; Werz, O; Dirsch, VM; Heiss, EH				Blazevic, Tina; Schwaiberger, Andrea V.; Schreiner, Cornelia E.; Schachner, Daniel; Schaible, Anja M.; Grojer, Christoph S.; Atanasov, Atanas G.; Werz, Oliver; Dirsch, Verena M.; Heiss, Elke H.			12/15-Lipoxygenase Contributes to Platelet-derived Growth Factor-induced Activation of Signal Transducer and Activator of Transcription 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Lipoxygenase Pathway; Redox Regulation; Signal Transduction; STAT3; Vascular Smooth Muscle Cells; Indirubin-3-monoxime; Platelet-derived Growth Factor	SMOOTH-MUSCLE-CELLS; PDGF-BETA-RECEPTOR; TYROSINE PHOSPHORYLATION; NEOINTIMA FORMATION; IN-VIVO; OXIDATIVE STRESS; SRC; KINASE; PROLIFERATION; INVOLVEMENT	We showed previously that the small molecule indirubin-3-monoxime (I3MO) prevents vascular smooth muscle cell (VSMC) proliferation by selectively inhibiting signal transducer and activator of transcription 3 (STAT3). Looking for the underlying upstream molecular mechanism, we here reveal the important role of reactive oxygen species (ROS) for PDGF-induced STAT3 activation in VSMC. We show that neither NADPH-dependent oxidases (Noxes) nor mitochondria, but rather 12/15-lipoxygenase (12/15-LO) are pivotal ROS sources involved in the redox-regulated signal transduction from PDGFR to STAT3. Accordingly, pharmacological and genetic interference with 12/15-LO activity selectively inhibited PDGF-induced Src activation and STAT3 phosphorylation. I3MO is able to blunt PDGF-induced ROS and 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) production, indicating an inhibitory action of I3MO on 12/15-LO and consequently on STAT3. We identify 12/15-LO as a hitherto unrecognized signaling hub in PDGF-triggered STAT3 activation and show for the first time a negative impact of I3MO on 12/15-LO.	[Blazevic, Tina; Schwaiberger, Andrea V.; Schreiner, Cornelia E.; Schachner, Daniel; Grojer, Christoph S.; Atanasov, Atanas G.; Dirsch, Verena M.; Heiss, Elke H.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Schaible, Anja M.; Werz, Oliver] Univ Jena, Chair Pharmaceut Med Chem, D-07743 Jena, Germany	University of Vienna; Friedrich Schiller University of Jena	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Blazevic, Tina/AAD-4212-2020; Atanasov, Atanas G./C-5535-2013; Heiss, Elke/B-6086-2015	Atanasov, Atanas G./0000-0003-2545-0967; Dirsch, Verena/0000-0002-9261-5293; Blazevic, Tina/0000-0002-2084-9074; Heiss, Elke/0000-0001-7618-5505	Austrian Science Fund (FWF) [P23317, S10704]; Austrian Science Fund (FWF) [P 23317] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P23317 (to E. H. H.) and S10704 (to V. M. D.).	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bronas UG, 2010, AM J LIFESTYLE MED, V4, P521, DOI 10.1177/1559827610375534; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen K, 2003, FREE RADICAL BIO MED, V35, P117, DOI 10.1016/S0891-5849(03)00239-9; Chiarugi P, 2008, MOL CELLS, V26, P329; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Heldin CH, 1997, FEBS LETT, V410, P17, DOI 10.1016/S0014-5793(97)00318-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; INUI H, 1993, J BIOL CHEM, V268, P17045; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; KNOSPE J, 1988, J CHROMATOGR, V442, P444, DOI 10.1016/S0021-9673(00)94498-4; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lennartsson J, 2013, J BIOL CHEM, V288, P15736, DOI 10.1074/jbc.M113.476424; Maheswaranathan M, 2011, J BIOL CHEM, V286, P35430, DOI 10.1074/jbc.M111.268284; Manea A, 2010, CELL TISSUE RES, V342, P325, DOI 10.1007/s00441-010-1060-y; Maziere C, 1999, FEBS LETT, V448, P49, DOI 10.1016/S0014-5793(99)00324-5; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Natarajan R, 1996, J CELL PHYSIOL, V169, P391, DOI 10.1002/(SICI)1097-4652(199611)169:2<391::AID-JCP19>3.3.CO;2-Q; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ramachandran A, 2002, FREE RADICAL BIO MED, V33, P1465, DOI 10.1016/S0891-5849(02)01142-5; Reddy MA, 2003, HYPERTENSION, V41, P1294, DOI 10.1161/01.HYP.0000069011.18333.08; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sachsenmaier C, 1999, ONCOGENE, V18, P3583, DOI 10.1038/sj.onc.1202694; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schreiner CE, 2011, CARDIOVASC RES, V90, P140, DOI 10.1093/cvr/cvq355; Schwaiberger AV, 2010, ARTERIOSCL THROM VAS, V30, P2475, DOI 10.1161/ATVBAHA.110.212654; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Smith SME, 2012, CHEM BIOL, V19, P752, DOI 10.1016/j.chembiol.2012.04.015; Smith WL, 2008, N COMP BIOC, P331, DOI 10.1016/B978-044453219-0.50014-3; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	53	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35592	35603		10.1074/jbc.M113.489013	http://dx.doi.org/10.1074/jbc.M113.489013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165129	hybrid, Green Published			2022-12-25	WOS:000329867600053
J	Sibilski, C; Mueller, T; Kollipara, L; Zahedi, RP; Rapp, UR; Rudel, T; Baljuls, A				Sibilski, Claudia; Mueller, Thomas; Kollipara, Laxmikanth; Zahedi, Rene P.; Rapp, Ulf R.; Rudel, Thomas; Baljuls, Angela			Tyr(728) in the Kinase Domain of the Murine Kinase Suppressor of RAS 1 Regulates Binding and Activation of the Mitogen-activated Protein Kinase Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MAP Kinases (MAPKs); Mass Spectrometry (MS); Molecular Modeling; Raf; Signal Transduction; KSR1; Src Family Kinases; Tyrosine Phosphorylation	KSR-1 GENE ENCODES; GROWTH-FACTOR; PHOSPHORYLATION SITES; ONCOGENIC RAS; A-RAF; SCAFFOLD; AUTOPHOSPHORYLATION; IDENTIFICATION; INTERACTS; QUALITY	Background: KSR1 coordinates the assembly of RAF-MEK-ERK complexes and regulates signal transduction. Results: LCK-dependent phosphorylation of KSR1 on Tyr(728) regulates MEK binding and activation. Conclusion: Tyr(728) phosphorylation may coordinate the transition between the scaffolding and catalytic function of KSR1 to fine-tune cellular responses. Significance: Tyrosine phosphorylation of KSR1 is a new regulatory link between Src family kinases and RAF/MEK/ERK signaling. In metazoans, the highly conserved MAPK signaling pathway regulates cell fate decision. Aberrant activation of this pathway has been implicated in multiple human cancers and some developmental disorders. KSR1 functions as an essential scaffold that binds the individual components of the cascade and coordinates their assembly into multiprotein signaling platforms. The mechanism of KSR1 regulation is highly complex and not completely understood. In this study, we identified Tyr(728) as a novel regulatory phosphorylation site in KSR1. We show that Tyr(728) is phosphorylated by LCK, uncovering an additional and unexpected link between Src kinases and MAPK signaling. To understand how phosphorylation of Tyr(728) may regulate the role of KSR1 in signal transduction, we integrated structural modeling and biochemical studies. We demonstrate that Tyr(728) is involved in maintaining the conformation of the KSR1 kinase domain required for binding to MEK. It also affects phosphorylation and activation of MEK by RAF kinases and consequently influences cell proliferation. Moreover, our studies suggest that phosphorylation of Tyr(728) may affect the intrinsic kinase activity of KSR1. Together, we propose that phosphorylation of Tyr(728) may regulate the transition between the scaffolding and the catalytic function of KSR1 serving as a control point used to fine-tune cellular responses.	[Sibilski, Claudia; Rapp, Ulf R.; Rudel, Thomas; Baljuls, Angela] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst Biosci, D-97074 Wurzburg, Germany; [Kollipara, Laxmikanth; Zahedi, Rene P.] ISAS eV, Leibniz Inst Analyt Wissensch, D-44139 Dortmund, Germany; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Div Mol Mech Lung Canc, D-61231 Bad Nauheim, Germany; [Baljuls, Angela] Univ Coll Dublin, Conway Inst, Syst Biol Ireland, Dublin 4, Ireland	University of Wurzburg; University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Max Planck Society; University College Dublin	Rudel, T (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de; angela.baljuls@ucd.ie	Zahedi, Rene/HGU-5710-2022; Zahedi, René/A-9148-2012	Zahedi, René/0000-0002-4960-5460; Laxmikanth, Kollipara/0000-0002-2673-0488; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487]; Project C3; Project B2; University of Wuerzburg Fellowship; Deutsche Forschungsgemeinschaft Fellowship; Science Foundation Ireland [06/CE/B1129]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; NATIONAL INSTITUTE ON AGING [R01AG032180, F32AG020039, R01AG033055] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Project C3; Project B2; University of Wuerzburg Fellowship; Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, under Project C3 (to U. R. R.) and Project B2 (to T. M.), by University of Wuerzburg Fellowship "Chancengleichheit fur Frauen in Forschung und Lehre" (to C. S.), by a Deutsche Forschungsgemeinschaft Fellowship (to A. B.), and by the Science Foundation Ireland under Grant 06/CE/B1129.; Supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; AMREIN KE, 1994, BBA-MOL CELL RES, V1222, P441, DOI 10.1016/0167-4889(94)90052-3; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Beck F, 2011, PROTEOMICS, V11, P1099, DOI 10.1002/pmic.201000562; Bell B, 1999, J BIOL CHEM, V274, P7982, DOI 10.1074/jbc.274.12.7982; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Burkhart JM, 2012, J PROTEOMICS, V75, P1454, DOI 10.1016/j.jprot.2011.11.016; Burkhart JM, 2011, PROTEOMICS, V11, P1049, DOI 10.1002/pmic.201000604; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Channavajhala PL, 2003, J BIOL CHEM, V278, P47089, DOI 10.1074/jbc.M306002200; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Goettel JA, 2011, EXP CELL RES, V317, P452, DOI 10.1016/j.yexcr.2010.11.018; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kilkenny DM, 2003, J BIOL CHEM, V278, P17448, DOI 10.1074/jbc.M209698200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lozano J, 2003, CANCER RES, V63, P4232; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PARK S, 1992, J BIOL CHEM, V267, P17194; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Vaudel M, 2013, PROTEOMICS, V13, P1036, DOI 10.1002/pmic.201200408; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Xia F, 2008, PLOS BIOL, V6, P1115, DOI 10.1371/journal.pbio.0060128; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Yan F, 2001, CANCER RES, V61, P963; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	57	3	3	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35237	35252		10.1074/jbc.M113.490235	http://dx.doi.org/10.1074/jbc.M113.490235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158441	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000329867600023
J	Verma, SK; Deshmukh, V; Liu, P; Nutter, CA; Espejo, R; Hung, ML; Wang, GS; Yeo, GW; Kuyumcu-Martinez, MN				Verma, Sunil K.; Deshmukh, Vaibhav; Liu, Patrick; Nutter, Curtis A.; Espejo, Rosario; Hung, Ming-Lung; Wang, Guey-Shin; Yeo, Gene W.; Kuyumcu-Martinez, Muge N.			Reactivation of Fetal Splicing Programs in Diabetic Hearts Is Mediated by Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Diabetes; Heart Development; Protein Kinase C (PKC); RNA-binding Protein; Signal Transduction	CORONARY-ARTERY-DISEASE; PLASMA-MEMBRANE CA2+; GENE-EXPRESSION; MESSENGER-RNA; SARCOPLASMIC-RETICULUM; MYOTONIC-DYSTROPHY; CARDIAC MYOCYTES; GROWTH-FACTOR; PKC-BETA; CARDIOMYOPATHY	Diabetic cardiomyopathy is one of the complications of diabetes that eventually leads to heart failure and death. Aberrant activation of PKC signaling contributes to diabetic cardiomyopathy by mechanisms that are poorly understood. Previous reports indicate that PKC is implicated in alternative splicing regulation. Therefore, we wanted to test whether PKC activation in diabetic hearts induces alternative splicing abnormalities. Here, using RNA sequencing we identified a set of 22 alternative splicing events that undergo a developmental switch in splicing, and we confirmed that splicing reverts to an embryonic pattern in adult diabetic hearts. This network of genes has important functions in RNA metabolism and in developmental processes such as differentiation. Importantly, PKC isozymes / control alternative splicing of these genes via phosphorylation and up-regulation of the RNA-binding proteins CELF1 and Rbfox2. Using a mutant of CELF1, we show that phosphorylation of CELF1 by PKC is necessary for regulation of splicing events altered in diabetes. In summary, our studies indicate that activation of PKC/ in diabetic hearts contributes to the genome-wide splicing changes through phosphorylation and up-regulation of CELF1/Rbfox2 proteins. These findings provide a basis for PKC-mediated cardiac pathogenesis under diabetic conditions.	[Verma, Sunil K.; Deshmukh, Vaibhav; Nutter, Curtis A.; Espejo, Rosario; Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Liu, Patrick; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92037 USA; [Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92037 USA; [Hung, Ming-Lung; Wang, Guey-Shin] Acad Sinica, Inst Biomed Sci, Taipei 11528, Taiwan	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Academia Sinica - Taiwan	Kuyumcu-Martinez, MN (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	nmmartin@utmb.edu	Verma, Sunil Kumar/J-8838-2019; Yeo, Gene/AAE-7676-2019; Wang, Guey-Shin/Q-3968-2018	Verma, Sunil Kumar/0000-0001-9443-2493; Yeo, Gene/0000-0002-0799-6037; Wang, Guey-Shin/0000-0003-4485-1811	National Institutes of Health [HG004659, 3NS075449]; American Heart Association [SDG-093022N]; March of Dimes Basil O'Connor Starter Scholar Award [5 FY12-21]; University of Texas Medical Branch; National Science Council, Taiwan; Institute of Biomedical Sciences, Academia Sinica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107294] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449, P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); University of Texas Medical Branch; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HG004659 and NS075449 (to G. W. Y.). This work was also supported by American Heart Association Grant SDG-093022N, March of Dimes Basil O'Connor Starter Scholar Award 5 FY12-21, and University of Texas Medical Branch start up funds (to M. N. K.-M.). This work was also supported in part by National Science Council, Taiwan, and Institute of Biomedical Sciences, Academia Sinica (to G.-S. W.). We thank Dr. David Konkel for critically editing the manuscript, Drs. Thai Ho and Rajalaxmi Natarajan for critically reading the manuscript, Dr. Thomas Wood for technical help in RNA-sequencing, and Dr. Adriana Paulucci for help in confocal microscopy. We also thank Dr. Nisha Garg for kindly providing control human heart tissues.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Alzugaray ME, 2009, ARCH BIOCHEM BIOPHYS, V490, P17, DOI 10.1016/j.abb.2009.07.022; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Arrington CB, 2012, EUR J MED GENET, V55, P235, DOI 10.1016/j.ejmg.2012.02.002; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Connelly KA, 2009, CIRC-HEART FAIL, V2, P129, DOI 10.1161/CIRCHEARTFAILURE.108.765750; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Depre C, 2000, J MOL CELL CARDIOL, V32, P985, DOI 10.1006/jmcc.2000.1139; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; DISATNIK MH, 1995, J MOL CELL CARDIOL, V27, P2473, DOI 10.1006/jmcc.1995.0235; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Harcourt BE, 2013, NAT REV ENDOCRINOL, V9, P113, DOI 10.1038/nrendo.2012.236; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kobayashi Y, 2012, HYPERTENSION, V59, P854, DOI 10.1161/HYPERTENSIONAHA.110.165068; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin WH, 2001, HUM MOL GENET, V10, P1753, DOI 10.1093/hmg/10.17.1753; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Liu YN, 2012, CLIN SCI, V122, P161, DOI 10.1042/CS20110176; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore SF, 2013, J BIOL CHEM, V288, P3918, DOI 10.1074/jbc.M112.429936; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Oppelt A, 2013, EMBO REP, V14, P57, DOI 10.1038/embor.2012.183; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Revil T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-399; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Salsali Afshin, 2006, Am J Ther, V13, P349, DOI 10.1097/00045391-200607000-00012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Van Belle T L, 2009, Drug Discov Today Dis Models, V6, P41; van't Padje S, 2009, J EXP BIOL, V212, P2564, DOI 10.1242/jeb.032532; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Xia XB, 2008, MOL VIS, V14, P1965; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; YTREHUS K, 1994, AM J PHYSIOL, V266, pH1145, DOI 10.1152/ajpheart.1994.266.3.H1145; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zhao YM, 2012, BIOCHEM BIOPH RES CO, V423, P212, DOI 10.1016/j.bbrc.2012.05.033; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	88	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35372	35386		10.1074/jbc.M113.507426	http://dx.doi.org/10.1074/jbc.M113.507426			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151077	hybrid, Green Published			2022-12-25	WOS:000329867600034
J	Mao, WG; He, HQ; Xu, Y; Chen, PY; Zhou, JY				Mao, Wei-Gao; He, Hai-Qiang; Xu, Yan; Chen, Ping-Yan; Zhou, Ji-Yuan			Powerful Haplotype-Based Hardy-Weinberg Equilibrium Tests for Tightly Linked Loci	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; DISEASE ASSOCIATIONS; FREQUENCY ESTIMATION; INFERENCE; ALGORITHM; TRAITS	Recently, there have been many case-control studies proposed to test for association between haplotypes and disease, which require the Hardy-Weinberg equilibrium (HWE) assumption of haplotype frequencies. As such, haplotype inference of unphased genotypes and development of haplotype-based HWE tests are crucial prior to fine mapping. The goodness-of-fit test is a frequently-used method to test for HWE for multiple tightly-linked loci. However, its degrees of freedom dramatically increase with the increase of the number of loci, which may lack the test power. Therefore, in this paper, to improve the test power for haplotype-based HWE, we first write out two likelihood functions of the observed data based on the Niu's model (NM) and inbreeding model (IM), respectively, which can cause the departure from HWE. Then, we use two expectation-maximization algorithms and one expectation-conditional-maximization algorithm to estimate the model parameters under the HWE, IM and NM models, respectively. Finally, we propose the likelihood ratio tests LRT1 and LRT2 for haplotype-based HWE under the NM and IM models, respectively. We simulate the HWE, Niu's, inbreeding and population stratification models to assess the validity and compare the performance of these two LRT tests. The simulation results show that both of the tests control the type I error rates well in testing for haplotype-based HWE. If the NM model is true, then LRT1 is more powerful. While, if the true model is the IM model, then LRT2 has better performance in power. Under the population stratification model, LRT2 is still more powerful. To this end, LRT2 is generally recommended. Application of the proposed methods to a rheumatoid arthritis data set further illustrates their utility for real data analysis.	[Mao, Wei-Gao; He, Hai-Qiang; Xu, Yan; Chen, Ping-Yan; Zhou, Ji-Yuan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China.	zhoujiyuan@gmail.com	Zhou, Ji-Yuan/AAI-4623-2020	Zhou, Ji-Yuan/0000-0003-0866-4402	National Natural Science Foundation of China [81072386]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201219, GW201237]; National Institutes of Health [R01 GM031575, NO1-AR-2-2263, RO1-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Public Health and Tropical Medicine of Southern Medical University, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (81072386) and grants from School of Public Health and Tropical Medicine of Southern Medical University, China (grant numbers: GW201219 and GW201237). The Genetic Analysis Workshops are supported by the National Institutes of Health grant R01 GM031575. The RA data were gathered with the support of grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos Christopher I, 2007, BMC Proc, V1 Suppl 1, pS3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fan SJ, 1989, NATURAL SCI J HAINAN, V2, P91; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang BE, 2007, GENET EPIDEMIOL, V31, P803, DOI 10.1002/gepi.20242; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Kuk AYC, 2009, BIOINFORMATICS, V25, P379, DOI 10.1093/bioinformatics/btn623; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; Min JY, 2010, J RHEUMATOL, V37, P291, DOI 10.3899/jrheum.090526; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeng D, 2005, GENET EPIDEMIOL, V28, P70, DOI 10.1002/gepi.20040; Zhang K, 2006, GENET EPIDEMIOL, V30, P423, DOI 10.1002/gepi.20154; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140; Zheng G, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4614-2245-7	26	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77399	10.1371/journal.pone.0077399	http://dx.doi.org/10.1371/journal.pone.0077399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167573	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500032
J	Kumar, A; Rajendran, V; Sethumadhavan, R; Purohit, R				Kumar, Ambuj; Rajendran, Vidya; Sethumadhavan, Rao; Purohit, Rituraj			Molecular Dynamic Simulation Reveals Damaging Impact of RAC1 F28L Mutation in the Switch I Region	PLOS ONE			English	Article							PROTEIN; ALGORITHMS; COMPLEX; CANCER	Ras-related C3 botulinum toxin substrate 1 (RAC1) is a plasma membrane-associated small GTPase which cycles between the active GTP-bound and inactive GDP-bound states. There is wide range of evidences indicating its active participation in inducing cancer-associated phenotypes. RAC1 F28L mutation (RACF28L) is a fast recycling mutation which has been implicated in several cancer associated cases. In this work we have performed molecular docking and molecular dynamics simulation (similar to 0.3 mu s) to investigate the conformational changes occurring in the mutant protein. The RMSD, RMSF and NHbonds results strongly suggested that the loss of native conformation in the Switch I region in RAC1 mutant protein could be the reason behind its oncogenic transformation. The overall results suggested that the mutant protein attained compact conformation as compared to the native. The major impact of mutation was observed in the Switch I region which might be the crucial reason behind the loss of interaction between the guanine ring and F28 residue.	[Kumar, Ambuj; Rajendran, Vidya; Sethumadhavan, Rao; Purohit, Rituraj] Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India; [Purohit, Rituraj] Human Genet Fdn, Turin, Italy	Vellore Institute of Technology	Purohit, R (corresponding author), Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India.	riturajpurohit@gmail.com	Purohit, Rituraj/I-8856-2012; Kumar, Ambuj/U-5268-2019; Kumar, Ambuj/E-4649-2012; Purohit, Rituraj/AAF-6257-2021	Purohit, Rituraj/0000-0002-2101-9398; Kumar, Ambuj/0000-0003-3692-3694; Purohit, Rituraj/0000-0002-2101-9398				Akunuru S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016951; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canduri F, 2008, MED CHEM, V4, P210, DOI 10.2174/157340608784325205; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Davis MJ, 2013, P NATL ACAD SCI USA, V110, P912, DOI 10.1073/pnas.1220895110; de Azevedo WF, 2011, CURR MED CHEM, V18, P1353; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P261, DOI 10.2174/138945010790711969; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1031, DOI 10.2174/138945008786949405; de Azevedo WF, 2001, BIOCHEM BIOPH RES CO, V287, P277, DOI 10.1006/bbrc.2001.5555; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Heberle G, 2011, CURR MED CHEM, V18, P1339, DOI 10.2174/092986711795029573; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KAMARAJ B, 2013, CELL BIOCH BIOPHYS, DOI DOI 10.1007/S12013-013-9697-2.PUBMED:23824587; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; KUMAR A, 2013, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2013.770373.PUBMED:23527964; Kumar A, 2014, CELL BIOCHEM BIOPHYS, V68, P233, DOI 10.1007/s12013-013-9705-6; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Perez PC, 2009, COMPUT BIOL MED, V39, P130, DOI 10.1016/j.compbiomed.2008.11.004; Purohit R, 2014, J BIOMOL STRUCT DYN, V32, P1033, DOI 10.1080/07391102.2013.803264; RAJENDRAN V, 2012, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2012.759885.PUBMED:23383724; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550	32	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77453	10.1371/journal.pone.0077453	http://dx.doi.org/10.1371/journal.pone.0077453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146998	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400109
J	Hebisch, E; Knebel, J; Landsberg, J; Frey, E; Leisner, M				Hebisch, Elke; Knebel, Johannes; Landsberg, Janek; Frey, Erwin; Leisner, Madeleine			High Variation of Fluorescence Protein Maturation Times in Closely Related Escherichia coli Strains	PLOS ONE			English	Article							CELL GENE-EXPRESSION; UNSTABLE VARIANTS; COMPETITION; DYNAMICS; PROMOTES; BIODIVERSITY; COOPERATION; ALLELOPATHY; BACTERIA; GROWTH	Fluorescent proteins (FPs) are widely used in biochemistry, biology and biophysics. For quantitative analysis of gene expression FPs are often used as marking molecules. Therefore, sufficient knowledge of maturation times and their affecting factors is of high interest. Here, we investigate the maturation process of the FPs GFP and mCherry expressed by the three closely related Escherichia coli strains of the Colicin E2 system, a model system for colicinogenic interaction. One strain, the C strain produces Colicin, a toxin to which the S strain is sensitive, and against which the R strain is resistant. Under the growth conditions used in this study, the S and R strain have similar growth rates, as opposed to the C strain whose growth rate is significantly reduced due to the toxin production. In combination with theoretical modelling we studied the maturation kinetics of the two FPs in these strains and could confirm an exponential and sigmoidal maturation kinetic for GFP and mCherry, respectively. Our subsequent quantitative experimental analysis revealed a high variance in maturation times independent of the strain studied. In addition, we determined strain dependent maturation times and maturation behaviour. Firstly, FPs expressed by the S and R strain mature on similar average time-scales as opposed to FPs expressed by the C strain. Secondly, dependencies of maturation time with growth conditions are most pronounced in the GFP expressing C strain: Doubling the growth rate of this C strain results in an increased maturation time by a factor of 1.4. As maturation times can vary even between closely related strains, our data emphasize the importance of profound knowledge of individual strains' maturation times for accurate interpretation of gene expression data.	[Hebisch, Elke] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Knebel, Johannes; Frey, Erwin; Leisner, Madeleine] Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Knebel, Johannes; Frey, Erwin; Leisner, Madeleine] Univ Munich, Dept Phys, Ctr NanoSci, Munich, Germany; [Landsberg, Janek] Univ Joseph Fourier Grenoble, Lab Interdisciplinaire Phys, St Martin Dheres, France	Max Planck Society; University of Munich; University of Munich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Leisner, M (corresponding author), Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany.	Madeleine.Leisner@physik.uni-muenchen.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358; Hebisch, Elke/0000-0002-6509-2191	DFG [RA655/5-1, LE2484/4-1]; Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	DFG(German Research Foundation (DFG)); Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	This work was supported by DFG grants RA655/5-1 and LE2484/4-1, the Nano Initiative Munich (NIM) and the Center for Nanoscience (CeNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Be'er A, 2010, P NATL ACAD SCI USA, V107, P6258, DOI 10.1073/pnas.1001062107; Bubendorfer S, 2012, MOL MICROBIOL, V83, P335, DOI 10.1111/j.1365-2958.2011.07934.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; Franke GC, 2007, J MICROBIOL METH, V71, P123, DOI 10.1016/j.mimet.2007.08.015; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; INOUYE S, 1994, FEBS LETT, V351, P211, DOI 10.1016/0014-5793(94)00859-0; Iwasa Y, 1998, EVOL ECOL, V12, P785, DOI 10.1023/A:1006590431483; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kuhr JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113013; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Lullmann H, 2006, PHARMAKOLOGIE TOXIKO, P495; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; Munch A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-229; Nakamaru M, 2000, THEOR POPUL BIOL, V57, P131, DOI 10.1006/tpbi.1999.1448; Prakash B, 2003, CURR SCI INDIA, V85, P1299; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaechter M, 2006, INT MICROBIOL, V9, P157; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tweeddale H, 1998, J BACTERIOL, V180, P5109, DOI 10.1128/JB.180.19.5109-5116.1998; van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	47	56	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75991	10.1371/journal.pone.0075991	http://dx.doi.org/10.1371/journal.pone.0075991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155882	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300016
J	Jiang, BJ; Yue, YL; Gao, YF; Ma, LM; Sun, S; Wu, CX; Hou, WS; Lam, HM; Han, TF				Jiang, Bingjun; Yue, Yanlei; Gao, Youfei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Lam, Hon-Ming; Han, Tianfu			GmFT2a Polymorphism and Maturity Diversity in Soybeans	PLOS ONE			English	Article							FLOWERING TIME; GENE; CLONING; E1	Background: Soybean is a short-day crop of agricultural, ecological, and economic importance. The sensitive photoperiod responses significantly limit its breeding and adaptation. GmFT2a, a putative florigen gene with different transcription profiles in two cultivars (late-maturing Zigongdongdou and early-maturing Heihe 27) with different maturity profiles, is key to flowering and maturation. However, up to now, its role in the diverse patterns of maturation in soybeans has been poorly understood. Methods: Eighty varieties, including 19 wild accessions, covering 11 of all 13 maturity groups, were collected. They were planted in pots and maintained under different photoperiodicity conditions (SD, short day; LD, long day; and ND, natural day). The day to first flowering was recorded and the sensitivity to photoperiod was investigated. Polymorphisms in the GmFT2a coding sequence were explored by searching the known SNP database (NCBI dbSNP). The GmFT2a promoter regions were then cloned from these varieties and sequenced. Further polymorphism and association analyses were conducted. Results: These varieties varied greatly in time to first flowering under ND and exhibited a consecutive distribution of photoperiod sensitivity, which suggested that there is rich diversity in flowering time. Furthermore, although GmFT2a had only one known synonymous SNP in the coding sequence, there were 17 haplotypes of the GmFT2a promoter region, HT06 of which was extremely abundant. Further association analysis found some SNPs that might be associated with day to first flowering and photoperiod sensitivity. Conclusion: Although GmFT2a is a key flowering gene, GmFT2a polymorphism does not appear to be responsible for maturity diversity in soybean.	[Jiang, Bingjun; Yue, Yanlei; Gao, Youfei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing 100193, Peoples R China; [Yue, Yanlei] Heilongjiang Acad Agr Sci, Mudanjiang Branch, Mudanjiang, Heilongjiang, Peoples R China; [Lam, Hon-Ming] Chinese Univ Hong Kong, Ctr Soybean Res, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Heilongjiang Academy of Agricultural Sciences; Chinese University of Hong Kong; Chinese University of Hong Kong	Han, TF (corresponding author), Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing 100193, Peoples R China.	tianfuhan@hotmail.com	Lam, Hon-Ming/A-9866-2008; Jiang, Bingjun/GWQ-4354-2022	Lam, Hon-Ming/0000-0002-6673-8740; 	China Agriculture Research System [CARS-04]; Natural Science Foundation of China [31201232]; Hong Kong RGC General Research Fund [468610]	China Agriculture Research System; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong RGC General Research Fund	This project was supported by the China Agriculture Research System (CARS-04) and the Natural Science Foundation of China (31201232, http://www.nsfc.gov.cn) and the Hong Kong RGC General Research Fund (468610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; BERNARD RL, 1972, CROP SCI, V12, P716, DOI 10.2135/cropsci1972.0011183X001200050067x; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Fei ZhiHong, 2009, Acta Agronomica Sinica, V35, P1525, DOI 10.3724/SP.J.1006.2009.01525; Hao G., 1992, Acta Agronomica Sinica, V18, P275; HARTWIG EE, 1970, TROP SCI, V12, P47; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Kong F, 2010, PLANT PHYSIOL; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Wang G. X., 1981, Scientia Agricultura Sinica, P39; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	35	17	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77474	10.1371/journal.pone.0077474	http://dx.doi.org/10.1371/journal.pone.0077474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155962	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300096
J	Kroeger, DR; Rudulier, CD; Bretscher, PA				Kroeger, David R.; Rudulier, Christopher D.; Bretscher, Peter A.			Antigen Presenting B Cells Facilitate CD4 T Cell Cooperation Resulting in Enhanced Generation of Effector and Memory CD4 T Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; LINKED RECOGNITION; OX40 LIGAND; LYMPHOCYTES; HELPER; DETERMINANTS; INDUCTION	We show that the in vivo generation of cytokine-producing CD4 T cells specific for a given major histocompatibility class-II (MHCII)-binding peptide of hen egg lysozyme (HEL) is facilitated when mice are immunized with splenic antigen presenting cells (APC) pulsed with this HEL peptide and another peptide that binds a different MHCII molecule. This enhanced generation of peptide-specific effector CD4 T cells requires that the same splenic APC be pulsed with both peptides. Pulsed B cells, but not pulsed dendritic cells (DCs), can mediate CD4 T cell cooperation, which can be blocked by disrupting OX40-OX40L (CD134-CD252) interactions. In addition, the generation of HEL peptide-specific CD4 T cell memory is greater when mice are primed with B cells pulsed with the two peptides than with B cells pulsed with the HEL-peptide alone. Based on our findings, we suggest CD4 T cell cooperation is important for vaccine design, underlies the phenomenon of "epitope-spreading" seen in autoimmunity, and that the efficacy of B cell-depletion in the treatment of human cell-mediated autoimmune disease is due to the abrogation of the interactions between autoimmune CD4 T cells that facilitates their activation.	[Kroeger, David R.; Rudulier, Christopher D.; Bretscher, Peter A.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Bretscher, PA (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	peter.bretscher@usask.ca			Natural Sciences and Engineering Research Council of Canada [327335-2008]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada operating grant to PAB (327335-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Akiba H, 1999, J IMMUNOL, V162, P7058; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BOCKENSTEDT LK, 1995, J IMMUNOL, V154, P3516; BRETSCHER PA, 1983, CELL IMMUNOL, V81, P345, DOI 10.1016/0008-8749(83)90242-3; BRETSCHER PA, 1983, J IMMUNOL, V131, P1103; BRETSCHER PA, 1986, J IMMUNOL, V137, P3726; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Creusot RJ, 2003, J IMMUNOL, V171, P240, DOI 10.4049/jimmunol.171.1.240; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; Evans DE, 2000, J IMMUNOL, V164, P688, DOI 10.4049/jimmunol.164.2.688; Gerloni M, 2000, P NATL ACAD SCI USA, V97, P13269, DOI 10.1073/pnas.230429197; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ismail N, 2005, IMMUNOLOGY, V115, P34, DOI 10.1111/j.1365-2567.2005.02128.x; Ismail N, 2001, EUR J IMMUNOL, V31, P1765, DOI 10.1002/1521-4141(200106)31:6<1765::AID-IMMU1765>3.0.CO;2-T; Jaiswal AI, 1997, J IMMUNOL, V159, P2282; JANSSON L, 1995, EUR J IMMUNOL, V25, P2195, DOI 10.1002/eji.1830250812; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kleindienst P, 2005, IMMUNOLOGY, V115, P556, DOI 10.1111/j.1365-2567.2005.02196.x; Kroeger DR, 2012, INT IMMUNOL; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Masten BJ, 1999, J IMMUNOL, V162, P1310; METLAY JP, 1989, J EXP MED, V169, P239, DOI 10.1084/jem.169.1.239; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; Peters NC, 2009, INT IMMUNOL, V21, P1213, DOI 10.1093/intimm/dxp085; Peters NC, 2005, EUR J IMMUNOL, V35, P56, DOI 10.1002/eji.200425581; Power CA, 1999, J IMMUNOL METHODS, V227, P99, DOI 10.1016/S0022-1759(99)00074-5; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Tsukada N, 2000, BLOOD, V95, P2434, DOI 10.1182/blood.V95.7.2434.007k11_2434_2439; TUCKER MJ, 1982, J EXP MED, V155, P1037, DOI 10.1084/jem.155.4.1037; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777	40	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77346	10.1371/journal.pone.0077346	http://dx.doi.org/10.1371/journal.pone.0077346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155947	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300081
J	Yi, X; Zhao, HM; Dong, XL; Wang, PD; Hu, MY; Zhong, GH				Yi, Xin; Zhao, Haiming; Dong, Xiaolin; Wang, Peidan; Hu, Meiying; Zhong, Guohua			BdorCSP2 Is Important for Antifeed and Oviposition-Deterring Activities Induced by Rhodojaponin-III against Bactrocera dorsalis	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA ORTHOPTERA; ODORANT-BINDING-PROTEIN; CHEMOSENSORY PROTEINS; EXPRESSION PATTERN; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; FRUIT-FLY; MOTH; IDENTIFICATION; LEPIDOPTERA	Rhodojaponin-III is a nonvolatile botanical grayanoid diterpene compound, which has antifeedant and oviposition deterrence effects against many kinds of insects. However, the molecular mechanism of the chemoreception process remains unknown. In this study, the important role of BdorCSP2 in the recognition of Rhodojaponin-III was identified. The full length cDNA encoding BdorCSP2 was cloned from legs of Bactrocera dorsalis. The results of expression pattern revealed that BdorCSP2 was abundantly expressed in the legs of adult B. dorsalis. Moreover, the expression of BdorCSP2 could be up-regulated by Rhodojaponin-III. In order to gain comprehensive understanding of the recognition process, the binding affinity between BdorCSP2 and Rhodojaponin-III was measured by fluorescence binding assay. Silencing the expression of BdorCSP2 through the ingestion of dsRNA could weaken the effect of oviposition deterrence and antifeedant of Rhodojaponin-III. These results suggested that BdorCSP2 of B. dorsalis could be involved in chemoreception of Rhodojaponin-III and played a critical role in antifeedant and oviposition behaviors induced by Rhodojaponin-III.	[Yi, Xin; Zhao, Haiming; Dong, Xiaolin; Wang, Peidan; Hu, Meiying; Zhong, Guohua] South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.com; guohuazhong@scau.edu.cn			National Nature Science Foundation, People's Republic of China [31071713]	National Nature Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation, People's Republic of China under grant number 31071713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; Anbutsu H, 2002, J INSECT PHYSIOL, V48, P459, DOI 10.1016/S0022-1910(02)00067-7; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Danty E, 1998, INSECT BIOCHEM MOLEC, V28, P387, DOI 10.1016/S0965-1748(98)00011-3; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Ferguson AW, 1999, J INSECT PHYSIOL, V45, P687, DOI 10.1016/S0022-1910(99)00046-3; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; KLOCKE JA, 1991, PHYTOCHEMISTRY, V30, P1797, DOI 10.1016/0031-9422(91)85015-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Li KM, 2012, J CHEM ECOL, V38, P287, DOI 10.1007/s10886-012-0085-y; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Martini X, 2013, B ENTOMOL RES, V103, P14, DOI 10.1017/S000748531200034X; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MITCHELL ER, 1985, J CHEM ECOL, V11, P609, DOI 10.1007/BF00988571; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; ROTHSCHILD M, 1988, PHYTOCHEMISTRY, V27, P101, DOI 10.1016/0031-9422(88)80598-3; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; STADLER E, 1995, PHYSIOL ENTOMOL, V20, P175, DOI 10.1111/j.1365-3032.1995.tb00814.x; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; VOLLER A, 1980, ENZYME LINKED IMMUNO, P402; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhang TT, 2012, J INTEGR AGR, V11, P430, DOI 10.1016/S2095-3119(12)60028-8; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhong GH, 2006, PEST MANAG SCI, V62, P976, DOI 10.1002/ps.1267; Zhong GuoHua, 2000, Journal of South China Agricultural University, V21, P40; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Zhou SH, 2009, J MORPHOL, V270, P1356, DOI 10.1002/jmor.10763	53	19	20	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77295	10.1371/journal.pone.0077295	http://dx.doi.org/10.1371/journal.pone.0077295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155937	Green Submitted, gold, Green Published			2022-12-25	WOS:000325887300071
J	Yu, HC; Lu, MC; Li, C; Huang, HL; Huang, KY; Liu, SQ; Lai, NS; Huang, HB				Yu, Hui-Chun; Lu, Ming-Chi; Li, Chin; Huang, Hsien-Lu; Huang, Kuang-Yung; Liu, Su-Qin; Lai, Ning-Sheng; Huang, Hsien-Bin			Targeted Delivery of an Antigenic Peptide to the Endoplasmic Reticulum: Application for Development of a Peptide Therapy for Ankylosing Spondylitis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CLASS-I MOLECULES; TRANSGENIC RATS; HLA-B27; SPONDYLOARTHRITIS; SPONDYLARTHRITIS; PATHOGENESIS; DISEASE; CELLS; INTERLEUKIN-23	The development of suitable methods to deliver peptides specifically to the endoplasmic reticulum (ER) can provide some potential therapeutic applications of such peptides. Ankylosing spondylitis (AS) is strongly associated with the expression of human leukocytic antigen-B27 (HLA-B27). HLA-B27 heavy chain (HC) has a propensity to fold slowly resulting in the accumulation of misfolded HLA-B27 HC in the ER, triggering the unfolded protein response, and forming a homodimer, (B27-HC)(2). Natural killer cells and T-helper 17 cells are then activated, contributing to the major pathogenic potentials of AS. The HLA-B27 HC is thus an important target, and delivery of an HLA-B27-binding peptide to the ER capable of promoting HLA-B27 HC folding is a potential mechanism for AS therapy. Here, we demonstrate that a His(6)-ubiquitin-tagged Tat-derived peptide (THU) can deliver an HLA-B27-binding peptide to the ER promoting HLA-B27 HC folding. The THU-HLA-B27-binding peptide fusion protein crossed the cell membrane to the cytosol through the Tat-derived peptide. The HLA-B27-binding peptide was specifically cleaved from THU by cytosolic ubiquitin C-terminal hydrolases and subsequently transported into the ER by the transporter associated with antigen processing. This approach has potential application in the development of peptide therapy for AS.	[Yu, Hui-Chun; Li, Chin; Huang, Hsien-Bin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Yu, Hui-Chun; Li, Chin; Huang, Hsien-Bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan; [Yu, Hui-Chun; Lu, Ming-Chi; Huang, Kuang-Yung; Liu, Su-Qin; Lai, Ning-Sheng] Buddhist DaLin Tzu Chi Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Hsien-Lu] Fooyin Univ, Dept Nutr & Hlth Sci, Kaohsiung, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Fooyin University	Lai, NS (corresponding author), Buddhist DaLin Tzu Chi Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan.	Q12015@tzuchi.com.tw; biohbh@ccu.edu.tw			DaLin Tzu Chi Buddhist Hospital [DTCRD SR98-2-3]	DaLin Tzu Chi Buddhist Hospital	This work was supported by grants from the DaLin Tzu Chi Buddhist Hospital [DTCRD SR98-2-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 1999, J IMMUNOL, V162, P5045; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; BREWERTON DA, 1973, LANCET, V1, P904; Brook H, 2006, ADV DRUG DELIV REV, V57, P559; CAFFREY MFP, 1973, NATURE, V242, P121, DOI 10.1038/242121a0; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Garcia F, 1997, TISSUE ANTIGENS, V49, P23, DOI 10.1111/j.1399-0039.1997.tb02705.x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Lu MC, 2008, CLIN IMMUNOL, V129, P462, DOI 10.1016/j.clim.2008.08.001; Mear JP, 1999, J IMMUNOL, V163, P6665; Melis L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2722; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; RUBEN S, 1989, J VIROL, V63, P1; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40; Smith JA, 2006, BEST PRACT RES CL RH, V20, P571, DOI 10.1016/j.berh.2006.03.001; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Turner MJ, 2005, J IMMUNOL, V175, P2438, DOI 10.4049/jimmunol.175.4.2438; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77451	10.1371/journal.pone.0077451	http://dx.doi.org/10.1371/journal.pone.0077451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155957	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300091
J	Huneke, NTM; Brown, CA; Burford, E; Watson, A; Trujillo-Barreto, NJ; El-Deredy, W; Jones, AKP				Huneke, Nathan T. M.; Brown, Christopher A.; Burford, Edward; Watson, Alison; Trujillo-Barreto, Nelson J.; El-Deredy, Wael; Jones, Anthony K. P.			Experimental Placebo Analgesia Changes Resting-State Alpha Oscillations	PLOS ONE			English	Article							WIDESPREAD MUSCULOSKELETAL PAIN; INTERNALLY DIRECTED ATTENTION; ANTERIOR CINGULATE CORTEX; LOW-BACK-PAIN; EEG-ALPHA; PREFRONTAL CORTEX; TONIC PAIN; ANTICIPATION; SYNCHRONIZATION; FIBROMYALGIA	The lack of clear understanding of the pathophysiology of chronic pain could explain why we currently have only a few effective treatments. Understanding how pain relief is realised during placebo analgesia could help develop improved treatments for chronic pain. Here, we tested whether experimental placebo analgesia was associated with altered resting-state cortical activity in the alpha frequency band of the electroencephalogram (EEG). Alpha oscillations have been shown to be influenced by top-down processes, which are thought to underpin the placebo response. Seventy-three healthy volunteers, split into placebo or control groups, took part in a well-established experimental placebo procedure involving treatment with a sham analgesic cream. We recorded ongoing (resting) EEG activity before, during, and after the sham treatment. We show that resting alpha activity is modified by placebo analgesia. Post-treatment, alpha activity increased significantly in the placebo group only (p < 0.001). Source analysis suggested that this alpha activity might have been generated in medial components of the pain network, including dorsal anterior cingulate cortex, medial prefrontal cortex, and left insula. These changes are consistent with a cognitive state of pain expectancy, a key driver of the placebo analgesic response. The manipulation of alpha activity may therefore present an exciting avenue for the development of treatments that directly alter endogenous processes to better control pain.	[Huneke, Nathan T. M.; Burford, Edward] Univ Manchester, Sch Med, Manchester, Lancs, England; [Brown, Christopher A.; Watson, Alison; Jones, Anthony K. P.] Univ Manchester, Inst Brain Behav & Mental Hlth, Human Pain Res Grp, Manchester, Lancs, England; [Trujillo-Barreto, Nelson J.] Cuban Neurosci Ctr, Havana, Cuba; [El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Brown, CA (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Human Pain Res Grp, Manchester, Lancs, England.	christopher.brown@manchester.ac.uk	Huneke, Nathan/ABD-9006-2020; El-deredy, Wael/H-6521-2015; Trujillo-Barreto, Nelson J/G-3764-2013	Huneke, Nathan/0000-0001-5981-6707; El-deredy, Wael/0000-0002-9822-1092; Trujillo-Barreto, Nelson J/0000-0001-6581-7503; Jones, Anthony/0000-0001-6944-9365	Dr Hadwen Trust for Humane Research; Arthritis Research UK	Dr Hadwen Trust for Humane Research; Arthritis Research UK(Versus Arthritis)	Funding came from the Dr Hadwen Trust for Humane Research (http://www.drhadwentrust.org/) and Arthritis Research UK (http://www.arthritisresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni C, 2006, J PAIN, V7, P709, DOI 10.1016/j.jpain.2006.03.005; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CA, 2008, PAIN, V139, P324, DOI 10.1016/j.pain.2008.04.028; Carlino E, 2011, CURR OPIN ANESTHESIO, V24, P540, DOI 10.1097/ACO.0b013e328349d0c2; CHEN ACN, 1983, INT J NEUROSCI, V18, P269, DOI 10.3109/00207458308987371; Chen Andrew C. N., 1994, Brain Topography, V7, P129, DOI 10.1007/BF01186771; Clauw DJ, 2010, NAT REV RHEUMATOL, V6, P439, DOI 10.1038/nrrheum.2010.120; *COLL ROY GEN PRAC, 1995, MORB STAT GEN PRACT, P1991; Cooper NR, 2006, NEUROREPORT, V17, P205, DOI 10.1097/01.wnr.0000198433.29389.54; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fell J, 2002, INT J NEUROSCI, V112, P1047, DOI 10.1080/00207450290026049; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Franciotti R, 2009, NEUROIMAGE, V46, P1082, DOI 10.1016/j.neuroimage.2009.03.034; FRYMOYER JW, 1984, J BONE JOINT SURG AM, V66A, P1048, DOI 10.2106/00004623-198466070-00011; Goldenberg DL, 2007, BEST PRACT RES CL RH, V21, P499, DOI 10.1016/j.berh.2007.02.012; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; HARDT JV, 1978, SCIENCE, V201, P79, DOI 10.1126/science.663641; Hsieh JC, 1999, NEUROSCI LETT, V262, P61, DOI 10.1016/S0304-3940(99)00060-9; Jensen KB, 2012, PAIN, V153, P1495, DOI 10.1016/j.pain.2012.04.010; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jones AKP, 2003, BRIT MED BULL, V65, P83, DOI 10.1093/bmb/65.1.83; JONES AKP, 1991, P ROY SOC B-BIOL SCI, V244, P39, DOI 10.1098/rspb.1991.0048; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knudsen L, 2011, SCAND J PAIN, V2, P108, DOI 10.1016/j.sjpain.2011.05.005; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; Meissner K, 2011, J NEUROSCI, V31, P16117, DOI 10.1523/JNEUROSCI.4099-11.2011; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Natvig B, 2001, J REHABIL MED, V33, P21; Nemoto H, 2007, EXP BRAIN RES, V179, P655, DOI 10.1007/s00221-006-0821-z; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phillips C, 2008, HEALTH POLICY, V88, P166, DOI 10.1016/j.healthpol.2008.03.008; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Watson A, 2007, NEUROREPORT, V18, P771, DOI 10.1097/WNR.0b013e3280c1e2a8; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003	64	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78278	10.1371/journal.pone.0078278	http://dx.doi.org/10.1371/journal.pone.0078278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147129	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400151
J	Mbonye, M; Seeley, J; Ssembajja, F; Birungi, J; Jaffar, S				Mbonye, Martin; Seeley, Janet; Ssembajja, Fatuma; Birungi, Josephine; Jaffar, Shabbar			Adherence to Antiretroviral Therapy in Jinja, Uganda: A Six-Year Follow-Up Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-CARE; IDENTITY; STIGMA; ART; POPULATION; PREVENTION; STRATEGIES; COSTS	Introduction: We report on the adherence experience of a group of people living with HIV on ART over six years in Uganda. Methods: Between 2005 and 2009, we followed up 41 participants who were also part of a clinical trial comparing home and facility based delivery of ART in Jinja, eastern Uganda. We conducted qualitative in-depth interviews at enrolment, 3, 6, 18 and 30 months to capture experiences with adherence over time. In 2011 we returned to these participants to find out how they were fairing with long term adherence. We managed to retrace 24 participants and interviewed them about their experience. We thematically analysed the data and compared findings over time. Results: Initially there were few barriers to adherence and many followed the adherence guidance closely. By year six, relaxation of these rules was noticeable although self-reported adherence continued to be high. Alcohol consumption was more common than before. Some relatives of the participants who had died claimed that some deaths were a result of alcohol. While participants reported that ART had allowed them to reclaim independence and return to work the changes in work and social routines created new challenges for adherence. Side effects like lipodystrophy were not only causing some stigma but for some tested their faith in the drugs. Many participants reported resumption of sexual lives but apart from those who selected same status partners, disclosure to new partners was minimal. Conclusion: Good adherence practice to ART wanes over the long-term, and people who may have disclosed at initiation find it difficult to do so to new partners once they are healthy. Further adherence interventions and support with disclosure over the course of therapy may need to be considered. (Words: 283)	[Mbonye, Martin; Seeley, Janet; Ssembajja, Fatuma] MRC UVRI Uganda Res Unit AIDS, Social Sci Programme, Entebbe, Uganda; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Seeley, Janet; Jaffar, Shabbar] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Birungi, Josephine] AIDS Support Org, Kampala, Uganda	University of East Anglia; University of London; London School of Hygiene & Tropical Medicine	Seeley, J (corresponding author), MRC UVRI Uganda Res Unit AIDS, Social Sci Programme, Entebbe, Uganda.	Janet.seeley@mrcuganda.org		Jaffar, Shabbar/0000-0002-9615-1588; Seeley, Janet/0000-0002-0583-5272	US Centers for Disease Control and Prevention; UK Medical Research Council; Boehringer Ingelheim; Medical Research Council [MC_U950080935, G0700837] Funding Source: researchfish; MRC [MC_U950080935, G0700837] Funding Source: UKRI	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to US Centers for Disease Control and Prevention and the UK Medical Research Council for funding the 2005-2008 research and Boehringer Ingelheim and the UK Medical Research Council for funding the 2011 study. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Barroso J, 2000, QUAL HEALTH RES, V10, P340, DOI 10.1177/104973200129118480; Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; Baumgartner LM, 2009, QUAL HEALTH RES, V19, P1730, DOI 10.1177/1049732309352907; Besada D, 2012, S AFR J HIV MED, P178, DOI 10.7196/SAJHIVMED.864; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Foster SD, 2010, AIDS CARE, V22, P35, DOI 10.1080/09540120903500027; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Jaffar S, 2008, TROP MED INT HEALTH, V13, P1096, DOI 10.1111/j.1365-3156.2008.02131.x; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Johnson MO, 2007, AIDS BEHAV, V11, P575, DOI 10.1007/s10461-007-9229-4; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; McNicholl IR, 2008, J MANAGE CARE PHARM, V14, pS12; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mpiima D, 2011, 6 IAS C HIV PATH TRE; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Russell S, 2007, HEALTH POLICY PLANN, V22, P344, DOI 10.1093/heapol/czm023; SANDSTROM KL, 1990, J CONTEMP ETHNOGR, V19, P271, DOI 10.1177/089124190019003002; Seeley J, 2009, CULT HEALTH SEX, V11, P703, DOI 10.1080/13691050903003897; Ssebbanja Peter Kitonsa, 2007, UNITED AIDS STORY TA; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; Wolff B, 2009, SAHARA J-J SOC ASP H, V6, P188, DOI 10.1080/17290376.2009.9724947	33	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78243	10.1371/journal.pone.0078243	http://dx.doi.org/10.1371/journal.pone.0078243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147126	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400150
J	Gao, MH; Lai, NC; Tang, T; Guo, T; Tang, RY; Chun, BJ; Wang, H; Dalton, NN; Suarez, J; Dillmann, WH; Hammond, HK				Gao, Mei Hua; Ngai Chin Lai; Tang, Tong; Guo, Tracy; Tang, Ruoying; Chun, Byeong Jo; Wang, Hong; Dalton, Nancy N.; Suarez, Jorge; Dillmann, Wolfgang H.; Hammond, H. Kirk			Preserved Cardiac Function despite Marked Impairment of cAMP Generation	PLOS ONE			English	Article							ADENYLYL-CYCLASE EXPRESSION; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; TRANSGENIC MICE; PHOSPHOLAMBAN PHOSPHORYLATION; PROTEIN; CARDIOMYOPATHY; OVEREXPRESSION; MYOCYTES; GENE	Objectives: So many clinical trials of positive inotropes have failed, that it is now axiomatic that agents that increase cAMP are deleterious to the failing heart. An alternative strategy is to alter myocardial Ca2+ handling or myofilament response to Ca2+ using agents that do not affect cAMP. Although left ventricular (LV) function is tightly linked to adenylyl cyclase (AC) activity, the beneficial effects of AC may be independent of cAMP and instead stem from effects on Ca2+ handling. Here we ask whether an AC mutant molecule that reduces LV cAMP production would have favorable effects on LV function through its effects on Ca2+ handling alone. Methods and Results: We generated transgenic mice with cardiac-directed expression of an AC6 mutant (AC6mut). Cardiac myocytes showed impaired cAMP production in response to isoproterenol (74% reduction; p<0.001), but LV size and function were normal. Isolated hearts showed preserved LV function in response to isoproterenol stimulation. AC6mut expression was associated with increased sarcoplasmic reticulum Ca2+ uptake and the EC50 for SERCA2a activation was reduced. Cardiac myocytes isolated from AC6mut mice showed increased amplitude of Ca2+ transients in response to isoproterenol (p = 0.0001). AC6mut expression also was associated with increased expression of LV S100A1 (p = 0.03) and reduced expression of phospholamban protein (p = 0.01). Conclusion: LV AC mutant expression is associated with normal cardiac function despite impaired cAMP generation. The mechanism appears to be through effects on Ca2+ handling - effects that occur despite diminished cAMP.	[Hammond, H. Kirk] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Hammond, HK (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA.	khammond@ucsd.edu		jeon, byeongjo/0000-0002-5240-4213	National Institute of Health [P01 HL66941, HL088426, HL081741]; Merit Review Awards from the Department of Veteran's Affairs [1 I01BX001515-01A1]; American Heart Association Western States Affiliate [0865064Y, 11GRNT7610059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081741, R01HL088426, P01HL066941] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Awards from the Department of Veteran's Affairs; American Heart Association Western States Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health grants (P01 HL66941, HL088426, and HL081741), Merit Review Awards from the Department of Veteran's Affairs (1 I01BX001515-01A1), and Grants-in-Aid from the American Heart Association Western States Affiliate (0865064Y and 11GRNT7610059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Gao MH, 2011, MOL PHARMACOL, V79, P381, DOI 10.1124/mol.110.067298; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; GAUDIN C, 1995, J CLIN INVEST, V95, P1676, DOI 10.1172/JCI117843; Iancu RV, 2008, CLIN EXP PHARMACOL P, V35, P1343, DOI 10.1111/j.1440-1681.2008.05020.x; Lai NC, 2008, J AM COLL CARDIOL, V51, P1490, DOI 10.1016/j.jacc.2008.01.015; Lai NC, 2004, CIRCULATION, V110, P330, DOI 10.1161/01.CIR.0000136033.21777.4D; Liggett SB, 2000, CIRCULATION, V101, P1707; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Roth DM, 2002, CIRCULATION, V105, P1989, DOI 10.1161/01.CIR.0000014968.54967.D3; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; Song W, 1996, BRAIN RES, V721, P204, DOI 10.1016/0006-8993(96)00172-2; Suarez J, 2008, AM J PHYSIOL-REG I, V295, pR1439, DOI 10.1152/ajpregu.00736.2007; Takahashi T, 2006, CIRCULATION, V114, P388, DOI 10.1161/CIRCULATIONAHA.106.632513; Tang T, 2004, AM J PHYSIOL-HEART C, V287, pH1906, DOI 10.1152/ajpheart.00356.2004; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069	30	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e72151	10.1371/journal.pone.0072151	http://dx.doi.org/10.1371/journal.pone.0072151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24147149	Green Published, Green Submitted, gold			2022-12-25	WOS:000324494000005
J	Tamura, M; Sasaki, Y; Koyama, R; Takeda, K; Idogawa, M; Tokino, T				Tamura, M.; Sasaki, Y.; Koyama, R.; Takeda, K.; Idogawa, M.; Tokino, T.			Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness	ONCOGENE			English	Article						FOXF1; p53 family; cell invasion; cell migration; E-cadherin	E-CADHERIN EXPRESSION; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; P63; SUPPRESSOR; METASTASIS; ADHESION; PROTEIN; P73; IDENTIFICATION	p53 is an established tumor suppressor that can activate the transcription of multiple target genes. Recent evidence suggests that p53 may contribute to the regulation of cell invasion and migration. In this study, we show that the forkhead box transcription factor FOXF1 is a novel target of the p53 family because FOXF1 is upregulated by p53, TAp73 and TAp63. We show that FOXF1 is induced upon DNA damage in a p53-dependent manner. Furthermore, we identified a response element located within the FOXF1 gene that is responsive to wild-type p53, TAp73 beta and TAp63 gamma. The ectopic expression of FOXF1 inhibited cancer cell invasion and migration, whereas the inactivation of FOXF1 stimulated cell invasion and migration. We also show that FOXF1 regulates the transcriptional activity of E-cadherin (CDH1) by acting on its FOXF1 consensus binding site located upstream of the E-cadherin gene. Collectively, our results show that FOXF1 is a p53 family target gene, and our data suggest that FOXF1 and p53 form a portion of a regulatory transcriptional network that appears to have an important role in cancer cell invasion and migration.	[Tamura, M.; Sasaki, Y.; Koyama, R.; Takeda, K.; Idogawa, M.; Tokino, T.] Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University	Tokino, T (corresponding author), Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	yasushi@sapmed.ac.jp; tokino@sapmed.ac.jp	Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019; Idogawa, Masashi/B-5208-2008	Sasaki, Yasushi/0000-0002-3500-8059; Idogawa, Masashi/0000-0002-8507-1726	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; BUSSEMAKERS MJG, 1994, BIOCHEM BIOPH RES CO, V203, P1291, DOI 10.1006/bbrc.1994.2322; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Cheng JC, 2011, ONCOGENE, V30, P3930, DOI 10.1038/onc.2011.117; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Hsiao BY, 2011, J MOL MED, V89, P481, DOI 10.1007/s00109-010-0717-z; Hwang CI, 2011, CELL CYCLE, V10, P3834, DOI 10.4161/cc.10.22.18294; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Ji XD, 1997, CELL GROWTH DIFFER, V8, P773; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Liefer KM, 2000, CANCER RES, V60, P4016; Liu JJ, 2010, FEBS LETT, V584, P619, DOI 10.1016/j.febslet.2009.12.011; Lo PK, 2013, EXP MOL PATHOL, V94, P262, DOI 10.1016/j.yexmp.2012.10.014; Lo PK, 2012, CELL SIGNAL, V24, P316, DOI 10.1016/j.cellsig.2011.09.017; Lo PK, 2010, CANCER RES, V70, P6047, DOI 10.1158/0008-5472.CAN-10-1576; Lomenick JP, 2006, AM J PHYSIOL-ENDOC M, V291, pE947, DOI 10.1152/ajpendo.00128.2006; Lu C, 2008, CANCER BIOL THER, V7, P2039, DOI 10.4161/cbt.7.12.7461; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Sasaki Y, 2003, CANCER RES, V63, P8145; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; Sasaki Y, 2011, CANCER RES, V71, P7038, DOI 10.1158/0008-5472.CAN-11-1053; Shaw-Smith C, 2010, EUR J MED GENET, V53, P6, DOI 10.1016/j.ejmg.2009.10.001; Shiota M, 2010, CLIN CANCER RES, V16, P5654, DOI 10.1158/1078-0432.CCR-10-0376; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Teh MT, 2002, CANCER RES, V62, P4773; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Watson JEV, 2004, ONCOGENE, V23, P3487, DOI 10.1038/sj.onc.1207474; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051	62	42	44	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4837	4846		10.1038/onc.2013.427	http://dx.doi.org/10.1038/onc.2013.427			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24186199				2022-12-25	WOS:000343240100005
J	Ruedel, A; Stark, K; Kaufmann, S; Bauer, R; Reinders, J; Rovensky, J; Blazickova, S; Oefner, PJ; Bosserhoff, AK				Ruedel, Anke; Stark, Klaus; Kaufmann, Simone; Bauer, Richard; Reinders, Joerg; Rovensky, Jozef; Blazickova, Stanislava; Oefner, Peter J.; Bosserhoff, Anja K.			N-cadherin promoter polymorphisms and risk of osteoarthritis	FASEB JOURNAL			English	Article						genetic association study; CDH2; hnRNP K; rs11564299	GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; EXPRESSION; SUSCEPTIBILITY; MIGRATION; TISSUE; CELLS; GENE; IDENTIFICATION	Osteoarthritis (OA) is the most common form of arthritis. It is characterized by cartilage destruction and bone remodeling, mediated in part by synovial fibroblasts (SFs). Given the functional significance of cadherins in these cells, we aimed at determining the role of genetic variants of N-cadherin (CDH2) in OA of the knee and hip. Six single-nucleotide polymorphisms in the genomic region of the CDH2 gene were genotyped in 312 patients with OA and 259 healthy control subjects. Gene expression of CDH2 was analyzed by qRT-PCR. Liquid chromatography-mass spectrometry was used to identify a transcription factor isolated by DNA pulldown. Its potential for binding to gene variants was examined by electrophoretic mobility shift assay, enzyme-linked immunosorbent assay, and chromatin immunoprecipitation. Genetic analysis identified a polymorphism located in the CDH2 promoter region to be associated with risk of OA. The minor allele of rs11564299 had a protective effect against OA. Compared to carriers of the major allele, carriers of the minor allele of rs11564299 displayed increased N-cadherin levels in SFs. Based on in silico analysis, the minor allele was predicted to generate a novel transcription factor binding site, Direct-binding assays and mass spectrometric analysis identified hnRNP K as binding selectively to the minor allele. In summary, a CDH2 promoter polymorphism influences the risk of OA, and hnRNP K was found to be involved in the regulation of elevated N-cadherin expression in patients with OA carrying the minor allele of rs11564299.Ruedel, A., Stark, K., Kaufmann, S., Bauer, R., Reinders, J., Rovensky, J., Blaikova, S., Oefner, P. J., Bosserhoff, A. K. N-cadherin promoter polymorphisms and risk of osteoarthritis.	[Ruedel, Anke; Kaufmann, Simone; Bosserhoff, Anja K.] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Stark, Klaus] Univ Regensburg, Dept Internal Med 2, D-93053 Regensburg, Germany; [Stark, Klaus] Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Reinders, Joerg; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Bauer, Richard] Univ Hosp Regensburg, Dept Oral & Maxillofacial Surg, Regensburg, Germany; [Rovensky, Jozef; Blazickova, Stanislava] Natl Inst Rheumat Dis, Piestany, Slovakia	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Bosserhoff, AK (corresponding author), Univ Regensburg, Inst Pathol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Stark, Klaus/L-7367-2013; Bosserhoff, Anja/GNH-4801-2022	Stark, Klaus/0000-0002-7832-1942; Bosserhoff, Anja/0000-0001-8147-394X; Reinders, Joerg/0000-0003-1025-7849	Deutsche Forschungsgemeinschaft (DFG) [FOR 696]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Rainer Straub (Internal Medicine I, University Hospital of Regensburg) for supplying the research material and for helpful discussions. This study was supported by Deutsche Forschungsgemeinschaft (DFG) grant FOR 696 to A.K.B. and K.S.	Agarwal SK, 2008, ARTHRITIS RHEUM-US, V58, P1044, DOI 10.1002/art.23369; [Anonymous], 2012, LANCET; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker SF, 2012, ARCH BIOCHEM BIOPHYS, V524, P30, DOI 10.1016/j.abb.2012.02.013; Benotmane AM, 1997, ANAL BIOCHEM, V250, P181, DOI 10.1006/abio.1997.2231; Bijsterbosch J, 2013, OSTEOARTHR CARTILAGE, V21, P565, DOI 10.1016/j.joca.2013.01.011; Blindt R, 2004, CARDIOVASC RES, V62, P212, DOI 10.1016/j.cardiores.2004.01.004; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Collinet C, 2013, PROG MOL BIOL TRANSL, V116, P25, DOI 10.1016/B978-0-12-394311-8.00002-9; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Evangelou E, 2013, ANN RHEUM DIS; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez A, 2013, OSTEOARTHR CARTILAGE, V21, P1443, DOI 10.1016/j.joca.2013.07.001; GRUNWALD GB, 1982, J CELL SCI, V55, P69; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ivanov AI, 2013, INT REV CEL MOL BIO, V303, P27, DOI 10.1016/B978-0-12-407697-6.00002-7; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Li G, 2001, CANCER RES, V61, P3819; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Miller LE, 2000, FASEB J, V14, P2097, DOI 10.1096/fj.99-1082com; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Panoutsopoulou K., 2013, J MED GENET, DOI 10.1136/jmedgenet-2013-101754; Peglion F, 2012, CELL ADHES MIGR, V6, P327, DOI 10.4161/cam.20855; PENGUE G, 1993, FEBS LETT, V321, P233, DOI 10.1016/0014-5793(93)80115-B; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schubert T, 2009, INT J IMMUNOPATH PH, V22, P715, DOI 10.1177/039463200902200317; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Waldron-Lynch F, 2001, GENES IMMUN, V2, P82, DOI 10.1038/sj.gene.6363738; Wenke AK, 2009, FEBS J, V276, P2494, DOI 10.1111/j.1742-4658.2009.06973.x; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	38	14	15	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					683	691		10.1096/fj.13-238295	http://dx.doi.org/10.1096/fj.13-238295			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24148886	Green Submitted			2022-12-25	WOS:000331072200016
J	Wu, J; Puppala, D; Feng, XD; Monetti, M; Lapworth, AL; Geoghegan, KF				Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Monetti, Mara; Lapworth, Amanda Lee; Geoghegan, Kieran F.			Chemoproteomic Analysis of Intertissue and Interspecies Isoform Diversity of AMP-activated Protein Kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Chemical Biology; Chemical Modification; Drug Discovery; Mass Spectrometry (MS)	GAMMA-SUBUNIT ISOFORMS; HUMAN SKELETAL-MUSCLE; LABEL-FREE; CHEMICAL PROTEOMICS; ENERGY SENSOR; DRUG TARGET; EXPRESSION; METFORMIN; EXERCISE; IDENTIFICATION	Background: AMPK is a heterotrimeric enzyme targeted for drug discovery (activation) in diabetes. Results: Diversity of AMPK was studied by chemical capture and proteomic LC-MS. Conclusion: AMPK of human and rat livers differs with respect to the chain. Certain direct activators only activate AMPK containing the 1 form. Significance: Interspecies divergence could compromise the translatability of preclinical data. AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that senses and governs changes in the cellular energy balance represented by concentrations of AMP, ADP, and ATP. Each of its three chains (, , and ) exists as either two or three subtypes, theoretically allowing up to 12 different forms of the complete enzyme. Tissue specificity in the distribution of AMPK subtypes is believed to underpin a range of biological functions for AMPK, a central regulator of metabolic function and response. It is of particular interest for drug discovery purposes to compare AMPK isoforms that are most prevalent in human liver and muscle with isoforms present in key preclinical species. To complement immunocapture/immunodetection methods, which for AMPK are challenged by sequence similarities and difficulties of obtaining accurate relative quantitation, AMPK was captured from lysates of a range of cells and tissues using the ActivX ATP probe. This chemical probe covalently attaches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinases, including AMPK, while also labeling a wide range of ATP-utilizing proteins. Affinity-based recovery of labeled proteins followed by gel-based fractionation of the captured sample was followed by proteomic characterization of AMPK polypeptides. In agreement with transcript-based analysis and previous indications from immunodetection, the results indicated that the predominant AMPK heterotrimer in human liver is 121 but that dog and rat livers mainly contain the 111 and 211 forms, respectively. Differences were not detected between the AMPK profiles of normal and diabetic human liver tissues.	[Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Geoghegan, Kieran F.] Pfizer Worldwide Res, Groton, CT 06340 USA; [Monetti, Mara; Lapworth, Amanda Lee] Pfizer Worldwide Res, Cambridge, MA 02139 USA	Pfizer; Pfizer	Geoghegan, KF (corresponding author), Pfizer Worldwide Res, Groton, CT 06340 USA.	kieran.f.geoghegan@pfizer.com						Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Balgley BM, 2008, ELECTROPHORESIS, V29, P3047, DOI 10.1002/elps.200800050; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Borg Jacques, 2011, Clin Proteomics, V8, P6, DOI 10.1186/1559-0275-8-6; Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cooney JM, 2012, J PROTEOME RES, V11, P1065, DOI 10.1021/pr200807p; Cooper B, 2010, J AM SOC MASS SPECTR, V21, P1534, DOI 10.1016/j.jasms.2010.05.001; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Drewes G, 2012, METHODS MOL BIOL, V803, P15, DOI 10.1007/978-1-61779-364-6_2; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Houston NL, 2011, J PROTEOME RES, V10, P763, DOI 10.1021/pr100913w; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hwang GW, 2010, J TOXICOL SCI, V35, P601, DOI 10.2131/jts.35.601; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; McAllister FE, 2013, ANAL CHEM, V85, P4666, DOI 10.1021/ac303478g; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Miao Q, 2012, EXPERT REV PROTEOMIC, V9, P281, DOI [10.1586/EPR.12.22, 10.1586/epr.12.22]; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piersma SR, 2010, J PROTEOME RES, V9, P1913, DOI 10.1021/pr901072h; Pinter K, 2012, CELL CYCLE, V11, P917, DOI 10.4161/cc.11.5.19412; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Rajamohan F, 2010, PROTEIN EXPRES PURIF, V73, P189, DOI 10.1016/j.pep.2010.04.022; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Van Summeren A, 2012, TOXICOL IN VITRO, V26, P373, DOI 10.1016/j.tiv.2012.01.012; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vogel Christine, 2012, Methods Mol Biol, V893, P321, DOI 10.1007/978-1-61779-885-6_20; Wadley GD, 2006, AM J PHYSIOL-ENDOC M, V290, pE694, DOI 10.1152/ajpendo.00464.2005; Wierzba K, 2011, CURR OPIN CHEM BIOL, V15, P57, DOI 10.1016/j.cbpa.2010.10.009; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223; Zanders ED, 2012, METHODS MOL BIOL, V800, P3, DOI 10.1007/978-1-61779-349-3_1; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	60	35	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35904	35912		10.1074/jbc.M113.508747	http://dx.doi.org/10.1074/jbc.M113.508747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187138	Green Published, hybrid			2022-12-25	WOS:000329814700027
J	Kiani, FA; Fischer, S				Kiani, Farooq Ahmad; Fischer, Stefan			Stabilization of the ADP/Metaphosphate Intermediate during ATP Hydrolysis in Pre-power Stroke Myosin QUANTITATIVE ANATOMY OF AN ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; ATPases; Bioenergetics; Biophysics; Computational Biology; Computer Modeling; Enzyme Catalysis; Enzyme Mechanisms; Myosin; Quantum Chemistry	ADENOSINE-TRIPHOSPHATE HYDROLYSIS; OXYGEN-EXCHANGE; MOLECULAR-DYNAMICS; MOTOR DOMAIN; SALT-BRIDGE; MECHANISM; COMPLEX; ACTIVATION; SIMULATION; PROTEINS	It has been proposed recently that ATP hydrolysis in ATPase enzymes proceeds via an initial intermediate in which the dissociated gamma-phosphate of ATP is bound in the protein as a metaphosphate (P gamma O3-). A combined quantum/classical analysis of this dissociated nucleotide state inside myosin provides a quantitative understanding of how the enzyme stabilizes this unusual metaphosphate. Indeed, in vacuum, the energy of the ADP(3-)center dot P gamma O3-center dot Mg2+ complex is much higher than that of the undissociated ATP(4-). The protein brings it to a surprisingly low value. Energy decomposition reveals how much each interaction in the protein stabilizes the metaphosphate state; backbone peptides of the P-loop contribute 50% of the stabilization energy, and the side chain of Lys-185(+) contributes 25%. This can be explained by the fact that these groups make strong favorable interactions with the alpha- and beta-phosphates, thus favoring the charge distribution of the metaphosphate state over that of the ATP state. Further stabilization (16%) is achieved by a hydrogen bond between the backbone C=O of Ser-237 (on loop Switch-1) and a water molecule perfectly positioned to attack the P gamma O3- in the subsequent hydrolysis step. The planar and singly negative P gamma O3- is a much better target for the subsequent nucleophilic attack by a negatively charged OH- than the tetrahedral and doubly negative P gamma O3- group of ATP. Therefore, we argue that the present mechanism of metaphosphate stabilization is common to the large family of nucleotide-hydrolyzing enzymes. Methodologically, this work presents a computational approach that allows us to obtain a truly quantitative conception of enzymatic strategy.	[Kiani, Farooq Ahmad; Fischer, Stefan] Heidelberg Univ, Computat Biochem Grp, Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Heidelberg Univ, Computat Biochem Grp, Interdisciplinary Ctr Sci Comp, Neuenheimerfeld 368, D-69120 Heidelberg, Germany.	Stefan.Fischer@iwr.uni-heidelberg.de		Kiani, Farooq/0000-0001-8773-3634	German Science Foundation (DFG) [SFB 623]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) through the module "SFB 623, Molecular Catalysis: Structure and Function Design."	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Akola J, 2003, J PHYS CHEM B, V107, P11774, DOI 10.1021/jp035538g; BAGSHAW CR, 1975, P NATL ACAD SCI USA, V72, P2592, DOI 10.1073/pnas.72.7.2592; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer P. D, 2003, NOBEL LECT CHEM 1996, P120; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DEMPSEY ME, 1963, J BIOL CHEM, V238, P2708; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gao J., 1996, REV COMP CH, P119; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Grigorenko BL, 2011, J MOL GRAPH MODEL, V31, P1, DOI 10.1016/j.jmgm.2011.07.005; Guo H, 2000, J PHYS CHEM B, V104, P9746, DOI 10.1021/jp0012247; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEVY HM, 1960, J BIOL CHEM, V235, P2628; LEVY HM, 1959, J BIOL CHEM, V234, P1102; LEVY HM, 1958, J AM CHEM SOC, V80, P3164, DOI 10.1021/ja01545a066; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; LYBRAND TP, 1985, J CHEM PHYS, V83, P2923, DOI 10.1063/1.449246; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; McGrath MJ, 2013, J AM CHEM SOC, V135, P8908, DOI 10.1021/ja401540g; MILLER DL, 1966, J AM CHEM SOC, V88, P1507, DOI 10.1021/ja00959a034; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; ROUX B, 1991, BIOPHYS J, V59, P961, DOI 10.1016/S0006-3495(91)82311-6; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schwarzl S. M, 2006, THESIS RUPRECHT KARL; Schwarzl SM, 2005, J COMPUT CHEM, V26, P1359, DOI 10.1002/jcc.20274; Schwarzl SM, 2006, BIOCHEMISTRY-US, V45, P5830, DOI 10.1021/bi052433q; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SHUKLA KK, 1977, BIOCHEMISTRY-US, V16, P132, DOI 10.1021/bi00620a022; SLEEP JA, 1978, BIOCHEMISTRY-US, V17, P5417, DOI 10.1021/bi00618a015; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SWANSON JR, 1966, BIOCHEM Z, V345, P395; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; VANBELLE D, 1987, J MOL BIOL, V198, P721, DOI 10.1016/0022-2836(87)90213-0; WEBB MR, 1981, J BIOL CHEM, V256, P910; Yang Y, 2008, J MOL BIOL, V381, P1407, DOI 10.1016/j.jmb.2008.06.071; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021	57	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35569	35580		10.1074/jbc.M113.500298	http://dx.doi.org/10.1074/jbc.M113.500298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165121	hybrid, Green Published			2022-12-25	WOS:000329867600051
J	Lukacs, V; Rives, JM; Sun, XH; Zakharian, E; Rohacs, T				Lukacs, Viktor; Rives, Jan-Michael; Sun, Xiaohui; Zakharian, Eleonora; Rohacs, Tibor			Promiscuous Activation of Transient Receptor Potential Vanilloid 1 (TRPV1) Channels by Negatively Charged Intracellular Lipids THE KEY ROLE OF ENDOGENOUS PHOSPHOINOSITIDES IN MAINTAINING CHANNEL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Inositol Phospholipid; Ion Channels; Phosphoinositides; TRP Channels; TRPV1	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; POTASSIUM CHANNELS; TRPM8 CHANNELS; MEMBRANE PHOSPHOINOSITIDES; CAPSAICIN RECEPTOR; PLASMA-MEMBRANE; PIP2 ACTIVATION; KIR CHANNELS; BETA-GAMMA; ATP	Background: Regulation of TRPV1 by phosphoinositides is controversial. Results: ATP reactivates TRPV1 after run-down in excised inside-out patches by generating phosphoinositides; many other negatively charged lipids may also support TRPV1 activity. Conclusion: Despite its promiscuous activation, phosphoinositides are the key endogenous cofactors for TRPV1 activity. Significance: Our data may reconcile discordant data obtained in different experimental settings. The regulation of the heat- and capsaicin-activated transient receptor potential vanilloid 1 (TRPV1) channels by phosphoinositides is controversial. Data in cellular systems support the dependence of TRPV1 activity on phosphoinositides. The purified TRPV1, however, was recently shown to be fully functional in artificial liposomes in the absence of phosphoinositides. Here, we show that several other negatively charged phospholipids, including phosphatidylglycerol, can also support TRPV1 activity in excised patches at high concentrations. When we incorporated TRPV1 into planar lipid bilayers consisting of neutral lipids, capsaicin-induced activity depended on phosphatidylinositol 4,5-bisphosphate. We also found that TRPV1 activity in excised patches ran down and that MgATP reactivated the channel. Inhibition of phosphatidylinositol 4-kinases or enzymatic removal of phosphatidylinositol abolished this effect of MgATP, suggesting that it activated TRPV1 by generating endogenous phosphoinositides. We conclude that endogenous phosphoinositides are positive cofactors for TRPV1 activity. Our data highlight the importance of specificity in lipid regulation of ion channels and may reconcile discordant data obtained in various experimental settings.	[Lukacs, Viktor; Rives, Jan-Michael; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Sun, Xiaohui; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Peoria	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA.	tibor.rohacs@rutgers.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Lukacs, Viktor/0000-0003-3652-5469	National Institutes of Health [RO1NS055159, RO1GM093290, RO1GM098052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290, R01GM098052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS055159 and RO1GM093290 (to T. R.) and RO1GM098052 (to E. Z.).	Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; El-Arabi AM, 2012, LAB CHIP, V12, P2409, DOI [10.1039/c2lc40087a, 10.1039/c21c40087a]; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gamper Nikita, 2012, Subcell Biochem, V59, P289, DOI 10.1007/978-94-007-3015-1_10; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Imai Y, 2012, J PHYSIOL-LONDON, V590, P1101, DOI 10.1113/jphysiol.2011.221358; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Krauter T, 2001, MOL PHARMACOL, V59, P1086, DOI 10.1124/mol.59.5.1086; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lemonnier L, 2008, CELL CALCIUM, V43, P506, DOI 10.1016/j.ceca.2007.09.001; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T., 2013, HDB EXP PHA IN PRESS; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs Tibor, 2013, Advances in Biological Regulation, V53, P341, DOI 10.1016/j.jbior.2013.07.004; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; White D.A., 1973, FORM FUNCTION PHOSPH; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	55	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35003	35013		10.1074/jbc.M113.520288	http://dx.doi.org/10.1074/jbc.M113.520288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158445	Green Published, hybrid			2022-12-25	WOS:000329867600003
J	Meng, L; Forouhar, F; Thieker, D; Gao, ZW; Ramiah, A; Moniz, H; Xiang, Y; Seetharaman, J; Milaninia, S; Su, M; Bridger, R; Veillon, L; Azadi, P; Kornhaber, G; Wells, L; Montelione, GT; Woods, RJ; Tong, L; Moremen, KW				Meng, Lu; Forouhar, Farhad; Thieker, David; Gao, Zhongwei; Ramiah, Annapoorani; Moniz, Heather; Xiang, Yong; Seetharaman, Jayaraman; Milaninia, Sahand; Su, Min; Bridger, Robert; Veillon, Lucas; Azadi, Parastoo; Kornhaber, Gregory; Wells, Lance; Montelione, Gaetano T.; Woods, Robert J.; Tong, Liang; Moremen, Kelley W.			Enzymatic Basis for N-Glycan Sialylation STRUCTURE OF RAT alpha 2,6-SIALYLTRANSFERASE (ST6GAL1) REVEALS CONSERVED AND UNIQUE FEATURES FOR GLYCAN SIALYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Carbohydrate Glycoprotein; Enzyme Structure; Glycobiology; Glycoprotein Biosynthesis; Molecular Dynamics; AMBER; GLYCAM	MOLECULAR-DYNAMICS SIMULATIONS; SUBSTRATE-SPECIFICITY; LINKED OLIGOSACCHARIDES; CONFORMATIONAL-CHANGES; CAMPYLOBACTER-JEJUNI; GENERALIZED BORN; BINDING; SIALYLTRANSFERASE; PROTEIN; GLYCOSYLTRANSFERASES	Background: Specificity and enzymology of glycan sialylation is poorly understood, despite its importance in biological recognition. Results: ST6GAL1 structure was determined, and substrate binding was modeled to probe active site specificity. Conclusion: The structure provides insights into the enzymatic basis of glycan sialylation. Significance: Knowledge of the enzyme structure can lead to broader understanding of enzymatic sialylation and selective inhibitor design. Glycan structures on glycoproteins and glycolipids play critical roles in biological recognition, targeting, and modulation of functions in animal systems. Many classes of glycan structures are capped with terminal sialic acid residues, which contribute to biological functions by either forming or masking glycan recognition sites on the cell surface or secreted glycoconjugates. Sialylated glycans are synthesized in mammals by a single conserved family of sialyltransferases that have diverse linkage and acceptor specificities. We examined the enzymatic basis for glycan sialylation in animal systems by determining the crystal structures of rat ST6GAL1, an enzyme that creates terminal 2,6-sialic acid linkages on complex-type N-glycans, at 2.4 resolution. Crystals were obtained from enzyme preparations generated in mammalian cells. The resulting structure revealed an overall protein fold broadly resembling the previously determined structure of pig ST3GAL1, including a CMP-sialic acid-binding site assembled from conserved sialylmotif sequence elements. Significant differences in structure and disulfide bonding patterns were found outside the sialylmotif sequences, including differences in residues predicted to interact with the glycan acceptor. Computational substrate docking and molecular dynamics simulations were performed to predict and evaluate the CMP-sialic acid donor and glycan acceptor interactions, and the results were compared with kinetic analysis of active site mutants. Comparisons of the structure with pig ST3GAL1 and a bacterial sialyltransferase revealed a similar positioning of donor, acceptor, and catalytic residues that provide a common structural framework for catalysis by the mammalian and bacterial sialyltransferases.	[Meng, Lu; Thieker, David; Gao, Zhongwei; Ramiah, Annapoorani; Moniz, Heather; Xiang, Yong; Bridger, Robert; Veillon, Lucas; Azadi, Parastoo; Wells, Lance; Woods, Robert J.; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Forouhar, Farhad; Seetharaman, Jayaraman; Milaninia, Sahand; Su, Min; Tong, Liang] Columbia Univ, Dept Biol Sci, Northeast Struct Genom Consortium, New York, NY 10027 USA; [Kornhaber, Gregory; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA; [Kornhaber, Gregory; Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland	University System of Georgia; University of Georgia; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Ollscoil na Gaillimhe-University of Galway	Woods, RJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rwoods@ccrc.uga.edu; ltong@columbia.edu; moremen@uga.edu	Meng, Lu/GXN-0092-2022; Wells, Lance/H-3118-2013; Moremen, Kelley/AAD-4661-2019	Thieker, David/0000-0003-0786-8278; Montelione, Gaetano/0000-0002-9440-3059; Wells, Lance/0000-0003-4956-5363; Bridger, Robert/0000-0003-2653-8813; Woods, Robert/0000-0002-2400-6293; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [P41GM103390, P41RR005351, R01GM094919, U54 GM094597]; Science Foundation of Ireland [08/IN.1/B2070]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM094919, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103390 (to K. W. M.), P41RR005351 (to Dr. James Prestegard), R01GM094919 (EUREKA) (to R. J. W.), and Grant U54 GM094597 for work performed in part as a community nominated project of the Protein Structure Initiative of the National Institutes of Health (to G. T. M. and L. T.). This work was also supported by Science Foundation of Ireland Grant 08/IN.1/B2070 (to R. J. W.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barton WA, 2006, PROTEIN SCI, V15, P2008, DOI 10.1110/ps.062244206; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Clark GF, 2013, HUM REPROD, V28, P566, DOI 10.1093/humrep/des447; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Drickamer K, 1997, STRUCTURE, V5, P465, DOI 10.1016/S0969-2126(97)00202-5; Duke R.E., 2012, AMBER 10; FAST DG, 1993, BIOCHIM BIOPHYS ACTA, V1202, P325, DOI 10.1016/0167-4838(93)90023-K; Frisch J.M., 2013, GAUSSIAN INC; FUKUDA MN, 1989, BLOOD, V73, P84; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirano Y, 2012, J BIOCHEM, V151, P197, DOI 10.1093/jb/mvr133; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Kadirvelraj R, 2006, P NATL ACAD SCI USA, V103, P8149, DOI 10.1073/pnas.0602815103; Kadirvelraj R, 2011, GLYCOBIOLOGY, V21, P973, DOI 10.1093/glycob/cwr030; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2013, ACTA CRYSTALLOGR D, V69, P1826, DOI 10.1107/S0907444913015412; Kwan EM, 2005, PROTEIN ENG DES SEL, V18, P497, DOI 10.1093/protein/gzi055; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee HJ, 2011, J BIOL CHEM, V286, P35922, DOI 10.1074/jbc.M111.261172; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Lutteke Thomas, 2009, V534, P293, DOI 10.1007/978-1-59745-022-5_21; Ma JY, 1997, J BIOL CHEM, V272, P672; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel RY, 2006, GLYCOBIOLOGY, V16, P108, DOI 10.1093/glycob/cwj046; PAULSON JC, 1984, EUR J BIOCHEM, V140, P523, DOI 10.1111/j.1432-1033.1984.tb08133.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Rakic B, 2013, GLYCOBIOLOGY, V23, P536, DOI 10.1093/glycob/cwt001; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rauvolfova J, 2008, CARBOHYD RES, V343, P1605, DOI 10.1016/j.carres.2008.05.002; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tozser J, 2005, FEBS J, V272, P514, DOI 10.1111/j.1742-4658.2004.04493.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; Wu XD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/591923; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; Yan HM, 2013, INT IMMUNOPHARMACOL, V16, P353, DOI 10.1016/j.intimp.2013.04.013; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366	95	90	90	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34680	34698		10.1074/jbc.M113.519041	http://dx.doi.org/10.1074/jbc.M113.519041			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24155237	Green Published, hybrid			2022-12-25	WOS:000329812800035
J	Eigemann, F; Vanormelingen, P; Hilt, S				Eigemann, Falk; Vanormelingen, Pieter; Hilt, Sabine			Sensitivity of the Green Alga Pediastrum duplex Meyen to Allelochemicals Is Strain-Specific and Not Related to Co-Occurrence with Allelopathic Macrophytes	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; POLYPHENOLIC ALLELOCHEMICALS; CHLOROPHYLL FLUORESCENCE; SUBMERGED MACROPHYTES; GENETIC ADAPTATION; INHIBITION; GROWTH; PHOTOSYNTHESIS; SPHAEROPLEALES; EVOLUTION	Interspecific differences in the response of microalgae to stress have numerous ecological implications. However, little is known of intraspecific sensitivities and the potential role of local genetic adaptation of populations. We compared the allelochemical sensitivity of 23 Pediastrum duplex Meyen strains, a common component of the freshwater phytoplankton. In order to test for local genetic adaptation, strains were isolated from water bodies with and without the allelopathically-active submerged macrophyte Myriophyllum. Strains were assigned to P. duplex on the basis of cell shape and colony morphology and only P. duplex strains that belonged to the same lineage in an ITS rDNA phylogeny were used. Inhibition of strain growth rates and maximum quantum yields of photosystem II were measured after exposure to tannic acid (TA) and co-culture with Myriophyllum spicatum. Growth rate inhibition varied over one order of magnitude between the P. duplex strains. There was no correlation between the presence of Myriophyllum in the source location and the sensitivity of the strains to TA or the presence of Myriophyllum, suggesting that at least strong unidirectional local adaptation to Myriophyllum had not taken place in the studied water bodies. The maximum quantum yield of photosystem II of TA exposed algae decreased, whereas the yield of algae exposed to M. spicatum was slightly higher than that of the controls. The ranking of P. duplex strain sensitivities differed between the types of exposure (single additions of TA versus co-existence with M. spicatum) and the parameter measured (growth rate versus maximum quantum yield), emphasizing the importance of measuring multiple traits when analysing strain-specific sensitivities towards allelochemicals. The observation that sensitivities to allelochemicals vary widely among strains of a single freshwater algal species should be taken into account if evaluating ecological consequences of allelopathic interactions.	[Eigemann, Falk; Hilt, Sabine] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Eigemann, Falk] Free Univ Berlin, Inst Biol, Berlin, Germany; [Vanormelingen, Pieter] Univ Ghent, Lab Protistol & Aquat Ecol, Ghent, Belgium	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Ghent University	Eigemann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.	eigemann@igb-berlin.de	Hilt, Sabine/C-4783-2011	Eigemann, Falk/0000-0002-4499-5682	German Research Foundation (DFG) [HI 1380/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	PD Dr. Sabine Hilt and Falk Eigemann were funded by the German Research Foundation (DFG, HI 1380/3-1). Dr. Pieter Vanormelingen is a postdoctoral research fellow with the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehri A. M., 2010, J APPL SCI, V10, P1769, DOI [10.3923/jas.2010.1769.1774, DOI 10.3923/JAS.2010.1769.1774]; Bahrs H, 2012, ENVIRON SCI POLLUT R, V19, P335, DOI 10.1007/s11356-011-0564-7; Bauer N, 2009, AQUAT BOT, V91, P110, DOI 10.1016/j.aquabot.2009.03.005; Behra R, 1999, ARCH ENVIRON CON TOX, V37, P36, DOI 10.1007/s002449900487; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; Bucolo P, 2012, J PHYCOL, V48, P1403, DOI 10.1111/j.1529-8817.2012.01221.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Carrillo E, 2003, PHYCOLOGIA, V42, P269, DOI 10.2216/i0031-8884-42-3-269.1; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; Eigemann F, 2013, AQUAT BOT, V104, P5, DOI 10.1016/j.aquabot.2012.10.005; FALKOWSKI PG, 1984, PHOTOSYNTHETICA, V18, P62; FISHER NS, 1973, NATURE, V241, P548, DOI 10.1038/241548a0; FOSTER PL, 1982, FRESHWATER BIOL, V12, P41, DOI 10.1111/j.1365-2427.1982.tb00602.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gross EM, 1996, PHYTOCHEMISTRY, V41, P133, DOI 10.1016/0031-9422(95)00598-6; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hilt S, 2006, J PHYCOL, V42, P1189, DOI 10.1111/j.1529-8817.2006.00286.x; Hilt S, 2012, J PHYCOL, V48, P40, DOI 10.1111/j.1529-8817.2011.01106.x; Hilt S, 2008, BASIC APPL ECOL, V9, P422, DOI 10.1016/j.baae.2007.04.003; Hilt S, 2006, AQUAT BOT, V85, P252, DOI 10.1016/j.aquabot.2006.05.004; Hoffman A.A., 1997, EXTREME ENV CHANGE E; Inderjit Wardle DA, 2011, TRENDS ECOL EVOL, V1442, P1; JENSEN A, 1974, J EXP MAR BIOL ECOL, V15, P145, DOI 10.1016/0022-0981(74)90040-9; Jensen CG, 2010, OECOLOGIA, V162, P1017, DOI 10.1007/s00442-009-1501-z; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Komarek J., 1983, BINNENGEWASSER PHY 1, P1044; Korner S, 2002, J PHYCOL, V38, P862, DOI 10.1046/j.1529-8817.2002.t01-1-02001.x; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Leu E, 2002, PLANT PHYSIOL, V130, P2011, DOI 10.1104/pp.011593; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; Lopez-Rodas V, 2011, J PHYCOL, V47, P1036, DOI 10.1111/j.1529-8817.2011.01035.x; Low-Decarie E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2598; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Lurling M, 2003, HYDROBIOLOGIA, V491, P145, DOI 10.1023/A:1024436508387; Marshall JA, 2002, J EXP MAR BIOL ECOL, V272, P13, DOI 10.1016/S0022-0981(02)00034-5; McManus HA, 2011, J PHYCOL, V47, P152, DOI 10.1111/j.1529-8817.2010.00940.x; MENZEL DW, 1970, SCIENCE, V167, P1724, DOI 10.1126/science.167.3926.1724; Mulderij G, 2005, AQUAT BOT, V82, P284, DOI 10.1016/j.aquabot.2005.04.001; MURPHY LS, 1980, LIMNOL OCEANOGR, V25, P160, DOI 10.4319/lo.1980.25.1.0160; NICKLISCH A, 1992, ARCH HYDROBIOL, P1; Planas D., 1981, VERH INT VEREIN LIMN, V21, P492; Rabotnov TA., 1982, EKOLOGIA, V3, P5; Reed DH, 2003, EVOLUTION, V57, P1822; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; TING CS, 1992, PLANT PHYSIOL, V100, P367, DOI 10.1104/pp.100.1.367; Vanormelingen P, 2007, J PHYCOL, V43, P378, DOI 10.1111/j.1529-8817.2007.00325.x; Vanormelingen P, 2009, LIMNOL OCEANOGR, V54, P503, DOI 10.4319/lo.2009.54.2.0503; WOOD AM, 1992, J PHYCOL, V28, P723, DOI 10.1111/j.0022-3646.1992.00723.x; ZECHMAN FW, 1994, J PHYCOL, V30, P507, DOI 10.1111/j.0022-3646.1994.00507.x	60	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78463	10.1371/journal.pone.0078463	http://dx.doi.org/10.1371/journal.pone.0078463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167626	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500087
J	Cuervo, JJ; Moller, AP				Cuervo, Jose J.; Moller, Anders P.			Temporal Variation in Population Size of European Bird Species: Effects of Latitude and Marginality of Distribution	PLOS ONE			English	Article							CLIMATE-CHANGE; DENSITY-DEPENDENCE; HABITAT FRAGMENTATION; EXTINCTION RISK; ABIOTIC FACTORS; NORTHERN BIRDS; MIGRATORY BIRD; RANGE MARGINS; TIME-SERIES; ABUNDANCE	In the Northern Hemisphere, global warming has been shown to affect animal populations in different ways, with southern populations in general suffering more from increased temperatures than northern populations of the same species. However, southern populations are also often marginal populations relative to the entire breeding range, and marginality may also have negative effects on populations. To disentangle the effects of latitude (possibly due to global warming) and marginality on temporal variation in population size, we investigated European breeding bird species across a latitudinal gradient. Population size estimates were regressed on years, and from these regressions we obtained the slope (a proxy for population trend) and the standard error of the estimate (SEE) (a proxy for population fluctuations). The possible relationships between marginality or latitude on one hand and slopes or SEE on the other were tested among populations within species. Potentially confounding factors such as census method, sampling effort, density-dependence, habitat fragmentation and number of sampling years were controlled statistically. Population latitude was positively related to regression slopes independent of marginality, with more positive slopes (i.e., trends) in northern than in southern populations. The degree of marginality was positively related to SEE independent of latitude, with marginal populations showing larger SEE (i.e., fluctuations) than central ones. Regression slopes were also significantly related to our estimate of density-dependence and SEE was significantly affected by the census method. These results are consistent with a scenario in which southern and northern populations of European bird species are negatively affected by marginality, with southern populations benefitting less from global warming than northern populations, thus potentially making southern populations more vulnerable to extinction.	[Cuervo, Jose J.] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Moller, Anders P.] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Cuervo, JJ (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.	jjcuervo@mncn.csic.es	Cuervo, José Javier/K-1646-2014; Moller, Anders/O-6665-2016	Cuervo, José Javier/0000-0001-7943-7835; Moller, Anders/0000-0003-3739-4675	Spanish National Research Council [EST001196]; Spanish Ministry of Science and Innovation; European Regional Development Fund [CGL2008-00137/BOS]	Spanish National Research Council; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This studied was supported by the Spanish National Research Council (grant EST001196) and by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (grant CGL2008-00137/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brewer AM, 2003, J ANIM ECOL, V72, P82, DOI 10.1046/j.1365-2656.2003.00682.x; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Cramp S., 1977, HDB BIRDS EUROPE MID, P1; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Cuervo JJ, 2001, EVOL ECOL, V15, P53, DOI 10.1023/A:1011913804309; Curnutt JL, 1996, OIKOS, V76, P131, DOI 10.2307/3545755; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Garcia JT, 2001, ECOGRAPHY, V24, P393, DOI 10.1034/j.1600-0587.2001.d01-195.x; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Jump AS, 2003, NEW PHYTOL, V160, P349, DOI 10.1046/j.1469-8137.2003.00873.x; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Mitchell TD, 2000, 1 U E ANGL TYND CTR; Moller AP, 2008, J EVOLUTION BIOL, V21, P213, DOI 10.1111/j.1420-9101.2007.01450.x; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; MOLLER AP, 1995, AM NAT, V145, P316, DOI 10.1086/285742; Nagylaki T, 1998, GENETICS, V149, P1599; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pena TS, 2005, OIKOS, V111, P253, DOI 10.1111/j.0030-1299.2005.14067.x; Pertoldi C, 2007, OIKOS, V116, P769, DOI 10.1111/j.2007.0030-1299.15672.x; Pertoldi C, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-47; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reed DH, 2004, ANIM CONSERV, V7, P1, DOI 10.1017/S1367943004003476; Renwick AR, 2012, DIVERS DISTRIB, V18, P121, DOI 10.1111/j.1472-4642.2011.00827.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saether BE, 2009, J ANIM ECOL, V78, P1063, DOI 10.1111/j.1365-2656.2009.01565.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sokal R. R., 2012, BIOMETRY; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	72	19	22	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77654	10.1371/journal.pone.0077654	http://dx.doi.org/10.1371/journal.pone.0077654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147048	Green Published, gold			2022-12-25	WOS:000326022200060
J	Lenz, M; Schuldt, BM; Muller, FJ; Schuppert, A				Lenz, Michael; Schuldt, Bernhard M.; Mueller, Franz-Josef; Schuppert, Andreas			PhysioSpace: Relating Gene Expression Experiments from Heterogeneous Sources Using Shared Physiological Processes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PROSTATE-CANCER; MICROARRAY; SIGNATURE; PATTERNS; LUNG; MAP	Relating expression signatures from different sources such as cell lines, in vitro cultures from primary cells and biopsy material is an important task in drug development and translational medicine as well as for tracking of cell fate and disease progression. Especially the comparison of large scale gene expression changes to tissue or cell type specific signatures is of high interest for the tracking of cell fate in (trans-) differentiation experiments and for cancer research, which increasingly focuses on shared processes and the involvement of the microenvironment. These signature relation approaches require robust statistical methods to account for the high biological heterogeneity in clinical data and must cope with small sample sizes in lab experiments and common patterns of co-expression in ubiquitous cellular processes. We describe a novel method, called PhysioSpace, to position dynamics of time series data derived from cellular differentiation and disease progression in a genome-wide expression space. The PhysioSpace is defined by a compendium of publicly available gene expression signatures representing a large set of biological phenotypes. The mapping of gene expression changes onto the PhysioSpace leads to a robust ranking of physiologically relevant signatures, as rigorously evaluated via sample-label permutations. A spherical transformation of the data improves the performance, leading to stable results even in case of small sample sizes. Using PhysioSpace with clinical cancer datasets reveals that such data exhibits large heterogeneity in the number of significant signature associations. This behavior was closely associated with the classification endpoint and cancer type under consideration, indicating shared biological functionalities in disease associated processes. Even though the time series data of cell line differentiation exhibited responses in larger clusters covering several biologically related patterns, top scoring patterns were highly consistent with a priory known biological information and separated from the rest of response patterns.	[Lenz, Michael; Schuldt, Bernhard M.; Schuppert, Andreas] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany; [Schuppert, Andreas] Bayer Technol Serv GmbH, Leverkusen, Germany	RWTH Aachen University; Bayer AG	Schuppert, A (corresponding author), Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany.	schuppert@aices.rwth-aachen.de	Müller, Franz-Josef/E-3336-2010; Lenz, Michael/J-4401-2016	Müller, Franz-Josef/0000-0001-9478-8430; Lenz, Michael/0000-0002-6319-6480; Schuppert, Andreas/0000-0003-3783-6605	German federal state of North Rhine Westphalia (NRW); European Union via the StemCellFactory; MedSys project of the Federal Ministry of Education and Research (BMBF) [0315416A]; Else Kroner-Fresenius-Stiftung	German federal state of North Rhine Westphalia (NRW); European Union via the StemCellFactory; MedSys project of the Federal Ministry of Education and Research (BMBF); Else Kroner-Fresenius-Stiftung	M.L. is supported by the German federal state of North Rhine Westphalia (NRW) and the European Union (European Regional Development Fund: Investing in Your Future) via the StemCellFactory project (stemcellfactory.de). B. M. S. was partially supported by the MedSys project of the Federal Ministry of Education and Research (BMBF, www.bmbf.de, Grant number 0315416A). F-J.M. is supported by an Else Kroner-Fresenius-Stiftung (www.ekfs.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gatti DM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-574; Gower AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-381; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NATURE, V478, pE4, DOI 10.1038/nature10543; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; R Development Core Team, 2011, R LANG ENV STAT COMP; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schneckener S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-73; Schneider MV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002789; Shao KF, 2013, MOL THER, V21, P240, DOI 10.1038/mt.2012.207; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Staaf J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-22; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Williams R, 2011, BIOESSAYS, V33, P880, DOI 10.1002/bies.201100073; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-53; Zheng-Bradley X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r124	49	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77627	10.1371/journal.pone.0077627	http://dx.doi.org/10.1371/journal.pone.0077627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147039	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200053
J	Wang, Y; Huang, XL; Qiao, GX				Wang, Yuan; Huang, Xiao-Lei; Qiao, Ge-Xia			Comparative Analysis of Mitochondrial Genomes of Five Aphid Species (Hemiptera: Aphididae) and Phylogenetic Implications	PLOS ONE			English	Article							TRANSFER-RNA; COMPLETE SEQUENCE; MOLECULAR PHYLOGENY; CODON USAGE; INSECTA; ORGANIZATION; LEPIDOPTERA; EVOLUTION; HYMENOPTERA; PATTERNS	Insect mitochondrial genomes (mitogenomes) are of great interest in exploring molecular evolution, phylogenetics and population genetics. Only two mitogenomes have been previously released in the insect group Aphididae, which consists of about 5,000 known species including some agricultural, forestry and horticultural pests. Here we report the complete 16,317 bp mitogenome of Cavariella salicicola and two nearly complete mitogenomes of Aphis glycines and Pterocomma pilosum. We also present a first comparative analysis of mitochondrial genomes of aphids. Results showed that aphid mitogenomes share conserved genomic organization, nucleotide and amino acid composition, and codon usage features. All 37 genes usually present in animal mitogenomes were sequenced and annotated. The analysis of gene evolutionary rate revealed the lowest and highest rates for COI and ATP8, respectively. A unique repeat region exclusively in aphid mitogenomes, which included variable numbers of tandem repeats in a lineage-specific manner, was highlighted for the first time. This region may have a function as another origin of replication. Phylogenetic reconstructions based on protein-coding genes and the stem-loop structures of control regions confirmed a sister relationship between Cavariella and pterocommatines. Current evidence suggest that pterocommatines could be formally transferred into Macrosiphini. Our paper also offers methodological instructions for obtaining other Aphididae mitochondrial genomes.	[Wang, Yuan; Huang, Xiao-Lei; Qiao, Ge-Xia] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Yuan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, XL (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangxl@ioz.ac.cn; qiaogx@ioz.ac.cn	Huang, Xiaolei/S-7781-2019	Huang, Xiaolei/0000-0002-6839-9922	National Natural Sciences Foundation of China [31272348]; National Science Funds for Distinguished Young Scientists [31025024]; National Science Fund for Fostering Talents in Basic Research [J1210002]; Ministry of Science and Technology of the People's Republic of China [2011FY120200]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Funds for Distinguished Young Scientists; National Science Fund for Fostering Talents in Basic Research; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	The work was supported by grants from the National Natural Sciences Foundation of China (31272348), National Science Funds for Distinguished Young Scientists (31025024), National Science Fund for Fostering Talents in Basic Research (J1210002), the Ministry of Science and Technology of the People's Republic of China (2011FY120200), and a grant from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman R., 2000, APHIDS WORLDS CROPS, P466; BLACKMAN RL, 2006, APHIDS WORLDS HERBAC, V2; Blackman RL, 1994, APHIDS WORLDS TREES, P987; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Carapelli A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-315; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Davila S, 2005, GENE, V360, P92, DOI 10.1016/j.gene.2005.06.008; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; EASTOP VF, 1979, SYMB BOT UPSAL, V22, P120; Favret C., 2013, APHID SPECIES FILE V; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; HEIE OE, 1992, APHIDOIDEA HEMIPTE 1; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Huang XL, 2012, ZOOL J LINN SOC-LOND, V165, P73, DOI 10.1111/j.1096-3642.2011.00795.x; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACKENZIE A, 1990, AM NAT, V136, P132, DOI 10.1086/285086; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; Nieto Nafria Juan M., 2011, P21; Nokkala C, 2007, EUR J ENTOMOL, V104, P661, DOI 10.14411/eje.2007.083; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Remaudiere G., 1997, Catalogue des Aphididae du monde: Homoptera Aphidoidea.; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Schuh R.T., 1995, CLASSIFICATION NATUR, P336; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057	59	48	53	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77511	10.1371/journal.pone.0077511	http://dx.doi.org/10.1371/journal.pone.0077511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147014	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200040
J	Li, YZ; Wang, HY; Xie, KL; Wang, CY; Yang, Z; Yu, YH; Wang, GL				Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yang, Zhuo; Yu, Yonghao; Wang, Guolin			Inhibition of Glycogen Synthase Kinase-3 beta Prevents Remifentanil-Induced Hyperalgesia via Regulating the Expression and Function of Spinal N-Methyl-D-Aspartate Receptors In Vivo and Vitro	PLOS ONE			English	Article							OPIOID-INDUCED HYPERALGESIA; INDUCED POSTOPERATIVE HYPERALGESIA; SYNAPTIC-TRANSMISSION; NEUROPATHIC PAIN; NMDA; TRAFFICKING; NEURONS; GSK-3; CONTRIBUTES; ANESTHETICS	A large number of experimental and clinical studies have confirmed that brief remifentanil exposure can enhance pain sensitivity presenting as opioid-induced hyperalgesia (OIH). N-methyl-D-aspartate (NMDA) receptor antagonists have been reported to inhibit morphine analgesic tolerance in many studies. Recently, we found that glycogen synthase kinase-3 beta (GSK-3 beta) modulated NMDA receptor trafficking in a rat model of remifentanil-induced postoperative hyperalgesia. In the current study, it was demonstrated that GSK-3 beta inhibition prevented remifentanil-induced hyperalgesia via regulating the expression and function of spinal NMDA receptors in vivo and in vitro. We firstly investigated the effects of TDZD-8, a selective GSK-3 beta inhibitor, on thermal and mechanical hyperalgesia using a rat model of remifentanil-induced hyperalgesia. GSK-3 beta activity as well as NMDA receptor subunits (NR1, NR2A and NR2B) expression and trafficking in spinal cord L-4-L-5 segments were measured by Western blot analysis. Furthermore, the effects of GSK-3 beta inhibition on NMDA-induced current amplitude and frequency were studied in spinal cord slices by whole-cell patch-clamp recording. We found that remifentanil infusion at 1 mu g.kg(-1).min(-1) and 2 mu g.kg(-1).min(-1) caused mechanical and thermal hyperalgesia, up-regulated NMDA receptor subunits NR1 and NR2B expression in both membrane fraction and total lysate of the spinal cord dorsal horn and increased GSK-3 beta activity in spinal cord dorsal horn. GSK-3 beta inhibitor TDZD-8 significantly attenuated remifentanil-induced mechanical and thermal hyperalgesia from 2 h to 48 h after infusion, and this was associated with reversal of up-regulated NR1 and NR2B subunits in both membrane fraction and total lysate. Furthermore, remifentanil incubation increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was prevented with the application of TDZD-8. These results suggest that inhibition of GSK-3 beta can significantly ameliorate remifentanil-induced hyperalgesia via modulating the expression and function of NMDA receptors, which present useful insights into the mechanistic action of GSK-3 beta inhibitor as potential anti-hyperalgesic agents for treating OIH.	[Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yu, Yonghao; Wang, Guolin] Tianjin Med Univ, Dept Anesthesiol, Gen Hosp, Tianjin, Peoples R China; [Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yu, Yonghao; Wang, Guolin] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China; [Yang, Zhuo] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Tianjin Medical University; Nankai University	Wang, GL (corresponding author), Tianjin Med Univ, Dept Anesthesiol, Gen Hosp, Tianjin, Peoples R China.	wangguolinemail@126.com			National Natural Science Foundation of China [NSFC 30972847]; Key Projects in the Tianjin Science & Technology Pillar Program [12ZCZDSY03000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program	This work was supported by the National Natural Science Foundation of China (NSFC 30972847) and Key Projects in the Tianjin Science & Technology Pillar Program (12ZCZDSY03000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chu LF, 2011, J PAIN, V12, P108, DOI 10.1016/j.jpain.2010.05.006; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Derrode N, 2003, BRIT J ANAESTH, V91, P842, DOI 10.1093/bja/aeg263; Dobashi T, 2010, NEUROSCI LETT, V485, P125, DOI 10.1016/j.neulet.2010.08.084; Giese KP, 2009, IUBMB LIFE, V61, P516, DOI 10.1002/iub.187; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; Guntz E, 2005, ANESTHESIOLOGY, V102, P1235, DOI 10.1097/00000542-200506000-00025; Hahnenkamp K, 2004, ANESTHESIOLOGY, V100, P1531, DOI 10.1097/00000542-200406000-00028; Hang LH, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13195; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lim HS, 2013, BIOL PHARM BULL, V36, P125, DOI 10.1248/bpb.b12-00760; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Mazzardo-Martins L, 2012, NEUROSCIENCE, V226, P411, DOI 10.1016/j.neuroscience.2012.09.020; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishimoto T, 2009, NEUROREPORT, V20, P161, DOI 10.1097/WNR.0b013e3283118450; Parkitna JR, 2006, J PHARMACOL EXP THER, V319, P832, DOI 10.1124/jpet.106.107581; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Shin SW, 2010, BRIT J ANAESTH, V105, P661, DOI 10.1093/bja/aeq257; Silverman SM, 2009, PAIN PHYSICIAN, V12, P679; Tian YT, 2010, NEUROSCI RES, V68, P167, DOI 10.1016/j.neures.2010.07.2030; Yang K, 2011, EUR J PHARMACOL, V670, P509, DOI 10.1016/j.ejphar.2011.09.009; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5; Yuan Y, 2013, ANESTH ANALG, V116, P473, DOI 10.1213/ANE.0b013e318274e3f1; Zhao M, 2008, ANESTHESIOLOGY, V109, P308, DOI 10.1097/ALN.0b013e31817f4c5d; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhu LQ, 2010, J NEUROSCI, V30, P3624, DOI 10.1523/JNEUROSCI.5223-09.2010	42	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77790	10.1371/journal.pone.0077790	http://dx.doi.org/10.1371/journal.pone.0077790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147079	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400134
J	Reilly, KJ; Spencer, KA				Reilly, Kevin J.; Spencer, Kristie A.			Sequence Complexity Effects on Speech Production in Healthy Speakers and Speakers with Hypokinetic or Ataxic Dysarthria	PLOS ONE			English	Article							SHORT-TERM-MEMORY; SYLLABLE FREQUENCY; PHONOLOGICAL SIMILARITY; PHONOTACTIC PROBABILITY; SERIAL ORDER; ARTICULATORY MOVEMENTS; PHONEMIC SIMILARITY; BASAL GANGLIA; MOTOR; CONSTRAINTS	The present study investigated the effects of sequence complexity, defined in terms of phonemic similarity and phonotoactic probability, on the timing and accuracy of serial ordering for speech production in healthy speakers and speakers with either hypokinetic or ataxic dysarthria. Sequences were comprised of strings of consonant-vowel (CV) syllables with each syllable containing the same vowel, /a/, paired with a different consonant. High complexity sequences contained phonemically similar consonants, and sounds and syllables that had low phonotactic probabilities; low complexity sequences contained phonemically dissimilar consonants and high probability sounds and syllables. Sequence complexity effects were evaluated by analyzing speech error rates and within-syllable vowel and pause durations. This analysis revealed that speech error rates were significantly higher and speech duration measures were significantly longer during production of high complexity sequences than during production of low complexity sequences. Although speakers with dysarthria produced longer overall speech durations than healthy speakers, the effects of sequence complexity on error rates and speech durations were comparable across all groups. These findings indicate that the duration and accuracy of processes for selecting items in a speech sequence is influenced by their phonemic similarity and/or phonotactic probability. Moreover, this robust complexity effect is present even in speakers with damage to subcortical circuits involved in serial control for speech.	[Reilly, Kevin J.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Spencer, Kristie A.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA	Northeastern University; University of Washington; University of Washington Seattle	Reilly, KJ (corresponding author), Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA.	k.reilly@neu.edu			National Institute on Deafness and Other Communication Disorders [1-F32-DC006782, 1-RO3-DC007066]; Human Subjects Recruitment Core [P30 DC004661]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007066, P30DC004661, F32DC006782] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Human Subjects Recruitment Core; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by Grants 1-F32-DC006782 and 1-RO3-DC007066 from the National Institute on Deafness and Other Communication Disorders and Grant P30 DC004661 (Human Subjects Recruitment Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 1997, BRAIN LANG, V56, P312, DOI 10.1006/brln.1997.1851; Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Ackermann H, 2007, CEREBELLUM, V6, P202, DOI 10.1080/14734220701266742; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Carreiras M, 2006, HUM BRAIN MAPP, V27, P963, DOI 10.1002/hbm.20236; Chiu MJ, 1996, EUR NEUROL, V36, P310, DOI 10.1159/000117278; Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Dell GS, 2000, J EXP PSYCHOL LEARN, V26, P1355, DOI 10.1037//0278-7393.26.6.1355; Duffy JR., 2012, MOTOR SPEECH DISORDE; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; ELLIS AW, 1980, J VERB LEARN VERB BE, V19, P624, DOI 10.1016/S0022-5371(80)90672-6; Farrell S, 2004, J MEM LANG, V51, P115, DOI 10.1016/S0749-596X(04)00029-4; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Goldrick M, 2004, J MEM LANG, V51, P586, DOI 10.1016/j.jml.2004.07.004; Goldrick M, 2008, COGNITION, V107, P1155, DOI 10.1016/j.cognition.2007.11.009; Goldrick M, 2006, LANG COGNITIVE PROC, V21, P649, DOI 10.1080/01690960500181332; Goldstein L, 2007, COGNITION, V103, P386, DOI 10.1016/j.cognition.2006.05.010; GORDON PC, 1987, LANGUAGE PERCEPTION, P445; Grossberg S, 2008, PSYCHOL REV, V115, P677, DOI 10.1037/a0012618; Hartley T, 1996, J MEM LANG, V35, P1, DOI 10.1006/jmla.1996.0001; Hertrich I, 1999, J SPEECH LANG HEAR R, V42, P367, DOI 10.1044/jslhr.4202.367; Ho AK, 1998, BRAIN LANG, V64, P122, DOI 10.1006/brln.1998.1959; Kendall DL, 2005, APHASIOLOGY, V19, P39, DOI 10.1080/02687030444000606; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; Kent RD, 1997, FOLIA PHONIATR LOGO, V49, P63, DOI 10.1159/000266440; KENT RD, 1979, J SPEECH HEAR RES, V22, P627, DOI 10.1044/jshr.2203.627; Klapp ST, 2003, J MOTOR BEHAV, V35, P135, DOI 10.1080/00222890309602129; Klein D, 2006, HUM BRAIN MAPP, V27, P153, DOI 10.1002/hbm.20174; Kreisler A, 2000, NEUROLOGY, V54, P1117, DOI 10.1212/WNL.54.5.1117; Kroger B. J., 2010, SPEECH MOTOR CONTROL, P23; Laganaro M, 2006, J MEM LANG, V55, P178, DOI 10.1016/j.jml.2006.05.001; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; LEVITT AG, 1985, J MEM LANG, V24, P717, DOI 10.1016/0749-596X(85)90055-5; Lewandowsky S, 2008, J MEM LANG, V58, P429, DOI 10.1016/j.jml.2007.01.005; LUDLOW CL, 1987, BRAIN LANG, V32, P195, DOI 10.1016/0093-934X(87)90124-6; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; MACKAY DG, 1970, NEUROPSYCHOLOGIA, V8, P323, DOI 10.1016/0028-3932(70)90078-3; MEYER DE, 1985, J MEM LANG, V24, P3, DOI 10.1016/0749-596X(85)90013-0; Mueller ST, 2003, J EXP PSYCHOL LEARN, V29, P1353, DOI 10.1037/0278-7393.29.6.1353; Munson B, 2001, J SPEECH LANG HEAR R, V44, P778, DOI 10.1044/1092-4388(2001/061); Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Page MPA, 2007, J MEM LANG, V56, P49, DOI 10.1016/j.jml.2006.09.002; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Peeva MG, 2010, NEUROIMAGE, V50, P626, DOI 10.1016/j.neuroimage.2009.12.065; Pickett ER, 1998, NEUROPSYCHOLOGIA, V36, P173, DOI 10.1016/S0028-3932(97)00065-1; Rauschecker AM, 2008, HUM BRAIN MAPP, V29, P1231, DOI 10.1002/hbm.20460; REILLY KJ, FRONT HUM NEUROSCI; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Riecker A, 2008, BRAIN LANG, V107, P102, DOI 10.1016/j.bandl.2008.01.008; Riva D, 1998, CORTEX, V34, P279, DOI 10.1016/S0010-9452(08)70755-X; Rogers MA, 1998, J SPEECH LANG HEAR R, V41, P258, DOI 10.1044/jslhr.4102.258; Schweppe J, 2011, J MEM LANG, V64, P256, DOI 10.1016/j.jml.2010.11.006; SEVALD CA, 1994, COGNITION, V53, P91, DOI 10.1016/0010-0277(94)90067-1; Shuster LI, 2005, BRAIN LANG, V93, P20, DOI 10.1016/j.bandl.2004.07.007; Sidtis JJ, 2006, NEUROIMAGE, V31, P246, DOI 10.1016/j.neuroimage.2005.12.005; Spencer KA, 2005, BRAIN LANG, V94, P347, DOI 10.1016/j.bandl.2005.01.008; STERNBERG S, 1980, PERCEPTION PRODUCTIO, P507; Sternberg S., 1978, INFORMATION PROCESSI, P117, DOI DOI 10.1016/B978-0-12-665960-3.50011-6; Tjaden K, 2005, J SPEECH LANG HEAR R, V48, P554, DOI 10.1044/1092-4388(2005/038); van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Vitevitch MS, 2004, J EXP PSYCHOL LEARN, V30, P514, DOI 10.1037/0278-7393.30.2.514; YORKSTON KM, 1984, ASSESSMENT INTELLIGE; Yunusova Y, 2008, J SPEECH LANG HEAR R, V51, P596, DOI 10.1044/1092-4388(2008/043)	76	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77450	10.1371/journal.pone.0077450	http://dx.doi.org/10.1371/journal.pone.0077450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146997	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400108
J	Gomez-Cabello, D; Jimeno, S; Fernandez-Avila, MJ; Huertas, P				Gomez-Cabello, Daniel; Jimeno, Sonia; Jesus Fernandez-Avila, Maria; Huertas, Pablo			New Tools to Study DNA Double-Strand Break Repair Pathway Choice	PLOS ONE			English	Article							END RESECTION; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; DAMAGE RESPONSE; INSTABILITY; MECHANISM; INSIGHTS	A broken DNA molecule is difficult to repair, highly mutagenic, and extremely cytotoxic. Such breaks can be repaired by homology-independent or homology-directed mechanisms. Little is known about the network that controls the repair pathway choice except that a licensing step for homology-mediated repair exists, called DNA-end resection. The choice between these two repair pathways is a key event for genomic stability maintenance, and an imbalance of the ratio is directly linked with human diseases, including cancer. Here we present novel reporters to study the balance between both repair options in human cells. In these systems, a double-strand break can be alternatively repaired by homology-independent or -dependent mechanisms, leading to the accumulation of distinct fluorescent proteins. These reporters thus allow the balance between both repair pathways to be analyzed in different experimental setups. We validated the reporters by analyzing the effect of protein downregulation of the DNA end resection and non-homologous end-joining pathways. Finally, we analyzed the role of the DNA damage response on double-strand break (DSB) repair mechanism selection. Our reporters could be used in the future to understand the roles of specific factors, whole pathways, or drugs in DSB repair pathway choice, or for genome-wide screening. Moreover, our findings can be applied to increase gene-targeting efficiency, making it a beneficial tool for a broad audience in the biological sciences.	[Gomez-Cabello, Daniel; Jimeno, Sonia; Jesus Fernandez-Avila, Maria; Huertas, Pablo] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain; [Jimeno, Sonia; Huertas, Pablo] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Huertas, P (corresponding author), Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain.	pablo.huertas@cabimer.es	Jimeno, Sonia/C-2514-2017; Jimeno González, Sonia/GJM-5073-2022; Gómez-Cabello, Daniel/AAJ-7788-2021; Huertas, Pablo/N-2245-2016	Jimeno González, Sonia/0000-0002-7034-0081; Gómez-Cabello, Daniel/0000-0002-2807-8438; Huertas, Pablo/0000-0002-1756-4449; Fernandez Avila, Maria Jesus/0000-0001-8476-9922	Spanish Ministry of Economy and Competitivity [SAF2010-14877]; European Research Council (ERC)	Spanish Ministry of Economy and Competitivity(Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work has been funded by a R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2010-14877) and an European Research Council (ERC) Starting Grant (DSBRECA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aylon Y, 2004, MUTAT RES-REV MUTAT, V566, P231, DOI 10.1016/j.mrrev.2003.10.001; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Munoz-Galvan S, 2013, NUCLEIC ACIDS RES, V41, P1669, DOI 10.1093/nar/gks1274; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	28	30	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77206	10.1371/journal.pone.0077206	http://dx.doi.org/10.1371/journal.pone.0077206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155929	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300063
J	Taylor, ML; Evans, JP; Garcia-Gonzalez, F				Taylor, Michelle L.; Evans, Jonathan P.; Garcia-Gonzalez, Francisco			No Evidence for Heritability of Male Mating Latency or Copulation Duration across Social Environments in Drosophila melanogaster	PLOS ONE			English	Article							SEXUAL SELECTION; FERTILIZATION SUCCESS; GENETIC VARIANCE; MATE CHOICE; SPERM COMPETITION; FEMALE FITNESS; FIELD CRICKET; COURTSHIP; QUALITY; RELIABILITY	A key assumption underpinning major models of sexual selection is the expectation that male sexual attractiveness is heritable. Surprisingly, however, empirical tests of this assumption are relatively scarce. Here we use a paternal full-sib/half-sib breeding design to examine genetic and environmental variation in male mating latency (a proxy for sexual attractiveness) and copulation duration in a natural population of Drosophila melanogaster. As our experimental design also involved the manipulation of the social environment within each full-sibling family, we were able to further test for the presence of genotype-by-environment interactions (GEIs) in these traits, which have the potential to compromise mate choice for genetic benefits. Our experimental manipulation of the social environment revealed plastic expression of both traits; males exposed to a rival male during the sensitive period of adult sexual maturation exhibited shorter mating latencies and longer copulation durations than those who matured in isolation. However, we found no evidence for GEIs, and no significant additive genetic variation underlying these traits in either environment. These results undermine the notion that the evolution of female choice rests on covariance between female preference and male displays, an expectation that underpins indirect benefit models such as the good genes and sexy sons hypotheses. However, our results may also indicate depletion of genetic variance in these traits in the natural population studied, thus supporting the expectation that traits closely aligned with reproductive fitness can exhibit low levels of additive genetic variance.	[Taylor, Michelle L.] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Evans, Jonathan P.; Garcia-Gonzalez, Francisco] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, WA, Australia; [Garcia-Gonzalez, Francisco] Spanish Res Council CSIC, Biol Donana Stn, Seville, Spain	University of Exeter; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC)	Taylor, ML (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, England.	m.l.taylor@exeter.ac.uk	Evans, Jonathan/A-1992-2011; Garcia-Gonzalez, Francisco/A-3780-2008	Garcia-Gonzalez, Francisco/0000-0001-9515-9038; Taylor, Michelle/0000-0001-5435-9623	Australian Research Council; Spanish Ministry of Economy through the Ramon y Cajal program; European Regional Development Fund [CGL2012-34685]	Australian Research Council(Australian Research Council); Spanish Ministry of Economy through the Ramon y Cajal program; European Regional Development Fund(European Commission)	Funding for this work was provided by the Australian Research Council Discovery Projects and ARC fellowships) to JPE and FGG. During the preparation of the manuscript FGG was also supported by the the Spanish Ministry of Economy through the Ramon y Cajal program and grant (co-funded by the European Regional Development Fund) CGL2012-34685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Bates D, 2013, ME4 LINEAR MIXED EFF; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Boake CRB, 1998, EVOLUTION, V52, P1487, DOI 10.1111/j.1558-5646.1998.tb02030.x; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Byrne PG, 2005, J EVOLUTION BIOL, V18, P1324, DOI 10.1111/j.1420-9101.2005.00918.x; Conner JK, 2003, EVOLUTION, V57, P487, DOI 10.1111/j.0014-3820.2003.tb01540.x; Core R Team, 2013, R LANG ENV STAT COMP; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Fisher R.A., 1930, GENETICAL THEORY NAT; Garcia-Gonzalez F, 2004, BEHAV ECOL, V15, P23, DOI 10.1093/beheco/arg095; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; Garcia-Gonzalez F, 2011, EVOLUTION, V65, P746, DOI 10.1111/j.1558-5646.2010.01127.x; Garcia-Gonzalez F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-140; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Hine E, 2002, P ROY SOC B-BIOL SCI, V269, P2215, DOI 10.1098/rspb.2002.2149; HOFFMANN AA, 1991, AM NAT, V138, P668, DOI 10.1086/285241; Hoffmann AA, 1999, HEREDITY, V82, P158, DOI 10.1038/sj.hdy.6884640; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; HOULE D, 1992, GENETICS, V130, P195; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2008, GENETICA, V132, P209, DOI 10.1007/s10709-007-9166-1; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Lize A, 2012, BIOL LETTERS, V8, P35, DOI 10.1098/rsbl.2011.0544; Lynch M., 1998, GENETICS ANAL QUANTI; Mills SC, 2007, EVOLUTION, V61, P1748, DOI 10.1111/j.1558-5646.2007.00145.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Petfield D, 2005, P NATL ACAD SCI USA, V102, P6045, DOI 10.1073/pnas.0409378102; Priest NK, 2008, AM NAT, V171, P10, DOI 10.1086/523944; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Roff DA, 2008, HEREDITY, V100, P32, DOI 10.1038/sj.hdy.6801048; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Rundle HD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-36; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P129, DOI 10.1007/BF02395441; StatSoft Inc, 2007, TAT DAT AN SOFTW SYS; Stewart AD, 2008, J EVOLUTION BIOL, V21, P1808, DOI 10.1111/j.1420-9101.2008.01593.x; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Taylor ML, 2008, ANIM BEHAV, V76, P963, DOI 10.1016/j.anbehav.2008.05.015; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Thomas ML, 2011, ANIM BEHAV, V82, P49, DOI 10.1016/j.anbehav.2011.03.023; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Watson NL, 2012, EVOL ECOL, V26, P139, DOI 10.1007/s10682-011-9484-8; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	61	10	11	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77347	10.1371/journal.pone.0077347	http://dx.doi.org/10.1371/journal.pone.0077347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155948	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300082
J	Pong, WW; Walker, J; Wylie, T; Magrini, V; Luo, JQ; Emnett, RJ; Choi, J; Cooper, ML; Griffith, M; Griffith, OL; Rubin, JB; Fuller, GN; Piwnica-Worms, D; Feng, X; Hambardzumyan, D; DiPersio, JF; Mardis, ER; Gutmann, DH				Pong, Winnie W.; Walker, Jason; Wylie, Todd; Magrini, Vincent; Luo, Jingqin; Emnett, Ryan J.; Choi, Jaebok; Cooper, Matthew L.; Griffith, Malachi; Griffith, Obi L.; Rubin, Joshua B.; Fuller, Gregory N.; Piwnica-Worms, David; Feng, Xi; Hambardzumyan, Dolores; DiPersio, John F.; Mardis, Elaine R.; Gutmann, David H.			F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; GENE-EXPRESSION; IN-VIVO; CELL; MICROGLIA; IDENTIFICATION; TRANSCRIPTS; RELEVANT; REVEALS; ROLES	Objective: Brain tumors (gliomas) contain large populations of infiltrating macrophages and recruited microglia, which in experimental murine glioma models promote tumor formation and progression. Among the barriers to understanding the contributions of these stromal elements to high-grade glioma (glioblastoma; GBM) biology is the relative paucity of tools to characterize infiltrating macrophages and resident microglia. In this study, we leveraged multiple RNA analysis platforms to identify new monocyte markers relevant to GBM patient outcome. Methods: High-confidence lists of mouse resident microglia-and bone marrow-derived macrophage-specific transcripts were generated using converging RNA-seq and microarray technologies and validated using qRT-PCR and flow cytometry. Expression of select cell surface markers was analyzed in brain-infiltrating macrophages and resident microglia in an induced GBM mouse model, while allogeneic bone marrow transplantation was performed to trace the origins of infiltrating and resident macrophages. Glioma tissue microarrays were examined by immunohistochemistry, and the Gene Expression Omnibus (GEO) database was queried to determine the prognostic value of identified microglia biomarkers in human GBM. Results: We generated a unique catalog of differentially-expressed bone marrow-derived monocyte and resident microglia transcripts, and demonstrated that brain-infiltrating macrophages acquire F11R expression in GBM and following bone-marrow transplantation. Moreover, mononuclear cell F11R expression positively correlates with human high-grade glioma and additionally serves as a biomarker for GBM patient survival, regardless of GBM molecular subtype. Significance: These studies establish F11R as a novel monocyte prognostic marker for GBM critical for defining a subpopulation of stromal cells for future potential therapeutic intervention.	[Pong, Winnie W.; Emnett, Ryan J.; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Walker, Jason; Wylie, Todd; Magrini, Vincent; Griffith, Malachi; Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Luo, Jingqin] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Cooper, Matthew L.; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; [Fuller, Gregory N.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Feng, Xi; Hambardzumyan, Dolores] Cleveland Clin Fdn, Dept Stem Cell Biol & Regenerat, Cleveland, OH 44195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Cleveland Clinic Foundation	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	gutmannd@neuro.wustl.edu	Feng, Xi/N-7160-2016; Magrini, Vincent/AAT-5830-2020; Griffith, Malachi/P-1285-2014; Mardis, Elaine/W-2202-2019; Griffith, Obi/P-1286-2014	Feng, Xi/0000-0002-6920-1519; Magrini, Vincent/0000-0002-2019-4872; Griffith, Malachi/0000-0002-6388-446X; Fuller, Gregory/0000-0001-9447-2647; Choi, Jaebok/0000-0002-5590-087X; Griffith, Obi/0000-0002-0843-4271; Gutmann, David/0000-0002-3127-5045; Pong, Winnie/0000-0001-8254-3305	National Cancer Institute [U01-CA160882, U01-CA141549]; National Institutes of Health [RC4-NS072916]; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [P30CA091842, U01CA160882, U01CA141549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS072916] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Cancer Institute (U01-CA160882 to DH and DHG; U01-CA141549 to DHG) and National Institutes of Health (RC4-NS072916 to DHG). WWP was partly supported by a grant from the W. M. Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bengtsson H, 2008, TECH REP, P1; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Levy A, 2012, NEURO-ONCOLOGY, V14, P1037, DOI 10.1093/neuonc/nos121; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Markovic DS, 2011, BRAIN BEHAV IMMUN, V25, P624, DOI 10.1016/j.bbi.2011.01.015; Murakami M, 2010, CANCER RES, V70, P1759, DOI 10.1158/0008-5472.CAN-09-1703; Pong WW, 2013, ANN NEUROL, V73, P303, DOI 10.1002/ana.23813; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rodero M, 2008, J CLIN ONCOL, V26, P5957, DOI 10.1200/JCO.2008.17.2833; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; Woodfin A, 2007, BLOOD, V110, P1848, DOI 10.1182/blood-2006-09-047431; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	41	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77571	10.1371/journal.pone.0077571	http://dx.doi.org/10.1371/journal.pone.0077571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147027	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400126
J	Tennakoon, JB; Shi, Y; Han, JJ; Tsouko, E; White, MA; Burns, AR; Zhang, A; Xia, X; Ilkayeva, OR; Xin, L; Ittmann, MM; Rick, FG; Schally, AV; Frigo, DE				Tennakoon, J. B.; Shi, Y.; Han, J. J.; Tsouko, E.; White, M. A.; Burns, A. R.; Zhang, A.; Xia, X.; Ilkayeva, O. R.; Xin, L.; Ittmann, M. M.; Rick, F. G.; Schally, A. V.; Frigo, D. E.			Androgens regulate prostate cancer cell growth via an AMPK-PGC-1 alpha-mediated metabolic switch	ONCOGENE			English	Article						androgen receptor; prostate cancer; AMP-activated protein kinase; peroxisome proliferator-activated receptor gamma coactivator 1 alpha; metabolism	FATTY-ACID OXIDATION; PROTEIN-KINASE AMPK; SKELETAL-MUSCLE; MOLECULAR-FEATURES; EXPRESSION; GLUCOSE; PROMOTES; PATHWAY; PHOSPHORYLATION; C-11-ACETATE	Prostate cancer is the most commonly diagnosed malignancy among men in industrialized countries, accounting for the second leading cause of cancer-related deaths. Although we now know that the androgen receptor (AR) is important for progression to the deadly advanced stages of the disease, it is poorly understood what AR-regulated processes drive this pathology. Here we demonstrate that AR regulates prostate cancer cell growth via the metabolic sensor 5'-AMP-activated protein kinase (AMPK), a kinase that classically regulates cellular energy homeostasis. In patients, activation of AMPK correlated with prostate cancer progression. Using a combination of radiolabeled assays and emerging metabolomic approaches, we also show that prostate cancer cells respond to androgen treatment by increasing not only rates of glycolysis, as is commonly seen in many cancers, but also glucose and fatty acid oxidation. Importantly, this effect was dependent on androgen-mediated AMPK activity. Our results further indicate that the AMPK-mediated metabolic changes increased intracellular ATP levels and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha)-mediated mitochondrial biogenesis, affording distinct growth advantages to the prostate cancer cells. Correspondingly, we used outlier analysis to determine that PGC-1 alpha is overexpressed in a subpopulation of clinical cancer samples. This was in contrast to what was observed in immortalized benign human prostate cells and a testosterone-induced rat model of benign prostatic hyperplasia. Taken together, our findings converge to demonstrate that androgens can co-opt the AMPK-PGC-1 alpha signaling cascade, a known homeostatic mechanism, to increase prostate cancer cell growth. The current study points to the potential utility of developing metabolic-targeted therapies directed toward the AMPK-PGC-1 alpha signaling axis for the treatment of prostate cancer.	[Tennakoon, J. B.; Shi, Y.; Han, J. J.; Tsouko, E.; White, M. A.; Frigo, D. E.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Burns, A. R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Zhang, A.; Xia, X.; Frigo, D. E.] Houston Methodist Res Inst, Ctr Genom Med, Houston, TX USA; [Ilkayeva, O. R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Xin, L.] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA; [Xin, L.] Baylor Coll Med, Dept Cellular Biol, Houston, TX 77030 USA; [Xin, L.; Ittmann, M. M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Xin, L.; Ittmann, M. M.] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Xin, L.; Ittmann, M. M.] Dan L Duncan Canc Ctr, Houston, TX USA; [Ittmann, M. M.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Rick, F. G.; Schally, A. V.] Vet Affairs Med Ctr, Miami, FL 33125 USA; [Rick, F. G.; Schally, A. V.] South Florida VA Fdn Res & Educ, Miami, FL 33125 USA; [Rick, F. G.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Urol, Miami, FL 33199 USA; [Schally, A. V.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Schally, A. V.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Miami, FL 33136 USA; [Schally, A. V.] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol, Miami, FL USA	University of Houston System; University of Houston; University of Houston System; University of Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Duke University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; Florida International University; University of Miami; University of Miami; University of Miami	Frigo, DE (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, 3605 Cullen Blvd,Bldg 545, Houston, TX 77204 USA.	frigo@uh.edu		Rick, Ferenc/0000-0001-6549-7597; Schally, Andrew/0000-0003-1273-6747; Frigo, Daniel/0000-0002-0713-471X	NIH [K01DK084205, P30EY007551, R00CA125937, P30CA125123]; DoD/PCRP grant [W81XWH-12-1-0204]; CPRIT grant [RP110005]; Texas Emerging Technology Fund; Golfers Against Cancer; Urology Care Foundation Research Scholars Program; AUA Southeastern Section; NATIONAL CANCER INSTITUTE [P30CA125123, R00CA125937] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD/PCRP grant; CPRIT grant; Texas Emerging Technology Fund; Golfers Against Cancer; Urology Care Foundation Research Scholars Program; AUA Southeastern Section; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Frigo Laboratory for technical advice, helpful suggestions and critical comments on this study and manuscript. We also thank Paul Landry for his assistance with Amira and mitochondrial volume measurements, the Duke University Department of Pathology's Electron Microscopy Core for help with transmission electron microscopy; Drs Dean Tang, Geoffrey Girnun and Thomas Westbrook for generously providing the LAPC9-derived tumors, shPGC-1 alpha constructs and pINDUCER22, respectively; Drs Timothy Koves and Pradip Saha for their advice on the CO<INF>2</INF> trap assays; Dr Christopher Newgard for help with the metabolomics; and Drs Sean McGuire and Kevin Phillips for critically reading this manuscript. This work was supported by NIH grants K01DK084205 (DEF), P30EY007551 (ARB), R00CA125937 (LX), P30CA125123 (Dan L Duncan Cancer Center Human Tissue Acquisition and Pathology Core), DoD/PCRP grant W81XWH-12-1-0204 (DEF), CPRIT grant RP110005 (LX) and grants from the Texas Emerging Technology Fund, the Golfers Against Cancer (DEF), the Urology Care Foundation Research Scholars Program and AUA Southeastern Section (FGR).	Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cormio A, 2009, BIOCHEM BIOPH RES CO, V390, P1182, DOI 10.1016/j.bbrc.2009.10.114; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Dakubo GD, 2006, J CLIN PATHOL, V59, P10, DOI 10.1136/jcp.2005.027664; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Jung SN, 2009, EXP CELL RES, V315, P2433, DOI 10.1016/j.yexcr.2009.05.018; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; Klimcakova E, 2012, CANCER RES, V72, P1538, DOI 10.1158/0008-5472.CAN-11-2967; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YY, 2010, ANTICANCER RES, V30, P369; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; O'Mahony F, 2012, MOL ENDOCRINOL, V26, P2058, DOI 10.1210/me.2012-1191; Oyama N, 2003, J NUCL MED, V44, P549; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Pillarsetty NV, 2009, J NUCL MED, V50, P1709, DOI 10.2967/jnumed.109.064212; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rick FG, 2011, P NATL ACAD SCI USA, V108, P3755, DOI 10.1073/pnas.1018086108; Rick FG, 2011, PROSTATE, V71, P736, DOI 10.1002/pros.21289; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shiota M, 2010, MOL ENDOCRINOL, V24, P114, DOI 10.1210/me.2009-0302; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stoss O, 2008, PROSTATE CANCER P D, V11, P166, DOI 10.1038/sj.pcan.4501001; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu EY, 2011, CLIN NUCL MED, V36, P192, DOI 10.1097/RLU.0b013e318208f140; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177; Zhang B, 2014, ONCOGENE, V33, P3099, DOI 10.1038/onc.2013.281	62	140	145	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5251	5261		10.1038/onc.2013.463	http://dx.doi.org/10.1038/onc.2013.463			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24186207	Green Accepted			2022-12-25	WOS:000345120400003
J	Shen, K; Wang, YQ; Fu, YHH; Zhang, Q; Feigon, J; Shan, SO				Shen, Kuang; Wang, Yaqiang; Fu, Yu-Hsien Hwang; Zhang, Qi; Feigon, Juli; Shan, Shu-ou			Molecular Mechanism of GTPase Activation at the Signal Recognition Particle (SRP) RNA Distal End	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Nuclear Magnetic Resonance; Protein Targeting; Protein-Nucleic Acid Interaction; RNA; Single Molecule Biophysics	RESIDUAL DIPOLAR COUPLINGS; ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; TRANSLATING RIBOSOME; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 4.5S RNA; RECEPTOR; MEMBRANE; DYNAMICS	Background: A large GTPase movement on the signal recognition particle (SRP) RNA activates GTP hydrolysis to complete protein targeting. Results: GTPase activation requires distinct primary and secondary docking sites and catalytic bases, optimally positioned on the SRP RNA. Conclusion: The SRP RNA forms a preorganized surface to mediate specific GTPase activation. Significance: Study of the SRP RNA broadens our understanding of RNA-protein recognition and protein targeting. The signal recognition particle (SRP) RNA is a universally conserved and essential component of the SRP that mediates the co-translational targeting of proteins to the correct cellular membrane. During the targeting reaction, two functional ends in the SRP RNA mediate distinct functions. Whereas the RNA tetraloop facilitates initial assembly of two GTPases between the SRP and SRP receptor, this GTPase complex subsequently relocalizes approximate to 100 to the 5,3-distal end of the RNA, a conformation crucial for GTPase activation and cargo handover. Here we combined biochemical, single molecule, and NMR studies to investigate the molecular mechanism of this large scale conformational change. We show that two independent sites contribute to the interaction of the GTPase complex with the SRP RNA distal end. Loop E plays a crucial role in the precise positioning of the GTPase complex on these two sites by inducing a defined bend in the RNA helix and thus generating a preorganized recognition surface. GTPase docking can be uncoupled from its subsequent activation, which is mediated by conserved bases in the next internal loop. These results, combined with recent structural work, elucidate how the SRP RNA induces GTPase relocalization and activation at the end of the protein targeting reaction.	[Shen, Kuang; Fu, Yu-Hsien Hwang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Wang, Yaqiang; Zhang, Qi; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Wang, Yaqiang/C-4705-2008; Zhang, Qi/B-5869-2014; Shen, Kuang/H-9441-2016	Wang, Yaqiang/0000-0002-6822-4778; Zhang, Qi/0000-0003-1754-4058; Hwang-Fu, Yu-Hsien/0000-0002-2861-4843	National Institutes of Health [GM078024, GM048123, GM45162]; Caltech Matching Fund [350270]; David and Lucile Packard Fellowship in Science and Engineering; Henry Dreyfus teacher-scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162, R01GM078024, R01GM048123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Matching Fund; David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Henry Dreyfus teacher-scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078024 (to S.-o. S.) and GM048123 (to J. F.) and a National Institutes of Health instrument supplement to Grant GM45162 (to D. C. Rees). This work was also supported by Caltech Matching Fund 350270 for the single molecule instruments, the David and Lucile Packard Fellowship in Science and Engineering (to S.-o. S.), and a Henry Dreyfus teacher-scholar award (to S.-o. S.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bailor MH, 2007, NAT PROTOC, V2, P1536, DOI 10.1038/nprot.2007.221; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2001, J MOL BIOL, V307, P229, DOI 10.1006/jmbi.2000.4454; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1997, J BIOMOL NMR, V9, P259, DOI 10.1023/A:1018622708674; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Flinders J, 2006, PROG NUCL MAG RES SP, V48, P137, DOI 10.1016/j.pnmrs.2006.03.001; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hansen AL, 2006, J MAGN RESON, V179, P299, DOI 10.1016/j.jmr.2005.12.012; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lentzen G, 1996, RNA, V2, P244; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Meissner A, 1999, J MAGN RESON, V139, P439, DOI 10.1006/jmre.1999.1788; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Voigts-Hoffmann F, 2013, MOL CELL; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WILSON C, 1988, J CELL BIOL, V107, P69, DOI 10.1083/jcb.107.1.69; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	48	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36385	36397		10.1074/jbc.M113.513614	http://dx.doi.org/10.1074/jbc.M113.513614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24151069	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000328883400020
J	Anders, K; Daminelli-Widany, G; Mroginski, MA; von Stetten, D; Essen, LO				Anders, Katrin; Daminelli-Widany, Grazia; Mroginski, Maria Andrea; von Stetten, David; Essen, Lars-Oliver			Structure of the Cyanobacterial Phytochrome 2 Photosensor Implies a Tryptophan Switch for Phytochrome Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Protein Conformation; Signal Transduction; Signaling; Structural Biology; Biliprotein; c-di-GMP Signaling; Photochromicity; Phytochrome; Red Light Photoreceptor	PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; CHROMOPHORE; PHOTOCONVERSION; STATE; PHOTOTAXIS; HOLOPHYTOCHROME; TRANSITION; LINKAGE; DOMAIN	Background: Phytochromes are red/far-red photoreceptors using a bilin chromophore. Results: Compared with Cph1, the Cph2 bilin-binding site differs around the propionates, but utilizes an otherwise conserved tongue for sealing the chromophore from solvent. Conclusion: The tongue signals via a tryptophan switch within the tongue-GAF domain interface. Significance: The first structure of a Cph2-type phytochrome indicates a common mechanism for photoswitching in all canonical phytochromes. Phytochromes are highly versatile photoreceptors, which occur ubiquitously in plants as well as in many light-responsive microorganisms. Here, photosynthetic cyanobacteria utilize up to three different phytochrome architectures, where only the plant-like and the single-domain cyanobacteriochromes are structurally characterized so far. Cph2 represents a third group in Synechocystis species and affects their capability of phototaxis by controlling c-di-GMP synthesis and degradation. The 2.6- crystal structure of its red/far-red responsive photosensory module in the P-r state reveals a tandem-GAF bidomain that lacks the figure-of-eight knot of the plant/cph1 subfamily. Its covalently attached phycocyanobilin chromophore adopts a highly tilted ZZZssa conformation with a novel set of interactions between its propionates and the GAF1 domain. The tongue-like protrusion from the GAF2 domain interacts with the GAF1-bound chromophore via its conserved PRXSF, WXE, and W(G/A)G motifs. Mutagenesis showed that the integrity of the tongue is indispensable for P-r P-fr photoconversion and involves a swap of the motifs' tryptophans within the tongue-GAF1 interface. This Trp switch is supposed to be a crucial element for the photochromicity of all multidomain phytochromes.	[Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Biomed Res Ctr, Dept Chem, D-35032 Marburg, Germany; [Daminelli-Widany, Grazia; Mroginski, Maria Andrea] Tech Univ Berlin, Dept Chem, D-10623 Berlin, Germany; [von Stetten, David] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Philipps University Marburg; Technical University of Berlin; European Synchrotron Radiation Facility (ESRF)	Essen, LO (corresponding author), Univ Marburg, Biomed Res Ctr FB15, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026; von Stetten, David/0000-0001-7906-9788	Deutsche Forschungsgemeinschaft Grants [ES152/9-1, MR81/3-1]; LOEWE Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology	This work was supported by Deutsche Forschungsgemeinschaft Grants ES152/9-1 and MR81/3-1 and the LOEWE Center for Synthetic Microbiology (to L.-O. E.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders K, 2011, PHOTOCHEM PHOTOBIOL, V87, P160, DOI 10.1111/j.1751-1097.2010.00845.x; Bakowies D, 1996, J PHYS CHEM-US, V100, P10580, DOI 10.1021/jp9536514; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Billeter SR, 2000, PHYS CHEM CHEM PHYS, V2, P2177, DOI 10.1039/a909486e; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; BUTLER WL, 1959, P NATL ACAD SCI USA, V45, P1703, DOI 10.1073/pnas.45.12.1703; Carpentier P, 2007, J APPL CRYSTALLOGR, V40, P1113, DOI 10.1107/S0021889807044202; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fiedler B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1481, DOI 10.1562/2005-06-28-RA-592; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jain R, 2012, J BACTERIOL, V194, P4285, DOI 10.1128/JB.00803-12; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Landgraf FT, 2001, FEBS LETT, V508, P459, DOI 10.1016/S0014-5793(01)02988-X; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Mailliet J, 2009, ACTA CRYSTALLOGR D, V65, P1232, DOI 10.1107/S0907444909034106; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Park CM, 2000, BIOCHEMISTRY-US, V39, P6349, DOI 10.1021/bi992916s; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Shang LX, 2010, BIOCHEMISTRY-US, V49, P6070, DOI 10.1021/bi100756x; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wilde A, 2002, MOL MICROBIOL, V44, P981, DOI 10.1046/j.1365-2958.2002.02923.x; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105	44	66	67	4	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35714	35725		10.1074/jbc.M113.510461	http://dx.doi.org/10.1074/jbc.M113.510461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174528	Green Published, hybrid			2022-12-25	WOS:000329814700010
J	Li, M; Khambu, B; Zhang, H; Kang, JH; Chen, XY; Chen, DH; Vollmer, L; Liu, PQ; Vogt, A; Yin, XM				Li, Min; Khambu, Bilon; Zhang, Hao; Kang, Jeong-Han; Chen, Xiaoyun; Chen, Daohong; Vollmer, Laura; Liu, Pei-Qing; Vogt, Andreas; Yin, Xiao-Ming			Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Biology; Lysosomes; mTOR; Signal Transduction	RAG GTPASES; ATG12-ATG5 CONJUGATE; CHEMICAL MODULATORS; NICLOSAMIDE; MECHANISM; PROTEIN; TFEB; ACTIVATION; RAGULATOR; MEMBRANE	Background: Lysosomes are required for autophagic degradation, which can be suppressed by lysosome inhibitors. Results: Inhibition of lysosome function resulted in autophagy activation via down-regulation of MTORC1. Conclusion: Lysosomes can affect autophagy initiation in addition to its role in autophagy degradation. Significance: The finding expands lysosome function to include regulation of autophagy activation and indicates a dual effect of lysosome inhibitors in autophagy. Autophagy can be activated via MTORC1 down-regulation by amino acid deprivation and by certain chemicals such as rapamycin, torin, and niclosamide. Lysosome is the degrading machine for autophagy but has also been linked to MTORC1 activation through the Rag/RRAG GTPase pathway. This association raises the question of whether lysosome can be involved in the initiation of autophagy. Toward this end, we found that niclosamide, an MTORC1 inhibitor, was able to inhibit lysosome degradation and increase lysosomal permeability. Niclosamide was ineffective in inhibiting MTORC1 in cells expressing constitutively activated Rag proteins, suggesting that its inhibitory effects were targeted to the Rag-MTORC1 signaling system. This places niclosamide in the same category of bafilomycin A(1) and concanamycin A, inhibitors of the vacuolar H+-ATPase, for its dependence on Rag GTPase in suppression of MTORC1. Surprisingly, classical lysosome inhibitors such as chloroquine, E64D, and pepstatin A were also able to inhibit MTORC1 in a Rag-dependent manner. These lysosome inhibitors were able to activate early autophagy events represented by ATG16L1 and ATG12 puncta formation. Our work established a link between the functional status of the lysosome in general to the Rag-MTORC1 signaling axis and autophagy activation. Thus, the lysosome is not only required for autophagic degradation but also affects autophagy activation. Lysosome inhibitors can have a dual effect in suppressing autophagy degradation and in initiating autophagy.	[Li, Min; Khambu, Bilon; Zhang, Hao; Chen, Xiaoyun; Chen, Daohong; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Li, Min; Liu, Pei-Qing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Kang, Jeong-Han] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Vollmer, Laura; Vogt, Andreas] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Sun Yat Sen University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, W 350 11th St, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Khambu, Bilon/P-6148-2019; Kang, Jeong-Han/J-3541-2019; Li, Min/B-1281-2011	Kang, Jeong-Han/0000-0002-9693-0696; Khambu, Bilon/0000-0002-9432-2064; li, min/0000-0002-5657-8675	NCI; NIMH, National Institutes of Health [R03MH083154, R01CA111456, R01CA 83817]; NCI, National Institutes of Health Grant [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA083817, P30CA047904, R01CA111456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH083154] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NCI and NIMH, National Institutes of Health Grants R03MH083154, R01CA111456, and R01CA 83817 (to X.-M. Y.). This work used the UPCI Chemical Biology facility that is supported in part by NCI, National Institutes of Health Grant P30CA047904.	Baek KH, 2012, CHEM SOC REV, V41, P3245, DOI 10.1039/c2cs15328a; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Cho YS, 2010, ARCH PHARM RES, V33, P1881, DOI 10.1007/s12272-010-1201-6; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; DITZEL J, 1967, ACTA MED SCAND, V182, P663; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Juhasz G, 2012, AUTOPHAGY, V8, P1875, DOI 10.4161/auto.21544; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yin X.-M., 2010, PUBCHEM BIOASSAY; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhang Y., 2012, PLOS ONE, V7; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	45	125	127	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35769	35780		10.1074/jbc.M113.511212	http://dx.doi.org/10.1074/jbc.M113.511212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174532	Green Published, hybrid			2022-12-25	WOS:000329814700015
J	Al-Khalaf, HH; Mohideen, P; Nallar, SC; Kalvakolanu, DV; Aboussekhra, A				Al-Khalaf, Huda H.; Mohideen, Peer; Nallar, Shreeram C.; Kalvakolanu, Dhananjaya V.; Aboussekhra, Abdelilah			The Cyclin-dependent Kinase Inhibitor p16(INK4a) Physically Interacts with Transcription Factor Sp1 and Cyclin-dependent Kinase 4 to Transactivate MicroRNA-141 and MicroRNA-146b-5p Spontaneously and in Response to Ultraviolet Light-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Complexes; Protein-DNA Interaction; shRNA; Signaling; Tumor suppressor gene	PROMOTES CELL-SURVIVAL; TUMOR-SUPPRESSOR; MIR-200 FAMILY; CANCER; GENE; EXPRESSION; SENESCENCE; IDENTIFICATION; INDUCTION; REGULATOR	Background: The cyclin-dependent kinase inhibitor p16(INK4a) is also a modulator of gene expression through an unknown mechanism. Results: p16(INK4a)-CDK4 forms a heterocomplex with Sp1, which induces the expression and UV-dependent up-regulation of miR-141 and miR-146b-5p. Conclusion: p16(INK4a)-CDK4 complex has transcriptional activity through interaction with the transcription factor Sp1. Significance: The microRNAs are novel effectors of the p16(INK4a)-CDK4 complex. p16(INK4a) is a tumor suppressor protein involved in several stress-related cellular responses, including apoptosis. Recent lines of evidence indicate that p16(INK4a) is also a modulator of gene expression. However, the molecular mechanisms underlying this novel function are still obscure. Here, we present clear evidence that p16(INK4a) modulates the levels of various microRNAs, with marked positive effect on miR-141 and miR-146b-5p. This effect is mediated through the formation of the p16-CDK4-Sp1 heterocomplex, which binds to Sp1 consensus-binding motifs present in the promoters of miR-141 and miR-146b-5p, and it enables their transcription. In addition, we have shown that p16(INK4a) interacts with Sp1 through the fourth ankyrin repeat, which is crucial for Sp1 binding to the miR-141 and miR-146b-5p promoters and their transcriptional activation. The physiological importance of this association was revealed by the inability of cancer-related p16(INK4a) mutants to interact with Sp1. Moreover, we have shown p16-CDK4-Sp1-dependent up-regulation of miR-141 and miR-146b-5p following UV light-induced DNA damage and the role of these two microRNAs in mediating p16-related induction of apoptosis in response to this genotoxic stress. Together, these results indicate that p16(INK4a) associates with CDK4 not only to inhibit the cell cycle but also to enable the transcription of two important onco-microRNAs, which act as downstream effectors.	[Al-Khalaf, Huda H.; Mohideen, Peer; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh 11211, Saudi Arabia; [Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	King Faisal Specialist Hospital & Research Center; University System of Maryland; University of Maryland Baltimore	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019	Abubucker, Peer Mohideen/0000-0002-1895-3585	National Institutes of Health [CA105005]; Research Advisory Council [2090027]; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Advisory Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA105005 (to D. V. K). This work was also supported by Research Advisory Council Proposal 2090027.	Al-Khalaf HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070133; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Al-Khalaf HH, 2011, MOL CANCER RES, V9, P311, DOI 10.1158/1541-7786.MCR-10-0506; Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Arslan AA, 2012, BREAST CANCER RES TR, V134, P981, DOI 10.1007/s10549-012-2017-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chien WW, 2011, ONCOGENE, V30, P1880, DOI 10.1038/onc.2010.570; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P94, DOI 10.1016/j.mrgentox.2010.05.006; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Mansilla S, 2008, BIOCHIMIE, V90, P976, DOI 10.1016/j.biochi.2007.12.008; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Oleaga C, 2012, BIOCHEM PHARMACOL, V84, P1581, DOI 10.1016/j.bcp.2012.09.014; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sabir M, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-11; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Sun P, 2010, J BIOL CHEM, V285, P27545, DOI 10.1074/jbc.M110.105767; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	51	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35511	35525		10.1074/jbc.M113.512640	http://dx.doi.org/10.1074/jbc.M113.512640			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163379	Green Published, hybrid			2022-12-25	WOS:000329867600046
J	Brahme, NN; Harburger, DS; Kemp-O'Brien, K; Stewart, R; Raghavan, S; Parsons, M; Calderwood, DA				Brahme, Nina N.; Harburger, David S.; Kemp-O'Brien, Karl; Stewart, Rachel; Raghavan, Srikala; Parsons, Maddy; Calderwood, David A.			Kindlin Binds Migfilin Tandem LIM Domains and Regulates Migfilin Focal Adhesion Localization and Recruitment Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Adhesion; Cytoskeleton; Fluorescence Resonance Energy Transfer (FRET); Integrin; LIM Domain; Focal Adhesion; Kindlin; Migfilin	INTEGRIN-BETA TAILS; FILAMIN-BINDING; CELL; ACTIVATION; MIGRATION; PROTEIN; COACTIVATOR; COMPETITION; MIG-2; TALIN	Focal adhesions (FAs), sites of tight adhesion to the extracellular matrix, are composed of clusters of transmembrane integrin adhesion receptors and intracellular proteins that link integrins to the actin cytoskeleton and signaling pathways. Two integrin-binding proteins present in FAs, kindlin-1 and kindlin-2, are important for integrin activation, FA formation, and signaling. Migfilin, originally identified in a yeast two-hybrid screen for kindlin-2-interacting proteins, is a LIM domain-containing adaptor protein found in FAs and implicated in control of cell adhesion, spreading, and migration. By binding filamin, migfilin provides a link between kindlin and the actin cytoskeleton. Here, using a combination of kindlin knockdown, biochemical pulldown assays, fluorescence microscopy, fluorescence resonance energy transfer (FRET), and fluorescence recovery after photobleaching (FRAP), we have established that the C-terminal LIM domains of migfilin dictate its FA localization, shown that these domains mediate an interaction with kindlin in vitro and in cells, and demonstrated that kindlin is important for normal migfilin dynamics in cells. We also show that when the C-terminal LIM domain region is deleted, then the N-terminal filamin-binding region of the protein, which is capable of targeting migfilin to actin-rich stress fibers, is the predominant driver of migfilin localization. Our work details a correlation between migfilin domains that drive kindlin binding and those that drive FA localization as well as a kindlin dependence on migfilin FA recruitment and mobility. We therefore suggest that the kindlin interaction with migfilin LIM domains drives migfilin FA recruitment, localization, and mobility.	[Brahme, Nina N.; Stewart, Rachel; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Harburger, David S.; Raghavan, Srikala; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kemp-O'Brien, Karl; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Raghavan, Srikala] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	Yale University; Yale University; University of London; King's College London; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Calderwood, DA (corresponding author), 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Parsons, Maddy/B-2203-2013; Calderwood, David A/AAC-6954-2019	Parsons, Maddy/0000-0002-2021-8379; Calderwood, David A/0000-0002-0791-4142; Stewart, Rachel/0000-0001-5864-3277	National Institutes of Health [RO1 GM-068600, RO1 GM088240, T32 GM-007223]; American Cancer Society [RSG-12-053-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600, R01GM088240, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM-068600, RO1 GM088240, and T32 GM-007223 and American Cancer Society Grant RSG-12-053-01.	Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morton PE, 2011, METHODS MOL BIOL, V769, P403, DOI 10.1007/978-1-61779-207-6_27; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Petricca G, 2009, EUR J ORAL SCI, V117, P518, DOI 10.1111/j.1600-0722.2009.00651.x; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	39	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35604	35616		10.1074/jbc.M113.483016	http://dx.doi.org/10.1074/jbc.M113.483016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165133	hybrid, Green Published			2022-12-25	WOS:000329867600054
J	Liu, JH; Guo, LX; Yin, F; Zhang, YL; Liu, ZX; Wang, YW				Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan; Wang, Yanwen			Geniposide Regulates Glucose-Stimulated Insulin Secretion Possibly through Controlling Glucose Metabolism in INS-1 Cells	PLOS ONE			English	Article							PEPTIDE-1 RECEPTOR PLAYS; PYRUVATE-CARBOXYLASE; PANCREATIC-ISLETS; BETA-CELLS; DIABETIC MICE; MALIC ENZYME; PC12 CELLS; RESISTANCE; GLUCOTOXICITY; ANAPLEROSIS	Glucose-stimulated insulin secretion (GSIS) is essential to the control of metabolic fuel homeostasis. The impairment of GSIS is a key element of beta-cell failure and one of causes of type 2 diabetes mellitus (T2DM). Although the K-ATP channel-dependent mechanism of GSIS has been broadly accepted for several decades, it does not fully describe the effects of glucose on insulin secretion. Emerging evidence has suggested that other mechanisms are involved. The present study demonstrated that geniposide enhanced GSIS in response to the stimulation of low or moderately high concentrations of glucose, and promoted glucose uptake and intracellular ATP levels in INS-1 cells. However, in the presence of a high concentration of glucose, geniposide exerted a contrary role on both GSIS and glucose uptake and metabolism. Furthermore, geniposide improved the impairment of GSIS in INS-1 cells challenged with a high concentration of glucose. Further experiments showed that geniposide modulated pyruvate carboxylase expression and the production of intermediates of glucose metabolism. The data collectively suggest that geniposide has potential to prevent or improve the impairment of insulin secretion in beta-cells challenged with high concentrations of glucose, likely through pyruvate carboxylase mediated glucose metabolism in beta-cells.	[Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan] Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China; [Liu, Jianhui; Guo, Lixia; Yin, Fei; Zhang, Yonglan; Liu, Zixuan] Chongqing Technol & Business Univ, Chongqing Key Lab Nat Med Res, Chongqing, Peoples R China; [Liu, Jianhui; Yin, Fei; Wang, Yanwen] Natl Res Council Canada, Charlottetown, PE, Canada; [Zhang, Yonglan] Chongqing Univ, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China	Chongqing Technology & Business University; Chongqing Technology & Business University; National Research Council Canada; Chongqing University	Liu, JH (corresponding author), Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China.	jhliu@ctbu.edu.cn	Liu, Jianhui/X-6679-2019		National Natural Science Foundation of China [30973576]; Chongqing Science & Technology committee (CSTC) [2012jjB10033, 2011jjA1396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science & Technology committee (CSTC)	This work was supported by grants from National Natural Science Foundation of China (30973576) and Chongqing Science & Technology committee (CSTC, 2012jjB10033, 2011jjA1396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buchanan Thomas A., 2003, Clinical Therapeutics, V25, pB32, DOI 10.1016/S0149-2918(03)80241-2; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Conget I, 2001, MED CLIN-BARCELONA, V116, P491, DOI 10.1016/S0025-7753(01)71882-9; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fex M, 2007, DIABETOLOGIA, V50, P74, DOI 10.1007/s00125-006-0464-4; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Grassiolli S, 2006, ENDOCRINE, V30, P191, DOI 10.1385/ENDO:30:2:191; Guo LX, 2012, ACTA PHARMACOL SIN, V33, P237, DOI 10.1038/aps.2011.146; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; Hollingdal M, 2000, DIABETES, V49, P1334, DOI 10.2337/diabetes.49.8.1334; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kojima K, 2011, BIOL PHARM BULL, V34, P1613, DOI 10.1248/bpb.34.1613; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Liu JH, 2012, DIABET MED IN PRESS; Liu JH, 2009, ACTA PHARMACOL SIN, V30, P159, DOI 10.1038/aps.2008.25; Liu JH, 2007, NEUROCHEM INT, V51, P361, DOI 10.1016/j.neuint.2007.04.021; Liu JH, 2006, INT J DEV NEUROSCI, V24, P419, DOI 10.1016/j.ijdevneu.2006.08.009; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MACDONALD MJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P128, DOI 10.1006/abbi.1995.1274; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Smith AJ, 2006, BIOCHEM BIOPH RES CO, V348, P1123, DOI 10.1016/j.bbrc.2006.07.170; Spacek T, 2008, INT J BIOCHEM CELL B, V40, P1522, DOI 10.1016/j.biocel.2007.11.015; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17; Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841; Yin F, 2010, ACTA PHARMACOL SIN, V31, P540, DOI 10.1038/aps.2010.28	52	15	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78315	10.1371/journal.pone.0078315	http://dx.doi.org/10.1371/journal.pone.0078315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167617	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500078
J	Ramaswami, G; Sukumar, R				Ramaswami, Geetha; Sukumar, Raman			Long-Term Environmental Correlates of Invasion by Lantana camara (Verbenaceae) in a Seasonally Dry Tropical Forest	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PLANT INVASIONS; SUCCESS; DISTURBANCE; MANAGEMENT; GRASSES; ECOLOGY	Invasive species, local plant communities and invaded ecosystems change over space and time. Quantifying this change may lead to a better understanding of the ecology and the effective management of invasive species. We used data on density of the highly invasive shrub Lantana camara (lantana) for the period 1990-2008 from a 50 ha permanent plot in a seasonally dry tropical forest of Mudumalai in southern India. We used a cumulative link mixed-effects regression approach to model the transition of lantana from one qualitative density state to another as a function of biotic factors such as indicators of competition from local species (lantana itself, perennial grasses, invasive Chromolaena odorata, the native shrub Helicteres isora and basal area of native trees) and abiotic factors such as fire frequency, inter-annual variability of rainfall and relative soil moisture. The density of lantana increased substantially during the study period. Lantana density was negatively associated with the density of H. isora, positively associated with basal area of native trees, but not affected by the presence of grasses or other invasive species. In the absence of fire, lantana density increased with increasing rainfall. When fires occurred, transitions to higher densities occurred at low rainfall values. In drier regions, lantana changed from low to high density as rainfall increased while in wetter regions of the plot, lantana persisted in the dense category irrespective of rainfall. Lantana seems to effectively utilize resources distributed in space and time to its advantage, thus outcompeting local species and maintaining a population that is not yet self-limiting. High-risk areas and years could potentially be identified based on inferences from this study for facilitating management of lantana in tropical dry forests.	[Ramaswami, Geetha; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Sukumar, Raman] Indian Inst Sci, Divecha Ctr Climate Change, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	Raman, Sukumar/C-9809-2013		Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	The Ministry of Environment and Forests, Government of India has funded this project since 1989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu Suresh, 2009, Ecological Restoration, V27, P467, DOI 10.3368/er.27.4.467; Banasiak SE, 2009, BIOL INVASIONS, V11, P215, DOI 10.1007/s10530-008-9226-1; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bhagwat SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032407; Blossey B., 1999, Biological Invasions, V1, P301, DOI 10.1023/A:1010084724526; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Buckley YM, 2003, J APPL ECOL, V40, P481, DOI 10.1046/j.1365-2664.2003.00821.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Castillo JM, 2007, BIODIVERS CONSERV, V16, P2123, DOI 10.1007/s10531-006-9131-9; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cleverly JR, 1997, OECOLOGIA, V111, P12, DOI 10.1007/s004420050202; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Duggin JA, 1998, FOREST ECOL MANAG, V109, P279, DOI 10.1016/S0378-1127(98)00252-7; Eagan JS, 1911, NILGIRI GUIDE DIRECT; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hiremath A.J., 2005, CONSERV SOC, V1, P26; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kulmatiski A, 2006, PLANT ECOL, V187, P261, DOI 10.1007/s11258-006-9140-5; Mandle L, 2011, BIOL INVASIONS, V13, P1815, DOI 10.1007/s10530-011-0001-3; Meekins JF, 2001, ECOL APPL, V11, P1336, DOI 10.2307/3060924; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Prasad AE, 2012, J TROP ECOL, V28, P55, DOI 10.1017/S0266467411000563; Raizada P, 2008, CURR SCI INDIA, V94, P180; Ramaswami G, 2013, PLANT ECOL, V214, P397, DOI 10.1007/s11258-013-0177-y; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Stevens JT, 2009, NEW PHYTOL, V184, P365, DOI 10.1111/j.1469-8137.2009.02965.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Sundaram B, 2012, BIOL INVASIONS, V14, P1127, DOI 10.1007/s10530-011-0144-2; Suresh H.S., 2011, ECOLOGY CONSERVATION, P37; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thomsen MA, 2006, PLANT ECOL, V186, P23, DOI 10.1007/s11258-006-9109-4; Totland O, 2005, FOREST ECOL MANAG, V215, P329, DOI 10.1016/j.foreco.2005.05.023; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x	44	18	20	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76995	10.1371/journal.pone.0076995	http://dx.doi.org/10.1371/journal.pone.0076995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167555	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000326034500014
J	Shen, B; Zhang, X; Du, YN; Wang, JY; Gong, J; Zhang, XD; Tate, PH; Li, HL; Huang, XX; Zhang, WS				Shen, Bin; Zhang, Xin; Du, Yinan; Wang, Jianying; Gong, Jun; Zhang, Xiaodong; Tate, Peri H.; Li, Hongliang; Huang, Xingxu; Zhang, Wensheng			Efficient Knockin Mouse Generation by ssDNA Oligonucleotides and Zinc-Finger Nuclease Assisted Homologous Recombination in Zygotes	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; EMBRYO MICROINJECTION; MAMMALIAN-CELLS; DISEASE-MODELS; ZEBRAFISH; TALENS; MUTATIONS; SYSTEM; ZIFIT; RATS	The generation of specific mutant animal models is critical for functional analysis of human genes. The conventional gene targeting approach in embryonic stem cells (ESCs) by homologous recombination is however laborious, slow, expensive, and limited to species with functional ESCs. It is therefore a long-sought goal to develop an efficient and simple alternative gene targeting strategy. Here we demonstrate that, by combining an efficient ZFN pair and ssODN, a restriction site and a loxP site were successfully introduced into a specific genomic locus. A targeting efficiency up to 22.22% was achieved by coinciding the insertion site and the ZFN cleavage site isogenic and keeping the length of the homology arms equal and isogenic to the endogenous target locus. Furthermore, we determine that ZFN and ssODN-assisted HR is ssODN homology arm length dependent. We further show that mutant alleles generated by ZFN and ssODN-assisted HR can be transmitted through the germline successfully. This study establishes an efficient gene targeting strategy by ZFN and ssODN-assisted HR in mouse zygotes, and provides a potential avenue for genome engineering in animal species without functional ES cell lines.	[Shen, Bin; Du, Yinan; Wang, Jianying; Huang, Xingxu] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Xin; Gong, Jun; Zhang, Xiaodong; Li, Hongliang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tate, Peri H.; Zhang, Wensheng] Wellcome Trust Sanger Inst, Cambridge, England	Nanjing University; Wuhan University; Wellcome Trust Sanger Institute	Huang, XX (corresponding author), Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China.	wz1@sanger.ac.uk; xingxuhuang@mail.nju.edu.cn	Du, Yinan/GPK-0826-2022; Shen, Bin/ABD-5084-2021	Du, Yinan/0000-0002-7678-7546; Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247	973 program [2009CB918703]	973 program(National Basic Research Program of China)	This work was supported by grants from the 973 program (2009CB918703)(http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2012, P NATL ACAD SCI USA, V109, P9354, DOI 10.1073/pnas.1121203109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	35	12	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77696	10.1371/journal.pone.0077696	http://dx.doi.org/10.1371/journal.pone.0077696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167580	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500039
J	Kariu, T; Smith, A; Yang, XL; Pal, U				Kariu, Toru; Smith, Alexis; Yang, Xiuli; Pal, Utpal			A Chitin Deacetylase-Like Protein Is a Predominant Constituent of Tick Peritrophic Membrane That Influences the Persistence of Lyme Disease Pathogens within the Vector	PLOS ONE			English	Article							OUTER-MEMBRANE; MATRIX; TRANSMISSION; PENETRATION; LEISHMANIA; COMPLEXES; INFECTION; INVASION; BINDING	Ixodes scapularis is the specific arthropod vector for a number of globally prevalent infections, including Lyme disease caused by the bacterium Borrelia burgdorferi. A feeding-induced and acellular epithelial barrier, known as the peritrophic membrane (PM) is detectable in I. scapularis. However, whether or how the PM influences the persistence of major tick-borne pathogens, such as B. burgdorferi, remains largely unknown. Mass spectrometry-based proteome analyses of isolated PM from fed ticks revealed that the membrane contains a few detectable proteins, including a predominant and immunogenic 60 kDa protein with homology to arthropod chitin deacetylase (CDA), herein termed I. scapularis CDA-like protein or IsCDA. Although IsCDA is primarily expressed in the gut and induced early during tick feeding, its silencing via RNA interference failed to influence either the occurrence of the PM or spirochete persistence, suggesting a redundant role of IsCDA in tick biology and host-pathogen interaction. However, treatment of ticks with antibodies against IsCDA, one of the most predominant protein components of PM, affected B. burgdorferi survival, significantly augmenting pathogen levels within ticks but without influencing the levels of total gut bacteria. These studies suggested a preferential role of tick PM in limiting persistence of B. burgdorferi within the vector. Further understanding of the mechanisms by which vector components contribute to pathogen survival may help the development of new strategies to interfere with the infection.	[Pal, Utpal] Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA; Univ Maryland Coll Pk, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Pal, U (corresponding author), Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015		National Institutes of Health [AI080615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080615, R56AI080615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the funding from National Institutes of Health (AI080615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897; Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kariu Toru, 2011, J Vis Exp, DOI 10.3791/2544; Kariu T, 2013, MOL MICROBIOL, V88, P510, DOI 10.1111/mmi.12202; Kato N, 2008, VECTOR-BORNE ZOONOT, V8, P701, DOI 10.1089/vbz.2007.0270; Kumar Manish, 2011, Vaccine, V29, P9012, DOI 10.1016/j.vaccine.2011.09.035; Kumar M, 2010, J INFECT DIS, V201, P1084, DOI 10.1086/651172; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U., 2010, BORRELIA MOL BIOL HO, P279; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; RUDZINSKA MA, 1982, CELL TISSUE RES, V221, P471; SCHLEIN Y, 1991, P ROY SOC B-BIOL SCI, V245, P121, DOI 10.1098/rspb.1991.0097; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Tellam RL, 2000, INSECT BIOCHEM MOLEC, V30, P1189, DOI 10.1016/S0965-1748(00)00097-7; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b; Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326; Zhang XY, 2009, J INFECT DIS, V200, P1318, DOI 10.1086/605846; ZHU Z, 1991, PARASITOL RES, V77, P635, DOI 10.1007/BF00931028	31	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78376	10.1371/journal.pone.0078376	http://dx.doi.org/10.1371/journal.pone.0078376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147133	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200097
J	Outani, H; Okada, M; Yamashita, A; Nakagawa, K; Yoshikawa, H; Tsumaki, N				Outani, Hidetatsu; Okada, Minoru; Yamashita, Akihiro; Nakagawa, Kanako; Yoshikawa, Hideki; Tsumaki, Noriyuki			Direct Induction of Chondrogenic Cells from Human Dermal Fibroblast Culture by Defined Factors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COLLAGEN GENE; CARTILAGE; SOX9; EXPRESSION; GENERATION; ENHANCER; MICROFRACTURE; EFFICIENT; DEFECTS	The repair of large cartilage defects with hyaline cartilage continues to be a challenging clinical issue. We recently reported that the forced expression of two reprogramming factors (c-Myc and Klf4) and one chondrogenic factor (SOX9) can induce chondrogenic cells from mouse dermal fibroblast culture without going through a pluripotent state. We here generated induced chondrogenic (iChon) cells from human dermal fibroblast (HDF) culture with the same factors. We developed a chondrocyte-specific COL11A2 promoter/enhancer lentiviral reporter vector to select iChon cells. The human iChon cells expressed marker genes for chondrocytes but not fibroblasts, and were derived from non-chondrogenic COL11A2-negative cells. The human iChon cells formed cartilage but not tumors in nude mice. This approach could lead to the preparation of cartilage directly from skin in human, without going through pluripotent stem cells.	[Outani, Hidetatsu; Okada, Minoru; Yamashita, Akihiro; Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Outani, Hidetatsu; Nakagawa, Kanako; Yoshikawa, Hideki; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Nakagawa, Kanako; Tsumaki, Noriyuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Tsumaki, N (corresponding author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	ntsumaki@cira.kyoto-u.ac.jp		Tsumaki, Noriyuki/0000-0002-0520-3654	MEXT [18390415, 19659378, 21390421]; JST, CREST	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by Scientific Research Grants Nos. 18390415, 19659378 and 21390421 from MEXT and the JST, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; ARGENTIN G, 1993, IN VITRO CELL DEV-AN, V29A, P603; Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Goessler UR, 2004, INT J MOL MED, V14, P1015; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu Y, 2000, J BIOL CHEM, V275, P12712, DOI 10.1074/jbc.275.17.12712; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Outani H, 2011, BIOCHEM BIOPH RES CO, V411, P607, DOI 10.1016/j.bbrc.2011.06.194; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	30	67	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77365	10.1371/journal.pone.0077365	http://dx.doi.org/10.1371/journal.pone.0077365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146984	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400103
J	Yu, DH; Yuan, K; Zhao, L; Liang, FR; Qin, W				Yu, Dahua; Yuan, Kai; Zhao, Ling; Liang, Fanrong; Qin, Wei			Regional Homogeneity Abnormalities Affected by Depressive Symptoms in Migraine Patients without Aura: A Resting State Study	PLOS ONE			English	Article							NEURAL ACTIVITY; MAJOR DEPRESSION; WHITE-MATTER; BRAIN; PAIN; METAANALYSIS; FMRI; INTEGRATION; PREVALENCE; DISORDER	Background: Bidirectional relationship between migraine and depression suggests that there might be some etiological risk factors shared. However, few studies investigated resting state abnormalities affected by depressive symptoms in migraine patients without aura (MWoA). Materials and Methods: According to their self-rating depression scale (SDS) score, MWoA were divided into twenty in the SDS (+) (SDS > 49) group and 20 in the SDS (-) (SDS <= 49) group. Regional homogeneity (ReHo) method were employed to assess local features of spontaneous brain activity between 1) all MWoA and healthy controls, 2) each subgroup and healthy controls, and 3) SDS (-) group and SDS (+) group. Results: Compared with healthy controls, decreased ReHo in similar regions were shown in the MWoA group and subgroups. It is noteworthy that the caudate showed increased ReHo in the SDS (-) group compared with healthy controls and the SDS (+) group. Moreover, the average ReHo values of the caudate in SDS (-) group were significantly positively correlated with duration of migraine. Conclusions: Our results suggested that ReHo patterns in migraine patients may be affected by depressive symptoms and serve as a biomarker to reflect depression severity in MWoA.	[Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Yu, Dahua; Yuan, Kai; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China	Inner Mongolia University of Science & Technology; Xidian University; Chengdu University of Traditional Chinese Medicine	Yuan, K (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	kyuan@xidian.edu.cn; lfr@cdutcm.edu.cn	Yuan, Kai/I-4150-2016; Yuan, Kai/M-9403-2013; 秦, 伟/J-9770-2016; Yu, Dahua/N-7242-2013	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Yu, Dahua/0000-0001-7850-7512; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707700]; National Natural Science Foundation of China [81301281, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 61179019, 61261028]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Inner Mongolia [2012MS0908]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Inner Mongolia	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2012CB518501, 2011CB707700, the National Natural Science Foundation of China under Grant Nos. 81301281, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 61179019, 61261028, the Fundamental Research Funds for the Central Universities and the Natural Science Foundation of Inner Mongolia under Grant Nos. 2012MS0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderjan D, 2010, PAIN, V151, P97, DOI 10.1016/j.pain.2010.06.024; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gabbay V, 2007, AM J PSYCHIAT, V164, P1881, DOI 10.1176/appi.ajp.2007.06122032; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; GUO W, 2011, J AFFECT DISORD; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; LAI CH, 2011, J AFFECT DISORD; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slaughter J R, 2001, CNS Spectr, V6, P306; Slaughter JR, 2001, J NEUROPSYCH CLIN N, V13, P187, DOI 10.1176/appi.neuropsych.13.2.187; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yu DH, 2013, NMR BIOMED, V26, P1103, DOI 10.1002/nbm.2924; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77933	10.1371/journal.pone.0077933	http://dx.doi.org/10.1371/journal.pone.0077933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147100	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400143
J	Gundavarapu, S; Mishra, NC; Singh, SP; Langley, RJ; Saeed, AI; Feghali-Bostwick, CA; McIntosh, JM; Hutt, J; Hegde, R; Buch, S; Sopori, ML				Gundavarapu, Sravanthi; Mishra, Neerad C.; Singh, Shashi P.; Langley, Raymond J.; Saeed, Ali Imran; Feghali-Bostwick, Carol A.; McIntosh, J. Michael; Hutt, Julie; Hegde, Ramakrishna; Buch, Shilpa; Sopori, Mohan L.			HIV gp120 Induces Mucus Formation in Human Bronchial Epithelial Cells through CXCR4/alpha 7-Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKING; ANTIRETROVIRAL THERAPY; MUCIN EXPRESSION; ENVELOPE PROTEIN; GENE-EXPRESSION; INFECTION; INDIVIDUALS; APOPTOSIS; ALPHA-7	Lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung infections are major causes of morbidity and mortality among HIV-infected patients even in the era of antiretroviral therapy (ART). Many of these diseases are strongly associated with smoking and smoking is more common among HIV-infected than uninfected people; however, HIV is an independent risk factor for chronic bronchitis, COPD, and asthma. The mechanism by which HIV promotes these diseases is unclear. Excessive airway mucus formation is a characteristic of these diseases and contributes to airway obstruction and lung infections. HIV gp120 plays a critical role in several HIV-related pathologies and we investigated whether HIV gp120 promoted airway mucus formation in normal human bronchial epithelial (NHBE) cells. We found that NHBE cells expressed the HIV-coreceptor CXCR4 but not CCR5 and produced mucus in response to CXCR4-tropic gp120. The gp120-induced mucus formation was blocked by the inhibitors of CXCR4, alpha 7-nicotinic acetylcholine receptor (alpha 7-nAChR), and gamma-aminobutyric acid (GABA)(A)R but not the antagonists of CCR5 and epithelial growth factor receptor (EGFR). These results identify two distinct pathways (alpha 7-nAChR-GABA(A)R and EGFR) for airway mucus formation and demonstrate for the first time that HIV-gp120 induces and regulates mucus formation in the airway epithelial cells through the CXCR4-alpha 7-nAChR-GABA(A)R pathway. Interestingly, lung sections from HIV +/- ART and simian immunodeficiency virus (SIV) +/- ART have significantly more mucus and gp120-immunoreactivity than control lung sections from humans and macaques, respectively. Thus, even after ART, lungs from HIV-infected patients contain significant amounts of gp120 and mucus that may contribute to the higher incidence of obstructive pulmonary diseases in this population.	[Gundavarapu, Sravanthi; Mishra, Neerad C.; Singh, Shashi P.; Langley, Raymond J.; Hutt, Julie; Sopori, Mohan L.] Lovelace Resp Res Inst, Resp Immunol Div, Albuquerque, NM USA; [Saeed, Ali Imran] Univ New Mexico, Albuquerque, NM 87131 USA; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hegde, Ramakrishna] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Lovelace Respiratory Research Institute; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Kansas; University of Kansas Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sopori, ML (corresponding author), Lovelace Resp Res Inst, Resp Immunol Div, Albuquerque, NM USA.	msopori@lrri.org		Buch, Shilpa/0000-0002-3103-6685	United States Army Medical Research and Material Command [GW093005]; Lovelace Respiratory Research Institute (IMMSPT); National Institutes of Health [DA024442];  [GM103801];  [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024442] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Lovelace Respiratory Research Institute (IMMSPT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from the United States Army Medical Research and Material Command (GW093005), Lovelace Respiratory Research Institute (IMMSPT), and GM103801 and GM48677. This work was also supported by the grant DA024442 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; CORBEIL J, 1995, J GEN VIROL, V76, P681, DOI 10.1099/0022-1317-76-3-681; Cummins NW, 2010, J INFECT DIS, V201, P1273, DOI 10.1086/651434; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Duaso Maria, 2012, Br J Community Nurs, V17, P356; El-Zimaity HMT, 1998, ARCH PATHOL LAB MED, V122, P732; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Grubb JR, 2006, AIDS, V20, P1095, DOI 10.1097/01.aids.0000226949.64600.f9; Gundavarapu S, 2012, J ALLERGY CLIN IMMUN, V130, P770, DOI 10.1016/j.jaci.2012.04.002; HARKEMA JR, 1992, AM J PATHOL, V141, P307; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maestrelli P, 2010, G Ital Med Lav Ergon, V32, P433; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1582, DOI 10.1164/ajrccm/141.6.1582; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Raynaud C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-117; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rubbo PA, 2011, CLIN IMMUNOL, V139, P142, DOI 10.1016/j.clim.2011.01.007; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Segal Leopoldo N, 2011, Proc Am Thorac Soc, V8, P282, DOI 10.1513/pats.201006-044WR; Stevceva L, 2008, J IMMUNOL, V181, P5510, DOI 10.4049/jimmunol.181.8.5510; Tavares Marques MA, 2007, REV PORT PNEUMOL, V13, P175; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wang DN, 2011, J VIROL, V85, P6403, DOI 10.1128/JVI.02389-10; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Williams MA, 2002, J HEMATOTH STEM CELL, V11, P829, DOI 10.1089/152581602760404630; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77160	10.1371/journal.pone.0077160	http://dx.doi.org/10.1371/journal.pone.0077160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155926	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300060
J	Li, YS; Ni, SY; Meng, Y; Shi, XL; Zhao, XW; Luo, HH; Li, X				Li, Yu-Sheng; Ni, Shu-Yuan; Meng, Ying; Shi, Xiao-Lan; Zhao, Xu-Wen; Luo, Hai-Hua; Li, Xu			Angiotensin II Facilitates Fibrogenic Effect of TGF-beta 1 through Enhancing the Down-Regulation of BAMBI Caused by LPS: A New Pro-Fibrotic Mechanism of Angiotensin II	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TOLL-LIKE RECEPTOR-4; GROWTH-FACTOR; LIVER FIBROSIS; RAT-LIVER; TRANSGENIC MICE; GENE-EXPRESSION; CROSS-TALK; IN-VITRO; PDGF-B	Angiotensin II has progressively been considered to play an important role in the development of liver fibrosis, although the mechanism isn't fully understood. The aim of this study was to investigate a possible pro-fibrotic mechanism, by which angiotensin II would enhance the pro-fibrotic effect of transforming growth factor beta 1 (TGF-beta 1) through up-regulation of toll-like receptor 4 (TLR4) and enhancing down-regulation of TGF-beta 1 inhibitory pseudo-receptor-BAMBI caused by LPS in hepatic stellate cells (HSCs). Firstly, the synergistic effects of angiotensin II, TGF-beta 1 and LPS on collagen 1 alpha production were confirmed in vitro by ELISA, in which angiotensin II, LPS and TGF-beta 1 were treated sequentially, and in vivo by immunofluorescence, in the experiments single or multiple intra-peritoneally implanted osmotic mini-pumps administrating angiotensin II or LPS combined with intra-peritoneal injections of TGF-beta 1 were used. We also found that only LPS and TGF-beta 1 weren't enough to induce obvious fibrogenesis without angiotensin II. Secondly, to identify the reason of why angiotensin II is so important, the minute level of TLR4 in activated HSCs-T6 and primary quiescent HSCs of rat, up-regulation of TLR4 by angiotensin II and blockage by different angiotensin II receptor type 1 (AT1) blockers in HSCs were assayed by western blotting in vitro and immunofluorescence in vivo. Finally, BAMBI expression level, which is regulated by LPS-TLR4 pathway, was detected by qRT-PCR and results showed angiotensin II enhanced the down-regulation of BAMBI mRNA caused by LPS in vitro and in vivo, and TLR4 neutralization antibody blocked this interactive effect. These data demonstrated that angiotensin II enhances LPS-TLR4 pathway signaling and further down-regulates expression of BAMBI through up-regulation of TLR4, which results in facilitation of pro-fibrotic activity of TGF-beta 1. Angiotensin II, LPS and TGF-beta 1 act synergistically during hepatic fibrogenesis, showing crosstalks between angiotensin II-AT1, LPS-TLR4 and TGF-beta 1-BAMBI signal pathways in rat HSCs.	[Li, Yu-Sheng; Shi, Xiao-Lan; Zhao, Xu-Wen; Luo, Hai-Hua] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Ni, Shu-Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Meng, Ying] Southern Med Univ, Nanfang Hosp, Dept Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Xu] Southern Med Univ, Nanfang Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China	Li, YS (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	tobyaron@163.com; aronlee@smu.edu.cn			National Natural Scientific Foundation of China [81070338, 30871155, 81100008]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Scientific Foundation of China (#81070338, 30871155 and 81100008). Website: www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bondeva T, 2007, AM J NEPHROL, V27, P308, DOI 10.1159/000102551; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Ikura Y, 2005, HEPATOL RES, V32, P107, DOI 10.1016/j.hepres.2005.01.017; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Iwaki T, 2005, BLOOD, V105, P2364, DOI 10.1182/blood-2004-06-2456; Kamada Y, 2003, HEPATOL RES, V25, P296, DOI 10.1016/S1386-6346(02)00306-6; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kinnman N, 2001, LAB INVEST, V81, P1709, DOI 10.1038/labinvest.3780384; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li YS, 2010, AM J PHYSIOL-LUNG C, V298, pL558, DOI 10.1152/ajplung.00225.2009; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Moreno M, 2008, CLIN LIVER DIS, V12, P825, DOI 10.1016/j.cld.2008.07.013; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 1996, AM J PATHOL, V148, P785; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; ROSS R, 1989, LANCET, V1, P1179; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shirai Y, 2013, J GASTROEN HEPATOL, V28, P723, DOI 10.1111/jgh.12112; Stevenson KM, 2000, HYPERTENSION, V36, P839, DOI 10.1161/01.HYP.36.5.839; Vogel S, 2000, J LIPID RES, V41, P882; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wickert L, 2004, J HEPATOL, V40, P69, DOI 10.1016/j.jhep.2003.09.026; Wolf G, 2006, J AM SOC NEPHROL, V17, P1585, DOI 10.1681/ASN.2005070699; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Wu J, 2009, INFLAMM RES, V58, P473, DOI 10.1007/s00011-009-0012-z; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	45	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76289	10.1371/journal.pone.0076289	http://dx.doi.org/10.1371/journal.pone.0076289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155898	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300032
J	Liu, ZL; Sun, M; Lu, KH; Liu, J; Zhang, ML; Wu, WQ; De, W; Wang, ZX; Wang, R				Liu, Zhili; Sun, Ming; Lu, Kaihua; Liu, Jing; Zhang, Meiling; Wu, Weiqin; De, Wei; Wang, Zhaoxia; Wang, Rui			The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21(WAF1/CIP1) Expression	PLOS ONE			English	Article							MICRORNA; EZH2; P21; CHEMOTHERAPY; PROMOTES; GROWTH	HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex 2 (PRC2) and is reported to reprogram chromatin organization and promote tumor progression. However, little is known about the roles of this gene in the development of chemoresistance phenotype of lung adenocarcinoma (LAD). Thus, we investigated the involvement of HOTAIR in the resistance of LAD cells to cisplatin. In this study, we show that HOTAIR expression was significantly upregulated in cisplatin-resistant A549/DDP cells compared with in parental A549 cells. Knockdown of HOTAIR by RNA interference could resensitize the responses of A549/DDP cells to cisplatin both in vitro and in vivo. In contrast, overexpression of HOTAIR could decrease the sensitivity of A549 and SPC-A1 cells to cisplatin. We also found that the siRNA/HOTAIR1-mediated chemosensivity enhancement was associated with inhibition of cell proliferation, induction of G(0)/G(1) cell-cycle arrest and apoptosis enhancement through regulation of p21(WAF1/CIP1) (p21) expression. Also, pcDNA/p21or siRNA/p21 could mimic the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on the sensitivity of LAD cells to cisplatin. Importantly, siRNA/p21 or pcDNA/p21 could partially rescue the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on both p21 expression and cisplatin sensitivity in LAD cells. Further, HOTAIR was observed to be significantly downregulated in cisplatin-responding LAD tissues, and its expression was inversely correlated with p21 mRNA expression. Taken together, our findings suggest that upregulation of HOTAIR contributes to the cisplatin resistance of LAD cells, at least in part, through the regulation of p21 expression.	[Liu, Zhili; Liu, Jing; Wang, Zhaoxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Sun, Ming; De, Wei] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Lu, Kaihua; Zhang, Meiling; Wu, Weiqin] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wang, Rui] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Wang, ZX (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	zhaoxiawang88@163.com; wangrui1977218@163.com			National Natural Science Foundation of China [81272601]; Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project [RC2011080]; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project [09-B1-021]; 333 high class Talented Man Project [2011-III-2630]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project; 333 high class Talented Man Project	This work was supported by grants from the National Natural Science Foundation of China (No. 81272601), the Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project (No. RC2011080), Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University, the Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project (No. 09-B1-021) and "333 high class Talented Man Project" (No. 2011-III-2630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Cao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052984; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chen JH, 2012, EXP BIOL MED, V237, P1110, DOI 10.1258/ebm.2012.012075; Chen YH, 2012, AM J TRANSL RES, V4, P364; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; FUJINO M, 1995, CANCER, V76, P2457, DOI 10.1002/1097-0142(19951215)76:12<2457::AID-CNCR2820761209>3.0.CO;2-X; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haenisch S, 2012, EPIGENOMICS-UK, V4, P369, DOI [10.2217/EPI.12.39, 10.2217/epi.12.39]; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Ivanov M, 2012, CLIN PHARMACOL THER, V92, P727, DOI 10.1038/clpt.2012.152; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joshi US, 1998, CANCER GENE THER, V5, P183; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Semaan A, 2011, PHARM RES-DORDR, V28, P3079, DOI 10.1007/s11095-011-0547-x; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Strathdee G, 2007, DIS MARKERS, V23, P43, DOI 10.1155/2007/610815; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Woo CJ, 2007, CELL, V129, P1257, DOI 10.1016/j.cell.2007.06.014; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Zhuang Y, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-35	42	73	87	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77293	10.1371/journal.pone.0077293	http://dx.doi.org/10.1371/journal.pone.0077293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155936	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300070
J	Singh, R; Rathore, YS; Singh, NS; Peddada, N; Ashish; Raychaudhuri, S				Singh, Richa; Rathore, Yogendra Singh; Singh, Naorem Santa; Peddada, Nagesh; Ashish; Raychaudhuri, Saumya			Substitution of Glutamate Residue by Lysine in the Dimerization Domain Affects DNA Binding Ability of HapR by Inducing Structural Deformity in the DNA Binding Domain	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVE VARIANT; QUORUM-SENSING SYSTEMS; SMALL-ANGLE SCATTERING; VIBRIO-CHOLERAE; RESOLUTION; MUTATIONS; HARVEYI; DIMER; LUXO	HapR has been given the status of a high cell density master regulatory protein in Vibrio cholerae. Though many facts are known regarding its structural and functional aspects, much still can be learnt from natural variants of the wild type protein. This work aims at investigating the nature of functional inertness of a HapR natural variant harboring a substitution of a conserved glutamate residue at position 117 which participates in forming a salt bridge by lysine (HapR(V2G)-(EK)-K-117). Experimental evidence presented here reveals the inability of this variant to interact with various cognate promoters by in vitro gel shift assay. Furthermore, the elution profiles of HapR(V2G)-(EK)-K-117 protein along with the wild type functional HapR(V2G) in size-exclusion chromatography as well as circular dichroism spectra did not reflect any significant differences in its structure, thereby indicating the intactness of dimer in the variant protein. To gain further insight into the global shape of the proteins, small angle X-ray scattering analysis (SAXS) was performed. Intriguingly, increased radius of gyration of HapR(V2G)-(EK)-K-117 of 27.5 A in comparison to the wild type protein from SAXS data analyses implied a significant alteration in the global shape of the dimeric HapR(V2G)-(EK)-K-117 protein. Structure reconstruction brought forth that the DNA binding domains were substantially "parted away" in this variant. Taken together, our data illustrates that substitution of the conserved glutamate residue by lysine in the dimerization domain induces separation of the two DNA binding domains from their native-like positioning without altering the dimeric status of HapR variant.	[Singh, Richa; Rathore, Yogendra Singh; Singh, Naorem Santa; Peddada, Nagesh; Ashish; Raychaudhuri, Saumya] CSIR Inst Microbial Technol, Div Mol Biol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR Inst Microbial Technol, Div Mol Biol, Chandigarh, India.	ashgang@imtech.res.in; saumya@rocketmail.com	Peddada, Nagesh/L-6760-2019; Raychaudhuri, Saumya/AFL-0368-2022	Peddada, Nagesh/0000-0003-4033-7305	Department of Biotechnology [BT/PR3583/MED/30/659/2011-GAP/106]; CSIR network project [NWP-UNSEEN/BSC0113]; University Grant Commission; Department of Biotechnology, India	Department of Biotechnology; CSIR network project(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was partly supported by grants from the Department of Biotechnology (BT/PR3583/MED/30/659/2011-GAP/106) and CSIR network project (NWP-UNSEEN/BSC0113). RS, YSR and NSS acknowledge the University Grant Commission and Department of Biotechnology, India respectively for fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Dongre M, 2011, J BIOL CHEM, V286, P15043, DOI 10.1074/jbc.M110.209346; Jawanda N, 2008, ARCH BIOCHEM BIOPHYS, V472, P51, DOI 10.1016/j.abb.2008.02.006; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pohl E, 2001, ACTA CRYSTALLOGR D, V57, P619, DOI 10.1107/S090744490100230X; Raychaudhuri S, 2006, GENE, V369, P126, DOI 10.1016/j.gene.2005.10.031; SMITH MD, 1995, J BIOL CHEM, V270, P28331; Stout TJ, 1998, BIOCHEMISTRY-US, V37, P14736, DOI 10.1021/bi981270l; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; Turton JPG, 2005, J CLIN ENDOCR METAB, V90, P4762, DOI 10.1210/jc.2005-0570; Vance RE, 2003, INFECT IMMUN, V71, P2571, DOI 10.1128/IAI.71.5.2571-2576.2003; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Wang YD, 2011, ENV MICROBIOL REP, V3, P218, DOI 10.1111/j.1758-2229.2010.00212.x; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76033	10.1371/journal.pone.0076033	http://dx.doi.org/10.1371/journal.pone.0076033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155884	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300018
J	Tesfaye, A; Stift, J; Maric, D; Cui, QW; Dienes, HP; Feinstone, SM				Tesfaye, Abeba; Stift, Judith; Maric, Dragan; Cui, Qingwen; Dienes, Hans-Peter; Feinstone, Stephen M.			Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses	PLOS ONE			English	Article							ANIMAL-MODELS; LIVER; MICE; REPLICATION; HEPATOCYTES; CHIMPANZEES; TRANSPLANTATION; REPOPULATION; DYSFUNCTION; MECHANISMS	While the chimpanzee remains the only animal that closely models human hepatitis C virus (HCV) infection, transgenic and immunodeficient mice in which human liver can be engrafted serve as a partial solution to the need for a small animal model for HCV infection. The established system that was based on mice carrying a transgene for urokinase-type plasminogen activator (uPA) gene under the control of the human albumin promoter has proved to be useful for studies of virus infectivity and for testing antiviral drug agents. However, the current Alb-uPA transgenic model with a humanized liver has practical limitations due to the inability to maintain non-engrafted mice as dizygotes for the transgene, poor engraftment of hemizygotes, high neonatal and experimental death rates of dizygous mice and a very short time window for hepatocyte engraftment. To improve the model, we crossed transgenic mice carrying the uPA gene driven by the major urinary protein promoter onto a SCID/Beige background (MUP-uPA SCID/Bg). These transgenic mice are healthy relative to Alb-uPA mice and provide a long window from about age 4 to 12 months for engraftment with human hepatocytes and infection with hepatitis C or hepatitis B (HBV) viruses. We have demonstrated engraftment of human hepatocytes by immunohistochemistry staining for human albumin (30-80% engraftment) and observed a correlation between the number of human hepatocytes inoculated and the level of the concentration of human albumin in the serum. We have shown that these mice support the replication of both HBV and all six major HCV genotypes. Using HBV and HCV inocula that had been previously tittered in chimpanzees, we showed that the mice had approximately the same sensitivity for infection as chimpanzees. These mice should be useful for isolating non-cell culture adapted viruses as well as testing of antiviral drugs, antibody neutralization studies and examination of phenotypic changes in viral mutants.	[Tesfaye, Abeba; Cui, Qingwen; Feinstone, Stephen M.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Stift, Judith; Dienes, Hans-Peter] Med Univ Vienna, Inst Pathol, Vienna, Austria; [Maric, Dragan] NINDS, Div Intramural Res, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tesfaye, A (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	abeba.tesfaye@fda.hhs.gov		Stift, Judith/0000-0001-5334-9343	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by internal funding from the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Heo J, 2006, HEPATOLOGY, V44, P1478, DOI 10.1002/hep.21441; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; *I MED NAT AC, 2011, CHIMP BIOM BEH RES A, P1465; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Momin B, 2012, J COMMUN HEALTH, V37, P912, DOI 10.1007/s10900-011-9507-y; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310; Puig M, 2002, J VIROL METHODS, V105, P253, DOI 10.1016/S0166-0934(02)00119-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; TABOR E, 1983, J INFECT DIS, V147, P531, DOI 10.1093/infdis/147.3.531; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Yamashita T, 2011, J GASTROEN HEPATOL, V26, P960, DOI 10.1111/j.1440-1746.2011.06723.x	32	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77298	10.1371/journal.pone.0077298	http://dx.doi.org/10.1371/journal.pone.0077298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155939	Green Submitted, gold, Green Published			2022-12-25	WOS:000325887300073
J	Krishnan, C; Ranganathan, R; Dhaher, YY; Rymer, WZ				Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.			A Pilot Study on the Feasibility of Robot-Aided Leg Motor Training to Facilitate Active Participation	PLOS ONE			English	Article							STROKE PATIENTS; GAIT; LOCOMOTION; MOVEMENT; THERAPY; REHABILITATION; PERFORMANCE; STRATEGIES; COCONTRACTION; RECOVERY	Robot-aided gait therapy offers a promising approach towards improving gait function in individuals with neurological disorders such as stroke or spinal cord injury. However, incorporation of appropriate control strategies is essential for actively engaging the patient in the therapeutic process. Although several control algorithms (such as assist-as-needed and error augmentation) have been proposed to improve active patient participation, we hypothesize that the therapeutic benefits of these control algorithms can be greatly enhanced if combined with a motor learning task to facilitate neural reorganization and motor recovery. Here, we describe an active robotic training approach (patient-cooperative robotic gait training combined with a motor learning task) using the Lokomat and pilot-tested whether this approach can enhance active patient participation during training. Six neurologically intact adults and three chronic stroke survivors participated in this pilot feasibility study. Participants walked in a Lokomat while simultaneously performing a foot target-tracking task that necessitated greater hip and knee flexion during the swing phase of the gait. We computed the changes in tracking error as a measure of motor performance and changes in muscle activation as a measure of active subject participation. Repeated practice of the motor-learning task resulted in significant reductions in target-tracking error in all subjects. Muscle activation was also significantly higher during active robotic training compared to simply walking in the robot. The data from stroke participants also showed a trend similar to neurologically intact participants. These findings provide a proof-of-concept demonstration that combining robotic gait training with a motor learning task enhances active participation.	[Krishnan, Chandramouli] Univ Michigan, Sch Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL USA	University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab	Krishnan, C (corresponding author), Univ Michigan, Sch Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA.	mouli@umich.edu	Ranganathan, Rajiv/E-3909-2010; Ranganathan, Rajiv/L-4380-2019; Ranganathan, Rajiv/ABI-2927-2020	Ranganathan, Rajiv/0000-0002-6924-253X; Ranganathan, Rajiv/0000-0002-6924-253X; 	Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant [H133E070013]; National Institute on Disability and Rehabilitation Research	Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant; National Institute on Disability and Rehabilitation Research	This study was supported by Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant (grant no. H133E070013) funded by the National Institute on Disability and Rehabilitation Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1996, BRIT MED J, V313, P1200, DOI 10.1136/bmj.313.7066.1200; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; BOGEY RA, 1992, ARCH PHYS MED REHAB, V73, P835; Boyer DM, 2007, J HUM EVOL, V53, P119, DOI 10.1016/j.jhevol.2006.10.007; Casadio M, 2009, FUNCT NEUROL, V24, P195; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Darainy M, 2008, EXP BRAIN RES, V190, P153, DOI 10.1007/s00221-008-1457-y; Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI 10.1177/1545968308315997; Dipietro L, 2012, IEEE T NEUR SYS REH, V20, P48, DOI 10.1109/TNSRE.2011.2175008; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Duschau-Wicke A, 2010, IEEE T NEUR SYS REH, V18, P38, DOI 10.1109/TNSRE.2009.2033061; Fagenbaum R, 2003, AM J SPORT MED, V31, P233, DOI 10.1177/03635465030310021301; Fattapposta F, 2008, ARCH ITAL BIOL, V146, P147; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; Gaser C, 2003, J NEUROSCI, V23, P9240; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Hornby TG, 2012, PHYS THER, V92, P1278, DOI 10.2522/ptj.20110310; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Kao PC, 2013, GAIT POSTURE, V37, P113, DOI 10.1016/j.gaitpost.2012.06.025; Kim SH, 2010, EXP BRAIN RES, V202, P809, DOI 10.1007/s00221-010-2187-5; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Krebs Herman Igo, 2012, Am J Phys Med Rehabil, V91, pS290, DOI 10.1097/PHM.0b013e31826bcd80; Krishnamoorthy Vijaya, 2008, J Neurol Phys Ther, V32, P192, DOI 10.1097/NPT.0b013e31818e8fc2; Krishnan C, 2012, ARCH PHYS MED REHABI; Krishnan C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-57; Krishnan C, 2010, MUSCLE NERVE, V41, P868, DOI 10.1002/mus.21613; Krishnan C, 2010, EUR J APPL PHYSIOL, V109, P527, DOI 10.1007/s00421-010-1391-0; Krishnan Chandramouli, 2009, Iowa Orthop J, V29, P149; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lewek MD, 2009, PHYS THER, V89, P829, DOI 10.2522/ptj.20080180; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Masia L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-44; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Ranganathan R, 2012, J NEUROPHYSIOL, V108, P1537, DOI 10.1152/jn.01112.2011; Reisman DS, 2009, NEUROREHAB NEURAL RE, V23, P735, DOI 10.1177/1545968309332880; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Roy A, 2011, J REHABIL RES DEV, V48, P417, DOI 10.1682/JRRD.2010.04.0078; Sanguineti V, 2009, STUD HEALTH TECHNOL, V145, P126, DOI 10.3233/978-1-60750-018-6-126; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Siengsukon C, 2009, NEUROREHAB NEURAL RE, V23, P327, DOI 10.1177/1545968308326631; Simpkins CA, 2012, NEUROSCIENCE CLIN EV; Vallery H, 2009, INT C REHAB ROBOT, P623, DOI 10.1109/ICORR.2009.5209595; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Williamson EM, 2009, EXP AGING RES, V35, P457, DOI 10.1080/03610730903175790	57	41	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77370	10.1371/journal.pone.0077370	http://dx.doi.org/10.1371/journal.pone.0077370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146986	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400113
J	Sridevi, P; Nhiayi, MK; Setten, RL; Wang, JYJ				Sridevi, Priya; Nhiayi, May K.; Setten, Ryan L.; Wang, Jean Y. J.			Persistent Inhibition of ABL Tyrosine Kinase Causes Enhanced Apoptotic Response to TRAIL and Disrupts the Pro-Apoptotic Effect of Chloroquine	PLOS ONE			English	Article							C-ABL; CANCER-CELLS; EXTRINSIC APOPTOSIS; DEATH; ACTIVATION; PROTEIN; PHOSPHORYLATION; CASPASE-8; LIGAND; CHEMOTHERAPY	TNF-Related Apoptosis Inducing Ligand (TRAIL) binds to and activates death receptors to stimulate caspase-8 and apoptosis with higher efficiency in cancer than normal cells but the development of apoptosis resistance has limited its clinical efficacy. We found that stable, but not transient knockdown of the ABL tyrosine kinase enhanced the apoptotic response to TRAIL. Re-expression of Abl, but not its nuclear import-or kinase-defective mutant, in the ABL-knockdown cells re-established apoptosis suppression. TRAIL is known to stimulate caspase-8 ubiquitination (Ub-C8), which can facilitate caspase-8 activation or degradation by the lysosomes. In the ABL-knockdown cells, we found a higher basal level of Ub-C8 that was not further increased by lysosomal inhibition. Re-expression of Abl in the ABL-knockdown cells reduced the basal Ub-C8, correlating with apoptosis suppression. We found that lysosomal inhibition by chloroquine (CQ) could also enhance TRAIL-induced apoptosis. However, this pro-apoptotic effect of CQ was lost in the ABL-knockdown cells but restored by Abl re-expression. Interestingly, kinase inhibition at the time of TRAIL stimulation was not sufficient to enhance apoptosis. Instead, persistent treatment for several days with imatinib, an ABL kinase inhibitor, was required to cause the enhanced and the CQ-insensitive apoptotic response to TRAIL. Together, these results show that persistent loss of nuclear ABL tyrosine kinase function can sensitize cells to TRAIL and suggest that long-term exposure to the FDA-approved ABL kinase inhibitors may potentiate apoptotic response to TRAIL-based cancer therapy.	[Sridevi, Priya; Nhiayi, May K.; Setten, Ryan L.; Wang, Jean Y. J.] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Med,Div Hematol Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JYJ (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Med,Div Hematol Oncol, La Jolla, CA 92093 USA.	jywang@ucsd.edu		Setten, Ryan/0000-0002-0956-7084	National Cancer Institute [RO1CA043054]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute RO1CA043054 to JYJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baskaran R, 1996, MOL CELL BIOL, V16, P3361; Baskaran R, 1997, J BIOL CHEM, V272, P18905, DOI 10.1074/jbc.272.30.18905; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; BONNEKOH B, 1989, ARCH DERMATOL RES, V281, P487, DOI 10.1007/BF00510085; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Eggert A, 2001, CANCER RES, V61, P1314; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; French LE, 1999, J EXP MED, V190, P891, DOI 10.1084/jem.190.7.891; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong JG, 1999, NATURE, V399, P806; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Huang DY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-35; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Jabbour E, 2009, CORE EVID, V4, P207; Jiang ZH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-88; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kelly MM, 2002, CANCER BIOL THER, V1, P520, DOI 10.4161/cbt.1.5.169; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nehme A, 1997, CANCER RES, V57, P3253; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ozoren N, 2000, INT J ONCOL, V16, P917; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Preyer M, 2007, CELL DEATH DIFFER, V14, P1139, DOI 10.1038/sj.cdd.4402119; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Sridevi P, 2013, CELL DEATH DIFFER, V20, P953, DOI 10.1038/cdd.2013.42; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; VEIGNIE E, 1991, ANN TROP MED PARASIT, V85, P229, DOI 10.1080/00034983.1991.11812550; Wang JYJ, 2004, ADV PROTEIN CHEM, V69, P101; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Xu J, 2006, CANCER RES, V66, P10092, DOI 10.1158/0008-5472.CAN-06-1633; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1996, J BIOL CHEM, V271, P26457, DOI 10.1074/jbc.271.43.26457; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zhao B, 2011, ASIAN PAC J CANCER P, V12, P2675; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	69	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77495	10.1371/journal.pone.0077495	http://dx.doi.org/10.1371/journal.pone.0077495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147007	Green Published, gold			2022-12-25	WOS:000325819400122
J	Wilkins, BJ; Lorent, K; Matthews, RP; Pack, M				Wilkins, Benjamin J.; Lorent, Kristin; Matthews, Randolph P.; Pack, Michael			p53-Mediated Biliary Defects Caused by Knockdown of cirh1a, the Zebrafish Homolog of the Gene Responsible for North American Indian Childhood Cirrhosis	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; ALAGILLE-SYNDROME; HUMAN JAGGED1; TRANSCRIPTION; MUTATIONS; P53; LOCALIZATION; INHIBITION; LIVER	North American Indian Childhood Cirrhosis (NAIC) is a rare, autosomal recessive, progressive cholestatic disease of infancy affecting the Cree-Ojibway first Nations of Quebec. All NAIC patients are homozygous for a missense mutation (R565W) in CIRH1A, the human homolog of the yeast nucleolar protein Utp4. Utp4 is part of the t-Utp subcomplex of the small subunit (SSU) processome, a ribonucleoprotein complex required for ribosomal RNA processing and small subunit assembly. NAIC has thus been proposed to be a primary ribosomal disorder (ribosomopathy); however, investigation of the pathophysiologic mechanism of this disease has been hindered by lack of an animal model. Here, using a morpholino oligonucleotide (MO)-based loss-of-function strategy, we have generated a model of NAIC in the zebrafish, Danio rerio. Zebrafish Cirhin shows substantial homology to the human homolog, and cirh1a mRNA is expressed in developing hepatocytes and biliary epithelial cells. Injection of two independent MOs directed against cirh1a at the one-cell stage causes defects in canalicular and biliary morphology in 5 dpf larvae. In addition, 5 dpf Cirhin-deficient larvae have dose-dependent defects in hepatobiliary function, as assayed by the metabolism of an ingested fluorescent lipid reporter. Previous yeast and in vitro studies have shown that defects in ribosome biogenesis cause stabilization and nuclear accumulation of p53, which in turn causes p53-mediated cell cycle arrest and/or apoptosis. Thus, the nucleolus appears to function as a cellular stress sensor in some cell types. In accordance with this hypothesis, transcriptional targets of p53 are upregulated in Cirhin-deficient zebrafish embryos, and defects in biliary function seen in Cirhin-deficient larvae are completely abrogated by mutation of tp53. Our data provide the first in vivo evidence of a role for Cirhin in biliary development, and support the hypothesis that congenital defects affecting ribosome biogenesis can activate a cellular stress response mediated by p53.	[Wilkins, Benjamin J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lorent, Kristin; Pack, Michael] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Matthews, Randolph P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Pack, M (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	mpack@mail.med.upenn.edu			National Institutes of Health [R01DK09211]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by National Institutes of Health grant R01DK09211 (M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Betard C, 2000, AM J HUM GENET, V67, P222, DOI 10.1086/302993; Bezerra J A, 2001, Semin Gastrointest Dis, V12, P54; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drouin E, 2000, J PEDIATR GASTR NUTR, V31, P395, DOI 10.1097/00005176-200010000-00013; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Freed EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002892; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Lorent K, 2010, DEV DYNAM, V239, P855, DOI 10.1002/dvdy.22220; Matthews RP, 2005, DEVELOPMENT, V132, P5295, DOI 10.1242/dev.02140; Matthews RP, 2004, DEV BIOL, V274, P245, DOI 10.1016/j.ydbio.2004.06.016; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Pack M, 1996, DEVELOPMENT, V123, P321; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roy Angshumoy, 2010, Surg Pathol Clin, V3, P743, DOI 10.1016/j.path.2010.06.006; Santos Jorge L, 2010, Curr Gastroenterol Rep, V12, P30, DOI 10.1007/s11894-009-0081-8; Schaff Z, 1979, ELECT MICROSCOPY HUM, V8; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Solanas M, 2001, BIOTECHNOL LETT, V23, P263, DOI 10.1023/A:1005693928291; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wilkins BJ, 2013, COMPR PHYSIOL, V3, P1213, DOI 10.1002/cphy.c120021; Yu B, 2005, EXP CELL RES, V311, P218, DOI 10.1016/j.yexcr.2005.08.012; Yu B, 2009, EXP CELL RES, V315, P3086, DOI 10.1016/j.yexcr.2009.08.017	41	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77670	10.1371/journal.pone.0077670	http://dx.doi.org/10.1371/journal.pone.0077670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147052	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400133
J	Yan, BX; Ma, JX; Zhang, J; Guo, Y; Riedel, H; Mueller, MD; Remick, SC; Yu, JJ				Yan, B-x; Ma, J-x; Zhang, J.; Guo, Y.; Riedel, H.; Mueller, M. D.; Remick, S. C.; Yu, J. J.			PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer	ONCOGENE			English	Article						PSP94; chemoresistance; PCK3145; signaling pathway; ovarian cancer	PROSTATIC SECRETORY PROTEIN; MESSENGER-RNA LEVELS; STEM-CELLS; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; BREAST-CANCER; LET-7; EXPRESSION; LIN28B; ERCC1	Tumor drug resistance remains a major challenge in the treatment of cancer. Here, we show that Prostatic secretory protein 94 (PSP94) levels are reduced in ovarian cancer patients with high levels of excision repair cross-complementing 1 (ERCC1), a marker for chemoresistance. We find that PSP94 is decreased in an ovarian cancer drug-resistant cell line, and plays an important role in the development of drug resistance in vitro. Our studies indicate that PSP94 can partially reverse drug resistance in mouse tumor models in vivo and that a PSP94 peptide derivative PCK3145 suppresses chemoresistant cancer cell and tumor growth in vitro and in vivo. Our investigation of the involved molecular mechanisms suggests that PSP94 may confer drug resistance by modulating the Lin28b/Let-7 signaling pathway. We introduce PSP94 and its peptide derivative PCK3145 as potential target to reverse chemoresistance in ovarian cancer and have begun to identify their relevant molecular targets in specific signaling pathways.	[Yan, B-x; Ma, J-x; Guo, Y.; Riedel, H.; Mueller, M. D.; Remick, S. C.; Yu, J. J.] W Virginia Univ, Sch Pharm, Dept Biochem, Sch Med,Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Yan, B-x; Zhang, J.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Ma, J-x] IcesnowYanyan Biosci Assoc, Beijing, Peoples R China; [Zhang, J.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Yan, B-x; Ma, J-x] Beijing Anim Sci Inst, Beijing, Peoples R China	West Virginia University; West Virginia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yan, BX (corresponding author), W Virginia Univ, Sch Pharm, Dept Biochem, Sch Med,Dept Basic Pharmaceut Sci, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	bxueyan@hotmail.com			Molecular Medicine Core Facility, Mary Babb Randolph Cancer Center, West Virginia University; Icesnow Yanyan Bioscience Association, Beijing	Molecular Medicine Core Facility, Mary Babb Randolph Cancer Center, West Virginia University; Icesnow Yanyan Bioscience Association, Beijing	We acknowledge the Molecular Medicine Core Facility, Mary Babb Randolph Cancer Center, West Virginia University and Icesnow Yanyan Bioscience Association, Beijing for supporting this study.	ABRAHAMSSON PA, 1990, ANDROLOGIA, V22, P122; Baijal-Gupta M, 2000, J ENDOCRINOL, V165, P425, DOI 10.1677/joe.0.1650425; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chan PSF, 1999, PROSTATE, V41, P99; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen TS, 2010, ADV DRUG DELIVER REV, V62, P1257, DOI 10.1016/j.addr.2010.07.008; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; FUCHTNER C, 1993, GYNECOL ONCOL, V48, P203, DOI 10.1006/gyno.1993.1034; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hawkins Robert E, 2005, Clin Prostate Cancer, V4, P91, DOI 10.3816/CGC.2005.n.016; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Li QD, 2000, ANTICANCER RES, V20, P645; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Reed E, 2003, CLIN CANCER RES, V9, P5299; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shukeir N, 2004, CANCER RES, V64, P5370, DOI 10.1158/0008-5472.CAN-04-0788; Shukeir N, 2003, CANCER RES, V63, P2072; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; WEIBER H, 1990, AM J PATHOL, V137, P593; Whitaker HC, 2010, PROSTATE, V70, P333, DOI 10.1002/pros.21059; XUAN JW, 1995, ONCOGENE, V11, P1041; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Yi Guo B Y, 2012, AACR AM ASS CANC RES, V53; Yu JJ, 1996, INT J ONCOL, V8, P313	43	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5288	5294		10.1038/onc.2013.466	http://dx.doi.org/10.1038/onc.2013.466			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24186202				2022-12-25	WOS:000345120400006
J	Park, TJ; Curran, T				Park, T-J; Curran, T.			Essential roles of Crk and CrkL in fibroblast structure and motility	ONCOGENE			English	Article						Crk; CrkL; focal adhesion; actin; cytoskeleton; motility	ADAPTER PROTEIN CRK; KEY SIGNALING INTEGRATORS; MICE LACKING; V-CRK; CANCER; ONCOGENE; PAXILLIN; PHOSPHORYLATION; TRANSFORMATION; P130(CAS)	Cytosolic proteins containing SH2 and SH3 domains, such as Crk and Crk-like (CrkL), are broadly expressed adapters that interact with a variety of proteins to fulfill key roles in signal transduction pathways triggered by activation of receptor and non-receptor tyrosine kinases. Crk and CrkL are similar to each other in structure and biochemical function, although they provide both distinct, as well as overlapping, biological roles during development. We developed a systematic approach to investigate Crk family functions at the cellular level by generating a conditional knock-out system for ablation of Crk and CrkL in cultured fibroblasts. The loss of both Crk and CrkL from fibroblasts resulted in reduced cell surface area and adoption of a rounded, refractile cellular phenotype. These morphological alterations were accompanied by a decrease in focal adhesion sites, reduced actin stress fibers and a collapse of microtubule structures. In addition, cells exhibited decreases in spontaneous motility and wound-healing behavior. Reduced p130Cas phosphorylation and actin levels closely followed the loss of Crk and CrkL, and stabilization of polymerized actin by jasplakinolide suppressed the morphological conversion. Ablation of Crk or CrkL alone conferred a much more modest phenotype suggesting that Crk and CrkL have overlapping functions that are critical for maintaining cell structure. The morphological alterations could be partially rescued by reintroduction of CrkII, and, to a lesser extent, CrkL. Taken together, our results suggest that Crk and CrkL have critical roles in cell structure and motility by maintaining cytoskeletal integrity.	[Park, T-J; Curran, T.] Childrens Hosp Philadelphia, Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Curran, T (corresponding author), Childrens Hosp Philadelphia, Res Inst, Colket Translat Res Bldg,Room 4060, Philadelphia, PA 19104 USA.	currant@email.chop.edu	Curran, Tom/F-5234-2018; Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Park, Taeju/0000-0003-3897-3994	Pennsylvania Department of Health Cure Formulary grant (SAP) [4100047628]	Pennsylvania Department of Health Cure Formulary grant (SAP)	We thank Hanna Li and Erin Finn for their technical assistance and Mateusz Koptyra for critical reading of the manuscript. This work was supported by a Pennsylvania Department of Health Cure Formulary grant (SAP#4100047628 to TC).	Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kong JY, 2004, CELL BIOL INT, V28, P781, DOI 10.1016/j.cellbi.2004.07.012; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SALGIA R, 1995, J BIOL CHEM, V270, P29145, DOI 10.1074/jbc.270.49.29145; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sriram Ganapathy, 2010, Genes Cancer, V1, P1132, DOI 10.1177/1947601910397188; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141	35	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5121	5132		10.1038/onc.2013.453	http://dx.doi.org/10.1038/onc.2013.453			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24166500				2022-12-25	WOS:000343768400007
J	Lee, SH; Zhu, CF; Peng, Y; Johnson, DT; Lehmann, L; Sun, ZJ				Lee, Suk Hyung; Zhu, Chunfang; Peng, Yue; Johnson, Daniel T.; Lehmann, Lynn; Sun, Zijie			Identification of a Novel Role of ZMIZ2 Protein in Regulating the Activity of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Catenin; Cell Signaling; Protein-Protein Interactions; Transcription Regulation; Wnt Signaling; PIAS-like Proteins; Wnt Ligand; ZMIZ2	PIAS-LIKE PROTEIN; RECEPTOR-MEDIATED TRANSCRIPTION; PROSTATE-CANCER CELLS; P53 TUMOR-SUPPRESSOR; BETA-CATENIN; ANDROGEN RECEPTOR; COLON-CARCINOMA; WNT; COMPLEX; EXPRESSION	Background: ZMIZ2 is a transcriptional coactivator, but its biological role has not been fully investigated. Results: We demonstrate a promotional role of ZMIZ2 in -catenin-mediated transcription and cell growth using a variety of biologically relevant in vitro and in vivo approaches. Conclusion: ZMIZ2 is a coactivator of the Wnt/-catenin signaling pathway. Significance: This study explores a novel mechanism for PIAS-like proteins in regulating Wnt signaling pathways. ZMIZ2, also named ZIMP7, is a protein inhibitor of activated STAT (PIAS)-like protein and a transcriptional coactivator. In this study, we investigated the interaction between ZMIZ2 and -catenin, a key regulator of the Wnt signaling pathway. We demonstrated that the expression of exogenous ZMIZ2 augments TCF (T cell factor) and -catenin-mediated transcription. In contrast, shRNA knockdown of ZMIZ2 expression specifically represses the enhancement of TCF/-catenin-mediated transcription by ZMIZ2. Using Wnt3a-conditioned medium, we demonstrated that ZMIZ2 can enhance Wnt ligand-induced TCF/-catenin-mediated transcription. We also showed a promotional role of ZMIZ2 in enhancing -catenin downstream target gene expression in human cells and in Zmiz2 null (Zmiz2(-/-)) mouse embryonic fibroblasts (MEFs). The regulatory role of Zmiz2 in Wnt-induced TCF/-catenin-mediated transcription can be restored in Zmiz2(-/-) MEFs that were infected with adenoviral expression vectors for Zmiz2. Moreover, enhancement of Zmiz2 on TCF/-catenin-mediated transcription was further demonstrated in Zmiz2 knockout and Axin2 reporter compound mice. Furthermore, the protein-protein interaction between ZMIZ2 and -catenin was identified by co-immunoprecipitation and in vitro protein pulldown assays. We also observed recruitment of endogenous ZMIZ2 onto the promoter region of the Axin 2 gene, a -catenin downstream target promoter, in a Wnt ligand-inducible manner. Finally, a promotional role of ZMIZ2 on cell growth was demonstrated in human cell lines and Zmiz2 knockout MEFs. Our findings demonstrate a novel interaction between ZMIZ2 and -catenin and elucidate a novel mechanism for PIAS-like proteins in regulating Wnt signaling pathways.	[Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute Public Health Service [R01 CA070297, R01 CA151623, U01 CA166894]; NATIONAL CANCER INSTITUTE [R01CA070297, U01CA166894, R01CA151623] Funding Source: NIH RePORTER	National Cancer Institute Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Public Health Service Grants R01 CA070297, R01 CA151623, and U01 CA166894.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li X, 2011, PLOS ONE, V6; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Rakowski LA, 2013, CANCER RES, V73, P930, DOI 10.1158/0008-5472.CAN-12-1389; Rodriguez-Magadan H, 2008, GENE EXPR PATTERNS, V8, P206, DOI 10.1016/j.modgep.2007.10.005; Rodriguez-Magadan H, 2010, GENE EXPR PATTERNS, V10, P16, DOI 10.1016/j.gep.2009.11.004; Rogers LM, 2013, J INVEST DERMATOL, V133, P1863, DOI 10.1038/jid.2013.77; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Soler G, 2008, LEUKEMIA, V22, P1278, DOI 10.1038/sj.leu.2405033; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Voeller HJ, 1998, CANCER RES, V58, P2520; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	61	15	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35913	35924		10.1074/jbc.M113.529727	http://dx.doi.org/10.1074/jbc.M113.529727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174533	Green Published, hybrid			2022-12-25	WOS:000329814700028
J	Wu, S; Zheng, SD; Huang, HL; Yan, LC; Yin, XF; Xu, HN; Zhang, KJ; Gui, JH; Chu, L; Liu, XY				Wu, Shuai; Zheng, Shui-Di; Huang, Hong-Ling; Yan, Li-Chong; Yin, Xiao-Fei; Xu, Hai-Neng; Zhang, Kang-Jian; Gui, Jing-Hua; Chu, Liang; Liu, Xin-Yuan			Lithium Down-regulates Histone Deacetylase 1 (HDAC1) and Induces Degradation of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; Histone Deacetylase; Histone Deacetylase Inhibitors; Huntington Disease; Neurodegeneration; MicroRNA; Autophagy	CELL-CYCLE ARREST; INDUCED NEURODEGENERATION; INHIBITS PROLIFERATION; LIVER PROLIFERATION; BINDING PROTEIN; AUTOPHAGY; DISEASE; CANCER; ACTIVATION; APOPTOSIS	Background: Lithium and valproic acid (VPA) exhibit a robust neuroprotective and anti-tumor effects in neural cells and tumor cells. Results: Lithium significantly down-regulates HDAC1 at the translational level by targeting HDAC1 mRNA. Conclusion: The decrease in HDAC1 is essential for the lithium-mediated, autophagic degradation of mutant huntingtin. Significance: This report is the first demonstration that HDAC1 decreases in response to lithium treatment. Lithium is an effective mood stabilizer that has been clinically used to treat bipolar disorder for several decades. Recent studies have suggested that lithium possesses robust neuroprotective and anti-tumor properties. Thus far, a large number of lithium targets have been discovered. Here, we report for the first time that HDAC1 is a target of lithium. Lithium significantly down-regulated HDAC1 at the translational level by targeting HDAC1 mRNA. We also showed that depletion of HDAC1 is essential for the neuroprotective effects of lithium and for the lithium-mediated degradation of mutant huntingtin through the autophagic pathway. Our studies explain the multiple functions of lithium and reveal a novel mechanism for the function of lithium in neurodegeneration.	[Wu, Shuai; Huang, Hong-Ling; Yan, Li-Chong; Yin, Xiao-Fei; Xu, Hai-Neng; Zhang, Kang-Jian; Chu, Liang; Liu, Xin-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Zheng, Shui-Di; Gui, Jing-Hua; Liu, Xin-Yuan] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 10018, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University	Chu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Yueyang Rd, Shanghai 200031, Peoples R China.	lchu@sibcb.ac.cn; xyliu@sibcb.ac.cn	Wu, Shuai/V-4605-2019; Xu, Haineng/A-4345-2016; Liu, Xinyuan/HDM-5505-2022	Xu, Haineng/0000-0001-7195-4897; Gui, Jinghua/0000-0003-2474-500X; Wu, Shuai/0000-0002-3183-5081	National Nature Science Foundation of China [30623003]; National Basic Research Program of China (973 Program) [2010CB529901]; National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program [2008ZX10002-023]; National Basic Research Committee of Science and Technology [06ZR14072, 074119508]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program; National Basic Research Committee of Science and Technology	This work was supported by the National Nature Science Foundation of China (30623003), the National Basic Research Program of China (973 Program) (2010CB529901), the important National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program (2008ZX10002-023), and the National Basic Research Committee of Science and Technology (06ZR14072 and 074119508).	Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Barrachina M, 2009, J NEUROPATH EXP NEUR, V68, P880, DOI 10.1097/NEN.0b013e3181af2e46; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Catalano MG, 2005, J CLIN ENDOCR METAB, V90, P1383, DOI 10.1210/jc.2004-1355; Chen HM, 2009, INT J NEUROPSYCHOPH, V12, P975, DOI 10.1017/S1461145709000029; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Macdonald A, 2008, INT J GERIATR PSYCH, V23, P704, DOI 10.1002/gps.1964; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; QUINN N, 1986, LANCET, V1, P1377; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rolli-Derkinderen M, 2003, J BIOL CHEM, V278, P18859, DOI 10.1074/jbc.M211696200; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stump RJW, 2006, J PATHOL, V210, P249, DOI 10.1002/path.2049; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Vincent T, 2008, ONCOGENE, V27, P5254, DOI 10.1038/onc.2008.152; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	75	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35500	35510		10.1074/jbc.M113.479865	http://dx.doi.org/10.1074/jbc.M113.479865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165128	Green Published, hybrid			2022-12-25	WOS:000329867600045
J	Seo, S; Takayama, K; Uno, K; Ohi, K; Hashimoto, R; Nishizawa, D; Ikeda, K; Ozaki, N; Nabeshima, T; Miyamoto, Y; Nitta, A				Seo, Seunghee; Takayama, Kanako; Uno, Kyosuke; Ohi, Kazutaka; Hashimoto, Ryota; Nishizawa, Daisuke; Ikeda, Kazutaka; Ozaki, Norio; Nabeshima, Toshitaka; Miyamoto, Yoshiaki; Nitta, Atsumi			Functional Analysis of Deep Intronic SNP rs13438494 in Intron 24 of PCLO Gene	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; BIPOLAR DISORDER; PROTEIN PICCOLO; DISEASE	The single nucleotide polymorphism (SNP) rs13438494 in intron 24 of PCLO was significantly associated with bipolar disorder in a meta-analysis of genome-wide association studies. In this study, we performed functional minigene analysis and bioinformatics prediction of splicing regulatory sequences to characterize the deep intronic SNP rs13438494. We constructed minigenes with A and C alleles containing exon 24, intron 24, and exon 25 of PCLO to assess the genetic effect of rs13438494 on splicing. We found that the C allele of rs13438494 reduces the splicing efficiency of the PCLO minigene. In addition, prediction analysis of enhancer/silencer motifs using the Human Splice Finder web tool indicated that rs13438494 induces the abrogation or creation of such binding sites. Our results indicate that rs13438494 alters splicing efficiency by creating or disrupting a splicing motif, which functions by binding of splicing regulatory proteins, and may ultimately result in bipolar disorder in affected people.	[Seo, Seunghee; Takayama, Kanako; Uno, Kyosuke; Miyamoto, Yoshiaki; Nitta, Atsumi] Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan; [Seo, Seunghee] Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Educ, Toyama 930, Japan; [Ohi, Kazutaka; Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Nishizawa, Daisuke; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi, Japan	University of Toyama; University of Toyama; Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Nagoya University; Meijo University	Nitta, A (corresponding author), Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan.	nitta@pha.u-toyama.ac.jp	Ozaki, Norio/M-8908-2014; Hashimoto, Ryota/P-8572-2014; Ohi, Kazutaka/J-7851-2019; Nitta, Atsumi/AAF-4211-2019; Hashimoto, Ryota/AAE-3200-2019	Ozaki, Norio/0000-0002-7360-4898; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Hashimoto, Ryota/0000-0002-5941-4238	Program for Next Generation World-Leading Researchers (NEXT Program) [LS047]; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labour and Welfare (MHLW); SRF Grant for Biomedical Research	Program for Next Generation World-Leading Researchers (NEXT Program); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); SRF Grant for Biomedical Research	This study was supported by the Program for Next Generation World-Leading Researchers (NEXT Program LS047), Grants-in-aid Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan, and for Scientific Research (KAKENHI)(B)(C) and Grant-in-Aid for Exploratory Research from Japan Society for the Promotion of Science (JSPS), Research on Regulatory Science of Pharmaceuticals, and Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare (MHLW), and a SRF Grant for Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Bray NJ, 2012, WORLD PSYCHIATRY, V11, P153; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cen X, 2008, MOL PSYCHIATR, V13, P451, DOI 10.1038/sj.mp.4002132; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Choi KH, 2011, BIOL PSYCHIAT, V69, P353, DOI 10.1016/j.biopsych.2010.09.042; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Insel TR, 2003, AM J PSYCHIAT, V160, P616, DOI 10.1176/appi.ajp.160.4.616; Kleinman JE, 2011, BIOL PSYCHIAT, V69, P298, DOI 10.1016/j.biopsych.2010.12.008; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; Nitta A, 2010, United States Patent US, Patent No. [7776538B2, 7776538]; Savas Sevtap, 2006, Human Genomics, V2, P274; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125	22	45	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76960	10.1371/journal.pone.0076960	http://dx.doi.org/10.1371/journal.pone.0076960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167553	gold, Green Published, Green Submitted			2022-12-25	WOS:000326034500012
J	So, BI; Song, YS; Fang, CH; Park, JY; Lee, Y; Shin, JH; Kim, H; Kim, KS				So, Byung-Im; Song, Yi-Sun; Fang, Cheng-Hu; Park, Jun-Young; Lee, Yonggu; Shin, Jeong Hun; Kim, Hyuck; Kim, Kyung-Soo			G-CSF Prevents Progression of Diabetic Nephropathy in Rat	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW-TRANSPLANTATION; ACUTE MYOCARDIAL-INFARCTION; FOOT PROCESS EFFACEMENT; STEM-CELL MOBILIZATION; VERSUS-HOST-DISEASE; OLETF RATS; EXTRACELLULAR-MATRIX; RENAL-DISEASE; TGF-BETA	Background: The protective effects of granulocyte colony-stimulating factor (G-CSF) have been demonstrated in a variety of renal disease models. However, the influence of G-CSF on diabetic nephropathy (DN) remains to be examined. In this study, we investigated the effect of G-CSF on DN and its possible mechanisms in a rat model. Methods: Otsuka Long-Evans Tokushima Fatty (OLETF) rats with early DN were administered G-CSF or saline intraperitoneally. Urine albumin creatinine ratio (UACR), creatinine clearance, mesangial matrix expansion, glomerular basement membrane (GBM) thickness, and podocyte foot process width (FPW) were measured. The levels of interleukin (IL)-1 beta, transforming growth factor (TGF)-beta 1, and type IV collagen genes expression in kidney tissue were also evaluated. To elucidate the mechanisms underlying G-CSF effects, we also assessed the expression of G-CSF receptor (G-CSFR) in glomeruli as well as mobilization of bone marrow (BM) cells to glomeruli using sex-mismatched BM transplantation. Results: After four weeks of treatment, UACR was lower in the G-CSF treatment group than in the saline group (p<0.05), as were mesangial matrix expansion, GBM thickness, and FPW (p<0.05). In addition, the expression of TGF-beta 1 and type IV collagen and IL-1 beta levels was lower in the G-CSF treatment group (p<0.05). G-CSFR was not present in glomerular cells, and G-CSF treatment increased the number of BM-derived cells in glomeruli (p<0.05). Conclusions: G-CSF can prevent the progression of DN in OLETF rats and its effects may be due to mobilization of BM cells rather than being a direct effect.	[So, Byung-Im; Song, Yi-Sun; Park, Jun-Young; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Fang, Cheng-Hu; Lee, Yonggu; Shin, Jeong Hun; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Fang, Cheng-Hu] Yanbian Univ, Coll Med, Dept Internal Med, Yanji, Peoples R China; [Kim, Hyuck] Hanyang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 133791, South Korea	Hanyang University; Hanyang University; Yanbian University; Hanyang University	Kim, KS (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea.	kskim@hanyang.ac.kr	Lee, Yonggu/Q-3832-2018; Shin, Jeong Hun/O-1273-2019	Lee, Yonggu/0000-0002-3757-3692; Shin, Jeong Hun/0000-0002-6718-9763				ADLER S, 1994, J AM SOC NEPHROL, V5, P1165; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Belmiro CLR, 2011, BRAZ J MED BIOL RES, V44, P624, DOI [10.1590/S0100-879X2011007500077, 10.1590/S0100-879X2011000700003]; BENNETT PH, 1995, AM J KIDNEY DIS, V25, P107; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Flaquer M, 2012, DIABETOLOGIA, V55, P2059, DOI 10.1007/s00125-012-2535-z; Fukuzawa Y, 1996, J LAB CLIN MED, V128, P568, DOI 10.1016/S0022-2143(96)90129-8; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Ho CC, 2010, ONCOTARGET, V1, P583; Hou XW, 2009, TOXICOL LETT, V187, P40, DOI 10.1016/j.toxlet.2009.01.025; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kim SY, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/945123; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Lim YH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-92; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; MOGENSEN CE, 1987, KIDNEY INT, V31, P673, DOI 10.1038/ki.1987.50; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Park KW, 2008, J MOL CELL CARDIOL, V45, P670, DOI 10.1016/j.yjmcc.2008.07.002; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; SHERIDAN WP, 1989, LANCET, V2, P891; Shoji E, 1997, DIGEST DIS SCI, V42, P915, DOI 10.1023/A:1018860313674; Song YS, 2013, ANN HEPATOL, V12, P115, DOI 10.1016/S1665-2681(19)31393-6; Sugimoto K, 2001, CLIN EXP PHARMACOL P, V28, P826, DOI 10.1046/j.1440-1681.2001.03530.x; Tai CY, 2004, TRANSPLANTATION, V77, P316, DOI 10.1097/01.TP.0000101511.11171.EF; Thomson SE, 2008, J DIABETES COMPLICAT, V22, P284, DOI 10.1016/j.jdiacomp.2007.07.001; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Tavares AMV, 2010, LIFE SCI, V87, P699, DOI 10.1016/j.lfs.2010.10.008; Wei QQ, 2011, AM J PHYSIOL-RENAL, V301, pF162, DOI 10.1152/ajprenal.00438.2010; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Yi-Sun S, 2013, ANN HEPATOL, V12, P115; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	43	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77048	10.1371/journal.pone.0077048	http://dx.doi.org/10.1371/journal.pone.0077048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167558	gold, Green Submitted, Green Published			2022-12-25	WOS:000326034500017
J	Luo, HM; Du, MH; Lin, ZL; Zhang, L; Ma, L; Wang, H; Yu, W; Lv, Y; Lu, JY; Pi, YL; Hu, S; Sheng, ZY				Luo, Hong-Min; Du, Ming-Hua; Lin, Zhi-Long; Zhang, Lin; Ma, Li; Wang, Huan; Yu, Wen; Lv, Yi; Lu, Jiang-Yang; Pi, Yu-Li; Hu, Sen; Sheng, Zhi-Yong			Valproic Acid Treatment Inhibits Hypoxia-Inducible Factor 1 alpha Accumulation and Protects against Burn-Induced Gut Barrier Dysfunction in a Rodent Model	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; LIGHT-CHAIN KINASE; HISTONE DEACETYLASE; GASTROINTESTINAL-TRACT; HEMORRHAGIC-SHOCK; FACTOR-I; VEGF; PERMEABILITY; INJURY; HIF-1	Objective: Burn-induced gut dysfunction plays an important role in the development of sepsis and multiple organ dysfunction. Emerging evidence suggests that hypoxia-inducible factor-1 alpha (HIF-1 alpha) is critical in paracelluar barrier functions via regulating vascular endothelial growth factor (VEGF) and myosin light chain kinase (MLCK) expression. Previous studies have also demonstrated that histone deacetylase inhibitors (HDACIs) can repress HIF-1 alpha. This study aims to examine whether valproic acid (VPA), a HDACI, protects against burn-induced gut barrier dysfunction via repressing HIF-1 alpha-dependent upregulation of VEGF and MLCK expression. Methods: Rats were subjected to third degree 55% TBSA burns and treated with/without VPA (300mg/kg). Intestinal barrier dysfunction was evaluated by permeability of intestinal mucosa to fluorescein isothiocyanate (FITC)-dextran and histologic evaluation. Histone acetylation, tight junction protein zonula occludens 1 (ZO-1), VEGF, MLCK and HIF-1 alpha were measured. In addition, CaCO2 cells were transfected with siRNA directed against HIF-1 alpha and were stimulated with CoCl2 (1mM) for 24 hours with/without VPA (2mM) followed by analysis of HIF-1 alpha, MLCK, VEGF and ZO-1. Results: Burn insults resulted in a significant increase in intestinal permeability and mucosal damage, accompanied by a significant reduction in histone acetylation, ZO-1, upregulation of VEGF, MLCK expression, and an increase in HIF-1 alpha accumulation. VPA significantly attenuated the increase in intestinal permeability, mucosa damage, histone deacetylation and changes in ZO-1 expression. VPA also attenuated the increased VEGF, MLCK and HIF-1 alpha protein levels. VPA reduced HIF-1 alpha, MLCK and VEGF production and prevented ZO-1 loss in CoCl2-stimulated Caco-2 cells. Moreover, transfection of siRNA directed against HIF-1 alpha led to inhibition of MLCK and VEGF production, accompanied by upregulation of ZO-1. Conclusions: These results indicate that VPA can protect against burn-induced gut barrier dysfunction. These protective effects may be due to its inhibitory action on HIF-1 alpha, leading to a reduction in intestinal VEGF and MLCK expression and minimizing ZO-1 degradation.	[Luo, Hong-Min; Du, Ming-Hua; Lin, Zhi-Long; Ma, Li; Wang, Huan; Yu, Wen; Lv, Yi; Hu, Sen; Sheng, Zhi-Yong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Lab Shock & Organ Dysfunct, Beijing, Peoples R China; [Zhang, Lin] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China; [Lu, Jiang-Yang] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Pathol, Beijing, Peoples R China; [Pi, Yu-Li] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ophtalmol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Hu, S (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Lab Shock & Organ Dysfunct, Beijing, Peoples R China.	bs0425@163.com; shengzhy@cae.cn	Luo, Hongmin/ABG-6510-2021		National Basic Research Program of China (973 Program) [2012CB518101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Program, Grant 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay I, 2008, BRAIN RES, V1234, P198, DOI 10.1016/j.brainres.2008.07.121; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Chen SY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197946; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Chong W, 2012, J TRAUMA ACUTE CARE, V72, P347, DOI 10.1097/TA.0b013e318243d8b2; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Comerford KM, 2002, CANCER RES, V62, P3387; Costantini TW, 2010, MOL IMAGING, V9, P30, DOI 10.2310/7290.2010.00001; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; EPSTEIN MD, 1992, PLAST RECONSTR SURG, V90, P524, DOI 10.1097/00006534-199209000-00032; Gosain A, 2005, J BURN CARE REHABIL, V26, P85, DOI 10.1097/01.BCR.0000150212.21651.79; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; Hindryckx P, 2010, J IMMUNOL, V185, P6306, DOI 10.4049/jimmunol.1002541; Hu S, 2012, BURNS, V38, P83, DOI 10.1016/j.burns.2011.03.015; Ikezu T, 1997, J BIOL CHEM, V272, P25289, DOI 10.1074/jbc.272.40.25289; Kaiser M, 2006, HAEMATOL-HEMATOL J, V91, P248; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; Liu H, 2011, CYTOKINE, V56, P581, DOI 10.1016/j.cyto.2011.08.023; Louis NA, 2006, J CELL BIOCHEM, V99, P1616, DOI 10.1002/jcb.20947; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Schaper J, 2013, ANESTHESIOLOGY, V118, P134, DOI 10.1097/ALN.0b013e3182784c93; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Tinsley JH, 2004, AM J PHYSIOL-LUNG C, V286, pL841, DOI 10.1152/ajplung.00341.2003; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zahs A, 2012, AM J PHYSIOL-GASTR L, V303, pG705, DOI 10.1152/ajpgi.00157.2012; Zgouras D, 2004, BIOCHEM BIOPH RES CO, V316, P693, DOI 10.1016/j.bbrc.2004.02.105	52	17	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77523	10.1371/journal.pone.0077523	http://dx.doi.org/10.1371/journal.pone.0077523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147016	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200041
J	Debinski, W; Dickinson, P; Rossmeisl, JH; Robertson, J; Gibo, DM				Debinski, Waldemar; Dickinson, Peter; Rossmeisl, John H.; Robertson, John; Gibo, Denise M.			New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; FOS-RELATED ANTIGEN-1; GLIOBLASTOMA-MULTIFORME; PSEUDOMONAS EXOTOXIN; MALIGNANT GLIOMA; RECEPTOR ALPHA-2; T-CELLS; INTERLEUKIN-13; THERAPY; PROTEIN	Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous astrocytomas in dogs resemble human disease and have been proposed as translational model system for investigation of novel therapeutic strategies for brain tumors. We have generated reagents for both detection and therapeutic targeting of IL-13RA2 in human and canine brain tumors. Peptides from three different regions of IL-13RA2 with 100% sequence identity between human and canine receptors were used as immunogens for generation of monoclonal antibodies. Recombinant canine mutant IL-13 (canIL-13.E13K) and canIL-13.E13K based cytotoxin were also produced. The antibodies were examined for their immunoreactivities in western blots, immunohistochemistry, immunofluorescence and cell binding assays using human and canine tumor specimen sections, tissue lysates and established cell lines; the cytotoxin was tested for specific cell killing. Several isolated MAbs were immunoreactive to IL-13RA2 in western blots of cell and tissue lysates from glioblastomas from both human and canine patients. Human and canine astrocytomas and oligodendrogliomas were also positive for IL-13RA2 to various degrees. Interestingly, both human and canine meningiomas also exhibited strong reactivity. Normal human and canine brain samples were virtually negative for IL-13RA2 using the newly generated MAbs. MAb 1E10B9 uniquely worked on tissue specimens and western blots, bound live cells and was internalized in GBM cells over-expressing IL-13RA2. The canIL-13.E13K cytotoxin was very potent and specific in killing canine GBM cell lines. Thus, we have obtained several monoclonal antibodies against IL-13RA2 cross-reacting with human and canine receptors. In addition to GBM, other brain tumors, such as high grade oligodendrogliomas, meningiomas and canine choroid plexus papillomas, appear to express the receptor at high levels and thus may be appropriate candidates for IL-13RA2-targeted imaging/therapies. Canine spontaneous primary brain tumors represent an excellent translational model for human counterparts.	[Debinski, Waldemar; Gibo, Denise M.] Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Dept Neurosurg, Winston Salem, NC USA; [Dickinson, Peter] Univ Calif Davis, Dept Surg & Radiol Sci, Sch Vet Med, Davis, CA 95616 USA; [Rossmeisl, John H.; Robertson, John] Virginia Tech, Dept Small Anim Clin Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA	Wake Forest University; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Debinski, W (corresponding author), Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Dept Neurosurg, Winston Salem, NC USA.	debinski@wakehealth.edu; pjdickinson@ucdavis.edu	Rossmeisl, John H/Q-7119-2016	Rossmeisl, John H/0000-0003-1655-7076	NCI [R01 CA74145, CA139099]; Wake Forest University School of Medicine, BTCOE; Paul C. and Borghild T. Petersen Foundation; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA074145, R01CA139099, P30CA093373] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wake Forest University School of Medicine, BTCOE; Paul C. and Borghild T. Petersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI grant R01 CA74145 and CA139099, the Translational Science Institute Team Award grant from Wake Forest University School of Medicine, BTCOE and the Paul C. and Borghild T. Petersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balyasnikova IV, 2012, J BIOL CHEM, V287, P30215, DOI 10.1074/jbc.M112.370015; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Candolfi M, 2010, P NATL ACAD SCI USA, V107, P20021, DOI 10.1073/pnas.1008261107; Debinski W, 1998, CRIT REV ONCOGENESIS, V9, P255; Debinski W, 1999, CLIN CANCER RES, V5, P985; Debinski W, 2005, MOL CANCER RES, V3, P237; Debinski W, 1998, NAT BIOTECHNOL, V16, P449, DOI 10.1038/nbt0598-449; Debinski W, 1995, CLIN CANCER RES, V1, P1253; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Debinski W, 2000, MOL MED, V6, P440, DOI 10.1007/BF03401786; Dickinson PJ, 2006, VET COMP ONCOL, V4, P132, DOI 10.1111/j.1476-5829.2006.00101.x; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; FANKHAUSER R, 1974, B WORLD HEALTH ORGAN, V50, P53; HAYES HM, 1975, INT J CANCER, V15, P39, DOI 10.1002/ijc.2910150106; Hu N., 2005, CANC THER, V3, P531; Joshi BH, 2000, CANCER RES, V60, P1168; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Lal A, 2002, CANCER RES, V62, P3335; Li CB, 2002, PROTEIN ENG, V15, P419, DOI 10.1093/protein/15.5.419; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LUGINBUHL H., 1968, PROGR NEUROLOGICAL S, V2, P85; Mintz A, 2003, J NEURO-ONCOL, V64, P117, DOI 10.1007/BF02700026; Mintz A, 2002, NEOPLASIA, V4, P388, DOI 10.1038/sj.neo.7900234; Mintz A, 2000, CRIT REV ONCOGENESIS, V11, P77; Mintz A, 2008, CANCER BIOTHER RADIO, V23, P581, DOI 10.1089/cbr.2008.0462; Okano F, 2002, CLIN CANCER RES, V8, P2851; Pluhar GE, 2010, VACCINE, V28, P3371, DOI 10.1016/j.vaccine.2010.02.082; PRIESTER WA, 1971, JNCI-J NATL CANCER I, V47, P1333; Priester WA, 1980, MONOGRAPH US DEP HLT, P1; Rossmeisl JH, 2013, JAVMA-J AM VET MED A, V242, P193, DOI 10.2460/javma.242.2.193; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Schneider R., 1978, TUMORS DOMESTIC ANIM, P1; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ulasov IV, 2007, HUM GENE THER, V18, P118, DOI 10.1089/hum.2006.146; Nguyen V, 2011, TRANSL ONCOL, V4, P390, DOI 10.1593/tlo.11175; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; York D, 2012, VET PATHOL, V49, P796, DOI 10.1177/0300985811424734; Zhou G, 2002, P NATL ACAD SCI USA, V99, P15124, DOI 10.1073/pnas.232588699	41	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77719	10.1371/journal.pone.0077719	http://dx.doi.org/10.1371/journal.pone.0077719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147065	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400128
J	Gwynn, EJ; Smith, AJ; Guy, CP; Savery, NJ; McGlynn, P; Dillingham, MS				Gwynn, Emma J.; Smith, Abigail J.; Guy, Colin P.; Savery, Nigel J.; McGlynn, Peter; Dillingham, Mark S.			The Conserved C-Terminus of the PcrA/UvrD Helicase Interacts Directly with RNA Polymerase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; UVRD HELICASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; MISMATCH REPAIR; PCRA HELICASE; TRANSCRIPTION; PROTEIN; REPLICATION	UvrD-like helicases play diverse roles in DNA replication, repair and recombination pathways. An emerging body of evidence suggests that their different cellular functions are directed by interactions with partner proteins that target unwinding activity to appropriate substrates. Recent studies in E. coli have shown that UvrD can act as an accessory replicative helicase that resolves conflicts between the replisome and transcription complexes, but the mechanism is not understood. Here we show that the UvrD homologue PcrA interacts physically with B. subtilis RNA polymerase, and that an equivalent interaction is conserved in E. coli where UvrD, but not the closely related helicase Rep, also interacts with RNA polymerase. The PcrA-RNAP interaction is direct and independent of nucleic acids or additional mediator proteins. A disordered but highly conserved C-terminal region of PcrA, which distinguishes PcrA/UvrD from otherwise related enzymes such as Rep, is both necessary and sufficient for interaction with RNA polymerase.	[Gwynn, Emma J.; Smith, Abigail J.; Savery, Nigel J.; Dillingham, Mark S.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol, Avon, England; [Guy, Colin P.; McGlynn, Peter] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [McGlynn, Peter] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Bristol; University of Aberdeen; University of York - UK	Dillingham, MS (corresponding author), Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol, Avon, England.	mark.dillingham@bristol.ac.uk		Savery, Nigel/0000-0002-0803-4075; McGlynn, Peter/0000-0001-8629-4713; Dillingham, Mark/0000-0002-4612-7141	Wellcome Trust [077368]; ERC; BBSRC [BB/I003142/1]; Biotechnology and Biological Sciences Research Council [BB/I001859/1, BB/I001859/2, BB/I003142/1] Funding Source: researchfish; BBSRC [BB/I001859/2, BB/I001859/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust project grant to MD (Reference: 077368), an ERC starting grant to MD (Acronym: SM-DNA-REPAIR) and a BBSRC project grant to PM, NS and MD (Reference: BB/I003142/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; CHEN CH, 2011, PLOS ONE, V21, P3150, DOI DOI 10.1371/J0URNAL.P0NE.0018910.PUBMED:21556138; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Delumeau O, 2011, PROTEOMICS, V11, P2992, DOI 10.1002/pmic.201000790; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; IORDANESCU S, 1993, MOL GEN GENET, V241, P185, DOI 10.1007/BF00280216; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanagaraj R, 2010, NUCLEIC ACIDS RES, V38, P8131, DOI 10.1093/nar/gkq697; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Mechanic LE, 1999, J BACTERIOL, V181, P2519, DOI 10.1128/JB.181.8.2519-2526.1999; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; MOSZER I, 1995, MICROBIOL-SGM, V141, P261, DOI 10.1099/13500872-141-2-261; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2002, MOL GENET GENOMICS, V267, P391, DOI 10.1007/s00438-002-0670-9; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Petit MA, 2002, EMBO J, V21, P3137, DOI 10.1093/emboj/cdf317; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Soultanas P, 1998, NUCLEIC ACIDS RES, V26, P2374, DOI 10.1093/nar/26.10.2374; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Urban A, 2007, APPL ENVIRON MICROB, V73, P6436, DOI 10.1128/AEM.00586-07; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Yeeles JTP, 2010, DNA REPAIR, V9, P276, DOI 10.1016/j.dnarep.2009.12.016; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12	62	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78141	10.1371/journal.pone.0078141	http://dx.doi.org/10.1371/journal.pone.0078141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147116	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400149
J	Auerbach, DS; Jones, J; Clawson, BC; Offord, J; Lenk, GM; Ogiwara, I; Yamakawa, K; Meisler, MH; Parent, JM; Isom, LL				Auerbach, David S.; Jones, Julie; Clawson, Brittany C.; Offord, James; Lenk, Guy M.; Ogiwara, Ikuo; Yamakawa, Kazuhiro; Meisler, Miriam H.; Parent, Jack M.; Isom, Lori L.			Altered Cardiac Electrophysiology and SUDEP in a Model of Dravet Syndrome	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; SUDDEN UNEXPECTED DEATH; LONG-QT SYNDROME; NEURONAL SODIUM-CHANNEL; PLURIPOTENT STEM-CELLS; MOUSE MODEL; INHIBITORY INTERNEURONS; POTENTIAL ROLE; RISK-FACTORS; HEART-RATE	Objective: Dravet syndrome is a severe form of intractable pediatric epilepsy with a high incidence of SUDEP: Sudden Unexpected Death in epilepsy. Cardiac arrhythmias are a proposed cause for some cases of SUDEP, yet the susceptibility and potential mechanism of arrhythmogenesis in Dravet syndrome remain unknown. The majority of Dravet syndrome patients have de novo mutations in SCN1A, resulting in haploinsufficiency. We propose that, in addition to neuronal hyperexcitability, SCN1A haploinsufficiency alters cardiac electrical function and produces arrhythmias, providing a potential mechanism for SUDEP. Methods: Postnatal day 15-21 heterozygous SCN1A-R1407X knock-in mice, expressing a human Dravet syndrome mutation, were used to investigate a possible cardiac phenotype. A combination of single cell electrophysiology and in vivo electrocardiogram (ECG) recordings were performed. Results: We observed a 2-fold increase in both transient and persistent Na+ current density in isolated Dravet syndrome ventricular myocytes that resulted from increased activity of a tetrodotoxin-resistant Na+ current, likely Na(v)1.5. Dravet syndrome myocytes exhibited increased excitability, action potential duration prolongation, and triggered activity. Continuous radiotelemetric ECG recordings showed QT prolongation, ventricular ectopic foci, idioventricular rhythms, beat-to-beat variability, ventricular fibrillation, and focal bradycardia. Spontaneous deaths were recorded in 2 DS mice, and a third became moribund and required euthanasia. Interpretation: These data from single cell and whole animal experiments suggest that altered cardiac electrical function in Dravet syndrome may contribute to the susceptibility for arrhythmogenesis and SUDEP. These mechanistic insights may lead to critical risk assessment and intervention in human patients.	[Auerbach, David S.; Clawson, Brittany C.; Offord, James; Isom, Lori L.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Jones, Julie; Lenk, Guy M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Meisler, Miriam H.; Parent, Jack M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Isom, Lori L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Parent, Jack M.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Ogiwara, Ikuo; Yamakawa, Kazuhiro] Riken Brain Sci Inst, Neurogenet Lab, Wako, Saitama, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; RIKEN	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	lisom@umich.edu	Auerbach, David/AAA-5466-2020; Yamakawa, Kazuhiro/N-5050-2015; Lenk, Guy M./Q-1226-2016; Clawson, Brittany C/U-3808-2017	Auerbach, David/0000-0001-9198-3847; Yamakawa, Kazuhiro/0000-0002-1478-4390; Lenk, Guy M./0000-0001-8092-1405; Clawson, Brittany C/0000-0003-4916-4201; Isom, Lori/0000-0002-9479-6729	University of Michigan Center for Organogenesis; Citizens United for Research in Epilepsy Foundation; Dravet Syndrome Foundation; NIH [T32HL007853]; Epilepsy Foundation;  [NIH-NS076752];  [NIH-NS076916]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS076752, R01NS034509, P20NS076916, R37NS076752, R01NS076752] Funding Source: NIH RePORTER	University of Michigan Center for Organogenesis(University of Michigan System); Citizens United for Research in Epilepsy Foundation; Dravet Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NIH-NS076752 (to LLI), NIH-NS076916 (to JMP), the University of Michigan Center for Organogenesis (to LLI), Citizens United for Research in Epilepsy Foundation (to JMP) and the Dravet Syndrome Foundation(to JMP and MHM). DSA was supported by NIH T32HL007853 to the University of Michigan Cardiovascular Center and a Postdoctoral Fellowship from the Epilepsy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsit GS, 2013, J MOL CELL CARDIOL, V61, P34, DOI 10.1016/j.yjmcc.2013.03.017; Agullo-Pascual E, 2013, CARDIOVASC RES; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Aurlien D, 2009, SEIZURE-EUR J EPILEP, V18, P158, DOI 10.1016/j.seizure.2008.07.008; Baruscotti M, 1997, J PHYSIOL-LONDON, V498, P641, DOI 10.1113/jphysiol.1997.sp021889; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Brette F, 2006, BIOCHEM BIOPH RES CO, V348, P1163, DOI 10.1016/j.bbrc.2006.07.189; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Delogu AB, 2011, EPILEPSIA, V52, P55, DOI 10.1111/j.1528-1167.2011.03003.x; Dravet Charlotte, 2005, Adv Neurol, V95, P71; Dravet C, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2011.02993.x; Ergul Y, 2013, ACTA NEUROL BELG, V113, P161, DOI 10.1007/s13760-012-0140-z; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Espinosa PS, 2009, NEUROLOGY, V72, P1702, DOI 10.1212/WNL.0b013e3181a55f90; Estrada G, 2011, PEPTIDES, V32, P75, DOI 10.1016/j.peptides.2010.11.001; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Guerrini R, 2003, J CLIN NEUROPHYSIOL, V20, P449, DOI 10.1097/00004691-200311000-00007; Haufe V, 2005, CARDIOVASC RES, V65, P117, DOI 10.1016/j.cardiores.2004.08.017; Herren AW, 2013, AM J PHYSIOL-HEART C, V305, pH431, DOI 10.1152/ajpheart.00306.2013; Inoue N, 2004, J AM COLL CARDIOL, V44, P914, DOI 10.1016/j.jacc.2004.05.054; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Kalume F, 2013, J CLIN INVEST, V123, P1798, DOI 10.1172/JCI66220; Kandler L, 2005, ACTA PAEDIATR, V94, P1243, DOI 10.1080/08035250510031025; Kaufmann SG, 2013, J MOL CELL CARDIOL, V61, P133, DOI 10.1016/j.yjmcc.2013.05.006; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Malhotra JD, 2001, CIRCULATION, V103, P1303; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mercier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048690; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Mistry A, 2012, STRAIN AGE DEPENDENT; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nashef L, 2007, EPILEPSIA, V48, P859, DOI 10.1111/j.1528-1167.2007.01082.x; Nei M, 2010, CURR NEUROL NEUROSCI, V10, P319, DOI 10.1007/s11910-010-0116-4; Noujaim SF, 2007, P NATL ACAD SCI USA, V104, P20985, DOI 10.1073/pnas.0709758104; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; OPPENHEIMER S, 1990, J ROY SOC MED, V83, P134, DOI 10.1177/014107689008300302; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pignier C, 2007, BASIC RES CARDIOL, V102, P553, DOI 10.1007/s00395-007-0676-x; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schuele SU, 2007, CLEV CLIN J MED, V74, P121, DOI 10.3949/ccjm.74.Suppl_1.S121; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Surges R, 2010, EPILEPSIA, V51, P233, DOI 10.1111/j.1528-1167.2009.02330.x; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Tavernor SJ, 1996, SEIZURE, V5, P79, DOI 10.1016/S1059-1311(96)80067-7; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zareba W, 2008, PROG CARDIOVASC DIS, V51, P264, DOI 10.1016/j.pcad.2008.10.006	79	101	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77843	10.1371/journal.pone.0077843	http://dx.doi.org/10.1371/journal.pone.0077843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155976	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300110
J	Mascarello, A; Mori, M; Chiaradia-Delatorre, LD; Menegatti, ACO; Delle Monache, F; Ferrari, F; Yunes, RA; Nunes, RJ; Terenzi, H; Botta, B; Botta, M				Mascarello, Alessandra; Mori, Mattia; Chiaradia-Delatorre, Louise Domeneghini; Orbem Menegatti, Angela Camila; Delle Monache, Franco; Ferrari, Franco; Yunes, Rosendo Augusto; Nunes, Ricardo Jose; Terenzi, Hernan; Botta, Bruno; Botta, Maurizio			Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (PtpB) Inhibitors from Natural Products	PLOS ONE			English	Article							SECRETED PHOSPHATASES; POTENT INHIBITORS; FORCE-FIELD; MPTPB; DERIVATIVES; ANTHRANOIDS; STRATEGIES; IMPAIRS; SITES; MICE	Protein tyrosine phosphatase B (PtpB) is one of the virulence factors secreted into the host cell by Mycobacterium tuberculosis. PtpB attenuates host immune defenses by interfering with signal transduction pathways in macrophages and, therefore, it is considered a promising target for the development of novel anti-tuberculosis drugs. Here we report the discovery of natural compound inhibitors of PtpB among an in house library of more than 800 natural substances by means of a multidisciplinary approach, mixing in silico screening with enzymatic and kinetics studies and MS assays. Six natural compounds proved to inhibit PtpB at low micromolar concentrations (< 30 mu M) with Kuwanol E being the most potent with K-i = 1.6 +/- 0.1 mu M. To the best of our knowledge, Kuwanol E is the most potent natural compound PtpB inhibitor reported so far, as well as it is the first non-peptidic PtpB inhibitor discovered from natural sources. Compounds herein identified may inspire the design of novel specific PtpB inhibitors.	[Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose] Univ Fed Santa Catarina, Lab Estrutura & Atividade, Florianopolis, SC, Brazil; [Mori, Mattia; Delle Monache, Franco; Ferrari, Franco; Botta, Bruno] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Mori, Mattia; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Chiaradia-Delatorre, Louise Domeneghini; Orbem Menegatti, Angela Camila; Terenzi, Hernan] Univ Fed Santa Catarina, Ctr Biol Mol Estrutural, Florianopolis, SC, Brazil; [Botta, Maurizio] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	Universidade Federal de Santa Catarina (UFSC); Sapienza University Rome; University of Siena; Universidade Federal de Santa Catarina (UFSC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Terenzi, H (corresponding author), Univ Fed Santa Catarina, Ctr Biol Mol Estrutural, Florianopolis, SC, Brazil.	hterenzi@ccb.ufsc.br; bruno.botta@uniroma1.it; botta.maurizio@gmail.com	MENEGATTI, Angela Camila Orbem/AAO-8258-2020; Menegatti, Angela/T-8514-2017; Terenzi, Hernan/ABI-1339-2020	MENEGATTI, Angela Camila Orbem/0000-0001-9319-1245; Mori, Mattia/0000-0003-2398-1254; Botta, Bruno/0000-0001-8707-4333	Istituto Italiano di Tecnologia - IIT - Center for Life Nano Science (IIT@Sapienza), viale Regina, Roma (Italy); CNPq; CAPES; MCT (Ministerio da Ciencia e Tecnologia); FAPESC in Brazil; CAPES in Italy	Istituto Italiano di Tecnologia - IIT - Center for Life Nano Science (IIT@Sapienza), viale Regina, Roma (Italy); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MCT (Ministerio da Ciencia e Tecnologia); FAPESC in Brazil; CAPES in Italy(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Istituto Italiano di Tecnologia - IIT (2011/2015) - Center for Life Nano Science (IIT@Sapienza), viale Regina Elena 291, 00161 Roma (Italy). CNPq, CAPES, MCT (Ministerio da Ciencia e Tecnologia) and FAPESC provided for financial support and fellowships in Brazil. This work form part of the doctoral thesis of A. Mascarello, which also thanks CAPES for the PDSE fellowship in Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LIGPREP VERS 2 5; [Anonymous], 2011, QIKPROP VERS 3 4; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031; Bringmann G., 1999, Pharmaceutical and Pharmacological Letters, V9, P41; Carosati E, 2004, J MED CHEM, V47, P5114, DOI 10.1021/jm0498349; Case D., 2011, AMBER 11; Chiaradia LD, 2008, BIOORG MED CHEM LETT, V18, P6227, DOI 10.1016/j.bmcl.2008.09.105; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Cuca-Suarez LE, 1998, REV COLOMB QUIM, V27, P17; de Oliveira KN, 2011, MEDCHEMCOMM, V2, P500, DOI 10.1039/c0md00253d; DELLEMONACHE F, 1992, PHYTOCHEMISTRY, V31, P259, DOI 10.1016/0031-9422(91)83049-Q; DELLEMONACHE F, 1979, TETRAHEDRON, V35, P2143; DELLEMONACHE G, 1977, GAZZ CHIM ITAL, V107, P189; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Ecco G, 2010, CHEM COMMUN, V46, P7501, DOI 10.1039/c0cc01704c; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ferrari F, 1999, PLANTA MED, V65, P85, DOI 10.1055/s-2006-960448; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Grundner C, 2007, STRUCTURE, V15, P499, DOI 10.1016/j.str.2007.03.003; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; He YT, 2013, J MED CHEM, V56, P832, DOI 10.1021/jm301781p; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; MARINIBETTOLO GB, 1964, ANN CHIM-ROME, V54, P1179; Mascarello A, 2010, BIOORGAN MED CHEM, V18, P3783, DOI 10.1016/j.bmc.2010.04.051; Mori M, 2012, VIRUS RES, V169, P377, DOI 10.1016/j.virusres.2012.05.011; Mori M, 2011, J CHEM INF MODEL, V51, P446, DOI 10.1021/ci100393m; Muller D, 2006, J MED CHEM, V49, P4871, DOI 10.1021/jm060327w; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; Noldin VF, 2003, QUIM NOVA, V26, P331, DOI 10.1590/S0100-40422003000300008; PINHEIRO RM, 1984, PHYTOCHEMISTRY, V23, P1737, DOI 10.1016/S0031-9422(00)83481-0; Silva APG, 2010, FUTURE MED CHEM, V2, P1325, DOI 10.4155/fmc.10.214; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Trani A, 2004, FITOTERAPIA, V75, P99, DOI 10.1016/j.fitote.2003.08.004; Trani M, 1997, GAZZ CHIM ITAL, V127, P415; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vintonyak VV, 2011, TETRAHEDRON, V67, P6713, DOI 10.1016/j.tet.2011.04.026; Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021; WANDER G, 1925, PHARM J, V115, P520; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	53	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77081	10.1371/journal.pone.0077081	http://dx.doi.org/10.1371/journal.pone.0077081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155919	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300053
J	Preston, GC; Feijoo-Carnero, C; Schurch, N; Cowling, VH; Cantrell, DA				Preston, Gavin C.; Feijoo-Carnero, Carmen; Schurch, Nick; Cowling, Victoria H.; Cantrell, Doreen A.			The Impact of KLF2 Modulation on the Transcriptional Program and Function of CD8 T Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; SERINE-PROTEASE INHIBITOR-6; L-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; UP-REGULATION; DIFFERENTIATION; TRAFFICKING; MEMORY; MIGRATION	Kruppel-like factor 2 (KLF2) is a transcription factor that is highly expressed in quiescent T lymphocytes and downregulated in effector T cells. We now show that antigen receptor engagement downregulates KLF2 expression in a graded response determined by the affinity of T cell antigen receptor (TCR) ligand and the integrated activation of protein kinase B and the MAP kinases ERK1/2. The present study explores the importance of KLF2 downregulation and reveals that the loss of KLF2 controls a select portion of the CD8 effector T cell transcriptional program. In particular, KLF2 loss is required for CD8 T cells to express the inflammatory chemokine receptor CXCR3 and for maximum clonal expansion of T cells. KLF2 thus negatively controls the ability of CD8 T cells to respond to the CXCR3 ligand CXCL10. Strikingly, the KLF2 threshold for restraining expression of CXCR3 is very low and quite distinct to the KLF2 threshold for restraining T cell proliferation. KLF2 is thus an analogue (tunable) not a digital (on/off) cellular switch where the magnitude of KLF2 expression differentially modifies the T cell responses.	[Preston, Gavin C.; Feijoo-Carnero, Carmen; Cowling, Victoria H.; Cantrell, Doreen A.] Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland; [Schurch, Nick] Univ Dundee, Data Anal Grp, Coll Life Sci, Dept Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	Schurch, Nicholas/I-4339-2019	Schurch, Nicholas/0000-0001-9068-9654; Cantrell, Doreen/0000-0001-7525-3350; Cowling, Victoria/0000-0001-7638-4870	Wellcome Trust [065975/Z/01/A]; Medical Research Council [G0700240] Funding Source: researchfish; MRC [G0700240] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by a Wellcome Trust Principal Research Fellowship (D.A.C.) and Program Grant no. 065975/Z/01/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Dubois S, 2003, P NATL ACAD SCI USA, V100, P14169, DOI 10.1073/pnas.2335979100; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; GUTIERREZ A, 2009, BLOOD; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phillips T, 2004, J IMMUNOL, V173, P3801, DOI 10.4049/jimmunol.173.6.3801; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Schober SL, 1999, J IMMUNOL, V163, P3662; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Taqueti VR, 2006, J IMMUNOL, V177, P5890, DOI 10.4049/jimmunol.177.9.5890; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	44	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77537	10.1371/journal.pone.0077537	http://dx.doi.org/10.1371/journal.pone.0077537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155966	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300100
J	Suarez, C; Espariz, M; Blancato, VS; Magni, C				Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian			Expression of the Agmatine Deiminase Pathway in Enterococcus faecalis Is Activated by the AguR Regulator and Repressed by CcpA and PTSMan Systems	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; GENE-CLUSTER; MERR FAMILY; OPERON; TRANSCRIPTION; BIOSYNTHESIS; CATABOLISM; RESISTANCE; VECTOR; BACTERIOCIN	Although the agmatine deiminase system (AgDI) has been investigated in Enterococcus faecalis, little information is available with respect to its gene regulation. In this study we demonstrate that the presence of exogenous agmatine induces the expression of agu genes in this bacterium. In contrast to the homologous and extensively characterized AgDI system of S. mutants, the aguBDAC operon in E. faecalis is not induced in response to low pH. In spite of this, agmatine catabolism in this bacterium contributes by neutralizing the external medium while enhancing bacterial growth. Our results indicate that carbon catabolic repression (CCR) operates on the AgDI system via a mechanism that involves interaction of CcpA and P-Ser-HPr with a cre site found in an unusual position considering the aguB promoter (55 nt upstream the + 1 position). In addition, we found that components of the mannose phosphotransferase (PTSMan) system also contributed to CCR in E. faecalis since a complete relief of the PTS-sugars repressive effect was observed only in a PTSMan and CcpA double defective strain. Our gene context analysis revealed that aguR is present in oral and gastrointestinal microorganisms. Thus, regulation of the aguBDAC operon in E. faecalis seems to have evolved to obtain energy and resist low pH conditions in order to persist and colonize gastrointestinal niches.	[Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian] Consejo Nacl Invest Cient & Tecn IBR CONICET, Inst Biol Mol Rosario, Lab Fisiol & Genet Bacterias Lact, Santa Fe, Argentina; [Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Santa Fe, Argentina	National University of Rosario	Magni, C (corresponding author), Consejo Nacl Invest Cient & Tecn IBR CONICET, Inst Biol Mol Rosario, Lab Fisiol & Genet Bacterias Lact, Santa Fe, Argentina.	magni@ibr-conicet.gov.ar	Blancato, Víctor/J-8976-2019; Magni, Christian/AAF-6476-2019; Espariz, Martin/AAF-6582-2019	Blancato, Víctor/0000-0003-3945-2859; Magni, Christian/0000-0002-5179-9700; Espariz, Martin/0000-0002-4090-515X	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT2010-1828, PICT 2008-1562]; European Union grant (BIAMFood) [KBBE-211441]; CONICET [PIP2012-2014]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); European Union grant (BIAMFood)(European Commission); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT2010-1828 and PICT 2008-1562, Argentina), a European Union grant (BIAMFood, contract KBBE-211441) and CONICET (PIP2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Blancato VS, 2010, LETT APPL MICROBIOL, V50, P542, DOI 10.1111/j.1472-765X.2010.02815.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Deloyer P, 2001, EUR J GASTROEN HEPAT, V13, P1027, DOI 10.1097/00042737-200109000-00005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Griswold AR, 2009, ORAL MICROBIOL IMMUN, V24, P79, DOI 10.1111/j.1399-302X.2008.00459.x; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Haenisch B, 2008, AM J PHYSIOL-GASTR L, V295, pG1104, DOI 10.1152/ajpgi.90374.2008; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hobman JL, 2007, MOL MICROBIOL, V63, P1275, DOI 10.1111/j.1365-2958.2007.05608.x; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Joyet P, 2013, BIOCH BIOPHYS ACTA; Ladero V, 2011, APPL ENVIRON MICROB, V77, P6409, DOI 10.1128/AEM.05507-11; Ladero V, 2010, CURR NUTR FOOD SCI, V6, P145, DOI 10.2174/157340110791233256; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; LeBlanc DJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P175, DOI 10.1007/0-387-30744-3_6; Leboeuf C, 2000, J BACTERIOL, V182, P5799, DOI 10.1128/JB.182.20.5799-5806.2000; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marelli B, 2010, WORLD J MICROB BIOT, V26, P999, DOI 10.1007/s11274-009-0262-5; Martin MG, 2004, J BACTERIOL, V186, P5649, DOI 10.1128/JB.186.17.5649-5660.2004; MARTINVERSTRAETE I, 1995, J BACTERIOL, V177, P6919, DOI 10.1128/jb.177.23.6919-6927.1995; Matsumoto M, 2011, MED HYPOTHESES, V77, P469, DOI 10.1016/j.mehy.2011.06.011; Molderings GJ, 2012, PHARMACOL THERAPEUT, V133, P351, DOI 10.1016/j.pharmthera.2011.12.005; Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026; Mortera P, 2012, APPL ENVIRON MICROB, V78, P1936, DOI 10.1128/AEM.07280-11; Opsata M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-224; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shalaby AR, 1996, SIGNIFICANCE BIOGENI; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Suarez CA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-227; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998	46	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76170	10.1371/journal.pone.0076170	http://dx.doi.org/10.1371/journal.pone.0076170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155893	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300027
J	Westman, G; Lidehall, AK; Magnusson, P; Ingelsson, M; Kilander, L; Lannfelt, L; Korsgren, O; Eriksson, BM				Westman, Gabriel; Lidehall, Anna-Karin; Magnusson, Peetra; Ingelsson, Martin; Kilander, Lena; Lannfelt, Lars; Korsgren, Olle; Eriksson, Britt-Marie			Decreased Proportion of Cytomegalovirus Specific CD8 T-Cells but No Signs of General Immunosenescence in Alzheimer's Disease	PLOS ONE			English	Article							ELDERLY INDIVIDUALS; ASSOCIATION; INFECTION; IMPACT; IMMUNE; CMV; SEROPOSITIVITY; LYMPHOCYTES; VIRUS; OLD	Cytomegalovirus (CMV) has been suggested as a contributing force behind the impaired immune responsiveness in the elderly, with decreased numbers of naive T-cells and an increased proportion of effector T-cells. Immunological impairment is also implicated as a part of the pathogenesis in Alzheimer's disease (AD). The aim of this study was to investigate whether AD patients present with a different CMV-specific CD8 immune profile compared to non-demented controls. Blood samples from 50 AD patients and 50 age-matched controls were analysed for HLA-type, CMV serostatus and systemic inflammatory biomarkers. Using multi-colour flow cytometry, lymphocytes from peripheral blood mononuclear cells were analysed for CMV-specific CD8 immunity with MHC-I tetramers A01, A02, A24, B07, B08 and B35 and further classified using CD27, CD28, CD45RA and CCR7 antibodies. Among CMV seropositive subjects, patients with AD had significantly lower proportions of CMV-specific CD8 T-cells compared to controls, 1.16 % vs. 4.13 % (p=0.0057). Regardless of dementia status, CMV seropositive subjects presented with a lower proportion of naive CD8 cells and a higher proportion of effector CD8 cells compared to seronegative subjects. Interestingly, patients with AD showed a decreased proportion of CMV-specific CD8 cells but no difference in general CD8 differentiation.	[Westman, Gabriel; Eriksson, Britt-Marie] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Westman, Gabriel; Lidehall, Anna-Karin; Magnusson, Peetra; Korsgren, Olle] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ingelsson, Martin; Kilander, Lena; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Westman, G (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	gabriel.westman@medsci.uu.se		Korsgren, Olle/0000-0002-8524-9547	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council [2006-2822, 2006-6326, 2006-3464]; Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	This work was funded by grants from The Family Ohlinder-Nielsen's Foundation, Uppsala University, Landstinget i Uppsala lan, Swedish Research Council (2006-2822, 2006-6326 and 2006-3464), Swedish Brain Foundation, Swedish Alzheimer Foundation and Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLFORS K, 1984, SCAND J INFECT DIS, V16, P335, DOI 10.3109/00365548409073957; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Colonna-Romano G, 2007, EXP GERONTOL, V42, P995, DOI 10.1016/j.exger.2007.05.006; Derhovanessian E, 2011, J GEN VIROL, V92, P2746, DOI 10.1099/vir.0.036004-0; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Gratama JW, 2001, BLOOD, V98, P1358, DOI 10.1182/blood.V98.5.1358; Herndler-Brandstetter D, 2012, J LEUKOCYTE BIOL, V91, P197, DOI 10.1189/jlb.0611299; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Mansouri H, 1995, COMPUT STAT DATA ANA; Marques AR, 2001, J NEUROVIROL, V7, P82; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nilsson Lars, 1998, Frontiers in Bioscience, V3, pD436; Pellicano M, 2012, J NEUROIMMUNOL, V242, P52, DOI 10.1016/j.jneuroim.2011.11.005; PIRTTILA T, 1992, J NEUROL SCI, V107, P160, DOI 10.1016/0022-510X(92)90284-R; Pita-Lopez Maria Luisa, 2009, Immun Ageing, V6, P11, DOI 10.1186/1742-4933-6-11; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Solana R, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-23; Sund F, 2010, CLIN TRANSPLANT, V24, P401, DOI 10.1111/j.1399-0012.2009.00976.x; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Vescovini R, 2004, EXP GERONTOL, V39, P1233, DOI 10.1016/j.exger.2004.04.004; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6	32	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77921	10.1371/journal.pone.0077921	http://dx.doi.org/10.1371/journal.pone.0077921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155977	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300111
J	Williams, KJ; Robinson, NE; Lim, A; Brandenberger, C; Maes, R; Behan, A; Bolin, SR				Williams, Kurt J.; Robinson, N. Edward; Lim, Ailam; Brandenberger, Christina; Maes, Roger; Behan, Ashley; Bolin, Steven R.			Experimental Induction of Pulmonary Fibrosis in Horses with the Gammaherpesvirus Equine Herpesvirus 5	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-HERPESVIRUS; INTERSTITIAL PNEUMONIA; LATENT INFECTION; LUNG INJURY; CELLS; DNA; PATHOGENESIS; TISSUE	Gammaherpesviruses (gamma HV) are implicated in the pathogenesis of pulmonary fibrosis in humans and murine models of lung fibrosis, however there is little direct experimental evidence that such viruses induce lung fibrosis in the natural host. The equine gamma HV EHV 5 is associated with equine multinodular pulmonary fibrosis (EMPF), a progressive fibrosing lung disease in its natural host, the horse. Experimental reproduction of EMPF has not been attempted to date. We hypothesized that inoculation of EHV 5 isolated from cases of EMPF into the lungs of clinically normal horses would induce lung fibrosis similar to EMPF. Neutralizing antibody titers were measured in the horses before and after inoculation with EHV 5. PCR and virus isolation was used to detect EHV 5 in antemortem blood and BAL samples, and in tissues collected postmortem. Nodular pulmonary fibrosis and induction of myofibroblasts occurred in EHV 5 inoculated horses. Mean lung collagen in EHV 5 inoculated horses (80 mu g/mg) was significantly increased compared to control horses (26 mu g/mg) (p < 0.5), as was interstitial collagen (32.6% +/- 1.2% vs 23% +/- 1.4%) (mean +/- SEM; p < 0.001). Virus was difficult to detect in infected horses throughout the experiment, although EHV 5 antigen was detected in the lung by immunohistochemistry. We conclude that the gamma HV EHV 5 can induce lung fibrosis in the horse, and hypothesize that induction of fibrosis occurs while the virus is latent within the lung. This is the first example of a gamma HV inducing lung fibrosis in the natural host.	[Williams, Kurt J.; Brandenberger, Christina; Maes, Roger; Bolin, Steven R.] Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Robinson, N. Edward; Behan, Ashley] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Lim, Ailam] Michigan State Univ, Coll Vet Med, Diagnost Ctr Populat & Anim Hlth, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Williams, KJ (corresponding author), Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA.	williamsk@dcpah.msu.edu			Pfizer Animal Health, New York, N.Y.	Pfizer Animal Health, New York, N.Y.	Pfizer Animal Health, New York, N.Y. provided funding for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; BOLIN SR, 1994, J VIROL METHODS, V48, P211, DOI 10.1016/0166-0934(94)90120-1; BRACK M, 1981, VIRCHOWS ARCH A, V392, P81, DOI 10.1007/BF00430551; Castriotta RJ, 2010, CHEST, V138, P693, DOI 10.1378/chest.09-3006; Chomczynski P, 2006, BIOTECHNIQUES, V40, P454, DOI 10.2144/000112149; Collard HR, 2003, ARCH INTERN MED, V163, P17, DOI 10.1001/archinte.163.1.17; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Doran P, 2005, AM J PHYSIOL-LUNG C, V289, pL709, DOI 10.1152/ajplung.00235.2005; Dynon K, 2001, AUST VET J, V79, P695, DOI 10.1111/j.1751-0813.2001.tb10674.x; Egan JJ, 1997, EUR RESPIR J, V10, P1433; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; Ehlers B, 2007, J VIROL, V81, P8091, DOI 10.1128/JVI.00255-07; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Hughes DJ, 2010, J VIROL, V84, P3949, DOI 10.1128/JVI.02085-09; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kleiboeker SB, 2002, J VET DIAGN INVEST, V14, P273, DOI 10.1177/104063870201400401; Lok S S, 2000, Monaldi Arch Chest Dis, V55, P146; Lok SS, 2002, EUR RESPIR J, V20, P1228, DOI 10.1183/09031936.02.00272902; Lok SS, 2001, RESP MED, V95, P787, DOI 10.1053/rmed.2001.1152; LOVE DN, 1971, VET REC, V89, P178, DOI 10.1136/vr.89.7.178; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Marenzoni ML, 2011, J VET DIAGN INVEST, V23, P802, DOI 10.1177/1040638711407890; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Naik PN, 2012, J GERONTOL A-BIOL, V67, P714, DOI 10.1093/gerona/glr211; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Nicholson AG, 2002, HISTOPATHOLOGY, V41, P381, DOI 10.1046/j.1365-2559.2002.01421.x; Nordengrahn A, 2002, VET RES, V33, P251, DOI 10.1051/vetres:2002013; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; PULKKINEN V, 2012, ANN MED; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Rovnak J, 1998, J VIROL, V72, P4237, DOI 10.1128/JVI.72.5.4237-4242.1998; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Stoolman JS, 2011, AM J PHYSIOL-LUNG C, V300, pL274, DOI 10.1152/ajplung.00028.2010; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; SWEAT F, 1964, ARCH PATHOL, V78, P69; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; Wang L, 2007, VET MICROBIOL, V121, P18, DOI 10.1016/j.vetmic.2006.11.009; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wong DM, 2008, JAVMA-J AM VET MED A, V232, P898, DOI 10.2460/javma.232.6.898; Xu JG, 2009, J GERONTOL A-BIOL, V64, P731, DOI 10.1093/gerona/glp040; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	59	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77754	10.1371/journal.pone.0077754	http://dx.doi.org/10.1371/journal.pone.0077754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147074	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400138
J	Lai, CH; Park, KS; Lee, DH; Alberobello, AT; Raffeld, M; Pierobon, M; Pin, E; Petricoin, EF; Wang, Y; Giaccone, G				Lai, C-H; Park, K-S; Lee, D-H; Alberobello, A. T.; Raffeld, M.; Pierobon, M.; Pin, E.; Petricoin, E. F., III; Wang, Y.; Giaccone, G.			HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer	ONCOGENE			English	Article						doxorubicin; Ganetespib; hsp90 inhibitor; rip1; SCLC	KAPPA-B ACTIVATION; POTENT ANTITUMOR-ACTIVITY; HSP90 INHIBITOR; SIGNALING PATHWAYS; PROTEIN; APOPTOSIS; CYCLOPHOSPHAMIDE; VINCRISTINE; DEATH; CISPLATIN	Small cell lung cancer (SCLC) at advanced stage is considered an incurable disease. Despite good response to initial chemotherapy, the responses in SCLC patients with metastatic disease are of short duration and resistance inevitably occurs. Although several target-specific drugs have altered the paradigm of treatment for many other cancers, we have yet to witness a revolution of the same magnitude in SCLC treatment. Anthracyclines, such as doxorubicin, have definite activity in this disease, and ganetespib has shown promising activity in preclinical models but underwhelming activity as a single agent in SCLC patients. Using SCLC cell lines, we demonstrated that ganetespib (IC50: 31 nM) was much more potent than 17-allylamino-17-demethoxygeldanamycin (17-AAG), a geldanamycin derivative (IC50: 16 mu M). Ganetespib inhibited SCLC cell growth via induction of persistent G2/M arrest and Caspase 3-dependent cell death. MTS assay revealed that ganetespib synergized with both doxorubicin and etoposide, two topoisomerase II inhibitors commonly used in SCLC chemotherapy. Expression of receptor-interacting serine/threonine-protein kinase 1 (RIP1), a protein that may function as a pro-survival scaffold protein or a pro-death kinase in TNFR1-activated cells, was induced by doxorubicin and downregulated by ganetespib. Depletion of RIP1 by either RIP1 small interfering RNA (siRNA) or ganetespib sensitized doxorubicin-induced cell death, suggesting that RIP1 may promote survival in doxorubicin-treated cells and that ganetespib may synergize with doxorubicin in part through the downregulation of RIP1. In comparison to ganetespib or doxorubicin alone, the ganetespib + doxorubicin combination caused significantly more growth regression and death of human SCLC xenografts in immunocompromised mice. We conclude that ganetespib and doxorubicin combination exhibits significant synergy and is efficacious in inhibiting SCLC growth in vitro and in mouse xenograft models. Our preclinical study suggests that ganetespib and doxorubicin combination therapy may be an effective strategy for SCLC treatment, which warrants clinical testing.	[Lai, C-H; Park, K-S; Lee, D-H; Alberobello, A. T.; Wang, Y.; Giaccone, G.] NCI, Med Oncol Branch, NIH, Bethesda, MD USA; [Raffeld, M.] NCI, Pathol Lab, NIH, Bethesda, MD USA; [Pierobon, M.; Pin, E.; Petricoin, E. F., III] George Masson Univ, Ctr Appl Prote & Mol Med, Manassas, VI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, Y (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd NW,W503 Res Bldg, Washington, DC 20007 USA.	yw350@georgetown.edu; gg496@georgetown.edu	Pierobon, Mariaelena/GXA-0544-2022; Giaccone, Giuseppe/E-8297-2017	Giaccone, Giuseppe/0000-0002-5023-7562; PIN, ELISA/0000-0002-2158-2674	National Cancer Institute; NATIONAL CANCER INSTITUTE [Z01BC010854, ZICBC011079, P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Leonard M Neckers for stimulating discussion during the course of the study and Dr Weiwen Ying (Synta Pharmaceuticals) for his valuable comments on the manuscript and for providing ganetespib for the study. This research was funded by the National Cancer Institute Intramural Program.	Banerji U, 2003, CURR CANCER DRUG TAR, V3, P385, DOI 10.2174/1568009033481813; Bansal H, 2010, BLOOD, V116, P4591, DOI 10.1182/blood-2009-10-247239; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Blagosklonny MV, 2001, LEUKEMIA, V15, P1537, DOI 10.1038/sj.leu.2402257; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Califano R, 2012, DRUGS, V72, P471, DOI 10.2165/11597640-000000000-00000; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; COOK RM, 1993, CURR PROB CANCER, V17, P71; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Demidenko ZN, 2006, CELL DEATH DIFFER, V13, P1434, DOI 10.1038/sj.cdd.4401812; Ettinger DS, 2010, J CLIN ONCOL, V28, P2598, DOI 10.1200/JCO.2009.26.7682; FUKUOKA M, 1991, J NATL CANCER I, V83, P855, DOI 10.1093/jnci/83.12.855; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kotani Y, 2012, J CLIN ONCOL M ABS S, V30, P7003; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Park Kang-Seo, 2011, Front Biosci (Elite Ed), V3, P341, DOI 10.2741/e249; Pelayo Alvarez M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/SYSTREV14651858.CD001990.PUB2; Pierobon M, 2012, METHODS MOL BIOL, V823, P215, DOI 10.1007/978-1-60327-216-2_14; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Proia DA, 2012, INVEST NEW DRUG, V30, P2201, DOI 10.1007/s10637-011-9790-6; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Schmittel A, 2011, EXPERT REV ANTICANC, V11, P631, DOI [10.1586/ERA.11.7, 10.1586/era.11.7]; Sculier JP, 1990, LUNG CANCER, V6, P110; Sheehan KM, 2008, ONCOGENE, V27, P323, DOI 10.1038/sj.onc.1210647; SHEPHERD FA, 1987, CANCER TREAT REP, V71, P941; Shibakura M, 2003, INT J CANCER, V103, P380, DOI 10.1002/ijc.10842; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Singhal SS, 2006, FEBS LETT, V580, P2258, DOI 10.1016/j.febslet.2006.03.038; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Srethapakdi M, 2000, CANCER RES, V60, P3940; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; von Pawel J, 1999, J CLIN ONCOL, V17, P658, DOI 10.1200/JCO.1999.17.2.658; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	53	40	43	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4867	4876		10.1038/onc.2013.439	http://dx.doi.org/10.1038/onc.2013.439			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24166505	Green Accepted			2022-12-25	WOS:000343240100008
J	Pushpavalli, SNCVL; Sarkar, A; Bag, I; Hunt, CR; Ramaiah, MJ; Pandita, TK; Bhadra, U; Pal-Bhadra, M				Pushpavalli, Sreerangam N. C. V. L.; Sarkar, Arpita; Bag, Indira; Hunt, Clayton R.; Ramaiah, M. Janaki; Pandita, Tej K.; Bhadra, Utpal; Pal-Bhadra, Manika			Argonaute-1 functions as a mitotic regulator by controlling Cyclin B during Drosophila early embryogenesis	FASEB JOURNAL			English	Article						p53; miR-317; grp; cdk1; Ago-1	RNA INTERFERENCE; GENE; DNA; MITOSIS; HETEROCHROMATIN; LOCALIZATION; INACTIVATION; MICROTUBULE; BIOGENESIS; DIVISION	The role of Ago-1 in microRNA (miRNA) biogenesis has been thoroughly studied, but little is known about its involvement in mitotic cell cycle progression. In this study, we established evidence of the regulatory role of Ago-1 in cell cycle control in association with the G(2)/M cyclin, cyclin B. Immunostaining of early embryos revealed that the maternal effect gene Ago-1 is essential for proper chromosome segregation, mitotic cell division, and spindle fiber assembly during early embryonic development. Ago-1 mutation resulted in the up-regulation of cyclin B-Cdk1 activity and down-regulation of p53, grp, mei-41, and wee1. The increased expression of cyclin B in Ago-1 mutants caused less stable microtubules and probably does not produce enough force to push the nuclei to the cortex, resulting in a decreased number of pole cells. The role of cyclin B in mitotic defects was further confirmed by suppressing the defects in the presence of one mutant copy of cyclin B. We identified involvement of 2 novel embryonic miRNAsmiR-981 and miR-317for spatiotemporal regulation of cyclin B. In summary, our results demonstrate that the haploinsufficiency of maternal Ago-1 disrupts mitotic chromosome segregation and spindle fiber assembly via miRNA-guided control during early embryogenesis in Drosophila. The increased expression of cyclin B-Cdk1 and decreased activity of the Cdk1 inhibitor and cell cycle checkpoint proteins (mei-41 and grp) in Ago-1 mutant embryos allow the nuclei to enter into mitosis prematurely, even before completion of DNA replication. Thus, our results have established a novel role of Ago-1 as a regulator of the cell cycle.Pushpavalli, S. N. C. V. L., Sarkar, A., Bag, I., Hunt C. R., Ramaiah, M. J., Pandita, T. K., Bhadra, U., Pal-Bhadra, M. Argonaute-1 functions as a mitotic regulator by controlling Cyclin B during Drosophila early embryogenesis.	[Pushpavalli, Sreerangam N. C. V. L.; Bhadra, Utpal] Ctr Cellular & Mol Biol, Funct Genom & Gene Silencing Grp, Hyderabad 500007, Andhra Pradesh, India; [Pushpavalli, Sreerangam N. C. V. L.; Sarkar, Arpita; Bag, Indira; Ramaiah, M. Janaki; Pal-Bhadra, Manika] Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500607, Andhra Pradesh, India; [Hunt, Clayton R.; Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); University of Texas System; University of Texas Southwestern Medical Center Dallas	Pal-Bhadra, M (corresponding author), Indian Inst Chem Technol, Ctr Chem Biol, Uppal Rd, Hyderabad 500607, Andhra Pradesh, India.	manikapb@gmail.com	RAMAIAH, JANAKI/AAL-9074-2020; Pandita, Tej K/AAM-9188-2020	Ramaiah, Janaki/0000-0003-1814-2819; Sarkar, Arpita/0000-0001-5061-2505	Wellcome Trust (UK) [GAP 0158, GAP0065]; India Department of Biotechnology (DBT) [GAP326]; NATIONAL CANCER INSTITUTE [R01CA154320, R01CA129537] Funding Source: NIH RePORTER	Wellcome Trust (UK)(Wellcome Trust); India Department of Biotechnology (DBT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Jim Birchler (University of Missouri, Columbia, MO, USA, W. E. Theurkauf (State University of New York, Stony Brook, NY, USA), G. Cavalli (Institute of Human Genetics, Montpellier, France), Stephen Cohen (European Molecular Biology Laboratory, Heidelberg, Germany) for the fly stocks, J. Raff (University of Cambridge, Cambridge, UK) for the centrosomin antibody, and P. Devender for maintenance of Drosophila culture. This work was supported by Wellcome Trust (UK) grants GAP 0158 to M.B.P. and GAP0065 to U.B. and by India Department of Biotechnology (DBT) grant GAP326 to M.B.P.	Azzam G, 2012, DEV BIOL, V365, P384, DOI 10.1016/j.ydbio.2012.03.005; Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Ji JY, 2002, GENETICS, V162, P1179; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Koesters R, 1999, GENOMICS, V61, P210, DOI 10.1006/geno.1999.5951; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Price D, 2000, GENETICS, V155, P159; Pushpavalli SNCVL, 2012, CHROMOSOME RES, V20, P333, DOI 10.1007/s10577-012-9279-y; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Stiffler LA, 1999, DEVELOPMENT, V126, P5505; Stoica C, 2006, J BIOL CHEM, V281, P37646, DOI 10.1074/jbc.M604476200; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; SULLIVAN W, 1993, MOL BIOL CELL, V4, P885, DOI 10.1091/mbc.4.9.885; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tram U., 2002, ENCY LIFE SCI; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	43	23	24	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					655	666		10.1096/fj.13-231167	http://dx.doi.org/10.1096/fj.13-231167			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24165481	Green Published			2022-12-25	WOS:000331072200013
J	Luoto, HH; Nordbo, E; Baykov, AA; Lahti, R; Malinen, AM				Luoto, Heidi H.; Nordbo, Erika; Baykov, Alexander A.; Lahti, Reijo; Malinen, Anssi M.			Membrane Na+-pyrophosphatases Can Transport Protons at Low Sodium Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Kinetics; Enzyme Mechanisms; Membrane Energetics; Membrane Proteins; Molecular Evolution; Proton Transport; Sodium Transport; Membrane Pyrophosphatase; Pyrophosphate	H+-PYROPHOSPHATASE; ESCHERICHIA-COLI; ATP SYNTHASE; TRANSLOCATING PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; BINDING; IDENTIFICATION; RESIDUES; ENZYME; IONS	Background: Prokaryotic membrane Na+-PPases couple PPi hydrolysis with active Na+ transport. Results: Na+-PPases can transport both Na+ and H+ at Na+ concentrations <5 mm but only Na+ above this level. Conclusion: Na+-PPases are dual specificity transporters in which H+ transport activity is masked under physiological conditions. Significance: Inherent Na+/H+ promiscuity provides a basis for Na+-PPase evolution to H+-PPase. Membrane-bound Na+-pyrophosphatase (Na+-PPase), working in parallel with the corresponding ATP-energized pumps, catalyzes active Na+ transport in bacteria and archaea. Each approximate to 75-kDa subunit of homodimeric Na+-PPase forms an unusual funnel-like structure with a catalytic site in the cytoplasmic part and a hydrophilic gated channel in the membrane. Here, we show that at subphysiological Na+ concentrations (<5 mm), the Na+-PPases of Chlorobium limicola, four other bacteria, and one archaeon additionally exhibit an H+-pumping activity in inverted membrane vesicles prepared from recombinant Escherichia coli strains. H+ accumulation in vesicles was measured with fluorescent pH indicators. At pH 6.2-8.2, H+ transport activity was high at 0.1 mm Na+ but decreased progressively with increasing Na+ concentrations until virtually disappearing at 5 mm Na+. In contrast, Na-22(+) transport activity changed little over a Na+ concentration range of 0.05-10 mm. Conservative substitutions of gate Glu(242) and nearby Ser(243) and Asn(677) residues reduced the catalytic and transport functions of the enzyme but did not affect the Na+ dependence of H+ transport, whereas a Lys(681) substitution abolished H+ (but not Na+) transport. All four substitutions markedly decreased PPase affinity for the activating Na+ ion. These results are interpreted in terms of a model that assumes the presence of two Na+-binding sites in the channel: one associated with the gate and controlling all enzyme activities and the other located at a distance and controlling only H+ transport activity. The inherent H+ transport activity of Na+-PPase provides a rationale for its easy evolution toward specific H+ transport.	[Luoto, Heidi H.; Nordbo, Erika; Lahti, Reijo; Malinen, Anssi M.] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University	Malinen, AM (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	anssi.malinen@utu.fi	Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012	Baykov, Alexander/0000-0002-2495-8200; Malinen, Anssi/0000-0003-2987-2649; Artukka, Erika/0000-0003-0035-6923	Academy of Finland [139031]; Russian Foundation for Basic Research [12-04-01002]; Ministry of Education and the Academy of Finland	Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and the Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grant 139031, Russian Foundation for Basic Research Grant 12-04-01002, and grants from the Ministry of Education and the Academy of Finland (to the National Graduate School in Informational and Structural Biology).	Baykov AA, 1996, EUR J BIOCHEM, V236, P121, DOI 10.1111/j.1432-1033.1996.00121.x; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2013, MICROBIOL MOL BIOL R, V77, P267, DOI 10.1128/MMBR.00003-13; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; Biegel E, 2011, J BIOL CHEM, V286, P6080, DOI 10.1074/jbc.M110.192823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADIO R, 1991, EUR BIOPHYS J, V19, P189; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; HARA Y, 1986, J BIOCHEM, V99, P531, DOI 10.1093/oxfordjournals.jbchem.a135509; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Huang YT, 2013, J BIOL CHEM, V288, P19312, DOI 10.1074/jbc.M113.469353; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; LAUBINGER W, 1989, BIOCHEMISTRY-US, V28, P7194, DOI 10.1021/bi00444a010; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Luoto HH, 2013, P NATL ACAD SCI USA, V110, P1255, DOI 10.1073/pnas.1217816110; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Nadson G.A., 1906, B JARD BOT ST PETERS, V6, P190; REIDLINGER J, 1994, EUR J BIOCHEM, V223, P275, DOI 10.1111/j.1432-1033.1994.tb18992.x; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ZHANG Y, 1995, J BIOL CHEM, V270, P87, DOI 10.1074/jbc.270.1.87; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	33	24	27	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35489	35499		10.1074/jbc.M113.510909	http://dx.doi.org/10.1074/jbc.M113.510909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158447	Green Published, hybrid			2022-12-25	WOS:000329867600044
J	Gotoh, A; Hidaka, M; Hirose, K; Uchida, T				Gotoh, Aina; Hidaka, Masafumi; Hirose, Keiko; Uchida, Takafumi			Gas7b (Growth Arrest Specific Protein 7b) Regulates Neuronal Cell Morphology by Enhancing Microtubule and Actin Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Alzheimer Disease; Electron Microscopy (EM); Microtubules; Neurite Outgrowth	TUBULIN; PURIFICATION; MATURATION; DYNAMICS; MAP2	Background: Growth arrest specific protein 7b (Gas7b) protein levels are significantly reduced in the brain tissue of patients with Alzheimer disease. Results: Gas7b enhances microtubule bundling and microtubule cross-linking with the actin filament. Conclusion: Gas7b regulates neural cell morphology by altering the cytoskeletal organization. Significance: A decrease in Gas7b levels impairs neural cell function. Neurons undergo several morphological changes as a part of normal neuron maturation process. Alzheimer disease is associated with increased neuroproliferation and impaired neuronal maturation. In this study, we demonstrated that Gas7b (growth arrest specific protein 7b) expression in a neuronal cell line, Neuro 2A, induces cell maturation by facilitating formation of dendrite-like processes and/or filopodia projections and that Gas7b co-localizes with neurite microtubules. Molecular analysis was performed to evaluate whether Gas7b associates with actin filaments and microtubules, and the data revealed two novel roles of Gas7b in neurite outgrowth: we showed that Gas7b enhances bundling of several microtubule filaments and connects microtubules with actin filaments. These results suggest that Gas7b governs neural cell morphogenesis by enhancing the coordination between actin filaments and microtubules. We conclude that lower neuronal Gas7b levels may impact Alzheimer disease progression.	[Gotoh, Aina; Hidaka, Masafumi; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan; [Hirose, Keiko] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058561, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Uchida, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Aoba Ku, 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp	; Hirose, Keiko/M-5429-2018	Uchida, Takafumi/0000-0003-3665-4906; Hirose, Keiko/0000-0003-4587-8346; Gotoh, Aina/0000-0002-0979-2265	JSPS [S 20228006, 11J07541]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [11J07541] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows and Scientific Research Kiban S 20228006 (to T. U.) and Research Fellowship from the JSPS for Young Scientists 11J07541 (to A. G.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama H, 2009, J BIOL CHEM, V284, P32695, DOI 10.1074/jbc.M109.035998; Alberts B, 2002, MOL BIOL CELL; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bouslama-Oueghlani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049015; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; Hidaka M, 2012, J BIOCHEM, V151, P593, DOI 10.1093/jb/mvs038; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Lu PJ, 1999, NATURE, V399, P784; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Ramjaun AR, 1999, J BIOL CHEM, V274, P19785, DOI 10.1074/jbc.274.28.19785; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; TAKEMURA R, 1992, J CELL SCI, V103, P953; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	30	18	20	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34699	34706		10.1074/jbc.M113.513119	http://dx.doi.org/10.1074/jbc.M113.513119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151073	Green Published, hybrid			2022-12-25	WOS:000329812800036
J	Couturier, LIE; Rohner, CA; Richardson, AJ; Marshall, AD; Jaine, FRA; Bennett, MB; Townsend, KA; Weeks, SJ; Nichols, PD				Couturier, Lydie I. E.; Rohner, Christoph A.; Richardson, Anthony J.; Marshall, Andrea D.; Jaine, Fabrice R. A.; Bennett, Michael B.; Townsend, Kathy A.; Weeks, Scarla J.; Nichols, Peter D.			Stable Isotope and Signature Fatty Acid Analyses Suggest Reef Manta Rays Feed on Demersal Zooplankton	PLOS ONE			English	Article							SHARKS RHINCODON-TYPUS; DISCRIMINATION FACTORS; TROPHIC POSITION; FISH; ECOLOGY; DIET; LIPIDS; MOVEMENTS; PROFILES; TISSUES	Assessing the trophic role and interaction of an animal is key to understanding its general ecology and dynamics. Conventional techniques used to elucidate diet, such as stomach content analysis, are not suitable for large threatened marine species. Non-lethal sampling combined with biochemical methods provides a practical alternative for investigating the feeding ecology of these species. Stable isotope and signature fatty acid analyses of muscle tissue were used for the first time to examine assimilated diet of the reef manta ray Manta alfredi, and were compared with different zooplankton functional groups (i.e. near-surface zooplankton collected during manta ray feeding events and non-feeding periods, epipelagic zooplankton, demersal zooplankton and several different zooplankton taxa). Stable isotope delta N-15 values confirmed that the reef manta ray is a secondary consumer. This species had relatively high levels of docosahexaenoic acid (DHA) indicating a flagellate-based food source in the diet, which likely reflects feeding on DHA-rich near-surface and epipelagic zooplankton. However, high levels of omega 6 polyunsaturated fatty acids and slightly enriched delta C-13 values in reef manta ray tissue suggest that they do not feed solely on pelagic zooplankton, but rather obtain part of their diet from another origin. The closest match was with demersal zooplankton, suggesting it is an important component of the reef manta ray diet. The ability to feed on demersal zooplankton is likely linked to the horizontal and vertical movement patterns of this giant planktivore. These new insights into the habitat use and feeding ecology of the reef manta ray will assist in the effective evaluation of its conservation needs.	[Couturier, Lydie I. E.; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Couturier, Lydie I. E.; Rohner, Christoph A.; Richardson, Anthony J.; Jaine, Fabrice R. A.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Dutton Pk, Qld, Australia; [Rohner, Christoph A.; Marshall, Andrea D.] Marine Megafauna Fdn, Manta Ray & Whale Shark Res Ctr, Praia Do Tofo, Inhambane, Mozambique; [Rohner, Christoph A.; Jaine, Fabrice R. A.; Weeks, Scarla J.] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, St Lucia, Qld, Australia; [Marshall, Andrea D.] Wild Me, Praia Do Tofo, Inhambane, Mozambique; [Townsend, Kathy A.] Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, PQ, Canada; [Nichols, Peter D.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Couturier, LIE (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	l.couturier@uq.edu.au	Richardson, Anthony J/B-3649-2010; Weeks, Scarla J/E-8632-2013; Couturier, Lydie I. E./J-9695-2014; Couturier, Lydie/I-9793-2019; Rohner, Chris/AAJ-1661-2020; Bennett, Michael/L-4483-2019; Jaine, Fabrice/D-1622-2016; Bennett, Michael/A-7218-2012; Nichols, Peter D/C-5128-2011; Townsend, Kathy Ann/K-9486-2016	Richardson, Anthony J/0000-0002-9289-7366; Weeks, Scarla J/0000-0002-0579-7069; Couturier, Lydie I. E./0000-0002-3885-3397; Couturier, Lydie/0000-0002-3885-3397; Rohner, Chris/0000-0001-8760-8972; Bennett, Michael/0000-0001-8051-0040; Jaine, Fabrice/0000-0002-9304-5034; Townsend, Kathy Ann/0000-0002-2581-2158; Marshall, Andrea/0000-0003-1886-5355	Australian Research Council [LP110100712]; Earthwatch Institute Australia; Sea World Research and Rescue Foundation Inc.; Sibelco Pty Ltd.	Australian Research Council(Australian Research Council); Earthwatch Institute Australia; Sea World Research and Rescue Foundation Inc.; Sibelco Pty Ltd.	This study was supported by the Australian Research Council Linkage Grant (LP110100712), Earthwatch Institute Australia, Sea World Research and Rescue Foundation Inc. and Sibelco Pty Ltd. Field work was supported by Casa Barry Lodge and Peri-Peri Divers in Mozambique, and Lady Elliot Island Eco Resort and Manta Lodge and Scuba Centre in Australia. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1980, J EXP MAR BIOL ECOL, V44, P133, DOI 10.1016/0022-0981(80)90150-1; ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Beckmann CL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P266, DOI 10.1086/669539; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; BURCHMORE JJ, 1988, AUST J MAR FRESH RES, V39, P709; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Chang KJL, 2012, APPL MICROBIOL BIOT, V93, P2215, DOI 10.1007/s00253-011-3856-4; Clark T.B., 2010, THESIS U HAWAII MANO; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Fry B, 1984, GONTRIB MAR SCI, V27, P13; Hall D, 2006, J EXP MAR BIOL ECOL, V336, P42, DOI 10.1016/j.jembe.2006.04.004; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Herman DP, 2005, MAR ECOL PROG SER, V302, P275, DOI 10.3354/meps302275; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hornberger GM, 1995, WATER RESOUR RES, V31, P2895; Howell KL, 2003, MAR ECOL PROG SER, V255, P193, DOI 10.3354/meps255193; Hudson IR, 2004, MAR ECOL PROG SER, V281, P109, DOI 10.3354/meps281109; Hussey NE, 2010, HYDROBIOLOGIA, V654, P1, DOI 10.1007/s10750-010-0361-1; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Hyndes GA, 1997, MAR BIOL, V128, P585, DOI 10.1007/s002270050125; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2008, THESIS U QUEENSLAND; Marshall AD, 2009, ZOOTAXA, P1; McMeans BC, 2012, J EXP MAR BIOL ECOL, V429, P55, DOI 10.1016/j.jembe.2012.06.017; Melo PAMC, 2010, MAR BIOL RES, V6, P530, DOI 10.1080/17451000903426557; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; Osada, 2010, RELATIONSHIP ZOOPLAN; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge H, 2010, MAR BIOL, V157, P1367, DOI 10.1007/s00227-010-1416-6; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Pitt KA, 2008, ESTUAR COAST SHELF S, V76, P827, DOI 10.1016/j.ecss.2007.08.011; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Core Team, 2022, R LANG ENV STAT COMP; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; Richardson A.J., 2000, Naga, V23, P29; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Sargent J.R., 1987, P119; SARGENT JR, 1988, HYDROBIOLOGIA, V167, P101, DOI 10.1007/BF00026297; Schaufler L, 2005, ICES CM ELASMOBRANCH, V19; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 1997, J FISH BIOL, V51, P436; STOECKER DK, 1990, J PLANKTON RES, V12, P891, DOI 10.1093/plankt/12.5.891; Syvaranta J, 2010, CAN J FISH AQUAT SCI, V67, P1721, DOI 10.1139/F10-091; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Whitley G. P., 1936, Australian Zoologist, V8, P164	79	78	78	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77152	10.1371/journal.pone.0077152	http://dx.doi.org/10.1371/journal.pone.0077152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167562	Green Submitted, gold, Green Published			2022-12-25	WOS:000326034500021
J	Chan, SW; Cheang, CC; Chirapart, A; Gerung, G; Tharith, C; Ang, P				Chan, Sze Wai; Cheang, Chi Chiu; Chirapart, Anong; Gerung, Grevo; Tharith, Chea; Ang, Put			Homogeneous Population of the Brown Alga Sargassum polycystum in Southeast Asia: Possible Role of Recent Expansion and Asexual Propagation	PLOS ONE			English	Article							INDO-MALAY-ARCHIPELAGO; BORING GIANT CLAM; GLACIAL REFUGIA; GENETIC DIVERSITY; PHYLOGEOGRAPHY; PHAEOPHYCEAE; INFERENCE; PACIFIC; FUCALES; GROWTH	Southeast Asia has been known as one of the biodiversity hotspots in the world. Repeated glacial cycles during Pleistocene were believed to cause isolation of marine taxa in refugia, resulting in diversification among lineages. Recently, ocean current was also found to be another factor affecting gene flow by restricting larval dispersal in animals. Macroalgae are unique in having mode of reproduction that differs from that of animals. Our study on the phylogeographical pattern of the brown macroalga Sargassum polycystum using nuclear Internal Transcribed Spacer 2 (ITS2), plastidal RuBisCO spacer (Rub spacer) and mitochondrial cytochrome oxidase subunit-III (Cox3) as molecular markers revealed genetic homogeneity across 27 sites in Southeast Asia and western Pacific, in sharp contrast to that revealed from most animal studies. Our data suggested that S. polycystum persisted in single refugium during Pleistocene in a panmixia pattern. Expansion occurred more recently after the Last Glacial Maximum and recolonization of the newly flooded Sunda Shelf could have involved asexual propagation of the species. High dispersal ability through floating fronds carrying developing germlings may also contribute to the low genetic diversity of the species.	[Chan, Sze Wai; Cheang, Chi Chiu; Ang, Put] Chinese Univ Hong Kong, Marine Sci Lab, Hong Kong, Hong Kong, Peoples R China; [Chirapart, Anong] Kasetsart Univ, Fac Fisheries, Dept Fishery Biol, Algal Bioresources Res Ctr, Bangkok, Thailand; [Gerung, Grevo] Sam Ratulangi Univ, Fac Fisheries & Marine Sci, Manado, Indonesia; [Tharith, Chea] Fisheries Adm, Res & Dev Inst MFReDI, Phnom Penh, Cambodia	Chinese University of Hong Kong; Kasetsart University; Universitas Sam Ratulangi	Ang, P (corresponding author), Chinese Univ Hong Kong, Marine Sci Lab, Hong Kong, Hong Kong, Peoples R China.	put-ang@cuhk.edu.hk	Cheang, Chi Chiu/C-3064-2013; Ang, Put/AAO-5490-2021	Cheang, Chi Chiu/0000-0003-3554-6647; 	Research Grant Council of Hong Kong	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by The Research Grant Council of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2009, MOL ECOL, V18, P212, DOI 10.1111/j.1365-294X.2008.04022.x; Barber PH, 2006, EVOLUTION, V60, P1825; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Cheang CC, 2010, J PHYCOL, V46, P1063, DOI 10.1111/j.1529-8817.2010.00901.x; Cheang CC, 2010, MOL ECOL, V19, P2933, DOI 10.1111/j.1365-294X.2010.04685.x; Chiang Y.-M., 1992, TAXONOMY EC SEAWEEDS, P35; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fraser CI, 2009, MOL ECOL, V18, P2287, DOI 10.1111/j.1365-294X.2009.04201.x; Fu YX, 1997, GENETICS, V147, P915; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guiry M. D., 2013, ALGAEBASE; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; Hu ZM, 2013, MAR BIOL, V160, P1407, DOI 10.1007/s00227-013-2192-x; Hu ZM, 2011, MOL ECOL, V20, P3894, DOI 10.1111/j.1365-294X.2011.05220.x; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; Knittweis L, 2009, CONSERV GENET, V10, P241, DOI 10.1007/s10592-008-9566-5; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Komatsu T, 2007, J MARINE SYST, V67, P245, DOI 10.1016/j.jmarsys.2006.05.018; Lee KM, 2012, MAR BIOL, V159, P1021, DOI 10.1007/s00227-012-1882-0; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mattio L, 2009, J PHYCOL, V45, P1213, DOI 10.1111/j.1529-8817.2009.00737.x; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nei M., 1987, MOL EVOLUTIONARY GEN; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Phillips NE, 2005, PHYCOL RES, V53, P1; Rao AS, 2002, INDIAN J MAR SCI, V31, P26; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 1997, GENETICS, V145, P1219; Stiger Valerie, 2003, Phycological Research, V51, P1; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; TRONO GC, 1990, HYDROBIOLOGIA, V204, P331, DOI 10.1007/BF00040253; Tseng C. K., 1992, TAXONOMY EC SEAWEEDS, V2, P23; Uwai S, 2006, HYDROBIOLOGIA, V553, P345, DOI 10.1007/s10750-005-0883-0; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE, V2, P1; Yeong MLB, 2012, J APPL PHYCOL, V25, P805; Yow YY, 2011, J APPL PHYCOL, V23, P219, DOI 10.1007/s10811-010-9535-5	50	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77662	10.1371/journal.pone.0077662	http://dx.doi.org/10.1371/journal.pone.0077662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147050	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200062
J	Song, HF; Josleyn, N; Janosko, K; Skinner, J; Reeves, RK; Cohen, M; Jett, C; Johnson, R; Blaney, JE; Bollinger, L; Jennings, G; Jahrling, PB				Song, Haifeng; Josleyn, Nicole; Janosko, Krisztina; Skinner, Jeff; Reeves, R. Keith; Cohen, Melanie; Jett, Catherine; Johnson, Reed; Blaney, Joseph E.; Bollinger, Laura; Jennings, Gerald; Jahrling, Peter B.			Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions	PLOS ONE			English	Article							NK CELLS; LYMPH-NODES; MEDIATED RESISTANCE; SMALLPOX VACCINE; DENDRITIC CELLS; T-CELLS; ACTIVATION; CHEMOKINE; RECEPTOR; EXPRESSION	Natural killer (NK) cells play critical roles in innate immunity and in bridging innate and adaptive immune responses against viral infection. However, the response of NK cells to monkeypox virus (MPXV) infection is not well characterized. In this intravenous challenge study of MPXV infection in rhesus macaques (Macaca mulatta), we analyzed blood and lymph node NK cell changes in absolute cell numbers, cell proliferation, chemokine receptor expression, and cellular functions. Our results showed that the absolute number of total NK cells in the blood increased in response to MPXV infection at a magnitude of 23-fold, manifested by increases in CD56+, CD16+, CD16-CD56-double negative, and CD16+ CD56+ double positive NK cell subsets. Similarly, the frequency and NK cell numbers in the lymph nodes also largely increased with the total NK cell number increasing 46.1-fold. NK cells both in the blood and lymph nodes massively proliferated in response to MPXV infection as measured by Ki67 expression. Chemokine receptor analysis revealed reduced expression of CXCR3, CCR7, and CCR6 on NK cells at early time points (days 2 and 4 after virus inoculation), followed by an increased expression of CXCR3 and CCR5 at later time points (days 7-8) of infection. In addition, MPXV infection impaired NK cell degranulation and ablated secretion of interferon-gamma and tumor necrosis factor-alpha. Our data suggest a dynamic model by which NK cells respond to MPXV infection of rhesus macaques. Upon virus infection, NK cells proliferated robustly, resulting in massive increases in NK cell numbers. However, the migrating capacity of NK cells to tissues at early time points might be reduced, and the functions of cytotoxicity and cytokine secretion were largely compromised. Collectively, the data may explain, at least partially, the pathogenesis of MPXV infection in rhesus macaques.	[Song, Haifeng; Josleyn, Nicole; Janosko, Krisztina; Cohen, Melanie; Jett, Catherine; Bollinger, Laura; Jennings, Gerald; Jahrling, Peter B.] NIAID, Integrated Res Facil, NIH, Frederick, MD USA; [Skinner, Jeff] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Reeves, R. Keith] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Johnson, Reed; Blaney, Joseph E.; Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Song, HF (corresponding author), NIAID, Integrated Res Facil, NIH, Frederick, MD USA.	haifengsong2003@yahoo.com		Skinner, Jeff/0000-0001-5697-0442; Cohen, Melanie/0000-0002-4839-9386	National Institute of Allergy and Infectious Diseases (NIAID) under Battelle Memorial [HHSN272200200016I]; NIAID Division of Intramural Research funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) under Battelle Memorial; NIAID Division of Intramural Research funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported under Battelle Memorial contract with National Institute of Allergy and Infectious Diseases (NIAID) (contract number HHSN272200200016I) and was also supported in part by NIAID Division of Intramural Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andrews DM, 2005, MOL IMMUNOL, V42, P547, DOI 10.1016/j.molimm.2004.07.040; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; ARITA I, 1985, AM J TROP MED HYG, V34, P781, DOI 10.4269/ajtmh.1985.34.781; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BIGGS EW, 1979, J AM POD ASSOC, V69, P241, DOI 10.7547/87507315-69-4-241; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carter DL, 1999, CYTOMETRY, V37, P41, DOI 10.1002/(SICI)1097-0320(19990901)37:1<41::AID-CYTO5>3.0.CO;2-4; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Fang M, 2010, J EXP MED, V207, P2369, DOI 10.1084/jem.20100282; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fogli M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000101; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Fritz EA, 2008, VIRAL IMMUNOL, V21, P355, DOI 10.1089/vim.2008.0023; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Hong HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00032; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; JACOBY RO, 1989, ARCH VIROL, V108, P49, DOI 10.1007/BF01313742; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Kim CH, 1999, CELL IMMUNOL, V193, P226, DOI 10.1006/cimm.1999.1483; Kim CH, 1998, J IMMUNOL, V160, P2418; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Orr MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015184; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Reed DS, 2004, VIRAL IMMUNOL, V17, P390, DOI 10.1089/vim.2004.17.390; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rodas JD, 2009, MEM I OSWALDO CRUZ, V104, P583, DOI 10.1590/S0074-02762009000400009; Ryan JC, 2001, IMMUNOL REV, V181, P126, DOI 10.1034/j.1600-065X.2001.1810110.x; Shafer-Weaver Kimberly A, 2004, J Transl Med, V2, P31, DOI 10.1186/1479-5876-2-31; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Song HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060533; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zielinski RJ, 2010, VACCINE, V28, P7081, DOI 10.1016/j.vaccine.2010.08.008	68	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77804	10.1371/journal.pone.0077804	http://dx.doi.org/10.1371/journal.pone.0077804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147080	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200078
J	McKay, FC; Hoe, E; Parnell, G; Gatt, P; Schibeci, SD; Stewart, GJ; Booth, DR				McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.			IL7R alpha Expression and Upregulation by IFN beta in Dendritic Cell Subsets Is Haplotype-Dependent	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; INTERFERON-BETA; INTERLEUKIN-7 RECEPTOR; EPITHELIAL-CELLS; IN-VIVO; IMMUNE-RESPONSE	The IL7R alpha gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of relatively less soluble receptor, and potentially more response to ligand. We have previously shown in CD4 T cells that IL7R alpha haplotypes 1 and 2, but not 4, respond to interferon beta (IFN beta), the most commonly used immunomodulatory drug in MS, and that haplotype 4 (Hap 4) homozygotes have the highest risk of developing MS. We now show that IL7R expression increases in myeloid cells in response to IFN beta, but that the response is haplotype-dependent, with cells from homozygotes for Hap 4 again showing no response. This was shown using freshly derived monocytes, in vitro cultured immature and mature monocyte-derived dendritic cells, and by comparing homozygotes for the common haplotypes, and relative expression of alleles in heterozygotes (Hap 4 vs not Hap 4). As for T cells, in all myeloid cell subsets examined, Hap 2 homozygotes showed a trend for reduced splicing of exon 6 compared to the other haplotypes, significantly so in most conditions. These data are consistent with increased signaling being protective from MS, constitutively and in response to IFN beta. We also demonstrate significant regulation of immune response, chemokine activity and cytokine biosynthesis pathways by IL7R alpha signaling in IFN beta -treated myeloid subsets. IFN beta-responsive genes are over-represented amongst genes associated with MS susceptibility. IL7R alpha haplotype may contribute to MS susceptibility through reduced capacity for IL7R alpha signalling in myeloid cells, especially in the presence of IFN beta, and is currently under investigation as a predictor of therapeutic response.	[McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.] Westmead Millennium Inst, Inst Immunol & Allergy Res, Sydney, NSW, Australia; [McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Stewart, GJ (corresponding author), Westmead Millennium Inst, Inst Immunol & Allergy Res, Sydney, NSW, Australia.	graeme.stewart@sydney.edu.au; david.booth@sydney.edu.au	Parnell, Grant/AAB-8155-2021	Parnell, Grant/0000-0002-2898-0253; McKay, Fiona Catherine/0000-0002-9610-0668	Australian Research Council; Biogen-Idec; Multiple Sclerosis Research Australia; Merck-Serono	Australian Research Council(Australian Research Council); Biogen-Idec(Biogen); Multiple Sclerosis Research Australia; Merck-Serono(Merck & Company)	This work was supported by grants from the Australian Research Council (Linkage grant with Biogen-Idec), and Multiple Sclerosis Research Australia. The authors also declare that we have received funding from a commercial source, Merck-Serono. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Capitini CM, 2009, J INTERN MED, V266, P141, DOI 10.1111/j.1365-2796.2009.02085.x; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Colgan J, 2006, NAT IMMUNOL, V7, P899, DOI 10.1038/ni0906-899; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Edstrom M, 2011, MULT SCLER J, V17, P57, DOI 10.1177/1352458510381256; Fazekas de St Groth B, 2012, IMMUNOL CELL BIOL, V90, P256, DOI 10.1038/icb.2011.113; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Gary-Gouy H, 2002, J INTERF CYTOK RES, V22, P653, DOI 10.1089/10799900260100132; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hoe E, 2010, J INTERF CYTOK RES, V30, P291, DOI 10.1089/jir.2009.0060; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kang SJ, 2010, IMMUNOBIOLOGY, V215, P153, DOI 10.1016/j.imbio.2009.03.001; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kroncke R, 1996, EUR J IMMUNOL, V26, P2541, DOI 10.1002/eji.1830261040; Krumbiegel D, 2008, PEDIAT ALLERG IMM-UK, V19, P513, DOI 10.1111/j.1399-3038.2007.00685.x; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mckay FC, 2008, GENES IMMUN, V9, P1, DOI 10.1038/sj.gene.6364436; Mei FJ, 2006, J NEUROL SCI, V246, P71, DOI 10.1016/j.jns.2006.02.008; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rane L, 2010, J NEUROIMMUNOL, V222, P82, DOI 10.1016/j.jneuroim.2010.02.014; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Sin WX, 2012, IMMUNOL RES; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; TRAUGOTT U, 1988, ANN NEUROL, V24, P243, DOI 10.1002/ana.410240211; van der Mei IAF, 2011, NEUROL CLIN, V29, P233, DOI 10.1016/j.ncl.2010.12.007; van der Mei IAF, 2010, ANN NEUROL, V67, P261, DOI 10.1002/ana.21849; van Holten J, 2005, ANN RHEUM DIS, V64, P1780, DOI 10.1136/ard.2005.040477; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Zang YCQ, 2004, MULT SCLER J, V10, P499, DOI 10.1191/1352458504ms1081oa; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	72	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77508	10.1371/journal.pone.0077508	http://dx.doi.org/10.1371/journal.pone.0077508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147013	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400117
J	Song, GX; Shen, YH; Zhu, JG; Liu, HL; Liu, M; Shen, YQ; Zhu, SS; Kong, XQ; Yu, ZB; Qian, LM				Song, Guixian; Shen, Yahui; Zhu, Jingai; Liu, Hailang; Liu, Ming; Shen, Ya-Qing; Zhu, Shasha; Kong, Xiangqing; Yu, Zhangbin; Qian, Lingmei			Integrated Analysis of Dysregulated lncRNA Expression in Fetal Cardiac Tissues with Ventricular Septal Defect	PLOS ONE			English	Article							LONG NONCODING RNAS; GENE REGULATORY NETWORKS; HEART; ENHANCERS; CELLS; CARDIOGENESIS; ANNOTATION; MECHANISMS; VERTEBRATE; INSIGHTS	Ventricular septal defects (VSD) are the most common form of congenital heart disease, which is the leading noninfectious cause of death in children; nevertheless, the exact cause of VSD is not yet fully understood. Long non-coding RNAs (lncRNAs) have been shown to play key roles in various biological processes, such as imprinting control, circuitry controlling pluripotency and differentiation, immune responses and chromosome dynamics. Notably, a growing number of lncRNAs have been implicated in disease etiology, although an association with VSD has not been reported. In the present study, we conducted an integrated analysis of dysregulated lncRNAs, focusing specifically on the identification and characterization of lncRNAs potentially involving in initiation of VSD. Comparison of the transcriptome profiles of cardiac tissues from VSD-affected and normal hearts was performed using a second-generation lncRNA microarray, which covers the vast majority of expressed RefSeq transcripts (29,241 lncRNAs and 30,215 coding transcripts). In total, 880 lncRNAs were upregulated and 628 were downregulated in VSD. Furthermore, our established filtering pipeline indicated an association of two lncRNAs, ENST00000513542 and RP11-473L15.2, with VSD. This dysregulation of the lncRNA profile provides a novel insight into the etiology of VSD and furthermore, illustrates the intricate relationship between coding and ncRNA transcripts in cardiac development. These data may offer a background/reference resource for future functional studies of lncRNAs related to VSD.	[Song, Guixian; Liu, Hailang; Liu, Ming; Kong, Xiangqing; Qian, Lingmei] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shen, Yahui] Nanjing Med Univ, Dept MICU, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Zhu, Jingai; Zhu, Shasha; Yu, Zhangbin] Nanjing Med Univ, Dept Pediat, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Shen, Ya-Qing] Taizhou Matern & Child Hlth Care Hosp, Dept Lab Med, Taizhou, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yu, ZB (corresponding author), Nanjing Med Univ, Dept Pediat, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China.	yuzhangbin@126.com; lmqian@njmu.edu.cn			National Natural Science Foundation of China [81070138]; Natural Science Foundation of Jiangsu Province, China [BK2010582]; Talent Foundation of Jiangsu Province, China [WSN-020]; Postgraduate Research and Innovation Project in Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Talent Foundation of Jiangsu Province, China; Postgraduate Research and Innovation Project in Jiangsu Province, China	This work was supported by grants from the National Natural Science Foundation of China (No. 81070138), the Natural Science Foundation of Jiangsu Province, China (No. BK2010582), the Talent Foundation of Jiangsu Province, China (WSN-020), and the Postgraduate Research and Innovation Project in Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S9; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mortlock DP, 2012, CURR PROTOC HUM GENE; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sadowski Sharyl L, 2009, Crit Care Nurs Clin North Am, V21, P37, DOI 10.1016/j.ccell.2008.10.001; Satou Y, 2006, GENE DEV, V20, P2634, DOI 10.1101/gad.1485706; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Wutz A, 2011, PROG MOL BIOL TRANSL, V101, P351, DOI 10.1016/B978-0-12-387685-0.00011-1	30	31	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77492	10.1371/journal.pone.0077492	http://dx.doi.org/10.1371/journal.pone.0077492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147006	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400113
J	Merelo, P; Xie, YK; Brand, L; Ott, F; Weigel, D; Bowman, JL; Heisler, MG; Wenkel, S				Merelo, Paz; Xie, Yakun; Brand, Lucas; Ott, Felix; Weigel, Detlef; Bowman, John L.; Heisler, Marcus G.; Wenkel, Stephan			Genome-Wide Identification of KANADI1 Target Genes	PLOS ONE			English	Article							CLASS IIIHD-ZIP; DEPENDENT AUXIN GRADIENTS; LEAF DEVELOPMENT; CELL FATE; ASYMMETRIC-LEAVES2 GENE; TRANSCRIPTION FACTORS; ARABIDOPSIS SHOOTS; NPY GENES; POLARITY; EXPRESSION	Plant organ development and polarity establishment is mediated by the action of several transcription factors. Among these, the KANADI (KAN) subclade of the GARP protein family plays important roles in polarity-associated processes during embryo, shoot and root patterning. In this study, we have identified a set of potential direct target genes of KAN1 through a combination of chromatin immunoprecipitation/DNA sequencing (ChIP-Seq) and genome-wide transcriptional profiling using tiling arrays. Target genes are over-represented for genes involved in the regulation of organ development as well as in the response to auxin. KAN1 affects directly the expression of several genes previously shown to be important in the establishment of polarity during lateral organ and vascular tissue development. We also show that KAN1 controls through its target genes auxin effects on organ development at different levels: transport and its regulation, and signaling. In addition, KAN1 regulates genes involved in the response to abscisic acid, jasmonic acid, brassinosteroids, ethylene, cytokinins and gibberellins. The role of KAN1 in organ polarity is antagonized by HD-ZIPIII transcription factors, including REVOLUTA (REV). A comparison of their target genes reveals that the REV/KAN1 module acts in organ patterning through opposite regulation of shared targets. Evidence of mutual repression between closely related family members is also shown.	[Merelo, Paz; Heisler, Marcus G.] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Heisler, Marcus G.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Xie, Yakun; Wenkel, Stephan] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany; [Brand, Lucas; Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Ott, Felix; Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany	European Molecular Biology Laboratory (EMBL); University of Sydney; Eberhard Karls University of Tubingen; Monash University; Max Planck Society	Bowman, JL (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	john.bowman@monash.edu; heisler@embl.de; stephan.wenkel@zmbp.uni-tuebingen.de	Weigel, Detlef/AAR-3312-2021; heisler, marcus G/B-9738-2015; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Cremades, Paz Merelo/B-8001-2019	heisler, marcus G/0000-0001-5644-8398; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Cremades, Paz Merelo/0000-0002-1301-7835; Bowman, John/0000-0001-7347-3691; Wenkel, Stephan/0000-0001-5764-9423; Xie, Yakun/0000-0003-1943-9577	Australian Research Council [DP0771232, DP110100070]; European Research Council (GA) [261081]; Deutsche Forschungsgemeinschaft [WE4281/6-1, WE4281/7-1]; European Union [256502]; Swiss national Science Foundation [PBZHA-1188060]	Australian Research Council(Australian Research Council); European Research Council (GA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Swiss national Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	MH acknowledges the Australian Research Council (http://www.arc.gov.au/) and European Research Council (GA No261081)(http://erc.europa.eu/) for current funding. The SW laboratory is funded by grants of the Deutsche Forschungsgemeinschaft (WE4281/6-1, WE4281/7-1) (http://www.dfg.de/) and the European Union (FP7 No. 256502) (http://cordis.europa.eu/fp7/home_en.html). LB was supported by the Swiss national Science Foundation (PBZHA-1188060)(http://www.snf.ch/E/Pages/default.aspx) and JLB acknowledges support from the Australian Research Council (DP0771232, DP110100070)(http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baima S, 1995, DEVELOPMENT, V121, P4171; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bou-Torrent J, 2012, PLANT SIGNAL BEHAV, V7, P1382, DOI 10.4161/psb.21824; Bowman JL, 2008, ANNU REV PLANT BIOL, V59, P67, DOI 10.1146/annurev.arplant.57.032905.105356; Brandt R, 2012, PLANT J, V72, P31, DOI 10.1111/j.1365-313X.2012.05049.x; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carrier DJ, 2008, PLANT PHYSIOL, V148, P529, DOI 10.1104/pp.108.122044; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Furutani M, 2007, DEVELOPMENT, V134, P3849, DOI 10.1242/dev.009654; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li YT, 2011, MOL PLANT, V4, P171, DOI 10.1093/mp/ssq052; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; LIU T, 2013, COLD SPRING HARB S Q, P1465; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Smith ZR, 2010, NATURE, V464, P423, DOI 10.1038/nature08843; Spalding EP, 2013, AM J BOT, V100, P203, DOI 10.3732/ajb.1200420; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Yang TB, 2000, J BIOL CHEM, V275, P3137, DOI 10.1074/jbc.275.5.3137; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	74	45	47	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77341	10.1371/journal.pone.0077341	http://dx.doi.org/10.1371/journal.pone.0077341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155946	Green Submitted, gold, Green Published			2022-12-25	WOS:000325887300080
J	Noirclerc-Savoye, M; Lantez, V; Signor, L; Philippe, J; Vernet, T; Zapun, A				Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre			Reconstitution of Membrane Protein Complexes Involved in Pneumococcal Septal Cell Wall Assembly	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; DIVISION PROTEIN; BACILLUS-SUBTILIS; FTSI PBP3; TRIMERIC COMPLEX; PEPTIDOGLYCAN; TRANSPEPTIDASE; LOCALIZATION	The synthesis of peptidoglycan, the major component of the bacterial cell wall, is essential to cell survival, yet its mechanism remains poorly understood. In the present work, we have isolated several membrane protein complexes consisting of the late division proteins of Streptococcus pneumoniae: DivIB, DivIC, FtsL, PBP2x and FtsW, or subsets thereof. We have co-expressed membrane proteins from S. pneumoniae in Escherichia coli. By combining two successive affinity chromatography steps, we obtained membrane protein complexes with a very good purity. These complexes are functional, as indicated by the retained activity of PBP2x to bind a fluorescent derivative of penicillin and to hydrolyze the substrate analogue S2d. Moreover, we have evidenced the stabilizing role of protein-protein interactions within each complex. This work paves the way for a complete reconstitution of peptidoglycan synthesis in vitro, which will be critical to the elucidation of its intricate regulation mechanisms.	[Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Struct, Grenoble, France; [Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] CNRS, Inst Biol Struct, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Noirclerc-Savoye, M (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.	marjolaine.noirclerc@ibs.fr; thierry.vernet@ibs.fr	Signor, Luca/O-7489-2014	Signor, Luca/0000-0003-3880-2466; Noirclerc-Savoye, Marjolaine/0000-0002-5481-6561; Zapun, Andre/0000-0001-8953-4399	"Coopol innovation France-Chine" program; FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	"Coopol innovation France-Chine" program; FRISBI; GRAL	This work was partly funded by the "Coopol innovation France-Chine" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI(ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	ADAM M, 1991, BIOCHEM J, V279, P601, DOI 10.1042/bj2790601; Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Berridge G, 2011, ANAL BIOCHEM, V410, P272, DOI 10.1016/j.ab.2010.11.008; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Di Guilmi AM, 1999, J BACTERIOL, V181, P2773, DOI 10.1128/JB.181.9.2773-2781.1999; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gerard P, 2002, J BACTERIOL, V184, P1925, DOI 10.1128/JB.184.7.1925-1931.2002; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Helassa N, 2012, FEBS J, V279, P2071, DOI 10.1111/j.1742-4658.2012.08592.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Korepanova A, 2012, CURR PROTOC PROTEIN, V29; Land AD, 2011, J BACTERIOL, V193, P4166, DOI 10.1128/JB.05245-11; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Lebar MD, 2013, J AM CHEM SOC, V135, P4632, DOI 10.1021/ja312510m; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Martos A, 2012, TRENDS CELL BIOL, V22, P634, DOI 10.1016/j.tcb.2012.09.003; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Massidda O, 2013, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.12189, DOI 10.1111/1462-2920.12189.PUBMED:23848140]; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Noirclerc-Savoye M, 2010, BIOTECHNOL J, V5, P978, DOI 10.1002/biot.201000132; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Perez-Nunez D, 2011, MOL MICROBIOL, V79, P759, DOI 10.1111/j.1365-2958.2010.07483.x; Piette A, 2004, J BACTERIOL, V186, P6110, DOI 10.1128/jb.186.18.6110-6117.2004; Robichon C, 2008, J BACTERIOL, V190, P6048, DOI 10.1128/JB.00462-08; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rowland SL, 2010, J BACTERIOL, V192, P6116, DOI 10.1128/JB.00783-10; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sham LT, 2012, CURR OPIN MICROBIOL, V15, P194, DOI 10.1016/j.mib.2011.12.013; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wadsworth KD, 2008, MOL MICROBIOL, V67, P1143, DOI 10.1111/j.1365-2958.2008.06114.x; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wissel MC, 2005, J BACTERIOL, V187, P320, DOI 10.1128/JB.187.1.320-328.2005; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zapun A, 2012, MICROB DRUG RESIST, V18, P256, DOI 10.1089/mdr.2011.0236; Zhao GS, 1997, J BACTERIOL, V179, P4901, DOI 10.1128/jb.179.15.4901-4908.1997	58	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75522	10.1371/journal.pone.0075522	http://dx.doi.org/10.1371/journal.pone.0075522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24147156	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200108
J	Xu, C; Lin, L; Cao, G; Chen, Q; Shou, P; Huang, Y; Han, Y; Wang, Y; Shi, Y				Xu, C.; Lin, L.; Cao, G.; Chen, Q.; Shou, P.; Huang, Y.; Han, Y.; Wang, Y.; Shi, Y.			Interferon-alpha-secreting mesenchymal stem cells exert potent antitumor effect in vivo	ONCOGENE			English	Article						mesenchymal stem cells; IFN alpha; NK cells; CD8(+) T cells; immune system; tumor	NATURAL-KILLER-CELLS; STROMAL CELLS; DELIVERY; TISSUE	Mesenchymal stem cells (MSCs) are a kind of adult stem cells that can be isolated easily from bone marrow, adipose tissue, umbilical cord and many other tissues. MSCs have been shown to specifically migrate to inflammatory sites, including tumors, and hold great promise as tumor-specific vectors to deliver antitumor agents. Interferon-alpha (IFN alpha) has been used in clinic to treat various types of tumors; however, because of its short half-life, significant therapeutic effects require high doses that often results in serious side effects. Here, we tested whether MSCs continuingly secreting IFN alpha can exert a persistent antitumor effect and eliminate the side effects associated with high clinical doses of recombinant IFN alpha. We found that even a small number of IFN alpha-secreting MSCs could potently halt B16 tumor growth in vivo. The antitumor activity of IFN alpha-secreting MSCs was largely abolished in immunodeficient mice, an effect largely attributed to natural killer cells and CD8(+) T cells. Therefore, IFNa-secreting MSCs provide an innovative strategy for tumor therapy.	[Xu, C.; Lin, L.; Cao, G.; Chen, Q.; Shou, P.; Huang, Y.; Han, Y.; Wang, Y.; Shi, Y.] Chinese Acad Sci, Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci,Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Shi, Y (corresponding author), Chinese Acad Sci, Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci,Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci, 225 South Chongqing Rd,1 Bldg, Shanghai, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	lin, liping/HGE-0871-2022; Xu, Chunliang/R-7065-2018; Shi, Yufang/AAE-4431-2020; Shou, Peishun/J-7985-2014; HUANG, YIN/AAH-6871-2020	Shi, Yufang/0000-0001-8964-319X; Shou, Peishun/0000-0001-7685-7471; HUANG, YIN/0000-0001-5602-9871; Chen, Qing/0000-0002-2088-0370; wang, ying/0000-0002-2571-9367	Scientific Innovation Project of the Chinese Academy of Science [XDA 01040107, XDA 01040110]; Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; National Science and Technology Project of China [31010103908, 81273316]; Shanghai Municipal Key Projects of Basic Research [12JC1409200]; Shanghai Municipal Natural Science Foundation [12ZR1452600]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP202]	Scientific Innovation Project of the Chinese Academy of Science; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Project of China; Shanghai Municipal Key Projects of Basic Research; Shanghai Municipal Natural Science Foundation; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from Scientific Innovation Project of the Chinese Academy of Science (XDA 01040107 and XDA 01040110), the Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630), the National Science and Technology Project of China (31010103908 and 81273316), Shanghai Municipal Key Projects of Basic Research (12JC1409200), Shanghai Municipal Natural Science Foundation (12ZR1452600), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences and the Chinese Academy of Sciences (2012KIP202).	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; Hainaut P, 2012, CURR OPIN ONCOL, V25, P50; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Loebinger MR, 2009, CANCER RES, V69, P8862, DOI 10.1158/0008-5472.CAN-09-1912; Pestka S, 2003, CANCER CELL, V4, P85, DOI 10.1016/S1535-6108(03)00193-4; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Studeny M, 2002, CANCER RES, V62, P3603; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wang B, 2010, EXPERT OPIN DRUG DEL, V7, P1159, DOI 10.1517/17425247.2010.513968; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Zou WB, 2012, CANCER RES, V72, P2980, DOI 10.1158/0008-5472.CAN-11-4216; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	29	34	36	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					5047	5052		10.1038/onc.2013.458	http://dx.doi.org/10.1038/onc.2013.458			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24186200				2022-12-25	WOS:000343768000009
J	Cordero-Espinoza, L; Hagen, T				Cordero-Espinoza, Lucia; Hagen, Thilo			Increased Concentrations of Fructose 2,6-Bisphosphate Contribute to the Warburg Effect in Phosphatase and Tensin Homolog (PTEN)-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Fructose 2; 6-Bisphosphate; Glycolysis; Phosphofructokinase; Pten; APC; C-Cdh1; PFKFB3	PROTEIN-KINASE B; HEART 6-PHOSPHOFRUCTO-2-KINASE; AEROBIC GLYCOLYSIS; PTEN; APC/C-CDH1; INHIBITION; METABOLISM; ACTIVATION; ELEVATION; CANCERS	Background: PTEN deficiency leads to increased glycolytic flux characteristic of cancer cells. Results: PTEN-deficient cells have high concentrations of fructose 2,6-bisphosphate due to protein stabilization of PFKFB3 that results from impaired APC/C-Cdh1-dependent degradation. Conclusion: Elevated fructose 2,6-bisphosphate concentrations contribute to the increased rates of glycolysis and proliferation in PTEN-deficient cells. Significance: Fructose 2,6-bisphosphate might be a crucial mediator of tumorigenesis in PTEN-deficient cells. Unlike normal differentiated cells, tumor cells metabolize glucose via glycolysis under aerobic conditions, a hallmark of cancer known as the Warburg effect. Cells lacking the commonly mutated tumor suppressor PTEN exhibit a glycolytic phenotype reminiscent of the Warburg effect. This has been traditionally attributed to the hyperactivation of PI3K/Akt signaling that results from PTEN loss. Here, we propose a novel mechanism whereby the loss of PTEN negatively affects the activity of the E3 ligase APC/C-Cdh1, resulting in the stabilization of the enzyme PFKFB3 and increased synthesis of its product fructose 2,6-bisphosphate (F2,6P(2)). We discovered that when compared with wild-type cells, PTEN knock-out mouse embryonic fibroblasts (PTEN KO MEF) have 2-3-fold higher concentrations of F2,6P(2), the most potent allosteric activator of the glycolytic enzyme phosphofructokinase-1 (PFK-1). Reintroduction of either wild-type or phosphatase mutant PTEN in the PTEN KO cells effectively lowers F2,6P(2) to the wild-type levels and reduces their lactate production. PTEN KO cells were found to have high protein levels of PFKFB3, which directly contribute to the increased concentrations of F2,6P(2). PTEN enhances interaction between PFKFB3 and Cdh1, and overexpression of Cdh1 down-regulates the PFKFB3 protein level in wild-type, but not in PTEN-deficient cells. Importantly, we found that the degradation of endogenous PFKFB3 in PTEN KO cells occurs at a slower rate than in wild-type cells. Our results suggest an important role for F2,6P(2) in the metabolic reprogramming of PTEN-deficient cells that has important consequences for cell proliferation.	[Cordero-Espinoza, Lucia; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.	bchth@nus.edu.sg		Cordero Espinoza, Lucia/0000-0002-2954-7654	Singapore Biomedical Research Council, A*Star [10/1/21/19/647]	Singapore Biomedical Research Council, A*Star	This work was supported by Grant 10/1/21/19/647 from the Singapore Biomedical Research Council, A*Star.	Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Blouin MJ, 2010, CANCER LETT, V289, P246, DOI 10.1016/j.canlet.2009.08.021; BROWN J, 1962, METABOLISM, V11, P1098; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lefebvre V, 1996, J BIOL CHEM, V271, P22289, DOI 10.1074/jbc.271.37.22289; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li M, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-2; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; Pfleger CM, 2000, GENE DEV, V14, P655; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	31	36	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36020	36028		10.1074/jbc.M113.510289	http://dx.doi.org/10.1074/jbc.M113.510289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169697	Green Published, hybrid			2022-12-25	WOS:000329814700037
J	Lee, J; Kim, HJ; Roh, J; Seo, Y; Kim, M; Jun, HR; Pham, CD; Kwon, MH				Lee, Jiyeon; Kim, Hye-Jin; Roh, Jooho; Seo, Youngsil; Kim, Minjae; Jun, Hye-Ryeong; Pham, Chuong D.; Kwon, Myung-Hee			Functional Consequences of Complementarity-determining Region Deactivation in a Multifunctional Anti-nucleic Acid Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Antibody Engineering; Autoimmunity; Immunology; Molecular Biology; Anti-DNA Antibody; CDR Deactivation; Cell Penetration; DNA Hydrolysis; Multifunctional Antibody	DNA ANTIBODIES; HEPARAN-SULFATE; HIGH-AFFINITY; BINDING; CDR; CELLS; LOCALIZATION; HYDROLYSIS; PATHWAY	Background: A subset of anti-DNA antibodies have DNA-hydrolysis and/or cell-penetration activity. Results: Deactivation of different complementarity-determining regions (CDRs) in a multifunctional anti-nucleic acid antibody alters the properties of the antibody. Conclusion: CDR1 of the light chain plays a crucial role in maintaining the properties of 3D8 scFv. Significance: Single complete CDR deactivation allows exploration of the molecular features of multifunctional anti-DNA antibodies. Many murine monoclonal anti-DNA antibodies (Abs) derived from mice models for systemic lupus erythematosus have additional cell-penetration and/or nucleic acid-hydrolysis properties. Here, we examined the influence of deactivating each complementarity-determining region (CDR) within a multifunctional anti-nucleic acid antibody (Ab) that possesses these activities, the catalytic 3D8 single chain variable fragment (scFv). CDR-deactivated 3D8 scFv variants were generated by replacing all of the amino acids within each CDR with Gly/Ser residues. The structure of 3D8 scFv accommodated single complete CDR deactivations. Different functional activities of 3D8 scFv were affected differently depending on which CDR was deactivated. The only exception was CDR1, located within the light chain (LCDR1); deactivation of LCDR1 abolished all of the functional activities of 3D8 scFv. A hybrid Ab, HW6/3D8L1, in which the LCDR1 from an unrelated Ab (HW6) was replaced with the LCDR1 from 3D8, acquired all activities associated with the 3D8 scFv. These results suggest that the activity of a multifunctional 3D8 scFv Ab can be modulated by single complete CDR deactivation and that the LCDR1 plays a crucial role in maintaining Ab properties. This study presents a new approach for determining the role of individual CDRs in multifunctional Abs with important implications for the future of Ab engineering.	[Lee, Jiyeon; Kim, Hye-Jin; Roh, Jooho; Seo, Youngsil; Kim, Minjae; Jun, Hye-Ryeong; Pham, Chuong D.; Kwon, Myung-Hee] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 443749, South Korea; [Kwon, Myung-Hee] Ajou Univ, Sch Med, Dept Microbiol, Suwon 443749, South Korea	Ajou University; Ajou University	Kwon, MH (corresponding author), Ajou Univ, Sch Med, Dept Microbiol, Woncheon Dong 5, Suwon 443749, South Korea.	kwonmh@ajou.ac.kr	Pham, Dinh-Chuong/L-8930-2018	Pham, Dinh-Chuong/0000-0002-3074-6941	Science Research Center Program of the National Research Foundation of Korea [20110030043]; Basic Science Research Program of the National Research Foundation of Korea [2011-0007358]; Department of Medical Sciences, the Graduate School, Ajou University	Science Research Center Program of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Department of Medical Sciences, the Graduate School, Ajou University	This work was supported by the Science Research Center Program (20110030043) and the Basic Science Research Program (2011-0007358) of the National Research Foundation of Korea and a grant (2011) from the Department of Medical Sciences, the Graduate School, Ajou University.	BERDEN JHM, 1989, NEPHROLOGIE, V10, P127; Clark LA, 2009, PROTEIN ENG DES SEL, V22, P93, DOI 10.1093/protein/gzn072; Dobroff AS, 2010, TRANSL ONCOL, V3, P204, DOI 10.1593/tlo.09316; FAABER P, 1986, J CLIN INVEST, V77, P1824, DOI 10.1172/JCI112508; Gololobov GV, 1997, MOL IMMUNOL, V34, P1083, DOI 10.1016/S0161-5890(97)00129-6; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jang EJ, 2009, IMMUNOL LETT, V124, P70, DOI 10.1016/j.imlet.2009.04.005; Jeong JG, 2011, BIOCHEM BIOPH RES CO, V406, P403, DOI 10.1016/j.bbrc.2011.02.054; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Krishnan MR, 2012, KIDNEY INT, V82, P184, DOI 10.1038/ki.2011.484; Lee EJ, 2007, BIOORGAN MED CHEM, V15, P2016, DOI 10.1016/j.bmc.2006.12.037; Lupinek C, 2009, J IMMUNOL, V182, P4817, DOI 10.4049/jimmunol.0800726; Murakami A, 2010, MOL IMMUNOL, V48, P48, DOI 10.1016/j.molimm.2010.09.013; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Petrovskaya LE, 2012, BIOCHEMISTRY-MOSCOW+, V77, P62, DOI 10.1134/S0006297912010075; Pham CD, 2012, J IMMUNOL, V189, P5755, DOI 10.4049/jimmunol.1200804; Putterman C, 2004, AUTOIMMUN REV, V3, P97, DOI 10.1016/S1568-9972(03)00082-X; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rahman A, 1998, SEMIN ARTHRITIS RHEU, V28, P141, DOI 10.1016/S0049-0172(98)80031-0; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Ternynck T, 1998, J AUTOIMMUN, V11, P511, DOI 10.1006/jaut.1998.0222; Timmerman P, 2010, J MOL RECOGNIT, V23, P559, DOI 10.1002/jmr.1017; Wellmann U, 2005, P NATL ACAD SCI USA, V102, P9258, DOI 10.1073/pnas.0500132102; Yanase K, 2005, J AUTOIMMUN, V24, P145, DOI 10.1016/j.jaut.2004.11.008; Zack DJ, 1996, J IMMUNOL, V157, P2082	31	7	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35877	35885		10.1074/jbc.M113.508499	http://dx.doi.org/10.1074/jbc.M113.508499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24155236	Green Published, hybrid			2022-12-25	WOS:000329814700024
J	Koya, T; Nishizawa, S; Ohno, Y; Goto, A; Ikuta, A; Suzuki, M; Ohira, T; Egawa, T; Nakai, A; Sugiura, T; Ohira, Y; Yoshioka, T; Beppu, M; Goto, K				Koya, Tomoyuki; Nishizawa, Sono; Ohno, Yoshitaka; Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Nakai, Akira; Sugiura, Takao; Ohira, Yoshinobu; Yoshioka, Toshitada; Beppu, Moroe; Goto, Katsumasa			Heat Shock Transcription Factor 1-Deficiency Attenuates Overloading-Associated Hypertrophy of Mouse Soleus Muscle	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; MOLECULAR CHAPERONES; RAT PLANTARIS; EXPRESSION; STRESS; CELL; INTERLEUKIN-6; PROTEINS; REGENERATION	Hypertrophic stimuli, such as mechanical stress and overloading, induce stress response, which is mediated by heat shock transcription factor 1 (HSF1), and up-regulate heat shock proteins (HSPs) in mammalian skeletal muscles. Therefore, HSF1-associated stress response may play a key role in loading-associated skeletal muscle hypertrophy. The purpose of this study was to investigate the effects of HSF1-deficiency on skeletal muscle hypertrophy caused by overloading. Functional overloading on the left soleus was performed by cutting the distal tendons of gastrocnemius and plantaris muscles for 4 weeks. The right muscle served as the control. Soleus muscles from both hindlimbs were dissected 2 and 4 weeks after the operation. Hypertrophy of soleus muscle in HSF1-null mice was partially inhibited, compared with that in wild-type (C57BL/6J) mice. Absence of HSF1 partially attenuated the increase of muscle wet weight and fiber cross-sectional area of overloaded soleus muscle. Population of Pax7-positive muscle satellite cells in HSF1-null mice was significantly less than that in wild-type mice following 2 weeks of overloading (p<0.05). Significant up-regulations of interleukin (IL)-1 beta and tumor necrosis factor mRNAs were observed in HSF1-null, but not in wild-type, mice following 2 weeks of overloading. Overloading-related increases of IL-6 and AFT3 mRNA expressions seen after 2 weeks of overloading tended to decrease after 4 weeks in both types of mice. In HSF1-null mice, however, the significant overloading-related increase in the expression of IL-6, not ATF3, mRNA was noted even at 4th week. Inhibition of muscle hypertrophy might be attributed to the greater and prolonged enhancement of IL-6 expression. HSF1 and/or HSF1-mediated stress response may, in part, play a key role in loading-induced skeletal muscle hypertrophy.	[Koya, Tomoyuki; Nishizawa, Sono; Beppu, Moroe] St Marianna Univ, Sch Med, Dept Orthopaed Surg, Kawasaki, Kanagawa, Japan; [Ohno, Yoshitaka; Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi, Japan; [Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan; [Nakai, Akira] Yamaguchi Univ, Grad Sch Med, Dept Mol Biol, Ube, Yamaguchi 755, Japan; [Sugiura, Takao] Yamaguchi Univ, Dept Exercise & Hlth Sci, Yamaguchi, Japan; [Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan; [Yoshioka, Toshitada] Hirosaki Gakuin Univ, Hirosaki, Aomori, Japan	Saint Marianna University; Yamaguchi University; Yamaguchi University; Osaka University	Goto, K (corresponding author), Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi, Japan.	gotok@sepia.ocn.ne.jp	Goto, Katsumasa/T-6789-2019	Goto, Katsumasa/0000-0001-5380-4561; Egawa, Tatsuro/0000-0001-9363-1589	Japan Society for the Promotion of Science [24650411, 24650407, 18200042]; Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported, in part, by Grants-in-Aid for Challenging Exploratory Research (24650411, KG; 24650407, Y Ohira) and Grants-in-Aid for Scientific Research (A, 18200042, TY) from Japan Society for the Promotion of Science, and the Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Del Aguila LF, 2000, AM J PHYSIOL-ENDOC M, V279, pE206, DOI 10.1152/ajpendo.2000.279.1.E206; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Goto K, 2003, PFLUG ARCH EUR J PHY, V447, P247, DOI 10.1007/s00424-003-1177-x; Goto K, 2007, BIOCHEM BIOPH RES CO, V358, P331, DOI 10.1016/j.bbrc.2007.04.129; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; Huey KA, 2006, J APPL PHYSIOL, V100, P451, DOI 10.1152/japplphysiol.01022.2005; Huey KA, 2010, EXP PHYSIOL, V95, P1145, DOI 10.1113/expphysiol.2010.054692; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Katsuki K, 2004, FEBS LETT, V571, P187, DOI 10.1016/j.febslet.2004.06.087; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; KILGORE JL, 1994, J APPL PHYSIOL, V76, P598, DOI 10.1152/jappl.1994.76.2.598; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Locke M, 2008, ACTA PHYSIOL, V192, P403, DOI 10.1111/j.1748-1716.2007.01764.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morioka S, 2008, J PHYSIOL SCI, V58, P397, DOI 10.2170/physiolsci.RP004008; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nishizawa S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.71; Ogata T, 2009, AM J PHYSIOL-REG I, V296, pR1557, DOI 10.1152/ajpregu.90911.2008; Oguro A, 2006, GENES CELLS, V11, P1253, DOI 10.1111/j.1365-2443.2006.01021.x; Oishi Y, 2003, JPN J PHYSIOL, V53, P281, DOI 10.2170/jjphysiol.53.281; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Santoro MG, 2008, BIOCHEM PHARMACOL, V59, P55; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shen WH, 2004, J IMMUNOL, V172, P7272, DOI 10.4049/jimmunol.172.12.7272; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Uehara K, 2004, JPN J PHYSIOL, V54, P263, DOI 10.2170/jjphysiol.54.263; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	57	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77788	10.1371/journal.pone.0077788	http://dx.doi.org/10.1371/journal.pone.0077788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167582	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500041
J	Holechek, SA; Denzler, KL; Heck, MC; Schriewer, J; Buller, RM; Legrand, FA; Verardi, PH; Jones, LA; Yilma, T; Jacobs, BL				Holechek, Susan A.; Denzler, Karen L.; Heck, Michael C.; Schriewer, Jill; Buller, R. Mark; Legrand, Fatema A.; Verardi, Paulo H.; Jones, Leslie A.; Yilma, Tilahun; Jacobs, Bertram L.			Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses	PLOS ONE			English	Article							ANTIPOXVIRUS COMPOUND ST-246; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-RESPONSES; NITRIC-OXIDE; MICE; SMALLPOX; INHIBITION; EFFICACY; PROTEIN; MODEL	Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this study, we analyzed post-exposure prophylaxis using several attenuated recombinant VACV in a mouse model. A recombinant VACV expressing murine interferon gamma (IFN-gamma) was most effective for post-exposure protection of mice infected with VACV and ectromelia virus (ECTV). Untreated animals infected with VACV exhibited severe weight loss and morbidity leading to 100% mortality by 8 to 10 days post-infection. Animals treated one day post-infection had milder symptoms, decreased weight loss and morbidity, and 100% survival. Treatment on days 2 or 3 post-infection resulted in 40% and 20% survival, respectively. Similar results were seen in ECTV-infected mice. Despite the differences in survival rates in the VACV model, the viral load was similar in both treated and untreated mice while treated mice displayed a high level of IFN-gamma in the serum. These results suggest that protection provided by IFN-gamma expressed by VACV may be mediated by its immunoregulatory activities rather than its antiviral effects. These results highlight the importance of IFN-gamma as a modulator of the immune response for post-exposure prophylaxis and could be used potentially as another post-exposure prophylaxis tool to prevent morbidity following infection with smallpox and other orthopoxviruses.	[Holechek, Susan A.; Denzler, Karen L.; Heck, Michael C.; Jacobs, Bertram L.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85069 USA; [Schriewer, Jill; Buller, R. Mark] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Legrand, Fatema A.; Jones, Leslie A.; Yilma, Tilahun] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Int Lab Mol Biol Trop Dis Agents,Sch Vet Med, Davis, CA 95616 USA; [Verardi, Paulo H.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA	Arizona State University; Arizona State University-Tempe; Saint Louis University; University of California System; University of California Davis; University of Connecticut	Jacobs, BL (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85069 USA.	bjacobs@asu.edu			Biodefense Countermeasures Development: Project Bioshield; Department of Health and Human Services, Public Health Services [R01AI06650101]; Arizona State University Graduate Professional Student Association; Arizona State University Faculty Emeriti Association Fellowship; More Graduate Education at Mountain States Alliance MGE@MSA; National Institutes of Health [AI54951, AI53811, AI59185]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059185, R01AI054951, R01AI095394, R21AI053811] Funding Source: NIH RePORTER	Biodefense Countermeasures Development: Project Bioshield; Department of Health and Human Services, Public Health Services; Arizona State University Graduate Professional Student Association; Arizona State University Faculty Emeriti Association Fellowship; More Graduate Education at Mountain States Alliance MGE@MSA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from the Biodefense Countermeasures Development: Project Bioshield, Department of Health and Human Services, Public Health Services grant R01AI06650101 to B.L.J., Arizona State University Graduate Professional Student Association research grant to S. A. H., Arizona State University Faculty Emeriti Association Fellowship to S. A. H. and More Graduate Education at Mountain States Alliance MGE@MSA. National Institutes of Health Grants AI54951 and AI53811 to T.D.Y. and AI59185 to P. H. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; ALCAMI A, 1995, J VIROL, V69, P4633; Amorosa VK, 2003, CLIN INFECT DIS, V37, P426, DOI 10.1086/375823; ANDERSON KP, 1988, J IMMUNOL, V140, P3599; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLOOM DC, 1991, J VIROL, V65, P1530, DOI 10.1128/JVI.65.3.1530-1542.1991; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Buller RM, 2004, VIROLOGY, V318, P474, DOI 10.1016/j.virol.2003.11.015; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Cheers C, 1999, IMMUNOL CELL BIOL, V77, P324, DOI 10.1046/j.1440-1711.1999.00829.x; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; De Clercq E, 2004, REV MED VIROL, V14, P289, DOI 10.1002/rmv.439; Earl P, 1991, CURRENT PROTOCOLS MO; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FENNER F, 1949, J IMMUNOL, V63, P341; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; FLEXNER C, 1987, NATURE, V330, P259, DOI 10.1038/330259a0; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Giavedoni L, 1997, J VIROL, V71, P866, DOI 10.1128/JVI.71.2.866-872.1997; GIAVEDONI LD, 1992, P NATL ACAD SCI USA, V89, P3409, DOI 10.1073/pnas.89.8.3409; Guerra S, 2005, J VIROL, V79, P2133, DOI 10.1128/JVI.79.4.2133-2140.2005; HARRIS N, 1995, J VIROL, V69, P910, DOI 10.1128/JVI.69.2.910-915.1995; Jentarra GM, 2008, VACCINE, V26, P2860, DOI 10.1016/j.vaccine.2008.03.044; KAPLAN C, 1989, ARCH VIROL, V106, P127, DOI 10.1007/BF01311044; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; KOHONENCORISH MRJ, 1990, EUR J IMMUNOL, V20, P157, DOI 10.1002/eji.1830200123; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740; LeDuc JW, 2002, EMERG INFECT DIS, V8, P743, DOI 10.3201/eid0807.020032; Legrand FA, 2005, P NATL ACAD SCI USA, V102, P2940, DOI 10.1073/pnas.0409846102; Legrand FA, 2004, J VIROL, V78, P2770, DOI 10.1128/JVI.78.6.2770-2779.2004; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; Moss B, 1991, CURRENT PROTOCOLS MO; Moss B, 2001, FIELDS VIROLOGY, P2849; MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Nalca A, 2011, J GEN VIROL, V92, P31, DOI 10.1099/vir.0.026237-0; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Parker S, 2009, VIROLOGY, V385, P11, DOI 10.1016/j.virol.2008.11.015; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Parker S, 2010, VIRUSES-BASEL, V2, P1918, DOI 10.3390/v2091918; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P4118, DOI 10.1128/AAC.00762-07; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; Raggo C, 2000, J GEN VIROL, V81, P2665, DOI 10.1099/0022-1317-81-11-2665; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sbrana E, 2007, AM J TROP MED HYG, V76, P768, DOI 10.4269/ajtmh.2007.76.768; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sharma DP, 1996, J VIROL, V70, P7103, DOI 10.1128/JVI.70.10.7103-7107.1996; Shors T, 1997, VIROLOGY, V239, P269, DOI 10.1006/viro.1997.8881; Smith SK, 2009, ANTIMICROB AGENTS CH, V53, P1007, DOI 10.1128/AAC.01044-08; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; Staib C, 2006, J GEN VIROL, V87, P2917, DOI 10.1099/vir.0.82068-0; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Thorne CD, 2003, ANN EMERG MED, V42, P665, DOI 10.1016/S0196-0644(03)00629-2; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; WALLACE GD, 1985, LAB ANIM SCI, V35, P41; Wittek R, 2006, INT J INFECT DIS, V10, P193, DOI 10.1016/j.ijid.2005.12.001; World Health Organization, 1980, GLOB ER SMALLP FIN R; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	73	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77879	10.1371/journal.pone.0077879	http://dx.doi.org/10.1371/journal.pone.0077879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147092	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200083
J	Whelan, J; Sonder, GJ; Bovee, L; Speksnijder, A; van den Hoek, A				Whelan, Jane; Sonder, Gerard J.; Bovee, Lian; Speksnijder, Arjen; van den Hoek, Anneke			Evaluation of Hepatitis A Vaccine in Post-Exposure Prophylaxis, The Netherlands, 2004-2012	PLOS ONE			English	Article							IMMUNE SERUM GLOBULIN; VIRUS-VACCINE; SINGLE; IMMUNOGENICITY; PREVENTION; AMSTERDAM; OUTBREAK; SAFETY; ADULTS	Background: The secondary attack rate of hepatitis A virus (HAV) among contacts of cases is up to 50%. Historically, contacts were offered immunoglobulin (IG, a human derived blood product) as post-exposure prophylaxis (PEP). Amid safety concerns about IG, HAV vaccine is increasingly recommended instead. Public health authorities' recommendations differ, particularly for healthy contacts >= 40 years old, where vaccine efficacy data is limited. We evaluated routine use of HAV vaccine as an alternative to immunoglobulin in PEP, in those considered at low risk of severe infection in the Netherlands. Methods: Household contacts of acute HAV cases notified in Amsterdam (2004-2012) were invited <= 14 days post-exposure, for baseline anti-HAV testing and PEP according to national guidelines: immunoglobulin if at risk of severe infection, or hepatitis A vaccine if healthy and at low risk (aged <30, or, 30-50 years and vaccinated <8 days post-exposure). Incidence of laboratory confirmed secondary infection in susceptible contacts was assessed 4-8 weeks post-exposure. In a vaccinated subgroup, relative risk (RR) of secondary infection with estimated using Poisson regression. Results: Of 547 contacts identified, 191 were susceptible to HAV. Per-protocol, 167 (87%) were vaccinated (mean: 6.7 days post-exposure, standard deviation(sd)=3.3) and 24 (13%) were given immunoglobulin (mean: 9.7 days postexposure, sd=2.8). At follow-up testing, 8/112 (7%) had a laboratory confirmed infection of whom 7 were symptomatic. All secondary infections occurred in vaccinated contacts, and half were >40 years of age. In healthy contacts vaccinated per-protocol <= 8 days post-exposure, RRref. <= 15 years of secondary infection in those >40 years was 12.0 (95%CI: 1.3-106.7). Conclusions: Timely administration of HAV vaccine in PEP was feasible and the secondary attack rate was low in those <40 years. Internationally, upper age-limits for post-exposure vaccination vary. Pending larger studies, immunoglobulin should be considered PEP of choice in people >40 years of age and those vulnerable to severe disease.	[Whelan, Jane; Sonder, Gerard J.; Bovee, Lian; van den Hoek, Anneke] Amsterdam Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Sonder, Gerard J.; van den Hoek, Anneke] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Speksnijder, Arjen] Amsterdam Publ Hlth Serv GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Whelan, J (corresponding author), Amsterdam Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.	jwhelan@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017	Speksnijder, Arjen/0000-0002-1966-7265; Whelan, Jane/0000-0003-3784-2749	Public Health Service of Amsterdam, the Netherlands	Public Health Service of Amsterdam, the Netherlands(Netherlands Government)	This research was funded by the Public Health Service of Amsterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY A, 1954, NEW ENGL J MED, V250, P412, DOI 10.1056/NEJM195403112501003; BRIEM H, 1994, J MED VIROL, V44, P443, DOI 10.1002/jmv.1890440424; BROOKS BF, 1953, NEW ENGL J MED, V249, P58, DOI 10.1056/NEJM195307092490202; Crowcroft N S, 2001, Commun Dis Public Health, V4, P213; De Schrijver K, 2011, HEPATITIS A GUIDELIN; GINGRICH GA, 1983, AM J PUBLIC HEALTH, V73, P1190, DOI 10.2105/AJPH.73.10.1190; Health Council of the Netherlands, 2001, HLTH COUNC NETH PUBL, V2001; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Koff RS, 1998, LANCET, V351, P1643, DOI 10.1016/S0140-6736(98)01304-X; Lee PI, 2008, NEW ENGL J MED, V358, P32, DOI [10.1056/NEJMc073258, DOI 10.1056/NEJMC073258.PUBMED:1824042818234760]; MOSLEY JW, 1968, AM J EPIDEMIOL, V87, P539, DOI 10.1093/oxfordjournals.aje.a120845; National Advisory Committee for Infectious Disease Control (LOI), 2002, ADV LOI WORKGR SAF G; National Advisory Committee on Immunization and the Public Health Agency of Canada, 2012, HEP A VACC POST IM 4; National Advisory Committee on Immunization (NACI), 2000, CAN COMMUN DIS REP, V26, P12; National Center for the coordination of Infectious Disease Control (LCI), 2011, GUID HEP A; Novak R., 2007, Morbidity and Mortality Weekly Report, V56, P1080; Queensland Health, 2013, HEP A QUEENSL HLTH G; Sagliocca L, 1999, LANCET, V353, P1136, DOI 10.1016/S0140-6736(98)08139-2; SHOUVAL D, 1993, J HEPATOL, V18, pS32, DOI 10.1016/S0168-8278(05)80375-7; SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M; Sonder GJB, 2004, AM J PUBLIC HEALTH, V94, P1620, DOI 10.2105/AJPH.94.9.1620; STOKES J, 1945, JAMA-J AM MED ASSOC, V127, P144, DOI 10.1001/jama.1945.02860030016004; Taliani G, 2003, VACCINE, V21, P2234, DOI 10.1016/S0264-410X(03)00138-5; Thomas LM, 2009, GUIDANCE PREVENTION; Tjon GMS, 2005, J MED VIROL, V77, P360, DOI 10.1002/jmv.20464; Tjon GMS, 2006, J MED VIROL, V78, P1398, DOI 10.1002/jmv.20711; Van Herck K, 2011, J MED VIROL, V83, P1885, DOI 10.1002/jmv.22200; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Whelan J, 2013, VACCINE, V31, P1806, DOI 10.1016/j.vaccine.2013.01.053	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78914	10.1371/journal.pone.0078914	http://dx.doi.org/10.1371/journal.pone.0078914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147144	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200102
J	Felici, R; Lapucci, A; Ramazzotti, M; Chiarugi, A				Felici, Roberta; Lapucci, Andrea; Ramazzotti, Matteo; Chiarugi, Alberto			Insight into Molecular and Functional Properties of NMNAT3 Reveals New Hints of NAD Homeostasis within Human Mitochondria	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; OPEN READING FRAMES; POLY(ADP-RIBOSE) POLYMERASE-1; SUBCELLULAR COMPARTMENTATION; ADENINE-DINUCLEOTIDES; NONCODING RNAS; DNA-REPAIR; METABOLISM; CELLS; DISEASE	Among the enzymes involved in NAD homeostasis, nicotinamide mononucleotide adenylyltransferases (NMNAT1-3) are central to intracellular NAD formation. Although NMNAT3 is postulated to be a mitochondrial enzyme contributing to NAD-dependent organelle functioning, information on endogenous proteins is lacking. We report that in human cells a single gene nmnat3 localized on chromosome 3 codes for two mRNA splice variants NMNATv1 and FKSG76, whereas the previously reported NMNAT3v2 transcript is not present. However, NMNAT3v1 and FKSG76 proteins are not detectable, consistent with the finding that an upstream ORF in their mRNAs negatively regulates translation. NMNAT3v1 transfection demonstrates that the protein is cytosolic and inactive, whereas FKSG76 is mitochondrial but operates NAD cleavage rather than synthesis. In keeping with the lack of NMNAT3, we show that extracellular NAD, but not its metabolic precursors, sustains mitochondrial NAD pool in an ATP-independent manner. Data of the present study modify the scenario of the origin of mitochondrial NAD by showing that, in human cells, NMNAT3 is absent in mitochondria, and, akin to plants and yeast, cytosolic NAD maintains the mitochondrial NAD pool.	[Felici, Roberta; Lapucci, Andrea; Ramazzotti, Matteo; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence	Felici, R (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	roberta.felici@unifi.it	Ramazzotti, Matteo/J-4866-2012; Lapucci, Andrea/AAA-6645-2019	Ramazzotti, Matteo/0000-0002-6862-9409; LAPUCCI, Andrea/0000-0001-9613-7164	Regione Toscana Progetto Salute; Regione Toscana; Fondazione Giuseppe Tomasello ONLUS; Italian Federation for Research on Multiple Sclerosis (FISM)	Regione Toscana Progetto Salute(Regione Toscana); Regione Toscana(Regione Toscana); Fondazione Giuseppe Tomasello ONLUS; Italian Federation for Research on Multiple Sclerosis (FISM)	This work was supported by Regione Toscana Progetto Salute 2009 and Regione Toscana 2012, Fondazione Giuseppe Tomasello ONLUS, Italian Federation for Research on Multiple Sclerosis (FISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chiarugi A, 2002, MOL BRAIN RES, V109, P179, DOI 10.1016/S0169-328X(02)00558-2; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; FORMENTINI L, 2008, BR J PHARM; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rustin P, 1997, MOL CELL BIOCHEM, V174, P115, DOI 10.1023/A:1006890525928; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	36	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76938	10.1371/journal.pone.0076938	http://dx.doi.org/10.1371/journal.pone.0076938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155910	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300044
J	Greco, A; Ragucci, M; Coda, ARD; Rosa, A; Gargiulo, S; Liuzzi, R; Gramanzini, M; Albanese, S; Pappata, S; Mancini, M; Brunetti, A; Salvatore, M				Greco, Adelaide; Ragucci, Monica; Coda, Anna Rita Daniela; Rosa, Alessandro; Gargiulo, Sara; Liuzzi, Raffaele; Gramanzini, Matteo; Albanese, Sandra; Pappata, Sabina; Mancini, Marcello; Brunetti, Arturo; Salvatore, Marco			High Frequency Ultrasound for In Vivo Pregnancy Diagnosis and Staging of Placental and Fetal Development in Mice	PLOS ONE			English	Article							GROWTH; TOOLS	Background: Ultrasound is a valuable non-invasive tool used in obstetrics and gynecology to monitor the growth and well being of the human fetus. The laboratory mouse has recently emerged as an appropriate model for fetal and perinatal studies because morphogenetic processes in mice exhibit adequate homology to those in humans, and genetic manipulations are relatively simple to perform in mice. High-frequency ultrasound (HFUS) has recently become available for small animal preclinical imaging and can be used to study pregnancy and development in the mouse. The objective of the current study was to assess the main applications of HFUS in the evaluation of fetal growth and placental function and to better understand human congenital diseases. Methodology/Principal Findings: On each gestational day, at least 5 dams were monitored with HFUS; a total of similar to 200 embryos were examined. Because it is not possible to measure each variable for the entire duration of the pregnancy, the parameters were divided into three groups as a function of the time at which they were measured. Univariate analysis of the relationship between each measurement and the embryonic day was performed using Spearman's rank correlation (Rs). Continuous linear regression was adopted for multivariate analysis of significant parameters. All statistical tests were two-sided, and a p value of 0.05 was considered statistically significant. Conclusions/Significance: The study describes the main applications of HFUS to assess changes in phenotypic parameters in the developing CD1 mouse embryo and fetus during pregnancy and to evaluating physiological fetal and placental growth and the development of principal organs such as the heart, kidney, liver, brain and eyes in the embryonic mouse. A database of normal structural and functional parameters of mouse development will provide a useful tool for the better understanding of morphogenetic and cardiovascular anomalies in transgenic and mutant mouse models.	[Greco, Adelaide; Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo; Salvatore, Marco] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy; [Greco, Adelaide; Ragucci, Monica; Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo] SDN, IRCCS Fdn, Naples, Italy; [Coda, Anna Rita Daniela; Rosa, Alessandro; Gargiulo, Sara; Liuzzi, Raffaele; Gramanzini, Matteo; Albanese, Sandra; Pappata, Sabina; Mancini, Marcello; Brunetti, Arturo] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo] Scarl, Naples, Italy	University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Greco, A (corresponding author), Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy.	adegreco@unina.it	Liuzzi, Raffaele/AIC-0886-2022; Greco, Adelaide/C-7679-2018; Brunetti, Arturo/AAE-5261-2019; Salvatore, Marco/K-8083-2016; Albanese, Sandra/Q-3827-2018	Liuzzi, Raffaele/0000-0002-2350-6691; Greco, Adelaide/0000-0001-6841-1963; Brunetti, Arturo/0000-0001-7057-3494; Salvatore, Marco/0000-0001-9734-7702; Albanese, Sandra/0000-0002-7112-273X				Brown SD, 2006, COMPARATIVE MED, V56, P262; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Carter AM, 2006, PLACENTA, V21, P41; Dickinson H, 2008, REPROD BIOL, V8, P229, DOI 10.1016/S1642-431X(12)60014-X; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Foster FS, 2000, ULTRASOUND MED BIOL, V26, P1, DOI 10.1016/S0301-5629(99)00096-4; Foster FS, 2003, INVEST OPHTH VIS SCI, V44, P2361, DOI 10.1167/iovs.02-0911; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kulandavelu S, 2006, ILAR J, V47, P103, DOI 10.1093/ilar.47.2.103; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; MAZZE RI, 1985, TERATOLOGY, V32, P339, DOI 10.1002/tera.1420320303; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Mullis PE, 2008, BEST PRACT RES CL EN, V22, P173, DOI 10.1016/j.beem.2007.07.010; Pallares P, 2008, THERIOGENOLOGY, V70, P44, DOI 10.1016/j.theriogenology.2008.02.012; Phoon CKL, 2006, PEDIATR RES, V60, P14, DOI 10.1203/01.pdr.0000219441.28206.79; Russo M, 2007, VET REC, V160, P446, DOI 10.1136/vr.160.13.446; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Spurney CF, 2004, J AM SOC ECHOCARDIOG, V17, P893, DOI 10.1016/j.echo.2004.04.028; Srinivasan S, 1998, CIRCULATION, V98, P912, DOI 10.1161/01.CIR.98.9.912; Turnbull DH, 1999, COMPUT MED IMAG GRAP, V23, P25, DOI 10.1016/S0895-6111(98)00060-3; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Zhao H, 2008, BIOL REPROD, V78, P744, DOI 10.1095/biolreprod.107.064899	24	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77205	10.1371/journal.pone.0077205	http://dx.doi.org/10.1371/journal.pone.0077205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155928	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300062
J	Janusz, P; Kotwicki, T; Andrusiewicz, M; Kotwicka, M				Janusz, Piotr; Kotwicki, Tomasz; Andrusiewicz, Miroslaw; Kotwicka, Malgorzata			XbaI and PvuII Polymorphisms of Estrogen Receptor 1 Gene in Females with Idiopathic Scoliosis: No Association with Occurrence or Clinical Form	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ALPHA-GENE; LINKAGE DISEQUILIBRIUM; NATURAL-HISTORY; GROWTH; WOMEN; RISK; ESR1	Introduction: XbaI single nucleotide polymorphism (SNP) (A/G rs934099) in estrogen receptor 1 gene (ESR1) was described to be associated with curve severity in Japanese idiopathic scoliosis (IS) patients and in Chinese patients with both curve severity and predisposition to IS. PvuII SNP (C/T rs2234693) of ESR1 was described to be associated with the occurrence of IS in the Chinese population; however, two replication studies did not confirm the findings. The ESR1 SNPs have never been studied in Caucasian IS patients. Methods: Case-control study. 287 females with IS underwent clinical, radiological and genetic examinations. The patients were divided into three groups according to curve progression velocity: non-progressive IS, slowly progressive IS (progression <1 degrees per month), and rapidly progressive IS (progression >= 1 degrees per month). The radiological maximum Cobb angle was measured and surgery rate established. A control group consisted of 182 healthy females. Results: All results followed Hardy-Weinberg equilibrium. In the case-control study, genotype frequency in the patients did not differ for the XbaI (AA = 33.5%, AG = 49.1%, GG = 17.4%), nor for the PvuII (TT = 26.8%, TC = 50.2%, CC = 23.0%) comparing to controls (AA = 33.5%, AG = 50.5%, GG = 15.9%) and (TT = 23.1%, TC = 51.1%, CC = 25.8%), respectively, p = 0.3685, p = 0.6046. The haplotype frequency for the patients (AT = 47.1%, GC = 39.2%, AC = 8.9%, GT = 2.8%) did not differ from the controls (AT = 44.8%, GC = 37.4%, AC = 14.0%, GT = 3.8%), p = 0.0645. No difference was found either in XbaI (p = 0.8671) or PvuII (p = 0.3601) allele distribution between the patients and the controls. In the case study, there was no significant difference in genotype frequency for the non-progressive, slowly progressive, and rapidly progressive scoliosis. No difference was found in genotype or haplotype distribution for the mean maximum Cobb angle or the surgery rate. Conclusions: No association was found between ESR1 XbaI or ESR1 PvuII SNP and idiopathic scoliosis in Caucasian females. None of the previously reported associations could be confirmed, regarding curve severity, progression or operation rate.	[Janusz, Piotr; Kotwicki, Tomasz] Univ Med Sci, Dept Pediat Orthoped & Traumatol, Spine Disorders Unit, Poznan, Poland; [Andrusiewicz, Miroslaw; Kotwicka, Malgorzata] Univ Med Sci, Dept Cell Biol, Poznan, Poland		Janusz, P (corresponding author), Univ Med Sci, Dept Pediat Orthoped & Traumatol, Spine Disorders Unit, Poznan, Poland.	mdpjanusz@gmail.com	Andrusiewicz, Mirosław/N-3449-2017; Andrusiewicz, Mirosław/ABG-4949-2021	Andrusiewicz, Mirosław/0000-0002-8781-3447; Andrusiewicz, Mirosław/0000-0002-8781-3447; Janusz, Piotr/0000-0001-5702-4933	National Research Centre [N N403 584038]	National Research Centre(National Research Centre (NRC))	This study was supported by the National Research Centre grant N N403 584038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Dimeglio A, 2011, J PEDIATR ORTHOPED, V31, pS28, DOI 10.1097/BPO.0b013e318202c25d; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gorman KF, 2012, EUR SPINE J, V21, P1905, DOI 10.1007/s00586-012-2389-6; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; HILL SM, 1989, CANCER RES, V49, P145; Ignaszak-Szczepaniak M, 2011, ACTA BIOCHIM POL, V58, P101; Inoue M, 2002, SPINE, V27, P2357, DOI 10.1097/00007632-200211010-00009; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; Kobayashi S, 1996, J BONE MINER RES, V11, P306; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kotwicki T, 2013, ADOLESC HEALTH MED T, V4, P59, DOI 10.2147/AHMT.S32088; Leboeuf D, 2009, TRENDS ENDOCRIN MET, V20, P147, DOI 10.1016/j.tem.2008.12.004; Letellier K, 2008, J PINEAL RES, V45, P383, DOI 10.1111/j.1600-079X.2008.00603.x; Li XF, 2008, EUR SPINE J, V17, P1431, DOI 10.1007/s00586-008-0757-z; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Molvarec A, 2007, CLIN CHIM ACTA, V382, P100, DOI 10.1016/j.cca.2007.04.003; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; Patel MS, 2000, J BONE MINER RES, V15, P2231, DOI 10.1359/jbmr.2000.15.11.2231; PENSLER JM, 1990, J BONE MINER RES, V5, P797; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Roszkowska-Gancarz M, 2010, CLIN CHIM ACTA, V411, P1883, DOI 10.1016/j.cca.2010.06.028; Stavrou I, 2002, HUM REPROD, V17, P1101, DOI 10.1093/humrep/17.4.1101; STOKES IAF, 1994, SPINE, V19, P236, DOI 10.1097/00007632-199401001-00020; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; Xu LL, 2011, EUR SPINE J, V20, P1757, DOI 10.1007/s00586-011-1874-7; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043163; Yim APY, 2012, SPINE, V37, pE1148, DOI 10.1097/BRS.0b013e31825c036d; Zhao Dong, 2009, Orthop Surg, V1, P222, DOI 10.1111/j.1757-7861.2009.00038.x	36	26	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76806	10.1371/journal.pone.0076806	http://dx.doi.org/10.1371/journal.pone.0076806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155906	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300040
J	Montero-Melendez, T; Llor, X; Garcia-Planella, E; Perretti, M; Suarez, A				Montero-Melendez, Trinidad; Llor, Xavier; Garcia-Planella, Esther; Perretti, Mauro; Suarez, Antonio			Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling	PLOS ONE			English	Article							MICROARRAY DATA; CROHNS-DISEASE; SIGNATURE; CLASSIFICATION; MANAGEMENT; PROGNOSIS; SURVIVAL; CANCER	Background: Improvement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD). This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications. The low sensitivity and specificity of current markers burden their general use in the clinical practice. New biomarkers with accurate predictive ability are needed to achieve a personalized approach that take the inter-individual differences into consideration. Methods: We performed a high throughput approach using microarray gene expression profiling of colon pinch biopsies from IBD patients to identify predictive transcriptional signatures associated with intestinal inflammation, differential diagnosis (Crohn's disease or ulcerative colitis), response to glucocorticoids (resistance and dependence) or prognosis (need for surgery). Class prediction was performed with self-validating Prophet software package. Results: Transcriptional profiling divided patients in two subgroups that associated with degree of inflammation. Class predictors were identified with predictive accuracy ranging from 67 to 100%. The expression accuracy was confirmed by real time-PCR quantification. Functional analysis of the predictor genes showed that they play a role in immune responses to bacteria (PTN, OLFM4 and LILRA2), autophagy and endocytocis processes (ATG16L1, DNAJC6, VPS26B, RABGEF1, ITSN1 and TMEM127) and glucocorticoid receptor degradation (STS and MMD2). Conclusions: We conclude that using analytical algorithms for class prediction discovery can be useful to uncover gene expression profiles and identify classifier genes with potential stratification utility of IBD patients, a major step towards personalized therapy.	[Montero-Melendez, Trinidad; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Llor, Xavier] Univ Illinois, Dept Med, Digest Dis & Nutr Sect, Chicago, IL USA; [Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Garcia-Planella, Esther] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Suarez, Antonio] Univ Granada, Ctr Invest Biomed, Armilla, Spain	University of London; Queen Mary University London; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Granada	Suarez, A (corresponding author), Univ Granada, Ctr Invest Biomed, Armilla, Spain.	asuarez@ugr.es	Montero-Melendez, Trinidad/AAF-6345-2020; SUAREZ, ANTONIO/L-9221-2014	SUAREZ, ANTONIO/0000-0002-1006-7490; Montero-Melendez, Trinidad/0000-0002-3563-376X	Fundacio la Marato de TV3 [031531]; Spanish Health Ministry - Carlos III Institute [PI61550]	Fundacio la Marato de TV3; Spanish Health Ministry - Carlos III Institute	This study was funded by Fundacio la Marato de TV3 (031531) and Spanish Health Ministry - Carlos III Institute (PI61550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugerie L, 2012, WORLD J GASTROENTERO, V18, P3806, DOI 10.3748/wjg.v18.i29.3806; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Ford LT, 2010, J CLIN PATHOL, V63, P288, DOI 10.1136/jcp.2009.069252; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Lu HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033478; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Medina I, 2007, BIOINFORMATICS, V23, P390, DOI 10.1093/bioinformatics/btl602; Oz HS, 2009, DIGEST DIS SCI, V54, P2561, DOI 10.1007/s10620-008-0673-4; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Srivastava Maya D, 2004, J Med, V35, P233; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; Tedla N, 2011, TISSUE ANTIGENS, V77, P305, DOI 10.1111/j.1399-0039.2011.01633.x; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Limbergen J, 2011, GASTROENTEROLOGY, V141, P1566, DOI 10.1053/j.gastro.2011.09.018	24	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76235	10.1371/journal.pone.0076235	http://dx.doi.org/10.1371/journal.pone.0076235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155895	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300029
J	Ntsekhe, M; Matthews, K; Syed, FF; Deffur, A; Badri, M; Commerford, PJ; Gersh, BJ; Wilkinson, KA; Wilkinson, RJ; Mayosi, BM				Ntsekhe, Mpiko; Matthews, Kerryn; Syed, Faisal F.; Deffur, Armin; Badri, Motasim; Commerford, Patrick J.; Gersh, Bernard J.; Wilkinson, Katalin A.; Wilkinson, Robert J.; Mayosi, Bongani M.			Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTERFERON-GAMMA; TNF-ALPHA; TGF-BETA; FIBROSIS; MANAGEMENT; INFECTION; IL-10	Background: Effusive constrictive pericarditis (ECP) is visceral constriction in conjunction with compressive pericardial effusion. The prevalence of proven tuberculous ECP is unknown. Whilst ECP is distinguished from effusive disease on hemodynamic grounds, it is unknown whether effusive-constrictive physiology has a distinct cytokine profile. We conducted a prospective study of prevalence and cytokine profile of effusive-constrictive disease in patients with tuberculous pericardial effusion. Methods: From July 2006 through July 2009, the prevalence of ECP and serum and pericardial levels of inflammatory cytokines were determined in adults with tuberculous pericardial effusion. The diagnosis of ECP was made by combined pericardiocentesis and cardiac catheterization. Results: Of 91 patients evaluated, 68 had tuberculous pericarditis. The 36/68 patients (52.9%; 95% confidence interval [CI]: 41.2-65.4) with ECP were younger (29 versus 37 years, P=0.02), had a higher pre-pericardiocentesis right atrial pressure (17.0 versus 10.0 mmHg, P<0.0001), serum concentration of interleukin-10 (IL-10) (38.5 versus 0.2 pg/ml, P<0.001) and transforming growth factor-beta (121.5 versus 29.1 pg/ml, P=0.02), pericardial concentration of IL-10 (84.7 versus 20.4 pg/ml, P=0.006) and interferon-gamma (2,568.0 versus 906.6 pg/ml, P=0.03) than effusive non-constrictive cases. In multivariable regression analysis, right atrial pressure > 15 mmHg (odds ratio [OR] = 48, 95% CI: 8.7-265; P<0.0001) and IL-10 > 200 pg/ml (OR=10, 95% CI: 1.1, 93; P=0.04) were independently associated with ECP. Conclusion: Effusive-constrictive disease occurs in half of cases of tuberculous pericardial effusion, and is characterized by greater elevation in the pre-pericardiocentesis right atrial pressure and pericardial and serum IL-10 levels compared to patients with effusive non-constrictive tuberculous pericarditis.	[Ntsekhe, Mpiko; Syed, Faisal F.; Badri, Motasim; Commerford, Patrick J.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa; [Ntsekhe, Mpiko; Syed, Faisal F.; Badri, Motasim; Commerford, Patrick J.; Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Matthews, Kerryn; Deffur, Armin; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, Western Cape, South Africa; [Syed, Faisal F.; Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Med, Rochester, MN USA; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, London NW7 1AA, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Cape Town; University of Cape Town; University of Cape Town; Mayo Clinic; MRC National Institute for Medical Research; Imperial College London	Mayosi, BM (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa.	bongani.mayosi@uct.ac.za	Wilkinson, Katalin/AAF-6805-2020; ntsekhe, mpiko/AAI-8001-2021; Wilkinson, Katalin/AAQ-7713-2021; Badri, Motasim/E-1141-2013	ntsekhe, mpiko/0000-0002-0851-7675; Wilkinson, Katalin/0000-0002-9796-2040; Badri, Motasim/0000-0002-5268-6492; Matthews, Kerryn/0000-0003-2695-5895; Mayosi, Bongani/0000-0001-6641-8950; Wilkinson, Robert/0000-0002-2753-1800	Medical Research Council of South Africa; National Research Foundation of South Africa; Lily and Ernst Hausmann Trust; United Kingdom Wellcome Trust [083226, 084323, 088316]; United Kingdom Medical Research Council [U. 1175.02.002.00014.01]; Edith Sorrell Clinical Fellowship	Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation of South Africa(National Research Foundation - South Africa); Lily and Ernst Hausmann Trust; United Kingdom Wellcome Trust(Wellcome Trust); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edith Sorrell Clinical Fellowship	This work was supported by the Medical Research Council of South Africa; the National Research Foundation of South Africa; the Lily and Ernst Hausmann Trust; the United Kingdom Wellcome Trust (083226, 084323, 088316) and United Kingdom Medical Research Council (U. 1175.02.002.00014.01). MN was a recipient of the Edith Sorrell Clinical Fellowship from 2008 to 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Burgess LJ, 2002, INT J TUBERC LUNG D, V6, P439; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Fiorenza G, 2005, IMMUNOL LETT, V98, P45, DOI 10.1016/j.imlet.2004.09.008; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; HANCOCK EW, 1971, CIRCULATION, V43, P183, DOI 10.1161/01.CIR.43.2.183; Hancock EW, 2004, NEW ENGL J MED, V350, P435, DOI 10.1056/NEJMp038199; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Jobsis PD, 2007, AM J PHYSIOL-HEART C, V293, pH3379, DOI 10.1152/ajpheart.00967.2007; Koksal D, 2006, TUBERK TORAK, V54, P17; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Matthews K, 2011, TUBERCULOSIS, V91, P587, DOI 10.1016/j.tube.2011.06.009; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746; Ntsekhe M, 2012, CARDIOVASC J AFR, V23, P281, DOI 10.5830/CVJA-2011-072; Ntsekhe M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002253; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reuter H, 2007, Cardiovasc J S Afr, V18, P20; Reuter H, 2005, TUBERCULOSIS EDINB, V86; Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630; Sagrista-Sauleda S, 2004, HEART, V90, P257, DOI 10.1136/hrt.2003.024828; Salami MA, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-066; Sasse SA, 2003, AM J RESP CRIT CARE, V168, P700, DOI 10.1164/rccm.2202043; Seiscento M, 2007, RESPIROLOGY, V12, P660, DOI 10.1111/j.1440-1843.2007.01135.x; Shabetai R, 2004, HEART, V90, P255, DOI 10.1136/hrt.2003.024810; Syed FF, 2007, PROG CARDIOVASC DIS, V50, P218, DOI 10.1016/j.pcad.2007.03.002; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	29	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77532	10.1371/journal.pone.0077532	http://dx.doi.org/10.1371/journal.pone.0077532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155965	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300099
J	Tamamura, Y; Tanaka, K; Akiba, M; Kanno, T; Hatama, S; Ishihara, R; Uchida, I				Tamamura, Yukino; Tanaka, Kiyoshi; Akiba, Masato; Kanno, Toru; Hatama, Shinichi; Ishihara, Ryoko; Uchida, Ikuo			Complete Nucleotide Sequences of Virulence-Resistance Plasmids Carried by Emerging Multidrug-Resistant Salmonella enterica Serovar Typhimurium Isolated from Cattle in Hokkaido, Japan	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; DT104 INFECTIONS; GENOMIC ISLAND; UNITED-STATES; DETERMINANTS; INTEGRONS; HUMANS; STRAIN	In the present study, we have shown that virulence-resistance plasmids from emerging multidrug-resistant isolates of Salmonella enterica serovar Typhimurium were derived from a virulence-associated plasmid, essential for systematic invasiveness of S. Typhimurium in mice (pSLT), through acquisition of a large insert containing a resistance island flanked by IS1294 elements. A bla(CMY-2)-carrying plasmid from a cefotaxime-resistant isolate comprised a segment of Escherichia coli plasmid pAR060302 and the replication region (IncFIB) of a virulence-resistance plasmid. These results provide insights into the evolution of drug resistance in emerging clones of S. Typhimurium.	[Tamamura, Yukino; Tanaka, Kiyoshi; Hatama, Shinichi; Ishihara, Ryoko; Uchida, Ikuo] Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan; [Akiba, Masato] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Kanno, Toru] Natl Inst Anim Hlth, Exot Dis Res Div, Kodaira, Tokyo, Japan; [Kanno, Toru; Uchida, Ikuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Uchida, I (corresponding author), Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan.	ikuouchi@affrc.go.jp						Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Besser TE, 2000, EPIDEMIOL INFECT, V124, P193, DOI 10.1017/S0950268899003283; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Brown HJ, 1996, J BACTERIOL, V178, P4429, DOI 10.1128/jb.178.15.4429-4437.1996; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Han J, 2012, FOOD RES INT, V45, P931, DOI 10.1016/j.foodres.2011.04.016; Herrero A, 2008, ANTIMICROB AGENTS CH, V52, P4514, DOI 10.1128/AAC.00563-08; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Ng LK, 1999, ANTIMICROB AGENTS CH, V43, P3018, DOI 10.1128/AAC.43.12.3018; Rodicio MR, 2011, REV MED MICROBIOL, V22, P55, DOI 10.1097/MRM.0b013e328346d87d; Rotger R, 1999, Int Microbiol, V2, P177; Sandvang D, 1998, FEMS MICROBIOL LETT, V160, P37, DOI 10.1016/S0378-1097(98)00006-8; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Sugawara M, 2011, J VET MED SCI; Tamamura Y, 2011, APPL ENVIRON MICROB, V77, P1739, DOI 10.1128/AEM.01910-10; Tavakoli N, 2000, PLASMID, V44, P66, DOI 10.1006/plas.1999.1460; THRELFALL EJ, 1994, VET REC, V134, P577, DOI 10.1136/vr.134.22.577; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347	22	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77644	10.1371/journal.pone.0077644	http://dx.doi.org/10.1371/journal.pone.0077644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155970	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300104
J	van Overbeek, EC; Staals, J; van Oostenbrugge, RJ				van Overbeek, Ellen C.; Staals, Julie; van Oostenbrugge, Robert J.			Vitamin B12 and Progression of White Matter Lesions. A 2-Year Follow-Up Study in First-Ever Lacunar Stroke Patients	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HOMOCYSTEINE; MRI; DISEASE	In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation.	[van Overbeek, Ellen C.; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	van Overbeek, EC (corresponding author), Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands.	e.overbeek@mumc.nl						BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Cavalieri M, 2012, STROKE, V43, P3266, DOI 10.1161/STROKEAHA.112.665703; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gianazza E, 2003, BIOCHEM J, V374, P239, DOI 10.1042/BJ20030059; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Mayhan WG, 2002, BRAIN RES, V927, P144, DOI 10.1016/S0006-8993(01)03348-0; Pieters B, 2009, STROKE, V40, P1623, DOI 10.1161/STROKEAHA.108.523431; Poggesi A, 2013, J NEUROL, V260, P1014, DOI 10.1007/s00415-012-6748-3; Prins ND, 2004, NEUROLOGY, V62, P1533, DOI 10.1212/01.WNL.0000123264.40498.B6; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Scalabrino G, 2005, EXP NEUROL, V192, P463, DOI 10.1016/j.expneurol.2004.12.020; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Spence JD, 2006, STROKE, V37, P2430, DOI 10.1161/01.STR.0000236633.40160.ee; Spence JD, 2011, JAMA-J AM MED ASSOC, V306, P2610, DOI 10.1001/jama.2011.1834; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78100	10.1371/journal.pone.0078100	http://dx.doi.org/10.1371/journal.pone.0078100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155983	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300117
J	Zhang, R; Rapin, N; Ying, ZX; Shklanka, E; Bodnarchuk, TW; Verge, VMK; Misra, V				Zhang, Rui; Rapin, Noreen; Ying, Zhengxin; Shklanka, Erika; Bodnarchuk, Timothy W.; Verge, Valerie M. K.; Misra, Vikram			Zhangfei/CREB-ZF - A Potential Regulator of the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MEDULLOBLASTOMA CELLS; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; ACTIVATOR PXBP1(S); MESSENGER-RNA; ER STRESS; DEGRADATION; PROTEASOME; INTERACTS	Cells respond to perturbations in the microenvironment of the endoplasmic reticulum (ER), and to the overloading of its capacity to process secretory and membrane-associate proteins, by activating the Unfolded Protein Response (UPR). Genes that mediate the UPR are regulated by three basic leucine-zipper (bLZip) motif-containing transcription factors - Xbp1s, ATF4 and ATF6. A failure of the UPR to achieve homeostasis and its continued stimulation leads to apoptosis. Mechanisms must therefore exist to turn off the UPR if it successfully restores normalcy. The bLZip protein Zhangfei/CREBZF/SMILE is known to suppress the ability of several, seemingly structurally unrelated, transcription factors. These targets include Luman/CREB3 and CREBH, ER-resident bLZip proteins known to activate the UPR in some cell types. Here we show that Zhangfei had a suppressive effect on most UPR genes activated by the calcium ionophore thapsigargin. This effect was at least partially due to the interaction of Zhangfei with Xbp1s. The leucine zipper of Zhangfei was required for this interaction, which led to the subsequent proteasomal degradation of Xbp1s. Zhangfei suppressed the ability of Xbp1s to activate transcription from a promoter containing unfolded protein response elements and significantly reduced the ability to Xbp1s to activate the UPR as measured by RNA and protein levels of UPR-related genes. Finally, specific suppression of endogenous Zhangfei in thapsigargin-treated primary rat sensory neurons with siRNA directed to Zhangfei transcripts, led to a significant increase in transcripts and proteins of UPR genes, suggesting a potential role for Zhangfei in modulating the UPR.	[Zhang, Rui; Rapin, Noreen; Shklanka, Erika; Bodnarchuk, Timothy W.; Misra, Vikram] Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada; [Rapin, Noreen; Verge, Valerie M. K.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N 0W0, Canada; [Rapin, Noreen; Verge, Valerie M. K.] Univ Saskatchewan, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Misra, V (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada.	Vikram.misra@usask.ca	Misra, Vikram/AAC-4266-2020; Ying, Zhengxin/A-8953-2011	Misra, Vikram/0000-0001-6818-7156; 	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research [MOP74747]; Government of China (China Scholarship Council) [RZ-2010635007, ZY-20106030170]; University of Saskatchewan College of Graduate Studies	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of China (China Scholarship Council); University of Saskatchewan College of Graduate Studies	This study was supported by a Discovery grant to VM from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) of Canada and a Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) grant to VMKV (MOP74747). RZ and ZY were supported by scholarships from the Government of China (China Scholarship Council, RZ-2010635007, ZY-20106030170) and the University of Saskatchewan College of Graduate Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bergeron T, 2012, VET COMP ONCOL; Bodnarchuk TW, 2012, J NEURO-ONCOL, V109, P485, DOI 10.1007/s11060-012-0927-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardin E, 2007, FEBS J, V274, P5865, DOI 10.1111/j.1742-4658.2007.06110.x; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Lee JH, 2012, MOL CELL BIOCHEM, V368, P147, DOI 10.1007/s11010-012-1353-4; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Lopez-Mateo I, 2012, CELL CYCLE, V11, P3887, DOI 10.4161/cc.22133; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Misra V, 2005, J BIOL CHEM, V280, P15257, DOI 10.1074/jbc.M500728200; Mukai R, 2011, BIOCHEM BIOPH RES CO, V409, P328, DOI 10.1016/j.bbrc.2011.05.014; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ohshima T, 2010, J CELL BIOCHEM, V111, P187, DOI 10.1002/jcb.22687; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; TAMURA K, 1989, CANCER RES, V49, P5380; Valderrama X, 2009, J NEURO-ONCOL, V91, P7, DOI 10.1007/s11060-008-9682-6; Valderrama X, 2008, J NEUROVIROL, V14, P425, DOI 10.1080/13550280802275904; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner M, 2011, CURR OPIN CLIN NUTR, V14, P367, DOI 10.1097/MCO.0b013e32834778d4; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	45	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77256	10.1371/journal.pone.0077256	http://dx.doi.org/10.1371/journal.pone.0077256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155933	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300067
J	Glorioso, N; Herrera, VL; Didishvili, T; Ortu, MF; Zaninello, R; Fresu, G; Argiolas, G; Troffa, C; Ruiz-Opazo, N				Glorioso, Nicola; Herrera, Victoria L.; Didishvili, Tamara; Ortu, Maria F.; Zaninello, Roberta; Fresu, Giovanni; Argiolas, Guiseppe; Troffa, Chiara; Ruiz-Opazo, Nelson			Sex-Specific Effects of NLRP6/AVR and ADM Loci on Susceptibility to Essential Hypertension in a Sardinian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; SALT-SENSITIVE HYPERTENSION; BLOOD-PRESSURE; ADRENOMEDULLIN GENE; RAT MODEL; VARIANTS; DISEASE; MICE	Coronary artery disease, heart failure, fatal arrhythmias, stroke, and renal disease are the most common causes of mortality for humans, and essential hypertension remains a major risk factor. Elucidation of susceptibility loci for essential hypertension has been difficult because of its complex, multifactorial nature involving genetic, environmental, and sex-and age-dependent nature. We investigated whether the 11p15.5 region syntenic to rat chromosome 1 region containing multiple blood pressure quantitative trait loci (QTL) detected in Dahl rat intercrosses harbors polymorphisms that contribute to susceptibility/resistance to essential hypertension in a Sardinian population. Initial testing performed using microsatellite markers spanning 18 Mb of 11p15.5 detected a strong association between D11S1318 (at 2.1 Mb, P = 0.004) and D11S1346 (at 10.6 Mb, P = 0.00000004), suggesting that loci in close proximity to these markers may contribute to susceptibility in our Sardinian cohort. NLR family, pyrin domain containing 6/angiotensin-vasopressin receptor (NLRP6/AVR), and adrenomedullin (ADM) are in close proximity to D11S1318 and D11S1346, respectively; thus we tested single nucleotide polymorphisms (SNPs) within NLRP6/AVR and ADM for their association with hypertension in our Sardinian cohort. Upon sex stratification, we detected one NLRP6/AVR SNP associated with decreased susceptibility to hypertension in males (rs7948797G, P = 0.029; OR = 0.73 [0.57-0.94]). For ADM, sex-specific analysis showed a significant association between rs4444073C, with increased susceptibility to essential hypertension only in the male population (P = 0.006; OR = 1.44 [1.13-1.84]). Our results revealed an association between NLRP6/AVR and ADM loci with male essential hypertension, suggesting the existence of sex-specific NLRP6/AVR and ADM variants affecting male susceptibility to essential hypertension.	[Glorioso, Nicola; Ortu, Maria F.; Zaninello, Roberta; Fresu, Giovanni; Argiolas, Guiseppe; Troffa, Chiara] AUO Univ Sassari, Hypertens & Related Dis Ctr, Sassari, Sardinia, Italy; [Herrera, Victoria L.; Didishvili, Tamara; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of Sassari; Boston University	Ruiz-Opazo, N (corresponding author), AUO Univ Sassari, Hypertens & Related Dis Ctr, Sassari, Sardinia, Italy.	nruizo@bu.edu			NIH [HL098939]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL098939 to NR-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao YN, 2003, HYPERTENSION, V42, P369, DOI 10.1161/01.HYP.0000088560.10830.37; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chao J, 2002, DRUG NEWS PERSPECT, V15, P511, DOI 10.1358/dnp.2002.15.8.840072; Charchar FJ, 2008, J HUM HYPERTENS, V22, P821, DOI 10.1038/jhh.2008.67; Chen GJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S4; Chen SF, 2013, HYPERTENS RES, V36, P74, DOI 10.1038/hr.2012.132; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Glorioso N, 2001, HYPERTENSION, V38, P204, DOI 10.1161/01.HYP.38.2.204; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Herrera VLM, 2008, PHYSIOL GENOMICS, V34, P65, DOI 10.1152/physiolgenomics.00199.2007; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2011, PHYSIOL GENOMICS, V43, P32, DOI 10.1152/physiolgenomics.00154.2010; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; HERRERA VLM, 1990, SCIENCE, V249, P1023, DOI 10.1126/science.1975705; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kauwe JSK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S84; Kobayashi Y, 2005, HYPERTENS RES, V28, P229, DOI 10.1291/hypres.28.229; Levy D, 2007, CIRCULATION, V115, P3079, DOI 10.1161/CIRCULATIONAHA.106.652842; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nishikimi T, 2007, CURR MED CHEM, V14, P1689, DOI 10.2174/092986707780830943; Pedelty L, 2008, AM J MED, V121, pS23, DOI 10.1016/j.amjmed.2008.05.019; PIAZZA A, 1993, SCIENCE, V260, P9, DOI DOI 10.1126/SCIENCE.260.5104.9.PUBMED:17793514; Ruiz-Opazo N, 2002, MOL MED, V8, P24, DOI 10.1007/BF03402000; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Wang ZG, 2008, CLIN EXP HYPERTENS, V30, P598, DOI 10.1080/10641960802443068	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77562	10.1371/journal.pone.0077562	http://dx.doi.org/10.1371/journal.pone.0077562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147025	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400125
J	Pieperhoff, MS; Schmitt, M; Ferguson, DJP; Meissner, M				Pieperhoff, Manuela S.; Schmitt, Miriam; Ferguson, David J. P.; Meissner, Markus			The Role of Clathrin in Post-Golgi Trafficking in Toxoplasma gondii	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MEMBRANE; PROTEIN; BIOGENESIS; IDENTIFICATION; RECRUITMENT; PLASMODIUM; EXPRESSION; APICOPLAST; TRANSPORT	Apicomplexan parasites are single eukaryotic cells with a highly polarised secretory system that contains unique secretory organelles (micronemes and rhoptries) that are required for host cell invasion. In contrast, the role of the endosomal system is poorly understood in these parasites. With many typical endocytic factors missing, we speculated that endocytosis depends exclusively on a clathrin-mediated mechanism. Intriguingly, in Toxoplasma gondii we were only able to observe the endogenous clathrin heavy chain 1 (CHC1) at the Golgi, but not at the parasite surface. For the functional characterisation of Toxoplasma gondii CHC1 we generated parasite mutants conditionally expressing the dominant negative clathrin Hub fragment and demonstrate that CHC1 is essential for vesicle formation at the trans-Golgi network. Consequently, the functional ablation of CHC1 results in Golgi aberrations, a block in the biogenesis of the unique secretory microneme and rhoptry organelles, and of the pellicle. However, we found no morphological evidence for clathrin mediating endocytosis in these parasites and speculate that they remodelled their vesicular trafficking system to adapt to an intracellular lifestyle.	[Pieperhoff, Manuela S.; Meissner, Markus] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Schmitt, Miriam] German Canc Res Ctr, Heidelberg, Germany; [Ferguson, David J. P.] Univ Oxford, Nuffield Dept Clin Lab Med, Oxford, England	University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Pieperhoff, MS (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	manuela.pieperhoff@glasgow.ac.uk; markus.meissner@glasgow.ac.uk		Meissner, Markus/0000-0002-5341-5969; Ferguson, David/0000-0001-5045-819X	Wellcome Trust [087582/Z/08/Z, 085349]; EviMalAr (European Union, FP7)	Wellcome Trust(Wellcome TrustEuropean Commission); EviMalAr (European Union, FP7)	D.J.P. Ferguson is supported by an equipment grant from the Wellcome Trust. This work was funded by a Wellcome Trust Senior Fellowship (087582/Z/08/Z) and EviMalAr (European Union, FP7). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Allen ML, 1997, MOL BIOCHEM PARASIT, V88, P43, DOI 10.1016/S0166-6851(97)00069-8; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bennett EM, 2001, TRAFFIC, V2, P851, DOI 10.1034/j.1600-0854.2001.21114.x; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Botero-Kleiven S, 2001, EXP PARASITOL, V98, P134, DOI 10.1006/expr.2001.4624; Breinich MS, 2009, CURR BIOL, V19, P277, DOI 10.1016/j.cub.2009.01.039; Burgess J, 2011, MOL BIOL CELL, V22, P2094, DOI 10.1091/mbc.E11-01-0054; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Elde NC, 2005, PLOS GENET, V1, P514, DOI 10.1371/journal.pgen.0010052; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferguson DJP, 1998, METH MOL B, V80, P297; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gerald NJ, 2001, CELL MOTIL CYTOSKEL, V48, P213, DOI 10.1002/1097-0169(200103)48:3<213::AID-CM1010>3.0.CO;2-V; GROSS U, 1993, PARASITOL RES, V79, P191, DOI 10.1007/BF00931891; Harper JM, 2004, INT J PARASITOL, V34, P1047, DOI 10.1016/j.ijpara.2004.05.006; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Holzenspies JJ, 2010, REPRODUCTION, V140, P223, DOI 10.1530/REP-10-0045; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Lige B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051773; Lingelbach K, 1998, J CELL SCI, V111, P1467; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Nevin WD, 2009, PARASITOL INT, V58, P86, DOI 10.1016/j.parint.2008.12.002; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Niswonger ML, 1997, P NATL ACAD SCI USA, V94, P8575, DOI 10.1073/pnas.94.16.8575; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Pfluger SL, 2005, EUKARYOT CELL, V4, P432, DOI 10.1128/EC.4.2.432-442.2005; Radulescu AE, 2012, FASEB J, V26, P129, DOI 10.1096/fj.10-167684; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; SADAK A, 1988, MOL BIOCHEM PARASIT, V29, P203, DOI 10.1016/0166-6851(88)90075-8; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SCHWARTZ AL, 1990, ANNU REV IMMUNOL, V8, P195, DOI 10.1146/annurev.immunol.8.1.195; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Starnes GL, 2006, J BIOL CHEM, V281, P30745, DOI 10.1074/jbc.M606523200; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wang C, 2013, PLANT CELL, V25, P499, DOI 10.1105/tpc.112.108373	67	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77620	10.1371/journal.pone.0077620	http://dx.doi.org/10.1371/journal.pone.0077620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147036	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325819400130
J	Chitnis, MM; Lodhia, KA; Aleksic, T; Gao, S; Protheroe, AS; Macaulay, VM				Chitnis, M. M.; Lodhia, K. A.; Aleksic, T.; Gao, S.; Protheroe, A. S.; Macaulay, V. M.			IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination	ONCOGENE			English	Article						IGF-1R; radiosensitization; DNA repair; double-strand break; non-homologous end joining; homologous recombination	GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER CELLS; DNA-DAMAGE RESPONSE; DEPENDENT PROTEIN-KINASE; PTEN WILD-TYPE; MITOTIC CATASTROPHE; IONIZING-RADIATION; DOWN-REGULATION; TUMOR-CELLS; CYCLIN D1	Inhibition of type 1 insulin-like growth factor receptor (IGF-1R) enhances tumor cell sensitivity to ionizing radiation. It is not clear how this effect is mediated, nor whether this approach can be applied effectively in the clinic. We previously showed that IGF-1R depletion delays repair of radiation-induced DNA double-strand breaks (DSBs), unlikely to be explained entirely by reduction in homologous recombination (HR) repair. The current study tested the hypothesis that IGF-1R inhibition induces a repair defect that involves non-homologous end joining (NHEJ). IGF-1R inhibitor AZ12253801 blocked cell survival and radiosensitized IGF-1R-overexpressing murine fibroblasts but not isogenic IGF-1R-null cells, supporting specificity for IGF-1R. IGF-1R inhibition enhanced radiosensitivity in DU145, PC3 and 22Rv1 prostate cancer cells, comparable to effects of Ataxia Telangiectasia Mutated inhibition. AZ12253801-treated DU145 cells showed delayed resolution of gamma H2AX foci, apparent within 1 h of irradiation and persisting for 24 h. In contrast, IGF-1R inhibition did not influence radiosensitivity or gamma H2AX focus resolution in LNCaP-LN3 cells, suggesting that radiosensitization tracks with the ability of IGF-1R to influence DSB repair. To differentiate effects on repair from growth and cell-survival responses, we tested AZ12253801 in DU145 cells at sub-SF50 concentrations that had no early (<= 48 h) effects on cell cycle distribution or apoptosis induction. Irradiated cultures contained abnormal mitoses, and after 5 days IGF-1R-inhibited cells showed enhanced radiation-induced polyploidy and nuclear fragmentation, consistent with the consequences of entry into mitosis with incompletely repaired DNA. AZ12253801 radiosensitized DNA-dependent protein kinase (DNA-PK)-proficient but not DNA-PK-deficient glioblastoma cells, and did not radiosensitize DNA-PK-inhibited DU145 cells, suggesting that in the context of DSB repair, IGF-1R functions in the same pathway as DNA-PK. Finally, IGF-1R inhibition attenuated repair by both NHEJ and HR in HEK293 reporter assays. These data indicate that IGF-1R influences DSB repair by both major DSB repair pathways, findings that may inform clinical application of this approach.	[Chitnis, M. M.; Lodhia, K. A.; Aleksic, T.; Gao, S.; Macaulay, V. M.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Dept Oncol Labs, Oxford OX3 9DS, England; [Chitnis, M. M.; Protheroe, A. S.; Macaulay, V. M.] Churchill Hosp, Canc & Haematol Ctr, Dept Oncol, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Macaulay, VM (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Dept Oncol Labs, Oxford OX3 9DS, England.	valentine.macaulay@oncology.ox.ac.uk			NIHR Oxford Biomedical Research Centre; Molecular and Cellular Medicine Board of the MRC; Cancer Research UK Clinical Research Fellowship; Prostate Cancer UK; NIHR Research Capability Funding; Breast Cancer Campaign; Medical Research Council [G0601061] Funding Source: researchfish; Prostate Cancer UK [G2012-25] Funding Source: researchfish; Breast Cancer Campaign [2012NovPR046] Funding Source: researchfish; MRC [G0601061] Funding Source: UKRI	NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Molecular and Cellular Medicine Board of the MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Clinical Research Fellowship; Prostate Cancer UK; NIHR Research Capability Funding; Breast Cancer Campaign; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Prostate Cancer UK; Breast Cancer Campaign; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the NIHR Oxford Biomedical Research Centre, Molecular and Cellular Medicine Board of the MRC, Cancer Research UK Clinical Research Fellowship to MMC, Prostate Cancer UK support to KL and TA, NIHR Research Capability Funding to KL, Breast Cancer Campaign for support to SG and HEFCE Clinical Senior Lectureship to VMM. We are grateful to Elaine Kilgour and Elizabeth Anderson at AstraZeneca for providing AZ12253801; Walter Bodmer for LNCaP-LN3 cells; Renato Baserga for R+ and R- cells; Dr Anne Kiltie for M059J and M059K cells; Jeremy Stark and Wojciech Niedzwiedz for HEK293 EJ5-GFP/TST and HEK293 DR-GFP/TST cells; Olga Perestenko for primary renal cancer cells; and Peter McHugh and Tim Humphrey for comments on the manuscript.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; ALLALUNISTURNER MJ, 1995, RADIAT RES, V144, P288, DOI 10.2307/3578948; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bielen A, 2012, P NATL ACAD SCI USA, V109, pE1267, DOI 10.1073/pnas.1105034109; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Bowen C, 2002, J BIOL CHEM, V277, P44969, DOI 10.1074/jbc.M202000200; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dupont J, 2003, CELL CYCLE, V2, P270, DOI 10.4161/cc.2.4.408; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fabbri F, 2008, J CELL PHYSIOL, V217, P494, DOI 10.1002/jcp.21522; Ferte C, 2013, MOL CANCER THER, V12, P1213, DOI 10.1158/1535-7163.MCT-12-1067; Flanigan SA, 2010, CLIN CANCER RES, V16, P5436, DOI 10.1158/1078-0432.CCR-10-2054; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gonzalez-Vasconcellos I, 2013, CANCER RES, V73, P4247, DOI 10.1158/0008-5472.CAN-12-3117; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grzmil M, 2004, J PATHOL, V202, P50, DOI 10.1002/path.1492; Harrington KJ, 2011, BRIT J CANCER, V105, P628, DOI 10.1038/bjc.2011.240; Hellawell GO, 2002, CANCER RES, V62, P2942; Hinz JM, 2005, DNA REPAIR, V4, P782, DOI 10.1016/j.dnarep.2005.03.005; Isebaert SF, 2011, INT J RADIAT ONCOL, V81, P239, DOI 10.1016/j.ijrobp.2011.03.030; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Javle M.M., 2011, J CLIN ONCOL S, V29; Jeon JH, 2008, CANCER LETT, V272, P232, DOI 10.1016/j.canlet.2008.07.011; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V286, pG412, DOI 10.1152/ajpgi.00403.2003; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Lehmann BD, 2007, CELL CYCLE, V6, P595, DOI 10.4161/cc.6.5.3901; Liao YD, 2005, HUM PATHOL, V36, P1186, DOI 10.1016/j.humpath.2005.07.023; Litzenburger BC, 2011, CLIN CANCER RES, V17, P2314, DOI 10.1158/1078-0432.CCR-10-1903; Lloret M, 2009, INT J RADIAT ONCOL, V73, P976, DOI 10.1016/j.ijrobp.2008.11.013; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Macaulay VM, 2001, ONCOGENE, V20, P4029, DOI 10.1038/sj.onc.1204565; McConkey DJ, 1996, CANCER RES, V56, P5594; Molife LR, 2010, BRIT J CANCER, V103, P332, DOI 10.1038/sj.bjc.6605767; Mujoo K, 2005, PROSTATE, V62, P91, DOI 10.1002/pros.20114; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Reiss K, 2000, ONCOGENE, V19, P2687, DOI 10.1038/sj.onc.1203587; Riesterer O, 2011, INT J RADIAT ONCOL, V79, P1179, DOI 10.1016/j.ijrobp.2010.10.003; Roberts DJ, 2012, ENVIRON MOL MUTAGEN, V53, P297, DOI 10.1002/em.21684; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sarfstein R, 2012, J BIOL CHEM, V287, P2766, DOI 10.1074/jbc.M111.281782; Scott SL, 2003, CANCER RES, V63, P7190; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shaw PHS, 2011, BRIT J CANCER, V105, P649, DOI 10.1038/bjc.2011.291; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Solier S, 2011, CANCER RES, V71, P906, DOI 10.1158/0008-5472.CAN-10-3297; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Sprenger CC, 2002, ONCOGENE, V21, P140, DOI 10.1038/sj.onc.1205021; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Sroka IC, 2008, PROSTATE, V68, P463, DOI 10.1002/pros.20718; Steiner MS, 2000, CANCER GENE THER, V7, P360, DOI 10.1038/sj.cgt.7700151; Tezuka M, 2001, CLIN CANCER RES, V7, P3206; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; Turney BW, 2012, RADIOTHER ONCOL, V103, P402, DOI 10.1016/j.radonc.2012.03.009; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wouters B., 2009, CELL DEATH IRRADIATI; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	73	62	62	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5262	5273		10.1038/onc.2013.460	http://dx.doi.org/10.1038/onc.2013.460			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24186206	Green Accepted			2022-12-25	WOS:000345120400004
J	Amelio, I; Markert, EK; Rufini, A; Antonov, AV; Sayan, BS; Tucci, P; Agostini, M; Mineo, TC; Levine, AJ; Melino, G				Amelio, I.; Markert, E. K.; Rufini, A.; Antonov, A. V.; Sayan, B. S.; Tucci, P.; Agostini, M.; Mineo, T. C.; Levine, A. J.; Melino, G.			p73 regulates serine biosynthesis in cancer	ONCOGENE			English	Article						serine; glucose; cancer metabolism; p73; GLS-2; lung adenocarcinoma	PYRUVATE-KINASE M2; CELL-SURVIVAL; P53; METABOLISM; APOPTOSIS; MICE; INSTABILITY; DELTA-NP73; SENESCENCE; DELTANP73	Activation of serine biosynthesis supports growth and proliferation of cancer cells. Human cancers often exhibit overexpression of phosphoglycerate dehydrogenase (PHGDH), the metabolic enzyme that catalyses the reaction that diverts serine biosynthesis from the glycolytic pathway. By refueling serine biosynthetic pathways, cancer cells sustain their metabolic requirements, promoting macromolecule synthesis, anaplerotic flux and ATP. Serine biosynthesis intersects glutaminolysis and together with this pathway provides substrates for production of antioxidant GSH. In human lung adenocarcinomas we identified a correlation between serine biosynthetic pathway and p73 expression. Metabolic profiling of human cancer cell line revealed that TAp73 activates serine biosynthesis, resulting in increased intracellular levels of serine and glycine, associated to accumulation of glutamate, tricarboxylic acid (TCA) anaplerotic intermediates and GSH. However, at molecular level p73 does not directly regulate serine metabolic enzymes, but transcriptionally controls a key enzyme of glutaminolysis, glutaminase-2 (GLS-2). p73, through GLS-2, favors conversion of glutamine in glutamate, which in turn drives the serine biosynthetic pathway. Serine and glutamate can be then employed for GSH synthesis, thus the p73-dependent metabolic switch enables potential response against oxidative stress. In knockdown experiment, indeed, TAp73 depletion completely abrogates cancer cell proliferation capacity in serine/glycine-deprivation, supporting the role of p73 to help cancer cells under metabolic stress. These findings implicate p73 in regulation of cancer metabolism and suggest that TAp73 influences glutamine and serine metabolism, affecting GSH synthesis and determining cancer pathogenesis.	[Amelio, I.; Rufini, A.; Antonov, A. V.; Sayan, B. S.; Tucci, P.; Agostini, M.; Melino, G.] Univ Leicester, Toxicol Unit, Med Res Council, Leicester LE1 9HN, Leics, England; [Markert, E. K.; Levine, A. J.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Rufini, A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Antonov, A. V.] Technol Univ, Mol Pharmacol Lab, St Petersburg, Russia; [Mineo, T. C.] Univ Roma Tor Vergata, Div Thorac Surg, Rome, Italy; [Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; Institute for Advanced Study - USA; University of Leicester; University of Rome Tor Vergata; University of Rome Tor Vergata	Melino, G (corresponding author), Univ Leicester, Toxicol Unit, Med Res Council, Leicester LE1 9HN, Leics, England.	gm89@le.ac.uk	Amelio, Ivano/AAI-4686-2020; Agostini, Massimiliano/AAE-7971-2019; Agostini, Massimiliano/G-9579-2014	Agostini, Massimiliano/0000-0003-3124-2072; Agostini, Massimiliano/0000-0003-3124-2072; Sayan, Berna/0000-0003-2305-1970; TUCCI, PAOLA/0000-0002-9349-5203; Amelio, Ivano/0000-0002-9126-5391	Medical Research Council, United Kingdom; Ministry of Education and Science of the Russian Federation [11.G34.31.0069, 14.B37.21.1967]; MIUR, MinSan/IDI-IRCCS [RF73, RF57, ACC12]; AIRC [2011-IG11955]; AIRC 5xmille (MCO) [9979]; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); MIUR, MinSan/IDI-IRCCS(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); AIRC 5xmille (MCO)(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by the Medical Research Council, United Kingdom; MIUR, MinSan/IDI-IRCCS (RF73, RF57), ACC12, AIRC (2011-IG11955), AIRC 5xmille (MCO #9979) to GM Work was supported by Ministry of Education and Science of the Russian Federation (11.G34.31.0069) to GM & (14.B37.21.1967) to AAV.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Bantel H, 2010, CELL CYCLE, V9, P2710, DOI 10.4161/cc.9.14.12592; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chang JY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.36; Cho JH, 2012, CELL DEATH DIFFER, V19, P703, DOI 10.1038/cdd.2011.142; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Conforti F, 2013, ONCOGENE, V32, P4758, DOI 10.1038/onc.2012.497; Conforti F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.27; Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Haruki N, 2001, AM J PATHOL, V159, P1345, DOI 10.1016/S0002-9440(10)62521-7; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang BH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.180; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kibe R, 2012, CELL DEATH DIFFER, V19, P1139, DOI 10.1038/cdd.2011.203; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Malatesta M, 2013, ONCOGENE, V32, P4721, DOI 10.1038/onc.2012.463; Masse I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.62; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ravni A, 2010, CELL CYCLE, V9, P1523, DOI 10.4161/cc.9.8.11291; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	47	77	82	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					5039	5046		10.1038/onc.2013.456	http://dx.doi.org/10.1038/onc.2013.456			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24186203	Green Submitted			2022-12-25	WOS:000343768000008
J	Trautmann, M; Sievers, E; Aretz, S; Kindler, D; Michels, S; Friedrichs, N; Renner, M; Kirfel, J; Steiner, S; Huss, S; Koch, A; Penzel, R; Larsson, O; Kawai, A; Tanaka, S; Sonobe, H; Waha, A; Schirmacher, P; Mechtersheimer, G; Wardelmann, E; Buttner, R; Hartmann, W				Trautmann, M.; Sievers, E.; Aretz, S.; Kindler, D.; Michels, S.; Friedrichs, N.; Renner, M.; Kirfel, J.; Steiner, S.; Huss, S.; Koch, A.; Penzel, R.; Larsson, O.; Kawai, A.; Tanaka, S.; Sonobe, H.; Waha, A.; Schirmacher, P.; Mechtersheimer, G.; Wardelmann, E.; Buettner, R.; Hartmann, W.			SS18-SSX fusion protein-induced Wnt/beta-catenin signaling is a therapeutic target in synovial sarcoma	ONCOGENE			English	Article						Synovial sarcoma; SYT-SSX; beta-catenin; Wnt signaling pathway; PKF115-584; CGP049090; PKF118-310	SMALL-MOLECULE ANTAGONISTS; SOFT-TISSUE SARCOMA; CELLS IN-VITRO; BETA-CATENIN; GENE-EXPRESSION; BREAST-CANCER; COMPLEX; TRANSLOCATION; INHIBITORS; MUTATIONS	Synovial sarcoma is a high-grade soft tissue malignancy characterized by a specific reciprocal translocation t(X; 18), which leads to the fusion of the SS18 (SYT) gene to one of three SSX genes (SSX1, SSX2 or SSX4). The resulting chimeric SS18-SSX protein is suggested to act as an oncogenic transcriptional regulator. Despite multimodal therapeutic approaches, metastatic disease is often lethal and the development of novel targeted therapeutic strategies is required. Several expression-profiling studies identified distinct gene expression signatures, implying a consistent role of Wnt/beta-catenin signaling in synovial sarcoma tumorigenesis. Here we investigate the functional and therapeutic relevance of Wnt/beta-catenin pathway activation in vitro and in vivo. Immunohistochemical analyses of nuclear beta-catenin and Wnt downstream targets revealed activation of canonical Wnt signaling in a significant subset of 30 primary synovial sarcoma specimens. Functional aspects of Wnt signaling including dependence of Tcf/beta-catenin complex activity on the SS18-SSX fusion proteins were analyzed. Efficient SS18-SSX-dependent activation of the Tcf/beta-catenin transcriptional complex was confirmed by TOPflash reporter luciferase assays and immunoblotting. In five human synovial sarcoma cell lines, inhibition of the Tcf/beta-catenin protein-protein interaction significantly blocked the canonical Wnt/beta-catenin signaling cascade, accompanied by the effective downregulation of Wnt targets (AXIN2, CDC25A, c-MYC, DKK1, CyclinD1 and Survivin) and the specific suppression of cell viability associated with the induction of apoptosis. In SYO-1 synovial sarcoma xenografts, administration of small molecule Tcf/beta-catenin complex inhibitors significantly reduced tumor growth, associated with diminished AXIN2 protein levels. In summary, SS18-SSX-induced Wnt/beta-catenin signaling appears to be of crucial biological importance in synovial sarcoma tumorigenesis and progression, representing a potential molecular target for the development of novel therapeutic strategies.	[Trautmann, M.; Sievers, E.; Kindler, D.; Michels, S.; Friedrichs, N.; Huss, S.; Wardelmann, E.; Buettner, R.; Hartmann, W.] Univ Hosp Cologne, Dept Pathol, D-50937 Cologne, Germany; [Trautmann, M.; Kirfel, J.; Steiner, S.] Univ Hosp Bonn, Dept Pathol, Bonn, Germany; [Aretz, S.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Renner, M.; Penzel, R.; Schirmacher, P.; Mechtersheimer, G.] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany; [Koch, A.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Larsson, O.] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [Kawai, A.] Natl Canc Ctr, Div Orthopaed Surg, Tokyo, Japan; [Tanaka, S.] Hokkaido Univ, Grad Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido, Japan; [Sonobe, H.] Chungoku Cent Hosp, Dept Lab Med, Fukuyama, Hiroshima, Japan; [Waha, A.] Univ Hosp Bonn, Dept Neuropathol, Bonn, Germany	University of Cologne; University of Bonn; University of Bonn; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Karolinska Institutet; National Cancer Center - Japan; Hokkaido University; University of Bonn	Hartmann, W (corresponding author), Univ Hosp Cologne, Dept Pathol, Kerpener Str 62, D-50937 Cologne, Germany.	wolfgang.hartmann@uk-koeln.de	Trautmann, Marcel/B-4627-2015; Aretz, Stefan/C-1241-2008; Hartmann, Wolfgang/G-1893-2017; Tanaka, Shinya/D-3586-2011	Trautmann, Marcel/0000-0002-5842-1196; Aretz, Stefan/0000-0002-5228-1890; Hartmann, Wolfgang/0000-0002-7609-5021; 	Wilhelm Sander-Stiftung; Dr Eberhard und Hilde Rudiger Stiftung; Deutsche Krebshilfe (KoSar sarcoma competence network); BONFOR (Medical Faculty, University Hospital Bonn, Bonn); Fortune program (Medical Faculty, University of Cologne, Cologne)	Wilhelm Sander-Stiftung; Dr Eberhard und Hilde Rudiger Stiftung; Deutsche Krebshilfe (KoSar sarcoma competence network); BONFOR (Medical Faculty, University Hospital Bonn, Bonn); Fortune program (Medical Faculty, University of Cologne, Cologne)	PKF115-584, CGP049090 and PKF118-310 were generously provided by A Wood (Novartis Pharma AG, Basel, Switzerland). This study was supported by Wilhelm Sander-Stiftung, Dr Eberhard und Hilde Rudiger Stiftung, Deutsche Krebshilfe (KoSar sarcoma competence network), BONFOR (Medical Faculty, University Hospital Bonn, Bonn) and Fortune program (Medical Faculty, University of Cologne, Cologne).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Friedrichs N, 2006, DIAGN MOL PATHOL, V15, P83, DOI 10.1097/00019606-200606000-00004; Friedrichs N, 2008, J PATHOL, V216, P428, DOI 10.1002/path.2438; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2009, CANCER RES, V69, P3657, DOI 10.1158/0008-5472.CAN-08-4127; Hasegawa T, 2001, HUM PATHOL, V32, P257, DOI 10.1053/hupa.2001.22764; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Michels S, 2013, CANCER RES, V73, P2518, DOI 10.1158/0008-5472.CAN-12-3023; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2002, CANCER RES, V62, P5859; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Nguyen Anne, 2009, Sarcoma, V2009, P794901, DOI 10.1155/2009/794901; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; NOJIMA T, 1990, ACTA PATHOL JAPON, V40, P486; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Provost E, 2005, ONCOGENE, V24, P2667, DOI 10.1038/sj.onc.1208346; Romagnolo B, 1999, CANCER RES, V59, P3875; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Saito T, 2002, J PATHOL, V196, P445, DOI 10.1002/path.1066; Sato H, 2001, VIRCHOWS ARCH, V438, P23; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; SONOBE H, 1992, LAB INVEST, V67, P498; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P93, DOI 10.1016/0165-4608(86)90153-6; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Webb J.L., 1966, ENZYME METABOLIC INH; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Weiss SW, 2007, ENZINGER, DOI DOI 10.3109/02844319209035195; Zhang M, 2013, ACS MED CHEM LETT, V4, P306, DOI 10.1021/ml300367f	52	64	69	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					5006	5016		10.1038/onc.2013.443	http://dx.doi.org/10.1038/onc.2013.443			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24166495				2022-12-25	WOS:000343768000005
J	Griffin, MJ; Zhou, YM; Kang, SN; Zhang, XL; Mikkelsen, TS; Rosen, ED				Griffin, Michael J.; Zhou, Yiming; Kang, Sona; Zhang, Xiaolan; Mikkelsen, Tarjei S.; Rosen, Evan D.			Early B-cell Factor-1 (EBF1) Is a Key Regulator of Metabolic and Inflammatory Signaling Pathways in Mature Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Chromatin Immunoprecipitation (ChiP); Inflammation; Signal Transduction; Transcription; Developmental Factors; B Lymphocyte; EBF1; Insulin Signaling	GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; FINGER PROTEIN; CLONING; DIFFERENTIATION; IDENTIFICATION; ESTABLISHMENT; ACTIVATION; NETWORK	Background: EBF1 is critical for early adipogenesis, yet its targets/function in mature fat cells are unknown. Results: EBF1 binds to and/or regulates many core genes in metabolic and inflammatory signaling pathways, and loss of EBF1 results in impaired insulin and inflammatory signaling. Conclusion: EBF1 regulates signaling pathways in adipocytes. Significance: We have defined a major regulator of metabolism and signal transduction in adipose cells. EBF1 plays a crucial role in early adipogenesis; however, despite high expression in mature adipocytes, its function in these cells is currently unknown. To identify direct and indirect EBF1 targets in fat, we undertook a combination of transcriptional profiling of EBF1-deficient adipocytes and genome-wide EBF1 location analysis. Our results indicate that many components of metabolic and inflammatory pathways are positively and directly regulated by EBF1, including PI3K/AKT, MAPK, and STAT1 signaling. Accordingly, we observed significant reduction of multiple signaling events in EBF1 knockdown cells as well as a reduction in insulin-stimulated glucose uptake and lipogenesis. Inflammatory signaling, gene expression, and secretion of inflammatory cytokines were also significantly affected by loss of EBF1 in adipocytes, although ChIP-sequencing results suggest that these actions are indirect. We also found that EBF1 occupies some 35,000 sites in adipocytes, most of which occur in enhancers. Significantly, comparison with three other published EBF1 ChIP-sequencing data sets in B-cells reveals both gene- and cell type-specific patterns of EBF1 binding. These results advance our understanding of the transcriptional mechanisms regulating signaling pathways in mature fat cells and indicate that EBF1 functions as a key integrator of signal transduction, inflammation, and metabolism.	[Griffin, Michael J.; Zhou, Yiming; Kang, Sona; Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Griffin, Michael J.; Rosen, Evan D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Xiaolan; Mikkelsen, Tarjei S.; Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Metab & Diabet, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Griffin, Michael/0000-0003-4252-2803	National Institutes of Health [R01 DK078061, F32 DK082161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078061, F32DK082161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078061 (to E. D. R.) and F32 DK082161 (to M. J. G.).	Balhoff JP, 1998, BIOCHEM BIOPH RES CO, V247, P894, DOI 10.1006/bbrc.1998.8890; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dowell P, 2002, J BIOL CHEM, V277, P1712, DOI 10.1074/jbc.M108589200; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fretz JA, 2010, ENDOCRINOLOGY, V151, P1611, DOI 10.1210/en.2009-0987; Gisler R, 2000, BLOOD, V96, P1457, DOI 10.1182/blood.V96.4.1457.h8001457_1457_1464; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Lee HS, 2009, CYTOKINE, V46, P160, DOI 10.1016/j.cyto.2008.12.025; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loots Gabriela G., 2007, V395, P237; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; MILATOVICH A, 1994, MAMM GENOME, V5, P211, DOI 10.1007/BF00360547; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364	47	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35925	35939		10.1074/jbc.M113.491936	http://dx.doi.org/10.1074/jbc.M113.491936			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174531	Green Published, hybrid			2022-12-25	WOS:000329814700029
J	Murray, DS; Chinnam, N; Tonthat, NK; Whitfill, T; Wray, LV; Fisher, SH; Schumacher, MA				Murray, David S.; Chinnam, Nagababu; Tonthat, Nam Ky; Whitfill, Travis; Wray, Lewis V., Jr.; Fisher, Susan H.; Schumacher, Maria A.			Structures of the Bacillus subtilis Glutamine Synthetase Dodecamer Reveal Large Intersubunit Catalytic Conformational Changes Linked to a Unique Feedback Inhibition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Enzyme Catalysis; Enzyme Inactivation; Enzyme Mechanisms; Enzyme Structure; Glutamine	AMINO-ACID AVAILABILITY; ESCHERICHIA-COLI; GENE-EXPRESSION; METHIONINE SULFOXIMINE; KINETIC PROPERTIES; CRYSTAL-STRUCTURES; NITROGEN; ENZYME; MYCOBACTERIA; COMPLEXES	Background:B. subtilis GS catalyzes the production of glutamine, a key metabolite in nitrogen assimilation. Results:B. subtilis GS forms a dodecamer that undergoes large intersubunit conformational changes during catalysis. Conclusion:B. subtilis GS structures reveal a heretofore unseen active site restructuring that is linked to a novel feedback regulatory mechanism. Significance: The GS specific regulatory/catalytic mechanism may be used to target Gram-positive pathogens. Glutamine synthetase (GS), which catalyzes the production of glutamine, plays essential roles in nitrogen metabolism. There are two main bacterial GS isoenzymes, GSI- and GSI-. GSI- enzymes, which have not been structurally characterized, are uniquely feedback-inhibited by Gln. To gain insight into GSI- function, we performed biochemical and cellular studies and obtained structures for all GSI- catalytic and regulatory states. GSI- forms a massive 600-kDa dodecameric machine. Unlike other characterized GS, the Bacillus subtilis enzyme undergoes dramatic intersubunit conformational alterations during formation of the transition state. Remarkably, these changes are required for active site construction. Feedback inhibition arises from a hydrogen bond network between Gln, the catalytic glutamate, and the GSI--specific residue, Arg(62), from an adjacent subunit. Notably, Arg(62) must be ejected for proper active site reorganization. Consistent with these findings, an R62A mutation abrogates Gln feedback inhibition but does not affect catalysis. Thus, these data reveal a heretofore unseen restructuring of an enzyme active site that is coupled with an isoenzyme-specific regulatory mechanism. This GSI--specific regulatory network could be exploited for inhibitor design against Gram-positive pathogens.	[Murray, David S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chinnam, Nagababu; Tonthat, Nam Ky; Whitfill, Travis; Schumacher, Maria A.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Wray, Lewis V., Jr.; Fisher, Susan H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Oregon Health & Science University; Duke University; Boston University	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, DUMC, 255 Nanaline H Duke,Box 3711, Durham, NC 27710 USA.	Maria.Schumacher@duke.edu	chinnam, Nagababu/AFS-2420-2022; Chinnam, Nagababu/ABF-5512-2021	chinnam, Nagababu/0000-0001-8925-5365; Chinnam, Nagababu/0000-0001-8925-5365; Whitfill, Travis/0000-0002-3277-4380	National Institutes of Health Grants [GM074815, GM051127]; M. D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM051127, R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074815 (to M. A. S.) and GM051127 (to S. H. F.). This work was also supported by an M. D. Anderson Trust Fellowship and Burroughs Wellcome Career Development Award (to M. A. S.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; BROWN JR, 1994, J MOL EVOL, V38, P566; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEUEL TF, 1970, J BIOL CHEM, V245, P5195; DEUEL TF, 1974, J BIOL CHEM, V249, P257; DEUEL TF, 1970, J BIOL CHEM, V245, P5206; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Ferson AE, 1996, MOL MICROBIOL, V22, P693, DOI 10.1046/j.1365-2958.1996.d01-1720.x; FISHER SH, 1984, J BACTERIOL, V157, P612, DOI 10.1128/JB.157.2.612-621.1984; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2002, J BACTERIOL, V184, P2148, DOI 10.1128/JB.184.8.2148-2154.2002; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Fisher SH, 2009, J BACTERIOL, V191, P2485, DOI 10.1128/JB.01734-08; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; Gill HS, 2001, BIOCHEMISTRY-US, V40, P1903, DOI 10.1021/bi002438h; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krajewski WW, 2008, J MOL BIOL, V375, P217, DOI 10.1016/j.jmb.2007.10.029; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P11184, DOI 10.1021/bi00203a014; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; PESOLE G, 1991, P NATL ACAD SCI USA, V88, P522, DOI 10.1073/pnas.88.2.522; Purich DL, 1998, ADV ENZYMOL RAMB, V72, P9; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; RHEE SG, 1981, J BIOL CHEM, V256, P644; SCHREIER HJ, 1989, J MOL BIOL, V210, P51, DOI 10.1016/0022-2836(89)90290-8; SHAPIRO BM, 1968, J BIOL CHEM, V243, P3769; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van Rooyen JM, 2011, STRUCTURE, V19, P471, DOI 10.1016/j.str.2011.02.001; WEDLER FC, 1972, J BIOL CHEM, V247, P993; WEDLER FC, 1976, J BIOL CHEM, V251, P7530; WEISBROD RE, 1973, J BIOL CHEM, V248, P3997; Wray LV, 2008, MOL MICROBIOL, V68, P277, DOI 10.1111/j.1365-2958.2008.06162.x; Wray LV, 2010, J BACTERIOL, V192, P5018, DOI 10.1128/JB.00509-10; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 2005, J BIOL CHEM, V280, P33298, DOI 10.1074/jbc.M504957200; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4	47	29	30	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35801	35811		10.1074/jbc.M113.519496	http://dx.doi.org/10.1074/jbc.M113.519496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158439	Green Published, hybrid			2022-12-25	WOS:000329814700018
J	Islam, M; Gor, J; Perkins, SJ; Ishikawa, Y; Bachinger, HP; Hohenester, E				Islam, Mehwaesh; Gor, Jayesh; Perkins, Stephen J.; Ishikawa, Yoshihiro; Baechinger, Hans Peter; Hohenester, Erhard			The Concave Face of Decorin Mediates Reversible Dimerization and Collagen Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix; Protein-Protein Interactions; Proteoglycan; Site-directed Mutagenesis	LEUCINE-RICH REPEAT; CRYSTAL-STRUCTURE; I COLLAGEN; TENDON COLLAGEN; CORE PROTEIN; X-RAY; FIBRILLOGENESIS; PROTEOGLYCANS; BIGLYCAN; SCATTERING	Background: In the crystal structure of decorin, the concave faces of two monomers interact to form a tight dimer. Results: The decorin dimer in solution is in equilibrium with stable monomers, and mutations on the concave face abolish collagen binding. Conclusion: Decorin binds collagen as a monomer. Significance: These findings help resolve the controversy about the functional oligomeric state of decorin. Decorin, the prototypical small leucine-rich proteoglycan, binds to collagen and thereby regulates collagen assembly into fibrils. The crystal structure of the decorin core protein revealed a tight dimer formed by the association of two monomers via their concave faces (Scott, P. G., McEwan, P. A., Dodd, C. M., Bergmann, E. M., Bishop, P. N., and Bella, J. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 15633-15638). Whether decorin binds collagen as a dimer has been controversial. Using analytical ultracentrifugation, we determined a dissociation constant of 1.37 +/- 0.30 m for the mouse decorin dimer. Dimerization could be abolished by engineering glycosylation sites into the dimer interface; other interface mutants remained dimeric. The monomeric mutants were as stable as wild-type decorin in thermal unfolding experiments. Mutations on the concave face of decorin abolished collagen binding regardless of whether the mutant proteins retained the ability to dimerize or not. We conclude that the concave face of decorin mediates collagen binding and that the dimer therefore must dissociate to bind collagen.	[Islam, Mehwaesh; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Imperial College London; University of London; University College London; Oregon Health & Science University	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk		Islam, Mehwaesh/0000-0003-1025-9852; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital; Wellcome Trust Senior Fellowship in Basic Biomedical Science [083942/Z/07/Z]; BBSRC [BB/E013104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish	Shriners Hospital; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from Shriners Hospital (to H. P. B.) and a Wellcome Trust Senior Fellowship in Basic Biomedical Science 083942/Z/07/Z (to E. H.).	Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Boehm MK, 1996, J MOL BIOL, V259, P718, DOI 10.1006/jmbi.1996.0353; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; LIU J, 1994, J BIOL CHEM, V269, P28366; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PRINGLE GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1405, DOI 10.1177/38.10.1698203; Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; Seiradake E, 2009, EMBO REP, V10, P736, DOI 10.1038/embor.2009.95; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	40	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35526	35533		10.1074/jbc.M113.504530	http://dx.doi.org/10.1074/jbc.M113.504530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24169694	hybrid, Green Published			2022-12-25	WOS:000329867600047
J	Chen, M; Zhang, WW; Lu, X; Hoggatt, AM; Gunst, SJ; Kassab, GS; Tune, JD; Herring, BP				Chen, Meng; Zhang, Wenwu; Lu, Xiao; Hoggatt, April M.; Gunst, Susan J.; Kassab, Ghassan S.; Tune, Johnathan D.; Herring, B. Paul			Regulation of 130-kDa Smooth Muscle Myosin Light Chain Kinase Expression by an Intronic CArG Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Calmodulin-dependent Protein Kinase (CaMK); Contractile Protein; Intestine; Myosin; Smooth Muscle; Serum Response Factor	SERUM RESPONSE FACTOR; BARRIER DYSFUNCTION; TELOKIN EXPRESSION; PROMOTER ACTIVITY; DISTINCT ROLES; DEFICIENT MICE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; PROTEIN	Background: Mechanisms regulating transcription of MLCK are poorly defined. Results: Deleting a CArG element from the mylk1 gene specifically decreased expression of the 130-kDa smMLCK isoform, resulting in decreased intestinal contractility and proliferation. Conclusion: The 130-kDa smMLCK isoform has functions that cannot be compensated for by the 220-kDa MLCK. Significance: Floxed mylk1 mice permit specific functions of the 130-kDa smMLCK to be determined. The mylk1 gene encodes a 220-kDa nonmuscle myosin light chain kinase (MLCK), a 130-kDa smooth muscle MLCK (smMLCK), as well as the non-catalytic product telokin. Together, these proteins play critical roles in regulating smooth muscle contractility. Changes in their expression are associated with many pathological conditions; thus, it is important to understand the mechanisms regulating expression of mylk1 gene transcripts. Previously, we reported a highly conserved CArG box, which binds serum response factor, in intron 15 of mylk1. Because this CArG element is near the promoter that drives transcription of the 130-kDa smMLCK, we examined its role in regulating expression of this transcript. Results show that deletion of the intronic CArG region from a -galactosidase reporter gene abolished transgene expression in mice in vivo. Deletion of the CArG region from the endogenous mylk1 gene, specifically in smooth muscle cells, decreased expression of the 130-kDa smMLCK by 40% without affecting expression of the 220-kDa MLCK or telokin. This reduction in 130-kDa smMLCK expression resulted in decreased phosphorylation of myosin light chains, attenuated smooth muscle contractility, and a 24% decrease in small intestine length that was associated with a significant reduction of Ki67-positive smooth muscle cells. Overall, these data show that the CArG element in intron 15 of the mylk1 gene is necessary for maximal expression of the 130-kDa smMLCK and that the 130-kDa smMLCK isoform is specifically required to regulate smooth muscle contractility and small intestine smooth muscle cell proliferation.	[Chen, Meng; Zhang, Wenwu; Lu, Xiao; Hoggatt, April M.; Gunst, Susan J.; Kassab, Ghassan S.; Tune, Johnathan D.; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu		Gunst, Susan/0000-0001-9836-4782; Tune, Johnathan/0000-0003-2959-0801	National Institutes of Health [HL085212]; American Heart Association (Midwest Affiliate); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Midwest Affiliate)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085212 (to B. P. H.).; Supported by a predoctoral fellowship from the American Heart Association (Midwest Affiliate).	Basu S, 2013, J BIOL CHEM, V288, P11191, DOI 10.1074/jbc.M112.442996; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen M, 2013, J BIOL CHEM, V288, P6397, DOI 10.1074/jbc.M112.409474; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Guo MZ, 2012, SHOCK, V38, P436, DOI 10.1097/SHK.0b013e318268c731; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Han YJ, 2006, MOL BIOL CELL, V17, P4039, DOI 10.1091/mbc.E06-04-0353; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Herring BP, 2001, AM J PHYSIOL-CELL PH, V280, pC12, DOI 10.1152/ajpcell.2001.280.1.C12; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Iida Y, 1997, AM J PHYSIOL-ENDOC M, V273, pE782, DOI 10.1152/ajpendo.1997.273.4.E782; Kamm K E, 1987, Prog Clin Biol Res, V245, P183; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Lu XA, 2011, AM J PHYSIOL-HEART C, V300, pH94, DOI 10.1152/ajpheart.00708.2010; Maksym GN, 2005, CAN J PHYSIOL PHARM, V83, P913, DOI 10.1139/Y05-091; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tian Y, 2013, MOL MED REP, V8, P294, DOI 10.3892/mmr.2013.1473; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Touw K, 2007, AM J PHYSIOL-CELL PH, V292, pC1024, DOI 10.1152/ajpcell.00445.2006; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yu Y, 2012, FEBS J, V279, P1485, DOI 10.1111/j.1742-4658.2012.08541.x; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10	51	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34647	34657		10.1074/jbc.M113.510362	http://dx.doi.org/10.1074/jbc.M113.510362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151072	hybrid, Green Published			2022-12-25	WOS:000329812800032
J	Ma, N; Liao, BJ; Zhang, H; Wang, LL; Shan, YL; Xue, YT; Huang, K; Chen, SB; Zhou, XX; Chen, Y; Pei, DQ; Pan, GJ				Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin			Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free beta-Thalassemia Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Therapy; Hemoglobin; Homologous Recombination; Induced Pluripotent Stem (iPS) Cell; -Thalassemia; HBB; TALEN; Gene Correction; iPS	HOMOLOGOUS RECOMBINATION; KNOCKOUT; MUTATION; PATIENT; VECTOR	Background: Gene editing in human patient-specific iPSCs is critical for regenerative medicine. Results: Nonintegrating -thalassemia iPSCs corrected by TALENs display undetectable off targets and can be differentiated into erythroblasts expressing normal -globin. Conclusion: TALENs can be used for HBB correction efficiently in -thalassemia iPSCs with different types. Significance: Our study extends TALENs for gene correction in patient-specific iPSCs and may have applications in cell therapy. -Thalassemia (-Thal) is a group of life-threatening blood disorders caused by either point mutations or deletions of nucleotides in -globin gene (HBB). It is estimated that 4.5% of the population in the world carry -Thal mutants (1), posing a persistent threat to public health. The generation of patient-specific induced pluripotent stem cells (iPSCs) and subsequent correction of the disease-causing mutations offer an ideal therapeutic solution to this problem. However, homologous recombination-based gene correction in human iPSCs remains largely inefficient. Here, we describe a robust process combining efficient generation of integration-free -Thal iPSCs from the cells of patients and transcription activator-like effector nuclease (TALEN)-based universal correction of HBB mutations in situ. We generated integration-free and gene-corrected iPSC lines from two patients carrying different types of homozygous mutations and showed that these iPSCs are pluripotent and have normal karyotype. We showed that the correction process did not generate TALEN-induced off targeting mutations by sequencing. More importantly, the gene-corrected -Thal iPS cell lines from each patient can be induced to differentiate into hematopoietic progenitor cells and then further to erythroblasts expressing normal -globin. Our studies provide an efficient and universal strategy to correct different types of -globin mutations in -Thal iPSCs for disease modeling and applications.	[Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Xue, Yanting] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Kaiyuan Ave Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Liao, Baojian/AAI-6286-2021; Wang, Linli/R-5688-2018	Wang, Linli/0000-0002-8380-6135; Pan, Guangjin/0000-0002-2378-7198	National Basic Research Program of China, 973 Program of China [2012CB966503]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01020202]; 973 Program of China [2011CB965204]; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010]; National Natural Science Foundation of China [31200970, 91213304]; Bureau of Science and Technology of Guangzhou Municipality, China [2010U1-E00521]; Hundred Talents Program of the Chinese Academy of Science	National Basic Research Program of China, 973 Program of China(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program of China(National Basic Research Program of China); National S&T Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Guangzhou Municipality, China; Hundred Talents Program of the Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China, 973 Program of China Grant 2012CB966503, "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01020202, 973 Program of China Grant 2011CB965204, National S&T Major Special Project on Major New Drug Innovation Grant 2011ZX09102-010, National Natural Science Foundation of China Grants 31200970 and 91213304, Bureau of Science and Technology of Guangzhou Municipality, China, Grant 2010U1-E00521 and funds from the Hundred Talents Program of the Chinese Academy of Science (to G. P.).	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gong L, 2000, BRIT J HAEMATOL, V111, P351, DOI 10.1046/j.1365-2141.2000.02311.x; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; KIMURA A, 1983, J BIOL CHEM, V258, P2748; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tuzmen S, 2001, BLOOD REV, V15, P19, DOI 10.1054/blre.2001.0147; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	35	114	128	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34671	34679		10.1074/jbc.M113.496174	http://dx.doi.org/10.1074/jbc.M113.496174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24155235	Green Published, hybrid			2022-12-25	WOS:000329812800034
J	Andersson, DA; Gentry, C; Light, E; Vastani, N; Vallortigara, J; Bierhaus, A; Fleming, T; Bevan, S				Andersson, David A.; Gentry, Clive; Light, Emily; Vastani, Nisha; Vallortigara, Julie; Bierhaus, Angelika; Fleming, Thomas; Bevan, Stuart			Methylglyoxal Evokes Pain by Stimulating TRPA1	PLOS ONE			English	Article							RENAL TUBULAR CELLS; ION-CHANNEL TRPA1; OXIDATIVE STRESS; DIABETIC-NEUROPATHY; PERIPHERAL NEUROPATHY; COVALENT MODIFICATION; ACTIVATE TRPA1; CALCIUM LEVELS; SERUM-ALBUMIN; GLYOXALASE-I	Diabetic neuropathy is a severe complication of long-standing diabetes and one of the major etiologies of neuropathic pain. Diabetes is associated with an increased formation of reactive oxygen species and the electrophilic dicarbonyl compound methylglyoxal (MG). Here we show that MG stimulates heterologously expressed TRPA1 in CHO cells and natively expressed TRPA1 in MDCK cells and DRG neurons. MG evokes [Ca2+](i)-responses in TRPA1 expressing DRG neurons but is without effect in neurons cultured from Trpa1(-/-) mice. Consistent with a direct, intracellular action, we show that methylglyoxal is significantly more potent as a TRPA1 agonist when applied to the intracellular face of excised membrane patches than to intact cells. Local intraplantar administration of MG evokes a pain response in Trpa1(+/+) but not in Trpa1(-/-) mice. Furthermore, persistently increased MG levels achieved by two weeks pharmacological inhibition of glyoxalase-1 (GLO-1), the rate-limiting enzyme responsible for detoxification of MG, evokes a progressive and marked thermal (cold and heat) and mechanical hypersensitivity in wildtype but not in Trpa1(-/-) mice. Our results thus demonstrate that TRPA1 is required both for the acute pain response evoked by topical MG and for the long-lasting pronociceptive effects associated with elevated MG in vivo. In contrast to our observations in DRG neurons, MG evokes indistinguishable [Ca2+](i)-responses in pancreatic beta-cells cultured from Trpa1(+/+) and Trpa1(-/-) mice. In vivo, the TRPA1 antagonist HC030031 impairs glucose clearance in the glucose tolerance test both in Trpa1(+/+) and Trpa1(-/-)mice, indicating a non-TRPA1 mediated effect and suggesting that results obtained with this compound should be interpreted with caution. Our results show that TRPA1 is the principal target for MG in sensory neurons but not in pancreatic beta-cells and that activation of TRPA1 by MG produces a painful neuropathy with the behavioral hallmarks of diabetic neuropathy.	[Andersson, David A.; Gentry, Clive; Light, Emily; Vastani, Nisha; Vallortigara, Julie; Bevan, Stuart] Kings Coll London, Wolfson CARD, London, England; [Bierhaus, Angelika; Fleming, Thomas] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany	University of London; King's College London; Ruprecht Karls University Heidelberg	Andersson, DA (corresponding author), Kings Coll London, Wolfson CARD, London, England.	david.andersson@kcl.ac.uk	Andersson, David A/C-3435-2008; Bevan, Stuart/A-8821-2008	Andersson, David A/0000-0001-7451-8548; Vastani, Nisha/0000-0003-0919-713X; Bevan, Stuart John/0000-0002-8977-1797	Medical Research Council [G0500847]; Deutsche Forschungsgemeinschaft [BI-1281/3-1, NA 138/7-1]; Dietmar-Hopp-Stiftung; MRC [G0500847] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by grants from the Medical Research Council (G0500847), Deutsche Forschungsgemeinschaft (BI-1281/3-1; NA 138/7-1) and the Dietmar-Hopp-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Blanco M, 2005, STROKE, V36, P1189, DOI 10.1161/01.STR.0000166054.55993.e5; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P276, DOI 10.1016/j.bmcl.2009.10.113; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Eberhardt MJ, 2012, J BIOL CHEM; Edwards JL, 2008, PHARM THER; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jan CR, 2003, PHARMACOL TOXICOL, V93, P123, DOI 10.1034/j.1600-0773.2003.930303.x; Jan CR, 1999, N-S ARCH PHARMACOL, V360, P249, DOI 10.1007/s002109900055; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Koivisto A, 2012, PHARMACOL RES, V65, P149, DOI 10.1016/j.phrs.2011.10.006; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LO TWC, 1994, J BIOL CHEM, V269, P32299; LO TWC, 1992, BIOCHEM PHARMACOL, V44, P2357, DOI 10.1016/0006-2952(92)90680-H; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Sommer C, 2007, LANCET NEUROL, V6, P632, DOI 10.1016/S1474-4422(07)70172-2; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Taylor-Clark TE, 2007, MOL PHARM; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turk Z, 2006, DIABETES METAB, V32, P176, DOI 10.1016/S1262-3636(07)70266-5; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023	62	81	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77986	10.1371/journal.pone.0077986	http://dx.doi.org/10.1371/journal.pone.0077986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167592	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500052
J	Fukuda, T; Sanui, T; Toyoda, K; Tanaka, U; Taketomi, T; Uchiumi, T; Nishimura, F				Fukuda, Takao; Sanui, Terukazu; Toyoda, Kyosuke; Tanaka, Urara; Taketomi, Takaharu; Uchiumi, Takeshi; Nishimura, Fusanori			Identification of Novel Amelogenin-Binding Proteins by Proteomics Analysis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; ENAMEL MATRIX PROTEINS; PERIODONTAL TISSUE REGENERATION; EPITHELIAL ROOT SHEATH; OSTEOGENIC DIFFERENTIATION; MESSENGER-RNA; IN-VITRO; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CELLS	Emdogain (enamel matrix derivative, EMD) is well recognized in periodontology. It is used in periodontal surgery to regenerate cementum, periodontal ligament, and alveolar bone. However, the precise molecular mechanisms underlying periodontal regeneration are still unclear. In this study, we investigated the proteins bound to amelogenin, which are suggested to play a pivotal role in promoting periodontal tissue regeneration. To identify new molecules that interact with amelogenin and are involved in osteoblast activation, we employed coupling affinity chromatography with proteomic analysis in fractionated SaOS-2 osteoblastic cell lysate. In SaOS-2 cells, many of the amelogenin-interacting proteins in the cytoplasm were mainly cytoskeletal proteins and several chaperone molecules of heat shock protein 70 (HSP70) family. On the other hand, the proteomic profiles of amelogenin-interacting proteins in the membrane fraction of the cell extracts were quite different from those of the cytosolic-fraction. They were mainly endoplasmic reticulum (ER)-associated proteins, with lesser quantities of mitochondrial proteins and nucleoprotein. Among the identified amelogenin-interacting proteins, we validated the biological interaction of amelogenin with glucose-regulated protein 78 (Grp78/Bip), which was identified in both cytosolic and membrane-enriched fractions. Confocal co-localization experiment strongly suggested that Grp78/Bip could be an amelogenin receptor candidate. Further biological evaluations were examined by Grp78/Bip knockdown analysis with and without amelogenin. Within the limits of the present study, the interaction of amelogenin with Grp78/Bip contributed to cell proliferation, rather than correlate with the osteogenic differentiation in SaOS-2 cells. Although the biological significance of other interactions are not yet explored, these findings suggest that the differential effects of amelogenin-derived osteoblast activation could be of potential clinical significance for understanding the cellular and molecular bases of amelogenin-induced periodontal tissue regeneration.	[Fukuda, Takao; Sanui, Terukazu; Toyoda, Kyosuke; Tanaka, Urara; Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Periodontol, Fukuoka 812, Japan; [Taketomi, Takaharu] Kurume Univ, Sch Med, Dent & Oral Med Ctr, Kurume, Fukuoka 830, Japan; [Uchiumi, Takeshi] Kyushu Univ, Dept Clin Chem & Lab Med, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; Kurume University; Kyushu University	Sanui, T (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Periodontol, Fukuoka 812, Japan.	sanuteru@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [21792124, 23792480]; Grants-in-Aid for Scientific Research [23792480] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (projects 21792124 and 23792480) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Ashizuka M, 2002, MOL CELL BIOL, V22, P6375, DOI 10.1128/MCB.22.18.6375-6383.2002; Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Bosshardt DD, 2004, J CLIN PERIODONTOL, V31, P184, DOI 10.1111/j.0303-6979.2004.00473.x; Chang YJ, 2010, ANN SURG ONCOL, V17, P1703, DOI 10.1245/s10434-010-0912-8; CHEN EH, 1994, DEV DYNAM, V199, P189, DOI 10.1002/aja.1001990304; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Drabek K, 2011, J BONE MINER RES, V26, P2045, DOI 10.1002/jbmr.435; Du C, 2005, J DENT RES, V84, P1070, DOI 10.1177/154405910508401120; Duan XJ, 2011, J CELL PHYSIOL, V226, P150, DOI 10.1002/jcp.22316; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Fukuda T, 2004, NUCLEIC ACIDS RES, V32, P611, DOI 10.1093/nar/gkh223; Gestrelius S, 2000, Clin Oral Investig, V4, P120, DOI 10.1007/s007840050127; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Greene SR, 2002, ARCH ORAL BIOL, V47, P211, DOI 10.1016/S0003-9969(01)00111-X; Gruenbaum-Cohen Y, 2009, J EXP ZOOL PART B, V312B, P445, DOI 10.1002/jez.b.21255; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Hino S, 2010, J BONE MINER METAB, V28, P131, DOI 10.1007/s00774-009-0117-z; Janones DS, 2005, ARCH ORAL BIOL, V50, P527, DOI 10.1016/j.archoralbio.2004.10.004; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; LYNGSTADAAS SP, 1990, J COMP PHYSIOL B, V160, P469, DOI 10.1007/BF00258973; Miron RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023375; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Prakash SK, 2005, CALCIFIED TISSUE INT, V77, P23, DOI 10.1007/s00223-004-1213-7; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ramseier CA, 2012, PERIODONTOL 2000, V59, P185, DOI 10.1111/j.1600-0757.2011.00432.x; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Ravindran S, 2012, HISTOCHEM CELL BIOL, V138, P113, DOI 10.1007/s00418-012-0952-1; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Saito M, 2012, EXPERT OPIN BIOL TH, V12, P299, DOI 10.1517/14712598.2012.655267; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Sanui T, 2009, ORAL MICROBIOL IMMUN, V24, P361, DOI 10.1111/j.1399-302X.2009.00523.x; Schwartz Z, 2000, J PERIODONTOL, V71, P1287, DOI 10.1902/jop.2000.71.8.1287; Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x; SENGER DR, 1979, CELL, V16, P885, DOI 10.1016/0092-8674(79)90103-X; Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tanimoto K, 2012, CELLS TISSUES ORGANS, V196, P411, DOI 10.1159/000335912; Tribl F, 2005, MOL CELL PROTEOMICS, V4, P945, DOI 10.1074/mcp.M400117-MCP200; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Xu L, 2008, J BIOCHEM, V144, P531, DOI 10.1093/jb/mvn096; Xu LM, 2006, J BIOL CHEM, V281, P2257, DOI 10.1074/jbc.M507695200; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	56	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78129	10.1371/journal.pone.0078129	http://dx.doi.org/10.1371/journal.pone.0078129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167599	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500059
J	Ku, YS; Koo, NSC; Li, FWY; Li, MW; Wang, HM; Tsai, SN; Sun, F; Lim, BL; Ko, WH; Lam, HM				Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Sun, Feng; Lim, Boon Leong; Ko, Wing-Hung; Lam, Hon-Ming			GmSAL1 Hydrolyzes Inositol-1,4,5-Trisphosphate and Regulates Stomatal Closure in Detached Leaves and Ion Compartmentalization in Plant Cells	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; TOBACCO NICOTIANA-TABACUM; TIME RT-PCR; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; SALT TOLERANCE; MOLECULAR CHARACTERIZATION; NEGATIVE REGULATOR; PHYTASE ACTIVITY; K+ CHANNELS	Inositol polyphosphatases are important regulators since they control the catabolism of phosphoinositol derivatives, which are often signaling molecules for cellular processes. Here we report on the characterization of one of their members in soybean, GmSAL1. In contrast to the substrate specificity of its Arabidopsis homologues (AtSAL1 and AtSAL2), GmSAL1 only hydrolyzes inositol-1,4,5-trisphosphate (IP3) but not inositol-1,3,4-trisphosphate or inositol-1,4-bisphosphate. The ectopic expression of GmSAL1 in transgenic Arabidopsis thaliana led to a reduction in IP3 signals, which was inferred from the reduction in the cytoplasmic signals of the in vivo biomarker pleckstrin homology domain-green florescent protein fusion protein and the suppression of abscisic acid-induced stomatal closure. At the cellular level, the ectopic expression of GmSAL1 in transgenic BY-2 cells enhanced vacuolar Na+ compartmentalization and therefore could partially alleviate salinity stress.	[Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Lam, Hon-Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China; [Ku, Yee-Shan; Koo, Nicolas Siu-Chung; Li, Francisca Wing-Yen; Li, Man-Wah; Wang, Hongmei; Tsai, Sau-Na; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Sun, Feng; Lim, Boon Leong] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Ko, Wing-Hung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Lam, Hon-Ming/A-9866-2008; Ko, Hung/R-1802-2018; Li, Man-Wah/AAZ-5724-2021; Li, Man-Wah/AAZ-5631-2021; Ku, Yee-Shan/ABZ-5538-2022; Lim, Boon Leong/D-3104-2009	Lam, Hon-Ming/0000-0002-6673-8740; Ko, Hung/0000-0002-2041-402X; Li, Man-Wah/0000-0003-4859-5683; Ku, Yee-Shan/0000-0002-9587-5648; Lim, Boon Leong/0000-0002-2720-2353	Hong Kong Research Grants Council General Research Fund [468409]; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	Sources of funding: Hong Kong Research Grants Council General Research Fund (Grant no. 468409), Lo Kwee-Seong Biomedical Research Fund, and Lee Hysan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Assmann S. M., 2010, PLANT HORMONES BIOSY, P399; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; Bechtold N, 1993, ARABIDOPSIS PROTOCOL, P259; Berdy SE, 2001, PLANT PHYSIOL, V126, P801, DOI 10.1104/pp.126.2.801; Berridge MJ, 1995, ANN NY ACAD SCI, V766, P31, DOI 10.1111/j.1749-6632.1995.tb26646.x; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Burnette RN, 2003, PLANT PHYSIOL, V132, P1011, DOI 10.1104/pp.019000; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; CHEUNG MY, 2013, PLANT CELL IN PRESS; DeWald DB, 2001, PLANT PHYSIOL, V126, P759, DOI 10.1104/pp.126.2.759; Ercetin ME, 2004, PLANT PHYSIOL, V135, P938, DOI 10.1104/pp.104.040253; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; INOUE H, 1985, PLANT PHYSIOL, V79, P389, DOI 10.1104/pp.79.2.389; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kaur N, 2005, CURR SCI INDIA, V88, P1771; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Moore DD, 1995, GLOB MOB SURV; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NAGATA T, 1981, MOL GEN GENET, V184, P161, DOI 10.1007/BF00272899; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SmolenskaSym G, 1996, PHYSIOL PLANTARUM, V96, P692, DOI 10.1111/j.1399-3054.1996.tb00244.x; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	55	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78181	10.1371/journal.pone.0078181	http://dx.doi.org/10.1371/journal.pone.0078181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167607	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500067
J	Nacoulma, AP; Megalizzi, V; Pottier, LR; De Lorenzi, M; Thoret, S; Dubois, J; Vandeputte, OM; Duez, P; Vereecke, D; El Jaziri, M				Nacoulma, Aminata P.; Megalizzi, Veronique; Pottier, Laurent R.; De Lorenzi, Manuela; Thoret, Sylviane; Dubois, Joelle; Vandeputte, Olivier M.; Duez, Pierre; Vereecke, Danny; El Jaziri, Mondher			Potent Antiproliferative Cembrenoids Accumulate in Tobacco upon Infection with Rhodococcus fascians and Trigger Unusual Microtubule Dynamics in Human Glioblastoma Cells	PLOS ONE			English	Article							NICOTIANA-TABACUM; IN-VITRO; TUBULIN; POLYMERIZATION; INHIBITION; COLCHICINE; TRICHOMES; EXTRACTS; CANCER; DEATH	Aims: Though plant metabolic changes are known to occur during interactions with bacteria, these were rarely challenged for pharmacologically active compounds suitable for further drug development. Here, the occurrence of specific chemicals with antiproliferative activity against human cancer cell lines was evidenced in hyperplasia (leafy galls) induced when plants interact with particular phytopathogens, such as the Actinomycete Rhodococcus fascians. Methods: We examined leafy galls fraction F3.1.1 on cell proliferation, cell division and cytoskeletal disorganization of human cancer cell lines using time-lapse videomicroscopy imaging, combined with flow cytometry and immunofluorescence analysis. We determined the F3.1.1-fraction composition by gas chromatography coupled to mass spectrometry. Results: The leafy galls induced on tobacco by R. fascians yielded fraction F3.1.1 which inhibited proliferation of glioblastoma U373 cells with an IC50 of 4.5 mu g/mL, F.3.1.1 was shown to increase cell division duration, cause nuclear morphological deformations and cell enlargement, and, at higher concentrations, karyokinesis defects leading to polyploidization and apoptosis. F3.1.1 consisted of a mixture of isomers belonging to the cembrenoids. The cellular defects induced by F3.1.1 were caused by a peculiar cytoskeletal disorganization, with the occurrence of fragmented tubulin and strongly organized microtubule aggregates within the same cell. Colchicine, paclitaxel, and cembrene also affected U373 cell proliferation and karyokinesis, but the induced microtubule rearrangement was very different from that provoked by F3.1.1. Altogether our data indicate that the cembrenoid isomers in F3.1.1 have a unique mode of action and are able to simultaneously modulate microtubule polymerization and stability.	[Nacoulma, Aminata P.; Megalizzi, Veronique; De Lorenzi, Manuela] Univ Libre Brussels, Fac Pharm, Toxicol Lab, Brussels, Belgium; [Pottier, Laurent R.; Duez, Pierre] Univ Libre Brussels, Fac Pharm, Lab Pharmacognosie Bromatol & Nutr Humaine, Brussels, Belgium; [Thoret, Sylviane; Dubois, Joelle] Ctr Natl Rech Sci, Inst Chim Subst Nat, Unite PR 2301, Gif Sur Yvette, France; [Vandeputte, Olivier M.; El Jaziri, Mondher] Univ Libre Brussels, Fac Sci, Lab Biotechnol Vegetale, Gosselies, Belgium; [Vereecke, Danny] Univ Ghent, Univ Coll Ghent, Dept Plant Prod, B-9000 Ghent, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Ghent University; HOGENT University College of Applied Sciences & Arts	Megalizzi, V (corresponding author), Univ Libre Brussels, Fac Pharm, Toxicol Lab, Brussels, Belgium.	vmegaliz@ulb.ac.be		Duez, Pierre/0000-0002-0484-1478; El Jaziri, Mondher/0000-0001-5787-6319	Belgian National Fund for Scientific Research (FNRS) [FRFC 2.4.593.09]	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	O.M.V. is a post-doctoral researcher of the F.R.S.-F.N.R.S. (Fonds de la Recherche Scientifique, Belgium). The authors gratefully thank the Belgian National Fund for Scientific Research (FNRS) (FRFC 2.4.593.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraka HN, 2011, PLANTA MED, V77, P467, DOI 10.1055/s-0030-1250478; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; Bombuwala K, 2006, BEILSTEIN J ORG CHEM, V2, DOI 10.1186/1860-5397-2-13; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Cui H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-76; Debeir O, 2008, EXP CELL RES, V314, P2985, DOI 10.1016/j.yexcr.2008.06.010; Forizs L, 2009, CURR MICROBIOL, V58, P483, DOI 10.1007/s00284-008-9352-0; GUO ZH, 1995, PLANT SCI, V110, P1, DOI 10.1016/0168-9452(95)04174-S; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; KEATES RAB, 1981, CAN J BIOCHEM CELL B, V59, P361, DOI 10.1139/o81-050; Kwiatkowski N, 2012, ACS CHEM BIOL, V7, P185, DOI 10.1021/cb200305u; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; Megalizzi V, 2011, THESIS U LIBRE BRUXE; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Nacoulma AP, 2013, INT J MOL SCI, V14, P12533, DOI 10.3390/ijms140612533; Nacoulma AP, 2012, J PHYTOPATHOL, V160, P617, DOI 10.1111/j.1439-0434.2012.01953.x; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Villanueva HE, 2010, REC NAT PROD, V4, P115; WAHLBERG I, 1987, NAT PROD REP, V4, P237, DOI 10.1039/np9870400237; ZAVALA F, 1980, J MED CHEM, V23, P546, DOI 10.1021/jm00179a014	25	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77529	10.1371/journal.pone.0077529	http://dx.doi.org/10.1371/journal.pone.0077529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167576	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500035
J	Kostyuk, SV; Konkova, MS; Ershova, ES; Alekseeva, AJ; Smirnova, TD; Stukalov, SV; Kozhina, EA; Shilova, NV; Zolotukhina, TV; Markova, ZG; Izhevskaya, VL; Baranova, A; Veiko, NN				Kostyuk, Svetlana V.; Konkova, Marina S.; Ershova, Elizaveta S.; Alekseeva, Anna J.; Smirnova, Tatiana D.; Stukalov, Sergey V.; Kozhina, Ekaterina A.; Shilova, Nadezda V.; Zolotukhina, Tatiana V.; Markova, Zhanna G.; Izhevskaya, Vera L.; Baranova, Ancha; Veiko, Natalia N.			An Exposure to the Oxidized DNA Enhances Both Instability of Genome and Survival in Cancer Cells	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; NF-KAPPA-B; OXIDATIVE STRESS; ADAPTIVE RESPONSE; HUMAN-LYMPHOCYTES; NUCLEAR; EXPRESSION; TRANSCRIPTION; ACTIVATION; TISSUE	Background: Cell free DNA (cfDNA) circulates throughout the bloodstream of both healthy people and patients with various diseases and acts upon the cells. Response to cfDNA depends on concentrations and levels of the damage within cfDNA. Oxidized extracellular DNA acts as a stress signal and elicits an adaptive response. Principal Findings: Here we show that oxidized extracellular DNA stimulates the survival of MCF-7 tumor cells. Importantly, in cells exposed to oxidized DNA, the suppression of cell death is accompanied by an increase in the markers of genome instability. Short-term exposure to oxidized DNA results in both single-and double strand DNA breaks. Longer treatments evoke a compensatory response that leads to a decrease in the levels of chromatin fragmentations across cell populations. Exposure to oxidized DNA leads to a decrease in the activity of NRF2 and an increase in the activity of NF-kB and STAT3. A model that describes the role of oxidized DNA released from apoptotic cells in tumor biology is proposed. Conclusions/Significance: Survival of cells with an unstable genome may substantially augment progression of malignancy. Further studies of the effects of extracellular DNA on malignant and normal cells are warranted.	[Kostyuk, Svetlana V.; Konkova, Marina S.; Ershova, Elizaveta S.; Alekseeva, Anna J.; Smirnova, Tatiana D.; Stukalov, Sergey V.; Kozhina, Ekaterina A.; Shilova, Nadezda V.; Zolotukhina, Tatiana V.; Markova, Zhanna G.; Izhevskaya, Vera L.; Baranova, Ancha; Veiko, Natalia N.] Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; [Ershova, Elizaveta S.] Russian Acad Med Sci, VA Negovsky Res Inst Gen Reanimatol, Moscow, Russia; [Baranova, Ancha] George Mason Univ, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Federal Research & Clinical Center of Intensive Care Medicine & Rehabilitology; Russian Academy of Medical Sciences; George Mason University	Kostyuk, SV (corresponding author), Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia.	svet.kostyuk@gmail.com; abaranov@gmu.edu	Konkova, Marina/F-3529-2017; Markova, Zhanna/B-1842-2016; , Ancha/B-4608-2012; Baranova, Anna/HGB-3721-2022; Izhevskaya, Vera/AAZ-6982-2020; Shilova, Nadezda/B-1822-2016; Ershova, Elizaveta/E-3220-2015	Markova, Zhanna/0000-0003-2941-2861; , Ancha/0000-0001-6810-5982; Izhevskaya, Vera/0000-0002-7246-5144; Shilova, Nadezda/0000-0002-0641-1084; Alekseeva, Anna/0000-0003-0164-0539; Ershova, Elizaveta/0000-0003-1206-5832	RFBR [12-04-32081, 12-04-32074]; Ministry of Education and Science of Russia [14.512.11.0090, 8273, 2012-1.1-12-000-2008-067]; Jeffress Foundation [J-1023]	RFBR(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Jeffress Foundation	This work was supported by the RFBR (12-04-32081; 12-04-32074), by the contracts No. 14.512.11.0090 and No. 8273 (under the call No. 2012-1.1-12-000-2008-067) of the Ministry of Education and Science of Russia and the Jeffress Foundation Grant No. J-1023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, ANN SURG ONCOL, V18, P2461, DOI 10.1245/s10434-011-1638-y; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bulicheva N, 2008, ANN NY ACAD SCI, V1137, P273, DOI 10.1196/annals.1448.023; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Efremova LV, 2010, B EXP BIOL MED+, V149, P196, DOI 10.1007/s10517-010-0906-3; Ermakov A. V., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P42; Ermakov A. V., 2009, Radiatsionnaya Biologiya Radioekologiya, V49, P34; Ermakov AV, 2008, ANN NY ACAD SCI, V1137, P41, DOI 10.1196/annals.1448.024; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Ermakov AV, 2011, MUTAT RES-FUND MOL M, V712, P1, DOI 10.1016/j.mrfmmm.2011.03.002; Ermakov AV, 2009, MUTAT RES-FUND MOL M, V669, P155, DOI 10.1016/j.mrfmmm.2009.06.005; ERMAKOV AV, 2011, CIRCULATING NUCL ACI, pCH16; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; GLEBOVA KV, 2011, J NUCL ACIDS INVESTI, V2, P28; Gong B, 2012, ONCOL LETT, V3, P897, DOI 10.3892/ol.2012.576; Gorges TM, 2012, BIOMARKERS, V17, P498, DOI 10.3109/1354750X.2012.689133; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guillaud P, 1989, Anal Cell Pathol, V1, P25; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hashad D, 2012, J CLIN LAB ANAL, V26, P467, DOI 10.1002/jcla.21548; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Henderson PT, 2010, MUTAT RES-GEN TOX EN, V703, P11, DOI 10.1016/j.mrgentox.2010.08.021; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Kamiya H, 2010, MUTAT RES-GEN TOX EN, V703, P32, DOI 10.1016/j.mrgentox.2010.06.003; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Konkova Marina S., 2010, International Journal of Low Radiation, V7, P446, DOI 10.1504/IJLR.2010.037667; Kostjuk S, 2012, EXPERT OPIN BIOL TH, V12, pS99, DOI 10.1517/14712598.2012.690028; Kostyuk SV, 2010, B EXP BIOL MED+, V149, P191, DOI 10.1007/s10517-010-0905-4; KOSTYUK SV, 2013, MUTAT RES, V1, P44378; Kostyuk SV, 2012, MUTAT RES-FUND MOL M, V729, P52, DOI [10.1016/j.mrfmmm.2011.09.005, 10.16/j.mrfmmm.2011.09.005]; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loseva P, 2012, EXPERT OPIN BIOL TH, V12, pS85, DOI 10.1517/14712598.2012.688948; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Roth C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-4; Sandholm J, 2012, BREAST CANCER RES TR, V132, P411, DOI 10.1007/s10549-011-1590-3; Swystun LL, 2011, J THROMB HAEMOST, V9, P2313, DOI 10.1111/j.1538-7836.2011.04465.x; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	54	27	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77469	10.1371/journal.pone.0077469	http://dx.doi.org/10.1371/journal.pone.0077469			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147001	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200037
J	Liu, L; Yan, B; Huang, JL; Gu, QH; Wang, LN; Fang, M; Jiao, JP; Yue, XQ				Liu, Long; Yan, Bing; Huang, Junlong; Gu, Qunhao; Wang, Lina; Fang, Meng; Jiao, Jianpeng; Yue, Xiaoqiang			The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; CARCINOEMBRYONIC ANTIGEN; CLINICAL-SIGNIFICANCE; PANCREATIC-CANCER; PROGNOSTIC VALUE; CA 72-4; SERUM; FUCOSYLATION; HAPTOGLOBIN	Background and Aims: To identify and validate N-glycan biomarkers in gastric cancer (GC) and to elucidate their underlying molecular mechanism of action. Methods: In total, 347 individuals, including patients with GC (gastric cancer) or atrophic gastritis and healthy controls, were randomly divided into a training group (n=287) and a retrospective validation group (n=60). Serum N-glycan profiling was achieved with DNA sequencer-assisted/fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). Two diagnostic models were constructed based on the N-glycan profiles using logistic stepwise regression. The diagnostic performance of each model was assessed in retrospective, prospective (n=60), and follow-up (n=40) cohorts. Lectin blotting was performed to determine total core-fucosylation, and the expression of genes involved in core-fucosylation in GC was analyzed by reverse transcriptase-polymerase chain reaction. Results: We identified at least 9 N-glycan structures (peaks) and the levels of core fucose residues and fucosyltransferase were significantly decreased in GC. Two diagnostic models, designated GCglycoA and GCglycoB, were constructed to differentiate GC from control and atrophic gastritis. The areas under the receiver operating characteristic (ROC) curves (AUC) for both GCglycoA and GCglycoB were higher than those for CEA, CA19-9, CA125 and CA72-4. Compared with CEA, CA19-9, CA125 and CA72-4, the sensitivity of GCglycoA increased 29.66%, 37.28%, 56.78% and 61.86%, respectively, and the accuracy increased 10.62%, 16.82%, 25.67% and 28.76%, respectively. For GCglycoB, the sensitivity increased 27.97%, 35.59%, 55.09% and 60.17% and the accuracy increased 21.26%, 24.64%, 31.40% and 34.30% compared with CEA, CA19-9, CA125 and CA72-4, respectively. After curative surgery, the core fucosylated peak (peak 3) and the total core fucosylated N-glycans (sumfuc) were reversed. Conclusions: The results indicated that the diagnostic models based on N-glycan markers are valuable and noninvasive alternatives for identifying GC. We concluded that decreased core-fucosylation in both tissue and serum from GC patients may result from the decreased expression of fucosyltransferase.	[Liu, Long; Wang, Lina; Yue, Xiaoqiang] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Yan, Bing; Jiao, Jianpeng] Second Mil Med Univ, Changzheng Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Huang, Junlong] Second Mil Med Univ, Fac Naval Med, Lab Stress Med, Dept Naut Med, Shanghai, Peoples R China; [Gu, Qunhao] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Fang, Meng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yue, XQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	yuexiaoqiang@163.com		Yue, Xiaoqiang/0000-0001-6872-9664	National Natural Science Foundation of China [81102693, 81102565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81102693 and 81102565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Carpelan-Holmstrom M, 2002, ANTICANCER RES, V22, P2311; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Gaspar MJ, 2001, TUMOR BIOL, V22, P318, DOI 10.1159/000050633; HAGA Y, 1986, AM J MED SCI, V292, P30, DOI 10.1097/00000441-198607000-00006; Ishizuka A, 2008, BIOCHEM J, V413, P227, DOI 10.1042/BJ20071562; Kim YG, 2009, ANAL BIOCHEM, V391, P151, DOI 10.1016/j.ab.2009.05.015; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lattova E, 2009, RAPID COMMUN MASS SP, V23, P2983, DOI 10.1002/rcm.4202; Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Miyamoto S, 2006, CURR OPIN MOL THER, V8, P507; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Saldova R, 2011, ANN ONCOL, V22, P1113, DOI 10.1093/annonc/mdq570; Tocchi A, 1998, J CANCER RES CLIN, V124, P450, DOI 10.1007/s004320050198; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; Ychou M, 2000, DIS MARKERS, V16, P105, DOI 10.1155/2000/595492; Zhao YP, 2012, CANCER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0043383.PUBMED:22912865	23	13	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77821	10.1371/journal.pone.0077821	http://dx.doi.org/10.1371/journal.pone.0077821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147084	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200079
J	Branco, S; Bruns, TD; Singleton, I				Branco, Sara; Bruns, Thomas D.; Singleton, Ian			Fungi at a Small Scale: Spatial Zonation of Fungal Assemblages around Single Trees	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; PRIMARY SUCCESSION; FOREST SOILS; MICROBIAL COMMUNITY; SPECIES RICHNESS; DIVERSITY; MYCELIUM; DIFFERENTIATION; IDENTIFICATION; PATTERNS	Biological communities are often structured by environmental factors even at small spatial scales. Fungi are no exception, though the patterns and mechanisms underlying their community structure are usually unknown. Previous work documented zonation in fungi under tree canopies primarily through their fruiting patterns. Here we investigate the existence of zonation patterns in fungal communities around isolated Pinus muricata trees of different ages in northern coastal California. Using a combination of ingrowth bags and pyrosequencing to target underground mycelium we found highly diverse soil fungal communities associated with single trees. Both ectomycorrhizal and non-ectomycorrhizal fungi were present in all samples, but the latter were more species rich, dominated the samples by sequence read abundance, and showed partitioning by canopy-defined zones and tree age. Soil chemistry was correlated with fungal zonation, but host root density was not. Our results indicate different guilds of fungi partition space differently and are driven by distinct environmental parameters.	[Branco, Sara; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Singleton, Ian] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singleton, Ian] Newcastle Univ, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of California System; University of California Berkeley; Newcastle University - UK; Newcastle University - UK	Branco, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	sara.mayer.branco@gmail.com		Singleton, Ian/0000-0002-3866-668X	National Science Foundation [DEB 0742868, DBI 1046115]; EC FP7 Marie Curie International Outgoing Fellowship award	National Science Foundation(National Science Foundation (NSF)); EC FP7 Marie Curie International Outgoing Fellowship award	Financial support was provided by National Science Foundation grants DEB 0742868 and DBI 1046115. IS acknowledges funding from an EC FP7 Marie Curie International Outgoing Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Deacon J. W., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P249; Dickie IA, 2002, NEW PHYTOL, V156, P527, DOI 10.1046/j.1469-8137.2002.00535.x; Feinstein LM, 2013, MOL ECOL, V22, P1171, DOI 10.1111/mec.12160; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hornung M., 1985, Soil Use and Management, V1, P24, DOI 10.1111/j.1475-2743.1985.tb00648.x; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kerekes J, 2013, MOL ECOL, V22, P2827, DOI 10.1111/mec.12259; MASON PA, 1987, FUNGAL INFECTION PLA, P253; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Murata M, 2013, MYCORRHIZA, V23, P641, DOI 10.1007/s00572-013-0504-0; Nara K, 2003, NEW PHYTOL, V159, P743, DOI 10.1046/j.1469-8137.2003.00844.x; Nara K, 2003, NEW PHYTOL, V158, P193, DOI 10.1046/j.1469-8137.2003.00724.x; Newton A. C., 1992, Mycorrhiza, V2, P75, DOI 10.1007/BF00203253; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Peay KG, 2011, FUNGAL ECOL, V4, P233, DOI 10.1016/j.funeco.2010.09.010; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; Peay KG, 2009, J ECOL, V97, P537, DOI 10.1111/j.1365-2745.2009.01489.x; Robinson CH, 2009, SOIL BIOL BIOCHEM, V41, P414, DOI 10.1016/j.soilbio.2008.10.021; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Talbot JM, 2013, SOIL BIOL BIOCHEM, V57, P282, DOI 10.1016/j.soilbio.2012.10.004; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Terwilliger J, 1999, OIKOS, V85, P83, DOI 10.2307/3546794; Trowbridge J, 2004, MYCORRHIZA, V14, P283, DOI 10.1007/s00572-003-0264-3; Wallander H, 2013, SOIL BIOL BIOCHEM, V57, P1034, DOI 10.1016/j.soilbio.2012.08.027; Wallander H, 2001, NEW PHYTOL, V151, P753, DOI 10.1046/j.0028-646x.2001.00199.x; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	54	38	38	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78295	10.1371/journal.pone.0078295	http://dx.doi.org/10.1371/journal.pone.0078295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147130	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400155
J	Ding, XB; Guo, L; Zhang, Y; Fan, SJ; Gu, M; Lu, Y; Jiang, D; Li, YM; Huang, C; Zhou, ZQ				Ding, Xiaobo; Guo, Lu; Zhang, Yu; Fan, Shengjie; Gu, Ming; Lu, Yan; Jiang, Dong; Li, Yiming; Huang, Cheng; Zhou, Zhiqin			Extracts of Pomelo Peels Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice through Activating the PPAR alpha and GLUT4 Pathway	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; CITRUS FLAVONOIDS; INSULIN-RESISTANCE; SERUM-CHOLESTEROL; ENERGY-METABOLISM; OXIDATIVE STRESS; NARINGIN; OBESITY; ANTIOBESITY; ANTIOXIDANT	Objective: Metabolic syndrome is a serious health problem in both developed and developing countries. The present study investigated the anti-metabolic disorder effects of different pomelo varieties on obese C57BL/6 mice induced by high-fat (HF) diet. Design: The peels of four pomelo varieties were extracted with ethanol and the total phenols and flavonoids content of these extracts were measured. For the animal experiment, the female C57BL/6 mice were fed with a Chow diet or a HF diet alone or supplemented with 1% (w/w) different pomelo peel extracts for 8 weeks. Body weight and food intake were measured every other day. At the end of the treatment, the fasting blood glucose, glucose tolerance and insulin (INS) tolerance test, serum lipid profile and insulin levels, and liver lipid contents were analyzed. The gene expression analysis was performed with a quantitative real-time PCR assay. Result: The present study showed that the Citrus grandis liangpinyou (LP) and beibeiyou (BB) extracts were more potent in anti-metabolic disorder effects than the duanshiyou (DS) and wubuyou (WB) extracts. Both LP and BB extracts blocked the body weight gain, lowered fasting blood glucose, serum TC, liver lipid levels, and improved glucose tolerance and insulin resistance, and lowered serum insulin levels in HF diet-fed mice. Compared with the HF group, LP and BB peel extracts increased the mRNA expression of PPAR alpha and its target genes, such as FAS, PGC-1 alpha and PGC-1 beta, and GLUT4 in the liver and white adipocyte tissue (WAT). Conclusion: We found that that pomelo peel extracts could prevent high-fat diet-induced metabolic disorders in C57BL/6 mice through the activation of the PPAR alpha and GLUT4 signaling. Our results indicate that pomelo peels could be used as a dietary therapy and the potential source of drug for metabolic disorders.	[Ding, Xiaobo; Guo, Lu; Zhang, Yu; Fan, Shengjie; Gu, Ming; Lu, Yan; Li, Yiming; Huang, Cheng] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Ding, Xiaobo; Lu, Yan; Zhou, Zhiqin] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Ding, Xiaobo; Lu, Yan; Zhou, Zhiqin] Minist Educ, Key Lab Hort Sci Southern Mountainous Reg, Chongqing, Peoples R China; [Jiang, Dong] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China	Shanghai University of Traditional Chinese Medicine; Southwest University - China; Chinese Academy of Agricultural Sciences	Li, YM (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China.	ymlius@163.com; chuang.shutcm@gmail.com; zzqswu@yahoo.com	Guo, Lu/AAZ-7783-2020	Guo, Lu/0000-0003-2121-6401	National Natural Science Foundation of China [31171930]; Fundamental Research Funds for the Central Universities [XDJK2013A014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the the National Natural Science Foundation of China (31171930) and the Fundamental Research Funds for the Central Universities (XDJK2013A014). All surgery was performed under ethyl urethane anesthesia, and all efforts were made to minimize suffering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, OVERVIEW CITRUS AURA, DOI DOI 10.5897/AJPS; Bok SH, 1999, J NUTR, V129, P1182, DOI 10.1093/jn/129.6.1182; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Committee CP, 2005, CHINESE PHARMACOPOEI, P1; Demonty I, 2010, J NUTR, V140, P1615, DOI 10.3945/jn.110.124735; Ding XB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/678592; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galleano M, 2012, ANN NY ACAD SCI, V1259, P87, DOI 10.1111/j.1749-6632.2012.06511.x; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Goto T, 2011, AM J PHYSIOL-ENDOC M, V301, pE1022, DOI 10.1152/ajpendo.00061.2011; Hong HJ, 2010, DANGYUJA CITRUS GRAN, P361; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Hung JY, 2010, LUNG CANCER, V68, P366, DOI 10.1016/j.lungcan.2009.08.013; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Jang HD, 2010, FOOD CHEM, V118, P554, DOI 10.1016/j.foodchem.2009.05.020; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Kang SI, 2012, BIOL PHARM BULL, V35, P223, DOI 10.1248/bpb.35.223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Lee YS, 2011, PHYTOMEDICINE, V18, P648, DOI 10.1016/j.phymed.2010.11.005; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lien DN, 2010, VNU J SCI NAT SCI TE, V26, P224; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Mulvihill EE, 2012, PPAR RES, V2012, DOI 10.1155/2012/857142; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; Park HJ, 2013, J NUTR BIOCHEM, V24, P419, DOI 10.1016/j.jnutbio.2011.12.009; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Raasmaja A, 2013, FOOD CHEM, V138, P1392, DOI 10.1016/j.foodchem.2012.09.140; Ramful D, 2010, J AGR FOOD CHEM, V58, P11119, DOI 10.1021/jf102762s; Roza JM, 2007, ALTERN THER HEALTH M, V13, P44; Sharma AK, 2011, BRIT J NUTR, V106, P1713, DOI 10.1017/S000711451100225X; Shin HS, 2011, FOOD SCI BIOTECHNOL, V20, P1235, DOI 10.1007/s10068-011-0170-y; Singhal J, 2012, CANCER PREV RES, V5, P473, DOI 10.1158/1940-6207.CAPR-11-0318; Steiner G, 2001, LANCET, V357, P905; Tanaka T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/516981; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Wang YC, 2008, FOOD CHEM, V106, P277, DOI 10.1016/j.foodchem.2007.05.086; Wu SJ, 2011, AFR J BIOTECHNOL, V10, P7668; Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084; Zarina Z., 2013, International Food Research Journal, V20, P313; Zhang Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/374936; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	43	47	50	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77915	10.1371/journal.pone.0077915	http://dx.doi.org/10.1371/journal.pone.0077915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147098	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400142
J	Shen, H; Gelberman, RH; Silva, MJ; Sakiyama-Elbert, SE; Thomopoulos, S				Shen, Hua; Gelberman, Richard H.; Silva, Matthew J.; Sakiyama-Elbert, Shelly E.; Thomopoulos, Stavros			BMP12 induces tenogenic differentiation of adipose-derived stromal cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; CHONDROGENIC DIFFERENTIATION; TENDON; MARROW; REPAIR; EXPRESSION; CARTILAGE; SCLERAXIS; GROWTH	Adipose-derived stromal cells (ASCs) are pluripotent cells that have the capacity to differentiate into tendon fibroblasts (TFs). They are abundant in adults, easy to access, and are therefore an ideal cell source for tendon tissue engineering. Despite this potential, the molecular cues necessary for tenogenic differentiation of ASCs are unknown. Unlike other bone morphogenetic proteins (BMPs), BMP12, BMP13, and BMP14 have been reported to be less osteo-chondrogenic and to induce tendon rather than bone formation in vivo. This study investigated the effects of BMP12 and BMP14 on ASC differentiation in vitro. In canine ASCs, BMP12 effectively increased the expression of the tendon markers scleraxis and tenomodulin at both mRNA and protein levels. Consistent with these results, BMP12 induced scleraxis promoter driven-GFP and tenomodulin protein expression in mouse ASCs. Although BMP12 also enhanced the expression of the cartilage matrix gene aggrecan in ASCs, the resulting levels remained considerably lower than those detected in tendon fibroblasts. In addition, BMP12 reduced expression of the bone marker osteocalcin, but not the osteogenic transcription factor runx-2. BMP14 exhibited similar, but marginally less potent and selective effects, compared to BMP12. BMPs are known to signal through the canonical Smad pathway and the non-canonical mitogen-activated protein kinase (MAPK) pathway. BMP12 triggered robust phosphorylation of Smad1/5/8 but not Smad2/3 or p38 MAPK in ASCs. The effect was likely conveyed by type I receptors ALK2/3/6, as phosphorylation of Smad1/5/8 was blocked by the ALK2/3/6 inhibitor LDN-193189 but not by the ALK4/5/7 inhibitor SB-505124. Moreover, ALK6 was found to be the most abundant type I receptor in ASCs, with mRNA expression 100 to 10,000 times that of any other type I receptor. Collectively, results support the conclusion that BMP12 induces tenogenic differentiation of ASCs via the Smad1/5/8 pathway.	[Shen, Hua; Gelberman, Richard H.; Silva, Matthew J.; Thomopoulos, Stavros] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Thomopoulos, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	thomopouloss@wudosis.wustl.edu	Sakiyama-Elbert, Shelly/A-6753-2008	Sakiyama-Elbert, Shelly/0000-0003-4832-5851; Silva, Matthew/0000-0001-7375-4522	NIH [AR062947]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was funded by the NIH (AR062947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010; GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X; Gimble Jeffrey M, 2011, Front Biosci (Schol Ed), V3, P69, DOI 10.2741/s133; Gruber R, 2000, CYTOKINE, V12, P1630, DOI 10.1006/cyto.2000.0760; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; HORIBE S, 1990, J ORTHOPAED RES, V8, P167, DOI 10.1002/jor.1100080203; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Lou JR, 1999, CLIN ORTHOP RELAT R, P333; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75; Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Rozemuller H, 2010, STEM CELLS DEV, V19, P1911, DOI 10.1089/scd.2009.0510; SCHELLENBERG A, 2013, STEM CELLS AGING MET, V976, P143; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma P, 2008, DISABIL REHABIL, V30, P1733, DOI 10.1080/09638280701788274; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silva Matthew J, 2002, J Orthop Sci, V7, P508, DOI 10.1007/s007760200090; Steurer Michael, 2008, BMC Res Notes, V1, P71, DOI 10.1186/1756-0500-1-71; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Valcourt U, 1999, EXP CELL RES, V251, P264, DOI 10.1006/excr.1999.4584; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515	57	62	67	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77613	10.1371/journal.pone.0077613	http://dx.doi.org/10.1371/journal.pone.0077613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155967	gold, Green Published			2022-12-25	WOS:000325887300101
J	Welch, KC; Allalou, A; Sehgal, P; Cheng, J; Ashok, A				Welch, Kenneth C., Jr.; Allalou, Amina; Sehgal, Prateek; Cheng, Jason; Ashok, Aarthi			Glucose Transporter Expression in an Avian Nectarivore: The Ruby-Throated Hummingbird (Archilochus colubris)	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IN-VIVO; DIFFERENTIAL EXPRESSION; CARBOHYDRATE-METABOLISM; TISSUE DISTRIBUTION; PASSER-DOMESTICUS; BROILER-CHICKENS; FUEL SELECTION; INGESTED SUGAR; INSULIN	Glucose transporter (GLUT) proteins play a key role in the transport of monosaccharides across cellular membranes, and thus, blood sugar regulation and tissue metabolism. Patterns of GLUT expression, including the insulin-responsive GLUT4, have been well characterized in mammals. However, relatively little is known about patterns of GLUT expression in birds with existing data limited to the granivorous or herbivorous chicken, duck and sparrow. The smallest avian taxa, hummingbirds, exhibit some of the highest fasted and fed blood glucose levels and display an unusual ability to switch rapidly and completely between endogenous fat and exogenous sugar to fuel energetically expensive hovering flight. Despite this, nothing is known about the GLUT transporters that enable observed rapid rates of carbohydrate flux. We examined GLUT (GLUT1, 2, 3, & 4) expression in pectoralis, leg muscle, heart, liver, kidney, intestine and brain from both zebra finches (Taeniopygia guttata) and ruby-throated hummingbirds (Archilochus colubris). mRNA expression of all four transporters was probed using reverse-transcription PCR (RT-PCR). In addition, GLUT1 and 4 protein expression were assayed by western blot and immunostaining. Patterns of RNA and protein expression of GLUT1-3 in both species agree closely with published reports from other birds and mammals. As in other birds, and unlike in mammals, we did not detect GLUT4. A lack of GLUT4 correlates with hyperglycemia and an uncoupling of exercise intensity and relative oxidation of carbohydrates in hummingbirds. The function of GLUTs present in hummingbird muscle tissue (e. g. GLUT1 and 3) remain undescribed. Thus, further work is necessary to determine if high capillary density, and thus surface area across which cellular-mediated transport of sugars into active tissues (e. g. muscle) occurs, rather than taxon-specific differences in GLUT density or kinetics, can account for observed rapid rates of sugar flux into these tissues.	[Welch, Kenneth C., Jr.; Allalou, Amina; Sehgal, Prateek; Cheng, Jason; Ashok, Aarthi] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough	Welch, KC (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.	kwelch@utsc.utoronto.ca	Welch, Kenneth C./F-1276-2011	Welch, Kenneth C./0000-0002-3283-6510; Allalou, Amina/0000-0002-2414-0206	Natural Sciences and Engineering Research Council (NSERC) of Canada [386466]; Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF) [25326]; Ontario Research Fund - Research Infrastructure Program (ORF-RIP) [25326]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF)(Canada Foundation for Innovation); Ontario Research Fund - Research Infrastructure Program (ORF-RIP)	This study was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant #386466 (http://www.nserc-crsng.gc.ca/index_eng.asp), Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF) grant #25326 (http://www.innovation.ca/), and Ontario Research Fund - Research Infrastructure Program (ORF-RIP) grant #25326 (http://www.ontario.ca/business-and-economy/ontario-research-fund) to KCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1975, ACTA PHYSIOL SCAND, V95, P203, DOI 10.1111/j.1748-1716.1975.tb10043.x; BAKER H G, 1975, Biotropica, V7, P37, DOI 10.2307/2989798; Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; Bertoldo A, 2006, DIABETES, V55, P3028, DOI 10.2337/db06-0762; Beuchat CA, 1998, COMP BIOCHEM PHYS A, V120, P409, DOI 10.1016/S1095-6433(98)10039-9; BONADONNA RC, 1993, DIABETES, V42, P191, DOI 10.2337/diabetes.42.1.191; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Brozinick JT, 1997, BIOCHEM J, V321, P75, DOI 10.1042/bj3210075; Carver FM, 2001, CELL MOL LIFE SCI, V58, P645, DOI 10.1007/PL00000887; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Chen CCW, FUNCT ECOL IN PRESS; CHEN KK, 1945, J PHARMACOL EXP THER, V84, P74; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Chida Y, 2000, COMP BIOCHEM PHYS C, V126, P187, DOI 10.1016/S0742-8413(00)00111-0; CODERRE L, 1995, J BIOL CHEM, V270, P27584, DOI 10.1074/jbc.270.46.27584; Croissant JD, 2000, J BIOL CHEM, V275, P1944, DOI 10.1074/jbc.275.3.1944; DIAMOND JM, 1986, NATURE, V320, P62, DOI 10.1038/320062a0; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fueger PT, 2004, ENDOCRINOLOGY, V145, P4912, DOI 10.1210/en.2004-0465; FURLER SM, 1991, AM J PHYSIOL, V261, pE337, DOI 10.1152/ajpendo.1991.261.3.E337; Gaudreault N, 2004, DIABETOLOGIA, V47, P2081, DOI 10.1007/s00125-004-1583-4; Grinyer I, 1969, CAN J ZOOL; HABER RS, 1993, ENDOCRINOLOGY, V132, P2538, DOI 10.1210/en.132.6.2538; Hall JR, 2006, J EXP BIOL, V209, P4490, DOI 10.1242/jeb.02532; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KARASOV WH, 1986, AUK, V103, P453, DOI 10.1093/auk/103.3.453; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Kristiansen S, 1997, AM J PHYSL ENDOC M; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauritzen HPMM, 2008, DIABETES, V57, P315, DOI 10.2337/db06-1578; MATHIEUCOSTELLO O, 1992, RESP PHYSIOL, V89, P113, DOI 10.1016/0034-5687(92)90075-8; McClelland GB, 2004, COMP BIOCHEM PHYS B, V139, P443, DOI 10.1016/j.cbpc.2004.07.003; McWhorter TJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P313, DOI 10.1086/316753; McWhorter TJ, 2006, BIOL LETT-UK, V2, P131, DOI 10.1098/rsbl.2005.0388; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; POST RL, 1961, J BIOL CHEM, V236, P269; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stuart CA, 2000, AM J PHYSIOL-ENDOC M, V279, pE855, DOI 10.1152/ajpendo.2000.279.4.E855; Suarez RK, 2011, J EXP BIOL, V214, P172, DOI 10.1242/jeb.047936; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; SUAREZ RK, 1990, P NATL ACAD SCI USA, V87, P9207, DOI 10.1073/pnas.87.23.9207; SUAREZ RK, 1991, P NATL ACAD SCI USA, V88, P4870, DOI 10.1073/pnas.88.11.4870; Sweazea KL, 2006, COMP BIOCHEM PHYS B, V144, P387, DOI 10.1016/j.cbpb.2006.04.009; Sweazea KL, 2006, COMP BIOCHEM PHYS B, V144, P263, DOI 10.1016/j.cbpb.2005.12.027; Sweazea KL, 2005, J EXP ZOOL PART A, V303A, P143, DOI 10.1002/jez.a.131; Teerijoki H, 2000, BBA-GENE STRUCT EXPR, V1494, P290, DOI 10.1016/S0167-4781(00)00216-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tokushima Y, 2005, COMP BIOCHEM PHYS B, V141, P43, DOI 10.1016/j.cbpc.2005.01.008; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Weber JM, 2004, INT CONGR SER, V1275, P22, DOI 10.1016/j.ics.2004.09.043; Welch KC, 2007, J EXP BIOL, V210, P2154, DOI 10.1242/jeb.005363; Welch KC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1082, DOI 10.1086/507665; Welch KC, 2009, COMP BIOCHEM PHYS B, V152, P324, DOI 10.1016/j.cbpb.2008.12.013; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; ZIERATH JR, 1995, BIOCHEM J, V311, P517, DOI 10.1042/bj3110517	64	18	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77003	10.1371/journal.pone.0077003	http://dx.doi.org/10.1371/journal.pone.0077003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155916	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300050
J	Bibault, JE; Dewas, S; Vautravers-Dewas, C; Hollebecque, A; Jarraya, H; Lacornerie, T; Lartigau, E; Mirabel, X				Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Hollebecque, Antoine; Jarraya, Hajer; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier			Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity	PLOS ONE			English	Article							PHASE-I; RADIOTHERAPY; TUMORS; REIRRADIATION; CANCER	Purpose: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife (R) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control and overall survival following this treatment. Patients and Methods: 75 patients with 96 liver-confined HCC were treated with SBRT at the Oscar Lambret Comprehensive Cancer Center. Fiducials were implanted in the liver before treatment and were used as markers to track the lesion's movement. Treatment response was scored according to RECIST v1.1. Local control and overall survival were calculated using the Kaplan and Meier method. A stepwise multivariate analysis (Cox regression) of prognostic factors was performed for local control and overall survival. Results: There were 67 patients with Child-Turcotte-Pugh (CTP) Class A and eight patients with CTP Class B. Treatment was administered in three sessions. A total dose of 40-45 Gy to the 80% isodose line was delivered. The median follow-up was 10 months (range, 3-49 months). The local control rate was 89.8% at 1 and 2 years. Overall survival was 78.5% and 50.4% at 1 and 2 years, respectively. Toxicity mainly consisted of grade 1 and grade 2 events. Higher alpha-fetoprotein (aFP) levels were associated with less favorable local control (HR= 1.001; 95% CI [1.000, 1.002]; p=0.0063). A higher dose was associated with better local control (HR= 0.866; 95% CI [0.753, 0.996]; p= 0.0441). A Child-Pugh score higher than 5 was associated with worse overall survival (HR= 3.413; 95% CI [1.235, 9.435]; p= 0.018). Conclusion: SBRT affords good local tumor control and higher overall survival rates than other historical controls (best supportive care or sorafenib). High aFP levels were associated with lesser local control, but a higher treatment dose improved local control.	[Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier] Acad Radiat Oncol Dept, Lille, France; [Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier] Univ Lille 2, CLCC Oscar Lambret, Lille, France; [Hollebecque, Antoine] Univ Paris, Inst Gustave Roussy, Dept Med, Villejuif, France; [Jarraya, Hajer] CLCC Oscar Lambret, Dept Radiol, Lille, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Centre Oscar Lambret	Mirabel, X (corresponding author), Acad Radiat Oncol Dept, Lille, France.	x-mirabel@o-lambret.fr	Hollebecque, Antoine/M-2695-2013; lartigau, eric/GSI-5327-2022	Hollebecque, Antoine/0000-0003-2869-7551; Lacornerie, Thomas/0000-0001-8994-5999; Bibault, Jean-Emmanuel/0000-0002-1728-6776	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; BLOMGREN H, 1995, ACTA ONCOL, V34, P861, DOI 10.3109/02841869509127197; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Comet B, 2012, INT J RADIAT ONCOL, V84, P203, DOI 10.1016/j.ijrobp.2011.11.054; Dewas S, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-166; Dewas S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-77; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feng M, 2011, SEMIN RADIAT ONCOL, V21, P271, DOI 10.1016/j.semradonc.2011.05.002; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Kang J-K, 2012, CANCER; Klein J, 2013, INT J RADIAT ONCOL, V87, P22, DOI 10.1016/j.ijrobp.2012.08.043; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lencioni R, 2012, SEMIN ONCOL, V39, P503, DOI 10.1053/j.seminoncol.2012.05.004; Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; McGinn CJ, 1998, J CLIN ONCOL, V16, P2246, DOI 10.1200/JCO.1998.16.6.2246; Romero AM, 2006, ACTA ONCOL, V45, P831, DOI 10.1080/02841860600897934; O'Connor JK, 2012, LIVER TRANSPLANT, V18, P949, DOI 10.1002/lt.23439; Qian J, 2003, WORLD J GASTROENTERO, V9, P1885, DOI 10.3748/wjg.v9.i9.1885; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Seo YS, 2010, J SURG ONCOL, V102, P209, DOI 10.1002/jso.21593; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; Vautravers-Dewas C, 2011, INT J RADIAT ONCOL, V81, pE39, DOI 10.1016/j.ijrobp.2010.12.047; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1	29	83	90	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77472	10.1371/journal.pone.0077472	http://dx.doi.org/10.1371/journal.pone.0077472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147002	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400120
J	Yousuf, MA; Zhou, XH; Mukherjee, S; Chintakuntlawar, AV; Lee, JY; Ramke, M; Chodosh, J; Rajaiya, J				Yousuf, Mohammad A.; Zhou, Xiaohong; Mukherjee, Santanu; Chintakuntlawar, Ashish V.; Lee, Jeong Yoon; Ramke, Mirja; Chodosh, James; Rajaiya, Jaya			Caveolin-1 Associated Adenovirus Entry into Human Corneal Cells	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; ALPHA(V) INTEGRINS; TYPE-19 INFECTION; EARLY STEPS; HOST-CELLS; CLATHRIN; ENDOCYTOSIS; EXPRESSION; RECEPTOR; SIMIAN-VIRUS-40	The cellular entry of viruses represents a critical area of study, not only for viral tropism, but also because viral entry dictates the nature of the immune response elicited upon infection. Epidemic keratoconjunctivitis (EKC), caused by viruses within human adenovirus species D (HAdV-D), is a severe, ocular surface infection associated with corneal inflammation. Clathrin-mediated endocytosis has previously been shown to play a critical role in entry of other HAdV species into many host cell types. However, HAdV-D endocytosis into corneal cells has not been extensively studied. Herein, we show an essential role for cholesterol rich, lipid raft microdomains and caveolin-1, in the entry of HAdV-D37 into primary human corneal fibroblasts. Cholesterol depletion using methyl-beta-cyclodextrin (M beta CD) profoundly reduced viral infection. When replenished with soluble cholesterol, the effect of M beta CD was reversed, allowing productive viral infection. HAdV-D37 DNA was identified in caveolin-1 rich endosomal fractions after infection. Src kinase activity was also increased in caveolin-1 rich endosomal fractions after infection, and Src phosphorylation and CXCL1 induction were both decreased in caveolin-1-/-mice corneas compared to wild type mice. siRNA knock down of caveolin-1 in corneal cells reduced chemokine induction upon viral infection, and caveolin-1-/-mouse corneas showed reduced cellular entry of HAdV-D37. As a control, HAdV-C2, a non-corneal pathogen, appeared to utilize the caveolar pathway for entry into A549 cells, but failed to infect corneal cells entirely, indicating virus and cell specific tropism. Immuno-electron microscopy confirmed the presence of caveolin-1 in HAdV-D37-containing vesicles during the earliest stages of viral entry. Collectively, these experiments indicate for the first time that HAdV-D37 uses a lipid raft mediated caveolin-1 associated pathway for entry into corneal cells, and connects the processes of viral entry with downstream proinflammatory cell signaling.	[Yousuf, Mohammad A.; Zhou, Xiaohong; Mukherjee, Santanu; Chintakuntlawar, Ashish V.; Lee, Jeong Yoon; Ramke, Mirja; Chodosh, James; Rajaiya, Jaya] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rajaiya, J (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.	jaya_rajaiya@meei.harvard.edu	Mukherjee, Santanu/AAF-1684-2020	Mukherjee, Santanu/0000-0001-8344-7200; Rajaiya, Jaya/0000-0002-4559-5613; Mittermaier, Mirja/0000-0003-0678-6676; Chintakuntlawar, Ashish/0000-0002-2907-6522	national Institutes of Health (NIH) [EY013124, EY021558, EY014104]; Research to Prevent Blindness Senior Scientific Investigator Award; Falk Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY013124, R01EY021558, P30EY014104] Funding Source: NIH RePORTER	national Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); Falk Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by national Institutes of Health (NIH) grants EY013124, EY021558, and EY014104, a Research to Prevent Blindness Senior Scientific Investigator Award (JC), the Falk Foundation, and the Massachusetts Lions Eye Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Cheshenko N, 2005, J BIOL CHEM, V280, P31116, DOI 10.1074/jbc.M503518200; Chintakuntlawar AV, 2007, INVEST OPHTH VIS SCI, V48, P781, DOI 10.1167/iovs.06-1036; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Chodosh J, 2000, INVEST OPHTH VIS SCI, V41, P783; Colin M, 2005, MOL THER, V11, P224, DOI 10.1016/j.ymthe.2004.10.007; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dunn EF, 2012, PROG MOL BIOL TRANSL, V106, P223, DOI 10.1016/B978-0-12-396456-4.00002-X; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; FAG JA, 2003, SUBCELLULAR FRACTION; Gilbert JM, 2000, J VIROL, V74, P8582, DOI 10.1128/JVI.74.18.8582-8588.2000; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guo CJ, 2011, J VIROL, V85, P6416, DOI 10.1128/JVI.01500-10; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; HORWITZ M, 1996, FIELDS VIROLOGY; Iacobelli-Martinez M, 2005, J VIROL, V79, P11259, DOI 10.1128/JVI.79.17.11259-11268.2005; Iacobelli-Martinez M, 2007, J VIROL, V81, P1305, DOI 10.1128/JVI.01926-06; Kalin S, 2010, J VIROL, V84, P5336, DOI 10.1128/JVI.02494-09; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Lauer KP, 2004, J GEN VIROL, V85, P2615, DOI 10.1099/vir.0.80118-0; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; Meier O, 2005, J VIROL, V79, P2604, DOI 10.1128/JVI.79.4.2604-2613.2005; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Natarajan K, 2003, J IMMUNOL, V170, P6234, DOI 10.4049/jimmunol.170.12.6234; Nemerow GR, 2009, MOL THER, V17, P1490, DOI 10.1038/mt.2009.177; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Rajaiya J, 2009, MOL VIS, V15, P2879; Rajaiya J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-17; Rajala MS, 2005, J VIROL, V79, P12332, DOI 10.1128/JVI.79.19.12332-12341.2005; Rauma T, 1999, J VIROL, V73, P9664, DOI 10.1128/JVI.73.11.9664-9668.1999; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Robinson CM, 2013, MBIO, V4, DOI 10.1128/mBio.00595-12; Robinson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-213; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sakurai F, 2006, GENE THER, V13, P1118, DOI 10.1038/sj.gt.3302749; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Schlormann W, 2010, HISTOCHEM CELL BIOL, V133, P223, DOI 10.1007/s00418-009-0651-8; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Stuart AD, 2002, J VIROL, V76, P9307, DOI 10.1128/JVI.76.18.9307-9322.2002; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thomas KW, 2002, J BIOL CHEM, V277, P492, DOI 10.1074/jbc.M108107200; Thorley JA, 2010, PROTOPLASMA, V244, P15, DOI 10.1007/s00709-010-0152-6; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Wang YH, 2009, J CLIN INVEST, V119, P1604, DOI 10.1172/JCI37905; Wang ZJ, 2009, ACS NANO, V3, P4110, DOI 10.1021/nn9012274; Westermann M, 1999, HISTOCHEM CELL BIOL, V111, P71, DOI 10.1007/s004180050335; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xiao JN, 2005, INVEST OPHTH VIS SCI, V46, P3777, DOI 10.1167/iovs.05-0724; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328	99	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77462	10.1371/journal.pone.0077462	http://dx.doi.org/10.1371/journal.pone.0077462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147000	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400119
J	Gao, S; Lu, L; Bai, Y; Zhang, P; Song, WB; Duan, CM				Gao, Shan; Lu, Ling; Bai, Yan; Zhang, Peng; Song, Weibo; Duan, Cunming			Structural and functional analysis of amphioxus HIF alpha reveals ancient features of the HIF alpha family	FASEB JOURNAL			English	Article						transactivation domain; oxygen-dependent degradation; cephalochordate; nuclear localization signal	HYPOXIA-INDUCIBLE FACTOR; TUMOR-SUPPRESSOR PROTEIN; FACTOR-I; GENE-EXPRESSION; MESENCHYMAL TRANSITION; NUCLEAR TRANSLOCATION; PROLYL HYDROXYLATION; DNA-BINDING; GROWTH; OXYGEN	Hypoxia-inducible factors (HIFs) are master regulators of the transcriptional response to hypoxia. To gain insight into the structural and functional evolution of the HIF family, we characterized the HIF alpha gene from amphioxus, an invertebrate chordate, and identified several alternatively spliced HIF alpha isoforms. Whereas HIF alpha Ia, the full-length isoform, contained a complete oxygen-dependent degradation (ODD) domain, the isoforms Ib, Ic, and Id had 1 or 2 deletions in the ODD domain. When tagged with GFP and tested in mammalian cells, the amphioxus HIF alpha Ia protein level increased in response to hypoxia or CoCl2 treatment, whereas HIF alpha Ib, Ic, and Id showed reduced or no hypoxia regulation. Deletion of the ODD sequence in HIF alpha Ia up-regulated the HIF alpha Ia levels under normoxia. Gene expression analysis revealed HIF alpha Ic to be the predominant isoform in embryos and larvae, whereas isoform Ia was the most abundant form in the adult stage. The expression levels of Ib and Id were very low. Hypoxia treatment of adults had no effect on the mRNA levels of these HIF alpha isoforms. Functional analyses in mammalian cells showed all 4 HIF alpha isoforms capable of entering the nucleus and activating hypoxia response element-dependent reporter gene expression. The functional nuclear location signal (NLS) mapped to 3 clusters of basic residues. (775)KKARL functioned as the primary NLS, but (KRK)-K-737 and (KK)-K-754 also contributed to the nuclear localization. All amphioxus HIF alpha isoforms had 2 functional transactivation domains (TADs). Its C-terminal transactivation (C-TAD) shared high sequence identity with the human HIF-1 alpha and HIF-2 alpha C-TAD. This domain contained a conserved asparagine, and its mutation resulted in an increase in transcriptional activity. These findings reveal many ancient features of the HIF alpha family and provide novel insights into the evolution of the HIF alpha family.-Gao, S., Lu, L., Bai, Y., Zhang, P., Song, W., Duan, C. Structural and functional analysis of amphioxus HIF alpha reveals ancient features of the HIF alpha family.	[Gao, Shan; Bai, Yan; Zhang, Peng; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Gao, Shan; Song, Weibo] Ocean Univ China, Sch Med & Pharm, Minist Educ, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Lu, Ling] Ocean Univ China, Sch Med & Pharm, Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China	University of Michigan System; University of Michigan; Ocean University of China; Ocean University of China	Duan, CM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	cduan@umich.edu	Zhang, Peng/I-3757-2018		U.S. National Science Foundation [IOB-0543018, IOS-1051034]; Division Of Integrative Organismal Systems [1051034] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Dr. Xungang Tan (Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China) for providing animals for the gene expression analysis; Drs. Yinlong Qiu, Ya Yang, and Wenfeng Qian (University of Michigan) for advice on the phylogenetic analysis; Dr. Jie Huang (Ocean University of China) for help with the tree computation; Dr. Eric Huang, (U.S. National Cancer Institute) for providing the pANRT construct; and Mr. Nicholas Silva (University of Michigan) for proofreading the manuscript. This work was supported by U.S. National Science Foundation grants IOB-0543018 and IOS-1051034 to C.D.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Barriga EH, 2013, J CELL BIOL, V201, P759, DOI 10.1083/jcb.201212100; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldser D, 1999, CANCER RES, V59, P3915; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han WQ, 2013, BBA-MOL CELL RES, V1833, P1454, DOI 10.1016/j.bbamcr.2013.02.029; Heidbreder M, 2003, FASEB J, V17, P1541, DOI 10.1096/fj.02-0963fje; Holland LZ, 2008, GENOME RES, V18, P1380; Holland LZ, 2010, INTEGR COMP BIOL, V50, P17, DOI 10.1093/icb/icq039; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lando D, 2000, J BIOL CHEM, V275, P4618, DOI 10.1074/jbc.275.7.4618; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Luo JC, 2001, ONCOGENE, V20, P1435, DOI 10.1038/sj.onc.1204228; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Romero NM, 2008, MOL CELL BIOL, V28, P3410, DOI 10.1128/MCB.01027-07; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Williams M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-64; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012	50	11	12	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1880	1890		10.1096/fj.12-220152	http://dx.doi.org/10.1096/fj.12-220152			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24174425	Green Submitted, Green Published			2022-12-25	WOS:000335344300032
J	Orecchia, A; Mettouchi, A; Uva, P; Simon, GC; Arcelli, D; Avitabile, S; Ragone, G; Meneguzzi, G; Pfenninger, KH; Zambruno, G; Failla, CM				Orecchia, Angela; Mettouchi, Amel; Uva, Paolo; Simon, Glenn C.; Arcelli, Diego; Avitabile, Simona; Ragone, Gianluca; Meneguzzi, Guerrino; Pfenninger, Karl H.; Zambruno, Giovanna; Failla, Cristina Maria			Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype	FASEB JOURNAL			English	Article						integrin alpha 5 beta 1; cell migration; vessel formation	PROTEIN-KINASE-C; EXTRACELLULAR-MATRIX; CROSS-TALK; INTEGRIN; MARCKS; G-ALPHA(13); RADIXIN; RHO; ALPHA(5)BETA(1); ACTIVATION	The aim of this study was to identify the molecular signals produced in human endothelial cells (ECs) by the interaction of 51 integrin with soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) present in the extracellular matrix. We generated a gene expression profile of ECs adhering to sVEGFR-1 or to fibronectin, the classic extracellular matrix ligand for 51 integrin or in a nonadhering condition. Several biological pathways were differently modulated, 3 protein kinase C substrates [adducin, myristoylated alanine-rich protein kinase C substrate (MARCKS), and radixin] were differently expressed and phosphorylated when cells adhering to sVEGFR-1 were compared with those adhering to fibronectin. Rac1 activation and G(13) protein involvement through the interaction with radixin were also detected after attachment to sVEGFR-1, and these responses depended on active VEGFR-2 signaling. On sVEGFR-1, ECs exhibited a motile phenotype that was consistent with the abundant presence of MARCKS, a stabilizer of dynamic adhesions. Moreover, ECs silenced for radixin expression no longer responded to the proangiogenic VEGFR-1-derived peptide 12. We propose that the presence of sVEGFR-1 in the EC microenvironment directs 51 integrin signaling to generate a dynamic, motile phenotype. Our findings also provide new insights into the mechanism of action of proangiogenic peptide 12, relevant to a therapeutic perspective.Orecchia, A., Mettouchi, A., Uva, P., Simon, G.C., Areclli, D., Avitabile, S., Ragone, G., Meneguzzi, G., Pfenninger, K.H., Zambruno, G., Failla, C.M. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype.	[Orecchia, Angela; Avitabile, Simona; Zambruno, Giovanna; Failla, Cristina Maria] Ist Ricovero & Cura Carattere Sci IRCCS, Ist Dermopat Immacolata, Mol & Cell Biol Lab, Rome, Italy; [Arcelli, Diego; Ragone, Gianluca] Ist Ricovero & Cura Carattere Sci IRCCS, Ist Dermopat Immacolata, Mol Oncol Lab, Rome, Italy; [Mettouchi, Amel; Meneguzzi, Guerrino] Fac Med Nice, INSERM, U634, F-06034 Nice, France; [Uva, Paolo] Ctr Adv Studies Res & Dev Sardinia CRS4, Bioinformat Lab, Cagliari, Italy; [Simon, Glenn C.; Pfenninger, Karl H.] Univ Colorado, Dept Pediat, Aurora, CO USA	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Colorado System; University of Colorado Anschutz Medical Campus	Failla, CM (corresponding author), IDI IRCCS, Mol & Cell Biol Lab, Via Monti Creta 104, I-00167 Rome, Italy.	c.failla@idi.it	Uva, Paolo/A-2877-2011; Zambruno, Giavanna/K-2933-2018; Failla, Cristina M./AAA-2881-2019	Uva, Paolo/0000-0002-9524-8492; METTOUCHI, Amel/0000-0003-1453-6482; Meneguzzi, Guerrino/0000-0002-1609-6540; Failla, Cristina/0000-0001-5991-8914; Zambruno, Giovanna/0000-0002-1295-056X	Agence Nationale de la Recherche [ANR-05135AS]; Centre National de la Recherche Scientifique; Italian Ministry of Health (Ricerca Corrente); Institut National de la Sante et de la Recherche Medicale fellowship	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Institut National de la Sante et de la Recherche Medicale fellowship	The authors thank Mauro Helmer Citterich for technical support in microarray hybridization and Maurizio Inzillo and Daniele Bartoloni for artwork. This work was supported by an Institut National de la Sante et de la Recherche Medicale fellowship to A.O. in the years 2007-2009, grants from the Agence Nationale de la Recherche (ANR-05135AS) and the Centre National de la Recherche Scientifique to A.M., and grants from the Italian Ministry of Health (Ricerca Corrente).	Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Disatnik MH, 2004, J CELL SCI, V117, P4469, DOI 10.1242/jcs.01309; Estrada-Bernal A, 2009, J CELL SCI, V122, P2300, DOI 10.1242/jcs.047860; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Gentleman R., 2011, GENEFILTER METHODS F; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; IZZARD CS, 1976, J CELL SCI, V21, P129; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Liu GQ, 2005, J BIOL CHEM, V280, P39042, DOI 10.1074/jbc.M504341200; Liu GQ, 2009, ANGIOGENESIS, V12, P1, DOI 10.1007/s10456-008-9123-3; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Orecchia A, 2003, J CELL SCI, V116, P3479, DOI 10.1242/jcs.00673; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons-Wingerter P, 2005, AM J PATHOL, V167, P193, DOI 10.1016/S0002-9440(10)62965-3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Soro S, 2008, BLOOD, V111, P3479, DOI 10.1182/blood-2007-03-077537; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Taverna D, 2001, CANCER RES, V61, P5255; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Wu J. M., 2011, GCRMA BACKGROUND ADJ; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhao Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1611, DOI 10.1152/ajpcell.2000.279.5.C1611	50	13	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					692	704		10.1096/fj.12-225771	http://dx.doi.org/10.1096/fj.12-225771			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24174428				2022-12-25	WOS:000331072200017
J	Pessentheiner, AR; Pelzmann, HJ; Walenta, E; Schweiger, M; Groschner, LN; Graier, WF; Kolb, D; Uno, K; Miyazaki, T; Nitta, A; Rieder, D; Prokesch, A; Bogner-Strauss, JG				Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Walenta, Evelyn; Schweiger, Martina; Groschner, Lukas N.; Graier, Wolfgang F.; Kolb, Dagmar; Uno, Kyosuke; Miyazaki, Toh; Nitta, Atsumi; Rieder, Dietmar; Prokesch, Andreas; Bogner-Strauss, Juliane G.			NAT8L (N-Acetyltransferase 8-Like) Accelerates Lipid Turnover and Increases Energy Expenditure in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Adipose Tissue Metabolism; Aspartate; Fatty Acid Metabolism; Lipid Metabolism; Brown Adipocytes; N-Acetylaspartate; N-Acetyltransferase 8-like; Energy Expenditure	FATTY-ACID OXIDATION; ACTIVATED-RECEPTOR-ALPHA; ADIPOSE-TISSUE; PPAR-ALPHA; MOUSE-LIVER; ACETYLASPARTATE; GENE; MITOCHONDRIA; METABOLISM; MUSCLE	Background: NAT8L (N-acetyltransferase 8-like) synthesizes N-acetylaspartate and is required for myelination in the brain. Its function in other tissues was undefined. Results:Nat8l is highly expressed in adipose tissues and impacts adipogenic marker gene expression, lipid turnover, and energy metabolism in brown adipocytes. Conclusion:Nat8l expression influences cellular bioenergetics in adipocytes. Significance: These findings establish a novel pathway in brown adipocyte metabolism. NAT8L (N-acetyltransferase 8-like) catalyzes the formation of N-acetylaspartate (NAA) from acetyl-CoA and aspartate. In the brain, NAA delivers the acetate moiety for synthesis of acetyl-CoA that is further used for fatty acid generation. However, its function in other tissues remained elusive. Here, we show for the first time that Nat8l is highly expressed in adipose tissues and murine and human adipogenic cell lines and is localized in the mitochondria of brown adipocytes. Stable overexpression of Nat8l in immortalized brown adipogenic cells strongly increases glucose incorporation into neutral lipids, accompanied by increased lipolysis, indicating an accelerated lipid turnover. Additionally, mitochondrial mass and number as well as oxygen consumption are elevated upon Nat8l overexpression. Concordantly, expression levels of brown marker genes, such as Prdm16, Cidea, Pgc1, Ppar, and particularly UCP1, are markedly elevated in these cells. Treatment with a PPAR antagonist indicates that the increase in UCP1 expression and oxygen consumption is PPAR-dependent. Nat8l knockdown in brown adipocytes has no impact on cellular triglyceride content, lipogenesis, or oxygen consumption, but lipolysis and brown marker gene expression are increased; the latter is also observed in BAT of Nat8l-KO mice. Interestingly, the expression of ATP-citrate lyase is increased in Nat8l-silenced adipocytes and BAT of Nat8l-KO mice, indicating a compensatory mechanism to sustain the acetyl-CoA pool once Nat8l levels are reduced. Taken together, our data show that Nat8l impacts on the brown adipogenic phenotype and suggests the existence of the NAT8L-driven NAA metabolism as a novel pathway to provide cytosolic acetyl-CoA for lipid synthesis in adipocytes.	[Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Walenta, Evelyn; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Schweiger, Martina] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Groschner, Lukas N.; Graier, Wolfgang F.] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Med Res Ctr, Core Facil Ultrastruct Anal, A-8010 Graz, Austria; [Uno, Kyosuke; Miyazaki, Toh; Nitta, Atsumi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 9300194, Japan; [Rieder, Dietmar] Med Univ Innsbruck, Bioctr, Div Bioinformat, A-6020 Innsbruck, Austria	Graz University of Technology; Graz University of Technology; University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Toyama; Medical University of Innsbruck	Bogner-Strauss, JG (corresponding author), Petersgasse 14-5, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Rieder, Dietmar/AAB-2609-2022; Graier, Wolfgang F./B-7052-2008; Groschner, Lukas/AHD-6319-2022; Groschner, Lukas/J-9398-2012; Nitta, Atsumi/AAF-4211-2019; PROKESCH, ANDREAS/B-6786-2019	Rieder, Dietmar/0000-0003-1754-690X; Graier, Wolfgang F./0000-0003-1871-3298; Groschner, Lukas/0000-0002-4325-0232; Groschner, Lukas/0000-0002-4325-0232; Pessentheiner, Ariane/0000-0002-5010-9528; Bogner-Strauss, Juliane/0000-0003-2459-0124; Schweiger, Martina/0000-0002-3419-1007; PROKESCH, ANDREAS/0000-0002-8487-7103	Austrian Science Fund FWF [DK-MCD W01226, P24143]; Program for Next Generation World-leading Researchers [LS047]; Smoking Research Foundation Grant for Biomedical Research; Austrian Science Fund (FWF) [P 24143] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Program for Next Generation World-leading Researchers; Smoking Research Foundation Grant for Biomedical Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF Grants DK-MCD W01226 and P24143, by Program for Next Generation World-leading Researchers Grant LS047, and by a Smoking Research Foundation Grant for Biomedical Research.	Aflaki E, 2011, J BIOL CHEM, V286, P7418, DOI 10.1074/jbc.M110.175703; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; DARNLEY AC, 1988, BIOCHEM J, V253, P351, DOI 10.1042/bj2530351; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Peng L, 2004, MECH AGEING DEV, V125, P337, DOI 10.1016/j.mad.2004.01.002; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SUGDEN MC, 1982, BIOSCIENCE REP, V2, P289, DOI 10.1007/BF01115114; Tahay G, 2012, BIOCHEM J, V441, P105, DOI 10.1042/BJ20111179; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36040	36051		10.1074/jbc.M113.491324	http://dx.doi.org/10.1074/jbc.M113.491324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24155240	Green Published, hybrid			2022-12-25	WOS:000329814700039
J	Zhou, Y; Maxwell, KN; Sezgin, E; Lu, M; Liang, H; Hancock, JF; Dial, EJ; Lichtenberger, LM; Levental, I				Zhou, Yong; Maxwell, Kelsey N.; Sezgin, Erdinc; Lu, Maryia; Liang, Hong; Hancock, John F.; Dial, Elizabeth J.; Lichtenberger, Lenard M.; Levental, Ilya			Bile Acids Modulate Signaling by Functional Perturbation of Plasma Membrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bile Acid; Lipid Raft; Membrane Bilayer; Membrane Biophysics; Membrane Lipids; Membrane Structure; Ras	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LIPID RAFTS; MODEL MEMBRANES; CELL-MEMBRANES; RAS PROTEINS; H-RAS; SPATIOTEMPORAL ORGANIZATION; PHOSPHOLIPID TRANSFER; K-RAS; VESICLES	Background: Bile acids (BAs) affect cellular membranes. Results: BAs stabilize domains in plasma membranes, leading to reorganization of membrane proteins and signaling perturbations. Conclusion: BAs affect cell function by modulating the stability of plasma membrane nanodomains. Significance: These results suggest mechanisms for regulation of functional membrane domains and nonreceptor-mediated BA signaling. Eukaryotic cell membranes are organized into functional lipid and protein domains, the most widely studied being membrane rafts. Although rafts have been associated with numerous plasma membrane functions, the mechanisms by which these domains themselves are regulated remain undefined. Bile acids (BAs), whose primary function is the solubilization of dietary lipids for digestion and absorption, can affect cells by interacting directly with membranes. To investigate whether these interactions affected domain organization in biological membranes, we assayed the effects of BAs on biomimetic synthetic liposomes, isolated plasma membranes, and live cells. At cytotoxic concentrations, BAs dissolved synthetic and cell-derived membranes and disrupted live cell plasma membranes, implicating plasma membrane damage as the mechanism for BA cellular toxicity. At subtoxic concentrations, BAs dramatically stabilized domain separation in Giant Plasma Membrane Vesicles without affecting protein partitioning between coexisting domains. Domain stabilization was the result of BA binding to and disordering the nonraft domain, thus promoting separation by enhancing domain immiscibility. Consistent with the physical changes observed in synthetic and isolated biological membranes, BAs reorganized intact cell membranes, as evaluated by the spatial distribution of membrane-anchored Ras isoforms. Nanoclustering of K-Ras, related to nonraft membrane domains, was enhanced in intact plasma membranes, whereas the organization of H-Ras was unaffected. BA-induced changes in Ras lateral segregation potentiated EGF-induced signaling through MAPK, confirming the ability of BAs to influence cell signal transduction by altering the physical properties of the plasma membrane. These observations suggest general, membrane-mediated mechanisms by which biological amphiphiles can produce their cellular effects.	[Zhou, Yong; Maxwell, Kelsey N.; Lu, Maryia; Liang, Hong; Hancock, John F.; Dial, Elizabeth J.; Lichtenberger, Lenard M.; Levental, Ilya] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Sezgin, Erdinc] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Texas System; University of Texas Health Science Center Houston; Max Planck Society	Zhou, Y (corresponding author), Suite R382,6431 Fannin St, Houston, TX 77030 USA.	yong.zhou@uth.tmc.edu; ilya.levental@uth.tmc.edu	Levental, Ilya/F-4707-2011; Sezgin, Erdinc/R-1980-2018	Levental, Ilya/0000-0002-1206-9545; Sezgin, Erdinc/0000-0002-4915-388X; Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [0GM066717]; Texas Medical Center Digestive Diseases Center [P30 DK56338]; Cancer Prevention and Research Institute of Texas Grant [R1215]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Medical Center Digestive Diseases Center; Cancer Prevention and Research Institute of Texas Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 0GM066717 (to. J. F. H.). This work was also supported by Pilot and Feasibility Grant P30 DK56338 from the Texas Medical Center Digestive Diseases Center (to Y. Z.) and Cancer Prevention and Research Institute of Texas Grant R1215 (to I. L.). L. M. L. is a founder and shareholder of PLx Pharma Inc., Houston TX.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Akare S, 2005, BBA-MOL CELL BIOL L, V1735, P59, DOI 10.1016/j.bbalip.2005.04.006; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; Caron RW, 2005, MOL CANCER THER, V4, P257; Choi JA, 2004, ONCOGENE, V23, P9, DOI 10.1038/sj.onc.1206982; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Esposito C, 2007, BIOPHYS J, V93, P3169, DOI 10.1529/biophysj.107.111922; FULLINGTON DA, 1990, BIOCHEMISTRY-US, V29, P879, DOI 10.1021/bi00456a005; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; HOFMANN AF, 1967, ANNU REV MED, V18, P333, DOI 10.1146/annurev.me.18.020167.002001; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Inder Kerry, 2008, Commun Integr Biol, V1, P178; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; LaRocca T. J., 2013, PLOS PATHOG, V9; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; MAZER NA, 1980, BIOCHEMISTRY-US, V19, P601, DOI 10.1021/bi00545a001; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; NICHOLS JW, 1986, BIOCHEMISTRY-US, V25, P4596, DOI 10.1021/bi00364a021; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; RODA A, 1983, J BIOL CHEM, V258, P6362; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHOEMAKER DG, 1990, BIOCHEMISTRY-US, V29, P5837, DOI 10.1021/bi00476a027; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Simons K, 2011, COLD SPRING HARB PER, V3; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Zhao J, 2013, BIOPHYS J, V104, P825, DOI 10.1016/j.bpj.2012.12.047; Zhou Y, 2012, J BIOL CHEM, V287, P16586, DOI 10.1074/jbc.M112.348490; Zhou Y, 2010, J BIOL CHEM, V285, P35188, DOI 10.1074/jbc.M110.141200; Zhou Y, 2010, AM J PHYSIOL-GASTR L, V298, pG722, DOI 10.1152/ajpgi.00387.2009; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811; Zhou Y, 2009, BBA-BIOMEMBRANES, V1788, P507, DOI 10.1016/j.bbamem.2008.12.008; Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x	62	64	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35660	35670		10.1074/jbc.M113.519116	http://dx.doi.org/10.1074/jbc.M113.519116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165125	hybrid, Green Published			2022-12-25	WOS:000329814700005
J	Ogura, Y; Mishra, V; Hindi, SM; Kuang, SH; Kumar, A				Ogura, Yuji; Mishra, Vivek; Hindi, Sajedah M.; Kuang, Shihuan; Kumar, Ashok			Proinflammatory Cytokine Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) Suppresses Satellite Cell Self-renewal through Inversely Modulating Notch and NF-kappa B Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Action; Inflammation; NF-B; Notch Pathway; Signaling; Skeletal Muscle; Stem Cells; Tumor Necrosis Factor (TNF); TWEAK; Satellite Cells; Self-renewal; Notch	SKELETAL-MUSCLE; REGULATORY FACTORS; TARGETED ABLATION; CROSS-TALK; MYOD; ACTIVATION; EXPRESSION; PROMOTES; PAX7; REGENERATION	Background: TNF-like weak inducer of apoptosis (TWEAK) cytokine is an important regulator of inflammation and skeletal muscle mass. Results: TWEAK represses Pax7 expression and Notch signaling and activates NF-B in satellite cells. Conclusion: TWEAK suppresses satellite cell self-renewal through reciprocally regulating Notch and NF-B signaling. Significance: Inhibition of TWEAK can be used as a therapeutic approach to maintain the satellite cell pool in skeletal muscle. Satellite cell self-renewal is an essential process to maintaining the robustness of skeletal muscle regenerative capacity. However, extrinsic factors that regulate self-renewal of satellite cells are not well understood. Here, we demonstrate that TWEAK cytokine reduces the proportion of Pax7(+)/MyoD(-) cells (an index of self-renewal) on myofiber explants and represses multiple components of Notch signaling in satellite cell cultures. The number of Pax7(+) cells is significantly increased in skeletal muscle of TWEAK knock-out (KO) mice compared with wild-type in response to injury. Furthermore, Notch signaling is significantly elevated in cultured satellite cells and in regenerating myofibers of TWEAK-KO mice. Forced activation of Notch signaling through overexpression of the Notch1 intracellular domain (N1ICD) rescued the TWEAK-mediated inhibition of satellite cell self-renewal. TWEAK also activates the NF-B transcription factor in satellite cells and inhibition of NF-B significantly improved the number of Pax7(+) cells in TWEAK-treated cultures. Furthermore, our results demonstrate that a reciprocal interaction between NF-B and Notch signaling governs the inhibitory effect of TWEAK on satellite cell self-renewal. Collectively, our study demonstrates that TWEAK suppresses satellite cell self-renewal through activating NF-B and repressing Notch signaling.	[Ogura, Yuji; Mishra, Vivek; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of Louisville; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kumar, A (corresponding author), 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kuang, Shihuan/0000-0001-9180-3180; Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1AR059810, RO1AG029623]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AR059810 and RO1AG029623 (to A. K.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; GUO K, 1995, MOL CELL BIOL, V15, P3823; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He W. A., 2013, J CLIN INVEST, DOI 10.1172/JCI68523; Hindi SM, 2012, MOL CELL BIOL, V32, P4833, DOI 10.1128/MCB.00717-12; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Relaix F, 2009, CURR OPIN CELL BIOL, V21, P748, DOI 10.1016/j.ceb.2009.10.002; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	56	33	40	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35159	35169		10.1074/jbc.M113.517300	http://dx.doi.org/10.1074/jbc.M113.517300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151074	Green Published, hybrid			2022-12-25	WOS:000329867600017
J	Park, KH; Kim, BJ; Shawl, AI; Han, MK; Lee, HC; Kim, UH				Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Han, Myung-Kwan; Lee, Hon Cheung; Kim, Uh-Hyun			Autocrine/Paracrine Function of Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) for Glucose Homeostasis in Pancreatic beta-Cells and Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Beta Cell; Calcium Signaling; Diabetes; NAADP	CYCLIC-ADP-RIBOSE; CA2+; CALCIUM; CD38; HYDROLYSIS; AGONIST; CYCLASE; ACINAR; 2ND-MESSENGER; ACTIVATION	Background: External application of a Ca2+-mobilizing messenger, NAADP, to -cells activates intracellular Ca2+ changes and stimulates insulin secretion. Results: NAADP is transported into adipocytes and -cells in a glucose-dependent manner and is also released from pancreatic islets upon stimulation by high glucose. Conclusion: NAADP functions in an auto-/paracrine manner to regulate glucose homeostasis. Significance: NAADP can be exploited as a potential antidiabetic agent. Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger for mobilizing Ca2+ from intracellular stores in various cell types. Extracellular application of NAADP has been shown to elicit intracellular Ca2+ signals, indicating that it is readily transported into cells. However, little is known about the functional role of this NAADP uptake system. Here, we show that NAADP is effectively transported into selected cell types involved in glucose homeostasis, such as adipocytes and pancreatic -cells, but not the acinar cells, in a high glucose-dependent manner. NAADP uptake was inhibitable by Ned-19, a NAADP mimic; dipyridamole, a nucleoside inhibitor; or NaN3, a metabolic inhibitor or under Ca2+-free conditions. Furthermore, NAADP was found to be released from pancreatic islets upon stimulation by high glucose. Consistently, administration of NAADP to type 2 diabetic mice improved glucose tolerance. We propose that NAADP is functioning as an autocrine/paracrine hormone important in glucose homeostasis. NAADP is thus a potential antidiabetic agent with therapeutic relevance.	[Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Ca2, Signaling Network, Jeonju 561180, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561180, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561180, South Korea; [Lee, Hon Cheung] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Peking University; University Town of Shenzhen	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Keumam Dong San 2-20, Jeonju 561180, South Korea.	uhkim@chonbuk.ac.kr	Lee, Hon Cheung/C-4329-2009	Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation [2012R1A3A2026453]; Korean government; Research Grants Council of Hong Kong [768408, 769309, 770610, 770111, 769912]	National Research Foundation; Korean government(Korean Government); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Research Foundation Grant 2012R1A3A2026453 funded by the Korean government (to U.-H. K.) and by Research Grants Council of Hong Kong Grants 768408, 769309, 770610, 770111, and 769912 (to H. C. L).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2002, DIABETES, V51, pS349, DOI 10.2337/diabetes.51.2007.S349; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Shawl AI, 2009, ISLETS, V1, P216, DOI 10.4161/isl.1.3.9646; SHIBATA A, 1976, DIABETES, V25, P667, DOI 10.2337/diabetes.25.8.667; Singaravelu K, 2006, CELL CALCIUM, V39, P143, DOI 10.1016/j.ceca.2005.10.001; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	37	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35548	35558		10.1074/jbc.M113.489278	http://dx.doi.org/10.1074/jbc.M113.489278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165120	Green Published, hybrid			2022-12-25	WOS:000329867600049
J	Bag, P; Ojha, D; Mukherjee, H; Halder, UC; Mondal, S; Chandra, NS; Nandi, S; Sharon, A; Sarkar, MC; Chakrabarti, S; Chattopadhyay, D				Bag, Paromita; Ojha, Durbadal; Mukherjee, Hemanta; Halder, Umesh Chandra; Mondal, Supriya; Chandra, Nidhi S.; Nandi, Suman; Sharon, Ashoke; Sarkar, Mamta Chawla; Chakrabarti, Sekhar; Chattopadhyay, Debprasad			An Indole Alkaloid from a Tribal Folklore Inhibits Immediate Early Event in HSV-2 Infected Cells with Therapeutic Efficacy in Vaginally Infected Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACYCLOVIR-RESISTANT; GENITAL HERPES; IN-VITRO; SIMPLEX; HARMALINE; GENE; ACTIVATION; MECHANISMS; HARMINE	Herpes genitalis, caused by HSV-2, is an incurable genital ulcerative disease transmitted by sexual intercourse. The virus establishes life-long latency in sacral root ganglia and reported to have synergistic relationship with HIV-1 transmission. Till date no effective vaccine is available, while the existing therapy frequently yielded drug resistance, toxicity and treatment failure. Thus, there is a pressing need for non-nucleotide antiviral agent from traditional source. Based on ethnomedicinal use we have isolated a compound 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole (HM) from the traditional herb Ophiorrhiza nicobarica Balkr, and evaluated its efficacy on isolates of HSV-2 in vitro and in vivo. The cytotoxicity (CC50), effective concentrations (EC50) and the mode of action of HM was determined by MTT, plaque reduction, time-of-addition, immunofluorescence (IFA), Western blot, qRT-PCR, EMSA, supershift and co-immunoprecipitation assays; while the in vivo toxicity and efficacy was evaluated in BALB/c mice. The results revealed that HM possesses significant anti-HSV-2 activity with EC50 of 1.1-2.8 mu g/ml, and selectivity index of >20. The time kinetics and IFA demonstrated that HM dose dependently inhibited 50-99% of HSV-2 infection at 1.5-5.0 mu g/ml at 2-4 h post-infection. Further, HM was unable to inhibit viral attachment or penetration and had no synergistic interaction with acyclovir. Moreover, Western blot and qRT-PCR assays demonstrated that HM suppressed viral IE gene expression, while the EMSA and co-immunoprecipitation studies showed that HM interfered with the recruitment of LSD-1 by HCF-1. The in vivo studies revealed that HM at its virucidal concentration was nontoxic and reduced virus yield in the brain of HSV-2 infected mice in a concentration dependent manner, compared to vaginal tissues. Thus, our results suggest that HM can serve as a prototype to develop non-nucleotide antiviral lead targeting the viral IE transcription for the management of HSV-2 infections.	[Bag, Paromita; Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Chandra, Nidhi S.; Chakrabarti, Sekhar; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata, India; [Halder, Umesh Chandra; Nandi, Suman; Sarkar, Mamta Chawla; Chakrabarti, Sekhar] Natl Inst Cholera & Enter Dis, Kolkata, India; [Sharon, Ashoke] Birla Inst Technol, Dept Appl Chem, Ranchi, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Birla Institute of Technology Mesra	Chattopadhyay, D (corresponding author), ID & BG Hosp, ICMR Virus Unit, Kolkata, India.	debprasadc@yahoo.co.in	Sharon, Ashoke/C-3916-2009; Sharon, Ashoke/GYU-7600-2022	Sharon, Ashoke/0000-0001-5738-1607; Sharon, Ashoke/0000-0001-5738-1607; CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X	Department of Biotechnology [BT/PR13759/PBD/ 17/686/2010]; Indian Council of Medical Research, New Delhi [45/2 /2010/PHA -BMS]	Department of Biotechnology; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The authors acknowledge financial support from the Department of Biotechnology (BT/PR13759/PBD/ 17/686/2010) and the Indian Council of Medical Research (45/2 /2010/PHA -BMS), New Delhi. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Bag P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-98; Berrougui H, 2006, PHARMACOL RES, V54, P150, DOI 10.1016/j.phrs.2006.04.001; CHATIS PA, 1991, VIROLOGY, V180, P793, DOI 10.1016/0042-6822(91)90093-Q; Chattopadhyay D, 2006, CHEMOTHERAPY, V52, P151, DOI 10.1159/000092859; Chattopadhyay Debprasad, 2007, Oriental Pharmacy and Experimental Medicine, V7, P395; Chiang LC, 2003, J ANTIMICROB CHEMOTH, V52, P194, DOI 10.1093/jac/dkg291; COCKTON JR, 1952, J PHARM PHARMACOL, V4, P959, DOI 10.1111/j.2042-7158.1952.tb13229.x; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DAGAR HS, 1991, ECON BOT, V45, P114, DOI 10.1007/BF02860056; FELSER JM, 1988, J VIROL, V62, P2076, DOI 10.1128/JVI.62.6.2076-2082.1988; Frazia SL, 2006, ANTIVIR THER, V11, P995; Ghosh S, 2012, J ETHNOPHARMACOL, V142, P714, DOI 10.1016/j.jep.2012.05.048; GIUS D, 1989, J VIROL, V63, P555, DOI 10.1128/JVI.63.2.555-563.1989; GNANN JW, 1983, PHARMACOTHERAPY, V3, P275; Habif T, 2004, WARTS HERPES SIMPLEX, P381; Jahaniani F, 2005, PHYTOCHEMISTRY, V66, P1581, DOI 10.1016/j.phytochem.2005.04.035; Kanekiyo K, 2007, BIOL PHARM BULL, V30, P1573, DOI 10.1248/bpb.30.1573; Khandelwal M, 2006, OBSTET GYNECOL, V107, P740, DOI 10.1097/01.AOG.0000202543.49213.6c; King NJC, 1998, J IMMUNOL, V160, P1173; Kleymann Gerald, 2003, Herpes, V10, P46; Kurokawa M, 2001, J PHARMACOL EXP THER, V297, P372; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Mayaud P, 2001, BRIT MED BULL, V58, P129, DOI 10.1093/bmb/58.1.129; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; OSTROVE JM, 1987, J VIROL, V61, P3726, DOI 10.1128/JVI.61.12.3726-3732.1987; Piret J, 2002, ANTIMICROB AGENTS CH, V46, P2933, DOI 10.1128/AAC.46.9.2933-2942.2002; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Sandri-Goldin RM., 2006, ALPH HERP MOL CELL; Shia SY, 2007, J CHROMATOGR B, V859, P119, DOI 10.1016/j.jchromb.2007.09.016; Stanberry LR, 2004, HERPES S3, V11, p161A; Stanford JA, 1998, NEUROSCI LETT, V241, P41, DOI 10.1016/S0304-3940(97)00974-9; Swetter SM, 1998, J INFECT DIS, V177, P543, DOI 10.1086/514229; VILLAMIL SM, 1995, ANTIVIR CHEM CHEMOTH, V6, P239, DOI 10.1177/095632029500600406; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wang X, 2008, J SEP SCI, V31, P3543, DOI 10.1002/jssc.200800322; Zheng XY, 2009, ARCH PHARM RES, V32, P1245, DOI 10.1007/s12272-009-1910-x; Zhou CH, 2002, J VIROL, V76, P5893, DOI 10.1128/JVI.76.12.5893-5904.2002	42	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77937	10.1371/journal.pone.0077937	http://dx.doi.org/10.1371/journal.pone.0077937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167591	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500050
J	Berger, L; Wilde, A				Berger, Lloyd; Wilde, Andrew			Glycolytic Metabolites Are Critical Modulators of Oocyte Maturation and Viability	PLOS ONE			English	Article							XENOPUS-LAEVIS OOCYTES; FROG OOCYTES; CELL-DEATH; IN-VIVO; APOPTOSIS; CARBON; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; AVAILABILITY; CASPASE-2; NEURONS	The maturation of an oocyte into an egg is a key step in preparation for fertilization. In Xenopus, oocyte maturation is independent of transcription, being regulated at the level of translation and post-translational modifications of proteins. To identify factors involved in the maturation process we used two-dimensional differential gel electrophoresis to compare the proteome of oocytes and eggs. Protein abundance changes were observed in multiple cellular pathways during oocyte maturation. Most prominent was a general reduction in abundance of enzymes in the glycolytic pathway. Injection into oocytes of the glycolytic intermediates glyceraldehyde-3-phosphate, phosphoenolpyruvate and glucose-6-phosphate prevented oocyte maturation. Instead, these metabolites stimulated ROS production and subsequent apoptosis of the oocyte. In contrast, all other metabolites tested had no effect on oocyte maturation and did not induce apoptosis. These data suggest that a subset of glycolytic metabolites have the capacity to regulate oocyte viability.	[Wilde, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Wilde, A (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	andrew.wilde@utoronto.ca		Wilde, Andrew/0000-0002-9812-3847	Canadian Institute for Health Research [CTP-79838]; Canadian Cancer Society [2011-700741]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	The work was supported by Canadian Institute for Health Research, team grant CTP-79838 and Canadian Cancer Society, 2011-700741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRACHET J, 1975, DIFFERENTIATION, V3, P3, DOI 10.1111/j.1432-0436.1975.tb00840.x; CICIRELLI MF, 1985, DEV BIOL, V108, P254, DOI 10.1016/0012-1606(85)90029-6; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; DESCHEPPER GG, 1987, HISTOCHEM J, V19, P467, DOI 10.1007/BF01675415; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; DWORKIN MB, 1991, TRENDS BIOCHEM SCI, V16, P229, DOI 10.1016/0968-0004(91)90091-9; DWORKIN MB, 1989, DEV BIOL, V132, P524, DOI 10.1016/0012-1606(89)90247-9; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; Hammes SR, 2004, MOL ENDOCRINOL, V18, P769, DOI 10.1210/me.2003-0317; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jessus C, 2004, BIOL CELL, V96, P187, DOI 10.1016/j.biolcel.2003.12.007; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Maller J L, 1980, Curr Top Cell Regul, V16, P271; Nutt LK, 2012, SEMIN CELL DEV BIOL, V23, P412, DOI 10.1016/j.semcdb.2012.03.015; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pan James G, 2007, Sci STKE, V2007, ppe14; Preller A, 1999, FEBS LETT, V446, P149, DOI 10.1016/S0014-5793(99)00192-1; Preller A, 2007, FEBS LETT, V581, P663, DOI 10.1016/j.febslet.2007.01.029; Sen A, 2011, STEROIDS, V76, P822, DOI 10.1016/j.steroids.2011.02.016; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Ureta T, 2000, FEBS LETT, V475, P145, DOI 10.1016/S0014-5793(00)01646-X; Ureta T, 2001, IUBMB LIFE, V51, P5, DOI 10.1080/15216540152034993; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou Y, 2009, MOL CELL BIOL, V29, P1786, DOI 10.1128/MCB.01815-08	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77612	10.1371/journal.pone.0077612	http://dx.doi.org/10.1371/journal.pone.0077612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167578	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500037
J	Hol, FJH; Galajda, P; Nagy, K; Woolthuis, RG; Dekker, C; Keymer, JE				Hol, Felix J. H.; Galajda, Peter; Nagy, Krisztina; Woolthuis, Rutger G.; Dekker, Cees; Keymer, Juan E.			Spatial Structure Facilitates Cooperation in a Social Dilemma: Empirical Evidence from a Bacterial Community	PLOS ONE			English	Article							STATIONARY-PHASE; ESCHERICHIA-COLI; PRISONERS-DILEMMA; EXPONENTIAL-GROWTH; SIMPSONS PARADOX; GENE-EXPRESSION; EVOLUTION; COMPETITION; GAME; DISPERSAL	Cooperative organisms are ubiquitous in nature, despite their vulnerability to exploitation by cheaters. Although numerous theoretical studies suggest that spatial structure is critical for cooperation to persist, the spatial ecology of microbial cooperation remains largely unexplored experimentally. By tracking the community dynamics of cooperating (rpoS wildtype) and cheating (rpoS mutant) Escherichia coli in well-mixed flasks and microfabricated habitats, we demonstrate that spatial structure stabilizes coexistence between wild-type and mutant and thus facilitates cooperator maintenance. We develop a method to interpret our experimental results in the context of game theory, and show that the game wild-type and mutant bacteria play in an unstructured environment changes markedly over time, and eventually obeys a prisoner's dilemma leading to cheater dominance. In contrast, when wild-type and mutant E. coli co-inhabit a spatially-structured habitat, cooperators and cheaters coexist at intermediate frequencies. Our findings show that even in microhabitats lacking patchiness or spatial heterogeneities in resource availability, surface growth allows cells to form multi-cellular aggregates, yielding a self-structured community in which cooperators persist.	[Hol, Felix J. H.; Galajda, Peter; Woolthuis, Rutger G.; Dekker, Cees; Keymer, Juan E.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands; [Galajda, Peter; Nagy, Krisztina] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Keymer, Juan E.] Inst Ecol & Biodiversidad, Santiago, Chile	Delft University of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Hol, FJH (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	f.j.h.hol@tudelft.nl; juan.keymer@gmail.com	Hol, Felix/AAL-3588-2021	Hol, Felix/0000-0001-8061-0826; Galajda, Peter/0000-0003-3308-088X; Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]; Hungarian Academy of Sciences	European Research Council(European Research Council (ERC)European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by a European Research Council grant NanoforBio (no. 247072) to CD. PG was supported by the Lendulet' program of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Greig D, 2004, P R SOC LONDON B, V271; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; Lambert G, 2011, J BACTERIOL, V193, P1878, DOI 10.1128/JB.01430-10; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lenski R., 2001, SELECTION, V1, P89; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; MacLean RC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000486; Maynard Smith J., 1982, pi; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Penn AS, 2012, FEMS IMMUNOL MED MIC, V65, P226, DOI 10.1111/j.1574-695X.2012.00970.x; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Skyrms B, 2003, STAG HUNT EVOLUTION; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; Vulic M, 2001, GENETICS, V158, P519; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	49	43	44	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77042	10.1371/journal.pone.0077042	http://dx.doi.org/10.1371/journal.pone.0077042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167557	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500016
J	Magombedze, G; Ngonghala, CN; Lanzas, C				Magombedze, Gesgam; Ngonghala, Calistus N.; Lanzas, Cristina			Evalution of the "Iceberg Phenomenon" in Johne's Disease through Mathematical Modelling	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; DAIRY-CATTLE; TRANSMISSION; CALVES; REPRODUCTION; ENVIRONMENT; INFECTION; MAP	Johne's disease (JD) is a chronic, enteric disease in ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP). Disease progression follows four distinct stages: silent, subclinical, clinical and advanced. Available diagnostic tests have poor sensitivity and cannot detect early stages of the infection; as a result, only animals in the clinical and advanced stages, which represent the tip of the 'iceberg', are identified through testing. The Iceberg Phenomenon is then applied to provide estimates for JD prevalence. For one animal in the advanced stage, it is assumed that there are one to two in the clinical stage, four to eight in the subclinical stage, and ten to fourteen in the silent stage. These ratios, however, are based on little evidence. To evaluate the ratios, we developed a deterministic ordinary differential equation model of JD transmission and disease progression dynamics. When duration periods associated with the natural course of the disease progression are used, the above ratios do not hold. The ratios used to estimate JD prevalence need to be further investigated.	[Magombedze, Gesgam; Ngonghala, Calistus N.; Lanzas, Cristina] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Lanzas, Cristina] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Magombedze, G (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA.	gmagombedze@nimbios.org	Ngonghala, Calistus/AAL-5812-2021; Ngonghala, Calistus N/C-5543-2014	Ngonghala, Calistus/0000-0002-8441-9495; Ngonghala, Calistus N/0000-0002-8441-9495; Magombedze, Gesham/0000-0003-2745-3475; Lanzas, Cristina/0000-0002-4039-0336	National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-250832858]; University of Tennessee, Knoxville; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-250832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Buergelt C. D., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P279; Calder R, WHAT IS JOHNES DIS; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; Council of Agricultural Science and Technology, 2001, JOHN DIS CATTL; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Humphry RW, 2006, VET J, V172, P432, DOI 10.1016/j.tvjl.2005.07.017; Jubb T, 2000, VET MICROBIOL, V77, P423, DOI 10.1016/S0378-1135(00)00327-8; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Marce C, 2011, PREVENTIVE VET MED; Mitchell RM, 2008, PREV VET MED, V83, P360, DOI 10.1016/j.prevetmed.2007.09.006; Mitchell RM, 2012, EPIDEMIOL INFECT, V140, P231, DOI 10.1017/S0950268811000689; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P1139, DOI 10.1128/CVI.00058-11; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P393, DOI 10.1128/CVI.00359-10; Stewart DJ, 2004, VET MICROBIOL, V104, P165, DOI 10.1016/j.vetmic.2004.09.007; USDA, 2011, NATL JOHNES ED INITI, V2; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van Roermund HJW, 2007, VET MICROBIOL, V122, P270, DOI 10.1016/j.vetmic.2007.01.016; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington R, 2011, VET IMMUNOLOGY IMMUN; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	27	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76636	10.1371/journal.pone.0076636	http://dx.doi.org/10.1371/journal.pone.0076636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167547	Green Published, gold, Green Submitted			2022-12-25	WOS:000326034500006
J	Carroll, IM; Ringel-Kulka, T; Ferrier, L; Wu, MC; Siddle, JP; Bueno, L; Ringel, Y				Carroll, Ian M.; Ringel-Kulka, Tamar; Ferrier, Laurent; Wu, Michael C.; Siddle, Jennica P.; Bueno, Lionel; Ringel, Yehuda			Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; STREPTOCOCCUS-PNEUMONIAE; BOWEL; PERMEABILITY; PAIN; PROTEOLYSIS; MICROFLORA; SIGNATURES; BACTERIA; COLITIS	Objective: Intestinal proteases carry out a variety of functions in the gastrointestinal (GI) tract. Studies have reported that elevated enteric proteases in patients with GI disease can alter intestinal physiology, however the origin (human vs. microbial) of elevated proteases in patients with GI disease is unclear. Aim: The aim of this study was to investigate the association between protease activity and the microbiota in human fecal samples. Design: In order to capture a wide range of fecal protease (FP) activity stool samples were collected from 30 IBS patients and 24 healthy controls. The intestinal microbiota was characterized using 454 high throughput pyro-sequencing of the 16S rRNA gene. The composition and diversity of microbial communities were determined and compared using the Quantitative Insights Into Microbial Ecology (QIIME) pipeline. FP activity levels were determined using an ELISA-based method. FP activity was ranked and top and bottom quartiles (n=13 per quartile) were identified as having high and low FP activity, respectively. Results: The overall diversity of the intestinal microbiota displayed significant clustering separation (p = 0.001) between samples with high vs. low FP activity. The Lactobacillales, Lachnospiraceae, and Streptococcaceae groups were positively associated with FP activity across the entire study population, whilst the Ruminococcaceae family and an unclassified Coriobacteriales family were negatively associated with FP activity. Conclusions: These data demonstrate significant associations between specific intestinal bacterial groups and fecal protease activity and provide a basis for further causative studies investigating the role of enteric microbes and GI diseases.	[Carroll, Ian M.; Siddle, Jennica P.; Ringel, Yehuda] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA; [Ringel-Kulka, Tamar] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Wu, Michael C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Ferrier, Laurent; Bueno, Lionel] INRA, Toxalim UMR1331, Neurogastroenterol & Nutr Grp, F-31931 Toulouse, France	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; INRAE	Ringel, Y (corresponding author), Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA.	ringel@med.unc.edu	Wu, Michael/X-5084-2019; Core, UNC Microbiome/AAB-3304-2022	Wu, Michael/0000-0002-3357-6570; Ferrier, Laurent/0000-0003-2981-7375	young investigator grant for probiotics research; global probiotics committee; National Institutes of Health [DK084294, DK075621];  [DK092330]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R03DK084294, K01DK092330, K23DK075621] Funding Source: NIH RePORTER	young investigator grant for probiotics research; global probiotics committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the young investigator grant for probiotics research, supported by the global probiotics committee, and by DK092330 awarded to IC. This study was also funded by DK084294 and DK075621 grants from the National Institutes of Health awarded to YR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annahazi A, 2009, PAIN, V144, P209, DOI 10.1016/j.pain.2009.04.017; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bonifait L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-47; Bustos D, 1998, MEDICINA-BUENOS AIRE, V58, P262; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018984; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Eeckhaut V, 2008, INT J SYST EVOL MICR, V58, P2799, DOI 10.1099/ijs.0.65730-0; Einsfeldt K, 2011, VACCINE, V29, P7136, DOI 10.1016/j.vaccine.2011.05.073; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; GIBSON SAW, 1989, APPL ENVIRON MICROB, V55, P679, DOI 10.1128/AEM.55.3.679-683.1989; Hague A, 1997, GASTROENTEROLOGY, V112, P1036, DOI 10.1053/gast.1997.v112.agast971036; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; MACFARLANE GT, 1988, J APPL BACTERIOL, V64, P37, DOI 10.1111/j.1365-2672.1988.tb02427.x; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Midtvedt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066074; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pruteanu M, 2011, INFLAMM BOWEL DIS, V17, P1189, DOI 10.1002/ibd.21475; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Roka R, 2007, NEUROGASTROENT MOTIL, V19, P57, DOI 10.1111/j.1365-2982.2006.00851.x; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Saifeddine M, 1996, BRIT J PHARMACOL, V118, P521, DOI 10.1111/j.1476-5381.1996.tb15433.x; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Shulman RJ, 2008, J PEDIATR-US, V153, P646, DOI 10.1016/j.jpeds.2008.04.062; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wani JH, 1996, INFECT IMMUN, V64, P3967, DOI 10.1128/IAI.64.10.3967-3974.1996; Williams David A., 1990, Vet Clin Pathol, V19, P20, DOI 10.1111/j.1939-165X.1990.tb00536.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004	44	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78017	10.1371/journal.pone.0078017	http://dx.doi.org/10.1371/journal.pone.0078017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147109	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200094
J	Daima, HK; Selvakannan, PR; Shukla, R; Bhargava, SK; Bansal, V				Daima, Hemant K.; Selvakannan, P. R.; Shukla, Ravi; Bhargava, Suresh K.; Bansal, Vipul			Fine-Tuning the Antimicrobial Profile of Biocompatible Gold Nanoparticles by Sequential Surface Functionalization Using Polyoxometalates and Lysine	PLOS ONE			English	Article							AG SHELL NANOPARTICLES; SILVER NANOPARTICLES; ANTIBACTERIAL ACTIVITY; AMINO-ACIDS; ESCHERICHIA-COLI; ANTIBIOTICS; TIO2; MECHANISMS; PARTICLES; CELLS	Antimicrobial action of nanomaterials is typically assigned to the nanomaterial composition, size and/or shape, whereas influence of complex corona stabilizing the nanoparticle surface is often neglected. We demonstrate sequential surface functionalization of tyrosine-reduced gold nanoparticles (AuNPs(Tyr)) with polyoxometalates (POMs) and lysine to explore controlled chemical functionality-driven antimicrobial activity. Our investigations reveal that highly biocompatible gold nanoparticles can be tuned to be a strong antibacterial agent by fine-tuning their surface properties in a controllable manner. The observation from the antimicrobial studies on a gram negative bacterium Escherichia coli were further validated by investigating the anticancer properties of these step-wise surface-controlled materials against A549 human lung carcinoma cells, which showed a similar toxicity pattern. These studies highlight that the nanomaterial toxicity and biological applicability are strongly governed by their surface corona.	[Daima, Hemant K.; Selvakannan, P. R.; Shukla, Ravi; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, NanoBiotechnol Res Lab, Melbourne, Vic 3001, Australia	Royal Melbourne Institute of Technology (RMIT)	Bansal, V (corresponding author), RMIT Univ, Sch Appl Sci, NanoBiotechnol Res Lab, Melbourne, Vic 3001, Australia.	vipul.bansal@rmit.edu.au	Bansal, Vipul/B-2485-2008; Bhargava, Suresh K./C-5783-2011; Daima, Hemant Kumar/D-3586-2013; Bhargava, Suresh K./AAQ-2675-2020; PERIASAMY, SELVAKANNAN/H-2418-2013	Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Daima, Hemant Kumar/0000-0002-9109-430X; Bhargava, Suresh K./0000-0002-3127-8166; Shukla, Ravi/0000-0002-1537-9637; PERIASAMY, SELVAKANNAN/0000-0001-5859-8226	Ian Potter Foundation	Ian Potter Foundation	Authors acknowledge the support of the Ian Potter Foundation for establishing a multimode spectroscopy facility at RMIT University that was used in this study. Authors also acknowledge the support of RMIT Microscopy and Microanalysis Facility (RMMF) for providing technical assistance and access to their characterization facilities. The technical assistance of Mr. Paul Morrison for acquiring ICP-MS data and Ms Zahra Homan for acquiring AAS data is also duly acknowledged.	Amin RM, 2009, NANOMEDICINE-UK, V4, P637, DOI 10.2217/NNM.09.50; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Daima H.K., 2011, INT C NAN TECHN SOC, P1; Daima HK, 2014, NANOSCALE, V6, P758, DOI 10.1039/c3nr03806h; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; FLYNN KJ, 1986, MAR BIOL, V90, P159, DOI 10.1007/BF00569122; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hasenknopf B, 2005, FRONT BIOSCI-LANDMRK, V10, P275, DOI 10.2741/1527; HILL CL, 1995, COORDIN CHEM REV, V143, P407, DOI 10.1016/0010-8545(95)01141-B; Hung A, 2013, CHEM SCI, V4, P928, DOI 10.1039/c2sc21639f; Iliev V, 2007, J MOL CATAL A-CHEM, V263, P32, DOI 10.1016/j.molcata.2006.08.019; Joshi H, 2004, J PHYS CHEM B, V108, P11535, DOI 10.1021/jp048766z; Kong YM, 2007, MATER LETT, V61, P2393, DOI 10.1016/j.matlet.2006.09.023; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Mandal S, 2003, J AM CHEM SOC, V125, P8440, DOI 10.1021/ja034972t; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/NCHEM.1012, 10.1038/nchem.1012]; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pearson A, 2011, LANGMUIR, V27, P9245, DOI 10.1021/la201655n; Pearson A, 2011, LANGMUIR, V27, P6661, DOI 10.1021/la2007765; POPE MT, 1991, ANGEW CHEM INT EDIT, V30, P34, DOI 10.1002/anie.199100341; Radovic-Moreno AF, 2012, ACS NANO, V6, P4279, DOI 10.1021/nn3008383; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q; ROSEN BP, 1971, J BIOL CHEM, V246, P3653; Sanyal A, 2005, ADV FUNCT MATER, V15, P273, DOI 10.1002/adfm.200400107; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Silverstein RB, 1967, SPECTROMETRIC IDENTI; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Yamase T, 2005, J MATER CHEM, V15, P4773, DOI 10.1039/b504585a	42	88	88	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e79676	10.1371/journal.pone.0079676	http://dx.doi.org/10.1371/journal.pone.0079676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147146	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200104
J	Gallopin, M; Rau, A; Jaffrezic, F				Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence			A Hierarchical Poisson Log-Normal Model for Network Inference from RNA Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQ; MICRORNAS	Gene network inference from transcriptomic data is an important methodological challenge and a key aspect of systems biology. Although several methods have been proposed to infer networks from microarray data, there is a need for inference methods able to model RNA-seq data, which are count-based and highly variable. In this work we propose a hierarchical Poisson log-normal model with a Lasso penalty to infer gene networks from RNA-seq data; this model has the advantage of directly modelling discrete data and accounting for inter-sample variance larger than the sample mean. Using real microRNA-seq data from breast cancer tumors and simulations, we compare this method to a regularized Gaussian graphical model on log-transformed data, and a Poisson log-linear graphical model with a Lasso penalty on power-transformed data. For data simulated with large inter-sample dispersion, the proposed model performs better than the other methods in terms of sensitivity, specificity and area under the ROC curve. These results show the necessity of methods specifically designed for gene network inference from RNA-seq data.	[Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence] INRA, Dept Genet Anim, Jouy En Josas, France; [Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence] AgroParis Tech, Dept Genet Anim, Paris, France; [Gallopin, Melina] Univ Paris 11, Dept Math, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Gallopin, M (corresponding author), INRA, Dept Genet Anim, Jouy En Josas, France.	melina.gallopin@jouy.inra.fr	Gallopin, Mélina/L-2937-2017	Gallopin, Mélina/0000-0002-2431-7825				Allen GI, 2012, IEEE INT C BIOINF BI; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auer PL, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1627; Bastian M., 2009, P 3 INT C WEBLOGS SO, DOI DOI 10.13140/2.1.1341.1520; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cai Y, 2012, IEEE INT WORK GENOM, P46, DOI 10.1109/GENSIPS.2012.6507723; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Erdos P, 1959, PUBLICATIONES MATH, V6, P419; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Giraud C, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1625; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo JA, 2011, BIOMETRIKA, V98, P1, DOI 10.1093/biomet/asq060; Hong SJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt145; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Karlis D, 2005, STAT COMPUT, V15, P255, DOI 10.1007/s11222-005-4069-4; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROBINSON MD, 2010, GENOME BIOL, V11; Schelldorfer N, 2012, J COMPUTATI IN PRESS, P1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Verzelen N, 2012, ELECTRON J STAT, V6, P38, DOI 10.1214/12-EJS666; Whittaker J., 1990, GRAPHICAL MODELS APP; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Zou C, 2012, CELL CYCLE, V11, P2137, DOI 10.4161/cc.20598	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77503	10.1371/journal.pone.0077503	http://dx.doi.org/10.1371/journal.pone.0077503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147011	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200039
J	Collier, N; Tran, MV; Le, HQ; Ha, QT; Oellrich, A; Rebholz-Schuhmann, D				Collier, Nigel; Mai-vu Tran; Hoang-quynh Le; Quang-Thuy Ha; Oellrich, Anika; Rebholz-Schuhmann, Dietrich			Learning to Recognize Phenotype Candidates in the Auto-Immune Literature Using SVM Re-Ranking	PLOS ONE			English	Article							ONTOLOGY; INFORMATION; GENE; TOOL; PROTEIN; CORPUS; NAMES	The identification of phenotype descriptions in the scientific literature, case reports and patient records is a rewarding task for bio-medical text mining. Any progress will support knowledge discovery and linkage to other resources. However because of their wide variation a number of challenges still remain in terms of their identification and semantic normalisation before they can be fully exploited for research purposes. This paper presents novel techniques for identifying potential complex phenotype mentions by exploiting a hybrid model based on machine learning, rules and dictionary matching. A systematic study is made of how to combine sequence labels from these modules as well as the merits of various ontological resources. We evaluated our approach on a subset of Medline abstracts cited by the Online Mendelian Inheritance of Man database related to auto-immune diseases. Using partial matching the best micro-averaged F-score for phenotypes and five other entity classes was 79.9%. A best performance of 75.3% was achieved for phenotype candidates using all semantics resources. We observed the advantage of using SVM-based learn-to-rank for sequence label combination over maximum entropy and a priority list approach. The results indicate that the identification of simple entity types such as chemicals and genes are robustly supported by single semantic resources, whereas phenotypes require combinations. Altogether we conclude that our approach coped well with the compositional structure of phenotypes in the auto-immune domain.	[Collier, Nigel; Rebholz-Schuhmann, Dietrich] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Collier, Nigel; Mai-vu Tran; Hoang-quynh Le] Natl Inst Informat, Tokyo, Japan; [Mai-vu Tran; Hoang-quynh Le; Quang-Thuy Ha] Univ Engn & Technol VNU, Knowledge Technol Lab, Hanoi, Vietnam; [Oellrich, Anika] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England; [Rebholz-Schuhmann, Dietrich] Univ Zurich, Dept Computat Linguist, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Vietnam National University Hanoi; Wellcome Trust Sanger Institute; University of Zurich	Collier, N (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	collier@ebi.ac.uk	Ha, Quang-Thuy/AAB-9678-2022	Ha, Quang-Thuy/0000-0002-3901-3357; Collier, Nigel/0000-0002-7230-4164; Rebholz-Schuhmann, Dietrich/0000-0002-1018-0370	EC Marie Curie International Incoming Fellowship grant [301806]; National Institute of Informatics internship grant	EC Marie Curie International Incoming Fellowship grant; National Institute of Informatics internship grant	NC is supported by an EC Marie Curie International Incoming Fellowship grant (http://ec.europa.eu/research/mariecurieactions/index_en.htm) for project Phenominer (project number 301806). MT and HL are supported by a National Institute of Informatics internship grant (www.nii.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswanger E, 2008, APPL ONTOL, V3, P205, DOI 10.3233/AO-2008-0057; Blake A., 2003, Tourism Economics, V9, P449; Campos D., 2013, BMC BIOINFORMATICS, V14; Carpenter Bob, 2007, P 2 BIOCR CHALL EV W, V23, P307; Chen LF, 2004, STUD HEALTH TECHNOL, V107, P758; Collier N, 2012, P 24 INT C COMP LING; Corbett P, 2007, P WORKSH BIONLP 2007, P57; Cui Licong, 2012, AMIA Annu Symp Proc, V2012, P1191; de Bruijn B, 2011, J AM MED INFORM ASSN, V18, P557, DOI 10.1136/amiajnl-2011-000150; Di Eugenio B, 2004, COMPUT LINGUIST, V30, P95, DOI 10.1162/089120104773633402; Doan S, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-36; Dowell KG, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap019; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fukuda K, 1998, Pac Symp Biocomput, P707; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; GKOUTOS G, 2004, BUILDING MOUSE PHENO, P178; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Grishman R, 1998, P 6 WORKSH VER LARG, P152; Groza Tudor, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P82, DOI 10.1007/978-3-642-35173-0_6; Groza T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-265; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Hirschman L., 2012, DATABASE, V2012; Hoehndorf R, 2012, BIOINFORMATICS, V28, P1783, DOI 10.1093/bioinformatics/bts250; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Hoehndorf R, 2010, BIOINFORMATICS, V26, P3112, DOI 10.1093/bioinformatics/btq578; Kabiljo R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-233; Kawazoe A, 2006, P INT WORKSH BIOM ON, P77; Kazama J., 2002, P WORKSHOP NATURAL L, P1, DOI DOI 10.3115/1118149.1118150; Khordad M, 2011, LECT NOTES ARTIF INT, V6657, P246, DOI 10.1007/978-3-642-21043-3_30; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim JD, 2006, TRNLPUT20061 U TOK S; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Krauthammer M, 2000, GENE, V259, P245, DOI 10.1016/S0378-1119(00)00431-5; Leaman Robert, 2008, Pac Symp Biocomput, P652; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Magnini B., 2006, P 2 WORKSH ONT LEARN, P26; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nigel C, 2000, P 18 C COMP LING COL, P201, DOI [DOI 10.3115/990820.990850, DOI 10.3115/990820]; Ohta Tomoko, 2012, P WORKSH DET STRUCT, P27; Okazaki N, 2007, CFRSUITE FAST IMPLEM; Ratnaparkhi Adwait, 1996, C EMP METH NAT LANG; Rebholz-Schuhmann Dietrich, 2011, J Biomed Semantics, V2 Suppl 5, pS11, DOI 10.1186/2041-1480-2-S5-S11; Rebholz-Schuhmann Dietrich, 2010, Journal of Bioinformatics and Computational Biology, V8, P163, DOI 10.1142/S0219720010004562; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Scheuermann Richard H, 2009, Summit Transl Bioinform, V2009, P116; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Shen D., 2004, ACL, P589, DOI [10.3115/1218955.1219030, DOI 10.3115/1218955.1219030]; Smedley D, 2013, NUCLEIC ACIDS RES, V2013; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Suakkaphong N, 2011, J AM SOC INF SCI TEC, V62, P727, DOI 10.1002/asi.21488; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tateisi Y, 2000, P COLING 2000 WORKSH, P28; Tsuruoka, 2004, P INT JOINT WORKSH N, P70, DOI DOI 10.3115/1567594.1567610; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y., 2003, P ACL 2003 WORKSH NA, P41; Tuason O, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P238; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Verspoor K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-207; Vlachos A., 2006, P HLT NAACL BIONLP W; Zhou G, 2004, P JOINT WORKSH NAT L, P96, DOI DOI 10.3115/1567594.1567616	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e72965	10.1371/journal.pone.0072965	http://dx.doi.org/10.1371/journal.pone.0072965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155869	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300003
J	Grama, CN; Suryanarayana, P; Patil, MA; Raghu, G; Balakrishna, N; Kumar, MNVR; Reddy, GB				Grama, Charitra N.; Suryanarayana, Palla; Patil, Madhoosudan A.; Raghu, Ganugula; Balakrishna, Nagalla; Kumar, M. N. V. Ravi; Reddy, Geereddy Bhanuprakash			Efficacy of Biodegradable Curcumin Nanoparticles in Delaying Cataract in Diabetic Rat Model	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VITRO; BIOAVAILABILITY; OFFICINALIS	Curcumin, the active principle present in the yellow spice turmeric, has been shown to exhibit various pharmacological actions such as antioxidant, anti-inflammatory, antimicrobial, and anti-carcinogenic activities. Previously we have reported that dietary curcumin delays diabetes-induced cataract in rats. However, low peroral bioavailability is a major limiting factor for the success of clinical utilization of curcumin. In this study, we have administered curcumin encapsulated nanoparticles in streptozotocin (STZ) induced diabetic cataract model. Oral administration of 2 mg/day nanocurcumin was significantly more effective than curcumin in delaying diabetic cataracts in rats. The significant delay in progression of diabetic cataract by nanocurcumin is attributed to its ability to intervene the biochemical pathways of disease progression such as protein insolubilization, polyol pathway, protein glycation, crystallin distribution and oxidative stress. The enhanced performance of nanocurcumin can be attributed probably to its improved oral bioavailability. Together, the results of the present study demonstrate the potential of nanocurcumin in managing diabetic cataract.	[Grama, Charitra N.; Kumar, M. N. V. Ravi] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Suryanarayana, Palla; Patil, Madhoosudan A.; Raghu, Ganugula; Balakrishna, Nagalla; Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of Strathclyde; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Kumar, MNVR (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	mnvrkumar@strath.ac.uk; geereddy@yahoo.com	Patil, Madhoosudan/Y-9859-2019; Reddy, G Bhanuprakash/AAJ-3494-2020; Nagalla, Balakrishna/GRR-4393-2022	Patil, Madhoosudan/0000-0002-1586-2792; Reddy, G Bhanuprakash/0000-0003-4787-3944; Nagalla, Balakrishna/0000-0002-5613-0942	Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; University of Strathclyde; Indian Council of Medical Research, India	Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; University of Strathclyde; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	GBR received grants from the Indian Council of Medical Research, Department of Science & Technology, Department of Biotechnology, Government of India; MNVR received from the University of Strathclyde; MAP received a research fellowship from Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Grama CN, 2011, CURR OPIN COLLOID IN, V16, P238, DOI 10.1016/j.cocis.2010.11.005; Italia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025744; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Krishnaswamy K, 1998, INDIAN J MED RES, V108, P167; Kumar MNVR, 2012, DRUG DISCOV TODAY, V17, P407, DOI 10.1016/j.drudis.2012.01.024; Kumar PA, 2009, J NUTR BIOCHEM, V20, P553, DOI 10.1016/j.jnutbio.2008.05.015; Kyselova Z, 2004, J DIABETES COMPLICAT, V18, P129, DOI 10.1016/S1056-8727(03)00009-6; Mares JA, 2004, NUTR REV, V62, P28, DOI 10.1301/nr.2004.jan.28-32; Mittal G, 2011, J CONTROL RELEASE, V150, P220, DOI 10.1016/j.jconrel.2010.11.013; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Muthenna P, 2009, FEBS LETT, V583, P3637, DOI 10.1016/j.febslet.2009.10.042; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580; Reddy PY, 2012, MOL VIS, V18, P495; Saraswat M, 2010, MOL VIS, V16, P1525; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; Suryanarayana P, 2007, MOL VIS, V13, P1291; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Suryanarayana P, 2003, MOL VIS, V9, P223; Takahashi M, 2009, J AGR FOOD CHEM, V57, P9141, DOI 10.1021/jf9013923; TAYLOR A, 1995, AM J CLIN NUTR, V62, P1439, DOI 10.1093/ajcn/62.6.1439S; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193	33	69	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78217	10.1371/journal.pone.0078217	http://dx.doi.org/10.1371/journal.pone.0078217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155984	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325887300118
J	Mittinty, MN; Golley, RK; Smithers, LG; Brazionis, L; Lynch, JW				Mittinty, Murthy N.; Golley, Rebecca K.; Smithers, Lisa G.; Brazionis, Laima; Lynch, John W.			A Preference Based Measure of Complementary Feeding Quality: Application to the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							DECISION-MAKING; UTILITY-THEORY; DIET QUALITY; HEALTH; BIOMARKERS; INDEXES	This paper presents the development of the Complementary Feeding Utility Index (CFUI), a composite index aimed to measure adherence to infant feeding guidelines. Through an axiomatic characterization this paper shows the advantages in using the CFUI are the following: it avoids the use of arbitrary cut-offs, and by converting observed diet preferences into utilities, summing the score is meaningful. In addition, as the CFUI is designed to be scored continuously, it allows the transition from intake of beneficial foods (in low quantities) and intake of detrimental foods (in high quantities) to be more subtle. The paper first describes the rationale being the development of the CFUI and then elaborates on the methodology used to develop the CFUI, including the process of selecting the components. The methodology is applied to data collected from the Avon Longitudinal Study of Parents and Children to show the advantages of the CFUI over traditional diet index approaches. Unlike traditional approaches, the distribution of the CFUI does not peak towards mean value but distributes evenly towards the tails of the distribution.	[Mittinty, Murthy N.; Smithers, Lisa G.; Brazionis, Laima; Lynch, John W.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Golley, Rebecca K.] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Adelaide; University of South Australia; University of Bristol	Mittinty, MN (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	murthy.mittinty@adelaide.edu.au	Lynch, John W/A-4797-2008; Golley, Rebecca K/D-1606-2009; Smithers, Lisa/D-1605-2009	Lynch, John W/0000-0003-2781-7902; Smithers, Lisa/0000-0002-6585-7836; Golley, Rebecca/0000-0001-5197-7987	UK Medical Research Council [74882]; Wellcome Trust [076467]; National Medical Health Research Council Australian Research Fellow; John Lynch NHMRC Australian Fellow Program; Medical Research Council [G9815508] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Medical Health Research Council Australian Research Fellow; John Lynch NHMRC Australian Fellow Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (Grant ref: 74882) the Wellcome Trust (Grant ref: 076467) and the University of Bristol provide core support for ALSPAC. John Lynch was supported with the National Medical Health Research Council Australian Research Fellow. MNM, LGS and LB were supported by John Lynch NHMRC Australian Fellow Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arvaniti F, 2008, CRIT REV FOOD SCI, V48, P317, DOI 10.1080/10408390701326268; DYER JS, 1992, MANAGE SCI, V38, P645, DOI 10.1287/mnsc.38.5.645; Emmett P, 2009, EUR J CLIN NUTR, V63, pS38, DOI 10.1038/ejcn.2008.63; Golley RK, 2012, J NUTR, V142, P901, DOI 10.3945/jn.111.154971; Hann CS, 2001, AM J CLIN NUTR, V74, P479; HARVEY CM, 1981, MANAGE SCI, V27, P190, DOI 10.1287/mnsc.27.2.190; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Keeney R. L., 1976, DECISIONS MULTIPLE O; Kourlaba G, 2009, ANN EPIDEMIOL, V19, P692, DOI 10.1016/j.annepidem.2009.03.019; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; NATHAN HSK, 2008, WP2008001 IGIDR; Neumann J., 1944, THEORY GAMES EC BEHA; Pohekar SD, 2004, RENEW SUST ENERG REV, V8, P365, DOI 10.1016/j.rser.2003.12.007; Salukvadze NI., 2007, MODEL ASSISTED STAT, V2, P239, DOI [10.3233/MAS-2007-2406., DOI 10.3233/MAS-2007-2406]; Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Waijers P, 2005, INDEXES OVERALL DIET; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X; World Health Organization, 2008, DEF CONCL CONS M H 1; Zeleny M., 1974, Computers & Operations Research, V1, P479, DOI 10.1016/0305-0548(74)90064-1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76111	10.1371/journal.pone.0076111	http://dx.doi.org/10.1371/journal.pone.0076111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155886	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300020
J	Xu, XH; Qu, WM; Bian, MJ; Huang, F; Fei, J; Urade, Y; Huang, ZL				Xu, Xin-Hong; Qu, Wei-Min; Bian, Min-Juan; Huang, Fang; Fei, Jian; Urade, Yoshihiro; Huang, Zhi-Li			Essential Roles of GABA Transporter-1 in Controlling Rapid Eye Movement Sleep and in Increased Slow Wave Activity after Sleep Deprivation	PLOS ONE			English	Article							UPTAKE INHIBITOR TIAGABINE; STEM GABAERGIC NEURONS; PARADOXICAL REM SLEEP; HOMEOSTATIC REGULATION; CEREBRAL-CORTEX; MICE; MECHANISMS; RECEPTOR; ACTIVATION; RAT	GABA is the major inhibitory neurotransmitter in the mammalian central nervous system that has been strongly implicated in the regulation of sleep. GABA transporter subtype 1 (GAT1) constructs high affinity reuptake sites for GABA and regulates GABAergic transmission in the brain. However, the role of GAT1 in sleep-wake regulation remains elusive. In the current study, we characterized the spontaneous sleep-wake cycle and responses to sleep deprivation in GAT1 knock-out (KO) mice. GAT1 KO mice exhibited dominant theta-activity and a remarkable reduction of EEG power in low frequencies across all vigilance stages. Under baseline conditions, spontaneous rapid eye movement (REM) sleep of KO mice was elevated both during the light and dark periods, and non-REM (NREM) sleep was reduced during the light period only. KO mice also showed more state transitions from NREM to REM sleep and from REM sleep to wakefulness, as well as more number of REM and NREM sleep bouts than WT mice. During the dark period, KO mice exhibited more REM sleep bouts only. Six hours of sleep deprivation induced rebound increases in NREM and REM sleep in both genotypes. However, slow wave activity, the intensity component of NREM sleep was briefly elevated in WT mice but remained completely unchanged in KO mice, compared with their respective baselines. These results indicate that GAT1 plays a critical role in the regulation of REM sleep and homeostasis of NREM sleep.	[Xu, Xin-Hong; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, Dept Pharmacol, Shanghai 200433, Peoples R China; [Qu, Wei-Min; Huang, Fang; Huang, Zhi-Li] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Bian, Min-Juan; Huang, Fang; Huang, Zhi-Li] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan	Fudan University; Fudan University; Fudan University; Tongji University	Qu, WM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Pharmacol, Shanghai 200433, Peoples R China.	quweimin@fudan.edu.cn; huangzl@fudan.edu.cn		Huang, Zhi-Li/0000-0001-9359-1150	National Natural Science Foundation of China [30901797, 30970955, 31070957, 31171010, 31121061, 31271164]; Shanghai Committee of Science and Technology [10441901600, 11ZR1402000, 13140903100]; National Basic Research Program of China [2009CB5220004, 2011CB711000]; Shanghai Leading Academic Discipline Project [B119]; Ph.D. Programs Foundation of Ministry of Education of China [20110071110033]; China National Science and Technology Major Project for Drug Discovery [2009ZX09303-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China National Science and Technology Major Project for Drug Discovery	This study was supported in part by grants-in-aid for scientific research from National Natural Science Foundation of China (30901797, 30970955, 31070957, 31171010, 31121061, 31271164), Shanghai Committee of Science and Technology (10441901600, 11ZR1402000, 13140903100), National Basic Research Program of China (2009CB5220004, 2011CB711000), Shanghai Leading Academic Discipline Project (B119), Ph.D. Programs Foundation of Ministry of Education of China (20110071110033) and China National Science and Technology Major Project for Drug Discovery (2009ZX09303-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borhegyi Z, 2004, J NEUROSCI, V24, P8470, DOI 10.1523/JNEUROSCI.1413-04.2004; Bragina L, 2008, J NEUROCHEM, V105, P1781, DOI 10.1111/j.1471-4159.2008.05273.x; Brodie MJ, 1995, EPILEPSIA, V36, pS7, DOI 10.1111/j.1528-1157.1995.tb06015.x; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Datta S, 2007, NEUROSCI BIOBEHAV R, V31, P775, DOI 10.1016/j.neubiorev.2007.02.004; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gong N, 2009, J NEUROSCI, V29, P15836, DOI 10.1523/JNEUROSCI.4643-09.2009; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Gvilia I, 2006, J NEUROSCI, V26, P9426, DOI 10.1523/JNEUROSCI.2012-06.2006; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; JUHASZ G, 1994, NEUROSCI LETT, V172, P155, DOI 10.1016/0304-3940(94)90685-8; Lancel M, 1998, BRIT J PHARMACOL, V123, P1471, DOI 10.1038/sj.bjp.0701769; Leach JP, 1998, LANCET, V351, P203, DOI 10.1016/S0140-6736(97)05035-6; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu Z, 2012, CNS NEUROSCI THER, V18, P623, DOI 10.1111/j.1755-5949.2012.00334.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mathias S, 2001, NEUROBIOL AGING, V22, P247, DOI 10.1016/S0197-4580(00)00232-3; McGinty D, 2001, SLEEP MED REV, V5, P323, DOI 10.1053/smrv.2001.0170; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Qiu MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045471; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Sanford LD, 2003, J NEUROPHYSIOL, V90, P938, DOI 10.1152/jn.00993.2002; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schachter SC, 1999, CLIN NEUROPHARMACOL, V22, P312; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Xi MC, 1999, J NEUROPHYSIOL, V82, P2015, DOI 10.1152/jn.1999.82.4.2015	45	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75823	10.1371/journal.pone.0075823	http://dx.doi.org/10.1371/journal.pone.0075823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155871	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300005
J	Dakshinamoorthy, G; Munirathinam, G; Stoicescu, K; Reddy, MV; Kalyanasundaram, R				Dakshinamoorthy, Gajalakshmi; Munirathinam, Gnanasekar; Stoicescu, Kristen; Reddy, Maryada Venkatarami; Kalyanasundaram, Ramaswamy			Large Extracellular Loop of Tetraspanin as a Potential Vaccine Candidate for Filariasis	PLOS ONE			English	Article							BRUGIA-MALAYI; PROTECTIVE IMMUNITY; LYMPHATIC FILARIASIS; ONCHOCERCA-VOLVULUS; BANCROFTIAN FILARIASIS; SCHISTOSOMA-MANSONI; ANTIBODY-RESPONSES; HIGH-LEVEL; INFECTION; ANTIGEN	Lymphatic filariasis affects nearly 120 million people worldwide and mass preventive chemotherapy is currently used as a strategy to control this infection. This has substantially reduced the incidence of the infection in several parts of the world. However, a prophylactic vaccine would be more effective in preventing future infections and will supplement the mass chemotherapy efforts. Unfortunately, there is no licensed vaccine available currently to prevent this infection. Molecules expressed on the surface of the parasite are potential candidates for vaccine development as they are exposed to the host immune system. In this study we show that the large extracellular loop of tetraspanin (TSP LEL), a protein expressed on the cuticle of Brugia malayi and Wuchereria bancrofti is a potential vaccine candidate. Our results showed that BmTSP LEL is expressed on the surface of B. malayi infective third stage larvae (L3) and sera from human subjects who are putatively immune to lymphatic filariasis carry high titer of IgG1 and IgG3 antibodies against BmTSP LEL and WbTSP LEL. We also showed that these antibodies in the sera of human subjects can participate in the killing of B. malayi L3 in an antibody dependent cell-mediated cytotoxicity mechanism. Vaccination trials in mice showed that close to 64% protection were achieved against challenge infections with B. malayi L3. Immunized animals showed high titer of anti-WbTSP LEL IgG1, IgG2a and IgG2b antibodies in the sera and IFN-gamma secreting cells in the spleen. Onchocerca volvulus another filarial parasite also expresses TSP LEL. Cross-reactivity studies showed that IgG1 antibody in the sera of endemic normal subjects, recognize OvTSP LEL. Similarly, anti-OvTSP LEL antibodies in the sera of subjects who are immune to O. volvulus were also shown to cross-react with rWbTSP LEL and rBmTSP LEL. These findings thus suggested that rTSP LEL can be developed as a potential vaccine candidate against multiple filarial infections.	[Dakshinamoorthy, Gajalakshmi; Munirathinam, Gnanasekar; Stoicescu, Kristen; Kalyanasundaram, Ramaswamy] Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA; [Reddy, Maryada Venkatarami] Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kalyanasundaram, R (corresponding author), Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA.	ramswamy@uic.edu			National Institutes of Health [RO1 AI064745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from National Institutes of Health through grant RO1 AI064745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM D, 1989, AM J TROP MED HYG, V40, P598, DOI 10.4269/ajtmh.1989.40.598; Anand SB, 2007, PARASITOL RES, V101, P981, DOI 10.1007/s00436-007-0571-2; Anand SB, 2012, APPL BIOCHEM BIOTECH, V167, P1351, DOI 10.1007/s12010-012-9643-6; Babayan SA, 2012, PARASITE IMMUNOL, V34, P243, DOI 10.1111/j.1365-3024.2011.01350.x; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; CASSONE A, 2010, MBIO, V1, DOI DOI 10.1128/MBI0.00042-10.PUBMED:20689748.RETRIEVED; Cho-Ngwa F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000800; Cupit PM, 2011, INT J PARASITOL, V41, P1249, DOI 10.1016/j.ijpara.2011.07.007; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Dang ZS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001570; Dang ZS, 2009, VACCINE, V27, P7339, DOI 10.1016/j.vaccine.2009.09.045; Dash Y, 2011, INFECT IMMUN, V79, P838, DOI 10.1128/IAI.00128-10; FAN S, 1991, CELL IMMUNOL, V135, P78, DOI 10.1016/0008-8749(91)90255-A; FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850; Gnanasekar M, 2008, DNA SEQUENCE, V19, P151, DOI 10.1080/10425170701517614; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoerauf A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/j.1469-0691.2011.03586.x; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Jones EL, 2011, BIOCHEM SOC T, V39, P506, DOI 10.1042/BST0390506; Jones MK, 2004, BIOESSAYS, V26, P752, DOI 10.1002/bies.20058; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kurniawan-Atmadja A, 1998, PARASITE IMMUNOL, V20, P9, DOI 10.1046/j.1365-3024.1998.t01-1-00118.x; Lahariya C, 2011, J VECTOR DIS, V48, P1; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; MacDonald AJ, 2002, INFECT IMMUN, V70, P2796, DOI 10.1128/IAI.70.6.2796-2804.2002; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Makepeace BL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000544; Michael E, 2000, TROP MED SCI PRACT, V1, P41; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Pearson MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001564; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Rao KVN, 2000, MOL BIOCHEM PARASIT, V107, P71, DOI 10.1016/S0166-6851(99)00231-5; Ravindran B, 2003, MED MICROBIOL IMMUN, V192, P41, DOI 10.1007/s00430-002-0157-7; ROZSNYAY Z, 1989, IMMUNOLOGY, V66, P491; Sahoo MK, 2009, VACCINE, V27, P4263, DOI 10.1016/j.vaccine.2009.05.015; Samykutty A, 2010, PROCEDIA VACCINOL, V3, P12, DOI 10.1016/j.provac.2010.11.003; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Steel C, 1996, J INFECT DIS, V174, P598, DOI 10.1093/infdis/174.3.598; Stewart GR, 1997, INFECT IMMUN, V65, P164, DOI 10.1128/IAI.65.1.164-170.1997; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Teillaud J. L., 2012, ELS, DOI [10.1002/ 9780470015902.a0000498.pub2, DOI 10.1002/9780470015902.A0000498.PUB2]; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Tran MH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000840; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037019; Zeldenryk LM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001366	56	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77394	10.1371/journal.pone.0077394	http://dx.doi.org/10.1371/journal.pone.0077394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146990	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400116
J	Franken, J; Brandt, BA; Tai, SL; Bauer, FF				Franken, Jaco; Brandt, Bianca A.; Tai, Siew L.; Bauer, Florian F.			Biosynthesis of Levan, a Bacterial Extracellular Polysaccharide, in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							WINE YEAST; LEVANSUCRASE; FERMENTATION; EXPRESSION; FRUCTANS; CLONING; MUTANT; DOMAIN; CDNA	Levans are fructose polymers synthesized by a broad range of micro-organisms and a limited number of plant species as non-structural storage carbohydrates. In microbes, these polymers contribute to the formation of the extracellular polysaccharide (EPS) matrix and play a role in microbial biofilm formation. Levans belong to a larger group of commercially important polymers, referred to as fructans, which are used as a source of prebiotic fibre. For levan, specifically, this market remains untapped, since no viable production strategy has been established. Synthesis of levan is catalysed by a group of enzymes, referred to as levansucrases, using sucrose as substrate. Heterologous expression of levansucrases has been notoriously difficult to achieve in Saccharomyces cerevisiae. As a strategy, this study used an invertase (Delta suc2) null mutant and two separate, engineered, sucrose accumulating yeast strains as hosts for the expression of the levansucrase M1FT, previously cloned from Leuconostoc mesenteroides. Intracellular sucrose accumulation was achieved either by expression of a sucrose synthase (Susy) from potato or the spinach sucrose transporter (SUT). The data indicate that in both.suc2 and the sucrose accumulating strains, the M1FT was able to catalyse fructose polymerisation. In the absence of the predicted M1FT secretion signal, intracellular levan accumulation was significantly enhanced for both sucrose accumulation strains, when grown on minimal media. Interestingly, co-expression of M1FT and SUT resulted in hyper-production and extracellular build-up of levan when grown in rich medium containing sucrose. This study presents the first report of levan production in S. cerevisiae and opens potential avenues for the production of levan using this well established industrial microbe. Furthermore, the work provides interesting perspectives when considering the heterologous expression of sugar polymerizing enzymes in yeast.	[Franken, Jaco; Brandt, Bianca A.; Tai, Siew L.; Bauer, Florian F.] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University	Bauer, FF (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa.	fb2@sun.ac.za	Bauer, Florian/A-1078-2013; Tai, Siew L/E-6476-2016	Bauer, Florian/0000-0001-5764-4542; Tai, Siew L/0000-0002-2148-3115; Brandt, Bianca Anina/0000-0001-9197-8095	NRF NPPD postdoctoral fellowship; National Research Foundation of SA [78691]; Winetech	NRF NPPD postdoctoral fellowship; National Research Foundation of SA; Winetech	JF was supported by an NRF NPPD postdoctoral fellowship. National Research Foundation of SA, grant number 78691 (http://www.nrf.ac.za/). The research was financially supported by Winetech, the research funding body of the SA wine industry (IWBT-Y08/01; http://www.winetech.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banguela A, 2011, J BIOTECHNOL, V154, P93, DOI 10.1016/j.jbiotec.2011.04.007; Batista AS, 2004, J MOL MICROB BIOTECH, V8, P26, DOI 10.1159/000082078; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Berthels NJ, 2004, FEMS YEAST RES, V4, P683, DOI 10.1016/j.femsyr.2004.02.005; Cairns AJ, 2003, J EXP BOT, V54, P549, DOI 10.1093/jxb/erg056; Chiang CJ, 2009, APPL MICROBIOL BIOT, V82, P445, DOI 10.1007/s00253-008-1772-z; Demel RA, 1998, BBA-BIOMEMBRANES, V1375, P36, DOI 10.1016/S0005-2736(98)00138-2; Dogsa I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062044; Eyeghe-Bickong HA, 2012, J CHROMATOGR B, V885, P43, DOI 10.1016/j.jchromb.2011.12.011; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Kang FK, 2005, BBA-GENE STRUCT EXPR, V1727, P5, DOI 10.1016/j.bbaexp.2004.10.012; Kang HK, 2011, FOOD SCI BIOTECHNOL, V20, P277, DOI 10.1007/s10068-011-0039-0; Krugel U, 2008, PLANT CELL, V20, P2497, DOI 10.1105/tpc.108.058271; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Liesche J, 2010, MOL PLANT, V3, P1064, DOI 10.1093/mp/ssq059; Olvera C, 2012, APPL ENVIRON MICROB, V78, P1820, DOI 10.1128/AEM.07222-11; Pretorius IS, 2005, AUST J GRAPE WINE R, V11, P83, DOI 10.1111/j.1755-0238.2005.tb00281.x; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Rehm J, 1998, J BACTERIOL, V180, P1305, DOI 10.1128/JB.180.5.1305-1310.1998; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; SALANOUBAT M, 1987, GENE, V60, P47, DOI 10.1016/0378-1119(87)90212-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOTTI PA, 1994, YEAST, V10, P29, DOI 10.1002/yea.320100104; Scotti PA, 1996, YEAST, V12, P953, DOI 10.1002/(SICI)1097-0061(199608)12:10<953::AID-YEA998>3.0.CO;2-#; Shida T, 2002, BIOSCI BIOTECH BIOCH, V66, P1555, DOI 10.1271/bbb.66.1555; SHIH IL, 2010, BIORESOURCE TECHNOL, V120, P3966; SHIMAMURA A, 1987, CARBOHYD RES, V165, P150, DOI 10.1016/0008-6215(87)80091-5; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; TOLEDO LET, 2001, ELECTRON J BIOTECHN, V7, P115; Turk SCHJ, 1997, NEW PHYTOL, V136, P29, DOI 10.1046/j.1469-8137.1997.00727.x; Velazquez-Hernandez ML, 2009, J APPL MICROBIOL, V106, P1763, DOI 10.1111/j.1365-2672.2008.04120.x; Volschenk H, 1997, NAT BIOTECHNOL, V15, P253, DOI 10.1038/nbt0397-253; WISE CS, 1955, ANAL CHEM, V27, P33, DOI 10.1021/ac60097a011	38	29	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77499	10.1371/journal.pone.0077499	http://dx.doi.org/10.1371/journal.pone.0077499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147008	gold, Green Published			2022-12-25	WOS:000325819400123
J	Liu, F; Gong, J; Huang, W; Wang, Z; Wang, M; Yang, J; Wu, C; Wu, Z; Han, B				Liu, F.; Gong, J.; Huang, W.; Wang, Z.; Wang, M.; Yang, J.; Wu, C.; Wu, Z.; Han, B.			MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes	ONCOGENE			English	Article						glioma; miR-106b-5p; cell proliferation; apoptosis; retinoblastoma-like (RBL1/2); caspase-8	EXPRESSION; MICRORNAS; MIR-106B; APOPTOSIS; CASPASE-8; MIR-20A; CLUSTER; RNAS	Aberrant expression of microRNAs (miRNAs) has been implicated in cancer initiation and progression. However, little is known about the potential role of miRNAs in glioma tumorigenesis. In this study, we found that miRNA-106b-5p was significantly upregulated in glioma tumor samples and cell lines compared with normal brain tissues, and its expression level correlated with the pathological grading. Overexpression of miR-106b-5p in glioma tumor cells significantly promoted cell proliferation, although inhibited cell apoptosis in vitro and in vivo. In contrast, knockdown of miR-106b-5p significantly inhibited cell proliferation, although enhanced cell apoptosis. Mechanistic study revealed that two target genes, retinoblastoma-like 1 (RBL1) and RBL2, were involved in miR-106b-5p's regulation of cell proliferation and one target gene, caspase-8 (CASP8), mediated miR-106b-5p's regulation of apoptosis. We also investigated the function of the three targets in glioma tumorigenesis by RNA interference manipulation and demonstrated that knockdown of these target genes led to cell proliferation enhancement or cell apoptosis inhibition in vitro. More interestingly, the expression levels of these targets were significantly downregulated in glioma samples and knockdown of these targets in glioma cells inhibited the xenograft tumor formation in vivo. Moreover, we verified the regulation function of miR-106b-5p and its targets on cell proliferation and apoptosis of the primary cultured astrocytes isolated from glioma tumor samples and healthy controls. Collectively, our findings show the critical roles of miR-106b-5p and its targets, RBL1, RBL2 and CASP8, in glioma tumorigenesis and provide potential candidates for malignant glioma therapy.	[Liu, F.; Gong, J.; Huang, W.; Wang, M.; Yang, J.; Wu, C.; Wu, Z.; Han, B.] Changzhou 2 Peoples Hosp, Dept Neurosurg, Changzhou 213003, Jiangsu, Peoples R China; [Wang, Z.] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Huang, W (corresponding author), Changzhou 2 Peoples Hosp, Dept Neurosurg, Changzhou 213003, Jiangsu, Peoples R China.	doctorliu411@163.com; w13306208761@hotmail.com			Open Project Program of Jiangsu Province's Key Discipline/Laboratory of Medicine [KF200971]; Changzhou Health Bureau [ZD201112]	Open Project Program of Jiangsu Province's Key Discipline/Laboratory of Medicine; Changzhou Health Bureau	This work was supported by the Open Project Program of Jiangsu Province's Key Discipline/Laboratory of Medicine (KF200971), Key Project of Changzhou Health Bureau (ZD201112).	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Ashley DM, 2005, CANCER-AM CANCER SOC, V104, P1487, DOI 10.1002/cncr.21323; Bogler O, 2005, J CELL BIOCHEM, V96, P16, DOI 10.1002/jcb.20475; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Guo CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017734; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Hudson RS, 2013, ONCOGENE, V32, P4139, DOI 10.1038/onc.2012.424; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Sharif A, 2012, METHODS MOL BIOL, V814, P137, DOI 10.1007/978-1-61779-452-0_11; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang X, 2012, ONCOL REP, V28, P1293, DOI 10.3892/or.2012.1927; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952	31	71	76	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4813	4822		10.1038/onc.2013.428	http://dx.doi.org/10.1038/onc.2013.428			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24166509	Bronze			2022-12-25	WOS:000343240100003
J	Gansler, J; Preissner, KT; Fischer, S				Gansler, Julia; Preissner, Klaus T.; Fischer, Silvia			Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells	FASEB JOURNAL			English	Article						extracellular RNA; tumor necrosis factor; vascular homeostasis	EXTRACELLULAR RNA; PANCREATIC RIBONUCLEASE; HISTONE DEACETYLASES; SERUM RIBONUCLEASE; CANCER; INFLAMMATION; CYTOKINES; PROTEIN; PROCOAGULANT; PERMEABILITY	Extracellular RNA (eRNA) released under injury or pathological conditions has been identified as a yet unrecognized vascular alarm signal to induce procoagulant, permeability-promoting, and proinflammatory activities. eRNA-induced functions were largely prevented by administration of RNase1 as a natural blood vessel-protective antagonist of eRNA. The aim of this study was to investigate the inflammatory regulation of endothelial cell RNase1, which is partly stored in Weibel-Palade bodies of these cells. Long-term treatment of human umbilical vein endothelial cells (HUVECs) with inflammatory agents like tumor necrosis factor (TNF-) or interleukin 1 (IL-1), but not with eRNA, significantly decreased the release (34 +/- 5%; 34 +/- 7% of control) as well as the cellular expression (19.5 +/- 5%; 33 +/- 8% of control) of RNase1. Down-regulation of RNase1 by TNF- stimulation or RNase1 siRNA knockdown increased the permeability of HUVEC monolayers, demonstrated by dearrangement of VE-cadherins at cell-cell borders. Mechanistically, cytokine-induced decrease of RNase1 expression did not involve the nuclear factor B (NFB) signaling pathway but epigenic modifications. Since inhibition of histone deacetylases resulted in recovery of RNase1 expression and secretion after cytokine treatment, an acetylation-dependent process of RNase1 regulation is proposed. These results indicate that cytokine-mediated down-regulation of RNase1 in endothelial cells may aggravate eRNA-induced inflammatory activities and thereby disturbs the vascular homeostasis of the extracellular RNA/RNase system.Gansler, J., Preissner, K. T., Fischer, S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells.	[Gansler, Julia; Preissner, Klaus T.; Fischer, Silvia] Univ Giessen, Sch Med, Inst Biochem, D-35392 Giessen, Germany	Justus Liebig University Giessen	Fischer, S (corresponding author), Univ Giessen, Sch Med, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	silvia.fischer@biochemie.med.uni-giessen.de	Fischer, Silvia/ABG-3104-2021		Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany) [SFB547, SPP1190, FI 543/2-1]; Excellence Cluster Cardiopulmonary System (ECCPS);  [IRTG-1566 (PROMISE)]	Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany)(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); 	The authors thank Jessica Schneider and Barbel Fuhler for their skilful technical assistance. Funding was obtained from the Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany), including SFB547, SPP1190, FI 543/2-1, the Excellence Cluster Cardiopulmonary System (ECCPS), and IRTG-1566 (PROMISE). The authors declare no conflicts of interest.	BARDON A, 1976, CLIN CHIM ACTA, V67, P231, DOI 10.1016/0009-8981(76)90331-4; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; CONWAY EM, 1988, MOL CELL BIOL, V8, P5588, DOI 10.1128/MCB.8.12.5588; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2013, CANCER RES, V73, P5080, DOI 10.1158/0008-5472.CAN-12-4657; Fischer S, 2012, THROMB HAEMOSTASIS, V108, P730, DOI 10.1160/TH12-03-0186; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; Grabiec AM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3137; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kawabata Tomoko, 2010, Arthritis Res Ther, V12, pR133, DOI 10.1186/ar3071; Landre JBP, 2002, J CELL BIOCHEM, V86, P540, DOI 10.1002/jcb.10234; Petaja J, 2011, THROMB RES, V127, pS34, DOI 10.1016/S0049-3848(10)70153-5; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Rugeles MT, 2003, AIDS, V17, P481, DOI 10.1097/00002030-200303070-00002; SENO M, 1994, BBA-GENE STRUCT EXPR, V1218, P466, DOI 10.1016/0167-4781(94)90208-9; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; SHEID B, 1977, CANCER, V39, P2204, DOI 10.1002/1097-0142(197705)39:5<2204::AID-CNCR2820390539>3.0.CO;2-Y; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; SZNAJD J, 1981, COR VASA, V23, P241; WEICKMANN JL, 1984, CANCER RES, V44, P1682; ZIMMERMAN SB, 1965, ANAL BIOCHEM, V10, P444, DOI 10.1016/0003-2697(65)90313-1	31	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					752	760		10.1096/fj.13-238600	http://dx.doi.org/10.1096/fj.13-238600			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24174426				2022-12-25	WOS:000331072200022
J	Penaloza, CG; Estevez, B; Han, DM; Norouzi, M; Lockshin, RA; Zakeri, Z				Penaloza, Carlos G.; Estevez, Brian; Han, Dinah M.; Norouzi, Melissa; Lockshin, Richard A.; Zakeri, Zahra			Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA	FASEB JOURNAL			English	Article						gender; sexual dimorphism; estrogen; 17-estradiol; 5-aza-2-deoxycytidine; sodium bisulfite; X-ist	GENDER-RELATED DIFFERENCES; METHYLTRANSFERASES DNMT3A; BOVINE BLASTOCYSTS; GENE-EXPRESSION; HORMONES; DISEASE; CELLS	Sexual differences are only partially attributable to hormones. Cultured male or female cells, even from embryos before sexual differentiation, differ in gene expression and sensitivity to toxins, and these differences persist in isolated primary cells. Male and female cells from Swiss Webster CWF mice manifest sex-distinct patterns of DNA methylation for X-ist and for cytochrome P450 (CYP; family members 1a1, 2e1m, and 7b1. Dnmt3l is differentially expressed but not differentially methylated, and Gapdh is neither differentially methylated nor expressed. CYP family genes differ in expression in whole tissue homogenates and cell cultures, with female Cyp expression 2- to 355-fold higher and Dnmt3l 12- to 32-fold higher in males. DNA methylation in the promoters of these genes is sex dimorphic; reducing methylation differences reduces to 1- to 6-fold differences in the expression of these genes. Stress or estradiol alters both methylation and gene expression. We conclude that different methylation patterns partially explain the sex-based differences in expression of CYP family members and X-ist, which potentially leads to inborn differences between males and females and their different responses to chronic and acute changes. Sex-differential methylation may have medical effects.Penaloza, C.G., Estevez, B., Han, D.M., Norouzi, M., Lockshin, R.A., Zakeri, Z. Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA.	[Penaloza, Carlos G.; Estevez, Brian; Han, Dinah M.; Norouzi, Melissa; Lockshin, Richard A.; Zakeri, Zahra] CUNY Queens Coll, Flushing, NY 11367 USA; [Penaloza, Carlos G.; Estevez, Brian; Han, Dinah M.; Norouzi, Melissa; Lockshin, Richard A.; Zakeri, Zahra] CUNY, Grad Ctr, Flushing, NY USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Zakeri, Z (corresponding author), CUNY Queens Coll, 65-30 Kissena Blvd,NSB E143, Flushing, NY 11367 USA.	zahra_zakeri@hotmail.com		Estevez, Brian/0000-0002-1863-7224	U.S. National Institutes of Health/National Institute of General Medical Sciences [T 34 GM070387]; Professional Staff Congress-City University of New York; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM070387] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Professional Staff Congress-City University of New York; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the U.S. National Institutes of Health/National Institute of General Medical Sciences (Minority Access to Research Careers-Undergraduate Student Training in Academic Research) grant T 34 GM070387, and by a Professional Staff Congress-City University of New York award to Z.F.Z.	Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bhadhprasit W, 2011, DRUG METAB DISPOS, V39, P490, DOI 10.1124/dmd.110.035980; Bourc'his D, 2008, MOL CELL ENDOCRINOL, V282, P87, DOI 10.1016/j.mce.2007.11.025; Bryant DN, 2010, NEUROSCIENCE, V170, P1261, DOI 10.1016/j.neuroscience.2010.08.019; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng YW, 2007, ENVIRON MOL MUTAGEN, V48, P14, DOI 10.1002/em.20270; Conerly M, 2010, DIS MODEL MECH, V3, P290, DOI 10.1242/dmm.004812; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Gebert C, 2009, GENOMICS, V94, P63, DOI 10.1016/j.ygeno.2009.03.004; Giltay EJ, 1999, ANN NY ACAD SCI, V876, P340, DOI 10.1111/j.1749-6632.1999.tb07658.x; Hazelhoff MH, 2012, INT J MOL SCI, V13, P10523, DOI 10.3390/ijms130810523; Jeng SR, 2012, GEN COMP ENDOCR, V175, P163, DOI 10.1016/j.ygcen.2011.11.005; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; Kolodkin MH, 2011, J NEUROENDOCRINOL, V23, P577, DOI 10.1111/j.1365-2826.2011.02147.x; Kouzmenko A, 2010, EPIGENOMICS-UK, V2, P765, DOI 10.2217/EPI.10.58; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lockshin MD, 2001, J APPL PHYSIOL, V91, P2366, DOI 10.1152/jappl.2001.91.5.2366; Lockshin MD, 2006, ORTHOP CLIN N AM, V37, P629, DOI 10.1016/j.ocl.2006.08.002; Macak-Safranko Z, 2011, EXP TOXICOL PATHOL, V63, P345, DOI 10.1016/j.etp.2010.02.009; Mollerup S, 1999, CANCER RES, V59, P3317; Ng Martin K C, 2007, Heart Lung Circ, V16, P185, DOI 10.1016/j.hlc.2007.02.108; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Qin HH, 2013, AUSTRALAS J DERMATOL, V54, P90, DOI 10.1111/j.1440-0960.2012.00968.x; Roughton K, 2012, EUR J NEUROSCI, V36, P2763, DOI 10.1111/j.1460-9568.2012.08197.x; Selmi C., 2012, AUTOIMMUN REV, V11, P6; Torcia MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039853; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vanselow J, 2011, GEN COMP ENDOCR, V170, P475, DOI 10.1016/j.ygcen.2010.11.003; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; Wang FF, 2010, HYPERTENSION, V55, P1172, DOI 10.1161/HYPERTENSIONAHA.110.150839; Wu L, 2012, J HUM HYPERTENS, V26, P731, DOI 10.1038/jhh.2011.96; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	37	35	37	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					966	977		10.1096/fj.13-233320	http://dx.doi.org/10.1096/fj.13-233320			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24161885	Green Published			2022-12-25	WOS:000331072200041
J	Hofmeister-Brix, A; Kollmann, K; Langer, S; Schultz, J; Lenzen, S; Baltrusch, S				Hofmeister-Brix, Anke; Kollmann, Katrin; Langer, Sara; Schultz, Julia; Lenzen, Sigurd; Baltrusch, Simone			Identification of the Ubiquitin-like Domain of Midnolin as a New Glucokinase Interaction Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Resonance Energy Transfer (FRET); Glucokinase; Insulin Secretion; Insulin Synthesis; Pancreatic Islets; Parkin; Ubiquitin; Midnolin; Two-hybrid System; Ubiquitin-like Domain	PANCREATIC BETA-CELLS; INSULIN-PRODUCING CELLS; SWISS-MODEL; REGULATORY PROTEIN; DIFFERENTIAL EXPRESSION; GLUCOSE-HOMEOSTASIS; PROTEASOME SYSTEM; GENE-EXPRESSION; RAT-LIVER; B-CELLS	Background: Glucokinase activity is regulated on the posttranslational level in pancreatic beta cells. Results: Searching a pancreatic islet yeast two-hybrid library, the ubiquitin-like domain of midnolin was identified to bind and inhibit glucokinase at low glucose, thereby reducing insulin secretion. Conclusion: Midnolin is a new glucokinase interaction partner. Significance: This is the first report demonstrating midnolin protein expression in pancreatic beta cells. Glucokinase acts as a glucose sensor in pancreatic beta cells. Its posttranslational regulation is important but not yet fully understood. Therefore, a pancreatic islet yeast two-hybrid library was produced and searched for glucokinase-binding proteins. A protein sequence containing a full-length ubiquitin-like domain was identified to interact with glucokinase. Mammalian two-hybrid and fluorescence resonance energy transfer analyses confirmed the interaction between glucokinase and the ubiquitin-like domain in insulin-secreting MIN6 cells and revealed the highest binding affinity at low glucose. Overexpression of parkin, an ubiquitin E3 ligase exhibiting an ubiquitin-like domain with high homology to the identified, diminished insulin secretion in MIN6 cells but had only some effect on glucokinase activity. Overexpression of the elucidated ubiquitin-like domain or midnolin, containing exactly this ubiquitin-like domain, significantly reduced both intrinsic glucokinase activity and glucose-induced insulin secretion. Midnolin has been to date classified as a nucleolar protein regulating mouse development. However, we could not confirm localization of midnolin in nucleoli. Fluorescence microscopy analyses revealed localization of midnolin in nucleus and cytoplasm and co-localization with glucokinase in pancreatic beta cells. In addition we could show that midnolin gene expression in pancreatic islets is up-regulated at low glucose and that the midnolin protein is highly expressed in pancreatic beta cells and also in liver, muscle, and brain of the adult mouse and cell lines of human and rat origin. Thus, the results of our study suggest that midnolin plays a role in cellular signaling of adult tissues and regulates glucokinase enzyme activity in pancreatic beta cells.	[Hofmeister-Brix, Anke; Kollmann, Katrin; Langer, Sara; Lenzen, Sigurd; Baltrusch, Simone] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany; [Schultz, Julia; Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, D-18057 Rostock, Germany	Hannover Medical School; University of Rostock	Baltrusch, S (corresponding author), Univ Rostock, Inst Med Biochem & Mol Biol, D-18057 Rostock, Germany.	simone.baltrusch@med.uni-rostock.de			Innovative Medicines Initiative Joint Undertaking Grant [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA)	Innovative Medicines Initiative Joint Undertaking Grant; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA)	The work was supported by Innovative Medicines Initiative Joint Undertaking Grant 155005 (Innovative Medicines Initiative for Diabetes), the resources of which are composed of financial contributions from the European Union Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies in kind contribution.	Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; Arden C, 2004, DIABETES, V53, P2346, DOI 10.2337/diabetes.53.9.2346; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, DIABETES, V55, pS55, DOI 10.2337/db06-S008; Baltrusch S, 2007, DIABETES, V56, P1305, DOI 10.2337/db06-0894; BEERS EP, 1993, J BIOL CHEM, V268, P21645; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNISHBOWDEN A, 1986, BIOCHEM J, V240, P293, DOI 10.1042/bj2400293; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Ding SY, 2011, J BIOL CHEM, V286, P16768, DOI 10.1074/jbc.M110.192799; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hofmeister-Brix A, 2013, BIOCHEM J, V456, P173, DOI 10.1042/BJ20130262; Huynh DP, 2001, DEV BRAIN RES, V130, P173, DOI 10.1016/S0165-3806(01)00234-6; IYNEDJIAN PB, 1986, P NATL ACAD SCI USA, V83, P1998, DOI 10.1073/pnas.83.7.1998; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KORANYI LI, 1992, DIABETES, V41, P807, DOI 10.2337/diabetes.41.7.807; Kuhn K, 2004, DEV BRAIN RES, V149, P131, DOI 10.1016/j.devbrainres.2004.02.001; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; LENZEN S, 1988, BIOCHEM PHARMACOL, V37, P371, DOI 10.1016/0006-2952(88)90201-8; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; Markwardt ML, 2012, MOL ENDOCRINOL, V26, P1617, DOI 10.1210/me.2012-1183; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; Matschinsky FM, 2006, DIABETES, V55, P1; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Negahdar M, 2012, BBA-MOL BASIS DIS, V1822, P1705, DOI 10.1016/j.bbadis.2012.07.005; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Schmitt H, 2011, DIABETOLOGIA, V54, P1744, DOI 10.1007/s00125-011-2133-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; SIBROWSKI W, 1984, J BIOL CHEM, V259, P343; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; TIEDGE M, 1995, BIOCHEM J, V308, P139, DOI 10.1042/bj3080139; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tsukahara M, 2000, GENE, V254, P45, DOI 10.1016/S0378-1119(00)00259-6; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walters KJ, 2004, BBA-MOL CELL RES, V1695, P73, DOI 10.1016/j.bbamcr.2004.10.005; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; YIN L, 1992, DIABETES, V41, P792; Zielak AE, 2008, MOL REPROD DEV, V75, P904, DOI 10.1002/mrd.20819	63	31	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35824	35839		10.1074/jbc.M113.526632	http://dx.doi.org/10.1074/jbc.M113.526632			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187134	hybrid, Green Published			2022-12-25	WOS:000329814700020
J	Hattori, T; Kishino, T; Stephen, S; Eberspaecher, H; Maki, S; Takigawa, M; de Crombrugghe, B; Yasuda, H				Hattori, Takako; Kishino, Tetsuya; Stephen, Shelley; Eberspaecher, Heidi; Maki, Sayumi; Takigawa, Masaharu; de Crombrugghe, Benoit; Yasuda, Hideyo			E6-AP/UBE3A Protein Acts as a Ubiquitin Ligase toward SOX9 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; E3 Ubiquitin Ligase; Protein Degradation; Proteomics; Ubiquitin; Ubiquitination; E6-AP; SOX9; UBE3A	CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; GENE; CARTILAGE; TRANSCRIPTION; EXPRESSION; COLLAGEN; DIFFERENTIATION; IDENTIFICATION	Background: Although the ubiquitin-proteasome pathway is thought to regulate the level of SOX9, the ubiquitin ligase involved has not yet been determined. Results: E6-AP/UBE3A was found to bind and ubiquitinate SOX9. Conclusion: E6-AP/UBE3A functions as a ubiquitin ligase toward SOX9 both in vitro and in vivo. Significance: These data provide the regulatory mechanism of the SOX9 level in chondrocytes by ubiquitin ligase. SOX9 is a transcription factor that acts as a key regulator at various stages of cartilage differentiation. There is ample evidence that intracellular SOX9 protein levels are tightly regulated both by sumoylation and by degradation through the ubiquitin-proteasome pathway. Using a proteomics approach, here we report the identification of a SOX9-binding protein, E6-AP/UBE3A, that may act as a ubiquitin ligase toward Sox9. E6-AP bound SOX9 through the region consisting mostly of its high mobility group domain in vitro. In nuclear lysates, FLAG-tagged E6-AP coprecipitated with Sox9 and its high mobility group domain. This finding was estimated using nuclear lysates from a chondrocytic cell line that endogenously expresses E6-AP and SOX9. Accordingly, ectopically expressed E6-AP and SOX9 colocalized in the nucleus. We show that E6-AP ubiquitinates SOX9 in vitro and in vivo and that SOX9 levels are enhanced after addition of the proteasome inhibitor bortezomib. Similar, siRNA knockdown of E6-AP and the E2 ligase Ubc9 increased cellular SOX9 amounts, supporting the notion that SOX9 may be ubiquitinated in hypertrophic chondrocytes by E6-AP and degraded by proteasomes. This is in accordance with the distribution of SOX9 levels, which are high in proliferating and prehypertrophic chondrocytes but low in hypertrophic chondrocytes, whereas E6-AP levels are high in hypertrophic chondrocytes and low in prehypertrophic chondrocytes. Furthermore, E6-AP-deficient mice showed SOX9 accumulation in chondrocytes and the brain. These findings support the concept that E6-AP regulates SOX9 levels in developing cartilage by acting as a ubiquitin ligase.	[Hattori, Takako; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Kita Ku, Okayama 7008525, Japan; [Kishino, Tetsuya] Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 852852, Japan; [Hattori, Takako; Stephen, Shelley; Eberspaecher, Heidi; de Crombrugghe, Benoit; Yasuda, Hideyo] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Maki, Sayumi; Yasuda, Hideyo] Nippon Flour Mills Co Ltd, Cent Lab, Biosci Lab, Atsugi, Kanagawa 2430041, Japan	Okayama University; Nagasaki University; University of Texas System; UTMD Anderson Cancer Center	Hattori, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	hattorit@md.okayama-u.ac.jp; h-yasuda@yk9.so-net.ne.jp			National Institutes of Health [RO1AR309854]; Ministry of Education, Culture, and Sports, Japan [21592359, 25462888]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, and Sports, Japan	This work was supported, in whole or in part, by National Institutes of Health grant RO1AR309854 (to B. d. C.).This work was also supported by Scientific Research Grants 21592359 and 25462888 from the Ministry of Education, Culture, and Sports, Japan (to T. H., M. T., and H. Y.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Ciechanover A, 1990, Semin Cell Biol, V1, P415; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dikic I, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-22; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Riemer S, 2002, J CELL BIOCHEM, V86, P688, DOI 10.1002/jcb.10260; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	43	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35138	35148		10.1074/jbc.M113.486795	http://dx.doi.org/10.1074/jbc.M113.486795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24155239	Green Published, hybrid			2022-12-25	WOS:000329867600015
J	Mulligan, C; Mindell, JA				Mulligan, Christopher; Mindell, Joseph A.			Mechanism of Transport Modulation by an Extracellular Loop in an Archaeal Excitatory Amino Acid Transporter (EAAT) Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Chemical Modification; Glutamate; Membrane Transport; Reconstitution of Membrane Transporters; Transporters; Protein Cross-linking	DEPENDENT ASPARTATE TRANSPORTER; GLUTAMATE TRANSPORTER; PYROCOCCUS-HORIKOSHII; CRYSTAL-STRUCTURE; TRANSLOCATION; BINDING; SODIUM; STOICHIOMETRY; SUBSTRATE; EXCHANGE	Background: The extracellular loop, 3L4, plays an important, unknown role in the transport cycle of the glutamate transporter homolog, Glt(Ph). Results: Cleaving 3L4 differentially affects transport cycle steps. Conclusion: 3L4 discriminates between substrate-loaded and empty states of the transporter. Significance: Empty and loaded forms of the transport domain have structurally distinguishable forms, reflecting essential features of the transport mechanism. Secondary transporters in the excitatory amino acid transporter family terminate glutamatergic synaptic transmission by catalyzing Na+-dependent removal of glutamate from the synaptic cleft. Recent structural studies of the aspartate-specific archaeal homolog, Glt(Ph), suggest that transport is achieved by a rigid body, piston-like movement of the transport domain, which houses the substrate-binding site, between the extracellular and cytoplasmic sides of the membrane. This transport domain is connected to an immobile scaffold by three loops, one of which, the 3-4 loop (3L4), undergoes substrate-sensitive conformational change. Proteolytic cleavage of the 3L4 was found to abolish transport activity indicating an essential function for this loop in the transport mechanism. Here, we demonstrate that despite the presence of fully cleaved 3L4, Glt(Ph) is still able to sample conformations relevant for transport. Optimized reconstitution conditions reveal that fully cleaved Glt(Ph) retains some transport activity. Analysis of the kinetics and temperature dependence of transport accompanied by direct measurements of substrate binding reveal that this decreased transport activity is not due to alteration of the substrate binding characteristics but is caused by the significantly reduced turnover rate. By measuring solute counterflow activity and cross-link formation rates, we demonstrate that cleaving 3L4 severely and specifically compromises one or more steps contributing to the movement of the substrate-loaded transport domain between the outward- and inward-facing conformational states, sparing the equivalent step(s) during the movement of the empty transport domain. These results reveal a hitherto unknown role for the 3L4 in modulating an essential step in the transport process.	[Mulligan, Christopher; Mindell, Joseph A.] NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247; Mulligan, Christopher/0000-0001-5157-4651	Intramural Research Program of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003014] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health, NINDS.	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Compton ELR, 2010, P NATL ACAD SCI USA, V107, P12840, DOI 10.1073/pnas.1003046107; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, J BACTERIOL, V192, P2900, DOI 10.1128/JB.00136-10; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P1284, DOI 10.1021/bi00219a018; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	27	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35266	35276		10.1074/jbc.M113.508408	http://dx.doi.org/10.1074/jbc.M113.508408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24155238	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000329867600025
J	Tipton, AR; Ji, WB; Sturt-Gillespie, B; Bekier, ME; Wang, KX; Taylor, WR; Liu, ST				Tipton, Aaron R.; Ji, Wenbin; Sturt-Gillespie, Brianne; Bekier, Michael E., II; Wang, Kexi; Taylor, William R.; Liu, Song-Tao			Monopolar Spindle 1 (MPS1) Kinase Promotes Production of Closed MAD2 (C-MAD2) Conformer and Assembly of the Mitotic Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; E3 Ubiquitin Ligase; Mitosis; Protein Complexes; Protein Kinases; BUBR1; MAD2; MPS1 Kinase; Mitotic Checkpoint Complex (MCC); Spindle Assembly Checkpoint	AURORA-B; ANAPHASE; CDC20; KINETOCHORES; BUBR1; INHIBITION; BINDING; MITOSIS; APC/C; COMPLEX/CYCLOSOME	Background: How MPS1 kinase functions during mitotic checkpoint signaling is not fully understood. Results: C-MAD2 expression rescues premature mitotic exit caused by MPS1 inhibition without localizing at kinetochores. Conclusion: MPS1 functions primarily to enhance C-MAD2 production and subsequent formation of the mitotic checkpoint complex. Significance: The results underscore the importance of MPS1 kinase in maintaining kinetochore localization and catalytic efficiency of the MAD1C-MAD2 core. MPS1 kinase is an essential component of the spindle assembly checkpoint (SAC), but its functioning mechanisms are not fully understood. We have shown recently that direct interaction between BUBR1 and MAD2 is critical for assembly and function of the human mitotic checkpoint complex (MCC), the SAC effector. Here we report that inhibition of MPS1 kinase activity by reversine disrupts BUBR1-MAD2 as well as CDC20-MAD2 interactions, causing premature activation of the anaphase-promoting complex/cyclosome. The effect of MPS1 inhibition is likely due to reduction of closed MAD2 (C-MAD2), as expressing a MAD2 mutant (MAD2(L13A)) that is locked in the C conformation rescued the checkpoint defects. In the presence of reversine, exogenous C-MAD2 does not localize to unattached kinetochores but is still incorporated into the MCC. Contrary to a previous report, we found that sustained MPS1 activity is required for maintaining both the MAD1C-MAD2 complex and open MAD2 (O-MAD2) at unattached kinetochores to facilitate C-MAD2 production. Additionally, mitotic phosphorylation of BUBR1 is also affected by MPS1 inhibition but seems dispensable for MCC assembly. Our results support the notion that MPS1 kinase promotes C-MAD2 production and subsequent MCC assembly to activate the SAC.	[Tipton, Aaron R.; Ji, Wenbin; Sturt-Gillespie, Brianne; Bekier, Michael E., II; Wang, Kexi; Taylor, William R.; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579	deArce Memorial Fund; Ohio Cancer Research Associates; National Science Foundation [MCB-1052413]	deArce Memorial Fund; Ohio Cancer Research Associates; National Science Foundation(National Science Foundation (NSF))	This work was supported by the deArce Memorial Fund, by Ohio Cancer Research Associates, and by National Science Foundation Grant MCB-1052413 (to S.T.L).	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Campbell MS, 2001, J CELL SCI, V114, P953; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Diaz-Martinez LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-23; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lau DTC, 2012, CURR BIOL, V22, P180, DOI 10.1016/j.cub.2011.12.029; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mariani L, 2012, CURR BIOL, V22, P1900, DOI 10.1016/j.cub.2012.08.028; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050	52	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35149	35158		10.1074/jbc.M113.522375	http://dx.doi.org/10.1074/jbc.M113.522375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151075	hybrid, Green Published			2022-12-25	WOS:000329867600016
J	Viswanatha, R; Wayt, J; Ohouo, PY; Smolka, MB; Bretscher, A				Viswanatha, Raghuvir; Wayt, Jessica; Ohouo, Patrice Y.; Smolka, Marcus B.; Bretscher, Anthony			Interactome Analysis Reveals Ezrin Can Adopt Multiple Conformational States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cytoskeleton; Ezrin; Phosphorylation; Plasma Membrane; Proteomics	GDP DISSOCIATION INHIBITOR; RETINAL-PIGMENT EPITHELIUM; SCAFFOLDING PROTEIN EBP50; H EXCHANGER NHE1; ERM PROTEINS; ACTIN CYTOSKELETON; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; CELL-MIGRATION; BINDING-SITE	Background: Ezrin is a conformationally regulated microfilament-membrane linker restricted to the apical aspect of epithelial cells. Results: Quantitative mass spectrometry identified proteins that associate with different ezrin conformations; the interactors include novel apical microvilli-associated proteins, with classes perceiving ezrin's conformation differentially. Conclusion: Different proteins selectively associate with three distinct conformational states of ezrin. Significance: This study extends the conformational activation model of ezrin and identifies new interacting partners. Ezrin, a member of the ezrin-radixin-moesin family (ERM), is an essential regulator of the structure of microvilli on the apical aspect of epithelial cells. Ezrin provides a linkage between membrane-associated proteins and F-actin, oscillating between active/open and inactive/closed states, and is regulated in part by phosphorylation of a C-terminal threonine. In the open state, ezrin can bind a number of ligands, but in the closed state the ligand-binding sites are inaccessible. In vitro analysis has proposed that there may be a third hyperactivated form of ezrin. To gain a better understanding of ezrin, we conducted an unbiased proteomic analysis of ezrin-binding proteins in an epithelial cell line, Jeg-3. We refined our list of interactors by comparing the interactomes using quantitative mass spectrometry between wild-type ezrin, closed ezrin, open ezrin, and hyperactivated ezrin. The analysis reveals several novel interactors confirmed by their localization to microvilli, as well as a significant class of proteins that bind closed ezrin. Taken together, the data indicate that ezrin can exist in three different conformational states, and different ligands perceive ezrin conformational states differently.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Bretscher, Anthony] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Bretscher, A (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, 257 Weill Hall, Ithaca, NY 14853 USA.	apb5@cornell.edu			National Institutes of Health [GM-036652, 5T32GM007273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, R01GM036652, R01GM097272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-036652 (to A. B.).; Supported in part by National Institutes of Health Training Grant 5T32GM007273.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Berryman MA, 2003, CELL MOTIL CYTOSKEL, V56, P159, DOI 10.1002/cm.10141; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Bonilha VL, 2001, INVEST OPHTH VIS SCI, V42, P3274; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Bretscher A, 1997, J CELL SCI, V110, P3011; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Chuang JZ, 2010, MOL BIOL CELL, V21, P3017, DOI 10.1091/mbc.E09-10-0907; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dominguez-Luis M, 2011, EUR J IMMUNOL, V41, P3436, DOI 10.1002/eji.201141764; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GARY R, 1993, P NATL ACAD SCI USA, V90, P10846, DOI 10.1073/pnas.90.22.10846; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; Granes F, 2000, J CELL SCI, V113, P1267; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Henning MS, 2011, VIROLOGY, V415, P114, DOI 10.1016/j.virol.2011.04.006; Hipfner DR, 2004, GENE DEV, V18, P2243, DOI 10.1101/gad.303304; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Hughes SC, 2010, J CELL SCI, V123, P1099, DOI 10.1242/jcs.059469; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Luo Y, 2012, ONCOGENE, V31, P306, DOI 10.1038/onc.2011.244; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; Matsui K, 2011, J PROTEOME RES, V10, P3983, DOI 10.1021/pr200577d; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Neisch AL, 2013, MOL BIOL CELL, V24, P1420, DOI 10.1091/mbc.E12-11-0800; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Ognibene M, 2011, J BIOL CHEM, V286, P29973, DOI 10.1074/jbc.M111.270785; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Sakurai T, 2008, J NEUROSCI RES, V86, P2602, DOI 10.1002/jnr.21705; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Spertini C, 2012, J BIOL CHEM, V287, P10693, DOI 10.1074/jbc.M111.318022; Sullivan A, 2003, EXP CELL RES, V284, P224, DOI 10.1016/S0014-4827(02)00054-X; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wang Z, 2011, INVEST OPHTH VIS SCI, V52, P5079, DOI 10.1167/iovs.10-6998; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zaarour RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037490; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	105	33	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35437	35451		10.1074/jbc.M113.505669	http://dx.doi.org/10.1074/jbc.M113.505669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151071	Green Published, hybrid			2022-12-25	WOS:000329867600040
J	Liu, L; Souto, J; Liao, WB; Jiang, YP; Li, YQ; Nishinakamura, R; Huang, SM; Rosengart, T; Yang, VW; Schuster, M; Ma, YP; Yang, JC				Liu, Li; Souto, Joseph; Liao, Wenbin; Jiang, Yongping; Li, Yangqiu; Nishinakamura, Ryuichi; Huang, Suming; Rosengart, Todd; Yang, Vincent W.; Schuster, Michael; Ma, Yupo; Yang, Jianchang			Histone Lysine-specific Demethylase 1 (LSD1) Protein Is Involved in Sal-like Protein 4 (SALL4)-mediated Transcriptional Repression in Hematopoietic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Marrow; DNA Methylation; Hematopoiesis; Repressor Protein; Stem Cells; Histone Demethylation; Mi-2 center dot NuRD Complex; SALL Family; Hematopoietic Progenitor	STEM/PROGENITOR CELLS; OKIHIRO-SYNDROME; GENE-EXPRESSION; PLURIPOTENCY; REGULATOR; MURINE; DIFFERENTIATION; PROLIFERATION; HOMOLOG; PATHWAY	Background: SALL4 plays important roles in regulating the growth of hematopoietic progenitor cells. Results: SALL4 dynamically recruits histone demethylase LSD1 to specific target genes. LSD1 negatively regulates SALL4-mediated gene expression by affecting local chromatin structure. Conclusion: Multiple epigenetic modifiers cooperatively modulate SALL4-mediated gene repression. Significance: This report provides a novel mechanism by which stem cell gene SALL4 controls hematopoietic progenitor cell properties. The stem cell protein SALL4 plays a critical role in hematopoiesis by regulating the cell fate. In primitive hematopoietic precursors, it activates or represses important genes via recruitment of various epigenetic factors such as DNA methyltransferases, and histone deacylases. Here, we demonstrate that LSD1, a histone lysine demethylase, also participates in the trans-repressive effects of SALL4. Based on luciferase assays, the amine oxidase domain of LSD1 is important in suppressing SALL4-mediated reporter transcription. In freshly isolated adult mouse bone marrows, both SALL4 and LSD1 proteins are preferentially expressed in undifferentiated progenitor cells and co-localize in the nuclei. Further sequential chromatin immunoprecipitation assay confirmed that these two factors share the same binding sites at the promoter regions of important hematopoietic regulatory genes including EBF1, GATA1, and TNF. In addition, studies from both gain- and loss-of-function models revealed that SALL4 dynamically controls the binding levels of LSD1, which is accompanied by a reversely changed histone 3 dimethylated lysine 4 at the same promoter regions. Finally, shRNA-mediated knockdown of LSD1 in hematopoietic precursor cells resulted in altered SALL4 downstream gene expression and increased cellular activity. Thus, our data revealed that histone demethylase LSD1 may negatively regulate SALL4-mediated transcription, and the dynamic regulation of SALL4-associated epigenetic factors cooperatively modulates early hematopoietic precursor proliferation.	[Liu, Li; Souto, Joseph; Yang, Jianchang] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11790 USA; [Liao, Wenbin; Ma, Yupo; Yang, Jianchang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11790 USA; [Yang, Vincent W.; Schuster, Michael] SUNY Stony Brook, Dept Med, Stony Brook, NY 11790 USA; [Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215126, Peoples R China; [Jiang, Yongping] Peking Union Med Coll, Suzhou 215126, Peoples R China; [Li, Yangqiu] Jinan Univ, Inst Hematol, Guangzhou 510632, Guangdong, Peoples R China; [Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Kumamoto 8600862, Japan; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA; [Rosengart, Todd] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jinan University; Kumamoto University; State University System of Florida; University of Florida; Baylor College of Medicine	Ma, YP (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11790 USA.	yupo.ma@stonybrookmedicine.edu; jianchang.yang@stonybrookmedicine.edu			National Institutes of Health [R01HL087948, R01 HL090589]; American Cancer Society Research Scholar Grant [RSG-12-216-01-LIB]; State New Drug Research Development [2011ZX09401-027, 2011ZX09102-010-04, 12C26213202208]; New York State Stem Cell Science (NYSTEM) [C028114, C026716]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948, R01HL090589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); State New Drug Research Development; New York State Stem Cell Science (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087948 (to Y. M.) and R01 HL090589 (to S. H.). This work was also supported by American Cancer Society Research Scholar Grant RSG-12-216-01-LIB (to J. Y.); State New Drug Research & Development Grants 2011ZX09401-027, 2011ZX09102-010-04, and 12C26213202208 (to Y. J.); and New York State Stem Cell Science (NYSTEM) Grants C028114 and C026716 (to the Stony Brook Stem Cell Center).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Du T, 2010, P NATL ACAD SCI USA, V107, P15904, DOI 10.1073/pnas.1010741107; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Gao C, 2013, TRANSFUSION, V53, P1037, DOI 10.1111/j.1537-2995.2012.03888.x; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Li AL, 2013, J CLIN INVEST, V123, P4195, DOI 10.1172/JCI62891; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Maier H, 2002, SEMIN IMMUNOL, V14, P415, DOI 10.1016/S1044532302000763; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Okuma E, 2000, LEUKEMIA, V14, P612, DOI 10.1038/sj.leu.2401716; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Satoh Y, 2008, J BIOL CHEM, V283, P30045, DOI 10.1074/jbc.M804768200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2012, CURR OPIN HEMATOL, V19, P287, DOI 10.1097/MOH.0b013e328353c684; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	33	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34719	34728		10.1074/jbc.M113.506568	http://dx.doi.org/10.1074/jbc.M113.506568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24163373	Green Published, hybrid			2022-12-25	WOS:000329812800038
J	Yang, NN; Sun, YH; Wang, YR; Long, C; Li, YY; Li, Y				Yang, Nina; Sun, Yuhan; Wang, Yaru; Long, Cui; Li, Yingyue; Li, Yun			Proteomic Analysis of the Low Mutation Rate of Diploid Male Gametes Induced by Colchicine in Ginkgo biloba L.	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; GLUTATHIONE S-TRANSFERASES; DYNAMIC INSTABILITY; STRESS RESPONSES; OXIDATIVE STRESS; XENOPUS EGGS; ARABIDOPSIS; EXPRESSION; GENES; COLD	Colchicine treatment of G. biloba microsporocytes results in a low mutation rate in the diploid (2n) male gamete. The mutation rate is significantly lower as compared to other tree species and impedes the breeding of new economic varieties. Proteomic analysis was done to identify the proteins that influence the process of 2n gamete formation in G. biloba. The microsporangia of G. biloba were treated with colchicine solution for 48 h and the proteins were analyzed using 2-D gel electrophoresis and compared to protein profiles of untreated microsporangia. A total of 66 proteins showed difference in expression levels. Twenty-seven of these proteins were identified by mass spectrometry. Among the 27 proteins, 14 were found to be up-regulated and the rest 13 were down-regulated. The identified proteins belonged to five different functional classes: ATP generation, transport and carbohydrate metabolism; protein metabolism; ROS scavenging and detoxifying enzymes; cell wall remodeling and metabolism; transcription, cell cycle and signal transduction. The identification of these differentially expressed proteins and their function could help in analysing the mechanism of lower mutation rate of diploid male gamete when the microsporangium of G. biloba was induced by colchicine.	[Yang, Nina; Sun, Yuhan; Wang, Yaru; Long, Cui; Li, Yingyue; Li, Yun] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China; [Wang, Yaru] Hebei Acad Agr & Forestry Sci, Shijiazhuang Pomol Inst, Shijiazhuang, Peoples R China	Beijing Forestry University; Hebei Academy of Agricultural & Forestry Sciences	Li, Y (corresponding author), Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China.	yunli63@gmail.com		Li, Yun/0000-0002-8426-565X	Research funds for the Doctoral Program of Higher Education of China [20110014110005]; National Natural Science Foundation of China [30771747]	Research funds for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research funds for the Doctoral Program of Higher Education of China (20110014110005) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) and the National Natural Science Foundation of China (30771747) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; Agrawal GK, 2002, PLANT PHYSIOL BIOCH, V40, P1061, DOI 10.1016/S0981-9428(02)01471-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BEALE SI, 1974, PLANT PHYSIOL, V53, P297, DOI 10.1104/pp.53.2.297; Brosche M, 1999, BBA-GENE STRUCT EXPR, V1447, P185, DOI 10.1016/S0167-4781(99)00154-2; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Chen YM, 2006, PLANT J, V47, P174, DOI 10.1111/j.1365-313X.2006.02783.x; [程金新 CHENG Jinxin], 2006, [北京林业大学学报, Journal of Beijing Forestry University], V28, P15; Chevalier C, 1996, PLANT SCI, V117, P95, DOI 10.1016/0168-9452(96)04399-3; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cummins I, 1997, PESTIC BIOCHEM PHYS, V59, P35, DOI 10.1006/pest.1997.2308; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; Dhugga KS, 1997, P NATL ACAD SCI USA, V94, P7679, DOI 10.1073/pnas.94.14.7679; Dixon D, 1997, PESTIC SCI, V50, P72, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;72::AID-PS553&gt;3.0.CO;2-Z; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Drazkiewicz M, 2003, CELL MOL BIOL LETT, V8, P777; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Feussner K, 1997, FEBS LETT, V409, P211, DOI 10.1016/S0014-5793(97)00509-7; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gao Peng, 2004, Journal of Beijing Forestry University, V26, P39; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GENSCHIK P, 1992, PLANT MOL BIOL, V20, P897, DOI 10.1007/BF00027161; Gomez MJR, 2000, J PHYSIOL BIOCHEM, V56, P33, DOI 10.1007/BF03179774; Gorg A, 1999, ELECTROPHORESIS, V20, P712; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; HOGETSU T, 1978, PLANTA, V140, P15, DOI 10.1007/BF00389374; JEPSON I, 1994, PLANT MOL BIOL, V26, P1855, DOI 10.1007/BF00019498; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jung YH, 2006, J PROTEOME RES, V5, P2586, DOI 10.1021/pr060092c; Kang XiangYang, 1999, Scientia Silvae Sinicae, V35, P21; KRAPP AR, 1995, ARCH BIOCHEM BIOPHYS, V317, P215, DOI 10.1006/abbi.1995.1156; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; [李云 Li Yun], 2005, [植物学通报, Chinese Bulletin of Botany], V22, P375; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Olmsted JB, 1991, CURR OPIN CELL BIOL, V3, P52, DOI 10.1016/0955-0674(91)90165-U; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; PRYER NK, 1992, J CELL SCI, V103, P965; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Riechers DE, 1997, PLANT PHYSIOL, V114, P1461, DOI 10.1104/pp.114.4.1461; Sagi G, 2005, PLANT CELL, V17, P1788, DOI 10.1105/tpc.105.031823; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SHERRIER DJ, 1994, PLANT J, V5, P185, DOI 10.1046/j.1365-313X.1994.05020185.x; SHIN M, 1965, J BIOL CHEM, V240, P1405; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Sun YH, 2011, AFR J BIOTECHNOL, V10, P5476; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Wang JY, 2003, BIOCHEMISTRY; Wang YaRu, 2010, Journal of Southwest Forestry University, V30, P45; Wang ZF, 2010, PLANT MOL BIOL, V74, P265, DOI 10.1007/s11103-010-9671-y; Wanke M, 2000, BBA-BIOMEMBRANES, V1463, P188, DOI 10.1016/S0005-2736(99)00191-1; Wegener A, 1997, CAN J FOREST RES, V27, P945, DOI 10.1139/cjfr-27-6-945; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Xu FX, 2002, PLANT PHYSIOL, V130, P362, DOI 10.1104/pp.004796; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhang JF, 2006, THESIS BEIJING FOR U, P2	71	3	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76088	10.1371/journal.pone.0076088	http://dx.doi.org/10.1371/journal.pone.0076088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167543	Green Published, Green Submitted, gold			2022-12-25	WOS:000326034500002
J	Hoover-Plow, J; Sa, QL; Huang, MG; Grondolsky, J				Hoover-Plow, Jane; Sa, Qila; Huang, Menggui; Grondolsky, Jessica			Genetic Dissection of Quantitative Trait Loci for Hemostasis and Thrombosis on Mouse Chromosomes 11 and 5 Using Congenic and Subcongenic Strains	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; VON-WILLEBRAND-FACTOR; NITRIC-OXIDE SYNTHASE; E-DEFICIENT MICE; ATHEROSCLEROSIS SUSCEPTIBILITY; LIPOPROTEIN METABOLISM; SUBSTITUTION STRAINS; ARTERIAL THROMBOSIS; INSULIN-RESISTANCE; HUMAN PLATELETS	Susceptibility to thrombosis varies in human populations as well as many inbred mouse strains. Only a small portion of this variation has been identified, suggesting that there are unknown modifier genes. The objective of this study was to narrow the quantitative trait locus (QTL) intervals previously identified for hemostasis and thrombosis on mouse distal chromosome 11 (Hmtb6) and on chromosome 5 (Hmtb4 and Hmtb5). In a tail bleeding/rebleeding assay, a reporter assay for hemostasis and thrombosis, subcongenic strain (6A-2) had longer clot stability time than did C57BL/6J (B6) mice but a similar time to the B6-Chr11(A/J) consomic mice, confirming the Hmtb6 phenotype. Six congenic and subcongenic strains were constructed for chromosome 5, and the congenic strain, 2A-1, containing the shortest A/J interval (16.6 cM, 26.6 Mbp) in the Hmtb4 region, had prolonged clot stability time compared to B6 mice. In the 3A-2 and CSS-5 mice bleeding time was shorter than for B6, mice confirming the Hmtb5 QTL. An increase in bleeding time was identified in another congenic strain (3A-1) with A/J interval (24.8 cM, 32.9 Mbp) in the proximal region of chromosome 5, confirming a QTL for bleeding previously mapped to that region and designated as Hmtb10. The subcongenic strain 4A-2 with the A/J fragment in the proximal region had a long occlusion time of the carotid artery after ferric chloride injury and reduced dilation after injury to the abdominal aorta compared to B6 mice, suggesting an additional locus in the proximal region, which was designated Hmtb11 (5 cM, 21.4 Mbp). CSS-17 mice crossed with congenic strains, 3A-1 and 3A-2, modified tail bleeding. Using congenic and subcongenic analysis, candidate genes previously identified and novel genes were identified as modifiers of hemostasis and thrombosis in each of the loci Hmtb6, Hmtb4, Hmtb10, and Hmtb11.	[Hoover-Plow, Jane] Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Cardiovasc Med, Cleveland, OH USA; Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hoover-Plow, J (corresponding author), Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Cardiovasc Med, Cleveland, OH USA.	hooverj@ccf.org		, Menggui/0000-0002-4942-5558	National Institutes of Health (NIH) [HL065204, HL078701]; American Heart Association [0825602D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065204, R01HL078701] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (NIH) HL065204, NIH HL078701, and the American Heart Association 0825602D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allayee H, 2003, ARTERIOSCL THROM VAS, V23, P1501, DOI 10.1161/01.ATV.0000090886.40027.DC; Almind K, 2003, DIABETES, V52, P1535, DOI 10.2337/diabetes.52.6.1535; Anderson PD, 2003, HUM GENET, V113, P10, DOI 10.1007/s00439-003-0933-5; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; BORCHMAN D, 1995, CLIN EXP IMMUNOL, V102, P373; Braun A, 2011, FRONT BIOSCI-LANDMRK, V16, P2144, DOI 10.2741/3844; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Caprini JA, 2004, CIRCULATION, V109, pI4, DOI 10.1161/01.CIR.0000122869.59485.36; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chiu S, 2007, PHYSIOL GENOMICS, V31, P75, DOI 10.1152/physiolgenomics.00267.2006; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Furie B, 1996, HAEMOSTASIS, V26, P60; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Ginsburg D, 2005, J THROMB HAEMOST, V3, P1561, DOI 10.1111/j.1538-7836.2005.01461.x; Godecke A, 1998, CIRC RES, V82, P186; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gwynn B, 2000, BLOOD, V96, P4227; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Hoover-Plow J, 2001, BRAIN RES, V898, P256, DOI 10.1016/S0006-8993(01)02191-6; Hoover-Plow JL, 2008, INFLAMM RES, V57, P457, DOI 10.1007/s00011-008-7062-5; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; HOOVERPLOW J, 1980, P SOC EXP BIOL MED, V165, P409; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Humphries S E, 1992, Ann Epidemiol, V2, P371; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kim E, 2003, BIOCHEM BIOPH RES CO, V304, P313, DOI 10.1016/S0006-291X(03)00588-6; Kubo Y, 2005, MOL CELL BIOL, V25, P4138, DOI 10.1128/MCB.25.10.4138-4149.2005; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Mehrabian M, 2001, CIRC RES, V89, P125, DOI 10.1161/hh1401.093458; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Mohlke KL, 1996, P NATL ACAD SCI USA, V93, P15352, DOI 10.1073/pnas.93.26.15352; Moore KJ, 2000, ANNU REV GENET, V34, P653, DOI 10.1146/annurev.genet.34.1.653; Mori T, 1996, THROMB HAEMOSTASIS, V75, P49; Mouzeyan A, 2000, J LIPID RES, V41, P573; Mu JL, 1999, J LIPID RES, V40, P1328; NADEAU JH, 1995, J INFLAMM, V45, P27; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; NAGGERT JK, 1995, MAMM GENOME, V6, P131, DOI 10.1007/BF00303258; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NOVAK EK, 1984, BLOOD, V63, P536; Nurden AT, 2012, EXPERT REV HEMATOL, V5, P487, DOI [10.1586/EHM.12.46, 10.1586/ehm.12.46]; PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230; Quinton TM, 2004, J THROMB HAEMOST, V2, P978, DOI 10.1111/j.1538-7836.2004.00741.x; RHEA KE, 1991, J ULTRAS MED, V10, P316; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sa Q, 2008, MAMM GENOME, V19, P406, DOI 10.1007/s00335-008-9122-0; Sa Q, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-9; Sa Q, 2010, MAMM GENOME, V21, P337, DOI 10.1007/s00335-010-9274-6; SCHLAGER G, 1967, GENETICS, V57, P319; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smith J, 2003, CURR OPIN LIPIDOL, V14, P499, DOI 10.1097/00041433-200310000-00011; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Voetsch B, 2004, ARTERIOSCL THROM VAS, V24, P216, DOI 10.1161/01.ATV.0000107402.79771.fc; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Yazbek SN, 2011, GENOME RES, V21, P1065, DOI 10.1101/gr.120741.111	74	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77539	10.1371/journal.pone.0077539	http://dx.doi.org/10.1371/journal.pone.0077539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147020	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200044
J	Langford-Smith, KJ; Sandiford, Z; Langford-Smith, A; Wilkinson, FL; Jones, SA; Wraith, JE; Wynn, RF; Bigger, BW				Langford-Smith, Kia J.; Sandiford, Zara; Langford-Smith, Alex; Wilkinson, Fiona L.; Jones, Simon A.; Wraith, J. Ed; Wynn, Robert F.; Bigger, Brian W.			Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW-TRANSPLANTATION; LOW-DOSE IRRADIATION; MIXED CHIMERISM; T-CELLS; COSTIMULATION BLOCKADE; MONOCLONAL-ANTIBODY; MEDIATED ALLORESISTANCE; ALLOGENEIC CHIMERISM; CENTRAL TOLERANCE	Non-myeloablative allogeneic haematopoietic stem cell transplantation (HSCT) is rarely achievable clinically, except where donor cells have selective advantages. Murine non-myeloablative conditioning regimens have limited clinical success, partly through use of clinically unachievable cell doses or strain combinations permitting allograft acceptance using immunosuppression alone. We found that reducing busulfan conditioning in murine syngeneic HSCT, increases bone marrow (BM): blood SDF-1 ratio and total donor cells homing to BM, but reduces the proportion of donor cells engrafting. Despite this, syngeneic engraftment is achievable with non-myeloablative busulfan (25 mg/kg) and higher cell doses induce increased chimerism. Therefore we investigated regimens promoting initial donor cell engraftment in the major histocompatibility complex barrier mismatched CBA to C57BL/6 allo-transplant model. This requires full myeloablation and immunosuppression with non-depleting anti-CD4/CD8 blocking antibodies to achieve engraftment of low cell doses, and rejects with reduced intensity conditioning (<= 75 mg/kg busulfan). We compared increased antibody treatment, G-CSF, niche disruption and high cell dose, using reduced intensity busulfan and CD4/8 blockade in this model. Most treatments increased initial donor engraftment, but only addition of co-stimulatory blockade permitted long-term engraftment with reduced intensity or non-myeloablative conditioning, suggesting that signal 1 and 2 T-cell blockade is more important than early BM niche engraftment for transplant success.	[Langford-Smith, Kia J.; Sandiford, Zara; Langford-Smith, Alex; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England; [Jones, Simon A.; Wraith, J. Ed] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England	University of Manchester; University of Manchester; Royal Manchester Children's Hospital	Bigger, BW (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Langford-Smith, Alex/K-7624-2017; Langford-Smith, Alex/H-5249-2011; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wynn, robert/0000-0002-6046-8428; Bigger, Brian/0000-0002-9708-1112; Wilkinson, Fiona/0000-0002-0358-3489	UK MPS Society; Canadian MPS Society	UK MPS Society; Canadian MPS Society	This study was funded by the UK MPS Society and the Canadian MPS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2001, J IMMUNOL, V167, P1103, DOI 10.4049/jimmunol.167.2.1103; Anam K, 2006, TRANSPL IMMUNOL, V15, P199, DOI 10.1016/j.trim.2005.09.009; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Baskiewicz-Masiuk M, 2009, FOLIA HISTOCHEMICA C, P395; Bigenzahn S, 2005, AM J TRANSPLANT, V5, P1237, DOI 10.1111/j.1600-6143.2005.00862.x; Bigger BW, 2006, GENE THER, V13, P117, DOI 10.1038/sj.gt.3302638; Blaha P, 2005, TRANSPLANTATION, V80, P237, DOI 10.1097/01.TP.0000164510.25625.70; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS324, DOI 10.1016/j.jaci.2009.11.014; Cui JS, 1999, BRIT J HAEMATOL, V107, P895, DOI 10.1046/j.1365-2141.1999.01779.x; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Daley SR, 2008, AM J TRANSPLANT, V8, P2265, DOI 10.1111/j.1600-6143.2008.02382.x; Davies JD, 1997, TRANSPLANTATION, V63, P1570, DOI 10.1097/00007890-199706150-00005; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Fehr T, 2005, EUR J IMMUNOL, V35, P2679, DOI 10.1002/eji.200526190; Ferrer IR, 2011, AM J TRANSPLANT, V11, P654, DOI 10.1111/j.1600-6143.2011.03473.x; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Graca L, 2004, P NATL ACAD SCI USA, V101, P10122, DOI 10.1073/pnas.0400084101; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Graca L, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-9; Honey K, 1999, J IMMUNOL, V163, P4805; Hsieh MM, 2007, EXP HEMATOL, V35, P1415, DOI 10.1016/j.exphem.2007.05.009; Ito H, 2001, J IMMUNOL, V166, P2970, DOI 10.4049/jimmunol.166.5.2970; Jopling C, 2001, BRIT J HAEMATOL, V113, P970, DOI 10.1046/j.1365-2141.2001.02825.x; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Lucas CL, 2011, BLOOD, V117, P5532, DOI 10.1182/blood-2010-11-318675; Luo B, 2007, EUR J IMMUNOL, V37, P1233, DOI 10.1002/eji.200636938; Mardiney M, 1996, BLOOD, V87, P4049; Meng A, 2003, EXP HEMATOL, V31, P1348, DOI 10.1016/j.exphem.2003.08.014; Metzler B, 2008, TRANSPL IMMUNOL, V20, P106, DOI 10.1016/j.trim.2008.07.002; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; Nierlich PN, 2010, TRANSPL INT, V23, P1179, DOI 10.1111/j.1432-2277.2010.01120.x; PREE I, 2006, DRUG DISCOV TODAY TH, V3, P41, DOI DOI 10.1016/J.DDSTR.2006.02.002; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; Quesenberry PJ, 2001, BLOOD, V97, P557, DOI 10.1182/blood.V97.2.557; Sergijenko A, MOL THERAPY IN PRESS; Seung E, 2003, J CLIN INVEST, V112, P795, DOI 10.1172/JC1200318599; Singhal S, 2000, BONE MARROW TRANSPL, V26, P489, DOI 10.1038/sj.bmt.1702542; Takeuchi Y, 2004, AM J TRANSPLANT, V4, P31, DOI 10.1046/j.1600-6135.2003.00272.x; Taylor PA, 2001, BLOOD, V98, P467, DOI 10.1182/blood.V98.2.467; Wekerle T, 2002, TRANSPL INT, V15, P248, DOI 10.1007/s00147-002-0411-3; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Westerhof GR, 2000, CANCER RES, V60, P5470; Westerhuis G, 2005, BLOOD, V106, P2215, DOI 10.1182/blood-2005-04-1391; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wilkinson FL, 2013, MOL THERAPY IN PRESS; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wynn R, 2011, HEMATOL-AM SOC HEMAT, P285, DOI 10.1182/asheducation-2011.1.285; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; Yamazaki M, 2007, AM J TRANSPLANT, V7, P1710, DOI 10.1111/j.1600-6143.2007.01839.x; YEAGER AM, 1991, BLOOD, V78, P3312	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77632	10.1371/journal.pone.0077632	http://dx.doi.org/10.1371/journal.pone.0077632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147041	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200054
J	Shin, J; Xie, DL; Zhong, XP				Shin, Jinwook; Xie, Danli; Zhong, Xiao-Ping			MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase zeta	PLOS ONE			English	Article							IMMUNE-SYSTEM; DIFFERENTIATION; RECOGNITION; ALPHA; RESPONSES; MIR-34A; IMPAIRS; ABSENCE; ANERGY; RAS	The engagement of the T cell receptor (TCR) induces the generation of diacylglycerol (DAG), an important second messenger activating both the Ras/Erk and PKC theta/NF kappa B pathways. DAG kinases (DGKs) participate in the metabolism of DAG by converting it to phosphatidic acid. DGK zeta has been demonstrated to be able to inhibit DAG signaling following TCR engagement. Deficiency of DGK zeta increases the sensitivity of T cells to TCR stimulation, resulting in enhanced T cell activation ex vivo and in vivo. However, the mechanisms that control DGK zeta expression are poorly understood. Here we demonstrate that DGK zeta mRNA is a direct target of a cellular microRNA miR-34a. The DGK zeta transcript is decreased, whereas the primary miR-34a is upregulated upon TCR stimulation. Ectopic miR-34a expression suppresses DGK zeta protein expression through the seed match binding to both the 3' untranslated region and coding region of DGK zeta mRNA, leading to increased ERK1/2 phosphorylation and surface expression of the T cell activation marker CD69 following TCR cross-linking. In contrast, overexpression of a miR-34a competitive inhibitor increases DGK zeta expression and suppresses TCR-mediated T cell activation. Together, our data demonstrate that miR-34a is a negative regulator for DGK zeta and may play an important role in regulating T cell activation.	[Shin, Jinwook; Xie, Danli; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Xie, Danli] Wenzhou Med Univ, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Wenzhou Medical University; Duke University	Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	zhong001@mc.duke.edu	Shin, Jinwook/AAG-6004-2019	Shin, Jinwook/0000-0003-3476-7595	National Institutes of Health [AI076357, AI079088, AI101206]; American Cancer Society [RSG-08-186-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079088, R01AI076357, R01AI101206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by the National Institutes of Health (AI076357, AI079088, and AI101206) and the American Cancer Society (RSG-08-186-01-LIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiang P, 2012, EXP CELL RES, V318, P1175, DOI 10.1016/j.yexcr.2012.03.018; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Kulis M, 2011, J ALLERGY CLIN IMMUN, V128, P212, DOI 10.1016/j.jaci.2011.02.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Martinez-Moreno M, 2012, MOL CELL BIOL, V32, P4168, DOI 10.1128/MCB.00654-12; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shin J, 2012, BLOOD, V119, P3306, DOI 10.1182/blood-2011-05-353342; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	41	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77983	10.1371/journal.pone.0077983	http://dx.doi.org/10.1371/journal.pone.0077983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147106	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200091
J	Balanda, KP; Buckley, CM; Barron, SJ; Fahy, LE; Madden, JM; Harrington, JM; Perry, IJ; Kearney, PM				Balanda, Kevin P.; Buckley, Claire M.; Barron, Steve J.; Fahy, Lorraine E.; Madden, Jamie M.; Harrington, Janas M.; Perry, Ivan J.; Kearney, Patricia M.			Prevalence of Diabetes in the Republic of Ireland: Results from the National Health Survey (SLAN) 2007	PLOS ONE			English	Article							DIAGNOSIS; MELLITUS	Background: Current estimates of diabetes prevalence in the Republic of Ireland (RoI) are based on UK epidemiological studies. This study uses Irish data to describe the prevalence of doctor-diagnosed diabetes amongst all adults aged 18+ years and undiagnosed diabetes amongst those aged 45+ years. Methods: The survey of lifestyle attitudes and nutrition (SLAN) 2007 is based on a nationally representative sample of Irish adults aged 18+ years (n = 10,364). Self-reported doctor-diagnosed diabetes was recorded for respondents in the full sample. Diabetes medication use, measured height and weight, and non-fasting blood samples were variously recorded in sub-samples of younger (n = 967) and older (n = 1,207) respondents. Results: The prevalence of doctor-diagnosed diabetes amongst adults aged 18+ years was 3.5% (95% CI 3.1% 3.9%). After adjustment for other explanatory variables; the risk of self-reported doctor-diagnosed diabetes was significantly related to age (p < 0.0001), employment status (p = 0.0003) and obesity (p = 0.0003). Amongst adults aged 45+ years, the prevalence of doctor-diagnosed diabetes was 8.9% (95% CI 7.3% - 10.5%) and undiagnosed diabetes was 2.8% (95% CI 1.4% - 4.1%). This represented 31.2% of diabetes cases in this age group. Conclusion: Notwithstanding methodological differences, these prevalence estimates are consistent with those in the UK and France. However, the percentage of undiagnosed cases amongst adults aged 45+ years appears to be higher in the RoI. Increased efforts to improve early detection and population level interventions to address adverse diet and lifestyle factors are urgently needed.	[Balanda, Kevin P.; Barron, Steve J.; Fahy, Lorraine E.] Inst Publ Hlth Ireland, Dublin, Ireland; [Buckley, Claire M.] Natl Univ Ireland Univ Coll Cork, Dept Gen Practice, Cork, Ireland; [Buckley, Claire M.; Madden, Jamie M.; Harrington, Janas M.; Perry, Ivan J.; Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	University College Cork; University College Cork	Balanda, KP (corresponding author), Inst Publ Hlth Ireland, Dublin, Ireland.	kevin.balanda@publichealth.ie	Harrington, Janas/AAV-8123-2021	Harrington, Janas/0000-0002-6238-7031; Kearney, Patricia/0000-0001-9599-3540; Madden, Jamie/0000-0003-2383-5150; Balanda, Kevin/0000-0002-6780-8536; Perry, Ivan/0000-0002-4965-9792	Health Research Board; Department of Health in the Republic of Ireland	Health Research Board; Department of Health in the Republic of Ireland	This work has been part-funded by the Health Research Board (www.hrb.ie) and the Department of Health (www.dohc.ie) in the Republic of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Association of Public Health Observatories, 2010, APHO DIAB PREV MOD K; Balanda K., 2010, MAKING CHRONIC CONDI; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; Central Statistics Office, 2006, CENS POP; Central Statistics Office, 2006, Q NAT HOUS SURV; Creagh D, 2002, Ir Med J, V95, P298; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department of Health and Children, 2005, REP NATL TASKFORCE O, P1; Department of Health and Children, 2010, CHANG CARD HLTH NAT, P2010; Fonseca V, 2009, DIABETES CARE, V32, P1344, DOI 10.2337/dc09-9034; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hayes L, 2012, DIABETIC MED, V29, P115, DOI 10.1111/j.1464-5491.2011.03389.x; Health Service Executive, 2008, 1 HLTH SERV EX; Mc Hugh S, 2009, PRIM CARE DIABETES, V3, P225, DOI 10.1016/j.pcd.2009.09.002; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morgan K, 2008, SLAN 2007 SURVEY LIF; Peters AL, 1996, JAMA-J AM MED ASSOC, V276, P1246, DOI 10.1001/jama.276.15.1246; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; Smith SM, 2003, DIABETIC MED, V20, P717, DOI 10.1046/j.1464-5491.2003.00998.x; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WAUGH N, 2007, HEALTH TECHNOL ASSES, V11, pR9; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78406	10.1371/journal.pone.0078406	http://dx.doi.org/10.1371/journal.pone.0078406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147134	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400157
J	Ben-Zvi, M; Amariglio, N; Paret, G; Nevo-Caspi, Y				Ben-Zvi, Michal; Amariglio, Ninette; Paret, Gideon; Nevo-Caspi, Yael			F11R Expression upon Hypoxia Is Regulated by RNA Editing	PLOS ONE			English	Article							GENE-EXPRESSION; DEAMINASE; ADENOSINE; ADAR1	F11R is a cell adhesion molecule found on the surface of human platelets. It plays a role in platelet aggregation, cell migration and cell proliferation. F11R is subjected to RNA editing, a post-transcriptional modification which affects RNA structure, stability, localization, translation and splicing. RNA editing in the 3'UTR of F11R and RNA levels are increased upon hypoxia. We therefore set to examine if RNA editing plays a role in the increase of F11R RNA seen upon hypoxic conditions. We show that ADAR1, but not ADAR2, takes part in the editing of F11R however editing alone is not sufficient for obtaining an elevation in RNA levels. In addition we show that hyper-edited mature mRNAs are retained in the nucleus and are associated with p54(nrb). We therefore conclude that hypoxia-induced edited RNAs of F11R are preferentially stabilized and accumulate in the nucleus preventing their export to the cytoplasm for translation. This mechanism may be used by additional proteins in the cell as part of the cell's effort to reduce metabolism upon hypoxic stress.	[Ben-Zvi, Michal; Paret, Gideon; Nevo-Caspi, Yael] Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pediat Crit Care Med, Tel Hashomer, Israel; [Ben-Zvi, Michal; Paret, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Amariglio, Ninette] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Amariglio, Ninette] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Bar Ilan University	Nevo-Caspi, Y (corresponding author), Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pediat Crit Care Med, Tel Hashomer, Israel.	yael.caspi@sheba.health.gov.il			Amisragaz; general internal departmental resources	Amisragaz; general internal departmental resources	Amisragaz is a non-medical and non-pharmaceutical Israeli company that philanthropically supports our Pediatric Intensive Care Department. The current work was funded by general internal departmental resources. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Kaplan C, 2008, NATION, V286, P30; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Severson EA, 2009, CURR OPIN CELL BIOL, V21, P701, DOI 10.1016/j.ceb.2009.06.005; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	27	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77702	10.1371/journal.pone.0077702	http://dx.doi.org/10.1371/journal.pone.0077702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147060	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400126
J	Donfrancesco, C; Palleschi, S; Palmieri, L; Rossi, B; Lo Noce, C; Pannozzo, F; Spoto, B; Tripepi, G; Zoccali, C; Giampaoli, S				Donfrancesco, Chiara; Palleschi, Simonetta; Palmieri, Luigi; Rossi, Barbara; Lo Noce, Cinzia; Pannozzo, Fabio; Spoto, Belinda; Tripepi, Giovanni; Zoccali, Carmine; Giampaoli, Simona			Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CREATININE MEASUREMENT; RENAL-FUNCTION; ASSOCIATION; ALBUMINURIA; PREDICTION; EQUATION; SMOKING; PROFILE; WOMEN	Background: Chronic kidney disease (CKD) independently increases the risk of death and cardiovascular disease (CVD) in the general population. However, the relationship between estimated glomerular filtration rate (eGFR) and CVD/death risk in a general population at low risk of CVD has not been explored so far. Design: Baseline and longitudinal data of 1465 men and 1459 women aged 35-74 years participating to the MATISS study, an Italian general population cohort, were used to evaluate the role of eGFR in the prediction of all-cause mortality and incident CVD. Methods: Bio-bank stored sera were used to evaluate eGFR at baseline. Serum creatinine was measured on thawed samples by means of an IDMS-calibrated enzymatic method. eGFR was calculated by the CKD-EPI formula. Results: At baseline, less than 2% of enrolled persons had eGFR < 60 mL/min/1.73m(2) and more than 70% had a 10-year cardiovascular risk score < 10%. In people 60 or more years old, the first and the last eGFR quintiles (< 90 and >= 109 mL/min/1.73m(2), respectively) were associated to an increased risk for both all-cause mortality (hazard ratio 1.6, 95% confidence interval 1.2-2.1 and 4.3, 1.6-11.7, respectively) and incident CVD (1.6, 1.0-2.4 and 7.0, 2.2-22.9, respectively), even if adjusted for classical risk factors. Conclusions: These findings strongly suggest that in an elderly, general population at low risk of CVD and low prevalence of reduced renal filtration, even a modest eGFR reduction is related to all-cause mortality and CVD incidence, underlying the potential benefit to this population of considering eGFR for their risk prediction.	[Donfrancesco, Chiara; Palmieri, Luigi; Lo Noce, Cinzia; Giampaoli, Simona] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Palleschi, Simonetta; Rossi, Barbara] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pannozzo, Fabio; Zoccali, Carmine] AUSL, Latina, Italy; [Spoto, Belinda; Tripepi, Giovanni] IBIM, CNT, Reggio Di Calabria, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Donfrancesco, C (corresponding author), Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.	chiara.donfrancesco@iss.it	Palleschi, Simonetta/G-8563-2011; Rossi, Barbara/AAB-6997-2021; PALMIERI, LUIGI/O-1845-2017; Rossi, Barbara/AAB-6108-2021; donfrancesco, chiara/K-1460-2016	Palleschi, Simonetta/0000-0002-2180-0168; Rossi, Barbara/0000-0002-4358-5243; PALMIERI, LUIGI/0000-0002-4298-2642; Zoccali, Carmine/0000-0002-6616-1996; donfrancesco, chiara/0000-0002-8040-5571	Italian Ministry of Health; SYSKID	Italian Ministry of Health(Ministry of Health, Italy); SYSKID	The MATISS Study is part of the CUORE Project - Epidemiology and Prevention of Cardiovascular Disease, funded by the Italian Ministry of Health and coordinated by the National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita, Rome, Italy. This study was also partially funded by a grant by SYSKID (System Biology towards novel understanding of CKD diagnosis and treatment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Cirillo M, 2012, J NEPHROL, V25, P7, DOI 10.5301/jn.5000045; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Donfrancesco C, 2010, G ITAL CARDIOL, V11, p20S, DOI 10.1714/576.6810; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Germano G, 2012, EUR HEART J, V33, P137; Giampaoli S, 2006, AM J EPIDEMIOL, V163, P893, DOI 10.1093/aje/kwj110; Giampaoli S, 1997, ACTA CARDIOL, V52, P411; GIAMPAOLI S, 2007, ITAL J PUBLIC HLTH, V5, P102; Gislefoss RE, 2008, SCAND J CLIN LAB INV, V68, P402, DOI 10.1080/00365510701809235; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Ishizaka N, 2008, HYPERTENS RES, V31, P485, DOI 10.1291/hypres.31.485; Ito H, 2011, AM J EPIDEMIOL, V174, P949, DOI 10.1093/aje/kwr185; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MAHMOODI BK, 2012, LANCET, V380, P1, DOI DOI 10.1016/S0140-6736(11)61925-9.PUBMED:22770441; Mathisen UD, 2011, J AM SOC NEPHROL, V22, P927, DOI 10.1681/ASN.2010050479; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nitsch D, 2006, NEPHROL DIAL TRANSPL, V21, P935, DOI 10.1093/ndt/gfk021; Palmieri L, 2006, EUR J CARDIOV PREV R, V13, P562, DOI 10.1097/01.hjr.0000221866.27039.4b; Palmieri Luigi, 2004, Ann Ist Super Sanita, V40, P393; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209; *WHO, 1999, MONICA MAN, P81146; World Health Organization, 1977, INT CLASS DIS MAN IN; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	38	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78475	10.1371/journal.pone.0078475	http://dx.doi.org/10.1371/journal.pone.0078475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147135	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400158
J	Pellegrino, P; Carnovale, C; Perrone, V; Pozzi, M; Antoniazzi, S; Clementi, E; Radice, S				Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Pozzi, Marco; Antoniazzi, Stefania; Clementi, Emilio; Radice, Sonia			Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems	PLOS ONE			English	Article								Objective: To evaluate epidemiological features of post vaccine acute disseminated encephalomyelitis (ADEM) by considering data from different pharmacovigilance surveillance systems. Methods: The Vaccine Adverse Event Reporting System (VAERS) database and the EudraVigilance post-authorisation module (EVPM) were searched to identify post vaccine ADEM cases. Epidemiological features including sex and related vaccines were analysed. Results: We retrieved 205 and 236 ADEM cases from the EVPM and VAERS databases, respectively, of which 404 were considered for epidemiological analysis following verification and causality assessment. Half of the patients had less than 18 years and with a slight male predominance. The time interval from vaccination to ADEM onset was 2-30 days in 61% of the cases. Vaccine against seasonal flu and human papilloma virus vaccine were those most frequently associated with ADEM, accounting for almost 30% of the total cases. Mean number of reports per year between 2005 and 2012 in VAERS database was 40 +/- 21.7, decreasing after 2010 mainly because of a reduction of reports associated with human papilloma virus and Diphtheria, Pertussis, Tetanus, Polio and Haemophilus Influentiae type B vaccines. Conclusions: This study has a high epidemiological power as it is based on information on adverse events having occurred in over one billion people. It suffers from lack of rigorous case verification due to the weakness intrinsic to the surveillance databases used. At variance with previous reports on a prevalence of ADEM in childhood we demonstrate that it may occur at any age when post vaccination. This study also shows that the diminishing trend in post vaccine ADEM reporting related to Diphtheria, Pertussis, Tetanus, Polio and Haemophilus Influentiae type B and human papilloma virus vaccine groups is most likely due to a decline in vaccine coverage indicative of a reduced attention to this adverse drug reaction.	[Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Clementi, Emilio; Radice, Sonia] Univ Milan, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, Milan, Italy; [Pozzi, Marco; Clementi, Emilio] Sci Inst IRCCS E Medea, I-23842 Bosisio Parini, Lecco, Italy; [Antoniazzi, Stefania] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; IRCCS Ca Granda Ospedale Maggiore Policlinico	Clementi, E (corresponding author), Univ Milan, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, Milan, Italy.	emilio.clementi@unimi.it; sonia.radice@unimi.it	Pozzi, Marco/Z-2684-2019; Pozzi, Marco/J-7915-2016; Carnovale, Carla/Z-3073-2019	Pozzi, Marco/0000-0002-3800-5697; Pozzi, Marco/0000-0002-3800-5697; Carnovale, Carla/0000-0002-4107-196X	Italian Medicines Agency, AIFA; Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project); Italian Ministry of Health	Italian Medicines Agency, AIFA; Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project); Italian Ministry of Health(Ministry of Health, Italy)	The financial support by the Italian Medicines Agency, AIFA, and the Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project, to EC) and the Italian Ministry of Health (RC 2013 to EC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetto L, 2004, J NEUROL NEUROSUR PS, V75, pI22, DOI 10.1136/jnnp.2003.034256; Burwen DR, 2012, AM J PUBLIC HEALTH, V102, P1921, DOI 10.2105/AJPH.2011.300510; Collet JP, 2007, MONITORING SIGNALS V, V78, P178; Huynh W, 2008, J CLIN NEUROSCI, V15, P1315, DOI 10.1016/j.jocn.2008.05.002; Lievano F, 2012, VACCINE, V30, P6918, DOI 10.1016/j.vaccine.2012.08.057; Loughlin AM, 2012, VACCINE, V30, P7253, DOI 10.1016/j.vaccine.2012.09.074; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; McNeil MM, 2013, VACCINE, V31, P2673, DOI 10.1016/j.vaccine.2013.04.009; Murthy SNK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e21; Shoamanesh A, 2011, VACCINE, V29, P8182, DOI 10.1016/j.vaccine.2011.08.103; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f	13	44	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77766	10.1371/journal.pone.0077766	http://dx.doi.org/10.1371/journal.pone.0077766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147076	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400133
J	Bent, ZW; Brazel, DM; Tran-Gyamfi, MB; Hamblin, RY; VanderNoot, VA; Branda, SS				Bent, Zachary W.; Brazel, David M.; Tran-Gyamfi, Mary B.; Hamblin, Rachelle Y.; VanderNoot, Victoria A.; Branda, Steven S.			Use of a Capture-Based Pathogen Transcript Enrichment Strategy for RNA-Seq Analysis of the Francisella Tularensis LVS Transcriptome during Infection of Murine Macrophages	PLOS ONE			English	Article							LIVE VACCINE STRAIN; VIRULENCE GENE-EXPRESSION; RESPIRATORY BURST; ESCHERICHIA-COLI; OXIDATIVE STRESS; PURINE AUXOTROPH; SUF OPERON; IDENTIFICATION; NOVICIDA; REGULATOR	Francisella tularensis is a zoonotic intracellular pathogen that is capable of causing potentially fatal human infections. Like all successful bacterial pathogens, F. tularensis rapidly responds to changes in its environment during infection of host cells, and upon encountering different microenvironments within those cells. This ability to appropriately respond to the challenges of infection requires rapid and global shifts in gene expression patterns. In this study, we use a novel pathogen transcript enrichment strategy and whole transcriptome sequencing (RNA-Seq) to perform a detailed characterization of the rapid and global shifts in F. tularensis LVS gene expression during infection of murine macrophages. We performed differential gene expression analysis on all bacterial genes at two key stages of infection: phagosomal escape, and cytosolic replication. By comparing the F. tularensis transcriptome at these two stages of infection to that of the bacteria grown in culture, we were able to identify sets of genes that are differentially expressed over the course of infection. This analysis revealed the temporally dynamic expression of a number of known and putative transcriptional regulators and virulence factors, providing insight into their role during infection. In addition, we identified several F. tularensis genes that are significantly up-regulated during infection but had not been previously identified as virulence factors. These unknown genes may make attractive therapeutic or vaccine targets.	[Bent, Zachary W.; Brazel, David M.; Tran-Gyamfi, Mary B.; Hamblin, Rachelle Y.; VanderNoot, Victoria A.; Branda, Steven S.] Sandia Natl Labs, Livermore, CA USA	United States Department of Energy (DOE); Sandia National Laboratories	Bent, ZW (corresponding author), Sandia Natl Labs, Livermore, CA USA.	zbent@sandia.gov		Branda, Steven/0000-0001-8763-1013; Brazel, David/0000-0001-5361-2498	U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Bent ZW, 2013, ANAL BIOCHEM, V438, P90, DOI 10.1016/j.ab.2013.03.008; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; Dai S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00144; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Edwards JA, 2011, INFECT IMMUN, V79, P3348, DOI 10.1128/IAI.05124-11; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FARON M, 2013, INFECT IMMUN, P1465; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fuller JR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-216; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grall N, 2009, MICROBIOL-SGM, V155, P2560, DOI 10.1099/mic.0.029058-0; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Ireland PM, 2011, MICROBIOL-SGM, V157, P3172, DOI 10.1099/mic.0.052902-0; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; MACK K, 1994, LETT APPL MICROBIOL, V19, P158, DOI 10.1111/j.1472-765X.1994.tb00931.x; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Mortensen BL, 2010, INFECT IMMUN, V78, P5022, DOI 10.1128/IAI.00544-10; Moule MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001065; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VanderNoot VA, 2012, BIOTECHNIQUES, V53, P373, DOI 10.2144/000113937; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zogaj X, 2012, INFECT IMMUN, V80, P4239, DOI 10.1128/IAI.00702-12	69	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77834	10.1371/journal.pone.0077834	http://dx.doi.org/10.1371/journal.pone.0077834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155975	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300109
J	Cereda, C; Leoni, E; Milani, P; Pansarasa, O; Mazzini, G; Guareschi, S; Alvisi, E; Ghiroldi, A; Diamanti, L; Bernuzzi, S; Ceroni, M; Cova, E				Cereda, Cristina; Leoni, Emanuela; Milani, Pamela; Pansarasa, Orietta; Mazzini, Giuliano; Guareschi, Stefania; Alvisi, Elena; Ghiroldi, Andrea; Diamanti, Luca; Bernuzzi, Stefano; Ceroni, Mauro; Cova, Emanuela			Altered Intracellular Localization of SOD1 in Leukocytes from Patients with Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; HEXANUCLEOTIDE REPEAT; OXIDATIVE STRESS; GENE-MUTATIONS; WILD-TYPE; ALS; LYMPHOCYTES; PROTEINS; C9ORF72; FORM	Several lines of evidence support the hypothesis of a toxic role played by wild type SOD1 (WT-SOD1) in the pathogenesis of sporadic amyotrophic lateral sclerosis (SALS). In this study we investigated both distribution and expression profile of WT-SOD1 in leukocytes from 19 SALS patients and 17 healthy individuals. Immunofluorescence experiments by confocal microscopy showed that SOD1 accumulates in the nuclear compartment in a group of SALS subjects. These results were also confirmed by western blot carried out on soluble nuclear and cytoplasmic fractions, with increased nuclear SOD1 level (p<0.05). In addition, we observed the presence of cytoplasmic SOD1 aggregates in agreement with an increased amount of the protein recovered by the insoluble fraction. A further confirmation of the overall increased level of SOD1 has been obtained from single cells analysis using flow cytometry as cells from SALS patients showed an higher SOD1 protein content (p<0.05). These findings add further evidence to the hypothesis of an altered WT-SOD1 expression profile in peripheral blood mononuclear cells (PBMCs) from patients with ALS suggesting that WT-SOD1 species with different degrees of solubility could be involved in the pathogenesis of the disease.	[Cereda, Cristina; Leoni, Emanuela; Milani, Pamela; Pansarasa, Orietta; Guareschi, Stefania; Ghiroldi, Andrea; Cova, Emanuela] C Mondino Natl Neurol Inst, Lab Expt Neurobiol, Pavia, Italy; [Leoni, Emanuela; Milani, Pamela; Alvisi, Elena; Ghiroldi, Andrea; Diamanti, Luca; Ceroni, Mauro] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Mazzini, Giuliano] Univ Pavia, Dept Anim Biol, IGM CNR, I-27100 Pavia, Italy; [Alvisi, Elena; Diamanti, Luca; Ceroni, Mauro] C Mondino Natl Neurol Inst, Div Gen Neurol, Pavia, Italy; [Bernuzzi, Stefano] IRCCS Fdn San Matteo, Immunohematol & Transfus Serv, Pavia, Italy; [Bernuzzi, Stefano] IRCCS Fdn San Matteo, Ctr Transplantat Immunol, Pavia, Italy	IRCCS Fondazione Casimiro Mondino; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Leoni, E (corresponding author), C Mondino Natl Neurol Inst, Lab Expt Neurobiol, Pavia, Italy.	emanuelaleoni@gmail.com	CEREDA, CRISTINA/G-8208-2011; Ghiroldi, Andrea/AAO-4409-2020; Diamanti, Luca/AAB-8860-2019; ceroni, mauro/G-7080-2011; Pansarasa, Orietta/A-2012-2019	CEREDA, CRISTINA/0000-0001-9571-0862; Ghiroldi, Andrea/0000-0002-2896-7390; ceroni, mauro/0000-0002-8947-5007; putchakatla, venkateswarlu/0000-0002-5045-9819; Diamanti, Luca/0000-0002-4540-6886				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armentero MT, 2011, NEUROBIOL AGING, V32, P2142, DOI 10.1016/j.neurobiolaging.2010.01.004; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Cereda C, 2006, NEUROL SCI, V27, P312, DOI 10.1007/s10072-006-0702-z; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Cova E, 2010, NEUROCHEM INT, V56, P687, DOI 10.1016/j.neuint.2010.02.004; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Gagliardi S, 2010, NEUROBIOL DIS, V39, P198, DOI 10.1016/j.nbd.2010.04.008; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Inoue E, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/795946; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mougeot JLC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-74; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Radunovic A, 1999, AMYOTROPH LATERAL SC, V1, P45; Rao AK, 2008, MOL ENDOCRINOL, V22, P1113, DOI 10.1210/me.2007-0381; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Vigilanza P, 2008, CELL MOL LIFE SCI, V65, P991, DOI 10.1007/s00018-008-7526-3; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zuo Z, 2011, BLOOD, V118, P413, DOI 10.1182/blood-2011-01-330704	45	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75916	10.1371/journal.pone.0075916	http://dx.doi.org/10.1371/journal.pone.0075916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155874	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300008
J	Chiang, TC; Liang, KC; Chen, JH; Hsieh, CH; Huang, YA				Chiang, Tzu-Ching; Liang, Keng-Chen; Chen, Jyh-Horng; Hsieh, Chao-Hsien; Huang, Yun-An			Brain Deactivation in the Outperformance in Bimodal Tasks: An fMRI Study	PLOS ONE			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; WORKING-MEMORY; VISUAL-MOTION; DEFAULT-MODE; INTEGRATION; PERCEPTION; MECHANISMS; RESOURCES; ANATOMY	While it is known that some individuals can effectively perform two tasks simultaneously, other individuals cannot. How the brain deals with performing simultaneous tasks remains unclear. In the present study, we aimed to assess which brain areas corresponded to various phenomena in task performance. Nineteen subjects were requested to sequentially perform three blocks of tasks, including two unimodal tasks and one bimodal task. The unimodal tasks measured either visual feature binding or auditory pitch comparison, while the bimodal task required performance of the two tasks simultaneously. The functional magnetic resonance imaging (fMRI) results are compatible with previous studies showing that distinct brain areas, such as the visual cortices, frontal eye field (FEF), lateral parietal lobe (BA7), and medial and inferior frontal lobe, are involved in processing of visual unimodal tasks. In addition, the temporal lobes and Brodmann area 43 (BA43) were involved in processing of auditory unimodal tasks. These results lend support to concepts of modality-specific attention. Compared to the unimodal tasks, bimodal tasks required activation of additional brain areas. Furthermore, while deactivated brain areas were related to good performance in the bimodal task, these areas were not deactivated where the subject performed well in only one of the two simultaneous tasks. These results indicate that efficient information processing does not require some brain areas to be overly active; rather, the specific brain areas need to be relatively deactivated to remain alert and perform well on two tasks simultaneously. Meanwhile, it can also offer a neural basis for biofeedback in training courses, such as courses in how to perform multiple tasks simultaneously.	[Chiang, Tzu-Ching] Natl Chung Cheng Univ, Dept Psychol, Min Hsiung Township, Chia Yi County, Taiwan; [Chiang, Tzu-Ching] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Liang, Keng-Chen] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Jyh-Horng; Hsieh, Chao-Hsien; Huang, Yun-An] Natl Taiwan Univ, Interdisciplinary MRI Lab, Taipei 10764, Taiwan	National Chung Cheng University; University System of Ohio; Ohio State University; National Taiwan University; National Taiwan University	Chiang, TC (corresponding author), Natl Chung Cheng Univ, Dept Psychol, Min Hsiung Township, Chia Yi County, Taiwan.	tcchiang@ccms.ntu.edu.tw	Hsieh, Chao-Hsien/AAM-3978-2021	Hsieh, Chao-Hsien/0000-0002-2249-1301; Liang, Keng-Chen/0000-0002-3292-6882; Huang, Yun-An/0000-0002-2401-6686	National Science Council of Taiwan [NSC-98-2410-H-194-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council of Taiwan (grant code: NSC-98-2410-H-194-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; ALLPORT DA, 1972, Q J EXP PSYCHOL, V24, P225, DOI 10.1080/00335557243000102; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen LH, 2010, BRAIN RES, V1354, P152, DOI 10.1016/j.brainres.2010.07.064; CHIANG TC, 2013, J BEHAV BRAIN SCI, V3, P1465; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Dufour A, 1999, EXP BRAIN RES, V126, P215, DOI 10.1007/s002210050731; Emberson LL, 2011, Q J EXP PSYCHOL, V64, P1021, DOI 10.1080/17470218.2010.538972; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Foxe JJ, 2005, EXP BRAIN RES, V166, P393, DOI 10.1007/s00221-005-2379-6; Gherri E, 2011, J COGNITIVE NEUROSCI, V23, P832, DOI 10.1162/jocn.2010.21468; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Houghton RJ, 2003, J EXP PSYCHOL HUMAN, V29, P731, DOI 10.1037/0096-1523.29.4.731; JOHNSTON WA, 1978, J EXP PSYCHOL GEN, V107, P420, DOI 10.1037/0096-3445.107.4.420; Kaiser P., 1991, LIMITS VISION, P171; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Leo F, 2008, EXP BRAIN RES, V186, P67, DOI 10.1007/s00221-007-1204-9; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; MCLEOD P, 1977, Q J EXP PSYCHOL, V29, P651, DOI 10.1080/14640747708400639; Milner AD, 2012, P ROY SOC B-BIOL SCI, V279, P2289, DOI 10.1098/rspb.2011.2663; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Patching GR, 2004, PERCEPT PSYCHOPHYS, V66, P131, DOI 10.3758/BF03194867; Patching GR, 2002, J EXP PSYCHOL HUMAN, V28, P755, DOI 10.1037//0096-1523.28.4.755; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees G, 1998, PHILOS T R SOC B, V353, P1283, DOI 10.1098/rstb.1998.0283; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SHIFFRIN RM, 1974, PERCEPT PSYCHOPHYS, V15, P460, DOI 10.3758/BF03199286; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Soto-Faraco S, 2002, Q J EXP PSYCHOL-A, V55, P23, DOI 10.1080/02724980143000136; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P389, DOI 10.3758/BF03211906; SUMMERFIELD C, 2009, COGNITIVE NEUROSCIEN, P1019; Talsma D, 2002, PSYCHOPHYSIOLOGY, V39, P689, DOI 10.1017/S004857720200152X; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P736, DOI 10.1111/1469-8986.3850736; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Vohn R, 2007, HUM BRAIN MAPP, V28, P1267, DOI 10.1002/hbm.20350; Wickens Christopher D., 1984, PROCESSING RESOURCES, P63	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77408	10.1371/journal.pone.0077408	http://dx.doi.org/10.1371/journal.pone.0077408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155952	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300086
J	Duell, BL; Carey, AJ; Dando, SJ; Schembri, MA; Ulett, GC				Duell, Benjamin L.; Carey, Alison J.; Dando, Samantha J.; Schembri, Mark A.; Ulett, Glen C.			Human Bladder Uroepithelial Cells Synergize with Monocytes to Promote IL-10 Synthesis and Other Cytokine Responses to Uropathogenic Escherichia coli	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; ALVEOLAR EPITHELIAL-CELLS; URINARY-TRACT-INFECTION; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; HOST; MODEL; INTERLEUKIN-10; MACROPHAGES; MIGRATION	Urinary tract infections are a major source of morbidity for women and the elderly, with Uropathogenic Escherichia coli (UPEC) being the most prevalent causative pathogen. Studies in recent years have defined a key anti-inflammatory role for Interleukin-10 (IL-10) in urinary tract infection mediated by UPEC and other uropathogens. We investigated the nature of the IL-10-producing interactions between UPEC and host cells by utilising a novel coculture model that incorporated lymphocytes, mononuclear and uroepithelial cells in histotypic proportions. This coculture model demonstrated synergistic IL-10 production effects between monocytes and uroepithelial cells following infection with UPEC. Membrane inserts were used to separate the monocyte and uroepithelial cell types during infection and revealed two synergistic IL-10 production effects based on contact-dependent and soluble interactions. Analysis of a comprehensive set of immunologically relevant biomarkers in monocyte-uroepithelial cell co-cultures highlighted that multiple cytokine, chemokine and signalling factors were also produced in a synergistic or antagonistic fashion. These results demonstrate that IL-10 responses to UPEC occur via multiple interactions between several cells types, implying a complex role for infection-related IL-10 during UTI. Development and application of the co-culture model described in this study is thus useful to define the degree of contact dependency of biomarker production to UPEC, and highlights the relevance of histotypic co-cultures in studying complex host-pathogen interactions.	[Duell, Benjamin L.; Carey, Alison J.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Dando, Samantha J.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	Griffith University; Griffith University; University of Queensland	Ulett, GC (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.	g.ulett@griffith.edu.au	Schembri, Mark A/C-7262-2009	Schembri, Mark A/0000-0003-4863-9260; Ulett, Glen/0000-0002-9638-8091; Dando, Samantha/0000-0002-5119-1711; /0000-0003-0660-8909	Australian National Health and Medical Research Council (NHMRC); Griffith University; Australian Research Council Future Fellowship; NHMRC Peter Doherty Australian Biomedical Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Griffith University(Griffith University); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Peter Doherty Australian Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC), and Griffith University. GCU is the recipient of an Australian Research Council Future Fellowship. AJC is the recipient of a NHMRC Peter Doherty Australian Biomedical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin OA, 2009, J NATL MED ASSOC, V101, P1268, DOI 10.1016/S0027-9684(15)31138-X; Andersen TE, 2012, INFECT IMMUN, V80, P1858, DOI 10.1128/IAI.06075-11; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Bacheller CD, 1997, MED CLIN N AM, V81, P719, DOI 10.1016/S0025-7125(05)70542-3; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; BENJAMIN D, 1992, BLOOD, V80, P1289; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DeFrances Carol J, 2004, Adv Data, P1; Duell BL, 2012, FEMS IMMUNOL MED MIC, V64, P295, DOI 10.1111/j.1574-695X.2012.00931.x; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Eghtesad M, 2001, IMMUNOLOGY, V102, P157, DOI 10.1046/j.1365-2567.2001.01172.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fazliana M, 2011, J ETHNOPHARMACOL, V136, P111, DOI 10.1016/j.jep.2011.04.018; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; GARDINER RA, 1986, BRIT J UROL, V58, P19, DOI 10.1111/j.1464-410X.1986.tb05420.x; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hannan TJ, 2013, CLIN SCI ADV UR TRAC; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Hilbert DW, 2012, MICROBES INFECT, V14, P628, DOI 10.1016/j.micinf.2012.01.010; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ipe DS, 2013, FEMS MICROBIOL LETT, V346, P1, DOI 10.1111/1574-6968.12204; Khalil A, 1997, J UROLOGY, V158, P1576, DOI 10.1016/S0022-5347(01)64282-4; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lloyd AL, 2009, INFECT IMMUN, V77, P5322, DOI 10.1128/IAI.00779-09; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mittal Rahul, 2009, J Infect Public Health, V2, P136, DOI 10.1016/j.jiph.2009.06.002; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronald A, 2002, AM J MED, V113, p14S; Sawant KV, 2007, INFECT IMMUN, V75, P1870, DOI 10.1128/IAI.00858-06; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Smith YC, 2006, INFECT IMMUN, V74, P750, DOI 10.1128/IAI.74.1.750-757.2006; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Ulett GC, 2005, J INFECT DIS, V191, P1761, DOI 10.1086/429693; Ulett GC, 1998, FEMS IMMUNOL MED MIC, V21, P283, DOI 10.1111/j.1574-695X.1998.tb01175.x; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120	64	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78013	10.1371/journal.pone.0078013	http://dx.doi.org/10.1371/journal.pone.0078013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155979	Green Published, gold			2022-12-25	WOS:000325887300113
J	Nakahira, K; Morita, A; Kim, NS; Yanagihara, I				Nakahira, Kumiko; Morita, Akihiro; Kim, Nam-Soon; Yanagihara, Itaru			Phosphorylation of FOXP3 by LCK Downregulates MMP9 Expression and Represses Cell Invasion	PLOS ONE			English	Article							TYROSINE KINASE P56(LCK); NUCLEAR FACTOR; CANCER-CELLS; T-CELLS; KAPPA-B; TRANSCRIPTION; ENTEROPATHY; PROGRESSION; ACTIVATION; ONCOGENE	Forkhead Box P3 (FOXP3) is a member of the forkhead/winged helix family of the transcription factors and plays an important role not only as a master gene in T-regulatory cells, but also as a tumor suppressor. In this study, we identified lymphocyte-specific protein tyrosine kinase (LCK), which correlates with cancer malignancy, as a binding partner of FOXP3. FOXP3 downregulated LCK-induced MMP9, SKP2, and VEGF-A expression. We observed that LCK phosphorylated Tyr-342 of FOXP3 by immunoprecipitation and in vitro kinase assay, and the replacement of Tyr-342 with phenylalanine (Y342F) abolished the ability to suppress MMP9 expression. Although FOXP3 decreased the invasive ability induced by LCK in MCF-7 cells, Y342F mutation in FOXP3 diminished this suppressive effect. Thus we demonstrate for the first time that LCK upregulates FOXP3 by tyrosine phosphorylation, resulting in decreased MMP9, SKP2, and VEGF-A expression, and suppressed cellular invasion. We consider that further clarification of transcriptional mechanism of FOXP3 may facilitate the development of novel therapeutic approaches to suppress cancer malignancy.	[Nakahira, Kumiko; Morita, Akihiro; Yanagihara, Itaru] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi Ku, Osaka, Japan; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Biomed Genom Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Yanagihara, I (corresponding author), Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi Ku, Osaka, Japan.	itaruy@mch.pref.osaka.jp			Ministry of Health, Labor and Welfare, Japan; Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23591609]; Foundation for Mother and Child Well-being, Osaka, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Mother and Child Well-being, Osaka, Japan	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, JapanH22-Kagaku-Ippann-006 (IY); Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan H22-Jisedai-Ippann008 (IY); Ministry of Education, Culture, Sports, Science and Technology (MEXT) 23591609 (IY), Japan, The Foundation for Mother and Child Well-being, Osaka, Japan (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwata M, 2007, BLOOD, V109, P85, DOI 10.1182/blood-2006-05-020289; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KOSTER A, 1991, ANTICANCER RES, V11, P193; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P52598, DOI 10.1074/jbc.M308941200; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Morawski PA, 2013, J BIOL CHEM; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yurchak LK, 1996, J BIOL CHEM, V271, P12549, DOI 10.1074/jbc.271.21.12549; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	29	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77099	10.1371/journal.pone.0077099	http://dx.doi.org/10.1371/journal.pone.0077099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155921	gold, Green Submitted, Green Published			2022-12-25	WOS:000325887300055
J	Norris, SL; Holmer, HK; Ogden, LA; Burda, BU; Fu, RW				Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.; Burda, Brittany U.; Fu, Rongwei			Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTEREST DISCLOSURES; ASSOCIATION; PREVALENCE; TRIALS	Background: Conflict of interest (COI) is an important potential source of bias in the development of clinical practice guidelines (CPGs). Objectives: To examine rates of disclosure of COI, including financial interests in companies that manufacture drugs that are recommended in CPGs on glycemic control in type 2 diabetes mellitus, and to explore the relationship between recommendations for specific drugs in a guideline and author COI. Methods: We identified a cohort of relevant guidelines from the National Guideline Clearinghouse (NGC) and abstracted COI disclosures from all guideline authors for this observational, cross-sectional study. We determined which hypoglycemic drugs were recommended in each guideline, and explored the relationship between specific disclosures and whether a drug was recommended. Results: Among 13 included guidelines, the percentage of authors with one or more financial disclosures varied from 0 to 94% (mean 44.2%), and was particularly high for two US-based guidelines (91% and 94%). Three guidelines disclosed no author financial COI. The percentage of authors with disclosures of financial interests in manufacturers of recommended drugs was also high (mean 30%). On average, 56% of manufacturers of patented drugs recommended in each guideline had one or more authors with a financial interest in their company. We did not find a significant relationship between financial interests and whether a drug was recommended in our sample; US-based guidelines were more likely to make recommendations for a specific drug compared to non-US based guidelines. Discussion: Authors of this cohort of guidelines have financial interests directly related to the drugs that they are recommending. Although we did not find an association between author COI and drugs recommended in these guidelines and we cannot draw conclusions about the validity of the recommendations, the credibility of many of these guidelines is in doubt.	[Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Burda, Brittany U.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Fu, Rongwei] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Kaiser Permanente; Oregon Health & Science University	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu		Holmer, Haley/0000-0003-4198-8708	Agency for Healthcare Research and Quality [HS018500-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018500] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript was the result of work performed for the Agency for Healthcare Research and Quality under grant HS018500-01 (S. Norris) (http://www.ahrq.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Diabetes Association (ADA), 2012, DIABETES CARE S1, V35, pS16, DOI DOI 10.2337/DC11-2080; [Anonymous], 2017, NATION; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhattacharyya N, 2009, OTOLARYNG HEAD NECK, V141, P311, DOI 10.1016/j.otohns.2009.06.010; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; *CADTH, 2009, OPT THER REC PRESCR, P1465; *CADTH, 2010, OPT THER REC PRESCR, P1465; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Chimonas S, 2011, ARCH INTERN MED, V171, P81, DOI 10.1001/archinternmed.2010.341; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fretheim Atle, 2006, Health Res Policy Syst, V4, P27, DOI 10.1186/1478-4505-4-27; FUGHBERMAN A, 2011, PLOS MED, P8; Germano G, 2012, EUR HEART J, V33, P137; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Holmer HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058625; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659; *ICSI, 2012, DIAGN MAN TYP 2 DIAB, P1465; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; NICE, 2010, LIR TREATM TYP 2 DIA; *NICE, 2008, MAN DIAB ITS COMPL P; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3; *PHARM RES MAN AM, 2011, IND PHARM PUBL HOUS, P1465; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Scottish Intercollegiate Guidelines Network Management of Diabetes, 2010, MAN DIAB NAT CLIN GU; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; *U MICH HLTH SYST, 2009, MAN TYP 2 DIAB MELL, P1465; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; 2011, WISC DIAB PREV CONTR, P1465; 2011, J PRIM HLTH CARE, P1465	50	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75284	10.1371/journal.pone.0075284	http://dx.doi.org/10.1371/journal.pone.0075284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155870	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300004
J	Verwer, PEB; ten Kate, MT; Falcone, FH; Morroll, S; Verbrugh, HA; Bakker-Woudenberg, IAJM; van de Sande, WWJ				Verwer, Patricia E. B.; ten Kate, Marian T.; Falcone, Franco H.; Morroll, Shaun; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.			Evidence Supporting a Role for Mammalian Chitinases in Efficacy of Caspofungin against Experimental Aspergillosis in Immunocompromised Rats	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INVASIVE PULMONARY ASPERGILLOSIS; ANTIFUNGAL ACTIVITY; SYSTEMIC INFECTION; NEUTROPENIC RATS; IN-VITRO; CHITOTRIOSIDASE; FUMIGATUS; ENDOCHITINASE; INFLAMMATION	Objectives: Caspofungin, currently used as salvage therapy for invasive pulmonary aspergillosis ( IPA), strangely only causes morphological changes in fungal growth in vitro but does not inhibit the growth. In vivo it has good efficacy. Therefore the question arises how this in vivo activity is reached. Caspofungin is known to increase the amount of chitin in the fungal cell wall. Mammals produce two chitinases, chitotriosidase and AMCase, which can hydrolyse chitin. We hypothesized that the mammalian chitinases play a role in the in vivo efficacy of caspofungin. Methods: In order to determine the role of chitotriosidase and AMCase in IPA, both chitinases were measured in rats which did or did not receive caspofungin treatment. In order to understand the role of each chitinase in the breakdown of the caspofungin-exposed cells, we also exposed caspofungin treated fungi to recombinant enzymes in vitro. Results: IPA in immunocompromised rats caused a dramatic increase in chitinase activity. This increase in chitinase activity was still noted when rats were treated with caspofungin. In vitro, it was demonstrated that the action of both chitinases were needed to lyse the fungal cell wall upon caspofungin exposure. Conclusion: Caspofungin seemed to alter the cell wall in such a way that the two chitinases, when combined, could lyse the fungal cell wall and assisted in clearing the fungal pathogen. We also found that both chitinases combined had a direct effect on the fungus in vitro.	[Verwer, Patricia E. B.; ten Kate, Marian T.; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Falcone, Franco H.; Morroll, Shaun] Univ Nottingham, Sch Pharm, Div Mol & Cellular Sci, Nottingham NG7 2RD, England	Erasmus University Rotterdam; Erasmus MC; University of Nottingham	Verwer, PEB (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	p.verwer@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021; Falcone, Franco/AAE-8026-2021; Falcone, Franco H/F-9210-2013	van de Sande, Wendy/0000-0002-8652-8783; Falcone, Franco/0000-0002-1732-9932; Falcone, Franco H/0000-0002-1732-9932	Wellcome Trust [GR065978MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (GR065978MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Bolar JP, 2001, TRANSGENIC RES, V10, P533, DOI 10.1023/A:1013036732691; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Chen L, 2009, CLIN EXP DERMATOL, V34, P55, DOI 10.1111/j.1365-2230.2008.03092.x; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Felse PA, 2000, BIOPROCESS ENG, V23, P127, DOI 10.1007/s004499900133; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Hall AJ, 2008, MICROBES INFECT, V10, P69, DOI 10.1016/j.micinf.2007.10.007; Hartl D, 2009, J IMMUNOL, V182, P5098, DOI 10.4049/jimmunol.0803446; Hohl TM, 2008, J INFECT DIS, V198, P176, DOI 10.1086/589304; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Moss RB, 2005, MED MYCOL, V43, pS203, DOI 10.1080/13693780500052255; Moss RB, 2010, CURR OPIN PULM MED, V16, P598, DOI 10.1097/MCP.0b013e32833e24a6; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Overdijk B, 1999, MICROBIOL-UK, V145, P259, DOI 10.1099/13500872-145-1-259; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; TRONSMO A, 1993, ANAL BIOCHEM, V208, P74, DOI 10.1006/abio.1993.1010; van de Sande WWJ, 2008, ANTIMICROB AGENTS CH, V52, P1345, DOI 10.1128/AAC.00536-07; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; van Vianen W, 2006, J ANTIMICROB CHEMOTH, V57, P732, DOI 10.1093/jac/dkl015; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75848	10.1371/journal.pone.0075848	http://dx.doi.org/10.1371/journal.pone.0075848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155872	Green Published, gold, Green Submitted			2022-12-25	WOS:000325887300006
J	Zhang, XL; Li, XC; Xiao, X; Sun, R; Tian, ZG; Wei, HM				Zhang, Xiaolong; Li, Xian Chang; Xiao, Xiang; Sun, Rui; Tian, Zhigang; Wei, Haiming			CD4(+)CD62L(+) Central Memory T Cells Can Be Converted to Foxp3(+) T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; B-VIRUS INFECTION; TGF-BETA; IN-VIVO; IMMUNE PATHOLOGY; REGULATORY CELLS; RETINOIC ACID; EXPRESSION; SUPPRESSION; INDUCTION	The peripheral Foxp3(+) Treg pool consists of naturally arising Treg (nTreg) and adaptive Treg cells (iTreg). It is well known that naive CD4(+) T cells can be readily converted to Foxp3(+) iTreg in vitro, and memory CD4(+) T cells are resistant to conversion. In this study, we investigated the induction of Foxp3(+) T cells from various CD4(+) T-cell subsets in human peripheral blood. Though naive CD4(+) T cells were readily converted to Foxp3(+) T cells with TGF-beta and IL-2 treatment in vitro, such Foxp3(+) T cells did not express the memory marker CD45RO as do Foxp3(+) T cells induced in the peripheral blood of Hepatitis B Virus (HBV) patients. Interestingly, a subset of human memory CD4(+) T cells, defined as CD62L(+) central memory T cells, could be induced by TGF-beta to differentiate into Foxp3(+) T cells. It is well known that Foxp3(+) T cells derived from human CD4(+)CD25(-) T cells in vitro are lack suppressive functions. Our data about the suppressive functions of CD4(+)CD62L(+) central memory T cell-derived Foxp3(+) T cells support this conception, and an epigenetic analysis of these cells showed a similar methylation pattern in the FOXP3 Treg-specific demethylated region as the naive CD4(+) T cell-derived Foxp3(+) T cells. But further research showed that mouse CD4(+) central memory T cells also could be induced to differentiate into Foxp3(+) T cells, such Foxp3(+) T cells could suppress the proliferation of effector T cells. Thus, our study identified CD4(+)CD62L(+) central memory T cells as a novel potential source of iTreg.	[Zhang, Xiaolong; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Li, Xian Chang; Xiao, Xiang] Brigham & Womens Hosp, Transplant Res Ctr, Boston, MA 02115 USA; [Li, Xian Chang; Xiao, Xiang] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Tian, Zhigang/J-3512-2013	Li, Xian Chang/0000-0002-5981-2762; xiao, xiang/0000-0001-6644-6118	Ministry of Science & Technology of China [2009CB522403, 2012CB519004]; Natural Science Foundation of China [31021061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070315] Funding Source: NIH RePORTER	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Ministry of Science & Technology of China (973 Basic Science Project 2009CB522403, 2012CB519004) and Natural Science Foundation of China (#31021061). This work was supported by Ministry of Science & Technology of China (973 Basic Science Project 2009CB522403, 2012CB519004) and Natural Science Foundation of China (#31021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Antunes I, 2008, IMMUNITY, V29, P782, DOI 10.1016/j.immuni.2008.09.016; Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dejaco C, 2006, EUR J IMMUNOL, V36, P245, DOI 10.1002/eji.200535651; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013267; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Stockinger B, 2004, SEMIN IMMUNOL, V16, P295, DOI 10.1016/j.smim.2004.08.010; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Sun C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002594; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wing K, 2002, IMMUNOLOGY, V106, P190, DOI 10.1046/j.1365-2567.2002.01412.x; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77322	10.1371/journal.pone.0077322	http://dx.doi.org/10.1371/journal.pone.0077322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155942	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300076
J	Gsell, M; Mascher, G; Schuiki, I; Ploier, B; Hrastnik, C; Daum, G				Gsell, Martina; Mascher, Gerald; Schuiki, Irmgard; Ploier, Birgit; Hrastnik, Claudia; Daum, Guenther			Transcriptional Response to Deletion of the Phosphatidylserine Decarboxylase Psd1p in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; PLASMA-MEMBRANE; MITOCHONDRIAL PHOSPHATIDYLETHANOLAMINE; BIOSYNTHETIC PATHWAYS; GENE; IDENTIFICATION; PROTEINS; PHOSPHATIDYLCHOLINE; LOCALIZATION; CASSETTE	In the yeast, Saccharomyces cerevisiae, the synthesis of the essential phospholipid phosphatidylethanolamine (PE) is accomplished by a network of reactions which comprises four different pathways. The enzyme contributing most to PE formation is the mitochondrial phosphatidylserine decarboxylase 1 (Psd1p) which catalyzes conversion of phosphatidylserine (PS) to PE. To study the genome wide effect of an unbalanced cellular and mitochondrial PE level and in particular the contribution of Psd1p to this depletion we performed a DNA microarray analysis with Delta psd1 deletion mutant. This approach revealed that 54 yeast genes were significantly up-regulated in the absence of PSD1 compared to wild type. Surprisingly, marked down-regulation of genes was not observed. A number of different cellular processes in different subcellular compartments were affected in Delta psd1 mutant. Deletion mutants bearing defects in all 54 candidate genes, respectively, were analyzed for their growth phenotype and their phospholipid profile. Only three mutants, namely Delta pm2, Delta gph1 and Delta rsb1, were affected in one of these parameters. The possible link of these mutations to PE deficiency and PSD1 deletion is discussed.	[Gsell, Martina; Mascher, Gerald; Schuiki, Irmgard; Ploier, Birgit; Hrastnik, Claudia; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund FWF [21429]; DK Molecular Enzymology [W901-B05]; Austrian Science Fund (FWF) [W 901, P 21429] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (http://www.fwf.ac.at/)(project 21429 and DK Molecular Enzymology W901-B05 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; DAUM G, 1982, J BIOL CHEM, V257, P3028; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Donzeau M, 1996, MOL MICROBIOL, V20, P449, DOI 10.1111/j.1365-2958.1996.tb02631.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heinisch JJ, 1998, YEAST, V14, P203, DOI 10.1002/(SICI)1097-0061(199802)14:3<203::AID-YEA205>3.3.CO;2-#; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HUI SW, 1981, ARCH BIOCHEM BIOPHYS, V207, P227, DOI 10.1016/0003-9861(81)90029-1; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Manente M, 2009, FEMS YEAST RES, V9, P673, DOI 10.1111/j.1567-1364.2009.00513.x; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Rachidi N, 2000, MOL MICROBIOL, V35, P1421, DOI 10.1046/j.1365-2958.2000.01807.x; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Sertil O, 1997, GENE, V192, P199, DOI 10.1016/S0378-1119(97)00028-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77380	10.1371/journal.pone.0077380	http://dx.doi.org/10.1371/journal.pone.0077380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146988	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400114
J	Itoh, M; Umegaki-Arao, N; Guo, ZY; Liu, L; Higgins, CA; Christiano, AM				Itoh, Munenari; Umegaki-Arao, Noriko; Guo, Zongyou; Liu, Liang; Higgins, Claire A.; Christiano, Angela M.			Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells (iPSCs)	PLOS ONE			English	Article							FIBROBLAST-LIKE CELLS; EPIDERMOLYSIS-BULLOSA; VII COLLAGEN; ASCORBIC-ACID; GENE CORRECTION; DIFFERENTIATION; INDUCTION; EXPRESSION; CARCINOMA; SUPPORT	Recent generation of patient-specific induced pluripotent stem cells (PS-iPSCs) provides significant advantages for cell-and gene-based therapy. Establishment of iPSC-based therapy for skin diseases requires efficient methodology for differentiating iPSCs into both keratinocytes and fibroblasts, the major cellular components of the skin, as well as the reconstruction of skin structures using these iPSC-derived skin components. We previously reported generation of keratinocytes from human iPSCs for use in the treatment of recessive dystrophic epidermolysis bullosa (RDEB) caused by mutations in the COL7A1 gene. Here, we developed a protocol for differentiating iPSCs into dermal fibroblasts, which also produce type VII collagen and therefore also have the potential to treat RDEB. Moreover, we generated in vitro 3D skin equivalents composed exclusively human iPSC-derived keratinocytes and fibroblasts for disease models and regenerative therapies for skin diseases, first demonstrating that iPSCs can provide the basis for modeling a human organ derived entirely from two different types of iPSC-derived cells.	[Itoh, Munenari; Umegaki-Arao, Noriko; Guo, Zongyou; Liu, Liang; Higgins, Claire A.; Christiano, Angela M.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA.	amc65@columbia.edu		Higgins, Claire/0000-0002-9742-5149; Itoh, Munenari/0000-0003-3640-6355	Dr. Ines Mandl Research Fellowship (Columbia University); NYSTAR (The New York State Foundation for Science, Technology and Innovation); National Institutes of Health/National Center for Advancing Translational Sciences) [SDH C024321, U18TR000561-01]; Helmsley Stem Cell Starter Grants (Columbia University); Core facilities of the Skin Disease Research Center at Columbia University (from NIH/NIAMS) [P30AR044535]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER	Dr. Ines Mandl Research Fellowship (Columbia University); NYSTAR (The New York State Foundation for Science, Technology and Innovation); National Institutes of Health/National Center for Advancing Translational Sciences); Helmsley Stem Cell Starter Grants (Columbia University); Core facilities of the Skin Disease Research Center at Columbia University (from NIH/NIAMS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the Dr. Ines Mandl Research Fellowship (Columbia University), and grants from NYSTAR (The New York State Foundation for Science, Technology and Innovation), SDH C024321 (New York State Stem Cell Science), U18TR000561-01 (As part of Tissue Chip Awards from National Institutes of Health/National Center for Advancing Translational Sciences) and Helmsley Stem Cell Starter Grants (Columbia University). This work was supported by the Core facilities of the Skin Disease Research Center at Columbia University (P30AR044535 from NIH/NIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Carlson Mark W, 2008, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1909s41; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; FRANCESCHI RT, 1992, NUTR REV, V50, P65; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hewitt KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017128; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Jonkman MF, 1999, AM J MED GENET, V85, P361, DOI 10.1002/(SICI)1096-8628(19990806)85:4<361::AID-AJMG11>3.0.CO;2-E; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Martins VL, 2009, J CELL SCI, V122, P1788, DOI 10.1242/jcs.042895; MAUVIEL A, 1994, J BIOL CHEM, V269, P25; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shamis Y, 2012, IN VITRO CELL DEV-AN, V48, P112, DOI 10.1007/s11626-011-9478-4; SHARON N, 2007, MESODERMAL DIFFERENT, P129; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Togo S, 2011, IN VITRO CELL DEV-AN, V47, P114, DOI 10.1007/s11626-010-9367-2; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; Uitto J, 2011, J INVEST DERMATOL, V132, P820; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2007, MOL THER, V15, P628, DOI 10.1038/sj.mt.6300041; Woodley DT, 2003, J INVEST DERMATOL, V121, P1021, DOI 10.1046/j.1523-1747.2003.12571.x; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	42	130	141	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77673	10.1371/journal.pone.0077673	http://dx.doi.org/10.1371/journal.pone.0077673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147053	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400134
J	Vleut, I; Levy-Tacher, SI; de Boer, WF; Galindo-Gonzalez, J; Vazquez, LB				Vleut, Ivar; Israel Levy-Tacher, Samuel; de Boer, Willem Frederik; Galindo-Gonzalez, Jorge; Vazquez, Luis-Bernardo			Tropical Secondary Forest Management Influences Frugivorous Bat Composition, Abundance and Fruit Consumption in Chiapas, Mexico	PLOS ONE			English	Article							RAIN-FOREST; COMMUNITY STRUCTURE; NEOTROPICAL FOREST; FORAGING HABITAT; SCATTERED TREES; SEED DISPERSAL; EATING BATS; SUCCESSION; VEGETATION; DIVERSITY	Most studies on frugivorous bat assemblages in secondary forests have concentrated on differences among successional stages, and have disregarded the effect of forest management. Secondary forest management practices alter the vegetation structure and fruit availability, important factors associated with differences in frugivorous bat assemblage structure, and fruit consumption and can therefore modify forest succession. Our objective was to elucidate factors (forest structural variables and fruit availability) determining bat diversity, abundance, composition and species-specific abundance of bats in (i) secondary forests managed by Lacandon farmers dominated by Ochroma pyramidale, in (ii) secondary forests without management, and in (iii) mature rain forests in Chiapas, Southern Mexico. Frugivorous bat species diversity (Shannon H') was similar between forest types. However, bat abundance was highest in rain forest and O. pyramidale forests. Bat species composition was different among forest types with more Carollia sowelli and Sturnira lilium captures in O. pyramidale forests. Overall, bat fruit consumption was dominated by early-successional shrubs, highest late-successional fruit consumption was found in rain forests and more bats consumed early-successional shrub fruits in O. pyramidale forests. Ochroma pyramidale forests presented a higher canopy openness, tree height, lower tree density and diversity of fruit than secondary forests. Tree density and canopy openness were negatively correlated with bat species diversity and bat abundance, but bat abundance increased with fruit abundance and tree height. Hence, secondary forest management alters forests' structural characteristics and resource availability, and shapes the frugivorous bat community structure, and thereby the fruit consumption by bats.	[Vleut, Ivar; Israel Levy-Tacher, Samuel; Vazquez, Luis-Bernardo] El Colegio De La Frontera Sur ECOSUR, San Cristobal Las Casas, Chiapas, Mexico; [de Boer, Willem Frederik] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico	El Colegio de la Frontera Sur (ECOSUR); Wageningen University & Research; Universidad Veracruzana	Vleut, I (corresponding author), El Colegio De La Frontera Sur ECOSUR, San Cristobal Las Casas, Chiapas, Mexico.	ivar82@yahoo.com	Galindo-González, Jorge/M-2585-2014; Levy-Tacher, Samuel/T-4454-2018; Vazquez, Luis-Bernardo/A-8358-2013	Galindo-González, Jorge/0000-0003-2583-2754; Levy-Tacher, Samuel/0000-0002-8853-4810; Vazquez, Luis-Bernardo/0000-0002-1673-2455	Etnobiologia para la Conservacion A.C.; CONACyT-Mexico [239503]	Etnobiologia para la Conservacion A.C.; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by Etnobiologia para la Conservacion A.C. and by a doctoral scholarship awarded to the first author by CONACyT-Mexico (Reg. 239503). Idea Wild and Fondo Institucional de Fomento Regional para el Desarrollo Cientifico, Tecnologico y de Innovacion (FORDECYT) (Agreement 116306) provided mist nets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WATCHING LACANDON MA; [Anonymous], 2005, ARBOLES TROPICALES M; Castro-Luna AA, 2012, MAMM BIOL, V77, P32, DOI 10.1016/j.mambio.2011.06.009; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; CROME FHJ, 1988, ECOLOGY, V69, P1960, DOI 10.2307/1941173; Dalling JW, 1999, J TROP ECOL, V15, P827, DOI 10.1017/S0266467499001200; Diemont SAW, 2006, ECOL ENG, V28, P205, DOI 10.1016/j.ecoleng.2005.10.012; Douterlungne D, 2010, RESTOR ECOL, V18, P322, DOI 10.1111/j.1526-100X.2008.00459.x; Dumont ER, 2003, BAT ECOLOGY, P398; Estrada A, 2001, ECOGRAPHY, V24, P94, DOI 10.1034/j.1600-0587.2001.240111.x; FAO, 2010, 163 FAO; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; Fleming T.H., 1986, FRUGIVORES SEED DISP, P1105; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; FLEMING TH, 1981, BIOTROPICA, V13, P45, DOI 10.2307/2388069; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Galindo-Gonzalez J, 2009, J TROP ECOL, V25, P205, DOI 10.1017/S0266467409005859; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; GREIG N, 1993, ECOLOGY, V74, P2125, DOI 10.2307/1940857; GUEVARA S, 1997, HIST NATURAL TUXTLAS, P43; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; JONES G, 1991, J ZOOL, V225, P393, DOI 10.1111/j.1469-7998.1991.tb03824.x; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Krebs C. J., 2014, ECOLOGICAL METHODOLO; KUNZ TH, 1994, FUNCT ECOL, V8, P665; Kunz TH, 2003, BAT ECOLOGY, P3; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lacki MJ, 2003, ACTA CHIROPTEROL, V5, P199, DOI 10.3161/001.005.0211; LEVY-TACHER S. I., 2000, THESIS COLEGIO POSGR; Levy-Tacher SI, 2005, J SUSTAIN AGR, V26, P49, DOI 10.1300/J064v26n01_06; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; MacSwiney MC, 2008, J APPL ECOL, V45, P1364, DOI 10.1111/j.1365-2664.2008.01531.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; McCune B, 2002, ANAL ECOLOGICAL COMM; Medellin R, 2008, IDENTIFICACION MURCI; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nations J. D., 1980, Journal of Anthropological Research, V36, P1; PALMEIRIM J, 1985, BIOTROPICA, V17, P82, DOI 10.2307/2388385; Pearson TRH, 2003, OECOLOGIA, V137, P456, DOI 10.1007/s00442-003-1361-x; R. D. C. Team, 2005, R LANG ENV STAT COMP; Reid F. A., 2009, FIELD GUIDE MAMMALS; Russo D, 2007, ACTA OECOL, V31, P119, DOI 10.1016/j.actao.2006.11.001; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schulze MD, 2000, BIOTROPICA, V32, P174, DOI 10.1646/0006-3606(2000)032[0174:ACOTPB]2.0.CO;2; Straube FC, 2002, CHIRO NEOTR, V8, P150, DOI DOI 10.1017/CB09781107415324.004; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Vleut I, 2013, J TROP ECOL, V29, P173, DOI 10.1017/S0266467413000126; Vleut I, 2012, J MAMMAL, V93, P1469, DOI 10.1644/12-MAMM-A-005.1; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Wulms M, 2009, THESIS U APPL SCI VE; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	71	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77584	10.1371/journal.pone.0077584	http://dx.doi.org/10.1371/journal.pone.0077584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147029	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400127
J	Toska, E; Shandilya, J; Goodfellow, SJ; Medler, KF; Roberts, SGE				Toska, E.; Shandilya, J.; Goodfellow, S. J.; Medler, K. F.; Roberts, S. G. E.			Prohibitin is required for transcriptional repression by the WT1-BASP1 complex	ONCOGENE			English	Article						WT1; BASP1; prohibitin; transcription	TUMOR-SUPPRESSOR; WILMS-TUMOR; CHROMATIN; BASP1; ACTIVATION; GENE; BRG1; WT1; RB; IDENTIFICATION	The Wilms' tumor-1 protein (WT1) is a transcriptional regulator that can either activate or repress genes controlling cell growth, apoptosis and differentiation. The transcriptional corepressor BASP1 interacts with WT1 and mediates WT1's transcriptional repression activity. BASP1 is contained within large complexes, suggesting that it works in concert with other factors. Here we report that the transcriptional repressor prohibitin is part of the WT1-BASP1 transcriptional repression complex. Prohibitin interacts with BASP1, colocalizes with BASP1 in the nucleus, and is recruited to the promoter region of WT1 target genes to elicit BASP1-dependent transcriptional repression. We demonstrate that prohibitin and BASP1 cooperate to recruit the chromatin remodeling factor BRG1 to WT1-responsive promoters and that this results in the dissociation of CBP from the promoter region of WT1 target genes. As seen with BASP1, prohibitin can associate with phospholipids. We demonstrate that the recruitment of PIP2 and HDAC1 to WT1 target genes is also dependent on the concerted activity of BASP1 and prohibitin. Our findings provide new insights into the function of prohibitin in transcriptional regulation and uncover a BASP1-prohibitin complex that plays an essential role in the PIP2-dependent recruitment of chromatin remodeling activities to the promoter.	[Toska, E.; Shandilya, J.; Medler, K. F.; Roberts, S. G. E.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Goodfellow, S. J.] Univ Dundee, Wellcome Trust Ctr Gene Regulat, Dundee, Scotland; [Roberts, S. G. E.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Dundee; University of Bristol	Roberts, SGE (corresponding author), SUNY Buffalo, Dept Biol Sci, Cooke Hall,North Campus, Buffalo, NY 14260 USA.	sr237@buffalo.edu	Toska, Eneda/AAQ-4369-2020; Roberts, Stefan GE/R-5537-2016; Toska, Eneda/AAO-1711-2020	Toska, Eneda/0000-0002-8974-9792; Roberts, Stefan GE/0000-0002-7535-6365; Medler, Kathryn/0000-0001-9664-3606; Shandilya, Jayasha/0000-0001-9911-8065	National Institute of General Medical Sciences [1R01GM098609]; Cancer Research UK [C1356/A6630]; National Science Foundation [DBI 0923133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098609] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences (1R01GM098609) (to KFM and SGER) and Cancer Research UK (C1356/A6630) (to SGER). We thank Alan Siegel for help with the confocal microscopy and the facility funded by National Science Foundation (DBI 0923133).	Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Carpenter B, 2004, MOL CELL BIOL, V24, P537, DOI 10.1128/MCB.24.2.537-549.2004; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Dai Y, 2008, CARCINOGENESIS, V29, P1725, DOI 10.1093/carcin/bgn117; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Goodfellow SJ, 2011, BIOCHEM J, V435, P113, DOI 10.1042/BJ20101734; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Green LM, 2009, NUCLEIC ACIDS RES, V37, P431, DOI 10.1093/nar/gkn955; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Han BK, 2011, GENE DEV, V25, P984, DOI 10.1101/gad.1998611; Hartkamp J, 2010, MOL CELL, V37, P159, DOI 10.1016/j.molcel.2009.12.023; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; He B, 2011, ENDOCRINOLOGY, V152, P1047, DOI 10.1210/en.2010-0732; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; McKay LM, 1999, ONCOGENE, V18, P6546, DOI 10.1038/sj.onc.1203046; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Moribe T, 2008, INT J ONCOL, V33, P949, DOI 10.3892/ijo_00000082; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Schneider M, 2010, DEVELOPMENT, V137, P4073, DOI 10.1242/dev.053405; Shandilya J, 2012, P NATL ACAD SCI USA, V10, P1073; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Toska E, 2012, CELL REP, V2, P462, DOI 10.1016/j.celrep.2012.08.005; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wang WH, 2001, J BIOL CHEM, V276, P16810, DOI 10.1074/jbc.M009687200; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yildirim S, 2013, J CELL SCI, V126, P2730, DOI 10.1242/jcs.123661; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	48	22	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5100	5108		10.1038/onc.2013.447	http://dx.doi.org/10.1038/onc.2013.447			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24166496	Green Accepted			2022-12-25	WOS:000343768400005
J	Chin, YKY; Headey, SJ; Mohanty, B; Patil, R; McEwan, PA; Swarbrick, JD; Mulhern, TD; Emsley, J; Simpson, JS; Scanlon, MJ				Chin, Yanni K. -Y.; Headey, Stephen J.; Mohanty, Biswaranjan; Patil, Rahul; McEwan, Paul A.; Swarbrick, James D.; Mulhern, Terrence D.; Emsley, Jonas; Simpson, Jamie S.; Scanlon, Martin J.			The Structure of Integrin alpha 1I Domain in Complex with a Collagen-mimetic Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix; Integrins; NMR; Protein Structure; Protein-Protein Interactions	ANGLE SCATTERING DATA; NMR STRUCTURE DETERMINATION; I-DOMAIN; BINDING-SITE; A-DOMAIN; DIVALENT-CATION; RECOGNITION; ALPHA(1)BETA(1); ACTIVATION; DYNAMICS	We have determined the structure of the human integrin 1I domain bound to a triple-helical collagen peptide. The structure of the 1I-peptide complex was investigated using data from NMR, small angle x-ray scattering, and size exclusion chromatography that were used to generate and validate a model of the complex using the data-driven docking program, HADDOCK (High Ambiguity Driven Biomolecular Docking). The structure revealed that the 1I domain undergoes a major conformational change upon binding of the collagen peptide. This involves a large movement in the C-terminal helix of the I domain that has been suggested to be the mechanism by which signals are propagated in the intact integrin receptor. The structure suggests a basis for the different binding selectivity observed for the 1I and 2I domains. Mutational data identify residues that contribute to the conformational change observed. Furthermore, small angle x-ray scattering data suggest that at low collagen peptide concentrations the complex exists in equilibrium between a 1:1 and 2:1 1I-peptide complex.	[Chin, Yanni K. -Y.; Headey, Stephen J.; Mohanty, Biswaranjan; Patil, Rahul; Swarbrick, James D.; Simpson, Jamie S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Australian Res Council, Ctr Excellence Coherent Xray Sci, Parkville, Vic 3052, Australia; [McEwan, Paul A.; Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Mulhern, Terrence D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	Monash University; Monash University; University of Nottingham; University of Melbourne	Scanlon, MJ (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	martin.scanlon@monash.edu	emsley, jonas/A-8509-2016; Simpson, Jamie/ABC-7083-2020; Mohanty, Biswaranjan/E-2080-2018; Chin, Yanni/D-2139-2017; Simpson, Jamie S/A-1700-2012	emsley, jonas/0000-0002-8949-8030; Simpson, Jamie/0000-0002-8894-422X; Mohanty, Biswaranjan/0000-0002-6921-343X; Chin, Yanni/0000-0002-3367-6897; Simpson, Jamie S/0000-0002-8894-422X; Scanlon, Martin/0000-0002-9230-7506; Headey, Stephen/0000-0001-8015-7064; Mulhern, Terrence/0000-0002-1609-7498; mcewan, paul/0000-0001-6097-1528	Monash-Nottingham Research Fund	Monash-Nottingham Research Fund	This work was supported in part by a grant from the Monash-Nottingham Research Fund.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chin Y. K., 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9465-7; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goddard T., 2001, SPARKY; Gullberg D, 2003, MOL B INT U, P67; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Gunn NJ, 2011, ACTA CRYSTALLOGR F, V67, P336, DOI 10.1107/S1744309110053728; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi M, 2012, J BIOL CHEM, V287, P35139, DOI 10.1074/jbc.M112.358648; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Vanderslice P, 2006, EXPERT OPIN INV DRUG, V15, P1235, DOI 10.1517/13543784.15.10.1235; Weinreb PH, 2012, J BIOL CHEM, V287, P32897, DOI 10.1074/jbc.M112.354365; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101	58	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36796	36809		10.1074/jbc.M113.480251	http://dx.doi.org/10.1074/jbc.M113.480251			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24187131	Green Published, hybrid			2022-12-25	WOS:000329189700004
J	Cobbold, SA; Vaughan, AM; Lewis, IA; Painter, HJ; Camargo, N; Perlman, DH; Fishbaugher, M; Healer, J; Cowman, AF; Kappe, SHI; Llinas, M				Cobbold, Simon A.; Vaughan, Ashley M.; Lewis, Ian A.; Painter, Heather J.; Camargo, Nelly; Perlman, David H.; Fishbaugher, Matthew; Healer, Julie; Cowman, Alan F.; Kappe, Stefan H. I.; Llinas, Manuel			Kinetic Flux Profiling Elucidates Two Independent Acetyl-CoA Biosynthetic Pathways in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Glycolysis; Malaria; Phosphoenolpyruvate Carboxykinase; Plasmodium; Pyruvate Dehydrogenase Complex; Tricarboxylic Acid (TCA) Cycle; Acetate	MALARIA PARASITE; PYRUVATE-DEHYDROGENASE; METABOLIC PATHWAYS; MITOCHONDRIAL METABOLISM; ACID DEHYDROGENASE; LACTATE PRODUCTION; TRANSPORT; COMPLEX; ERYTHROCYTES; INFECTION	Background: The acetyl-CoA biosynthetic pathways of the malaria parasite are unclear. Results: C-13-Labeling experiments in parasites lacking a functional pyruvate dehydrogenase (PDH) complex show that the PDH does not contribute significantly to the acetyl-CoA pool. Conclusion: The majority of acetyl-CoA biosynthesis in the parasite derives from a PDH-like enzyme and acetyl-CoA synthetase. Significance: The two routes for acetyl-CoA synthesis appear to have separate functions. The malaria parasite Plasmodium falciparum depends on glucose to meet its energy requirements during blood-stage development. Although glycolysis is one of the best understood pathways in the parasite, it is unclear if glucose metabolism appreciably contributes to the acetyl-CoA pools required for tricarboxylic acid metabolism (TCA) cycle and fatty acid biosynthesis. P. falciparum possesses a pyruvate dehydrogenase (PDH) complex that is localized to the apicoplast, a specialized quadruple membrane organelle, suggesting that separate acetyl-CoA pools are likely. Herein, we analyze PDH-deficient parasites using rapid stable-isotope labeling and show that PDH does not appreciably contribute to acetyl-CoA synthesis, tricarboxylic acid metabolism, or fatty acid synthesis in blood stage parasites. Rather, we find that acetyl-CoA demands are supplied through a PDH-like enzyme and provide evidence that the branched-chain keto acid dehydrogenase (BCKDH) complex is performing this function. We also show that acetyl-CoA synthetase can be a significant contributor to acetyl-CoA biosynthesis. Interestingly, the PDH-like pathway contributes glucose-derived acetyl-CoA to the TCA cycle in a stage-independent process, whereas anapleurotic carbon enters the TCA cycle via a stage-dependent phosphoenolpyruvate carboxylase/phosphoenolpyruvate carboxykinase process that decreases as the parasite matures. Although PDH-deficient parasites have no blood-stage growth defect, they are unable to progress beyond the oocyst phase of the parasite mosquito stage.	[Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Llinas, Manuel] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA; [Cobbold, Simon A.; Lewis, Ian A.; Painter, Heather J.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Perlman, David H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vaughan, Ashley M.; Camargo, Nelly; Fishbaugher, Matthew; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Healer, Julie; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Princeton University; Princeton University; Center for Infectious Disease Research; Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle	Llinas, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA.	manuel@psu.edu		Cobbold, Simon/0000-0002-9927-8998; Lewis, Ian A./0000-0002-5753-499X	National Institutes of Health Director's New Innovators Award [1DP2OD001315-01]; Center for Quantitative Biology [R56 AI080685, P50 GM071508]; Burroughs Welcome Fund; National Health and Medical Research Council (NHMRC) of Australia; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovators Award; Center for Quantitative Biology; Burroughs Welcome Fund(Burroughs Wellcome Fund); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovators Award 1DP2OD001315-01) (to M. L.) and Grants R56 AI080685 (to S. H. I. K.) and P50 GM071508 (Center for Quantitative Biology; to M. L.). This work was also supported through generous support from the Burroughs Welcome Fund (to M. L.) and National Health and Medical Research Council (NHMRC) of Australia and Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme (to A. F. C.).	Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; ATAMNA H, 1994, MOL BIOCHEM PARASIT, V67, P79, DOI 10.1016/0166-6851(94)90098-1; Beier John C., 1998, P49; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cobbold SA, 2011, INT J PARASITOL, V41, P125, DOI 10.1016/j.ijpara.2010.09.001; CRANMER SL, 1995, J BIOL CHEM, V270, P15045, DOI 10.1074/jbc.270.25.15045; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Frltzler JM, 2007, EUKARYOT CELL, V6, P2018, DOI 10.1128/EC.00210-07; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Heath C, 2007, FEBS J, V274, P5406, DOI 10.1111/j.1742-4658.2007.06067.x; Kamphorst JJ, 2011, ANAL CHEM, V83, P9114, DOI 10.1021/ac202220b; KANAANI J, 1991, J CELL PHYSIOL, V149, P469, DOI 10.1002/jcp.1041490316; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lentner C., 1992, GEIGY SCI TABLES, V1, P167; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Mi-ichi F, 2006, PARASITOLOGY, V133, P399, DOI 10.1017/S0031182006000540; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Mogi T, 2010, PARASITOL INT, V59, P305, DOI 10.1016/j.parint.2010.04.005; Olszewski Kellen L, 2013, Methods Mol Biol, V923, P259; Olszewski KL, 2011, MOL BIOCHEM PARASIT, V175, P95, DOI 10.1016/j.molbiopara.2010.09.001; PAXTON R, 1982, J BIOL CHEM, V257, P4433; PAXTON R, 1986, BIOCHEM J, V234, P295, DOI 10.1042/bj2340295; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; PFALLER MA, 1982, EXP PARASITOL, V54, P391, DOI 10.1016/0014-4894(82)90048-0; Polonais V, 2010, BIOL CELL, V102, P435, DOI 10.1042/BC20100005; Ralph SA, 2005, MOL MICROBIOL, V55, P1, DOI 10.1111/j.1365-2958.2004.04314.x; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; ROTH EF, 1982, BIOCHEM BIOPH RES CO, V109, P355, DOI 10.1016/0006-291X(82)91728-4; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Seeber F, 2008, TRENDS PARASITOL, V24, P468, DOI 10.1016/j.pt.2008.07.004; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; ZOLG JW, 1984, IN VITRO CELL DEV B, V20, P205, DOI 10.1007/BF02618189	57	53	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36338	36350		10.1074/jbc.M113.503557	http://dx.doi.org/10.1074/jbc.M113.503557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24163372	hybrid, Green Published			2022-12-25	WOS:000328883400016
J	Daly, NL; Thorstholm, L; Greenwood, KP; King, GJ; Rosengren, KJ; Heras, B; Martin, JL; Craik, DJ				Daly, Norelle L.; Thorstholm, Louise; Greenwood, Kathryn P.; King, Gordon J.; Rosengren, K. Johan; Heras, Begona; Martin, Jennifer L.; Craik, David J.			Structural Insights into the Role of the Cyclic Backbone in a Squash Trypsin Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NMR; Peptide Conformation; Peptide Interactions; Protease Inhibitor; Structural Biology; Cyclic Peptides; Cyclotides	MAGNETIC-RESONANCE RELAXATION; X-RAY-DIFFRACTION; CIRCULAR PROTEINS; PLANT CYCLOTIDES; KNOTTED PROTEINS; MCOTI-II; PEPTIDES; FRAGMENTS; DYNAMICS; DESIGN	Background: MCoTI-II is a potent serine protease inhibitor with a cyclic protein backbone. Results: Its three-dimensional structure and dynamics in complex with trypsin were determined using x-ray and NMR methods. Conclusion: The cyclic backbone of MCoTI-II participates in favorable interactions with trypsin. Significance: We demonstrate a new role for backbone cyclization in enhancing enzyme inhibitory activity. MCoTI-II is a head-to-tail cyclic peptide with potent trypsin inhibitory activity and, on the basis of its exceptional proteolytic stability, is a valuable template for the design of novel drug leads. Insights into inhibitor dynamics and interactions with biological targets are critical for drug design studies, particularly for protease targets. Here, we show that the cyclization and active site loops of MCoTI-II are flexible in solution, but when bound to trypsin, the active site loop converges to a single well defined conformation. This finding of reduced flexibility on binding is in contrast to a recent study on the homologous peptide MCoTI-I, which suggested that regions of the peptide are more flexible upon binding to trypsin. We provide a possible explanation for this discrepancy based on degradation of the complex over time. Our study also unexpectedly shows that the cyclization loop, not present in acyclic homologues, facilitates potent trypsin inhibitory activity by engaging in direct binding interactions with trypsin.	[Daly, Norelle L.; Thorstholm, Louise; Greenwood, Kathryn P.; King, Gordon J.; Heras, Begona; Martin, Jennifer L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns 4878, Australia; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Cairns 4878, Australia; [Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia	University of Queensland; University of Queensland; James Cook University; James Cook University; La Trobe University	Craik, DJ (corresponding author), Univ Queensland, St Lucia, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Greenwood, Kathryn/U-6965-2017; King, Gordon/J-8718-2014; Craik, David/B-1695-2010; Rosengren, K. Johan/P-4450-2016; Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Greenwood, Kathryn/0000-0002-1556-0065; Craik, David/0000-0003-0007-6796; Rosengren, K. Johan/0000-0002-5007-8434; Heras, Begona/0000-0003-3469-7988; King, Gordon/0000-0001-5592-5789; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council [DP0984390]; National Health and Medical Research Council of Australia [APP1028509]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (DP0984390) and the National Health and Medical Research Council of Australia (APP1028509).	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; BODE W, 1989, FEBS LETT, V242, P285, DOI 10.1016/0014-5793(89)80486-7; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Craik DJ, 2007, MOL BIOSYST, V3, P257, DOI 10.1039/b616856f; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Creighton T.E., 1992, PROTEINS STRUCTURES; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; JARVIS JA, 1993, BIOCHEM BIOPH RES CO, V192, P991, DOI 10.1006/bbrc.1993.1514; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1981, BIOCHEMISTRY-US, V20, P6250, DOI 10.1021/bi00524a053; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1999, J AM CHEM SOC, V121, P4316, DOI 10.1021/ja984480u; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36141	36148		10.1074/jbc.M113.528240	http://dx.doi.org/10.1074/jbc.M113.528240			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169696	hybrid, Green Published			2022-12-25	WOS:000329814700048
J	Wilcoxen, J; Hille, R				Wilcoxen, Jarett; Hille, Russ			The Hydrogenase Activity of the Molybdenum/Copper-containing Carbon Monoxide Dehydrogenase of Oligotropha carboxidovorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbon Monoxide; Copper; Enzyme Kinetics; Hydrogenase; Kinetics; Molybdenum; CO Dehydrogenase	CO-DEHYDROGENASE; XANTHINE-OXIDASE; PSEUDOMONAS-CARBOXYDOVORANS; COPPER; MECHANISM; OXIDATION; SITE; OXIDOREDUCTASE; REDUCTION; CLUSTER	Background: CO dehydrogenase oxidizes CO to CO2 under aerobic conditions. Results: CO dehydrogenase also oxidizes H-2, eliciting a new EPR signal. Conclusion: CO dehydrogenase is an effective hydrogenase, and the EPR signal observed provides new mechanistic information. Significance: We have gained a deeper understanding of the chemistry catalyzed by this enzyme and new information concerning the mechanism of H-2 oxidation. The reaction of the air-tolerant CO dehydrogenase from Oligotropha carboxidovorans with H-2 has been examined. Like the Ni-Fe CO dehydrogenase, the enzyme can be reduced by H-2 with a limiting rate constant of 5.3 s(-1) and a dissociation constant K-d of 525 m; both k(red) and k(red)/K-d, reflecting the breakdown of the Michaelis complex and the reaction of free enzyme with free substrate in the low [S] regime, respectively, are largely pH-independent. During the reaction with H-2, a new EPR signal arising from the Mo/Cu-containing active site of the enzyme is observed which is distinct from the signal seen when the enzyme is reduced by CO, with greater g anisotropy and larger hyperfine coupling to the active site Cu-63,Cu-65. The signal also exhibits hyperfine coupling to at least two solvent-exchangeable protons of bound substrate that are rapidly exchanged with solvent. Proton coupling is also evident in the EPR signal seen with the dithionite-reduced native enzyme, and this coupling is lost in the presence of bicarbonate. We attribute the coupled protons in the dithionite-reduced enzyme to coordinated water at the copper site in the native enzyme and conclude that bicarbonate is able to displace this water from the copper coordination sphere. On the basis of our results, a mechanism for H-2 oxidation is proposed which involves initial binding of H-2 to the copper of the binuclear center, displacing the bound water, followed by sequential deprotonation through a copper-hydride intermediate to reduce the binuclear center.	[Wilcoxen, Jarett; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1462 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Wilcoxen, Jarett M/F-9794-2013	Wilcoxen, Jarett M/0000-0003-2220-0815	Department of Energy [13ER16411]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant 13ER16411 (to R. H.).	BHATNAGAR L, 1987, FEMS MICROBIOL LETT, V41, P337; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; CYPIONKA H, 1983, J BACTERIOL, V156, P1178, DOI 10.1128/JB.156.3.1178-1187.1983; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Frohman DJ, 2013, INORG CHEM, V52, P816, DOI 10.1021/ic301941k; Gourlay C, 2006, J AM CHEM SOC, V128, P2164, DOI 10.1021/ja056500f; HILLE R, 1993, BIOCHEMISTRY-US, V32, P3973, DOI 10.1021/bi00066a018; Hille R, 2001, J BIOL CHEM, V276, P31193, DOI 10.1074/jbc.M100673200; Hofmann M, 2005, J BIOL INORG CHEM, V10, P490, DOI 10.1007/s00775-005-0661-5; Hulley EB, 2013, J AM CHEM SOC, V135, P11736, DOI 10.1021/ja405755j; Kemper PR, 1998, J AM CHEM SOC, V120, P13494, DOI 10.1021/ja9822658; Leger C, 2002, BIOCHEMISTRY-US, V41, P15736, DOI 10.1021/bi026586e; MAHONEY WS, 1988, J AM CHEM SOC, V110, P291, DOI 10.1021/ja00209a048; Menon S, 1996, BIOCHEMISTRY-US, V35, P15814, DOI 10.1021/bi9615598; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; MEYER O, 1980, J BACTERIOL, V141, P74, DOI 10.1128/JB.141.1.74-80.1980; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; Moersdorf Gerhard, 1992, Biodegradation, V3, P61; Moser R, 2010, J AM CHEM SOC, V132, P7852, DOI 10.1021/ja102689e; OLSON JS, 1974, J BIOL CHEM, V249, P4363; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; Santiago B, 1996, FEMS MICROBIOL LETT, V136, P157; Siegbahn PEM, 2005, J COMPUT CHEM, V26, P888, DOI 10.1002/jcc.20230; Siegbahn PEM, 2007, CHEM REV, V107, P4414, DOI 10.1021/cr050185y; Speight J.G., 2017, LANGES HDB CHEM; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Wang N, 2013, DALTON T, V42, P12059, DOI 10.1039/c3dt51371h; Wilcoxen J, 2011, J AM CHEM SOC, V133, P12934, DOI 10.1021/ja205073j; Wilcoxen J, 2011, BIOCHEMISTRY-US, V50, P1910, DOI 10.1021/bi1017182; Zhang B, 2010, J BIOL CHEM, V285, P12571, DOI 10.1074/jbc.M109.076851	33	24	24	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36052	36060		10.1074/jbc.M113.522441	http://dx.doi.org/10.1074/jbc.M113.522441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165123	hybrid, Green Published			2022-12-25	WOS:000329814700040
J	Amatsu, S; Sugawara, Y; Matsumura, T; Kitadokoro, K; Fujinaga, Y				Amatsu, Sho; Sugawara, Yo; Matsumura, Takuhiro; Kitadokoro, Kengo; Fujinaga, Yukako			Crystal Structure of Clostridium botulinum Whole Hemagglutinin Reveals a Huge Triskelion-shaped Molecular Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Botulinum Toxin; Carbohydrate-binding Protein; Crystal Structure; E-cadherin; Epithelial Cell; Protein Complexes; Bacterial Pathogenesis; Hemagglutinin	C PROGENITOR TOXIN; SUGAR-BINDING SITES; X-RAY-DIFFRACTION; EPITHELIAL BARRIER; HA PROTEINS; SIALIC-ACID; NEUROTOXIN; SUBCOMPONENT; CELLS; INTERNALIZATION	Clostridium botulinum HA is a component of the large botulinum neurotoxin complex and is critical for its oral toxicity. HA plays multiple roles in toxin penetration in the gastrointestinal tract, including protection from the digestive environment, binding to the intestinal mucosal surface, and disruption of the epithelial barrier. At least two properties of HA contribute to these roles: the sugar-binding activity and the barrier-disrupting activity that depends on E-cadherin binding of HA. HA consists of three different proteins, HA1, HA2, and HA3, whose structures have been partially solved and are made up mainly of -strands. Here, we demonstrate structural and functional reconstitution of whole HA and present the complete structure of HA of serotype B determined by x-ray crystallography at 3.5 resolution. This structure reveals whole HA to be a huge triskelion-shaped molecule. Our results suggest that whole HA is functionally and structurally separable into two parts: HA1, involved in recognition of cell-surface carbohydrates, and HA2-HA3, involved in paracellular barrier disruption by E-cadherin binding.	[Amatsu, Sho; Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Sugawara, Yo; Matsumura, Takuhiro; Fujinaga, Yukako] Osaka Univ, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kyoto Institute of Technology; Osaka University	Kitadokoro, K (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Matsugasakigosyokaido Cho, Kyoto 6068585, Japan.	kengo@kit.ac.jp; yukafuji@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Amatsu, Sho/0000-0003-0692-264X	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan)	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan)	We thank Dr. E. Yamashita and Prof. A. Nakagawa (SPring-8 beamline BL44XU) for help with the x-ray data collection. Diffraction data were collected at Osaka University beamline BL44XU at SPring-8 (equipped with a Rayonix MX300-HE detector), which is financially supported by Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We also thank Asami Sano, Takayuki Yoshimura, and Kaoru Sasaki for technical assistance.	Arimitsu H, 2003, INFECT IMMUN, V71, P1599, DOI 10.1128/IAI.71.3.1599-1603.2003; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Arndt JW, 2005, J MOL BIOL, V346, P1083, DOI 10.1016/j.jmb.2004.12.039; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI 10.1099/mic.0.26805-0; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Inui K, 2010, J VET MED SCI, V72, P1251, DOI 10.1292/jvms.10-0090; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; JANCARIK J, 1991, J MOL BIOL, V221, P31, DOI 10.1016/0022-2836(91)80198-4; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Kojima S, 2005, BIOCHEM BIOPH RES CO, V331, P571, DOI 10.1016/j.bbrc.2005.04.007; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Nakamura T, 2011, ARCH BIOCHEM BIOPHYS, V512, P69, DOI 10.1016/j.abb.2011.05.012; Nakamura T, 2009, J MOL BIOL, V385, P1193, DOI 10.1016/j.jmb.2008.11.039; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V319, P327, DOI 10.1016/j.bbrc.2004.04.183; Niwa K, 2007, FEMS IMMUNOL MED MIC, V49, P346, DOI 10.1111/j.1574-695X.2006.00205.x; Niwa K, 2010, VET MICROBIOL, V141, P312, DOI 10.1016/j.vetmic.2009.09.008; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Sugawara Y, 2011, CELL ADHES MIGR, V5, P34, DOI 10.4161/cam.5.1.13574; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Uotsu N, 2006, BBA-MOL CELL RES, V1763, P120, DOI 10.1016/j.bbamcr.2005.11.014; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055	42	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35617	35625		10.1074/jbc.M113.521179	http://dx.doi.org/10.1074/jbc.M113.521179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165130	Green Published, hybrid			2022-12-25	WOS:000329867600055
J	Reddy, DS; Bhatnagar-Mathur, P; Cindhuri, KS; Sharma, KK				Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Cindhuri, Katamreddy Sri; Sharma, Kiran K.			Evaluation and Validation of Reference Genes for Normalization of Quantitative Real-Time PCR Based Gene Expression Studies in Peanut	PLOS ONE			English	Article							INTERNAL CONTROL GENES; ARACHIS-HYPOGAEA L.; RT-PCR; HOUSEKEEPING GENES; ACCURATE NORMALIZATION; CROP IMPROVEMENT; IDENTIFICATION; SELECTION; RESISTANCE; NUMBER	The quantitative real-time PCR (qPCR) based techniques have become essential for gene expression studies and high-throughput molecular characterization of transgenic events. Normalizing to reference gene in relative quantification make results from qPCR more reliable when compared to absolute quantification, but requires robust reference genes. Since, ideal reference gene should be species specific, no single internal control gene is universal for use as a reference gene across various plant developmental stages and diverse growth conditions. Here, we present validation studies of multiple stably expressed reference genes in cultivated peanut with minimal variations in temporal and spatial expression when subjected to various biotic and abiotic stresses. Stability in the expression of eight candidate reference genes including ADH3, ACT11, ATPsyn, CYP2, ELF1B, G6PD, LEC and UBC1 was compared in diverse peanut plant samples. The samples were categorized into distinct experimental sets to check the suitability of candidate genes for accurate and reliable normalization of gene expression using qPCR. Stability in expression of the references genes in eight sets of samples was determined by geNorm and NormFinder methods. While three candidate reference genes including ADH3, G6PD and ELF1B were identified to be stably expressed across experiments, LEC was observed to be the least stable, and hence must be avoided for gene expression studies in peanut. Inclusion of the former two genes gave sufficiently reliable results; nonetheless, the addition of the third reference gene ELF1B may be potentially better in a diverse set of tissue samples of peanut.	[Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Cindhuri, Katamreddy Sri; Sharma, Kiran K.] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Bhatnagar-Mathur, P (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India.	p.bhatnagar@cgiar.org	Sharma, Kiran/C-5715-2014; Sharma, Kiran/GZL-1834-2022; Bhatnagar-Mathur, Pooja/C-5730-2014	Sharma, Kiran/0000-0002-1200-8857; Bhatnagar-Mathur, Pooja/0000-0002-4150-8287	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was undertaken as part of the CGIAR Research Program on Grain Legumes and partly supported by a grant from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Brand Yael, 2010, Peanut Science, V37, P12, DOI 10.3146/PS09-014.1; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FAO, 2009, FAO STAT DAT; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kumar PL, 2007, PATANCHERU; LEDT, 2012, PLOS ONE, V0007; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Peterhansel C., 2004, Biomedical Engineering, Applications Basis Communications, V16, P1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmidt MA, 2001, PLANT CELL REP, V20, P422, DOI 10.1007/s002990100326; Sharma HC, 2002, PLANT SCI, V163, P381, DOI 10.1016/S0168-9452(02)00133-4; Sharma KK, 2000, IN VITRO CELL DEV-PL, V36, P83, DOI 10.1007/s11627-000-0019-1; SUBRAHMANYAM P, 1985, PLANT DIS, V69, P951, DOI 10.1094/PD-69-951; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; YOKOYAMA S, 1993, MOL BIOL EVOL, V10, P1215	54	58	62	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78555	10.1371/journal.pone.0078555	http://dx.doi.org/10.1371/journal.pone.0078555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167633	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326034500094
J	Fu, JQ; Akhmedov, D; Berdeaux, R				Fu, Jingqi; Akhmedov, Dmitry; Berdeaux, Rebecca			The Short Isoform of the Ubiquitin Ligase NEDD4L Is a CREB Target Gene in Hepatocytes	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; REGULATES HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; COACTIVATOR TORC2; C2 DOMAIN; PHOSPHORYLATION; EXPRESSION; KINASE; HYPERTENSION	During cycles of fasting and feeding, liver function is regulated by both transcriptional and post-translational events. Regulated protein degradation has recently emerged as a key mechanism to control abundance of specific hepatic proteins under different nutritional conditions. As glucagon signaling through cAMP and PKA is central to glucose output during fasting, we hypothesized that this signaling pathway may also regulate ubiquitin ligases in the fasted state. Here we show that fasting stimuli promote expression of the short isoform of the E3 ubiquitin ligase Nedd4l in primary mouse hepatocytes. Nedd4l-short mRNA and NEDD4L (short isoform) protein accumulate in glucagon-treated primary mouse hepatocytes and in liver tissues during fasting. We identified a functional cAMP response element in the alternate Nedd4l-short promoter; mutation of this element blunts cAMP-induced expression of a Nedd4l reporter construct. CREB occupies the endogenous Nedd4l locus near this element. CREB and its coactivator CRTC2, both activated by fasting stimuli, contribute to glucagon-stimulated Nedd4l-short expression in primary hepatocytes. siRNA-mediated Nedd4l depletion in primary hepatocytes did not affect gluconeogenic gene expression, glucose output or glycogen synthesis. Our findings reveal a new mechanism of Nedd4l transcriptional regulation in liver cells.	[Fu, Jingqi; Akhmedov, Dmitry] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Berdeaux, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.	Rebecca.berdeaux@uth.tmc.edu		Berdeaux, Rebecca/0000-0002-9929-1711; Fu, Jingqi/0000-0003-3871-428X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK092590, P30DK056338]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059847]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK092590] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases (R01DK092590, P30DK056338) and Arthritis and Musculoskeletal and Skin Diseases (R01AR059847). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; FLEIG WE, 1987, J BIOL CHEM, V262, P1155; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hasstedt SJ, 2013, J HUM GENET, V58, P378, DOI 10.1038/jhg.2013.21; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonough CW, 2009, HUM GENET, V126, P805, DOI 10.1007/s00439-009-0732-8; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Qi H, 2003, MOL CELL ENDOCRINOL, V210, P51, DOI 10.1016/j.mce.2003.08.009; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Salway JG., 2004, METABOLISM GLANCE, V3rd, P125; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Stewart R, 2013, P NATL ACAD SCI USA, V110, P117, DOI 10.1073/pnas.1212676110; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Van Huysse JW, 2012, HYPERTENSION, V60, P691, DOI 10.1161/HYPERTENSIONAHA.112.193045; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YL, 2013, INT J MOL SCI, V14, P7433, DOI 10.3390/ijms14047433; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yu JX, 2013, J BIOL CHEM, V288, P3823, DOI 10.1074/jbc.M112.397885; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	43	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78522	10.1371/journal.pone.0078522	http://dx.doi.org/10.1371/journal.pone.0078522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147136	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200098
J	Jin, JO; Shinohara, Y; Yu, Q				Jin, Jun-O; Shinohara, Yoshinori; Yu, Qing			Innate Immune Signaling Induces Interleukin-7 Production from Salivary Gland Cells and Accelerates the Development of Primary Sjogren's Syndrome in a Mouse Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; AUTOIMMUNE EXOCRINOPATHY; EPITHELIAL-CELLS; T-CELLS; EXPRESSION; MICE; PATHOGENESIS; ACTIVATION; IL-7; INDUCTION	Elevated IL-7 in the target tissues is closely associated with multiple autoimmune disorders, including Sjogren's syndrome (SS). We recently found that IL-7 plays an essential role in the development and onset of primary SS (pSS) in C57BL/6.NOD-Aec1Aec2 mice, a well-defined mouse model of primary SS. However, environmental signals that cause excessive IL-7 production are not well-characterized. Innate immune signaling plays a critical role in shaping the adaptive immune responses including autoimmune responses. We and others have previously shown that innate immune signaling can induce IL-7 expression in lungs and intestines of C57BL/6 mice. In this study, we characterized the effects of poly I:C, a double-stranded RNA analog and toll-like receptor 3 agonist, on the induction of IL-7 expression in salivary glands and on pSS development. We showed that poly I:C administration to C57BL/6 mice rapidly induced IL-7 expression in the salivary glands in a type 1 IFN- and IFN-gamma-dependent manner. Moreover, poly I:C-induced IL-7 contributed to the optimal up-regulation of CXCL9 in the salivary glands, which may subsequently promote recruitment of more IFN-gamma-producing T cells. Repeated administration of poly I:C to C57BL/6.NOD-Aec1Aec2 mice accelerated the development of SS-like exocrinopathy, and this effect was abolished by the blockade of IL-7 receptor signaling with a neutralizing antibody. Finally, poly I:C or a combination of IFN-alpha and IFN-gamma induced IL-7 gene expression and protein production in a human salivary gland epithelial cell line. Hence, we demonstrate that IL-7 expression in the salivary gland cells can be induced by poly I:C and delineate a crucial mechanism by which innate immune signals facilitate the development of pSS, which is through induction of IL-7 in the target tissues.	[Jin, Jun-O; Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Shinohara, Yoshinori] Kyushu Univ, Div Oral Rehabil, Fukuoka 812, Japan	Harvard University; Forsyth Institute; Kyushu University	Yu, Q (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA.	qyu@forsyth.org	yu, qing/HGC-4611-2022; Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	National Institutes of Health [P30DE020751]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institutes of Health (P30DE020751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; Cha S, 2002, ADV EXP MED BIOL, V506, P1035; Deshmukh US, 2009, J ORAL PATHOL MED, V38, P42, DOI 10.1111/j.1600-0714.2008.00700.x; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Hartgring SAY, 2010, ARTHRITIS RHEUM-US, V62, P2716, DOI 10.1002/art.27578; Hayakawa I, 2007, IMMUNOLOGY, V122, P73, DOI 10.1111/j.1365-2567.2007.02614.x; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Jin J-O, 2013, ARTHRITIS RHEUM; Jin JO, 2013, J LEUKOCYTE BIOL, V93, P413, DOI 10.1189/jlb.0712360; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Li J, 2010, KOREAN J PHYSIOL PHA, V14, P235, DOI 10.4196/kjpp.2010.14.4.235; Mariette X, 2010, CURR OPIN RHEUMATOL, V22, P471, DOI 10.1097/BOR.0b013e32833c36c5; Matsumoto M, 2011, REV MED VIROL; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Nandula SR, 2011, ORAL DIS, V17, P801, DOI 10.1111/j.1601-0825.2011.01839.x; Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Nguyen CQ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2676; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Segal B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-46; Sharma R, 2009, J IMMUNOL, V183, P3212, DOI 10.4049/jimmunol.0804355; Shinohara T, 2011, J IMMUNOL, V186, P2623, DOI 10.4049/jimmunol.1000057; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; Vosters JL, 2009, ARTHRITIS RHEUM-US, V60, P3633, DOI 10.1002/art.24980; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Yamazaki M, 2003, J IMMUNOL, V171, P1556, DOI 10.4049/jimmunol.171.3.1556; Yin HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018003	51	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77605	10.1371/journal.pone.0077605	http://dx.doi.org/10.1371/journal.pone.0077605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147035	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200051
J	Kidoaki, S; Sakashita, H				Kidoaki, Satoru; Sakashita, Hiroyuki			Rectified Cell Migration on Saw-Like Micro-Elastically Patterned Hydrogels with Asymmetric Gradient Ratchet Teeth	PLOS ONE			English	Article							FORCE MICROSCOPY; STEM-CELLS; MOTILITY; HAPTOTAXIS; SUBSTRATE; MOVEMENT; MORPHOGENESIS; RIGIDITY; GELATIN	To control cell motility is one of the essential technologies for biomedical engineering. To establish a methodology of the surface design of elastic substrate to control the long-range cell movements, here we report a sophisticated cell culture hydrogel with a micro-elastically patterned surface that allows long-range durotaxis. This hydrogel has a sawlike pattern with asymmetric gradient ratchet teeth, and rectifies random cell movements. Durotaxis only occurs at boundaries in which the gradient strength of elasticity is above a threshold level. Consequently, in gels with unit teeth patterns, durotaxis should only occur at the sides of the teeth in which the gradient strength of elasticity is above this threshold level. Therefore, such gels are expected to support the long-range biased movement of cells via a mechanism similar to the Feynman-Smoluchowski ratchet, i.e., rectified cell migration. The present study verifies this working hypothesis by using photolithographic microelasticity patterning of photocurable gelatin gels. Gels in which each teeth unit was 100-120 mu m wide with a ratio of ascending: descending elasticity gradient of 1: 2 and a peak elasticity of ca. 100 kPa supported the efficient rectified migration of 3T3 fibroblast cells. In addition, long-range cell migration was most efficient when soft lanes were introduced perpendicular to the saw-like patterns. This study demonstrates that asymmetric elasticity gradient patterning of cell culture gels is a versatile means of manipulating cell motility.	[Kidoaki, Satoru] Kyushu Univ, Inst Mat Chem & Engn, Res Field Biomed & Biophys Chem, Fukuoka 812, Japan; [Sakashita, Hiroyuki] Kyushu Univ, Grad Sch Engn, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kidoaki, S (corresponding author), Kyushu Univ, Inst Mat Chem & Engn, Res Field Biomed & Biophys Chem, Fukuoka 812, Japan.	kidoaki@ms.ifoc.kyushu-u.ac.jp	Kidoaki, Satoru/AAR-2704-2020	Kidoaki, Satoru/0000-0001-9138-0018	Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency; Cabinet Office, Government of Japan	Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency; Cabinet Office, Government of Japan	This work was supported by the Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency, and the Funding Program for World-Leading Innovative R&D on Science and Technology "Innovative NanoBiodevice based on Single Molecule Analysis" from the Cabinet Office, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Feynman RP., 1963, FEYNMAN LECT PHYS, V1, P46; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hess DA, 2011, METHODS MOL BIOL, V750, P25, DOI 10.1007/978-1-61779-145-1_2; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Ko YG, 2013, BIOMATERIALS, V34, P353, DOI 10.1016/j.biomaterials.2012.09.071; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lowe B, 1997, J EXP BIOL, V200, P1593; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237; PARENTE L, 1979, AGENTS ACTIONS, V9, P190, DOI 10.1007/BF02024733; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0; TRINKAUS JP, 1985, J NEUROSCI RES, V13, P1, DOI 10.1002/jnr.490130102; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Wu HW, 1998, SCANNING, V20, P389; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	42	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78067	10.1371/journal.pone.0078067	http://dx.doi.org/10.1371/journal.pone.0078067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147112	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200095
J	Fregnani, CMS; Fregnani, JHTG; Latorre, MDDD; de Almeida, AM				Sirna Fregnani, Cristiane Menezes; Tavares Guerreiro Fregnani, Jose Humberto; Dias de Oliveira Latorre, Maria do Rosario; de Almeida, Ana Maria			Evaluation of the Psychometric Properties of the Functional Assessment of Cancer Therapy-Cervix Questionnaire in Brazil	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY SF-36; CHINESE VERSION; RELIABILITY; VALIDATION; VALIDITY; ONCOLOGY	Background: Although cervical cancer is the second most common tumor among Brazilian women, studies that evaluate the quality of life of these women are still scarce. This situation is explained by the lack of specific and validated tools for this purpose in Portuguese (Brazil). The aim of this study was to evaluate the psychometric properties of the Portuguese version of the FACT-CX (Functional Assessment of Cancer Therapy-Cervix) questionnaire in a population of Brazilian women with cervical cancer. Methods: The psychometric properties of the FACT-CX questionnaire were tested in a sample of 100 women diagnosed with cervical cancer who were previously treated in the Barretos Cancer Hospital. We analyzed the internal consistency (Cronbach's alpha), reproducibility (intraclass correlation coefficient - ICC), confirmatory factor analysis, convergent validity (correlation with the SF-36 questionnaire), and discriminant validity by disease stage and two questions related to self-perception of health was also performed. Results: The scales had Cronbach's alpha coefficients ranging from 0.61 to 0.80. However, three scales did not have a statistically significant coefficient greater than 0.70. The ICC ranged from 0.68 to 0.82 and all considered satisfactory. Factor analysis did not generate consistent components. The FACT-G and FACT-CX total scores had good internal consistency and reproducibility, and also correlated well with the General Health and Vitality scales of the SF-36. However, only two FACT-CX scales had a significant correlation with SF-36. Discriminant analysis showed that FACT-CX failed to discriminate groups according to clinical stage but was able to divide the women according to the self-perception of health. Conclusion: FATC-CX total score had good internal consistency, reproducibility and discriminant validity. In addition, it correlated well with General Health and Vitality scales of SF-36. However, three scales had questionable internal consistency and only two had significant correlation with SF-36.	[Sirna Fregnani, Cristiane Menezes] Univ Sao Paulo, Coll Nursing, Grad Program Publ Hlth Nursing, BR-14049 Ribeirao Preto, Brazil; [Sirna Fregnani, Cristiane Menezes; Tavares Guerreiro Fregnani, Jose Humberto] Barretos Canc Hosp IEP HCB, Res & Teaching Inst, Barretos, Brazil; [Dias de Oliveira Latorre, Maria do Rosario] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [de Almeida, Ana Maria] Univ Sao Paulo, Dept Maternal Infant & Publ Hlth Nursing, Coll Nursing, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade de Sao Paulo	Fregnani, CMS (corresponding author), Univ Sao Paulo, Coll Nursing, Grad Program Publ Hlth Nursing, BR-14049 Ribeirao Preto, Brazil.	cfregnani@usp.br	Fregnani, José H/H-4238-2012; Latorre, Maria RDO/J-5780-2014; Almeida, Ana Maria/I-2247-2012	Fregnani, José H/0000-0002-5235-6469; Latorre, Maria RDO/0000-0002-5189-3457; 				Abayomi J, 2005, J HUM NUTR DIET, V18, P353, DOI 10.1111/j.1365-277X.2005.00633.x; Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; Bensoussan A, 2001, AUST NZ J PUBL HEAL, V25, P71, DOI 10.1111/j.1467-842X.2001.tb00554.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Boling W, 2003, INT J GYNECOL CANCER, V13, P5, DOI 10.1046/j.1525-1438.2003.13051.x; Brasil, 2011, EST 2012 INC CANC BR; Cella D, 2010, GYNECOL ONCOL, V119, P531, DOI 10.1016/j.ygyno.2010.08.020; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Ciconelli R., 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Colwell HH, 2010, ONCOLOGIST, V15, P308, DOI 10.1634/theoncologist.2009-0034; Debb SM, 2011, PSYCHO-ONCOLOGY, V20, P19, DOI 10.1002/pon.1698; Ding Y, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-124; Fayers P. M., 2000, QUALITY LIFE ASSESSM; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandes WC, 2010, REV LAT-AM ENFERM, V18, P360, DOI 10.1590/S0104-11692010000300010; Fleiss J., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Garland SN, 2011, CANCER-AM CANCER SOC, V117, P1302, DOI 10.1002/cncr.25556; Hu J, 2010, DIABETES RES CLIN PR, V88, P273, DOI 10.1016/j.diabres.2010.03.005; Ishikawa NM, 2010, SUPPORT CARE CANCER, V18, P481, DOI 10.1007/s00520-009-0697-0; Janda M, 2005, GYNECOL ONCOL, V97, P568, DOI 10.1016/j.ygyno.2005.01.047; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Mastropietro Ana Paula, 2007, Rev. Saúde Pública, V41, P260, DOI 10.1590/S0034-89102007000200013; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Park SY, 2007, CANCER-AM CANCER SOC, V110, P2716, DOI 10.1002/cncr.23094; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Penson RT, 2006, INT J GYNECOL OBSTET, V95, pS247, DOI 10.1016/S0020-7292(06)60040-4; Pignata S, 2001, ANN ONCOL, V12, pS37, DOI 10.1093/annonc/12.suppl_3.S37; Sanchez R, 2011, QUAL LIFE RES, V20, P19, DOI 10.1007/s11136-010-9727-0; Sapnas Kathryn G, 2002, J Nurs Meas, V10, P135; Shin DW, 2009, ONCOLOGY-BASEL, V76, P190, DOI 10.1159/000201571; Tong MCF, 2009, HEAD NECK-J SCI SPEC, V31, P738, DOI 10.1002/hed.21023; Victorson D, 2008, QUAL LIFE RES, V17, P1137, DOI 10.1007/s11136-008-9398-2; Wan CH, 2007, LUNG CANCER, V56, P415, DOI 10.1016/j.lungcan.2007.01.004; Ward WL, 1999, QUAL LIFE RES, V8, P181, DOI 10.1023/A:1008821826499; Ware J.E., 1994, SF 36 PHYS MENTAL HL; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79	38	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77947	10.1371/journal.pone.0077947	http://dx.doi.org/10.1371/journal.pone.0077947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24147102	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400144
J	Dun, W; Lowe, JS; Wright, P; Hund, TJ; Mohler, PJ; Boyden, PA				Dun, Wen; Lowe, John S.; Wright, Patrick; Hund, Thomas J.; Mohler, Peter J.; Boyden, Penelope A.			Ankyrin-G Participates in I-Na Remodeling in Myocytes from the Border Zones of Infarcted Canine Heart	PLOS ONE			English	Article							SUBENDOCARDIAL PURKINJE MYOCYTES; EXTENSIVE MYOCARDIAL-INFARCTION; CHANNEL; CELLS; EXCITABILITY; CONNEXIN43; CURRENTS; PROTEIN; FIBERS	Cardiac Na channel remodeling provides a critical substrate for generation of reentrant arrhythmias in border zones of the infarcted canine heart. Recent studies show that Na(v)1.5 assembly and function are linked to ankyrin-G, gap, and mechanical junction proteins. In this study our objective is to expound the status of the cardiac Na channel, its interacting protein ankyrinG and the mechanical and gap junction proteins at two different times post infarction when arrhythmias are known to occur; that is, 48 hr and 5 day post coronary occlusion. Previous studies have shown the origins of arrhythmic events come from the subendocardial Purkinje and epicardial border zone. Our Purkinje cell (Pcell) voltage clamp study shows that I-Na and its kinetic parameters do not differ between Pcells from the subendocardium of the 48hr infarcted heart (IZPCs) and control non-infarcted Pcells (NZPCs). Immunostaining studies revealed that disturbances of Na(v)1.5 protein location with ankyrin-G are modest in 48 hr IZPCs. Therefore, Na current remodeling does not contribute to the abnormal conduction in the subendocardial border zone 48 hr post myocardial infarction as previously defined. In addition, immunohistochemical data show that Cx40/Cx43 co-localize at the intercalated disc (IDs) of control NZPCs but separate in IZPCs. At the same time, Purkinje cell desmoplakin and desmoglein2 immunostaining become diffuse while plakophilin2 and plakoglobin increase in abundance at IDs. In the epicardial border zone 5 days post myocardial infarction, immunoblot and immunocytochemical analyses showed that ankyrin-G protein expression is increased and re-localized to submembrane cell regions at a time when Nav1.5 function is decreased. Thus, Na(v)1.5 and ankyrin-G remodeling occur later after myocardial infarction compared to that of gap and mechanical junctional proteins. Gap and mechanical junctional proteins remodel in IZPCs early, perhaps to help maintain Na(v)1.5 subcellular location position and preserve its function soon after myocardial infarction.	[Dun, Wen; Boyden, Penelope A.] Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA; [Lowe, John S.; Wright, Patrick; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Columbia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dun, W (corresponding author), Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA.	pab4@columbia.edu	Hund, Thomas/C-9222-2012		National Institutes of Health [HL105983, HL066140, HL084583, HL083422, HL096805, HL114893]; Saving Tiny Hearts Society; American Heart Association; Gilead Sciences Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL066140, R00HL096805, R01HL114893, R01HL105983, R01HL084583, K99HL096805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; American Heart Association(American Heart Association); Gilead Sciences Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [HL105983, HL066140 to PAB];[HL084583, HL083422 to PJM]; [HL096805, HL114893 to TJH]; Saving Tiny Hearts Society (PJM), American Heart Association (PJM), and Gilead Sciences Research Scholars Program (TJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; BOYDEN PA, 1989, CIRC RES, V65, P955, DOI 10.1161/01.RES.65.4.955; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; FRIEDMAN PL, 1975, CIRC RES, V36, P127, DOI 10.1161/01.RES.36.1.127; FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; HARRIS AS, 1950, CIRCULATION, V1, P1318, DOI 10.1161/01.CIR.1.6.1318; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; JECK C, 1995, CIRCULATION, V92, P465, DOI 10.1161/01.CIR.92.3.465; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Noorman M, 2013, HEART RHYTHM, V10, P412, DOI 10.1016/j.hrthm.2012.11.018; Peters NS, 1997, CIRCULATION, V95, P988; Pieperhoff S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00022; Pieperhoff S, 2010, EUR J CELL BIOL, V89, P365, DOI 10.1016/j.ejcb.2009.11.025; Pinto JMB, 1998, J CARDIOVASC ELECTR, V9, P299, DOI 10.1111/j.1540-8167.1998.tb00915.x; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Wit A. L., 1993, VENTRICULAR ARRHYTHM	24	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78087	10.1371/journal.pone.0078087	http://dx.doi.org/10.1371/journal.pone.0078087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155982	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300116
J	Forwood, SE; Walker, AD; Hollands, GJ; Marteau, TM				Forwood, Suzanna E.; Walker, Alexander D.; Hollands, Gareth J.; Marteau, Theresa M.			Choosing between an Apple and a Chocolate Bar: the Impact of Health and Taste Labels	PLOS ONE			English	Article							VEGETABLE INTAKE; FOOD; CHOICE; FRUIT; EAT	Increasing the consumption of fruit and vegetables is a central component of improving population health. Reasons people give for choosing one food over another suggest health is of lower importance than taste. This study assesses the impact of using a simple descriptive label to highlight the taste as opposed to the health value of fruit on the likelihood of its selection. Participants (N=439) were randomly allocated to one of five groups that varied in the label added to an apple: apple; healthy apple; succulent apple; healthy and succulent apple; succulent and healthy apple. The primary outcome measure was selection of either an apple or a chocolate bar as a dessert. Measures of the perceived qualities of the apple (taste, health, value, quality, satiety) and of participant characteristics (restraint, belief that tasty foods are unhealthy, BMI) were also taken. When compared with apple selection without any descriptor (50%), the labels combining both health and taste descriptors significantly increased selection of the apple ('healthy & succulent' 65.9% and 'succulent & healthy' 62.4%), while the use of a single descriptor had no impact on the rate of apple selection ('healthy' 50.5% and 'succulent' 52%). The strongest predictors of individual dessert choice were the taste score given to the apple, and the lack of belief that healthy foods are not tasty. Interventions that emphasize the taste attributes of healthier foods are likely to be more effective at achieving healthier diets than those emphasizing health alone.	[Forwood, Suzanna E.; Walker, Alexander D.; Hollands, Gareth J.; Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Forwood, SE (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England.	Sef26@cam.ac.uk	Forwood, Suzanna/A-5376-2008	Forwood, Suzanna/0000-0002-8406-5121; Hollands, Gareth/0000-0002-0492-3924; Marteau, Theresa/0000-0003-3025-1129	Department of Health, UK	Department of Health, UK	This research was funded by the Department of Health, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernev A, 2011, J CONSUM PSYCHOL, V21, P178, DOI 10.1016/j.jcps.2010.08.002; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x; Papies EK, 2012, CURR OBES REP, V1, P99, DOI 10.1007/s13679-012-0009-8; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Wardle J, 2000, HEALTH EDUC RES, V15, P39, DOI 10.1093/her/15.1.39; Yeomans MR, 2001, PHYSIOL BEHAV, V73, P533, DOI 10.1016/S0031-9384(01)00502-9	13	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77500	10.1371/journal.pone.0077500	http://dx.doi.org/10.1371/journal.pone.0077500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155964	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300098
J	Inai, K; Burnside, JL; Hoffman, S; Toole, BP; Sugi, Y				Inai, Kei; Burnside, Jessica L.; Hoffman, Stanley; Toole, Bryan P.; Sugi, Yukiko			BMP-2 Induces Versican and Hyaluronan That Contribute to Post-EMT AV Cushion Cell Migration	PLOS ONE			English	Article							HEART-VALVE DEVELOPMENT; EXPRESSION; GROWTH; ACTIVATION; RECEPTOR; PROTEIN; KINASE; MATRIX; TRANSFORMATION; PROLIFERATION	Distal outgrowth and maturation of mesenchymalized endocardial cushions are critical morphogenetic events during post-EMT atrioventricular (AV) valvuloseptal morphogenesis. We explored the role of BMP-2 in the regulation of valvulogenic extracellular matrix (ECM) components, versican and hyaluronan (HA), and cell migration during post-EMT AV cushion distal outgrowth/expansion. We observed intense staining of versican and HA in AV cushion mesenchyme from the early cushion expansion stage, Hamburger and Hamilton (HH) stage-17 to the cushion maturation stage, HH stage-29 in the chick. Based on this expression pattern we examined the role of BMP-2 in regulating versican and HA using 3D AV cushion mesenchymal cell (CMC) aggregate cultures on hydrated collagen gels. BMP-2 induced versican expression and HA deposition as well as mRNA expression of versican and Has2 by CMCs in a dose dependent manner. Noggin, an antagonist of BMP, abolished BMP-2-induced versican and HA as well as mRNA expression of versican and Has2. We further examined whether BMP-2-promoted cell migration was associated with expression of versican and HA. BMP-2-promoted cell migration was significantly impaired by treatments with versican siRNA and HA oligomer. In conclusion, we provide evidence that BMP-2 induces expression of versican and HA by AV CMCs and that these ECM components contribute to BMP-2-induced CMC migration, indicating critical roles for BMP-2 in distal outgrowth/expansion of mesenchymalized AV cushions.	[Sugi, Yukiko] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Cardiovasc Dev Biol Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Sugi, Y (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	sugiy@musc.edu			AHA [10GRANT3900044]; Lawrence J. and Florence A. DeGeorge Charitable Trust; GEAR TO [0056]; NIH [HL33756, P20 GM103444];  [NSF-EPS-0903795]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL033756, R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444] Funding Source: NIH RePORTER	AHA(American Heart Association); Lawrence J. and Florence A. DeGeorge Charitable Trust; GEAR TO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following sources supported this work: AHA 10GRANT3900044 and Lawrence J. and Florence A. DeGeorge Charitable Trust (YS); NSF-EPS-0903795, GEAR TO #0056 (YS), NIH HL33756 (RRM), NIH P20 GM103444 (N. Vyavahare, YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; BALDWIN HS, 1994, CIRC RES, V74, P244, DOI 10.1161/01.RES.74.2.244; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Casini P, 2012, DEV DYNAM, V241, P294, DOI 10.1002/dvdy.23715; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Craig EA, 2009, GLYCOBIOLOGY, V19, P890, DOI 10.1093/glycob/cwp064; DE LA CRUZ M V, 1998, LIVING MORPHOGENESIS; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Klewer SE, 2006, GENE EXPR PATTERNS, V6, P462, DOI 10.1016/j.modgep.2005.11.005; Lebaron RG, 1996, PERSPECT DEV NEUROBI, V3, P261; Lincoln J, 2006, DEV BIOL, V292, P290, DOI 10.1016/j.ydbio.2005.12.042; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Okagawa H, 2007, DEV BIOL, V306, P179, DOI 10.1016/j.ydbio.2007.03.015; Oosthoek PW, 1998, ANAT EMBRYOL, V198, P317, DOI 10.1007/s004290050187; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Singh R, 2012, CELL MOL LIFE SCI, V69, P1377, DOI 10.1007/s00018-011-0884-2; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Sugi Y, 2003, DEV BIOL, V258, P252, DOI 10.1016/S0012-1606(03)00099-X; SUGI Y, 2012, J NEONATAL BIOL, V1, P101; Toole B P, 2001, Methods Mol Biol, V171, P479; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	57	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77593	10.1371/journal.pone.0077593	http://dx.doi.org/10.1371/journal.pone.0077593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147033	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400129
J	Boerma, LJ; Xia, G; Qui, C; Cox, BD; Chalmers, MJ; Smith, CD; Lobo-Ruppert, S; Griffin, PR; Muccio, DD; Renfrow, MB				Boerma, LeeAnn J.; Xia, Gang; Qui, Cheng; Cox, Bryan D.; Chalmers, Michael J.; Smith, Craig D.; Lobo-Ruppert, Susan; Griffin, Patrick R.; Muccio, Donald D.; Renfrow, Matthew B.			Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor alpha Ligand Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RXR-ALPHA; MAMMARY-CARCINOMA; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; SELECTIVE LIGAND; STRUCTURAL BASIS; HYDROGEN/DEUTERIUM EXCHANGE; NEOPLASTIC TRANSFORMATION; 9-CIS-RETINOIC ACID; LGD1069 TARGRETIN	Retinoid X receptors (RXRs) are obligate partners for several other nuclear receptors, and they play a key role in several signaling processes. Despite being a promiscuous heterodimer partner, this nuclear receptor is a target of therapeutic intervention through activation using selective RXR agonists (rexinoids). Agonist binding to RXR initiates a large conformational change in the receptor that allows for coactivator recruitment to its surface and enhanced transcription. Here we reveal the structural and dynamical changes produced when a coactivator peptide binds to the human RXR alpha ligand binding domain containing two clinically relevant rexinoids, Targretin and 9-cis-UAB30. Our results show that the structural changes are very similar for each rexinoid and similar to those for the pan-agonist 9-cis-retinoic acid. The four structural changes involve key residues on helix 3, helix 4, and helix 11 that move from a solvent-exposed environment to one that interacts extensively with helix 12. Hydrogen-deuterium exchange mass spectrometry reveals that the dynamics of helices 3, 11, and 12 are significantly decreased when the two rexinoids are bound to the receptor. When the pan-agonist 9-cis-retinoic acid is bound to the receptor, only the dynamics of helices 3 and 11 are reduced. The four structural changes are conserved in all x-ray structures of the RXR ligand-binding domain in the presence of agonist and coactivator peptide. They serve as hallmarks for how RXR changes conformation and dynamics in the presence of agonist and coactivator to initiate signaling.	[Boerma, LeeAnn J.; Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Xia, Gang; Qui, Cheng; Cox, Bryan D.; Muccio, Donald D.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Smith, Craig D.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Lobo-Ruppert, Susan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Chalmers, Michael J.; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Scripps Research Institute; State University System of Florida; University of Florida	Muccio, DD (corresponding author), Univ Alabama Birmingham, Dept Chem, 901 14th St South, Birmingham, AL 35294 USA.	muccio@uab.edu; renfrow@uab.edu		Renfrow, Matthew B./0000-0002-4193-7305; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [2 P50 CA089019, 5 P50 CA089019, RR17261]; Alabama Drug Discovery Alliance; Komen Foundation [BCTR 20000690]; NATIONAL CANCER INSTITUTE [P50CA089019, P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270, S10RR017261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance; Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2 P50 CA089019 (to D. D. M.), 5 P50 CA089019 (to M. B. R.), RR17261 (to M. B. R.). This work was also supported by a grant from the Alabama Drug Discovery Alliance (to M. B. R.) and Komen Foundation Grant BCTR 20000690 (to D. D. M.).	ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Atigadda VR, 2003, J MED CHEM, V46, P3766, DOI 10.1021/jm030095q; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bischoff ED, 1999, J NATL CANCER I, V91, P2118, DOI 10.1093/jnci/91.24.2118; Bischoff ED, 1998, CANCER RES, V58, P479; BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; DAWSON MI, 1995, J MED CHEM, V38, P3368, DOI 10.1021/jm00017a021; Duvic M, 2001, ARCH DERMATOL, V137, P581; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Egea PF, 2001, ACTA CRYSTALLOGR D, V57, P434, DOI 10.1107/S0907444901000385; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Ghosh JC, 2002, P NATL ACAD SCI USA, V99, P5842, DOI 10.1073/pnas.092043399; Gottardis MM, 1996, CANCER RES, V56, P5566; Grubbs CJ, 2006, CARCINOGENESIS, V27, P1232, DOI 10.1093/carcin/bgi308; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kang S, 2008, J MOL BIOL, V381, P772, DOI 10.1016/j.jmb.2008.03.004; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P14263, DOI 10.1021/bi00043a034; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P13717, DOI 10.1021/bi00042a001; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kolesar JM, 2010, CANCER PREV RES, V3, P1565, DOI 10.1158/1940-6207.CAPR-10-0149; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Lindeblad M, 2011, DRUG CHEM TOXICOL, V34, P300, DOI 10.3109/01480545.2010.536771; Lippert WP, 2009, CHEMMEDCHEM, V4, P1143, DOI 10.1002/cmdc.200900090; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Lu JY, 2006, BIOCHEMISTRY-US, V45, P1629, DOI 10.1021/bi051474j; Lubet RA, 2005, CARCINOGENESIS, V26, P441, DOI 10.1093/carcin/bgh338; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Muccio DD, 1998, J MED CHEM, V41, P1679, DOI 10.1021/jm970635h; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Santin EP, 2009, J MED CHEM, V52, P3150, DOI 10.1021/jm900096q; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rocha GM, 2001, P NATL ACAD SCI USA, V98, P5317, DOI 10.1073/pnas.091057698; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Vedell PT, 2013, MOL PHARMACOL, V83, P698, DOI 10.1124/mol.112.082404; Xia G, 2011, BIOCHEMISTRY-US, V50, P93, DOI 10.1021/bi101288y; Yan XG, 2004, BIOCHEMISTRY-US, V43, P909, DOI 10.1021/bi030183c; Yasmin R, 2010, J MOL BIOL, V397, P1121, DOI 10.1016/j.jmb.2010.02.030; Zhang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028253; Zhang HT, 2011, J BIOL CHEM, V286, P24593, DOI 10.1074/jbc.M111.245498; Zhang HT, 2011, J MOL BIOL, V407, P13, DOI 10.1016/j.jmb.2011.01.032; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031811	65	40	40	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					814	826		10.1074/jbc.M113.476861	http://dx.doi.org/10.1074/jbc.M113.476861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24187139	Green Published, hybrid			2022-12-25	WOS:000330541200019
J	Turpeinen, H; Oksanen, A; Kivinen, V; Kukkurainen, S; Uusimaki, A; Ramet, M; Parikka, M; Hytonen, VP; Nykter, M; Pesu, M				Turpeinen, Hannu; Oksanen, Anna; Kivinen, Virpi; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Nykter, Matti; Pesu, Marko			Proprotein Convertase Subtilisin/Kexin Type 7 (PCSK7) Is Essential for the Zebrafish Development and Bioavailability of Transforming Growth Factor beta 1a (TGF beta 1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Homology Modeling; Protease; Transforming Growth Factor (TGF); PC7; Otolith; PCSK7; Proprotein Convertase; Zebrafish	CRYSTAL-STRUCTURE; SITE-1 PROTEASE; FURIN; EXPRESSION; MICE; PC7; CLEAVAGE; CELLS; EMBRYOGENESIS; DISRUPTION	Background: The in vivo importance of PCSK7 in the vertebrates is currently poorly understood. Results: Inhibiting PCSK7 in zebrafish results in various developmental defects and dysregulation of gene expressions. Conclusion: PCSK7 is essential for zebrafish development and regulates the expression and proteolytic cleavage of TGF1a. Significance: PCSK inhibitors are considered future therapeutics for human diseases; understanding the biological role of PCSK7 is therefore critical. Proprotein convertase subtilisin/kexin (PCSK) enzymes convert proproteins into bioactive end products. Although other PCSK enzymes are known to be essential for biological processes ranging from cholesterol metabolism to host defense, the in vivo importance of the evolutionarily ancient PCSK7 has remained enigmatic. Here, we quantified the expressions of all pcsk genes during the 1st week of fish development and in several tissues. pcsk7 expression was ubiquitous and evident already during the early development. To compare mammalian and zebrafish PCSK7, we prepared homology models, which demonstrated remarkable structural conservation. When the PCSK7 function in developing larvae was inhibited, we found that PCSK7-deficient fish have defects in various organs, including the brain, eye, and otic vesicle, and these result in mortality within 7 days postfertilization. A genome-wide analysis of PCSK7-dependent gene expression showed that, in addition to developmental processes, several immune system-related pathways are also regulated by PCSK7. Specifically, the PCSK7 contributed to the mRNA expression and proteolytic cleavage of the cytokine TGF1a. Consequently, tgf1a morphant fish displayed phenotypical similarities with pcsk7 morphants, underscoring the importance of this cytokine in the zebrafish development. Targeting PCSK activity has emerged as a strategy for treating human diseases. Our results suggest that inhibiting PCSK7 might interfere with normal vertebrate development.	[Turpeinen, Hannu; Oksanen, Anna; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Pesu, Marko] Univ Tampere, Inst Biomed Technol, FI-33520 Tampere, Finland; [Turpeinen, Hannu; Oksanen, Anna; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Pesu, Marko] BioMediTech, Tampere 33520, Finland; [Kivinen, Virpi; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, Tampere 33720, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere 33521, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu 90029, Finland; [Ramet, Mika] Univ Oulu, Dept Pediat, Med Res Ctr, Oulu 90014, Finland; [Hytonen, Vesa P.; Pesu, Marko] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere 33520, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; Pirkanmaa Hospital District	Turpeinen, H (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FinnMedi 2,5th Fl,Biokatu 8, FI-33520 Tampere, Finland.	hannu.turpeinen@uta.fi	Hytonen, Vesa P./E-8855-2013; Pesu, Marko/L-6344-2013; Parikka, Mataleena/D-4364-2014	Hytonen, Vesa P./0000-0002-9357-1480; Pesu, Marko/0000-0002-7541-3921; Parikka, Mataleena/0000-0001-5555-3815; Nykter, Matti/0000-0001-6956-2843; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [128623, 135980, 121003, 140978, 132877]; European Community; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Tampere Graduate Program in Biomedicine and Biotechnology; Finnish Cultural Foundation; Finnish Foundation for Technology Promotion; Laboratoriolaaketieteen edistamissaatio; Tampere University Hospital [9M080, 9N056]	Academy of Finland(Academy of Finland); European Community(European Commission); Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Tampere Graduate Program in Biomedicine and Biotechnology; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Technology Promotion; Laboratoriolaaketieteen edistamissaatio; Tampere University Hospital	This work was supported by Academy of Finland Projects 128623, 135980 (to M. Pesu), 121003 (to M. Parikka), 140978 (to V. H.), and 132877 (to M. N.); a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (to M. Pesu); the Emil Aaltonen Foundation (to M. Pesu); the Sigrid Juselius Foundation (to M. Pesu); the Tampere Tuberculosis Foundation (to M. Pesu); the Tampere Graduate Program in Biomedicine and Biotechnology (to A. O. and S. K.); the Finnish Cultural Foundation (to A. O. and V. K.); the Finnish Foundation for Technology Promotion (to V. K.); Laboratoriolaaketieteen edistamissaatio (to A. O.); and Competitive Research Funding of the Tampere University Hospital Grants 9M080 and 9N056 (to M. Pesu).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Chitramuthu BP, 2011, METHODS MOL BIOL, V768, P273, DOI 10.1007/978-1-61779-204-5_15; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, GENE DEV, V14, P1146; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Gagnon J, 2011, LIFE SCI, V88, P212, DOI 10.1016/j.lfs.2010.11.010; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Mbikay M, 2010, FEBS LETT, V584, P701, DOI 10.1016/j.febslet.2009.12.018; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Senturker S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039380; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Stawowy P, 2001, J HISTOCHEM CYTOCHEM, V49, P323, DOI 10.1177/002215540104900306; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Turpeinen H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-618; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Wheatley JL, 2007, P NATL ACAD SCI USA, V104, P6626, DOI 10.1073/pnas.0701983104; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; Zhu XR, 1998, J BIOL CHEM, V273, P1158, DOI 10.1074/jbc.273.2.1158	59	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36610	36623		10.1074/jbc.M113.453183	http://dx.doi.org/10.1074/jbc.M113.453183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178295	Green Published, hybrid			2022-12-25	WOS:000328883400041
J	Danopoulos, S; Parsa, S; Al Alam, D; Tabatabai, R; Baptista, S; Tiozzo, C; Carraro, G; Wheeler, M; Barreto, G; Braun, T; Li, XK; Hajihosseini, MK; Bellusci, S				Danopoulos, Soula; Parsa, Sara; Al Alam, Denise; Tabatabai, Reza; Baptista, Sheryl; Tiozzo, Caterina; Carraro, Gianni; Wheeler, Matthew; Barreto, Guillermo; Braun, Thomas; Li, Xiaokun; Hajihosseini, Mohammad K.; Bellusci, Saverio			Transient Inhibition of FGFR2b-Ligands Signaling Leads to Irreversible Loss of Cellular beta-Catenin Organization and Signaling in AER during Mouse Limb Development	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; MAMMARY-GLAND; MAINTENANCE; EXPRESSION; ORGANOGENESIS; MISEXPRESSION; INDUCTION; INTEGRINS; ROLES; FGF10	The vertebrate limbs develop through coordinated series of inductive, growth and patterning events. Fibroblast Growth Factor receptor 2b (FGFR2b) signaling controls the induction of the Apical Ectodermal Ridge (AER) but its putative roles in limb outgrowth and patterning, as well as in AER morphology and cell behavior have remained unclear. We have investigated these roles through graded and reversible expression of soluble dominant-negative FGFR2b molecules at various times during mouse limb development, using a doxycycline/transactivator/tet(O)-responsive system. Transient attenuation (<= 24 hours) of FGFR2b-ligands signaling at E8.5, prior to limb bud induction, leads mostly to the loss or truncation of proximal skeletal elements with less severe impact on distal elements. Attenuation from E9.5 onwards, however, has an irreversible effect on the stability of the AER, resulting in a progressive loss of distal limb skeletal elements. The primary consequences of FGFR2b-ligands attenuation is a transient loss of cell adhesion and down-regulation of P63, beta 1-integrin and E-cadherin, and a permanent loss of cellular beta-catenin organization and WNT signaling within the AER. Combined, these effects lead to the progressive transformation of the AER cells from pluristratified to squamous epithelial-like cells within 24 hours of doxycycline administration. These findings show that FGFR2b-ligands signaling has critical stage-specific roles in maintaining the AER during limb development.	[Danopoulos, Soula; Parsa, Sara; Baptista, Sheryl; Bellusci, Saverio] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Danopoulos, Soula; Parsa, Sara; Al Alam, Denise; Tabatabai, Reza; Tiozzo, Caterina; Bellusci, Saverio] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Parsa, Sara] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tiozzo, Caterina] Nassau Univ, Med Ctr, Dept Pediat, New York, NY USA; [Carraro, Gianni; Bellusci, Saverio] Univ Giessen, Lung Ctr, Dept Internal Med 2, D-35390 Giessen, Germany; [Wheeler, Matthew; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany; [Barreto, Guillermo] Max Planck Inst Heart & Lung Res, LOEWE Res Grp Lung Canc Epigenet, Bad Nauheim, Germany; [Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Southern California; Children's Hospital Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Justus Liebig University Giessen; Max Planck Society; Max Planck Society; Wenzhou Medical University; University of East Anglia	Bellusci, S (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	sbellusci@chla.usc.edu	Braun, Thomas/B-2310-2008; Barreto, Guillermo/U-5718-2017; Alam, Denise Al/AAG-9406-2019; tiozzo, caterina/AAD-1170-2022	Barreto, Guillermo/0000-0002-7777-4712; Tiozzo, Caterina/0000-0001-8317-7183; Carraro, Gianni/0000-0003-0824-7692; Baptista, Sheryl/0000-0002-0687-4089; Braun, Thomas/0000-0002-6165-4804	American Lung Association; NIH [HL086322, HD052609, HL074832]; DFG, LOEWE initiative; Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany	American Lung Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG, LOEWE initiative; Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany	D.A.A. acknowledges the support of the American Lung Association. S. B. acknowledges support from NIH (HL086322, HD052609 and HL074832) and DFG, LOEWE initiative as well as the Excellence Cluster in Cardio-Pulmonary system, Giessen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Altabef M, 1997, DEVELOPMENT, V124, P4547; Altabef M, 2000, DEV BIOL, V222, P307, DOI 10.1006/dbio.2000.9659; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Furniss D, 2009, J MED GENET, V46, P730, DOI 10.1136/jmg.2009.066027; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Satoh A, 2010, DEV BIOL, V342, P157, DOI 10.1016/j.ydbio.2010.03.018; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yu K, 2008, DEVELOPMENT, V135, P483, DOI 10.1242/dev.013268	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76248	10.1371/journal.pone.0076248	http://dx.doi.org/10.1371/journal.pone.0076248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167544	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500003
J	Giugno, R; Bonnici, V; Bombieri, N; Pulvirenti, A; Ferro, A; Shasha, D				Giugno, Rosalba; Bonnici, Vincenzo; Bombieri, Nicola; Pulvirenti, Alfredo; Ferro, Alfredo; Shasha, Dennis			GRAPES: A Software for Parallel Searching on Biological Graphs Targeting Multi-Core Architectures	PLOS ONE			English	Article							TOOL	Biological applications, from genomics to ecology, deal with graphs that represents the structure of interactions. Analyzing such data requires searching for subgraphs in collections of graphs. This task is computationally expensive. Even though multicore architectures, from commodity computers to more advanced symmetric multiprocessing (SMP), offer scalable computing power, currently published software implementations for indexing and graph matching are fundamentally sequential. As a consequence, such software implementations (i) do not fully exploit available parallel computing power and (ii) they do not scale with respect to the size of graphs in the database. We present GRAPES, software for parallel searching on databases of large biological graphs. GRAPES implements a parallel version of well-established graph searching algorithms, and introduces new strategies which naturally lead to a faster parallel searching system especially for large graphs. GRAPES decomposes graphs into subcomponents that can be efficiently searched in parallel. We show the performance of GRAPES on representative biological datasets containing antiviral chemical compounds, DNA, RNA, proteins, protein contact maps and protein interactions networks.	[Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Bonnici, Vincenzo; Bombieri, Nicola] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy; [Shasha, Dennis] NYU, Courant Inst Math Sci, New York, NY USA	University of Catania; University of Verona; New York University	Giugno, R (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	giugno@dmi.unict.it	bonnici, vincenzo/AAY-7461-2020; Bombieri, Nicola/AAD-9726-2019; Pulvirenti, Alfredo/I-7272-2018	bonnici, vincenzo/0000-0002-1637-7545; Pulvirenti, Alfredo/0000-0002-9764-0295; Giugno, Rosalba/0000-0001-9843-7638; Bombieri, Nicola/0000-0003-3256-5885	U.S. National Science Foundation [0922738, 0929338, 1158273]; National Institutes of Health [GM32877-21/22, 2R01GM032877-25A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032877] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DS's work was partly supported by U.S. National Science Foundation grants 0922738, 0929338, 1158273 and National Institutes of Health grants GM32877-21/22 and 2R01GM032877-25A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banks E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r138; Bonnici V, 2010, LECT N BIOINFORMAT, V6282, P195, DOI 10.1007/978-3-642-16001-1_17; Cheng J., 2007, SIGMOD, P857, DOI DOI 10.1145/1247480.1247574; Cohen E, 2001, IEEE T KNOWL DATA EN, V13, P64, DOI 10.1109/69.908981; Cordella LP, 2004, IEEE T PATTERN ANAL, V26, P1367, DOI 10.1109/TPAMI.2004.75; Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137; Di Natale R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-96; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; Ferro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S10; He H., 2006, ICDE, P38; He YN, 2002, P NATL ACAD SCI USA, V99, P10325, DOI 10.1073/pnas.152161599; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Klein K, 2011, PROC INT CONF DATA, P1115, DOI 10.1109/ICDE.2011.5767909; Lacroix V, 2006, IEEE ACM T COMPUT BI, V3, P360, DOI 10.1109/TCBB.2006.55; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Messmer BT, 1995, LECT NOTES COMPUTER, V1035, P373; Rajapakse HA, 2007, CURR TOP MED CHEM, V7, P966, DOI 10.2174/156802607780906816; Shasha D., 2002, PODS, P39, DOI DOI 10.1145/543613.543620; Ullmann JR, 2011, J EXPT ALGORITHMICS, V15; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Williams DW, 2007, ICDE, P976; Yan X., 2004, PROC ACM SIGMOD INT, P335, DOI DOI 10.1145/1007568.1007607; Zhang C, 2012, BIOINFORMATICS, V28, P1943, DOI 10.1093/bioinformatics/bts278; Zhang S, 2007, P IEEE 23 INT C DAT, P181; Zhao P, 2007, VLDB, P938; Zou L., 2008, P 11 INT C EXTENDING, P181	28	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e76911	10.1371/journal.pone.0076911	http://dx.doi.org/10.1371/journal.pone.0076911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167551	Green Submitted, Green Published, gold			2022-12-25	WOS:000326034500010
J	Redeker, C; Schuster-Gossler, K; Kremmer, E; Gossler, A				Redeker, Christian; Schuster-Gossler, Karin; Kremmer, Elisabeth; Gossler, Achim			Normal Development in Mice Over-Expressing the Intracellular Domain of DLL1 Argues against Reverse Signaling by DLL1 In Vivo	PLOS ONE			English	Article							NOTCH LIGAND DELTA1; NUCLEOTIDE-SEQUENCE; DROSOPHILA-MELANOGASTER; TRANSMEMBRANE PROTEIN; PROGENITOR CELLS; GENE-EXPRESSION; LEXA GENE; MOUSE; PROTEOLYSIS; ACTIVATION	The Notch signaling pathway mediates the direct communication between adjacent cells and regulates multiple developmental processes. Interaction of the Notch receptor with its ligands induces the liberation of the intracellular portion of Notch (NICD) referred to as regulated intramembraneous proteolysis (RIP). NICD translocates to the nucleus, and by complexing with the DNA binding protein RBPj kappa and other cofactors activates transcription of bHLH genes. RIP-like processing of various mammalian Notch ligands (DLL1, JAG1 and JAG2) and the translocation of their intracellular domains (ICDs) to the nucleus has also been observed. These observations together with effects of over-expressed ligand ICDs in cultured cells on cell proliferation, differentiation, and Notch activity and target gene expression have led to the idea that the intracellular domains of Notch ligands have signaling functions. To test this hypothesis in vivo we have generated ES cells and transgenic mice that constitutively express various versions of the intracellular domain of mouse DLL1. In contrast to other cell lines, expression of DICDs in ES cells did not block proliferation or stimulate neuronal differentiation. Embryos with ubiquitous DICD expression developed to term without any apparent phenotype and grew up to viable and fertile adults. Early Notch-dependent processes or expression of selected Notch target genes were unaltered in transgenic embryos. In addition, we show that mouse DICD enters the nucleus inefficiently. Collectively, our results argue against a signaling activity of the intracellular domain of DLL1 in mouse embryos in vivo.	[Redeker, Christian; Schuster-Gossler, Karin; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany; [Kremmer, Elisabeth] Forschungszentrum Umwelt & Gesundheit GmbH, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gossler, A (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, D-30623 Hannover, Germany.	gossler.achim@mh-hannover.de			DFG (Deutsche Forschungsgemeinschaft) [GO449/10]; Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"; DFG-Project "Open Access Publishing" by the German Research Foundation	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"; DFG-Project "Open Access Publishing" by the German Research Foundation(German Research Foundation (DFG))	This work was supported by DFG (Deutsche Forschungsgemeinschaft) grant GO449/10 to AG, and by funding of the Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy". The article processing charge was funded by means of the DFG-Project "Open Access Publishing" by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047785; Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; EBINA Y, 1983, J BIOL CHEM, V258, P3258; Feller J, 2008, GENE DEV, V22, P2166, DOI 10.1101/gad.480408; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Gravano DM, 2010, IMMUNOL CELL BIOL, V88, P746, DOI 10.1038/icb.2010.30; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HORII T, 1981, CELL, V23, P689, DOI 10.1016/0092-8674(81)90432-3; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jung J, 2011, MOL CELLS, V32, P161, DOI 10.1007/s10059-011-1046-y; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kiyota T, 2004, MECH DEVELOP, V121, P573, DOI 10.1016/j.mod.2004.03.034; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Liebler SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053074; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MIKI T, 1981, NUCLEIC ACIDS RES, V9, P529, DOI 10.1093/nar/9.3.529; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Ramos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015515; Rocha SF, 2009, DEV BIOL, V328, P54, DOI 10.1016/j.ydbio.2009.01.011; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019	55	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e79050	10.1371/journal.pone.0079050	http://dx.doi.org/10.1371/journal.pone.0079050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24167636	Green Submitted, gold, Green Published			2022-12-25	WOS:000326034500097
J	Rundle, CH; Mohan, S; Edderkaoui, B				Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra			Duffy Antigen Receptor for Chemokines Regulates Post-Fracture Inflammation	PLOS ONE			English	Article							C-C CHEMOKINES; ENDOTHELIAL-CELLS; MESSENGER-RNA; GROWTH-FACTOR; MICE LACKING; LUNG INJURY; EXPRESSION; BONE; GENE; DARC	There is now considerable experimental data to suggest that inflammatory cells collaborate in the healing of skeletal fractures. In terms of mechanisms that contribute to the recruitment of inflammatory cells to the fracture site, chemokines and their receptors have received considerable attention. Our previous findings have shown that Duffy antigen receptor for chemokines (Darc), the non-classical chemokine receptor that does not signal, but rather acts as a scavenger of chemokines that regulate cell migration, is a negative regulator of peak bone density in mice. Furthermore, because Darc is expressed by inflammatory and endothelial cells, we hypothesized that disruption of Darc action will affect post-fracture inflammation and consequently will affect fracture healing. To test this hypothesis, we evaluated fracture healing in mice with targeted disruption of Darc and corresponding wild type (WT) control mice. We found that fracture callus cartilage formation was significantly greater (33%) at 7 days post-surgery in Darc-KO compared to WT mice. The increased cartilage was associated with greater Collagen (Col) II expression at 3 days post-fracture and Col-X at 7 days post-fracture compared to WT mice, suggesting that Darc deficiency led to early fracture cartilage formation and differentiation. We then compared the expression of cytokine and chemokine genes known to be induced during inflammation. Interleukin (Il)-1 beta, Il-6, and monocyte chemotactic protein 1 were all down regulated in the fractures derived from Darc-KO mice at one day post-fracture, consistent with an altered inflammatory response. Furthermore, the number of macrophages was significantly reduced around the fractures in Darc-KO compared to WT mice. Based on these data, we concluded that Darc plays a role in modulating the early inflammatory response to bone fracture and subsequent cartilage formation. However, the early cartilage formation was not translated with an early bone formation at the fracture site in Darc-KO compared to WT mice.	[Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra] Jerry L Pettis Mem Vet Adm Med Ctr, Res Serv, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA; [Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Edderkaoui, B (corresponding author), Jerry L Pettis Mem Vet Adm Med Ctr, Res Serv, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA.	Bouchra.Edderkaoui@va.gov			USAMRMC ORTHOPAEDIC RESEARCH PROGRAM [W81XWH-10-1-0952]	USAMRMC ORTHOPAEDIC RESEARCH PROGRAM	The project described was supported by USAMRMC ORTHOPAEDIC RESEARCH PROGRAM (http://mrmc-rad6.army.mil/). Grant/Contract/MIPR No.: W81XWH-10-1-0952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bancroft JD, 2002, ENZYME HISTOCHEMISTR; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; CHAUDHURI A, 1989, J BIOL CHEM, V264, P13770; Chaudhuri A, 2003, CYTOKINE, V21, P137, DOI 10.1016/S1043-4666(03)00033-4; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Chung R, 2006, J LEUKOCYTE BIOL, V80, P1272, DOI 10.1189/jlb.0606365; CRUESS RL, 1975, CAN J SURG, V18, P403; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; Edderkaoui B, 2007, GENOME RES, V17, P577, DOI 10.1101/gr.6009507; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Frost A, 1997, ACTA ORTHOP SCAND, V68, P91, DOI 10.3109/17453679709003987; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Goldring MB, 1992, DEGRADATION ARTICULA; Harrison SL, 2011, J ORTHOP RES, V29, P1361, DOI 10.1002/jor.21321; Hierl T, 1998, EXP CLIN ENDOCR DIAB, V106, P324, DOI 10.1055/s-0029-1211993; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Iwamoto S, 1996, BLOOD, V87, P378; Johnson CS, 2000, BONE, V26, P461, DOI 10.1016/S8756-3282(00)00244-1; Jung YS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.48; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; LINKHART TA, 1991, J BONE MINER RES, V6, P1285; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; MCGRATH MH, 1985, ANN PLAS SURG, V15, P105, DOI 10.1097/00000637-198508000-00004; Morioka M, 2000, BIOCHEM BIOPH RES CO, V268, P60, DOI 10.1006/bbrc.1999.2063; Mumme M, 2012, EUR CELLS MATER, V24, P224, DOI 10.22203/eCM.v024a16; Olmedo ML, 1999, J ORTHOP TRAUMA, V13, P356, DOI 10.1097/00005131-199906000-00006; Olmedo ML, 2000, CELL MOL BIOL, V46, P89; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; RICKARD DJ, 1993, CALCIFIED TISSUE INT, V52, P227, DOI 10.1007/BF00298724; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; SIMMONS DJ, 1985, CLIN ORTHOP RELAT R, P100; Studer RK, 2004, ARTHRITIS RES THER, V6, pR56, DOI 10.1186/ar1022; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; Vielhauer V, 2009, AM J PATHOL, V175, P119, DOI 10.2353/ajpath.2009.080590; Walsh M, 2010, J BONE JOINT SURG AM, V92A, P1082, DOI 10.2106/JBJS.H.01329; Westacott CI, 1996, SEMIN ARTHRITIS RHEU, V25, P254, DOI 10.1016/S0049-0172(96)80036-9; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yuan GH, 2001, DRUG NEWS PERSPECT, V14, P591; Yuan GH, 2001, ARTHRITIS RHEUM-US, V44, P1056, DOI 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.0.CO;2-U; Zarbock A, 2010, AM J PHYSIOL-LUNG C, V298, pL462, DOI 10.1152/ajplung.00224.2009	53	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77362	10.1371/journal.pone.0077362	http://dx.doi.org/10.1371/journal.pone.0077362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146983	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200034
J	Shrivastava, P; Bagchi, T				Shrivastava, Parul; Bagchi, Tamishraha			IL-10 Modulates In Vitro Multinucleate Giant Cell Formation in Human Tuberculosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; PULMONARY TUBERCULOSIS; GRANULOMA-FORMATION; INTERFERON-GAMMA; IFN-GAMMA; INFECTION; LUNG; BETA	Background: Multinucleated giant cells (MGC) are the histologic hallmark of granuloma which is known to limit tuberculosis infection. Both Th1 and Th2 type of cytokines regulate the immune response occurring within the granulomas. The objective of the study was to determine whether tuberculosis patient monocytes differed in their MGC forming ability as compared to healthy controls. Methods: In vitro MGC formation was carried out by treatment of monocytes with cytokine containing culture supernatant of ConA or PPD stimulated peripheral mononuclear cells. IL-2, TNF-alpha, IL-4, IL-10 and TGF-beta cytokine levels were analysed in culture supernatants using ELISA. IL-4 and IL-10 were added to culture supernatant separately and simultaneously along with their respective neutralizing antibodies and their consequent effect on MGC formation was evaluated. Results : MGC formation was significantly low in patient monocytes incubated with autologous culture supernatant as compared to control culture supernatant. Cytokine analysis of the culture supernatants revealed that while IL-4 levels were similar in patients and controls, increased IL-10 levels were found in patients. Exogenous addition of IL-10 resulted in reduced MGC formation. Contrastingly, when IL-4 was added exogenously, it led to increased MGC formation. The effects of both IL-10 and IL-4 were reversed upon addition of their respective antibodies. Conclusion: The findings suggest that one of the factors contributing to the disease could be the effect of cytokines on the functionality of monocytes, which are crucial in the fight against the organism. Significantly reduced MGC formation was observed on addition of IL-10. The findings imply an overriding role of IL-10 in MGC formation. The suppressive effect of IL-10 on MGC formation was further confirmed by addition of IL-10 neutralizing antibody.	[Bagchi, Tamishraha] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India; Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Bagchi, T (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India.	mailforbagchi@yahoo.com			University Grants Commission (Government of India); UGC-DRS programme	University Grants Commission (Government of India)(University Grants Commission, India); UGC-DRS programme	The authors would like to thank the University Grants Commission (Government of India) for the award of Research Fellowships in Sciences for Meritorious Students to P. S. and for research funds under the UGC-DRS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2004, INFECT IMMUN, V72, P1358, DOI 10.1128/IAI.72.3.1358-1363.2004; Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Aung H, 2000, TUBERCLE LUNG DIS, V80, P61, DOI 10.1054/tuld.2000.0235; Binder F, 2013, MOL IMMUNOL, V54, P157, DOI 10.1016/j.molimm.2012.12.004; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; de Waal Malefyt R, 2013, J IMMUNOL, V190, P2778, DOI [10.4049/jimmunol.1202722, DOI 10.4049/JIMMUN0L.1202722.PUBMED:23396944]; Ehlers S, 2005, CLIN INFECT DIS, V41, pS199, DOI 10.1086/429998; Ehlers S, 2010, CELL HOST MICROBE, V7, P6, DOI 10.1016/j.chom.2009.12.010; Gasser A, 1999, INFECT IMMUN, V67, P395, DOI 10.1128/IAI.67.1.395-402.1999; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Ohtsuka K, 1998, J IMMUNOL, V160, P2539; Pereira CB, 2004, MICROBES INFECT, V6, P25, DOI 10.1016/j.micinf.2003.10.007; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Shaler CR, 2011, AM J PATHOL, V178, P1622, DOI 10.1016/j.ajpath.2010.12.022; TAKASHIMA T, 1993, J IMMUNOL, V150, P3002; TOOSSI Z, 1995, INFECT IMMUN, V63, P224, DOI 10.1128/IAI.63.1.224-228.1995; Vernal Rolando, 2008, Infectious Disorders - Drug Targets, V8, P207; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	28	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77680	10.1371/journal.pone.0077680	http://dx.doi.org/10.1371/journal.pone.0077680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147054	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200064
J	Goyal, RK; Hancock, REW; Mattoo, AK; Misra, S				Goyal, Ravinder K.; Hancock, Robert E. W.; Mattoo, Autar K.; Misra, Santosh			Expression of an Engineered Heterologous Antimicrobial Peptide in Potato Alters Plant Development and Mitigates Normal Abiotic and Biotic Responses	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SIGNALING PATHWAYS; PRIMARY METABOLISM; DEFENSE RESPONSES; CATIONIC PEPTIDE; GENE-EXPRESSION; BROAD-SPECTRUM	Antimicrobial cationic peptides (AMPs) are ubiquitous small proteins used by living cells to defend against a wide spectrum of pathogens. Their amphipathic property helps their interaction with negatively charged cellular membrane of the pathogen causing cell lysis and death. AMPs also modulate signaling pathway(s) and cellular processes in animal models; however, little is known of cellular processes other than the pathogen-lysis phenomenon modulated by AMPs in plants. An engineered heterologous AMP, msrA3, expressed in potato was previously shown to cause resistance of the transgenic plants against selected fungal and bacterial pathogens. These lines together with the wild type were studied for growth habits, and for inducible defense responses during challenge with biotic (necrotroph Fusarium solani) and abiotic stressors (dark-induced senescence, wounding and temperature stress). msrA3-expression not only conferred protection against F. solani but also delayed development of floral buds and prolonged vegetative phase. Analysis of select gene transcript profiles showed that the transgenic potato plants were suppressed in the hypersensitive (HR) and reactive oxygen species (ROS) responses to both biotic and abiotic stressors. Also, the transgenic leaves accumulated lesser amounts of the defense hormone jasmonic acid upon wounding with only a slight change in salicylic acid as compared to the wild type. Thus, normal host defense responses to the pathogen and abiotic stressors were mitigated by msrA3 expression suggesting MSRA3 regulates a common step(s) of these response pathways. The stemming of the pathogen growth and mitigating stress response pathways likely contributes to resource reallocation for higher tuber yield.	[Goyal, Ravinder K.; Misra, Santosh] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Mattoo, Autar K.] ARS, Henry A Wallace Beltsville Agr Res Ctr, USDA, Sustainable Agr Syst Lab, Beltsville, MD USA	University of Victoria; University of British Columbia; United States Department of Agriculture (USDA)	Mattoo, AK (corresponding author), ARS, Henry A Wallace Beltsville Agr Res Ctr, USDA, Sustainable Agr Syst Lab, Beltsville, MD USA.	autar.mattoo@ars.usda.gov	Hancock, Robert E. W./E-1145-2013; Mattoo, Autar/U-9751-2019	Hancock, Robert E. W./0000-0001-5989-8503; Mattoo, Autar/0000-0001-9226-7164	NCE-AFMNet, Canada	NCE-AFMNet, Canada	This study was funded by the NCE-AFMNet, Canada grant (to S.M.). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman T, 2012, MOL PLANT MICROBE IN, V25, P1584, DOI 10.1094/MPMI-07-12-0187-R; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alkan N, 2012, MOL PLANT MICROBE IN, V25, P85, DOI 10.1094/MPMI-01-11-0020; Almasia NI, 2008, MOL PLANT PATHOL, V9, P329, DOI 10.1111/J.1364-3703.2008.00469.X; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bellincampi D, 2000, PLANT PHYSIOL, V122, P1379, DOI 10.1104/pp.122.4.1379; Bernards MA, 1999, PLANT PHYSIOL, V121, P135, DOI 10.1104/pp.121.1.135; Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; D'Ippolito S, 2010, PHYSIOL MOL PLANT P, V75, P3, DOI 10.1016/j.pmpp.2010.09.002; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Fatima T, 2012, FUNCT PLANT BIOL, V39, P246, DOI 10.1071/FP11240; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Garcia-Olmedo F, 2001, FEBS LETT, V498, P219, DOI 10.1016/S0014-5793(01)02456-5; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; GRAHAM TL, 1977, APPL ENVIRON MICROB, V34, P424, DOI 10.1128/AEM.34.4.424-432.1977; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Horvath DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042036; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Hyodo H., 1991, PLANT HORMONE ETHYLE; Jansky S., 2000, Plant Breeding Reviews, V19, P69; Jones RW, 2005, GEN IMPROV SOLAN CRO, V1, P397; Kausch KD, 2012, AMINO ACIDS, V42, P843, DOI 10.1007/s00726-011-1000-5; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Knorzer OC, 1996, PHYSIOL PLANTARUM, V97, P388, DOI 10.1034/j.1399-3054.1996.970225.x; Kumar V, 2004, P NATL ACAD SCI USA, V101, P10535, DOI 10.1073/pnas.0403496101; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Martinez C, 1998, MOL PLANT MICROBE IN, V11, P1038, DOI 10.1094/MPMI.1998.11.11.1038; MEHTA RA, 1992, J BIOL CHEM, V267, P2810; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murphy AS, 1999, PLANT PHYSIOL, V121, P1375, DOI 10.1104/pp.121.4.1375; Nahirnak V, 2012, PLANT PHYSIOL, V158, P252, DOI 10.1104/pp.111.186544; Nambeesan S, 2012, PLANT PHYSIOL, V158, P1034, DOI 10.1104/pp.111.188698; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Osusky M, 2005, THEOR APPL GENET, V111, P711, DOI 10.1007/s00122-005-2056-y; Osusky M, 2004, TRANSGENIC RES, V13, P181, DOI 10.1023/B:TRAG.0000026076.72779.60; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pelegrini PB, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/250349; Ponti D, 2003, BIOCHEM J, V370, P121, DOI 10.1042/BJ20021444; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Razdan M.K., 2005, GENETIC IMPROVEMENT, V1; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robinson MW, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00325; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; ROSS H, 1986, ADV PLANT BREED S13; Royo J, 1996, J BIOL CHEM, V271, P21012, DOI 10.1074/jbc.271.35.21012; Scalschi L, 2013, MOL PLANT PATHOL, V14, P342, DOI 10.1111/mpp.12010; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Segura A, 1999, MOL PLANT MICROBE IN, V12, P16, DOI 10.1094/MPMI.1999.12.1.16; Sklensky DE, 2011, J EXP BOT, V62, P4323, DOI 10.1093/jxb/err148; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Suzuki Y, 2013, J EXP BOT, V64, P1145, DOI 10.1093/jxb/ers398; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; TENG PS, 1984, CRC CR REV PLANT SCI, V2, P21, DOI 10.1080/07352688409382187; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Ton J, 2002, MOL PLANT MICROBE IN, V15, P27, DOI 10.1094/MPMI.2002.15.1.27; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Vicente R., 2011, Agronomy Research, V9, P501; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zimnoch-Guzowska E, 2005, GEN IMPROV SOLAN CRO, V1, P339; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	113	26	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77505	10.1371/journal.pone.0077505	http://dx.doi.org/10.1371/journal.pone.0077505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147012	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400116
J	Wei, JS; Johansson, P; Chen, L; Song, YK; Tolman, C; Li, S; Hurd, L; Patidar, R; Wen, XY; Badgett, TC; Cheuk, ATC; Marshall, JC; Steeg, PS; Diez, JPV; Yu, YL; Gutkind, JS; Khan, J				Wei, Jun S.; Johansson, Peter; Chen, Li; Song, Young K.; Tolman, Catherine; Li, Samuel; Hurd, Laura; Patidar, Rajesh; Wen, Xinyu; Badgett, Thomas C.; Cheuk, Adam T. C.; Marshall, Jean-Claude; Steeg, Patricia S.; Diez, Jose P. Vaque; Yu, Yanlin; Gutkind, J. Silvio; Khan, Javed			Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID LPA; CELL MOTILITY; ALK KINASE; N-MYC; CANCER; EXPRESSION; TUMORS; GENE; DNA; TRANSCRIPTION	Neuroblastoma is one of the most genomically heterogeneous childhood malignances studied to date, and the molecular events that occur during the course of the disease are not fully understood. Genomic studies in neuroblastoma have showed only a few recurrent mutations and a low somatic mutation burden. However, none of these studies has examined the mutations arising during the course of disease, nor have they systemically examined the expression of mutant genes. Here we performed genomic analyses on tumors taken during a 3.5 years disease course from a neuroblastoma patient (bone marrow biopsy at diagnosis, adrenal primary tumor taken at surgical resection, and a liver metastasis at autopsy). Whole genome sequencing of the index liver metastasis identified 44 non-synonymous somatic mutations in 42 genes (0.85 mutation/MB) and a large hemizygous deletion in the ATRX gene which has been recently reported in neuroblastoma. Of these 45 somatic alterations, 15 were also detected in the primary tumor and bone marrow biopsy, while the other 30 were unique to the index tumor, indicating accumulation of de novo mutations during therapy. Furthermore, transcriptome sequencing on the 3 tumors demonstrated only 3 out of the 15 commonly mutated genes (LPAR1, GATA2, and NUFIP1) had high level of expression of the mutant alleles, suggesting potential oncogenic driver roles of these mutated genes. Among them, the druggable G-protein coupled receptor LPAR1 was highly expressed in all tumors. Cells expressing the LPAR1 R163W mutant demonstrated a significantly increased motility through elevated Rho signaling, but had no effect on growth. Therefore, this study highlights the need for multiple biopsies and sequencing during progression of a cancer and combinatorial DNA and RNA sequencing approach for systematic identification of expressed driver mutations.	[Wei, Jun S.; Johansson, Peter; Chen, Li; Song, Young K.; Tolman, Catherine; Li, Samuel; Hurd, Laura; Patidar, Rajesh; Wen, Xinyu; Badgett, Thomas C.; Cheuk, Adam T. C.; Khan, Javed] NCI, Oncogen Sect, Pediat Oncol Branch, Adv Technol Ctr, Bethesda, MD 20892 USA; [Wen, Xinyu] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21701 USA; [Marshall, Jean-Claude; Steeg, Patricia S.] NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Diez, Jose P. Vaque; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Cell Growth Regulat Sect, Bethesda, MD USA; [Yu, Yanlin] NCI, Canc Modeling Sect, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, JS (corresponding author), NCI, Oncogen Sect, Pediat Oncol Branch, Adv Technol Ctr, Bethesda, MD 20892 USA.	weij@mail.nih.gov; khanjav@mail.nih.gov	Leon, Javier/K-4615-2014; Gutkind, J. Silvio/J-1201-2016; Khan, Javed/P-9157-2014; Patidar, Rajesh/G-9389-2019; Johansson, Peter A/K-1053-2014; Patidar, Rajesh/M-5520-2019; Vaqué, José P/H-8413-2015	Gutkind, J. Silvio/0000-0002-5150-4482; Patidar, Rajesh/0000-0003-3578-8208; Johansson, Peter A/0000-0001-7015-5452; Patidar, Rajesh/0000-0003-3578-8208; Vaqué, José P/0000-0002-3913-2495	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011002, ZIABC010806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Berenjeno IM, 2007, ONCOGENE, V26, P4295, DOI 10.1038/sj.onc.1210194; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cabart P, 2004, ONCOGENE, V23, P5316, DOI 10.1038/sj.onc.1207684; Caselli R, 2007, J HUM GENET, V52, P535, DOI 10.1007/s10038-007-0151-4; Castel V, 2010, CLIN TRANSL ONCOL, V12, P49, DOI 10.1007/s12094-010-0466-z; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen QR, 2007, J MOL DIAGN, V9, P80, DOI 10.2353/jmoldx.2007.060111; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Deshpande GP, 2009, DNA REPAIR, V8, P672, DOI 10.1016/j.dnarep.2009.01.016; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Esiashvili N, 2007, PEDIATR BLOOD CANCER, V49, P41, DOI 10.1002/pbc.20859; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOODMAN M, 1999, CANC INCIDENCE SURVI, P1975; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitter D, 2011, EUR J HUM GENET, V19, P947, DOI 10.1038/ejhg.2011.58; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Obo Y, 2009, MUTAT RES-FUND MOL M, V660, P47, DOI 10.1016/j.mrfmmm.2008.10.005; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Podda MG, 2010, TUMORI, V96, P684, DOI 10.1177/030089161009600507; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shida D, 2003, CANCER RES, V63, P1706; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Willett RT, 2011, J NEUROSCI, V31, P4444, DOI 10.1523/JNEUROSCI.4616-10.2011; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yamada T, 2009, BIOCHEM BIOPH RES CO, V378, P424, DOI 10.1016/j.bbrc.2008.11.044; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	67	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77731	10.1371/journal.pone.0077731	http://dx.doi.org/10.1371/journal.pone.0077731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147068	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400129
J	Galletti, MFBM; Fujita, A; Nishiyama, MY; Malossi, CD; Pinter, A; Soares, JF; Daffre, S; Labruna, MB; Fogaca, AC				Galletti, Maria Fernanda B. M.; Fujita, Andre; Nishiyama, Milton Y., Jr.; Malossi, Camila D.; Pinter, Adriano; Soares, Joao F.; Daffre, Sirlei; Labruna, Marcelo B.; Fogaca, Andrea C.			Natural Blood Feeding and Temperature Shift Modulate the Global Transcriptional Profile of Rickettsia rickettsii Infecting Its Tick Vector	PLOS ONE			English	Article							BRAZILIAN SPOTTED-FEVER; AMBLYOMMA-AUREOLATUM; GENE-EXPRESSION; ANKYRIN REPEAT; PROTEIN; AMPLIFICATION; CAJENNENSE; EVOLUTION; BACTERIUM; INVASION	Rickettsia rickettsii is an obligate intracellular tick-borne bacterium that causes Rocky Mountain Spotted Fever (RMSF), the most lethal spotted fever rickettsiosis. When an infected starving tick begins blood feeding from a vertebrate host, R. rickettsii is exposed to a temperature elevation and to components in the blood meal. These two environmental stimuli have been previously associated with the reactivation of rickettsial virulence in ticks, but the factors responsible for this phenotype conversion have not been completely elucidated. Using customized oligonucleotide microarrays and high-throughput microfluidic qRT-PCR, we analyzed the effects of a 10 degrees C temperature elevation and of a blood meal on the transcriptional profile of R. rickettsii infecting the tick Amblyomma aureolatum. This is the first study of the transcriptome of a bacterium in the genus Rickettsia infecting a natural tick vector. Although both stimuli significantly increased bacterial load, blood feeding had a greater effect, modulating five-fold more genes than the temperature upshift. Certain components of the Type IV Secretion System (T4SS) were up-regulated by blood feeding. This suggests that this important bacterial transport system may be utilized to secrete effectors during the tick vector's blood meal. Blood feeding also up-regulated the expression of antioxidant enzymes, which might correspond to an attempt by R. rickettsii to protect itself against the deleterious effects of free radicals produced by fed ticks. The modulated genes identified in this study, including those encoding hypothetical proteins, require further functional analysis and may have potential as future targets for vaccine development.	[Galletti, Maria Fernanda B. M.; Malossi, Camila D.; Daffre, Sirlei; Fogaca, Andrea C.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Dept Ciencias Comp, Inst Matemat & Estatist, Sao Paulo, Brazil; [Nishiyama, Milton Y., Jr.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Pinter, Adriano] Superintendencia Controle Endemias SUCEN, Sao Paulo, Brazil; [Soares, Joao F.; Labruna, Marcelo B.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Fogaca, AC (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	deafog@usp.br	Daffre, Sirlei/M-4233-2013; Fogaca, Andrea/C-1322-2012; Nishiyama, Milton Y/H-4002-2013; Nishiyama, Milton/AAE-5736-2021; Labruna, Marcelo B/B-6241-2013; Galletti, Maria Fernanda BM/M-4738-2013; Pinter, Adriano/AAG-6459-2019; Fujita, Andre/Q-1271-2019; Fogaca, Andrea C/M-4267-2013; Pinter, Adriano/B-9827-2012	Daffre, Sirlei/0000-0002-9966-0433; Nishiyama, Milton Y/0000-0002-2410-0562; Nishiyama, Milton/0000-0002-2410-0562; Labruna, Marcelo B/0000-0002-9675-3132; Pinter, Adriano/0000-0003-4596-3268; Fujita, Andre/0000-0002-7756-7051; Pinter, Adriano/0000-0003-4596-3268; Dantas Malossi, Camila/0000-0002-3841-2479; Fogaca, Andrea/0000-0002-0890-6136	Sao Paulo Research Foundation (FAPESP) [2008/053570-0]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]	This work was supported by funds from the Sao Paulo Research Foundation (FAPESP; Grant 2008/053570-0), the Coordination for the Improvement of Higher Education Personnel (CAPES), and the National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Dzik JM, 2010, ACTA BIOCHIM POL, V57, P443; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; GILFORD JH, 1955, P NATL ACAD SCI USA, V41, P870, DOI 10.1073/pnas.41.11.870; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Guedes E, 2005, MEM I OSWALDO CRUZ, V100, P841, DOI 10.1590/S0074-02762005000800004; HAYES SF, 1982, INFECT IMMUN, V37, P779, DOI 10.1128/IAI.37.2.779-785.1982; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Kang Y, 2011, GENOME RES, V21, P925, DOI 10.1101/gr.116103.110; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Labruna MB, 2008, J MED ENTOMOL, V45, P1156, DOI 10.1603/0022-2585(2008)45[1156:CSOLSO]2.0.CO;2; Labruna MB, 2011, EMERG INFECT DIS, V17, P829, DOI 10.3201/eid1705.101524; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Lawson JN, 2006, DNA CELL BIOL, V25, P627, DOI 10.1089/dna.2006.25.627; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Policastro PF, 1997, J MED MICROBIOL, V46, P839, DOI 10.1099/00222615-46-10-839; Rahman MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003399; Rahman MS, 2005, MICROBIOL-SGM, V151, P589, DOI 10.1099/mic.0.27556-0; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rovery C, 2005, ANN NY ACAD SCI, V1063, P79, DOI 10.1196/annals.1355.011; Spencer RR, 1923, PUBLIC HEALTH REP, V38, P333, DOI 10.2307/4576667; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Uchiyama T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00230; Voth Daniel E, 2011, Cell Logist, V1, P128; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Walker DH, 2001, AM J TROP MED HYG, V65, P936, DOI 10.4269/ajtmh.2001.65.936; WINKLER HH, 1976, J BIOL CHEM, V251, P389	50	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77388	10.1371/journal.pone.0077388	http://dx.doi.org/10.1371/journal.pone.0077388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155949	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300083
J	Hibert, P; Prunier-Mirebeau, D; Beseme, O; Chwastyniak, M; Tamareille, S; Lamon, D; Furber, A; Pinet, F; Prunier, F				Hibert, Pierre; Prunier-Mirebeau, Delphine; Beseme, Olivia; Chwastyniak, Maggy; Tamareille, Sophie; Lamon, Delphine; Furber, Alain; Pinet, Florence; Prunier, Fabrice			Apolipoprotein A-I Is a Potential Mediator of Remote Ischemic Preconditioning	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; 1ST MYOCARDIAL-INFARCTION; HIGH-DENSITY-LIPOPROTEINS; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; ADENOSINE RECEPTORS; RENAL ISCHEMIA; RAT-HEART; PROTECTS; OCCLUSION	Background: Remote ischemic preconditioning (RIPC) has emerged as an attractive strategy in clinical settings. Despite convincing evidence of the critical role played by circulating humoral mediators, their actual identities remain unknown. In this study, we aimed to identify RIPC-induced humoral mediators using a proteomic approach. Methods: and Results Rats were exposed to 10-min limb ischemia followed by 5-(RIPC 5') or 10-min (RIPC 10') reperfusion prior to blood sampling. The control group only underwent blood sampling. Plasma samples were analyzed using surface-enhanced laser desorption and ionization - time of flight - mass spectrometry (SELDI-TOF-MS). Three protein peaks were selected for their significant increase in RIPC 10'. They were identified and confirmed as apolipoprotein A-I (ApoA-I). Additional rats were exposed to myocardial ischemia-reperfusion (I/R) and assigned to one of the following groups RIPC+myocardial infarction (MI) (10-min limb ischemia followed by 10-min reperfusion initiated 20 minutes prior to myocardial I/R), ApoA-I+MI (10 mg/kg ApoA-I injection 10 minutes before myocardial I/R), and MI (no further intervention). In comparison with untreated MI rats, RIPC reduced infarct size (52.2 +/- 3.7% in RIPC+MI vs. 64.9 +/- 2.6% in MI; p<0.05). Similarly, ApoA-I injection decreased infarct size (50.9 +/- 3.8%; p<0.05 vs. MI). Conclusions: RIPC was associated with a plasmatic increase in ApoA-I. Furthermore, ApoA-I injection before myocardial I/R recapitulated the cardioprotection offered by RIPC in rats. This data suggests that ApoA-I may be a protective blood-borne factor involved in the RIPC mechanism.	[Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France; [Hibert, Pierre; Tamareille, Sophie; Lamon, Delphine; Furber, Alain; Prunier, Fabrice] Univ Angers, Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Prunier-Mirebeau, Delphine] Univ Angers, CHU Angers, Dept Biochim & Genet, CNRS,INSERM,U771,UMR 6214, Angers, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Univ Lille Nord France, IFR142, Lille, France; [Furber, Alain; Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France; [Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Lille - ISITE; CHU Lille	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	faprunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; Prunier, Delphine/K-3301-2015; Tamareille, Sophie/K-1770-2015; Pinet, Florence/F-2892-2013	Tamareille, Sophie/0000-0001-8563-6558; Pinet, Florence/0000-0002-5471-1487	Servier and Conseil General du Maine et Loire; ANR [ANR-11-EMMA-029-01]; Fondation Coeur Recherche	Servier and Conseil General du Maine et Loire(Region Pays de la Loire); ANR(French National Research Agency (ANR)); Fondation Coeur Recherche	Delphine Lamon and Pierre Hibert were supported by fellowships from Servier and Conseil General du Maine et Loire, respectively. This work was supported in part by grants from ANR (ANR-11-EMMA-029-01) and the Fondation Coeur & Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Beseme O, 2010, ELECTROPHORESIS, V31, P2697, DOI 10.1002/elps.201000188; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Dickson EW, 1999, J THROMB THROMBOLYS, V8, P123, DOI 10.1023/A:1008911101951; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Diwan V, 2008, J CARDIOVASC PHARM, V51, P126, DOI 10.1097/FJC.0b013e31815d88c9; Dubois E, 2011, PROTEOM CLIN APPL, V5, P57, DOI 10.1002/prca.201000056; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Ghanbari-Niaki A, 2007, BIOCHEM BIOPH RES CO, V361, P841, DOI 10.1016/j.bbrc.2007.07.100; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gu SS, 2007, LIFE SCI, V81, P702, DOI 10.1016/j.lfs.2007.06.021; Hajrasouliha AR, 2008, EUR J PHARMACOL, V579, P246, DOI 10.1016/j.ejphar.2007.09.034; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Khabazian BM, 2009, EUR J APPL PHYSIOL, V107, P351, DOI 10.1007/s00421-009-1133-3; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OXMAN T, 1997, AM J PHYSIOL-HEART C, V273, pH1707; Pell TJ, 1998, AM J PHYSIOL-HEART C, V275, pH1542, DOI 10.1152/ajpheart.1998.275.5.H1542; Peralta C, 2001, HEPATOLOGY, V33, P100, DOI 10.1053/jhep.2001.20529; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Puppione DL, 2009, COMP BIOCHEM PHYS D, V4, P305, DOI 10.1016/j.cbd.2009.09.001; Rossoni G, 2004, J PHARMACOL EXP THER, V308, P79, DOI 10.1124/jpet.103.057141; Shi N, 2008, J BIOMED SCI, V15, P577, DOI 10.1007/s11373-008-9258-7; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Weinbrenner C, 2004, CARDIOVASC RES, V61, P591, DOI 10.1016/j.cardiores.2003.10.008; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Xiao L, 2001, EUR J PHARMACOL, V427, P131, DOI 10.1016/S0014-2999(01)01231-6	50	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77211	10.1371/journal.pone.0077211	http://dx.doi.org/10.1371/journal.pone.0077211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155931	Green Published, gold			2022-12-25	WOS:000325887300065
J	Lin, SF; Lin, JD; Chou, TC; Huang, YY; Wong, RJ				Lin, Shu-Fu; Lin, Jen-Der; Chou, Ting-Chao; Huang, Yu-Yao; Wong, Richard J.			Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELL-LINES; INCREASING INCIDENCE; VALPROIC ACID; IN-VITRO; PACLITAXEL; CARCINOMA; APOPTOSIS; REPAIR; SENSITIVITY	Background: We evaluated the therapeutic effects of the histone deacetylase inhibitor PXD101 alone and in combination with conventional chemotherapy in treating thyroid cancer. Methodology/Principal Findings: We studied eight cell lines from four types of thyroid cancer (papillary, follicular, anaplastic and medullary). The cytotoxicity of PXD101 alone and in combination with three conventional chemotherapeutic agents (doxorubicin, paclitaxel and docetaxel) was measured using LDH assay. Western blot assessed expression of acetylation of histone H3, histone H4 and tubulin, proteins associated with apoptosis, RAS/RAF/ERK and PI3K/AKT/mTOR signaling pathways, DNA damage and repair. Apoptosis and intracellular reactive oxygen species (ROS) were measured by flow cytometry. Mice bearing flank anaplastic thyroid cancers (ATC) were daily treated with intraperitoneal injection of PXD101 for 5 days per week. PXD101 effectively inhibited thyroid cancer cell proliferation in a dose-dependent manner. PXD101 induced ROS accumulation and inhibited RAS/RAF/ERK and PI3K/mTOR pathways in sensitive cells. Double-stranded DNA damage and apoptosis were induced by PXD101 in both sensitive and resistant cell lines. PXD101 retarded growth of 8505C ATC xenograft tumors with promising safety. Combination therapy of PXD101with doxorubicin and paclitaxel demonstrated synergistic effects against four ATC lines in vitro. Conclusions: PXD101 represses thyroid cancer proliferation and has synergistic effects in combination with doxorubicin and paclitaxel in treating ATC. These findings support clinical trials using PXD101 for patients with this dismal disease.	[Lin, Shu-Fu; Lin, Jen-Der; Huang, Yu-Yao] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan; [Chou, Ting-Chao] Mem Sloan Kettering Canc Ctr, Lab Preclin Pharmacol Core, New York, NY 10021 USA; [Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Chang Gung Memorial Hospital; Chang Gung University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Huang, YY (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan.	yyh@cgmh.org.tw; wongr@mskcc.org	Chou, Ting-Chao/B-4111-2009; Chou, Ting-Chao/AAA-7881-2020	Chou, Ting-Chao/0000-0002-3340-1594; Chou, Ting-Chao/0000-0002-3340-1594; Huang, Yu-Yao/0000-0002-4501-6140; Lin, Shu-Fu/0000-0001-8877-9685	Chang Gung Memorial Hospital; Chang Gung University [CMRPG3A0161, CMRPG3A0162, CMRPG3A0163, CMRPG370581, CMRPG370582, CMRPG370583]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University	This work was supported by Chang Gung Memorial Hospital and Chang Gung University (CMRPG3A0161, CMRPG3A0162, CMRPG3A0163, CMRPG370581, CMRPG370582 and CMRPG370583)(http://www.cgmh.org.tw/. http://www.cgu.edu.tw/bin/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Borbone E, 2010, ONCOGENE, V29, P105, DOI 10.1038/onc.2009.306; Catalano MG, 2007, ENDOCR-RELAT CANCER, V14, P839, DOI 10.1677/ERC-07-0096; Catalano MG, 2006, J ENDOCRINOL, V191, P465, DOI 10.1677/joe.1.06970; CHAN D, 2013, J CANCER RES CLIN, P24064; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; Greenberg VL, 2001, THYROID, V11, P315, DOI 10.1089/10507250152039046; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; Huang YY, 2007, J CLIN ENDOCR METAB, V92, P1965, DOI 10.1210/jc.2007-0040; Hwang JJ, 2010, J UROLOGY, V184, P2557, DOI 10.1016/j.juro.2010.07.035; Ito Y, 2013, NAT REV ENDOCRINOL, V9, P178, DOI 10.1038/nrendo.2012.257; Jin N, 2011, CLIN CANCER RES, V17, P6482, DOI 10.1158/1078-0432.CCR-11-0933; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Lassen U, 2010, BRIT J CANCER, V103, P12, DOI 10.1038/sj.bjc.6605726; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046726; Luong QT, 2006, CLIN CANCER RES, V12, P5570, DOI 10.1158/1078-0432.CCR-06-0367; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mitsiades CS, 2005, CLIN CANCER RES, V11, P3958, DOI 10.1158/1078-0432.CCR-03-0776; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; Plumb JA, 2003, MOL CANCER THER, V2, P721; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Wirth LJ, 2013, NEW ENGL J MED, V368, P664, DOI 10.1056/NEJMcpc1210080; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Zarnegar R, 2002, SURGERY, V132, P984, DOI 10.1067/msy.2002.128690	52	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77684	10.1371/journal.pone.0077684	http://dx.doi.org/10.1371/journal.pone.0077684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155971	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300105
J	Ruan, ZY; Zhai, Y; Song, JL; Shi, YH; Li, K; Zhao, B; Yan, YC				Ruan, Zhiyong; Zhai, Yi; Song, Jinlong; Shi, Yanhua; Li, Kang; Zhao, Bin; Yan, Yanchun			Molecular Cloning and Characterization of a Newly Isolated Pyrethroid-Degrading Esterase Gene from a Genomic Library of Ochrobactrum anthropi YZ-1	PLOS ONE			English	Article							HYDROLYZING CARBOXYLESTERASE GENE; LAMBDA-CYHALOTHRIN; BIOCHEMICAL-CHARACTERIZATION; PURIFICATION; INSECTICIDES; STRAIN; BIODEGRADATION; LIVER; FATE	A novel pyrethroid-degrading esterase gene pytY was isolated from the genomic library of Ochrobactrum anthropi YZ-1. It possesses an open reading frame (ORF) of 897 bp. Blast search showed that its deduced amino acid sequence shares moderate identities (30% to 46%) with most homologous esterases. Phylogenetic analysis revealed that PytY is a member of the esterase VI family. pytY showed very low sequence similarity compared with reported pyrethroid-degrading genes. PytY was expressed, purified, and characterized. Enzyme assay revealed that PytY is a broad-spectrum degrading enzyme that can degrade various pyrethroids. It is a new pyrethroid-degrading gene and enriches genetic resource. Kinetic constants of Km and Vmax were 2.34 mmol.L-1 21 and 56.33 nmol min(-1), respectively, with lambda-cyhalothrin as substrate. PytY displayed good degrading ability and stability over a broad range of temperature and pH. The optimal temperature and pH were of 35 degrees C and 7.5. No cofactors were required for enzyme activity. The results highlighted the potential use of PytY in the elimination of pyrethroid residuals from contaminated environments.	[Ruan, Zhiyong; Zhao, Bin] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Song, Jinlong; Shi, Yanhua; Yan, Yanchun] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Zhai, Yi] Chongqing Acad Agr Sci, Inst Agr Engn, Chongqing, Peoples R China; [Ruan, Zhiyong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Li, Kang] Natl Inst Food & Drug Control, Inst Biol Prod Control, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; National Institute of Food & Drug Control - China	Zhao, B (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China.	binzhao@mail.hzau.edu.cn; yanyanchun@caas.cn			Hi-Tech Research and Development Program of China [2008AA10Z402]; National Natural Science Foundation of China [31170119]; Basic Research Fund of CAAS [0042012003, 0042011006]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Fund of CAAS	This work was supported by the Hi-Tech Research and Development Program of China (2008AA10Z402), the National Natural Science Foundation of China (31170119), and the Basic Research Fund of CAAS (Nos. 0042012003 and 0042011006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1981, SCIENCE, V211, P132, DOI 10.1126/science.7444456; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiang SW, 1996, PESTIC BIOCHEM PHYS, V54, P181, DOI 10.1006/pest.1996.0022; Choi YJ, 2004, APPL ENVIRON MICROB, V70, P3213, DOI 10.1128/AEM.70.6.3213-3221.2004; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DEMOUTE JP, 1989, PESTIC SCI, V27, P375, DOI 10.1002/ps.2780270406; Fetoui H, 2010, EXP TOXICOL PATHOL, V62, P593, DOI 10.1016/j.etp.2009.08.004; Giri S, 2002, MUTAT RES-GEN TOX EN, V520, P125, DOI 10.1016/S1383-5718(02)00197-3; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Housset P., 2009, Bayer CropScience Journal, V62, P135; Kasai S., 2004, Journal of Pesticide Science, V29, P220, DOI 10.1584/jpestics.29.220; Katsuda Y, 1999, PESTIC SCI, V55, P775, DOI 10.1002/(SICI)1096-9063(199908)55:8&lt;775::AID-PS27&gt;3.0.CO;2-N; Kolaczinski JH, 2004, FOOD CHEM TOXICOL, V42, P697, DOI 10.1016/j.fct.2003.12.008; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Li G, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-38; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Lutnicka H, 1999, WATER RES, V33, P3441, DOI 10.1016/S0043-1354(99)00054-8; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; MIYAMOTO J, 1968, AGR BIOL CHEM TOKYO, V32, P628, DOI 10.1080/00021369.1968.10859116; Sambrook J., 2001, MOL CLONING LAB MANU; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; SMITH TM, 1986, RESIDUE REV, V97, P93; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Stok JE, 2004, J BIOL CHEM, V279, P29863, DOI 10.1074/jbc.M403673200; SUZUKI T, 1978, PESTIC BIOCHEM PHYS, V8, P186, DOI 10.1016/0048-3575(78)90038-X; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velmurugan B, 2007, ENVIRON TOXICOL PHAR, V24, P286, DOI 10.1016/j.etap.2007.07.001; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yang C. R., 2010, PROCESS BIOCHEM, V45, P1937; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P1152, DOI 10.1016/j.fct.2010.02.002; Zhai Y, 2012, J HAZARD MATER, V221, P206, DOI 10.1016/j.jhazmat.2012.04.031; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhang Q, 2010, J ENVIRON SCI, V22, P428, DOI 10.1016/S1001-0742(09)60125-X	37	28	35	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77329	10.1371/journal.pone.0077329	http://dx.doi.org/10.1371/journal.pone.0077329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155944	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300078
J	Ruffinatti, FA; Gilardino, A; Lovisolo, D; Ferraro, M				Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide; Ferraro, Mario			Spatial Wavelet Analysis of Calcium Oscillations in Developing Neurons	PLOS ONE			English	Article							GROWTH CONE; TRANSIENTS; SIGNALS; DIFFERENTIATION; BIOLOGY; CELLS	Calcium signals play a major role in the control of all key stages of neuronal development, and in particular in the growth and orientation of neuritic processes. These signals are characterized by high spatial compartmentalization, a property which has a strong relevance in the different roles of specific neuronal regions in information coding. In this context it is therefore important to understand the structural and functional basis of this spatial compartmentalization, and in particular whether the behavior at each compartment is merely a consequence of its specific geometry or the result of the spatial segregation of specific calcium influx/efflux mechanisms. Here we have developed a novel approach to separate geometrical from functional differences, regardless on the assumptions on the actual mechanisms involved in the generation of calcium signals. First, spatial indices are derived with a wavelet-theoretic approach which define a measure of the oscillations of cytosolic calcium concentration in specific regions of interests (ROIs) along a cell, in our case developing chick ciliary ganglion neurons. The resulting spatial profile demonstrates clearly that different ROIs along the neuron are characterized by specific patterns of calcium oscillations. Next we have investigated whether this inhomogeneity is due just to geometrical factors, namely the surface to volume ratio in the different subcompartments (e.g. soma vs. growth cone) or it depends on their specific biophysical properties. To this aim correlation functions are computed between the activity indices and the surface/volume ratio along the cell: the data thus obtained are validated by a statistical analysis on a dataset of 15 different cells. This analysis shows that whereas in the soma calcium dynamics is highly correlated to the surface/volume ratio, correlations drop in the growth cone-neurite region, suggesting that in this latter case the key factor is the expression of specific mechanisms controlling calcium influx/efflux.	[Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Ferraro, Mario] Univ Turin, Dept Phys, Turin, Italy; [Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide] Univ Turin, NIS Interdept Ctr, Turin, Italy; [Lovisolo, Davide; Ferraro, Mario] Univ Turin, Neurosci Inst Turin, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Ferraro, M (corresponding author), Univ Turin, Dept Phys, Turin, Italy.	ferraro@ph.unito.it	RUFFINATTI, FEDERICO ALESSANDRO/ABA-8065-2020	RUFFINATTI, FEDERICO ALESSANDRO/0000-0002-3084-0380	University of Turin	University of Turin	This research has been performed exclusively thanks to institutional funds of University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1914, DIALOGUES 2 NEW SCI; Bussow R, 2007, MECH SYST SIGNAL PR, V21, P2970, DOI 10.1016/j.ymssp.2007.06.001; Berrill NJ, 1935, J MORPHOL, V56, P353, DOI 10.1002/jmor.1050570204; Bottenstein JE, 1983, CURRENT METHODS CELL, V4, P107; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Debnath L, 1998, INT J MATH EDUC SCI, V29, P677; Distasi C, 1998, EUR J NEUROSCI, V10, P2276, DOI 10.1046/j.1460-9568.1998.00239.x; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Munck S, 2002, CELL CALCIUM, V31, P27, DOI 10.1054/ceca.2001.0253; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Ruffinatti FA, 2011, J NEUROSCI METH, V199, P310, DOI 10.1016/j.jneumeth.2011.05.009; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tang FJ, 2003, J NEUROSCI, V23, P927; Thompson D.W, 1917, GROWTH FORM; Thul R, 2008, ADV EXP MED BIOL, V641, P1; Van Acker K, 2000, J NEUROPHYSIOL, V83, P1052, DOI 10.1152/jn.2000.83.2.1052; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yamada RX, 2008, J NEUROSCI, V28, P4613, DOI 10.1523/JNEUROSCI.0019-08.2008; ZADOR A, 1994, J NEUROSCI, V14, P4705; Zamburlin P, 2009, J NEUROSCI METH, V185, P178, DOI 10.1016/j.jneumeth.2009.09.013; Zamburlin P, 2013, PFLUGERS AR IN PRESS; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75986	10.1371/journal.pone.0075986	http://dx.doi.org/10.1371/journal.pone.0075986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155880	Green Submitted, Green Published, gold			2022-12-25	WOS:000325887300014
J	Oster, AM; Russell, K; Wiegand, RE; Valverde, E; Forrest, DW; Cribbin, M; Le, BC; Paz-Bailey, G				Oster, Alexandra M.; Russell, Kate; Wiegand, Ryan E.; Valverde, Eduardo; Forrest, David W.; Cribbin, Melissa; Le, Binh C.; Paz-Bailey, Gabriela		NHBS Study Grp	HIV Infection and Testing among Latino Men Who Have Sex with Men in the United States: The Role of Location of Birth and Other Social Determinants	PLOS ONE			English	Article							VIRAL-HEPATITIS; HEALTH-CARE; BLACK-MEN; YOUNG MEN; SURVEILLANCE; PREVENTION; PREVALENCE; IMPACT; GAY; DISPARITIES	Background: In the United States, Latino men who have sex with men (MSM) are disproportionately affected by HIV. Latino MSM are a diverse group who differ culturally based on their countries or regions of birth and their time in the United States. We assessed differences in HIV prevalence and testing among Latino MSM by location of birth, time since arrival, and other social determinants of health. Methods: For the 2008 National HIV Behavioral Surveillance System, a cross-sectional survey conducted in large US cities, MSM were interviewed and tested for HIV infection. We used generalized estimating equations to test associations between various factors and 1) prevalent HIV infection and 2) being tested for HIV infection in the past 12 months. Results: Among 1734 Latino MSM, HIV prevalence was 19%. In multivariable analysis, increasing age, low income, and gay identity were associated with HIV infection. Moreover, men who were U.S.-born or who arrived >= 5 years ago had significantly higher HIV prevalence than recent immigrants. Among men not reporting a previous positive HIV test, 63% had been tested for HIV infection in the past 12 months; recent testing was most strongly associated with having seen a health care provider and disclosing male-male attraction/sexual behavior to a health care provider. Conclusions: We identified several social determinants of health associated with HIV infection and testing among Latino MSM. Lower HIV prevalence among recent immigrants contrasts with higher prevalence among established immigrants and suggests a critical window of opportunity for HIV prevention, which should prioritize those with low income, who are at particular risk for HIV infection. Expanding health care utilization and encouraging communication with health care providers about sexual orientation may increase testing.	[Oster, Alexandra M.; Russell, Kate; Wiegand, Ryan E.; Valverde, Eduardo; Cribbin, Melissa; Le, Binh C.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Forrest, David W.] Univ Miami, Miami, FL USA	Centers for Disease Control & Prevention - USA; University of Miami	Oster, AM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	AOster@cdc.gov		Woodworth, Kate/0000-0001-9343-3355; Wiegand, Ryan/0000-0002-9486-1850	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The National HIV Behavioral Surveillance System is funded by the Centers for Disease Control and Prevention (CDC). Study design and data collection are conducted by funded sites in accordance with a standardized protocol developed by CDC. Data analysis and preparation of the manuscript were conducted by CDC staff.	Allen DR, 2009, PUBLIC HEALTH REP, V124, P26, DOI 10.1177/003335490912400106; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2001, SOCIAL DISCRIMINATIO; Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Behel SK, 2008, J URBAN HEALTH, V85, P727, DOI 10.1007/s11524-008-9303-x; Beltran VM, 2011, PUBLIC HEALTH REP, V126, P41, DOI 10.1177/00333549111260S309; Bianchi FT, 2007, CULT HEALTH SEX, V9, P505, DOI 10.1080/13691050701243547; Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Espinoza L, 2008, JAIDS-J ACQ IMM DEF, V49, P94, DOI 10.1097/QAI.0b013e3181820129; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Herek GM, 1999, AM BEHAV SCI, V42, P1126; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; London A S, 1999, J Immigr Health, V1, P195, DOI 10.1023/A:1021811917532; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Malebranche DJ, 2004, J NATL MED ASSOC, V96, P97; Mancl LA, 2001, BIOMETRICS, V57, P126, DOI 10.1111/j.0006-341X.2001.00126.x; Pew Hispanic Center, 2012, STAT PORTR HISP US 2; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Satcher D, 2010, PUBLIC HEALTH REP, V125, P6, DOI 10.1177/00333549101250S402; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; World Health Organization, 2010, HLTH MIGR WAY FORW R	26	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73779	10.1371/journal.pone.0073779	http://dx.doi.org/10.1371/journal.pone.0073779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24147151	Green Published, gold			2022-12-25	WOS:000324338200079
J	Zhang, Q; Sun, J; Liu, SZ; Wei, QP				Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping			Manure Refinement Affects Apple Rhizosphere Bacterial Community Structure: A Study in Sandy Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PYROSEQUENCING REVEALS; LOESS PLATEAU; LAND-USE; DIVERSITY; LANDSCAPE; ROOTS; CHINA; SCALE	We used DNA-based pyrosequencing to characterize the bacterial community structure of the sandy soil of an apple orchard with different manure ratios. Five manure percentages (5%, 10%, 15%, 20% and 25%) were examined. More than 10,000 valid reads were obtained for each replicate. The communities were composed of five dominant groups (Proteobacteria, Actinobacteria, Chloroflexi, Acidobacteria and Bacteroidetes), of which Proteobacteria content gradually decreased from 41.38% to 37.29% as manure ratio increased from 0% to 25%, respectively. Redundancy analysis showed that 37 classes were highly correlated with manure ratio, 18 of which were positively correlated. Clustering revealed that the rhizosphere samples were grouped into three components: low manure (control, 5%) treatment, medium manure (10%, 15%) treatment and high manure (20%, 25%) treatment. Venn analysis of species types of these three groups revealed that the bacteria community difference was primarily reflected by quantity ratio rather than species variety. Although greater manure content led to higher soil organic matter content, the medium manure improved soil showed the highest urease activity and saccharase activity, while 5% to 20% manure ratio improvement also resulted in higher bacteria diversity than control and 25% manure ratio treatment. Our experimental results suggest that the use of a proper manure ratio results in significantly higher soil enzyme activity and different bacteria community patterns, whereas the use of excessive manure amounts has negative effect on soil quality.	[Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]	China Agriculture Research System	China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), http://english.agri.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alkorta Itziar, 2003, Rev Environ Health, V18, P65; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bougnom B. P., 2012, Organic Agriculture, V2, P1, DOI 10.1007/s13165-012-0020-0; Bougnom B.P., 2009, BODENKULT, V60, P5; Chenu C, 2000, SOIL SCI SOC AM J, V64, P1479, DOI 10.2136/sssaj2000.6441479x; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Feris K, 2003, APPL ENVIRON MICROB, V69, P5563, DOI 10.1128/AEM.69.9.5563-5573.2003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kindler R, 2006, SOIL BIOL BIOCHEM, V38, P2860, DOI 10.1016/j.soilbio.2006.04.047; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwon S, 2010, J MICROBIOL BIOTECHN, V20, P1717, DOI 10.4014/jmb.1007.07012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Makhalanyane TP, 2012, ENV MICROBIOLOGY REP; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Militon C, 2010, FEMS MICROBIOL ECOL, V74, P669, DOI 10.1111/j.1574-6941.2010.00982.x; MILLER S.S., 2002, J TREE FRUIT PRODUCT, V31, P11, DOI DOI 10.1300/J072V03N01_; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Francisco SS, 2011, J SCI FOOD AGR, V91, P1569, DOI 10.1002/jsfa.4349; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tekere M, 2012, AFR J MICROBIOL RES, V6, P4993, DOI 10.5897/AJMR12.250; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; WU QT, 1994, CAN J MICROBIOL, V40, P916, DOI 10.1139/m94-147	43	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76937	10.1371/journal.pone.0076937	http://dx.doi.org/10.1371/journal.pone.0076937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155909	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300043
J	Montanari, S; Saeed, M; Knabel, M; Kim, Y; Troggio, M; Malnoy, M; Velasco, R; Fontana, P; Won, K; Durel, CE; Perchepied, L; Schaffer, R; Wiedow, C; Bus, V; Brewer, L; Gardiner, SE; Crowhurst, RN; Chagne, D				Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Kim, YoonKyeong; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo; Won, KyungHo; Durel, Charles-Eric; Perchepied, Laure; Schaffer, Robert; Wiedow, Claudia; Bus, Vincent; Brewer, Lester; Gardiner, Susan E.; Crowhurst, Ross N.; Chagne, David			Identification of Pyrus Single Nucleotide Polymorphisms (SNPs) and Evaluation for Genetic Mapping in European Pear and Interspecific Pyrus Hybrids	PLOS ONE			English	Article							LINKAGE MAPS; GENOME SEQUENCE; VENTURIA-PIRINA; DIVERSITY; JAPANESE; FRUIT; RESISTANCE	We have used new generation sequencing (NGS) technologies to identify single nucleotide polymorphism (SNP) markers from three European pear (Pyrus communis L.) cultivars and subsequently developed a subset of 1096 pear SNPs into high throughput markers by combining them with the set of 7692 apple SNPs on the IRSC apple Infinium (R) II 8K array. We then evaluated this apple and pear Infinium (R) II 9K SNP array for large-scale genotyping in pear across several species, using both pear and apple SNPs. The segregating populations employed for array validation included a segregating population of European pear ('Old Home' x 'Louise Bon Jersey') and four interspecific breeding families derived from Asian (P. pyrifolia Nakai and P. bretschneideri Rehd.) and European pear pedigrees. In total, we mapped 857 polymorphic pear markers to construct the first SNP-based genetic maps for pear, comprising 78% of the total pear SNPs included in the array. In addition, 1031 SNP markers derived from apple (13% of the total apple SNPs included in the array) were polymorphic and were mapped in one or more of the pear populations. These results are the first to demonstrate SNP transferability across the genera Malus and Pyrus. Our construction of high density SNP-based and gene-based genetic maps in pear represents an important step towards the identification of chromosomal regions associated with a range of horticultural characters, such as pest and disease resistance, orchard yield and fruit quality.	[Montanari, Sara; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo] Fdn Edmund Mach, Ist Agr San Michele Adige, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Wiedow, Claudia; Gardiner, Susan E.; Chagne, David] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] Univ Angers, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] AgroCampus Ouest, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Saeed, Munazza] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Knaebel, Mareike; Schaffer, Robert] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Kim, YoonKyeong; Won, KyungHo] Pear Res Stn, Natl Inst Hort & Herbal Sci, Naju, South Korea; [Schaffer, Robert; Crowhurst, Ross N.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Bus, Vincent] Hawkes Bay Res Ctr, Havelock North, New Zealand; [Brewer, Lester] Motueka Res Ctr, Motueka, New Zealand	Fondazione Edmund Mach; New Zealand Institute for Plant & Food Research Ltd; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Massey University; University of Auckland; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; New Zealand Institute for Plant & Food Research Ltd	Chagne, D (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand.	David.Chagne@plantandfood.co.nz	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" [27744]; National Institute of Horticultural and Herbal Science grant	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future"; National Institute of Horticultural and Herbal Science grant	SM is funded by the FEM PhD school. MS is funded by a Massey University Doctoral Scholarship. MK is funded by the New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" (Contract number: 27744). The visiting scientist fellowship of YKK to PFR was funded by a National Institute of Horticultural and Herbal Science grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brewer L, 2005, ACTA HORTIC, P595, DOI 10.17660/ActaHortic.2005.671.83; Brewer L. R., 2002, Acta Horticulturae, P571; Brewer LR, 2009, NEW ZEAL J CROP HORT, V37, P211, DOI 10.1080/01140670909510266; Bus V, 2013, ACTA HORTIC, V976, P493, DOI 10.17660/ActaHortic.2013.976.69; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Dondini L, 2004, MOL BREEDING, V14, P407, DOI 10.1007/s11032-004-0505-y; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hand ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-219; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iketani H, 2001, BREEDING SCI, V51, P179, DOI 10.1270/jsbbs.51.179; Jacob HB, 1998, ACTA HORTIC, P169, DOI 10.17660/ActaHortic.1998.475.20; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu Min, 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P303; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pierantoni L, 2004, THEOR APPL GENET, V109, P1519, DOI 10.1007/s00122-004-1775-9; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Terakami S, 2013, ACTA HORTIC, V976, P463; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321; Yamamoto Toshiya, 2009, V6, P163, DOI 10.1007/978-0-387-77491-6_8	47	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77022	10.1371/journal.pone.0077022	http://dx.doi.org/10.1371/journal.pone.0077022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155917	Green Published, Green Submitted, gold			2022-12-25	WOS:000325887300051
J	Montanari, S; Louys, J; Price, GJ				Montanari, Shaena; Louys, Julien; Price, Gilbert J.			Pliocene Paleoenvironments of Southeastern Queensland, Australia Inferred from Stable Isotopes of Marsupial Tooth Enamel	PLOS ONE			English	Article							CHINCHILLA LOCAL FAUNA; EASTERN AUSTRALIA; LATE PLEISTOCENE; OXYGEN ISOTOPES; ATMOSPHERIC CO2; CARBON ISOTOPES; BONE PHOSPHATE; ICE CORE; ECOLOGY; BIOGEOCHEMISTRY	The Chinchilla Local Fauna is a diverse assemblage of both terrestrial and aquatic Pliocene vertebrates from the fluviatile Chinchilla Sand deposits of southeastern Queensland, Australia. It represents one of Australia's few but exceptionally rich Pliocene vertebrate localities, and as such is an important source of paleoecological data concerning Pliocene environmental changes and its effects on ecosystems. Prior inferences about the paleoenvironment of this locality made on the basis of qualitative observations have ranged from grassland to open woodland to wetland. Examination of the carbon and oxygen isotopes in the tooth enamel of marsupials from this site represents a quantitative method for inferring the paleoenvironments and paleoecology of the fossil fauna. Results from Chinchilla show that Protemnodon sp. indet. consumed both C3 and C4 photosynthesis plant types (mean delta C-13= -14.5 +/- 2.0%), and therefore probably occupied a mixed vegetation environment. Macropus sp. indet. from Chinchilla also consumed a mixed diet of both C3 and C4 plants, with more of a tendency for C4 plant consumption (mean delta C-13= -10.3 +/- 2.3%). Interestingly, their isotopic dietary signature is more consistent with tropical and temperate kangaroo communities than the sub-tropical communities found around Chinchilla today. Other genera sampled in this study include the extinct kangaroo Troposodon sp. indet. and the fossil diprotodontid Euryzygoma dunense each of which appear to have occupied distinct dietary niches. This study suggests that southeastern Queensland hosted a mosaic of tropical forests, wetlands and grasslands during the Pliocene and was much less arid than previously thought.	[Montanari, Shaena] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Louys, Julien; Price, Gilbert J.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia	American Museum of Natural History (AMNH); University of Queensland	Montanari, S (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	smontanari@amnh.org	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	National Science Foundation; Richard Gilder Graduate School; University of Queensland; University of Queensland [2012003222]; Australian Research Council [DE120101533]; Australian Research Council (ARC) [DP0881279]	National Science Foundation(National Science Foundation (NSF)); Richard Gilder Graduate School; University of Queensland(University of Queensland); University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Australian Research Council (ARC)(Australian Research Council)	SM was supported by the National Science Foundation Graduate Research Fellowship and the Richard Gilder Graduate School. JL is supported by University of Queensland Postdoctoral Fellowship and University of Queensland Early Career Research Grant 2012003222. GJP is supported by Australian Research Council grant DE120101533 and Australian Research Council (ARC) Discovery Grant DP0881279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer M, 1994, HIST AUSTR VEGETATIO, P80; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; BARTHOLOMAI A, 1975, Memoirs of the Queensland Museum, V17, P195; Bartholomai A., 1976, BUREAU MINERAL RESOU, V166, P151; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson L, 2004, ALCHERINGA, V28, P275, DOI 10.1080/03115510408619285; Dawson L, 2004, ALCHERINGA, V28, P267, DOI 10.1080/03115510408619284; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; Forbes MS, 2010, PALAEOGEOGR PALAEOCL, V291, P319, DOI 10.1016/j.palaeo.2010.03.003; Fraser RA, 2008, PALAEOGEOGR PALAEOCL, V269, P66, DOI 10.1016/j.palaeo.2008.08.004; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GAFFNEY E S, 1981, American Museum Novitates, P1; GAFFNEY ES, 1979, J PALEONTOL, V53, P1354; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Grocke DR, 1997, AUST J BOT, V45, P607, DOI 10.1071/BT96040; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; Hill Robert S., 1992, Beagle, V9, P1; Hill RS, 1994, HIST AUSTR VEGETATIO; HILLSON S, 1996, DENT ANTHR; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; LEETHORP JA, 1989, J HUM EVOL, V18, P183, DOI 10.1016/0047-2484(89)90048-1; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; LOCKER S, 1986, INITIAL REP DEEP SEA, V90, P1079; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; Mackness BS, 2000, AUST J EARTH SCI, V47, P807, DOI 10.1046/j.1440-0952.2000.00812.x; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McGowran B., 2000, Memoir of the Association of Australasian Palaeontologists, V23, P405; Murphy BP, 2007, GEOCHIM COSMOCHIM AC, V71, P3847, DOI 10.1016/j.gca.2007.05.012; Murphy BP, 2007, FUNCT ECOL, V21, P757, DOI 10.1111/j.1365-2435.2007.01284.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLSON S L, 1975, Emu, V75, P49; OLSON S L, 1977, Emu, V77, P127; Price GJ, 2012, EPISODES, V35, P160, DOI 10.18814/epiiugs/2012/v35i1/015; Price GJ, 2008, QUATERNARY SCI REV, V27, P2516, DOI 10.1016/j.quascirev.2008.08.026; Price GJ, 2009, REC AUST MUS, V61, P39, DOI 10.3853/j.0067-1975.61.2009.1518; Prideaux GJ, 2007, NATURE, V445, P422, DOI 10.1038/nature05471; Sponheimer M, 1999, J ARCHAEOL SCI, V26, P723, DOI 10.1006/jasc.1998.0388; Tedford R. H., 1992, Beagle, V9, P173; Tedford R. H., 2006, ALCHERINGA AUSTRALAS, V30, P313, DOI [10.1080/03115510609506870, DOI 10.1080/03115510609506870]; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Woods J.T., 1960, J GEOL SOC AUST, V7, P393; Wroe S, 2000, ALCHERINGA, V24, P319, DOI 10.1080/03115510008619535; Yeakel JD, 2007, P ROY SOC B-BIOL SCI, V274, P1723, DOI 10.1098/rspb.2007.0330	52	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66221	10.1371/journal.pone.0066221	http://dx.doi.org/10.1371/journal.pone.0066221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	24155917	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400088
J	Dahal, N; Abdelhamed, H; Lu, JJ; Karsi, A; Lawrence, ML				Dahal, Neeti; Abdelhamed, Hossam; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.			Tricarboxylic Acid Cycle and One-Carbon Metabolism Pathways Are Important in Edwardsiella ictaluri Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUMARATE REDUCTASE; CHANNEL CATFISH; SUCCINATE-DEHYDROGENASE; MUTANT; REPLACEMENT; EXPRESSION; VACCINE; GENES; LIVE	Edwardsiella ictaluri is a Gram-negative facultative intracellular pathogen causing enteric septicemia of channel catfish (ESC). The disease causes considerable economic losses in the commercial catfish industry in the United States. Although antibiotics are used as feed additive, vaccination is a better alternative for prevention of the disease. Here we report the development and characterization of novel live attenuated E. ictaluri mutants. To accomplish this, several tricarboxylic acid cycle (sdhC, mdh, and frdA) and one-carbon metabolism genes (gcvP and glyA) were deleted in wild type E. ictaluri strain 93146 by allelic exchange. Following bioluminescence tagging of the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, Delta gcvP, and Delta glyA mutants, their dissemination, attenuation, and vaccine efficacy were determined in catfish fingerlings by in vivo imaging technology. Immunogenicity of each mutant was also determined in catfish fingerlings. Results indicated that all of the E. ictaluri mutants were attenuated significantly in catfish compared to the parent strain as evidenced by 2,265-fold average reduction in bioluminescence signal from all the mutants at 144 h post-infection. Catfish immunized with the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, and Delta glyA mutants had 100% relative percent survival (RPS), while E. ictaluri Delta gcvP vaccinated catfish had 31.23% RPS after re-challenge with the wild type E. ictaluri.	[Dahal, Neeti; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.] Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA; [Abdelhamed, Hossam] Benha Univ, Fac Vet Med, Dept Fish Dis & Management, Moshtohor Toukh, Egypt	Mississippi State University; Egyptian Knowledge Bank (EKB); Benha University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA.	karsi@cvm.msstate.edu; lawrence@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019; Dahanukar, Neelesh/B-2816-2012	Karsi, Attila/0000-0001-6845-3346; Dahanukar, Neelesh/0000-0001-7162-9023; Padhye, Anand/0000-0002-5971-4759; Molur, Sanjay/0000-0001-8230-518X; Modak, Nikhil/0000-0003-3303-7056	United States Department of Agriculture [2009-65119-05671]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The research reported herein was supported by United States Department of Agriculture grant #2009-65119-05671 to MLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; [Anonymous], 2006, CASE SUMMARY REPORT; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Booth NJ, 2006, J AQUAT ANIM HEALTH, V18, P101, DOI 10.1577/H05-025.1; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Ge ZM, 2000, MICROB PATHOGENESIS, V29, P279, DOI 10.1006/mpat.2000.0391; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Karsi A, 2007, PLASMID, V57, P286, DOI 10.1016/j.plasmid.2006.11.002; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karsi A, 2009, APPL ENVIRON MICROB, V75, P2166, DOI 10.1128/AEM.02449-08; Klesius PH, 1997, AQUACULTURE, V157, P147, DOI 10.1016/S0044-8486(97)00076-8; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lawrence ML, 1997, VET MICROBIOLOGY PAR; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MEEDEL TH, 1974, J BACTERIOL, V118, P905, DOI 10.1128/JB.118.3.905-910.1974; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; PLAMANN MD, 1983, MOL GEN GENET, V192, P15, DOI 10.1007/BF00327641; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; STAUFFER LT, 1994, GENE, V142, P17, DOI 10.1016/0378-1119(94)90349-2; Thune RL, 1999, J AQUAT ANIM HEALTH, V11, P358, DOI 10.1577/1548-8667(1999)011&lt;0358:AAMOEI&gt;2.0.CO;2; USDA, 2003, HIGHL NAHMS CATF 2 2; Waterstrat PR, 1988, J FISH DIS, V289-294; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	35	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65973	10.1371/journal.pone.0065973	http://dx.doi.org/10.1371/journal.pone.0065973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762452	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800082
